PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Balasubramaniyan, N; Devereaux, MW; Orlicky, DJ; Sokol, RJ; Suchy, FJ				Balasubramaniyan, Natarajan; Devereaux, Michael W.; Orlicky, David J.; Sokol, Ronald J.; Suchy, Frederick J.			miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; SALT EXPORT PUMP; NUCLEAR RECEPTORS; EMERGING ROLES; BILE; LIVER; ACID; MICRORNAS; TRANSPORTERS; GENES	ATP-binding cassette, subfamily B member 11 (ABCB11) is an efflux transporter for bile acids on the liver canalicular membrane. The expression of this transporter is reduced in cholestasis; however, the mechanisms contributing to this reduction are unclear. In this study, we sought to determine whether miR-199a-5p contributes to the depletion of ABCB11/Abcb11 in cholestasis in mice. In a microRNA (miRNA) screen of mouse liver after common bile duct ligation (CBDL), we found that miR-199a-5p was significantly upregulated by approximately fourfold. In silico analysis predicted that miR-199a-5p would target the 3'-untranslated region (3'-UTR) of ABCB11/Abcb11 mRNA. The expression of ABCB11-3'-UTR luciferase construct in Huh-7 cells was markedly inhibited by cotransfection of a miRNA-199a-5p mimic, which was reversed by an miRNA-199a-5p mimic inhibitor. We also show treatment of mice after CBDL with the potent nuclear receptor FXR agonist obeticholic acid (OCA) significantly increased Abcbll mRNA and protein and decreased miR-199a-5p expression. Computational mapping revealed a well-conserved FXR-binding site (FXRE) in the promoter of the gene encoding miR199a-5, termed miR-199a-2. Electromobility shift, chromatin immunoprecipitation, and miR199a-2 promoter-luciferase assays confirmed that this binding site was functional. Finally, CBDL in mice led to depletion of nuclear repressor NcoR1 binding at the miR199a-2 promoter, which facilitates transcription of miR199a-2. In CBDL mice treated with OCA, NcoR1 recruitment to the miR199a-2 FXRE was maintained at levels found in sham-operated mice. In conclusion, we demonstrate that miR-199a-5p is involved in regulating ABCB11/Abcb11 expression, is aberrantly upregulated in obstructive cholestasis, and is downregulated by the FXR agonist OCA.	[Balasubramaniyan, Natarajan; Devereaux, Michael W.; Sokol, Ronald J.; Suchy, Frederick J.] Childrens Hosp Colorado, Digest Hlth Inst, Dept Pediat, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Sch Med, 13123 East 16th Ave, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Suchy, FJ (corresponding author), Childrens Hosp Colorado, Digest Hlth Inst, Dept Pediat, Aurora, CO 80045 USA.	Frederick.suchy@childrenscoloraao.org		Orlicky, David/0000-0002-0417-1400; Balasubramabiyan, Natarajan/0000-0002-8952-0920; Sokol, Ronald/0000-0001-7433-4095				Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; Alles J, 2019, NUCLEIC ACIDS RES, V47, P3353, DOI 10.1093/nar/gkz097; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Ananthanarayanan M, 2004, J BIOL CHEM, V279, P54348, DOI 10.1074/jbc.M410021200; Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Balasubramaniyan N, 2019, HEPATOL COMMUN, V3, P1674, DOI 10.1002/hep4.1433; Balasubramaniyan N, 2016, AM J PHYSIOL-GASTR L, V310, pG618, DOI 10.1152/ajpgi.00363.2015; Balasubramaniyan N, 2012, AM J PHYSIOL-GASTR L, V302, pG937, DOI 10.1152/ajpgi.00441.2011; Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Chai J, 2011, J GASTROINTEST SURG, V15, P996, DOI 10.1007/s11605-011-1473-2; Chen HL, 2008, PEDIATR RES, V63, P667, DOI 10.1203/PDR.0b013e318170a6b5; Chopra AR, 2011, CELL METAB, V13, P35, DOI 10.1016/j.cmet.2010.12.001; Dai BH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.134; Fehlmann T, 2019, RNA BIOL, V16, P93, DOI 10.1080/15476286.2018.1559689; Fiorucci S, 2019, HANDB EXP PHARMACOL, V256, P283, DOI 10.1007/164_2019_227; Gege C, 2019, HANDB EXP PHARMACOL, V256, P167, DOI 10.1007/164_2019_232; GOULD SJ, 1988, ANAL BIOCHEM, V175, P5, DOI 10.1016/0003-2697(88)90353-3; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haenisch S, 2014, BRIT J CLIN PHARMACO, V77, P587, DOI 10.1111/bcp.12251; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Kanda T, 2010, HEPATO-GASTROENTEROL, V57, P1013; Keitel V, 2019, HANDB EXP PHARMACOL, V256, P299, DOI 10.1007/164_2019_231; Kemper JK, 2011, BBA-MOL BASIS DIS, V1812, P842, DOI 10.1016/j.bbadis.2010.11.011; Kong B, 2012, HEPATOLOGY, V56, P1034, DOI 10.1002/hep.25740; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lee JM, 2000, GASTROENTEROLOGY, V118, P163, DOI 10.1016/S0016-5085(00)70425-2; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Otsuka M, 2017, J HUM GENET, V62, P75, DOI 10.1038/jhg.2016.53; Oulas A, 2015, METHODS MOL BIOL, V1269, P207, DOI 10.1007/978-1-4939-2291-8_13; Perino A, 2021, PHYSIOL REV, V101, P683, DOI 10.1152/physrev.00049.2019; Plotnikova O, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00933; Sakurai K, 2011, CANCER RES, V71, P1680, DOI 10.1158/0008-5472.CAN-10-2345; Schueller F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010261; Sohail MI, 2017, MOL PHARMACOL, V92, P401, DOI 10.1124/mol.117.108688; Soroka CJ, 2014, MOL ASPECTS MED, V37, P3, DOI 10.1016/j.mam.2013.05.001; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Thoeni C, 2019, CAN J GASTROENTEROL, V2019, DOI 10.1155/2019/1085717; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Yang ZH, 2015, ACTA PHARM SIN B, V5, P145, DOI 10.1016/j.apsb.2015.01.002; Yang ZH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-31; Zhan YY, 2017, ONCOTARGET, V8, P67169, DOI 10.18632/oncotarget.18052; Zhang CY, 2019, ARTIF CELL NANOMED B, V47, P4110, DOI 10.1080/21691401.2019.1683566; Zollner G, 2003, J HEPATOL, V39, P480, DOI 10.1016/S0168-8278(03)00228-9; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	50	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101400	10.1016/j.jbc.2021.101400	http://dx.doi.org/10.1016/j.jbc.2021.101400			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774795	gold, Green Published			2022-12-26	WOS:000748397200012
J	Simoes, RF; Pino, R; Moreira-Soares, M; Kovarova, J; Neuzil, J; Travasso, R; Oliveira, PJ; Cunha-Oliveira, T; Pereira, FB				Simoes, Rui F.; Pino, Rute; Moreira-Soares, Mauricio; Kovarova, Jaromira; Neuzil, Jiri; Travasso, Rui; Oliveira, Paulo J.; Cunha-Oliveira, Teresa; Pereira, Francisco B.			Quantitative analysis of neuronal mitochondrial movement reveals patterns resulting from neurotoxicity of rotenone and 6-hydroxydopamine	FASEB JOURNAL			English	Article						exploratory data analysis; live cell imaging; mitochondria movement; neurotoxicants; principal component analysis; trajectory descriptors	AXONAL-TRANSPORT; PARKINSONS-DISEASE; OXIDATIVE DAMAGE; ANIMAL-MODELS; TRAFFICKING; MICROTUBULES; TRANSMISSION; MICROSCOPY; DENDRITES; TOXICITY	Alterations in mitochondrial dynamics, including their intracellular trafficking, are common early manifestations of neuronal degeneration. However, current methodologies used to study mitochondrial trafficking events rely on parameters that are primarily altered in later stages of neurodegeneration. Our objective was to establish a reliable applied statistical analysis to detect early alterations in neuronal mitochondrial trafficking. We propose a novel quantitative analysis of mitochondria trajectories based on innovative movement descriptors, including straightness, efficiency, anisotropy, and kurtosis. We evaluated time- and dose-dependent alterations in trajectory descriptors using biological data from differentiated SH-SY5Y cells treated with the mitochondrial toxicants 6-hydroxydopamine and rotenone. MitoTracker Red CMXRos-labelled mitochondria movement was analyzed by total internal reflection fluorescence microscopy followed by computational modelling to describe the process. Based on the aforementioned trajectory descriptors, this innovative analysis of mitochondria trajectories provides insights into mitochondrial movement characteristics and can be a consistent and sensitive method to detect alterations in mitochondrial trafficking occurring in the earliest time points of neurodegeneration.	[Simoes, Rui F.; Oliveira, Paulo J.; Cunha-Oliveira, Teresa] UC Biotech, Ctr Neurosci & Cell Biol, CNC, Cantanhede, Portugal; [Pino, Rute; Pereira, Francisco B.] Univ Coimbra, Dept Informat Engn, CISUC, Coimbra, Portugal; [Moreira-Soares, Mauricio] Univ Oslo, OCBE, Fac Med, Oslo, Norway; [Moreira-Soares, Mauricio] Univ Oslo, Fac Math & Nat Sci, Ctr Bioinformat, Oslo, Norway; [Kovarova, Jaromira; Neuzil, Jiri] Czech Acad Sci, Inst Biotechnol, Prague, Czech Republic; [Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld, Australia; [Travasso, Rui] Univ Coimbra, Dept Phys, CFisUC, Coimbra, Portugal; [Pereira, Francisco B.] Coimbra Polytech ISEC, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; University of Oslo; University of Oslo; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Griffith University; Universidade de Coimbra	Cunha-Oliveira, T (corresponding author), Ctr Neuroscience & Cell Biol, CNC, MitoXT Mitochondrial Toxicol & Expt Therapeut Lab, UC Biotech Bldg Lote 8A,Biocant Pk, P-3060197 Cantanhede, Portugal.	teresa.oliveira@uc-biotech.pt	Travasso, Rui/B-8342-2018; Simoes, Rui/AFT-8875-2022; Cunha-Oliveira, Teresa/A-3054-2009; Oliveira, Paulo/H-1980-2011	Travasso, Rui/0000-0001-6078-0721; Simoes, Rui/0000-0003-2718-9950; Cunha-Oliveira, Teresa/0000-0002-7382-0339; Moreira-Soares, Mauricio/0000-0001-9928-7256; Pereira, Francisco B./0000-0002-1937-6548; Oliveira, Paulo/0000-0002-5201-9948	Czech Science Foundation [20-05942S, 21-04607X]; EC \ H2020 \ H2020 Priority Excellent Science \ H2020 Marie Sklodowska-Curie Actions (MSCA) [801133]; MEC \ Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BTM-SAL/29297/2017, POCI-01-0145-FEDER-029297, PD/ BD/128254/2016, DL57/2016/CP1448/CT0016, UIDB/04539/2020, PTDC/MED-FAR/29391/2017, POCI-01-0145-FEDER-029391, UIDB/04564/2020, UIDP/04564/2020]	Czech Science Foundation(Grant Agency of the Czech Republic); EC \ H2020 \ H2020 Priority Excellent Science \ H2020 Marie Sklodowska-Curie Actions (MSCA); MEC \ Fundacao para a Ciencia e a Tecnologia (FCT)	Czech Science Foundation, Grant/ Award Number: 20--05942S and 21--04607X; EC | H2020 | H2020 Priority Excellent Science | H2020 Marie Sklodowska--Curie Actions (MSCA), Grant/Award Number: 801133; MEC | Fundacao para a Ciencia e a Tecnologia (FCT), Grant/Award Number: PTDC/BTM--SAL/29297/2017, POCI--01--0145--FEDER--029297, PD/ BD/128254/2016, DL57/2016/CP1448/ CT0016, UIDB/04539/2020, PTDC/ MED--FAR/29391/2017, POCI--01--0145--FEDER--029391, UIDB/04564/2020 and UIDP/04564/2020	[Anonymous], 2020, TRAJPY V 1 3 1; Arkin H, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4788616; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Axelrod D, 2008, METHOD CELL BIOL, V89, P169, DOI 10.1016/S0091-679X(08)00607-9; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Billups B, 2002, J NEUROSCI, V22, P5840; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Brickley K, 2011, J BIOL CHEM, V286, P18079, DOI 10.1074/jbc.M111.236018; Bros H, 2015, TRAFFIC, V16, P906, DOI 10.1111/tra.12291; Bros H, 2014, EXP NEUROL, V261, P127, DOI 10.1016/j.expneurol.2014.06.018; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Chen MM, 2016, PROTEIN CELL, V7, P804, DOI 10.1007/s13238-016-0268-3; Coutu DL, 2013, J CELL SCI, V126, P3805, DOI 10.1242/jcs.118349; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Friendly M, 2013, STAT SCI, V28, P1, DOI 10.1214/12-STS402; Gerencser AA, 2008, BIOPHYS J, V95, P3079, DOI 10.1529/biophysj.108.135657; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Jiang Q, 2006, J BIOL CHEM, V281, P29391, DOI 10.1074/jbc.M602740200; Kandel J, 2015, BIOTECHNOL BIOENG, V112, P1395, DOI 10.1002/bit.25563; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Lee BJ, 2017, MOL BIOL CELL, V28, P3573, DOI 10.1091/mbc.E17-08-0508; Ligon LA, 2000, J COMP NEUROL, V427, P340, DOI 10.1002/1096-9861(20001120)427:3<340::AID-CNE2>3.0.CO;2-Y; Lu X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-17; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002; MacAskill AF, 2009, MOL CELL NEUROSCI, V40, P301, DOI 10.1016/j.mcn.2008.10.016; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Medler K, 2002, J NEUROPHYSIOL, V87, P1426, DOI 10.1152/jn.00627.2001; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Moreira-Soares M, 2020, J PHYS-CONDENS MAT, V32, DOI 10.1088/1361-648X/ab7c17; MORRIS RL, 1993, J CELL SCI, V104, P917; Nguyen MM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-38; Patel VP, 2012, BBA-MOL BASIS DIS, V1822, P1773, DOI 10.1016/j.bbadis.2012.08.002; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Poulter NS, 2015, METHODS MOL BIOL, V1251, P1, DOI 10.1007/978-1-4939-2080-8_1; R Core Team, 2020, R LANG ENV STAT COMP; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Schuler F, 2001, BBA-BIOENERGETICS, V1506, P79, DOI 10.1016/S0005-2728(01)00183-9; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Sheng ZH, 2014, J CELL BIOL, V204, P1087, DOI 10.1083/jcb.201312123; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Simoes RF, 2021, FOOD CHEM TOXICOL, V149, DOI 10.1016/j.fct.2021.111967; Srivastava AS, 2007, BIOCHEM BIOPH RES CO, V361, P953, DOI 10.1016/j.bbrc.2007.07.139; Stepkowski TM, 2017, CELL MOL NEUROBIOL, V37, P1055, DOI 10.1007/s10571-016-0438-0; Sumantran VN, 2011, METHODS MOL BIOL, V731, P219, DOI 10.1007/978-1-61779-080-5_19; Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040; THEODOROU DN, 1985, MACROMOLECULES, V18, P1206, DOI 10.1021/ma00148a028; Uversky VN, 2004, CELL TISSUE RES, V318, P225, DOI 10.1007/s00441-004-0937-z; Wagner T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170165; Yau KW, 2016, J NEUROSCI, V36, P1071, DOI 10.1523/JNEUROSCI.2430-15.2016	60	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22024	10.1096/fj.202100899R	http://dx.doi.org/10.1096/fj.202100899R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34751984	Green Submitted, Green Published			2022-12-26	WOS:000722321300021
J	Zhang, R; Isozumi, N; Mori, M; Okuta, R; Singkaravanit-Ogawa, S; Imamura, T; Kurita, JI; Gan, P; Shirasu, K; Ohki, S; Takano, Y				Zhang, Ru; Isozumi, Noriyoshi; Mori, Masashi; Okuta, Ryuta; Singkaravanit-Ogawa, Suthitar; Imamura, Tomohiro; Kurita, Jun-Ichi; Gan, Pamela; Shirasu, Ken; Ohki, Shinya; Takano, Yoshitaka			Fungal effector SIB1 of Colletotrichum orbiculare has unique structural features and can suppress plant immunity in Nicotiana benthamiana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; ANTHRACNOSE FUNGUS; ANTIFUNGAL PROTEIN; CELL-DEATH; N-15 NMR; DYNAMICS; HOST; RNA; EXPRESSION; INFECTION	Fungal plant pathogens secrete virulence-related proteins, called effectors, to establish host infection; however, the de-tails are not fully understood yet. Functional screening of effector candidates using Agrobacterium-mediated transient expression assay in Nicotiana benthamiana identified two virulence-related effectors, named SIB1 and SIB2 (Suppression of Immunity in N. benthamiana), of an anthracnose fungus Colletotrichum orbiculare, which infects both cucur-bits and N. benthamiana. The Agrobacterium-mediated transient expression of SIB1 or SIB2 increased the susceptibility of N. benthamiana to C. orbiculare, which suggested these effectors can suppress immune responses in N. benthamiana. The presence of SIB1 and SIB2 homologs was found to be limited to the genus Colletotrichum. SIB1 suppressed both (i) the generation of reactive oxygen species triggered by two different pathogen-associated molecular patterns, chitin and flg22, and (ii) the cell death response triggered by the Phytophthora infestans INF1 elicitin in N. benthamiana. We determined the NMR-based structure of SIB1 to obtain its structural insights. The three-dimensional structure of SIB1 comprises five beta-strands, each containing three disulfide bonds. The overall conformation was found to be a cylindrical shape, such as the well-known antiparallel beta-barrel structure. However, the beta-strands were found to display a unique topology, one pair of these beta-strands formed a parallel beta-sheet. These results suggest that the effector SIB1 present in Colletotrichum fungi has unique structural features and can suppress pathogen-associated molecular pattern- triggered immunity in N. benthamiana.	[Zhang, Ru; Okuta, Ryuta; Singkaravanit-Ogawa, Suthitar; Takano, Yoshitaka] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Isozumi, Noriyoshi; Ohki, Shinya] Japan Adv Inst Sci & Technol JAIST, Ctr Nano Mat & Technol CNMT, Nomi, Ishikawa, Japan; [Mori, Masashi; Imamura, Tomohiro] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan; [Kurita, Jun-Ichi] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa, Japan; [Gan, Pamela; Shirasu, Ken] RIKEN, Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan	Kyoto University; Japan Advanced Institute of Science & Technology (JAIST); Ishikawa Prefecture University; Yokohama City University; RIKEN	Takano, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.; Ohki, S (corresponding author), Japan Adv Inst Sci & Technol JAIST, Ctr Nano Mat & Technol CNMT, Nomi, Ishikawa, Japan.; Mori, M (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan.	mori@ishikawa-pu.ac.jp; shinya-o@jaist.ac.jp; takano.yoshitaka.2x@kyoto-u.ac.jp	Shirasu, Ken/ABF-5306-2020; Shirasu, Ken/A-4455-2010	Shirasu, Ken/0000-0002-0349-3870; Shirasu, Ken/0000-0002-0349-3870	KAKENHI [18H02204, 21H05032, 17K08194, 17H06172, 19K15846]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (18H02204 and 21H05032 [to Y. T.], 17K08194 [to S. O.], 17H06172 [to K. S.], 19K15846 [to P. G.] [KAKENHI]).	Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asakura M, 2009, PLANT CELL, V21, P1291, DOI 10.1105/tpc.108.060996; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; Caldwell JE, 1998, NAT STRUCT BIOL, V5, P427, DOI 10.1038/nsb0698-427; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Costa LM, 2014, SCIENCE, V344, P168, DOI 10.1126/science.1243005; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dohi K, 2006, ARCH VIROL, V151, P1075, DOI 10.1007/s00705-005-0705-8; Dohi K, 2007, PLANT BIOTECHNOL-NAR, V24, P367, DOI 10.5511/plantbiotechnology.24.367; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; Gan P, 2019, MOL PLANT MICROBE IN, V32, P1088, DOI 10.1094/MPMI-12-18-0352-A; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Graciet E, 2009, P NATL ACAD SCI USA, V106, P13618, DOI 10.1073/pnas.0906404106; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hagiwara Y, 2003, EMBO J, V22, P344, DOI 10.1093/emboj/cdg033; Imamura T, 2021, PLANT CELL REP, V40, P433, DOI 10.1007/s00299-020-02654-5; Inagaki A, 2000, CAN J MICROBIOL, V46, P150, DOI 10.1139/cjm-46-2-150; Irieda H, 2019, P NATL ACAD SCI USA, V116, P496, DOI 10.1073/pnas.1807297116; Irieda H, 2014, PLANT CELL, V26, P2265, DOI 10.1105/tpc.113.120600; Isozumi N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89485-w; Isozumi N, 2019, BIOCHEM BIOPH RES CO, V514, P803, DOI 10.1016/j.bbrc.2019.05.007; ITO K, 1992, BIOSCI BIOTECH BIOCH, V56, P906, DOI 10.1271/bbb.56.906; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanneganti TD, 2006, MOL PLANT MICROBE IN, V19, P854, DOI 10.1094/MPMI-19-0854; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEPPLER LD, 1989, PHYTOPATHOLOGY, V79, P974, DOI 10.1094/Phyto-79-974; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUBO Y, 1991, MOL PLANT MICROBE IN, V4, P440, DOI 10.1094/MPMI-4-440; Kubo Y, 2013, J GEN PLANT PATHOL, V79, P233, DOI 10.1007/s10327-013-0451-9; Lee W, 2014, J BIOMOL NMR, V60, P73, DOI 10.1007/s10858-014-9855-x; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao YD, 2003, NUCLEIC ACIDS RES, V31, P5247, DOI 10.1093/nar/gkg746; Liu B, 2007, PHYTOPATHOLOGY, V97, P1305, DOI 10.1094/PHYTO-97-10-1305; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Ohki S, 2008, J BIOMOL NMR, V42, P271, DOI 10.1007/s10858-008-9283-x; Ohki S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1520; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ramachandran SR, 2017, PHYTOPATHOLOGY, V107, P75, DOI 10.1094/PHYTO-02-16-0083-R; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Shen S, 2001, EUR J PLANT PATHOL, V107, P767, DOI 10.1023/A:1012280102161; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shimada C, 2006, MOL PLANT MICROBE IN, V19, P270, DOI 10.1094/MPMI-19-0270; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Takano Y, 2006, MOL MICROBIOL, V60, P81, DOI 10.1111/j.1365-2958.2006.05080.x; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Win J, 2012, Cold Spring Harb Symp Quant Biol, V77, P235, DOI 10.1101/sqb.2012.77.015933; Yoshino K, 2012, MOL PLANT MICROBE IN, V25, P625, DOI 10.1094/MPMI-12-11-0316; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680	72	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101370	10.1016/j.jbc.2021.101370	http://dx.doi.org/10.1016/j.jbc.2021.101370			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756891	Green Published, gold, Green Submitted			2022-12-26	WOS:000765319800002
J	Ahmed, S; Roy, MC; Al Baki, MA; Jung, JK; Lee, D; Kim, Y				Ahmed, Shabbir; Roy, Miltan Chandra; Al Baki, Md. Abdullah; Jung, Jin Kyo; Lee, Daeweon; Kim, Yonggyun			CRISPR/Cas9 mutagenesis against sex pheromone biosynthesis leads to loss of female attractiveness in Spodoptera exigua, an insect pestt	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; DESATURASE GENE; COA DESATURASE; MOTH; EVOLUTION; GLAND; ACID; IDENTIFICATION; RECEPTOR; PCR	Virgin female moths are known to release sex pheromones to attract conspecific males. Accurate sex pheromones are required for their chemical communication. Sex pheromones of Spodoptera exigua, a lepidopteran insect, contain unsaturated fatty acid derivatives having a double bond at the 12th carbon position. A desaturase of S. exigua (SexiDES5) was proposed to have dual functions by forming double bonds at the 11th and 12th carbons to synthesize Z9,E12-tetradecedienoic acid, which could be acetylated to be a main sex pheromone component Z9,E12-tetradecenoic acetate (Z9E12-14:Ac). A deletion of SexiDES5 using CRISPR/Cas9 was generated and inbred to obtain homozygotes. Mutant females could not produce Z9E12-14:Ac along with Z9-14:Ac and Z11-14:Ac. Subsequently, pheromone extract of mutant females did not induce a sensory signal in male antennae. They failed to induce male mating behavior including hair pencil erection and orientation. In the field, these mutant females did not attract any males while control females attracted males. These results indicate that SexiDES5 can catalyze the desaturation at the 11th and 12th positions to produce sex pheromone components in S. exigua. This study also suggests an application of the genome editing technology to insect pest control by generating non-attractive female moths.	[Ahmed, Shabbir; Roy, Miltan Chandra; Al Baki, Md. Abdullah; Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea; [Jung, Jin Kyo] Natl Inst Crop Sci, Dept Cent Area Crop Sci, Div Crop Cultivat & Environm Res, Rural Dev Adm, Suwon, South Korea; [Lee, Daeweon] Kyungsung Univ, Metabol Res Ctr Funct Mat, Busan, South Korea	Andong National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Kyungsung University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr	Ahmed, Shabbir/AFL-5760-2022	Ahmed, Shabbir/0000-0001-8428-0895; lee, dae-weon/0000-0002-6076-6070; Kim, Yonggyun/0000-0002-6840-2167	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Exporting Promotion Technology Development Program - Ministry of Agriculture, Food and Rural Affairs, Republic of Korea [321100-3]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Exporting Promotion Technology Development Program - Ministry of Agriculture, Food and Rural Affairs, Republic of Korea	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Exporting Promotion Technology Development Program funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA) (321100-3), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2021, ARCH INSECT BIOCHEM, V106, DOI 10.1002/arch.21748; Bousquet F, 2012, P NATL ACAD SCI USA, V109, P249, DOI 10.1073/pnas.1109166108; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cheng YX, 2010, ARCH INSECT BIOCHEM, V75, P13, DOI 10.1002/arch.20379; DERENOBALES M, 1987, TRENDS BIOCHEM SCI, V12, P364, DOI 10.1016/0968-0004(87)90167-8; Ding BJ, 2011, INSECT BIOCHEM MOLEC, V41, P715, DOI 10.1016/j.ibmb.2011.05.003; Dong Shuanglin, 2002, Acta Phytophylacica Sinica, V29, P19; Gantz VM, 2018, CURR OPIN INSECT SCI, V28, P66, DOI 10.1016/j.cois.2018.05.006; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Hagstrom AK, 2014, J CHEM ECOL, V40, P63, DOI 10.1007/s10886-013-0373-1; Hasan MA, 2019, INSECT BIOCHEM MOLEC, V111, DOI 10.1016/j.ibmb.2019.103179; Jung Chung Ryul, 2003, Journal of Asia-Pacific Entomology, V6, P175, DOI 10.1016/S1226-8615(08)60183-1; Jurenka RA, 1997, CELL MOL LIFE SCI, V53, P501, DOI 10.1007/s000180050062; Jurenka R, 2017, CURR OPIN INSECT SCI, V24, P29, DOI 10.1016/j.cois.2017.09.002; Kim Y, 2020, DEV COMP IMMUNOL, V111, DOI 10.1016/j.dci.2020.103743; Kim Y, 2018, DEV COMP IMMUNOL, V83, P130, DOI 10.1016/j.dci.2017.12.005; Knipple DC, 1998, P NATL ACAD SCI USA, V95, P15287, DOI 10.1073/pnas.95.26.15287; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofstedt C, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P43; Park Y, 2015, INSECT BIOCHEM MOLEC, V66, P13, DOI 10.1016/j.ibmb.2015.09.012; Peyou-Ndi MM, 2000, ARCH BIOCHEM BIOPHYS, V376, P399, DOI 10.1006/abbi.2000.1733; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; ROELOFS WL, 1995, P NATL ACAD SCI USA, V92, P44, DOI 10.1073/pnas.92.1.44; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; SAS Institute, 1989, SAS STAT US GUID REL, V3rd; Serra M, 2007, P NATL ACAD SCI USA, V104, P16444, DOI 10.1073/pnas.0705385104; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shen JM, 2020, J MOL BIOL, V432, P5152, DOI 10.1016/j.jmb.2020.05.017; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sun D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00608; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Tsfadia O, 2008, INSECT BIOCHEM MOLEC, V38, P552, DOI 10.1016/j.ibmb.2008.01.005; Vatanparast M, 2019, J ASIA-PAC ENTOMOL, V22, P645, DOI 10.1016/j.aspen.2019.04.009; Wang HL, 2010, INSECT BIOCHEM MOLEC, V40, P742, DOI 10.1016/j.ibmb.2010.07.009; Xia YH, 2019, J CHEM ECOL, V45, P378, DOI 10.1007/s10886-019-01067-3; Zhang YN, 2019, PESTIC BIOCHEM PHYS, V156, P152, DOI 10.1016/j.pestbp.2019.02.018; Zhang YN, 2017, MOL GENET GENOMICS, V292, P795, DOI 10.1007/s00438-017-1307-3; Zhou XR, 2008, INSECT MOL BIOL, V17, P667, DOI 10.1111/j.1365-2583.2008.00841.x; Zuo YY, 2017, INSECT BIOCHEM MOLEC, V89, P79, DOI 10.1016/j.ibmb.2017.09.005	41	0	0	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259322	10.1371/journal.pone.0259322	http://dx.doi.org/10.1371/journal.pone.0259322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788305	Green Published, gold			2022-12-26	WOS:000735920500020
J	Candeias, J; Schmidt-Weber, CB; Buters, J				Candeias, Joana; Schmidt-Weber, Carsten B.; Buters, Jeroen			Dosing intact birch pollen grains at the air-liquid interface (ALI) to the immortalized human bronchial epithelial cell line BEAS-2B	PLOS ONE			English	Article							BET V 1; ADHESION MOLECULE-1 ICAM-1; GRASS-POLLEN; ALLERGEN EXPOSURE; DENDRITIC CELLS; KAPPA-B; CHALLENGE; CHAMBER; RESPONSES; RELEASE	In real life, humans are exposed to whole pollen grains at the air epithelial barrier. We developed a system for in vitro dosing of whole pollen grains at the Air-Liquid Interface (ALI) and studied their effect on the immortalized human bronchial epithelial cell line BEAS-2B. Pollen are sticky and large particles. Dosing pollen needs resuspension of single particles rather than clusters, and subsequent transportation to the cells with little loss to the walls of the instrumentation i.e. in a straight line. To avoid high speed impacting insults to cells we chose sedimentation by gravity as a delivery step. Pollen was resuspended into single particles by pressured air. A pollen dispersion unit including PTFE coating of the walls and reduced air pressure limited impaction loss to the walls. The loss of pollen to the system was still about 40%. A linear dose effect curve resulted in 327-2834 pollen/cm(2) (+/- 6.1%), the latter concentration being calculated as the amount deposited on epithelial cells on high pollen days. After whole pollen exposure, the largest differential gene expression at the transcriptomic level was late, about 7 hours after exposure. Inflammatory and response to stimulus related genes were up-regulated. We developed a whole pollen exposure air-liquid interface system (Pollen-ALI), in which cells can be gently and reliably dosed.	[Candeias, Joana; Schmidt-Weber, Carsten B.; Buters, Jeroen] Tech Univ Munich, Ctr Allergy & Environm ZAUM, German Ctr Lung Res DZL, Helmholtz Ctr Munich, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Buters, J (corresponding author), Tech Univ Munich, Ctr Allergy & Environm ZAUM, German Ctr Lung Res DZL, Helmholtz Ctr Munich, Munich, Germany.	buters@tum.de		Candeias, Joana/0000-0002-6239-6157; Buters, Jeroen/0000-0003-3581-5472	Helmholtz Center Munich, Munich, Germany in the frame of Task Force Allergy, subject "Air"	Helmholtz Center Munich, Munich, Germany in the frame of Task Force Allergy, subject "Air"	The study was in-house funded by the Helmholtz Center Munich, Munich, Germany in the frame of Task Force Allergy, subject "Air". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas I, 2019, ENVIRON RES, V171, P510, DOI 10.1016/j.envres.2019.01.052; Akdis CA, 2021, NAT REV IMMUNOL, V21, P739, DOI 10.1038/s41577-021-00538-7; Amador GJ, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/aa5c6e; Badorrek P, 2017, ANN ALLERG ASTHMA IM, V118, P290, DOI 10.1016/j.anai.2017.01.018; Behrendt H, 2001, INT ARCH ALLERGY IMM, V124, P121, DOI 10.1159/000053688; Bergmann KC, 2021, WORLD ALLERGY ORGAN, V14, DOI 10.1016/j.waojou.2020.100494; Blume C, 2015, TISSUE BARRIERS, V3, DOI 10.1080/15476286.2015.1062316; BROWN HM, 1973, ACTA ALLERGOL, V28, P132, DOI 10.1111/j.1398-9995.1973.tb01319.x; Buters JTM, 2018, CLIN TRANSL ALLERGY, V8, DOI 10.1186/s13601-018-0197-8; Buters JTM, 2010, ALLERGY, V65, P850, DOI 10.1111/j.1398-9995.2009.02286.x; Buters JTM, 2008, INT ARCH ALLERGY IMM, V145, P122, DOI 10.1159/000108137; Buters JTM, 2012, ATMOS ENVIRON, V55, P496, DOI 10.1016/j.atmosenv.2012.01.054; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; CIPRANDI G, 1994, AM J RESP CRIT CARE, V150, P1653, DOI 10.1164/ajrccm.150.6.7524984; DEVALIA JL, 1990, RESP MED, V84, P303, DOI 10.1016/S0954-6111(08)80058-3; Ge XH, 2021, AM J TRANSL RES, V13, P326; Gizurarson S, 2012, CURR DRUG DELIV, V9, P566, DOI 10.2174/156720112803529828; Golovko A. V., 2013, Optika Atmosfery i Okeana, V26, P513; Hohlfeld JM, 2010, CLIN EXP ALLERGY, V40, P998, DOI 10.1111/j.1365-2222.2010.03498.x; Ihantola T, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00355-1; Kim TH, 2012, INT ARCH ALLERGY IMM, V158, P387, DOI 10.1159/000333103; Krug N, 2003, CLIN EXP ALLERGY, V33, P1667, DOI 10.1111/j.1365-2222.2003.01810.x; Krusche J, 2019, J ALLERGY CLIN IMMUN, V144, P1684, DOI 10.1016/j.jaci.2019.07.029; Larson D, 2020, J ALLERGY CLIN IMMUN, V145, P1585, DOI 10.1016/j.jaci.2020.02.024; Le Floc'h A, 2020, ALLERGY, V75, P1188, DOI 10.1111/all.14151; Li W, 2020, THORAX, V75, P1047, DOI 10.1136/thoraxjnl-2019-213771; Matsuyama T, 2003, POWDER TECHNOL, V135, P14, DOI 10.1016/S0032-5910(03)00154-2; Metz J, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10020056; NIKLAS KJ, 1985, BOT REV, V51, P328, DOI 10.1007/BF02861079; Noon L, 1911, LANCET, V1, P1572; Oeder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126536; Ogden T L, 1975, Inhaled Part, V4 Pt 1, P93; Orban NT, 2021, CLIN EXP ALLERGY, V51, P329, DOI 10.1111/cea.13775; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Ouyang YH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24831-z; Papazian D, 2015, CLIN EXP IMMUNOL, V181, P207, DOI 10.1111/cei.12611; Pfaar Oliver, 2021, Allergy, V76, P3589, DOI 10.1111/all.14957; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Pohl F., 1937, BOT ZENTRALBLATT, V57, P112; R Core Team, 2020, R LANG ENV STAT COMP; Ring J, 2011, ALLERGY, V66, P713, DOI 10.1111/j.1398-9995.2010.02541.x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roschmann KIL, 2012, CLIN EXP IMMUNOL, V167, P413, DOI 10.1111/j.1365-2249.2011.04522.x; Roschmann KIL, 2011, CLIN EXP ALLERGY, V41, P830, DOI 10.1111/j.1365-2222.2011.03713.x; San-Miguel-Ayanz J., 2016, EUROPEAN ATLAS FORES, V11; Sapcariu SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157964; Schappi GF, 1997, J ALLERGY CLIN IMMUN, V100, P656, DOI 10.1016/S0091-6749(97)70170-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shaw SK, 2004, J EXP MED, V200, P1571, DOI 10.1084/jem.20040965; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Stifelman M, 2007, SCI TOTAL ENVIRON, V373, P585, DOI 10.1016/j.scitotenv.2006.11.041; Strand V, 1998, EUR RESPIR J, V12, P6, DOI 10.1183/09031936.98.12010006; Stylianou E., 2006, ENCY RESP MED, P350; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Visez N, 2015, J AEROSOL SCI, V89, P77, DOI 10.1016/j.jaerosci.2015.07.005; Voegler T, 2017, ALLERGO J, V26, P20, DOI 10.1007/s15007-017-1495-5; Vroman H, 2018, J ALLERGY CLIN IMMUN, V141, P1620, DOI 10.1016/j.jaci.2017.08.012; Wagener AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080257; WEGNER CD, 1990, SCIENCE, V247, P456, DOI 10.1126/science.1967851; Wu YF, 2020, AUTOPHAGY, V16, P435, DOI 10.1080/15548627.2019.1628536; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zissler UM, 2016, MUCOSAL IMMUNOL, V9, P917, DOI 10.1038/mi.2015.110; Zissler UM, 2018, J ALLERGY CLIN IMMUN, V142, P1980, DOI 10.1016/j.jaci.2018.07.027; Zuberbier T, 2017, J ALLERGY CLIN IMMUN, V139, P1158, DOI 10.1016/j.jaci.2016.08.025	65	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259914	10.1371/journal.pone.0259914	http://dx.doi.org/10.1371/journal.pone.0259914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784380	Green Published, gold			2022-12-26	WOS:000755277300028
J	Poosekeaw, P; Pairojkul, C; Sripa, B; Ngiamwibool, PS; Iamsaard, S; Sakonsinsiri, C; Thanan, R; Ungarreevittaya, P				Poosekeaw, Pirawan; Pairojkul, Chawalit; Sripa, Banchob; Ngiamwibool, Prakasit Sa; Iamsaard, Sitthichai; Sakonsinsiri, Chadamas; Thanan, Raynoo; Ungarreevittaya, Piti			Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma	PLOS ONE			English	Article							CELL-PROLIFERATION; PROGNOSTIC-FACTORS; ADENOCARCINOMA; AMPLIFICATION; APOPTOSIS; PATHWAYS; IMAGEJ; DUCT; NODE	Cholangiocarcinoma (CCA) is a group of heterogenous malignancies arising from bile duct epithelium with distinct pathological features. Adaptor proteins have implicated in cell proliferation, migration, and invasion of different cancer cells. The objective of this study was to assess whether the adaptor protein XB130 (AFAP1L2) is a critical biological determinant of CCA outcome. XB130 expression levels were investigated in four CCA cell lines compared to an immortalized cholangiocyte cell line by Western blotting. Small interfering (si) RNA-mediated XB130 gene silencing was conducted to evaluate the effects of reduced XB130 expression on cell proliferation, migration, and invasion by MTT, transwell migration and cell invasion assay. The immunohistochemical quantification of XB130 levels were performed in surgically resected formalin-fixed, paraffin-embedded specimens obtained from 151 CCA patients. The relationship between XB130 expression and the clinicopathological parameters of CCA patients were analyzed. Our results showed that XB130 was highly expressed in KKU-213A cell line. Knockdown of XB130 using siRNA significantly decreased the proliferation, migration, and invasion properties of KKU-213A cells through the inhibition of PI3K/Akt pathway, suggesting that XB130 plays an important role in CCA progression. Moreover, elevated XB130 expression levels were positive relationship with lymphovascular space invasion (LVSI), intrahepatic type of CCA, high TNM staging (stage III, IV), high T classification (T3, T4), and lymph node metastasis. We provide the first evidence that the overexpression of XB130 is associated with tumorigenic properties of CCA cells, leading to CCA progression with aggressive clinical outcomes.	[Poosekeaw, Pirawan; Pairojkul, Chawalit; Sripa, Banchob; Ngiamwibool, Prakasit Sa; Ungarreevittaya, Piti] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Iamsaard, Sitthichai] Khon Kaen Univ, Fac Med, Dept Anat, Khon Kaen, Thailand; [Sakonsinsiri, Chadamas; Thanan, Raynoo] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Sakonsinsiri, Chadamas; Thanan, Raynoo] Khon Kaen Univ, Cholangiocarcinoma Res Inst, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; Khon Kaen University	Ungarreevittaya, P (corresponding author), Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand.	pitiun@kku.ac.th		Iamsaard, Sitthichai/0000-0002-6793-2879	Invitation Research Fund from Faculty of Medicine, Khon Kaen University, Thailand [IN63122]; Thailand Research Fund [RSA6280005]	Invitation Research Fund from Faculty of Medicine, Khon Kaen University, Thailand; Thailand Research Fund(Thailand Research Fund (TRF))	This study was financially supported by Invitation Research Fund from Faculty of Medicine, Khon Kaen University, Thailand to P.P. and P.U. (IN63122) and Thailand Research Fund to R.T. (RSA6280005).	Al-Bahrani R, 2013, ANN CLIN LAB SCI, V43, P195; Ando H, 2010, DIGEST SURG, V27, P87, DOI 10.1159/000286463; Chaiprasert T, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070263; Chen B, 2016, ONCOTARGET, V7, P59377, DOI 10.18632/oncotarget.11074; Chen MH, 2014, ONCOTARGET, V5, P2372, DOI 10.18632/oncotarget.1706; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crowe AR, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3465; Doherty Bryan, 2017, Curr Gastroenterol Rep, V19, P2, DOI 10.1007/s11894-017-0542-4; Emmadi R, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/180259; Huang MP, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0870-3; Kaewlert W, 2018, HORM CANCER-US, V9, P408, DOI 10.1007/s12672-018-0349-2; Ke FY, 2017, DRUG DES DEV THER, V11, P1753, DOI 10.2147/DDDT.S132488; Kim HJ, 2007, ANN ONCOL, V18, P892, DOI 10.1093/annonc/mdm006; KLATSKIN G, 1965, AM J MED, V38, P241, DOI 10.1016/0002-9343(65)90178-6; Li JC, 2015, INT J CLIN EXP PATHO, V8, P5300; Lodyga M, 2009, ONCOGENE, V28, P937, DOI 10.1038/onc.2008.447; Mao ZY, 2015, MED SCI MONITOR, V21, P2375, DOI 10.12659/MSM.893586; Menakongka A, 2010, WORLD J GASTROENTERO, V16, P713, DOI 10.3748/wjg.v16.i6.713; Moodley S, 2015, MOL BIOL CELL, V26, P4492, DOI 10.1091/mbc.E15-07-0483; Nakanuma Y, 2014, J HEPATO-BIL-PAN SCI, V21, P441, DOI 10.1002/jhbp.70; Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419; Rosen RD, 2020, STATPEARLS; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shen JC, 2017, MOL MED REP, V16, P5592, DOI 10.3892/mmr.2017.7279; Shi M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-1; Shiozaki A, 2013, ANN SURG ONCOL, V20, P3140, DOI 10.1245/s10434-012-2474-4; Shiozaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043646; Shiozaki Atsushi, 2011, J Clin Bioinforma, V1, P10, DOI 10.1186/2043-9113-1-10; Sriamporn S, 2004, TROP MED INT HEALTH, V9, P588, DOI 10.1111/j.1365-3156.2004.01234.x; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Sripa B, 2020, HUM CELL, V33, P695, DOI 10.1007/s13577-020-00334-w; Takeshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059057; Tang HW, 2018, INTRACTABLE RARE DIS, V7, P106, DOI 10.5582/irdr.2018.01047; Thanan R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051796; Toba H, 2015, ONCOTARGET, V6, P30803, DOI 10.18632/oncotarget.5062; Wirasorn K, 2013, WORLD J GASTRO ONCOL, V5, P81, DOI 10.4251/wjgo.v5.i4.81; Bai XH, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/903014; Xu J, 2007, J BIOL CHEM, V282, P16401, DOI 10.1074/jbc.M701684200; Yamanaka D, 2012, MOL ENDOCRINOL, V26, P1043, DOI 10.1210/me.2011-1349; Yothaisong S, 2013, TUMOR BIOL, V34, P3637, DOI 10.1007/s13277-013-0945-2; Zhang JL, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-49; Zhu BQ, 2020, CANCER MED-US, V9, P783, DOI 10.1002/cam4.2719; Zhu XY, 2017, INT J MOL MED, V40, P1143, DOI 10.3892/ijmm.2017.3113	43	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259075	10.1371/journal.pone.0259075	http://dx.doi.org/10.1371/journal.pone.0259075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780466	Green Published, gold			2022-12-26	WOS:000755305800018
J	Yeshaneh, A; Fentahun, T; Belachew, T; Mohammed, A; Adane, D				Yeshaneh, Alex; Fentahun, Temesgen; Belachew, Tefera; Mohammed, Anissa; Adane, Daniel			Utilization of growth monitoring and promotion services and associated factors among children aged 0-23 months in Banja District, Northwest Ethiopia 2020: A cross-sectional study	PLOS ONE			English	Article								Background Growth monitoring and promotion are the basic malnutrition preventive strategies usually used to assess the growth of children using anthropometric measurements in comparison with world health organization standards. However, the utilization of growth monitoring and promotion services is inadequate in most developing countries. Therefore, this study aimed to assess the utilization of growth monitoring and promotion service and associated factors among children aged 0-23-month in Banja District, Northwest Ethiopia, 2020. Methods A community-based cross-sectional study was conducted from February 2 to April 1, 2020. A total of 572 children were selected using a simple random sampling technique. Data were collected using structured and pre-tested interviewer-administered questionnaires. Data were entered into Epi data version 4.6 and analyzed using the statistical package for social science (SPSS) version 25. Both binary and multivariable logistic regression analyses with a 95% confidence level were used to identify the associated factors. Statistical significance was set at p <0.05. Results This finding revealed that the proportion of growth monitoring and promotion services utilization was 38.9% [95%CI: 34.8%, 43.0%]. Child age from 0-11 months [AOR = 4.98 (95% CI: 2.75,8.37)], mothers who can read and write Amharic language [AOR = 2.04 (95%CI: 1.02,4.08)], know the benefits of weighing their child monthly [AOR = 2.9 (95%CI: 1.23, 6.94)], presence of growth monitoring service nearby [AOR = 3.2 (95%CI: 1.59,6.31)] and monthly income >= 2000 Ethiopian birr [AOR = 1.75(95% CI = 1.08, 3.02)] were some of the factors significantly associated with utilization of growth monitoring and promotion services. Conclusion and recommendation The findings indicate that utilization of growth monitoring and promotion services is mainly affected by child age, mother/caregiver ability to read and write Amharic language, having maternal information on the benefit of the weighing child, presence of service nearby health facility, and mother/caregiver monthly income. Preparation of growth monitoring charts in local language (Awigna) and creating awareness on the proper utilization of growth monitoring and promotion services is strongly recommended.	[Yeshaneh, Alex; Adane, Daniel] Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia; [Fentahun, Temesgen; Mohammed, Anissa] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dessie, Ethiopia; [Belachew, Tefera] Jimma Univ, Fac Publ Hlth, Inst Hlth, Nutr & Dietet Dept, Jimma, Ethiopia	Jimma University	Yeshaneh, A (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.	alexyeshaneh7@gmail.com	Yeshaneh, Alex/AAD-1562-2021; Mohammed, Anissa/GNP-7326-2022	Yeshaneh, Alex/0000-0001-5876-7325; Mohammed, Anissa/0000-0002-1580-4269; Endalew, daniel/0000-0002-3540-4844				Adu-Gyamfi AB., 2013, INT J INNOV ED, V1, P04, DOI [10.1155/2020/6840609, DOI 10.1155/2020/6840609]; Ashworth A, 2008, MATERN CHILD NUTR, V4, P86, DOI 10.1111/j.1740-8709.2007.00125.x; Belayneh M, 2021, ECOL FOOD NUTR, V60, P44, DOI 10.1080/03670244.2020.1789865; Daniel B., 2017, J NUTR DISORD, V7, P216, DOI [10.4172/2161-0509.1000216, DOI 10.4172/2161-0509.1000216]; Debuo D., 2017, SCI J PUBLIC HLTH, V5, P20, DOI [10.11648/j.sjph.20170501.13, DOI 10.11648/J.SJPH.20170501.13]; Desalegne L., 2017, ASSESSMENT KNOWLEDGE; Feleke FW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177502; Flandez KaramanLeon., 2015, NUTR ASSESSMENT GROW; FMoH E, 2015, HLTH SECT TRANSF PLA, P184; Gyampoh S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-180; Liu Q., 2017, COCHRANE DB SYST REV, V2017, P1, DOI [10.1002/14651858.CD010102.pub2, DOI 10.1002/14651858.CD010102.PUB2]; Melkamu AW, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1489-4; Mengitsu B, 2016, INT HEALTH, V8, pi34, DOI 10.1093/inthealth/ihw007; Nyabutio JI., 2015, THESIS KENYATTA U NA; Plan officer, 2012, BANJ WOR HLTH SECT A; Roberfroid D, 2005, TROP MED INT HEALTH, V10, P1121, DOI 10.1111/j.1365-3156.2005.01498.x; Roberfroid D, 2005, J HEALTH POPUL NUTR, V23, P207; Seidu F, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10980-w; The Federal Democratic Republic of Ethiopia Ministry of Health, 2015, WOR BAS 2 ETH HLTH S; UNICEF, 2007, REV GROWTH MON ITS, P1; USAID, 2014, JSI RES TRAIN 1 INC; Van Zadelhoff SJ., 2014, CHILD GROWTH MONITOR, DOI [10.1177/0969733014557115, DOI 10.1177/0969733014557115]	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259968	10.1371/journal.pone.0259968	http://dx.doi.org/10.1371/journal.pone.0259968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780536	Green Published, gold			2022-12-26	WOS:000755305800075
J	Obusan, MCM; Caras, JAA; Lumang, LSL; Calderon, EJS; Villanueva, RMD; Salibay, CC; Siringan, MAT; Rivera, WL; Masangkay, JS; Aragones, LV				Obusan, Marie Christine M.; Caras, Jamaica Ann A.; Lumang, Lara Sabrina L.; Calderon, Erika Joyce S.; Villanueva, Ren Mark D.; Salibay, Cristina C.; Siringan, Maria Auxilia T.; Rivera, Windell L.; Masangkay, Joseph S.; Aragones, Lemnuel, V			Bacteriological and histopathological findings in cetaceans that stranded in the Philippines from 2017 to 2018	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; SARCOCYSTIS-NEURONA; ANTIBIOTIC-RESISTANCE; TOXOPLASMA-GONDII; ANTIMICROBIAL SUSCEPTIBILITY; PATHOLOGICAL FINDINGS; ESCHERICHIA-COLI; NEOSPORA-CANINUM; MARINE MAMMALS; SEA	The relatively high frequency of marine mammal stranding events in the Philippines provide many research opportunities. A select set of stranders (n = 21) from 2017 to 2018 were sampled for bacteriology and histopathology. Pertinent tissues and bacteria were collected from individuals representing eight cetacean species (i.e. Feresa attenuata, Kogia breviceps, Globicephala macrorhynchus, Grampus griseus, Lagenodelphis hosei, Peponocephala electra, Stenella attenuata and Stenella longirostris) and were subjected to histopathological examination and antibiotic resistance screening, respectively. The antibiotic resistance profiles of 24 bacteria (belonging to genera Escherichia, Enterobacter, Klebsiella, Proteus, and Shigella) that were isolated from four cetaceans were determined using 18 antibiotics. All 24 isolates were resistant to at least one antibiotic class, and 79.17% were classified as multiple antibiotic resistant (MAR). The MAR index values of isolates ranged from 0.06 to 0.39 with all the isolates resistant to erythromycin (100%; n = 24) and susceptible to imipenem, doripenem, ciprofloxacin, chloramphenicol, and gentamicin (100%; n = 24). The resistance profiles of these bacteria show the extent of antimicrobial resistance in the marine environment, and may inform medical management decisions during rehabilitation of stranded cetaceans. Due to inadequate gross descriptions and limited data gathered by the responders during the stranding events, the significance of histopathological lesions in association with disease diagnosis in each cetacean stranding or mortality remained inconclusive; however, these histopathological findings may be indicative or contributory to the resulting debility and stress during their strandings. The findings of the study demonstrate the challenges faced by cetacean species in the wild, such as but not limited to, biological pollution through landsea movement of effluents, fisheries interactions, and anthropogenic activities.	[Obusan, Marie Christine M.; Caras, Jamaica Ann A.; Lumang, Lara Sabrina L.; Calderon, Erika Joyce S.; Villanueva, Ren Mark D.] Univ Philippines Diliman, Coll Sci, Inst Biol, Microbial Ecol Terr & Aquat Syst, Quezon City, Philippines; [Obusan, Marie Christine M.; Siringan, Maria Auxilia T.] Univ Philippines Diliman, Coll Sci, Nat Sci Res Inst, Quezon City, Philippines; [Caras, Jamaica Ann A.; Aragones, Lemnuel, V] Univ Philippines Diliman, Coll Sci, Inst Environm Sci & Meteorol, Marine Mammal Res Stranding Lab, Quezon City, Philippines; [Salibay, Cristina C.] De La Salle Univ Dasmarinas, Coll Sci & Comp Studies, City Of Dasmarinas Cavit, Philippines; [Rivera, Windell L.] Univ Philippines Diliman, Coll Sci, Inst Biol, Pathogen Host Environm Interact Res Lab, Quezon City, Philippines; [Masangkay, Joseph S.] Univ Philippines Los Banos, Coll Vet Med, Los Banos, Laguna, Philippines	University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Diliman; De La Salle University Dasmarinas; University of the Philippines System; University of the Philippines Diliman; University of the Philippines System; University of the Philippines Los Banos	Obusan, MCM (corresponding author), Univ Philippines Diliman, Coll Sci, Inst Biol, Microbial Ecol Terr & Aquat Syst, Quezon City, Philippines.; Obusan, MCM (corresponding author), Univ Philippines Diliman, Coll Sci, Nat Sci Res Inst, Quezon City, Philippines.	mmobusan@up.edu.ph		Aragones, Lemnuel/0000-0002-3318-3857; Rivera, Windell/0000-0002-4659-6132; Lumang, Lara Sabrina/0000-0003-1322-871X	Natural Sciences Research Institute, University of the Philippines Diliman [BIO-19-1-05]; Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman [171704SOS]	Natural Sciences Research Institute, University of the Philippines Diliman; Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman	MCMO and LVA received funding for the study through project grants BIO-19-1-05 (Natural Sciences Research Institute, University of the Philippines Diliman) for the conduct of methodology and 171704SOS (Office of the Vice Chancellor for Research and Development, University of the Philippines Diliman) for sample collection respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed O.B., 2017, INT J BIOASSAYS, V6, DOI [10.21746/ijbio.2017.04.004, DOI 10.21746/IJBIO.2017.04.004]; Alpers CE., 2013, ROBBINS BASIC PATHOL, P517; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado-Rybak M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00684; ANDREMONT A, 1986, ANTIMICROB AGENTS CH, V29, P515, DOI 10.1128/AAC.29.3.515; Aragones L. V., 2019, MARINE MAMMAL STRAND; Aragones LV, 2010, AQUAT MAMM, V36, P219, DOI 10.1578/AM.36.3.2010.219; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Aznar FJ, 2007, INT J PARASITOL, V37, P243, DOI 10.1016/j.ijpara.2006.10.010; Barbosa L, 2015, INT J PARASITOL, V45, P595, DOI 10.1016/j.ijpara.2015.02.013; Barkovskii AL, 2015, J APPL MICROBIOL, V118, P764, DOI 10.1111/jam.12735; Baticados M.C.L., 1992, P 1 S DIS AS AQ 26 2, P531; Bogomolni AL, 2008, DIS AQUAT ORGAN, V81, P13, DOI 10.3354/dao01936; Bondoc Jonah L., 2017, Philippine Journal of Veterinary Medicine, V54, P64; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bossart Gregory D., 2006, Oceanography, V19, P134; Brownstein D, 2011, J WILDLIFE DIS, V47, P278, DOI 10.7589/0090-3558-47.2.278; Camara Nakita, 2019, Vet Rec, V185, P694, DOI 10.1136/vr.105562; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Cornaglia E, 2000, J VET MED A, V47, P129, DOI 10.1046/j.1439-0442.2000.00268.x; Costa-Silva S, 2019, REV BRAS PARASITOL V, V28, P395, DOI [10.1590/S1984-29612019051, 10.1590/s1984-29612019051]; Cozzi B., 2009, OPEN ZOOLOGY J, V2, P24; Diaz-Delgado J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204444; Domiciano IG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149295; Dubey JP, 2000, J PARASITOL, V86, P1150, DOI 10.1645/0022-3395(2000)086[1150:ICOSNI]2.0.CO;2; Dubey JP, 2006, VET PARASITOL, V137, P36, DOI 10.1016/j.vetpar.2005.12.017; Dubey JP, 2003, VET PARASITOL, V116, P275, DOI 10.1016/S0304-4017(03)00263-2; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; Gibson AK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001142; Giorda F, 2017, J WILDLIFE DIS, V53, P795, DOI 10.7589/2016-07-150; Girard YA, 2016, INT J PARASITOL-PAR, V5, P5, DOI 10.1016/j.ijppaw.2015.11.003; Gonzales-Viera O, 2015, J COMP PATHOL, V152, P345, DOI 10.1016/j.jcpa.2015.02.004; Gonzales-Viera Omar, 2011, Brazilian Journal of Veterinary Pathology, V4, P23; Greig Thomas W., 2007, Aquatic Mammals, V33, P185, DOI 10.1578/AM.33.2.2007.185; Guimaraes JP, 2015, J PARASITOL, V101, P248, DOI 10.1645/14-513.1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hatosy SM, 2015, APPL ENVIRON MICROB, V81, P7593, DOI 10.1128/AEM.00736-15; Hudzicki J., 2009, KIRBY BAUER DISK DIF, P1; IJsseldijk LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201221; IUCN. IUCN, 2020, IUCN RED LIST THREAT; Jaber JR, 2004, VET PATHOL, V41, P147, DOI 10.1354/vp.41-2-147; Jepson PD, 2000, VET REC, V146, P721, DOI 10.1136/vr.146.25.721; Kirillova V, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2694-y; Ko FC, 2014, J HAZARD MATER, V277, P127, DOI 10.1016/j.jhazmat.2013.12.057; KOOYMAN GL, 1973, AM ZOOL, V13, P457; KRUMPERMAN PH, 1983, APPL ENVIRON MICROB, V46, P165, DOI 10.1128/AEM.46.1.165-170.1983; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Leeney RH, 2008, BIODIVERS CONSERV, V17, P2323, DOI 10.1007/s10531-008-9377-5; Li WT, 2018, ENVIRON POLLUT, V235, P534, DOI 10.1016/j.envpol.2018.01.010; Lourenco NGGS, 2007, J VENOM ANIM TOXINS, V13, P472, DOI 10.1590/S1678-91992007000200006; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Managaki S, 2007, ENVIRON SCI TECHNOL, V41, P8004, DOI 10.1021/es0709021; Maravic A, 2015, MAR POLLUT BULL, V90, P60, DOI 10.1016/j.marpolbul.2014.11.021; Marigo J, 2010, J WILDLIFE DIS, V46, P599, DOI 10.7589/0090-3558-46.2.599; Mcfee WE, 2009, J WILDLIFE DIS, V45, P575; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Miller MA, 2001, PARASITOL RES, V87, P252, DOI 10.1007/s004360000340; Miller MA, 2010, VET RES, V41, DOI 10.1051/vetres/2009049; Morell M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41848; NCCLS (National Committee for Clinical Laboratory Standards), 2002, PERFORMANCE STANDARD; Obusan MCM, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2112-5; Obusan MCM, 2018, AQUAT MAMM, V44, P568, DOI 10.1578/AM.44.5.2018.568; Obusan MCM, 2015, AQUAT MAMM, V41, P149, DOI 10.1578/AM.41.2.2015.149; Pacini AF., 2016, ACOUSTICAL SOC AM, V27, P010043; Peng C, 2015, INT J ENV RES PUB HE, V12, P12304, DOI 10.3390/ijerph121012304; Pugliares KR., WHOI200706; Rako-Gospic N, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P367, DOI 10.1016/B978-0-12-805052-1.00023-1; Roberts MC., 2019, J INTEGR OMICS, V9; Rose JM, 2009, FEMS MICROBIOL ECOL, V67, P421, DOI 10.1111/j.1574-6941.2009.00648.x; Rosonke BJ, 1999, J AM VET MED ASSOC, V215, P1839; Ross MH., 2011, HISTOLOGY TEXT ATLAS, P996; Samuel Y, 2005, J ACOUST SOC AM, V117, P1465, DOI 10.1121/1.1847993; Sandhu R, 2016, INDIAN J MICROBIOLOG, V3, P299, DOI [10.5958/2394-5478.2016.00064.9, DOI 10.5958/2394-5478.2016.00064.9]; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Seguel M, 2020, DIS AQUAT ORGAN, V141, P25, DOI 10.3354/dao03509; Seguel M, 2017, VET PATHOL, V54, P846, DOI 10.1177/0300985817705172; Sierra E, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00650; Siquier Gabriela Failla, 2003, Latin American Journal of Aquatic Mammals, V2, P95; Smith H., 2015, BENSONS MICROBIOLOGI, V13th, P105; Stoddard RA, 2008, PUBLIC HEALTH REP, V123, P360, DOI 10.1177/003335490812300316; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; The European Committee on Antimicrobial Susceptibility Testing, 2018, BREAKPOINT TABLES IN; van Hoek AHAM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00203; Wallace CC, 2013, ECOHEALTH, V10, P201, DOI 10.1007/s10393-013-0842-6; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Whitaker DM, 2018, J WILDLIFE DIS, V54, P659, DOI 10.7589/2017-07-178; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Zheng B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01061	89	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0243691	10.1371/journal.pone.0243691	http://dx.doi.org/10.1371/journal.pone.0243691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762695	Green Submitted, Green Published, gold			2022-12-26	WOS:000755316600001
J	Raghavan, RK; Koestel, ZL; Boorgula, G; Hroobi, A; Ganta, R; Harrington, J; Goodin, D; Stich, RW; Anderson, G				Raghavan, Ram K.; Koestel, Zoe L.; Boorgula, Gunavanthi; Hroobi, Ali; Ganta, Roman; Harrington, John, Jr.; Goodin, Doug; Stich, Roger W.; Anderson, Gary			Unexpected winter questing activity of ticks in the Central Midwestern United States	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; AMBLYOMMA-AMERICANUM ACARI; GEOGRAPHIC-DISTRIBUTION; HOST ASSOCIATIONS; SEASONAL ACTIVITY; IXODIDAE; DETERMINANTS; OKLAHOMA; USA	Unexpected questing activity of ticks was noted during the winter months of January and February in the Central Midwestern states of Kansas, Missouri, Oklahoma, and Arkansas. From nine geographically distinct locations, four species of ticks were collected using the flagging method, of which the lone star tick, Amblyomma americanum, was most abundant, followed by the American dog tick, Dermacentor variabilis, the Gulf coast tick, Amblyomma maculatum, and the Black legged tick, Ixodes scapularis. More A. americanum nymphs were caught questing than male or female adults. The winter activity of these medically important ticks in this region poses concern for public health and offers an insight into future tick activity in light of ongoing climate change. More studies on the seasonality of these tick species, and how different climate parameters affect their seasonal activity in this region are warranted and would be expected to benefit for both human and veterinary medicine.	[Raghavan, Ram K.; Koestel, Zoe L.; Stich, Roger W.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Raghavan, Ram K.] Univ Missouri, Sch Hlth Profess, Dept Publ Hlth, Columbia, MO 65211 USA; [Boorgula, Gunavanthi] Univ Texas Hlth Sci Ctr, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX USA; [Hroobi, Ali] Al Baha Univ, Coll Sci, Dept Biol, Al Baha, Saudi Arabia; [Ganta, Roman] Kansas State Univ, Coll Vet Med, Dept Diagnost Med, Pathobiol, Manhattan, KS 66506 USA; [Anderson, Gary] Kansas State Univ, Coll Vet Med, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Al Baha University; Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.; Raghavan, RK (corresponding author), Univ Missouri, Sch Hlth Profess, Dept Publ Hlth, Columbia, MO 65211 USA.	RaghavanRK@missouri.edu	Hroobi, Ali/GQQ-3058-2022	Stich, Roger/0000-0002-9749-2034; Raghavan, Ram/0000-0002-2657-3398	Kansas State Veterinary Diagnostic Laboratory	Kansas State Veterinary Diagnostic Laboratory	This study was supported by Kansas State Veterinary Diagnostic Laboratory.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; [Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; Barnard D. R., 1986, Morphology, physiology, and behavioral biology of ticks, P428; Beckham TR., 2015, VECTOR-BORNE ZOONOT, V15, P453; Boorgula GDY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237191; Brunsell NA, 2010, INT J CLIMATOL, V30, P1178, DOI 10.1002/joc.1958; Burks Charles S., 1996, P85; Dautel H, 2008, INT J MED MICROBIOL, V298, P50, DOI 10.1016/j.ijmm.2008.01.010; GINSBERG HS, 1989, EXP APPL ACAROL, V7, P313, DOI 10.1007/BF01197925; Hair J.A., 1986, P406; Hanzlicek GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151924; Hroobi A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250272; Kiewra D, 2016, TICKS TICK-BORNE DIS, V7, P1124, DOI 10.1016/j.ttbdis.2016.08.012; KOCH HG, 1982, J MED ENTOMOL, V19, P293, DOI 10.1093/jmedent/19.3.293; Kollars TM, 2000, J PARASITOL, V86, P1156, DOI 10.1645/0022-3395(2000)086[1156:HAASAO]2.0.CO;2; Kollars TM, 1999, J MED ENTOMOL, V36, P720, DOI 10.1093/jmedent/36.6.720; Meyer L., 2014, CLIMATE CHANGE 2014; NOAA National Centers for Environmental Information, 2017, STAT CLIM NAT CLIM R; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peterson AT, 2017, J MED ENTOMOL, V54, P1103, DOI 10.1093/jme/tjx097; Peterson AT, 2017, J MED ENTOMOL, V54, P1080, DOI 10.1093/jme/tjx095; Raghavan RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209082; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P569, DOI 10.1089/vbz.2016.1975; Raghavan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150180; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P205, DOI 10.1089/vbz.2015.1837; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Raghavan RK, 2014, VECTOR-BORNE ZOONOT, V14, P486, DOI 10.1089/vbz.2013.1496; Raghavan RK, 2013, VECTOR-BORNE ZOONOT, V13, P449, DOI 10.1089/vbz.2012.1234; Raghavan RK, 2013, GEOSPATIAL HEALTH, V7, P169, DOI 10.4081/gh.2013.78; Rynkiewicz EC, 2014, EXP APPL ACAROL, V64, P109, DOI 10.1007/s10493-014-9798-7; Savage HM, 2018, J MED ENTOMOL, V55, P1613, DOI 10.1093/jme/tjy103; Savage HM, 2018, J MED ENTOMOL, V55, P701, DOI 10.1093/jme/tjx251; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Small MM, 2019, J VECTOR ECOL, V44, P105, DOI 10.1111/jvec.12334	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259769	10.1371/journal.pone.0259769	http://dx.doi.org/10.1371/journal.pone.0259769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762706	gold, Green Published			2022-12-26	WOS:000755316600036
J	Valladares, V; Pasquini, C; Thiengo, SC; Mello-Silva, CC				Valladares, Vanessa; Pasquini, Celio; Thiengo, Silvana Carvalho; Mello-Silva, Clelia Christina			Feasibility of near-infrared spectroscopy for species identification and parasitological diagnosis of freshwater snails of the genus Biomphalaria (Planorbidae)	PLOS ONE			English	Article							ORGANIC SHELL MATRIX; GLABRATA; METABOLISM; MOLLUSCA	Near Infrared Spectroscopy (NIRS) has been applied in epidemiological surveillance studies of insect vectors of parasitic diseases, such as the Dengue's mosquitoes. However, regarding mollusks, vectors of important worldwide helminth diseases such as schistosomiasis, fascioliasis and angiostrongyliasis, NIRS studies are rare. This work proposes to establish and standardize the procedure of data collection and analysis using NIRS applied to medical malacology, i.e., to mollusk vectors identifications. Biomphalaria shells and live snails were analyzed regarding several operational aspects, such as: moisture, shell side and position of the live animal for acquisition of NIR spectra. Representative spectra of Biomphalaria shells and live snails were collected using an average of 50 scans per sample and resolution of 16 cm(-1) . For shells, the sample should first be dried for a minimum of 15 days at an average temperature of 26 +/- 1 degrees C, and then placed directly in the equipment measurement window with its left side facing the light beam. Live animals should be dried with absorbent paper; placed into a glass jar, and analyzed similarly to the shells. Once standardized, the technique was applied aiming at two objectives: identification of Biomphalaria using only the shells and parasitological diagnosis for Schistosoma mansoni infection. The discrimination of the three Biomphalaria species intermediate hosts of S. mansoni only by shell has technical limit due to the scarcity of organic material. Nevertheless, it was possible to differentiate B. straminea from B. tenagophila and B. glabrata with 96% accuracy. As for the parasitological diagnosis, it was possible to differentiate infected mollusks shedding S. mansoni cercariae from the non-infected ones with 82, 5% accuracy. In conclusion, the Near Infrared Spectroscopy (NIR's) technique has proven to be an innovative and sound tool to detect infection by S. mansoni in the different species of Biomphalaria intermediate hosts.	[Valladares, Vanessa; Mello-Silva, Clelia Christina] Fiocruz MS, Inst Oswaldo Cruz, Evaluat & Promot Environm Hlth Lab, Rio De Janeiro, RJ, Brazil; [Pasquini, Celio] State Univ Campinas UNICAMP, Natl Inst Adv Analyt Sci & Technol INCTAA, Chem Inst, Campinas, SP, Brazil; [Thiengo, Silvana Carvalho] Fiocruz MS, Inst Oswaldo Cruz, Lab Malacol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Estadual de Campinas; Fundacao Oswaldo Cruz	Thiengo, SC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Malacol, Rio De Janeiro, RJ, Brazil.	scarvalhothiengo@gmail.com		Valladares, Vanessa/0000-0002-2364-4437; Thiengo, Silvana/0000-0002-5547-206X	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) [001]	Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially supported by the Coordination for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES) - Finance Code 001.	BECKER W, 1983, COMP BIOCHEM PHYS B, V76, P215, DOI 10.1016/0305-0491(83)90061-5; Brasil. Ministerio da Saude, 2014, SECR VIG SAUD DEP VI, V1; Brasil. Ministerio da Saude, 2008, SECR VIG SAUD DEP VI, V2; Brown MR, 2011, AQUACULTURE, V317, P233, DOI 10.1016/j.aquaculture.2011.04.017; Dauphin Y, 2000, COMP BIOCHEM PHYS A, V126, P367, DOI 10.1016/S1095-6433(00)00213-0; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; de Paula SM, 2009, MICRON, V40, P669, DOI 10.1016/j.micron.2009.05.006; Ellis JW, 1938, J CHEM PHYS, V6, P108, DOI 10.1063/1.1750197; Fernandes JN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0496; Ferreira CMM, 2015, QUIMIOMETRIA CONCEIT, V2, P43; Fluckiger M, 2011, FOOD CHEM, V126, P1817, DOI 10.1016/j.foodchem.2010.12.078; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x; Hasse B, 2000, CHEM-EUR J, V6, P3679, DOI 10.1002/1521-3765(20001016)6:20<3679::AID-CHEM3679>3.0.CO;2-#; Livingstone D.R., 1983, P177; Madigan T, 2012, FOOD ANAL METHOD, V5, P995, DOI 10.1007/s12161-011-9329-7; Magalhaes A. C., 2011, Revista de Patologia Tropical, V40, P46; Maia MF., 2019, MALARIA J, V18; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Marxen JC, 1997, COMP BIOCHEM PHYS B, V118, P23, DOI 10.1016/S0305-0491(97)00010-2; Marxen JC, 1998, BIOL BULL-US, V194, P231, DOI 10.2307/1543052; Mello-Silva CC, 1998, MEM I OSWALDO CRUZ, V93, P227, DOI 10.1590/S0074-02761998000700040; Mello-Silva CC, 2011, ACTA TROP, V117, P101, DOI 10.1016/j.actatropica.2010.10.007; Mello-Silva CC, 2010, MEM I OSWALDO CRUZ, V105, P492, DOI 10.1590/S0074-02762010000400024; Paraense WL, 2008, SCHISTOSOMA MANSONI, P285; Pasquini C, 2003, J BRAZIL CHEM SOC, V14, P198, DOI 10.1590/S0103-50532003000200006; Pasquini C, 2018, ANAL CHIM ACTA, V1026, P8, DOI 10.1016/j.aca.2018.04.004; Petrone L, 2008, BIOFOULING, V24, P405, DOI 10.1080/08927010802339970; Pinheiro J, 2007, TOPICOS MALACOLOGIA, V18; Santhanagopalan V, 2000, COMP BIOCHEM PHYS A, V125, P469, DOI 10.1016/S1095-6433(00)00173-2; Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657; Sikulu-Lord MT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27998-7; Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759; Silva LD, 2017, BRAZ J BIOL, V77, P304, DOI 10.1590/1519-6984.13315; Valladares V, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.636206; Vance CK, 2016, J NEAR INFRARED SPEC, V24, P1, DOI 10.1255/jnirs.1199; Vidigal THDA, 2000, PARASITOLOGY, V121, P611, DOI 10.1017/S0031182000006831; Wysokowski M, 2014, PALEOBIOLOGY, V40, P529, DOI 10.1666/13083	38	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259832	10.1371/journal.pone.0259832	http://dx.doi.org/10.1371/journal.pone.0259832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762684	gold, Green Published			2022-12-26	WOS:000755316600044
J	Kumar, NP; Padmapriyadarsini, C; Rajamanickam, A; Bhavani, PK; Nancy, A; Jayadeepa, B; Selvaraj, N; Asokan, D; Renji, RM; Venkataramani, V; Tripathy, S; Babu, S				Kumar, Nathella Pavan; Padmapriyadarsini, Chandrasekaran; Rajamanickam, Anuradha; Bhavani, Perumal Kannabiran; Nancy, Arul; Jayadeepa, Bharathi; Selvaraj, Nandhini; Asokan, Dinesh; Renji, Rachel Mariam; Venkataramani, Vijayalakshmi; Tripathy, Srikanth; Babu, Subash			BCG vaccination induces enhanced frequencies of memory T cells and altered plasma levels of common gamma c cytokines in elderly individuals	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; RANDOMIZED-TRIAL; CHILD SURVIVAL; IFN-GAMMA; PROTECTION; IMMUNITY; DIFFERENTIATION; TUBERCULOSIS; BIRTH; METAANALYSIS	BCG vaccination is known to induce innate immune memory, which confers protection against heterologous infections. However, the effect of BCG vaccination on the conventional adaptive immune cells subsets is not well characterized. We investigated the impact of BCG vaccination on the frequencies of T cell subsets and common gamma c (gamma c) cytokines in a group of healthy elderly individuals (age 60-80 years) at one month post vaccination as part of our clinical study to examine the effect of BCG on COVID-19. Our results demonstrate that BCG vaccination induced enhanced frequencies of central (p<0.0001) and effector memory (p<0.0001) CD4+ T cells and diminished frequencies of naive (p<0.0001), transitional memory (p<0.0001), stem cell memory (p = 0.0001) CD4+ T cells and regulatory T cells. In addition, BCG vaccination induced enhanced frequencies of central (p = 0.0008), effector (p<0.0001) and terminal effector memory (p<0.0001) CD8+ T cells and diminished frequencies of naive (p<0.0001), transitional memory (p<0.0001) and stem cell memory (p = 0.0034) CD8+T cells. BCG vaccination also induced enhanced plasma levels of IL-7 (p<0.0001) and IL-15 (p = 0.0020) but diminished levels of IL-2 (p = 0.0033) and IL-21 (p = 0.0020). Thus, BCG vaccination was associated with enhanced memory T cell subsets as well as memory enhancing gamma c cytokines in elderly individuals, suggesting its ability to induce non-specific adaptive immune responses.	[Kumar, Nathella Pavan; Padmapriyadarsini, Chandrasekaran; Bhavani, Perumal Kannabiran; Jayadeepa, Bharathi; Asokan, Dinesh; Tripathy, Srikanth] ICMR Natl Inst Res TB Int Ctr Excellence Res, Chennai, Tamil Nadu, India; [Rajamanickam, Anuradha; Nancy, Arul; Selvaraj, Nandhini; Renji, Rachel Mariam; Venkataramani, Vijayalakshmi; Babu, Subash] ICMR Natl Inst Res TB, Chennai, Tamil Nadu, India; [Tripathy, Srikanth] Dr DY Patil Med Coll Hosp & Res Ctr, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Medical College, Hospital & Research Centre	Kumar, NP (corresponding author), ICMR Natl Inst Res TB Int Ctr Excellence Res, Chennai, Tamil Nadu, India.; Babu, S (corresponding author), ICMR Natl Inst Res TB, Chennai, Tamil Nadu, India.	pavankumarn@nirt.res.in; sbabu@nirt.res.in	Babu, Subash/GXG-4746-2022	Rajamanickam, Anuradha/0000-0002-8143-5502				Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Berg RE, 2002, EUR J IMMUNOL, V32, P2807, DOI 10.1002/1521-4141(2002010)32:10<2807::AID-IMMU2807>3.0.CO;2-0; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Curtis N, 2020, LANCET, V395, P1545, DOI 10.1016/S0140-6736(20)31025-4; Fewkes NM, 2010, CANCER J, V16, P392, DOI 10.1097/PPO.0b013e3181eacbc4; Fritschi N, 2020, PAEDIATR RESPIR REV, V36, P57, DOI 10.1016/j.prrv.2020.08.004; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Grant EJ, 2016, CURR OPIN VIROL, V16, P132, DOI 10.1016/j.coviro.2016.01.016; Gustafson CE, 2020, J ALLERGY CLIN IMMUN, V145, P1309, DOI 10.1016/j.jaci.2020.03.017; Haahr S, 2016, INT J EPIDEMIOL, V45, P2122, DOI 10.1093/ije/dyw244; Habib T, 2003, J ALLERGY CLIN IMMUN, V112, P1033, DOI 10.1016/j.jaci.2003.08.039; Hassan J, 1998, EUR J IMMUNOL, V28, P3057, DOI 10.1002/(SICI)1521-4141(199810)28:10<3057::AID-IMMU3057>3.3.CO;2-Q; Hirve S, 2012, VACCINE, V30, P7300, DOI 10.1016/j.vaccine.2012.09.035; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kanai T, 1996, J IMMUNOL, V157, P3681; Kanegane H, 1996, BLOOD, V88, P230; Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Kumar NP, 2021, INT J INFECT DIS, V110, P98, DOI 10.1016/j.ijid.2021.07.041; Kumar NP, 2015, IMMUNOLOGY, V146, P243, DOI 10.1111/imm.12496; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; Madsen AMR, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04714-3; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Mathurin KS, 2009, J VIROL, V83, P3528, DOI 10.1128/JVI.02393-08; Moorlag SJCFM, 2019, CLIN MICROBIOL INFEC, V25, P1473, DOI 10.1016/j.cmi.2019.04.020; Moulton LH, 2005, TROP MED INT HEALTH, V10, P947, DOI 10.1111/j.1365-3156.2005.01434.x; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Ohrui Takashi, 2005, Nihon Ronen Igakkai Zasshi, V42, P34; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Rajamanickam A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225611; Rakshit S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130540; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Rossey I, 2014, VACCINE, V32, P6130, DOI 10.1016/j.vaccine.2014.08.063; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Roth A, 2004, PEDIATR INFECT DIS J, V23, P544, DOI 10.1097/01.inf.0000129693.81082.a0; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Sallard E, 2021, INFECT DIS NOW, V51, P7, DOI 10.1016/j.medmal.2020.09.013; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Suzukawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152483; ten Doesschate T, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04389-w; Waickman AT, 2016, CELL MOL LIFE SCI, V73, P253, DOI 10.1007/s00018-015-2062-4; Wardhana, 2011, Acta Med Indones, V43, P185; Zens KD, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85832	56	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258743	10.1371/journal.pone.0258743	http://dx.doi.org/10.1371/journal.pone.0258743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758029	Green Accepted, gold, Green Published			2022-12-26	WOS:000755112500008
J	Zhou, N; Ho, JPTF; Klop, C; Schreurs, R; Beenen, LFM; Aarab, G; de Lange, J				Zhou, Ning; Ho, Jean-Pierre T. F.; Klop, Cornelis; Schreurs, Ruud; Beenen, Ludo F. M.; Aarab, Ghizlane; de Lange, Jan			Intra-individual variation of upper airway measurements based on computed tomography	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; MAXILLOMANDIBULAR ADVANCEMENT; PHARYNGEAL AIRWAY; RELIABILITY; AGREEMENT; POSITION; ANATOMY; UPRIGHT; SUPINE	The aims of this study were (1) to quantify the intra-individual variation in the upper airway measurements on supine computed tomography (CT) scans at two different time points; and (2) to identify the most stable parameters of the upper airway measurements over time. Ten subjects with paired CT datasets (3-6 months interval) were studied, using computer software to segment and measure the upper airway. The minimum cross-sectional area of the total airway and all its segments (velopharynx, oropharynx, tongue base, and epiglottis) generally had the largest variation, while the length of the total airway had the lowest variation. Sphericity was the only parameter that was stable over time (relative difference <15%), both in the total airway and each subregion. There was considerable intra-individual variation in CT measurements of the upper airway, with the same patient instruction protocol for image acquisitions. The length of the total airway, and the sphericity of the total upper airway and each segment were stable over time. Hence, such intra-individual variation should be taken into account when interpreting and comparing upper airway evaluation parameters on CT in order to quantify treatment results or disease progress.	[Zhou, Ning; Ho, Jean-Pierre T. F.; Klop, Cornelis; Schreurs, Ruud; de Lange, Jan] Univ Amsterdam, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands; [Zhou, Ning; Ho, Jean-Pierre T. F.; Klop, Cornelis; Schreurs, Ruud; de Lange, Jan] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Zhou, Ning; Ho, Jean-Pierre T. F.; Klop, Cornelis; Schreurs, Ruud; Aarab, Ghizlane; de Lange, Jan] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Zhou, Ning; Aarab, Ghizlane] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Orofacial Pain & Dysfunct, Amsterdam, Netherlands; [Ho, Jean-Pierre T. F.] Northwest Clin, Dept Oral & Maxillofacial Surg, Alkmaar, Netherlands; [Schreurs, Ruud] Radboud Univ Nijmegen Med Ctr, Dept Oral & Maxillofacial Surg, Nijmegen, Netherlands; [Beenen, Ludo F. M.] Univ Amsterdam, Dept Radiol, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands	University of Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam	Zhou, N (corresponding author), Univ Amsterdam, Dept Oral & Maxillofacial Surg, Amsterdam UMC, Amsterdam, Netherlands.; Zhou, N (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.; Zhou, N (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.; Zhou, N (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Orofacial Pain & Dysfunct, Amsterdam, Netherlands.	n.zhou@amsterdamumc.nl	Beenen, Ludo F/AAA-3114-2021	Beenen, Ludo F/0000-0001-9204-1026; Ho, Jean-Pierre/0000-0001-8396-2501				Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Abramson Z, 2011, J ORAL MAXIL SURG, V69, P677, DOI 10.1016/j.joms.2010.11.037; Abramson Z, 2010, J ORAL MAXIL SURG, V68, P354, DOI 10.1016/j.joms.2009.09.087; Alsufyani NA, 2017, ORAL RADIOL, V33, P161, DOI 10.1007/s11282-017-0280-1; Behrents RG, 2019, AM J ORTHOD DENTOFAC, V156, P13, DOI 10.1016/j.ajodo.2019.04.009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Butterfield KJ, 2015, J ORAL MAXIL SURG, V73, P1133, DOI 10.1016/j.joms.2014.11.020; Camacho M, 2014, J LARYNGOL OTOL, V128, P824, DOI 10.1017/S0022215114001686; Chen H, 2016, SLEEP MED, V21, P19, DOI 10.1016/j.sleep.2016.01.022; Chen H, 2016, OR SURG OR MED OR PA, V122, P104, DOI 10.1016/j.oooo.2016.04.005; Ciscar MA, 2001, EUR RESPIR J, V17, P79, DOI 10.1183/09031936.01.17100790; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; El H, 2010, AM J ORTHOD DENTOFAC, V137, DOI [10.1016/j.ajodo.2009.11.010, 10.1016/j.ajodo.2010.01.014]; Ferguson KA, 1997, AM J RESP CRIT CARE, V155, P1748, DOI 10.1164/ajrccm.155.5.9154887; Fleiss JL., 1999, DESIGN ANAL CLIN EXP, P186; Gandedkar NH, 2017, J ORAL MAXIL SURG, V75, P2411, DOI 10.1016/j.joms.2017.05.028; Guijarro-Martinez R, 2013, INT J ORAL MAX SURG, V42, P1140, DOI 10.1016/j.ijom.2013.03.007; Gurani SF, 2020, ORTHOD CRANIOFAC RES, V23, P102, DOI 10.1111/ocr.12348; Gurani Sirwan Fernandez, 2016, J Oral Maxillofac Res, V7, pe1, DOI 10.5037/jomr.2016.7101; Hackshaw A, 2008, EUR RESPIR J, V32, P1141, DOI 10.1183/09031936.00136408; Hassan B, 2013, EUR J ORTHODONT, V35, P38, DOI 10.1093/ejo/cjr050; Hsieh YJ, 2014, BRIT J ORAL MAX SURG, V52, P445, DOI 10.1016/j.bjoms.2014.02.006; Kaur S, 2014, NIGER J CLIN PRACT, V17, P629, DOI 10.4103/1119-3077.141431; Kezirian EJ, 2011, EUR ARCH OTO-RHINO-L, V268, P1233, DOI 10.1007/s00405-011-1633-8; Klazen YP, 2019, J ORAL MAXIL SURG, V77, P1869, DOI 10.1016/j.joms.2019.03.017; Liang QY, 2021, CRANIO, V39, P125, DOI 10.1080/08869634.2019.1602310; Luiz RR, 2005, J CLIN EPIDEMIOL, V58, P215, DOI 10.1016/j.jclinepi.2004.07.007; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Major MP, 2006, AM J ORTHOD DENTOFAC, V130, P700, DOI 10.1016/j.ajodo.2005.05.050; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Ryan DPO, 2019, AM J ORTHOD DENTOFAC, V156, P53, DOI 10.1016/j.ajodo.2018.07.024; Ogawa T, 2007, ORAL SURG ORAL MED O, V103, P102, DOI 10.1016/j.tripleo.2006.06.008; Ponce-Garcia C, 2018, ANGLE ORTHOD, V88, P233, DOI 10.2319/071217-468.1; Schendel SA, 2012, J ORAL MAXIL SURG, V70, P2174, DOI 10.1016/j.joms.2011.10.013; SCHWAB RJ, 1993, AM REV RESPIR DIS, V148, P1385, DOI 10.1164/ajrccm/148.5.1385; Van Holsbeke CS, 2014, J AEROSOL MED PULM D, V27, P51, DOI 10.1089/jamp.2012.1010; Zimmerman JN, 2019, EUR J ORTHODONT, V41, P101, DOI 10.1093/ejo/cjy058	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259739	10.1371/journal.pone.0259739	http://dx.doi.org/10.1371/journal.pone.0259739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739525	Green Published, gold			2022-12-26	WOS:000755000800053
J	Ibrahium, SM; Farghali, AA; Mahmoud, R; Wahba, AA; El-Ashram, S; Mahran, HA; Aboelhadid, SM				Ibrahium, Samar M.; Farghali, Ahmed A.; Mahmoud, Rehab; Wahba, Ahmed A.; El-Ashram, Saeed; Mahran, Hesham A.; Aboelhadid, Shawky M.			New insight on some selected nanoparticles as an effective adsorbent toward diminishing the health risk of deltamethrin contaminated water	PLOS ONE			English	Article							LAYERED DOUBLE HYDROXIDE; COMET ASSAY; MAGNETIC NANOPARTICLES; LEAF EXTRACT; SILVER NANOPARTICLES; AQUEOUS-SOLUTION; GREEN SYNTHESIS; WASTE-WATER; IN-VITRO; REMOVAL	Deltamethrin is a widely used insecticide that kills a wide variety of insects and ticks. Deltamethrin resistance develops as a result of intensive, repeated use, as well as increased environmental contamination and a negative impact on public health. Its negative impact on aquatic ecology and human health necessitated the development of a new technique for environmental remediation and wastewater treatment, such as the use of nanotechnology. The co-precipitation method was used to create Zn-Fe/LDH, Zn-AL-GA/LDH, and Fe-oxide nanoparticles (NPs), which were then characterized using XRD, FT-IR, FE-SEM, and HR-TEM. The kinetic study of adsorption test revealed that these NPs were effective at removing deltamethrin from wastewater. The larval packet test, which involved applying freshly adsorbed deltamethrin nanocomposites (48 hours after adsorption), and the comet assay test were used to confirm that deltamethrin had lost its acaricidal efficacy. The kinetics of the deltamethrin adsorption process was investigated using several kinetic models at pH 7, initial concentration of deltamethrin 40 ppm and temperature 25 degrees C. Within the first 60 min, the results indicated efficient adsorption performance in deltamethrin removal, the maximum adsorption capacity was 27.56 mg/L, 17.60 mg/L, and 3.06 mg/L with the Zn-Al LDH/GA, Zn-Fe LDH, and Fe Oxide, respectively. On tick larvae, the results of the freshly adsorbed DNC bioassay revealed larval mortality. This suggests that deltamethrin's acaricidal activity is still active. However, applying DNCs to tick larvae 48 hours after adsorption had no lethal effect, indicating that deltamethrin had lost its acaricidal activity. The latter result corroborated the results of the adsorption test's kinetic study. Furthermore, the comet assay revealed that commercial deltamethrin caused 28.51% DNA damage in tick cells, which was significantly higher than any DNC. In conclusion, the NPs used play an important role in deltamethrin decontamination in water, resulting in reduced public health risk. As a result, these NPs could be used as a method of environmental remediation.	[Ibrahium, Samar M.] Anim Hlth Res Inst, Fayoum Branch, Al Fayyum, Egypt; [Farghali, Ahmed A.] Beni Suef Univ, Fac PostGrad Studies Adv Sci PSAS, Mat Sci & Nanotechnol Dept, Bani Suwayf, Egypt; [Mahmoud, Rehab] Beni Suef Univ, Fac Sci, Dept Chem, Bani Suwayf, Egypt; [Wahba, Ahmed A.] Anim Hlth Res Inst, Parasitol Dept, Dokki, Egypt; [El-Ashram, Saeed] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China; [El-Ashram, Saeed] Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt; [Mahran, Hesham A.] Jazan Univ, Coll Publ Hlth & Trop Med, Hlth Informat Dept, Jazan, Saudi Arabia; [Mahran, Hesham A.] Beni Suef Univ, Fac Vet Med, Hyg Zoonoses & Epidemiol Dept, Bani Suwayf, Egypt; [Aboelhadid, Shawky M.] Beni Suef Univ, Fac Vet Med, Dept Parasitol, Bani Suwayf, Egypt	Animal Health Research Institute (AHRI); Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Animal Health Research Institute (AHRI); Foshan University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Jazan University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University	Ibrahium, SM (corresponding author), Anim Hlth Res Inst, Fayoum Branch, Al Fayyum, Egypt.; El-Ashram, S (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.; El-Ashram, S (corresponding author), Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt.	Drsamarmahmoud333@yahoo.com; elashram@yahoo.com	El-Ashram, Saeed/AAC-6060-2021	El-Ashram, Saeed/0000-0003-0389-1980; ibrahium, samar/0000-0002-2517-1848				Abd Elhaleem MB, 2020, RSC ADV, V10, P13196, DOI 10.1039/c9ra08355c; Abdelsalam E, 2017, ENERGY, V120, P842, DOI 10.1016/j.energy.2016.11.137; Aboelhadid SM, 2020, J BIOMED NANOTECHNOL, V16, P1765, DOI 10.1166/jbn.2020.3005; Abusalem M., 2019, JJEES, V10, P161; Ajitha B, 2018, ADV POWDER TECHNOL, V29, P86, DOI 10.1016/j.apt.2017.10.015; Ali T, 2018, DRUG CHEM TOXICOL, V41, P213, DOI 10.1080/01480545.2017.1343342; Augustyniak M, 2016, MUTAT RES-REV MUTAT, V767, P67, DOI 10.1016/j.mrrev.2015.09.001; Balcomb B, 2015, CHEMISTRYOPEN, V4, P137, DOI 10.1002/open.201402074; Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203; Bhanu Shrivastava, 2011, International Journal of Environmental Sciences, V1, P977; Boclair JW, 1999, CHEM MATER, V11, P298, DOI 10.1021/cm980523u; Castillo-Henriquez L, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10091763; Chattopadhyay P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-284; Choi HJ, 2017, WATER SCI TECHNOL, V76, P2638, DOI 10.2166/wst.2017.346; Cui Y, 2019, FISH SHELLFISH IMMUN, V94, P730, DOI 10.1016/j.fsi.2019.09.068; Cycon M, 2014, INT J ENVIRON SCI TE, V11, P1305, DOI 10.1007/s13762-013-0322-0; Dadfar SM, 2019, ADV DRUG DELIVER REV, V138, P302, DOI 10.1016/j.addr.2019.01.005; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; de Campos-Pereira M., 2008, PRIMERIAEDICAO; de Souza TC, 2020, TOXICOL ENV HEALTH, V12, P149, DOI 10.1007/s13530-020-00048-4; DRUMMOND RO, 1973, J ECON ENTOMOL, V66, P130, DOI 10.1093/jee/66.1.130; Ducornez S, 2005, VET PARASITOL, V130, P285, DOI 10.1016/j.vetpar.2005.04.018; El Golli-Bennour E, 2019, ENVIRON SCI POLLUT R, V26, P18856, DOI 10.1007/s11356-019-05253-4; El-Reesh GYA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57519-4; FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3; Field LM, 2017, EUR BIOPHYS J BIOPHY, V46, P675, DOI 10.1007/s00249-016-1195-1; Ghafari B, 2017, WATER SCI TECHNOL, V76, P847, DOI 10.2166/wst.2017.251; Ghosh S, 2006, EXP APPL ACAROL, V40, P49, DOI 10.1007/s10493-006-9022-5; Hamed HS, 2019, FISH PHYSIOL BIOCHEM, V45, P71, DOI 10.1007/s10695-018-0535-8; Humbert H, 2008, WATER RES, V42, P1635, DOI 10.1016/j.watres.2007.10.012; Iftekhar S, 2018, CHEM ENG J, V347, P398, DOI 10.1016/j.cej.2018.04.126; Jia ZQ, 2006, J HAZARD MATER, V129, P234, DOI 10.1016/j.jhazmat.2005.08.032; Kirsten KS, 2017, FISH SHELLFISH IMMUN, V64, P78, DOI 10.1016/j.fsi.2017.03.006; Lu HT, 2015, CHEM ENG J, V276, P365, DOI 10.1016/j.cej.2015.04.095; Maclachlan D., 2018, PEST RES FOOD 2018 J; Mahgoub SM, 2020, RSC ADV, V10, P27633, DOI 10.1039/d0ra04898d; Mahmoud EA, 2020, FISH SHELLFISH IMMUN, V102, P422, DOI 10.1016/j.fsi.2020.04.061; Mahmoud RK, 2020, WATER AIR SOIL POLL, V231, DOI 10.1007/s11270-020-04629-4; Maity D, 2007, J MAGN MAGN MATER, V308, P46, DOI 10.1016/j.jmmm.2006.05.001; Martins R. M., 2006, Revista Brasileira de Plantas Medicinais, V8, P71; Mascolo MC, 2013, MATERIALS, V6, P5549, DOI 10.3390/ma6125549; Moaty SAA, 2016, MAT SCI ENG C-MATER, V68, P184, DOI 10.1016/j.msec.2016.05.110; Mohammed AN, 2020, ENVIRON SCI POLLUT R, V27, P42791, DOI 10.1007/s11356-020-10054-1; Mourid E, 2019, APPL CLAY SCI, V168, P87, DOI 10.1016/j.clay.2018.11.005; Neamat-Allah ANF, 2021, AQUAC RES, V52, P518, DOI 10.1111/are.14910; Pawar A.S., 2016, INT J CURR MICROBIOL, V5, P258; Rafique U, 2016, OPEN LIFE SCI, V11, P417, DOI 10.1515/biol-2016-0055; Rahman MF, 2002, MUTAT RES-GEN TOX EN, V516, P139, DOI 10.1016/S1383-5718(02)00033-5; Ravichandran V, 2016, MATER LETT, V180, P264, DOI 10.1016/j.matlet.2016.05.172; Rodrigues GR, 2019, INT J PHARMACEUT, V555, P356, DOI 10.1016/j.ijpharm.2018.11.043; Rosario-Cruz R, 2009, PARASITOL RES, V105, P1145, DOI 10.1007/s00436-009-1539-1; Shafaei F, 2020, J CHIN CHEM SOC-TAIP, V67, P891, DOI 10.1002/jccs.201800489; Sheng TC, 2019, ENVIRON SCI POLLUT R, V26, P7102, DOI 10.1007/s11356-019-04191-5; Sivakami M, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.104420; Stara A, 2018, CHEM-BIOL INTERACT, V291, P95, DOI 10.1016/j.cbi.2018.06.012; Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018; Tabassum H, 2015, ECOL INDIC, V58, P411, DOI 10.1016/j.ecolind.2015.06.008; Villarini M, 1998, TOXICOLOGY, V130, P129, DOI 10.1016/S0300-483X(98)00097-3; Wang JT, 2010, J COLLOID INTERF SCI, V349, P578, DOI 10.1016/j.jcis.2010.04.081; Wu ZL, 2019, ULTRASON SONOCHEM, V52, P530, DOI 10.1016/j.ultsonch.2018.12.032; Yang Q, 2017, CATAL COMMUN, V99, P15, DOI 10.1016/j.catcom.2017.05.010; Younes HA, 2019, J TAIWAN INST CHEM E, V102, P297, DOI 10.1016/j.jtice.2019.06.018; Zaher A, 2020, ENVIRON SCI POLLUT R, V27, P12256, DOI 10.1007/s11356-020-07750-3; Zarandi MJE, 2016, WATER SCI TECHNOL, V74, P38, DOI 10.2166/wst.2016.152; Zhang RH, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2020.103908; Zhou KQ, 2018, COMPOS PART A-APPL S, V107, P144, DOI 10.1016/j.compositesa.2017.12.026	67	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258749	10.1371/journal.pone.0258749	http://dx.doi.org/10.1371/journal.pone.0258749			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735469	Green Published, gold			2022-12-26	WOS:000755077100031
J	Song, YW; Zhao, FK; Ma, W; Li, G				Song, Yaowen; Zhao, Fangkun; Ma, Wei; Li, Guang			Hotspots and trends in liver kinase B1 research: A bibliometric analysis	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; ACTIVATED PROTEIN-KINASE; CANCER-CELLS; DOWN-REGULATION; LKB1 KINASE; AMPK; GENE; SUPPRESSION; METABOLISM; LKB1/STK11	Introduction In the past 22 years, a large number of publications have reported that liver kinase B1 (LKB1) can regulate a variety of cellular processes and play an important role in many diseases. However, there is no systematic bibliometric analysis on the publications of LKB1 to reveal the research hotspots and future direction. Methods Publications were retrieved from the Web of Science Core Collection (WoSCC), Scopus, and PubMed databases. CiteSpace and VOSviewer were used to analysis the top countries, institutions, authors, source journals, discipline categories, references, and keywords. Results In the past 22 years, the number of LKB1 publications has increased gradually by year. The country, institution, author, journals that have published the most articles and cited the most frequently were the United States, Harvard University, Prof. Benoit Viollet, Journal of Biochemistry and Plos One. The focused research hotspot was the molecular functions of LKB1. The emerging hotspots and future trends are the clinical studies about LKB1 and comutated genes as biomarkers in tumors, especially in lung adenocarcinoma. Conclusions Our research could provide knowledge base, frontiers, emerging hotspots and future trends associated with LKB1 for researchers in this field, and contribute to finding potential cooperation possibilities.	[Song, Yaowen; Li, Guang] China Med Univ, Affiliated Hosp 1, Dept Radiotherapy Oncol, Shenyang, Peoples R China; [Zhao, Fangkun] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Peoples R China; [Ma, Wei] China Med Univ, Affiliated Hosp 1, Dept Breast Surg, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Li, G (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiotherapy Oncol, Shenyang, Peoples R China.	li13804058616@163.com						Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Bhatt V, 2019, GENE DEV, V33, P150, DOI 10.1101/gad.320481.118; Bonanno L, 2017, CLIN CANCER RES, V23, P3316, DOI 10.1158/1078-0432.CCR-16-2410; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Cai DJ, 2020, CANCER MED-US, V9, P84, DOI 10.1002/cam4.2682; Caiola E, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0954-5; Chen CM, 2012, EXPERT OPIN BIOL TH, V12, P593, DOI 10.1517/14712598.2012.674507; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Chen XX, 2021, SCI TOTAL ENVIRON, V774, DOI 10.1016/j.scitotenv.2021.145585; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Contreras CM, 2008, CANCER RES, V68, P759, DOI 10.1158/0008-5472.CAN-07-5014; Devos P, 2020, HYPERTENSION, V76, P1649, DOI 10.1161/HYPERTENSIONAHA.120.15711; Dong LX, 2013, ACTA PHARMACOL SIN, V34, P314, DOI 10.1038/aps.2012.143; Dong SM, 1998, CANCER RES, V58, P3787; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28074-w; Esteve-Puig R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004721; Fang BL, 2016, ACTA BIOCH BIOPH SIN, V48, P27, DOI 10.1093/abbs/gmv090; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Gatalica Z, 2018, EUR J CANCER, V94, P179, DOI 10.1016/j.ejca.2018.02.021; Ghisi ND, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139359; Gill RK, 2011, ONCOGENE, V30, P3784, DOI 10.1038/onc.2011.98; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He TY, 2014, ANN SURG ONCOL, V21, pS703, DOI 10.1245/s10434-014-3824-1; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hollstein PE, 2019, CANCER DISCOV, V9, P1606, DOI 10.1158/2159-8290.CD-18-1261; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Jalkh N, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0244-7; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang SP, 2020, INT J BIOL MACROMOL, V151, P1277, DOI 10.1016/j.ijbiomac.2019.10.174; Jin CN, 2021, FOOD CHEM TOXICOL, V154, DOI 10.1016/j.fct.2021.112350; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kottakis F, 2012, CELL RES, V22, P1617, DOI 10.1038/cr.2012.108; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Leprivier G, 2013, CELL, V153, P1064, DOI 10.1016/j.cell.2013.04.055; Li FM, 2015, CANCER CELL, V27, P698, DOI 10.1016/j.ccell.2015.04.001; Li GH, 2015, ATHEROSCLEROSIS, V243, P223, DOI 10.1016/j.atherosclerosis.2015.09.020; Liang X, 2014, INT J ONCOL, V44, P1989, DOI 10.3892/ijo.2014.2351; Liang YX, 2021, J AGR FOOD CHEM, V69, P8257, DOI 10.1021/acs.jafc.1c02596; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Liu X, 2014, CLIN CHEM, V60, P1004, DOI 10.1373/clinchem.2014.225565; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Loi S, 2013, JNCI-J NATL CANCER I, V105, P960, DOI 10.1093/jnci/djt121; Mans LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07116-9; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Moral-Sanz J, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau0296; Morton JP, 2010, GASTROENTEROLOGY, V139, P586, DOI 10.1053/j.gastro.2010.04.055; O'Farrell F, 2017, NAT CELL BIOL, V19, P1412, DOI 10.1038/ncb3631; Parikh Anish B, 2019, Cancer Treat Res Commun, V20, P100150, DOI 10.1016/j.ctarc.2019.100150; Parikh AB, 2017, INVEST NEW DRUG, V35, P813, DOI 10.1007/s10637-017-0511-7; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Paunkov A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090353; Resta N, 2013, DIGEST LIVER DIS, V45, P606, DOI 10.1016/j.dld.2012.12.018; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; Rowan A, 2000, J PATHOL, V192, P203; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shan TZ, 2017, J CELL PHYSIOL, V232, P2653, DOI 10.1002/jcp.25786; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Skoulidis F, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.102; Skoulidis F, 2018, CANCER DISCOV, V8, P822, DOI 10.1158/2159-8290.CD-18-0099; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Spicer J, 2004, CURR BIOL, V14, pR383, DOI 10.1016/j.cub.2004.05.012; Synnestvedt Marie B, 2005, AMIA Annu Symp Proc, P724; Thomson DM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103125; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; van Lier MGF, 2010, AM J GASTROENTEROL, V105, P1258, DOI 10.1038/ajg.2009.725; Verrall B, 2020, SCI TOTAL ENVIRON, V748, DOI 10.1016/j.scitotenv.2020.141344; Wang Q., 2021, WHAT BIBLIOMETRIC AN, DOI [10.2196/25789 34014832, DOI 10.2196/2578934014832]; Wang Yudong, 2018, Oncotarget, V9, P33258, DOI 10.18632/oncotarget.25947; Wei QC, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08101-2; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu HG, 2015, ONCOGENE, V34, P3848, DOI 10.1038/onc.2014.315; Xu ZY, 2017, J CELL PHYSIOL, V232, P2296, DOI 10.1002/jcp.25643; Yang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10575; Yang RQ, 2019, JNCI-J NATL CANCER I, V111, P664, DOI 10.1093/jnci/djy166; Yang TL, 2004, GENE CHROMOSOME CANC, V41, P250, DOI 10.1002/gcc.20080; Yang YB, 2015, J GASTROEN HEPATOL, V30, P609, DOI 10.1111/jgh.12723; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang WM, 2017, ONCOL LETT, V14, P2075, DOI 10.3892/ol.2017.6431; Zhao RX, 2014, CURR DRUG TARGETS, V15, P32, DOI 10.2174/1389450114666140106095811; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhong DS, 2013, THORAC CANCER, V4, P229, DOI 10.1111/1759-7714.12003; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zulato E, 2018, BIOCHEM PHARMACOL, V156, P479, DOI 10.1016/j.bcp.2018.09.019	96	1	1	13	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259240	10.1371/journal.pone.0259240	http://dx.doi.org/10.1371/journal.pone.0259240			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735498	Green Published, gold			2022-12-26	WOS:000755077100056
J	Fazil, MHUT; Chirumamilla, CS; Perez-Novo, C; Wong, BHS; Kumar, S; Sze, SK; Vanden Berghe, W; Verma, NK				Fazil, Mobashar Hussain Urf Turabe; Chirumamilla, Chandra Sekhar; Perez-Novo, Claudina; Wong, Brandon Han Siang; Kumar, Sunil; Sze, Siu Kwan; Vanden Berghe, Wim; Verma, Navin Kumar			The steroidal lactone withaferin A impedes T-cell motility by inhibiting the kinase ZAP70 and subsequent kinome signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZAP-70 TYROSINE KINASE; MIGRATION; PHOSPHORYLATION; POLARIZATION; ICAM-1; LFA-1; MICROTUBULES; WITHANOLIDE; LEUKOCYTES; TARGETS	The steroidal lactone withaferin A (WFA) is a dietary phytochemical, derived from Withania somnifera. It exhibits a wide range of biological properties, including immunomodulatory, anti-inflammatory, antistress, and anticancer activities. Here we investigated the effect of WFA on T-cell motility, which is crucial for adaptive immune responses as well as autoimmune reactions. We found that WFA dose-dependently (within the concentration range of 0.3-1.25 mu M) inhibited the ability of human T-cells to migrate via cross-linking of the lymphocyte function-associated antigen-1 (LFA-1) integrin with its ligand, intercellular adhesion molecule 1 (ICAM-1). Coimmunoprecipitation of WFA interacting proteins and subsequent tandem mass spectrometry identified a WFA-interactome consisting of 273 proteins in motile T-cells. In particular, our data revealed significant enrichment of the zeta-chain-associated protein kinase 70 (ZAP70) and cytoskeletal actin protein interaction networks upon stimulation. Phospho-peptide mapping and kinome analysis substantiated kinase signaling downstream of ZAP70 as a key WFA target, which was further confirmed by bait-pulldown and Western immunoblotting assays. The WFA-ZAP70 interaction was disrupted by a disulfide reducing agent dithiothreitol, suggesting an involvement of cysteine covalent binding interface. In silk degrees docking predicted WFA binding to ZAP70 at cystine 560 and 564 residues. These findings provide a mechanistic insight whereby WFA binds to and inhibits the ZAP70 kinase and impedes T-cell motility. We therefore conclude that WFA may be exploited to pharmacologically control host immune responses and potentially prevent autoimmune-mediated pathologies.	[Fazil, Mobashar Hussain Urf Turabe; Wong, Brandon Han Siang; Verma, Navin Kumar] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Clin Sci Bldg, Singapore, Singapore; [Chirumamilla, Chandra Sekhar; Perez-Novo, Claudina; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Chirumamilla, Chandra Sekhar; Perez-Novo, Claudina; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Integrated Personalized & Precis Oncol Network IP, Antwerp, Belgium; [Wong, Brandon Han Siang] Nanyang Technol Univ Singapore, NTU Inst Hlth Technol HealthTech NTU, Interdisciplinary Grad Programme, Singapore, Singapore; [Kumar, Sunil] Indian Council Agr Res, Natl Bur Agriculturally Important Microorganisms, Mau, Uttar Pradesh, India; [Sze, Siu Kwan] Nanyang Technol Univ Singapore, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Antwerp; University of Antwerp; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agriculturally Important Microorganisms; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Verma, NK (corresponding author), Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Clin Sci Bldg, Singapore, Singapore.; Vanden Berghe, W (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium.; Vanden Berghe, W (corresponding author), Univ Antwerp, Dept Biomed Sci, Integrated Personalized & Precis Oncol Network IP, Antwerp, Belgium.	wim.vandenberghe@uantwerpen.de; nkverma@ntu.edu.sg	Berghe, Wim Vanden/S-6425-2018; Verma, Navin Kumar/B-7641-2008	Berghe, Wim Vanden/0000-0003-0161-7355; Verma, Navin Kumar/0000-0002-5940-6633; Fazil, M H U Turabe/0000-0002-4621-8625; Wong, Brandon Han Siang/0000-0001-6825-550X; Perez Novo, Claudina/0000-0003-4562-4346	Foundation Against Cancer (Belgium) [7872]; Hercules Foundation (Belgium) [AUHA/13/012]; Research Foundation - Flanders (FWO, Belgium) [G059713N/G079614N]	Foundation Against Cancer (Belgium); Hercules Foundation (Belgium); Research Foundation - Flanders (FWO, Belgium)(FWO)	W. V. B. acknowledges funding support from the Foundation Against Cancer (Grant number-7872, Belgium), Hercules Foundation (Grant number-AUHA/13/012, Belgium), and Research Foundation - Flanders (FWO, grant numbers G059713N/G079614N, Belgium).	Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Chen C, 2014, J BIOL CHEM, V289, P28478, DOI 10.1074/jbc.M114.567446; Chen WY, 2008, J BIOL CHEM, V283, P17184, DOI 10.1074/jbc.M709447200; Chirumamilla CS, 2019, METHODS MOL BIOL, V1930, P99, DOI 10.1007/978-1-4939-9036-8_13; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Dom M, 2018, J PROTEOMICS, V179, P17, DOI 10.1016/j.jprot.2018.02.013; Dubey S, 2021, J IMMUNOL RES, V2021, DOI 10.1155/2021/9483433; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Faruki S, 2000, J CELL SCI, V113, P2557; Fazil MHUT, 2016, SCI REP-UK, V6, DOI 10.1038/srep37721; Fazil MHUT, 2012, J MOL MODEL, V18, P1, DOI 10.1007/s00894-010-0947-6; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Grossman EA, 2017, CELL CHEM BIOL, V24, P1368, DOI 10.1016/j.chembiol.2017.08.013; Heyninck K, 2014, BIOCHEM PHARMACOL, V91, P501, DOI 10.1016/j.bcp.2014.08.004; Hua S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00127; Hui KL, 2017, P NATL ACAD SCI USA, V114, pE4175, DOI 10.1073/pnas.1614291114; Jenkins MR, 2014, ELIFE, V3, DOI 10.7554/eLife.01310; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kizhakeyil A, 2019, METHODS MOL BIOL, V1930, P11, DOI 10.1007/978-1-4939-9036-8_2; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lefort Craig T, 2010, J Vis Exp, DOI 10.3791/2017; Levoin N, 2011, ACS MED CHEM LETT, V2, P293, DOI 10.1021/ml100288q; LEY SC, 1994, EUR J IMMUNOL, V24, P99, DOI 10.1002/eji.1830240116; Lin XQ, 2020, MOLECULES, V25, DOI 10.3390/molecules25061375; Logie E, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9111107; Loppow D, 2000, EUR RESPIR J, V16, P324, DOI 10.1034/j.1399-3003.2000.16b22.x; Mace EM, 2010, BLOOD, V116, P1272, DOI 10.1182/blood-2009-12-261487; Malik F, 2007, LIFE SCI, V80, P1525, DOI 10.1016/j.lfs.2007.01.029; Martin-Cofreces NB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00024; Mastrogiovanni M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.591348; Maxwell MJ, 2012, J AUTOIMMUN, V38, P381, DOI 10.1016/j.jaut.2012.04.001; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Meng W, 2008, ANAL CHEM, V80, P9797, DOI 10.1021/ac801344z; Ong ST, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00397; Ong ST, 2014, J BIOL CHEM, V289, P19420, DOI 10.1074/jbc.M113.545863; Peer D, 2007, P NATL ACAD SCI USA, V104, P4095, DOI 10.1073/pnas.0608491104; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Piechocka IK, 2021, BIOPHYS J, V120, P2644, DOI 10.1016/j.bpj.2021.05.016; ROSAZZA JP, 1978, STEROIDS, V31, P671, DOI 10.1016/S0039-128X(78)80007-5; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith A, 2007, IMMUNOL REV, V218, P135, DOI 10.1111/j.1600-065X.2007.00537.x; Soede RDM, 1998, J CELL BIOL, V142, P1371, DOI 10.1083/jcb.142.5.1371; Soede RDM, 1999, J IMMUNOL, V163, P4253; Song KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11938-y; Stark AK, 2015, CURR OPIN PHARMACOL, V23, P82, DOI 10.1016/j.coph.2015.05.017; Terazawa S, 2015, ARCH DERMATOL RES, V307, P73, DOI 10.1007/s00403-014-1518-y; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tuettenberg A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149193; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Verma NK, 2016, J IMMUNOL, V197, P108, DOI 10.4049/jimmunol.1501264; Verma NK, 2014, EUR J IMMUNOL, V44, P3484, DOI 10.1002/eji.201344428; Verma NK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02642; Verma NK, 2019, METHODS MOL BIOL, V1930, P19, DOI 10.1007/978-1-4939-9036-8_3; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Walling BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00952; White PT, 2016, ADV EXP MED BIOL, V928, P329, DOI 10.1007/978-3-319-41334-1_14; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039	66	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101377	10.1016/j.jbc.2021.101377	http://dx.doi.org/10.1016/j.jbc.2021.101377			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34742736	Green Published, gold			2022-12-26	WOS:000748084900015
J	Qayyum, MZ; Molodtsov, V; Renda, A; Murakami, KS				Qayyum, M. Zuhaib; Molodtsov, Vadim; Renda, Andrew; Murakami, Katsuhiko S.			Structural basis of RNA polymerase recycling by the Swi2/Snf2 family of ATPase RapA in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL HOMOLOG; PROTEIN RAPA; TRANSCRIPTION	After transcription termination, cellular RNA polymerases (RNAPs) are occasionally trapped on DNA, impounded in an undefined post-termination complex (PTC), limiting the free RNAP pool and subsequently leading to inefficient transcription. In Escherichia coli, a Swi2/Snf2 family of ATPase called RapA is known to be involved in countering such inefficiency through RNAP recycling; however, the precise mechanism of this recycling is unclear. To better understand its mechanism, here we determined the structures of two sets of E. coli RapA-RNAP complexes, along with the RNAP core enzyme and the elongation complex, using cryo-EM. These structures revealed the large conformational changes of RNAP and RapA upon their association that has been implicated in the hindrance of PTC formation. Our results along with DNA-binding assays reveal that although RapA binds RNAP away from the DNA-binding main channel, its binding can allosterically close the RNAP clamp, thereby preventing its nonspecific DNA binding and PTC formation. Taken together, we propose that RapA acts as a guardian of RNAP by which RapA prevents nonspecific DNA binding of RNAP without affecting the binding of promoter DNA recognition a factor, thereby enhancing RNAP recycling.	[Qayyum, M. Zuhaib; Molodtsov, Vadim; Renda, Andrew; Murakami, Katsuhiko S.] Penn State Univ, Ctr RNA Mol Biol, Ctr Struct Biol, Dept Biochem & Mol Biol, University Pk, PA USA; [Molodtsov, Vadim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Molodtsov, Vadim] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Murakami, KS (corresponding author), St Jude Childrens Res Hosp, Danny Thomas Res Ctr, Dept Struct Biol, Prot Technol Ctr, Memphis, TN 38105 USA.	kum14@psu.edu	Qayyum, Mohammad Zuhaib/AAD-8672-2022	Qayyum, Mohammad Zuhaib/0000-0003-2442-4812; Molodtsov, Vadim/0000-0003-3002-4794; Murakami, Katsuhiko/0000-0003-2244-0501	National Institutes of Health [R01 GM087350, R35 GM131860]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants (R01 GM087350 and R35 GM131860 to K. S. M.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; Duchi D, 2018, NUCLEIC ACIDS RES, V46, P7284, DOI 10.1093/nar/gky482; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Harden TT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14208-9; Huang YH, 2020, MOL CELL, V79, P1024, DOI 10.1016/j.molcel.2020.08.010; Jin DJ, 2011, BBA-GENE REGUL MECH, V1809, P470, DOI 10.1016/j.bbagrm.2011.03.003; Johnson GE, 2020, NATURE, V585, P124, DOI 10.1038/s41586-020-2638-5; Kakar S, 2015, J BIOL CHEM, V290, P23656, DOI 10.1074/jbc.M114.618801; Kang JY, 2021, ELIFE, V10, DOI 10.7554/eLife.62117; Kang JY, 2019, J MOL BIOL, V431, P4007, DOI 10.1016/j.jmb.2019.07.017; Kang W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14200-3; Kouba T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20158-4; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Liu B, 2015, P NATL ACAD SCI USA, V112, P2006, DOI 10.1073/pnas.1417152112; McKinley BA, 2007, NUCLEIC ACIDS RES, V35, P7044, DOI 10.1093/nar/gkm747; Miller M, 2021, TRANSCR-AUSTIN, V12, P92, DOI 10.1080/21541264.2021.1964328; Muzzin O, 1998, J BIOL CHEM, V273, P15157, DOI 10.1074/jbc.273.24.15157; Narayanan A, 2018, J BIOL CHEM, V293, P7367, DOI 10.1074/jbc.RA118.002161; Newing TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20157-5; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Pei HH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20159-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qayyum M. Z., 2021, ENCY BIOL CHEM, V4, P358; Richmond M, 2011, BIOCHEMISTRY-US, V50, P2298, DOI 10.1021/bi101017x; Roberts JW, 2019, J MOL BIOL, V431, P4030, DOI 10.1016/j.jmb.2019.04.003; Said N, 2021, SCIENCE, V371, P44, DOI 10.1126/science.abd1673; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Shi J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10958-8; Shin Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20776-y; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; Sukhodolets MV, 2001, GENE DEV, V15, P3330, DOI 10.1101/gad.936701; Sukhodolets MV, 2000, J BIOL CHEM, V275, P22090, DOI 10.1074/jbc.M000056200; Sutherland Catherine, 2018, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0004-2018; Svetlov Vladimir, 2015, Methods Mol Biol, V1276, P13, DOI 10.1007/978-1-4939-2392-2_2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang CY, 2020, SCIENCE, V369, P1359, DOI 10.1126/science.abb5317; Webster MW, 2020, SCIENCE, V369, P1355, DOI 10.1126/science.abb5036; Wiedermannova J, 2014, NUCLEIC ACIDS RES, V42, P5151, DOI 10.1093/nar/gku113; Yakhnin AV, 2020, CRIT REV BIOCHEM MOL, V55, P716, DOI 10.1080/10409238.2020.1828261; Yawn B, 2009, BIOCHEMISTRY-US, V48, P7794, DOI 10.1021/bi9004123; Yin Z, 2019, P NATL ACAD SCI USA, V116, P18384, DOI 10.1073/pnas.1909801116; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	51	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101404	10.1016/j.jbc.2021.101404	http://dx.doi.org/10.1016/j.jbc.2021.101404			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774797	Green Published, gold			2022-12-26	WOS:000748397200002
J	Kanda, J; Nakahara, S; Nakamura, S; Miyake, Y; Shimizu, K; Yokobori, S; Yaguchi, A; Sakamoto, T				Kanda, Jun; Nakahara, Shinji; Nakamura, Shunsuke; Miyake, Yasufumi; Shimizu, Keiki; Yokobori, Shoji; Yaguchi, Arino; Sakamoto, Tetsuya			Association between active cooling and lower mortality among patients with heat stroke and heat exhaustion	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; COLD-WATER IMMERSION; EXERTIONAL HEATSTROKE; HYPERTHERMIA; TEMPERATURE; WAVE	Body cooling is recommended for patients with heat stroke and heat exhaustion. However, differences in the outcomes of patients who do or do not receive active cooling therapy have not been determined. The best available evidence supporting active cooling is based on a case series without comparison groups; thus, the effectiveness of this method in improving patient prognoses cannot be appropriately quantified. Therefore, we compared the outcomes of heat stroke patients receiving active cooling with those of patients receiving rehydration-only therapy. This prospective observational multicenter registry-based study of heat stroke and heat exhaustion patients was conducted in Japan from 2010 to 2019. The patients were stratified into the "severe" group or the "mild-to-moderate" group, per clinical findings on admission. After conducting multivariate logistic regression analyses, we compared the prognoses between patients who received "active cooling + rehydration" and patients who received "rehydration only," with in-hospital death as the endpoint. Sex, age, onset situation (i.e., exertional or non-exertional), core body temperature, liver damage, renal dysfunction, and disseminated intravascular coagulation were considered potential covariates. Among those who received active cooling and rehydration-only therapy, the in-hospital mortality rates were 21.5% and 35.5%, respectively, for severe patients (n = 231) and 3.9% and 5.7%, respectively, for mild-to-moderate patients (n = 578). Rehydration-only therapy was associated with a higher in-hospital mortality in patients with severe heat illness (adjusted odds ratio [aOR], 3.29; 95% confidence interval [CI], 1.21-8.90), whereas the cooling methods were not associated with lower in-hospital mortality in patients with mild-to-moderate heat illness (aOR, 2.22; 95% CI, 0.92-5.84). Active cooling was associated with lower in-hospital mortality only in the severe group. Our results indicated that active cooling should be recommended as an adjunct to rehydration-only therapy for patients with severe heat illness.	[Kanda, Jun; Yokobori, Shoji; Yaguchi, Arino] Japanese Assoc Acute Med Heatstroke & Hypothermia, Tokyo, Japan; [Kanda, Jun; Nakahara, Shinji; Miyake, Yasufumi; Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Nakahara, Shinji] Kanagawa Univ Human Serv, Grad Sch Hlth Innovat, Yokosuka, Kanagawa, Japan; [Nakamura, Shunsuke] Yokohama Rosai Hosp, Ctr Emergency Med, Yokohama, Kanagawa, Japan; [Shimizu, Keiki] Tokyo Metropolitan Tama Med Ctr, Emergency & Crit Care Ctr, Tokyo, Japan; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Yaguchi, Arino] Tokyo Womens Med Univ, Dept Crit Care & Emergency Med, Tokyo, Japan	Teikyo University; Yokohama Rosai Hospital; Nippon Medical School; Tokyo Women's Medical University	Kanda, J (corresponding author), Japanese Assoc Acute Med Heatstroke & Hypothermia, Tokyo, Japan.; Kanda, J (corresponding author), Teikyo Univ, Sch Med, Dept Emergency Med, Tokyo, Japan.	jkanda-cib@umin.ac.jp		Kanda, Jun/0000-0001-6328-8732	Japan Society for the Promotion of Science KAKENHI [JP19K18365]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI (JP19K18365) to JK (https://kaken.nii.ac.jp/en/ grant/KAKENHI-PROJECT-19K18365/). The funding organization did not play any role in the study; the views expressed in this paper do not reflect the views of the Ministry.	ALASKA AK, 1987, LANCET, V1, P381; BELLER GA, 1975, MIL MED, V140, P464; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bouchama A, 2007, ARCH INTERN MED, V167, P2170, DOI 10.1001/archinte.167.20.ira70009; Butts CL, 2016, J ATHL TRAINING, V51, P252, DOI 10.4085/1062-6050-51.4.01; Casa DJ, 2007, EXERC SPORT SCI REV, V35, P141; Clark J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3477; COSTRINI A, 1990, MED SCI SPORT EXER, V22, P15; COSTRINI AM, 1979, AM J MED, V66, P296, DOI 10.1016/0002-9343(79)90548-5; Davis BC, 2017, LIVER INT, V37, P509, DOI 10.1111/liv.13373; Demartini JK, 2015, MED SCI SPORT EXER, V47, P240, DOI 10.1249/MSS.0000000000000409; Dematte JE, 1998, ANN INTERN MED, V129, P173, DOI 10.7326/0003-4819-129-3-199808010-00001; Phung D, 2017, ENVIRON POLLUT, V220, P597, DOI 10.1016/j.envpol.2016.10.008; Epstein Y, 2019, NEW ENGL J MED, V380, P2449, DOI 10.1056/NEJMra1810762; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fire and Disaster Management Agency of Japan, 2019, 2018 WHIT PAP FIR SE; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Gaudio FG, 2016, J EMERG MED, V50, P607, DOI 10.1016/j.jemermed.2015.09.014; GRAHAM BS, 1986, ARCH INTERN MED, V146, P87, DOI 10.1001/archinte.146.1.87; Hifumi T, 2018, J CRIT CARE, V44, P306, DOI 10.1016/j.jcrc.2017.12.003; Japanese Association for Acute Medicine, 2015, GUID HEATSTR 2015; KHOGALI M, 1980, LANCET, V2, P276; KIELBLOCK AJ, 1986, S AFR MED J, V69, P378; Li TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep37294; McDermott BP, 2009, J ATHL TRAINING, V44, P84, DOI 10.4085/1062-6050-44.1.84; Ministry of Health Labour and Welfare, 2019, VIT STAT JAP 2018; Miyake Y., 2008, NIHON KYUKYU IGAKUKA, V19, P309, DOI [10.3893/jjaam.19.309, DOI 10.3893/JJAAM.19.309]; Miyake Y., 2010, J JPN ASS ACUTE MED, V21, P230, DOI [10.3893/jjaam.21.230, DOI 10.3893/JJAAM.21.230(INJAPANESEWITHENGLISHABSTRACT), DOI 10.3893/JJAAM.21.230]; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; Morch Sofie Sondergaard, 2017, Case Rep Crit Care, V2017, P6219236, DOI 10.1155/2017/6219236; ODONNELL TF, 1975, JAMA-J AM MED ASSOC, V234, P824, DOI 10.1001/jama.234.8.824; Pirard P, 2005, Euro Surveill, V10, P153; Proulx CI, 2003, J APPL PHYSIOL, V94, P1317, DOI 10.1152/japplphysiol.00541.2002; SHIBOLET S, 1967, Q J MED, V36, P525; Shimazaki J, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.516; Statistical Bureau of Japan, 2020, CURRENT POPULATION E; Tawatsupa B, 2012, J EPIDEMIOL, V22, P251, DOI 10.2188/jea.JE20110082; VICARIO SJ, 1986, AM J EMERG MED, V4, P394, DOI 10.1016/0735-6757(86)90185-3; Zhang K., 2015, Environmental Health, V14	39	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259441	10.1371/journal.pone.0259441	http://dx.doi.org/10.1371/journal.pone.0259441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788312	gold, Green Published			2022-12-26	WOS:000735920500027
J	Lantoine, P; Lecocq, M; Bougard, C; Dousset, E; Marqueste, T; Bourdin, C; Allegre, JM; Bauvineau, L; Mesure, S				Lantoine, Pascaline; Lecocq, Mathieu; Bougard, Clement; Dousset, Erick; Marqueste, Tanguy; Bourdin, Christophe; Allegre, Jean-Marc; Bauvineau, Laurent; Mesure, Serge			Car seat impact on driver's sitting behavior and perceived discomfort during prolonged real driving on varied road types	PLOS ONE			English	Article							INTERFACE PRESSURE; AUTOMOTIVE SEAT; LOW-BACK; COMFORT; POSTURE; PREDICTION; MOVEMENT; DESIGN	Prolonged driving under real conditions can entail discomfort linked to driving posture, seat design features, and road properties like whole-body vibrations (WBV). This study evaluated the effect of three different seats (S-1 = soft; S-2 = firm; S-3 = soft with suspension system) on driver's sitting behavior and perceived discomfort on different road types in real driving conditions. Twenty-one participants drove the same 195 km itinerary alternating highway, city, country, and mountain segments. Throughout the driving sessions, Contact Pressure (CP), Contact Surface (CS), Seat Pressure Distribution Percentage (SPD%) and Repositioning Movements (RM) were recorded via two pressure mats installed on seat cushion and backrest. Moreover every 20 minutes, participants rated their whole-body and local discomfort. While the same increase in whole-body discomfort with driving time was observed for all three seats, S-3 limited local perceived discomfort, especially in buttocks, thighs, neck, and upper back. The pressure profiles of the three seats were similar for CP, CS and RM on the backrest but differed on the seat cushion. The soft seats (S-1 & S-3) showed better pressure distribution, with lower SPD% than the firm seat (S-2). All three showed highest CP and CS under the thighs. Road type also affected both CP and CS of all three seats, with significant differences appearing between early city, highway and country segments. In the light of these results, automotive manufacturers could enhance seat design for reduced driver discomfort by combining a soft seat cushion to reduce pressure peaks, a firm backrest to support the trunk, and a suspension system to minimize vibrations.	[Lantoine, Pascaline; Lecocq, Mathieu; Dousset, Erick; Marqueste, Tanguy; Bourdin, Christophe; Mesure, Serge] Aix Marseille Univ, ISM, CNRS, Marseille, France; [Lantoine, Pascaline; Bougard, Clement; Allegre, Jean-Marc; Bauvineau, Laurent] Ctr Tech Velizy, Stellantis, Velizy Villacoublay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lantoine, P (corresponding author), Aix Marseille Univ, ISM, CNRS, Marseille, France.; Lantoine, P (corresponding author), Ctr Tech Velizy, Stellantis, Velizy Villacoublay, France.	pascaline_lantoine@hotmail.com	Marqueste, Tanguy/AAM-9751-2021; Bourdin, Christophe/O-9395-2017; MESURE, Serge/CAF-8351-2022	Marqueste, Tanguy/0000-0002-2620-1551; Bourdin, Christophe/0000-0003-4149-1347; Mesure, Serge/0000-0002-4431-2984; LANTOINE, Pascaline/0000-0003-4311-6487	OpenLab "Automotive Motion Lab"; Aix-Marseille University; CNRS; Groupe Stellantis; ANRT; Stellantis	OpenLab "Automotive Motion Lab"; Aix-Marseille University; CNRS(Centre National de la Recherche Scientifique (CNRS)); Groupe Stellantis; ANRT(French National Research Agency (ANR)); Stellantis	The present study was supported by the OpenLab "Automotive Motion Lab" which is a collaborative structure involving Aix-Marseille University, CNRS, and Groupe Stellantis. We would like to thank Serge Tribut, Julien Bonnet, John Masson, Antonio Gomes and Christophe Broquet from Groupe PSA for their work on the vehicle and on the seats. Our thanks to Issam Rosti (ALTRAN, Morocco) for his help with the Matlab analysis, and to Marjorie Sweetko for English language editing.; This work was funded by the ANRT and Stellantis. The funder provided support in the form of salaries for authors Lantoine P., Bougard C., Bauvineau L. and Allegre J.-M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adler S., 2017, THESIS FRIEDRICH SCH; Ahmadian M, 2002, SAE TECHNICAL PAPER; Andreoni G, 2002, APPL ERGON, V33, P511, DOI 10.1016/S0003-6870(02)00069-8; Arien C, 2013, ACCIDENT ANAL PREV, V61, P43, DOI 10.1016/j.aap.2012.12.044; Battie MC, 2002, LANCET, V360, P1369, DOI 10.1016/S0140-6736(02)11399-7; Baucher J., 2006, ITBM RBM, V27, P133, DOI [10.1016/j.rbmret.2006.05.002, DOI 10.1016/J.RBMRET.2006.05.002]; Bordignon M, 2018, J AGRIC SAF HEALTH, V24, P13, DOI 10.13031/jash.12209; Carcone SM, 2007, APPL ERGON, V38, P755, DOI 10.1016/j.apergo.2006.11.001; Dankaerts W, 2006, SPINE, V31, P2017, DOI 10.1097/01.brs.0000228728.11076.82; Daruis DDI, 2012, ADV MATER RES-SWITZ, V433-440, P4997, DOI 10.4028/www.scientific.net/AMR.433-440.4997; de Looze MP, 2003, ERGONOMICS, V46, P985, DOI 10.1080/0014013031000121977; Ebe K, 2000, ERGONOMICS, V43, P791, DOI 10.1080/001401300404751; El Falou W, 2003, APPL ERGON, V34, P249, DOI 10.1016/S0003-6870(03)00011-5; European Commission, 2012, DRIV PARK PATT EUR C, DOI [10.2790/7028, DOI 10.2790/7028]; Fenety PA, 2000, APPL ERGON, V31, P383; Fojtlin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208599; GRIECO A, 1986, ERGONOMICS, V29, P345, DOI 10.1080/00140138608968270; Gyi DE, 1999, APPL ERGON, V30, P99, DOI 10.1016/S0003-6870(98)00018-0; Hiemstra-van Mastrigt S, 2017, ERGONOMICS, V60, P889, DOI 10.1080/00140139.2016.1233356; Jackson C, 2009, AVIAT SPACE ENVIR MD, V80, P565, DOI 10.3357/ASEM.2320.2009; Jagannath M, 2014, APPL ERGON, V45, P1140, DOI 10.1016/j.apergo.2014.02.001; Khamis N.K., 2019, INT J INNOV TECHNOL, V8, P4189, DOI [10.35940/ijitee.L3668.1081219, DOI 10.35940/IJITEE.L3668.1081219]; Kilincsoy U, 2016, WORK, V54, P895, DOI 10.3233/WOR-162350; Kim JH, 2018, APPL ERGON, V68, P80, DOI 10.1016/j.apergo.2017.10.021; Kim SG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187918; Kolich M, 2004, ERGONOMICS, V47, P841, DOI 10.1080/0014013042000193273; Kolich M, 2004, INT J IND ERGONOM, V33, P285, DOI 10.1016/j.ergon.2003.10.004; Kolich Mike, 2002, Int J Occup Saf Ergon, V8, P483; Kyung G, 2008, INT J IND ERGONOM, V38, P516, DOI 10.1016/j.ergon.2007.08.010; Kyung G, 2008, INT J IND ERGONOM, V38, P526, DOI 10.1016/j.ergon.2007.08.011; Kyung G, 2013, ERGONOMICS, V56, P1795, DOI 10.1080/00140139.2013.840391; Lecocq M, 2020, APPL ERGON, V87, DOI 10.1016/j.apergo.2020.103118; Liang CC, 2008, IND HEALTH, V46, P125, DOI 10.2486/indhealth.46.125; Lis AM, 2007, EUR SPINE J, V16, P283, DOI 10.1007/s00586-006-0143-7; Makhsous M, 2012, HUM FACTORS, V54, P1066, DOI 10.1177/0018720812457681; Mandal SK., 2015, ASIAN J CURRENT ENG, V4, P62; Mansfield N, 2015, APPL ERGON, V50, P153, DOI 10.1016/j.apergo.2015.03.010; Mansfield NJ., 2014, ISRN AUTOMOTIVE ENG, V2014, P1; Maradei F, 2017, WORK, V56, P99, DOI 10.3233/WOR-162464; Mehta CR, 2000, INT J IND ERGONOM, V25, P661, DOI 10.1016/S0169-8141(99)00054-2; Mergl C., 2005, SAE TECHNICAL PAPER; Na S, 2005, INT J IND ERGONOM, V35, P1085, DOI 10.1016/j.ergon.2005.03.004; Oron-Gilad Tal, 2007, Traffic Inj Prev, V8, P281, DOI 10.1080/15389580701354318; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Reed M.P., 1999, SAE TECHNICAL PAPER; Reed MP, 2002, HUM FACTORS, V44, P557, DOI 10.1518/0018720024496917; Reenalda J, 2009, J REHABIL RES DEV, V46, P577, DOI 10.1682/JRRD.2008.12.0164; Reenen HHHV, 2008, ERGONOMICS, V51, P637, DOI 10.1080/00140130701743433; Romelfanger M, 2019, APPL ERGON, V75, P257, DOI 10.1016/j.apergo.2018.08.020; Sammonds GM, 2017, APPL ERGON, V58, P119, DOI 10.1016/j.apergo.2016.05.009; van Veen VS., 2015, J ERGON, V05; Varela M, 2019, APPL ERGON, V74, P214, DOI 10.1016/j.apergo.2018.08.024; Vergara M, 2002, APPL ERGON, V33, P1, DOI 10.1016/S0003-6870(01)00056-4; Vink P, 2012, APPL ERGON, V43, P271, DOI 10.1016/j.apergo.2011.06.001; Vink P., 2014, SWEETNESS DISCOMFORT; Vink P, 2017, APPL ERGON, V58, P287, DOI 10.1016/j.apergo.2016.07.004; Wong WY, 2008, GAIT POSTURE, V27, P168, DOI 10.1016/j.gaitpost.2007.03.001; Wu X, 1999, INT J IND ERGONOM, V24, P545, DOI 10.1016/S0169-8141(98)00058-4; Zenk R, 2012, APPL ERGON, V43, P290, DOI 10.1016/j.apergo.2011.06.004	59	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259934	10.1371/journal.pone.0259934	http://dx.doi.org/10.1371/journal.pone.0259934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784401	Green Published, gold			2022-12-26	WOS:000755277300031
J	Hermena, EW; Bouamama, S; Liversedge, SP; Drieghe, D				Hermena, Ehab W.; Bouamama, Sana; Liversedge, Simon P.; Drieghe, Denis			Does diacritics-based lexical disambiguation modulate word frequency, length, and predictability effects? An eye-movements investigation of processing Arabic diacritics	PLOS ONE			English	Article							AMBIGUOUS WORDS; CONTEXTUAL CONSTRAINT; FIXATION TIMES; READERS; INFORMATION; PERCEPTION; RECOGNITION; RESOLUTION; VOWELS	In Arabic, a predominantly consonantal script that features a high incidence of lexical ambiguity (heterophonic homographs), glyph-like marks called diacritics supply vowel information that clarifies how each consonant should be pronounced, and thereby disambiguate the pronunciation of consonantal strings. Diacritics are typically omitted from print except in situations where a particular homograph is not sufficiently disambiguated by the surrounding context. In three experiments we investigated whether the presence of disambiguating diacritics on target homographs modulates word frequency, length, and predictability effects during reading. In all experiments, the subordinate representation of the target homographs was instantiated by the diacritics (in the diacritized conditions), and by the context subsequent to the target homographs. The results replicated the effects of word frequency (Experiment 1), word length (Experiment 2), and predictability (Experiment 3). However, there was no evidence that diacritics-based disambiguation modulated these effects in the current study. Rather, diacritized targets in all experiments attracted longer first pass and later (go past and/or total fixation count) processing. These costs are suggested to be a manifestation of the subordinate bias effect. Furthermore, in all experiments, the diacritics-based disambiguation facilitated later sentence processing, relative to when the diacritics were absent. The reported findings expand existing knowledge about processing of diacritics, their contribution towards lexical ambiguity resolution, and sentence processing.	[Hermena, Ehab W.] Zayed Univ, Coll Nat & Hlth Sci, Dept Psychol, Cognit & Neurosci Res Lab, Dubai, U Arab Emirates; [Bouamama, Sana; Drieghe, Denis] Univ Southampton, Ctr Percept & Cognit, Psychol, Southampton, Hants, England; [Liversedge, Simon P.] Univ Cent Lancashire, Sch Psychol, Percept Cognit & Neurosci Grp, Preston, Lancs, England	Zayed University; University of Southampton; University of Central Lancashire	Hermena, EW (corresponding author), Zayed Univ, Coll Nat & Hlth Sci, Dept Psychol, Cognit & Neurosci Res Lab, Dubai, U Arab Emirates.	ehab.hermena@zu.ac.ae	Hermena, Ehab W./ABF-8078-2021	Hermena, Ehab W./0000-0002-3338-7980; Drieghe, Denis/0000-0001-9630-8410	Leverhulme Trust [RPG-2013-205]; Zayed University [R17035]	Leverhulme Trust(Leverhulme Trust); Zayed University	EWH, SB, SPL, DD supported by Leverhulme Trust Research Grant RPG-2013-205. EWH partially supported by Zayed University Grant R17035.	Abu-Rabia S, 1998, READ WRIT, V10, P105, DOI 10.1023/A:1007906222227; Abu-Rabia S, 2001, READ WRIT, V14, P39, DOI 10.1023/A:1008147606320; Abu-Rabia S., 1995, INT Q, V16, P1, DOI [10.1080/0270271950160101, DOI 10.1080/0270271950160101]; AbuRabia S, 1997, J PSYCHOLINGUIST RES, V26, P465, DOI 10.1023/A:1025034220924; Ashby J, 2005, Q J EXP PSYCHOL-A, V58, P1065, DOI 10.1080/02724980443000476; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boudelaa S, 2010, BEHAV RES METHODS, V42, P481, DOI 10.3758/BRM.42.2.481; Brysbaert M., 2005, COGNITIVE PROCESS, P53, DOI [DOI 10.1093/ACPROF:OSO/9780198566816.003.0003, 10.1093/acprof:oso/9780198566816.001.0001]; DOPKINS S, 1992, J MEM LANG, V31, P461, DOI 10.1016/0749-596X(92)90023-Q; Drieghe D, 2005, J EXP PSYCHOL HUMAN, V31, P954, DOI 10.1037/0096-1523.31.5.954; Drieghe D, 2004, EUR J COGN PSYCHOL, V16, P79, DOI 10.1080/09541440340000141; Duffy S.A., 2001, CONSEQUENCES MEANING, P27, DOI DOI 10.1037/10459-002; DUFFY SA, 1988, J MEM LANG, V27, P429, DOI 10.1016/0749-596X(88)90066-6; Fitzsimmons G, 2011, PSYCHON B REV, V18, P736, DOI 10.3758/s13423-011-0105-x; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; Hautala J, 2011, VISION RES, V51, P1719, DOI 10.1016/j.visres.2011.05.015; Hermena EW, 2019, J EXP PSYCHOL LEARN, V45, P934, DOI 10.1037/xlm0000626; Hermena EW, 2017, J EXP PSYCHOL LEARN, V43, P451, DOI 10.1037/xlm0000319; Hermena EW, 2016, J EXP PSYCHOL HUMAN, V42, P2021, DOI 10.1037/xhp0000294; Hermena EW, 2015, J EXP PSYCHOL HUMAN, V41, P494, DOI 10.1037/xhp0000032; Hy?n? J., 2011, OXFORD HDB EYE MOVEM, P819, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0045; HYONA J, 1993, SCAND J PSYCHOL, V34, P293, DOI 10.1111/j.1467-9450.1993.tb01126.x; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; INHOFF AW, 1986, PERCEPT PSYCHOPHYS, V40, P431, DOI 10.3758/BF03208203; Jeffreys H., 1961, THEORY OF PROBABILIT; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Juhasz BJ, 2011, OXFORD HDB EYE MOVEM, P873, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0048; Kambe G, 2001, MEM COGNITION, V29, P363, DOI 10.3758/BF03194931; Kliegl R, 2006, J EXP PSYCHOL GEN, V135, P12, DOI 10.1037/0096-3445.135.1.12; Kliegl R, 2004, EUR J COGN PSYCHOL, V16, P262, DOI 10.1080/09541440340000213; Lee MD, 2013, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Leinenger M, 2017, J MEM LANG, V93, P82, DOI 10.1016/j.jml.2016.09.002; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; Morey R.D., 2013, BAYESFACTOR COMPUTAT; Norris D, 2006, PSYCHOL REV, V113, P327, DOI 10.1037/0033-295X.113.2.327; Norris D, 2008, J EXP PSYCHOL GEN, V137, P434, DOI 10.1037/a0012799; Norris D, 2012, PSYCHOL REV, V119, P517, DOI 10.1037/a0028450; PACHT JM, 1993, J PSYCHOLINGUIST RES, V22, P251; Paterson KB, 2015, PSYCHON B REV, V22, P1443, DOI 10.3758/s13423-015-0809-4; R Core Team, 2020, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1989, J EXP PSYCHOL LEARN, V15, P779, DOI 10.1037/0278-7393.15.5.779; Rayner K, 1996, J EXP PSYCHOL HUMAN, V22, P1188, DOI 10.1037/0096-1523.22.5.1188; RAYNER K, 1981, Q J EXP PSYCHOL-A, V33, P351, DOI 10.1080/14640748108400798; Rayner K, 1996, PSYCHON B REV, V3, P504, DOI 10.3758/BF03214555; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Rayner K, 2004, J EXP PSYCHOL HUMAN, V30, P720, DOI 10.1037/0096-1523.30.4.720; RAYNER K, 1976, VISION RES, V16, P829, DOI 10.1016/0042-6989(76)90143-7; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Rayner K., 2011, OXFORD HDB EYE MOVEM, P751, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0041; Rayner K, 2006, BRIT J PSYCHOL, V97, P467, DOI 10.1348/000712605X89363; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle Erik D., 2007, P271, DOI 10.1016/B978-008044980-7/50014-8; Rodd JM, 2020, PERSPECT PSYCHOL SCI, V15, P411, DOI 10.1177/1745691619885860; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; SERENO SC, 1992, PSYCHOL SCI, V3, P296, DOI 10.1111/j.1467-9280.1992.tb00676.x; Sereno SC, 2006, J EXP PSYCHOL HUMAN, V32, P335, DOI 10.1037/0096-1523.32.2.335; Share DL, 2018, J LEARN DISABIL-US, V51, P444, DOI 10.1177/0022219417718198; Sheridan H, 2012, MEM COGNITION, V40, P1122, DOI 10.3758/s13421-012-0216-2; Sheridan H, 2009, PSYCHON B REV, V16, P875, DOI 10.3758/PBR.16.5.875; Venables W.N., 2002, MODERN APPL STAT S, V4th ed., DOI [10.1007/978-0387-21706-2, DOI 10.1007/978-0387-21706-2]; von der Malsburg T, 2017, J MEM LANG, V94, P119, DOI 10.1016/j.jml.2016.10.003; White SJ, 2005, PSYCHON B REV, V12, P466, DOI 10.3758/BF03193789	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259987	10.1371/journal.pone.0259987	http://dx.doi.org/10.1371/journal.pone.0259987			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780557	Green Accepted, gold, Green Published			2022-12-26	WOS:000755305800079
J	Larson, MR; Biddle, K; Gorman, A; Boutom, S; Rosenshine, I; Saper, MA				Larson, Matthew R.; Biddle, Kassia; Gorman, Adam; Boutom, Sarah; Rosenshine, Ilan; Saper, Mark A.			Escherichia coli O127 group 4 capsule proteins assemble at the outer membrane	PLOS ONE			English	Article							STRUCTURAL BASIS; O-ANTIGEN; TYROSINE-KINASE; SIGNAL PEPTIDES; POLYSACCHARIDES; IDENTIFICATION; VIRULENCE; GENES; BIOSYNTHESIS; COLONIZATION	Enteropathogenic Escherichia coli O127 is encapsulated by a protective layer of polysaccharide made of the same strain specific O-antigen as the serotype lipopolysaccharide. Seven genes encoding capsule export functions comprise the group 4 capsule (gfc) operon. Genes gfcE, etk and etp encode homologs of the group 1 capsule secretion system but the upstream gfcABCD genes encode unknown functions specific to group 4 capsule export. We have developed an expression system for the large-scale production of the outer membrane protein GfcD. Contrary to annotations, we find that GfcD is a non-acylated integral membrane protein. Circular dichroism spectroscopy, light-scattering data, and the HHomp server suggested that GfcD is a monomeric beta-barrel with 26 beta-strands and an internal globular domain. We identified a set of novel protein-protein interactions between GfcB, GfcC, and GfcD, both in vivo and in vitro, and quantified the binding properties with isothermal calorimetry and biolayer interferometry. GfcC and GfcB form a high-affinity heterodimer with a K-D near 100 nM. This heterodimer binds to GfcD (K-D = 28 mu M) significantly better than either GfcB or GfcC alone. These gfc proteins may form a complex at the outer membrane for group 4 capsule secretion or for a yet unknown function.	[Larson, Matthew R.; Biddle, Kassia; Gorman, Adam; Boutom, Sarah; Saper, Mark A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Boutom, Sarah; Saper, Mark A.] Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA; [Rosenshine, Ilan] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, Fac Med, Jerusalem, Israel; [Larson, Matthew R.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison	Saper, MA (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.; Saper, MA (corresponding author), Univ Michigan, Program Biophys, Ann Arbor, MI 48109 USA.	saper@umich.edu		Larson, Matt/0000-0003-2116-5747; Boutom, Sarah/0000-0002-0440-5035	National Institutes of Health National Institute of Allergy and Infectious Diseases [R21 AI088543]	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MAS R21 AI088543 National Institutes of Health National Institute of Allergy and Infectious Diseases Funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu M, 2018, NAT BIOTECHNOL, V36, P103, DOI 10.1038/nbt.4024; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bushell SR, 2013, STRUCTURE, V21, P844, DOI 10.1016/j.str.2013.03.010; Caboni M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004749; Campos MA, 2004, INFECT IMMUN, V72, P7107, DOI 10.1128/IAI.72.12.7107-7114.2004; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Croxatto A, 2007, ENVIRON MICROBIOL, V9, P370, DOI 10.1111/j.1462-2920.2006.01147.x; Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; Eaton J, 2017, GNU OCTAVE VERSION 4; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferrieres L, 2007, MICROBIOL-SGM, V153, P1070, DOI 10.1099/mic.0.2006/002907-0; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lung TWF, 2014, CELL MICROBIOL, V16, P1736, DOI 10.1111/cmi.12371; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nickerson NN, 2014, P NATL ACAD SCI USA, V111, P8203, DOI 10.1073/pnas.1400341111; Noinaj N, 2015, METHODS MOL BIOL, V1329, P51, DOI 10.1007/978-1-4939-2871-2_4; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Rahn A, 2003, J BACTERIOL, V185, P5882, DOI 10.1128/JB.185.19.5882-5890.2003; Remmert M, 2009, NUCLEIC ACIDS RES, V37, pW446, DOI 10.1093/nar/gkp325; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Sathiyamoorthy K, 2011, BIOCHEMISTRY-US, V50, P5465, DOI 10.1021/bi101869h; Schlosser-Silverman E, 2000, J BACTERIOL, V182, P5225, DOI 10.1128/JB.182.18.5225-5230.2000; Shifrin Y, 2008, J BACTERIOL, V190, P5063, DOI 10.1128/JB.00440-08; Solan R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2104059118; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Tan JQ, 2014, ACTA CRYSTALLOGR D, V70, P2054, DOI 10.1107/S1399004714001850; Temel DB, 2013, J BIOL CHEM, V288, P15212, DOI 10.1074/jbc.M113.457804; Thomassin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082475; Thurlow CM, 2019, AQUACULTURE, V512, DOI 10.1016/j.aquaculture.2019.734334; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitmore L, 2017, NUCLEIC ACIDS RES, V45, pD303, DOI 10.1093/nar/gkw796; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108	52	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259900	10.1371/journal.pone.0259900	http://dx.doi.org/10.1371/journal.pone.0259900			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780538	Green Published, gold			2022-12-26	WOS:000755305800067
J	Wallace, JM; Shepherd, PO; Milne, JS; Aitken, RP				Wallace, Jacqueline M.; Shepherd, Paul O.; Milne, John S.; Aitken, Raymond P.			Perinatal complications and maximising lamb survival in an adolescent paradigm characterised by premature delivery and low birthweight	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; ADULT EWES; FETAL-GROWTH; GESTATION LENGTH; POSTNATAL LAMB; OVULATION RATE; PRETERM BIRTH; RISK-FACTORS; SHEEP; MORTALITY	The competition for nutrients in overnourished and still-growing adolescent sheep negatively impacts gestation length, colostrum supply and lamb birthweight, all of which may affect neonatal morbidity and survival to weaning. Herein perinatal complications and the requirement for supplementary feeding were analysed in relation to gestational-intake, and the degree of premature delivery and prenatal growth-restriction exhibited. Pregnancies were established by embryo transfer and the mean/standard deviation (SD) gestation length and birthweight of the optimally-fed control group (n = 100) was used to define early delivery and reduced birthweight categories (1.5 and 3.0 SDs below the control mean for each aspect). Control lambs were largely delivered at term (94%), and had a normal birthweight (92%), while very preterm (<= 139days, 18.5%) and preterm delivery (140-142days, 54.8%), extremely low birthweight (ELBW; females <= 2838g and males <= 3216g, 21.1%) and low birthweight (LBW; females 2839 to <= 4001g and males 3217 to <= 4372g, 32.2%), were common in the overnourished group (n = 270, P<0.001). Accordingly, overnourished dams were more likely to lamb without assistance while the incidence of major dystocia was greater in controls. Initial lamb vigour at birth was independent of gestational-intake, delivery or birthweight category but both ELBW and very premature lambs required more assistance with feeding in the first 24h postnatal, primarily reflecting low colostrum availability. Indeed, relative to normal, ELBW lambs had a greater risk of experiencing mismothering, and enhanced likelihood of requiring supplementary feeding throughout the neonatal period (P<0.001). ELBW lambs also had a greater possibility of respiratory issues at birth (P<0.01) and renal complications (P<0.001), while very preterm delivery was associated with an increased risk of gastrointestinal tract problems (P<0.01). In spite of these complications, all-cause mortality was low (5.4%) suggesting that our proactive neonatal care regime can overcome many of the issues associated with extreme prematurity and low birthweight.	[Wallace, Jacqueline M.; Shepherd, Paul O.; Milne, John S.; Aitken, Raymond P.] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland	University of Aberdeen	Wallace, JM (corresponding author), Univ Aberdeen, Rowett Inst, Aberdeen, Scotland.	Jacqueline.Wallace@abdn.ac.uk		Wallace, Jacqueline/0000-0003-3099-5902	Scottish Government's Rural and Environment Science and Analytical Services Division	Scottish Government's Rural and Environment Science and Analytical Services Division	This work was funded by the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFRC, 1993, ENERGY PROTEIN REQUI; Alsweiler JM, 2013, NEONATOLOGY, V103, P83, DOI 10.1159/000342240; Beck NFG, 1996, ANIM SCI, V62, P79, DOI 10.1017/S135772980001434X; Bernal AL, 2003, BJOG-INT J OBSTET GY, V110, P39, DOI 10.1016/S1470-0328(03)00023-5; Berry MJ, 2016, BRIT J NUTR, V116, P1912, DOI 10.1017/S0007114516004013; Bessette NW, 2010, REPROD FERT DEVELOP, V22, P459, DOI 10.1071/RD09156; Binns SH, 2002, PREV VET MED, V52, P287, DOI 10.1016/S0167-5877(01)00255-0; Bloomfield FH, 2003, SCIENCE, V300, P606, DOI 10.1126/science.1080803; Christley RM, 2003, PREV VET MED, V57, P209, DOI 10.1016/S0167-5877(02)00235-0; Corner RA, 2013, SMALL RUMINANT RES, V114, P126, DOI 10.1016/j.smallrumres.2013.05.018; DAWES GS, 1965, NATURE, V207, P330, DOI 10.1038/207330a0; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; De Matteo R, 2010, REPROD SCI, V17, P724, DOI 10.1177/1933719110369182; Dwyer CM, 2016, ANIMAL, V10, P449, DOI 10.1017/S1751731115001974; Dwyer CM, 2012, PREV VET MED, V103, P257, DOI 10.1016/j.prevetmed.2011.09.002; Dwyer CM, 1996, REPROD FERT DEVELOP, V8, P1123, DOI 10.1071/RD9961123; EALES FA, 1986, VET REC, V119, P543, DOI 10.1136/vr.119.22.543; Edwards SJ, 2016, ANIM REPROD SCI, V167, P125, DOI 10.1016/j.anireprosci.2016.02.017; Everett-Hincks J. M., 2007, Proceedings of the New Zealand Society of Animal Production, V67, P55; Flinn T, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00510-w; Gardner DS, 2007, REPRODUCTION, V133, P297, DOI 10.1530/REP-06-0042; Glover AV, 2018, SEMIN FETAL NEONAT M, V23, P126, DOI 10.1016/j.siny.2017.11.007; Gonzalez SG, 1998, APPL ANIM BEHAV SCI, V61, P41, DOI 10.1016/S0168-1591(98)00172-5; Haikerwal A, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115648; Hinch GN, 2014, ANIM PROD SCI, V54, P656, DOI 10.1071/AN13236; Holmoy IH, 2012, PREV VET MED, V107, P231, DOI 10.1016/j.prevetmed.2012.06.007; HUFFMAN EM, 1985, THERIOGENOLOGY, V24, P163, DOI 10.1016/0093-691X(85)90180-3; Jacobson C, 2020, SMALL RUMINANT RES, V192, DOI 10.1016/j.smallrumres.2020.106209; Kenyon PR, 2014, SMALL RUMINANT RES, V118, P2, DOI 10.1016/j.smallrumres.2013.12.022; Lea RG, 2007, REPRODUCTION, V133, P785, DOI 10.1530/REP-06-0294; McHugh N, 2016, ANIMAL, V10, P89, DOI 10.1017/S1751731115001664; MCMILLAN WH, 1985, ANIM REPROD SCI, V8, P235, DOI 10.1016/0378-4320(85)90028-4; Monteiro APA, 2014, J DAIRY SCI, V97, P6426, DOI 10.3168/jds.2013-7891; Nash ML, 1996, VET REC, V139, P64, DOI 10.1136/vr.139.3.64; Nowak R, 2000, REV REPROD, V5, P153, DOI 10.1530/ror.0.0050153; OCONNOR CE, 1992, APPL ANIM BEHAV SCI, V33, P345, DOI 10.1016/S0168-1591(05)80071-1; Oliver M H, 2007, Soc Reprod Fertil Suppl, V64, P397; Orgeig S, 2010, AM J PHYSIOL-LUNG C, V298, pL575, DOI 10.1152/ajplung.00226.2009; Osorio JS, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00509-3; Peel RK, 2012, J ANIM SCI, V90, P3698, DOI 10.2527/jas.2012-5140; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; QUIRKE JF, 1983, J REPROD FERTIL, V68, P289, DOI 10.1530/jrf.0.0680289; QUIRKE JF, 1977, J REPROD FERTIL, V51, P487, DOI 10.1530/jrf.0.0510487; Refshauge G, 2016, ANIM PROD SCI, V56, P726, DOI 10.1071/AN15121; Ren SQ, 2018, AM J PHYSIOL-GASTR L, V315, pG855, DOI 10.1152/ajpgi.00169.2018; Robinson J. J., 2002, P189, DOI 10.1079/9780851995953.0189; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sawalha RM, 2007, ANIMAL, V1, P151, DOI 10.1017/S1751731107340056; Schreuder M, 2006, KIDNEY BLOOD PRESS R, V29, P108, DOI 10.1159/000094538; Smistad M, 2020, ACTA VET SCAND, V62, DOI 10.1186/s13028-020-00561-z; Trahair JF, 1997, J NUTR, V127, P637, DOI 10.1093/jn/127.4.637; Wallace JM, 2008, PLACENTA, V29, P718, DOI 10.1016/j.placenta.2008.05.006; Wallace JM, 2006, BRIT J NUTR, V96, P1060, DOI 10.1017/BJN20061979; Wallace JM, 2021, REPRODUCTION, V161, P227, DOI 10.1530/REP-20-0533; Wallace JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228732; Wallace JM, 2019, J ENDOCRINOL, V242, pT1, DOI 10.1530/JOE-18-0670; Wallace JM, 2018, REPRODUCTION, V156, P103, DOI [10.1530/REP-18-0048, 10.1530/rep-18-0048]; Wallace JM, 2014, J MOL ENDOCRINOL, V53, P131, DOI 10.1530/JME-14-0123; Wallace JM, 2014, REPROD FERT DEVELOP, V26, P665, DOI 10.1071/RD13090; Wallace JM, 2005, BRIT J NUTR, V94, P533, DOI 10.1079/BJN20041398; Wallace JM, 1996, J REPROD FERTIL, V107, P183, DOI 10.1530/jrf.0.1070183; Wallace JM, 2003, J PHYSIOL-LONDON, V547, P85, DOI 10.1113/jphysiol.2002.023333; Wallace JM, 2002, AM J PHYSIOL-REG I, V282, pR1027, DOI 10.1152/ajpregu.00465.2001; Wallace JM, 1997, J ENDOCRINOL, V155, P359, DOI 10.1677/joe.0.1550359; Wallace JM, 1999, BIOL REPROD, V61, P101, DOI 10.1095/biolreprod61.1.101; Wallace JM., 2008, P PHYSL SOC, V11, pPC37	66	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259890	10.1371/journal.pone.0259890	http://dx.doi.org/10.1371/journal.pone.0259890			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780509	Green Published, gold			2022-12-26	WOS:000755305800063
J	Decker, MR; Wood, SN; Thiongo, M; Byrne, ME; Devoto, B; Morgan, R; Bevilacqua, K; Williams, A; Stuart, HC; Wamue-Ngare, G; Heise, L; Glass, N; Anglewicz, P; Gummerson, E; Gichangi, P				Decker, Michele R.; Wood, Shannon N.; Thiongo, Mary; Byrne, Meagan E.; Devoto, Bianca; Morgan, Rosemary; Bevilacqua, Kristin; Williams, Anaise; Stuart, H. Colleen; Wamue-Ngare, Grace; Heise, Lori; Glass, Nancy; Anglewicz, Philip; Gummerson, Elizabeth; Gichangi, Peter			Gendered health, economic, social and safety impact of COVID-19 on adolescents and young adults in Nairobi, Kenya	PLOS ONE			English	Article							HARD-TO-REACH; WOMEN; SURVEILLANCE; POPULATIONS; LESSONS	Background Infectious disease outbreaks like COVID-19 and their mitigation measures can exacerbate underlying gender disparities, particularly among adolescents and young adults in densely populated urban settings. Methods An existing cohort of youth ages 16-26 in Nairobi, Kenya completed a phone-based survey in August-October 2020 (n = 1217), supplemented by virtual focus group discussions and interviews with youth and stakeholders, to examine economic, health, social, and safety experiences during COVID-19, and gender disparities therein. Results COVID-19 risk perception was high with a gender differential favoring young women (95.5% vs. 84.2%; p<0.001); youth described mixed concern and challenges to prevention. During COVID-19, gender symmetry was observed in constrained access to contraception among contraceptive users (40.4% men; 34.6% women) and depressive symptoms (21.8% men; 24.3% women). Gender disparities rendered young women disproportionately unable to meet basic economic needs (adjusted odds ratio [aOR] = 1.21; p<0.05) and in need of healthcare during the pandemic (aOR = 1.59; p<0.001). At a bivariate level, women had lower full decisional control to leave the house (40.0% vs. 53.2%) and less consistent access to safe, private internet (26.1% vs. 40.2%), while men disproportionately experienced police interactions (60.1%, 55.2% of which included extortion). Gender-specific concerns for women included menstrual hygiene access challenges (52.0%), increased reliance on transactional partnerships, and gender-based violence, with 17.3% reporting past-year partner violence and 3.0% non-partner sexual violence. Qualitative results contextualize the mental health impact of economic disruption and isolation, and, among young women, privacy constraints. Implications Youth and young adults face gendered impacts of COVID-19, reflecting both underlying disparities and the pandemic's economic and social shock. Economic, health and technology-based supports must ensure equitable access for young women. Gender-responsive recovery efforts are necessary and must address the unique needs of youth.	[Decker, Michele R.; Wood, Shannon N.; Byrne, Meagan E.; Devoto, Bianca; Bevilacqua, Kristin; Williams, Anaise; Heise, Lori; Anglewicz, Philip] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Decker, Michele R.; Wood, Shannon N.; Byrne, Meagan E.; Anglewicz, Philip; Gummerson, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Bill & Melinda Gates Inst Populat & Reprod Hlth, Baltimore, MD 21205 USA; [Thiongo, Mary; Gichangi, Peter] Int Ctr Reprod Hlth Kenya, Nairobi, Kenya; [Morgan, Rosemary] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Stuart, H. Colleen] Johns Hopkins Carey Business Sch, Baltimore, MD USA; [Wamue-Ngare, Grace] Kenyatta Univ, Dept Sociol Gender & Dev Studies, Nairobi, Kenya; [Wamue-Ngare, Grace] Kenyatta Univ, Womens Econ Empowerment Hub, Nairobi, Kenya; [Glass, Nancy] Johns Hopkins Sch Nursing, Baltimore, MD USA; [Glass, Nancy] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD USA; [Gichangi, Peter] Tech Univ Mombasa, Mombasa, Kenya; [Gichangi, Peter] Univ Ghent, Dept Publ Hlth & Primary Care, Fac Med & Hlth Sci, Ghent, Belgium	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Bill & Melinda Gates Foundation; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Kenyatta University; Kenyatta University; Johns Hopkins University; Johns Hopkins University; Technical University of Mombasa; Ghent University; Ghent University Hospital	Decker, MR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Decker, MR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Bill & Melinda Gates Inst Populat & Reprod Hlth, Baltimore, MD 21205 USA.	mdecker@jhu.edu		Wamue Ngare, Grace/0000-0001-5969-5052; Thiongo, Mary/0000-0002-0598-995X; Morgan, Rosemary/0000-0001-5009-8470; Gummerson, Elizabeth/0000-0002-5097-0588; Wood, Shannon/0000-0003-4389-3526; Bevilacqua, Kristin/0000-0002-3260-3733	Bill & Melinda Gates Foundation [010481]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by the Bill & Melinda Gates Foundation [010481]. Funders had no role in the study design, data collection, decision to publish nor preparation of the manuscript. Under the Foundation grant conditions, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.	Ajari E., 2020, EUROPEAN J ENV PUBLI, V4; Aluga MA, 2020, J MICROBIOL IMMUNOL, V53, P671, DOI 10.1016/j.jmii.2020.04.011; Austrian K., COVID 19 REL KNOWL A; Baird S., 2020, M Q ADOLESCENTS EXP; Center on Gender Equity and Health, 2021, COVID 19 GEND RES LM; Center on Gender Equity and Health, EVID BAS MEAS EMP RE; Challa S, 2018, WOMEN HEALTH, V58, P434, DOI 10.1080/03630242.2017.1306607; Connell R.W., 1987, GENDER POWER SOC PER; Cousins S, 2020, LANCET, V396, P301, DOI 10.1016/S0140-6736(20)31679-2; Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704; Flowe H., 2020, SEXUAL OTHER FORMS V; Harrington EK, 2016, CULT HEALTH SEX, V18, P453, DOI 10.1080/13691058.2015.1091507; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Human Rights Watch, 2020, KENY POL BRUT CURF; JHPIEGO, 2016, GEND AN TOOLK HLTH S; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Johnston LG, 2010, AIDS CARE, V22, P784, DOI 10.1080/09540120903373557; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Kenya National Bureau of Statistics (KNBS), 2020, EC SURV 2020; Kenya National Bureau of Statistics (KNBS), 2019, 2019 KENY POP HOUS C; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Krugu JK, 2017, CULT HEALTH SEX, V19, P293, DOI 10.1080/13691058.2016.1216167; Langsi R, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18030899; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Morgan R, 2016, HEALTH POLICY PLANN, V31, P1069, DOI 10.1093/heapol/czw037; OECD, 2018, BRIDG RUR DIG DIV; Operario D, 2004, PSYCHOL HEALTH, V19, P237, DOI 10.1080/08870440310001638098; Pinchoff J, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042749; Pinchoff J, 2021, J URBAN HEALTH, V98, P211, DOI 10.1007/s11524-020-00507-w; Pinchoff J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244053; Quaife M, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01779-4; Rossouw L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052571; van Daalen KR, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003549; Wamoyi J, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0650-0; Wenham C, 2020, NATURE, V583, P194, DOI 10.1038/d41586-020-02006-z; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, 2016, BUILD LESS WHO PUB P; WHO, 2007, ADR SEX GEND EP PRON; Wirtz AL, 2019, J MED INTERNET RES, V21, DOI 10.2196/12569; World Bank Group, 2014, VOICE AGENCY EMPOWER	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259583	10.1371/journal.pone.0259583	http://dx.doi.org/10.1371/journal.pone.0259583			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY0QZ	34752473	gold, Green Published			2022-12-26	WOS:000754499700020
J	Covian, R; Edwards, L; He, Y; Kim, G; Houghton, C; Levine, RL; Balaban, RS				Covian, Raul; Edwards, Lanelle; He, Yi; Kim, Geumsoo; Houghton, Carly; Levine, Rodney L.; Balaban, Robert S.			Energy homeostasis is a conserved process: Evidence from Paracoccus denitrificans' response to acute changes in energy demand	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PEPTIDE IDENTIFICATION; METABOLIC HOMEOSTASIS; OXIDATIVE-PHOSPHORYLATION; BACTERIAL SUSPENSIONS; GLUTAMINE-SYNTHETASE; POTASSIUM-TRANSPORT; TURBIDITY CHANGES; ESCHERICHIA-COLI; LACTIC-ACID	Paracoccus denitrificans is a model organism for the study of oxidative phosphorylation. We demonstrate a very high respiratory capacity compared to mitochondria when normalizing to cytochrome aa(3) content even in the absence of alternative terminal oxidases. To gain insight into conserved mechanisms of energy homeostasis, we characterized the metabolic response to K+ reintroduction. A rapid 3-4-fold increase in respiration occurred before substantial cellular K+ accumulation followed by a sustained increase of up to 6-fold that persisted after net K+ uptake stopped. Proton motive force (Delta p) was slightly higher upon addition of K+ with Delta pH increasing and compensating for membrane potential (Delta Psi) depolarization. Blocking the F0F1-ATP synthase (Complex V) with venturicidin revealed that the initial K+-dependent respiratory activation was primarily due to K+ influx. However, the ability to sustain an increased respiration rate was partially dependent on Complex V activity. The 6-fold stimulation of respiration by K+ resulted in a small net reduction of most cytochromes, different from the pattern observed with chemical uncoupling and consistent with balanced input and utilization of reducing equivalents. Metabolomics showed increases in glycolytic and TCA cycle intermediates together with a decrease in basic amino acids, suggesting an increased nitrogen mobilization upon K+ replenishment. ATP and GTP concentrations increased after K+ addition, indicating a net increase in cellular potential energy. Thus, K+ stimulates energy generation and utilization resulting in an almost constant Delta p and increased high-energy phosphates during large acute and steady state changes in respiration. The specific energy consuming processes and signaling events associated with this simultaneous activation of work and metabolism in P. denitrificans remain unknown. Nevertheless, this homeostatic behavior is very similar to that observed in mitochondria in tissues when cellular energy requirements increase. We conclude that the regulation of energy generation and utilization to maintain homeostasis is conserved across the prokaryote/eukaryote boundary.	[Covian, Raul; Edwards, Lanelle; Houghton, Carly; Balaban, Robert S.] NHLBI, Lab Cardiac Energet, NIH, Bldg 10, Bethesda, MD 20892 USA; [He, Yi] NHLBI, Fermentat Facil, NIH, Bldg 10, Bethesda, MD 20892 USA; [Kim, Geumsoo; Levine, Rodney L.] NHLBI, Lab Biochem, NIH, Bldg 10, Bethesda, MD 20892 USA; [Houghton, Carly] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol,Pittsburgh Ctr Evolutio, Carnegie Mellon Univ Pittsburgh Joint PhD Program, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Covian, R (corresponding author), NHLBI, Lab Cardiac Energet, NIH, Bldg 10, Bethesda, MD 20892 USA.; Levine, RL (corresponding author), NHLBI, Lab Biochem, NIH, Bldg 10, Bethesda, MD 20892 USA.	raul.coviangarcia@nih.gov; rlevine@nih.gov			Intramural Research Program of the National Heart, Lung, and Blood Institute [ZIA HL000225, ZIA HL004601-33]	Intramural Research Program of the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/about/divisions/division-intramuralresearch) under grants ZIA HL000225 to RLL and ZIA HL004601-33 to RSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENDORF K, 1992, ANN NY ACAD SCI, V671, P228, DOI 10.1111/j.1749-6632.1992.tb43799.x; AVIDOR Y, 1956, J GEN MICROBIOL, V14, P76, DOI 10.1099/00221287-14-1-76; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Balaban RS, 2006, ANN NY ACAD SCI, V1080, P140, DOI 10.1196/annals.1380.013; Balaban RS, 2012, J GEN PHYSIOL, V139, P407, DOI 10.1085/jgp.201210783; Balaban RS, 1996, ANAL BIOCHEM, V237, P274, DOI 10.1006/abio.1996.0239; Bashant KR, 2021, ANN RHEUM DIS, V80, P209, DOI 10.1136/annrheumdis-2020-218338; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; BENDER RA, 1977, J BACTERIOL, V129, P1001, DOI 10.1128/JB.129.2.1001-1009.1977; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; BOLGIANO B, 1988, BIOCHIM BIOPHYS ACTA, V933, P341, DOI 10.1016/0005-2728(88)90041-2; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; BUSH LP, 1969, PLANT PHYSIOL, V44, P347, DOI 10.1104/pp.44.3.347; Cao Y, 2013, NATURE, V496, P317, DOI 10.1038/nature12056; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chess DJ, 2012, OPTICAL SPECTROSCOPY; Covian R, 2014, BBA-BIOENERGETICS, V1837, P1913, DOI 10.1016/j.bbabio.2014.08.006; De Baere S, 2013, J PHARMACEUT BIOMED, V80, P107, DOI 10.1016/j.jpba.2013.02.032; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; ERECINSKA M, 1981, J BIOL CHEM, V256, P278; ERECINSKA M, 1985, FEBS LETT, V188, P145, DOI 10.1016/0014-5793(85)80892-9; ERECINSKA M, 1979, ARCH BIOCHEM BIOPHYS, V197, P463, DOI 10.1016/0003-9861(79)90268-6; Femnou AN, 2017, AM J PHYSIOL-HEART C, V313, pH1199, DOI 10.1152/ajpheart.00306.2017; FERGUSON SJ, 1977, BIOCHEM SOC T, V5, P1525, DOI 10.1042/bst0051525; Ferguson SJ, 2018, IUBMB LIFE, V70, P1214, DOI 10.1002/iub.1962; Glancy B, 2021, PHYSIOL REV, V101, P1561, DOI 10.1152/physrev.00040.2020; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Henry H, 2012, BIOMED CHROMATOGR, V26, P425, DOI 10.1002/bmc.1681; HILL AV, 1950, BIOCHIM BIOPHYS ACTA, V4, P4, DOI 10.1016/0006-3002(50)90003-5; Hochachka PW, 1997, J EXP BIOL, V200, P381; JACOBUS WE, 1982, J BIOL CHEM, V257, P2397; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; Kall L, 2008, J PROTEOME RES, V7, P40, DOI 10.1021/pr700739d; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim N, 2012, BIOPHYS J, V102, P1194, DOI 10.1016/j.bpj.2012.02.003; Kraegeloh A, 2005, J BACTERIOL, V187, P1036, DOI 10.1128/JB.187.3.1036-1043.2005; KREBS HA, 1957, BIOCHEM J, V66, P53, DOI 10.1042/bj0660053; LARDY HA, 1952, J BIOL CHEM, V195, P215; LAZZARINO G, 1991, ANAL BIOCHEM, V197, P191, DOI 10.1016/0003-2697(91)90378-7; LJUNGDAHL PO, 1986, METHOD ENZYMOL, V126, P181; MAGER J, 1956, J GEN MICROBIOL, V14, P69, DOI 10.1099/00221287-14-1-69; Margulis L., 1981, P1; MATULA TI, 1969, J BACTERIOL, V100, P403, DOI 10.1128/JB.100.1.403-410.1969; MCCARTHY JEG, 1981, BIOCHEM J, V196, P311, DOI 10.1042/bj1960311; Mendoza-Hoffmann F, 2018, CELL REP, V22, P1067, DOI 10.1016/j.celrep.2017.12.106; MILLER S, 1964, J GEN MICROBIOL, V36, P123, DOI 10.1099/00221287-36-1-123; MILLER S, 1958, J GEN MICROBIOL, V18, P221, DOI 10.1099/00221287-18-1-221; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; NOKHAL TH, 1986, ARCH MICROBIOL, V145, P197, DOI 10.1007/BF00446780; NOSSAL PM, 1951, BIOCHEM J, V49, P407; Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001; Pedersen BP, 2019, MOL MEMBR BIOL, V35, P21, DOI 10.1080/09687688.2019.1638977; Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x; RICHARDS OC, 1961, J BIOL CHEM, V236, P3177; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; SENEZ JC, 1962, BACTERIOL REV, V26, P95, DOI 10.1128/MMBR.26.2_Pt_1-2.95-107.1962; SMITH L, 1991, J BIOENERG BIOMEMBR, V23, P303, DOI 10.1007/BF00762224; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Steinbach HB, 1962, COMP BIOCHEM PHYSIOL, V4, P678; STEWART LMD, 1985, J GEN MICROBIOL, V131, P77; SUGDEN PH, 1975, BIOCHEM J, V150, P113, DOI 10.1042/bj1500113; Thoden JB, 1998, BIOCHEMISTRY-US, V37, P8825, DOI 10.1021/bi9807761; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; VANSPANNING RJM, 1990, J BACTERIOL, V172, P986, DOI 10.1128/jb.172.2.986-996.1990; VANSPANNING RJM, 1991, J BACTERIOL, V173, P6962, DOI 10.1128/jb.173.21.6962-6970.1991; Wilson DF, 2015, AM J PHYSIOL-ENDOC M, V308, pE506, DOI 10.1152/ajpendo.00544.2014; WOOLFOLK CA, 1966, ARCH BIOCHEM BIOPHYS, V116, P177, DOI 10.1016/0003-9861(66)90026-9; WORONICK CL, 1960, J BIOL CHEM, V235, P9; Zharova TV, 2004, J BIOL CHEM, V279, P12319, DOI 10.1074/jbc.M311397200	82	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259636	10.1371/journal.pone.0259636	http://dx.doi.org/10.1371/journal.pone.0259636			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748578	Green Published, gold			2022-12-26	WOS:000755468000043
J	Owusu, PN; Reininghaus, U; Koppe, G; Dankwa-Mullan, I; Barnighausen, T				Owusu, Priscilla N.; Reininghaus, Ulrich; Koppe, Georgia; Dankwa-Mullan, Irene; Baernighausen, Till			Artificial intelligence applications in social media for depression screening: A systematic review protocol for content validity processes	PLOS ONE			English	Review							PRIMARY-CARE; MENTAL-ILLNESS; HEALTH-STATUS; INSTRUMENTS; EXPERIENCES; FRAMEWORK	Background The popularization of social media has led to the coalescing of user groups around mental health conditions; in particular, depression. Social media offers a rich environment for contextualizing and predicting users' self-reported burden of depression. Modern artificial intelligence (AI) methods are commonly employed in analyzing user-generated sentiment on social media. In the forthcoming systematic review, we will examine the content validity of these computer-based health surveillance models with respect to standard diagnostic frameworks. Drawing from a clinical perspective, we will attempt to establish a normative judgment about the strengths of these modern AI applications in the detection of depression. Methods We will perform a systematic review of English and German language publications from 2010 to 2020 in PubMed, APA PsychInfo, Science Direct, EMBASE Psych, Google Scholar, and Web of Science. The inclusion criteria span cohort, case-control, cross-sectional studies, randomized controlled studies, in addition to reports on conference proceedings. The systematic review will exclude some gray source materials, specifically editorials, newspaper articles, and blog posts. Our primary outcome is self-reported depression, as expressed on social media. Secondary outcomes will be the types of AI methods used for social media depression screen, and the clinical validation procedures accompanying these methods. In a second step, we will utilize the evidence-strengthening Population, Intervention, Comparison, Outcomes, Study type (PICOS) tool to refine our inclusion and exclusion criteria. Following the independent assessment of the evidence sources by two authors for the risk of bias, the data extraction process will culminate in a thematic synthesis of reviewed studies. Discussion We present the protocol for a systematic review which will consider all existing literature from peer reviewed publication sources relevant to the primary and secondary outcomes. The completed review will discuss depression as a self-reported health outcome in social media material. We will examine the computational methods, including AI and machine learning techniques which are commonly used for online depression surveillance. Furthermore, we will focus on standard clinical assessments, as indicating content validity, in the design of the algorithms. The methodological quality of the clinical construct of the algorithms will be evaluated with the COnsensus-based Standards for the selection of health status Measurement Instruments (COSMIN) framework. We conclude the study with a normative judgment about the current application of AI to screen for depression on social media.	[Owusu, Priscilla N.; Baernighausen, Till] Univ Hosp Heidelberg, Inst Global Hlth, Heidelberg, Germany; [Reininghaus, Ulrich; Koppe, Georgia] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Heidelberg, Germany; [Dankwa-Mullan, Irene] IBM Watson Hlth, Bethesda, MD USA; [Baernighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health	Owusu, PN (corresponding author), Univ Hosp Heidelberg, Inst Global Hlth, Heidelberg, Germany.	priscilla.owusu@uni-heidelberg.de	Reininghaus, Ulrich/ABE-1130-2020	Reininghaus, Ulrich/0000-0002-9227-5436; Owusu, Priscilla/0000-0001-8709-6161	Heidelberg University Library	Heidelberg University Library	This review is supported by resources available through the Heidelberg Institute of Global Health and the Heidelberg University Library.	Alegria M, 2013, PATIENT EDUC COUNS, V93, P188, DOI 10.1016/j.pec.2013.07.001; Bank World, MENTAL HLTH; Barnett-Page E, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-59; Barros JM, 2020, J MED INTERNET RES, V22, DOI 10.2196/13680; Belnap BH, 2006, ADM POLICY MENT HLTH, V33, P65, DOI 10.1007/s10488-005-4237-z; Buchanan EA, 2012, INTERNET RES ETHICS; Chancellor S, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0233-7; Committee on Psychological Testing Including Validity Testing for Social Security Administration Disability Determinations; Board on the Health of Select Populations; Institute of Medicine, 2015, SELF REP MEAS SYMPT; Coppersmith G, 2015, PROC 2 WORKSHOP COMP, P31, DOI [10.3115/v1/W15-1204, DOI 10.3115/V1/W15-1204]; Corrigan PW, 2014, PSYCHOL SCI PUBL INT, V15, P37, DOI 10.1177/1529100614531398; Cortland CI, 2017, J PERS SOC PSYCHOL, V113, P547, DOI 10.1037/pspi0000100; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; De Choudhury M., 2013, P SIGCHI C HUM FACT, P3267, DOI [DOI 10.1145/2470654.2466447, 10.1145/2470654.2466447]; De Choudhury M, 2014, P 17 ACM C COMP SUPP, P626, DOI DOI 10.1145/2531602.2531675; Duan L, 2020, J AFFECT DISORDERS, V275, P112, DOI 10.1016/j.jad.2020.06.029; Eaton WW, 2000, ARCH GEN PSYCHIAT, V57, P217, DOI 10.1001/archpsyc.57.3.217; Ernala SK, 2019, CHI 2019: PROCEEDINGS OF THE 2019 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, DOI 10.1145/3290605.3300364; Escobar-Viera CG, 2018, CYBERPSYCH BEH SOC N, V21, P437, DOI 10.1089/cyber.2017.0668; Friedenberg M., 2018, PROC 5 WORKSHOP COMP, P25, DOI [DOI 10.18653/V1/W18-0603, 10.18653/v1/W18]; Garrett Natalie, 2020, AIES '20: Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society, P272, DOI 10.1145/3375627.3375868; Gkotsis G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45141; Guntuku SC, 2017, CURR OPIN BEHAV SCI, V18, P43, DOI 10.1016/j.cobeha.2017.07.005; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Harrigian K., 2020, ARXIV PREPRINT ARXIV; Jablensky A, 2016, WORLD PSYCHIATRY, V15, P26, DOI 10.1002/wps.20284; Jaidka K, 2020, P NATL ACAD SCI USA, V117, P10165, DOI 10.1073/pnas.1906364117; Jani BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074610; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Krafft P. M., 2020, AIES '20: Proceedings of the AAAI/ACM Conference on AI, Ethics, and Society, P72, DOI 10.1145/3375627.3375835; Kupferberg A, 2016, NEUROSCI BIOBEHAV R, V69, P313, DOI 10.1016/j.neubiorev.2016.07.002; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; McClellan C, 2017, J AM MED INFORM ASSN, V24, P496, DOI 10.1093/jamia/ocw133; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Naslund JA, 2016, EPIDEMIOL PSYCH SCI, V25, P113, DOI 10.1017/S2045796015001067; National Institute of Health and Clinical Excellence, 2009, DEPR PEOPL CHRON PHY; Ortigo K.M., 2010, CONT DIRECTIONS PSYC, P374; Pei Wang, 2019, Journal of Artificial General Intelligence, V10, P1, DOI 10.2478/jagi-2019-0002; Pew Research Center Internet and Technology., SOC MED FACT SHEET; Pincus HA, 2001, GEN HOSP PSYCHIAT, V23, P311, DOI 10.1016/S0163-8343(01)00165-7; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Regier DA, 1998, ARCH GEN PSYCHIAT, V55, P109, DOI 10.1001/archpsyc.55.2.109; Robinson KA, 2011, J CLIN EPIDEMIOL, V64, P1325, DOI 10.1016/j.jclinepi.2011.06.009; Saltz J, 2019, ACM T COMPUT EDUC, V19, DOI 10.1145/3341164; Schumann I, 2012, FAM PRACT, V29, P255, DOI 10.1093/fampra/cmr092; Sheehan David V, 2004, Manag Care, V13, P6; Siemieniuk R., WHAT IS GRADE BMJ BE; STRUTZEL E, 1968, NURS RES, V17, P364; Susser E, 2006, PSYCHIAT EPIDEMIOLOG; Thorstad R, 2019, BEHAV RES METHODS, V51, P1586, DOI 10.3758/s13428-019-01235-z; UNICEF, ENS MENT HLTH WELL B; Wagner E H, 1999, Manag Care Q, V7, P56; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; WEISSMAN MM, 1987, AM J PUBLIC HEALTH, V77, P445, DOI 10.2105/AJPH.77.4.445; World Health Organization, 2020, DEPRESSION; Yazdavar AH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226248; Zamanzadeh Vahid, 2015, J Caring Sci, V4, P165, DOI 10.15171/jcs.2015.017; Zirikly A., 2019, PROC 6 WORKSHOP COMP, P24, DOI [10.18653/v1/W19-3003, DOI 10.18653/V1/W19-3003]	59	1	1	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259499	10.1371/journal.pone.0259499	http://dx.doi.org/10.1371/journal.pone.0259499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748571	Green Published, gold			2022-12-26	WOS:000755468000032
J	Ruiz-Torres, SJ; Bourn, JR; Benight, NM; Hunt, BG; Lester, C; Waltz, SE				Ruiz-Torres, Sasha J.; Bourn, Jennifer R.; Benight, Nancy M.; Hunt, Brian G.; Lester, Carissa; Waltz, Susan E.			Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35	ONCOGENE			English	Article							RECEPTOR TYROSINE KINASE; STIMULATING PROTEIN; IFN-GAMMA; PERITONEAL-MACROPHAGES; TUMOR-GROWTH; ACTIVATION; EXPRESSION; CELLS; IL-12; INHIBITION	Tumor associated macrophages (TAMs) play a major role in regulating mammary tumor growth and in directing the responses of tumor infiltrating leukocytes in the microenvironment. However, macrophage-specific mechanisms regulating the interactions of macrophages with tumor cells and other leukocytes that support tumor progression have not been extensively studied. In this study, we show that the activation of the RON receptor tyrosine kinase signaling pathway specifically in macrophages supports breast cancer growth and metastasis. Using clinically relevant murine models of breast cancer, we demonstrate that loss of macrophage RON expression results in decreases in mammary tumor cell proliferation, survival, cancer stem cell self-renewal, and metastasis. Macrophage RON signaling modulates these phenotypes via direct effects on the tumor proper and indirectly by regulating leukocyte recruitment including macrophages, T-cells, and B-cells in the mammary tumor microenvironment. We further show that macrophage RON expression regulates the macrophage secretome including IL-35 and other immunosuppressive factors. Overall, our studies implicate activation of RON signaling in macrophages as a key player in supporting a thriving mammary pro-tumor microenvironment through novel mechanisms including the augmentation of tumor cell properties through IL-35.	[Ruiz-Torres, Sasha J.; Bourn, Jennifer R.; Benight, Nancy M.; Hunt, Brian G.; Lester, Carissa; Waltz, Susan E.] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA; [Waltz, Susan E.] Cincinnati Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Waltz, SE (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA.; Waltz, SE (corresponding author), Cincinnati Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.	susan.waltz@uc.edu		Bourn, Jennifer/0000-0002-0902-2850; Waltz, Susan/0000-0003-3572-4642; Hunt, Brian/0000-0003-4155-730X	US Department of Veterans Affairs [1IOBX000803]; National Institutes of Health [R01 CA239697, T32 CA117846, F31 CA228373]; National Institutes of Diabetes & Digestive & Kidney Diseases [P30 DK078392]	US Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Vidjaya L. Premkumar, Lennox Brooks, Rebekah Karns, James Davis, and Madison Nashu for their technical and bioinformatic assistance. US Department of Veterans Affairs research grant 1IOBX000803 (SEW); National Institutes of Health grants R01 CA239697 (SEW), T32 CA117846 (SEW, SJRT, NMB, JRB), F31 CA228373 (BGH, SEW), and National Institutes of Diabetes & Digestive & Kidney Diseases grant P30 DK078392.	Benight NM, 2015, ONCOTARGET, V6, P17445, DOI 10.18632/oncotarget.3641; Benight NM, 2012, EXPERT OPIN THER TAR, V16, P921, DOI 10.1517/14728222.2012.710200; Brunelleschi S, 2001, BRIT J PHARMACOL, V134, P1285, DOI 10.1038/sj.bjp.0704356; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen YQ, 1998, J IMMUNOL, V161, P4950; Choi JJ, 2015, CLIN REV ALLERG IMMU, V49, P327, DOI 10.1007/s12016-015-8468-9; Dambuza IM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00838-4; De Nardo D, 2018, METHODS MOL BIOL, V1784, P35, DOI 10.1007/978-1-4939-7837-3_4; Eyob H, 2013, CANCER DISCOV, V3, P751, DOI 10.1158/2159-8290.CD-12-0480; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Gurusamy D, 2013, CANCER RES, V73, P1752, DOI 10.1158/0008-5472.CAN-12-2474; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hunt BG, 2020, BREAST CANCER RES TR, V181, P529, DOI 10.1007/s10549-020-05653-y; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; IWAMA A, 1995, BLOOD, V86, P3394, DOI 10.1182/blood.V86.9.3394.bloodjournal8693394; Jadus MR, 1996, BLOOD, V87, P5232, DOI 10.1182/blood.V87.12.5232.bloodjournal87125232; Kollet JI, 2006, MOL IMMUNOL, V43, P623, DOI 10.1016/j.molimm.2005.04.004; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kourko O, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00969; Kulkarni RM, 2014, HEPATOB PANCREAT DIS, V13, P281, DOI 10.1016/S1499-3872(14)60254-X; KULKARNI RM, 2014, AM J PHYSIOL-GASTR L, V306; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lee CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06268-0; Lindsten T, 2017, INT J ONCOL, V51, P104, DOI 10.3892/ijo.2017.3996; Liu JG, 2004, J BIOL CHEM, V279, P55609, DOI 10.1074/jbc.M406565200; McClaine RJ, 2010, NEOPLASIA, V12, P650, DOI 10.1593/neo.10476; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Nanney LB, 1998, J INVEST DERMATOL, V111, P573, DOI 10.1046/j.1523-1747.1998.00332.x; Nikolaidis NM, 2011, INNATE IMMUN-LONDON, V17, P499, DOI 10.1177/1753425910383725; Nikolaidis NM, 2010, SHOCK, V33, P197, DOI 10.1097/SHK.0b013e3181ae8155; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Pylayeva-Gupta Y, 2016, CLIN CANCER RES, V22, P4973, DOI 10.1158/1078-0432.CCR-16-0743; Ray M, 2010, J IMMUNOL, V185, P7309, DOI 10.4049/jimmunol.1000095; Ruiz-Torres SJ, 2017, ONCOTARGET, V8, P58918, DOI 10.18632/oncotarget.19441; Sainz B, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9012369; Sawant DV, 2015, J INTERF CYTOK RES, V35, P499, DOI 10.1089/jir.2015.0015; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Singh Saroj, 2017, Biochim Open, V4, P8, DOI 10.1016/j.biopen.2016.11.002; Stuart WD, 2011, HEPATOLOGY, V53, P1618, DOI 10.1002/hep.24239; Sullivan C, 2020, MOL CANCER RES, V18, P1244, DOI 10.1158/1541-7786.MCR-20-0060; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; WANG MH, 1994, J BIOL CHEM, V269, P14027; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Wilson CB, 2008, J IMMUNOL, V181, P2303, DOI 10.4049/jimmunol.181.4.2303; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	50	3	3	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					321	333		10.1038/s41388-021-02091-y	http://dx.doi.org/10.1038/s41388-021-02091-y		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34743208	Green Accepted			2022-12-26	WOS:000715015000002
J	Bowler-Barnett, E; Martinez-Garcia, FD; Sherwood, M; Aleidan, A; John, S; Weston, S; Wang, YH; Divecha, N; Skipp, P; Ewing, RM				Bowler-Barnett, Emily; Martinez-Garcia, Francisco D.; Sherwood, Matthew; Aleidan, Ahood; John, Steve; Weston, Sara; Wang, Yihua; Divecha, Nullin; Skipp, Paul; Ewing, Rob M.			Proteomic characterization of GSK3 beta knockout shows altered cell adhesion and metabolic pathway utilisation in colorectal cancer cells	PLOS ONE			English	Article							KINASE; GENE	Glycogen-specific kinase (GSK3 beta) is an integral regulator of the Wnt signalling pathway as well as many other diverse signalling pathways and processes. Dys-regulation of GSK3 beta is implicated in many different pathologies, including neurodegenerative disorders as well as many different tumour types. In the context of tumour development, GSK3 beta has been shown to play both oncogenic and tumour suppressor roles, depending upon tissue, signalling environment or disease progression. Although multiple substrates of the GSK3 beta kinase have been identified, the wider protein networks within which GSK3 beta participates are not well known, and the consequences of these interactions not well understood. In this study, LC-MS/MS expression analysis was performed using knockout GSK3 beta colorectal cancer cells and isogenic controls in colorectal cancer cell lines carrying dominant stabilizing mutations of beta-catenin. Consistent with the role of GSK3 beta, we found that beta-catenin levels and canonical Wnt activity are unaffected by knockout of GSK3 beta and therefore used this knockout cell model to identify other processes in which GSK3 beta is implicated. Quantitative proteomic analysis revealed perturbation of proteins involved in cell-cell adhesion, and we characterized the phenotype and altered proteomic profiles associated with this. We also characterized the perturbation of metabolic pathways resulting from GSK3 beta knockout and identified defects in glycogen metabolism. In summary, using a precision colorectal cancer cell-line knockout model with constitutively activated beta-catenin we identified several of the diverse pathways and processes associated with GSK3 beta function.	[Bowler-Barnett, Emily; Martinez-Garcia, Francisco D.; Sherwood, Matthew; Aleidan, Ahood; John, Steve; Weston, Sara; Wang, Yihua; Divecha, Nullin; Skipp, Paul; Ewing, Rob M.] Univ Southampton, Fac Environm & Life Sci, Sch Biol Sci, Southampton, Hants, England; [Bowler-Barnett, Emily] European Bioinformat Inst, EMBL EBI, Cambridge, England; [Martinez-Garcia, Francisco D.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Southampton; European Molecular Biology Laboratory (EMBL); University of Groningen	Ewing, RM (corresponding author), Univ Southampton, Fac Environm & Life Sci, Sch Biol Sci, Southampton, Hants, England.	rob.ewing@soton.ac.uk		Wang, Yihua/0000-0001-5561-0648				Albrecht LV, 2015, J CELL BIOL, V208, P597, DOI 10.1083/jcb.201406020; Bailey CK, 2012, J BIOL CHEM, V287, P19472, DOI 10.1074/jbc.M112.345728; Beaulieu JF, 2020, CANCERS, V12, DOI 10.3390/cancers12010041; Cormier Kevin W, 2017, F1000Res, V6, DOI 10.12688/f1000research.10557.1; Dembowy J, 2015, ONCOGENE, V34, P3514, DOI 10.1038/onc.2014.279; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; EMBI N, 1979, EUR J BIOCHEM, V100, P339, DOI 10.1111/j.1432-1033.1979.tb04176.x; Escobar DJ, 2015, J CELL SCI, V128, P1150, DOI 10.1242/jcs.163824; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Lal H, 2014, CIRCULATION, V130, P419, DOI 10.1161/CIRCULATIONAHA.113.008364; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; Pramanik KC, 2015, ONCOTARGET, V6, P11561, DOI 10.18632/oncotarget.3427; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Shinde MY, 2017, J BIOL CHEM, V292, P18240, DOI 10.1074/jbc.M117.813527; Sklyarova T, 2008, J INVEST DERMATOL, V128, P1375, DOI 10.1038/sj.jid.5701189; Sumigray KD, 2012, MOL BIOL CELL, V23, P792, DOI 10.1091/mbc.E11-11-0923; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Walko G, 2015, CELL TISSUE RES, V360, P529, DOI 10.1007/s00441-015-2216-6; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Zeng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091231; Zhao C., 2014, BIO-PROTOCOL, V4, pe1183	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0246707	10.1371/journal.pone.0246707	http://dx.doi.org/10.1371/journal.pone.0246707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739494	gold, Green Published, Green Submitted			2022-12-26	WOS:000755000800001
J	Kulik, ZT; Lungmus, JK; Angielczyk, KD; Sidor, CA				Kulik, Zoe T.; Lungmus, Jacqueline K.; Angielczyk, Kenneth D.; Sidor, Christian A.			Living fast in the Triassic: New data on life history in Lystrosaurus (Therapsida: Dicynodontia) from northeastern Pangea	PLOS ONE			English	Article							END-PERMIAN EXTINCTION; KAROO-BASIN; SOUTH-AFRICA; MASS EXTINCTION; GROWTH-PATTERNS; BONE-HISTOLOGY; BOUNDARY; CLIMATE; DIVERSIFICATION; CLASSIFICATION	Lystrosaurus was one of the few tetrapods to survive the Permo-Triassic mass extinction, the most profound biotic crisis in Earth's history. The wide paleolatitudinal range and high abundance of Lystrosaurus during the Early Triassic provide a unique opportunity to investigate changes in growth dynamics and longevity following the mass extinction, yet most studies have focused only on species that lived in the southern hemisphere. Here, we present the long bone histology from twenty Lystrosaurus skeletal elements spanning a range of sizes that were collected in the Jiucaiyuan Formation of northwestern China. In addition, we compare the average body size of northern and southern Pangean Triassic-aged species and conduct cranial geometric morphometric analyses of southern and northern taxa to begin investigating whether specimens from China are likely to be taxonomically distinct from South African specimens. We demonstrate that Lystrosaurus from China have larger average body sizes than their southern Pangean relatives and that their cranial morphologies are distinctive. The osteohistological examination revealed sustained, rapid osteogenesis punctuated by growth marks in some, but not all, immature individuals from China. We find that the osteohistology of Chinese Lystrosaurus shares a similar growth pattern with South African species that show sustained growth until death. However, bone growth arrests more frequently in the Chinese sample. Nevertheless, none of the long bones sampled here indicate that maximum or asymptotic size was reached, suggesting that the maximum size of Lystrosaurus from the Jiucaiyuan Formation remains unknown.	[Kulik, Zoe T.; Sidor, Christian A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kulik, Zoe T.; Sidor, Christian A.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Lungmus, Jacqueline K.] Smithsonian Natl Museum Nat Hist, Washington, DC USA; [Angielczyk, Kenneth D.] Field Museum Nat Hist, Negaunee Integrat Res Ctr, Chicago, IL 60605 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Smithsonian Institution; Smithsonian National Museum of Natural History; Field Museum of Natural History (Chicago)	Kulik, ZT (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Kulik, ZT (corresponding author), Univ Washington, Burke Museum, Seattle, WA 98195 USA.	zkulik@uw.edu		Sidor, Christian/0000-0003-0742-4829; Kulik, Zoe/0000-0003-0789-5380				Adams D.C., 2016, GEOMORPH SOFTWARE GE; Adams DC, 2018, SYST BIOL, V67, P14, DOI 10.1093/sysbio/syx055; Allen BJ, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1125; [Anonymous], 2005, J SYST PALAEONTOL, V3, P203; [Anonymous], 1990, SKELETAL BIOMINERALI, DOI DOI 10.1029/SC005P0175; Araujo R, 2017, PEERJ, V5, DOI 10.7717/peerj.3119; Benton MJ, 2014, GONDWANA RES, V25, P1308, DOI 10.1016/j.gr.2012.12.010; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bernardi M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2331; Botha J, 2007, ZOOL J LINN SOC-LOND, V149, P477; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Botha J, 2007, LETHAIA, V40, P125, DOI 10.1111/j.1502-3931.2007.00011.x; Botha J, 2020, PEERJ, V8, DOI 10.7717/peerj.10408; Botha J, 2020, PALAEOGEOGR PALAEOCL, V540, DOI 10.1016/j.palaeo.2019.109467; Botha-Brink J, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1365080; Botha-Brink J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24053; Botha-Brink J, 2010, ZOOL J LINN SOC-LOND, V160, P341, DOI 10.1111/j.1096-3642.2009.00601.x; Camp J., 2010, MORPHOLOGICAL VARIAT; Camp J, 2011, J VERTEBR PALEONTOL, V31, P82; Canoville A, 2015, ANAT REC, V298, P1237, DOI 10.1002/ar.23160; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; Castanet J., 1988, SKELETOCHRONOLOGICAL, P14; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/ngeo1475, 10.1038/NGEO1475]; Cheng Zhengwu, 1986, China Ministry of Geology and Mineral Resources Geological Memoirs Series 2, V3, P207; Cluver MA., 1970, THESIS STELLENBOSCH; Codron J, 2017, J EVOLUTION BIOL, V30, P40, DOI 10.1111/jeb.12983; Colbert EH., 1974, AM MUS NOVIT, P44; COSGRIFF JW, 1982, J PALEONTOL, V56, P371; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; CURREY JD, 1960, Q J MICROSC SCI, V101, P351; de Buffrenil V, 2021, BONE TISSUE TYPES BR, P147; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Enlow D. E., 1958, Texas Journal of Science, V10, P187; Enlow H., 1957, TEX J SCI 2, V9, P30; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Ferretti A, 2002, ANAT EMBRYOL, V206, P21, DOI 10.1007/s00429-002-0265-6; Frank TD, 2021, GEOLOGY, V49, P1089, DOI 10.1130/G48795.1; Frobisch J, 2013, PALAEOGEOGR PALAEOCL, V372, P50, DOI 10.1016/j.palaeo.2012.10.036; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Gastaldo RA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15243-7; Griffin CT, 2021, BIOL REV, V96, P470, DOI 10.1111/brv.12666; Grine Frederick E., 2006, P432; Gubin Yuri M., 1993, Bulletin of the New Mexico Museum of Natural History and Science, V3, P169; Han FL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248681; Harries PJ, 2009, PALAEOGEOGR PALAEOCL, V284, P4, DOI 10.1016/j.palaeo.2009.08.021; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Huttenlocker AK, 2014, PEERJ, V2, DOI 10.7717/peerj.325; Huttenlocker AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087553; Huttenlocker AK, 2013, PALEOBIOLOGY, V39, P253, DOI 10.1666/12020; Jasinoski SC, 2009, ANAT REC, V292, P862, DOI 10.1002/ar.20906; Kammerer CF, 2020, PEERJ, V8, DOI 10.7717/peerj.9925; Kammerer CF, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1596921; Kidder DL, 2004, PALAEOGEOGR PALAEOCL, V203, P207, DOI 10.1016/S0031-0182(03)00667-9; Kiehl JT, 2005, GEOLOGY, V33, P757, DOI 10.1130/G21654.1; King G.M., 1988, Handbuch der Palaeoherpetologie, V17C, P1; King G.M., 1991, Historical Biology, V4, P323; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lamm ET, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P55; Li J., 2008, SCI PRESS, P379; Liu J, 2021, GLOBAL PLANET CHANGE, V205, DOI 10.1016/j.gloplacha.2021.103618; Liu Jun, 2002, Vertebrata Palasiatica, V40, P267; Lucas S.G., 2002, CHINESE FOSSIL VERTE; Marotti Gastone, 2010, Italian Journal of Anatomy and Embryology, V115, P123; Mchugh JB, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.902845; Metcalfe I, 2009, J ASIAN EARTH SCI, V36, P503, DOI 10.1016/j.jseaes.2008.06.005; Mishra S, 2019, PALAEOGEOGR PALAEOCL, V534, DOI 10.1016/j.palaeo.2019.109292; Mori R, 2003, CELLS TISSUES ORGANS, V175, P43, DOI 10.1159/000073436; Nacarino-Meneses C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198511; Nicolas M, 2010, LETHAIA, V43, P45, DOI 10.1111/j.1502-3931.2009.00171.x; Nowak H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07945-w; Olivier C, 2017, BIOL J LINN SOC, V121, P409, DOI 10.1093/biolinnean/blw044; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Prondvai E, 2014, BIOL J LINN SOC, V112, P799, DOI 10.1111/bij.12323; RAUP DM, 1984, P NATL ACAD SCI-BIOL, V81, P801, DOI 10.1073/pnas.81.3.801; Ray S, 2005, PALAEONTOLOGY, V48, P1169, DOI 10.1111/j.1475-4983.2005.00513.x; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Ray S., 2012, FORERUNNERS MAMMALS, P29; Ray Sanghamitra, 2009, Palaeoworld, V18, P53, DOI 10.1016/j.palwor.2008.09.001; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; Retallack GJ, 2006, GEOL SOC AM SPEC PAP, V399, P249, DOI 10.1130/2006.2399(12); Rey K, 2017, ELIFE, V6, DOI 10.7554/eLife.28589; Ricqles A., 1969, ANN PALEO, V40, P1; Ricqles A. de, 1974, EVOL THEORY, V1, P51; Rohlf FJ., 2017, TPSDIG2; Roopnarine PD, 2019, EARTH-SCI REV, V189, P244, DOI 10.1016/j.earscirev.2018.10.014; Roopnarine PD, 2015, SCIENCE, V350, P90, DOI 10.1126/science.aab1371; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Scotese C.R., 2018, PALEOMAP PALEODIGITA; Scotese CR., 2021, ANNU REV EARTH PL SC, V49; Shapiro F, 2019, EUR CELLS MATER, V38, P137, DOI 10.22203/eCM.v038a11; Sinsch U., 2007, GROWTH MARKS NATTERJ, P9; SMITH RMH, 1995, PALAEOGEOGR PALAEOCL, V117, P81, DOI 10.1016/0031-0182(94)00119-S; Smith Roger, 2012, P30; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002; Sobolev SV, 2011, NATURE, V477, P312, DOI 10.1038/nature10385; Stein K, 2014, BIOL REV, V89, P24, DOI 10.1111/brv.12041; Sun A. L., 1964, Vertebrata Palasiatica, V8, P216; Sun A-L., 1973, PERMO TRIASSIC VERTE, P53; SUN AL, 1980, VERTEBRAT PALASIATIC, V18, P100; Sun YD, 2012, SCIENCE, V338, P366, DOI 10.1126/science.1224126; Surkov MV, 2005, J VERTEBR PALEONTOL, V25, P402, DOI 10.1671/0272-4634(2005)025[0402:LGADFT]2.0.CO;2; Tabor NJ, 2017, J VERTEBR PALEONTOL, V37, P240, DOI 10.1080/02724634.2017.1415211; Tripathi C., 1961, REC GEOL SURV INDIA, V89, P407; Urbanek Adam, 1993, Historical Biology, V7, P29; Viglietti PA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017045118; Viglietti PA, 2018, J AFR EARTH SCI, V138, P102, DOI 10.1016/j.jafrearsci.2017.11.010; Wan M-L., 2021, PALAEOWORLD; Wan ML, 2019, REV PALAEOBOT PALYNO, V263, P12, DOI 10.1016/j.revpalbo.2019.01.004; Ward PD, 2000, SCIENCE, V289, P1740, DOI 10.1126/science.289.5485.1740; Whitney MR, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01207-6; Winguth A, 2013, GLOBAL PLANET CHANGE, V105, P160, DOI 10.1016/j.gloplacha.2012.06.006; Winguth AME, 2015, PALAEOGEOGR PALAEOCL, V440, P316, DOI 10.1016/j.palaeo.2015.09.008; Yang W, 2021, EARTH-SCI REV; Yang W, 2010, GLOBAL PLANET CHANGE, V73, P15, DOI 10.1016/j.gloplacha.2010.03.008; Young C. C., 1939, Bulletin of the Geological Society of China, V19, P111; Young CC, 1935, B GEOL SOC CHINA, P483; YUAN P. L., 1934, BULL GEOL SOC CHINA, V13, P575	121	4	4	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259369	10.1371/journal.pone.0259369	http://dx.doi.org/10.1371/journal.pone.0259369			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739492	Green Published, gold			2022-12-26	WOS:000755000800027
J	Kvanta, H; Bolk, J; Strindberg, M; Jimenez-Espinoza, C; Brostrom, L; Padilla, N; Aden, U				Kvanta, Hedvig; Bolk, Jenny; Strindberg, Marika; Jimenez-Espinoza, Carmen; Brostrom, Lina; Padilla, Nelly; Aden, Ulrika			Exploring the distribution of grey and white matter brain volumes in extremely preterm children, using magnetic resonance imaging at term age and at 10 years of age	PLOS ONE			English	Article							ACTIVE PERINATAL-CARE; CORTICAL THICKNESS; ADOLESCENTS; INFANTS; CHILDHOOD; GROWTH; BIRTH; BORN; MATURATION; ABNORMALITIES	Objectives To investigate differences in brain volumes between children born extremely preterm and term born controls at term age and at 10 years of age. Study design Children born extremely preterm (EPT), up to 26 weeks and 6 days gestational age, in Stockholm between January 1 2004 to March 31 2007 were included in this population-based cohort study. A total of 45 EPT infants were included at term age and 51 EPT children were included at 10 years of age. There were 27 EPT children included at both time points. Two different control groups were recruited; 15 control infants were included at term age and 38 control children at 10 years of age. The primary outcomes were the grey and white matter volumes. Linear regression, adjusted for intracranial volume and sex, was used. Results At term age, the extremely preterm infants had significantly smaller grey matter volume compared to the control infants with an adjusted mean difference of 5.0 cm(3) and a 95% confidence interval of -8.4 to -1.5 (p = 0.004). At 10 years of age the extremely preterm children had significantly smaller white matter volume compared to the control children with an adjusted mean difference of 6.0 cm(3) and a 95% confidence interval of -10.9 to -1.0 (p = 0.010). Conclusion Extremely preterm birth was associated with reduced grey matter volume at term age and reduced white matter volume at 10 years of age compared to term born controls.	[Kvanta, Hedvig; Strindberg, Marika; Brostrom, Lina; Padilla, Nelly; Aden, Ulrika] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Bolk, Jenny] Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden; [Bolk, Jenny] Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden; [Bolk, Jenny; Brostrom, Lina] South Gen Hosp, Sachs Children & Youth Hosp, Stockholm, Sweden; [Jimenez-Espinoza, Carmen] Univ La Laguna, Fac Hlth Sci, Dept Basic Med Sci, Physiol Sect, Tenerife, Spain; [Aden, Ulrika] Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Universidad de la Laguna; Karolinska Institutet; Karolinska University Hospital	Kvanta, H (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Hedvig.kvanta@ki.se	Jimenez-Espinoza, Carmen/L-8449-2014	Jimenez-Espinoza, Carmen/0000-0002-6254-2396; Kvanta, Hedvig/0000-0003-3557-9000				Alexander B, 2019, NEUROIMAGE, V185, P654, DOI 10.1016/j.neuroimage.2018.07.021; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Arhan E, 2017, CHILD NERV SYST, V33, P1317, DOI 10.1007/s00381-017-3421-2; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bolk J, 2018, JAMA PEDIATR, V172, P765, DOI 10.1001/jamapediatrics.2018.1394; Bouyssi-Kobar M., 2016, PEDIATRICS, P138, DOI [10.1186/s12887-016-0669-8 27544347, DOI 10.1186/S12887-016-0669-827544347]; Cheong JLY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077475; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cormack BE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092029; Coupe P, 2017, HUM BRAIN MAPP, V38, P5501, DOI 10.1002/hbm.23743; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Domellof M, 2018, PEDIATRICS, V142, pS533, DOI 10.1542/peds.2018-0478C; Gregory Katherine E, 2011, Adv Neonatal Care, V11, P155, DOI 10.1097/ANC.0b013e31821baaf4; Gui L, 2019, NEUROIMAGE, V185, P728, DOI 10.1016/j.neuroimage.2018.06.034; Helenius K, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1264; Holm SK, 2018, PEDIATR RES, V83, P804, DOI 10.1038/pr.2017.312; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Inder TE, 2003, J PEDIATR-US, V143, P171, DOI 10.1067/S0022-3476(03)00357-3; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Jernigan TL, 2016, DEV COGN NEUROS-NETH, V18, P2, DOI 10.1016/j.dcn.2015.07.008; Johnson MH, 2015, DEV PSYCHOPATHOL, V27, P425, DOI 10.1017/S0954579415000073; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Karolis VR, 2017, NEUROIMAGE, V163, P379, DOI 10.1016/j.neuroimage.2017.09.039; Kelly CE, 2020, NEUROIMAGE, V220, DOI 10.1016/j.neuroimage.2020.117068; Kiss JZ, 2014, CURR OPIN NEUROL, V27, P133, DOI 10.1097/WCO.0000000000000068; KM A., 2017, THESIS U MASSACHUSET; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Lemola S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183519; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Lind A, 2011, PEDIATR RADIOL, V41, P953, DOI 10.1007/s00247-011-2071-x; Liu DW, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00356; Makropoulos A, 2016, NEUROIMAGE, V125, P456, DOI 10.1016/j.neuroimage.2015.10.047; Matthews LG, 2018, PEDIATR RES, V83, P976, DOI 10.1038/pr.2018.4; Ment LR, 2009, PEDIATRICS, V123, P503, DOI 10.1542/peds.2008-0025; Monson BB, 2016, JAMA PEDIATR, V170, P772, DOI 10.1001/jamapediatrics.2016.0781; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Moura LM, 2017, BRAIN IMAGING BEHAV, V11, P808, DOI 10.1007/s11682-016-9555-0; Norman M, 2019, JAMA-J AM MED ASSOC, V321, P1188, DOI 10.1001/jama.2019.2021; Northam GB, 2011, ANN NEUROL, V69, P702, DOI 10.1002/ana.22263; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; O'Brien LM, 2011, PSYCHIAT RES-NEUROIM, V193, P113, DOI 10.1016/j.pscychresns.2011.01.007; Padilla N, 2015, CEREB CORTEX, V25, P1897, DOI 10.1093/cercor/bht431; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Pernet C, 2009, HUM BRAIN MAPP, V30, P2278, DOI 10.1002/hbm.20670; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Phillips JP, 2011, PEDIATR NEUROL, V45, P215, DOI 10.1016/j.pediatrneurol.2011.06.001; Reiss AL, 2004, J PEDIATR-US, V145, P242, DOI 10.1016/j.jpeds.2004.04.031; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Schneider Juliane, 2019, Handb Clin Neurol, V162, P155, DOI 10.1016/B978-0-444-64029-1.00007-2; Serenius F, 2016, JAMA PEDIATR, V170, P954, DOI 10.1001/jamapediatrics.2016.1210; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Thompson DK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14334-9; Vandewouw MM, 2020, HUM BRAIN MAPP, V41, P892, DOI 10.1002/hbm.24847; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Walhovd KB, 2017, CEREB CORTEX, V27, P1472, DOI 10.1093/cercor/bhv301; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; Young JM, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101855	69	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259717	10.1371/journal.pone.0259717	http://dx.doi.org/10.1371/journal.pone.0259717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739529	gold, Green Published			2022-12-26	WOS:000755000800052
J	Hsieh, HY; Huang, LC; Yu, HR; Kuo, KC; Chen, WH; Su, CH; Lee, CP; Chen, KJ; Yang, YH; Sheen, JM				Hsieh, Hsin-Yi; Huang, Lin-Chi; Yu, Hong-Ren; Kuo, Kuang-Che; Chen, Wan-Hsuan; Su, Chung-Hao; Lee, Chuan-Pin; Chen, Ko-Jung; Yang, Yao-Hsu; Sheen, Jiunn-Ming			Pediatric thalassemic patients have higher incidence of asthma: A nationwide population-based retrospective cohort study	PLOS ONE			English	Article							CHILDHOOD ASTHMA; PULMONARY COMPLICATIONS; ATOPIC-DERMATITIS; SCREENING-PROGRAM; RISK-FACTOR; INFECTIONS; DISORDERS; INCREASE; CHILDREN	Introduction Patients with hemoglobinopathies have been reported to have higher rates of pulmonary complications. Few studies have investigated the association between thalassemia and asthma in children. Methods We used the data of one million individuals randomly selected from the Registry for Beneficiaries of the National Health Insurance Research Database. One thalassemic child was matched with four control children without thalassemia according to sex, birth year, birth season, prematurity, and previous enteroviral infection. Results A total of 800 hundred thalassemic children and 3200 controls were included. Children with thalassemia had higher rates of developing asthma (41.81 vs 25.70 per 1000 person-years, P < 0.001) than the non-thalassemia controls with an adjusted hazard ratio of 1.37 (95% confidence interval [CI] = 1.19-1.58). Boys in the thalassemia cohort had a significantly higher adjusted incidence hazard ratio (IRR) of asthma than those in the non-thalassemia cohort (adjusted IRR = 1.45, 95% CI = 1.02-1.73). The risk of atopic and nonatopic asthma was higher in the thalassemia cohort than in the non-thalassemia cohort (IRR = 1.3, 1.61, respectively). Conclusions Children with thalassemia were more likely to develop asthma. More attention should be paid to the early diagnosis of asthma and prevention of asthma attacks.	[Hsieh, Hsin-Yi; Yu, Hong-Ren; Kuo, Kuang-Che; Sheen, Jiunn-Ming] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Hsieh, Hsin-Yi; Yu, Hong-Ren; Kuo, Kuang-Che; Sheen, Jiunn-Ming] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Huang, Lin-Chi; Chen, Wan-Hsuan; Su, Chung-Hao; Sheen, Jiunn-Ming] Chiayi Chang Gung Mem Hosp, Dept Pediat, Chiayi, Taiwan; [Huang, Lin-Chi; Chen, Wan-Hsuan; Su, Chung-Hao; Yang, Yao-Hsu; Sheen, Jiunn-Ming] Chang Gung Univ, Coll Med, Chiayi, Taiwan; [Lee, Chuan-Pin; Chen, Ko-Jung; Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Sheen, JM (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.; Sheen, JM (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Sheen, JM (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Pediat, Chiayi, Taiwan.; Yang, YH; Sheen, JM (corresponding author), Chang Gung Univ, Coll Med, Chiayi, Taiwan.; Yang, YH (corresponding author), Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan.; Yang, YH (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan.	r95841012@ntu.edu.tw; ray.sheen@gmail.com						Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411; [Anonymous], 2012, CURR ADTHM PREV PERC; [Anonymous], GLOBAL INITIATIVE AS; Chern JPS, 2008, PEDIATR BLOOD CANCER, V50, P58, DOI 10.1002/pbc.21185; Chern JPS, 2006, PEDIATR BLOOD CANCER, V46, P72, DOI 10.1002/pbc.20343; Darabi B, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0367-9; Darveaux JI, 2014, J ALLER CL IMM-PRACT, V2, P658, DOI 10.1016/j.jaip.2014.09.011; Ferrante G, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00186; Heymann PW, 2004, J ALLERGY CLIN IMMUN, V114, P239, DOI 10.1016/j.jaci.2004.04.006; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Ko T. M., 1989, Journal of the Formosan Medical Association, V88, P678; KO T-M, 1988, Taiwan yixuehui zazhi, V87, P146; Ku MS, 2012, PEDIAT ALLERG IMM-UK, V23, P623, DOI 10.1111/j.1399-3038.2012.01345.x; Lee YL, 2007, PEDIAT ALLERG IMM-UK, V18, P188, DOI 10.1111/j.1399-3038.2006.00504.x; Lee ZM, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000005827, 10.1097/md.0000000000005827]; Lin CH, 2015, EUR J CLIN MICROBIOL, V34, P1773, DOI 10.1007/s10096-015-2411-0; Mehari A, 2016, CHEST, V149, P1313, DOI 10.1016/j.chest.2015.11.016; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Paaso EMS, 2013, AM J RESP CRIT CARE, V188, P624, DOI 10.1164/rccm.201212-2236LE; Palma-Carlos A G, 2005, Eur Ann Allergy Clin Immunol, V37, P177; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Peebles R. Stokes Jr., 2004, Journal of Allergy and Clinical Immunology, V113, pS15, DOI 10.1016/j.jaci.2003.10.033; Piatti G, 2006, ACTA HAEMATOL-BASEL, V116, P25, DOI 10.1159/000092344; Rachmilewitz EA, 2011, BLOOD, V118, P3479, DOI 10.1182/blood-2010-08-300335; Ramakrishnan K, 2010, LUNG INDIA, V27, P51, DOI 10.4103/0970-2113.63605; Shah R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02997; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Thomas AO, 2014, PEDIAT ALLERG IMM-UK, V25, P122, DOI 10.1111/pai.12147; Tsai TA, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.574014; Vij R, 2010, CHEST, V138, P973, DOI 10.1378/chest.10-0317; Wang LC, 2020, J FORMOS MED ASSOC, V119, P1854, DOI 10.1016/j.jfma.2020.02.014; Wang YC, 2018, PEDIATR INFECT DIS J, V37, P844, DOI [10.1097/INF.0000000000001918, 10.1097/inf.0000000000001918]; Woo A, 2021, J ALLERGY CLIN IMMUN, V147, P135, DOI 10.1016/j.jaci.2020.04.041; Yang JM, 2020, J ALLERGY CLIN IMMUN, V146, P790, DOI 10.1016/j.jaci.2020.08.008; Yung JA, 2018, ANN ALLERG ASTHMA IM, V120, P488, DOI 10.1016/j.anai.2018.01.016; Zhang J, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0583-9; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258727	10.1371/journal.pone.0258727	http://dx.doi.org/10.1371/journal.pone.0258727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735494	Green Published, gold			2022-12-26	WOS:000755077100029
J	Kim, BH; Kim, DI; Bae, KW; Park, UC				Kim, Bo Hee; Kim, Dong Ik; Bae, Ki Woong; Park, Un Chul			Influence of postoperative ectopic inner foveal layer on visual function after removal of idiopathic epiretinal membrane	PLOS ONE			English	Article							ANISEIKONIA; METAMORPHOPSIA; ASSOCIATIONS; PATHOGENESIS	Purpose To investigate the functional and anatomical parameters and their postoperative changes according to the ectopic inner foveal layer (EIFL) staging scheme for idiopathic epiretinal membrane (ERM). Methods In this prospective study, patients with idiopathic ERM underwent pars plana vitrectomy and ERM removal, and were followed-up for 6 months. The associations of EIFL with pre- and postoperative functional and anatomical parameters were analyzed. Results A total of 84 eyes (84 patients) were included: 39 (46.4%), 33 (39.3%), and 12 (14.3%) as EIFL stages 2, 3, and 4, respectively. At 6 months after surgery, the mean best-corrected visual acuity (BCVA) significantly improved in all EIFL stages (P <= 0.003); however, metamorphopsia improved only in eyes with EIFL stage 2 (P = 0.039) and 3 (P = 0.011). The aniseikonia and foveal avascular zone (FAZ) area showed no significant postoperative changes in any of the EIFL stages. Both preoperatively and during 6 months after surgery, the EIFL stage showed a significant correlation with BCVA (P <= 0.033), metamorphopsia (P <= 0.008), central macular thickness (P < 0.001), and FAZ parameters (P <= 0.016) at each time point, but not with aniseikonia. Significant correlations of EIFL thickness with BCVA (P = 0.028) and metamorphopsia (P = 0.006) before surgery were not persistent after surgery. Conclusion Both pre- and postoperatively, the staging of EIFL, rather than its thickness, is a simple and adequate surrogate marker for visual acuity and metamorphopsia in eyes with idiopathic ERM.	[Kim, Bo Hee; Kim, Dong Ik; Bae, Ki Woong; Park, Un Chul] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU)	Park, UC (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	ucpark@snu.ac.kr						Alkabes M, 2020, ACTA OPHTHALMOL, V98, P780, DOI 10.1111/aos.14336; Cho KH, 2016, AM J OPHTHALMOL, V168, P139, DOI 10.1016/j.ajo.2016.05.011; Chung H, 2015, INVEST OPHTH VIS SCI, V56, P6542, DOI 10.1167/iovs.15-16874; Colakoglu A, 2017, INT J OPHTHALMOL-CHI, V10, P1759, DOI 10.18240/ijo.2017.11.19; dell'Omo R, 2013, INVEST OPHTH VIS SCI, V54, P7803, DOI 10.1167/iovs.13-12817; Doguizi S, 2018, EYE, V32, P1652, DOI 10.1038/s41433-018-0153-9; Falkner-Radler CI, 2010, OPHTHALMOLOGY, V117, P798, DOI 10.1016/j.ophtha.2009.08.034; Gonzalez-Saldivar G., 2019, RETINA-J RET VIT DIS; Govetto A, 2019, RETINA-J RET VIT DIS, V39, P347, DOI 10.1097/IAE.0000000000001940; Govetto A, 2017, AM J OPHTHALMOL, V175, P99, DOI 10.1016/j.ajo.2016.12.006; Han J, 2016, RETINA-J RET VIT DIS, V36, P311, DOI 10.1097/IAE.0000000000000731; Ichikawa Y, 2018, EYE, V32, P400, DOI 10.1038/eye.2017.201; Ichikawa Y, 2017, RETINA-J RET VIT DIS, V37, P673, DOI 10.1097/IAE.0000000000001232; Joe SG, 2013, ACTA OPHTHALMOL, V91, pE242, DOI 10.1111/aos.12017; Khanna RK, 2021, GRAEF ARCH CLIN EXP, V259, P1723, DOI 10.1007/s00417-020-05064-1; Kim JH, 2013, GRAEF ARCH CLIN EXP, V251, P1055, DOI 10.1007/s00417-012-2120-7; Kiss CG, 2008, BRIT J OPHTHALMOL, V92, P84, DOI 10.1136/bjo.2007.124016; Krarup T, 2020, ACTA OPHTHALMOL, V98, P716, DOI 10.1111/aos.14449; Moon BG, 2020, RETINA-J RET VIT DIS, V40, P1160, DOI 10.1097/IAE.0000000000002530; Mori K, 2004, RETINA-J RET VIT DIS, V24, P57, DOI 10.1097/00006982-200402000-00009; Okamoto F, 2014, OPHTHALMOLOGY, V121, P2255, DOI 10.1016/j.ophtha.2014.05.016; Shiihara H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74190-x; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Suh MH, 2009, AM J OPHTHALMOL, V147, P473, DOI 10.1016/j.ajo.2008.09.020; Tanikawa A, 2018, JPN J OPHTHALMOL, V62, P280, DOI 10.1007/s10384-018-0581-x	25	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259388	10.1371/journal.pone.0259388	http://dx.doi.org/10.1371/journal.pone.0259388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735519	Green Published, gold			2022-12-26	WOS:000755077100070
J	Pickering, J; Attridge, N; Inglis, M				Pickering, Jayne; Attridge, Nina; Inglis, Matthew			Cognitive performance in pain is predicted by effort, not goal desire	PLOS ONE			English	Article							THRESHOLDS	Background Pain's disruptive effects on cognition are well documented. The seminal goal-pursuit account of pain suggests that cognitive disruption is less likely if participants are motivated to attended to a focal goal and not a pain goal. Objectives Existing theory is unclear about the conceptualisation and operationalisation of 'focal goal'. This study aims to clarify how goals should be conceptualised and further seeks to test the theory of the goal-pursuit account. Methods In a pre-registered laboratory experiment, 56 participants completed an arithmetic task in high-reward/low-reward and pain/control conditions. Pain was induced via cold-water immersion. Results High levels of reported effort exertion predicted cognitive-task performance, whereas desire for rewards did not. Post-hoc analyses further suggest that additional effort in the pain condition compensated for pain's disruptive effects, but when this extra effort was not exerted, performance deficits were observed in pain, compared to control, conditions. Conclusion Results suggest that 'motivation', or commitment to a focal goal, is best understood as effort exertion and not as a positive desire to achieve a goal. These results solidify existing theory and aid researchers in operationalising these constructs.	[Pickering, Jayne; Inglis, Matthew] Loughborough Univ, Ctr Math Cognit, Loughborough, Leics, England; [Attridge, Nina] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	Loughborough University; University of Portsmouth	Pickering, J (corresponding author), Loughborough Univ, Ctr Math Cognit, Loughborough, Leics, England.	j.pickering2@lboro.ac.uk		Attridge, Nina/0000-0001-9586-372X				Attridge N, 2017, J PAIN, V18, P29, DOI 10.1016/j.jpain.2016.09.007; Berryman C, 2014, CLIN PSYCHOL REV, V34, P563, DOI 10.1016/j.cpr.2014.08.003; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Bouaziz N, 2017, PSYCHIAT RES, V254, P275, DOI 10.1016/j.psychres.2017.04.045; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Cancela T, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000917; De Brauwer J, 2006, J EXP CHILD PSYCHOL, V94, P43, DOI 10.1016/j.jecp.2005.11.004; Department for Education, 2018, MULT TABL CHECK TRIA; Fields H., 2006, P 11 WORLD C PAIN SE, P449; Gneezy U, 2000, Q J ECON, V115, P791, DOI 10.1162/003355300554917; Jensen MP., 2018, PSYCHOL APPROACHES P, V3rd, P78; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Prescott SA, 2017, CONN'S TRANSLATIONAL NEUROSCIENCE, P517, DOI 10.1016/B978-0-12-802381-5.00037-3; Schrooten MGS, 2012, PAIN, V153, P1180, DOI 10.1016/j.pain.2012.01.025; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Verhoeven K, 2010, PAIN, V149, P229, DOI 10.1016/j.pain.2010.01.019; Wasner GL, 2008, CLIN NEUROPHYSIOL, V119, P2389, DOI 10.1016/j.clinph.2008.07.223; Wolf S, 1941, J CLIN INVEST, V20, P521, DOI 10.1172/JCI101245; ZIEGLER D, 1988, J NEUROL NEUROSUR PS, V51, P1420, DOI 10.1136/jnnp.51.11.1420	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258874	10.1371/journal.pone.0258874	http://dx.doi.org/10.1371/journal.pone.0258874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735492	gold, Green Published			2022-12-26	WOS:000755077100036
J	Kim, W; Chung, C				Kim, Woonhee; Chung, ChiHye			Brain-wide cellular mapping of acute stress-induced activation in male and female mice	FASEB JOURNAL			English	Article						c-Fos; depression; female; immobilization stress; sex specificity	MEDIAL PREFRONTAL CORTEX; GENDER-DIFFERENCES; SEX-DIFFERENCES; SYNAPTIC POTENTIATION; DEPRESSION; PREVALENCE; ADOLESCENT; REUNIENS; HABENULA; MODEL	Mood disorders are more prevalent and often reported to be more severe in women; however, little is known about the underlying mechanisms of this sexual prevalence. To gain insight into the functional differences in female brains in response to stress, we systemically compared brain activation in male and female C57BL/6N mice after acute stress exposure. We measured c-Fos expression levels in 18 brain areas related to stress responses after a 3-h long restraint stress and found that activation was sexually dimorphic in several brain areas, including the nucleus accumbens, ventral tegmental area, nucleus reuniens, and medial part of the lateral habenula. Moreover, stress-activated a substantial number of cells in the medial prefrontal cortex, amygdala, and lateral part of the lateral habenula; however, the levels of activation were comparable in males and females, suggesting that the core stress responding machineries are largely shared. Pearson correlation analysis revealed several interesting connections between the analyzed areas that are implicated in stress responses and depression. Overall, stress strengthened intra-circuitries in the hippocampus, amygdala, and prefrontal cortex in female mice, whereas more longer-range connections were highlighted in stressed male mice. Our study provides a highly valuable neuroanatomical framework for investigating the circuit mechanism underlying the higher vulnerability to depression in women.	[Kim, Woonhee; Chung, ChiHye] Konkuk Univ, Dept Biol Sci, 120 Neungdong Ro, Seoul 05029, South Korea	Konkuk University	Chung, C (corresponding author), Konkuk Univ, Dept Biol Sci, 120 Neungdong Ro, Seoul 05029, South Korea.	cchung@konkuk.ac.kr		Chung, ChiHye/0000-0002-3104-2399	National Research Foundation of Korea [NRF--2019M3C7A1031742, NRF-2020R1A2C2005868]	National Research Foundation of Korea(National Research Foundation of Korea)	National Research Foundation of Korea, Grant/Award Number: NRF--2019M3C7A1031742 and NRF-2020R1A2C2005868	Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Bambico FR, 2019, PSYCHOPHARMACOLOGY, V236, P1917, DOI 10.1007/s00213-019-5177-8; Bebbington PE, 1998, PSYCHOL MED, V28, P9, DOI 10.1017/S0033291797006077; Blume SR, 2017, J NEUROSCI, V37, P10567, DOI 10.1523/JNEUROSCI.0758-17.2017; Boku S, 2018, PSYCHIAT CLIN NEUROS, V72, P3, DOI 10.1111/pcn.12604; Brancato A, 2017, NEUROSCIENCE, V350, P180, DOI 10.1016/j.neuroscience.2017.03.014; Cassel JC, 2013, PROG NEUROBIOL, V111, P34, DOI 10.1016/j.pneurobio.2013.08.006; Caviedes A, 2017, CURR PHARM DESIGN, V23, P3154, DOI 10.2174/1381612823666170111141915; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Di S, 2016, J NEUROSCI, V36, P8461, DOI 10.1523/JNEUROSCI.2279-15.2016; Distler U, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020313; Goodwill HL, 2019, NEUROPSYCHOPHARMACOL, V44, P711, DOI 10.1038/s41386-018-0195-5; Harro Jaanus, 2013, Curr Top Behav Neurosci, V14, P29, DOI 10.1007/7854_2012_221; Hetzel A, 2014, NEUROPSYCHOPHARMACOL, V39, P2114, DOI 10.1038/npp.2014.60; Hodes GE, 2015, J NEUROSCI, V35, P16362, DOI 10.1523/JNEUROSCI.1392-15.2015; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; Markham JA, 2005, HIPPOCAMPUS, V15, P97, DOI 10.1002/hipo.20034; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Nasca C, 2015, P NATL ACAD SCI USA, V112, P14960, DOI 10.1073/pnas.1516016112; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Park H, 2017, CELL REP, V20, P289, DOI 10.1016/j.celrep.2017.06.049; Park H, 2017, J NEUROSCI, V37, P6021, DOI 10.1523/JNEUROSCI.2281-16.2017; Patten SB, 2016, SOC PSYCH PSYCH EPID, V51, P203, DOI 10.1007/s00127-015-1166-3; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Salk RH, 2017, PSYCHOL BULL, V143, P783, DOI 10.1037/bul0000102; Seo JS, 2018, MOL PSYCHIATR, V23, P1113, DOI 10.1038/mp.2017.96; Sood A, 2018, STRESS, V21, P136, DOI 10.1080/10253890.2017.1422488; Staiti AM, 2011, NEUROPHARMACOLOGY, V61, P544, DOI 10.1016/j.neuropharm.2011.04.005; Thompson SM, 2015, TRENDS NEUROSCI, V38, P279, DOI 10.1016/j.tins.2015.03.003; Viena TD, 2018, HIPPOCAMPUS, V28, P297, DOI 10.1002/hipo.22831; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Wellman CL, 2020, INT REV NEUROBIOL, V150, P129, DOI 10.1016/bs.irn.2019.11.007; Wissman AM, 2012, BRAIN STRUCT FUNCT, V217, P181, DOI 10.1007/s00429-011-0353-6; Zhong J, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0066-x; Zimmerman EC, 2016, J NEUROSCI, V36, P8977, DOI 10.1523/JNEUROSCI.1402-16.2016	37	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22041	10.1096/fj.202101287R	http://dx.doi.org/10.1096/fj.202101287R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34780680				2022-12-26	WOS:000722321300049
J	Yi, YY; Zhu, H; Klausen, C; Leung, PCK				Yi, Yuyin; Zhu, Hua; Klausen, Christian; Leung, Peter C. K.			Transcription factor SOX4 facilitates BMP2-regulated gene expression during invasive trophoblast differentiation	FASEB JOURNAL			English	Article						BMP2; SOX4; transcription factor; trophoblast invasion	EPITHELIAL-MESENCHYMAL TRANSITION; NEURITE-PROMOTING FACTOR; EXTRAVILLOUS TROPHOBLAST; MICE LACKING; TGF-BETA; CELLS; TUMORIGENESIS; INHIBITOR; DEFECTS; TARGETS	The interplay between growth factors, signaling pathways and transcription factors during placental development is key to controlling trophoblast differentiation. Bone morphogenetic protein 2 (BMP2) has been implicated in trophoblast invasion and spiral artery remodeling during early placental development. However, the molecular mechanisms by which these are accomplished have not been fully elucidated, particularly for transcriptional regulation of key transcription factors. Here, we identified SOX4 as a direct target gene induced by BMP2 in first-trimester placental trophoblasts. Analysis of single-cell RNA-seq data from first-trimester placentas and decidua tissues revealed that SOX4 expression is mainly localized in extravillous trophoblast and decidual stromal cells. Moreover, gain- and loss-of-function approaches demonstrated that SOX4 exerts a pro-invasive role in human trophoblasts, and this effect contributes to BMP2-enhanced trophoblast invasion. Importantly, we found that SOX4 was required for BMP2-induced regulation of a subset of genes associated with cell migration and extracellular matrix organization. We also show that SOX4-dependent regulation of the BMP2 target SERPINE2 occurs via binding of SOX4 to regulatory elements such as enhancers, thereby promoting BMP2-induced trophoblast invasion. In conclusion, these findings uncover a novel mechanism involving SOX4 that shapes the BMP2-regulated transcriptional network during invasive trophoblast development.	[Yi, Yuyin; Zhu, Hua; Klausen, Christian; Leung, Peter C. K.] Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada	University of British Columbia	Leung, PCK (corresponding author), Univ British Columbia, BC Childrens Hosp Res Inst, Dept Obstet & Gynaecol, Room 317,950 West 28th Ave, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca		Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research Foundation Grant [143317]; BC Children's Hospital Research Institute studentship	Canadian Institutes of Health Research Foundation Grant(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Research Institute studentship	This study was supported by a Canadian Institutes of Health Research Foundation Grant to P.C.K.L. (#143317). Y.Y. was supported by a BC Children's Hospital Research Institute studentship	Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bilir B, 2016, CANCER RES, V76, P1112, DOI 10.1158/0008-5472.CAN-15-1868; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CARMELIET P, 1993, J CLIN INVEST, V92, P2746, DOI 10.1172/JCI116892; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Chern SR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-106; DaSilva-Arnold S, 2015, PLACENTA, V36, P1412, DOI 10.1016/j.placenta.2015.10.013; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; Davies JE, 2016, CELL ADHES MIGR, V10, P310, DOI 10.1080/19336918.2016.1170258; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GLOOR S, 1986, CELL, V47, P687; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hanieh H, 2020, SEMIN CANCER BIOL, V67, P91, DOI 10.1016/j.semcancer.2019.06.022; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jafarnejad SM, 2013, CELL MOL LIFE SCI, V70, P2677, DOI 10.1007/s00018-012-1187-y; Jiao CJ, 2016, ONCOL REP, V36, P2960, DOI 10.3892/or.2016.5121; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Lai YH, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-50; Latos PA, 2016, DEVELOPMENT, V143, P3650, DOI 10.1242/dev.133462; Liu C, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110485; Lourenco AR, 2017, TRENDS CANCER, V3, P571, DOI 10.1016/j.trecan.2017.06.002; Moreno CS, 2020, SEMIN CANCER BIOL, V67, P57, DOI 10.1016/j.semcancer.2019.08.027; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; STONE SR, 1987, ARCH BIOCHEM BIOPHYS, V252, P237, DOI 10.1016/0003-9861(87)90028-2; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Vervoort SJ, 2018, ELIFE, V7, DOI 10.7554/eLife.27706; Vervoort SJ, 2018, NUCLEIC ACIDS RES, V46, P9578, DOI 10.1093/nar/gky755; Vicovac L, 1996, ACTA ANAT, V156, P202; WHITE EA, 1993, THROMB HAEMOSTASIS, V69, P119; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Yang F, 2018, CELL DEATH DIFFER, V25, P2209, DOI 10.1038/s41418-018-0123-6; You JL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.607332; Zhao HJ, 2020, CELL SIGNAL, V67, DOI 10.1016/j.cellsig.2019.109489; Zhao HJ, 2020, FASEB J, V34, P3151, DOI 10.1096/fj.201902168RR; Zhao HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0230-1	44	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22028	10.1096/fj.202100925RR	http://dx.doi.org/10.1096/fj.202100925RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34739154				2022-12-26	WOS:000722321300015
J	da Silva, TL; Pazin, A; Romano, MMD; Ferriani, VPL; Marin-Neto, JA; Maciel, BC; Schmidt, A				da Silva, Telemaco Luis, Jr.; Pazin-Filho, Antonio; Romano, Minna M. D.; Ferriani, Virginia P. L.; Marin-Neto, Jose A.; Maciel, Benedito C.; Schmidt, Andre			Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction	PLOS ONE			English	Article							HEART-DISEASE; JONES CRITERIA; ECHOCARDIOGRAPHY; DIAGNOSIS; PREVALENCE; STATEMENT; CARDITIS; VALVITIS; CHILDREN; RISK	Background Rheumatic heart disease (RHD) complicating acute rheumatic fever (ARF) remains an important health problem in developing countries. No definitive diagnostic test for ARF exists and the role of Doppler echocardiography (DEC) for long-term prognostic evaluation following ARF is not well established. Objective To investigate the prognostic value of DEC in patients with ARF as a predictor of chronic valve dysfunction. Methods Prospectively enrolled patients with clinical ARF had a DEC performed soon after diagnosis and repeated at 1, 3, 6 and 12 months and thereafter at every 1-2 years. We defined chronic valve dysfunction by >= 3 of the following: increased valve thickening, commissure fusion, subvalvular thickening, reduced leaflet mobility, non-trivial mitral and/or aortic regurgitation. We performed univariate analysis and developed multivariate logistic regression models to identify variables that may influence evolution to RHD. p<0.05 was considered significant. Results We evaluated 70(57% men) patients, 10.85.6 years-old during the ARF episode and followed for 95 +/- 26 months. Chronic valve dysfunction was identified in 36(51.4%) which fulfilled criteria for RHD and 10(27.8%) of them died or underwent valve surgery. Univariate analysis showed that mitral valve thickening and presence of mitral regurgitation at baseline DEC, were associated with RHD(p<0.01). Multivariate logistic regression showed that only mitral valve thickness either as a continuous (Odds-Ratio:5.8;95%CI:1.7-19.7) or as a categorical variable (Odds-Ratio:4.04;95%CI:1.06-15.3) was an independent predictor of chronic valve dysfunction. Conclusions Mitral leaflets thickening documented at the time of diagnosis of ARF is a consistent prognostic marker for the subsequent evolution to RHD.	[da Silva, Telemaco Luis, Jr.; Pazin-Filho, Antonio; Romano, Minna M. D.; Marin-Neto, Jose A.; Maciel, Benedito C.; Schmidt, Andre] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Sao Paulo, Brazil; [Ferriani, Virginia P. L.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pediat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Schmidt, A (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Internal Med, Sao Paulo, Brazil.	aschmidt@fmrp.usp.br	Schmidt, André/G-1569-2011; Pazin Filho, Antonio/E-9495-2010; Romano, Minna Moreira Dias/K-1820-2013	Schmidt, André/0000-0002-1090-8165; Pazin Filho, Antonio/0000-0001-5242-329X; Romano, Minna Moreira Dias/0000-0002-2526-0656; Romano, Minna/0000-0002-8742-3764; Paes Leme Ferriani, Virginia/0000-0002-9555-9389				Agarwal P K, 1998, J Assoc Physicians India, V46, P937; Atalay S, 2019, CARDIOL YOUNG, V29, P1272, DOI 10.1017/S1047951119002075; Barbosa MM, 2016, HEART, V102, P3, DOI 10.1136/heartjnl-2015-308802; Beaton A, 2017, CIRCULATION, V136, P2233, DOI 10.1161/CIRCULATIONAHA.117.029936; Beaton A, 2012, CIRCULATION, V125, P3127, DOI 10.1161/CIRCULATIONAHA.112.092312; Caldas AM, 2008, PEDIATR CARDIOL, V29, P1048, DOI 10.1007/s00246-008-9242-z; Choudhary D, 2021, ECHOCARDIOGR-J CARD, V38, P1173, DOI 10.1111/echo.15035; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Gewitz MH, 2015, CIRCULATION, V131, P1806, DOI 10.1161/CIR.0000000000000205; Gomes NFA, 2021, ARQ BRAS CARDIOL, V116, P404, DOI 10.36660/abc.20200154; Hawkins K, 2008, ECHOCARDIOGR-J CARD, V25, P119, DOI 10.1111/j.1540-8175.2007.00575.x; Jones TD, 1944, J AMER MED ASSOC, V126, P481, DOI 10.1001/jama.1944.02850430015005; Karthikeyan G, 2018, LANCET, V392, P161, DOI 10.1016/S0140-6736(18)30999-1; Lanna CCD, 2003, CARDIOL YOUNG, V13, P431, DOI 10.1017/S104795110300091X; Lin BA, 2010, J AM SOC ECHOCARDIOG, V23, P993, DOI 10.1016/j.echo.2010.06.011; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; McMillan DJ, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.674805; Mirabel M, 2015, INT J CARDIOL, V188, P89, DOI 10.1016/j.ijcard.2015.04.007; Nascimento BR, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008039; Nunes MCP, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.118.007928; Ozkutlu S, 2001, CARDIOL YOUNG, V11, P255, DOI 10.1017/S1047951101000269; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; Remenyi B, 2012, NAT REV CARDIOL, V9, P297, DOI 10.1038/nrcardio.2012.7; Remond M, 2015, INT J CARDIOL, V198, P117, DOI 10.1016/j.ijcard.2015.07.005; SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X; Saxena A, 2011, HEART, V97, P2018, DOI 10.1136/heartjnl-2011-300792; Schmidt A, 2001, J AM SOC ECHOCARDIOG, V14, P569, DOI 10.1067/mje.2001.113545; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Watkins DA, 2017, NEW ENGL J MED, V377, P713, DOI 10.1056/NEJMoa1603693; WEISSMAN NJ, 1994, AM J CARDIOL, V73, P1080, DOI 10.1016/0002-9149(94)90287-9	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259737	10.1371/journal.pone.0259737	http://dx.doi.org/10.1371/journal.pone.0259737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788321	Green Published, gold			2022-12-26	WOS:000735920500038
J	Plasonja, N; Brytek-Matera, A; Decamps, G				Plasonja, Natalija; Brytek-Matera, Anna; Decamps, Greg			YFrench validation of the Weight Efficacy Life-Style questionnaire (WEL): Links with mood, self-esteem and stress among the general population and a clinical sample of individuals with overweight and obesity	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BEHAVIOR-CHANGE; FAST-FOOD; WOMEN; DEPRESSION; MANAGEMENT; PREDICTOR; SCALE; CONSTRUCTION; EXERCISE	Eating self-efficacy refers to a person's belief in their ability to regulate eating. Although the Weight Efficacy Life-Style questionnaire (WEL) is one of the most widely used eating self-efficacy tools, its French validation is lacking. The objective of this research was to validate a French version of the WEL in a general and a clinical sample, and to explore the links between eating self-efficacy and psychosocial variables. In study 1, the general population sample included 432 adults (93% of women, mean age = 43.18 +/- 11.93 years). In study 2, the clinical sample included 2010 adults with overweight and obesity (87% of women, mean age = 44.44 +/- 11.25 years). Exploratory and confirmatory factor analyses were performed. Two distinct versions of the WEL were retained: a 12-item questionnaire intended for use in the general population, named WEL-Fr-G, and an 11-item questionnaire for clinical samples, named WEL-Fr-C. The two French versions of the WEL presented strong reliability and sensibility. In addition, study 2 provided support for the measurement invariance of the WEL-Fr-C across sex and Body Mass Index. The two versions are therefore psychometrically sound instruments for assessing eating self-efficacy in the general population (WEL-Fr-G) and clinical samples (WEL-Fr-C).	[Plasonja, Natalija; Decamps, Greg] Univ Bordeaux, LabPsy, Bordeaux, France; [Brytek-Matera, Anna] Univ Wroclaw, Inst Psychol, Wroclaw, Poland	UDICE-French Research Universities; Universite de Bordeaux; University of Wroclaw	Plasonja, N (corresponding author), Univ Bordeaux, LabPsy, Bordeaux, France.	natalija.plasonja@u-bordeaux.fr	Plasonja, Natalija/ABA-1059-2021	Plasonja, Natalija/0000-0002-5753-675X	PiLeJe Laboratoire [2019/0009]; Excellence Initiative -Research University"program of the University of Wroclaw	PiLeJe Laboratoire; Excellence Initiative -Research University"program of the University of Wroclaw	Our study was co-funded by PiLeJe Laboratoire, within the framework of the CIFRE convention, grant number 2019/0009, and the,Excellence Initiative -Research University"program for years 2020-2026 of the University of Wroclaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames GE, 2015, EAT BEHAV, V18, P115, DOI 10.1016/j.eatbeh.2015.05.003; Ames GE, 2012, EAT BEHAV, V13, P375, DOI 10.1016/j.eatbeh.2012.03.013; Annesi JJ, 2020, J PRIM PREV, V41, P105, DOI 10.1007/s10935-020-00580-6; Annesi JJ, 2017, J NUTR EDUC BEHAV, V49, P505, DOI 10.1016/j.jneb.2017.03.004; Arata A., 2008, QUAD ITAL PSICH, V27, P83; Armitage CJ, 2014, PATIENT EDUC COUNS, V95, P254, DOI 10.1016/j.pec.2014.01.015; Bacaro V, 2020, OBES RES CLIN PRACT, V14, P301, DOI 10.1016/j.orcp.2020.03.004; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 1977, COGNITIVE THER RES, V1, P177, DOI [10.1007/BF01186792, DOI 10.1007/BF01186792]; Bas M, 2009, APPETITE, V52, P209, DOI 10.1016/j.appet.2008.09.017; Batsis JA, 2009, APPETITE, V52, P637, DOI 10.1016/j.appet.2009.02.017; Berman Erica S, 2006, Eat Behav, V7, P79, DOI 10.1016/j.eatbeh.2005.07.004; Bratman S., 1997, YOGA J, P42; Byrne S, 2012, APPETITE, V58, P695, DOI 10.1016/j.appet.2012.01.005; Cargill BR, 1999, OBES RES, V7, P379, DOI 10.1002/j.1550-8528.1999.tb00421.x; Cattelino E, 2019, J APPL DEV PSYCHOL, V60, P127, DOI 10.1016/j.appdev.2018.09.007; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Chang L, 2015, CURR PROB PEDIATR AD, V45, P134, DOI 10.1016/j.cppeds.2015.03.003; Chang MW, 2020, APPETITE, V151, DOI 10.1016/j.appet.2020.104700; Chang MW, 2019, APPETITE, V140, P248, DOI 10.1016/j.appet.2019.05.031; Chang MW, 2003, J NUTR EDUC BEHAV, V35, P302, DOI 10.1016/S1499-4046(06)60344-8; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Churchill S, 2014, APPETITE, V80, P131, DOI 10.1016/j.appet.2014.05.008; Clark M M, 2000, Eat Behav, V1, P47, DOI 10.1016/S1471-0153(00)00009-X; CLARK MM, 1991, J CONSULT CLIN PSYCH, V59, P739, DOI 10.1037/0022-006X.59.5.739; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; CONDIOTTE MM, 1981, J CONSULT CLIN PSYCH, V49, P648, DOI 10.1037/0022-006X.49.5.648; Cuadrado E, 2018, APPETITE, V120, P6, DOI 10.1016/j.appet.2017.08.015; DeVellis RF, 2017, SCALE DEV THEORY APP, V4th ed; Dorling JL, 2019, APPETITE, V143, DOI 10.1016/j.appet.2019.104397; Ebel R.L., 1972, ESSENTIALS ED MEASUR, V2nd, P232; Eck K., 2019, J ACAD NUTR DIET, V119, P28; Fabrega-Cuadros R, 2020, MATURITAS, V142, P1, DOI 10.1016/j.maturitas.2020.06.019; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Flolo TN., 2014, PEERJ, P2; Flolo TN, 2019, SURG OBES RELAT DIS, V15, P161, DOI 10.1016/j.soard.2018.12.011; Fontes AD, 2020, BRAZ J PHYS THER, V24, P161, DOI 10.1016/j.bjpt.2019.02.009; FOREYT JP, 1995, INT J EAT DISORDER, V17, P263, DOI 10.1002/1098-108X(199504)17:3&lt;263::AID-EAT2260170307&gt;3.0.CO;2-N; Formica V., 2020, ENDOCRINE METABOLIC; FRIEDMAN MA, 1995, PSYCHOL BULL, V117, P3, DOI 10.1037/0033-2909.117.1.3; Fueyo-Diaz R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00342; Gana K., 2018, INTRO MODELISATION E; GLYNN SM, 1986, COGNITIVE THER RES, V10, P403, DOI 10.1007/BF01173294; Goodarzi MO, 2018, LANCET DIABETES ENDO, V6, P223, DOI 10.1016/S2213-8587(17)30200-0; Han J., 2020, EVIDENCE PUBLIC HOUS, DOI [10.1016/j.regsciurbeco.2020.103565, DOI 10.1016/J.REGSCIURBECO.2020.103565]; Hankins M, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-19; Harvinder Kaur G. S., 2018, Malaysian Journal of Nutrition, V24, P427; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Holley S, 2017, PEDIATR PULM, V52, P430, DOI 10.1002/ppul.23556; Huang SH, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114999; Ijaz K, 2020, INT J HUM-COMPUT INT, V36, P1195, DOI 10.1080/10447318.2020.1726107; Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004; Jakicic JM, 2005, AM J CLIN NUTR, V82, p226S, DOI 10.1093/ajcn/82.1.226S; JEFFERY RW, 1984, PREV MED, V13, P155, DOI 10.1016/0091-7435(84)90048-3; Jorgensen TD, 2015, **DATA OBJECT**; Kadden RM, 2011, ADDICT BEHAV, V36, P1120, DOI 10.1016/j.addbeh.2011.07.032; Karl JP, 2014, APPETITE, V80, P204, DOI 10.1016/j.appet.2014.05.017; Kawaguchi K, 2020, INT J CLIN ONCOL, V25, P2122, DOI 10.1007/s10147-020-01765-z; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kotecki J., 2019, J ACAD NUTR DIET, V119, P74; Kulik NL, 2019, HEALTH EDUC BEHAV, V46, P602, DOI 10.1177/1090198119826298; Latimer L, 2011, J NUTR EDUC BEHAV, V43, P279, DOI 10.1016/j.jneb.2010.09.007; Linde JA, 2006, HEALTH PSYCHOL, V25, P282, DOI 10.1037/0278-6133.25.3.282; Lombardo C, 2021, EAT WEIGHT DISORD-ST, V26, P295, DOI 10.1007/s40519-020-00854-2; Martin PD, 2004, OBES RES, V12, P646, DOI 10.1038/oby.2004.74; Mason KE, 2018, LANCET PUBLIC HEALTH, V3, pE24, DOI 10.1016/S2468-2667(17)30212-8; McCafferty BJ, 2020, TECH VASC INTERV RAD, V23, DOI 10.1016/j.tvir.2020.100653; McCarroll ML, 2014, GYNECOL ONCOL, V132, P397, DOI 10.1016/j.ygyno.2013.12.023; Menendez-Gonzalez L, 2018, ENFERM CLIN, V28, P154, DOI 10.1016/j.enfcli.2018.02.005; Morin P, 2013, APPETITE, V65, P43, DOI 10.1016/j.appet.2013.01.012; Nansel TR, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-125; Newton S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177151; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Pedersen S, 2018, SOC SCI MED, V208, P18, DOI 10.1016/j.socscimed.2018.05.016; Perri M. G., 2002, Handbook of obesity treatment, P357; Persky S, 2020, APPETITE, V155, DOI 10.1016/j.appet.2020.104824; Pinto BM, 1999, OBES RES, V7, P288, DOI 10.1002/j.1550-8528.1999.tb00408.x; Polsky JY, 2016, PREV MED, V82, P28, DOI 10.1016/j.ypmed.2015.11.008; Presnell Katherine, 2008, Eat Behav, V9, P170, DOI 10.1016/j.eatbeh.2007.07.005; Prochaska JO., 2008, TRANSTHEORETICAL MOD, V37, P99; Richert J, 2010, APPETITE, V54, P611, DOI 10.1016/j.appet.2010.03.006; Rish JM., 2015, CLIN GUIDE TREATMENT, P43; Robinson E, 2020, NEUROSCI BIOBEHAV R, V119, P468, DOI 10.1016/j.neubiorev.2020.10.009; Romieu I, 2017, CANCER CAUSE CONTROL, V28, P247, DOI 10.1007/s10552-017-0869-z; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Sajjad A, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118674; Scoffier S, 2010, SCAND J MED SCI SPOR, V20, P696, DOI 10.1111/j.1600-0838.2009.00984.x; Shin H, 2011, NUTR RES, V31, P822, DOI 10.1016/j.nutres.2011.09.022; Steinbeck KS, 2018, NAT REV ENDOCRINOL, V14, P331, DOI 10.1038/s41574-018-0002-8; Verdot C., 2017, B EPID MIOL HEBDOMAD, V13, P234; Wadden T. A., 2002, Handbook of obesity treatment, P229; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wilson KE, 2016, PSYCHOL ASSESSMENT, V28, P1255, DOI 10.1037/pas0000249; Wilson-Barlow L, 2014, EAT BEHAV, V15, P490, DOI 10.1016/j.eatbeh.2014.06.004; Wingo BC, 2013, J NUTR EDUC BEHAV, V45, P314, DOI 10.1016/j.jneb.2012.12.004; World Health Organization, PROC TRANSL AD INSTR; World Health Organization. Regional Office for Europe, 1998, WELLB MEAS PRIM HLTH; Yu Y, 2019, SURG OBES RELAT DIS, V15, P995, DOI 10.1016/j.soard.2019.02.009; Zhao HY, 2018, DIABETES RES CLIN PR, V143, P113, DOI 10.1016/j.diabres.2018.07.011	101	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259885	10.1371/journal.pone.0259885	http://dx.doi.org/10.1371/journal.pone.0259885			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784370	Green Published, gold			2022-12-26	WOS:000755277300026
J	Schommer, SK; Harrison, N; Linville, M; Samuel, MS; Hammond, SL; Wells, KD; Prather, RS				Schommer, Susan K.; Harrison, Nicholas; Linville, Michael; Samuel, Melissa S.; Hammond, Sabrina L.; Wells, Kevin D.; Prather, Randall S.			Serologic titers to Leptospira in vaccinated pigs and interpretation for surveillance	PLOS ONE			English	Article							DIAGNOSIS; SWINE; SEROVARS; BRATISLAVA; GILTS; PCR	Diagnosis and surveillance of pathogenic Leptospira is difficult as organisms may be intermittently shed and in small numbers. Therefore, serologic testing by the microscopic agglutination test (MAT) is the primary screening method for leptospirosis. While a MAT titer >= 1:100 is considered to be a positive result, interpretation is complicated by the use of commercial vaccines in pigs. Most guidelines for interpretation of MAT titers in pigs were published in the 1970's and 1980's, prior to the development of the current multivalent vaccines. We evaluated MAT titers in routinely vaccinated healthy research pigs compared to their unvaccinated cohorts. Our study confirmed previous reports that the Pomona serovar elicits minimal antibody response even after a second booster 6 months after initial vaccination. However, MAT titers of >= 1:3,200 were detected as early as 4 weeks post initial vaccination for serovars Bratislava and Icterohaemorrhagiae and remained as high as >= 1:1,600 prior to booster at 24 weeks post vaccination. Our study determined that high levels of MAT titers can occur from vaccination alone and high titers are not necessarily indicative of infection. Therefore, the interpretation of MAT titers as indicators of Leptospira infection should be readdressed.	[Schommer, Susan K.; Samuel, Melissa S.; Hammond, Sabrina L.; Wells, Kevin D.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Natl Swine Resource & Res Ctr, Columbia, MO 65211 USA; [Harrison, Nicholas; Linville, Michael] Univ Missouri, Off Anim Resources, Columbia, MO USA; [Harrison, Nicholas] Lab Anim Med, Ashland, OH USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Schommer, SK (corresponding author), Univ Missouri, Div Anim Sci, Natl Swine Resource & Res Ctr, Columbia, MO 65211 USA.	SchommerS@UMSystem.edu		Schommer, Susan/0000-0002-9553-9353	National Institute of Allergy and Infectious Disease; National Institute of Heart, Lung and Blood; Office of the Director [U42OD011140]	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	SKS, KDW, RSP received Funding for the National Swine Resource and Research Center is from the National Institute of Allergy and Infectious Disease, the National Institute of Heart, Lung and Blood, and the Office of the Director (U42OD011140) https://www.niaid.nih.gov/https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-heart-lung-blood-institute-nhlbi The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035; Arent Z.J., 2019, DIS SWINE, P854; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Blanchard S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03006-20; Bolin C, 2000, EMERGING DISEASES OF ANIMALS, P185; Bolin C A, 1991, J Vet Diagn Invest, V3, P152; BOLIN CA, 1992, J VET DIAGN INVEST, V4, P87, DOI 10.1177/104063879200400121; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Cole J R Jr, 1979, Proc Annu Meet U S Anim Health Assoc, P189; ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6; Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6; FRANTZ JC, 1989, AM J VET RES, V50, P1044; Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x; HANSON LE, 1972, J AM VET MED ASSOC, V161, P1235; Jacobs AAC, 2015, VACCINE, V33, P3963, DOI 10.1016/j.vaccine.2015.06.048; Killoran K., 2016, PORCINE CYTOMEGALOVI; Miller MD, 2011, J VET INTERN MED, V25, P426, DOI 10.1111/j.1939-1676.2011.0704.x; O'Keefe JS, 2002, NEW ZEAL VET J, V50, P9, DOI 10.1080/00480169.2002.36242; OIE, 2021, MANUAL DIAGNOSTIC TE, DOI [10.3390/ani11061782, DOI 10.3390/ANI11061782]; Pedersen K, 2015, EPIDEMIOL INFECT, V143, P2131, DOI 10.1017/S0950268814003148; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Rocha BR, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20170088; SANFORD SE, 1990, CAN VET J, V31, P277; Sooryanarain H, 2020, EMERG INFECT DIS, V26, P354, DOI 10.3201/eid2602.191348; Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17; WHYTE PBD, 1982, AUST VET J, V59, P41, DOI 10.1111/j.1751-0813.1982.tb02713.x; YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260052	10.1371/journal.pone.0260052	http://dx.doi.org/10.1371/journal.pone.0260052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784395	Green Published, gold			2022-12-26	WOS:000755277300040
J	Liu, XQ; Shao, XR; Liu, Y; Dong, ZX; Chan, SH; Shi, YY; Chen, SN; Qi, L; Zhong, L; Yu, Y; Lv, T; Yang, PF; Li, LY; Wang, XB; Zhang, XD; Li, X; Zhao, WX; Sehgal, L; Li, M; Zhang, XD				Liu, Xue-Qi; Shao, Xin-Rong; Liu, Ye; Dong, Zhao-Xia; Chan, Sze-Hoi; Shi, Yuan-Yuan; Chen, Shu-Na; Qi, Lin; Zhong, Li; Yu, Yue; Lv, Ting; Yang, Peng-Fei; Li, Li-Yan; Wang, Xiao-Bin; Zhang, Xu-Dong; Li, Xin; Zhao, Wenxue; Sehgal, Lalit; Li, Miao; Zhang, Xing-Ding			Tight junction protein 1 promotes vasculature remodeling via regulating USP2/TWIST1 in bladder cancer	ONCOGENE			English	Article							TUMOR ANGIOGENESIS; MESENCHYMAL TRANSITION; VASCULOGENIC MIMICRY; BREAST-CANCER; GROWTH; MACROPHAGES; METASTASIS; TWIST1; PHOSPHORYLATION; MODEL	Bladder cancer (BLCA) is the most common malignant tumor of the urinary system and is characterized by high metastatic rates and poor prognosis. The expression of tight junction protein 1 (TJP1) is associated with bladder cancer invasion; however, the mechanism by which TJP1 affects vasculature remodeling remains unknown. In this study, we found that TJP1 expression correlated with tumor angiogenesis and poor overall survival in clinical samples. Furthermore, TJP1 overexpression promoted tumor angiogenesis in BLCA cells and stimulated recruitment of macrophages to tumors by upregulating CCL2 expression. Mechanistically, TJP1 interacted with TWIST1 and enhanced the transcriptional activity of CCL2. The impairment of tumor angiogenesis caused by knockdown of TJP1 was dramatically rescued by overexpression of TWIST1. Furthermore, TJP1 recruited USP2, which deubiquitinated TWIST1, thereby protecting TWIST1 from proteasome-mediated protein degradation. In conclusion, our results suggest that TJP1 controls angiogenesis in BLCA via TWIST1-dependent regulation of CCL2. We demonstrate that TJP1 functions as a scaffold for the interaction between USP2 and TWIST1 and this may provide potential therapeutic targets in bladder cancer.	[Liu, Xue-Qi; Shao, Xin-Rong; Dong, Zhao-Xia; Chan, Sze-Hoi; Shi, Yuan-Yuan; Chen, Shu-Na; Qi, Lin; Yu, Yue; Li, Li-Yan; Zhang, Xu-Dong; Li, Xin; Zhao, Wenxue; Zhang, Xing-Ding] Sun Yat Sen Univ, Mol Canc Res Ctr, Sch Med, Shenzhen Campus Sun Yat Sen Univ, Shenzhen, Peoples R China; [Liu, Ye; Lv, Ting; Yang, Peng-Fei] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 5, Zhuhai, Peoples R China; [Zhong, Li] Sun Yat Sen Univ, Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Peoples R China; [Wang, Xiao-Bin] China Med Univ, Ctr Reprod Med, Androl Sect, Shengjing Hosp, Shenyang, Peoples R China; [Sehgal, Lalit] Ohio State Univ, Dept Internal Med, Div Hematol, Comprehens Canc Ctr, Columbus, OH USA; [Li, Miao] Shenzhen Univ, Shenzhen Second Peoples Hosp, Affiliated Hosp 1, Shenzhen, Peoples R China; [Li, Miao] Shenzhen Univ, Sch Biomed Engn, Guangdong Key Lab Biomed Measurements & Ultrasoun, Hlth Sci Ctr, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; China Medical University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Second People's Hospital of Shenzhen; Shenzhen University; Shenzhen University	Zhang, XD (corresponding author), Sun Yat Sen Univ, Mol Canc Res Ctr, Sch Med, Shenzhen Campus Sun Yat Sen Univ, Shenzhen, Peoples R China.; Li, M (corresponding author), Shenzhen Univ, Shenzhen Second Peoples Hosp, Affiliated Hosp 1, Shenzhen, Peoples R China.	limiao27@mail.sysu.edu.cn; zhangxd39@mail.sysu.edu.cn	; Li, Xin/A-4137-2011	Liu, Xueqi/0000-0002-8295-032X; Zhong, Li/0000-0002-1646-2862; Li, Xin/0000-0001-8328-4894; Yang, Pengfei/0000-0001-5266-2311	National Natural Science Foundation of China [81970191, 32170789, 3210050130]; Guangdong Natural Science Foundation of China [2018A0303130090]; Shenzhen Science and Technology Innovation Commission, China [JCYJ20190807160209294, JCYJ20190807160813467]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Commission, China	We thank Prof. Kang (Sun Yat-sen University Cancer Center) for kindly providing T24 and 5637 bladder cancer cells and the faculty (Fifth Affiliated Hospital of Sun Yat-sen University) for collecting the clinical samples. This work was supported in part by the National Natural Science Foundation of China (grant no. 81970191; 32170789; 3210050130); supported by Guangdong Natural Science Foundation of China (grant no. 2018A0303130090); supported by Shenzhen Science and Technology Innovation Commission, China (JCYJ20190807160209294, JCYJ20190807160813467).	Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Bauer H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/402593; Beutel O, 2019, CELL, V179, P923, DOI 10.1016/j.cell.2019.10.011; Black PC, 2007, CANCER METAST REV, V26, P623, DOI 10.1007/s10555-007-9084-9; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; Dhanasekaran R, 2020, ELIFE, V9, DOI 10.7554/eLife.50731; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; He JB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1512-6; HENRY N, 1983, FEBS LETT, V161, P243, DOI 10.1016/0014-5793(83)81017-5; Hsu YL, 2017, ONCOGENE, V36, P4929, DOI 10.1038/onc.2017.105; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Koga M, 2008, BIOCHEM BIOPH RES CO, V365, P279, DOI 10.1016/j.bbrc.2007.10.182; Laakkonen JP, 2017, ANGIOGENESIS, V20, P109, DOI 10.1007/s10456-016-9532-7; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Lesage J, 2017, FASEB J, V31, P1678, DOI 10.1096/fj.201600890R; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li CW, 2016, CANCER RES, V76, P1451, DOI 10.1158/0008-5472.CAN-15-1941; Li FT, 2020, CANCERS, V12, DOI 10.3390/cancers12061582; Li TL, 2018, ONCOL LETT, V16, P687, DOI 10.3892/ol.2018.8733; Liu XW, 2016, AM J PATHOL, V186, P2486, DOI 10.1016/j.ajpath.2016.04.018; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Martin TA, 2002, J CELL PHYSIOL, V192, P268, DOI 10.1002/jcp.10133; Meng J, 2019, ONCOGENE, V38, P228, DOI 10.1038/s41388-018-0428-4; Naito S, 2016, EUR UROL, V70, P506, DOI 10.1016/j.eururo.2016.03.053; Neufeld G, 2006, CANCER METAST REV, V25, P373, DOI 10.1007/s10555-006-9011-5; Ponce M. Lourdes, 2009, V467, P183, DOI 10.1007/978-1-59745-241-0_10; Rao Q, 2016, ONCOTARGET, V7, P7842, DOI 10.18632/oncotarget.5467; Ribatti D, 2007, CANCER LETT, V248, P18, DOI 10.1016/j.canlet.2006.06.007; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts CM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3169-9; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Singh S, 2007, CANCER METAST REV, V26, P453, DOI 10.1007/s10555-007-9068-9; Sun T, 2011, HEPATOLOGY, V54, P1690, DOI 10.1002/hep.24543; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Tran LD, 2021, NAT REV CANCER, V21, P104, DOI 10.1038/s41568-020-00313-1; Tsai KW, 2018, ANTICANCER RES, V38, P4607, DOI 10.21873/anticanres.12765; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang SY, 2012, BREAST CANCER RES TR, V133, P1037, DOI 10.1007/s10549-011-1902-7; Wang XS, 2015, FEBS J, V282, P4376, DOI 10.1111/febs.13502; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang WH, 2016, ONCOGENE, V35, P2287, DOI 10.1038/onc.2015.291; Yang Z, 2020, CANCER LETT, V473, P118, DOI 10.1016/j.canlet.2019.12.018; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zhao ZX, 2017, ONCOTARGET, V8, P20380, DOI 10.18632/oncotarget.14608; Zhou L, 2016, ONCOTARGET, V7, P76214, DOI 10.18632/oncotarget.12775	49	4	4	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					502	514		10.1038/s41388-021-02112-w	http://dx.doi.org/10.1038/s41388-021-02112-w		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34782718				2022-12-26	WOS:000718778400002
J	Zheng, YL; Wu, JJ; Deng, R; Lin, CS; Huang, YH; Yang, X; Wang, CH; Yang, MM; He, YF; Lu, JB; Su, XD; Yan, Q; Zhu, YH; Guan, XY; Li, Y; Yun, JP				Zheng, Yinli; Wu, Jinjun; Deng, Ru; Lin, Censhan; Huang, Yuhua; Yang, Xia; Wang, Chunhua; Yang, Mingming; He, Yangfan; Lu, Jiabin; Su, Xiaodong; Yan, Qian; Zhu, Yinghui; Guan, Xinyuan; Li, Yan; Yun, Jingping			G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript	ONCOGENE			English	Article							RNA-BINDING PROTEINS; HEPATOCELLULAR-CARCINOMA; CANCER; EXPRESSION; INVASION; LINK	Metastasis is the leading cause of death of patients with esophageal squamous cell carcinoma (ESCC). Although an increasing number of studies have demonstrated the involvement of G3BP2 in several human cancers, how G3BP2 interacts with long noncoding RNAs and regulates mRNA transcripts in mediating ESCC metastasis remains unclear. In this study, we uncovered that G3BP2 was upregulated in ESCC. Further analysis revealed that upregulation of G3BP2 was significantly correlated with lymph node metastasis, depth of tumor invasion and unfavorable outcomes in ESCC patients. Both in vitro and in vivo functional assays demonstrated that G3BP2 dramatically enhanced ESCC cell migration and invasion. Mechanistically, LINC01554 maintained the high G3BP2 expression in ESCC by protecting G3BP2 from degradation through ubiquitination and the interaction domains within LINC01554 and G3BP2 were identified. In addition, RNA-seq revealed that HDGF was regulated by G3BP2. G3BP2 bound to HDGF mRNA transcript to stabilize its expression. Ectopic expression of HDGF effectively abolished the G3BP2 depletion-mediated inhibitory effect on tumor cell migration. Intriguingly, introduction of compound C108 which can inhibit G3BP2 remarkedly suppressed ESCC cell metastasis in vitro and in vivo. Collectively, this study describes a newly discovered regulatory axis, LINC01554/G3BP2/HDGF, that facilitates ESCC metastasis and will provide novel therapeutic strategies for ESCC.	[Zheng, Yinli; Deng, Ru; Lin, Censhan; Huang, Yuhua; Yang, Xia; Wang, Chunhua; Yang, Mingming; He, Yangfan; Lu, Jiabin; Su, Xiaodong; Zhu, Yinghui; Guan, Xinyuan; Li, Yan; Yun, Jingping] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China; [Zheng, Yinli; Deng, Ru; Lin, Censhan; Huang, Yuhua; Yang, Xia; Wang, Chunhua; Yang, Mingming; He, Yangfan; Lu, Jiabin; Yun, Jingping] Sun Yat Sen Univ, Dept Pathol, Canc Ctr, Guangzhou 510060, Peoples R China; [Wu, Jinjun] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Joint Lab Translat Canc Res Chinese Med, Minist Educ Peoples Republ China, Guangzhou 510006, Peoples R China; [Su, Xiaodong] Sun Yat Sen Univ, Dept Thorac Surg, Canc Ctr, Guangzhou 510060, Peoples R China; [Yan, Qian] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Dept Colorectal Surg,Guangdong Prov Key Lab Color, Guangzhou 510000, Peoples R China; [Guan, Xinyuan] Univ Hong Kong, Dept Clin Oncol, State Key Lab Liver Res, Hong Kong 852, Peoples R China; [Guan, Xinyuan] Univ Hong Kong, Dept Clin Oncol, Shenzhen Hosp, Shenzhen 518053, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Ministry of Education, China; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; University of Hong Kong	Li, Y; Yun, JP (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China.; Yun, JP (corresponding author), Sun Yat Sen Univ, Dept Pathol, Canc Ctr, Guangzhou 510060, Peoples R China.	liy6@mail.sysu.edu.cn; yunjp@sysucc.org.cn			National Natural Science Foundation of Guangdong Province [2018B030311005]; National Natural Science Foundation of China [82003056, 82072611, 82072604]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110054]; China Postdoctoral Science Foundation [2019M663307]; Young Talent Teachers Plan of Sun Yat-sen University [20YKPY183]	National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Young Talent Teachers Plan of Sun Yat-sen University	This study was supported by The National Natural Science Foundation of Guangdong Province (No.2018B030311005), The National Natural Science Foundation of China (No.82003056, 82072611, 82072604), Guangdong Basic and Applied Basic Research Foundation (No. 2019A1515110054), China Postdoctoral Science Foundation (No. 2019M663307), and Young Talent Teachers Plan of Sun Yat-sen University (No.20YKPY183).	Alam U, 2019, BBA-MOL CELL RES, V1866, P360, DOI 10.1016/j.bbamcr.2018.09.001; Ashikari D, 2017, ONCOGENE, V36, P6272, DOI 10.1038/onc.2017.225; Azad TD, 2020, GASTROENTEROLOGY, V158, P494, DOI 10.1053/j.gastro.2019.10.039; Bao CH, 2014, FUTURE ONCOL, V10, P2675, DOI 10.2217/fon.14.194; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Chen XX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00650-0; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fu QF, 2017, CLIN CANCER RES, V23, P6336, DOI 10.1158/1078-0432.CCR-16-2813; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gao Y, 2013, HUM GENET, V132, P649, DOI 10.1007/s00439-013-1276-5; Gupta N, 2017, P NATL ACAD SCI USA, V114, P1033, DOI 10.1073/pnas.1525387114; Hao QY, 2020, EUR REV MED PHARMACO, V24, P12667, DOI 10.26355/eurrev_202012_24164; Heijink AM, 2019, CELL REP, V28, P2345, DOI 10.1016/j.celrep.2019.07.070; Hu XT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1095-y; Hubner JM, 2019, NEURO-ONCOLOGY, V21, P878, DOI 10.1093/neuonc/noz058; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Lin CH, 2020, CANCERS, V12, DOI 10.3390/cancers12092690; Lin YW, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6229-5; Liu HW, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01241-2; Liu X, 2017, GASTROENTEROLOGY, V153, P166, DOI 10.1053/j.gastro.2017.03.033; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Noh JH, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1471; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Takayama KI, 2018, MOL CANCER RES, V16, P846, DOI 10.1158/1541-7786.MCR-17-0471; Taniuchi K, 2011, MOL CANCER RES, V9, P856, DOI 10.1158/1541-7786.MCR-10-0574; Tian H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18929-0; Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819; Wang Q, 2020, GUT, V69, P1193, DOI 10.1136/gutjnl-2019-319639; Wang Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1105-0; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Yang Y, 2021, ONCOGENE, V40, P731, DOI 10.1038/s41388-020-01485-8; Yao RW, 2019, NAT CELL BIOL, V21, P542, DOI 10.1038/s41556-019-0311-8; Yuan YH, 2009, CIRC RES, V105, P1177, DOI 10.1161/CIRCRESAHA.109.204669; Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X; Zheng YL, 2019, THERANOSTICS, V9, P796, DOI 10.7150/thno.28992; Zuo XL, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-019-0839-x	40	4	4	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					515	526		10.1038/s41388-021-02073-0	http://dx.doi.org/10.1038/s41388-021-02073-0		NOV 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34782720	hybrid, Green Published			2022-12-26	WOS:000718778400005
J	Pandeya, A; Yang, L; Alegun, O; Karunasena, C; Risko, C; Li, ZY; Wei, YA				Pandeya, Ankit; Yang, Ling; Alegun, Olaniyi; Karunasena, Chamikara; Risko, Chad; Li, Zhenyu; Wei, Yinan			Biotinylation as a tool to enhance the uptake of small molecules in Gram-negative bacteria	PLOS ONE			English	Article							MICROBIAL IRON CHELATORS; ESCHERICHIA-COLI; PERMEATION PATHWAYS; OUTER-MEMBRANE; CANCER-CELLS; PERMEABILITY; COMPLEXES; MECHANISM	Antibiotic resistance is a major public health concern. The shrinking selection of effective antibiotics and lack of new development is making the situation worse. Gram-negative bacteria more specifically pose serious threat because of their double layered cell envelope and effective efflux systems, which is a challenge for drugs to penetrate. One promising approach to breach this barrier is the "Trojan horse strategy". In this technique, an antibiotic molecule is conjugated with a nutrient molecule that helps the antibiotic to enter the cell through dedicated transporters for the nutrient. Here, we explored the approach using biotin conjugation with a florescent molecule Atto565 to determine if biotinylation enhances accumulation. Biotin is an essential vitamin for bacteria and is obtained through either synthesis or uptake from the environment. We found that biotinylation enhanced accumulation of Atto565 in E. coli. However, the enhancement did not seem to be due to uptake through biotin transporters since the presence of free biotin had no observable impact on accumulation. Accumulated compound was mostly in the periplasm, as determined by cell fractionation studies. This was further confirmed through the observation that expression of streptavidin in the periplasm specifically enhanced the accumulation of biotinylated Atto565. This enhancement was not observed when streptavidin was expressed in the cytoplasm indicating no significant distribution of the compound inside the cytoplasm. Using gene knockout strains, plasmid complementation and mutagenesis studies we demonstrated that biotinylation made the compound a better passenger through OmpC, an outer membrane porin. Density functional theory (DFT)-based evaluation of the three-dimensional geometries showed that biotinylation did not directly stabilize the conformation of the compound to make it favorable for the entry through a pore. Further studies including molecular dynamics simulations are necessary to determine the possible mechanisms of enhanced accumulation of the biotinylated Atto565.	[Pandeya, Ankit; Yang, Ling; Alegun, Olaniyi; Karunasena, Chamikara; Risko, Chad; Wei, Yinan] Univ Kentucky, Coll Arts & Sci, Dept Chem, Lexington, KY 40506 USA; [Karunasena, Chamikara; Risko, Chad] Univ Kentucky, Ctr Appl Energy & Res, Lexington, KY USA; [Li, Zhenyu] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Wei, YA (corresponding author), Univ Kentucky, Coll Arts & Sci, Dept Chem, Lexington, KY 40506 USA.	Yinan.wei@uky.edu	Alegun, Olaniyi/CAG-4577-2022; Alegun, Olaniyi/HII-3248-2022; Pandeya, Ankit/B-8875-2019	Pandeya, Ankit/0000-0002-7433-3129; Karunasena, Chamikara/0000-0002-0631-9034	NSF [CHE-1709381, CMMI 1563412]; NIH/NIAID [AI137020, AI142063]; NIH/NHLBI [HL142640, HL146744]; NIH/NIGMS [GM132443]	NSF(National Science Foundation (NSF)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.W. acknowledge funding from NSF CHE-1709381, NIH/NIAID AI137020 and AI142063. Y. W. and Z. L. acknowledge funding from NIH/NHLBI HL142640, and NIH/NIGMS GM132443. Z.L. acknowledge funding from NIH/NHLBI HL146744. C.K. and C.R. acknowledge funding from the NSF through award CMMI 1563412. Supercomputing resources at UK on the Lipscomb High Performance Computing Cluster were provided by the UK Information Technology Department and the Center for Computational Sciences (CCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gutierrez S, 2018, ACS INFECT DIS, V4, P1487, DOI 10.1021/acsinfecdis.8b00108; Anes J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00587; Bassetti M, 2021, LANCET INFECT DIS, V21, P226, DOI 10.1016/S1473-3099(20)30796-9; Chang C.C., 2018, J EXP MICROBIOL IMMU, V22, P1; Chen SY, 2010, BIOCONJUGATE CHEM, V21, P979, DOI 10.1021/bc9005656; Choi JJ, 2018, EXPERT OPIN INV DRUG, V27, P193, DOI 10.1080/13543784.2018.1426745; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dumont E, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800242; EVANS CT, 1993, BIOCHEM J, V291, P927, DOI 10.1042/bj2910927; Finkenwirth F, 2014, BIOENGINEERED, V5, P129, DOI 10.4161/bioe.26887; Gorska A, 2014, TRENDS PHARMACOL SCI, V35, P442, DOI 10.1016/j.tips.2014.06.007; HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096; Hu WW, 2017, J INORG BIOCHEM, V175, P47, DOI 10.1016/j.jinorgbio.2017.07.002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeschek M, 2017, METAB ENG, V40, P33, DOI 10.1016/j.ymben.2016.12.013; Jeschek M, 2016, NATURE, V537, P661, DOI 10.1038/nature19114; Kojima S, 2014, J BIOL CHEM, V289, P26464, DOI 10.1074/jbc.M114.585869; Kong HM, 2019, EUR J MED CHEM, V182, DOI 10.1016/j.ejmech.2019.111615; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Lu T, 2012, J MOL GRAPH MODEL, V38, P314, DOI 10.1016/j.jmgm.2012.07.004; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Maiti S, 2018, EUR J MED CHEM, V145, P206, DOI 10.1016/j.ejmech.2018.01.001; MILLER MJ, 1993, ACCOUNTS CHEM RES, V26, P241, DOI 10.1021/ar00029a003; Negash KH, 2019, MOLECULES, V24, DOI 10.3390/molecules24183314; Neumann W, 2018, J BIOL INORG CHEM, V23, P1025, DOI 10.1007/s00775-018-1588-y; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Pandeya A, 2020, BIOCHEM BIOPHYS REP, V24, DOI 10.1016/j.bbrep.2020.100849; Pandeya A, 2020, ACS INFECT DIS, V6, P2337, DOI 10.1021/acsinfecdis.0c00384; Ponchon L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt576; Prajapati JD, 2018, J PHYS CHEM B, V122, P1417, DOI 10.1021/acs.jpcb.7b12568; Prajapati JD, 2017, J CHEM THEORY COMPUT, V13, P4553, DOI 10.1021/acs.jctc.7b00467; Rajapaksha P, 2020, ACS OMEGA, V5, P21844, DOI 10.1021/acsomega.0c02921; Richter MF, 2019, ANN NY ACAD SCI, V1435, P18, DOI 10.1111/nyas.13598; Richter MF, 2017, NATURE, V545, P299, DOI 10.1038/nature22308; Roosenberg JM, 2000, CURR MED CHEM, V7, P159, DOI 10.2174/0929867003375353; Ropponen HK, 2021, RSC MED CHEM, V12, P593, DOI 10.1039/d0md00409j; Ruggiu F, 2019, ACS INFECT DIS, V5, P1688, DOI 10.1021/acsinfecdis.9b00256; Russell-Jones G, 2004, J INORG BIOCHEM, V98, P1625, DOI 10.1016/j.jinorgbio.2004.07.009; Sanderson TJ, 2020, ACS INFECT DIS, V6, P2532, DOI 10.1021/acsinfecdis.0c00568; Sauvageot E, 2017, METALLOMICS, V9, P1820, DOI 10.1039/c7mt00262a; Sirithanakorn C, 2021, FEMS MICROBIOL REV, V45, DOI 10.1093/femsre/fuab003; Southwell JW, 2021, CHEMMEDCHEM, V16, P1063, DOI 10.1002/cmdc.202000806; Tillotson Glenn S, 2016, Infect Dis (Auckl), V9, P45, DOI 10.4137/idrt.s31567; Vadlapudi AD, 2013, INT J PHARMACEUT, V441, P535, DOI 10.1016/j.ijpharm.2012.10.047; Vergalli J, 2020, NAT REV MICROBIOL, V18, P164, DOI 10.1038/s41579-019-0294-2; Walker JR, 2005, APPL ENVIRON MICROB, V71, P1850, DOI 10.1128/AEM.71.4.1850-1855.2005; Yang WJ, 2009, EUR J MED CHEM, V44, P862, DOI 10.1016/j.ejmech.2008.04.021; Zgurskaya HI, 2000, MOL MICROBIOL, V37, P219, DOI 10.1046/j.1365-2958.2000.01926.x; Zhao S, 2020, ORG LETT, V22, P6632, DOI 10.1021/acs.orglett.0c02403	49	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0260023	10.1371/journal.pone.0260023	http://dx.doi.org/10.1371/journal.pone.0260023			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767592	gold, Green Published			2022-12-26	WOS:000755249300058
J	Amodeo, I; De Nunzio, G; Raffaeli, G; Borzani, I; Griggio, A; Conte, L; Macchini, F; Condo, V; Persico, N; Fabietti, I; Ghirardello, S; Pierro, M; Tafuri, B; Como, G; Cascio, D; Colnaghi, M; Mosca, F; Cavallaro, G				Amodeo, Ilaria; De Nunzio, Giorgio; Raffaeli, Genny; Borzani, Irene; Griggio, Alice; Conte, Luana; Macchini, Francesco; Condo, Valentina; Persico, Nicola; Fabietti, Isabella; Ghirardello, Stefano; Pierro, Maria; Tafuri, Benedetta; Como, Giuseppe; Cascio, Donato; Colnaghi, Mariarosa; Mosca, Fabio; Cavallaro, Giacomo			A maChine and deep Learning Approach to predict pulmoNary hyperteNsIon in newbornS with congenital diaphragmatic Hernia (CLANNISH): Protocol for a retrospective study	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; ENDOSCOPIC TRACHEAL OCCLUSION; COLONY-FORMING CELLS; MOVING BLOOD-VOLUME; FETAL LUNG-VOLUME; ANTENATAL PREDICTION; LIVER HERNIATION; INFANTS; MORBIDITY; SURVIVAL	Introduction Outcome predictions of patients with congenital diaphragmatic hernia (CDH) still have some limitations in the prenatal estimate of postnatal pulmonary hypertension (PH). We propose applying Machine Learning (ML), and Deep Learning (DL) approaches to fetuses and newborns with CDH to develop forecasting models in prenatal epoch, based on the integrated analysis of clinical data, to provide neonatal PH as the first outcome and, possibly: favorable response to fetal endoscopic tracheal occlusion (FETO), need for Extracorporeal Membrane Oxygenation (ECMO), survival to ECMO, and death. Moreover, we plan to produce a (semi)automatic fetus lung segmentation system in Magnetic Resonance Imaging (MRI), which will be useful during project implementation but will also be an important tool itself to standardize lung volume measures for CDH fetuses. Methods and analytics Patients with isolated CDH from singleton pregnancies will be enrolled, whose prenatal checks were performed at the Fetal Surgery Unit of the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (Milan, Italy) from the 30th week of gestation. A retrospective data collection of clinical and radiological variables from newborns' and mothers' clinical records will be performed for eligible patients born between 01/01/2012 and 31/12/2020. The native sequences from fetal magnetic resonance imaging (MRI) will be collected. Data from different sources will be integrated and analyzed using ML and DL, and forecasting algorithms will be developed for each outcome. Methods of data augmentation and dimensionality reduction (feature selection and extraction) will be employed to increase sample size and avoid overfitting. A software system for automatic fetal lung volume segmentation in MRI based on the DL 3D U-NET approach will also be developed. Ethics and dissemination This retrospective study received approval from the local ethics committee (Milan Area 2, Italy). The development of predictive models in CDH outcomes will provide a key contribution in disease prediction, early targeted interventions, and personalized management, with an overall improvement in care quality, resource allocation, healthcare, and family savings. Our findings will be validated in a future prospective multicenter cohort study.	[Amodeo, Ilaria; Raffaeli, Genny; Condo, Valentina; Ghirardello, Stefano; Como, Giuseppe; Colnaghi, Mariarosa; Mosca, Fabio; Cavallaro, Giacomo] Fdn IRCCS Ca Granda Osped Maggiore Policli, NICU, Milan, Italy; [De Nunzio, Giorgio; Conte, Luana; Tafuri, Benedetta] Univ Salento, Dept Math & Phys E Giorgi, Lab Biomed Phys & Environm, Lecce, Italy; [De Nunzio, Giorgio; Conte, Luana; Tafuri, Benedetta] Univ Salento, Lab Interdisciplinary Res Appl Med DReAM, Adv Data Anal Med ADAM, Lecce, Italy; [De Nunzio, Giorgio; Conte, Luana; Tafuri, Benedetta] Azienda Sanitaria Locale ASL, Lecce, Italy; [Raffaeli, Genny; Persico, Nicola; Mosca, Fabio] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Borzani, Irene] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Pediat Radiol Unit, Milan, Italy; [Griggio, Alice] Univ Milano Bicocca, Monza & Brianza Mother & Child Fdn, San Gerardo Hosp, Monza, Italy; [Macchini, Francesco] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pediat Surg, Milan, Italy; [Persico, Nicola; Fabietti, Isabella] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Obstet & Gynecol, Milan, Italy; [Pierro, Maria] Bufalini Hosp, NICU, Azienda Unita Sanitaria Locale Romagna, Cesena, Italy; [Cascio, Donato] Univ Palermo, Dept Chem & Phys, Palermo, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Salento; University of Salento; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; San Gerardo Hospital; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Palermo	Cavallaro, G (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policli, NICU, Milan, Italy.	giacomo.cavallaro@policlinico.mi.it	Cascio, Donato/H-9812-2015; Raffaeli, Genny GR/I-1900-2017; Cavallaro, Giacomo/F-5660-2011; Amodeo, Ilaria/AAC-6605-2022; Mosca, Fabio/C-5826-2017; De Nunzio, Giorgio/L-7283-2015	Cascio, Donato/0000-0001-6522-1259; Raffaeli, Genny GR/0000-0001-9175-9394; Cavallaro, Giacomo/0000-0002-4921-1437; Amodeo, Ilaria/0000-0002-2650-0084; Mosca, Fabio/0000-0001-6477-0299; De Nunzio, Giorgio/0000-0002-1998-0286; Tafuri, Benedetta/0000-0002-2931-6039				Abman SH, 2015, CIRCULATION, V132, P2037, DOI 10.1161/CIR.0000000000000329; Acker SN, 2015, J PEDIATR-US, V166, P178, DOI 10.1016/j.jpeds.2014.09.010; Acker SN, 2013, AM J PHYSIOL-LUNG C, V305, pL943, DOI 10.1152/ajplung.00226.2013; Alphonse RS, 2014, CIRCULATION, V129, P2144, DOI 10.1161/CIRCULATIONAHA.114.009124; Amodeo I, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.692210; Amodeo I, 2022, EUR J PEDIATR, V181, P323, DOI 10.1007/s00431-021-04207-8; Amodeo I, 2021, EUR J PEDIATR, V180, P1675, DOI 10.1007/s00431-020-03898-9; Amodeo I, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.581809; Au-Yong-Oliveira M, 2021, J MED SYST, V45, DOI 10.1007/s10916-020-01691-7; Ayers B, 2020, ANN THORAC SURG, V110, P1193, DOI 10.1016/j.athoracsur.2020.03.128; Baker CD, 2013, J PEDIATR-US, V163, P905, DOI 10.1016/j.jpeds.2013.04.010; Basurto D, 2019, BEST PRACT RES CL OB, V58, P93, DOI 10.1016/j.bpobgyn.2018.12.010; Bellman R, 1961, ADAPTIVE CONTROL PRO, P96; Benachi A, 2014, SEMIN FETAL NEONAT M, V19, P331, DOI 10.1016/j.siny.2014.09.005; Beurskens LWJE, 2013, BIRTH DEFECTS RES A, V97, P60, DOI 10.1002/bdra.23093; Beurskens LWJE, 2010, PEDIATRICS, V126, P712, DOI 10.1542/peds.2010-0521; Boucherat O, 2010, AM J PHYSIOL-LUNG C, V298, pL849, DOI 10.1152/ajplung.00333.2009; Bouchghoul H, 2018, PRENATAL DIAG, V38, P638, DOI 10.1002/pd.5326; Brooks B, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0493-5; Callaway DA, 2018, J PEDIATR GENET, V7, P164, DOI 10.1055/s-0038-1655755; Cannie M, 2009, ULTRASOUND OBST GYN, V34, P678, DOI 10.1002/uog.7326; Chang R, 2004, J PEDIATR SURG, V39, P825, DOI 10.1016/j.jpedsurg.2004.02.015; Chung C, 2021, J AM COLL RADIOL, V18, P170, DOI 10.1016/j.jacr.2020.09.050; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Cooper JN, 2018, J SURG RES, V221, P311, DOI 10.1016/j.jss.2017.09.002; Cordier AG, 2015, ULTRASOUND OBST GYN, V46, P155, DOI 10.1002/uog.14759; Cordier AG, 2020, SEMIN PERINATOL, V44, DOI 10.1053/j.semperi.2019.07.002; Coughlin MA, 2016, J PEDIATR SURG, V51, P1091, DOI 10.1016/j.jpedsurg.2015.10.082; Cruz-Martinez R, 2013, ULTRASOUND OBST GYN, V41, P59, DOI 10.1002/uog.11212; Cruz-Martinez R, 2019, PRENATAL DIAG, V39, P45, DOI 10.1002/pd.5401; Dassios T, 2019, PEDIATR CRIT CARE ME, V20, P534, DOI 10.1097/PCC.0000000000001912; DeKoninck P, 2014, PRENATAL DIAG, V34, P977, DOI 10.1002/pd.4408; DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001; Deprest JA, 2021, NEW ENGL J MED, V385, P107, DOI 10.1056/NEJMoa2027030; Deprest J, 2014, SEMIN FETAL NEONAT M, V19, P338, DOI 10.1016/j.siny.2014.09.006; Deprest JA, 2021, NEW ENGL J MED, V385, P119, DOI 10.1056/NEJMoa2026983; Deprest JA, 2009, SEMIN FETAL NEONAT M, V14, P8, DOI 10.1016/j.siny.2008.08.010; Duda R.O., 2000, PATTERN CLASSIFICATI; Ferguson DM, 2021, NEONATOLOGY, V118, P147, DOI 10.1159/000512966; Fraga M V, 2012, LUNG DEV EMBRYOLOGY, P571; Fuke S, 2003, AM J OBSTET GYNECOL, V188, P228, DOI 10.1067/mob.2003.69; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Hamilton EF, 2020, J MATERN-FETAL NEO M, V33, P73, DOI 10.1080/14767058.2018.1487395; Harting MT, 2014, SEMIN FETAL NEONAT M, V19, P370, DOI 10.1016/j.siny.2014.09.004; Hernandez-Andrade E, 2004, ULTRASOUND OBST GYN, V23, P369, DOI 10.1002/uog.1003; Hollinger LE, 2020, SEMIN PERINATOL, V44, DOI 10.1053/j.semperi.2019.07.010; Huang C., 2019, LECT NOTES COMPUTER; Irles C, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112509; Jani J, 2007, ULTRASOUND OBST GYN, V30, P67, DOI 10.1002/uog.4052; Kardon G, 2017, DIS MODEL MECH, V10, P955, DOI 10.1242/dmm.028365; Keijzer R, 2000, AM J PATHOL, V156, P1299, DOI 10.1016/S0002-9440(10)65000-6; KLUTH D, 1990, J PEDIATR SURG, V25, P850, DOI 10.1016/0022-3468(90)90190-K; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Liu H, 1998, FEATURE EXTRACTION C; Lu L., 2017, PART ADV COMPUTER VI, V10, P978; Mani S, 2014, J AM MED INFORM ASSN, V21, P326, DOI 10.1136/amiajnl-2013-001854; Martin-Sanchez F, 2014, Yearb Med Inform, V9, P14, DOI 10.15265/IY-2014-0020; Masino AJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212665; Massaro GD, 1996, ANNU REV PHYSIOL, V58, P73; Pierro M, 2014, SEMIN FETAL NEONAT M, V19, P357, DOI 10.1016/j.siny.2014.09.008; Podda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31920-6; Rizzo G, 1996, ULTRASOUND OBST GYN, V8, P87, DOI 10.1046/j.1469-0705.1996.08020087.x; Romiti A, 2020, J MATERN-FETAL NEO M, V33, P1330, DOI 10.1080/14767058.2018.1517329; Romiti A, 2022, J MATERN-FETAL NEO M, V35, P269, DOI 10.1080/14767058.2020.1716714; Ronneberger O., 2015, P INT C MED IM COM, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Ruano R, 2014, ULTRASOUND OBST GYN, V43, P662, DOI 10.1002/uog.13223; Ruano R, 2006, AM J OBSTET GYNECOL, V195, P1720, DOI 10.1016/j.ajog.2006.05.010; Russo FM, 2017, ULTRASOUND OBST GYN, V49, P704, DOI 10.1002/uog.16000; Russo FM, 2018, PRENATAL DIAG, V38, P629, DOI 10.1002/pd.5297; Russo FM, 2017, SEMIN FETAL NEONAT M, V22, P383, DOI 10.1016/j.siny.2017.11.002; Rypens F, 2001, RADIOLOGY, V219, P236, DOI 10.1148/radiology.219.1.r01ap18236; Savelli S, 2020, PRENATAL DIAG, V40, P136, DOI 10.1002/pd.5619; Sbragia L, 2014, BRAZ J MED BIOL RES, V47, P171, DOI 10.1590/1414-431X20133221; Shehata SMK, 1999, THORAX, V54, P427, DOI 10.1136/thx.54.5.427; Short BL, 2005, SEMIN PERINATOL, V29, P45, DOI 10.1053/j.semperi.2005.02.007; Shorten C, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0197-0; Slavotinek AM, 2014, EUR J MED GENET, V57, P418, DOI 10.1016/j.ejmg.2014.04.012; Sluiter I, 2013, EXP MOL PATHOL, V94, P195, DOI 10.1016/j.yexmp.2012.09.010; Snoek KG, 2018, NEONATOLOGY, V113, P63, DOI 10.1159/000480451; Snoek KG, 2016, NEONATOLOGY, V110, P66, DOI 10.1159/000444210; Sokol J, 2006, AM J OBSTET GYNECOL, V195, P470, DOI 10.1016/j.ajog.2006.02.009; Stark AR, 2008, PEDIATRICS, V121, P627, DOI 10.1542/peds.2007-3282; Taormina V, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10196940; Thebaud B, 1999, AM J PHYSIOL-LUNG C, V277, pL423, DOI 10.1152/ajplung.1999.277.2.L423; Van der Veeken L, 2018, GYNECOL SURG, V15, DOI 10.1186/s10397-018-1041-9; VANMEURS KP, 1993, J PEDIATR-US, V122, P893, DOI 10.1016/S0022-3476(09)90013-0; Victoria T, 2012, PRENATAL DIAG, V32, P715, DOI 10.1002/pd.3890; Wanner J., 2020, MUCH IS BLACK BOX VA; Wong M, 2018, J PEDIATR SURG, V53, P918, DOI 10.1016/j.jpedsurg.2018.02.015; Yamoto M, 2018, PEDIATR SURG INT, V34, P161, DOI 10.1007/s00383-017-4184-2; Zamora IJ, 2013, J PEDIATR SURG, V48, P1165, DOI 10.1016/j.jpedsurg.2013.03.010	91	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259724	10.1371/journal.pone.0259724	http://dx.doi.org/10.1371/journal.pone.0259724			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752491	Green Published, gold			2022-12-26	WOS:000754499700031
J	Shin, DH; Kim, SH; Choi, M; Bae, YK; Han, C; Choi, BK; Kim, SS; Han, JY				Shin, Dong Hoon; Kim, Sun Ha; Choi, Minyoung; Bae, Young-Ki; Han, Chungyong; Choi, Beom K.; Kim, Sang Soo; Han, Ji-Youn			Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1	ONCOGENE			English	Article							FACTOR RECEPTOR; EGF RECEPTOR; RAS; ADAM17; CHEMOTHERAPY; ACTIVATION; PHYSIOLOGY; PATHWAYS; GENETICS; CLEAVAGE	We previously found the SLC3A2-NRG1 (S-N) fusion gene in a lung adenocarcinoma specimen without known driver mutations and validated this in 59 invasive mucinous adenocarcinoma (IMA) samples. Interestingly, KRAS mutation coexisted (62.5%) in 10 out of 16 NRG1 fusions. In this study, we examined the role of mutant KRAS in regulating the S-N fusion protein in KRAS mutant (H358) and wild-type (Calu-3) cells. KRAS mutation-mediated increase in MEK1/2 and ERK1/2 activity enhanced disintegrin and metalloproteinase (ADAM)17 activity, which increased the shedding of NRG1 from the S-N fusion protein. The cleavage of NRG1 also increased the phosphorylation of ERBB2-ERBB3 heterocomplex receptors and their downstream signalling pathways, including PI3K/Akt/mTOR, even under activated KRAS mutation signalling. The concurrence of S-N fusion and KRAS mutation synergistically increased cell proliferation, colony formation, tumour growth, and the cells' resistance to EGFR kinase inhibitors more than KRAS mutation alone. Targeted inhibition of MEK1/2, and ADAM17 significantly induced apoptosis singly and when combined with each mutation singly or with chemotherapy in both the concurrent KRAS mutant and S-N fusion xenograft and lung orthotopic models. Taken together, this is the first study to report that KRAS mutation increased NRG1 cleavage from the S-N fusion protein through ADAM17, thereby enhancing the Ras/Raf/MEK/ERK and ERBB/PI3K/Akt/mTOR pathways. Moreover, the coexistence of KRAS mutant and S-N fusion in lung tumours renders them vulnerable to MEK1/2 and/or ADAM17 inhibitors, at least in part, due to their dependency on the strong positive loop between KRAS mutation and S-N fusion.	[Shin, Dong Hoon; Kim, Sun Ha; Choi, Minyoung; Bae, Young-Ki; Han, Chungyong; Choi, Beom K.; Kim, Sang Soo; Han, Ji-Youn] Res Inst, Goyang S, South Korea; [Shin, Dong Hoon; Kim, Sun Ha] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Canc Biomed Sci, Goyang Si, Gyeonggi Do, South Korea	National Cancer Center - Korea (NCC)	Shin, DH; Han, JY (corresponding author), Res Inst, Goyang S, South Korea.; Shin, DH (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Canc Biomed Sci, Goyang Si, Gyeonggi Do, South Korea.	dhshin@ncc.re.kr; jymama@ncc.re.kr			National Cancer Centre [NCC-2010070, 2110340]; National Research Fund [NRF-2021R1F1A1062721]	National Cancer Centre; National Research Fund(Luxembourg National Research Fund)	This work was supported by grants (NCC-2010070 and 2110340) funded by the National Cancer Centre, and NRF-2021R1F1A1062721 funded by the National Research Fund.	Ambrogio C, 2017, ONCOGENE, V36, P2309, DOI 10.1038/onc.2016.385; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Baumgart A, 2010, CANCER RES, V70, P5368, DOI 10.1158/0008-5472.CAN-09-3763; BOS JL, 1989, CANCER RES, V49, P4682; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Chang JC, 2021, CLIN CANCER RES, V27, P4066, DOI 10.1158/1078-0432.CCR-21-0423; Chen JC, 2016, PHYSIOL REV, V96, P1025, DOI 10.1152/physrev.00030.2015; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cisowski J, 2016, ONCOGENE, V35, P1328, DOI 10.1038/onc.2015.186; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hames ML, 2016, LUNG CANCER, V92, P29, DOI 10.1016/j.lungcan.2015.11.004; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Janssens E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052915; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Jonna S, 2019, CLIN CANCER RES, V25, P4966, DOI 10.1158/1078-0432.CCR-19-0160; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamb A, 2003, MOL BIOL CELL, V14, P2201, DOI 10.1091/mbc.E02-11-0732; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; Kim BM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8275256; Kim TM, 2015, J THORAC ONCOL, V10, P1736, DOI 10.1097/JTO.0000000000000688; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kwan JC, 2009, J MED CHEM, V52, P5732, DOI 10.1021/jm9009394; Ma SQ, 2021, ONCOGENE, V40, P2596, DOI 10.1038/s41388-021-01734-4; Ni SS, 2013, TUMOR BIOL, V34, P1813, DOI 10.1007/s13277-013-0721-3; Saad MI, 2019, CANCERS, V11, DOI 10.3390/cancers11091218; Saad MI, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809976; Sharma A, 2016, CLIN CANCER RES, V22, P4428, DOI 10.1158/1078-0432.CCR-15-2449; Sharma SV, 2010, BIOCHEM PHARMACOL, V80, P666, DOI 10.1016/j.bcp.2010.03.001; Shin DH, 2018, MOL CANCER THER, V17, P2024, DOI 10.1158/1535-7163.MCT-17-1178; Shin DH, 2016, ONCOTARGET, V7, P69450, DOI 10.18632/oncotarget.11913; Torti D, 2011, EMBO MOL MED, V3, P623, DOI 10.1002/emmm.201100176; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Unni AM, 2015, ELIFE, V4, DOI 10.7554/eLife.06907; Van Schaeybroeck S, 2011, CANCER RES, V71, P1071, DOI 10.1158/0008-5472.CAN-10-0714; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14513-7; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Ying HQ, 2016, GENE DEV, V30, P355, DOI 10.1101/gad.275776.115; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Zheng ZY, 2020, CANCER CELL, V37, P387, DOI 10.1016/j.ccell.2020.02.003; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	48	4	4	4	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2022	41	2					280	292		10.1038/s41388-021-02097-6	http://dx.doi.org/10.1038/s41388-021-02097-6		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YC1XK	34743207				2022-12-26	WOS:000715015000001
J	Lisowska-Myjak, B; Zborowska, H; Jazwiec, R; Karlinska, M; Skarzynska, E				Lisowska-Myjak, Barbara; Zborowska, Hanna; Jazwiec, Radoslaw; Karlinska, Maria; Skarzynska, Ewa			Serum indoxyl sulphate and its relation to albumin and alpha(1)-acid glycoprotein as a potential biomarkers of maternal intestinal metabolism during pregnancy and postpartum	PLOS ONE			English	Article							UREMIC TOXINS; MICROBIOME; BINDING; PROTEIN; CAPACITY; INDOLE	Background Serum indoxyl sulfate (IS) levels depend on the production of indole in the gut. The biological effects of IS in the vascular bed could be confirmed by changes in the levels of individual serum proteins during normal pregnancy and in the postpartum period as compared with non-pregnant controls. Albumin (Alb) and alpha(1)-acid glycoprotein (AGP, orosomucoid) are the most abundant serum carrier proteins with potential interrelationships with serum levels of IS. Methods Serum levels of IS, Alb and AGP were measured in 84 pregnant women in the first, second and third trimester of pregnancy and in the postpartum period, as well as in non-pregnant controls (n = 20), using ultra-performance liquid chromatography (UPLC) coupled to mass spectrometry (IS), colorimetric assay (Alb) and immunoturbidimetric assay (AGP). Results The postpartum serum levels [mg/L] of IS were lower (p = 0.027) than in the second trimester (meanSD: 0.85 +/- 0.39 vs 0.58 +/- 0.32). There were no differences in the IS to ALB ratio calculated in the three trimesters of pregnancy, the postpartum period, and in the non-pregnant controls. The IS/AGP ratio increased from the first to the second trimester (p = 0.039), and decreased in the postpartum period (p<0.05), when it was lower than in the second and third trimester. Conclusions The variability of the serum IS/AGP ratio during pregnancy and in the postpartum period may reflect shared involvement in the regulation of their intravascular relationships. The link between serum levels of IS derived from the gut and AGP could serve a potential biomarkers of maternal intestinal metabolism during pregnancy and postpartum.	[Lisowska-Myjak, Barbara; Skarzynska, Ewa] Med Univ Warsaw, Dept Biochem & Clin Chem, Warsaw, Poland; [Zborowska, Hanna] Med Univ Warsaw, Dept Lab Diagnost, Warsaw, Poland; [Jazwiec, Radoslaw] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Karlinska, Maria] Med Univ Warsaw, Dept Med Informat & Telemed, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw	Skarzynska, E (corresponding author), Med Univ Warsaw, Dept Biochem & Clin Chem, Warsaw, Poland.	ewaskarzynska@wp.pl						Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377; Chu D, 2017, AM J OBSTET GYNECOL, V216, pS18, DOI 10.1016/j.ajog.2016.11.917; Devine E, 2014, TOXINS, V6, P416, DOI 10.3390/toxins6020416; Edwards SM, 2017, MCN-AM J MATERN-CHIL, V42, P310, DOI 10.1097/NMC.0000000000000372; Ellis RJ, 2016, NEPHROLOGY, V21, P170, DOI 10.1111/nep.12580; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Fuhler GM, 2020, BEST PRACT RES CL GA, V44-45, DOI 10.1016/j.bpg.2020.101671; Fujii H, 2011, THER APHER DIAL, V15, P125, DOI 10.1111/j.1744-9987.2010.00883.x; Gryp T, 2020, KIDNEY INT, V97, P1230, DOI 10.1016/j.kint.2020.01.028; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Hoyer FF, 2019, CIRCULATION, V139, P97, DOI 10.1161/CIRCULATIONAHA.118.037308; Ikeda S, 2019, INT HEART J, V60, P7, DOI 10.1536/ihj.18-672; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; JENSEN KB, 1976, SCAND J GASTROENTERO, V11, P177; Kozyrskyj AL, 2019, EBIOMEDICINE, V39, P21, DOI 10.1016/j.ebiom.2018.11.058; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Leong SC, 2016, TOXINS, V8, DOI 10.3390/toxins8120358; Lisowska-Myjak B, 2014, NEPHRON CLIN PRACT, V128, P303, DOI 10.1159/000369817; Longo Sherri A, 2010, Clin Colon Rectal Surg, V23, P80, DOI 10.1055/s-0030-1254294; Mei CL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02886; Prince AL, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023051; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080604; Stegmayr BG, 2015, ACTA PHYSIOL, V215, P5, DOI 10.1111/apha.12546; Tanaka S, 2020, TOXINS, V12, DOI 10.3390/toxins12080502; URIEN S, 1991, BIOCHEM J, V280, P277, DOI 10.1042/bj2800277; van der Giessen J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030261; Zborowska H., 2016, INT J GASTROENTEROL, DOI [10.5171/2016.730986, DOI 10.5171/2016.730986]; Zhou ZJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44448-0	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259501	10.1371/journal.pone.0259501	http://dx.doi.org/10.1371/journal.pone.0259501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739491	gold, Green Published			2022-12-26	WOS:000755000800036
J	Kong, LZ; Cheng, JY				Kong, Lingzhi; Cheng, Jinyong			Based on improved deep convolutional neural network model pneumonia image classification	PLOS ONE			English	Article								Pneumonia remains the leading infectious cause of death in children under the age of five, killing about 700,000 children each year and affecting 7% of the world's population. X-ray images of lung become the key to the diagnosis of this disease, skilled doctors in the diagnosis of a certain degree of subjectivity, if the use of computer-aided medical diagnosis to automatically detect lung abnormalities, will improve the accuracy of diagnosis. This research aims to introduce a deep learning technology based on the combination of Xception neural network and long-term short-term memory (LSTM), which can realize automatic diagnosis of patients with pneumonia in X-ray images. First, the model uses the Xception network to extract the deep features of the data, passes the extracted features to the LSTM, and then the LSTM detects the extracted features, and finally selects the most needed features. Secondly, in the training set samples, the traditional cross-entropy loss cannot more balance the mismatch between categories. Therefore, this research combines Pearson's feature selection ideas, fusion of the correlation between the two loss functions, and optimizes the problem. The experimental results show that the accuracy rate of this paper is 96%, the receiver operator characteristic curve accuracy rate is 99%, the precision rate is 98%, the recall rate is 91%, and the F1 score accuracy rate is 94%. Compared with the existing technical methods, the research has achieved expected results on the currently available datasets. And assist doctors to provide higher reliability in the classification task of childhood pneumonia.	[Kong, Lingzhi; Cheng, Jinyong] Qilu Univ Technol, Shandong Acad Sci, Sch Comp Sci & Technol, Jinan, Peoples R China	Qilu University of Technology	Cheng, JY (corresponding author), Qilu Univ Technol, Shandong Acad Sci, Sch Comp Sci & Technol, Jinan, Peoples R China.	cjy@qlu.edu.cn						Ayan E., 2019, 2019 SCIENT M EL, P1; Bhandary A, 2020, PATTERN RECOGN LETT, V129, P271, DOI 10.1016/j.patrec.2019.11.013; Buades A, 2011, IMAGE PROCESS ON LIN, V1, P208, DOI 10.5201/ipol.2011.bcm_nlm; Cai CJ, 2020, J MED CHEM, V63, P8683, DOI 10.1021/acs.jmedchem.9b02147; Capizzi G, 2020, IEEE T FUZZY SYST, V28, P1178, DOI 10.1109/TFUZZ.2019.2952831; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Lujan-Garcia JE, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10082908; Ergen T, 2018, IEEE T NEUR NET LEAR, V29, P3772, DOI 10.1109/TNNLS.2017.2741598; Hashmi MF, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060417; Hu M., 2020, IEEE ACCESS, DOI [10.1109/ACCESS.2020.3009667, DOI 10.1109/ACCESS.2020.3009667]; Ioffe S., 2015, INT C MACH LEARN APP, P448; Johnson S., VIRAL PNEUMONIA SYMP; Kaggle, TUB TB CHEST X RAY D; Ke Q, 2019, EXPERT SYST APPL, V126, P218, DOI 10.1016/j.eswa.2019.01.060; Kermany D, 2018, PMENDELEY DATA; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Khan MA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11050811; Khan MA, 2021, CMC-COMPUT MATER CON, V67, P3381, DOI 10.32604/cmc.2021.014983; Khan MA, 2021, IEEE J BIOMED HEALTH, V25, P4267, DOI 10.1109/JBHI.2021.3067789; Khan MA, 2021, COMPUT ELECTR ENG, V90, DOI 10.1016/j.compeleceng.2020.106960; Khan MA, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10080565; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lessmann N, 2018, IEEE T MED IMAGING, V37, P615, DOI 10.1109/TMI.2017.2769839; Liang GB, 2020, COMPUT METH PROG BIO, V187, DOI 10.1016/j.cmpb.2019.06.023; Liu TL, 2018, J ELECTRON INF TECHN, V40, P2395, DOI 10.11999/JEIT171116; Mackey Tim, 2020, JMIR Public Health Surveill, V6, pe19509, DOI 10.2196/19509; Manikandan T, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0539-9; Murala S, 2019, J HEALTHC ENG, V2019, DOI 10.1155/2019/9581275; Naz J, 2021, CMC-COMPUT MATER CON, V69, P607, DOI 10.32604/cmc.2021.017101; Nusrat Jahan M., 2021, 2021 INT C INF COMM, P235, DOI [10.1109/ICICT4SD50815.2021.9397055, DOI 10.1109/ICICT4SD50815.2021.9397055]; Pannu HS, 2019, NEURAL COMPUT APPL, V31, P2195, DOI 10.1007/s00521-017-3181-7; Pathak Y, 2022, IRBM, V43, P87, DOI 10.1016/j.irbm.2020.05.003; Rizal A, 2017, 2017 INTERNATIONAL CONFERENCE ON CONTROL, ELECTRONICS, RENEWABLE ENERGY AND COMMUNICATIONS (ICCREC), P93; Santosh KC, 2018, IEEE T MED IMAGING, V37, P1168, DOI 10.1109/TMI.2017.2775636; Sharif M.I., 2021, COMPLEX INTELL SYST, P1, DOI [10.1007/s40747-021-00321-0, DOI 10.1007/s40747-021-00321-0]; Sifre L, 2014, THESIS; Sokooti H, 2021, IEEE ACCESS, V9, P62008, DOI 10.1109/ACCESS.2021.3074124; Stephen O, 2019, J HEALTHC ENG, V2019, DOI 10.1155/2019/4180949; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2017, 31 AAAI C ART INT, P1, DOI DOI 10.5555/3298023.3298188; Thakur S., 2021, ADV INTELLIGENT SYST, DOI [10.1007/978-981-15-4992-2_31, DOI 10.1007/978-981-15-4992-2_31]; Tilve A, 2020, 2020 INT C EMERGING, P1, DOI 10.1109/ic-ETITE47903.2020.152; Tobias Rogelio Ruzcko NMI, 2020, 2020 RIVF INT C COMP; Wozniak M, 2018, SWARM EVOL COMPUT, V41, P69, DOI 10.1016/j.swevo.2018.01.008; Xia XL, 2017, 2017 2ND INTERNATIONAL CONFERENCE ON IMAGE, VISION AND COMPUTING (ICIVC 2017), P783, DOI 10.1109/ICIVC.2017.7984661; Xu KL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122054; Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199; Zhang Q., 2018, CHONGQING DAXUE XUEB, DOI [10.11835/j.issn.1000-582X.2018.05.011, DOI 10.11835/J.ISSN.1000-582X.2018.05.011]; Zhang S., 2019, JISUANJI XUEBAO, DOI [10.11897/SP.J.1016.2019.00453, DOI 10.11897/SP.J.1016.2019.00453]; [张燕 Zhang Yan], 2020, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V26, P643	50	3	3	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258804	10.1371/journal.pone.0258804	http://dx.doi.org/10.1371/journal.pone.0258804			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735483	gold, Green Published			2022-12-26	WOS:000755077100034
J	Landin, EJB; Williams, C; Ryan, SA; Bochel, A; Akter, N; Redfield, C; Sessions, RB; Dedi, N; Taylor, RJ; Crump, MP				Landin, Erik J. B.; Williams, Christopher; Ryan, Sara A.; Bochel, Alice; Akter, Nahida; Redfield, Christina; Sessions, Richard B.; Dedi, Neesha; Taylor, Richard J.; Crump, Matthew P.			The structural basis for high affinity binding of alpha 1-acid glycoprotein to the potent antitumor compound UCN-01	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA(1)-ACID GLYCOPROTEIN; GENETIC-VARIANTS; HEPATIC-UPTAKE; DRUG-BINDING; PROTEIN; PHARMACOKINETICS; IMATINIB; CLEARANCE; INHIBITOR; DYNAMICS	The alpha 1-acid glycoprotein (AGP) is an abundant blood plasma protein with important immunomodulatory functions coupled to endogenous and exogenous ligand-binding properties. Its affinity for many drug-like structures, however, means AGP can have a significant effect on the pharmokinetics and pharmacodynamics of numerous small molecule therapeutics. Staurosporine, and its hydroxylated forms UCN-01 and UCN-02, are kinase inhibitors that have been investigated at length as antitumour compounds. Despite their potency, these compounds display poor pharmokinetics due to binding to both AGP variants, AGP1 and AGP2. The recent renewed interest in UCN-01 as a cytostatic protective agent prompted us to solve the structure of the AGP2-UCN-01 complex by X-ray crystallography, revealing for the first time the precise binding mode of UCN-01. The solution NMR suggests AGP2 undergoes a significant conformational change upon ligand binding, but also that it uses a common set of sidechains with which it captures key groups of UCN-01 and other small molecule ligands. We anticipate that this structure and the supporting NMR data will facilitate rational redesign of small molecules that could evade AGP and therefore improve tissue distribution.	[Landin, Erik J. B.; Williams, Christopher; Ryan, Sara A.; Bochel, Alice; Akter, Nahida; Crump, Matthew P.] Univ Bristol, Sch Chem, Bristol, Avon, England; [Williams, Christopher] Univ Bristol, BrisSynBio, Bristol, Avon, England; [Redfield, Christina] Univ Oxford, Dept Biochem, Oxford, England; [Sessions, Richard B.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Dedi, Neesha; Taylor, Richard J.] UCB Biopharma, Discovery Sci, Slough, Berks, England	University of Bristol; University of Bristol; University of Oxford; University of Bristol	Crump, MP (corresponding author), Univ Bristol, Sch Chem, Bristol, Avon, England.; Taylor, RJ (corresponding author), UCB Biopharma, Discovery Sci, Slough, Berks, England.	Richard.taylor@ucb.com; matt.crump@bristol.ac.uk	AKTER, NAHIDA/GRO-3281-2022; Williams, Christopher/P-4904-2015	AKTER, NAHIDA/0000-0002-1164-8051; Landin, Erik/0000-0002-7367-8985; Akter, Nahida/0000-0001-7091-7090; Crump, Matthew/0000-0002-7868-5818; Bochel, Alice/0000-0003-2517-4990; Williams, Christopher/0000-0001-5806-9842; Ryan, Sara/0000-0003-4035-8536; Sessions, Richard/0000-0003-0320-0895	BBSRC SWBIO DTP [BB/T008741/1]; BBSRC/EPSRC; Bristol Centre for Synthetic Biology [BB/L01386X/1]; Commonwealth Scholarship Commission [BDCS-2017-50]; EPSRC [EP/R029849/1]; Wellcome Institutional Strategic Support Fund; John Fell Fund; Edward Penley Abraham Cephalosporin Fund at the University of Oxford	BBSRC SWBIO DTP(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/EPSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Engineering & Physical Sciences Research Council (EPSRC)); Bristol Centre for Synthetic Biology; Commonwealth Scholarship Commission; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Institutional Strategic Support Fund; John Fell Fund; Edward Penley Abraham Cephalosporin Fund at the University of Oxford	Funding and additional information-We thank the BBSRC SWBIO DTP (BB/T008741/1) for funding (E. J. B. L. and A. B.) . We thank BBSRC/EPSRC for funding C. W. and the Bristol 700 MHz NMR facility through the Bristol Centre for Synthetic Biology (BB/L01386X/1) . We also thank the Commonwealth Scholarship Commission for funding (N. A.) (BDCS-2017-50) . We thank EPSRC (EP/R029849/1) and the Wellcome Institutional Strategic Support Fund, John Fell Fund and Edward Penley Abraham Cephalosporin Fund at the University of Oxford, for funding the 950 MHz NMR facility.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bteich M, 2021, J PHARM SCI-US, V110, P1385, DOI [10.1016/j.xphs.2020.07.009, 10.1016/j.xphs.2020.11.009]; Bteich M, 2020, J PHARM SCI-US, V109, P3190, DOI 10.1016/j.xphs.2020.07.003; Bteich M, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02879; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; di Masi A, 2016, J CONTROL RELEASE, V228, P191, DOI 10.1016/j.jconrel.2016.02.049; Elg SA, 1997, CANCER, V80, P1448, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1448::AID-CNCR12>3.3.CO;2-D; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes CL, 2015, GLYCOBIOLOGY, V25, P1125, DOI 10.1093/glycob/cwv041; Fitos I, 2012, INT J BIOL MACROMOL, V50, P788, DOI 10.1016/j.ijbiomac.2011.11.023; Fitos I, 2006, BBA-GEN SUBJECTS, V1760, P1704, DOI 10.1016/j.bbagen.2006.08.015; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fuse E, 1998, CANCER RES, V58, P3248; Fuse E, 2005, J CLIN PHARMACOL, V45, P394, DOI 10.1177/0091270005274549; Gambacorti-Passerini C, 2003, CLIN CANCER RES, V9, P625; Herve F, 1998, MOL PHARMACOL, V54, P129, DOI 10.1124/mol.54.1.129; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Huang ZQ, 2013, CURR DRUG METAB, V14, P226; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Israili ZH, 2001, DRUG METAB REV, V33, P161, DOI 10.1081/DMR-100104402; Jackson JR, 2000, CANCER RES, V60, P566; Jo M, 2017, J NEUROSCI, V37, P2878, DOI 10.1523/JNEUROSCI.2534-16.2017; Johnson LN, 2002, PHARMACOL THERAPEUT, V93, P113, DOI 10.1016/S0163-7258(02)00181-X; Katsuki M, 2004, PHARM RES-DORDR, V21, P1648, DOI 10.1023/B:PHAM.0000041461.93787.6b; Kumar K, 2018, CHEM SCI, V9, P2655, DOI 10.1039/c7sc04905f; Mills JL, 2009, BIOCHEMISTRY-US, V48, P7411, DOI 10.1021/bi900535j; MIZUNO K, 1995, FEBS LETT, V359, P259, DOI 10.1016/0014-5793(95)00042-8; Mull BB, 2020, BRIT J CANCER, V122, P812, DOI 10.1038/s41416-019-0707-z; Nishi K, 2019, J PHARM SCI-US, V108, P3911, DOI 10.1016/j.xphs.2019.09.003; Nishi K, 2011, J BIOL CHEM, V286, P14427, DOI 10.1074/jbc.M110.208926; Omura S, 2018, J ANTIBIOT, V71, P688, DOI 10.1038/s41429-018-0029-z; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Ruiz M, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.686251; Schonfeld DL, 2008, J MOL BIOL, V384, P393, DOI 10.1016/j.jmb.2008.09.020; Smith SA, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-018-2551-x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilson W, 2017, UCN 01 7 HYDROXYSTAU; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu D, 2018, P NATL ACAD SCI USA, V115, P8763, DOI 10.1073/pnas.1807439115; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200	45	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101392	10.1016/j.jbc.2021.101392	http://dx.doi.org/10.1016/j.jbc.2021.101392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34758357	Green Published, gold			2022-12-26	WOS:000748397200010
J	McKee, AG; Kuntz, CP; Ortega, JT; Woods, H; Most, V; Roushar, FJ; Meiler, J; Jastrzebska, B; Schlebach, JP				McKee, Andrew G.; Kuntz, Charles P.; Ortega, Joseph T.; Woods, Hope; Most, Victoria; Roushar, Francis J.; Meiler, Jens; Jastrzebska, Beata; Schlebach, Jonathan P.			Systematic profiling of temperature- and retinal-sensitive rhodopsin variants by deep mutational scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CYSTIC-FIBROSIS; TEZACAFTOR-IVACAFTOR; POTASSIUM CHANNEL; PROTEIN; SOFTWARE; FLEXIBILITY; PARAMETERS; ENERGETICS; INSIGHTS	Membrane protein variants with diminished conformational stability often exhibit enhanced cellular expression at reduced growth temperatures. The expression of "temperature-sensitive" variants is also typically sensitive to corrector molecules that bind and stabilize the native conformation. There are many examples of temperature-sensitive rhodopsin variants, the misfolding of which is associated with the molecular basis of retinitis pigmentosa. In this work, we employ deep mutational scanning to compare the effects of reduced growth temperature and 9-cis-retinal, an investigational corrector, on the plasma membrane expression of 700 rhodopsin variants in HEK293T cells. We find that the change in expression at reduced growth temperatures correlates with the response to 9-cis-retinal among variants bearing mutations within a hydrophobic transmembrane domain (TM2). The most sensitive variants appear to disrupt a native helical kink within this transmembrane domain. By comparison, mutants that alter the structure of a polar transmembrane domain (TM7) exhibit weaker responses to temperature and retinal that are poorly correlated. Statistical analyses suggest that this observed insensitivity cannot be attributed to a single variable, but likely arises from the composite effects of mutations on the energetics of membrane integration, the stability of the native conformation, and the integrity of the retinal-binding pocket. Finally, we show that the characteristics of purified temperature- and retinal-sensitive variants suggest that the proteostatic effects of retinal may be manifested during translation and cotranslational folding. Together, our findings highlight several biophysical constraints that appear to influence the sensitivity of genetic variants to temperature and small-molecule correctors.	[McKee, Andrew G.; Kuntz, Charles P.; Roushar, Francis J.; Schlebach, Jonathan P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Ortega, Joseph T.; Jastrzebska, Beata] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Woods, Hope; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Woods, Hope] Vanderbilt Univ, Chem & Phys Biol Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Most, Victoria; Meiler, Jens] Univ Leipzig, Inst Drug Dev, Leipzig, SAC, Germany	Indiana University System; Indiana University Bloomington; Case Western Reserve University; Vanderbilt University; Vanderbilt University; Leipzig University	Schlebach, JP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	jschleba@indiana.edu	Ortega, Joseph/AFN-8883-2022	Meiler, Jens/0000-0001-8945-193X; Most, Victoria/0000-0002-2263-4608; Jastrzebska, Beata/0000-0001-5209-8685	National Institutes of Health (NIH) [R01GM129261, EY025214]; Graduate Training Program in Quantitative and Chemical Biology at Indiana University [T32 GM109825]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Training Program in Quantitative and Chemical Biology at Indiana University	This research was supported in part by grants from the National Institutes of Health (NIH) (R01GM129261 to J. P. S. and EY025214 to B. J.). F. J. R. acknowledges receipt of a predoctoral fellowship from the Graduate Training Program in Quantitative and Chemical Biology at Indiana University (T32 GM109825). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Cao Z, 2012, P NATL ACAD SCI USA, V109, P8121, DOI 10.1073/pnas.1201298109; Cheong HI, 2007, NEPHROLOGY, V12, P113, DOI 10.1111/j.1440-1797.2006.00759.x; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Fleming KG, 2014, ANNU REV BIOPHYS, V43, P233, DOI 10.1146/annurev-biophys-051013-022926; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Isin B, 2008, BIOPHYS J, V95, P789, DOI 10.1529/biophysj.107.120691; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Koulechova DA, 2015, J MOL BIOL, V427, P3316, DOI 10.1016/j.jmb.2015.08.014; Kroncke BM, 2016, BIOCHEMISTRY-US, V55, P5002, DOI 10.1021/acs.biochem.6b00537; Kroncke BM, 2015, BIOCHEMISTRY-US, V54, P2551, DOI 10.1021/acs.biochem.5b00189; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mallory DP, 2018, BIOCHEMISTRY-US, V57, P5188, DOI 10.1021/acs.biochem.8b00403; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; Matreyek KA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx183; Middleton PG, 2019, NEW ENGL J MED, V381, P1809, DOI 10.1056/NEJMoa1908639; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; O'Donnell BM, 2017, J BIOL CHEM, V292, P12813, DOI 10.1074/jbc.M117.786376; Penn WD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay7505; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Roushar FJ, 2019, J AM CHEM SOC, V141, P204, DOI 10.1021/jacs.8b08243; Salazar MD, 2020, BIOCHEMISTRY-US, V59, P1367, DOI 10.1021/acs.biochem.9b00956; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Seurig M, 2019, NAT CHEM BIOL, V15, P945, DOI 10.1038/s41589-019-0356-9; Singhal A, 2016, EMBO REP, V17, P1431, DOI 10.15252/embr.201642671; Singhal A, 2013, EMBO REP, V14, P520, DOI 10.1038/embor.2013.44; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Tian H, 2017, BIOPHYS J, V113, P60, DOI 10.1016/j.bpj.2017.05.036; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	44	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101359	10.1016/j.jbc.2021.101359	http://dx.doi.org/10.1016/j.jbc.2021.101359			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756884	Green Published, Green Submitted, gold			2022-12-26	WOS:000765319800007
J	Sirp, A; Roots, K; Nurm, K; Tuvikene, J; Sepp, M; Timmusk, T				Sirp, Alex; Roots, Kaisa; Nurm, Kaja; Tuvikene, Juergen; Sepp, Mari; Timmusk, Tonis			Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; COMMON VARIANTS; CONFERRING RISK; CLINICAL SCORE; MUTATIONS; GENE; FAMILY; HAPLOINSUFFICIENCY	Transcription factor 4 (TCF4) is a basic helix-loop-helix transcription factor essential for neurocognitive development. The aberrations in TCF4 are associated with neuro-developmental disorders including schizophrenia, intellectual disability, and Pitt-Hopkins syndrome, an autism-spectrum disorder characterized by developmental delay. Several disease-associated missense mutations in TCF4 have been shown to interfere with TCF4 function, but for many mutations, the impact remains undefined. Here, we tested the effects of 12 functionally uncharacterized disease-associated missense mutations and variations in TCF4 using transient expression in mammalian cells, confocal imaging, in vitro DNA-binding assays, and reporter assays. We show that Pitt-Hopkins syndrome-associated missense mutations within the basic helix-loop-helix domain of TCF4 and a Rett-like syndrome-associated mutation in a transcription activation domain result in altered DNA-binding and transcriptional activity of the protein. Some of the missense variations found in schizophrenia patients slightly increase TCF4 transcriptional activity, whereas no effects were detected for missense mutations linked to mild intellectual disability. We in addition find that the outcomes of several disease-related mutations are affected by cell type, TCF4 isoform, and dimerization partner, suggesting that the effects of TCF4 mutations are context-dependent. Together with previous work, this study provides a basis for the interpretation of the functional consequences of TCF4 missense variants.	[Sirp, Alex; Roots, Kaisa; Nurm, Kaja; Tuvikene, Juergen; Sepp, Mari; Timmusk, Tonis] Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia; [Tuvikene, Juergen; Timmusk, Tonis] Protobios LLC, Tallinn, Estonia; [Sepp, Mari] Heidelberg Univ ZMBH, Ctr Mol Biol, D-69120 Heidelberg, Germany	Tallinn University of Technology; Protobios LLC; Ruprecht Karls University Heidelberg	Sepp, M; Timmusk, T (corresponding author), Tallinn Univ Technol, Dept Chem & Biotechnol, Tallinn, Estonia.; Timmusk, T (corresponding author), Protobios LLC, Tallinn, Estonia.; Sepp, M (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, D-69120 Heidelberg, Germany.	m.sepp@zmbh.uni-heidelberg.de; tonis.timmusk@taltech.ee	; Timmusk, Tonis/H-4889-2015; Sepp, Mari/F-5987-2012	Sirp, Alex/0000-0002-0439-7952; Tuvikene, Jurgen/0000-0002-9665-760X; Roots, Kaisa/0000-0002-0060-300X; Timmusk, Tonis/0000-0002-1015-3348; Sepp, Mari/0000-0003-1733-8385	European Regional Development Fund [ASTRA 2014-2020.4.01.16-0032]; Estonian Research Council [IUT19-18, PRG805]; European Union through the European Regional Development Fund [2014-2020.4.01.15-0012]; H2020-MSCA-RISE-2016 [EU734791]; Pitt Hopkins Research Foundation [8, 21]; Million Dollar Bike Ride Pilot Grant Program for Rare Disease Research at the University of Pennsylvania Orphan Disease Center [MDBR-16-122-PHP, MDBR-17-127-Pitt Hopkins]	European Regional Development Fund(European Commission); Estonian Research Council(Estonian Research Council); European Union through the European Regional Development Fund(European Commission); H2020-MSCA-RISE-2016; Pitt Hopkins Research Foundation; Million Dollar Bike Ride Pilot Grant Program for Rare Disease Research at the University of Pennsylvania Orphan Disease Center	We thank Epp Vali for technical assistance and Laura Tamberg and Anastassia Subina for discussions and critical reading of the article. We thank the 'TUT Institutional Development Program for 2016-2022' Graduate School in Clinical Medicine, which received funding from the European Regional Development Fund under program ASTRA 2014-2020.4.01.16-0032 in Estonia. This study was supported by Estonian Research Council (institutional research funding IUT19-18 and grant PRG805), European Union through the European Regional Development Fund (Project no. 2014-2020.4.01.15-0012) and H2020-MSCA-RISE-2016 (EU734791), Pitt Hopkins Research Foundation (Grants no. 8 and 21) and Million Dollar Bike Ride Pilot Grant Program for Rare Disease Research at the University of Pennsylvania Orphan Disease Center (grants MDBR-16-122-PHP and MDBR-17-127-Pitt Hopkins).	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Badowska DM, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-01026-7; Basmanav FB, 2015, AM J MED GENET B, V168, P354, DOI 10.1002/ajmg.b.32318; Brockschmidt A, 2007, HUM MOL GENET, V16, P1488, DOI 10.1093/hmg/ddm099; Brzozka MM, 2010, BIOL PSYCHIAT, V68, P33, DOI 10.1016/j.biopsych.2010.03.015; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chang W, 1996, J BIOL CHEM, V271, P17733, DOI 10.1074/jbc.271.30.17733; Chen WY, 2013, GENE DEV, V27, P1596, DOI 10.1101/gad.216192.113; de Pontual L, 2009, HUM MUTAT, V30, P669, DOI 10.1002/humu.20935; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; Esvald EE, 2020, J NEUROSCI, V40, P1405, DOI 10.1523/JNEUROSCI.0367-19.2019; Fischer B, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-23; Forrest M, 2012, HUM MUTAT, V33, P1676, DOI 10.1002/humu.22160; Forrest MP, 2018, SCHIZOPHRENIA BULL, V44, P1100, DOI 10.1093/schbul/sbx164; Forrest MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073169; Goldfarb AN, 1998, J BIOL CHEM, V273, P2866, DOI 10.1074/jbc.273.5.2866; Greb-Markiewicz B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52239-w; Hamdan FF, 2013, CLIN GENET, V83, P198, DOI 10.1111/j.1399-0004.2012.01890.x; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hellwig M, 2019, ACTA NEUROPATHOL, V137, P657, DOI 10.1007/s00401-019-01982-5; Herbst A, 2008, BIOCHEM BIOPH RES CO, V370, P327, DOI 10.1016/j.bbrc.2008.03.081; Hu X, 2014, MOL PSYCHIATR, V19, P857, DOI 10.1038/mp.2013.131; Jung M, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0200-1; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kalscheuer VM, 2008, AM J MED GENET A, V146A, P2053, DOI 10.1002/ajmg.a.32419; Kennedy AJ, 2016, CELL REP, V16, P2666, DOI 10.1016/j.celrep.2016.08.004; Kharbanda M, 2016, EUR J MED GENET, V59, P310, DOI 10.1016/j.ejmg.2016.04.003; Kim H, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.00042; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lotan A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00331; Ma CG, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0114-x; Maduro V, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0439-6; Marangi G, 2012, AM J MED GENET A, V158A, P1604, DOI 10.1002/ajmg.a.35419; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Murre C, 2019, GENE DEV, V33, P6, DOI 10.1101/gad.320663.118; Page SC, 2018, MOL PSYCHIATR, V23, P304, DOI 10.1038/mp.2017.37; Persson P, 2000, BIOCHEM BIOPH RES CO, V274, P22, DOI 10.1006/bbrc.2000.3090; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quednow BB, 2014, CELL MOL LIFE SCI, V71, P2815, DOI 10.1007/s00018-013-1553-4; Quednow BB, 2011, J NEUROSCI, V31, P6684, DOI 10.1523/JNEUROSCI.0526-11.2011; Rannals MD, 2016, NEURON, V90, P43, DOI 10.1016/j.neuron.2016.02.021; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Schoof M, 2020, EUR J NEUROSCI, V51, P2219, DOI 10.1111/ejn.14674; Sepp M, 2012, HUM MOL GENET, V21, P2873, DOI 10.1093/hmg/dds112; Sepp M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022138; Sepp X, 2017, J NEUROSCI, V37, P10516, DOI [10.1513/JNEUROSCI.1151-17.2017, 10.1523/JNEUROSCI.1151-17.2017]; SHIRAKATA M, 1995, EMBO J, V14, P1766, DOI 10.1002/j.1460-2075.1995.tb07165.x; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Srivastava S, 2018, NEUROGENETICS, V19, P41, DOI 10.1007/s10048-017-0535-3; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, HUM MOL GENET, V20, P4076, DOI 10.1093/hmg/ddr325; Takano K, 2010, CLIN GENET, V78, P282, DOI 10.1111/j.1399-0004.2010.01380.x; Tamberg L, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.042747; Tamberg L, 2015, BIOL OPEN, V4, P1762, DOI 10.1242/bio.014696; Thaxton C, 2018, J NEUROSCI, V38, P918, DOI 10.1523/JNEUROSCI.1305-17.2017; Torshizi AD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4139; Whalen S, 2012, HUM MUTAT, V33, P64, DOI 10.1002/humu.21639; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Zhuang Y, 1996, MOL CELL BIOL, V16, P2898; Zollino M, 2019, CLIN GENET, V95, P462, DOI 10.1111/cge.13506; Zweier C, 2008, J MED GENET, V45, P738, DOI 10.1136/jmg.2008.060129; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	67	4	4	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101381	10.1016/j.jbc.2021.101381	http://dx.doi.org/10.1016/j.jbc.2021.101381			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0HN	34748727	gold, Green Published			2022-12-26	WOS:000748311800006
J	Yu, J; Schilling, L; Eller, T; Canalis, E				Yu, Jungeun; Schilling, Lauren; Eller, Tabitha; Canalis, Ernesto			Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; BONE-RESORBING ACTIVITY; HAJDU-CHENEY-SYNDROME; CELL-CELL FUSION; DC-STAMP; HES GENES; OC-STAMP; RANKL; TRANSCRIPTION; MUTATIONS	Notch2(tm1)(.)(1Ecan) mice, which harbor a mutation replicating that found in Hajdu-Cheney syndrome, exhibit marked osteopenia because of increased osteoclast number and bone resorption. Hairy and enhancer of split 1 (HES1) is a Notch target gene and a transcriptional modulator that determines osteoclast cell fate decisions. Transcript levels of Hes1 increase in Notch2(tm1)(.)(1Ecan) bone marrow-derived macrophages (BMMs) as they mature into osteoclasts, suggesting a role in osteoclastogenesis. To determine whether HES1 is responsible for the phenotype of Notch2(tm1)(.)(1Ecan) mice and the skeletal manifestations of Hajdu-Cheney syndrome, Hesl was inactivated in Ctsk-expressing cells from Notch2(tm1)(.)(1Ecan) mice. Ctsk encodes the protease cathepsin K, which is expressed preferentially by osteoclasts. We found that the osteopenia of Notch2(tm1)(.)(1Ecan) mice was ameliorated, and the enhanced osteoclastogenesis was reversed in the context of the Hes1 inactivation. Microcomputed tomography revealed that the downregulation of Hes1 in Ctsk-expressing cells led to increased bone volume/total volume in female mice. In addition, cultures of BMMs from Ctsk(Cre/WT);Hes1(Delta/Delta) mice displayed a decrease in osteoclast number and size and decreased bone-resorbing capacity. Moreover, activation of HES1 in Ctsk-expressing cells led to osteopenia and enhanced osteoclast number, size, and bone resorptive capacity in BMM cultures. Osteoclast phenotypes and RNA-Seq of cells in which HES1 was activated revealed that HES1 modulates cell-cell fusion and bone-resorbing capacity by supporting sealing zone formation. In conclusion, we demonstrate that HES1 is mechanistically relevant to the skeletal manifestation of Notch2(tm1)(.)(1Ecan) mice and is a novel determinant of osteoclast differentiation and function.	[Yu, Jungeun; Canalis, Ernesto] UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA; [Yu, Jungeun; Schilling, Lauren; Eller, Tabitha; Canalis, Ernesto] UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA; [Canalis, Ernesto] UConn Hlth, Dept Med, Farmington, CT 06030 USA		Canalis, E (corresponding author), UConn Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, UConn Musculoskeletal Inst, Farmington, CT 06030 USA.; Canalis, E (corresponding author), UConn Hlth, Dept Med, Farmington, CT 06030 USA.	canalis@uchc.edu		Yu, Jungeun/0000-0002-4036-4867	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [AR078149, AR072987]; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [DK045227]	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health grant AR078149 (to E. C.) and AR072987 (to E. C.) and from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health DK045227 (to E. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Blumenauer BT, 2002, CLIN EXP RHEUMATOL, V20, P574; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Canalis E, 2018, OSTEOPOROSIS INT, V29, P2611, DOI 10.1007/s00198-018-4694-3; Canalis E, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.620334; Canalis E, 2018, J BIOL CHEM, V293, P14165, DOI 10.1074/jbc.RA118.004242; Canalis E, 2018, METABOLISM, V80, P48, DOI 10.1016/j.metabol.2017.08.002; Canalis E, 2017, ENDOCRINOLOGY, V158, P730, DOI 10.1210/en.2016-1787; Canalis E, 2016, J BIOL CHEM, V191, P1538, DOI 10.1074/jbc.M115.685453; Chen XW, 2019, J CELL PHYSIOL, V234, P20944, DOI 10.1002/jcp.28699; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Csete D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00937; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Feng X, 2013, BONE RES, V1, DOI 10.4248/BR201301003; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hotokezaka H, 2007, J CELL BIOCHEM, V101, P122, DOI 10.1002/jcb.21167; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Ishii M, 2008, MOD RHEUMATOL, V18, P220, DOI 10.1007/s10165-008-0051-2; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Jacome-Galarza C, 2014, J CELL BIOCHEM, V115, P1449, DOI 10.1002/jcb.24801; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JH, 2009, J IMMUNOL, V183, P1862, DOI 10.4049/jimmunol.0803007; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Kwon JO, 2016, BIOCHEM BIOPH RES CO, V477, P1078, DOI 10.1016/j.bbrc.2016.07.046; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00450; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Mun SH, 2021, J BONE MINER RES, V36, P1104, DOI 10.1002/jbmr.4270; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Sakka S, 2017, J CLIN ENDOCR METAB, V102, P4163, DOI 10.1210/jc.2017-01102; Shin B, 2014, J BIOL CHEM, V289, P35868, DOI 10.1074/jbc.M114.589614; Shiratori T, 2018, J IMMUNOL, V200, P218, DOI 10.4049/jimmunol.1602035; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Soysa NS, 2016, BIOCHEM BIOPH RES CO, V476, P115, DOI 10.1016/j.bbrc.2016.05.019; Spinardi L, 2006, EUR J CELL BIOL, V85, P191, DOI 10.1016/j.ejcb.2005.08.005; Sugita S, 2015, P NATL ACAD SCI USA, V112, P3080, DOI 10.1073/pnas.1419699112; Takagi T, 2017, BIOSCI BIOTECH BIOCH, V81, P1220, DOI 10.1080/09168451.2017.1281729; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takito J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040984; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tiedemann K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00054; UDELL J, 1986, ARTHRITIS RHEUM, V29, P1032, DOI 10.1002/art.1780290815; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Wong GW, 2012, BLOOD, V120, P1439, DOI 10.1182/blood-2011-12-395319; Xing LP, 2012, WORLD J ORTHOP, V3, P212, DOI 10.5312/wjo.v3.i12.212; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang M, 2008, J CELL PHYSIOL, V215, P497, DOI 10.1002/jcp.21331; Yang YL, 2019, J BIOL CHEM, V294, P15395, DOI 10.1074/jbc.RA119.010139; Yao J, 2001, MOL CELL BIOL, V21, P1962, DOI 10.1128/MCB.21.6.1962-1972.2001; Yu J, 2020, BONE, V138, DOI 10.1016/j.bone.2020.115474; Yu J, 2019, J BIOL CHEM, V294, P14203, DOI 10.1074/jbc.RA119.009824; Yu JG, 2018, AM J PATHOL, V188, P149, DOI 10.1016/j.ajpath.2017.09.010; Zanotti S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086757; Zanotti S, 2011, J BIOL CHEM, V286, P2648, DOI 10.1074/jbc.M110.183038; Zhao BH, 2017, CURR OSTEOPOROS REP, V15, P126, DOI 10.1007/s11914-017-0358-z; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao W, 2013, OSTEOPOROSIS INT, V24, P2275, DOI 10.1007/s00198-013-2298-5	85	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101376	10.1016/j.jbc.2021.101376	http://dx.doi.org/10.1016/j.jbc.2021.101376			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34742737	gold, Green Published			2022-12-26	WOS:000748084900003
J	Bortolotto, GA; Thomas, L; Hammond, P; Zerbini, AN				Bortolotto, Guilherme A.; Thomas, Len; Hammond, Philip; Zerbini, Alexandre N.			Alternative method for assessment of southwestern Atlantic humpback whale population status	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; BAYESIAN-APPROACH; ABROLHOS BANK; ABUNDANCE; BRAZIL; GROUNDS	The population of humpback whales (Megaptera novaeangliae) wintering off eastern South America was exploited by commercial whaling almost to the point of extinction in the mid-twentieth century. Since cessation of whaling in the 1970s it is recovering, but the timing and level of recovery is uncertain. We implemented a Bayesian population dynamics model describing the population's trajectory from 1901 and projecting it to 2040 to revise a previous population status assessment that used Sampling-Importance-Resampling in a Bayesian framework. Using our alternative method for model fitting (Markov chain Monte Carlo), which is more widely accessible to ecologists, we replicate a "base case scenario" to verify the effect on model results, and introduce additional data to update the status assessment. Our approach allowed us to widen the previous informative prior on carrying capacity to better reflect scientific uncertainty around historical population levels. The updated model provided more precise estimates for population sizes over the period considered (1901-2040) and suggests that carrying capacity (K: median 22,882, mean 22,948, 95% credible interval [CI] 22,711-23,545) and minimum population size (N-1958: median 305, mean 319, 95% CI 271-444) might be lower than previously estimated (K: median 24,558, mean 25,110, 95% CI 22,791-31,118; N-1958: median 503, mean 850, 95% CI 159-3,943). However, posterior 95% credible intervals of parameters in the updated model overlap those of the previous study. Our approach provides an accessible framework for investigating the status of depleted animal populations for which information is available on historical mortality (e.g., catches) and intermittent estimates of population size and/or trend.	[Bortolotto, Guilherme A.; Hammond, Philip] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Bortolotto, Guilherme A.; Thomas, Len; Hammond, Philip] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland; [Bortolotto, Guilherme A.; Zerbini, Alexandre N.] Inst Aqualie Juiz de Fora, Minas Gerais, Brazil; [Zerbini, Alexandre N.] Univ Washington, Cooperat Inst Climate, Ocean & Ecosystem Studies, Seattle, WA 98195 USA; [Zerbini, Alexandre N.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Marine Mammal Lab, Seattle, WA 98115 USA; [Zerbini, Alexandre N.] Marine Ecol & Telemetry Res, Seabeck, WA USA	University of St Andrews; University of St Andrews; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Bortolotto, GA (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.; Bortolotto, GA (corresponding author), Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland.; Bortolotto, GA (corresponding author), Inst Aqualie Juiz de Fora, Minas Gerais, Brazil.	bortolotto.ga@gmail.com		Hammond, Philip/0000-0002-2381-8302; Bortolotto, Guilherme Augusto/0000-0002-5343-6575; Thomas, Len/0000-0002-7436-067X	Brazilian National Council for Scientific and Technological Development [208203/2014-1]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work is a result of GAB PhD studies, for which the Brazilian National Council for Scientific and Technological Development (https:// www.gov.br/cnpq/pt-br) granted scholarship number 208203/2014-1, through the Science without borders programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C., 2006, SCA06HW47 IWC WORK; Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; Andriolo Artur, 2010, Endangered Species Research, V11, P233, DOI 10.3354/esr00282; Anonymous, 2011, Journal of Cetacean Research and Management Special Issue, V3, P1; Auger-Methe M, 2021, ECOL MONOGR, V91, DOI 10.1002/ecm.1470; Bezamat C, 2015, AQUAT CONSERV, V25, P712, DOI 10.1002/aqc.2523; Bortolotto GA, 2017, MAR ECOL PROG SER, V585, P213, DOI 10.3354/meps12393; Bortolotto GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164596; de Morais IOB, 2017, MAMMAL REV, V47, P11, DOI 10.1111/mam.12073; BRASIL M of M and E, 2016, AG NAC PETR GAS NAT; Butterworth DS., 1994, REP INT WHAL COMM, P491; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clapham PJ, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P1070; Clapham PJ., 2006, IWC SCI COMM; Engel MH, 2009, MAR MAMMAL SCI, V25, P964, DOI 10.1111/j.1748-7692.2009.00301.x; Findlay KP., 2000, MEM QUEENSL MUSEUM, V47, P411; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 1995, BAYESIAN DATA ANAL; Gimenez O., 2009, WINBUGS POPULATION E, DOI [10.1007/978-0-387-78151-8, DOI 10.1007/978-0-387-78151-8]; Jackson JA, 2006, SCA06HW52 IWC WORK C, P19; Johnston Susan J., 2011, Journal of Cetacean Research and Management, P309; Kruschke, 2014, DOING BAYESIAN DATA, P776; Marshall CR, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0217; Martins CCA., 2001, MEMOIRS QUEENSLAND M, V47, P563; MCALLISTER MK, 1994, CAN J FISH AQUAT SCI, V51, P2673, DOI 10.1139/f94-267; Newman KB, 2014, METH STAT ECOL, P1; Ott PH, 2016, INT WHAL COMM SCI CO; Pavanato HJ, 2017, ECOL MODEL, V358, P10, DOI 10.1016/j.ecolmodel.2017.05.003; Pella J. J., 1969, Bulletin Inter-American Tropical Tuna Commission, V13, P421; R Core Team, 2020, R LANG ENV STAT COMP; Rosenbaum HC., 2006, MITOCHONDRIAL DNA DI; Stevick Peter T., 2006, Journal of Cetacean Research and Management, V8, P297; Ward Eric, 2011, Journal of Cetacean Research and Management, P145; Wedekin LL, 2017, MAR ECOL PROG SER, V575, P195, DOI 10.3354/meps12211; Wedekin LL., 2011, THESIS U FEDERAL PAR; Wiliamson G.R., 1975, Scientific Rep Whales Res Inst Tokyo, VNo. 27, P37; Zemsky VA., 1996, SOVIET ANTARCTIC WHA, V2nd ed; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini AN, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190368; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P131; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y; Zerbini AN, 2005, IWC SCI COMM, P13	42	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259541	10.1371/journal.pone.0259541	http://dx.doi.org/10.1371/journal.pone.0259541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788309	Green Published, gold			2022-12-26	WOS:000735920500030
J	Cheong, SM; Assenova, VA				Cheong, So-Min; Assenova, Valentina A.			Absorptive capacity facilitates adaptation to novel environmental disasters	PLOS ONE			English	Article							CLIMATE-CHANGE ADAPTATION; EXPLORATION; STRATEGIES; INTERPLAY; SUPPORT	Absorptive capacity-the ability to learn and apply external knowledge and information to acquire material resources-is an essential but overlooked driver in community adaptation to new and unprecedented disasters. We analyzed data from a representative random sample of 603 individuals from 25 coastal communities in Louisiana affected by the Deepwater Horizon oil spill. We used simultaneous equation models to assess the relationship between absorptive capacity and resource acquisition for affected individuals after the disaster. Results show that the diversity of individuals' prior knowledge coupled with the community's external orientation and internal cohesion facilitate resource use. They go beyond simply providing resources and demonstrate individual and community features necessary for absorbing information and knowledge and help devise adaptation strategies to address the dynamics of changing economic, social, and political environment after the disaster.	[Cheong, So-Min] Univ Kansas, Dept Geog & Atmospher Sci, Lawrence, KS 66045 USA; [Assenova, Valentina A.] Univ Penn, Wharton Sch, Dept Management, Philadelphia, PA 19104 USA	University of Kansas; University of Pennsylvania	Cheong, SM (corresponding author), Univ Kansas, Dept Geog & Atmospher Sci, Lawrence, KS 66045 USA.	somin@ku.edu		/0000-0002-5637-8139	NSF CAREER Award; National Academies Gulf Research Program	NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Academies Gulf Research Program	The first author, So-Min Cheong received the NSF CAREER Award and the National Academies Gulf Research Program grant to conduct research related to the paper. So-Min Cheong's salary was supported with the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2018, NAT CLIM CHANGE, V8, P651, DOI 10.1038/s41558-018-0208-8; ANDREWS SB, 1995, ADMIN SCI QUART, V40, P355, DOI 10.2307/2393644; Chamlee-Wright E, 2009, J URBAN AFF, V31, P615, DOI 10.1111/j.1467-9906.2009.00479.x; Chen HP, 2017, GEOPHYS RES LETT, V44, P2436, DOI 10.1002/2016GL072439; Cheong SM, 2014, ECOL SOC, V19, DOI 10.5751/ES-06382-190229; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Collins M., 2019, EXTREMES ABRUPT CHAN, P589, DOI [10.1017/9781009157964.008, DOI 10.1017/9781009157964.008]; Cutter SL, 2021, ANN AM ASSOC GEOGR, V111, P819, DOI 10.1080/24694452.2020.1744423; Dale A, 2010, COMMUNITY DEV J, V45, P5, DOI 10.1093/cdj/bsn028; Forino G, 2017, INT J DISAST RISK RE, V24, P100, DOI 10.1016/j.ijdrr.2017.05.021; Goss M, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab83a7; Gupta AK, 2006, ACAD MANAGE J, V49, P693, DOI 10.2307/20159793; Izumi T, 2019, PROG DISASTER SCI, V2, DOI 10.1016/j.pdisas.2019.100033; Kawamoto K, 2019, INT J DISAST RISK RE, V33, P64, DOI 10.1016/j.ijdrr.2018.09.010; Lawrence J., 2017, ROUTLEDGE HDB DISAST, P418; Lubchenco J, 2012, P NATL ACAD SCI USA, V109, P20212, DOI 10.1073/pnas.1204729109; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; Masterson VA, 2017, ECOL SOC, V22, DOI 10.5751/ES-08872-220149; Matusik SF, 2005, J MANAGE, V31, P549, DOI 10.1177/0149206304272293; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mortreux C, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.467; Nangombe S, 2018, NAT CLIM CHANGE, V8, P375, DOI 10.1038/s41558-018-0145-6; Oktari RS, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101881; Perrow C., 2011, NORMAL ACCIDENTS; Portes A, 2014, P NATL ACAD SCI USA, V111, P18407, DOI 10.1073/pnas.1421888112; Rahman MT, 2019, INT J EMERG MANAG, V15, P276, DOI 10.1504/IJEM.2019.102314; Seebauer S, 2020, GLOBAL ENVIRON CHANG, V60, DOI 10.1016/j.gloenvcha.2019.102018; Siders AR, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.573; Smith EC, 2018, PREHOSP DISASTER MED, V33, P418, DOI 10.1017/S1049023X18000638; Talanow K, 2021, J RURAL STUD, V81, P203, DOI 10.1016/j.jrurstud.2020.10.026; Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640; Urwin K, 2008, GLOBAL ENVIRON CHANG, V18, P180, DOI 10.1016/j.gloenvcha.2007.08.002; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; White G.F., 2001, GLOBAL ENVIRON CHANG, V3, P81, DOI [10.3763/ehaz.2001.0308, DOI 10.3763/EHAZ.2001.0308, DOI 10.1016/S1464-2867(01)00021-3]; Wolf J, 2010, GLOBAL ENVIRON CHANG, V20, P44, DOI 10.1016/j.gloenvcha.2009.09.004	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259368	10.1371/journal.pone.0259368	http://dx.doi.org/10.1371/journal.pone.0259368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788322	Green Published, gold			2022-12-26	WOS:000735920500022
J	Ejigu, BA; Asfaw, MD; Cavalerie, L; Abebaw, T; Nanyingi, M; Baylis, M				Ejigu, Bedilu Alamirie; Asfaw, Manalebish Debalike; Cavalerie, Lisa; Abebaw, Tilahun; Nanyingi, Mark; Baylis, Matthew			Assessing the impact of non-pharmaceutical interventions (NPI) on the dynamics of COVID-19: A mathematical modelling study of the case of Ethiopia	PLOS ONE			English	Article								The World Health Organization (WHO) declared COVID-19 a pandemic on March 11, 2020 and by November 14, 2020 there were 53.3M confirmed cases and 1.3M reported deaths in the world. In the same period, Ethiopia reported 102K cases and 1.5K deaths. Effective public health preparedness and response to COVID-19 requires timely projections of the time and size of the peak of the outbreak. Currently, Ethiopia under the COVAX facility has begun vaccinating high risk populations but due to vaccine supply shortages and the absence of an effective treatment, the implementation of NPIs (non-pharmaceutical interventions), like hand washing, wearing face coverings or social distancing, still remain the most effective methods of controlling the pandemic as recommended by WHO. This study proposes a modified Susceptible Exposed Infected and Recovered (SEIR) model to predict the number of COVID-19 cases at different stages of the disease under the implementation of NPIs at different adherence levels in both urban and rural settings of Ethiopia. To estimate the number of cases and their peak time, 30 different scenarios were simulated. The results indicated that the peak time of the pandemic is different in urban and rural populations of Ethiopia. In the urban population, under moderate implementation of three NPIs the pandemic will be expected to reach its peak in December, 2020 with 147,972 cases, of which 18,100 are symptomatic and 957 will require admission to an Intensive Care Unit (ICU). Among the implemented NPIs, increasing the coverage of wearing masks by 10% could reduce the number of new cases on average by one-fifth in urban-populations. Varying the coverage of wearing masks in rural populations minimally reduces the number of cases. In conclusion, the models indicate that the projected number of hospital cases during the peak time is higher than the Ethiopian health system capacity. To contain symptomatic and ICU cases within the health system capacity, the government should pay attention to the strict implementation of the existing NPIs or impose additional public health measures.	[Ejigu, Bedilu Alamirie] Addis Ababa Univ, Coll Nat & Computat Sci, Dept Stat, Addis Ababa, Ethiopia; [Asfaw, Manalebish Debalike; Abebaw, Tilahun] Addis Ababa Univ, Coll Nat & Computat Sci, Dept Math, Addis Ababa, Ethiopia; [Cavalerie, Lisa; Nanyingi, Mark; Baylis, Matthew] Univ Liverpool, Inst Infect Vet & Ecol Sci, Dept Livestock & One Hlth, Liverpool, Merseyside, England; [Cavalerie, Lisa] Int Livestock Res Inst, Addis Ababa, Ethiopia; [Nanyingi, Mark] Univ Nairobi, Sch Publ Hlth, Dept Epidemiol & Publ Hlth, Nairobi, Kenya	Addis Ababa University; Addis Ababa University; University of Liverpool; CGIAR; International Livestock Research Institute (ILRI); University of Nairobi	Ejigu, BA (corresponding author), Addis Ababa Univ, Coll Nat & Computat Sci, Dept Stat, Addis Ababa, Ethiopia.	bedilu.alamirie@aau.edu.et		Cavalerie, Lisa/0000-0001-7187-3800; Asfaw, Manalebish Debalike/0000-0002-6435-7805	sandpit project of the One Health Regional Network for the Horn of Africa (HORN) project; UK Research and Innovation (UKRI); Global Challenges Research Fund (GCRF) from the Growing Research Capability call [BB/P027954/1]	sandpit project of the One Health Regional Network for the Horn of Africa (HORN) project; UK Research and Innovation (UKRI); Global Challenges Research Fund (GCRF) from the Growing Research Capability call	This work was supported as a sandpit project of the One Health Regional Network for the Horn of Africa (HORN) project to Addis Ababa University, Ethiopia. The HORN project is funded by UK Research and Innovation (UKRI) and the Global Challenges Research Fund (GCRF) from the Growing Research Capability call awarded to the University of Liverpool, UK (project number BB/P027954/1). Funders had no role in the design, analysis and interpretation of the results.	Africa CDC (Centre for Disease Control and Prevention), 2020, CORONAVIRUS DIS 2019; Alemneh HT., 2020, MATH MODELING OPTIMA, DOI [10.1101/2020.07.23.20160473, DOI 10.1101/2020.07.23.20160473]; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Banholzer N., 2020, IMPACT NONPHARMACEUT; Baye K., 2020, INT FOOD POLICY RES; Bloomfield SF, 2007, AM J INFECT CONTROL, V35, pS27, DOI 10.1016/j.ajic.2007.07.001; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV KE; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; EPHI. Ethiopian Public Health Institute, 2020, COVID 19 PANDEMIC PR; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Frost I, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044149; Goshu D, 2020, EC WELFARE EFFECTS C; Health NJ, 2020, HAND WASHING; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Kassa SM, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109968; Kebede SW., 2020, FRONTIER; Khoshnaw SHA, 2020, MATH MODEL NAT PHENO, V15, DOI 10.1051/mmnp/2020020; Laelago T, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0677-x; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; MATLAB, 2020, MATWORKSTHE LANGUAGE; Musa R., ASSESSMENT IMPACTS P, DOI [10.1101/2020.11.13.20231159, DOI 10.1101/2020.11.13.20231159]; Neto OP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20687-y; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Nicholas GD., 2020, LANCET PUBLIC HEALTH; Njenga MK, 2020, AM J TROP MED HYG, V103, P564, DOI 10.4269/ajtmh.20-0474; OECD-Development-Pathways, 2020, RURAL DEV STRATEGY R; Oliveira JF, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-19798-3; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Patel M, 2021, SCI TOTAL ENVIRON, V765, DOI 10.1016/j.scitotenv.2020.142698; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Ryu S, 2020, EMERG INFECT DIS, V26, P961, DOI 10.3201/eid2605.190993; Shen L, 2020, J MED ECON, V23, P456, DOI 10.1080/13696998.2020.1717500; Siraj A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003055; Takele R, 2020, INFECT DIS MODEL, V5, P598, DOI 10.1016/j.idm.2020.08.005; United-Nations, 2020, UNWORLD POPULATION P; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Vytla Vishnu, 2021, Journal of Physics: Conference Series, V1797, DOI 10.1088/1742-6596/1797/1/012009; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; WHO . World Health Organisation, 2019, MONITORING HLTH SDGS; Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x; World Health Organization, 2021, NOV COR 2019 NCOV SI; World-Bank, 2016, MEASURING RURAL ACCE, P18; Xiao JY, 2020, EMERG INFECT DIS, V26, P967, DOI 10.3201/eid2605.190994; 2020, BMJ	48	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259874	10.1371/journal.pone.0259874	http://dx.doi.org/10.1371/journal.pone.0259874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784379	Green Submitted, Green Published, gold			2022-12-26	WOS:000755277300025
J	Li, XY; English, AS; Kulich, SJ				Li, Xiaoyuan; English, Alexander S.; Kulich, Steve J.			Anger among Chinese migrants amid COVID-19 discrimination: The role of host news coverage, cultural distance, and national identity	PLOS ONE			English	Article							COLLECTIVE SELF-ESTEEM; GROUP-BASED EMOTIONS; SOCIAL IDENTITY; INTERNATIONAL NEWS; VICARIOUS RACISM; ETHNIC MEDIA; ACCULTURATION; EXPERIENCES; IDENTIFICATION; AMERICANS	As the early COVID-19 outbreak sparked xenophobia against people of Asian and Chinese background, we collected data from Chinese migrants worldwide to test how discrimination at a macro-level was perceived by the Chinese during COVID-19 globally. Specifically, we examined (1) whether/how the Chinese migrants were aware of discrimination against their co-nationals during COVID; (2) if so, whether anger was a predominant reaction of these Chinese towards certain exposure to relevant information; (3) how responses of anger transcend across the group of Chinese migrants. Integrating the ecological approach to media and cultural psychology, as well as the intergroup perspective of social psychology, we conducted a study that explored the impact of traditional media exposure to discrimination on collective anger-a process mediated by national identity among the Chinese migrants. Findings provide some evidence that geographically dispersed mono-cultural groups may share or identify with collective emotions when facing xenophobic threats in a macro context. Further examination of cultural distance (between China and the host country) among the Chinese migrants also revealed a particular interaction between host newspaper coverage and cultural distance on national identity. These findings suggest further research to examine the emotional norms of similar cultures bonded via strong collective identities in times of intergroup threat and the theoretical possibility for diasporic identity processes.	[Li, Xiaoyuan; Kulich, Steve J.] Shanghai Int Studies Univ, Intercultural Inst, Shanghai, Peoples R China; [English, Alexander S.] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou, Zhejiang, Peoples R China	Shanghai International Studies University; Zhejiang University	English, AS (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou, Zhejiang, Peoples R China.	AEnglish@zju.edu.cn	English, Alexander/U-7190-2019	English, Alexander/0000-0002-0142-146X; Li, Xiaoyuan/0000-0003-1892-3594				Alencar A, 2017, EUR J COMMUN, V32, P151, DOI 10.1177/0267323117689993; Ali M, 2011, J MUSLIM MINOR AFF, V31, P355, DOI 10.1080/13602004.2011.599543; Anderson B., 1983, IMAGINED COMMUNITIES; Anderson Benedict, 1998, SPECTRE COMPARISONS, P192; [Anonymous], 2002, EXPLOR MEDIA ECOL; [Anonymous], 2020, UN NEWS; Appadurai A., 1996, MODERNITY LARGE CULT; Bailey OG., 2008, MEDIATED CROSSROADS, P17; Bank World, 2019, CHIN TRAD BAL EXP IM; Berry J.W., 2007, ACCULTURATION STRATE, P69; Berry JW., 2018, SOCIOECONOMIC ENV HU, DOI [10.1093/oso/9780190492908.001.0001, DOI 10.1093/OSO/9780190492908.001.0001]; Betton V, 2015, BRIT J PSYCHIAT, V206, P443, DOI 10.1192/bjp.bp.114.152835; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bos L, 2016, INT J INTERCULT REL, V55, P97, DOI 10.1016/j.ijintrel.2016.10.002; Branscombe NR, 1999, J PERS SOC PSYCHOL, V77, P135, DOI 10.1037/0022-3514.77.1.135; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bronfenbrenner U., 2005, MAKING HUMAN BEINGS, DOI [10.1016/s1499-4046(06)60265-0, DOI 10.1016/S1499-4046(06)60265-0]; Brooks R, 2021, BRIT J EDUC STUD, V69, P557, DOI 10.1080/00071005.2021.1948501; Chan M, 2017, J MASS COMMUN Q, V94, P663, DOI 10.1177/1077699016638837; Chang A, 2020, J MED INTERNET RES, V22, DOI 10.2196/21504; Chung RYN, 2020, LANCET, V395, P686, DOI 10.1016/S0140-6736(20)30358-5; CNN, 2020, CNN 0131; Cohen, 2007, HDB CULTURAL PSYCHOL, P307; Coleman S, 2016, MEDIATED CITY NEWS P; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Craig MA, 2016, CURR DIR PSYCHOL SCI, V25, P21, DOI 10.1177/0963721415611252; CROCKER J, 1994, PERS SOC PSYCHOL B, V20, P503, DOI 10.1177/0146167294205007; Croucher SM, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00039; Cui X, 2018, J BROADCAST ELECTRON, V62, P91, DOI 10.1080/08838151.2017.1402906; DeSteno D, 2004, PSYCHOL SCI, V15, P319, DOI 10.1111/j.0956-7976.2004.00676.x; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Djerf-Pierre M, 2017, J COMMUN, V67, P733, DOI 10.1111/jcom.12327; Doveling Katrin, 2009, THEORIZING EMOTIONS, P315; Drury J, 2018, EUR REV SOC PSYCHOL, V29, P38, DOI 10.1080/10463283.2018.1471948; English AS, 2021, INT J INTERCULT REL, V80, P349, DOI 10.1016/j.ijintrel.2020.10.006; Esses VM, 2021, GROUP PROCESS INTERG, V24, P253, DOI 10.1177/1368430220983470; Evans S, 2016, ENVIRON COMMUN, V10, P492, DOI 10.1080/17524032.2015.1088459; Fiddian-Qasmiyeh E., 2012, WILEY BLACKWELL ENCY, P1, DOI [10.1002/9780470670590.wbeog148, DOI 10.1002/9780470670590.WBEOG148]; Forgey Quint, 2020, POLITICO; Gao ZP, 2021, J HUMANIST PSYCHOL, V61, P198, DOI 10.1177/0022167820980620; Gee E., 2020, INT ENCY MEDIA PSYCH, P1, DOI [10.1002/9781119011071.iemp0161, DOI 10.1002/9781119011071.IEMP0161]; Georgiou M., 2005, DYNAMICS DIASPORAS S; Georgiou M., 2012, HDB GLOBAL MEDIA RES, P365; Giordano AL, 2021, J COLL COUNS, V24, P4, DOI 10.1002/jocc.12173; Greenwald AG, 2014, AM PSYCHOL, V69, P669, DOI 10.1037/a0036056; Gross K, 2003, J COMMUN, V53, P411, DOI 10.1093/joc/53.3.411; Guo L, 2020, J BROADCAST ELECTRON, V64, P418, DOI 10.1080/08838151.2020.1796391; Han N, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.632204; Himelboim I, 2010, J MASS COMMUN Q, V87, P297, DOI 10.1177/107769901008700205; Hopkins N, 2016, COGNITION EMOTION, V30, P20, DOI 10.1080/02699931.2015.1015969; Human Rights Watch,, 2020, COV 19 FUEL ANTIAS R; Imperato C, 2021, INT J INTERCULT REL, V81, P131, DOI 10.1016/j.ijintrel.2021.01.006; Jiang K, 2016, INT J COMMUN-US, V10, P3710; Kashima Y, 2021, GROUP PROCESS INTERG, V24, P223, DOI 10.1177/1368430220982075; Keles JY., 2019, HDB DIASPORAS MEDIA, P329; Kessler T, 2005, J EXP SOC PSYCHOL, V41, P677, DOI 10.1016/j.jesp.2005.01.001; Kim Y., 2021, ROUTLEDGE HDB ASIAN, P303; Kleinberg KB, 2010, J CONFLICT RESOLUT, V54, P687, DOI 10.1177/0022002710364128; Knobloch-Westerwick S, 2015, COMMUN RES, V42, P959, DOI 10.1177/0093650214539173; Kulich SJ., 2021, INT J INTERCULT REL, V80, pA1, DOI 0.1016/j.ijintrel.2020.12.003; Kuppens T, 2013, COGNITION EMOTION, V27, P1359, DOI 10.1080/02699931.2013.785387; Lawlor A, 2017, INT J COMMUN-US, V11, P967; LAZARUS RS, 1962, PSYCHOL MONOGR, V76, P1; Leonard DJ, 2011, GROUP PROCESS INTERG, V14, P99, DOI 10.1177/1368430210373779; Levenson T., 2020, ATLANTIC; Li XH, 2017, APPL MATH COMPUT, V310, P182, DOI 10.1016/j.amc.2017.03.031; Liu C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134720; Liu PL, 2020, CYBERPSYCH BEH SOC N, V23, P789, DOI 10.1089/cyber.2020.0363; Lu J., 2017, THESIS QUEENSLAND U, DOI [10.5204/thesis.eprints.112817, DOI 10.5204/THESIS.EPRINTS.112817]; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Ma Laurence J. C., 2003, CHINESE DIASPORA SPA; Mackie D.M., 2015, APA HDB PERSONALITY, P263, DOI [10.1037/14342-010, DOI 10.1037/14342-010]; Mackie DM, 2017, GROUP PROCESS INTERG, V20, P658, DOI 10.1177/1368430217702725; Maier S, 2010, J MASS COMMUN Q, V87, P548, DOI 10.1177/107769901008700307; Maoz I, 2009, J PEACE RES, V46, P525, DOI 10.1177/0022343309334613; Marino S, 2015, SOC MEDIA SOC, V1, DOI 10.1177/2056305115622479; Markus HR, 2017, PERSPECT PSYCHOL SCI, V12, P855, DOI 10.1177/1745691617718799; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mason TB, 2017, CULT DIVERS ETHN MIN, V23, P174, DOI 10.1037/cdp0000099; Matar D, 2006, J ETHN MIGR STUD, V32, P1027, DOI 10.1080/13691830600761537; McCombs M. E., 2005, JOURNALISM STUD, V6, P543, DOI [10.1080/14616700500250438, DOI 10.1080/14616700500250438]; McCombs ME, 2014, MASS COMMUN SOC, V17, P781, DOI 10.1080/15205436.2014.964871; Mercer D., 2020, CORONAVIRUS HATE CRI; Miconi D, 2020, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2020.146; Miller S. S, 2017, UNDERSTANDING ANGRY, P29; Misra S, 2020, PSYCHOL TRAUMA-US, V12, P461, DOI 10.1037/tra0000821; Miyamoto Y, 2013, ADV EXP SOC PSYCHOL, V47, P131, DOI 10.1016/B978-0-12-407236-7.00003-6; Monnier A., 2019, HDB DIASPORAS MEDIA, P343; Monterde A, 2015, INFORM COMMUN SOC, V18, P930, DOI 10.1080/1369118X.2015.1043315; Moon R, 2016, INT J COMMUN-US, V10, P2381; Moors A, 2013, EMOT REV, V5, P119, DOI 10.1177/1754073912468165; Morales PS, 2021, MEDIA CULT SOC, V43, P648, DOI 10.1177/0163443720972307; Morgan M, 2009, COMMUN SER, P34; Mundt M, 2018, SOC MEDIA SOC, V4, DOI 10.1177/2056305118807911; Muthukrishna M, 2020, PSYCHOL SCI, V31, P678, DOI 10.1177/0956797620916782; Nystrom C., 1973, THESIS NEW YORK U; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Painter J, 2020, CLIMATIC CHANGE, V162, P2379, DOI 10.1007/s10584-020-02813-3; Parker D., 2009, CHINA ABROAD TRAVELS, P225, DOI [10.5790/hongkong/9789622099456.003.0013, DOI 10.5790/HONGKONG/9789622099456.003.0013]; Pew Research Center, 2019, ATT CHIN; Porat R, 2016, COGNITION EMOTION, V30, P66, DOI 10.1080/02699931.2015.1039495; Reece D, 2000, INT J INTERCULT REL, V24, P807, DOI 10.1016/S0147-1767(00)00033-X; Reid S.A., 2004, J MEDIA PSYCHOL-GER, V16, P17, DOI [https://doi.org/10.1026/1617-6383.16.1.17, DOI 10.1026/1617-6383.16.1.17, 10.1026/1617-6383.16.1.17]; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Saeri AK, 2015, ANAL SOC ISS PUB POL, V15, P303, DOI 10.1111/asap.12081; Safran William., 1991, DIASPORA J TRANSNATI, V1, P83, DOI [10.1353/dsp.1991.0004, DOI 10.1353/DSP.1991.0004]; Sakurai T, 2017, SHS WEB CONF, V33, DOI 10.1051/shsconf/20173300008; Saleem M, 2019, J COMMUN, V69, P214, DOI 10.1093/joc/jqz001; Saleem M, 2019, MEDIA PSYCHOL, V22, P373, DOI 10.1080/15213269.2017.1302345; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Schultz F, 2011, PUBLIC RELAT REV, V37, P20, DOI 10.1016/j.pubrev.2010.12.001; Scolari CA, 2012, COMMUN THEOR, V22, DOI 10.1111/j.1468-2885.2012.01404.x; Segev E, 2016, INT NEWS ONLINE GLOB; Shi Yu, 2005, CONTINUUM-J MEDIA CU, V19, P55, DOI [DOI 10.1080/1030431052000336298, 10.1080/1030431052000336298]; Shimizu K, 2020, LANCET, V395, P685, DOI 10.1016/S0140-6736(20)30357-3; Shu J, 2017, J EXP PSYCHOL GEN, V146, P1164, DOI 10.1037/xge0000335; Shweder R.A., 1998, HDB CHILD PSYCHOL, V1, P865, DOI DOI 10.1002/9780470147658.CHPSY0113; Slater MD, 2007, COMMUN THEOR, V17, P281, DOI 10.1111/j.1468-2885.2007.00296.x; Smets K., 2019, HDB DIASPORAS MEDIA, P97, DOI doi.org/10.1002/9781119236771.ch7; Smets K, 2018, INT COMMUN GAZ, V80, P603, DOI 10.1177/1748048518802204; Smith ER, 2016, CURR OPIN PSYCHOL, V11, P15, DOI 10.1016/j.copsyc.2016.04.005; Steinert S, 2021, ETHICS INF TECHNOL, V23, P59, DOI 10.1007/s10676-020-09545-z; Stephan W.G., 2017, INT ENCY INTERCULTUR, P1, DOI [10.1002/9781118783665.ieicc0162, DOI 10.1002/9781118783665.IEICC0162]; Stevenson N., 2002, UNDERSTANDING MEDIA; Strate L., 2004, COMMUN RES TRENDS, V23, P1; Strate L., 2016, INT ENCY COMMUNICATI, P1, DOI [10.1002/9781118766804.wbiect137, DOI 10.1002/9781118766804.WBIECT137]; Su JC, 2014, COGNITION EMOTION, V28, P1313, DOI 10.1080/02699931.2014.881322; Suanet I, 2009, J COMMUNITY APPL SOC, V19, P182, DOI 10.1002/casp.989; Sun W., 2016, MEDIA COMMUNICATION, P1; Sun WN, 2021, GLOB MEDIA CHINA, V6, P24, DOI 10.1177/2059436421988977; Sun Wanning, 2013, ROUTLEDGE HDB CHINES, P433; Sun Wanning, 2002, LEAVING CHINA MEDIA; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tamir M, 2016, J PERS SOC PSYCHOL, V111, P67, DOI 10.1037/pspp0000072; Tan C-B., 2016, ROUTLEDGE HDB CHINES; Tandoc EC, 2019, JOURNAL PRACT, V13, P178, DOI 10.1080/17512786.2017.1423237; Tankard JW, 2001, LEA COMMUN SER, P95; TAYLOR DM, 1994, ONT SYMP P, V7, P233; Taylor S., 2019, PSYCHOL PANDEMICS PR, P57; Trepte S., 2017, INT ENCY MEDIA EFFEC, P1, DOI [10.1002/9781118783764.wbieme0088, 10.1002/]; Trepte S, 2018, J MEDIA PSYCHOL-GER, V30, P66, DOI 10.1027/1864-1105/a000182; Trepte S, 2008, COMMUNICATIONS-GER, V33, P1, DOI 10.1515/COMMUN.2008.001; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Truong KA, 2016, INT J QUAL STUD EDUC, V29, P224, DOI 10.1080/09518398.2015.1023234; Tsagarousianou R., 2017, WESTMINST PAP COMMUN, V1, DOI [10.16997/wpcc.203, DOI 10.16997/WPCC.203]; Tsai PC, 2018, COUNS PSYCHOL, V46, P351, DOI 10.1177/0011000018761892; Valcanis T., 2011, ETC REV GEN SEMANT, V68, P33; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; WALKER I, 1984, BRIT J SOC PSYCHOL, V23, P301, DOI 10.1111/j.2044-8309.1984.tb00645.x; Wang J, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110349; Wang SM, 2021, EUR SOC, V23, pS721, DOI 10.1080/14616696.2020.1836384; Ward C, 2008, INT J INTERCULT REL, V32, P105, DOI 10.1016/j.ijintrel.2007.11.002; Wiard V., 2019, OXFORD RES ENCY COMM, DOI [10.1093/acrefore/9780190228613.013.847, DOI 10.1093/ACREFORE/9780190228613.013.847]; Witteborn S., 2019, HDB DIASPORAS MEDIA, P179; Wofford N, 2019, SOC PSYCHOL PERS SCI, V10, P121, DOI 10.1177/1948550617746218; Wu HD, 2000, J COMMUN, V50, P110, DOI 10.1093/joc/50.2.110; Yin H, 2015, NEW MEDIA SOC, V17, P556, DOI 10.1177/1461444813505363; Yu HQ, 2019, MEDIA INT AUST, V173, P17, DOI 10.1177/1329878X19875854	159	5	5	7	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259866	10.1371/journal.pone.0259866	http://dx.doi.org/10.1371/journal.pone.0259866			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784374	gold, Green Published			2022-12-26	WOS:000755277300024
J	Bui, T; Gu, Y; Ancot, F; Sanguin-Gendreau, V; Zuo, DM; Muller, WJ				Bui, Tung; Gu, Yu; Ancot, Frederic; Sanguin-Gendreau, Virginie; Zuo, Dongmei; Muller, William J.			Emergence of beta 1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment	ONCOGENE			English	Article							EXTRACELLULAR-MATRIX; MOUSE MODEL; PROGRESSION; DISRUPTION; KINASE	The molecular and cellular mechanisms underlying mammary tumour dormancy and cancer recurrence are unclear and remain to be elucidated. Here, we report that mammary epithelial-specific disruption of beta 1 integrin in a murine model of Luminal B human breast cancer drastically impairs tumour growth with proliferation block, apoptosis induction and cellular senescence. beta 1 integrin-deficient dormant lesions show activation of the tumour suppressor p53, and tumours that circumvent dormancy possess p53 mutation analogous to those in human disease. We further demonstrate that mammary epithelial deletion of p53 in beta 1 integrin-deficient mice fully rescues tumour dormancy and bypasses cellular senescence. Additionally, recurrent beta 1 integrin-deficient tumours exhibit fibrosis with increased cancer-associated fibroblast infiltration and extracellular matrix deposition, absent in fast-growing beta 1 integrin/p53-deficient lesions. Taken together, these observations argue that beta 1 integrin modulates p53-dependent cellular senescence resulting in tumour dormancy and that pro-tumourigenic stromal cues and intrinsic genetic mutation are required for dormancy exit.	[Bui, Tung; Gu, Yu; Ancot, Frederic; Sanguin-Gendreau, Virginie; Zuo, Dongmei; Muller, William J.] McGill Univ, Rosalind & Morris Goodman Canc Inst, Montreal, PQ H3A 1A3, Canada; [Bui, Tung; Gu, Yu; Muller, William J.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Muller, William J.] McGill Univ, Fac Med, Montreal, PQ H3G 2M1, Canada	McGill University; McGill University; McGill University	Muller, WJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Inst, Montreal, PQ H3A 1A3, Canada.; Muller, WJ (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.; Muller, WJ (corresponding author), McGill Univ, Fac Med, Montreal, PQ H3G 2M1, Canada.	william.muller@mcgill.ca			Cedars Cancer Institute Fellowship; McGill Integrated Cancer Research Training Programme award; CURE Foundation Fellowship in Breast Cancer Research; Canderel Graduate Studentship Award; Canada Research Chair in Molecular Oncology; CIHR Foundation; CCSRI innovation programmes	Cedars Cancer Institute Fellowship; McGill Integrated Cancer Research Training Programme award; CURE Foundation Fellowship in Breast Cancer Research; Canderel Graduate Studentship Award; Canada Research Chair in Molecular Oncology(Canada Research Chairs); CIHR Foundation(Canadian Institutes of Health Research (CIHR)); CCSRI innovation programmes	We thank Alain Sarabia Pacis, Goodman Cancer Institute Bionformatics Core, Canadian Tumour for Computational Genomics (C3G), McGill University for bioinformatic analyses of RNA-seq and scRNA-seq data, Dr. Erika Wee and the Advanced BioImaging Facility, McGill University for analysis using Imaris software, Cleber Silveira Moraes from GCI Histology Core, Cynthia Lavoie for monitoring mouse cohort and Mitra Cowen from GCI Transgenic Core. We are also grateful to Dr. Stephen Dilworth for supplying PyV mT antibodies. TB is supported by the Cedars Cancer Institute Fellowship and McGill Integrated Cancer Research Training Programme award. YG is supported by the CURE Foundation Fellowship in Breast Cancer Research and the Canderel Graduate Studentship Award. WJM is supported by Canada Research Chair in Molecular Oncology and grants from CIHR Foundation and CCSRI innovation programmes.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bartoschek M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07582-3; Bui T, 2019, CELL REP, V29, P589, DOI 10.1016/j.celrep.2019.09.004; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Faget DV, 2019, NAT REV CANCER, V19, P439, DOI 10.1038/s41568-019-0156-2; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Grochova D, 2008, ONCOGENE, V27, P1243, DOI 10.1038/sj.onc.1210748; Gunther EJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0551com; Hamidi H, 2019, NAT REV CANCER, V19, P179, DOI 10.1038/s41568-019-0112-1; Ilic D, 1998, J CELL BIOL, V143, P547; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Jones MC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0227; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Kren A, 2007, EMBO J, V26, P2832, DOI 10.1038/sj.emboj.7601738; Lahlou H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3131; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Marcotte R, 2012, P NATL ACAD SCI USA, V109, P2808, DOI 10.1073/pnas.1018861108; Marino S, 2000, GENE DEV, V14, P994; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; McConnell JC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0664-2; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Murnyak B, 2016, ONCOTARGET, V7, P64910, DOI 10.18632/oncotarget.11912; Pelaez R, 2019, CANCERS, V11, DOI 10.3390/cancers11050615; Phan TG, 2020, NAT REV CANCER, V20, P398, DOI 10.1038/s41568-020-0263-0; Pontier SM, 2010, ONCOGENE, V29, P3374, DOI 10.1038/onc.2010.86; Pontier SM, 2008, APMIS, V116, P677, DOI 10.1111/j.1600-0463.2008.01026.x; Rao T, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3603; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Smith HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10681-4; Triana-Martinez F, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020346; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Winkler J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18794-x; Zerdoumi Y, 2017, HUM MOL GENET, V26, P2591, DOI 10.1093/hmg/ddx106	35	2	2	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					527	537		10.1038/s41388-021-02107-7	http://dx.doi.org/10.1038/s41388-021-02107-7		NOV 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34782719	hybrid, Green Published			2022-12-26	WOS:000718778400004
J	Croijmans, I; Beetsma, D; Aarts, H; Gortemaker, I; Smeets, M				Croijmans, Ilja; Beetsma, Daniel; Aarts, Henk; Gortemaker, Ilse; Smeets, Monique			The role of fragrance and self-esteem in perception of body odors and impressions of others	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; PSYCHOMETRIC PROPERTIES; PERSONALITY; CUES; JUDGMENTS; TRUSTWORTHINESS; QUESTIONNAIRE; TESTOSTERONE; PREFERENCE; EVOLUTION	Human sweat odor serves as social communication signal for a person's traits and emotional states. This study explored whether body odors can also communicate information about one's self-esteem, and the role of applied fragrance in this relationship. Female participants were asked to rate self-esteem and attractiveness of different male contestants of a dating show, while being exposed to male participant's body odors differing in self-esteem. High self-esteem sweat was rated more pleasant and less intense than low self-esteem sweat. However, there was no difference in perceived self-esteem and attractiveness of male contestants in videos, hence explicit differences in body odor did not transfer to judgments of related person characteristics. When the body odor was fragranced using a fragranced body spray, male contestants were rated as having higher self-esteem and being more attractive. The finding that body odors from male participants differing in self-esteem are rated differently and can be discriminated suggests self-esteem has distinct perceivable olfactory features, but the remaining findings imply that only fragrance affect the psychological impression someone makes. These findings are discussed in the context of the role of body odor and fragrance in human perception and social communication.	[Croijmans, Ilja; Beetsma, Daniel; Aarts, Henk; Smeets, Monique] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Gortemaker, Ilse; Smeets, Monique] UNILEVER R&D Beauty & Personal Care Sci & Technol, Consumer Sci, Rotterdam, Netherlands; [Gortemaker, Ilse] ABN AMRO Bank NV, Amsterdam, Netherlands	Utrecht University	Croijmans, I (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	i.m.croijmans@uu.nl		Croijmans, Ilja/0000-0001-9812-0040	Unilever RD; Unilever	Unilever RD(Unilever); Unilever(Unilever)	This study was sponsored by Unilever R&D. We are grateful to Philippe Valcasara and to Jasper de Groot for their contributions to this study. Recruitment and data collection was performed with the help of two external agencies. Data collection, processing and analysis was done by Utrecht University.; Unilever provided financial support for supplies and participant remuneration and material support by supplying fragranced (test product) body sprays in cans free of labels. Unilever also provided support in the form of salaries for IG and MS. The specific roles of these authors are articulated in the `author contributions' section. IG served as operations manager overseeing the project from Unilever. She provided feedback on study design and a manuscript draft. However, Unilever did not have a role in the data collection and analysis or decision to publish.	Aarts H, 2003, J PERS SOC PSYCHOL, V84, P18, DOI 10.1037/0022-3514.84.1.18; Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; Allen C, 2016, EVOL HUM BEHAV, V37, P481, DOI 10.1016/j.evolhumbehav.2016.05.001; Boone RT, 2003, J NONVERBAL BEHAV, V27, P163, DOI 10.1023/A:1025341931128; Chaplin WF, 2000, J PERS SOC PSYCHOL, V79, P110, DOI 10.1037/0022-3514.79.1.110; Chopra A, 2008, NEUROIMAGE, V40, P1257, DOI 10.1016/j.neuroimage.2008.01.015; Clark CJ, 2018, ANIM BEHAV, V143, P83, DOI 10.1016/j.anbehav.2018.07.009; Classen C., 1994, AROMA CULTURAL HIST; Croijmans I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155845; Croy I, 2017, CHEMOSENS PERCEPT, V10, P81, DOI 10.1007/s12078-017-9230-x; Cudo A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226213; Dalton P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077144; de Groot JHB, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.581701; de Groot JHB, 2018, PSYCHONEUROENDOCRINO, V98, P177, DOI 10.1016/j.psyneuen.2018.08.005; de Groot JHB, 2017, PERSPECT PSYCHOL SCI, V12, P306, DOI 10.1177/1745691616676599; de Groot JHB, 2015, PSYCHOL SCI, V26, P684, DOI 10.1177/0956797614566318; Degel J, 1999, CHEM SENSES, V24, P317, DOI 10.1093/chemse/24.3.317; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P120, DOI 10.1037//0022-3514.69.1.120; Eastwick PW, 2011, J PERS SOC PSYCHOL, V101, P993, DOI 10.1037/a0024061; Elliott B, 2017, PHYSIOL BEHAV, V173, P23, DOI 10.1016/j.physbeh.2017.01.036; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferdenzi C, 2008, INT J BEHAV DEV, V32, P422, DOI 10.1177/0165025408093661; Ferdenzi C, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0268; Fontaine JRJ, 2007, PSYCHOL SCI, V18, P1050, DOI 10.1111/j.1467-9280.2007.02024.x; Ford MB, 2010, J PERS SOC PSYCHOL, V98, P405, DOI 10.1037/a0017345; Franck E, 2008, PSYCHOL BELG, V48, P25, DOI 10.5334/pb-48-1-25; GABRIEL MT, 1994, J PERS, V62, P143, DOI 10.1111/j.1467-6494.1994.tb00798.x; Gaby JM, 2017, CHEM SENSES, V42, P405, DOI 10.1093/chemse/bjx012; Graziano WG, 2007, J PERS SOC PSYCHOL, V93, P583, DOI 10.1037/0022-3514.93.4.583; Harris MA, 2020, J PERS SOC PSYCHOL, V119, P1459, DOI 10.1037/pspp0000265; Haviland-Jones JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154495; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; HEATHERTON TF, 1991, J PERS SOC PSYCHOL, V60, P895, DOI 10.1037/0022-3514.60.6.895; Hughes SM, 2014, J NONVERBAL BEHAV, V38, P107, DOI 10.1007/s10919-013-0163-z; Hummel T, 2010, J NEUROL, V257, P1316, DOI 10.1007/s00415-010-5516-5; James A.G., 2020, SKIN MICROBIOME HDB, V1st, P79; Kamiloglu RG, 2018, CHEM SENSES, V43, P419, DOI 10.1093/chemse/bjy029; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Koster EP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00064; Kramer RSS, 2010, Q J EXP PSYCHOL, V63, P2273, DOI 10.1080/17470211003770912; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Laska M, 2007, PRIMATES, V48, P160, DOI 10.1007/s10329-006-0019-9; Leary MR, 1999, CURR DIR PSYCHOL SCI, V8, P32, DOI 10.1111/1467-8721.00008; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Lenochova P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033810; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Lynge Olsson N, 2021, REEFMASTER; Macmillan N. A., 1991, DETECTION THEORY USE; Mahmut MK, 2019, PHYSIOL BEHAV, V207, P179, DOI 10.1016/j.physbeh.2019.05.003; Mahmut MK, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00261; Majid A, 2017, PERCEPTION, V46, P406, DOI 10.1177/0301006616688224; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Morey R.D., 2018, BAYESFACTOR COMPUTAT; Naumann LP, 2009, PERS SOC PSYCHOL B, V35, P1661, DOI 10.1177/0146167209346309; NUTTIN JM, 1985, EUR J SOC PSYCHOL, V15, P353, DOI 10.1002/ejsp.2420150309; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Orth U, 2018, PSYCHOL BULL, V144, P1045, DOI 10.1037/bul0000161; OWENS TJ, 1993, SOC PSYCHOL QUART, V56, P288, DOI 10.2307/2786665; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Penn DJ, 2007, J R SOC INTERFACE, V4, P331, DOI 10.1098/rsif.2006.0182; Rawal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088438; Roberts S. Craig, 2009, International Journal of Cosmetic Science, V31, P47, DOI 10.1111/j.1468-2494.2008.00477.x; Robinson KJ, 2012, J RES PERS, V46, P227, DOI 10.1016/j.jrp.2011.12.002; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Salmivalli C, 1999, PERS SOC PSYCHOL B, V25, P1268, DOI 10.1177/0146167299258008; SALOVEY P, 1989, J PERS SOC PSYCHOL, V57, P539, DOI 10.1037/0022-3514.57.3.539; Schilling B, 2010, CHEMOECOLOGY, V20, P135, DOI 10.1007/s00049-009-0035-5; Sinclair SJ, 2010, EVAL HEALTH PROF, V33, P56, DOI 10.1177/0163278709356187; Smeets MAM, 2020, METABOLITES, V10, DOI 10.3390/metabo10030084; Sorokowska A, 2018, CHEM SENSES, V43, P503, DOI 10.1093/chemse/bjy038; Sorokowska A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00530; Sorokowska A, 2012, EUR J PERSONALITY, V26, P496, DOI 10.1002/per.848; Stieger S., 2011, SOC PSYCHOL-GERMANY; Stieger S, 2013, SELF IDENTITY, V12, P201, DOI 10.1080/15298868.2012.655897; Toma CL, 2008, PERS SOC PSYCHOL B, V34, P1023, DOI 10.1177/0146167208318067; Trivedi DK, 2019, ACS CENTRAL SCI, V5, P599, DOI 10.1021/acscentsci.8b00879; Ueda Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02097; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wood AP., 2010, HDB HYDROCARBON LIPI; Wyatt TD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2994; Zhou W, 2009, PSYCHOL SCI, V20, P1118, DOI 10.1111/j.1467-9280.2009.02413.x; ZWEIGENHAFT RL, 1977, SOC BEHAV PERSONAL, V5, P177, DOI 10.2224/sbp.1977.5.1.177	86	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0258773	10.1371/journal.pone.0258773	http://dx.doi.org/10.1371/journal.pone.0258773			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780484	gold, Green Published			2022-12-26	WOS:000755305800017
J	Nathan, DM; Krause-Steinrauf, H; Braffett, BH; Arends, VL; Younes, N; McGee, P; Lund, C; Johnson, M; Lorenzi, G; Gao, XY; Steffes, MW; Lachin, JM				Nathan, David M.; Krause-Steinrauf, Heidi; Braffett, Barbara H.; Arends, Valerie L.; Younes, Naji; McGee, Paula; Lund, Claire; Johnson, Mary; Lorenzi, Gayle; Gao, Xiaoyu; Steffes, Michael W.; Lachin, John M.		GRADE Res Grp; DCCT EDIC Res Grp	Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies	PLOS ONE			English	Article								Background We compared HbA1c values obtained from capillary blood collection kits versus venous whole blood collections in study participants with type 1 or type 2 diabetes. Methods A total of 122 subjects, 64 with type 2 diabetes participating in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study and 58 with type 1 diabetes from the Epidemiology of Diabetes Interventions and Complications (EDIC) Study, participated in the validation study. Capillary tubes were filled by fingerstick by the participants on the same day as the collection of venous whole blood samples in EDTA-containing test tubes and were mailed to the central laboratory. HbA1c in all samples was measured with the same high-performance liquid chromatography. GRADE participants also completed a questionnaire on the ease of performing capillary collections. Results Participants from 22 clinical centers (GRADE n = 5, EDIC n = 17) were between 35 and 86 years of age, with 52% male and diverse race/ethnicities. Venous HbA1c results ranged between 5.4-11.9% (35.5-106.6 mmol/mol) with corresponding capillary results ranging between 4.2-11.9% (22.4-106.6 mmol/mol). The venous and capillary results were highly correlated (R-2 = 0.993) and 96.7% differed by <= 0.2% (2.2 mmol/mol). Of participants surveyed, 69% indicated that the instructions and collection were easy to follow and 97% felt the collection method would be easy to do at home. Conclusions The capillary blood HbA1c results compared well with the conventional venous whole blood results. The capillary kits can be employed in other studies to reduce interruption of critical data collection and potentially to augment clinical care when in-person visits are not possible.	[Nathan, David M.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Krause-Steinrauf, Heidi; Braffett, Barbara H.; Younes, Naji; McGee, Paula; Lund, Claire; Gao, Xiaoyu; Lachin, John M.] George Washington Univ, Milken Inst Sch Publ Hlth, Biostat Ctr, Rockville, MD 20852 USA; [Arends, Valerie L.; Steffes, Michael W.] Univ Minnesota, Dept Lab Med & Pathol, Adv Res & Diagnost Lab, Minneapolis, MN 55455 USA; [Johnson, Mary] Hlth Partners Inst, Int Diabet Ctr, Minneapolis, MN USA; [Lorenzi, Gayle] Univ Calif San Diego, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; George Washington University; University of Minnesota System; University of Minnesota Twin Cities; International Diabetes Center; University of California System; University of California San Diego	Krause-Steinrauf, H (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Biostat Ctr, Rockville, MD 20852 USA.	heidi@bsc.gwu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health [U01DK098246]; NIDDK [U34DK088043]; American Diabetes Association; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease [U01 DK094176, U01 DK094157]; National Eye Institute; National Institute of Neurologic Disorders and Stroke; General Clinical Research Centers Program (1993-2007); Clinical Translational Science Center Program (2006-present), Bethesda, Maryland, USA;  [P30 DK017047];  [P30 DK02054144];  [P30 DK020572];  [P30 DK072476];  [P30 DK079626];  [P30 DK092926];  [U54 GM104940];  [UL1 TR000439];  [UL1 TR000445];  [UL1 TR001108];  [UL1 TR001409];  [UL1 TR001449];  [UL1 TR002243];  [UL1 TR002345];  [UL1 TR002378];  [UL1 TR002489];  [UL1 TR002529];  [UL1 TR002535];  [UL1 TR002537];  [UL1 TR002548]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); General Clinical Research Centers Program (1993-2007); Clinical Translational Science Center Program (2006-present), Bethesda, Maryland, USA; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	Financial support for the GRADE Study is supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health under Award Number U01DK098246. Financial support for the planning of GRADE was provided by a U34 planning grant from the NIDDK (U34DK088043). The American Diabetes Association supported the initial planning meeting for the U34 proposal. The National Heart, Lung, and Blood Institute and the Centers for Disease Control and Prevention also provided funding support. Educational materials have been provided by the National Diabetes Education Program. Material support in the form of donated medications and supplies has been provided by Becton, Dickinson and Company, Bristol-Myers Squibb, Merck, NovoNordisk, Roche Diagnostics, and Sanofi. Industry contributors had no role in the design or conduct of the study or in the analysis or data or preparation of publications. The Department of Veterans Affairs provided resources and facilities. The DCCT/EDIC has been supported by cooperative agreement grants (1982-1993, 2012-2017, 2017-2022), and contracts (1982-2012) with the Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Disease (current grant numbers U01 DK094176 and U01 DK094157), and through support by the National Eye Institute, the National Institute of Neurologic Disorders and Stroke, the General Clinical Research Centers Program (1993-2007), and Clinical Translational Science Center Program (2006-present), Bethesda, Maryland, USA. Industry contributors have had no role in the DCCT/EDIC study but have provided free or discounted supplies or equipment to support participants' adherence to the study: Abbott Diabetes Care (Alameda, CA), Animas (Westchester, PA), Bayer Diabetes Care (North America Headquarters, Tarrytown, NY), Becton, Dickinson and Company (Franklin Lakes, NJ), Eli Lilly (Indianapolis, IN), Extend Nutrition (St. Louis, MO), Insulet Corporation (Bedford, MA), Lifescan (Milpitas, CA), Medtronic Diabetes (Minneapolis, MN), Nipro Home Diagnostics (Ft. Lauderdale, FL), Nova Diabetes Care (Billerica, MA), Omron (Shelton, CT), Perrigo Diabetes Care (Allegan, MI), Roche Diabetes Care (Indianapolis, IN), and SanofiAventis (Bridgewater, NJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; GRADE: Additional support was provided by grant numbers P30 DK017047, P30 DK02054144, P30 DK020572, P30 DK072476, P30 DK079626, P30 DK092926, U54 GM104940, UL1 TR000439, UL1 TR000445, UL1 TR001108, UL1 TR001409, UL1 TR001449, UL1 TR002243, UL1 TR002345, UL1 TR002378, UL1 TR002489, UL1 TR002529, UL1 TR002535, UL1 TR002537, and UL1 TR002548. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck RW, 2021, DIABETES TECHNOL THE, V23, P537, DOI 10.1089/dia.2021.0023; BioRad, 2019, BIORAD QXDXTM BCR AB; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Genuth S, 1999, DIABETES CARE, V22, P99; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Nathan DM, 2013, DIABETES CARE, V36, P2254, DOI 10.2337/dc13-0356; Sacks DB, 2011, DIABETES CARE, V34, P1419, DOI 10.2337/dc11-9997; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; VOSS EM, 1992, DIABETES CARE, V15, P700, DOI 10.2337/diacare.15.5.700; VOSS EM, 1993, DIABETES CARE, V16, P665, DOI 10.2337/diacare.16.4.665; Wexler DJ, 2019, DIABETES CARE, V42, P2098, DOI 10.2337/dc19-0901	11	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0257154	10.1371/journal.pone.0257154	http://dx.doi.org/10.1371/journal.pone.0257154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780485	gold, Green Published			2022-12-26	WOS:000755305800006
J	Pattnaik, A; Mohan, D; Tsui, A; Chipokosa, S; Katengeza, H; Ndawala, J; Marx, MA				Pattnaik, Anooj; Mohan, Diwakar; Tsui, Amy; Chipokosa, Sam; Katengeza, Hans; Ndawala, Jameson; Marx, Melissa A.			The aggregate effect of implementation strength of family planning programs on modern contraceptive use at the health systems level in rural Malawi	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; DESIRED FERTILITY; ACCESS; SERVICES; QUALITY; WORKERS; DEMAND; WOMEN; CARE	To explore the association between the strength of implementation of family planning (FP) programs on the use of modern contraceptives. Specifically, how strongly these programs are being implemented across a health facility's catchment area in Malawi and the odds of a woman in that catchment area is using modern contraceptives. This information can be used to assess whether the combined impact of multiple large-scale FP programs is leading to change in the health outcomes they aim to improve. We used data from the 2017 Implementation Strength Assessment (ISA) that quantified how much of family planning programs at the health facility and community health worker levels were being implemented across every district of Malawi. We used a summary measure developed in a previous study that employs quantitative methods to combine data across FP domains and health system levels. We tested the association of this summary measure for implementation strength with household data from the 2015 Malawi Demographic Health Survey (DHS). We found that areas with stronger implementation of FP programs had higher odds of women using modern contraceptives compared with areas with weaker implementation. The association of ISA with use of modern contraception was different by education, marital status, and geography. After controlling for these factors, we found that the adjusted odds of using a modern contraceptive was three times higher in catchment areas with high implementation strength compared to those with lower strength. Metrics that summarize how strongly FP programs are being implemented were used to show a statistically significantly positive relationship between increasing implementation strength and higher rates of modern contraceptive use. Decisionmakers at the various levels of health authority can use this type of summary measure to better understand the combined impact of their diverse FP programming and inform future programmatic and policy decisions. The findings also reinforce the idea that having a well-supported and supplied cadre of community health workers supplementing FP provision at the health facility can be an important health systems mechanism, especially in rural settings and to target youth populations.	[Pattnaik, Anooj; Mohan, Diwakar; Marx, Melissa A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Tsui, Amy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Chipokosa, Sam; Ndawala, Jameson] Natl Stat Off, Zomba, Malawi; [Katengeza, Hans] Minist Hlth, Reprod Hlth Directorate, Lilongwe, Malawi	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Pattnaik, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ajpattnaik@gmail.com			Global Affairs of Canada [7059904, 7061914]	Global Affairs of Canada	MM received funding from Global Affairs of Canada on two grants: 1) Real Accountability: Data Analysis for Results (RADAR) and the National Evaluation Program (NEP) projects. The grant number for RADAR was 7061914 and 7059904 for NEP. The URL for the funder, Global Affairs of Canada, is: https://www.international.gc.ca/gac-amc/index.aspx?lang=eng The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Behrman JA, 2015, DEMOGRAPHY, V52, P787, DOI 10.1007/s13524-015-0392-3; Bongaarts J, 2017, INT PERSPECT SEX R H, V43, P41, DOI 10.1363/43e3917; Bongaarts J, 2017, POPUL DEV REV, V43, P39, DOI 10.1111/j.1728-4457.2016.00164.x; Burgert CR, 2014, DHS SPATIAL ANAL REP; Chansa C., 2018, Expanding health care provision in a low-income country: the experience of Malawi; Child D., 2006, ESSENTIALS FACTOR AN; Chipokosa S, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020901; Cleland J, 2014, STUD FAMILY PLANN, V45, P105, DOI 10.1111/j.1728-4465.2014.00380.x; Digitale J, 2017, ANN AM ACAD POLIT SS, V669, P93, DOI 10.1177/0002716216678591; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; Goodkind D, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1423861; Government of Malawi, 2015, MAL COST IMPL PLAN F; International Monetary Fund, 2017, 17184 IMF; Jain AK, 2012, INT PERSPECT SEX R H, V38, P15, DOI 10.1363/3801512; Jain Aparna., 2014, INCONSISTENCIES TOTA; Jayachandran V, 2016, MALAWI MED J, V28, P48, DOI 10.4314/mmj.v28i2.4; Kidayi PL., 2015, ADV SEX MED, V05, P43, DOI DOI 10.4236/ASM.2015.53006; Kuang B, 2016, INT PERSPECT SEX R H, V42, P33, DOI 10.1363/42e0316; Leslie HH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002464; Lutz W, 2014, POPUL DEV REV, V40, P527, DOI 10.1111/j.1728-4457.2014.00696.x; May JF, 2017, POPUL DEV REV, V43, P308, DOI 10.1111/j.1728-4457.2016.00165.x; Ministry of Development Planning and Cooperation, 2010, RAP POP DEV MAL; Ministry of Health [Malawi], 2011, MAL HLTH SECT STRAT; National Statistical Office, 2015, MAL MDG ENDL SURV 20; National Statistical Office and ICF, 2017, MAL DEM HLTH SURV 20; National Statistics Office, 2008 MAL POP HOUS CE; Pattnaik A., RAW DATA SCORE COMP, V2021; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Peters MA, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00242-z; PRITCHETT LH, 1994, POPUL DEV REV, V20, P1, DOI 10.2307/2137629; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Ross J, 2017, DYNAMICS FAMILY PLAN; Ross J, 2013, J BIOSOC SCI, V45, P761, DOI 10.1017/S0021932012000715; Sedgh G., 2016, UNMET NEED CONTRACEP; Shiferaw S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187311; Skiles MP, 2015, INT PERSPECT SEX R H, V41, P20, DOI 10.1363/4102015; Skiles MP, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-14; Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9; Team R.C, R LANG ENV STAT COMP; Tessema GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165627; Tsui AO., 2002, MEASURE EVALUATION; Wang W., 2012, DHS ANAL STUD; White JS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-143; Yao J, 2013, SOC SCI MED, V96, P60, DOI [10.1016/j.socscimed.2013.07.025, 10.1016/j.socscimed.2012.11.005]	45	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0232504	10.1371/journal.pone.0232504	http://dx.doi.org/10.1371/journal.pone.0232504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780507	Green Published, gold, Green Submitted			2022-12-26	WOS:000755305800001
J	Bezstarosti, K; Lamers, MM; Doff, WAS; Wever, PC; Thai, KTD; van Kampen, JJA; Haagmans, BL; Demmers, JAA				Bezstarosti, Karel; Lamers, Mart M.; Doff, Wouter A. S.; Wever, Peter C.; Thai, Khoa T. D.; van Kampen, Jeroen J. A.; Haagmans, Bart L.; Demmers, Jeroen A. A.			Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens	PLOS ONE			English	Article							SAMPLES	The rapid, sensitive and specific detection of SARS-CoV-2 is critical in responding to the current COVID-19 outbreak. In this proof-of-concept study, we explored the potential of targeted mass spectrometry (MS) based proteomics for the detection of SARS-CoV-2 proteins in both research samples and clinical specimens. First, we assessed the limit of detection for several SARS-CoV-2 proteins by parallel reaction monitoring (PRM) MS in infected Vero E6 cells. For tryptic peptides of Nucleocapsid protein, the limit of detection was estimated to be in the mid-attomole range (9E-13 g). Next, this PRM methodology was applied to the detection of viral proteins in various COVID-19 patient clinical specimens, such as sputum and nasopharyngeal swabs. SARS-CoV-2 proteins were detected in these samples with high sensitivity in all specimens with PCR Ct values <24 and in several samples with higher CT values. A clear relationship was observed between summed MS peak intensities for SARS-CoV-2 proteins and Ct values reflecting the abundance of viral RNA. Taken together, these results suggest that targeted MS based proteomics may have the potential to be used as an additional tool in COVID-19 diagnostics.	[Bezstarosti, Karel; Doff, Wouter A. S.; Demmers, Jeroen A. A.] Erasmus MC, Prote Ctr, Rotterdam, Netherlands; [Lamers, Mart M.; van Kampen, Jeroen J. A.; Haagmans, Bart L.] Erasmus MC, Virosci Dept, Rotterdam, Netherlands; [Wever, Peter C.] Jeroen Bosch Hosp, Shertogenbosch, Netherlands; [Thai, Khoa T. D.] Star Shl Med Diagnost Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Jeroen Bosch Ziekenhuis	Demmers, JAA (corresponding author), Erasmus MC, Prote Ctr, Rotterdam, Netherlands.	j.demmers@erasmusmc.nl	Demmers, Jeroen AA/F-4046-2016; Haagmans, Bart/E-9791-2015	Demmers, Jeroen AA/0000-0002-8757-9611; Haagmans, Bart/0000-0001-6221-2015; Thai, Khoa (T.D.)/0000-0003-4872-9960; Doff, Wouter/0000-0001-9755-6686				[Anonymous], 2020, CELL, DOI DOI 10.1016/j.cell.2020.05.032; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Davidson AD, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00763-0; Foster MW, 2015, ANAL CHEM, V87, P10247, DOI 10.1021/acs.analchem.5b01544; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Haas P, 2021, J PROTEOME RES, V20, P1133, DOI 10.1021/acs.jproteome.0c00764; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Ihling C, 2020, J PROTEOME RES, V19, P4389, DOI 10.1021/acs.jproteome.0c00280; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Liu GW, 2014, ANAL CHEM, V86, P8336, DOI 10.1021/ac501837t; Santana WI, 2014, ANAL CHEM, V86, P4088, DOI 10.1021/ac4040778; Santosh Renuse., 2020, TEST RETEST RETEST U, DOI [10.1101/2020.08.05.20168948, DOI 10.1101/2020.08.05.20168948]; W.H.O, 2020, DECL GLOB EM WUH COR; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zecha J, 2020, MOL CELL PROTEOMICS, V19, DOI 10.1074/mcp.RA120.002164	17	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259165	10.1371/journal.pone.0259165	http://dx.doi.org/10.1371/journal.pone.0259165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762662	Green Published, gold			2022-12-26	WOS:000755316600015
J	Bradshaw, AV; Campbell, P; Schapira, AHV; Morris, HR; Taanman, JW				Bradshaw, Aaron, V; Campbell, Philip; Schapira, Anthony H., V; Morris, Huw R.; Taanman, Jan-Willem			The PINK1-Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells	PLOS ONE			English	Article							PARKINSONS-DISEASE; PINK1; MUTATIONS; UBIQUITIN; RISK; MITOCHONDRIA; PARK2; GENE	Mutations in the PINK1 and PRKN genes are the most common cause of early-onset familial Parkinson disease. These genes code for the PINK1 and Parkin proteins, respectively, which are involved in the degradation of dysfunctional mitochondria through mitophagy. An early step in PINK1 -Parkin mediated mitophagy is the ubiquitination of the mitofusin proteins MFN1 and -2. The ubiquitination of MFN1 and -2 in patient samples may therefore serve as a biomarker to determine the functional effects of PINK1 and PRKN mutations, and to screen idiopathic patients for potential mitophagy defects. We aimed to characterise the expression of the PINK1 -Parkin mitophagy machinery in peripheral blood mononuclear cells (PBMCs) and assess if these cells could serve as a platform to evaluate mitophagy via analysis of MFN1 and -2 ubiquitination. Mitophagy was induced through mitochondrial depolarisation by treatment with the protonophore CCCP and ubiquitinated MFN proteins were analysed by western blotting. In addition, PINK1 and PRKN mRNA and protein expression levels were characterised with reverse transcriptase quantitative PCR and western blotting, respectively. Whilst CCCP treatment led to MFN ubiquitination in primary fibroblasts, SH-SY5Y neuroblastoma cells and Jurkat leukaemic cells, treatment of PBMCs did not induce ubiquitination of MFN. PRKN mRNA and protein was readily detectable in PBMCs at comparable levels to those observed in Jurkat and fibroblast cells. In contrast, PINK1 protein was undetectable and PINK1 mRNA levels were remarkably low in control PBMCs. Our findings suggest that the PINK1 -Parkin mitophagy signalling pathway is not functional in PBMCs. Therefore, PBMCs are not a suitable biosample for analysis of mitophagy function in Parkinson disease patients.	[Bradshaw, Aaron, V; Campbell, Philip; Schapira, Anthony H., V; Morris, Huw R.; Taanman, Jan-Willem] UCL, Dept Clin & Movement Neurosci, Queen Sq Inst Neurol, London, England	University of London; University College London	Taanman, JW (corresponding author), UCL, Dept Clin & Movement Neurosci, Queen Sq Inst Neurol, London, England.	j.taanman@ucl.ac.uk	; Schapira, Anthony/A-1245-2010; Taanman, Jan-Willem/A-5379-2011	Campbell, Philip/0000-0002-1357-9256; Schapira, Anthony/0000-0002-3018-3966; Bradshaw, Aaron/0000-0002-1405-2288; Taanman, Jan-Willem/0000-0002-5476-9785	Michael J. Fox Foundation for Parkinson's Research [15271]; Royal Free Charity [42]; European Union Horizon 2020 Research and Innovation programme [668738]; Medical Research Council [MR/M006646/1]	Michael J. Fox Foundation for Parkinson's Research; Royal Free Charity; European Union Horizon 2020 Research and Innovation programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JWT, 15271, Michael J. Fox Foundation for Parkinson's Research, https://www.michaeljfox. org/, NO JWT, 42, Royal Free Charity, https:// royalfreecharity.org/, NO AHVS, 668738, European Union Horizon 2020 Research and Innovation programme https://ec.europa.eu/programmes/ horizon2020/en/home, NO AHVS, MR/M006646/1, Medical Research Council, https://mrc.ukri.org/, NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Espay AJ, 2017, NAT REV NEUROL, V13, P119, DOI 10.1038/nrneurol.2016.196; Gandhi S, 2017, BRAIN, V140, P2, DOI 10.1093/brain/aww320; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Gioia L, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4718-6; Grievink HW, 2016, BIOPRESERV BIOBANK, V14, P410, DOI 10.1089/bio.2015.0104; Hattori N, 2017, J NEURAL TRANSM, V124, P1037, DOI 10.1007/s00702-017-1742-7; Hsieh CH, 2016, CELL STEM CELL, V19, P709, DOI 10.1016/j.stem.2016.08.002; Huttenlocher J, 2015, HUM MOL GENET, V24, P5637, DOI 10.1093/hmg/ddv277; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kasap M, 2009, NEUROSCI LETT, V460, P196, DOI 10.1016/j.neulet.2009.05.079; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044; Li J, 2019, ISCIENCE, V16, P468, DOI 10.1016/j.isci.2019.06.008; Manzanillo PS, 2013, NATURE, V501, P512, DOI 10.1038/nature12566; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2021, J CELL SCI, V134, DOI 10.1242/jcs.240465; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Puschmann A, 2017, BRAIN, V140, P98, DOI 10.1093/brain/aww261; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sunada Y, 1998, NEUROSCI LETT, V254, P180, DOI 10.1016/S0304-3940(98)00697-1; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Tsang M, 2017, BIOTECHNIQUES, V63, P230, DOI 10.2144/000114610; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Villa E, 2017, CELL REP, V20, P2846, DOI 10.1016/j.celrep.2017.08.087; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walsh TG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32716-4; Wang XN, 2017, AUTOPHAGY, V13, P1998, DOI 10.1080/15548627.2017.1327511; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yi W, 2019, HUM MOL GENET, V28, P2811, DOI 10.1093/hmg/ddz080	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259903	10.1371/journal.pone.0259903	http://dx.doi.org/10.1371/journal.pone.0259903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762687	Green Published, gold, Green Submitted			2022-12-26	WOS:000755316600053
J	Raab, M; Matthess, Y; Raab, CA; Gutfreund, N; Dotsch, V; Becker, S; Sanhaji, M; Strebhardt, K				Raab, Monika; Matthess, Yves; Raab, Christopher A.; Gutfreund, Niklas; Doetsch, Volker; Becker, Sven; Sanhaji, Mourad; Strebhardt, Klaus			A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1	ONCOGENE			English	Article							POLO-LIKE KINASE-1; AURORA-A; STRUCTURAL BASIS; CANCER; PHOSPHORYLATION; EXPRESSION; CELLS; DEGRADATION; CHECKPOINT; VOLASERTIB	Polo-like kinase 1 (PLK1) is a crucial regulator of cell cycle progression. It is established that the activation of PLK1 depends on the coordinated action of Aurora-A and Bora. Nevertheless, very little is known about the spatiotemporal regulation of PLK1 during G2, specifically, the mechanisms that keep cytoplasmic PLK1 inactive until shortly before mitosis onset. Here, we describe PLK1 dimerization as a new mechanism that controls PLK1 activation. During the early G2 phase, Bora supports transient PLK1 dimerization, thus fine-tuning the timely regulated activation of PLK1 and modulating its nuclear entry. At late G2, the phosphorylation of T210 by Aurora-A triggers dimer dissociation and generates active PLK1 monomers that support entry into mitosis. Interfering with this critical PLK1 dimer/monomer switch prevents the association of PLK1 with importins, limiting its nuclear shuttling, and causes nuclear PLK1 mislocalization during the G2-M transition. Our results suggest a novel conformational space for the design of a new generation of PLK1 inhibitors.	[Raab, Monika; Matthess, Yves; Raab, Christopher A.; Becker, Sven; Sanhaji, Mourad; Strebhardt, Klaus] Goethe Univ, Med Sch, Dept Gynecol, Frankfurt, Germany; [Gutfreund, Niklas; Doetsch, Volker] Goethe Univ, Inst Viophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Gutfreund, Niklas; Doetsch, Volker] Goethe Univ, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Strebhardt, Klaus] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ)	Sanhaji, M; Strebhardt, K (corresponding author), Goethe Univ, Med Sch, Dept Gynecol, Frankfurt, Germany.; Strebhardt, K (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.	mourad.sanhaji@kgu.de; strebhardt@em.uni-frankfurt.de		Sanhaji, Mourad/0000-0001-8202-0694; Strebhardt, Klaus/0000-0003-2173-9763	Deutsche Forschungsgemeinschaft; Messer Stiftung; Deutsche Krebshilfe; German Cancer Consortium (DKTK), Heidelberg; Verein zur Forderung der Wissenschaft; Pravention and Therapie von Kehlkopfkrebs e.V; Projekt DEAL	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Messer Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); German Cancer Consortium (DKTK), Heidelberg; Verein zur Forderung der Wissenschaft; Pravention and Therapie von Kehlkopfkrebs e.V; Projekt DEAL	This work was supported by grants from the Deutsche Forschungsgemeinschaft (M. Raab), Messer Stiftung, Deutsche Krebshilfe, German Cancer Consortium (DKTK), Heidelberg and Verein zur Forderung der Wissenschaft, Pravention and Therapie von Kehlkopfkrebs e.V. Open Access funding enabled and organized by Projekt DEAL.	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Asteriti IA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00283; Barbosa J, 2020, EMBO J, V39, DOI 10.15252/embj.2018100789; Baxter M, 2020, CHEMMEDCHEM, V15, P1058, DOI 10.1002/cmdc.202000137; Bruinsma W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00132; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Byrne DP, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax2713; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; de Carcer G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05429-5; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Gheghiani L, 2017, CELL REP, V19, P2060, DOI 10.1016/j.celrep.2017.05.031; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Gutteridge REA, 2016, MOL CANCER THER, V15, P1427, DOI 10.1158/1535-7163.MCT-15-0897; Joukov V, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4195; Joukov V, 2014, MOL CELL, V55, P578, DOI 10.1016/j.molcel.2014.06.016; Kachaner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01876-8; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lee MS, 2009, BBA-MOL CELL RES, V1793, P1571, DOI 10.1016/j.bbamcr.2009.07.005; Li HC, 2010, EMBO J, V29, P2953, DOI 10.1038/emboj.2010.174; Lim DC, 2020, MOL CELL ONCOL, V7, DOI 10.1080/23723556.2020.1832419; Lossl P, 2016, ACS CENTRAL SCI, V2, P445, DOI 10.1021/acscentsci.6b00053; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macville M, 1999, CANCER RES, V59, P141; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Meng L, 2015, MOL CELL BIOL, V35, P2626, DOI 10.1128/MCB.00068-15; Meunier S, 2016, TRENDS CELL BIOL, V26, P80, DOI 10.1016/j.tcb.2015.09.001; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Park CH, 2015, J BIOL CHEM, V290, P8569, DOI 10.1074/jbc.M114.623546; Pitzius S, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1936-z; Pujade-Lauraine E, 2016, J CLIN ONCOL, V34, P706, DOI 10.1200/JCO.2015.62.1474; Qi FF, 2018, CELL REP, V24, P546, DOI 10.1016/j.celrep.2018.06.087; Raab M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45627-9; Raab M, 2018, ACS CHEM BIOL, V13, P1921, DOI 10.1021/acschembio.7b01078; Rapley J, 2005, MOL CELL BIOL, V25, P1309, DOI 10.1128/MCB.25.4.1309-1324.2005; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Sells TB, 2015, ACS MED CHEM LETT, V6, P630, DOI 10.1021/ml500409n; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; Singh P, 2021, MOL CELL, V81, P67, DOI 10.1016/j.molcel.2020.10.040; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Song XH, 2020, FASEB J, V34, P4348, DOI 10.1096/fj.201902007R; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1485539; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Tsuchiya Y, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101318; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Wilhelm T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11584-0; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Xu J, 2013, NAT STRUCT MOL BIOL, V20, P1047, DOI 10.1038/nsmb.2623; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zhu K, 2016, STRUCTURE, V24, P1110, DOI 10.1016/j.str.2016.04.012; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	62	2	2	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					372	386		10.1038/s41388-021-02094-9	http://dx.doi.org/10.1038/s41388-021-02094-9		NOV 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34759346	Green Published, hybrid			2022-12-26	WOS:000716867900001
J	Hacisalihoglu, G; Beisel, NS; Settles, AM				Hacisalihoglu, Gokhan; Beisel, Nicole S.; Settles, A. Mark			Characterization of pea seed nutritional value within a diverse population of Pisum sativum	PLOS ONE			English	Article							HIGH COPPER INTAKE; FIELD PEAS; HEALTH-BENEFITS; NUTRIENTS; ASSOCIATION; IONOMICS; VARIETY; PROTEIN	Micronutrient malnutrition is a global concern that affects more than two billion people worldwide. Pea (Pisum sativum) is a nutritious pulse crop with potential to assist in tackling hidden hunger. Here we report seed ionomic data of 96 diverse pea accessions collected via inductively coupled plasma mass spectrometry (ICP-MS). We found a 100 g serving of peas provides the following average percent daily value for U.S. recommendations: 8% Ca, 39% Mg, 73% Cu, 37% Fe, 63% Mn, 45% Zn, 28% K, and 43% P. Correlations were observed between the majority of minerals tested suggesting strong interrelationships between mineral concentration levels. Hierarchical clustering identified fifteen accessions with high-ranking mineral concentrations. Thirty accessions could be compared to earlier inductively coupled optical emission spectrometry (ICP-OES) data, which revealed significant differences particularly for elements at extreme low or high levels of accumulation. These results improve our understanding of the range of variation in mineral content found in peas and provide additional mineral data resources for germplasm selection.	[Hacisalihoglu, Gokhan] Florida A&M Univ, Dept Biol Sci, Tallahassee, FL 32307 USA; [Beisel, Nicole S.; Settles, A. Mark] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Settles, A. Mark] NASA, Ames Res Ctr, Bioengn Branch, Moffett Field, CA 94035 USA	State University System of Florida; Florida A&M University; State University System of Florida; University of Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Settles, AM (corresponding author), Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA.; Settles, AM (corresponding author), NASA, Ames Res Ctr, Bioengn Branch, Moffett Field, CA 94035 USA.	settles@ufl.edu						Amarakoon D, 2015, J FOOD COMPOS ANAL, V37, P67, DOI 10.1016/j.jfca.2014.09.001; Asaro A, 2016, G3-GENES GENOM GENET, V6, P4175, DOI 10.1534/g3.116.034827; Bamrah RK, 2019, CROP SCI, V59, P2689, DOI 10.2135/cropsci2019.01.0004; Baxter IR, 2013, CROP SCI, V53, P208, DOI 10.2135/cropsci2012.02.0135; Bonilla I, 2004, PLANT SOIL, V267, P97, DOI 10.1007/s11104-005-4689-7; Cheng P, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0277-6; Cousin R, 1997, FIELD CROP RES, V53, P111, DOI 10.1016/S0378-4290(97)00026-9; Coyne C. J., 2005, Pisum Genetics, V37, P1; Dahl WJ, 2012, BRIT J NUTR, V108, pS3, DOI 10.1017/S0007114512000852; Day L, 2013, TRENDS FOOD SCI TECH, V32, P25, DOI 10.1016/j.tifs.2013.05.005; Demirbas A, 2018, INT J AGRIC BIOL, V20, P701, DOI 10.17957/IJAB/15.0545; FAOSTAT, 2019, FAO STAT DAT; Gawalko E, 2009, FOOD ADDIT CONTAM A, V26, P1002, DOI 10.1080/02652030902894389; Godecke T, 2018, GLOB FOOD SECUR-AGR, V17, P21, DOI 10.1016/j.gfs.2018.03.004; Grela ER, 2017, EUR FOOD RES TECHNOL, V243, P1385, DOI 10.1007/s00217-017-2849-7; Hacisalihoglu G, 2020, J SCI FOOD AGR, V100, P3488, DOI [10.1002/jsfa.10389, 10.31220/osf.io/7j9cy]; Hacisalihoglu G, 2018, J INTEGR PLANT BIOL, V60, P232, DOI 10.1111/jipb.12612; Hacisalihoglu G, 2017, J PLANT NUTR, V40, P2808, DOI 10.1080/01904167.2017.1382528; Hacisalihoglu G, 2013, J PLANT NUTR, V36, P772, DOI 10.1080/01904167.2012.754041; Harmankaya M., 2010, South-Western Journal of Horticulture Biology and Environment, V1, P159; Institute of Medicine, 2001, DIETARY REFERENCE IN, P224; Iqbal A, 2006, FOOD CHEM, V97, P331, DOI 10.1016/j.foodchem.2005.05.011; Izquierdo P, 2018, THEOR APPL GENET, V131, P1645, DOI 10.1007/s00122-018-3104-8; Jha AB, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010073; Kar Satismruti, 2013, American Journal of Plant Sciences, V4, P1309; Kessler H, 2008, J NEURAL TRANSM, V115, P1181, DOI 10.1007/s00702-008-0080-1; Kwon SJ, 2012, GENES GENOM, V34, P305, DOI 10.1007/s13258-011-0213-z; Marschner H., 1986, Mineral nutrition of higher plants.; Moore KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25130-3; Mudryj AN, 2014, APPL PHYSIOL NUTR ME, V39, P1197, DOI 10.1139/apnm-2013-0557; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Pita-Barbosa A, 2019, THEOR EXP PLANT PHYS, V31, P71, DOI 10.1007/s40626-019-00144-y; Poblaciones MJ, 2018, J PLANT NUTR SOIL SC, V181, P932, DOI 10.1002/jpln.201800251; Ray H, 2014, CROP SCI, V54, P1698, DOI 10.2135/cropsci2013.08.0568; Rehman HM, 2019, PLANT CELL ENVIRON, V42, P52, DOI 10.1111/pce.13368; Robinson GHJ, 2019, NUTR BULL, V44, P202, DOI 10.1111/nbu.12399; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sharma P, 2017, FOOD REV INT, V33, P1, DOI 10.1080/87559129.2015.1137309; Tan Grace Z H, 2017, Front Plant Sci, V8, P1755, DOI 10.3389/fpls.2017.01755; Turnlund JR, 2005, AM J CLIN NUTR, V81, P822, DOI 10.1093/ajcn/81.4.822; Turnlund JR, 2004, AM J CLIN NUTR, V79, P1037; USDA-NASS, 2019, LAND VALUES 2019 SUM; Wang N, 2004, J SCI FOOD AGR, V84, P1021, DOI 10.1002/jsfa.1742; Wang N, 2008, FOOD CHEM, V111, P132, DOI 10.1016/j.foodchem.2008.03.047; Wang XY, 2012, FIELD CROP RES, V134, P130, DOI 10.1016/j.fcr.2012.06.002; Warkentin TD, 1997, CAN J PLANT SCI, V77, P101, DOI 10.4141/P96-059; Warkentin T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092563; WHO, 2006, GUIDELINES FOOD FORT; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	49	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259565	10.1371/journal.pone.0259565	http://dx.doi.org/10.1371/journal.pone.0259565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735531	Green Published, gold			2022-12-26	WOS:000755077100094
J	Khan, MA; Kumar, P; Akif, M; Miyoshi, H				Khan, Mateen A.; Kumar, Pankaj; Akif, Mohd.; Miyoshi, Hiroshi			Phosphorylation of eukaryotic initiation factor eIFiso4E enhances the binding rates to VPg of turnip mosaic virus	PLOS ONE			English	Article							GENOME-LINKED PROTEIN; MESSENGER-RNA CAP; CIRCULAR-DICHROISM SPECTROSCOPY; TRANSLATION INITIATION; FACTOR 4E; SERUM-ALBUMIN; FACTORS EIF4F; WEB SERVER; POTYVIRUS; HOST	Binding of phosphorylated eIFiso4E with viral genome-linked protein (VPg) of turnip mosaic virus was examined by stopped-flow, fluorescence, circular dichroism (CD) spectroscopy, and molecular docking analysis. Phosphorylation of eIFiso4E increased (4-fold) the binding rates as compared to unphosphorylated eIFiso4E with VPg. Stopped-flow kinetic studies of phosphorylated eIFiso4E with VPg showed a concentration-independent conformational change. The dissociation rate was about 3-fold slower for eIFiso4E.VPg complex upon phosphorylation. Phosphorylation enhanced the association rates and lowered the dissociation rates for the eIFiso4E.VPg binding, with having higher preferential binding to eIFiso4Ep. Binding rates for the interaction of eIFiso4Ep with VPg increased (6-fold) with an increase in temperature, 278 K to 298 K. The activation energies for binding of eIFiso4Ep and eIFiso4E with VPg were 37.2 +/- 2.8 and 52.6 +/- 3.6 kJ/mol, respectively. Phosphorylation decreased the activation energy for the binding of eIFiso4E to VPg. The reduced energy barrier suggests more stable platform for eIFiso4Ep.VPg initiation complex formation, which was further supported by molecular docking analysis. Moreover, far-UV CD studies revealed that VPg formed complex with eIFiso4Ep with substantial change in the secondary structure. These results suggested that phosphorylation, not only reduced the energy barrier and dissociation rate but also enhanced binding rate, and an overall conformational change, which provides a more stable platform for efficient viral translation.	[Khan, Mateen A.] Alfaisal Univ, Coll Sci & Gen Studies, Dept Life Sci, Riyadh, Saudi Arabia; [Kumar, Pankaj; Akif, Mohd.] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, India; [Miyoshi, Hiroshi] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa, Japan	Alfaisal University; University of Hyderabad; Saint Marianna University	Khan, MA (corresponding author), Alfaisal Univ, Coll Sci & Gen Studies, Dept Life Sci, Riyadh, Saudi Arabia.	matkhan@alfaisal.edu		Miyoshi, Hiroshi/0000-0002-0489-9848; Khan, Mateen A./0000-0002-2300-4595; Mohd., Akif/0000-0001-8462-7166				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURROUGHS JN, 1978, J GEN VIROL, V41, P443, DOI 10.1099/0022-1317-41-2-443; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; de Oliveira LC, 2019, P NATL ACAD SCI USA, V116, P24056, DOI 10.1073/pnas.1904752116; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Eskelin K, 2011, J VIROL, V85, P9210, DOI 10.1128/JVI.00052-11; Gallie DR, 1997, J BIOL CHEM, V272, P1046, DOI 10.1074/jbc.272.2.1046; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grzela R, 2006, BIOCHIMIE, V88, P887, DOI 10.1016/j.biochi.2006.02.012; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2002, INT J BIOL MACROMOL, V30, P171, DOI 10.1016/S0141-8130(02)00017-X; Khan MA, 2002, INT J BIOL MACROMOL, V30, P243, DOI 10.1016/S0141-8130(02)00038-7; Khan MA., 2020, SPECTROCHIM ACTA, V243, P1, DOI [10.1016/j.saa.2020.11877632829157, DOI 10.1016/J.SAA.2020.11877632829157]; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Khan MA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250374; Khan MA, 2019, J BIOCHEM, V165, P167, DOI 10.1093/jb/mvy091; Khan MA, 2018, INT J BIOL MACROMOL, V106, P387, DOI 10.1016/j.ijbiomac.2017.08.041; Khrapunov S, 2009, ANAL BIOCHEM, V389, P174, DOI 10.1016/j.ab.2009.03.036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Li XH, 1997, J VIROL, V71, P1598, DOI 10.1128/JVI.71.2.1598-1607.1997; Luo YJ, 2001, J BIOL CHEM, V276, P43083, DOI 10.1074/jbc.M104970200; Margreitter C, 2013, NUCLEIC ACIDS RES, V41, pW422, DOI 10.1093/nar/gkt416; Mayberry LK, 2011, J BIOL CHEM, V286, P42566, DOI 10.1074/jbc.M111.280099; Michon T, 2006, FEBS J, V273, P1312, DOI 10.1111/j.1742-4658.2006.05156.x; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Miyoshi H, 2008, BIOCHIMIE, V90, P1427, DOI 10.1016/j.biochi.2008.03.013; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Nicolas O, 1997, VIROLOGY, V237, P452, DOI 10.1006/viro.1997.8780; Okade H, 2009, J BIOCHEM, V145, P299, DOI 10.1093/jb/mvn180; OLSEN K, 1993, BIOCHEMISTRY-US, V32, P9686, DOI 10.1021/bi00088a021; Qadeer A, 2013, ARCH BIOCHEM BIOPHYS, V540, P101, DOI 10.1016/j.abb.2013.10.015; Rabbani G, 2018, CURR PROTEIN PEPT SC, V19, P948, DOI 10.2174/1389203718666170828122927; Rabbani G, 2015, RSC ADV, V5, P20115, DOI 10.1039/c4ra17093h; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rajamaki ML, 1999, MOL PLANT MICROBE IN, V12, P1074, DOI 10.1094/MPMI.1999.12.12.1074; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rodger Alison, 2005, V305, P343; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Royall E, 2015, J BIOL CHEM, V290, P4748, DOI 10.1074/jbc.M114.602649; Sabharwal P, 2018, VIROLOGY, V524, P18, DOI 10.1016/j.virol.2018.08.002; Sadowy E, 2001, ADV VIRUS RES, V57, P185, DOI 10.1016/S0065-3527(01)57004-9; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tavert-Roudet G, 2017, MOL PLANT MICROBE IN, V30, P754, DOI 10.1094/MPMI-04-17-0091-R; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Walsh JA, 2002, MOL PLANT PATHOL, V3, P289, DOI 10.1046/j.1364-3703.2002.00132.x; Walter J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165618; Walter J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071794; Wang YH, 1996, BBA-PROTEIN STRUCT M, V1297, P207, DOI 10.1016/S0167-4838(96)00119-7; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; WEBSTER C, 1991, J BIOL CHEM, V266, P23341; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	66	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259688	10.1371/journal.pone.0259688	http://dx.doi.org/10.1371/journal.pone.0259688			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735537	Green Published, gold			2022-12-26	WOS:000755077100104
J	Mugo, BC; Lekopien, C; Owiny, M				Mugo, Bernard Chege; Lekopien, Cornelius; Owiny, Maurice			'We dry contaminated meat to make it safe': An assessment of knowledge, attitude and practices on anthrax during an outbreak, Kisumu, Kenya, 2019	PLOS ONE			English	Article								Introduction Anthrax is the highest-ranked priority zoonotic disease in Kenya with about ten human cases annually. Anthrax outbreak was reported in Kisumu East Sub County after some villagers slaughtered and ate beef from a cow suspected to have died of anthrax. We aimed at establishing the magnitude of the outbreak, described associated factors, and assessed community knowledge, attitude, and practices on anthrax. Methods We reviewed human and animal records, conducted case search and contact tracing using standard case definitions in the period from July 1through to July 28, 2019. A cross-sectional study was conducted to assess community knowledge, attitude, and practices towards anthrax. The household selection was done using multistage sampling. We cleaned and analyzed data in Ms. Excel and Epi Info. Descriptive statistics were carried out for continuous and categorical variables while analytical statistics for the association between dependent and independent variables were calculated. Results Out of 53 persons exposed through consumption or contact with suspicious beef, 23 cases (confirmed: 1, probable: 4, suspected: 18) were reviewed. The proportion of females was 52.17% (12/23), median age 13.5 years and range 45 years. The attack rate was 43.4% (23/53) and the case fatality rate was 4.35% (1/23). Knowledge level, determined by dividing those considered to be 'having good knowledge' on anthrax (numerator) by the total number of respondents (denominator) in the population regarding cause, transmission, symptoms and prevention was 51% for human anthrax and 52% for animal anthrax. Having good knowledge on anthrax was associated with rural residence [OR = 5.5 (95% CI 2.1-14.4; p<0.001)], having seen a case of anthrax [OR = 6.2 (95% CI 2.8-14.2; p<0.001)] and among those who present cattle for vaccination [OR = 2.6 (95% CI 1.2-5.6; p = 0.02)]. About 23.2% (26/112) would slaughter and sell beef to neighbors while 63.4% (71/112) would bury or burn the carcass. Nearly 93.8% (105/112) believed vaccination prevents anthrax. However, 5.4% (62/112) present livestock for vaccination. Conclusion Most anthrax exposures were through meat consumption. Poor knowledge of the disease might hamper prevention and control efforts.	[Mugo, Bernard Chege; Lekopien, Cornelius; Owiny, Maurice] Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya		Mugo, BC (corresponding author), Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya.	bernardchegevet@gmail.com		Chege, Bernard/0000-0002-3435-4902				Ahsan MM, 2013, THAI J VET MED, V43, P449; Bengis RG, 2014, REV SCI TECH OIE, V33, P593, DOI 10.20506/rst.33.2.2309; Bennett AM, 2016, J APPL MICROBIOL, V121, P840, DOI 10.1111/jam.13201; Carlson CJ, 2019, NAT MICROBIOL, V4, P1337, DOI 10.1038/s41564-019-0435-4; Case SI., 2018, SPECIMEN SHIPPING, P1; Chacha I., 2016, INT J ANIM VET SCI, V10, P419; Chitrakar B, 2019, CRIT REV FOOD SCI, V59, P2734, DOI 10.1080/10408398.2018.1466265; County Government of Kisumu, 2018, KIS COUNT ANN DEV PL, P2; Finke EJ, 2020, EUR J MICROBIOL IMMU, V10, P29, DOI 10.1556/1886.2020.00008; Gachohi JM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819001304, 10.1017/s0950268819001304]; Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20; Hampson K, 2011, J APPL ECOL, V48, P1333, DOI 10.1111/j.1365-2664.2011.02030.x; John K, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-162; Kenya National Bureau of Statistics, 2019 KEN POP HOUS CE, V1; Menton J, 1937, BRIT MED J, V1937, P1273; Misgie F., 2015, ACAD J ANIM DIS, V4, P196, DOI DOI 10.5829/IDOSI.AJAD.2015.4.3.96127; Munyua P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161576; Muturi M, 2018, AM J TROP MED HYG, V99, P833, DOI 10.4269/ajtmh.18-0224; Mwakapeje E. R., 2017, International Journal of One Health, V3, P66, DOI 10.14202/IJOH.2017.66-76; Mwakapeje ER, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180479; Nakanwagi M, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008026; Ngetich W., 2019, INT J AGR ENV BIORES, V4; Omballa VO, 2016, AM J TROP MED HYG, V94, P43, DOI 10.4269/ajtmh.15-0320; Ravenel MP., 2008, AM J PUBLIC HLTH NAT, V30, P299, DOI [10.2105/ajph.30.3.299, DOI 10.2105/AJPH.30.3.299]; Rushton J., 2008, The economics of animal health and production, P243, DOI 10.1079/9781845931940.0243; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Sarmah H.K., 2013, INT J APPL MATH STAT, V2, P33; Seid K, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-2267-0; Sitali DC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005580; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Territory AC., 2009, ANIMAL DIS ACT 2005; Traxler RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224176	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259017	10.1371/journal.pone.0259017	http://dx.doi.org/10.1371/journal.pone.0259017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735481	gold, Green Published			2022-12-26	WOS:000755077100042
J	Taylor, MR; Garrison, MM; Rosenberg, AR				Taylor, Mallory R.; Garrison, Michelle M.; Rosenberg, Abby R.			Heart rate variability and psychosocial symptoms in adolescents and young adults with cancer	PLOS ONE			English	Article							CHILDHOOD-CANCER; DEPRESSION SCALE; HOSPITAL ANXIETY; RELIABILITY; IMPACT; MORTALITY; SURVIVORS; DISTRESS; VALIDITY; OUTCOMES	Background Heart Rate Variability (HRV) is a valid, scalable biomarker of stress. We aimed to examine associations between HRV and psychosocial outcomes in adolescents and young adults (AYAs) with cancer. Methods This was a secondary analysis of baseline data from a randomized trial testing a resilience intervention in AYAs with cancer. Two widely used HRV metrics, the standard deviation of normal to normal beats (SDNN) and root mean square of successive differences (RMSSD), were derived from electrocardiograms. Patient-reported outcome (PRO) survey measures included quality of life, anxiety, depression, distress, and resilience. Linear regression models were used to test associations between HRV and PRO scores. The Wilcoxon rank sum test was used to test differences in median HRV values among participant subgroups. Results Among the n = 76 patients with available electrocardiograms, the mean age was 16 years (SD 3y), 63% were white, and leukemia/lymphoma was the most common diagnosis. Compared to healthy adolescents, AYAs with cancer had lower median HRV (SDNN [Females: 31.9 (12.8-50.7) vs 66.4 (46.0-86.8), p<0.01; Males: 29.9 (11.5-47.9) vs 63.2 (48.4-84.6), p<0.01]; RMSSD [Females: 28.2 (11.1-45.5) vs 69.0 (49.1-99.6), p<0.01; Males: 27.9 (8.6-48.6) vs 58.7 (44.8-88.2), p<0.01]). There was no statistically significant association between PRO measures and SDNN or RMSSD in either an unadjusted or adjusted linear regression models. Conclusion In this secondary analysis, we did not find an association between HRV and psychosocial PROs among AYAs with cancer. HRV measures were lower than for healthy adolescents. Larger prospective studies in AYA biopsychosocial research are needed.	[Taylor, Mallory R.; Rosenberg, Abby R.] Univ Washington, Sch Med, Dept Pediat, Div Hematol Oncol, Seattle, WA 98195 USA; [Taylor, Mallory R.; Rosenberg, Abby R.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Palliat Care & Resilience Lab, Seattle, WA 98101 USA; [Taylor, Mallory R.; Rosenberg, Abby R.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA; [Garrison, Michelle M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Taylor, MR (corresponding author), Univ Washington, Sch Med, Dept Pediat, Div Hematol Oncol, Seattle, WA 98195 USA.; Taylor, MR (corresponding author), Seattle Childrens Res Inst, Ctr Clin & Translat Res, Palliat Care & Resilience Lab, Seattle, WA 98101 USA.; Taylor, MR (corresponding author), Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA.	molly.taylor@seattlechildrens.org	Garrison, Michelle/GZL-8214-2022	Taylor, Mallory/0000-0002-8998-4530				Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Appelhans BM, 2008, BIOL PSYCHOL, V77, P174, DOI 10.1016/j.biopsycho.2007.10.004; Barron TI, 2011, J CLIN ONCOL, V29, P2635, DOI 10.1200/JCO.2010.33.5422; Berger C, 2019, J ADOLESC YOUNG ADUL, V8, P9, DOI 10.1089/jayao.2018.0021; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Camm AJ, 1996, CIRCULATION, V93, P1043; Chalmers JA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00080; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Crosswell AD, 2014, PSYCHONEUROENDOCRINO, V45, P58, DOI 10.1016/j.psyneuen.2014.03.011; De Couck M, 2013, CANCER EPIDEMIOL, V37, P737, DOI 10.1016/j.canep.2013.04.016; Eiser C, 2009, SEMIN ONCOL, V36, P275, DOI 10.1053/j.seminoncol.2009.03.005; El-Jawahri A, 2017, CANCER-AM CANCER SOC, V123, P1828, DOI 10.1002/cncr.30546; Fitzgerald P, 2015, BMJ SUPPORT PALLIAT, V5, P381, DOI 10.1136/bmjspcare-2012-000380; Johnston Brian W, 2020, J Intensive Care Soc, V21, P148, DOI 10.1177/1751143719853744; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564; Kemper KJ, 2008, PEDIATR RES, V64, P105, DOI 10.1203/PDR.0b013e318174e6fb; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kirizawa JM, 2020, SUPPORT CARE CANCER, V28, P35, DOI 10.1007/s00520-019-05047-x; Kloter E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00623; Knight J., 2018, BIOL BLOOD MARROW TR, pS253; Koenig J, 2016, CLIN PSYCHOL REV, V46, P136, DOI 10.1016/j.cpr.2016.04.013; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Leandro Rodriguez-Linares Leandro, 2019, R PACKAGE VERSION 42; Lischke A, 2018, J PSYCHOSOM RES, V106, P56, DOI 10.1016/j.jpsychores.2018.01.005; Lutgendorf SK, 2010, J CLIN ONCOL, V28, P4094, DOI 10.1200/JCO.2009.26.9357; Mewton L, 2016, PSYCHOL ASSESSMENT, V28, P1232, DOI 10.1037/pas0000239; Munoz ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138921; Nussinovitch U, 2011, ANN NONINVAS ELECTRO, V16, P117, DOI 10.1111/j.1542-474X.2011.00417.x; O'Higgins CM, 2018, SUPPORT CARE CANCER, V26, P3353, DOI 10.1007/s00520-018-4318-7; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rohatgi A, 2020, WEBPLOTDIGITIZER; Rosenberg AR, 2018, CANCER-AM CANCER SOC, V124, P3909, DOI 10.1002/cncr.31666; Shaashua L, 2017, CLIN CANCER RES, V23, P4651, DOI 10.1158/1078-0432.CCR-17-0152; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Sharma VK, 2015, J CLIN DIAGN RES, V9, pCC08, DOI 10.7860/JCDR/2015/15373.6662; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; van der Geest IMM, 2013, J PEDIAT HEMATOL ONC, V35, P525, DOI 10.1097/MPH.0b013e31829f2799; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Verhoof EJA, 2014, CHILD ADOL PSYCH MEN, V8, DOI 10.1186/1753-2000-8-12; Volden PA, 2013, BRAIN BEHAV IMMUN, V30, pS26, DOI 10.1016/j.bbi.2012.10.022; Wang JT, 1996, J NETW COMPUT APPL, V19, P295, DOI 10.1006/jnca.1996.0020	45	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259385	10.1371/journal.pone.0259385	http://dx.doi.org/10.1371/journal.pone.0259385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735505	gold, Green Published			2022-12-26	WOS:000755077100069
J	Thomas, KN; Zimmel, KN; Roach, AN; Basel, A; Mehta, NA; Bedi, YS; Golding, MC				Thomas, Kara N.; Zimmel, Katherine N.; Roach, Alexis N.; Basel, Alison; Mehta, Nicole A.; Bedi, Yudhishtar S.; Golding, Michael C.			Maternal background alters the penetrance of growth phenotypes and sex-specific placental adaptation of offspring sired by alcohol-exposed males	FASEB JOURNAL			English	Article						developmental programming; fetal alcohol spectrum disorder (FASDs); genetic background; mitochondrial disfunction; oxidative phosphorylation; paternal epigenetic inheritance; placental adaptation; placental dysfunction; preconception exposure; RRID; IMSR_CRL; 22; RRID; IMSR_JAX; 000664; RRID; SCR_002798	FETAL-GROWTH; ETHANOL TERATOGENESIS; IMPRINTED GENES; LATE-GESTATION; MOUSE MODEL; MALE-MICE; RESTRICTION; MITOEPIGENETICS; CONSUMPTION; OVERGROWTH	Epigenetic mechanisms of paternal inheritance are an emerging area of interest in our efforts to understand fetal alcohol spectrum disorders. In rodent models examining maternal alcohol exposures, different maternal genetic backgrounds protect or sensitize offspring to alcohol-induced teratogenesis. However, whether maternal background can mitigate sperm-inherited alterations in developmental programming and modify the penetrance of growth defects induced by preconception paternal alcohol exposures remains unaddressed. In our previous studies examining pure C57Bl/6J crosses, the offspring of alcohol-exposed sires exhibited fetal growth restriction, enlarged placentas, and decreased placental efficiency. Here, we find that in contrast to our previous studies, the F1 offspring of alcohol-exposed C57Bl/6J sires and CD-1 dams do not exhibit fetal growth restriction, with male fetuses developing smaller placentas and increased placental efficiencies. However, in these hybrid offspring, preconception paternal alcohol exposure induces sex-specific changes in placental morphology. Specifically, the female offspring of alcohol-exposed sires displayed structural changes in the junctional and labyrinth zones, along with increased placental glycogen content. These changes in placental organization are accompanied by female-specific alterations in the expression of imprinted genes Cdkn1c and H19. Although male placentae do not display overt changes in placental histology, using RNA-sequencing, we identified programmed alterations in genes regulating oxidative phosphorylation, mitochondrial function, and Sirtuin signaling. Collectively, our data reveal that preconception paternal alcohol exposure transmits a stressor to developing offspring, that males and females exhibit distinct patterns of placental adaptation, and that maternal genetic background can modulate the effects of paternal alcohol exposure.	[Thomas, Kara N.; Zimmel, Katherine N.; Roach, Alexis N.; Basel, Alison; Mehta, Nicole A.; Bedi, Yudhishtar S.; Golding, Michael C.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Golding, MC (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA.	mgolding@cvm.tamu.edu		Zimmel, Katherine/0000-0002-8243-6953; GOLDING, MICHAEL/0000-0003-1631-2175; Bedi, Yudhishtar/0000-0002-1213-4116	HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA028219]; W. M. Keck Foundation	HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA); W. M. Keck Foundation(W.M. Keck Foundation)	HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R01AA028219; W. M. Keck Foundation (W.M. Keck Foundation)	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Albers RE, 2018, THERIOGENOLOGY, V107, P115, DOI 10.1016/j.theriogenology.2017.10.049; Bailoo JD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00232; Bedi Y, 2019, REPROD TOXICOL, V87, P11, DOI 10.1016/j.reprotox.2019.04.006; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carnahan MN, 2013, ALCOHOL, V47, P109, DOI 10.1016/j.alcohol.2012.12.003; Champroux A, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00050; Chan JC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15305-w; Chang RC, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00403-w; Chang RC, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0254-0; Chang RC, 2017, EPIGENETICS-US, V12, P841, DOI 10.1080/15592294.2017.1363952; Coan PM, 2010, J PHYSIOL-LONDON, V588, P527, DOI 10.1113/jphysiol.2009.181214; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Dackor J, 2009, GENETICS, V183, P207, DOI 10.1534/genetics.109.104372; Dackor J, 2009, MAMM GENOME, V20, P339, DOI 10.1007/s00335-009-9189-2; De Clercq K, 2019, P NATL ACAD SCI USA, V116, P13927, DOI 10.1073/pnas.1902688116; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donald KA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00294; Dong Z, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00004; Downing C, 2009, ALCOHOL CLIN EXP RES, V33, P1238, DOI 10.1111/j.1530-0277.2009.00949.x; Eberhart JK, 2016, ALCOHOL CLIN EXP RES, V40, P1154, DOI 10.1111/acer.13066; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Gardebjer EM, 2014, PLACENTA, V35, P50, DOI 10.1016/j.placenta.2013.10.008; GILLIAM DM, 1990, ALCOHOL CLIN EXP RES, V14, P539, DOI 10.1111/j.1530-0277.1990.tb01196.x; Gilliam DM, 1997, ALCOHOL CLIN EXP RES, V21, P28; Hayward CE, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00028; Heyne GW, 2015, J AM ASSOC LAB ANIM, V54, P368; Hsu CW, 2016, DEV BIOL, V419, P229, DOI 10.1016/j.ydbio.2016.09.011; Immler S, 2018, HEREDITY, V121, P239, DOI 10.1038/s41437-018-0111-0; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Kalisch-Smith JI, 2017, PLACENTA, V54, P10, DOI 10.1016/j.placenta.2016.12.008; Kalisch-Smith JI, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172205; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Larriba E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5020-3; Le Blevec E, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110964; Lesciotto KM, 2020, DEV DYNAM, V249, P573, DOI 10.1002/dvdy.136; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Pruis MGM, 2015, ACTA PHYSIOL, V215, P127, DOI 10.1111/apha.12562; Rennie MY, 2012, AM J PHYSIOL-HEART C, V302, pH1261, DOI 10.1152/ajpheart.00776.2011; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rompala GR, 2019, ALCOHOL CLIN EXP RES, V43, P1032, DOI 10.1111/acer.14029; Rompala GR, 2017, ALCOHOL, V60, P169, DOI 10.1016/j.alcohol.2016.11.001; Rosenfeld CS, 2015, ENDOCRINOLOGY, V156, P3422, DOI 10.1210/en.2015-1227; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sadakierska-Chudy A, 2014, PHARMACOL THERAPEUT, V144, P226, DOI 10.1016/j.pharmthera.2014.06.002; Schaefer G Bradley, 2011, J Ark Med Soc, V108, P38; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sittig LJ, 2011, FASEB J, V25, P2313, DOI 10.1096/fj.10-179234; Sofronescu AG, 2010, CARDIOVASC RES, V87, P102, DOI 10.1093/cvr/cvq025; Thiele Todd E, 2014, Curr Protoc Neurosci, V68, DOI 10.1002/0471142301.ns0949s68; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tunster SJ, 2016, DEV BIOL, V418, P55, DOI 10.1016/j.ydbio.2016.08.014; Tunster SJ, 2016, DEV BIOL, V409, P251, DOI 10.1016/j.ydbio.2015.10.015; Tunster SJ, 2012, PLACENTA, V33, P124, DOI 10.1016/j.placenta.2011.11.011; Tunster SJ, 2014, DIS MODEL MECH, V7, P1185, DOI 10.1242/dmm.017079; Tunster SJ, 2011, DIS MODEL MECH, V4, P814, DOI 10.1242/dmm.007328; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Watkins AJ, 2017, BBA-MOL BASIS DIS, V1863, P1371, DOI 10.1016/j.bbadis.2017.02.009; WHITTEN WK, 1968, SCIENCE, V161, P584, DOI 10.1126/science.161.3841.584	63	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22035	10.1096/fj.202101131R	http://dx.doi.org/10.1096/fj.202101131R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748230	Green Published			2022-12-26	WOS:000722321300006
J	Lucchini, M; Gerosa, T; Pancheva, M; Pisati, M; Respi, C; Riva, E				Lucchini, Mario; Gerosa, Tiziano; Pancheva, Marta; Pisati, Maurizio; Respi, Chiara; Riva, Egidio			Differential effects of COVID-19 and containment measures on mental health: Evidence from ITA.LI-Italian Lives, the Italian household panel	PLOS ONE			English	Article								This study used a subsample of a household panel study in Italy to track changes in mental health before the onset of COVID-19 and into the first lockdown period, from late April to early September 2020. The results of the random-effects regression analyses fitted on a sample of respondents aged 16 years and older (N = 897) proved that there was a substantial and statistically significant short-term deterioration in mental health (from 78,5 to 67,9; beta = -10.5, p < .001; Cohen's d -.445), as measured by a composite index derived from the mental component of the 12-item Short-Form Health Survey (SF-12). The findings also showed heterogeneity in the COVID-related effects. On the one hand, evidence has emerged that the pandemic acted as a great leveller of pre-existing differences in mental health across people of different ages: the decrease was most pronounced among those aged 16-34 (from 84,2 to 66,5; beta = -17.7, p < .001; Cohen's d -.744); however, the magnitude of change reduced as age increased and turned to be non-significant among individuals aged 70 and over. On the other hand, the COVID-19 emergency widened the mental health gender gap and created new inequalities, based on the age of the youngest child being taken care of within the household.	[Lucchini, Mario; Gerosa, Tiziano; Pisati, Maurizio; Respi, Chiara; Riva, Egidio] Univ Milano Bicocca, Dept Sociol & Social Res, Milan, Italy; [Pancheva, Marta] Sophia Univ Inst, Dept Econ & Management, Figline E Incise Valdarn, Italy	University of Milano-Bicocca	Riva, E (corresponding author), Univ Milano Bicocca, Dept Sociol & Social Res, Milan, Italy.	egidio.riva@unimib.it		Riva, Egidio/0000-0002-5136-8046; Gerosa, Tiziano/0000-0001-6030-416X	Italian Ministry of Education, Universities and Research under the "Departments of Excellence 2018-2022" initiative [232]; Department of Sociology and Social Research of the University of Milan-Bicocca [2018-NAZ-0116]; Department of Sociology and Social Research of the University of Milan-Bicocca	Italian Ministry of Education, Universities and Research under the "Departments of Excellence 2018-2022" initiative; Department of Sociology and Social Research of the University of Milan-Bicocca; Department of Sociology and Social Research of the University of Milan-Bicocca	ITA.LI -Italian Lives project is funded by the Italian Ministry of Education, Universities and Research under the "Departments of Excellence 2018-2022" initiative (Italian Law 232 of 11 December 2016) (https://www.miur.gov.it/dipartimenti-di-eccellenza).Internal grant number at the Department of Sociology and Social Research of the University of Milan-Bicocca is 2018-NAZ-0116. The award was received by the Department of Sociology and Social Research of the University of Milan-Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster S., 2020, 202004 U FREIB, V22, P117, DOI DOI 10.13140/RG.2.2.17900.39043; Banks J., 2020, IFS WORKING PAPERS, DOI https://doi.org/10.1920/wp.ifs.2020.1620; Barbara G, 2020, J WOMENS HEALTH, V29, P1239, DOI 10.1089/jwh.2020.8590; Brodeur A, 2020, DISCUSSION PAPERS, V3204; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Campbell D. T., 1963, HDB RES TEACHING, P171; Daly M, 2021, J PSYCHIATR RES, V136, P603, DOI 10.1016/j.jpsychires.2020.10.035; Del Boca D, 2020, REV ECON HOUSEHOLD, V18, P1001, DOI 10.1007/s11150-020-09502-1; Ebrahimi OV, 2021, CLIN PSYCHOL SCI, V9, P489, DOI 10.1177/2167702621994545; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Eurofound, 2020, WOM LAB MARK EQ HAS; Fancourt D, 2020, COVID 19 SOCIAL STUD; Ferrera M., 1996, J EUR SOC POLICY, V6, P17, DOI [10.1177/095892879600600102, DOI 10.1177/09582879600600102]; Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.89; Fisher JRW, 2020, MED J AUSTRALIA, V213, P458, DOI 10.5694/mja2.50831; Forbes MK, 2019, CLIN PSYCHOL SCI, V7, P900, DOI 10.1177/2167702619859337; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Goldman-Mellor SJ, 2010, INT J MENT HEALTH, V39, P6, DOI 10.2753/IMH0020-7411390201; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; International Labour Organization, 2021, BUILD FORW FAIR WOM; Jia HM, 2009, PUBLIC HEALTH REP, V124, P692, DOI 10.1177/003335490912400511; Joaquim RM., 2021, CURR RES BEHAV SCI, V2, P100019, DOI 10.1016/j.crbeha.2021.100019; Kuhn U, 2021, EUR SOC, V23, pS942, DOI 10.1080/14616696.2020.1839671; Kulic N, 2021, EUR SOC, V23, pS400, DOI 10.1080/14616696.2020.1828974; Margerison-Zilko Claire, 2016, Curr Epidemiol Rep, V3, P81; Matthews T, 2019, PSYCHOL MED, V49, P268, DOI 10.1017/S0033291718000788; Maunder RG, 2009, GEN HOSP PSYCHIAT, V31, P316, DOI 10.1016/j.genhosppsych.2009.04.004; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Paulino M, 2021, PSYCHOL HEALTH MED, V26, P44, DOI 10.1080/13548506.2020.1808236; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Refle JE., 2020, 1 RESULTS SWISS HOUS; Respi C, RASSEGNA ITALIANA SO, V62, P39; Rossi R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00790; SCHLAGER D, 1993, BRIT J PSYCHIAT, V163, P322, DOI 10.1192/bjp.163.3.322; Settersten RA, 2020, ADV LIFE COURSE RES, V45, DOI 10.1016/j.alcr.2020.100360; Tubadji A., 2020, CTR EC POLICY RES, V20, P109; Varma P, 2021, PROG NEURO-PSYCHOPH, V109, DOI 10.1016/j.pnpbp.2020.110236; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Ware J E Jr, 1995, Med Care, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WHO, 2011, IMP EC CRIS MENT HLT; Yamamura E., 2020, EC VETTED REAL TIME, V23, P303	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259989	10.1371/journal.pone.0259989	http://dx.doi.org/10.1371/journal.pone.0259989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784397	Green Published, gold			2022-12-26	WOS:000755277300035
J	Rivera-Ortiz, J; Pla-Tenorio, J; Cruz, ML; Colon, K; Perez-Morales, J; Rodriguez, JA; Martinez-Sicari, J; Noel, RJ				Rivera-Ortiz, Jocelyn; Pla-Tenorio, Jessalyn; Cruz, Myrella L.; Colon, Krystal; Perez-Morales, Jaileene; Rodriguez, Julio A., Jr.; Martinez-Sicari, Jorge; Noel, Richard J.			Blockade of beta adrenergic receptors protects the blood brain barrier and reduces systemic pathology caused by HIV-1 Nef protein	PLOS ONE			English	Article							EXPRESSION; INFECTION; HAART; RAT; INFLAMMATION; ENCEPHALITIS; COMORBIDITY; MACROPHAGES; DYSFUNCTION; IMPAIRMENT	Combination antiretroviral therapy (cART) targets viral replication, but early viral protein production by astrocytes may still occur and contribute to the progression of HIV-1 associated neurocognitive disorders and secondary complications seen in patients receiving cART. In prior work with our model, astrocytic HIV-1 Nef expression exhibits neurotoxic effects leading to neurological damage, learning impairment, and immune upregulation that induces inflammation in the lungs and small intestine (SI). In this follow-up study, we focus on the sympathetic nervous system (SNS) as the important branch for peripheral inflammation resulting from astrocytic Nef expression. Male and female Sprague Dawley rats were infused with transfected astrocytes to produce Nef. The rats were divided in four groups: Nef, Nef + propranolol, propranolol and naive. The beta-adrenergic blocker, propranolol, was administered for 3 consecutive days, starting one day prior to surgery. Two days after the surgery, the rats were sacrificed, and then blood, brain, small intestine (SI), and lung tissues were collected. Levels of IL-1 beta were higher in both male and female rats, and treatment with propranolol restored IL-1 beta to basal levels. We observed that Nef expression decreased staining of the tight junction protein claudin-5 in brain tissue while animals co-treated with propranolol restored claudin-5 expression. Lungs and SI of rats in the Nef group showed histological signs of damage including larger Peyer's Patches, increased tissue thickness, and infiltration of immune cells; these findings were abrogated by propranolol co-treatment. Results suggest that interruption of the beta adrenergic signaling reduces the peripheral organ inflammation caused after Nef expression in astrocytes of the brain.	[Rivera-Ortiz, Jocelyn; Colon, Krystal] Wistar Inst Anat & Biol, HIV Immunopathogenesis Lab 1, 3601 Spruce St, Philadelphia, PA 19104 USA; [Pla-Tenorio, Jessalyn; Cruz, Myrella L.; Perez-Morales, Jaileene; Martinez-Sicari, Jorge; Noel, Richard J.] Ponce Hlth Sci Univ, Ponce Res Inst, Dept Basic Sci, Ponce, PR 00716 USA; [Rodriguez, Julio A., Jr.] Cooper Univ Hosp, Dept Orthopaed Surg, Camden, NJ USA	The Wistar Institute; Ponce Health Sciences University; Cooper University Hospital	Noel, RJ (corresponding author), Ponce Hlth Sci Univ, Ponce Res Inst, Dept Basic Sci, Ponce, PR 00716 USA.	rnoel@psm.edu			NIH [GM106970, DA026722, MD007579, 5R25GM08240611]; NIHNCI [2U54CA163071-06]; Molecular and Genomics Core; Behavioral Research and Integrative Neuroscience Core	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHNCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular and Genomics Core; Behavioral Research and Integrative Neuroscience Core	These studies were supported by NIH grants GM106970 (RJN), DA026722 (RJN), MD007579 (RJN). JRO, JPM and JPT, were supported by NIH training grant 5R25GM08240611. Pre-doc to Post-doc Transition program NIHNCI 2U54CA163071-06 to JPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alcira Benitez for assistance with the tissue preparation and Dr. Angel Isidro for tissue evaluation. We thank Ms. Alina G. Cruz for professional editing. We acknowledge support from the Molecular and Genomics Core and the Behavioral Research and Integrative Neuroscience Core.	Bernstein IM, 2009, REPROD SCI, V16, P980, DOI 10.1177/1933719109338876; Calderon TM, 2017, J NEUROIMMUNE PHARM, V12, P353, DOI 10.1007/s11481-017-9726-9; Chompre G, 2013, NEUROBIOL DIS, V49, P128, DOI 10.1016/j.nbd.2012.08.007; Delaloye J, 2015, J VIROL, V89, P3819, DOI 10.1128/JVI.03061-14; Dever SM, 2016, J NEUROVIROL, V22, P866, DOI 10.1007/s13365-016-0464-1; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Ferdin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191613; Galandrin S, 2008, MOL PHARMACOL, V74, P162, DOI 10.1124/mol.107.043893; Gelman BB, 2012, J NEUROIMMUNE PHARM, V7, P686, DOI 10.1007/s11481-012-9345-4; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Goulet JL, 2007, CLIN INFECT DIS, V45, P1593, DOI 10.1086/523577; Hagena H, 2016, CEREB CORTEX, V26, P1349, DOI 10.1093/cercor/bhv330; HURWITZ AA, 1994, ADV NEUROIMMUNOL, V4, P249, DOI 10.1016/S0960-5428(06)80263-9; Ironson G, 2008, INT J BEHAV MED, V15, P221, DOI 10.1080/10705500802219606; Isidro RA, 2015, HISTOCHEM CELL BIOL, V144, P613, DOI 10.1007/s00418-015-1364-9; Izeboud CA, 1999, J RECEPT SIGNAL TR R, V19, P191, DOI 10.3109/10799899909036645; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Justice Amy C, 2006, Top HIV Med, V14, P159; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kilbourne AM, 2001, J CLIN EPIDEMIOL, V54, pS22, DOI 10.1016/S0895-4356(01)00443-7; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Kolmus K, 2015, BRAIN BEHAV IMMUN, V45, P297, DOI 10.1016/j.bbi.2014.10.007; Li H, 2014, AM J RESP CRIT CARE, V190, P85, DOI 10.1164/rccm.201106-1151OC; Liu X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09867; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Lutgen V, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008381; Mudd JC, 2016, J INFECT DIS, V214, pS58, DOI 10.1093/infdis/jiw258; NEWTON HB, 1995, AM FAM PHYSICIAN, V51, P387; Orandle AS, 2001, J VIROL, V75, P4448, DOI 10.1128/JVI.75.9.4448-4452.2001; Patel S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01307-17; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Raymond AD, 2016, J NEUROVIROL, V22, P129, DOI 10.1007/s13365-015-0397-0; Rivera J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225760; Robinson-Papp J, 2013, J NEUROVIROL, V19, P172, DOI 10.1007/s13365-013-0160-3; Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171; Schifitto G, 2000, ARCH NEUROL-CHICAGO, V57, P1027, DOI 10.1001/archneur.57.7.1027; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sporer B, 2000, J NEUROIMMUNOL, V102, P125, DOI 10.1016/S0165-5728(99)00170-8; SUTIN J, 1992, BRAIN RES BULL, V29, P277, DOI 10.1016/0361-9230(92)90057-5; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259446	10.1371/journal.pone.0259446	http://dx.doi.org/10.1371/journal.pone.0259446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784367	Green Published, gold			2022-12-26	WOS:000755277300011
J	Shin, Y; Kim, S; Ghate, NB; Rhie, SK; An, W				Shin, Yonghwan; Kim, Sungmin; Ghate, Nikhil B.; Rhie, Suhn K.; An, Woojin			MMP-9 drives the melanomagenic transcription program through histone H3 tail proteolysis	ONCOGENE			English	Article							MATRIX METALLOPROTEINASES; MUTATIONS; INHIBITION; GENE; BRAF; PROGRESSION; CLEAVAGE; TRIGGERS; BIOLOGY; EZH2	Melanoma is a type of skin cancer that develops in pigment-producing melanocytes and often spreads to other parts of the body. Aberrant gene expression has been considered as a crucial step for increasing the risk of melanomagenesis, but how chromatin reorganization contributes to this pathogenic process is still not well understood. Here we report that matrix metalloproteinase 9 (MMP-9) localizes to the nucleus of melanoma cells and potentiates gene expression by proteolytically clipping the histone H3 N-terminal tail (H3NT). From genome-wide studies, we discovered that growth-regulatory genes are selectively targeted and activated by MMP-9-dependent H3NT proteolysis in melanoma cells. MMP-9 cooperates functionally with p300/CBP because MMP-9 cleaves H3NT in a manner that is dependent on p300/CBP-mediated acetylation of H3K18. The functional significance of MMP-9-dependent H3NT proteolysis is further underscored by the fact that RNAi knockdown and small-molecule inhibition of MMP-9 and p300/CBP impede melanomagenic gene expression and melanoma tumor growth. Together, our data establish new functions and mechanisms for nuclear MMP-9 in promoting melanomagenesis and demonstrate how MMP-9-dependent H3NT proteolysis can be exploited to prevent and treat melanoma skin cancer.	[Shin, Yonghwan; Kim, Sungmin; Ghate, Nikhil B.; Rhie, Suhn K.; An, Woojin] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA	University of Southern California	An, W (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Med, Los Angeles, CA 90033 USA.	woojinan@usc.edu		Rhie, Suhn/0000-0002-5522-5296; Kim, Sungmin/0000-0001-5873-6430	NIH [AR073233, P30CA014089]; National Cancer Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant AR073233 awarded to WA. The study was also partly supported by award number P30CA014089 from the National Cancer Institute.	Agrawal A, 2008, CHEMMEDCHEM, V3, P812, DOI 10.1002/cmdc.200700290; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; Bruschi F, 2013, PATHOGENS, V2, P105, DOI 10.3390/pathogens2010105; Chen HX, 2014, J INVEST DERMATOL, V134, P2080, DOI 10.1038/jid.2014.161; Daura E, 2021, NEUROBIOL DIS, V156, DOI 10.1016/j.nbd.2021.105418; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00417-z; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong JL, 2003, CANCER RES, V63, P3883; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Faiao-Flores F, 2019, CLIN CANCER RES, V25, P5686, DOI 10.1158/1078-0432.CCR-18-3382; Ferrari KJ, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1228; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fu CH, 2020, MOL MED REP, V21, P1421, DOI 10.3892/mmr.2020.10950; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Guarneri C, 2017, ONCOL REP, V37, P737, DOI 10.3892/or.2017.5362; Hoffmann F, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-0818-7; Kim E, 2019, CANCER RES, V79, P2649, DOI 10.1158/0008-5472.CAN-18-2331; Kim JM, 2018, ONCOGENE, V37, P5749, DOI 10.1038/s41388-018-0356-3; Kim K, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0193-1; Kim K, 2016, GENE DEV, V30, P208, DOI 10.1101/gad.268714.115; Kim K, 2013, MOL CELL, V52, P459, DOI 10.1016/j.molcel.2013.09.017; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lue JK, 2019, CLIN CANCER RES, V25, P5271, DOI 10.1158/1078-0432.CCR-18-3989; Mahmoud F, 2016, CANCER BIOL THER, V17, P579, DOI 10.1080/15384047.2016.1167291; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Napoli S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051151; Papazafiropoulou A, 2009, HIPPOKRATIA, V13, P76; Rangaswami H, 2007, ONCOL REP, V18, P909; Rice JC, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00398-4; Santos MCLG, 2004, J ORAL REHABIL, V31, P660, DOI 10.1111/j.1365-2842.2004.01297.x; Shen J, 2017, EMBO REP, V18, P2131, DOI 10.15252/embr.201743892; Shin Y, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0270-0; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vargova Viola, 2012, Exp Suppl, V103, P1, DOI 10.1007/978-3-0348-0364-9_1; Wang R, 2018, MOL CANCER THER, V17, P2543, DOI 10.1158/1535-7163.MCT-18-0511; Wilmott JS, 2015, MODERN PATHOL, V28, P884, DOI 10.1038/modpathol.2015.34; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhao XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023409; Zhou SH, 2021, AGEING RES REV, V69, DOI 10.1016/j.arr.2021.101349	46	3	3	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					560	570		10.1038/s41388-021-02109-5	http://dx.doi.org/10.1038/s41388-021-02109-5		NOV 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785776				2022-12-26	WOS:000719277200005
J	Chen, Q; Liu, J; He, Y; Yang, L; Luo, HQ; Wang, YX; Zhang, XW; Li, NX				Chen, Qing; Liu, Jun; He, Yang; Yang, Liu; Luo, Huiqiang; Wang, Yixi; Zhang, Xuewen; Li, Ningxiu			Prevalence of HBsAg among reproductive age couples in Chongqing: A population-based, cross-sectional study	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GLOBAL BURDEN; RURAL CHINA; INFECTION; DISEASE; WOMEN; EPIDEMIOLOGY; RISK	Hepatitis B is a leading cause of death worldwide. Here, we performed a large, population-based, cross-sectional study in Chongqing, China from 2011 to 2016 to assess the prevalence of HBsAg among couples of reproductive age, to predict subsequent trends, and to provide evidence for the WHO goal of "the elimination of viral hepatitis as a public health threat by 2030". A total of 386,286 couples aged 20 to 49 years were enrolled in the study. Approximately 14.35% of couples were HBsAg positive, including 95.00% with discordant HBsAg positivity. HBsAg prevalence was higher in men than in women. Among different occupations, the two categories of "houseworker" (female 6.73%, male 9.99%) and "unemployed" (female 6.64%, male 9.94%) showed the highest HBsAg positivity. In different regions, the lowest prevalence appeared in southeastern Chongqing (female 4.87%, male 7.71%). In 2030, the HBsAg positivity rate is expected to be 2.79%, 7.27% and 5.13% in females, males, and the whole population, respectively. According to the trends, this rate would drop to less than 2% in 2034, 2078 and 2051. In conclusion, the HBsAg prevalence in Chongqing is still relatively high compared with that in other parts of western China, especially among reproductive-age men. HBsAg-positive couples should be taken as an important unit of care. Vaccination is necessary before pregnancy if no antibody is found. More attention should be given to people without stable jobs. HBsAg-positive rate will decrease perceptibly by 2030 and will reach the level of low in epidemic areas by 2050.	[Chen, Qing; Luo, Huiqiang; Wang, Yixi; Zhang, Xuewen; Li, Ningxiu] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Chen, Qing; Luo, Huiqiang; Wang, Yixi; Zhang, Xuewen; Li, Ningxiu] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China; [Chen, Qing; Liu, Jun; He, Yang; Yang, Liu] Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhang, Xuewen] Jining Med Univ, Jining, Shandong, Peoples R China	Sichuan University; Sichuan University; Jining Medical University	Li, NX (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Li, NX (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.; Liu, J; He, Y (corresponding author), Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China.	37457824@qq.com; 30016447@qq.com; liningxiu@163.com		Chen, Qing/0000-0003-0071-1227	Science and Technology Bureau and Health Commission of Chongqing [2019MSXM053]	Science and Technology Bureau and Health Commission of Chongqing	QC received the fund from Science and Technology Bureau and Health Commission of Chongqing (2019MSXM053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, GLOB HEP REP 2017; Bartholomew ML, 2018, CLIN OBSTET GYNECOL, V61, P137, DOI 10.1097/GRF.0000000000000331; Chen P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2922-7; Cui FuQiang, 2018, Chinese Journal of Viral Diseases, V8, P257; Gheorghe L, 2013, EUR J GASTROEN HEPAT, V25, P56, DOI 10.1097/MEG.0b013e328358b0bb; Lao TT, 2014, B WORLD HEALTH ORGAN, V92, P782, DOI 10.2471/BLT.13.133413; Liu J, 2017, J VIRAL HEPATITIS, V24, P679, DOI 10.1111/jvh.12693; Liu J, 2014, CHIN J CLIN INFECT D, V7, P506; Liu JY, 2017, INT J INFECT DIS, V61, P13, DOI 10.1016/j.ijid.2017.05.015; Liu J, 2019, B WORLD HEALTH ORGAN, V97, P230, DOI [10.2471/BLT.18.219469, 10.2471/blt.18.219469]; Liu J, 2017, LANCET GLOB HEALTH, V5, pE624, DOI 10.1016/s2214-109x(17)30142-0; Liu J, 2016, LANCET INFECT DIS, V16, P80, DOI 10.1016/S1473-3099(15)00218-2; Liu JY, 2018, THESIS AIR FORCE MED; Liu M, 2016, LANCET INFECT DIS, V16, P151, DOI 10.1016/S1473-3099(16)00011-6; Liu Z, 2018, J VIRAL HEPATITIS, V25, P1543, DOI 10.1111/jvh.12938; Qiu-ju D., 2013, BEIJING DA XUE XUE B, V45; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wang M, 2015, J INFECT DEV COUNTR, V9, P770, DOI 10.3855/jidc.6938; Wang SS, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5984-6; Zeng FF, 2016, SCI REP-UK, V6, DOI 10.1038/srep36186; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42822; Zhang S, 2010, INT J GYNECOL OBSTET, V109, P194, DOI 10.1016/j.ijgo.2010.01.002; Zhang Y, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-25; Zheng H, 2018, J VIRAL HEPATITIS, V25, P88, DOI 10.1111/jvh.12757; 张世琨, 2015, [中华医学杂志, National Medical Journal of China], V95, P162; 桑国卫, 2015, [中华医学杂志, National Medical Journal of China], V95, P161; 王巧梅, 2015, [中华医学杂志, National Medical Journal of China], V95, P166	30	0	0	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260028	10.1371/journal.pone.0260028	http://dx.doi.org/10.1371/journal.pone.0260028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780552	gold, Green Published			2022-12-26	WOS:000755305800086
J	Holmes, HM; Jove, AG; Tan, MC; El-Serag, HB; Thrift, AP				Holmes, Hudson M.; Jove, Andre G.; Tan, Mimi C.; El-Serag, Hashem B.; Thrift, Aaron P.			Alcohol consumption and the risk of gastric intestinal metaplasia in a US Veterans population	PLOS ONE			English	Article							HELICOBACTER-PYLORI; ACID-SECRETION; LIFE-STYLE; CANCER; ESOPHAGEAL; BEVERAGES; DRINKING; CARCINOGENESIS; ADENOCARCINOMA; METAANALYSIS	Background Chronic alcohol use is a risk factor for non-cardia gastric adenocarcinoma. However, it is less well understood whether alcohol use is a risk factor for premalignant mucosal changes, namely gastric intestinal metaplasia. We examined the association between various parameters of alcohol use and risk of gastric intestinal metaplasia. Methods We used data from 2084 participants (including 403 with gastric intestinal metaplasia) recruited between February 2008-August 2013 into a cross-sectional study at the Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas. All participants underwent a study upper endoscopy with systematic gastric mapping biopsies. Cases had intestinal metaplasia on any non-cardia gastric biopsy. Participants self-reported lifetime history of alcohol consumption, along with other lifestyle risk factors, through a study survey. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) for categories of average alcohol consumption using multivariable logistic regression, and restricted cubic spline regression to explore the potential shape of a dose-response relationship. Results Compared to lifelong non-drinkers, individuals who consumed on average >= 28 drinks per week had no elevated risk for gastric intestinal metaplasia (adjusted OR, 1.27; 95% CI, 0.74-2.19). Based on a spline regression curve and its 95% CI, there was also no demonstrable association between cumulative lifetime alcohol consumption and risk of gastric intestinal metaplasia. Similarly, we found no association between beverage type (beer, wine, liquor/spirits) and risk for gastric intestinal metaplasia. Conclusions Neither amount of alcohol consumed nor specific beverage type was associated with risk of gastric intestinal metaplasia.	[Holmes, Hudson M.; Jove, Andre G.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Tan, Mimi C.; El-Serag, Hashem B.] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [El-Serag, Hashem B.] Michael E DeBakey VA Med Ctr, Houston VA HSR&D Ctr Innovat Qual Effectiveness &, Houston, TX USA; [Thrift, Aaron P.] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA; [Thrift, Aaron P.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Thrift, AP (corresponding author), Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA.; Thrift, AP (corresponding author), Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.	aaron.thrift@bcm.edu		Thrift, Aaron/0000-0002-0084-5308	National Institute of Diabetes and Digestive and Kidney Diseases [DK056338]; U.S. Department of Veterans Affairs [CIN 13413]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (DK056338) and the U.S. Department of Veterans Affairs (CIN 13413).	Bode C, 2003, BEST PRACT RES CL GA, V17, P575, DOI 10.1016/S1521-6918(03)00034-9; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buckland G, 2015, INT J CANCER, V137, P598, DOI 10.1002/ijc.29411; Buis M.L., 2009, STAT SOFTWARE COMPON; Busuttil RA, 2009, J GASTROEN HEPATOL, V24, P193, DOI 10.1111/j.1440-1746.2008.05774.x; CHARI S, 1993, GUT, V34, P843, DOI 10.1136/gut.34.6.843; CHARI ST, 1993, SCAND J GASTROENTERO, V28, P289, DOI 10.3109/00365529309090243; CORREA P, 1992, CANCER RES, V52, P6735; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fischbach LA, 2014, AM J GASTROENTEROL, V109, P357, DOI 10.1038/ajg.2013.443; Islami F, 2011, INT J CANCER, V129, P2473, DOI 10.1002/ijc.25885; Jaiswal M, 2001, AM J PHYSIOL-GASTR L, V281, pG626, DOI 10.1152/ajpgi.2001.281.3.G626; Jarl J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-600; Jedrychowski Wieslaw, 1999, Polish Journal of Pathology, V50, P289; Kaneko K, 2010, J CLIN GASTROENTEROL, V44, P173, DOI 10.1097/MCG.0b013e3181bb837a; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Knoll MR, 1998, ENDOSCOPY, V30, P293, DOI 10.1055/s-2007-1001257; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Marques-Lespier JM, 2016, GASTROENTEROL CLIN N, V45, P413, DOI 10.1016/j.gtc.2016.04.002; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Nguyen TH, 2021, CLIN GASTROENTEROL H, V19, P269, DOI 10.1016/j.cgh.2020.03.015; NOMURA A, 1990, CANCER RES, V50, P627; Russo A, 2001, AM J GASTROENTEROL, V96, P1402, DOI 10.1111/j.1572-0241.2001.03773.x; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Singer Manfred V, 2002, Rom J Gastroenterol, V11, P197; SINGER MV, 1987, GASTROENTEROLOGY, V93, P1247, DOI 10.1016/0016-5085(87)90252-6; Tan MC, 2020, AM J GASTROENTEROL, V115, P381, DOI 10.14309/ajg.0000000000000498; Teyssen S, 2003, BEST PRACT RES CL GA, V17, P557, DOI 10.1016/S1521-6918(03)00049-0; Thrift AP, 2014, DIGEST DIS SCI, V59, P108, DOI 10.1007/s10620-013-2892-6; Tramacere I, 2012, ANN ONCOL, V23, P287, DOI 10.1093/annonc/mdr136; Tramacere I, 2012, ANN ONCOL, V23, P28, DOI 10.1093/annonc/mdr135; World Health Organization International Agency for Research on Cancer, 1988, IARC MONOGRAPHS EVAL, V44; You WC, 2000, J NATL CANCER I, V92, P1607, DOI 10.1093/jnci/92.19.1607	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260019	10.1371/journal.pone.0260019	http://dx.doi.org/10.1371/journal.pone.0260019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780551	Green Published, gold			2022-12-26	WOS:000755305800085
J	Sixtus, RP; Pacharinsak, C; Gray, CL; Berry, MJ; Dyson, RM				Sixtus, Ryan P.; Pacharinsak, Cholawat; Gray, Clint L.; Berry, Mary J.; Dyson, Rebecca M.			Differential effects of four intramuscular sedatives on cardiorespiratory stability in juvenile guinea pigs (Cavia porcellus)	PLOS ONE			English	Article							ANESTHETIC INDUCTION AGENT; THAN 12 WEEKS; CLINICAL-EVALUATION; ALFAXALONE; REGIMENS; KETAMINE; MIDAZOLAM; EFFICACY; CATS	Background Non-invasive physiological monitoring can induce stress in laboratory animals. Sedation reduces the level of restraint required, thereby improving the validity of physiological signals measured. However, sedatives may alter physiological equilibrium introducing unintended bias and/or, masking the experimental outcomes of interest. We aimed to investigate the cardiorespiratory effects of four short-acting sedatives in juvenile guinea pigs. Method 12 healthy, 38 (26-46) day-old Dunkin Hartley guinea pigs were included in this blinded, randomised, crossover design study. Animals were sedated by intramuscular injection using pre-established minimum effective doses of either alfaxalone (5 mg/kg), diazepam (5 mg/ kg), ketamine (30 mg/kg), or midazolam (2 mg/kg) administered in random order with a minimum washout period of 48 hours between agents. Sedative depth, a composite score comprised of five assessment criteria, was observed every 5-min from dosing until arousal. Physiological monitoring of cardiorespiratory status included measures of heart rate, blood pressure, respiratory rate, and peripheral microvascular perfusion. Results Ketamine and alfaxalone were most effective in inducing stable sedation suitable for physiological monitoring, and diazepam less-so. Midazolam was unsuitable due to excessive hypersensitivity. All sedatives significantly increased heart rate above non-sedated control rates (P< 0.0001), without altering blood pressure or microvascular perfusion. Alfaxalone and ketamine reduced respiratory rate relative to their control condition (P< 0.0001, P = 0.05, respectively), but within normative ranges. Conclusion Ketamine and alfaxalone are the most effective sedatives for inducing short duration, stable sedation with minimal cardiorespiratory depression in guinea pigs, while diazepam is lessso. However, alfaxalone is the most appropriate sedative for longitudinal studies requiring multiple physiological timepoints.	[Sixtus, Ryan P.; Gray, Clint L.; Berry, Mary J.; Dyson, Rebecca M.] Univ Otago, Dept Paediat & Child Hlth, Wellington, New Zealand; [Pacharinsak, Cholawat] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	University of Otago; Stanford University	Dyson, RM (corresponding author), Univ Otago, Dept Paediat & Child Hlth, Wellington, New Zealand.	becs.dyson@otago.ac.nz		Sixtus, Ryan/0000-0002-2041-8928; Dyson, Rebecca/0000-0003-2319-6897	Otago Foundation Trust; Health Research Council (New Zealand) [18580]; Neonatal Trust (NZ); Heart Foundation (NZ); University of Otago Health Sciences Career Development Fellowship	Otago Foundation Trust; Health Research Council (New Zealand)(Health Research Council of New Zealand); Neonatal Trust (NZ); Heart Foundation (NZ); University of Otago Health Sciences Career Development Fellowship	This work was supported by the Otago Foundation Trust and a Health Research Council (New Zealand) Project Grant [Grant Number 18580] awarded to RMD. RPS was supported by Postgraduate Scholarships from the Neonatal Trust (NZ) and the Heart Foundation (NZ). RMD was supported by a University of Otago Health Sciences Career Development Fellowship. The funders had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit this article for publication.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Ambros B, 2008, AM J VET RES, V69, P1391, DOI 10.2460/ajvr.69.11.1391; [Anonymous], 2011, LAB ANIMAL, V40, P214, DOI [10.1038/laban0711-214, DOI 10.1038/LABAN0711-214]; d'Ovidio D, 2018, VET ANAESTH ANALG, V45, P183, DOI 10.1016/j.vaa.2017.08.004; Dang V, 2008, J AM ASSOC LAB ANIM, V47, P56; Denison P., 2013, CLIN LAB ANIMAL MED; Dyson RM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12145; Farag E., 2018, BASIC SCI ANESTHESIA; Flecknell P., 2016, LAB ANIMAL ANAESTHES, V4, P350; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; Hall RW, 2009, CLIN PERINATOL, V36, P15, DOI 10.1016/j.clp.2008.09.007; Higuchi S, 2016, JPN J VET RES, V64, P131, DOI 10.14943/jjvr.64.2.131; Ishikawa Y, 2019, J VET MED SCI, V81, P851, DOI 10.1292/jvms.18-0618; Jevtovic-Todorovic V, 2001, BRAIN RES, V895, P264, DOI 10.1016/S0006-8993(01)02079-0; Jevtovic-Todorovic Vesna, 2016, Anesthesiol Clin, V34, P439, DOI 10.1016/j.anclin.2016.04.001; Jones KL, 2012, J EXOT PET MED, V21, P347, DOI 10.1053/j.jepm.2012.09.011; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; KURZ A, 1995, ANESTH ANALG, V81, P393, DOI 10.1097/00000539-199508000-00032; Lemke K.A., 2007, LUMB JONESVETERINARY, V4th ed., P229; Mans C, 2012, J AVIAN MED SURG, V26, P130, DOI 10.1647/2011-037R.1; Muir W, 2008, VET ANAESTH ANALG, V35, P451, DOI 10.1111/j.1467-2995.2008.00406.x; O'Hagan BJ, 2012, AUST VET J, V90, P395, DOI 10.1111/j.1751-0813.2012.00983.x; O'Hagan BJ, 2012, AUST VET J, V90, P346, DOI 10.1111/j.1751-0813.2012.00974.x; Pearson M, 2003, P AM AC VET PHARM TH; Pfeiffer N., 2013, Open Access Animal Physiology, V5, P15; PRYSROBERTS C, 1980, BRIT J ANAESTH, V52, P363, DOI 10.1093/bja/52.4.363; Radde GR, 1996, LAB ANIM-UK, V30, P220, DOI 10.1258/002367796780684935; Rajan V, 2009, LASER MED SCI, V24, P269, DOI 10.1007/s10103-007-0524-0; Roustit M, 2010, MICROVASC RES, V79, P102, DOI 10.1016/j.mvr.2010.01.001; Scallet AC, 2004, TOXICOL SCI, V81, P364, DOI 10.1093/toxsci/kfh224; Schmitz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161258; Schwenke DO, 2004, COMPARATIVE MED, V54, P77; Shiotani Motohiro, 2007, Journal of Pharmacological and Toxicological Methods, V55, P27, DOI 10.1016/j.vascn.2006.04.008; Sixtus RP, 2021, PHARMACOL RES PERSPE, V9, DOI 10.1002/prp2.713; Weeks KL, 2019, AM J PHYSIOL-HEART C, V317, pH627, DOI 10.1152/ajpheart.00327.2019; Whittem T, 2008, J VET PHARMACOL THER, V31, P571, DOI 10.1111/j.1365-2885.2008.00998.x	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259559	10.1371/journal.pone.0259559	http://dx.doi.org/10.1371/journal.pone.0259559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780534	Green Published, gold, Green Accepted			2022-12-26	WOS:000755305800032
J	Cookson, D; Jolley, D; Dempsey, RC; Povey, R				Cookson, Darel; Jolley, Daniel; Dempsey, Robert C.; Povey, Rachel			A social norms approach intervention to address misperceptions of anti-vaccine conspiracy beliefs amongst UK parents	PLOS ONE			English	Article							PERSONALIZED NORMATIVE FEEDBACK; COLLEGE DRINKING; PREVENTION; PERCEPTIONS; HESITANCY; EFFICACY; STUDENTS; REFUSAL; MEASLES; REDUCE	Anti-vaccine conspiracy beliefs among parents can reduce vaccination intentions. Parents' beliefs in anti-vaccine conspiracy theories are also related to their perceptions of other parents' conspiracy beliefs. Further, research has shown that parents hold misperceptions of anti-vaccine conspiracy belief norms: UK parents over-estimate the anti-vaccine conspiracy beliefs of other parents. The present study tested the effectiveness of a Social Norms Approach intervention, which corrects misperceptions using normative feedback, to reduce UK parents' anti-vaccine conspiracy beliefs and increase vaccination intentions. At baseline, 202 UK parents of young children reported their personal belief in anti-vaccine conspiracy theories, future intentions to vaccinate, and their perceptions of other UK parents' beliefs and intentions. Participants were then randomly assigned to a normative feedback condition (n = 89) or an assessment-only control condition (n = 113). The normative feedback compared participants' personal anti-vaccine conspiracy beliefs and perceptions of other UK parents' beliefs with actual normative belief levels. Parents receiving the normative feedback showed significantly reduced personal belief in anti-vaccine conspiracy beliefs at immediate post-test. As hypothesised, changes in normative perceptions of anti-vaccine conspiracy beliefs mediated the effect of the intervention. The intervention, did not directly increase vaccination intentions, however mediation analysis showed that the normative feedback increased perceptions of other parents' vaccination intentions, which in turn increased personal vaccination intentions. No significant effects remained after a six-week follow-up. The current research demonstrates the potential utility of Social Norms Approach interventions for correcting misperceptions and reducing anti-vaccine conspiracy beliefs among UK parents. Further research could explore utilising a top-up intervention to maintain the efficacy.	[Cookson, Darel] Nottingham Trent Univ, Sch Social Sci, Dept Psychol, Nottingham, England; [Jolley, Daniel] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Dempsey, Robert C.] Manchester Metropolitan Univ, Fac Hlth, Dept Psychol, Manchester, Lancs, England; [Povey, Rachel] Staffordshire Univ, Staffordshire Ctr Psychol Res, Sch Life Sci & Educ, Stoke On Trent, Staffs, England	Nottingham Trent University; Northumbria University; Manchester Metropolitan University; Staffordshire University	Dempsey, RC (corresponding author), Manchester Metropolitan Univ, Fac Hlth, Dept Psychol, Manchester, Lancs, England.	r.dempsey@mmu.ac.uk	Dempsey, Robert C./ABB-3296-2021	Dempsey, Robert C./0000-0002-6477-2363; Jolley, Daniel/0000-0001-7232-8599	Staffordshire University	Staffordshire University	The funders of the PhD Studentship (Staffordshire University) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The last author (RP) is currently employed as an Associate Professor at Staffordshire University. The PhD Studentship provided funding to the first author (DC) which was used to support participant reimbursements.	Acquah N.K., 2021, COVID 19 VACCINES; Betsch C, 2013, MED DECIS MAKING, V33, P14, DOI 10.1177/0272989X12452342; Betsch C, 2013, HEALTH PSYCHOL, V32, P146, DOI 10.1037/a0027387; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Borsari B, 2001, J SUBST ABUSE, V13, P391, DOI 10.1016/S0899-3289(01)00098-0; Brown AK, 2010, J ADOLESCENCE, V33, P603, DOI 10.1016/j.adolescence.2009.12.003; Calvert S, 2021, APPETITE, V166, DOI 10.1016/j.appet.2021.105462; Cialdini R. B., 1998, HDB SOCIAL PSYCHOL, P151; Cialdini RB, 2005, PSYCHOL INQ, V16, P158, DOI 10.1207/s15327965pli1604_03; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Cookson D, 2021, GROUP PROCESS INTERG, V24, P759, DOI 10.1177/1368430221993907; Dempsey RC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02180; Douglas KM, 2017, CURR DIR PSYCHOL SCI, V26, P538, DOI 10.1177/0963721417718261; Drew L, 2019, NATURE, V575, pS58, DOI 10.1038/d41586-019-03642-w; Dube E, 2015, VACCINE, V33, P4191, DOI 10.1016/j.vaccine.2015.04.041; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FISCHHOFF B, 1975, J EXP PSYCHOL HUMAN, V1, P288, DOI 10.1037/0096-1523.1.3.288; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Grande-Gosende A, 2020, J GAMBL STUD, V36, P1, DOI 10.1007/s10899-019-09866-9; Green R, 2018, PERS INDIV DIFFER, V125, P30, DOI 10.1016/j.paid.2017.12.023; Hornsey MJ, 2018, HEALTH PSYCHOL, V37, P307, DOI 10.1037/hea0000586; Jolley D., 2017, J APPL SOC PSYCHOL, DOI [10.1111/jasp.12417, DOI 10.1111/JASP.12417]; Jolley D, 2020, BRIT J SOC PSYCHOL, V59, P628, DOI 10.1111/bjso.12394; Jolley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089177; Jolley D, 2014, BRIT J PSYCHOL, V105, P35, DOI 10.1111/bjop.12018; LaBrie JW, 2013, J CONSULT CLIN PSYCH, V81, P1074, DOI 10.1037/a0034087; Lantian A, 2016, INT REV SOC PSYCHOL, V29, P1, DOI 10.5334/irsp.8; Marley S, 2016, PSYCHOL HEALTH, V31, P1007, DOI 10.1080/08870446.2016.1161192; McAlaney J, 2011, DRUG-EDUC PREV POLIC, V18, P81, DOI 10.3109/09687631003610977; McAlpine K. E., 2020, INT J MOL SCI, V101; Muscat M, 2011, J INFECT DIS, V204, pS353, DOI 10.1093/infdis/jir067; Neighbors C, 2015, J CONSULT CLIN PSYCH, V83, P500, DOI 10.1037/a0039125; Neighbors C, 2010, J CONSULT CLIN PSYCH, V78, P898, DOI 10.1037/a0020766; NHS, 2019, WHY VACC IS SAF IMP; On K., 2020, INT J NURS STUD, V114, P103854; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Pischke CR, 2015, ADDICT BEHAV, V51, P158, DOI 10.1016/j.addbeh.2015.07.012; Reid AE, 2013, HEALTH PSYCHOL, V32, P551, DOI 10.1037/a0028140; Reid AE, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P263, DOI 10.1007/978-0-387-09488-5_19; Ruiz JB, 2021, VACCINE, V39, P1080, DOI 10.1016/j.vaccine.2021.01.010; Sadaf A, 2013, VACCINE, V31, P4293, DOI 10.1016/j.vaccine.2013.07.013; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Taylor P, 2021, J SOC PSYCHOL, V161, P182, DOI 10.1080/00224545.2020.1784825; Thangaraju P, 2019, CUKUROVA MED J, V44, P1150, DOI 10.17826/cumj.514157; Tomljenovic H, 2020, PSYCHOL HEALTH, V35, P538, DOI 10.1080/08870446.2019.1673894; van der Linden S, 2015, J ENVIRON PSYCHOL, V41, P112, DOI 10.1016/j.jenvp.2014.11.012; von Wagner C, 2019, PATIENT EDUC COUNS, V102, P1621, DOI 10.1016/j.pec.2019.04.001; Walsh S, 2015, EPIDEMIOL INFECT, V143, P550, DOI 10.1017/S0950268814000752; WHO, 2019, IMM AG 2030, P1; Williams L, 2020, BRIT J HEALTH PSYCH, V25, P1039, DOI 10.1111/bjhp.12468	52	11	11	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258985	10.1371/journal.pone.0258985	http://dx.doi.org/10.1371/journal.pone.0258985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767581	Green Published, Green Accepted, gold			2022-12-26	WOS:000755249300018
J	Lee, WJ; Jung, KH; Nam, HW; Lee, YS				Lee, Woo-Jin; Jung, Keun-Hwa; Nam, Hyun-Woo; Lee, Yong-Seok			Effect of obstructive sleep apnea on cerebrovascular compliance and cerebral small vessel disease	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; RESPIRATORY DISTURBANCE INDEX; ARTERIAL STIFFNESS; OXIDATIVE STRESS; BLOOD-FLOW; PULSATILITY; DEMENTIA; RISK; INFLAMMATION; INTEGRITY	Reduced cerebrovascular compliance is the major mechanism of cerebral small vessel disease (SVD). Obstructive sleep apnea (OSA) also promotes SVD development, but the underlying mechanism was not elucidated. We investigated the association among OSA, cerebrovascular compliance, and SVD parameters. This study retrospectively included individuals >= 50 years of age, underwent overnight polysomnographic (PSG) for the evaluation of OSA, and performed MRI and transcranial Doppler (TCD) within 12 months of interval without a neurological event between the evaluations. TCD parameters for the cerebrovascular compliance included middle cerebral artery pulsatility index (MCA PI) and mean MCA resistance index ratio (MRIR). SVD parameters included white matter hyperintensity (WMH) volume, number of lacunes, enlarged perivascular space (ePVS) score, and the presence of microbleeds or lacunes. Ninety-seven individuals (60.8% male, mean age 70.0 +/- 10.5 years) were included. MRIR was associated with higher respiratory distress index (B = 0.003; 95% confidence interval [CI] 0.001-0.005; P = 0.021), while MCA PI was not associated with any of the PSG markers for OSA severity. Apnea-hypopnea index was associated with the log-transformed total WMH volume (B = 0.008; 95% confidence interval [CI] 0.001-0.016; P = 0.020), subcortical WMH volume (B = 0.015; 95% CI 0.007-0.022; P<0.001), total ePVS score (B = 0.024; 95% CI 0.003-0.045; P = 0.026), and centrum semiovale ePVS score (B = 0.026; 95% CI 0.004-0.048; P = 0.019), and oxygen-desaturation index with periventricular WMH volume, independently from age, MCA PI, and MRIR. This study concluded that OSA is associated with reduced cerebrovascular compliance and also with SVD independently from cerebrovascular compliance. Underlying pathomechanistic link might be region specific.	[Lee, Woo-Jin; Jung, Keun-Hwa] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Nam, Hyun-Woo; Lee, Yong-Seok] Seoul Natl Univ, Seoul Metropolitan Govt Boramae Med Ctr, Coll Med, Dept Neurol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Nam, HW; Lee, YS (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt Boramae Med Ctr, Coll Med, Dept Neurol, Seoul, South Korea.	hwnam85@gmail.com; mercades@snu.ac.kr		Jung, Keun-Hwa/0000-0003-1433-8005	Korean Society of Neurosonology, Republic of Korea	Korean Society of Neurosonology, Republic of Korea	This work was supported by a research grant funded by the Korean Society of Neurosonology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee G, 2017, BRAIN, V140, P1107, DOI 10.1093/brain/awx003; Bash S, 2005, AM J NEURORADIOL, V26, P1012; Berry R.B., 2012, AASM MANUAL SCORING, V176, P2012; Berry RB, 2017, J CLIN SLEEP MED, V13, P665, DOI 10.5664/jcsm.6576; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Castronovo V, 2014, SLEEP, V37, P1465, DOI 10.5665/sleep.3994; Chen HL, 2015, SLEEP, V38, P361, DOI 10.5665/sleep.4490; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; de Bruijn RFAG, 2015, JAMA NEUROL, V72, P1288, DOI 10.1001/jamaneurol.2015.2161; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Del Brutto OH, 2017, SLEEP MED, V37, P10, DOI 10.1016/j.sleep.2017.06.009; Drager LF, 2009, HYPERTENSION, V53, P64, DOI 10.1161/HYPERTENSIONAHA.108.119420; DROSTE DW, 1993, SLEEP, V16, P603; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Huang YH, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz264; Iannella G, 2021, EUR ARCH OTO-RHINO-L, V278, P883, DOI 10.1007/s00405-020-06316-w; Iannella G, 2020, EUR ARCH OTO-RHINO-L, V277, P1793, DOI 10.1007/s00405-020-05883-2; Iannella G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17031120; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Jelic S, 2008, CIRCULATION, V117, P2270, DOI 10.1161/CIRCULATIONAHA.107.741512; Ju YE, 2016, ANN NEUROL, V80, P154, DOI 10.1002/ana.24672; Kidwell CS, 2001, J NEUROIMAGING, V11, P229, DOI 10.1111/j.1552-6569.2001.tb00039.x; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Lee LA, 2011, OTOLARYNG HEAD NECK, V144, P632, DOI 10.1177/0194599810395104; Lee WH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36474-1; Lee WJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236473; Lee WJ, 2018, JAMA NEUROL, V75, P80, DOI 10.1001/jamaneurol.2017.2853; Lee WJ, 2017, RADIOLOGY, V284, P824, DOI 10.1148/radiol.2017162064; Liao Z., 2019, BMC NEUROL, V19, P1, DOI [10.1186/s12883-018-1232-z, DOI 10.1186/S12883-018-1232-Z]; Lyons OD, 2015, CAN J CARDIOL, V31, P918, DOI 10.1016/j.cjca.2015.03.014; Maniaci A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020277; Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253; Morgan BJ, 2007, ADV EXP MED BIOL, V618, P69; Ooms S, 2014, JAMA NEUROL, V71, P971, DOI 10.1001/jamaneurol.2014.1173; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Passali D, 2015, ACTA OTORHINOLARYNGO, V35, P420, DOI 10.14639/0392-100X-895; Peker Y, 2000, AM J RESP CRIT CARE, V162, P81, DOI 10.1164/ajrccm.162.1.9905035; Peled N, 1998, AM J HYPERTENS, V11, P1284, DOI 10.1016/S0895-7061(98)00159-9; Potter GM, 2015, CEREBROVASC DIS, V39, P224, DOI 10.1159/000375153; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Song TJ, 2017, SLEEP MED, V30, P36, DOI 10.1016/j.sleep.2016.03.006; Tummala S, 2016, J NEUROSCI RES, V94, P915, DOI 10.1002/jnr.23788; Urbano F, 2008, J APPL PHYSIOL, V105, P1852, DOI 10.1152/japplphysiol.90900.2008; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; Weller RO, 2015, BRAIN PATHOL, V25, P63, DOI 10.1111/bpa.12218; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zarrinkoob L, 2016, J CEREBR BLOOD F MET, V36, P1519, DOI 10.1177/0271678X16629486	50	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259469	10.1371/journal.pone.0259469	http://dx.doi.org/10.1371/journal.pone.0259469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767578	gold, Green Published			2022-12-26	WOS:000755249300030
J	Fonseca, E; Both, C; Cechin, SZ; Winck, G				Fonseca, Erica; Both, Camila; Cechin, Sonia Zanini; Winck, Gisele			Pet distribution modelling: Untangling the invasive potential of Trachemys dorbigni (Emydidae) in the Americas	PLOS ONE			English	Article							SCRIPTA-ELEGANS; TURTLES IMPLICATIONS; ESTABLISHMENT; BIOGEOGRAPHY; ACCURACY; HABITAT; IMPACT; NICHE; SUITABILITY; LOCALITIES	Human activities have been changing the global biogeographic patterns by the introductions of invasive species. For reptiles, the invasion rate increase of non-native species is remarkably related to the pet trade, especially for freshwater turtles. Here we estimated the invasive potential of the South American turtle Trachemys dorbigni in the Americas using a combination of climatic and human activity variables. We built species distribution models based on data from the native and invasive ranges, using the ensemble model from five different algorithms (GAM, MAXENT, BRT, RF and GBM). We compared the two models' performance and predictions, one calibrated with only climatic variables (climate-driven), and the second also included a descriptive variable of human activity (climate plus humandriven). Suitable areas for T. dorbignicovered occurrence areas of its congeners and highly diversified ecoregions, such as the eastern USA, the islands of Central America, and the south eastern and eastern Brazilian coast. Our results indicate that human activities allow T. dorbigni to establish populations outside of its original climatic niche. Including human activity variables proved fundamental to refining the results to identify more susceptible areas to invasion and to allow the efficient targeting of prevention measures. Finally, we suggested a set of actions to prevent T. dorbigni becoming a highly impacting species in the areas identified as more prone to its invasion.	[Fonseca, Erica; Cechin, Sonia Zanini] Univ Fed Santa Maria, Dept Biol, Programa Posgrad Biodiversidade Anim, Santa Maria, RS, Brazil; [Both, Camila] Univ Fed Rio Grande do Sul, Dept Interdisciplinar, Campus Litoral Norte, Tramandai, Brazil; [Winck, Gisele] Univ Savoie Mt Blanc, Univ Grenoble Alpes, Lab Ecol Alpine LECA, CNRS, Grenoble, France; [Winck, Gisele] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal do Rio Grande do Sul; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Fundacao Oswaldo Cruz	Fonseca, E (corresponding author), Univ Fed Santa Maria, Dept Biol, Programa Posgrad Biodiversidade Anim, Santa Maria, RS, Brazil.	erica.fonsecae@gmail.com	Winck, Gisele/A-4148-2012	Winck, Gisele/0000-0002-6876-4803	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ MCTIC) [206876/2017-3, 309095/2016-6, 150621/2018-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ MCTIC) (Synthesis Center on Biodiversity and Ecosystem Services) [152411/2020-8, 151224/ 2021-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/MEC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ MCTIC); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/ MCTIC) (Synthesis Center on Biodiversity and Ecosystem Services); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/MEC)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq/ MCTIC) provided postdoctoral fellowship grant to GW (processes n. 206876/2017-3; and the Synthesis Center on Biodiversity and Ecosystem Services, SinBiose: 152411/2020-8 and 151224/ 2021-8), and supported SC (309095/2016-6), and CB (150621/2018-3). EF received doctoral scholarship grant provided by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES/MEC).	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Alcalde L, 2012, CHELONIAN CONSERV BI, V11, P128, DOI 10.2744/02k.1; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anastacio PM, 2019, SCI TOTAL ENVIRON, V650, P1923, DOI 10.1016/j.scitotenv.2018.09.251; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; ANLA . Autoridad Nacional de Licencias Ambientales, 2013, RES 447 15 MAYO 2013; [Anonymous], 1877, DIFFERENT FORMS FLOW; Auliya M, 2016, BIOL CONSERV, V204, P103, DOI 10.1016/j.biocon.2016.05.017; Bager A, 2012, TROP ZOOL, V25, P31, DOI 10.1080/03946975.2012.679393; Bager A, 2007, HERPETOLOGICA, V63, P56, DOI 10.1655/0018-0831(2007)63[56:NEOAPO]2.0.CO;2; Baillie J.E.M., 2010, EVOLUTION LOST STATU; Banha F, 2017, ECOL MODEL, V360, P45, DOI 10.1016/j.ecolmodel.2017.06.026; Barbet-Massin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193085; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beans CM, 2012, BIOL INVASIONS, V14, P2067, DOI 10.1007/s10530-012-0214-0; Bevan HR., 2019, FRONTIERS BIOGEOGRAP, V11, DOI [10.21425/F5FBG42596, DOI 10.21425/F5FBG42596]; Blackburn TM, 2015, MOL ECOL, V24, P1942, DOI 10.1111/mec.13075; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bujes CS., 2008, NAT CONSERV, V6, P47; Bush ER, 2014, CONSERV BIOL, V28, P663, DOI 10.1111/cobi.12240; Cadi A, 2004, BIODIVERS CONSERV, V13, P2511, DOI 10.1023/B:BIOC.0000048451.07820.9c; Capinha C, 2015, SCIENCE, V348, P1248, DOI 10.1126/science.aaa8913; Cassey P, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005987; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Ferreira RB, 2012, AMPHIBIA-REPTILIA, V33, P387, DOI 10.1163/15685381-00002841; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Figuereido PI, 2014, VERIFICACAO OCORRENC; Fonseca E, 2019, DIVERS DISTRIB, V25, P1130, DOI 10.1111/ddi.12920; Fritz U, 2012, J ZOOL SYST EVOL RES, V50, P125, DOI 10.1111/j.1439-0469.2011.00647.x; Gallardo B, 2019, CUAD INVESTIG GEOGR, V45, P61, DOI 10.18172/cig.3627; Global Invasive Species Database-GISD, 2019, DAT GISD; Hill MP, 2019, PEST MANAG SCI, V75, P134, DOI 10.1002/ps.5192; Holland B, 2019, GREAT BASIN SHRUB ST; Horus Institute, 2016, BAS DAD ESP EX INV B; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Kopecky O, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013057; Kraus Fred, 2009, V4, P1; Lake TA, 2019, **DATA OBJECT**, DOI [10.13020/z71w-jx69, DOI 10.13020/Z71W-JX69]; Liang WW, 2018, ECOL MODEL, V388, P1, DOI 10.1016/j.ecolmodel.2018.09.018; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mahoney PJ, 2015, DIVERS DISTRIB, V21, P64, DOI 10.1111/ddi.12240; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Molina FB., 2006, PARQUES URBANOS MEIO, P203; Rodrigues JFM, 2018, ACTA OECOL, V88, P52, DOI 10.1016/j.actao.2018.03.005; Mothes CC, 2019, J BIOGEOGR, V46, P432, DOI 10.1111/jbi.13511; Mungi NA, 2018, BIOL INVASIONS, V20, P1849, DOI 10.1007/s10530-018-1666-7; Nakazawa M., 2018, **DATA OBJECT**; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parham JF, 2013, MOL PHYLOGENET EVOL, V67, P176, DOI 10.1016/j.ympev.2013.01.004; Pearson SH, 2015, BIOL CONSERV, V186, P115, DOI 10.1016/j.biocon.2015.03.001; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Polo-Cavia Nuria, 2014, Basic and Applied Herpetology, V28, P5; Polo-Cavia N, 2011, BIOL INVASIONS, V13, P1387, DOI 10.1007/s10530-010-9897-2; Polo-Cavia N, 2010, BIOL INVASIONS, V12, P2141, DOI 10.1007/s10530-009-9615-0; Poulos HM, 2012, AQUAT INVASIONS, V7, P59, DOI 10.3391/ai.2012.7.1.007; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Ringuelet R. A., 1961, Physis, V22, P151; Rodriguez-Rey M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217896; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Santana Daniel Oliveira, 2014, Herpetology Notes, V7, P211; Santos TG., 2009, HERPETOL BULL, V108, P27; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thuiller W, 2019, **DATA OBJECT**; Tingley R, 2018, ECOGRAPHY, V41, P635, DOI 10.1111/ecog.02841; USGS, 2001, HYDRO 1K EL DER DAT; Vargas-Ramirez M, 2017, J ZOOL SYST EVOL RES, V55, P326, DOI 10.1111/jzs.12179; Vogt R.C., 2015, PROCESSO AVALIACAO R; WCS-Wildlife Conservation Society and CIESIN-Center for International Earth Science Information Network at Columbia University, 2005, **DATA OBJECT**, DOI [10.7927/H4BP00QC, DOI 10.7927/H4BP00QC]; Zhu G., 2016, J PEST SCI, P1, DOI [10.1007/s10340-016, DOI 10.1007/S10340-016]	81	0	0	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259626	10.1371/journal.pone.0259626	http://dx.doi.org/10.1371/journal.pone.0259626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762709	Green Published, gold			2022-12-26	WOS:000755316600030
J	Hu, SH; Luo, WY; Darzi, A; Pan, YX; Zhao, GC; Liu, YX; Xiong, CF				Hu, Songhua; Luo, Weiyu; Darzi, Aref; Pan, Yixuan; Zhao, Guangchen; Liu, Yuxuan; Xiong, Chenfeng			Do racial and ethnic disparities in following stay-at-home orders influence COVID-19 health outcomes? A mediation analysis approach	PLOS ONE			English	Article							HUMAN MOBILITY	Racial/ethnic disparities are among the top-selective underlying determinants associated with the disproportional impact of the COVID-19 pandemic on human mobility and health outcomes. This study jointly examined county-level racial/ethnic differences in compliance with stay-at-home orders and COVID-19 health outcomes during 2020, leveraging two-year geo-tracking data of mobile devices across similar to 4.4 million point-of-interests (POls) in the contiguous United States. Through a set of structural equation modeling, this study quantified how racial/ethnic differences in following stay-at-home orders could mediate COVID-19 health outcomes, controlling for state effects, socioeconomics, demographics, occupation, and partisanship. Results showed that counties with higher Asian populations decreased most in their travel, both in terms of reducing their overall POls' visiting and increasing their staying home percentage. Moreover, counties with higher White populations experienced the lowest infection rate, while counties with higher African American populations presented the highest case-fatality ratio. Additionally, control variables, particularly partisanship, median household income, percentage of elders, and urbanization, significantly accounted for the county differences in human mobility and COVID-19 health outcomes. Mediation analyses further revealed that human mobility only statistically influenced infection rate but not case-fatality ratio, and such mediation effects varied substantially among racial/ethnic compositions. Last, robustness check of racial gradient at census block group level documented consistent associations but greater magnitude. Taken together, these findings suggest that US residents' responses to COVID-19 are subject to an entrenched and consequential racial/ethnic divide.	[Hu, Songhua; Luo, Weiyu; Darzi, Aref; Zhao, Guangchen; Liu, Yuxuan; Xiong, Chenfeng] Univ Maryland, Maryland Transportat Inst MTI, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Pan, Yixuan; Xiong, Chenfeng] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Xiong, CF (corresponding author), Univ Maryland, Maryland Transportat Inst MTI, Dept Civil & Environm Engn, College Pk, MD 20742 USA.; Xiong, CF (corresponding author), Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA.	cxiong@umd.edu	Pan, Yixuan/AHC-8675-2022; Zhao, Guangchen/CAJ-1069-2022; Hu, Songhua/ABF-2415-2021	Zhao, Guangchen/0000-0002-0803-207X; Darzi, Aref/0000-0003-2558-5570; Luo, Weiyu/0000-0002-7987-2199; Hu, Songhua/0000-0002-0731-3080				Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Allcott H, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104254; Almagro M, 2022, J URBAN ECON, V127, DOI 10.1016/j.jue.2020.103293; Beck MJ, 2020, J TRANSP GEOGR, V88, DOI 10.1016/j.jtrangeo.2020.102846; Beck MJ, 2020, TRANSPORT POLICY, V96, P76, DOI 10.1016/j.tranpol.2020.07.001; Benitez Joseph, 2020, J Econ Race Policy, V3, P243, DOI 10.1007/s41996-020-00068-9; Bhowmik T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249133; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Bushman K., 2020, ARXIV PREPRINT ARXIV; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Chen JT, 2021, J PUBLIC HEALTH MAN, V27, pS43, DOI 10.1097/PHH.0000000000001263; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Coelho FC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238214; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Garnier R, 2021, J MED INTERNET RES, V23, DOI 10.2196/24591; Gibbons J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251960; Gollwitzer A, 2020, NAT HUM BEHAV, V4, P1186, DOI 10.1038/s41562-020-00977-7; Grantz KH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18190-5; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Hancock GR, 2006, QUANT METH EDUC BEHA, P1; Hu SH, 2021, TRANSPORT RES D-TR E, V90, DOI 10.1016/j.trd.2020.102654; Hu SH, 2021, J TRANSP GEOGR, V91, DOI 10.1016/j.jtrangeo.2021.102997; Hu SH, 2021, TRANSPORT RES C-EMER, V124, DOI 10.1016/j.trc.2020.102955; Huang V.S., 2020, SOCIAL DISTANCING VU; Huang X, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241957; Jay J, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00998-2; Jiang YQ, 2021, ISPRS INT J GEO-INF, V10, DOI 10.3390/ijgi10050344; Jing Y., 2021, JOINT ANAL SCOOTER S; Johnson-Agbakwu CE, 2022, J RACIAL ETHN HEALTH, V9, P52, DOI 10.1007/s40615-020-00928-y; Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297; Kubota Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239385; Lee MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241468; McGrail DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236619; MIT, MIT EL DAT; Papageorge NW, 2021, J POPUL ECON, V34, P691, DOI 10.1007/s00148-020-00818-x; PATTERSON HD, 1981, BIOMETRICS, V37, P862, DOI 10.2307/2530185; SafeGraph, SAFEGRAPH DAT AC; Squire RF, QUANTIFYING SAMPLING; Sun Q., 2020, ARXIV PREPRINT ARXIV; Sy KTL., 2020, AM J EPIDEMIOL, DOI [10.1101/2020.05.28.20115949, DOI 10.1093/AJE/KWAA277]; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; Xiong CF, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0344; Xiong CF, 2020, P NATL ACAD SCI USA, V117, P27087, DOI 10.1073/pnas.2010836117; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	48	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259803	10.1371/journal.pone.025980	http://dx.doi.org/10.1371/journal.pone.025980			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762685				2022-12-26	WOS:000755316600039
J	Hugues, Y; Diaz-Zavala, RG; Quizan-Plata, T; Corvalan, C; Haby, MM				Hugues, Yazmin; Diaz-Zavala, Rolando G.; Quizan-Plata, Trinidad; Corvalan, Camila; Haby, Michelle M.			Poor compliance with school food environment guidelines in elementary schools in Northwest Mexico: A cross-sectional study	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; OBESITY; POLICY; CHILDREN; TAX	Background In Mexico, 35.5% of school-age children were overweight or obese in 2018. The school food environment is important because children spend a significant part of their time at school and consume one-third to one-half of their daily meals there. In 2014, a Federal Government guideline for the sale and distribution of food and beverages in Mexican schools was published (the AGREEMENT) but the extent of its implementation is not known. Methods Descriptive cross-sectional study in a representative, random sample of elementary schools, using the tools of the INFORMAS network. Data collection included: a) an interview with a school authority; b) a checklist of items available in the school canteen; c) a checklist of the school breakfast menu; and d) an evaluation of the physical environment. The main indicators were: percentage of implementation (self-report) of the AGREEMENT and percentage of compliance (researcher verified) with the AGREEMENT (based on tools b and c). Results 119 schools participated (response rate 87.5%), with 15.1% (95%CI 9.2-22.8) of the schools reporting having fully implemented the AGREEMENT. However, only 1% (95%CI 0-5.3) of the school canteens and 71.4% (95%CI 57.8-82.7) of the school breakfast menus fully complied with the AGREEMENT. A variety of sugar-sweetened beverages and energy-dense, nutrient poor products were found in the school canteens. Further, only 43.7% of the water fountains in schools were functional and 23.4% were clean. In only 24.4% of schools had the school authorities received formal training related to the AGREEMENT and in 28.6% of schools had the parents received information about the AGREEMENT. Conclusion The AGREEMENT has been poorly implemented in elementary schools in Mexico. Actions are needed to encourage and support its full implementation to improve the food environment in Mexican schools.	[Hugues, Yazmin; Diaz-Zavala, Rolando G.; Quizan-Plata, Trinidad; Haby, Michelle M.] Univ Sonora, Dept Chem & Biol Sci, Div Biol & Hlth Sci, Hermosillo, Sonora, Mexico; [Corvalan, Camila] Univ Chile, Inst Nutr & Food Technol INTA, Santiago, Chile	Universidad de Sonora; Universidad de Chile	Haby, MM (corresponding author), Univ Sonora, Dept Chem & Biol Sci, Div Biol & Hlth Sci, Hermosillo, Sonora, Mexico.	haby@unimelb.edu.au	Díaz-Zavala, Rolando G./F-4355-2019; Haby, Michelle/AGL-3386-2022; Corvalan, Camila/B-2914-2011	Díaz-Zavala, Rolando G./0000-0001-9104-409X; Haby, Michelle/0000-0001-6203-9195; QUIZAN-PLATA, TRINIDAD/0000-0003-2765-4795; Corvalan, Camila/0000-0003-3766-7709; Quizan-Plata, Trinidad/0000-0003-0081-7144	Division of Biological and Health Sciences of the University of Sonora; CONACYT (National Council of Science and Technology)	Division of Biological and Health Sciences of the University of Sonora; CONACYT (National Council of Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Division of Biological and Health Sciences of the University of Sonora funded the printing of the instruments for data collection as well as fuel costs. YHA received a Masters degree scholarship from CONACYT (National Council of Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Borjas S., 2005, SALUD TABASCO, V11, P333; Colchero MA, 2017, J NUTR, V147, P1552, DOI 10.3945/jn.117.251892; Barquera S, 2013, OBES REV, V14, P69, DOI 10.1111/obr.12096; Barquera S, 2020, LANCET DIABETES ENDO, V8, P746, DOI 10.1016/S2213-8587(20)30269-2; de Silva-Sanigorski A, 2011, AUST NZ J PUBL HEAL, V35, P117, DOI 10.1111/j.1753-6405.2010.00694.x; El Poder del Consumidor, 2018, EXECUTIVE SUMMARY EX; Gabriel CG, 2009, ARCH LATINOAM NUTR, V59, P128; Hawkes C, 2015, LANCET, V385, P2410, DOI 10.1016/S0140-6736(14)61745-1; He C, 2014, PERSPECT PUBLIC HEAL, V134, P110, DOI 10.1177/1757913913517976; Instituto Nacional de Salud Publica, 2012, ENCUESTA NACL SALUD; Instituto Nacional de Salud Publica, 2016, ENCUESTA NACL SALUD; Jimenez-Aguilar A, 2017, J PUBLIC HEALTH POL, V38, P407, DOI 10.1057/s41271-017-0090-z; KREFTING L, 1991, AM J OCCUP THER, V45, P214, DOI 10.5014/ajot.45.3.214; L'Abbe M, 2013, OBES REV, V14, P96, DOI 10.1111/obr.12079; Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mathias KC, 2013, AM J PREV MED, V44, P351, DOI 10.1016/j.amepre.2012.11.036; Micha R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194555; Peat J., 2008, MED STAT GUIDE DATA, V1st ed; Quizán Plata Trinidad, 2013, Estud. soc, V21, P175; Reilly K, 2016, HEALTH PROMOT J AUST, V27, P215, DOI 10.1071/HE16053; Sacks G, 2021, ANNU REV PUBL HEALTH, V42, P345, DOI 10.1146/annurev-publhealth-100919-114442; Secretaria de Educacion Publica Secretaria de Salud, 2014, ACUERDO MEDIANTE CUA; Shamah-Levy T., 2020, ENCUESTA NACL SALUD; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; STRUTZEL E, 1968, NURS RES, V17, P364; Swinburn B, 2013, OBES REV, V14, P1, DOI 10.1111/obr.12087; Taillie LS, 2017, PREV MED, V105, pS37, DOI 10.1016/j.ypmed.2017.07.009; Theodore FL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198585; Vandevijvere S., 2018, HLTH ARE NZ FOOD ENV; Vandevijvere S, 2019, OBES REV, V20, P141, DOI 10.1111/obr.12850; White M, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1752063; Wolfenden L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011677.pub2; Wolfenden L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0537-9; Wolfenden L, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0147-3	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259720	10.1371/journal.pone.0259720	http://dx.doi.org/10.1371/journal.pone.0259720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762702	Green Published, gold			2022-12-26	WOS:000755316600034
J	Maeda, K; Kuriyama, N; Nakagawa, Y; Ito, T; Hayasaki, A; Gyoten, K; Fujii, T; Iizawa, Y; Murata, Y; Tanemura, A; Kishiwada, M; Sakurai, H; Mizuno, S				Maeda, Koki; Kuriyama, Naohisa; Nakagawa, Yuki; Ito, Takahiro; Hayasaki, Aoi; Gyoten, Kazuyuki; Fujii, Takehiro; Iizawa, Yusuke; Murata, Yasuhiro; Tanemura, Akihiro; Kishiwada, Masashi; Sakurai, Hiroyuki; Mizuno, Shugo			Optimal management of peripancreatic fluid collection with postoperative pancreatic fistula after distal pancreatectomy: Significance of computed tomography values for predicting fluid infection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INFLAMMATORY COMPLICATIONS; SURGICAL COMPLICATIONS; SURGERY; CLASSIFICATION; CLOSURE; TRIAL	Peripancreatic fluid collections have been observed in most patients with postoperative pancreatic fistula after distal pancreatectomy; however, optimal management remains unclear. This study aimed to evaluate the management and outcomes of patients with postoperative pancreatic fistula and verify the significance of computed tomography values for predicting peripancreatic fluid infections after distal pancreatectomy. We retrospectively investigated 259 consecutive patients who underwent distal pancreatectomy. Grade B postoperative pancreatic fistula patients were divided into two subgroups (B-antibiotics group and B-intervention group) and outcomes were compared. Predictive factor analysis of peripancreatic fluid infection was performed. Clinically relevant postoperative pancreatic fistulas developed in 88 (34.0%) patients. The duration of hospitalization was significantly longer in the B-intervention (n = 54) group than in the B-antibiotics group (n = 31; 41 vs. 17 days, p < 0.001). Computed tomography values of the infected peripancreatic fluid collections were significantly higher than those of the non-infected peripancreatic fluid collections (26.3 vs. 16.1 Hounsfield units, respectively; p < 0.001). The outcomes of the patients with grade B postoperative pancreatic fistulas who received therapeutic antibiotics only were considerably better than those who underwent interventions. Computed tomography values may be useful in predicting peripancreatic fluid collection infection after distal pancreatectomy.	[Maeda, Koki; Kuriyama, Naohisa; Nakagawa, Yuki; Ito, Takahiro; Hayasaki, Aoi; Gyoten, Kazuyuki; Fujii, Takehiro; Iizawa, Yusuke; Murata, Yasuhiro; Tanemura, Akihiro; Kishiwada, Masashi; Sakurai, Hiroyuki; Mizuno, Shugo] Mie Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Tsu, Mie, Japan; [Maeda, Koki] Mie Univ Hosp, Reg Med Support Ctr, Tsu, Mie, Japan	Mie University; Mie University	Kuriyama, N (corresponding author), Mie Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Grad Sch Med, Tsu, Mie, Japan.	naokun@med.mie-u.ac.jp		Fujii, Takehiro/0000-0002-4454-4283; Maeda, Koki/0000-0002-7846-3748				Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Chang YR, 2016, ANN SURG TREAT RES, V91, P247, DOI 10.4174/astr.2016.91.5.247; Chikhladze S, 2020, ASIAN J SURG, V43, P227, DOI 10.1016/j.asjsur.2019.03.009; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Facy O, 2016, ANN SURG, V263, P961, DOI 10.1097/SLA.0000000000001303; Giardino A, 2016, J GASTROINTEST SURG, V20, P1482, DOI 10.1007/s11605-016-3171-6; Gnannt R, 2015, INVEST RADIOL, V50, P17, DOI 10.1097/RLI.0000000000000090; Kawai M, 2016, ANN SURG, V264, P180, DOI 10.1097/SLA.0000000000001395; Kim E, 2018, HPB, V20, P1051, DOI 10.1016/j.hpb.2018.05.004; Loos M, 2018, SURGERY, V164, P1185, DOI 10.1016/j.surg.2018.07.024; Maggino L, 2019, ANN SURG, V269, P1146, DOI 10.1097/SLA.0000000000002673; Nakamura M, 2015, J HEPATO-BIL-PAN SCI, V22, P731, DOI 10.1002/jhbp.268; Nappo G, 2019, PANCREATOLOGY, V19, P449, DOI 10.1016/j.pan.2019.03.004; Otsubo T, 2017, J HEPATO-BIL-PAN SCI, V24, P252, DOI 10.1002/jhbp.444; Sato K, 2015, NAGOYA J MED SCI, V77, P563; Song KB, 2019, SURG ENDOSC, V33, P3314, DOI 10.1007/s00464-018-06621-w; Sugimoto M, 2013, J HEPATO-BIL-PAN SCI, V20, P538, DOI 10.1007/s00534-013-0596-0; Takeda Y, 2020, J HEPATO-BIL-PAN SCI, V27, P1011, DOI 10.1002/jhbp.838; Targarona EM, 2000, BRIT J SURG, V87, P536, DOI 10.1046/j.1365-2168.2000.01429.x; Tjaden C, 2016, HPB, V18, P35, DOI 10.1016/j.hpb.2015.10.006; Uemura K, 2017, BRIT J SURG, V104, P536, DOI 10.1002/bjs.10458; Venkat R, 2012, ANN SURG, V255, P1048, DOI 10.1097/SLA.0b013e318251ee09; Warschkow R, 2012, LANGENBECK ARCH SURG, V397, P727, DOI 10.1007/s00423-012-0944-6; Wennerblom J, 2021, BRIT J SURG, V108, P265, DOI 10.1093/bjs/znaa113; Yamashita S, 2016, WORLD J SURG, V40, P1226, DOI 10.1007/s00268-015-3399-4; Yang F, 2019, J GASTROINTEST SURG, V23, P2449, DOI 10.1007/s11605-019-04155-7; Yoshino J, 2019, WORLD J SURG, V43, P2069, DOI 10.1007/s00268-019-05009-8	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259701	10.1371/journal.pone.0259701	http://dx.doi.org/10.1371/journal.pone.0259701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752498	Green Published, gold			2022-12-26	WOS:000754499700028
J	Zemanova, N; Lnenickova, K; Vavreckova, M; Anzenbacherova, E; Anzenbacher, P; Zapletalova, I; Hermanova, P; Hudcovic, T; Kozakova, H; Jourova, L				Zemanova, Nina; Lnenickova, Katerina; Vavreckova, Marketa; Anzenbacherova, Eva; Anzenbacher, Pavel; Zapletalova, Iveta; Hermanova, Petra; Hudcovic, Tomas; Kozakova, Hana; Jourova, Lenka			Gut microbiome affects the metabolism of metronidazole in mice through regulation of hepatic cytochromes P450 expression	PLOS ONE			English	Article							DRUG; ENZYMES	Microbiome is now considered as a significant metabolic organ with an immense potential to influence overall human health. A number of diseases that are associated with pharmacotherapy interventions was linked with altered gut microbiota. Moreover, it has been reported earlier that gut microbiome modulates the fate of more than 30 commonly used drugs and, vice versa, drugs have been shown to affect the composition of the gut microbiome. The molecular mechanisms of this mutual relationship, however, remain mostly elusive. Recent studies indicate an indirect effect of the gut microbiome through its metabolites on the expression of biotransformation enzymes in the liver. The aim of this study was to analyse the effect of gut microbiome on the fate of metronidazole in the mice through modulation of system of drug metabolizing enzymes, namely by alteration of the expression and activity of selected cytochromes P450 (CYPs). To assess the influence of gut microbiome, germ-free mice (GF) in comparison to control specific-pathogen-free (SPF) mice were used. First, it has been found that the absence of microbiota significantly affected plasma concentration of metronidazole, resulting in higher levels (by 30%) of the parent drug in murine plasma of GF mice. Further, the significant interaction between presence/absence of the gut microbiome and effect of metronidazole application, which together influence mRNA expression of CAR, PPAR alpha, Cyp2b10 and Cyp2c38 was determined. Administration of metronidazole itself influenced significantly mRNA expression of Cyp1a2, Cyp2b10, Cyp2c38 and Cyp2d22. Finally, GF mice have shown lower level of enzyme activity of CYP2A and CYP3A than their SPF counterparts. The results hence have shown that, beside direct bacterial metabolism, different expression and enzyme activity of hepatic CYPs in the presence/absence of gut microbiota may be responsible for the altered metronidazole metabolism.	[Zemanova, Nina; Lnenickova, Katerina; Vavreckova, Marketa; Anzenbacherova, Eva; Jourova, Lenka] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic; [Anzenbacher, Pavel; Zapletalova, Iveta] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic; [Hermanova, Petra; Hudcovic, Tomas; Kozakova, Hana] Czech Acad Sci, Inst Microbiol, Lab Gnotobiol, Novy Hradek, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Jourova, L (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic.	LenkaJourova@seznam.cz	Zemanová, Nina/AGV-9716-2022	Zemanova, Nina/0000-0001-9356-1381; Jourova, Lenka/0000-0003-3195-6710	Czech Science Foundation [19-08294S]; Internal Student Grant Agency of Palacky University [IGA_LF_2020_022]	Czech Science Foundation(Grant Agency of the Czech Republic); Internal Student Grant Agency of Palacky University	This work was supported by the Czech Science Foundation (www.gacr.cz) [grant 19-08294S], which was awarded to TH and EA and the Internal Student Grant Agency of Palacky ' University (www.psup.cz) [grant IGA_LF_2020_022] awarded to NZ and MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Bendesky A, 2002, MUTAT RES-REV MUTAT, V511, P133, DOI 10.1016/S1383-5742(02)00007-8; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Dingsdag SA, 2018, J ANTIMICROB CHEMOTH, V73, P265, DOI 10.1093/jac/dkx351; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Hammer H, 2021, ARCH TOXICOL, V95, P117, DOI 10.1007/s00204-020-02939-4; Jourova L, 2017, FOLIA MICROBIOL, V62, P463, DOI 10.1007/s12223-017-0517-8; Jourova L, 2020, PHYSIOL RES, V69, pS583, DOI 10.33549/physiolres.934607; Jourova L, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01303; Jourova L, 2019, XENOBIOTICA, V49, P1296, DOI 10.1080/00498254.2018.1558310; Jourova L, 2016, BIOMED PAP, V160, P317, DOI 10.5507/bp.2016.039; Kim DH, 2015, DRUG METAB DISPOS, V43, P1581, DOI 10.1124/dmd.115.063867; KOCH RL, 1979, J PHARMACOL EXP THER, V208, P406; Lake BG, 1987, PREPARATION CHARACTE; Lamp KC, 1999, CLIN PHARMACOKINET, V36, P353, DOI 10.2165/00003088-199936050-00004; Leitsch D, 2019, PARASITOLOGY, V146, P1167, DOI [10.1017/S0031182017002025, 10.1017/s0031182017002025]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Matuskova Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087150; Pearce RE, 2013, DRUG METAB DISPOS, V41, P1686, DOI 10.1124/dmd.113.052548; Pelissier MA, 2010, FEMS MICROBIOL ECOL, V73, P601, DOI 10.1111/j.1574-6941.2010.00916.x; Phillips I., 2006, HUMANA PRESS, V320, P364, DOI [10.1385/1592599982, DOI 10.1385/1592599982]; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; SCHELINE RR, 1968, J PHARM SCI, V57, P2021, DOI 10.1002/jps.2600571202; Selwyn FP, 2016, DRUG METAB DISPOS, V44, P262, DOI 10.1124/dmd.115.067504; Selwyn FP, 2015, DRUG METAB DISPOS, V43, P1572, DOI 10.1124/dmd.115.063545; Stancil S, 2016, FASEB J, V30; Symonds DA, 2006, TOXICOL SCI, V89, P510, DOI 10.1093/toxsci/kfj044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONBERGMANN K, 1985, KLIN WOCHENSCHR, V63, P279; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Yoo DH, 2014, DRUG METAB DISPOS, V42, P1508, DOI 10.1124/dmd.114.058354; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zemanova N, 2022, J CHROMATOGR SCI, V60, P81, DOI 10.1093/chromsci/bmab049; Zemanova N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65595-9; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009; Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3	39	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259643	10.1371/journal.pone.0259643	http://dx.doi.org/10.1371/journal.pone.0259643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752478	Green Published, gold			2022-12-26	WOS:000754499700021
J	Tejero, JM; Bar-Oz, G; Bar-Yosef, O; Meshveliani, T; Jakeli, N; Matskevich, Z; Pinhasi, R; Belfer-Cohen, A				Tejero, Jose-Miguel; Bar-Oz, Guy; Bar-Yosef, Ofer; Meshveliani, Tengiz; Jakeli, Nino; Matskevich, Zinovi; Pinhasi, Ron; Belfer-Cohen, Anna			New insights into the Upper Palaeolithic of the Caucasus through the study of personal ornaments. Teeth and bones pendants from Satsurblia and Dzudzuana caves (Imereti, Georgia)	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; MODERN HUMANS; BONDI CAVE; HUMAN REMAINS; BLOMBOS CAVE; SHELL BEADS; MIDDLE; EUROPE; AGE; ZOOARCHAEOLOGY	The region of western Georgia (Imereti) in the Southern Caucasus has been a major geographic corridor for human migrations during the Middle and Upper Paleolithic. Data of recent research and excavations in this region display its importance as a possible route for the dispersal of anatomically modern humans (AMH) into northern Eurasia. Nevertheless, within the local research context, bone-working and personal ornaments have yet contributed but little to the Upper Palaeolithic (UP) regional sequence's characterization. Here we present an archaeozoological, technological and use-wear study of pendants from two local UP assemblages, originating in the Dzudzuana Cave and Satsurblia Cave. The ornaments were made mostly of perforated teeth, though some specimens were made on bone. Both the manufacturing marks made during preparation and use-wear traces indicate that they were personal ornaments, used as pendants or attached to garments. Detailed comparison between ornament assemblages from northern and southern Caucasus reveal that they are quite similar, supporting the observation of cultural bonds between the two regions, demonstrated previously through lithic techno-typological affinities. Furthermore, our study highlights the importance attributed to red deer (Cervus elaphus) by the UP societies of the Caucasus in sharing aesthetic values and/or a symbolic sphere.	[Tejero, Jose-Miguel; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Tejero, Jose-Miguel] Univ Barcelona, Seminari Estudis & Recerques Prehist, Barcelona, Spain; [Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, Haifa, Israel; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Meshveliani, Tengiz; Jakeli, Nino] Georgian Natl Museum, Tbilisi, Georgia; [Matskevich, Zinovi] Israel Antiqu Author, Jerusalem, Israel; [Belfer-Cohen, Anna] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University of Vienna; University of Barcelona; University of Haifa; Harvard University; Hebrew University of Jerusalem	Tejero, JM (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria.; Tejero, JM (corresponding author), Univ Barcelona, Seminari Estudis & Recerques Prehist, Barcelona, Spain.; Belfer-Cohen, A (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.	jose.miguel.tejero@univie.ac.at; anna.belfer-cohen@mail.huji.ac.il	Tejero, Jose-Miguel/A-9818-2017	Tejero, Jose-Miguel/0000-0002-7888-6951	CNRS UMR 7041 ArScAn equipe Ethnologie prehistorique; MINECO [HAR 2017-86509]; Grup de Recerca de Qualitat de la Generalitat de Catalunya [SGR2017-00011]; University of Vienna; OBY research project; RP research project; TM research project; GBO research project; ABC research project	CNRS UMR 7041 ArScAn equipe Ethnologie prehistorique; MINECO(Spanish Government); Grup de Recerca de Qualitat de la Generalitat de Catalunya; University of Vienna; OBY research project; RP research project; TM research project; GBO research project; ABC research project	The analytical work of J.-MT was funded by CNRS UMR 7041 ArScAn equipe Ethnologie prehistorique (Director P. Bodu), MINECO project HAR 2017-86509, Grup de Recerca de Qualitat de la Generalitat de Catalunya SGR2017-00011 (Director J.M. Fullola). Fieldwork at Dzudzuana and Satsurblia was funded by OBY, RP, TM, GBO, and ABC research projects.; Thanks are due to Randall White for his contribution to the study of European Early Upper Palaeolithic ornaments and Danniella Bar-Yosef Mayer for her contribution to the study of Levantine Aurignacian ornaments. We are especially grateful to the academic editor Marco Peresani, David Caramelli, and Fabio Di Vincenzo for their thoughtful and constructive comments and suggestions that significantly contributed to improving the previous versions of the manuscript. Open access funding provided by University of Vienna.	Adler DS, 2008, J HUM EVOL, V55, P817, DOI 10.1016/j.jhevol.2008.08.010; Adler DS, 2006, CURR ANTHROPOL, V47, P89, DOI 10.1086/432455; Adler DS., 2002, LATE MIDDLE PALAEOLI; Akerman K, 2018, ARCHAEOLOGY OF PORTABLE ART: SOUTHEAST ASIAN, PACIFIC, AND AUSTRALIAN PERSPECTIVES, P199; Alex B, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701450; Antl W, 2015, ANTHROPOL-INT J HUM, V53, P233; Aubert M, 2019, NATURE, V576, P442, DOI 10.1038/s41586-019-1806-y; Averbouh A, 2000, TECHNOLOGIE MATIERE; Balme Jane, 2019, Paleoanthropology, P177; Bar-Oz G, 2008, INT J OSTEOARCHAEOL, V18, P131, DOI 10.1002/oa.926; Bar-Oz G, 2009, ARCHAEOL ETHNOL ANTH, V37, P15, DOI 10.1016/j.aeae.2009.05.002; Bar -Oz G., 2002, ARCHAEOL ETHNOL ANTH, V4, P45; Bar-Oz Guy, 2005, Journal of Taphonomy, V3, P185; Bar-Oz G, 2012, J ARCHAEOL SCI, V39, P2452, DOI 10.1016/j.jas.2012.02.014; Bar-Yosef Mayer D.E., 2005, PAL ORIENT, V31, P176, DOI DOI 10.3406/PALEO.2005.4796; Bar-Yosef O, 2011, ANTIQUITY, V85, P331, DOI 10.1017/S0003598X0006779X; Bar-Yosef O, 2006, ANTHROPOL-INT J HUM, V44, P49; Barge-Mahieu H., 1991, FICHES TYPOLOGIQUES, P1; Barnard A., 1999, EVOLUTION CULTURE IN, P50; Baryshnikov Gennady F., 2002, Russian Journal of Theriology, V1, P61; Belfer-Cohen A, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.03063; Belmaker M, 2016, QUATERN INT, V425, P4, DOI 10.1016/j.quaint.2016.06.022; Bendukidze O., 1978, CBORNIK PESHCHERI GR, V7, P72; Bergman C.-A., 1987, MAIN OUTIL MANCHES E, P117; Bertrand A., 1999, ARMATURES SAGAIES MA; BINFORD LR, 1971, AM ANTIQUITY, V36, P6, DOI 10.1017/S0081130000002525; BROWN WAB, 1991, J ZOOL, V224, P519, DOI 10.1111/j.1469-7998.1991.tb03783.x; Bruch AA., 2014, ANTIQUITY, V88; Brumm A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd4648; Caceres I., 2002, CURRENT TOPICS TAPHO, P471; Catchpole EA, 2004, J AGR BIOL ENVIR ST, V9, P1, DOI 10.1198/1085711043172; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO, DOI [10.1038/298011a0, DOI 10.1038/298011A0]; Conard NJ, 2003, NATURE, V426, P830, DOI 10.1038/nature02186; Cristiani E, 2014, J ANTHROPOL ARCHAEOL, V36, P21, DOI 10.1016/j.jaa.2014.06.009; Cristiani E, 2014, J ARCHAEOL SCI, V46, P292, DOI 10.1016/j.jas.2014.03.018; Cullen VL, 2021, J HUM EVOL, V151, DOI 10.1016/j.jhevol.2020.102908; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2002, J ARCHAEOL SCI, V29, P211, DOI 10.1006/jasc.2001.0687; d'Errico F, 2003, J WORLD PREHIST, V17, P1, DOI 10.1023/A:1023980201043; d'Errico F., 1993, MANIPULATION TRANSPO, V12, P145; Dayet L, 2017, J ARCHAEOL SCI-REP, V13, P635, DOI 10.1016/j.jasrep.2017.05.015; Delporte H., 1988, FICHES TYPOLOGIQUES; dErrico F., 2011, PALEO, V22, P301; Dutkiewicz E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00704-x; Fernandez Alvarez, EURASIAN PREHISTORY, V5, P31; Fernandez Jalvo Y., 1990, TAFONOMIA FOSILIZACI, P105; Frison GC, 1998, P NATL ACAD SCI USA, V95, P14576, DOI 10.1073/pnas.95.24.14576; Giacobinni G., 1999, FACIES LEPTOLITHIQUE, P25; Golovanova L.V., 2020, ENV CULTURE SUBSISTE, Vfirst; Golovanova L.V., 2012, AURIGNACIAN YAFTEH C, P137; Golovanova L.V., 2006, EURASIAN PREHISTORY, V4, P43; Golovanova LV, 2010, ANTIQUITY, V84, P299, DOI 10.1017/S0003598X0006659X; Golovanova LV, 2010, CURR ANTHROPOL, V51, P655, DOI 10.1086/656185; Goss R.J., 1983, DEER ANTLERS REGENER; Gravel-Miguel C., 2011, EXOTICISM PORTABLE A; Harrod L.H, 2000, ANIMALS CAME DANCING; Henshilwood C., 2014, MCGRAW HILL YB SCI T; Henshilwood C.S., 2011, HOMOSYMBOLICUS DAWN; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Heptner VG., 1989, UNGULATES, V1; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Hubbard T., 2009, CANADIAN J NATIVE ST, V29, P65, DOI [DOI 10.1002/9780471729259.MC16G01S10, 10.1002/9780471729259.mc16g01s10]; Jakeli N., 2012, P GEORG NAT MUS NAT, P37; Kalandadze A.N., 1978, CAVES GEORGIA, P116; Kalandadze K., 2004, GEORGIAN RUSSIAN SUM; Kandel AW, 2017, J HUM EVOL, V110, P37, DOI 10.1016/j.jhevol.2017.05.010; Kitagawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239865; Knecht H, 1991, TECHNOLOGICAL INNOVA; Krivoshapkin A, 2018, ANTIQUITY, V92, DOI 10.15184/aqy.2018.221; Kuhn S.L., 2007, RETHINKING HUMAN REV, P45; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; Langley M.C., 2015, GENESIS CREATIVITY O, P57; Langley MC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3831; Lbova L, 2021, QUATERN INT, V573, P4, DOI 10.1016/j.quaint.2020.05.035; Leonardi M., 2020, FOLLOWING NICHE RECO; Li F, 2018, J CHEM RES, P170, DOI [10.3184/174751918X15222671415597, 10.1016/j.jhevol.2018.02.011]; Liolios D., 1999, VARIABILITE CARACTER; Liubin VP., 1898, PALEOLIT KAVKAZA SEV, P9; Maigrot Y., 2003, ETUDE TECHNOLOGIQUE; Majkic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173435; Mannermaa K, 2021, ARCHAEOL ANTHROP SCI, V13, DOI 10.1007/s12520-020-01237-5; Marder O, 2021, J HUM EVOL, V160, DOI 10.1016/j.jhevol.2019.102705; Margherita C, 2017, J HUM EVOL, V113, P83, DOI 10.1016/j.jhevol.2017.07.011; Mattson H.V., 2021, PERSONAL ADORNMENT C; Mayer DEBY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234924; Mayer Daniella E. Bar-Yosef, 2019, Paleoanthropology, P105; Mayer DEBY, 2015, QUATERN INT, V390, P79, DOI 10.1016/j.quaint.2015.05.042; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; McAdam L, 2018, ARCHAEOLOGY OF PORTABLE ART: SOUTHEAST ASIAN, PACIFIC, AND AUSTRALIAN PERSPECTIVES, P220; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Mesheviliani T., 1999, PREHISTOIRE EUROPEEN, V15, P79; Meshveliani T, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P129; Meshveliani T., 2007, PALEORIENT, V33, P47, DOI [10.3406/paleo.2007.5220, DOI 10.3406/PALEO.2007.5220]; Moncel MH, 2013, QUATERN INT, V316, P3, DOI 10.1016/j.quaint.2012.09.012; NICHOLSON RA, 1993, J ARCHAEOL SCI, V20, P411, DOI 10.1006/jasc.1993.1025; Niedzialkowska M, 2021, J BIOGEOGR, V48, P147, DOI 10.1111/jbi.13989; Otte M, 1979, PALEOLITHIQUE SUPERI, V5; Petillon J-M., 2006, MAGDALENIENS ARMES T; Pinhasi R, 2012, J HUM EVOL, V63, P770, DOI 10.1016/j.jhevol.2012.08.004; Pinhasi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111271; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Pleurdeau D, 2016, QUATERNARY SCI REV, V146, P77, DOI 10.1016/j.quascirev.2016.06.003; Prevost, 2021, QUATERN INT; Rosso DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177298; Rosso DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164793; Shaham D., 2014, THESIS HEBREW U JERU; Shunkov MV, 2020, QUATERN INT, V559, P47, DOI 10.1016/j.quaint.2020.07.027; Sommer RS, 2008, QUATERNARY SCI REV, V27, P714, DOI 10.1016/j.quascirev.2007.11.016; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Spennemann D., 1989, ARCHAEOZOOLOGIA, V3, P51; Speth J.D., 2018, ARCHAEOLOGY LARGE SC, P161, DOI DOI 10.2307/J.CTV14H5HS.10; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Stiner Mary C., 2014, Biology Theory, V9, P51, DOI 10.1007/s13752-013-0157-4; Stiner MC, 2013, J HUM EVOL, V64, P380, DOI 10.1016/j.jhevol.2013.01.008; Taborin Y., 2004, PARURE TEMPS PREHIST; Taborin Y., 1993, GALLIA PREHISTOI S29; Tartar E., 2009, ETUDE TROIS SITES AB; Tartar E, 2013, J ARCHAEOL SCI, V40, P2723, DOI 10.1016/j.jas.2013.02.009; Tejero J-M, 2013, INT SERIES, V2469; Tejero JM, 2021, J HUM EVOL, V160, DOI 10.1016/j.jhevol.2020.102870; Tejero JM, 2018, P NATL ACAD SCI USA, V115, P5145, DOI 10.1073/pnas.1717145115; Tejero JM, 2016, VERTEBR PALEOBIOL PA, P55, DOI 10.1007/978-94-024-0899-7_5; Tejero JM, 2016, QUATERN INT, V403, P90, DOI 10.1016/j.quaint.2015.11.028; Tejero JM, 2015, J ARCHAEOL SCI, V61, P59, DOI 10.1016/j.jas.2015.05.003; Tejero JM, 2014, J ANTHROPOL ARCHAEOL, V36, P72, DOI 10.1016/j.jaa.2014.08.004; Tejero JM, 2012, J ARCHAEOL SCI, V39, P332, DOI 10.1016/j.jas.2011.09.018; Tornero C, 2016, J HUM EVOL, V97, P27, DOI 10.1016/j.jhevol.2016.05.001; Tushabramishvili N, 2012, J HUM EVOL, V62, P179, DOI 10.1016/j.jhevol.2011.11.001; Tyzzer EE, 1936, AM ANTIQUITY, V1, P261, DOI 10.2307/275242; Vanhaeren M., 2002, FONCTIONS PARURE PAL; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Vercoutere C., 2004, UTILISATION ANIMAL C; Vereshchagin NK, 1967, MAMMALS CAUCASUS HIS; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; WHITE R, 1992, CURR ANTHROPOL, V33, P85, DOI 10.1086/204020; White R., 1983, LASCAUX COMPLEX RECO, P277; White R., 2007, RETHINKING HUMAN REV, P287; White R., 2001, ATHENA REV, V2, P41, DOI DOI 10.1016/J.JHEVOL.2008.08.017; White R., 2007, AURIGNACIEN GROTTE R, P257; Wolf S., 2005, AURIGNACIAN GENIUS A, P330; Yeshurun R, 2014, ARCHAEOL ETHNOL ANTH, V42, P2, DOI 10.1016/j.aeae.2015.04.002; Yeshurun R., 2018, ORIGINS BONE TOOL TE, P287; Zilhao J., 2006, TRABALHOS ARQUEOLOGI, P53; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	148	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258974	10.1371/journal.pone.0258974	http://dx.doi.org/10.1371/journal.pone.0258974			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748581	Green Published, gold			2022-12-26	WOS:000755468000017
J	Chen, YL; Lin, WC; Liao, YH; Chen, Y; Kang, PY				Chen, Yi-Lang; Lin, Wei-Cheng; Liao, Ying-Hua; Chen, Yi; Kang, Pei-Yu			Changing the pattern of the back-muscle flexion-relaxation phenomenon through flexibility training in relatively inflexible young men	PLOS ONE			English	Article							INDIVIDUAL FLEXIBILITY; HAMSTRING FLEXIBILITY; LUMBAR; POSTURE; MOTION; RANGE; ANGLE; EXTENSION; MOVEMENT; PROGRAM	Although several studies have investigated the back-muscle flexion-relaxation phenomenon (FRP), the effect of individual flexibility on the FRP has been discussed infrequently, with very limited data on the influence of flexibility training on the FRP. This study thus examined the effect of flexibility training on the change of back-muscle FRP pattern in relatively inflexible young men. We collected and analyzed the valid data from 20 male participants (10 each with high and low flexibility included in the control and trained groups, respectively) when flexing their trunks at seven trunk flexion positions (0 degrees-90 degrees, in increments of 15 degrees); their erector spinae and hamstring activation, pelvic tilt, and lumbosacral angle were then recorded. After 7 weeks of flexibility training for the low-flexibility group, no difference in flexibility was discovered between this group and the control (originally high-flexibility) group. The trunk flexion experiment was then repeated. The results showed that before the training stage, the low-flexibility group had lower erector spinae and higher hamstring activation, a larger pelvic tilt, and a smaller lumbosacral angle. By contrast, after training, the erector spinae and hamstring activation, pelvic tilt, and lumbosacral angle were significantly changed, and no intergroup differences were observed in FRP patterns. The study results suggest that flexibility training changes lumbopelvic movement and thereby reduces the degree of the back-muscle FRP when trunk flexion is performed.	[Chen, Yi-Lang; Lin, Wei-Cheng; Liao, Ying-Hua; Kang, Pei-Yu] Ming Chi Univ Technol, Dept Ind Engn & Management, New Taipei, Taiwan; [Chen, Yi] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan	Ming Chi University of Technology; National Taiwan University	Chen, YL (corresponding author), Ming Chi Univ Technol, Dept Ind Engn & Management, New Taipei, Taiwan.	ylchen@mail.mcut.edu.tw	Chen, Yi-Lang/AAJ-8758-2020	Chen, Yi-Lang/0000-0002-1292-0758				Alessa F, 2018, HUM MOVEMENT SCI, V57, P59, DOI 10.1016/j.humov.2017.11.006; Ayala F, 2012, PHYS THER SPORT, V13, P219, DOI 10.1016/j.ptsp.2011.11.001; BARILGINGRAS G, 1995, ERGONOMICS, V38, P905, DOI 10.1080/00140139508925159; Battaglia G, 2014, CLIN INTERV AGING, V9, P653, DOI 10.2147/CIA.S59548; Chen YL, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10175967; Chen YL, 2020, INT J IND ERGONOM, V76, DOI 10.1016/j.ergon.2020.102938; Chen YL, 2018, INT J IND ERGONOM, V68, P82, DOI 10.1016/j.ergon.2018.06.009; Chen YL, 1997, CLIN BIOMECH, V12, P185, DOI 10.1016/S0268-0033(97)00076-4; Chen YL., 2019, INT J IND ERGON, V74, P1; Decoster LC, 2004, J ATHL TRAINING, V39, P330; Eungpinichpong W, 2013, APPL ERGON, V44, P1024, DOI 10.1016/j.apergo.2013.04.002; FLOYD WF, 1951, LANCET, V260, P133, DOI 10.1016/S0140-6736(51)91212-3; GAJDOSIK RL, 1994, J ORTHOP SPORT PHYS, V20, P213, DOI 10.2519/jospt.1994.20.4.213; Gupta A, 2001, J BIOMECH, V34, P491, DOI 10.1016/S0021-9290(00)00213-X; Hashemirad F, 2009, J ELECTROMYOGR KINES, V19, P746, DOI 10.1016/j.jelekin.2008.02.004; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Holmstrom E, 2005, APPL ERGON, V36, P513, DOI 10.1016/j.apergo.2004.10.015; Jin S, 2015, INT J IND ERGONOM, V46, P7, DOI 10.1016/j.ergon.2015.01.008; Keller TS, 2002, J SPINAL DISORD TECH, V15, P312, DOI 10.1097/00024720-200208000-00009; Kuukkanen T, 2000, Physiother Res Int, V5, P46, DOI 10.1002/pri.183; Lopez-Minarro PA, 2010, SCI SPORT, V25, P188, DOI 10.1016/j.scispo.2009.10.004; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P3, DOI DOI 10.1201/9781420036985.AX2; Moore T M, 1998, AAOHN J, V46, P563; Muyor JM, 2012, J BACK MUSCULOSKELET, V25, P161, DOI 10.3233/BMR-2012-0323; Ning XP, 2012, CLIN BIOMECH, V27, P422, DOI 10.1016/j.clinbiomech.2011.11.003; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Pincivero DM, 2003, MED SCI SPORT EXER, V35, P1720, DOI 10.1249/01.MSS.0000089246.90005.47; Reid DA, 2004, MED SCI SPORT EXER, V36, P1944, DOI 10.1249/01.MSS.0000145462.36207.20; Sanchez-Zuriaga D, 2016, J ELECTROMYOGR KINES, V28, P152, DOI 10.1016/j.jelekin.2016.04.007; Shin G, 2004, J ELECTROMYOGR KINES, V14, P485, DOI 10.1016/j.jelekin.2003.12.001; Shin G, 2009, SPINE, V34, P1873, DOI 10.1097/BRS.0b013e3181aa6a55; Sihvonen T, 1997, ARCH PHYS MED REHAB, V78, P486, DOI 10.1016/S0003-9993(97)90161-1; Solomonow M, 2003, CLIN BIOMECH, V18, P273, DOI 10.1016/S0268-0033(03)00024-X; Stegeman D., 2007, ENSCHEDE ROESSINGH R, P108; Ulrey BL, 2012, WORK, V41, P2381, DOI 10.3233/WOR-2012-0469-2381; Vera-Garcia FJ, 2010, J ELECTROMYOGR KINES, V20, P10, DOI 10.1016/j.jelekin.2009.03.010; Yoo IG, 2012, J PHYS THER SCI, V24, P659, DOI 10.1589/jpts.24.659	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259619	10.1371/journal.pone.0259619	http://dx.doi.org/10.1371/journal.pone.0259619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739500	Green Published, gold			2022-12-26	WOS:000755000800043
J	Veals, AM; Koprowski, JL; Bergman, DL; VerCauteren, KC; Wester, DB				Veals, Amanda M.; Koprowski, John L.; Bergman, David L.; VerCauteren, Kurt C.; Wester, David B.			Occurrence of mesocarnivores in montane sky islands: How spatial and temporal overlap informs rabies management in a regional hotspot	PLOS ONE			English	Article							GRAY FOXES; INTERSPECIFIC COMPETITION; INTRAGUILD PREDATION; SYMPATRIC CARNIVORES; UNITED-STATES; FOOD-HABITS; SPACE USE; COYOTES; BOBCATS; SURVEILLANCE	Interspecific interactions among mesocarnivores can influence community dynamics and resource partitioning. Insights into these interactions can enhance understanding of local ecological processes that have impacts on pathogen transmission, such as the rabies lyssavirus. Host species ecology can provide an important baseline for disease management strategies especially in biologically diverse ecosystems and heterogeneous landscapes. We used a mesocarnivore guild native to the southwestern United States, a regional rabies hotspot, that are prone to rabies outbreaks as our study system. Gray foxes (Urocyon cinereoargenteus), striped skunks (Mephitis mephitis), bobcats (Lynx rufus), and coyotes (Canis latrans) share large portions of their geographic ranges and can compete for resources, occupy similar niches, and influence population dynamics of each other. We deployed 80 cameras across two mountain ranges in Arizona, stratified by vegetation type. We used two-stage modeling to gain insight into species occurrence and co-occurrence patterns. There was strong evidence for the effects of elevation, season, and temperature impacting detection probability of all four species, with understory height and canopy cover also influencing gray foxes and skunks. For all four mesocarnivores, a second stage multi-species co-occurrence model better explained patterns of detection than the single-species occurrence model. These four species are influencing the space use of each other and are likely competing for resources seasonally. We did not observe spatial partitioning between these competitors, likely due to an abundance of cover and food resources in the biologically diverse system we studied. From our results we can draw inferences on community dynamics to inform rabies management in a regional hotspot. Understanding environmental factors in disease hotspots can provide useful information to develop more reliable early-warning systems for viral outbreaks. We recommend that disease management focus on delivering oral vaccine baits onto the landscape when natural food resources are less abundant, specifically during the two drier seasons in Arizona (pre-monsoon spring and autumn) to maximize intake by all mesocarnivores.	[Veals, Amanda M.; Koprowski, John L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Bergman, David L.] Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Phoenix, AZ USA; [VerCauteren, Kurt C.] Anim & Plant Hlth Inspect Serv, USDA, Natl Wildlife Res Ctr, Wildlife Serv, Ft Collins, CO USA; [Wester, David B.] Texas A&M Univ, Kingsville, TX USA; [Koprowski, John L.] Univ Wyoming, Haub Sch Environm & Nat Resources, Laramie, WY USA	University of Arizona; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University Kingsville; University of Wyoming	Veals, AM (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	amveals@gmail.com	; Bergman, David/C-6874-2015	Veals Dutt, Amanda/0000-0001-5129-3462; Bergman, David/0000-0002-6757-643X				Alexander KA, 2012, VECTOR-BORNE ZOONOT, V12, P1005, DOI 10.1089/vbz.2012.0987; Allen LJS, 2009, J THEOR BIOL, V260, P510, DOI 10.1016/j.jtbi.2009.07.009; ANDELT WF, 1985, WILDLIFE MONOGR, P1; Arechiga-Ceballos N, 2019, GAC MED MEX, V155, P228, DOI 10.24875/GMM.M19000266; Arizona Department of Health Services, 2018, 2018 RAB AR; Basset A, 2007, OIKOS, V116, P1363, DOI 10.1111/j.2007.0030-1299.15702.x; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; BEKOFF M, 1977, Mammalian Species, V79, P1; Benton MB, MERGING SCI MANAGEME; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Birhane MG, 2017, JAVMA-J AM VET MED A, V250, P1117, DOI 10.2460/javma.250.10.1117; Caley P, 2004, J APPL ECOL, V41, P94, DOI 10.1111/j.1365-2664.2004.00867.x; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Chamberlain MJ, 2005, AM MIDL NAT, V153, P171, DOI 10.1674/0003-0031(2005)153[0171:OISUAB]2.0.CO;2; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Coronel-Arellano H, 2018, J MAMMAL, V99, P465, DOI 10.1093/jmammal/gyx151; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Davis CL, 2018, ECOL LETT, V21, P1401, DOI 10.1111/ele.13124; Deyoung RW, 2009, J WILDLIFE MANAGE, V73, P1292, DOI 10.2193/2008-336; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Egan ME, 2021, CAN J ZOOL, V99, P63, DOI 10.1139/cjz-2019-0246; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Feldhamer G., 2003, WILD MAMMALS N AM, V2; FRITZELL E K, 1982, Mammalian Species, P1, DOI 10.2307/3503957; Garton E. O., 2012, WILDLIFE TECHNIQUES, V1, P1; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Haley BS, 2019, ENVIRON SCI POLLUT R, V26, P9816, DOI 10.1007/s11356-019-04200-7; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hoffmeister D. F., 1986, MAMMALS ARIZONA; Holmala K, 2009, THESIS ARIZONA STATE; Jones AK., 2016, THESIS U NEW MEXICO; Kanda LL, 2009, ECOLOGY, V90, P1574, DOI 10.1890/08-1263.1; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; Larson RN, 2015, WEST N AM NATURALIST, V75, P339, DOI 10.3398/064.075.0311; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Lombardi JV, 2020, ECOL EVOL, V10, P4903, DOI 10.1002/ece3.6242; Lombardi JV, 2017, URBAN ECOSYST, V20, P1239, DOI 10.1007/s11252-017-0676-z; Ma XY, 2018, JAVMA-J AM VET MED A, V252, P945, DOI 10.2460/javma.252.8.945; Macdonald DW, 2004, J ZOOL, V263, P385, DOI 10.1017/S0952836904005400; McColgin ME, 2018, J MAMMAL, V99, P64, DOI 10.1093/jmammal/gyx153; Melville HIAS, 2015, SOUTHEAST NAT, V14, P447, DOI 10.1656/058.014.0306; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Natural Resources Conservation Service, 2017, NAT WAT CLIM CTR DAT; Neale JCC, 2001, CAN J ZOOL, V79, P1794, DOI 10.1139/cjz-79-10-1794; Neale JCC, 2001, OIKOS, V94, P236, DOI 10.1034/j.1600-0706.2001.940204.x; NELSON K., 2010, NATL RABIES MANAGEME; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; PAINE RT, 1990, AUK, V107, P1; Periquet S, 2015, BIOL REV, V90, P1197, DOI 10.1111/brv.12152; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Robinson QH, 2014, ECOLOGY, V95, P3112; ROSATTE RC, 1992, J WILDLIFE DIS, V28, P562, DOI 10.7589/0090-3558-28.4.562; ROSENZWEIG ML, 1966, J MAMMAL, V47, P602, DOI 10.2307/1377891; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Sanderson H.R., 2009, LAST REFUGE MT GRAHA; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smyser TJ, 2010, J WILDLIFE MANAGE, V74, P1405, DOI 10.2193/2009-299; Soto C, 2015, OECOLOGIA, V179, P223, DOI 10.1007/s00442-015-3311-9; Strickler GS, 1959, USE DENSIOMETER ESTI; Ten Eyck P, 2018, SANKHYA SER B, V80, P98, DOI 10.1007/s13571-017-0130-5; Theimer TC, 2017, J WILDLIFE DIS, V53, P382, DOI 10.7589/2016-09-203; Thompson K, 2016, THESIS U ARIZONA; Thornton DH, 2004, J MAMMAL, V85, P973, DOI 10.1644/BEH-020; U.S. Forest Service, 2016, COR NAT FOR GIS DAT; U.S. Forest Service, 2016, AP SITGR NAT FOR GIS; USDA-APHIS Wildlife Services, 2015, NAT RAB MAN PROGR OV; Vahle JR., 1978, THESIS ARIZONA STATE; Van Devender TR, 2013, BIODIVERSITY MADREAN; van Valkenburgh B., 1989, P410; Velasco-Villa A, 2017, ANTIVIR RES, V146, P221, DOI 10.1016/j.antiviral.2017.03.013; WADE-SMITH J, 1982, Mammalian Species, P1, DOI 10.2307/3503883; Wang XL, 2022, ENGINEERING-PRC, V8, P108, DOI 10.1016/j.eng.2020.12.019; Wang YW, 2015, BIOL CONSERV, V190, P23, DOI 10.1016/j.biocon.2015.05.007; Warshall P, 1995, MADREAN SKY ISLAND A; Western Regional Climate Center, 2017, COL AR WEATH DAT	78	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259260	10.1371/journal.pone.0259260	http://dx.doi.org/10.1371/journal.pone.0259260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739496	Green Published, gold			2022-12-26	WOS:000755000800022
J	Sultana, MA; Cluning, C; Kwong, WS; Polain, N; Pavlos, NJ; Ratajczak, T; Walsh, JP; Xu, JK; Rea, SL				Sultana, Melanie A.; Cluning, Carmel; Kwong, Wai-Sin; Polain, Nicole; Pavlos, Nathan J.; Ratajczak, Thomas; Walsh, John P.; Xu, Jiake; Rea, Sarah L.			The SQSTM1/p62 UBA domain regulates Ajuba localisation, degradation and NF-kappa B signalling function	PLOS ONE			English	Article							LIM PROTEIN AJUBA; PAGETS-DISEASE; ACTIVATION; MUTATION; PATHWAY; P62; PATHOGENESIS; BONE	The LIM-domain containing protein Ajuba and the scaffold protein SQSTM1/p62 regulate signalling of NF-kappa B, a transcription factor involved in osteoclast differentiation and survival. The ubiquitin-associated domain of SQSTM1/p62 is frequently mutated in patients with Paget's disease of bone. Here, we report that Ajuba activates NF-kappa B activity in HEK293 cells, and that co-expression with SQSTM1/p62 inhibits this activation in an UBA domain-dependent manner. SQSTM1/p62 regulates proteins by targeting them to the ubiquitin-proteasome system or the autophagy-lysosome pathway. We show that Ajuba is degraded by autophagy, however co-expression with SQSTM1/p62 (wild type or UBA-deficient) protects Ajuba levels both in cells undergoing autophagy and those exposed to proteasomal stress. Additionally, in unstressed cells co-expression of SQSTM1/p62 reduces the amount of Ajuba present in the nucleus. SQSTM1/p62 with an intact ubiquitin-associated domain forms holding complexes with Ajuba that are not destined for degradation yet inhibit signalling. Thus, in situations with altered levels and localization of SQSTM1/p62 expression, such as osteoclasts in Paget's disease of bone and various cancers, SQSTM1/p62 may compartmentalize Ajuba and thereby impact its cellular functions and disease pathogenesis. In Paget's, ubiquitin-associated domain mutations may lead to increased or prolonged Ajuba-induced NF-kappa B signalling leading to increased osteoclastogenesis. In cancer, Ajuba expression promotes cell survival. The increased levels of SQSTM1/p62 observed in cancer may enhance Ajuba-mediated cancer cell survival.	[Sultana, Melanie A.; Ratajczak, Thomas; Rea, Sarah L.] Univ Western Australia, Harry Perkins Inst Med Res, Neurogenet Lab, Nedlands, WA, Australia; [Sultana, Melanie A.; Cluning, Carmel; Kwong, Wai-Sin; Ratajczak, Thomas; Walsh, John P.; Rea, Sarah L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Polain, Nicole; Rea, Sarah L.] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia; [Pavlos, Nathan J.] Univ Western Australia, Sch Biomed Sci, Crawley, WA, Australia; [Walsh, John P.] Univ Western Australia, Sch Med, Crawley, WA, Australia; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA, Australia; [Rea, Sarah L.] Univ Western Australia, Perron Inst Neurol & Translat Sci, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia	Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; Murdoch University; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Rea, SL (corresponding author), Univ Western Australia, Harry Perkins Inst Med Res, Neurogenet Lab, Nedlands, WA, Australia.; Rea, SL (corresponding author), Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia.; Rea, SL (corresponding author), Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia.; Rea, SL (corresponding author), Univ Western Australia, Perron Inst Neurol & Translat Sci, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia.	sarah.rea@murdoch.edu.au	Walsh, John/GQI-2785-2022; Rea, Sarah/GYJ-4753-2022	Walsh, John/0000-0002-1766-2612; Rea, Sarah Lyn/0000-0002-2181-9491; Xu, Jiake/0000-0003-2021-8309; Pavlos, Nathan/0000-0001-7003-188X				Bi LH, 2018, GENE, V644, P148, DOI 10.1016/j.gene.2017.11.017; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Feng YF, 2005, MOL CELL BIOL, V25, P4010, DOI 10.1128/MCB.25.10.4010-4022.2005; Feng YF, 2007, J BIOL CHEM, V282, P39, DOI 10.1074/jbc.M607399200; Galson Deborah L, 2014, J Bone Metab, V21, P85, DOI 10.11005/jbm.2014.21.2.85; Garcia-Cattaneo A, 2013, CELL ADHES MIGR, V7, P283, DOI 10.4161/cam.24646; Haraguchi K, 2008, ONCOGENE, V27, P274, DOI 10.1038/sj.onc.1210644; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kisseleva M, 2005, MOL CELL BIOL, V25, P3956, DOI 10.1128/MCB.25.10.3956-3966.2005; Marie H, 2003, J BIOL CHEM, V278, P1220, DOI 10.1074/jbc.M205391200; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Najat D, 2009, J BONE MINER RES, V24, P632, DOI 10.1359/JBMR.081204; Pratt SJ, 2005, J CELL BIOL, V168, P813, DOI 10.1083/jcb.200406083; Ralston SH, 2014, CURR OSTEOPOROS REP, V12, P263, DOI 10.1007/s11914-014-0219-y; Rea SL, 2006, J BONE MINER RES, V21, P1136, DOI 10.1359/JBMR.060405; Rea SL, 2013, ENDOCR REV, V34, P501, DOI 10.1210/er.2012-1034; Rea SL, 2009, J BONE MINER RES, V24, P1216, DOI [10.1359/jbmr.090214, 10.1359/JBMR.090214]; Sanchez-Martin P, 2019, FEBS J, V286, P8, DOI 10.1111/febs.14712; Wright T, 2013, BONE, V52, P699, DOI 10.1016/j.bone.2012.10.023; Yang WL, 2018, J CELL PHYSIOL, V233, P4606, DOI 10.1002/jcp.26372; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	25	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259556	10.1371/journal.pone.0259556	http://dx.doi.org/10.1371/journal.pone.0259556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735553	Green Published, gold			2022-12-26	WOS:000755077100092
J	Tesema, GA; Tessema, ZT; Angaw, DA; Tamirat, KS; Teshale, AB				Tesema, Getayeneh Antehunegn; Tessema, Zemenu Tadesse; Angaw, Dessie Abebaw; Tamirat, Koku Sisay; Teshale, Achamyeleh Birhanu			Geographic weighted regression analysis of hot spots of anemia and its associated factors among children aged 6-59 months in Ethiopia: A geographic weighted regression analysis and multilevel robust Poisson regression analysis	PLOS ONE			English	Article							NUTRITIONAL-STATUS; IRON-DEFICIENCY; YOUNG-CHILDREN; LOW-INCOME; PREVALENCE; EPIDEMIOLOGY; BIRTH	Introduction Anemia among children aged 6-59 months remains a major public health problem in low-and high-income countries including Ethiopia. Anemia is associated with significant consequences on the health of children such as under-five morbidity and mortality, increased risk of infection, and poor academic performance. The prevalence of anemia in Ethiopia has varied across areas. Therefore, this study aimed to investigate the geographic weighted regression analysis of anemia and its associated factors among children aged 6-59 months in Ethiopia. Methods This study was based on the 2016 Ethiopian Demographic and Health Survey (EDHS) data. A total weighted sample of 8482 children aged 6-59 months was included. For the spatial analysis, Arc-GIS version 10.7 and SaTScan version 9.6 statistical software were used. Spatial regression was done to identify factors associated with the hotspots of anemia and model comparison was based on adjusted R-2 and Corrected Akaike Information Criteria (AICc). For the associated factors, the multilevel robust Poisson regression was fitted since the prevalence of anemia was greater than 10%. Variables with a p-value < 0.2 in the bi-variable analysis were considered for the multivariable analysis. In the multivariable multilevel robust Poisson regression analysis, the adjusted prevalence ratio with the 95% confidence interval was reported to declare the statistical significance and strength of association. Results The prevalence of anemia among children aged 6-59 months was 57.56% (95%CI: 56.50%, 58.61%) with significant spatial variation across regions in Ethiopia. The significant hot spot areas of anemia among children aged 6-59 months were detected in the central, west, and east Afar, Somali, Dire Dawa, Harari, and northwest Gambella regions. Mothers who had anemia, a child aged 23-59 months, mothers aged 15-19 years, and coming from a household with a poorer or poorest household were significant predictors of the spatial variations of anemia among children aged 6-59 months. In the multilevel robust Poisson analysis, born to mothers aged 30-39 (APR = 0.84, 95% CI: 0.76, 0.92) and 40-49 years (APR = 0.73, 95% CI: 0.65, 0.83), mothers who didn't have formal education (APR = 1.10, 95% CI: 1.00, 1.20), Children in the poorest household wealth index (APR = 1.17, 95% CI: 1.06, 1.29), being 4-6 (APR = 1.08, 95% CI: 1.02, 1.13) and above 6 order of birth (APR = 1.15, 95% CI: 1.07, 1.23), children born to anemic mothers (APR = 1.24, 95% CI: 1.19, 1.29), children aged 24-59 months (APR = 0.70, 95% CI: 0.68, 0.73), stunted children (APR = 1.09, 95% CI: 1.04, 1.13) and underweight children (APR = 1.07, 95% CI: 1.03, 1.13) were significantly associated with anemia among children aged 6-59 months. Conclusion and recommendation Anemia is still a public health problem for children in Ethiopia. Residing in a geographic area where a high proportion of children born to mothers aged 15-19 years, a child aged 6-23 months, coming from a household with poorer or poorest wealth index, and mothers with anemia increased the risk of experiencing anemia among children aged 6-59 months. Maternal education, maternal age, child age, household wealth, stunting, underweight, birth order, and maternal anemia were significant predictors of anemia among children. The detailed map of anemia hot spots among children aged 6-59 months and its predictors could assist program planners and decision-makers to design targeted public health interventions.	[Tesema, Getayeneh Antehunegn; Tessema, Zemenu Tadesse; Angaw, Dessie Abebaw; Tamirat, Koku Sisay; Teshale, Achamyeleh Birhanu] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar	Tesema, GA (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia.	getayenehantehunegn@gmail.com	Teshale, Achamyeleh/HHN-8416-2022					Abeshu M., 2016, J NUTR SCI, V6, P2; Alebel A, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0173-x; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; Anteneh ZA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249412; Asif AM, 2020, PUBLIC HEALTH, V183, P94, DOI 10.1016/j.puhe.2020.03.029; Asresie M.B., 2020, DETERMINANTS ANEMIA, V2020; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Buitron D, 2004, REV PANAM SALUD PUBL, V15, P151, DOI 10.1590/S1020-49892004000300003; Chang SC, 2003, J PEDIATR-US, V143, P250, DOI 10.1067/S0022-3476(03)00363-9; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Chen YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068336; Choi HJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-870; de Mendonca EB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245458; Degefa N, 2019, INT J PEDIAT, V2019, DOI 10.1155/2019/3293516; Ejigu BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197171; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Fabunmi TM, 2013, INT J CHILD HEALTH N, V2, P39, DOI 10.6000/1929-4247.2013.02.01.7; Foody GM, 2003, REMOTE SENS ENVIRON, V88, P283, DOI 10.1016/j.rse.2003.08.004; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Gebreegziabiher G, 2014, ANEMIA, V2014, DOI 10.1155/2014/245870; Gebreweld A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218961; Gebrie A, 2020, AFR HEALTH SCI, V20, P2007, DOI 10.4314/ahs.v20i4.59; Getahun Z., 2001, Ethiopian Journal of Health Development, V15, P55; Goto Y, 2017, PARASITOL RES, V116, P457, DOI 10.1007/s00436-016-5313-x; Green R., 1999, SEMIN HEMATOL, pc1964; Greenwood BM, 1997, ANN TROP MED PARASIT, V91, P763, DOI 10.1080/00034989760518; Habte Dereje, 2013, Afr J Reprod Health, V17, P110; Hailegebreal S, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045544; Irwin JJ, 2001, AM FAM PHYSICIAN, V64, P1379; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Kawo KN, 2018, ANEMIA, V2018, DOI 10.1155/2018/3087354; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Laillou A, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13132; Li HX, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09129-y; Lutter CK, 2008, J NUTR, V138, P2523, DOI 10.3945/jn.108.095406; Mathur NB, 2014, INDIAN J PEDIATR, V81, P143, DOI 10.1007/s12098-013-1153-1; Menon MP, 2015, AM J TROP MED HYG, V93, P521, DOI 10.4269/ajtmh.15-0102; Milman N, 2011, ANN HEMATOL, V90, P369, DOI 10.1007/s00277-010-1144-5; Cartes RM, 2012, ENDOCR DEV, V22, P302, DOI 10.1159/000326706; Molla T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4045-2; Nazeer M, 2018, J OCEAN U CHINA, V17, P305, DOI 10.1007/s11802-018-3380-6; Nyarango RM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-237; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1353/geo.2003.0008; Obasohan PE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238829; Parbey PA, 2019, ANEMIA, V2019, DOI 10.1155/2019/2139717; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Rahman MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219170; Ren A, 2007, INT J GYNECOL OBSTET, V98, P124, DOI 10.1016/j.ijgo.2007.05.011; ROCHE M, 1966, AM J TROP MED HYG, V15, P1032, DOI 10.4269/ajtmh.1966.15.1032; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Sendeku FW, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2835-0; Shenton LM, 2020, MATERN CHILD HLTH J, V24, P483, DOI 10.1007/s10995-019-02865-7; Shrestha PM, 2006, THESIS U CALGARY CAN; Sinha N, 2008, Indian J Med Sci, V62, P45; Smits HL, 2009, EXPERT REV ANTI-INFE, V7, P37, DOI 10.1586/14787210.7.1.37; SPIVAK JL, 1994, SEMIN ONCOL, V21, P3; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; STEINBERG MH, 1983, AM J PATHOL, V113, P396; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; Takele K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7273-4; Tamiru D, 2017, ETHIOP J HEALTH SCI, V27, P245, DOI 10.4314/ejhs.v27i3.6; Tezera R, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0741-6; Tsai PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-464; Visser J, 2013, S AFR J CLIN NUTR, V26, P166; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; Wang FL, 2017, SCI REP-UK, V7, DOI 10.1038/srep44726; Wilson M.E., 2010, INFECT DIS, P1055; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632	74	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259147	10.1371/journal.pone.0259147	http://dx.doi.org/10.1371/journal.pone.0259147			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735486	gold, Green Published			2022-12-26	WOS:000755077100048
J	Gong, J; Chung, TH; Zheng, J; Zheng, HY; Chang, LJ				Gong, Jie; Chung, Tsai-Hua; Zheng, Jie; Zheng, Huyong; Chang, Lung-Ji			Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; ENDOTHELIAL-CELLS; TRANSPLANTATION; EXPRESSION; PHENOTYPE; CORRECTS; PLASMA; MECHANISMS; SECRETION; VECTORS	Hemophilia A (HA) is a bleeding disorder caused by deficiency of the coagulation factor VIII (F8). F8 replacement is standard of care, whereas gene therapy (F8 gene) for HA is an attractive investigational approach. However, the large size of the F8 gene and the immunogenicity of the product present challenges in development of the F8 gene therapy. To resolve these problems, we synthesized a shortened F8 gene (F8-BDD) and cloned it into a lentiviral vector (LV). The F8-BDD produced mainly short cleaved inactive products in LV-transduced cells. To improve F8 functionality, we designed two novel F8-BDD genes, one with an insertion of eight specific N-glycosylation sites (F8-N8) and another which restored all N-glycosylation sites (F8-299) in the B domain. Although the overall protein expression was reduced, high coagulation activity (>100-fold) was detected in the supernatants of LV-F8-N8- and LV-F8-299-transduced cells. Protein analysis of F8 and the procoagulation cofactor, von Willebrand Factor, showed enhanced interaction after restoration of B domain glycosylation using F8-299. HA mouse hematopoietic stem cell transplantation studies illustrated that the bleeding phenotype was corrected after LV-F8-N8 or -299 gene transfer into the hematopoietic stem cells. Importantly, the F8-299 modification markedly reduced immunogenicity of the F8 protein in these HA mice. In conclusion, the modified F8-299 gene could be efficiently packaged into LV and, although with reduced expression, produced highly stable and functional F8 protein that corrected the bleeding phenotype without inhibitory immunogenicity. We anticipate that these results will be beneficial in the development of gene therapies against HA.	[Gong, Jie; Chung, Tsai-Hua; Chang, Lung-Ji] Univ Elect Sci & Technol China, Sch Med, Chengdu, Sichuan, Peoples R China; [Chung, Tsai-Hua; Chang, Lung-Ji] Shenzhen GenoImmune Med Inst, Shenzhen, Peoples R China; [Zheng, Jie; Zheng, Huyong; Chang, Lung-Ji] Capital Med Univ, Beijing Childrens Hosp, Hematol Ctr, Beijing, Peoples R China	University of Electronic Science & Technology of China; Capital Medical University	Chang, LJ (corresponding author), Univ Elect Sci & Technol China, Sch Med, Chengdu, Sichuan, Peoples R China.; Chang, LJ (corresponding author), Shenzhen GenoImmune Med Inst, Shenzhen, Peoples R China.; Chang, LJ (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Hematol Ctr, Beijing, Peoples R China.	c@szgimi.org		Chang, Lung-Ji/0000-0003-2395-5216	Foundation for Introduction and Training of Outstanding Scholarship of the Na-tional "985" Project, China [A1098531023601102]; Funda-mental Research Funds for the Central Universities, China [ZYGX2016Z009]	Foundation for Introduction and Training of Outstanding Scholarship of the Na-tional "985" Project, China; Funda-mental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	-We thank Haokun Yuan and Haolin Wang for caring for the mice, Yue Qin for the LV packaging, Liu Xu for qPCR detection, Ying Shi for advice of experimental methods, and Dr Biljana Horn and Thomas Horn for reading and revising the article. This work was supported by grants from the Foundation for Introduction and Training of Outstanding Scholarship of the Na-tional "985" Project, China (A1098531023601102) and the Funda-mental Research Funds for the Central Universities, China (ZYGX2016Z009) .	Barrow RT, 2001, BLOOD, V97, P169, DOI 10.1182/blood.V97.1.169; Bastos JL, 2012, REV SAUDE PUBL, V46, P269, DOI 10.1590/S0034-89102012000200009; Cerullo V, 2007, MOL THER, V15, P2080, DOI 10.1038/sj.mt.6300308; Chang L.-J., 2001, Current Gene Therapy, V1, P237, DOI 10.2174/1566523013348634; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; Chang LJ, 2010, METHODS MOL BIOL, V614, P161, DOI 10.1007/978-1-60761-533-0_11; Chen Xiaochuan, 2004, Retrovirology, V1, P37, DOI 10.1186/1742-4690-1-37; Crawford B, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.33; Croteau SE, 2021, AM J HEMATOL, V96, P128, DOI 10.1002/ajh.26018; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; EATON DL, 1987, J BIOL CHEM, V262, P3285; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Follenzi A, 2008, J CLIN INVEST, V118, P935, DOI 10.1172/JCI32748; Follenzi A, 2012, BLOOD, V119, P5532, DOI 10.1182/blood-2011-07-367680; Gale AJ, 2008, J BIOL CHEM, V283, P16355, DOI 10.1074/jbc.M708985200; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Guo XL, 2019, CURR GENE THER, V19, P264, DOI 10.2174/1566523219666190924121836; Iwakuma T, 1999, VIROLOGY, V261, P120, DOI 10.1006/viro.1999.9850; Jiang HC, 2006, TRANSPL P, V38, P1483, DOI 10.1016/j.transproceed.2006.03.020; KAUFMAN RJ, 1988, J BIOL CHEM, V263, P6352; Kumar HPM, 1996, BIOTECHNOL APPL BIOC, V24, P207; Kumaran V, 2005, J THROMB HAEMOST, V3, P2022, DOI 10.1111/j.1538-7836.2005.01508.x; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; LIU LX, 1994, TRANSPLANT INT, V7, P201, DOI 10.1111/j.1432-2277.1994.tb01291.x; Liu Yang, 2012, World J Exp Med, V2, P30, DOI 10.5493/wjem.v2.i2.30; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; MCKEE PA, 1970, J LAB CLIN MED, V75, P391; Merlin S, 2019, BLOOD ADV, V3, P825, DOI 10.1182/bloodadvances.2018027979; Miao CH, 2016, THROMB J, V14, DOI 10.1186/s12959-016-0105-1; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Pan JL, 2016, BLOOD, V128, P104, DOI 10.1182/blood-2015-12-684688; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Pasi KJ, 2020, NEW ENGL J MED, V382, P29, DOI 10.1056/NEJMoa1908490; PITTMAN DD, 1993, BLOOD, V81, P2925; Plantier JL, 2010, J THROMB HAEMOST, V8, P286, DOI 10.1111/j.1538-7836.2009.03675.x; SAHUD MA, 1970, NEW ENGL J MED, V283, P48; Samelson-Jones BJ, 2019, MOL THER-METH CLIN D, V12, P184, DOI 10.1016/j.omtm.2018.12.007; Shahani T, 2014, J THROMB HAEMOST, V12, P36, DOI 10.1111/jth.12412; Shi QZ, 2014, BLOOD, V123, P395, DOI 10.1182/blood-2013-08-520478; Soucie JM, 1998, AM J HEMATOL, V59, P288, DOI 10.1002/(SICI)1096-8652(199812)59:4<288::AID-AJH4>3.0.CO;2-I; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; TOOLE JJ, 1986, P NATL ACAD SCI USA, V83, P5939, DOI 10.1073/pnas.83.16.5939; Verbruggen B, 2001, THROMB HAEMOSTASIS, V86, P1435; Wang XF, 2020, BLOOD ADV, V4, P5722, DOI 10.1182/bloodadvances.2020002479; Wang XF, 2015, MOL THER, V23, P617, DOI 10.1038/mt.2015.20; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Weber A, 2018, MOL THER-METH CLIN D, V10, P29, DOI 10.1016/j.omtm.2018.05.004; WEISS HJ, 1977, J CLIN INVEST, V60, P390, DOI 10.1172/JCI108788; Zanolini D, 2015, HAEMATOLOGICA, V100, P881, DOI 10.3324/haematol.2014.123117	53	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101397	10.1016/j.jbc.2021.101397	http://dx.doi.org/10.1016/j.jbc.2021.101397			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774524	Green Published, gold			2022-12-26	WOS:000748397200001
J	Ots, N				Ots, Nele			Cognitive constraints on advance planning of sentence intonation	PLOS ONE			English	Article							WORKING-MEMORY; LEXICAL ACCESS; LANGUAGE PRODUCTION; SPEECH PRODUCTION; SPOKEN-LANGUAGE; TIME; INFORMATION; PROSODY; DECLINATION; PERCEPTION	Pitch peaks tend to be higher at the beginning of longer than shorter sentences (e.g., 'A farmer is pulling donkeys' vs 'A farmer is pulling a donkey and goat'), whereas pitch valleys at the ends of sentences are rather constant for a given speaker. These data seem to imply that speakers avoid dropping their voice pitch too low by planning the height of sentence-initial pitch peaks prior to speaking. However, the length effect on sentence-initial pitch peaks appears to vary across different types of sentences, speakers and languages. Therefore, the notion that speakers plan sentence intonation in advance due to the limitations in low voice pitch leaves part of the data unexplained. Consequently, this study suggests a complementary cognitive account of length-dependent pitch scaling. In particular, it proposes that the sentence-initial pitch raise in long sentences is related to high demands on mental resources during the early stages of sentence planning. To tap into the cognitive underpinnings of planning sentence intonation, this study adopts the methodology of recording eye movements during a picture description task, as the eye movements are the established approximation of the real-time planning processes. Measures of voice pitch (Fundamental Frequency) and incrementality (eye movements) are used to examine the relationship between (verbal) working memory (WM), incrementality of sentence planning and the height of sentence-initial pitch peaks.	[Ots, Nele] Wolfgang Goethe Univ, Inst Linguist, Frankfurt, Hessen, Germany	Goethe University Frankfurt	Ots, N (corresponding author), Wolfgang Goethe Univ, Inst Linguist, Frankfurt, Hessen, Germany.	ots@em.uni-frankfurt.de		Ots, Nele/0000-0002-4660-434X	Fritz Thyssen Stiftung [10.18.2.040]	Fritz Thyssen Stiftung	Nele Ots - holding a grant "Planning sentences and sentence intonation crosslinguisticially" funded by Fritz Thyssen Stiftung (10.18.2.040SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." This statement is fully correct for my submission.	Asu E. L., 2016, P SPEECH PROSODY; Asu EL., 2004, FONETIKA DHE FONOLOG; Asu EvaLiina., 1999, P 14 INT C PHON SCI, pp. 1873; Asu EvaLiina., 2005, P 2 BALT C HUM LANG, P95; ATKINSON JE, 1978, J ACOUST SOC AM, V63, P211, DOI 10.1121/1.381716; Barthel M, 2019, COGNITIVE SCI, V43, DOI 10.1111/cogs.12768; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckman Mary E., 1986, PHONOLOGY YB, V3, P255, DOI [10.1017/S095267570000066X, DOI 10.1017/S095267570000066X]; Birch S, 1995, LANG SPEECH, V38, P365, DOI 10.1177/002383099503800403; Bock J.K., 1994, HDB PSYCHOLINGUISTIC, P945; Bock J. K., 2004, INTERFACE LANGUAGE V, P249; BOCK JK, 1983, MEM COGNITION, V11, P64, DOI 10.3758/BF03197663; Boersma P., 2020, PRAAT DOING PHONETIC; Breen M, 2010, LANG COGNITIVE PROC, V25, P1044, DOI 10.1080/01690965.2010.504378; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Campbell N, 1998, INTONATION THEORY MO, P67; Christodoulides G., 2016, THESIS U CATHOLIQUE; Cooper W. E., 2012, FUNDAMENTAL FREQUENC; COOPER WE, 1985, J ACOUST SOC AM, V77, P2142, DOI 10.1121/1.392372; CUTLER A, 1977, LANG SPEECH, V20, P1, DOI 10.1177/002383097702000101; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; Dahan D, 2002, J MEM LANG, V47, P292, DOI 10.1016/S0749-596X(02)00001-3; Dell GS, 1999, COGNITIVE SCI, V23, P517, DOI 10.1207/s15516709cog2304_6; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; Fery C, 2008, J PHONETICS, V36, P680, DOI 10.1016/j.wocn.2008.05.001; Fuchs S, 2013, J PHONETICS, V41, P29, DOI 10.1016/j.wocn.2012.08.007; Garrett M., 1980, LANGUAGE PRODUCTION, V1, P177; Garrett MF., 1975, PSYCHOL LEARN MOTIV, P133, DOI DOI 10.1016/S0079-7421(08)60270-4; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Griffin ZM, 2011, MENT LEX, V6, P53, DOI 10.1075/ml.6.1.03gri; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Griffin ZM, 2001, COGNITION, V82, pB1, DOI 10.1016/S0010-0277(01)00138-X; Hardy SM, 2020, J EXP PSYCHOL LEARN, V46, P720, DOI 10.1037/xlm0000754; Hart Jt., 1990, CAMBRIDGE STUDIES SP; Honda K, 1999, LANG SPEECH, V42, P401, DOI 10.1177/00238309990420040301; Honda K., 2004, SPEECH PROSODY; Huttunen K, 2011, APPL ERGON, V42, P348, DOI 10.1016/j.apergo.2010.08.005; Ishkhanyan B, 2019, J PSYCHOLINGUIST RES, V48, P61, DOI 10.1007/s10936-018-9589-0; Ivanova I, 2019, J EXP PSYCHOL LEARN, V45, P1791, DOI 10.1037/xlm0000672; Jarvinen K, 2015, FOLIA PHONIATR LOGO, V67, P1, DOI 10.1159/000381183; Kisler T, 2017, COMPUT SPEECH LANG, V45, P326, DOI 10.1016/j.csl.2017.01.005; Klaus J, 2017, Q J EXP PSYCHOL, V70, P811, DOI 10.1080/17470218.2016.1167926; Konopka AE, 2014, COGNITIVE PSYCHOL, V73, P1, DOI 10.1016/j.cogpsych.2014.04.001; Koppel Kristina, 2020, EESTI KEELE UHENDKOR, DOI [10.15155/3-00-0000-0000-0000-08565L, DOI 10.15155/3-00-0000-0000-0000-08565L]; Kuchinsky SE, 2011, J EXP PSYCHOL LEARN, V37, P748, DOI 10.1037/a0022637; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LADD DR, 1988, J ACOUST SOC AM, V84, P530, DOI 10.1121/1.396830; Lehiste Ilse., 1973, GLOSSA, V7, P107; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; LIVELY SE, 1993, J ACOUST SOC AM, V93, P2962, DOI 10.1121/1.405815; Maeda S, 1976, CHARACTERIZATION AM; Martin R.C., 2014, OXFORD HDB LANGUAGE, P437; Martin RC, 2014, ACTA PSYCHOL, V152, P120, DOI 10.1016/j.actpsy.2014.08.006; MEHTA G, 1988, LANG SPEECH, V31, P135, DOI 10.1177/002383098803100203; Mumu EmblyLeilani., 2017, DISSERTATION; Norcliffe E, 2015, LANG COGN NEUROSCI, V30, P1187, DOI 10.1080/23273798.2015.1006238; Oppermann F, 2010, J MEM LANG, V63, P526, DOI 10.1016/j.jml.2010.07.004; Peters J, 2020, P 10 C SPEECH PROSOD, P231; Petrone C, 2017, J PHONETICS, V61, P71, DOI 10.1016/j.wocn.2017.01.002; Pierrehumbert J., 1984, LANGUAGE SOUND STRUC, P155; POWER MJ, 1985, Q J EXP PSYCHOL-A, V37, P367, DOI 10.1080/14640748508400940; Prieto P., 2006, SPEECH PROSODY, P803; R Core Team, 2020, R LANG ENV STAT COMP; Sauppe S., 2013, P 35 ANN M COGNITIVE, P1265; Sauppe S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01648; Slevc LR, 2011, J EXP PSYCHOL LEARN, V37, P1503, DOI 10.1037/a0024350; STRIK H, 1992, J PHONETICS, V20, P15, DOI 10.1016/S0095-4470(19)30250-5; Swerts M, 2002, J PHONETICS, V30, P629, DOI 10.1006/jpho.2002.0178; THORSEN NG, 1980, J ACOUST SOC AM, V67, P1014, DOI 10.1121/1.384069; Toepel U, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-53; Tondering J., 2011, P ICPHS, P2010; van de Velde M, 2014, J MEM LANG, V71, P124, DOI 10.1016/j.jml.2013.11.001; van Mersbergen M, 2020, FOLIA PHONIATR LOGO; Wagner M, 2010, LANG COGNITIVE PROC, V25, P905, DOI 10.1080/01690961003589492; Wagner V, 2010, J EXP PSYCHOL LEARN, V36, P423, DOI 10.1037/a0018619; Watson DG, 2008, COGNITION, V106, P1548, DOI 10.1016/j.cognition.2007.06.009; Weber A, 2006, LANG SPEECH, V49, P367, DOI 10.1177/00238309060490030301; Westfall J, 2014, J EXP PSYCHOL GEN, V143, P2020, DOI 10.1037/xge0000014; Wheeldon L, 2013, Q J EXP PSYCHOL, V66, P1653, DOI 10.1080/17470218.2012.754913; Wheeldon LR, 2003, LANG COGNITIVE PROC, V18, P431, DOI 10.1080/01690960244000063; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yuan JH, 2014, SPEECH COMMUN, V65, P67, DOI 10.1016/j.specom.2014.06.001	86	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259343	10.1371/journal.pone.0259343	http://dx.doi.org/10.1371/journal.pone.0259343			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784351	Green Published, gold			2022-12-26	WOS:000755277300010
J	Deng, YH; Zhang, XX; Tao, CY; Liang, YJ; Yuan, J; Yang, SH; Yang, YR; Xiong, XY				Deng, Yuan-Hong; Zhang, Xin-Xiao; Tao, Chuan-Yuan; Liang, Yan-Jing; Yuan, Jing; Yang, Su-Hao; Yang, Yuan-Rui; Xiong, Xiao-Yi			Succinylation profiles of brain injury after intracerebral hemorrhage	PLOS ONE			English	Article							PROTEIN POSTTRANSLATIONAL MODIFICATIONS; LYSINE SUCCINYLATION; IDENTIFICATION; INVOLVEMENT; FERROPTOSIS; METABOLISM	Protein posttranslational modifications (PTMs) regulate the biological processes of human diseases by genetic code expansion and cellular pathophysiology regulation; however, system-wide changes in PTM levels in the intracerebral hemorrhage (ICH) brain remain poorly understood. Succinylation refers to a major PTM during the regulation of multiple biological processes. In this study, according to the methods of quantitative succinyllysine proteomics based on high-resolution mass spectrometry, we investigated ICH-associated brain protein succinyllysine modifications and obtained 3,680 succinylated sites and quantified around 3,530 sites. Among them, 25 succinyllysine sites on 23 proteins were upregulated (hypersuccinylated), whereas 13 succinyllysine sites on 12 proteins were downregulated (hyposuccinylated) following ICH. The cell component enrichment analysis of these succinylproteins with significant changes showed that 58.3% of the hyposuccinylated proteins were observed in the mitochondria, while the hyper-succinylproteins located in mitochondria decreased in the percentage to about 35% in ICH brains with a concomitant increase in the percentage of cytoplasm to 30.4%. Further bioinformatic analysis showed that the succinylproteins were mostly mitochondria and synapse-related subcellular located and involved in many pathophysiological processes, like metabolism, synapse working, and ferroptosis. Moreover, the integrative analysis of our succinylproteomics data and previously published transcriptome data showed that the mRNAs matched by most differentially succinylated proteins were especially highly expressed in neurons, endothelial cells, and astrocytes. Our study uncovers some succinylation-affected processes and pathways in response to ICH brains and gives us novel insights into understanding pathophysiological processes of brain injury caused by ICH.	[Deng, Yuan-Hong; Zhang, Xin-Xiao; Liang, Yan-Jing; Yuan, Jing; Yang, Su-Hao; Xiong, Xiao-Yi] Chengdu Univ Tradit Chinese Med, Acupuncture & Tuina Sch, Teaching Hosp 3, Chengdu, Peoples R China; [Deng, Yuan-Hong; Zhang, Xin-Xiao; Liang, Yan-Jing; Yuan, Jing; Yang, Su-Hao; Xiong, Xiao-Yi] Acupuncture & Chronobiol Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Tao, Chuan-Yuan] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Peoples R China; [Yang, Yuan-Rui] Gen Hosp Western Theater Command, Dept Geriatr, Chengdu, Sichuan, Peoples R China	Chengdu University of Traditional Chinese Medicine; Sichuan University	Xiong, XY (corresponding author), Chengdu Univ Tradit Chinese Med, Acupuncture & Tuina Sch, Teaching Hosp 3, Chengdu, Peoples R China.; Xiong, XY (corresponding author), Acupuncture & Chronobiol Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.; Yang, YR (corresponding author), Gen Hosp Western Theater Command, Dept Geriatr, Chengdu, Sichuan, Peoples R China.	308129281@qq.com; xiongxy_89@163.com	Xiong, Xiao-Yi/AAJ-5423-2020	Xiong, Xiao-Yi/0000-0003-0720-907X	Science Foundation for Distinguished Young Scholars in Science and Technology Department in Sichuan Province [2020JDJQ0046]; National Natural Science Foundation of China [81701292]	Science Foundation for Distinguished Young Scholars in Science and Technology Department in Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the Science Foundation for Distinguished Young Scholars in Science and Technology Department in Sichuan Province (2020JDJQ0046) and the National Natural Science Foundation of China (81701292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no financial conflicts of interest to disclose. The specific roles of these authors are articulated in the author contributions section.	Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Bao WD, 2020, AGING CELL, V19, DOI 10.1111/acel.13235; Cao F, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.551065; Chen B, 2019, BRAIN RES BULL, V153, P122, DOI 10.1016/j.brainresbull.2019.08.013; Cheng Y, 2016, PROTEOME SCI, V14, DOI 10.1186/s12953-016-0092-y; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; Cordonnier C, 2018, LANCET, V392, P1257, DOI 10.1016/S0140-6736(18)31878-6; Dasari R, 2020, J MOL NEUROSCI, V70, P1186, DOI 10.1007/s12031-020-01526-7; Deng SX, 2018, J MOL NEUROSCI, V66, P639, DOI 10.1007/s12031-018-1206-z; Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, pH347, DOI 10.1152/ajpheart.00900.2015; Guo JH, 2017, PLANT PHYSIOL, V173, P668, DOI 10.1104/pp.16.00795; Hsu JM, 2018, CANCER RES, V78, P6349, DOI 10.1158/0008-5472.CAN-18-1892; Jin WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147586; Klimova N, 2018, TRANSL STROKE RES, V9, P223, DOI 10.1007/s12975-017-0569-8; Li PF, 2020, AGING-US, V12, P22794, DOI 10.18632/aging.103938; Liu J, 2016, IMMUNITY, V45, P15, DOI 10.1016/j.immuni.2016.06.020; Liu T, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1130; Marcelli S, 2018, CURR ALZHEIMER RES, V15, P313, DOI 10.2174/1567205014666170505095109; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Moursel LG, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00102; Pan C, 2018, MOL NEUROBIOL, V55, P1556, DOI 10.1007/s12035-016-0363-8; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wan JR, 2019, STROKE VASC NEUROL, V4, P93, DOI 10.1136/svn-2018-000205; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Xu XY, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3977-y; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	29	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259798	10.1371/journal.pone.0259798	http://dx.doi.org/10.1371/journal.pone.0259798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780519	Green Published, gold			2022-12-26	WOS:000755305800053
J	Omar, HS; Al Mutery, A; Osman, NH; Reyad, NEHA; Abou-Zeid, MA				Omar, Hanaa S.; Al Mutery, Abdullah; Osman, Neama H.; Reyad, Nour El-Houda A.; Abou-Zeid, Mohamed A.			Genetic diversity, antifungal evaluation and molecular docking studies of Cu-chitosan nanoparticles as prospective stem rust inhibitor candidates among some Egyptian wheat genotypes	PLOS ONE			English	Article							AMPLIFIED POLYMORPHISM SRAP; PUCCINIA-GRAMINIS; 3 COMPONENTS; LEAF RUST; IN-VITRO; RESISTANCE; MARKERS; MAP; GROWTH; PLANTS	Wheat has a remarkable importance among cereals worldwide. Wheat stem and leaf rust constitute the main threats that destructively influence grain quality and yield production. Pursuing resistant cultivars and developing new genotypes including resistance genes is believed to be the most effective tool to overcome these challenges. This study is the first to use molecular markers to evaluate the genetic diversity of eighteen Egyptian wheat genotypes. Moreover, the molecular docking analysis was also used to assess the Cu-chitosan nanoparticle (CuChNp) treatment and its mode of action in disease control management. The tested genotypes were categorized into two main cluster groups depending on the similarity matrix, i.e the most resistant and susceptible genotypes to stem and leaf rust races. The results of SCoT primers revealed 140 polymorphic and 5 monomorphic bands with 97% polymorphism. While 121 polymorphic and 74 monomorphic bands were scored for SRAP primers (99% polymorphism). The genotypes Sakha 94, Sakha 95, Beni Sweif 4, Beni Sweif 7, Sohag 4 and Sohag 5 were resistant, while Giza 160 was highly susceptible to all stem rust races at the seedling stage. However, in the adult stage, the 18 genotypes were evaluated for stem and leaf rust-resistant in two different locations, i.e. Giza and Sids. In this investigation, for the first time, the activity of CuChNp was studied and shown to have the potential to inhibit stem and leaf rust in studied Egyptian wheat genotypes. The Spraying Cu-chitosan nanoparticles showed that the incubation and latent periods were increased in treated plants of the tested genotypes. Molecular modeling revealed their activity against the stem and leaf rust development. The SRAP and SCoT markers were highly useful tools for the classification of the tested wheat genotypes, although they displayed high similarities at the morphological stage. However, Cu-chitosan nanoparticles have a critical and effective role in stem and leaf rust disease control.	[Omar, Hanaa S.; Osman, Neama H.] Cairo Univ, Fac Agr, Genet Dept, Giza, Egypt; [Omar, Hanaa S.] Cairo Univ, Fac Agr, CURP, GMO Lab, Res Pk, Giza, Egypt; [Al Mutery, Abdullah] Univ Sharjah, Coll Sci, Dept Appl Biol, Sharjah, U Arab Emirates; [Al Mutery, Abdullah] Univ Sharjah, Mol Genet & Stem Cell Res Lab, Sharjah, U Arab Emirates; [Reyad, Nour El-Houda A.] Cairo Univ, Fac Agr, Plant Pathol Dept, Giza, Egypt; [Abou-Zeid, Mohamed A.] Plant Pathol Res Inst, Wheat Dis Res Dept, ARC, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; University of Sharjah; University of Sharjah; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Omar, HS (corresponding author), Cairo Univ, Fac Agr, Genet Dept, Giza, Egypt.; Omar, HS (corresponding author), Cairo Univ, Fac Agr, CURP, GMO Lab, Res Pk, Giza, Egypt.	Hanaa8324@yahoo.com		reyad, nourelhouda/0000-0001-8048-3636; Abou-Zeid, Mohamed/0000-0001-8545-4332				Abou-Deif M. H., 2013, Middle East Journal of Scientific Research, V15, P168; Abou-Zeid MA., 2018, EGYPT J PHYTOPATHOL, V46, P215, DOI [10.21608/ejp.2018.87793, DOI 10.21608/EJP.2018.87793]; Abou-Zeid MA., 2017, EGYPT J PHYTOPATHOL, V45, P231, DOI [10.21608/ejp.2017.88616, DOI 10.21608/EJP.2017.88616]; Abou-Zeid MA., 2014, INT J PLANT SOIL SCI, V3, P671, DOI [10.9734/IJPSS/2014/8567, DOI 10.9734/IJPSS/2014/8567]; Abou-Zeid MA., 2018, EGYPT J PLANT BREED, V22, P849; Abou-Zeid MA, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-020-02813-6; Abouseadaa HH, 2020, SAUDI J BIOL SCI, V27, P1649, DOI 10.1016/j.sjbs.2020.03.007; Abouzied HM., 2019, J AGR ENV SCI, V8, P25; Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7; Arab SA, 2021, PLANT CELL BIOTECHNO, V22, P73; Atia MAM, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10071378; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruno KS, 2004, EUKARYOT CELL, V3, P1525, DOI 10.1128/EC.3.6.1525-1532.2004; Chaves MS., 2011, EMBR TRIG CPACT; Choudhary R. C., 2017, NANOTECHNOLOGY, P227, DOI 10.1007/978-981-10-4573-8_10; Cochran W.G., 1967, STAT METHODS; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Cuccioloni M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70042-w; Cuccioloni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13709-1; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Draz IS, 2019, ANN AGR SCI-CAIRO, V64, P39, DOI 10.1016/j.aoas.2019.05.007; El-Hussein A. A., 2014, International Journal of Plant Breeding and Genetics, V8, P89; El-Moneim A, 2019, J PLANT PRODUCTION S, V8, P31; Fazeli-Nasab B., 2018, IDENTIFICATION GENET, V23, P57; Gowayed SMH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248890; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021895; Hamidi H, 2014, CEREAL RES COMMUN, V42, P558, DOI 10.1556/CRC.2014.0010; Hanaa SO., 2020, PHYTOCHEM ANALYSIS, P1, DOI [10.1002/pca.3018, DOI 10.1002/PCA.3018]; Hasan MA., 2016, MINUFIYA J AGR RES, V41, P621; Hasan MA., 2015, J PLANT PROT PATHOL, V22, P689, DOI [10.21608/jppp.2015.74961, DOI 10.21608/JPPP.2015.74961]; Hu GG, 2007, MOL PLANT MICROBE IN, V20, P637, DOI 10.1094/MPMI-20-6-0637; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Kheiri A, 2016, INT J BIOL MACROMOL, V93, P1261, DOI 10.1016/j.ijbiomac.2016.09.072; Kokhmetova A, 2011, CZECH J GENET PLANT, V47, pS146, DOI 10.17221/3270-CJGPB; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Maluin FN, 2020, MOLECULES, V25, DOI 10.3390/molecules25071611; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Min JS, 2009, PLANT PATHOLOGY J, V25, P376, DOI 10.5423/PPJ.2009.25.4.376; Mokhtar MM, 2020, AOB PLANTS, V12, DOI 10.1093/aobpla/plaa064; Mokhtari N, 2013, PLANT SYST EVOL, V299, P1285, DOI 10.1007/s00606-013-0796-8; Naseri B, 2021, J PLANT PATHOL, V103, P197, DOI 10.1007/s42161-020-00709-w; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; OHM HW, 1976, PHYTOPATHOLOGY, V66, P1356, DOI 10.1094/Phyto-66-1356; Olfat M, 2013, EGYPT J PHYTOPATHOL, V41, P99, DOI [10.21608/ejp.2013.100339, DOI 10.21608/EJP.2013.100339]; Olfat MM., 2006, AMALS AGR SC MOSHTOH, V45, P639; Olivera PD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01719; PANDEY G, 1989, TETRAHEDRON, V45, P6867, DOI 10.1016/S0040-4020(01)89154-7; Peng S, 2008, BIOCHEM SYST ECOL, V36, P531, DOI 10.1016/j.bse.2008.03.010; Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007; Raman M, 2003, CURR BIOL, V13, pR886, DOI 10.1016/j.cub.2003.10.053; Ritu Paliwal, 2013, International Journal of Medicinal and Aromatic Plants, V3, P413; Robarts DWH, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400017; ROELFS AP, 1993, PLANT DIS, V77, P1122, DOI 10.1094/PD-77-1122; Rosegrant MW., 1995, 5 IFPRI; Roy R.N., 2006, FAO FERTILIZER PLANT, V16, P368, DOI DOI 10.1017/S0014479706394537; Saharan V, 2015, INT J BIOL MACROMOL, V75, P346, DOI 10.1016/j.ijbiomac.2015.01.027; Sakulkoo W, 2018, SCIENCE, V359, P1399, DOI 10.1126/science.aaq0892; Sathiyabama M, 2018, J AGR FOOD CHEM, V66, P1784, DOI 10.1021/acs.jafc.7b05921; Savolainen V, 2000, SYST BIOL, V49, P306, DOI 10.1093/sysbio/49.2.306; Shehab-Eldeen MT., 2020, J PLANT PROT PATHOL, V11, P1071, DOI [10.21608/jpp.2020.122667, DOI 10.21608/JPP.2020.122667]; Shreen S., 2019, INT J ENV SCI, P87, DOI [10.21608/cat.2019.28611, DOI 10.21608/CAT.2019.28611]; SNEATH P H, 1973, P573; TERVET IW, 1951, PHYTOPATHOLOGY, V41, P282; Uzun A, 2009, SCI HORTIC-AMSTERDAM, V121, P306, DOI 10.1016/j.scienta.2009.02.018; Van der Plank TE., 1963, PLANT DIS EPIDEMICS; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yeboah MA, 2007, AFR J BIOTECHNOL, V6, P2784	68	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0257959	10.1371/journal.pone.0257959	http://dx.doi.org/10.1371/journal.pone.0257959			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767570	gold, Green Published			2022-12-26	WOS:000755249300003
J	Figueiredo, JC; Passarelli, MN; Wei, W; Ahnen, DJ; Morris, JS; Corley, L; Mehta, T; Bartley, AN; McKeown-Eyssen, G; Bresalier, RS; Barry, EL; Goel, A; Mesa, GH; Hamilton, SR; Baron, JA				Figueiredo, Jane C.; Passarelli, Michael N.; Wei, Wei; Ahnen, Dennis J.; Morris, Jeffrey S.; Corley, Lynda; Mehta, Trupti; Bartley, Angela N.; McKeown-Eyssen, Gail; Bresalier, Robert S.; Barry, Elizabeth L.; Goel, Ajay; Mesa, Goretti Hernandez; Hamilton, Stanley R.; Baron, John A.			Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions	PLOS ONE			English	Article							HYPERPLASTIC POLYPS; PATHWAY; GROWTH; COLON; KI-67; IMMUNOHISTOCHEMISTRY; POLYPECTOMY; VALIDATION; MUTATIONS; MORTALITY	Background Adenomas and serrated lesions represent heterogeneous sets of early precursors in the colorectum with varying malignant potential. They are often distinguished by their histopathologic differences, but little is known about potential differences in regulation of epithelial proliferation and apoptosis. Methods We conducted a protein expression analysis using tissue microarrays of 625 colorectal adenomas and 142 serrated lesions to determine potential differences in regulation of epithelial proliferation and apoptosis. We quantitated proliferation with Ki-67; apoptosis with activated caspase-3 (CASP3); up- and down-regulators of proliferation with cyclin D1, p16(INK2), and p21(Cip1); and apoptosis regulators with BAX, BCL2, and survivin. Linear mixed effects models and circos diagrams were used to determine relationships among expression and lesion characteristics. Results Adenomas had a significantly higher CASP-3 labeling index (LI) than serrated lesions, resulting in a lower net growth ratio (Ki-67 LI/activated CASP-3 LI, p-value<0.0001). Cyclin D1 LI, p16 LI and p21 LI were lower in adenomas compared to serrated lesions, while expression of both BCL2 and BAX were higher (p <0.001). Among adenomas, cyclin D1 LI and p16 LI levels increased with greater villous component, and the highest BAX expression was detected in adenomas larger than 2 cm (both p<0.0001). Right-sided adenomas had higher CASP3 LI than left colorectal adenomas (p = 0.008). Significant differences in cyclin D1 LI, p21 LI and survivin LI were also observed across histopathologic subtypes of serrated lesions. Conclusions Our findings demonstrate different patterns of regulatory protein expression in adenomas than serrated lesions, especially involving apoptosis.	[Figueiredo, Jane C.] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Passarelli, Michael N.; Barry, Elizabeth L.] Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH USA; [Wei, Wei] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA; [Ahnen, Dennis J.] Univ Colorado, Sch Med, Div Gastroenterol & Hepatol, Denver, CO USA; [Morris, Jeffrey S.] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Corley, Lynda; Mehta, Trupti; Bartley, Angela N.; Hamilton, Stanley R.] Univ Texas MD Anderson Canc Ctr, Div Pathol & Lab Med, Dept Pathol, Houston, TX 77030 USA; [Bartley, Angela N.] St Joseph Mercy Hosp, Ann Arbor, MI 48104 USA; [McKeown-Eyssen, Gail] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Bresalier, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Goel, Ajay] Baylor Scott & White Res Inst, Ctr Translat Genom & Oncol, Ctr Gastrointestinal Res, Dallas, TX USA; [Goel, Ajay] Baylor Res Inst & Sammons Canc, Charles A Sammons Canc Ctr, Dallas, TX USA; [Goel, Ajay; Hamilton, Stanley R.] City Hope Natl Med Ctr, Dept Pathol, Natl Canc Ctr, Duarte, CA USA; [Mesa, Goretti Hernandez] Univ Hosp Canary Isl, Dept Gastroenterol, Tenerife, Spain; [Baron, John A.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA	Cedars Sinai Medical Center; Dartmouth College; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; Saint Joseph Mercy Health System (SJMHS); University of Toronto; University of Texas System; UTMD Anderson Cancer Center; Baylor Health Care System; Baylor University Medical Center; Baylor University Medical Center; City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidad de la Laguna; University of North Carolina; University of North Carolina Chapel Hill	Figueiredo, JC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.	jane.figueiredo@cshs.org			NCI [R01CA059005, U54CA100971];  [P30CA16672];  [R01CA244845];  [R01CA178744];  [P50CA221707]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; 	Dr. Baron received funding from NCI R01CA059005 and U54CA100971. Dr. Hamilton received funding from P30CA16672. Drs. Figueiredo, Ahnen, McKeown-Eyssen, Bresalier and Barry received funding from R01CA059005. Dr. Morris received funding R01CA244845, R01CA178744 and P50CA221707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bettington ML, 2015, MODERN PATHOL, V28, P414, DOI 10.1038/modpathol.2014.122; BOSARI S, 1995, HUM PATHOL, V26, P534, DOI 10.1016/0046-8177(95)90250-3; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Druliner BR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21525-4; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; East JE, 2017, GUT, V66, P1181, DOI 10.1136/gutjnl-2017-314005; Endo A, 2013, VIRCHOWS ARCH, V462, P131, DOI 10.1007/s00428-012-1365-1; Erichsen R, 2016, GASTROENTEROLOGY, V150, P895, DOI 10.1053/j.gastro.2015.11.046; Fujishima N, 1996, J GASTROENTEROL, V31, P207, DOI 10.1007/BF02389519; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Gupta Samir, 2020, Gastroenterology, V158, P1154, DOI 10.1053/j.gastro.2020.02.014; Gupta S, 2020, GASTROENTEROLOGY, V158, P1131, DOI 10.1053/j.gastro.2019.10.026; Hao XP, 1998, VIRCHOWS ARCH, V433, P523, DOI 10.1007/s004280050284; Hashimoto T, 2017, AM J SURG PATHOL, V41, P1188, DOI 10.1097/PAS.0000000000000877; Horkko TT, 2003, SCAND J GASTROENTERO, V38, P1241, DOI 10.1080/00365520310006603; Iwabuchi M, 2000, ANTICANCER RES, V20, P1141; Jiao YF, 2008, ONCOLOGY-BASEL, V74, P127, DOI 10.1159/000151359; Kalimuthu SN, 2016, WORLD J GASTRO ONCOL, V8, P805, DOI 10.4251/wjgo.v8.i12.805; Kang M, 1997, AM J SURG PATHOL, V21, P417, DOI 10.1097/00000478-199704000-00007; Khoury JD, 2018, CLIN CANCER RES, V24, P521, DOI 10.1158/1078-0432.CCR-17-1597; Kikuchi Y, 1997, VIRCHOWS ARCH, V431, P111, DOI 10.1007/s004280050076; Komori K, 2003, PATHOL INT, V53, P277, DOI 10.1046/j.1440-1827.2003.01476.x; Ladas SD, 2005, J PATHOL, V206, P62, DOI 10.1002/path.1739; Mitomi H, 2003, J CANCER RES CLIN, V129, P449, DOI 10.1007/s00432-003-0478-y; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; Oka S, 2002, SCAND J GASTROENTERO, V37, P1194, DOI 10.1080/003655202760373416; Okamoto K, 2017, J GASTROEN HEPATOL, V32, P358, DOI 10.1111/jgh.13482; Saleh H A, 1999, Pathol Oncol Res, V5, P273, DOI 10.1053/paor.1999.0231; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Siegel RL, 2017, JAMA-J AM MED ASSOC, V318, P572, DOI 10.1001/jama.2017.7630; Sinicrope FA, 1996, CLIN CANCER RES, V2, P1999; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Song MY, 2020, LANCET GASTROENTEROL, V5, P537, DOI 10.1016/S2468-1253(20)30009-1; Su YH, 2006, CANCER EPIDEM BIOMAR, V15, P1719, DOI 10.1158/1055-9965.EPI-05-0946; Tada T, 2003, HEPATO-GASTROENTEROL, V50, P1756; Tateyama H, 2002, AM J SURG PATHOL, V26, P249, DOI 10.1097/00000478-200202000-00013; WHO Classification of Tumours Editorial Board, 2019, DIGESTIVE SYSTEM TUM, V5th	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0258878	10.1371/journal.pone.0258878	http://dx.doi.org/10.1371/journal.pone.0258878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762658	Green Published, gold			2022-12-26	WOS:000755316600007
J	Maurice, MN; Huseein, EAM; Monib, MESMM; Alsharif, FM; Namazi, NI; Ahmad, AA				Maurice, Maria Naged; Huseein, Enas Abdelhameed Mahmoud; Monib, Mohamed El-Salahy M. M.; Alsharif, Fahd M.; Namazi, Nader Ibrahim; Ahmad, Alzahraa Abdelraouf			Evaluation of the scolicidal activities of eugenol essential oil and its nanoemulsion against protoscoleces of hydatid cysts	PLOS ONE			English	Article							IN-VITRO; ANTHELMINTIC ACTIVITY; GOLD NANOPARTICLES; ECHINOCOCCOSIS; L.; INACTIVATE; STABILITY; MECHANISM; TOXICITY; EFFICACY	Background Cystic echinococcosis caused by the cestode Echinococcus granulosus remains a serious helminthic zoonosis affecting humans and animals in many endemic developing countries. Surgical intervention is the best management choice, although it is associated with high recurrence rates and serious complications. Also, the commonly used chemotherapeutics exhibited serious side effects. This study aimed to evaluate the protoscolicidal effects of eugenol (Eug) essential oil and its nanoemulsion (Eug-NE) against protoscoleces (PCs) of hydatid cysts in vitro. Methods Eug-NE was prepared and characterized. Their cytotoxicity on macrophages was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. E. granulosus PCs were treated with various concentrations of Eug and Eug-NE at different exposure times. The viability of protoscoleces was evaluated by the eosin exclusion test, and the changes in the morphology of protoscoleces were assessed. Albendazole (ABZ) was used as a positive control. Results The cellular cytotoxicity of Eug and Eug-NE on macrophage cells, in minimum and maximum concentrations (0.2 and 1 mu l/mL), were nearly negligible ranging from 4.7% to 8.3% and 3.7% to 7.2%, respectively. The results showed highly significant activity of Eug-NE and Eug against hydatid PCs compared to ABZ (P< 0.05). Eug and Eug-NE have similar proto-scolicidal effects at all used concentrations. Their highest scolicidal activity (100% mortality rate) was recorded at 1 mu l/ml after 30 min incubation (LC50 = 0.298-LC90 = 0.521 and LC50 = 0.309-LC90 = 0.646, respectively). Both formulations showed time- and dose-dependent effects. Conclusions This study suggested the potent scolicidal activities of Eug and Eug-NE as promising alter- native scolicidal agents. Future studies are recommended to explore the mechanism of action and treatment response in vivo and clinical settings.	[Maurice, Maria Naged; Huseein, Enas Abdelhameed Mahmoud; Monib, Mohamed El-Salahy M. M.; Ahmad, Alzahraa Abdelraouf] Assiut Univ, Fac Med, Dept Med Parasitol, Assiut, Egypt; [Alsharif, Fahd M.] Al Azhar Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Assiut, Egypt; [Namazi, Nader Ibrahim] Taibah Univ, Coll Pharm, Dept Pharmaceut & Pharmaceut Technol, Madinah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Al Azhar University; Taibah University	Ahmad, AA (corresponding author), Assiut Univ, Fac Med, Dept Med Parasitol, Assiut, Egypt.	zahraaabdelraouf@aun.edu.eg		Eisa, Fahd/0000-0003-0956-2870; Namazi, Nader/0000-0002-7508-2448	grant office at Faculty of Medicine, Assiut University, Egypt	grant office at Faculty of Medicine, Assiut University, Egypt	The study was gratefully funded by the grant office at Faculty of Medicine, Assiut University, Egypt (December, 2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elsalam KA, 2015, APPL NANOSCI, V5, P255, DOI 10.1007/s13204-014-0398-y; Adas G, 2009, WORLD J GASTROENTERO, V15, P112, DOI 10.3748/wjg.15.112; Ali Nehad Mahmoud, 2016, J Parasit Dis, V40, P893, DOI 10.1007/s12639-014-0600-x; [Anonymous], 1996, Bull World Health Organ, V74, P231; Baqer NN., 2014, ANTIPROTOSCOLICES EF, V2, P59; Barabadi H, 2017, ENVIRON SCI POLLUT R, V24, P5800, DOI 10.1007/s11356-016-8291-8; Batiha GES, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020202; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Danaei M, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10020057; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Di Pasqua R, 2007, J AGR FOOD CHEM, V55, P4863, DOI 10.1021/jf0636465; Donsi F, 2012, J BIOTECHNOL, V159, P342, DOI 10.1016/j.jbiotec.2011.07.001; Echeverria Javier, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6020042; El-kady AM, 2019, INFECT DRUG RESIST, V12, P709, DOI 10.2147/IDR.S196544; El-On J, 2003, ACTA TROP, V85, P243, DOI 10.1016/S0001-706X(02)00217-6; Esmaeili F, 2016, PHARM DEV TECHNOL, V21, P887, DOI 10.3109/10837450.2015.1078353; Fabbri J, 2018, ACTA TROP, V187, P5, DOI 10.1016/j.actatropica.2018.07.013; Fabri RL, 2012, AN ACAD BRAS CIENC, V84, P1073, DOI 10.1590/S0001-37652012000400021; Ghosh V, 2014, COLLOID SURFACE B, V114, P392, DOI 10.1016/j.colsurfb.2013.10.034; Higuita NIA, 2016, J CLIN MICROBIOL, V54, P518, DOI 10.1128/JCM.02420-15; Hu QB, 2016, INT J BIOL MACROMOL, V87, P130, DOI 10.1016/j.ijbiomac.2016.02.051; Huang Y, 2002, J STORED PROD RES, V38, P403, DOI 10.1016/S0022-474X(01)00042-X; Hyldgaard M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00012; Islamuddin M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005011; Kar A, 2021, INT IMMUNOPHARMACOL, V91, DOI 10.1016/j.intimp.2020.107291; Karimi Yazdi Monire, 2020, J Parasit Dis, V44, P429, DOI 10.1007/s12639-020-01193-w; Kohansal MH, 2017, ACTA TROP, V176, P385, DOI 10.1016/j.actatropica.2017.09.013; Kowsari N, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-021-04765-8; Kumar Manish, 2019, Prev Nutr Food Sci, V24, P225, DOI 10.3746/pnf.2019.24.3.225; Labsi M, 2019, ACTA TROP, V197, DOI 10.1016/j.actatropica.2019.105050; Labsi M, 2016, ASIAN PAC J TROP MED, V9, P208, DOI 10.1016/j.apjtm.2016.01.038; Li W, 2015, LWT-FOOD SCI TECHNOL, V62, P39, DOI 10.1016/j.lwt.2015.01.012; Longuespee R, 2017, MOL BIOCHEM PARASIT, V211, P9, DOI 10.1016/j.molbiopara.2016.12.002; Lucia A, 2020, B INSECTOL, V73, P153; Ma WR, 2019, VET PARASITOL, V266, P56, DOI 10.1016/j.vetpar.2018.12.012; Machado M, 2011, EXP PARASITOL, V127, P732, DOI 10.1016/j.exppara.2011.01.011; Mahapatra SK, 2011, INT IMMUNOPHARMACOL, V11, P485, DOI 10.1016/j.intimp.2010.12.020; Mahmoudvand H, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2527-3; Mahmoudvand H, 2016, BIOMED PHARMACOTHER, V82, P393, DOI 10.1016/j.biopha.2016.05.012; Mahmoudvand H, 2016, J INVEST SURG, V29, P137, DOI 10.3109/08941939.2015.1088601; Mahmoudvand H, 2014, KOREAN J PARASITOL, V52, P653, DOI 10.3347/kjp.2014.52.6.653; Mahmoudvand H, 2014, INT J SURG, V12, P399, DOI 10.1016/j.ijsu.2014.03.017; Majeed H, 2016, FOOD CHEM, V197, P75, DOI 10.1016/j.foodchem.2015.10.015; Michiels J, 2008, J SCI FOOD AGR, V88, P2371, DOI 10.1002/jsfa.3358; Misra P, 2009, J MED MICROBIOL, V58, P1058, DOI 10.1099/jmm.0.009290-0; Moazeni M, 2019, J VISC SURG, V156, P291, DOI 10.1016/j.jviscsurg.2019.01.002; Moazeni M, 2019, IRAN J PARASITOL, V14, P214, DOI 10.18502/ijpa.v14i2.1133; Moazeni M, 2017, RES VET SCI, V114, P308, DOI 10.1016/j.rvsc.2017.06.003; Moazeni Mohammad, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P616, DOI 10.1016/S2221-1691(12)60107-5; Moazeni M, 2012, VET PARASITOL, V187, P203, DOI 10.1016/j.vetpar.2011.12.025; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Napooni S., 2019, Comparative Clinical Pathology, V28, P143, DOI 10.1007/s00580-018-2807-1; Napooni S, 2019, ACTA PARASITOL, V64, P367, DOI 10.2478/s11686-019-00054-8; Navvabi A, 2019, EXP PARASITOL, V203, P19, DOI 10.1016/j.exppara.2019.05.009; Norouzi R, 2020, INT J NANOMED, V15, P1095, DOI 10.2147/IJN.S228538; Norouzi Roghayeh, 2019, Nanomedicine Research Journal, V4, P23, DOI 10.22034/nmrj.2019.01.004; Pawlowski Z.S., 2001, WHOOIE MAN ECHINOCOC; Pelozo MF, 2021, J PHARM PHARM SCI, V24, P421, DOI 10.18433/jpps31839; Pensel P E, 2014, Interdiscip Perspect Infect Dis, V2014, P693289, DOI 10.1155/2014/693289; Pessoa LM, 2002, VET PARASITOL, V109, P59, DOI 10.1016/S0304-4017(02)00253-4; Pradeep Kumar, 2014, Journal of Biology and Earth Sciences, V4, pB57; Pramod G Nagaraju., 2020, NANOENCAPSULATION CL, DOI [10.1101/2020.08.28.269886, DOI 10.1101/2020.08.28.269886]; Pramod K., 2015, J ANAL SCI TECHNOL, V6, P34, DOI DOI 10.1186/S40543-015-0073-2; Rahimi MT, 2015, INT J SURG, V19, P128, DOI 10.1016/j.ijsu.2015.05.043; Raja MRC, 2017, EUR J MED CHEM, V139, P503, DOI 10.1016/j.ejmech.2017.08.030; Sadjadi SM, 2006, PARASITOL INT, V55, pS197, DOI 10.1016/j.parint.2005.11.030; Santoro GF, 2007, EXP PARASITOL, V116, P283, DOI 10.1016/j.exppara.2007.01.018; Selles S. M. A., 2020, Comparative Clinical Pathology, V29, P705, DOI 10.1007/s00580-020-03114-y; Sonalkar M. Y., 2014, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V3, P1409; Stamatakos M, 2009, PARASITOL INT, V58, P115, DOI 10.1016/j.parint.2009.01.002; Sutili Fernando J., 2014, Pan-American Journal of Aquatic Sciences, V9, P223; Tuhfa T., 2017, TIKRIT J PURE SCI, V22, P20; Ueda-Nakamura T, 2006, PARASITOL INT, V55, P99, DOI 10.1016/j.parint.2005.10.006; van Zyl RL, 2006, J ESSENT OIL RES, V18, P129, DOI 10.1080/10412905.2006.12067134; Vuitton DA, 2009, EXPERT REV ANTI-INFE, V7, P145, DOI 10.1586/14787210.7.2.145; Wang LJ, 2007, J COLLOID INTERF SCI, V314, P230, DOI 10.1016/j.jcis.2007.04.079; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Xie YJ, 2015, IND CROP PROD, V77, P780, DOI 10.1016/j.indcrop.2015.09.044; Xin Q., 2019, VET RES, P1, DOI [10.1186/s13567-018-0620-0, DOI 10.1186/S13567-018-0620-0]; Yadav MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119564; Yones DA, 2011, KOREAN J PARASITOL, V49, P255, DOI 10.3347/kjp.2011.49.3.255	81	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259290	10.1371/journal.pone.0259290	http://dx.doi.org/10.1371/journal.pone.0259290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762675	gold, Green Published			2022-12-26	WOS:000755316600017
J	Saenz, SA; Local, A; Carr, T; Shakya, A; Koul, S; Hu, HQ; Chourb, L; Stedman, J; Malley, J; D'Agostino, LA; Shanmugasundaram, V; Malona, J; Schwartz, CE; Beebe, L; Clements, M; Rajaraman, G; Cho, J; Jiang, L; Dubrovskiy, A; Kreilein, M; Shimanovich, R; Hamann, LG; Escoubet, L; Ellis, JM				Saenz, Steven A.; Local, Andrea; Carr, Tiffany; Shakya, Arvind; Koul, Shivsmriti; Hu, Haiqing; Chourb, Lisa; Stedman, Justin; Malley, Jenna; D'Agostino, Laura Akullian; Shanmugasundaram, Veerabahu; Malona, John; Schwartz, C. Eric; Beebe, Lisa; Clements, Meghan; Rajaraman, Ganesh; Cho, John; Jiang, Lan; Dubrovskiy, Alex; Kreilein, Matt; Shimanovich, Roman; Hamann, Lawrence G.; Escoubet, Laure; Ellis, J. Michael			Small molecule allosteric inhibitors of ROR gamma t block Th17-dependent inflammation and associated gene expression in vivo	PLOS ONE			English	Article							CELLS; DIFFERENTIATION; TH17; IMMUNITY; DISTINCT; LINEAGE; DEVELOP; IL-17	Retinoic acid receptor-related orphan nuclear receptor (ROR) gamma t is a member of the RORC nuclear hormone receptor family of transcription factors. ROR gamma t functions as a critical regulator of thymopoiesis and immune responses. ROR gamma t is expressed in multiple immune cell populations including Th17 cells, where its primary function is regulation of immune responses to bacteria and fungi through IL-17A production. However, excessive IL-17A production has been linked to numerous autoimmune diseases. Moreover, Th17 cells have been shown to elicit both pro- and anti-tumor effects. Thus, modulation of the ROR gamma t/IL-17A axis may represent an attractive therapeutic target for the treatment of autoimmune disorders and some cancers. Herein we report the design, synthesis and characterization of three selective allosteric ROR gamma t inhibitors in preclinical models of inflammation and tumor growth. We demonstrate that these compounds can inhibit Th17 differentiation and maintenance in vitro and Th17-dependent inflammation and associated gene expression in vivo, in a dose-dependent manner. Finally, ROR gamma t inhibitors were assessed for efficacy against tumor formation. While, ROR gamma t inhibitors were shown to inhibit tumor formation in pancreatic ductal adenocarcinoma (PDAC) organoids in vitro and modulate ROR gamma t target genes in vivo, this activity was not sufficient to delay tumor volume in a KP/C human tumor mouse model of pancreatic cancer.	[Saenz, Steven A.; Carr, Tiffany; Jiang, Lan; Dubrovskiy, Alex] Bristol Myers Squibb, Immunol Cardiovasc & Fibrosis, Cambridge, MA 02142 USA; [Local, Andrea; Shakya, Arvind; Koul, Shivsmriti; Escoubet, Laure] Bristol Myers Squibb, Oncogenesis Themat Res Ctr, San Diego, CA USA; [Hu, Haiqing; Chourb, Lisa; Stedman, Justin; Beebe, Lisa; Shimanovich, Roman] Bristol Myers Squibb, Preclin Candidate Optimizat, Cambridge, MA USA; [Malley, Jenna; Clements, Meghan; Rajaraman, Ganesh] Celgene Corp, Nonclin Dev, Cambridge, MA USA; [D'Agostino, Laura Akullian; Shanmugasundaram, Veerabahu; Hamann, Lawrence G.; Ellis, J. Michael] Bristol Myers Squibb, Small Mol Drug Discovery, Cambridge, MA 02142 USA; [Malona, John; Schwartz, C. Eric] Bristol Myers Squibb, Drug Subst Dev, Summit, NJ USA; [Cho, John] Celgene Corp, Immunol & Inflammat, Cambridge, MA USA; [Kreilein, Matt] Bristol Myers Squibb, Drug Substance Dev, Summit, NJ USA; [Malley, Jenna; Hamann, Lawrence G.] Takeda Pharmaceut, Cambridge, MA USA; [Malona, John] Jnana Therapeut, Boston, MA USA; [Schwartz, C. Eric] Cedilla Therapeut, Cambridge, MA USA; [Clements, Meghan] AbbVie, Worcester, MA USA; [Rajaraman, Ganesh] Novartis Pharmaceut, Cambridge, MA USA; [Cho, John] KSQ Therapeut, Cambridge, MA USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; AbbVie; Novartis	Saenz, SA (corresponding author), Bristol Myers Squibb, Immunol Cardiovasc & Fibrosis, Cambridge, MA 02142 USA.; Ellis, JM (corresponding author), Bristol Myers Squibb, Small Mol Drug Discovery, Cambridge, MA 02142 USA.	steven.saenz@bms.com; michael.ellis@bms.com			Takeda Pharmaceuticals; Jnana Therapeutics; Cedilla Therapeutics; AbbVie; Novartis Pharmaceuticals; KSQ Therapeutics; Bristol Myers Squibb	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Jnana Therapeutics; Cedilla Therapeutics; AbbVie(AbbVie); Novartis Pharmaceuticals(Novartis); KSQ Therapeutics; Bristol Myers Squibb(Bristol-Myers Squibb)	All authors are either present or former employees of Celgene Corporation and/or Bristol Myers Squibb and own stocks and/or shares of Bristol Myers Squibb. All work for the current study was performed by authors only while employed at Celgene Corporation or Bristol Myers Squibb. Celgene Corporation is a wholly owned subsidiary of Bristol Myers Squibb. The Bristol Myers Squibb was the sole funder for this study and provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. Jenna Malley & Lawrence G. Hamann are currently employed by Takeda Pharmaceuticals. John Malona is currently employed by Jnana Therapeutics. C. Eric Schwartz is currently employed by Cedilla Therapeutics. Meghan Clements is currently employed by AbbVie. Ganesh Rajaraman is currently employed by Novartis Pharmaceuticals. John Cho is currently employed by KSQ Therapeutics. Neither Takeda Pharmaceuticals, Jnana Therapeutics, Cedilla Therapeutics, AbbVie, Novartis Pharmaceuticals or KSQ Therapeutics provided funding to the current work. The specific roles of each author are articulated in the `Author contributions' section.	Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Banerjee D, 2016, IMMUNOLOGY, V147, P399, DOI 10.1111/imm.12570; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Driehuis E, 2019, P NATL ACAD SCI USA, V116, P26580, DOI 10.1073/pnas.1911273116; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Garcet S, 2018, J ALLERGY CLIN IMMUN, V142, P1010, DOI 10.1016/j.jaci.2018.05.039; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Guo YX, 2016, CELL REP, V17, P3206, DOI 10.1016/j.celrep.2016.11.073; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Liljevald M, 2016, AUTOIMMUN REV, V15, P1062, DOI 10.1016/j.autrev.2016.07.036; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lytle NK, 2019, CELL, V177, P572, DOI 10.1016/j.cell.2019.03.010; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Mahalingam D, 2019, CLIN CANCER RES, V25, P3508, DOI 10.1158/1078-0432.CCR-18-3185; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Okada S, 2015, SCIENCE, V349, P606, DOI 10.1126/science.aaa4282; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Rutz S, 2016, CYTOKINE GROWTH F R, V30, P1, DOI 10.1016/j.cytogfr.2016.07.004; Scheepstra M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9833; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Ueda E, 2002, CANCER RES, V62, P901; Vitae Pharmaceuticals I, 2016, ASC MULT DOS STUD VT; Zhang HJ, 2020, ACS MED CHEM LETT, V11, P114, DOI 10.1021/acsmedchemlett.9b00431; Zhang Y, 2015, ACTA PHARMACOL SIN, V36, P71, DOI 10.1038/aps.2014.120; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0248034	10.1371/journal.pone.0248034	http://dx.doi.org/10.1371/journal.pone.0248034			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752458	Green Published, Green Submitted, gold			2022-12-26	WOS:000754499700002
J	Thomson, E; Dawson, R; H'ng, CH; Adikusuma, F; Piltz, S; Thomas, PQ				Thomson, Ella; Dawson, Ruby; H'ng, Chee Ho; Adikusuma, Fatwa; Piltz, Sandra; Thomas, Paul Q.			The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; STEM-CELLS; CNS; KIDNEY; SOX	Enhancers are vitally important during embryonic development to control the spatial and temporal expression of genes. Recently, large scale genome projects have identified a vast number of putative developmental regulatory elements. However, the proportion of these that have been functionally assessed is relatively low. While enhancers have traditionally been studied using reporter assays, this approach does not characterise their contribution to endogenous gene expression. We have studied the murine Nestin (Nes) intron 2 enhancer, which is widely used to direct exogenous gene expression within neural progenitor cells in cultured cells and in vivo. We generated CRISPR deletions of the enhancer region in mice and assessed their impact on Nes expression during embryonic development. Loss of the Nes neural enhancer significantly reduced Nes expression in the developing CNS by as much as 82%. By assessing NES protein localization, we also show that this enhancer region contains repressor element(s) that inhibit Nes expression within the vasculature. Previous reports have stated that Nes is an essential gene, and its loss causes embryonic lethality. We also generated 2 independent Nes null lines and show that both develop without any obvious phenotypic effects. Finally, through crossing of null and enhancer deletion mice we provide evidence of trans-chromosomal interaction of the Nes enhancer and promoter.	[Thomson, Ella; Dawson, Ruby; H'ng, Chee Ho; Adikusuma, Fatwa; Piltz, Sandra; Thomas, Paul Q.] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Adikusuma, Fatwa; Thomas, Paul Q.] Univ Adelaide, Sch Biomed, Adelaide, SA, Australia; [Adikusuma, Fatwa; Piltz, Sandra; Thomas, Paul Q.] South Australian Hlth & Med Res Inst, South Australian Genome Editing Facil, Adelaide, SA, Australia; [Thomas, Paul Q.] South Australian Hlth & Med Res Inst, Genome Editing Program, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); South Australian Health & Medical Research Institute (SAHMRI)	Thomas, PQ (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), Univ Adelaide, Sch Biomed, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), South Australian Hlth & Med Res Inst, South Australian Genome Editing Facil, Adelaide, SA, Australia.; Thomas, PQ (corresponding author), South Australian Hlth & Med Res Inst, Genome Editing Program, Adelaide, SA, Australia.	paul.thomas@adelaide.edu.au	Thomson, Ella/I-6722-2018	Thomson, Ella/0000-0002-5596-3563				Abed JA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12208-3; Adikusuma F, 2017, GENETICS, V206, P1495, DOI 10.1534/genetics.117.202549; Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bernal A, 2018, CELL MOL LIFE SCI, V75, P2177, DOI 10.1007/s00018-018-2794-z; Cadiz-Rivera B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092947; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kvon EZ, 2015, GENOMICS, V106, P185, DOI 10.1016/j.ygeno.2015.06.007; Le Noir S, 2017, ONCOTARGET, V8, P12929, DOI 10.18632/oncotarget.14585; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim B, 2018, MOL CELL, V70, P287, DOI 10.1016/j.molcel.2018.02.029; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; McAninch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113361; Mellert DJ, 2012, GENETICS, V191, P1129, DOI 10.1534/genetics.112.140475; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665, DOI 10.14670/HH-20.665; Mohseni P, 2011, J NEUROSCI, V31, P11547, DOI 10.1523/JNEUROSCI.4396-10.2011; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Shin YJ, 2013, CELL TISSUE RES, V351, P383, DOI 10.1007/s00441-012-1538-x; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tanimoto K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203099; Trumpp A, 1999, GENE DEV, V13, P3136, DOI 10.1101/gad.13.23.3136; Wagner N, 2006, AM J PHYSIOL-REG I, V291, pR779, DOI 10.1152/ajpregu.00219.2006; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Xu D, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008663; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0258538	10.1371/journal.pone.0258538	http://dx.doi.org/10.1371/journal.pone.0258538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739481	Green Submitted, Green Published, gold			2022-12-26	WOS:000755000800006
J	Choi, SW; Kim, S; Park, HT; Park, HE; Choi, JS; Yoo, HS				Choi, Sung-Woon; Kim, Suji; Park, Hong-Tae; Park, Hyun-Eui; Choi, Jeong-Soo; Yoo, Han Sang			MicroRNA profiling in bovine serum according to the stage of Mycobacterium avium subsp. paratuberculosis infection	PLOS ONE			English	Article							JOHNES-DISEASE; DIAGNOSIS; TUBERCULOSIS; EXPRESSION; BIOMARKERS; RESPONSES; IMMUNITY; PATHWAY; MIRNAS; CANCER	Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of Johne's disease (JD), and it causes diarrhea and weakness in cattle. During a long subclinical stage, infected animals without clinical signs shed pathogens through feces. For this reason, the diagnosis of JD during the subclinical stage is very important. Circulating miRNAs are attracting attention as useful biomarkers in various veterinary diseases because of their expression changes depending on the state of the disease. Based on current knowledge, circulating miRNAs extracted from bovine serum were used to develop a diagnostic tool for JD. In this study, the animals were divided into 4 groups according to fecal shedding, the presence of antibodies, and clinical signs. Gene expression was analyzed by performing miRNA sequencing for each group, and it was identified that the miRNA expression changed more as the MAP infection progressed. The eight miRNAs that were differentially expressed in all infected groups were selected as biomarker candidates based on their significant differences compared to the control group. These biomarker candidates were validated by qRT-PCR. Considering the sequencing data, two upregulated miRNAs and two downregulated miRNAs showed the same trend in the validation results. Network analysis was also conducted and the results showed that mRNAs (IL-10, TGF-beta 1) associated with regulatory T cells were predicted to be activated in the subclinical stage. Taken together, our data suggest that two miRNAs (bta-miR-374b, bta-miR-2887) may play major roles in the immune response to MAP infection during the subclinical stage.	[Choi, Sung-Woon; Kim, Suji; Park, Hong-Tae; Park, Hyun-Eui; Choi, Jeong-Soo; Yoo, Han Sang] Seoul Natl Univ, Dept Infect Dis, Coll Vet Med, Seoul, South Korea; [Choi, Sung-Woon; Kim, Suji; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, BK21 FOUR Future Vet Med Leading Educ & Res Ctr, Seoul, South Korea; [Park, Hong-Tae; Yoo, Han Sang] Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea; [Park, Hyun-Eui] Gyeongsang Natl Univ, Life Sci Res Inst, Dept Microbiol, Coll Med, Jinju, South Korea; [Choi, Jeong-Soo] Anim & Plant Quarantine Agcy, Div Bacterial Dis, Gimcheon Si, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gyeongsang National University; Animal & Plant Quarantine Agency	Yoo, HS (corresponding author), Seoul Natl Univ, Dept Infect Dis, Coll Vet Med, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, BK21 FOUR Future Vet Med Leading Educ & Res Ctr, Seoul, South Korea.; Yoo, HS (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, Coll Vet Med, Seoul, South Korea.	yoohs@snu.ac.kr		Kim, Suji/0000-0001-8901-0085; Choi, Sungwoon/0000-0002-1915-112X; YOO, HAN SANG/0000-0003-0548-0835				Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Al Hajri SM, 2007, VET MICROBIOL, V121, P384, DOI 10.1016/j.vetmic.2007.01.025; Ariel O, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02874; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bhaskaran M, 2014, VET PATHOL, V51, P759, DOI 10.1177/0300985813502820; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cai MC, 2018, CELL STRESS CHAPERON, V23, P663, DOI 10.1007/s12192-018-0876-3; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Correia CN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00118; Coussens PM, 2012, COMP IMMUNOL MICROB, V35, P233, DOI 10.1016/j.cimid.2012.01.004; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092477; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Englund S, 2002, FEMS MICROBIOL LETT, V209, P267, DOI 10.1111/j.1574-6968.2002.tb11142.x; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Gupta SK, 2018, J DAIRY SCI, V101, P10259, DOI 10.3168/jds.2018-14785; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hussain T, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0152-z; Johnson DS, 2012, CURR OPIN PHARMACOL, V12, P458, DOI 10.1016/j.coph.2012.02.003; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawless N, 2014, G3-GENES GENOM GENET, V4, P957, DOI 10.1534/g3.113.009936; Lewandowska-Sabat AM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4591-3; Li JZ, 2018, VET MICROBIOL, V224, P58, DOI 10.1016/j.vetmic.2018.08.028; Li R, 2015, INT J MOL SCI, V16, P4997, DOI 10.3390/ijms16034997; Li Yu, 2012, Genomics Proteomics & Bioinformatics, V10, P246, DOI 10.1016/j.gpb.2012.07.005; Malvisi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164461; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNees AL, 2015, EXPERT REV GASTROENT, V9, P1523, DOI 10.1586/17474124.2015.1093931; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishimura T, 2017, J INFECT CHEMOTHER, V23, P703, DOI 10.1016/j.jiac.2017.07.015; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Park H.-T., 2020, KOREAN J VET RES, V60, P117, DOI [10.14405/kjvr.2020.60.3.117, DOI 10.14405/KJVR.2020.60.3.117]; Park HT, 2016, J VET MED SCI, V78, P1537, DOI 10.1292/jvms.15-0271; Park HongTae, 2014, Korean Journal of Veterinary Research, V54, P55, DOI 10.14405/kjvr.2014.54.1.55; Park HE, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.637716; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Roussey Jonathan A, 2014, Front Vet Sci, V1, P20, DOI 10.3389/fvets.2014.00020; Sechi LA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00096; Shaughnessy RG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62843-w; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Sole C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080773; Souza CD, 2007, AM J VET RES, V68, P625, DOI 10.2460/ajvr.68.6.625; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Tiwari A, 2006, CAN VET J, V47, P874; Uno S., 2021, POTENTIAL BIOMARKER; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; van Hulzen KJE, 2012, J DAIRY SCI, V95, P2740, DOI 10.3168/jds.2011-5005; Vegh P, 2015, TUBERCULOSIS, V95, P60, DOI 10.1016/j.tube.2014.10.011; Vouret-Craviari V, 1997, CYTOKINE, V9, P992, DOI 10.1006/cyto.1997.0242; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Whitlock RH, 1996, VET CLIN N AM-FOOD A, V12, P345, DOI 10.1016/S0749-0720(15)30410-2; Widdison S, 2008, MOL IMMUNOL, V45, P740, DOI 10.1016/j.molimm.2007.06.357; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xiong DD, 2017, ONCOL REP, V37, P3297, DOI 10.3892/or.2017.5600; Yim HCH, 2011, P NATL ACAD SCI USA, V108, P17749, DOI 10.1073/pnas.1104892108	68	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259539	10.1371/journal.pone.0259539	http://dx.doi.org/10.1371/journal.pone.0259539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735546	Green Published, gold			2022-12-26	WOS:000755077100089
J	Merga, J; Wirtu, D; Bekuma, TT; Regasa, MT				Merga, Jaleta; Wirtu, Desalegn; Bekuma, Tariku Tesfaye; Regasa, Misganu Teshoma			Unintended pregnancy and the factors among currently pregnant married youths in Western Oromia, Ethiopia: A mixed method	PLOS ONE			English	Article							WOMEN	Background Unintended pregnancy is a global concern affecting both developed and developing countries. Some young women who had unintended pregnancies obtain an abortion while others carry their pregnancies to term, incurring the risk of morbidity and mortality higher than those for adult women. Despite the availability of highly effective methods of contraception, different studies in Ethiopia revealed that there is a high level of unintended pregnancy. Objective To assess the magnitude of unintended pregnancy and associated factors among currently pregnant married youths in Kiremu district. Methods A community-based cross-sectional study was conducted among currently pregnant married 15-24 years women. Multi-stage stratified sampling technique was used to select 434 study units. Ten kebeles were randomly selected and samples were selected from each of ten kebeles by simple random sampling using kebeles household identification numbers as the sampling frame. Quantitative data was entered with SPSS version 20 and crude and adjusted odds ratio together with their 95%CI were computed and interpreted accordingly. A p-value<0.05 was considered to declare a result as statistically significant in this study. In-depth interviews and transcripts of the recorded discussions were coded and analyzed thematically. The results were finally presented in texts, tables, and graphs. Result Unintended pregnancies among currently pregnant married young women in the study area were 31.1%. Educational status (AOR = 3.195,95%CI = 1.757,5.811),being Gov't employee (AOR = 0.039, 95% CI = 0.002,0.988), ever heard contraceptives(AOR = 0.260, 95%CI = 0.077, 0.876), ever used contraceptives (AOR = 0.348,95%CI = 0.168,0.717),discussion about contraceptives with husband(AOR = 0.027,95%CI = 0.015, 0.050),fear of side effect of contraceptives (AOR = 5.819,95% CI = 1.438,23.422), autonomy on health (AOR = 0.122,95%CI = 0.035,0.431), age at first marriage (AOR = 3.195, 95%CI = 1.757,5.811), age first pregnancy(AOR = 23.660,95%CI = 12.573,44.522), being visited by health care providers (AOR = 0.202,95%CI = 0.073,0.566) and average birth interval (AOR = 3.472,95%CI = 1.392,8.61) were the factors associated with unintended pregnancy. Conclusion and recommendation Significant proportion of women had an unintended pregnancy in the study area. Therefore, emphasis should be given to married youths especially on women empowerment, encouraging partner discussions, and providing appropriate counseling on contraceptive side effects by giving due attention to those marred at younger ages (<18 years).	[Merga, Jaleta; Wirtu, Desalegn; Bekuma, Tariku Tesfaye] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Regasa, Misganu Teshoma] Wollega Univ, Inst Hlth Sci, Dept Midwifery, Nekemte, Ethiopia		Bekuma, TT (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	tarii2007@gmail.com		Wirtu, Dessalegn/0000-0002-5902-8978				[Anonymous], 2016, INDIAN J RES, V5; [Anonymous], 2016, ETH DEP HLTH SURV; Areemit Rosawan, 2012, J Med Assoc Thai, V95 Suppl 7, pS134; Asmare G, 2016, REPROD SYST SEX DISO, V5, P193; Aziz Ali S, 2016, J MIDWIFERY REPROD H, V4, P513; Beyene A, 2016, PREVALENCE UNINTENDE; Birhanu D., 2015, GLOBAL J MED RES INT, V15; Centers for Disease Control and Prevention (CDC), 2015, UNINTENDED PREGNANCY; Darroch JE, 2016, ADDING IT COSTS BENE; Denberu B., 2017, GLOB J REPROD MED, V1; Dixit P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-84; Duressa LT., 2018, J WOMENS HLTH CARE, V7, P446; Fetene T., 2014, SCI J PUBLIC HLTH, V2, P92; FMOH, 2006, NATL REPROD HLTH STR; Gessessew Amanuel, 2010, Afr J Reprod Health, V14, P183; Goshu YA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210206; Habib MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1339-z; Habte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082987; Hamdela B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039074; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Kibret A., 2015, J WOMENS HLTH CARE, V4, P232; Mulat S., 2017, J WOMENS HLTH CARE, V6, P387; Olsson CA, 2014, J ADOLESCENT HEALTH, V54, P698, DOI 10.1016/j.jadohealth.2013.10.203; Partnership for Maternal Newborn and Child Health WHO, 2014, POL GUID IMPL ESS IN; Rahman M, 2012, MATERN CHILD HLTH J, V16, P1206, DOI 10.1007/s10995-011-0897-3; Reddy P., 2016, TEENAGE PREGNANCY S; Tsegaye M., 2018, PREVALENCE UNINTENDE; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36; Woog V., 2017, SEXUAL REPROD HLTH N; World Health Organization, REPROD HEALTH; Yenealem F, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4203-6	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259262	10.1371/journal.pone.0259262	http://dx.doi.org/10.1371/journal.pone.0259262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735534	Green Published, gold			2022-12-26	WOS:000755077100060
J	Sorensen, G; Rickhag, M; Leo, D; Lycas, MD; Ridderstrom, PH; Weikop, P; Lilja, JH; Rifes, P; Herborg, F; Woldbye, D; Wortwein, G; Gainetdinov, RR; Fink-Jensen, A; Gether, U				Sorensen, Gunnar; Rickhag, Mattias; Leo, Damiana; Lycas, Matthew D.; Ridderstrom, Pernille Herrstedt; Weikop, Pia; Lilja, Jamila H.; Rifes, Pedro; Herborg, Freja; Woldbye, David; Wortwein, Gitta; Gainetdinov, Raul R.; Fink-Jensen, Anders; Gether, Ulrik			Disruption of the PDZ domain-binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D2 RECEPTORS; MONOAMINE TRANSPORTERS; MICE LACKING; IN-VIVO; COCAINE; ADDICTION; LOCALIZATION; TRANSMISSION; BRAIN; METABOLISM	The dopamine (DA) transporter (DAT) is part of a pre-synaptic multiprotein network involving interactions with scaffold proteins via its C-terminal PDZ domain-binding sequence. Using a mouse model expressing DAT with mutated PDZ-binding sequence (DAT-AAA), we previously demonstrated the importance of this binding sequence for striatal expression of DAT. Here, we show by application of direct stochastic reconstruction microscopy not only that the striatal level of transporter is reduced in DAT-AAA mice but also that the nanoscale distribution of this transporter is altered with a higher propensity of DAT-AAA to localize to irregular nanodomains in dopaminergic terminals. In parallel, we observe mesostriatal DA adaptations and changes in DA-related behaviors distinct from those seen in other genetic DAT mouse models. DA levels in the striatum are reduced to X45% of that of WT, accompanied by elevated DA turnover. Nonetheless, fast-scan cyclic voltammetry recordings on striatal slices reveal a larger amplitude and prolonged clearance rate of evoked DA release in DAT-AAA mice compared with WT mice. Autoradiography and radioligand binding show reduced DA D2 receptor levels, whereas immunohistochemistry and autoradiography show unchanged DA D1 receptor levels. In behavioral experiments, we observe enhanced self-administration of liquid food under both a fixed ratio of one and progressive ratio schedule of reinforcement but a reduction compared with WT when using cocaine as reinforcer. In summary, our data demonstrate how disruption of PDZ domain interactions causes changes in DAT expression and its nanoscopic distribution that in turn alter DA clearance dynamics and related behaviors.	[Sorensen, Gunnar; Rickhag, Mattias; Lycas, Matthew D.; Lilja, Jamila H.; Rifes, Pedro; Herborg, Freja; Woldbye, David; Gether, Ulrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Copenhagen, Denmark; [Sorensen, Gunnar; Ridderstrom, Pernille Herrstedt; Weikop, Pia; Wortwein, Gitta; Fink-Jensen, Anders] Mental Hlth Ctr, Psychiat Ctr Copenhagen, Lab Neuropsychiat, Copenhagen, Denmark; [Sorensen, Gunnar; Ridderstrom, Pernille Herrstedt; Weikop, Pia; Wortwein, Gitta; Fink-Jensen, Anders] Univ Copenhagen, Copenhagen, Denmark; [Leo, Damiana] Italian Inst Technol, Neurosci & Brain Technol Dept, Genoa, Italy; [Gainetdinov, Raul R.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg, Russia; [Gainetdinov, Raul R.] St Petersburg State Univ, St Petersburg Univ Hosp, St Petersburg, Russia; [Leo, Damiana] Univ Mons, Dept Neurosci, Mons, Belgium	University of Copenhagen; University of Copenhagen; Istituto Italiano di Tecnologia - IIT; Saint Petersburg State University; Saint Petersburg State University; University of Mons	Gether, U (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Copenhagen, Denmark.	gether@sund.ku.dk		Gether, Ulrik/0000-0002-0020-3807; Wortwein, Gitta/0000-0001-6981-7885; Leo, Damiana/0000-0001-9219-5498	University of Copenhagen BioScaRT Program of Excellence; National Institutes of Health [P01 DA 12408]; Independent Research Fund Denmark-Medical Sciences [4004-00097B]; Lundbeck Foundation [R199-2015-2110, R77-2010-6815]; Novo Nordisk Foundation [NNF16OC0023104]; St. Petersburg State University, St. Petersburg, Russia [51143531]	University of Copenhagen BioScaRT Program of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Independent Research Fund Denmark-Medical Sciences; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); St. Petersburg State University, St. Petersburg, Russia	The work was supported by the University of Copenhagen BioScaRT Program of Excellence (to G. S., D. W., G. W., A. F.-J., and U. G.), the National Institutes of Health grants P01 DA 12408 (to U. G.), Independent Research Fund Denmark-Medical Sciences (4004-00097B to U. G.), Lundbeck Foundation R199-2015-2110 and R77-2010-6815 (to U. G. and M. R.), the Novo Nordisk Foundation (NNF16OC0023104) (to U. G.), and St. Petersburg State University, St. Petersburg, Russia (project ID: 51143531) (to R. R. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashok AH, 2017, JAMA PSYCHIAT, V74, P511, DOI 10.1001/jamapsychiatry.2017.0135; Block ER, 2015, J NEUROSCI, V35, P12845, DOI 10.1523/JNEUROSCI.1391-15.2015; Brody AL, 2004, AM J PSYCHIAT, V161, P1211, DOI 10.1176/appi.ajp.161.7.1211; Chen R, 2006, P NATL ACAD SCI USA, V103, P9333, DOI 10.1073/pnas.0600905103; Choquet D, 2020, CURR OPIN NEUROBIOL, V63, P137, DOI 10.1016/j.conb.2020.04.003; Cliburn RA, 2017, J CHEM NEUROANAT, V83, P82, DOI 10.1016/j.jchemneu.2016.11.003; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; DiCarlo GE, 2019, J CLIN INVEST, V129, P3407, DOI 10.1172/JCI127411; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Flagel SB, 2016, P NATL ACAD SCI USA, V113, pE2861, DOI 10.1073/pnas.1520491113; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; German CL, 2015, PHARMACOL REV, V67, P1005, DOI 10.1124/pr.114.010397; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Hironaka N, 2004, ANN NY ACAD SCI, V1025, P140, DOI 10.1196/annals.1316.018; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jaber M, 1999, EUR J NEUROSCI, V11, P3499, DOI 10.1046/j.1460-9568.1999.00764.x; Jensen KL, 2017, JOVE-J VIS EXP, DOI 10.3791/56093; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kenny PJ, 2013, CURR OPIN NEUROBIOL, V23, P535, DOI 10.1016/j.conb.2013.04.012; Kenny PJ, 2011, NAT REV NEUROSCI, V12, P638, DOI 10.1038/nrn3105; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KUHR WG, 1986, BRAIN RES, V381, P168, DOI 10.1016/0006-8993(86)90707-9; Leo D, 2018, J NEUROSCI, V38, P1959, DOI 10.1523/JNEUROSCI.1931-17.2018; Levet F, 2015, NAT METHODS, V12, P1065, DOI [10.1038/NMETH.3579, 10.1038/nmeth.3579]; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lycas M. D., 2020, BIORXIV; Marcellino D, 2012, SYNAPSE, V66, P196, DOI 10.1002/syn.21501; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Martinez D, 2012, BIOL PSYCHIAT, V71, P192, DOI 10.1016/j.biopsych.2011.08.024; Martinez D, 2009, AM J PSYCHIAT, V166, P1170, DOI 10.1176/appi.ajp.2009.08121801; Mergy MA, 2014, P NATL ACAD SCI USA, V111, pE4779, DOI 10.1073/pnas.1417294111; Nader MA, 2008, PHILOS T R SOC B, V363, P3223, DOI 10.1098/rstb.2008.0092; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pecina S, 2003, J NEUROSCI, V23, P9395; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Runegaard AH, 2017, EUR J NEUROSCI, V45, P121, DOI 10.1111/ejn.13347; Schmidt LS, 2011, PSYCHOPHARMACOLOGY, V216, P367, DOI 10.1007/s00213-011-2225-4; Sorensen G, 2012, PSYCHOPHARMACOLOGY, V222, P565, DOI 10.1007/s00213-012-2651-y; Thomsen M, 2009, J PHARMACOL EXP THER, V331, P204, DOI 10.1124/jpet.109.156265; Thomsen M, 2009, J NEUROSCI, V29, P1087, DOI 10.1523/JNEUROSCI.4037-08.2009; Trifilieff P, 2014, NEUROPHARMACOLOGY, V76, P498, DOI 10.1016/j.neuropharm.2013.06.031; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wang GJ, 2012, MOL PSYCHIATR, V17, P918, DOI 10.1038/mp.2011.86; Wang GJ, 2011, OBESITY, V19, P1601, DOI 10.1038/oby.2011.27; Wang YN, 2014, OPT EXPRESS, V22, P15982, DOI 10.1364/OE.22.015982; Weikop P, 2007, J PSYCHOPHARMACOL, V21, P795, DOI 10.1177/0269881107077347; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	63	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101361	10.1016/j.jbc.2021.101361	http://dx.doi.org/10.1016/j.jbc.2021.101361			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756883	gold, Green Published			2022-12-26	WOS:000765319800005
J	Ahmed, S; Nicholson, CE; Muto, P; Perry, JJ; Dean, JR				Ahmed, Shara; Nicholson, Catherine E.; Muto, Paul; Perry, Justin J.; Dean, John R.			Applied aerial spectroscopy: A case study on remote sensing of an ancient and semi-natural woodland	PLOS ONE			English	Article							TREE SPECIES CLASSIFICATION; OIL PALM TREES	An area of ancient and semi-natural woodland (ASNW) has been investigated by applied aerial spectroscopy using an unmanned aerial vehicle (UAV) with multispectral image (MSI) camera. A novel normalised difference spectral index (NDSI) algorithm was developed using principal component analysis (PCA). This novel NDSI was then combined with a simple segmentation method of thresholding and applied for the identification of native tree species as well as the overall health of the woodland. Using this new approach allowed the identification of trees at canopy level, across 7.4 hectares (73,934 m(2)) of ASNW, as oak (53%), silver birch (37%), empty space (9%) and dead trees (1%). This UAV derived data was corroborated, for its accuracy, by a statistically valid ground-level field study that identified oak (47%), silver birch (46%) and dead trees (7.4%). This simple innovative approach, using a low-cost multirotor UAV with MSI camera, is both rapid to deploy, was flown around 100 m above ground level, provides useable high resolution (5.3 cm / pixel) data within 22 mins that can be interrogated using readily available PC-based software to identify tree species. In addition, it provides an overall oversight of woodland health and has the potential to inform a future woodland regeneration strategy.	[Ahmed, Shara; Nicholson, Catherine E.; Perry, Justin J.; Dean, John R.] Northumbria Univ, Dept Appl Sci, Ellison Bldg, Newcastle Upon Tyne, Tyne & Wear, England; [Muto, Paul] Nat England, Hampshire Court, Lancaster House, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University	Dean, JR (corresponding author), Northumbria Univ, Dept Appl Sci, Ellison Bldg, Newcastle Upon Tyne, Tyne & Wear, England.	john.dean@northumbria.ac.uk	Nicholson, Catherine/A-4481-2010	Nicholson, Catherine/0000-0002-3570-0627; Dean, John/0000-0001-5729-356X; Perry, Justin/0000-0002-3436-0093				[Anonymous], 2005, CONSERVATION HDB; Atkinson S., 2011, WOODL TRUST GRANTHAM, P1; Cao JJ, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010089; Chemura A, 2015, ISPRS J PHOTOGRAMM, V100, P118, DOI 10.1016/j.isprsjprs.2014.07.013; Cooper NS, 2000, BIODIVERS CONSERV, V9, P1131, DOI 10.1023/A:1008991117172; Dainelli R., 2021, FORESTS, V12, P1; Fagan M., 2009, RFF, P3; Fassnacht FE, 2016, REMOTE SENS ENVIRON, V186, P64, DOI 10.1016/j.rse.2016.08.013; Franklin SE, 2018, INT J REMOTE SENS, V39, P5236, DOI 10.1080/01431161.2017.1363442; Freudenberg M, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11030312; Fu W., 2020, MANUAL DIGITAL EARTH, P55, DOI 10.1007/978-981-32-9915-3_3; Gartner P, 2016, REMOTE SENS ENVIRON, V177, P237, DOI 10.1016/j.rse.2016.01.028; Gini R, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7080315; Gorrod Emma J., 2009, Ecological Management & Restoration, V10, P31, DOI 10.1111/j.1442-8903.2009.00437.x; Guimaraes N, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12061046; Heikkinen V, 2010, IEEE T GEOSCI REMOTE, V48, P1355, DOI 10.1109/TGRS.2009.2032239; Hernandez-Santin L, 2019, DRONES-BASEL, V3, DOI 10.3390/drones3010009; Lechner AM, 2020, ONE EARTH, V2, P405, DOI 10.1016/j.oneear.2020.05.001; Li L, 2015, REMOTE SENS-BASEL, V7, P1206, DOI 10.3390/rs70201206; Li WJ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11010011; Li XH, 2014, IEEE T GEOSCI REMOTE, V52, P7086, DOI 10.1109/TGRS.2014.2307354; Amigo JM, 2020, DATA HANDL SCI TECHN, V32, P3, DOI 10.1016/B978-0-444-63977-6.00001-8; Mishra NB, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7110445; Miyoshi GT, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12020244; Morley PJ, 2020, ENVIRON RES COMMUN, V2, DOI 10.1088/2515-7620/aba7a0; Office for National Statistics, LOC AR REP; Raparelli E, 2019, INT J REMOTE SENS, V40, P9070, DOI 10.1080/01431161.2019.1569793; Rogan J, 2003, PHOTOGRAMM ENG REM S, V69, P793, DOI 10.14358/PERS.69.7.793; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Salovaara KJ, 2005, REMOTE SENS ENVIRON, V97, P39, DOI 10.1016/j.rse.2005.04.013; Santo RD, 2012, EINSTEIN-SAO PAULO, V10, pxv; Santoso H, 2016, INT J REMOTE SENS, V37, P5122, DOI 10.1080/01431161.2016.1226527; Saynajoki R, 2008, SENSORS-BASEL, V8, P5037, DOI 10.3390/s8085037; Secord J, 2007, IEEE GEOSCI REMOTE S, V4, P196, DOI 10.1109/LGRS.2006.888107; Shafri HZM, 2011, INT J REMOTE SENS, V32, P2095, DOI 10.1080/01431161003662928; Sothe C, 2020, GISCI REMOTE SENS, V57, P369, DOI 10.1080/15481603.2020.1712102; Srestasathiern P, 2014, REMOTE SENS-BASEL, V6, P9749, DOI 10.3390/rs6109749; Strimbu VF, 2015, ISPRS J PHOTOGRAMM, V104, P30, DOI 10.1016/j.isprsjprs.2015.01.018; Su G., 2009, IEEE T GEOSCI ELECT, P623; Tehrany MS, 2017, J NAT CONSERV, V40, P12, DOI 10.1016/j.jnc.2017.08.004; Tuominen S, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10050714; Woodland Trust, ANC WOODL; Xue JR, 2017, J SENSORS, V2017, DOI 10.1155/2017/1353691; Yaney-Keller A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217310; Zerger Andre, 2006, Ecological Management & Restoration, V7, pS37, DOI 10.1111/j.1442-8903.2006.00290.x	45	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260056	10.1371/journal.pone.0260056	http://dx.doi.org/10.1371/journal.pone.0260056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780569	gold, Green Published, Green Accepted			2022-12-26	WOS:000755305800091
J	Koivunen, V; Juonala, M; Venermo, M; Laivuori, M; Jalkanen, JM; Hakovirta, HH				Koivunen, V; Juonala, M.; Venermo, M.; Laivuori, M.; Jalkanen, J. M.; Hakovirta, H. H.			Toe pressure and toe brachial index are predictive of cardiovascular mortality regardless of the most diseased arterial segment in symptomatic lower-extremity artery disease-A retrospective cohort study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; RISK-FACTORS; ATHEROSCLEROSIS; PREVALENCE; AMPUTATION; SURVIVAL; ISCHEMIA; PAD	Objective Although lower extremity arterial disease (LEAD) is most often multisegmental, the predominant disease location and risk factors differ between patients. Ankle-brachial index (ABI), toe-brachial index (TBI), and toe pressure (TP) are predictive of outcome in LEAD patients. Previously, we reported a classification method defining the most diseased arterial segment (MDAS); crural (CR), femoropopliteal (FP), or aortoiliac (AOI). Current study aimed to analyze the associations between MDAS, peripheral pressure measurements and cardiovascular mortality. Materials and methods We reviewed retrospectively 729 consecutive LEAD patients (Rutherford 2-6) who underwent digital subtraction angiography between January, 2009 to August, 2011 and had standardized peripheral pressure measurements. Results In Cox Regression analyses, cardiovascular mortality was associated with MDAS and non-invasive pressure indices as follows; MDAS AOI, TP <30 mmHg (HR 3.00, 95% CI 1.13-7.99); MDAS FP, TP <30 mmHg (HR 2.31, 95% CI 1.36-3.94), TBI <0.25 (HR 3.20, 95% CI 1.34-7.63), ABI <0.25 (HR 5.45, 95% CI 1.56-19.0) and >= 1.30 (HR 6.71, 95% CI 1.89-23.8), and MDAS CR, TP <30 mmHg (HR 4.26, 95% CI 2.19-8.27), TBI <0.25 (HR 7.71, 95% CI 1.86-32.9), and ABI <0.25 (HR 2.59, 95% CI 1.15-5.85). Conclusions Symptomatic LEAD appears to be multisegmental with severe infrapopliteal involvement. Because of this, TP and TBI are strongly predictive of cardiovascular mortality and they should be routinely measured despite the predominant disease location or clinical presentation.	[Koivunen, V; Juonala, M.; Jalkanen, J. M.; Hakovirta, H. H.] Univ Turku, Fac Med, Turku, Finland; [Juonala, M.] Univ Turku, Dept Internal Med, Turku, Finland; [Juonala, M.] Turku Univ Hosp, Div Med, Turku, Finland; [Venermo, M.; Laivuori, M.] Helsinki Univ Hosp, Abdominal Ctr, Dept Vasc Surg, Helsinki, Finland; [Venermo, M.; Laivuori, M.] Univ Helsinki, Helsinki, Finland; [Jalkanen, J. M.; Hakovirta, H. H.] Univ Turku, Turku Univ Hosp, Dept Vasc Surg, Turku, Finland; [Hakovirta, H. H.] Satakunta Cent Hosp, Dept Surg, Pori, Finland	University of Turku; University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; Satakunta Central Hospital	Koivunen, V (corresponding author), Univ Turku, Fac Med, Turku, Finland.	veekoi@utu.fi	Hakovirta, Harri/ABD-2437-2020	Hakovirta, Harri/0000-0002-1518-045X; Juonala, Markus/0000-0001-9498-364X	Turku University Hospital	Turku University Hospital	Authors M.J. and H.H.H were funded by federal research grants from Turku University Hospital. The funder (Turku University Hospital) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2006, CIRCULATION, V113, P2623, DOI 10.1161/CIRCULATIONAHA.105.608679; Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Chen Q, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000304; Chisalita SI, 2020, DIABETES RES CLIN PR, V161, DOI 10.1016/j.diabres.2020.108040; Diehm N, 2006, EUR J VASC ENDOVASC, V31, P59, DOI 10.1016/j.ejvs.2005.09.006; Gray BH, 2010, ANN VASC SURG, V24, P349, DOI 10.1016/j.avsg.2009.07.034; Hanssen NMJ, 2012, DIABETES CARE, V35, P1731, DOI 10.2337/dc12-0178; Hyun Suzanne, 2014, J Vasc Surg, V60, P390, DOI 10.1016/j.jvs.2014.02.008; Jalkanen JM, 2016, ATHEROSCLEROSIS, V251, P328, DOI 10.1016/j.atherosclerosis.2016.04.016; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; Laivuori M, 2021, J VASC SURG, V73, P641, DOI 10.1016/j.jvs.2020.06.104; Leskinen Y, 2002, AM J KIDNEY DIS, V40, P472, DOI 10.1053/ajkd.2002.34885; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Ozkan U, 2009, J VASC INTERV RADIOL, V20, P437, DOI 10.1016/j.jvir.2009.01.010; Potier L, 2011, EUR J VASC ENDOVASC, V41, P110, DOI 10.1016/j.ejvs.2010.09.020; Prasad R, 2019, HEMODIAL INT, V23, P214, DOI 10.1111/hdi.12734; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Singh GD, 2017, VASC MED, V22, P210, DOI 10.1177/1358863X16689831; Stoekenbroek RM, 2015, EUR J VASC ENDOVASC, V49, P192, DOI 10.1016/j.ejvs.2014.10.020; Suominen V, 2008, EUR J VASC ENDOVASC, V35, P709, DOI 10.1016/j.ejvs.2008.01.013; Suominen V, 2010, EUR J VASC ENDOVASC, V39, P316, DOI 10.1016/j.ejvs.2009.12.003; Vallabhaneni R, 2016, J VASC SURG, V63, P105, DOI 10.1016/j.jvs.2015.07.095; Wickstrom JE, 2017, EUR J VASC ENDOVASC, V53, P696, DOI 10.1016/j.ejvs.2017.02.012; Wickstrom JE, 2017, ATHEROSCLEROSIS, V264, P44, DOI 10.1016/j.atherosclerosis.2017.07.023; Wukich DK, 2015, FOOT ANKLE INT, V36, P1391, DOI 10.1177/1071100715593888; Zobel EH, 2017, DIABETOLOGIA, V60, P1883, DOI 10.1007/s00125-017-4344-x	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259122	10.1371/journal.pone.0259122	http://dx.doi.org/10.1371/journal.pone.0259122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780498	gold, Green Published			2022-12-26	WOS:000755305800020
J	Snyder, RL; Anderson, LE; White, KA; Tavitian, S; Fike, LV; Jones, HN; Jacobs-Slifka, KM; Stone, ND; Sinkowitz-Cochran, RL				Snyder, Rachel L.; Anderson, Laura E.; White, Katelyn A.; Tavitian, Stephanie; Fike, Lucy, V; Jones, Heather N.; Jacobs-Slifka, Kara M.; Stone, Nimalie D.; Sinkowitz-Cochran, Ronda L.			A qualitative assessment of factors affecting nursing home caregiving staff experiences during the COVID-19 pandemic	PLOS ONE			English	Article								Background A large portion of COVID-19 cases and deaths in the United States have occurred in nursing homes; however, current literature including the frontline perspective of staff working in nursing homes is limited. The objective of this qualitative assessment was to better understand what individual and facility level factors may have contributed to the impact of COVID-19 on Certified Nursing Assistants (CNAs) and Environmental Services (EVS) staff working in nursing homes. Methods Based on a simple random sample from the National Healthcare Safety Network (NHSN), 7,520 facilities were emailed invitations requesting one CNA and/or one EVS staff member for participation in a voluntary focus group over Zoom. Facility characteristics were obtained via NHSN and publicly available sources; participant demographics were collected via SurveyMonkey during registration and polling during focus groups. Qualitative information was coded using NVIVO and Excel. Results Throughout April 2021, 23 focus groups including 110 participants from 84 facilities were conducted homogenous by participant role. Staffing problems were a recurring theme reported. Participants often cited the toll the pandemic took on their emotional well-being, describing increased stress, responsibilities, and time needed to complete their jobs. The lack of consistent and systematic guidance resulting in frequently changing infection prevention protocols was also reported across focus groups. Conclusions Addressing concerns of low wages and lack of financial incentives may have the potential to attract and retain employees to help alleviate nursing home staff shortages. Additionally, access to mental health resources could help nursing home staff cope with the emotional burden of the COVID-19 pandemic. These frontline staff members provided invaluable insight and should be included in improvement efforts to support nursing homes recovering from the impact of COVID-19 as well as future pandemic planning.	[Snyder, Rachel L.; Anderson, Laura E.; White, Katelyn A.; Tavitian, Stephanie; Fike, Lucy, V; Jones, Heather N.; Jacobs-Slifka, Kara M.; Stone, Nimalie D.; Sinkowitz-Cochran, Ronda L.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Snyder, RL (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	oeg5@cdc.gov		White, Katelyn/0000-0002-3605-6781				[Anonymous], CDCATSDR SOCIAL VULN; [Anonymous], NCHS URBAN RURAL CLA; [Anonymous], COVID 19 NURSING HOM; Berridge C, 2018, J APPL GERONTOL, V37, P419, DOI 10.1177/0733464816665204; Gainer DM, 2021, J OCCUP ENVIRON MED, V63, P89, DOI 10.1097/JOM.0000000000002086; Krueger RA, 2014, FOCUS GROUPS PRACTIC; Lee JT, 2021, MMWR-MORBID MORTAL W, V70, P1036, DOI [10.1101/2021.05.14.21257224v1, 10.15585/mmwr.mm7030a2externalicon, 10.15585/mmwr.mm7030a2]; MacCannell T, 2022, CLIN INFECT DIS, V74, P829, DOI 10.1093/cid/ciab553; McGarry BE, 2020, HEALTH AFFAIR, V39, P1812, DOI 10.1377/hlthaff.2020.01269; Seshadri S, 2021, INFECT CONT HOSP EP, V42, P1020, DOI 10.1017/ice.2020.393; Travers JL, 2020, BMC NURS, V19, DOI 10.1186/s12912-020-00489-9; True S., 2020, COVID 19 WORKERS RIS; Van Houtven CH, 2020, J AM GERIATR SOC, V68, P1657, DOI 10.1111/jgs.16509; White EM, 2021, J AM MED DIR ASSOC, V22, P199, DOI 10.1016/j.jamda.2020.11.022; Wright HM, 2021, J PSYCHIATR RES, V137, P673, DOI 10.1016/j.jpsychires.2020.10.045; Young KP, 2021, PSYCHIAT SERV, V72, P122, DOI 10.1176/appi.ps.202000424	16	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260055	10.1371/journal.pone.0260055	http://dx.doi.org/10.1371/journal.pone.0260055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780563	Green Published, gold			2022-12-26	WOS:000755305800090
J	Sakurai, K; Itou, T; Morita, M; Kasahara, E; Moriyama, T; Macpherson, T; Ozawa, T; Miyamoto, Y; Yoneda, Y; Sekiyama, A; Oka, M; Hikida, T				Sakurai, Koki; Itou, Taichi; Morita, Makiko; Kasahara, Emiko; Moriyama, Tetsuji; Macpherson, Tom; Ozawa, Takaaki; Miyamoto, Yoichi; Yoneda, Yoshihiro; Sekiyama, Atsuo; Oka, Masahiro; Hikida, Takatoshi			Effects of Importin alpha 1/KPNA1 deletion and adolescent social isolation stress on psychiatric disorder-associated behaviors in mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ELEVATED PLUS-MAZE; PREPULSE INHIBITION; NUCLEAR-TRANSPORT; SCHIZOPHRENIA; PROLACTIN; EXPRESSION; ANXIETY; GENE; ENVIRONMENT	Importin alpha 1/KPNA1 is a member of the Importin alpha family widely present in the mammalian brain and has been characterized as a regulator of neuronal differentiation, synaptic functionality, and anxiety-like behavior. In humans, a de novo mutation of the KPNA1 (human Importin alpha 5) gene has been linked with schizophrenia; however, the precise roles of KPNA1 in disorder-related behaviors are still unknown. Moreover, as recent studies have highlighted the importance of gene-environment interactions in the development of psychiatric disorders, we investigated the effects of Kpna1 deletion and social isolation stress, a paradigm that models social stress factors found in human patients, on psychiatric disorder-related behaviors in mice. Through assessment in a behavioral battery, we found that Kpna1 knockout resulted in the following behavioral phenotype: (1) decreased anxiety-like behavior in an elevated plus maze test, (2) short term memory deficits in novel object recognition test (3) impaired sensorimotor gating in a prepulse inhibition test. Importantly, exposure to social isolation stress resulted in additional behavioral abnormalities where isolated Kpna1 knockout mice exhibited: (1) impaired aversive learning and/or memory in the inhibitory avoidance test, as well as (2) increased depression-like behavior in the forced swim test. Furthermore, we investigated whether mice showed alterations in plasma levels of stress-associated signal molecules (corticosterone, cytokines, hormones, receptors), and found that Kpna1 knockout significantly altered levels of corticosterone and LIX (CXCL5). Moreover, significant decreases in the level of prolactin were found in all groups except for group-housed wild type mice. Our findings demonstrate that Kpna1 deletion can trigger widespread behavioral abnormalities associated with psychiatric disorders, some of which were further exacerbated by exposure to adolescent social isolation. The use of Kpna1 knockout mice as a model for psychiatric disorders may show promise for further investigation of gene-environment interactions involved in the pathogenesis of psychiatric disorders.	[Sakurai, Koki; Macpherson, Tom; Ozawa, Takaaki; Hikida, Takatoshi] Osaka Univ, Inst Prot Res, Lab Adv Brain Funct, Osaka, Japan; [Sakurai, Koki; Macpherson, Tom; Ozawa, Takaaki; Hikida, Takatoshi] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan; [Itou, Taichi; Morita, Makiko; Macpherson, Tom; Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Dept Res & Drug Discovery, Kyoto, Japan; [Kasahara, Emiko; Sekiyama, Atsuo] Osaka Univ, Grad Sch Pharmaceut Sci, Adv Pharmaco Sci, Osaka, Japan; [Moriyama, Tetsuji] Univ Fukui, Fac Med Sci, Dept Cell Biol & Biochem, Fukui, Japan; [Miyamoto, Yoichi; Oka, Masahiro] Natl Inst Biomed Innovat Hlth & Nutr, Lab Nucl Transport Dynam, Osaka, Japan; [Yoneda, Yoshihiro] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan	Osaka University; Osaka University; Kyoto University; Osaka University; University of Fukui	Hikida, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Adv Brain Funct, Osaka, Japan.; Hikida, T (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka, Japan.; Hikida, T (corresponding author), Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Dept Res & Drug Discovery, Kyoto, Japan.	hikida@protein.osaka-u.ac.jp		/0000-0001-6952-7749; Miyamoto, Yoichi/0000-0003-4016-1119	Japan Society for the Promotion of Science KAKENHI [JP18K15044, JP26870341, JP21K15210, JP19K21806, JP19K03385, JP19H01769, JP21H00311, JP16H04789, JP16H06568, JP18H02542, JP21H05694]; AMED [JP21wm0425010]; Sasakawa Scientific Research Grant; Takeda Life Science Research Foundation; Taiju Life Social Welfare Foundation; Life Science Foundation of Japan; Salt Science Research Foundation [2137, 2146]; HOKUTO foundation for the promotion of biological science; Smoking Research Foundation; Research Foundation for Opto-science and Technology; Mitsubishi Foundation; Kowa Life Science Foundation; Collaborative Research Program of Institute for Protein Research, Osaka University [ICR-21-3]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Sasakawa Scientific Research Grant; Takeda Life Science Research Foundation; Taiju Life Social Welfare Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Salt Science Research Foundation; HOKUTO foundation for the promotion of biological science; Smoking Research Foundation; Research Foundation for Opto-science and Technology; Mitsubishi Foundation; Kowa Life Science Foundation; Collaborative Research Program of Institute for Protein Research, Osaka University	This study was supported by the Japan Society for the Promotion of Science KAKENHI grants (JP18K15044 and JP26870341 to T. Moriyama; JP21K15210 to T. Macpherson; JP19K21806, JP19K03385, JP19H01769, JP21H00311 to T.O.; JP16H04789 to Y.Y. and M. O.; JP16H06568, JP18H02542, JP21H05694 to T. H), AMED under Grant Number JP21wm0425010 to T.H., The Sasakawa Scientific Research Grant to K.S., Takeda Life Science Research Foundation to T.O. and T.H., Taiju Life Social Welfare Foundation to T.H., Life Science Foundation of Japan to T.H., The Salt Science Research Foundation, No. 2137 to T.H., No. 2146 to T.O., HOKUTO foundation for the promotion of biological science to T.O., Smoking Research Foundation to T.H., Research Foundation for Opto-science and Technology, The Mitsubishi Foundation to T.O., Kowa Life Science Foundation to T.O., and the Collaborative Research Program of Institute for Protein Research, Osaka University, ICR-21-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyan J, 2018, NEUROPSYCHOPHARMACOL, V43, P931, DOI 10.1038/npp.2017.260; Audet MC, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00156; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Bernard V, 2019, NAT REV ENDOCRINOL, V15, P356, DOI 10.1038/s41574-019-0194-6; Bostwick JR, 2009, PHARMACOTHERAPY, V29, P64, DOI 10.1592/phco.29.1.64; Bouwknecht JA, 2007, BRAIN RES BULL, V72, P32, DOI 10.1016/j.brainresbull.2006.12.009; Bradley AJ, 2010, J PSYCHOPHARMACOL, V24, P91, DOI 10.1177/1359786810385491; Brebner K, 2000, NEUROPSYCHOPHARMACOL, V22, P566, DOI 10.1016/S0893-133X(99)00166-9; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Cacioppo JT, 2015, ANNU REV PSYCHOL, V66, P733, DOI 10.1146/annurev-psych-010814-015240; Canto-de-Souza L, 2016, NEUROBIOL LEARN MEM, V130, P44, DOI 10.1016/j.nlm.2016.01.012; Chida Y, 2006, BRAIN RES, V1067, P201, DOI 10.1016/j.brainres.2005.10.042; Cinalli DA, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.527543; Dean B, 2013, MOL PSYCHIATR, V18, P767, DOI 10.1038/mp.2012.95; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Esquifino AI, 2004, ENDOCRINE, V25, P41, DOI 10.1385/ENDO:25:1:41; Estanislau C, 2011, BEHAV PROCESS, V86, P46, DOI 10.1016/j.beproc.2010.08.008; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Hamasaki Y, 2021, CHILD PSYCHIAT HUM D, V52, P808, DOI 10.1007/s10578-020-01064-8; Hayakawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21260-w; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hikida T, 2020, NEUROSCI RES, V151, P38, DOI 10.1016/j.neures.2019.02.007; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Himmerich H, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00030; Ho YJ, 2002, BEHAV BRAIN RES, V136, P1, DOI 10.1016/S0166-4328(02)00089-X; Hosokawa K, 2008, NEUROSCIENCE, V157, P864, DOI 10.1016/j.neuroscience.2008.09.045; Ishikawa Y, 2021, BRIT J PHARMACOL, V178, P827, DOI 10.1111/bph.15203; Johnson JD, 2019, J ENDOCR SOC, V3, P1302, DOI 10.1210/js.2019-00053; Jouan L, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-9; Kiselycznyk C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00010; Kobayashi Y, 2021, NEUROPSYCHOPHARM REP, V41, P416, DOI 10.1002/npr2.12178; Kopec AM, 2019, TRENDS NEUROSCI, V42, P337, DOI 10.1016/j.tins.2019.02.005; Kozuka T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38910-2; Kraeuter AK, 2019, METHODS MOL BIOL, V1916, P105, DOI 10.1007/978-1-4939-8994-2_10; Lee JS, 2021, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.616389; Lueptow LM, 2017, JOVE-J VIS EXP, DOI 10.3791/55718; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Macpherson T, 2019, NEUROCHEM INT, V126, P11, DOI 10.1016/j.neuint.2019.02.011; Marvaldi L, 2020, SCIENCE, V369, P842, DOI 10.1126/science.aaz5875; Matsumoto Y, 2018, BIOL OPEN, V7, DOI 10.1242/bio.034710; Mena A, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00202; Miyamoto Y, 2020, FASEB J, V34, P16224, DOI 10.1096/fj.202000768RR; Miyamoto Y, 2016, J BIOCHEM, V160, P69, DOI 10.1093/jb/mvw036; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Moriyama T, 2011, FEBS J, V278, P1561, DOI 10.1111/j.1742-4658.2011.08079.x; Morris CP, 2012, DIS MARKERS, V33, P163, DOI [10.1155/2012/651707, 10.3233/DMA-2012-0921]; Mumtaz F, 2018, BIOMED PHARMACOTHER, V105, P1205, DOI 10.1016/j.biopha.2018.05.086; Nie X, 2018, NEURON, V99, P464, DOI 10.1016/j.neuron.2018.06.035; Niwa M, 2013, SCIENCE, V339, P335, DOI 10.1126/science.1226931; Niwa M, 2011, INT J NEUROPSYCHOPH, V14, P459, DOI 10.1017/S1461145710001239; Orti-Casan N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00049; Osterlund C, 2011, J ENDOCRINOL, V208, P311, DOI 10.1530/JOE-10-0413; Panayotis N, 2018, CELL REP, V25, P3169, DOI 10.1016/j.celrep.2018.11.066; Panayotis N, 2015, TRENDS NEUROSCI, V38, P108, DOI 10.1016/j.tins.2014.12.001; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Perello M, 2006, LIFE SCI, V78, P1857, DOI 10.1016/j.lfs.2005.08.029; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Rajkumar RP, 2014, SCHIZOPHR RES TREAT, V2014, DOI 10.1155/2014/175360; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Rohleder C, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00148; Roussos P, 2013, NEUROPSYCHOPHARMACOL, V38, P533, DOI 10.1038/npp.2012.215; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Shmidt T, 2007, NAT CELL BIOL, V9, P1337, DOI 10.1038/ncb1207-1337; Shoji H, 2021, MOL BRAIN, V14, DOI 10.1186/s13041-020-00721-2; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Stuart MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00357; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Takahashi N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.8; Tchessalova D, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00039; Teixeira AL, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00241; Torner L, 2002, EUR J NEUROSCI, V15, P1381, DOI 10.1046/j.1460-9568.2002.01965.x; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Torner L, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00025; Tsuang Ming T, 2004, World Psychiatry, V3, P73; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang LY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0474-6; Wei J, 2005, NEUROSCI RES, V52, P342, DOI 10.1016/j.neures.2005.04.005; Winslow JT, 2002, BIOL PSYCHIAT, V51, P859, DOI 10.1016/S0006-3223(02)01345-8; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21410; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035; Yan Z, 2022, MOL PSYCHIATR, V27, P445, DOI 10.1038/s41380-021-01092-3; Yankelevitch-Yahav R, 2015, JOVE-J VIS EXP, DOI 10.3791/52587; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuhara N, 2013, DEV CELL, V26, P123, DOI 10.1016/j.devcel.2013.06.022; Yoshiya M, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00191	99	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258364	10.1371/journal.pone.0258364	http://dx.doi.org/10.1371/journal.pone.0258364			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767585	Green Published, gold			2022-12-26	WOS:000755249300007
J	Wolde, FB; Ali, JH; Mengistu, YG				Wolde, Firmaye Bogale; Ali, Jemal Haidar; Mengistu, Yalemwork Getnet			Employed mothers' breastfeeding: Exploring breastfeeding experience of employed mothers in different work environments in Ethiopia	PLOS ONE			English	Article							WORKPLACE; INFANT	Background One of the most cost-effective interventions to enhance child health with the potential to reach families of all economic backgrounds is breastfeeding. Despite the many benefits optimal breastfeeding has, its practice is low due to various barriers among which maternal employment is mentioned repeatedly. Accordingly, this study has explored the experience of employed mothers with regards to breastfeeding, employment, and work environment in Addis Ababa Ethiopia. Methods and findings A descriptive Phenomenology strategy was employed among 17 mothers drawn from different organizations, conveniently, that offer accommodation of six months maternity leave or onsite child care center or had only three months maternity leave. Data were collected through in-depth interviews until information saturation was reached. Recorded interviews were transcribed and translated and the information obtained was then organized and coded to generate overarching themes. Two themes on facilitators and barriers, and addressing barriers were generated after analysis. Mothers recognize the importance of breastfeeding for children but returning to work at three months is expressed as a major barrier to continuous breastfeeding. Mothers who have access to supporting conditions at their workplace expressed better breastfeeding practice and better satisfaction with their job. Conclusions Providing employed mothers with a supporting environment helps them work with better stability, motivation, and satisfaction. This however requires a suitable accommodation with a focus on the different kinds of work environments of the mothers and the different risks related to each respective environment via scaling up and monitoring breastfeeding interventions and calling upon institutions to remove structural and societal barriers to breastfeeding.	[Wolde, Firmaye Bogale] Ethiopian Publ Hlth Inst, Dept Knowledge Translat, Addis Ababa, Ethiopia; [Ali, Jemal Haidar; Mengistu, Yalemwork Getnet] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Wolde, FB (corresponding author), Ethiopian Publ Hlth Inst, Dept Knowledge Translat, Addis Ababa, Ethiopia.	fbfbogale93@gmail.com		Wolde, Firmaye/0000-0003-2987-8872				Agency C.S. and M. ORC, 2005, ETHIOPIA DEMOGRAPHIC; Agunbiade OM, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-5; Alive and Thrive, 2015, OPTIMAL BREASTFEEDIN; Amin RM, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-4; Arthur Chris Rodgers, 2003, J Miss State Med Assoc, V44, P383; Ashmika M., 2014, FOOD NUTR J, V2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Brown A., 2001, J HUMAN LACTATION SA, V17; Brown A., 2001, J HUMAN LACTATION SA, V17, P39; Chekol DA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0118-9; Creswell J.W., 2009, QUALITATIVE QUANTITA, V3; Ekanem I., 2012, J FOOD RES, V1; Favin M., 1996, GUIDE QUALITATIVE RE; FDRE House of People's Representative, 2019, FED NEG GAZ FED DEM, V25, P11691; Frehiwot W., 2014, ETHIOPIA; Fund U.N.C.s., 2019, FAMILY FRIENDLY POLI; Gebrekidan K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252445; Gebrekidan K, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13190; Hailu S, 2014, J COMMUNITY MED HLTH, V4; Hirani S., 2016, AVAILABILITY BREASTF; internation I., 2011, ETHIOPIA DEMOGRAPHIC; Jantzer AM, 2018, J HUM LACT, V34, P379, DOI 10.1177/0890334417707956; Kebede T, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-019-0250-9; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; McGuire S, 2015, ADV NUTR, V6, P134, DOI 10.3945/an.114.007781; Naeem S.Z., 2008, INT J CARING SCI, V1; Organization I.L, 2000, MATERNITY PROTECTION; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Sari Y., 2015, INT J RES MED SCI, V3, P2599; Skafida V, 2012, MATERN CHILD HLTH J, V16, P519, DOI 10.1007/s10995-011-0743-7; Soomro A., 2015, FACTORS AFFECTING BR; Soomro JA, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0084-7; Sousan e.a.V., 2017, NURS HEALTH SCI, V19; Tadesse F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7345-5; Tsai SY, 2013, BREASTFEED MED, V8, P210, DOI 10.1089/bfm.2012.0119; UN, 2012, WORLDS WOMEN TRENDS; UNICEF, 2013, IMPROVING CHILD NUTR; W R., 2004, MCN AM J MATERNAL CH, V29, P222, DOI [10.1097/00005721-200407000-00004, DOI 10.1097/00005721-200407000-00004]; Ware JL, 2019, BREASTFEED MED, V14, P465, DOI 10.1089/bfm.2019.0067; WHO, 2021, INF YOUNG CHILD FEED; World Health Organization, 2001, OPTIMAL DURATION EXC	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259831	10.1371/journal.pone.0259831	http://dx.doi.org/10.1371/journal.pone.0259831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767615	Green Published, gold			2022-12-26	WOS:000755249300053
J	Onyango, EO; Crush, J; Owuor, S				Onyango, Elizabeth Opiyo; Crush, Jonathan; Owuor, Samuel			Preparing for COVID-19: Household food insecurity and vulnerability to shocks in Nairobi, Kenya	PLOS ONE			English	Article							POLITICAL VIOLENCE; ADAPTATION; SECURITY; IMPACTS; AFRICA; PRICE	An understanding of the types of shocks that disrupt and negatively impact urban household food security is of critical importance to develop relevant and targeted food security emergency preparedness policies and responses, a fact magnified by the current COVID-19 pandemic. This gap is addressed by the current study which draws from the Hungry Cities Partnership (HCP) city-wide household food insecurity survey of Nairobi city in Kenya. It uses both descriptive statistics and multilevel modelling using General Linear Mixed Models (GLMM) to examine the relationship between household food security and 16 different shocks experienced in the six months prior to the administration of the survey. The findings showed that only 29% of surveyed households were completely food secure. Of those experiencing some level of food insecurity, more experienced economic (55%) than sociopolitical (16%) and biophysical (10%) shocks. Economic shocks such as food price increases, loss of employment, and reduced income were all associated with increased food insecurity. Coupled with the lack of functioning social safety nets in Nairobi, households experiencing shocks and emergencies experience serious food insecurity and related health effects. In this context, the COVID-19 pandemic is likely to have a major negative economic impact on many vulnerable urban households. As such, there is need for new policies on urban food emergencies with a clear emergency preparedness plan for responding to major economic and other shocks that target the most vulnerable.	[Onyango, Elizabeth Opiyo; Crush, Jonathan] Balsillie Sch Int Affairs, Waterloo, ON, Canada; [Crush, Jonathan] Wilfrid Laurier Univ, Waterloo, ON, Canada; [Crush, Jonathan] Univ Western Cape, Cape Town, South Africa; [Owuor, Samuel] Univ Nairobi, Nairobi, Kenya	University of Waterloo; Wilfrid Laurier University; University of the Western Cape; University of Nairobi	Crush, J (corresponding author), Balsillie Sch Int Affairs, Waterloo, ON, Canada.; Crush, J (corresponding author), Wilfrid Laurier Univ, Waterloo, ON, Canada.; Crush, J (corresponding author), Univ Western Cape, Cape Town, South Africa.	jcrush@balsillieschool.ca		Crush, Jonathan/0000-0003-3342-3192	Social Sciences and Humanities Research Council of Canada (SSHRC) [895-2013-3005, 895-2021-1004]; International Development Research Centre (IDRC) [107775-001]; Queen Elizabeth Advanced Scholars Program [Laurier_2016_QES-AS]	Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); International Development Research Centre (IDRC); Queen Elizabeth Advanced Scholars Program	JC, SO Social Sciences and Humanities Research Council of Canada (SSHRC) Grant No: 895-2013-3005 https://www.sshrc-crsh.gc.ca/ home-accueil-eng.aspx JC, SO Social Sciences and Humanities Research Council of Canada (SSHRC) Grant No: 895-2021-1004 https://www.sshrc-crsh. gc.ca/home-accueil-eng.aspx JC, SO International Development Research Centre (IDRC) Grant No: 107775-001 https://www.idrc.ca/en JC, EO Queen Elizabeth Advanced Scholars Program Grant No: Laurier_2016_QES-AS, Jonathan Crush, Elizabeth Onyango https://www.univcan.ca/programs-andscholarships/queen-elizabeth-scholars/qes- advanced-scholars/.	Aday S, 2020, FOOD QUAL SAF-OXFORD, V4, P167, DOI 10.1093/fqsafe/fyaa024; Ahmed S., 2019, GEO GEOG ENV, P6; Akter S, 2014, GLOBAL ENVIRON CHANG, V25, P150, DOI 10.1016/j.gloenvcha.2014.02.003; Ansah IGK, 2021, CLIM DEV, V13, P414, DOI 10.1080/17565529.2020.1785832; Ansah IGK, 2019, FOOD SECUR, V11, P1187, DOI 10.1007/s12571-019-00968-1; Cardwell R, 2020, WORLD DEV, V135, DOI 10.1016/j.worlddev.2020.105059; Coates J., 2007, FOOD NUTR TECHNICAL; Coates J, 2013, GLOB FOOD SECUR-AGR, V2, P188, DOI 10.1016/j.gfs.2013.05.002; Corburn J, 2020, J URBAN HEALTH, V97, P348, DOI 10.1007/s11524-020-00438-6; Crush J, 2019, ROUTL STUD FOOD SOC, P42; Darma, 2020, INT J ADV SCI TECHNO, V29, P10338, DOI DOI 10.2478/MDKE-2020-0024; Devereux S, 2020, FOOD SECUR, V12, P769, DOI 10.1007/s12571-020-01085-0; FAO, 2014, WORLD REF BAS SOIL R, P191; Farrell P, 2020, FOOD SECUR, V12, P783, DOI 10.1007/s12571-020-01087-y; Frayne B, 2010, INT DEV PLANN REV, V32, P291, DOI 10.3828/idpr.2010.10; Fuseni I, 2018, FOOD NUTR SECURITY S, P66; Galanakis CM, 2020, FOODS, V9, DOI 10.3390/foods9040523; Hamilton H, 2020, FUTURES, V123, DOI 10.1016/j.futures.2020.102601; Heltberg R, 2015, J DEV STUD, V51, P209, DOI 10.1080/00220388.2014.959934; High Level Panel of Experts, 2020, IMP COVID 19 FOOD SE, P34; Iheme G.O., 2020, WORLD NUTR, V11, P35, DOI [DOI 10.2139/SSRN.3703169, 10.2139/ssrn.3703169]; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Kimani-Murage EW, 2014, J URBAN HEALTH, V91, P1098, DOI 10.1007/s11524-014-9894-3; Kiria Chege C., 2021, CIAT PUBLICATION, V514; KNBS, 2020, SURV SOC EC IMP COVI; Laborde D, 2020, SCIENCE, V369, P500, DOI 10.1126/science.abc4765; Lokonon BOK, 2015, AFR J AGRIC RESOUR E, V10, P234; Misselhorn AA, 2005, GLOBAL ENVIRON CHANG, V15, P33, DOI 10.1016/j.gloenvcha.2004.11.003; Mohamed S., 2016, RAPID URBANISATION U, P97; Mueller JC, 2018, TERROR POLIT VIOLENC, V30, P116, DOI 10.1080/09546553.2016.1165213; Mueller SD, 2011, J CONTEMP AFR STUD, V29, P99, DOI 10.1080/02589001.2011.537056; Nairobi City Council, 2020, NAIR CIT COUNTR FOOD; Nechifor V, 2021, GLOB FOOD SECUR-AGR, V28, DOI 10.1016/j.gfs.2021.100514; Niles MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192928; Nyadera IN, 2020, INT SOC WORK, V63, P838, DOI 10.1177/0020872820944997; Ouko K. O., 2020, Review of Agricultural and Applied Economics, V23, P72, DOI 10.15414/raae.2020.23.02.72-80; Owuor S., 2019, SUSTAINABLE DEV AFRI, P161; Owuor S., 2018, 11 HCP; Schielzeth H, 2013, METHODS ECOL EVOL, V4, P14, DOI 10.1111/j.2041-210x.2012.00251.x; Schofield L, 2013, SPOTTING INVISIBLE C; Shilomboleni Helena, 2020, AAS Open Res, V3, P27, DOI 10.12688/aasopenres.13078.1; Skrondal A., 2003, NOR EPIDEMIOL, P13; START Network, 2017, URBAN EARL WARN EARL; Tevera D., 2016, RAPID URBANISATION U, P157; Tongruksawattana S, 2019, CLIM DEV, V11, P710, DOI 10.1080/17565529.2018.1562862; Verpoorten M, 2013, FOOD POLICY, V39, P51, DOI 10.1016/j.foodpol.2012.12.006; Wagner J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11071963; Wien M, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0033-0; Zhong TY, 2022, DEV POLICY REV, V40, DOI 10.1111/dpr.12575	49	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259139	10.1371/journal.pone.0259139	http://dx.doi.org/10.1371/journal.pone.0259139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762674	gold, Green Published			2022-12-26	WOS:000755316600013
J	Ayouni, S; Hajjej, F; Maddeh, M; Al-Otaibi, S				Ayouni, Sarra; Hajjej, Fahima; Maddeh, Mohamed; Al-Otaibi, Shaha			A new ML-based approach to enhance student engagement in online environment	PLOS ONE			English	Article							LEARNING ANALYTICS; COMPUTER; SCHOOL	The educational research is increasingly emphasizing the potential of student engagement and its impact on performance, retention and persistence. This construct has emerged as an important paradigm in the higher education field for many decades. However, evaluating and predicting the student's engagement level in an online environment remains a challenge. The purpose of this study is to suggest an intelligent predictive system that predicts the student's engagement level and then provides the students with feedback to enhance their motivation and dedication. Three categories of students are defined depending on their engagement level (Not Engaged, Passively Engaged, and Actively Engaged). We applied three different machine-learning algorithms, namely Decision Tree, Support Vector Machine and Artificial Neural Network, to students' activities recorded in Learning Management System reports. The results demonstrate that machine learning algorithms could predict the student's engagement level. In addition, according to the performance metrics of the different algorithms, the Artificial Neural Network has a greater accuracy rate (85%) compared to the Support Vector Machine (80%) and Decision Tree (75%) classification techniques. Based on these results, the intelligent predictive system sends feedback to the students and alerts the instructor once a student's engagement level decreases. The instructor can identify the students' difficulties during the course and motivate them through e-mail reminders, course messages, or scheduling an online meeting.	[Ayouni, Sarra; Hajjej, Fahima; Al-Otaibi, Shaha] Princess Nourah Bint Abdulrahman Univ, Coll Comp & Informat Sci, Dept Informat Syst, Riyadh, Saudi Arabia; [Maddeh, Mohamed] King Saud Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University; King Saud University	Ayouni, S (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Comp & Informat Sci, Dept Informat Syst, Riyadh, Saudi Arabia.	saayouni@pnu.edu.sa	Al-Otaibi, Shaha/AHA-7277-2022; Ayouni, Sarra/CAH-4562-2022					Aldiab A, 2019, ENRGY PROCED, V160, P731, DOI 10.1016/j.egypro.2019.02.186; Allen I.E., 2013, CHANGING COURSE 10 Y; Alzahrani N.A., 2019, BIOSC BIOTECH RES CO, V12; Appleton JJ, 2008, PSYCHOL SCHOOLS, V45, P369, DOI 10.1002/pits.20303; Ayouni S., 2021, MATER TODAY-PROC; Ayouni S, 2021, INT J INF COMMUN TEC, V17, P17, DOI 10.4018/IJICTE.2021040102; Azcona D, 2019, USER MODEL USER-ADAP, V29, P759, DOI 10.1007/s11257-019-09234-7; Braten I, 2006, COMPUT HUM BEHAV, V22, P1027, DOI 10.1016/j.chb.2004.03.026; Macarini LAB, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9245523; Cagliero L, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11041420; Carini RM, 2006, RES HIGH EDUC, V47, P1, DOI 10.1007/s11162-005-8150-9; Christenson SL, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P1, DOI 10.1007/978-1-4614-2018-7; Coates H., 2007, ASSESS EVAL HIGH EDU, V32, P121, DOI DOI 10.1080/02602930600801878; Conrad R.M., 2012, CONTINUING ENGAGE ON; Costa EB, 2017, COMPUT HUM BEHAV, V73, P247, DOI 10.1016/j.chb.2017.01.047; D'Mello S, 2018, EMOT REV, V10, P174, DOI 10.1177/1754073917696583; Dabbagh N., 2004, INT J E LEARNING, V3; Dixson MD, 2015, ONLINE LEARN, V19, P143; Duderstadt J.J., 2002, HIGHER ED DIGITAL AG; Eyink JR, 2020, J APPL SOC PSYCHOL, V50, P10, DOI 10.1111/jasp.12637; Fauth B, 2014, LEARN INSTR, V29, P1, DOI 10.1016/j.learninstruc.2013.07.001; FINN JD, 1993, J NEGRO EDUC, V62, P249, DOI 10.2307/2295464; Fisher C.W., 1985, INSTR SCI, Vvol. 15, P169; Fuente-Mella H., 2020, APPL SCI MDPI, V10; Gasevic D., 2017, J LEARN ANAL, V4; Golladay RM, 2000, J COMPUT INFORM SYST, V40, P69; Hajjej F., 2021, INT J WEB BASED LEAR, V15, P21; Hlaoui YB, 2016, COMPUT APPL ENG EDUC, V24, P951, DOI 10.1002/cae.21770; Hussain M, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/6347186; Iwendi C, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092559; Iwendi C, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8111331; Jayaprakash S.M., 2014, J LEARN ANAL, V1, P6; Jiang PC, 2020, IEEE ACCESS, V8, P219775, DOI 10.1109/ACCESS.2020.3042775; Karlos S, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10238413; Kerwin L. A, 2015, IMPACT WEB 2 0 ED IT; Klem AM, 2004, J SCHOOL HEALTH, V74, P262, DOI 10.1111/j.1746-1561.2004.tb08283.x; Kuh GD, 2001, J COLL STUDENT DEV, V42, P217; Lee JS, 2014, J EDUC RES, V107, P177, DOI 10.1080/00220671.2013.807491; Liu D, 2020, IEEE ACCESS, V8, P194894, DOI 10.1109/ACCESS.2020.3033200; Maeroff GI, 2003, CLASSROOM OF ONE: HOW ONLINE LEARNING IS CHANGING OUR SCHOOLS AND COLLEGES, P1; Mandernach B.J., 2015, INT J LEARN TEACH ED, V12, P1, DOI 10.1080/02602938.2021.1986468; Martin F, 2018, ONLINE LEARN, V22, P205, DOI 10.24059/olj.v22i1.1092; Motz B, 2019, PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON LEARNING ANALYTICS & KNOWLEDGE (LAK'19), P300, DOI 10.1145/3303772.3303789; Namoun A, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11010237; Ofori F., 2020, J INFORM TECHNOLOGY, V4, P33; Onan A, 2020, COMPUT APPL ENG EDUC, V28, P117, DOI 10.1002/cae.22179; Robinson CC, 2008, J EDUC BUS, V84, P101, DOI 10.3200/JOEB.84.2.101-109; Rodgers T., 2008, INT J CYBER SOC ED, V1, P143; Seaman J.E., 2018, GRADE INCREASE TRACK; Steinberg L., 1996, SEXUALITY CHRIST REN; Steve K, 2012, MOOCS CREDIT; Thurmond V., 2004, INT J INSTRUCTIONAL; Trowler V., 2010, STUDENT ENGAGEMENT L; Umer R, 2019, 2019 INTERNATIONAL CONFERENCE ON BIG DATA AND EDUCATION (ICBDE 2019), P52, DOI 10.1145/3322134.3322140	54	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258788	10.1371/journal.pone.0258788	http://dx.doi.org/10.1371/journal.pone.0258788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9NU	34758022	gold, Green Published			2022-12-26	WOS:000755112500009
J	Figueroa, LL; Maran, A; Pelini, SL				Figueroa, Laura L.; Maran, Audrey; Pelini, Shannon L.			Increasing temperatures reduce invertebrate abundance and slow decomposition	PLOS ONE			English	Article							LEAF-LITTER DECOMPOSITION; CLIMATE-CHANGE; TERRESTRIAL ECOSYSTEMS; SOIL FAUNA; FOREST; CHEMISTRY; RESPONSES; RATES; BIODIVERSITY; MICROCOSMS	Decomposition is an essential ecosystem service driven by interacting biotic and abiotic factors. Increasing temperatures due to climate change can affect soil moisture, soil fauna, and subsequently, decomposition. Understanding how projected climate change scenarios will affect decomposition is of vital importance for predicting nutrient cycling and ecosystem health. In this study, we experimentally addressed the question of how the early stages of decomposition would vary along a gradient of projected climate change scenarios. Given the importance of biodiversity for ecosystem service provisioning, we measured the effect of invertebrate exclusion on red maple (Acer rubrum) leaf litter breakdown along a temperature gradient using litterbags in warming chambers over a period of five weeks. Leaf litter decomposed more slowly in the warmer chambers and in the litterbag treatment that minimized invertebrate access. Moreover, increasing air temperature reduced invertebrate abundance and richness, and altered the community composition, independent of exclusion treatment. Using structural equation models, we were able to disentangle the effects of average air temperature on leaf litter loss, finding a direct negative effect of warming on the early stages of decomposition, independent of invertebrate abundance. This result indicates that not only can climate change affect the invertebrate community, but may also directly influence how the remaining organisms interact with their environment and their effectiveness at provisioning ecosystem services. Overall, our study highlights the role of biodiversity in maintaining ecosystem services and contributes to our understanding of how climate change could disrupt nutrient cycling.	[Figueroa, Laura L.; Maran, Audrey; Pelini, Shannon L.] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Maran, Audrey; Pelini, Shannon L.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Figueroa, Laura L.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Figueroa, Laura L.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Harvard University; University System of Ohio; Bowling Green State University; University of Massachusetts System; University of Massachusetts Amherst; Cornell University	Figueroa, LL (corresponding author), Harvard Univ, Harvard Forest, Petersham, MA 01366 USA.; Figueroa, LL (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.; Figueroa, LL (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	llf44@umass.edu		Figueroa, Laura/0000-0003-0655-8278				Abrams MD, 1998, BIOSCIENCE, V48, P355, DOI 10.2307/1313374; Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; ANDERSON JM, 1991, ECOL APPL, V1, P326, DOI 10.2307/1941761; Barton K, 2015, PACKAGE MUMIN VERSIO, V1, P18; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; BERG B, 1993, BIOGEOCHEMISTRY, V20, P127, DOI 10.1007/BF00000785; Berg B., 2014, PLANT LITTER DECOMPO, VThird Edition; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Bradford MA, 2016, J ECOL, V104, P229, DOI 10.1111/1365-2745.12507; Chung H, 2013, J PLANT RES, V126, P447, DOI 10.1007/s10265-013-0565-3; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Del Toro I, 2015, J ANIM ECOL, V84, P1233, DOI 10.1111/1365-2656.12367; Diamond SE, 2012, ECOLOGY, V93, P2305, DOI 10.1890/11-2296.1; Ferreira V, 2015, FRESHWATER BIOL, V60, P881, DOI 10.1111/fwb.12539; Ferreira V, 2015, CAN J FISH AQUAT SCI, V72, P206, DOI 10.1139/cjfas-2014-0119; Fitzgerald JL, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3473; Frouz J, 2015, EUR J SOIL BIOL, V68, P18, DOI 10.1016/j.ejsobi.2015.03.002; Gonzalez G, 2001, ECOLOGY, V82, P955, DOI 10.1890/0012-9658(2001)082[0955:SFAPLD]2.0.CO;2; Guo C, 2020, FUNCT ECOL, V34, P735, DOI 10.1111/1365-2435.13496; HAIMI J, 1990, BIOL FERT SOILS, V10, P178; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hunter MD, 2003, PEDOBIOLOGIA, V47, P101, DOI 10.1078/0031-4056-00174; Innangi M, 2015, APPL SOIL ECOL, V93, P88, DOI 10.1016/j.apsoil.2015.04.007; Joly FX, 2018, FUNCT ECOL, V32, P2605, DOI 10.1111/1365-2435.13178; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Lenth R., 2018, R PACKAGE VERSION, V1, P3; Meyer L., 2014, CLIMATE CHANGE 2014; Meyer WM, 2011, SOIL BIOL BIOCHEM, V43, P206, DOI 10.1016/j.soilbio.2010.10.005; Moise ERD, 2014, OECOLOGIA, V176, P1151, DOI 10.1007/s00442-014-3068-6; Ojala R, 2001, PEDOBIOLOGIA, V45, P443, DOI 10.1078/0031-4056-00098; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Ott D, 2012, PHILOS T R SOC B, V367, P3025, DOI 10.1098/rstb.2012.0240; Pelini SL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00143.1; Pelini SL, 2012, ECOL EVOL, V2, P3009, DOI 10.1002/ece3.407; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; Perreault JM, 2006, PEDOBIOLOGIA, V50, P397, DOI 10.1016/j.pedobi.2006.07.003; Prescott CE, 2004, CAN J FOREST RES, V34, P1714, DOI 10.1139/X04-040; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Rouifed S, 2010, OECOLOGIA, V163, P247, DOI 10.1007/s00442-009-1528-1; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; SINGH JS, 1977, BOT REV, V43, P499, DOI 10.1007/BF02860844; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; van Geffen KG, 2011, OECOLOGIA, V167, P1163, DOI 10.1007/s00442-011-2051-8; Vasconcelos HL, 2005, OECOLOGIA, V144, P456, DOI 10.1007/s00442-005-0117-1; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wang ZH, 2015, APPL SOIL ECOL, V92, P64, DOI 10.1016/j.apsoil.2015.03.010; Zuur Alain F., 2009, P1	57	1	2	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0259045	10.1371/journal.pone.0259045	http://dx.doi.org/10.1371/journal.pone.0259045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758046	Green Published, gold			2022-12-26	WOS:000755112500017
J	Cho, IH; Kim, MS; Heo, NH; Kim, SY				Cho, In Hwan; Kim, Min Seong; Heo, Nam Hun; Kim, So Young			Birth-related retinal hemorrhages: The Soonchunhyang University Cheonan Hospital universal newborn eye screening (SUCH-NES) study	PLOS ONE			English	Article							RETINOPATHY; TELEMEDICINE; SYSTEM	Purpose To report the prevalence, related factors, and characteristics of birth-related retinal hemorrhages (RHs) according to their severity in healthy newborns using a telemedicine network and wide-field digital retinal imaging (WFDRI). Methods Newborns who underwent WFDRI at 61 obstetrics/gynecology hospitals between January 2017 and December 2019 were enrolled. Demographics and related factors were compared among newborns with and without RHs. The newborns' eyes were divided into the minimal, mild, moderate, and severe groups according to the number of RHs, and characteristics like bilaterality, laterality, involved retinal layer, involved zone, macular and/or optic nerve (ON) involvement were compared. Results Among 56247 newborns, 13026 had birth-related RHs (23.2%). Normal spontaneous vaginal delivery (NSVD) showed the highest association with RHs (odds ratio, 19.774; 95% confidence interval, 18.277-21.393; P < 0.001) on multivariate analysis. Bilateral RHs (8414/13026; 64.59%) were more common than unilateral RHs (4612/13026; 35.41%); however, unilateral RHs (2383/4217; 56.51%) were more common than bilateral RHs (1834/4217; 43.49%) in the minimal group. RHs showed no laterality differences between the two eyes (P = 0.493). Most RHs were intraretinal (18678/21440; 87.12%), and 2328 (31.65%) eyes with preretinal hemorrhage were observed in the severe group. Zone I RHs were common in the minimal (7072/7090; 99.75%), mild (4953/4960; 99.86%), and moderate (2013/2035; 98.92%) groups; zone I and II RHs were common in the severe group (4843/7355; 65.85%); and RHs in zone III were rare (7/21440; 0.03%). Most RHs showed no macular and/or ON involvement in the minimal and mild group; however, this was common in the severe group (7111/7355; 96.68%). Conclusions Birth-related RHs were common in healthy newborns and were significantly associated with NSVD. RHs were usually bilateral, intraretinal, and distributed posterior to the retina, but severe RHs had unique characteristics. Future long-term and longitudinal studies are required to elucidate the prognosis of severe RHs.	[Cho, In Hwan; Kim, Min Seong; Kim, So Young] Soonchunhyang Univ, Coll Med, Dept Ophthalmol, Cheonan, South Korea; [Heo, Nam Hun] Soonchunhyang Univ, Clin Trial Ctr, Cheonan, South Korea	Soonchunhyang University; Soonchunhyang University	Kim, SY (corresponding author), Soonchunhyang Univ, Coll Med, Dept Ophthalmol, Cheonan, South Korea.	ophdrkim@gmail.com			SoonChunHyang Research Fund	SoonChunHyang Research Fund	So Young Kim is supported by SoonChunHyang Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Aziz Ayman A, 2014, CMAJ, V186, P1012, DOI 10.1503/cmaj.131357; Airiani Suzanna, 2010, Retin Cases Brief Rep, V4, P23, DOI 10.1097/ICB.0b013e31818c5e2e; Binenbaum G, 2013, PEDIATRICS, V132, pE430, DOI 10.1542/peds.2013-0262; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; BIST H K, 1989, Indian Pediatrics, V26, P558; Callaway NF, 2016, OPHTHALMOLOGY, V123, P1043, DOI 10.1016/j.ophtha.2016.01.004; Chee R, 2018, EYE, V32, P50, DOI 10.1038/eye.2017.133; Chen F, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0887-y; Choi Youn Joo, 2011, Korean J Ophthalmol, V25, P311, DOI 10.3341/kjo.2011.25.5.311; Dai SA, 2011, CLIN EXP OPHTHALMOL, V39, P23, DOI 10.1111/j.1442-9071.2010.02399.x; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; GILES CL, 1960, AM J OPHTHALMOL, V49, P1005, DOI 10.1016/0002-9394(60)91824-9; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Goyal P, 2018, EYE, V32, P67, DOI 10.1038/eye.2017.129; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Kim SY, 2018, J AAPOS, V22, P139, DOI 10.1016/j.jaapos.2017.12.006; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Li LH, 2017, OSLI RETINA, V48, P983, DOI 10.3928/23258160-20171130-05; Li LH, 2013, BRIT J OPHTHALMOL, V97, P588, DOI 10.1136/bjophthalmol-2012-302539; Ma Y, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0943-7; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Quinn GE, 2014, JAMA OPHTHALMOL, V132, P1178, DOI 10.1001/jamaophthalmol.2014.1604; SEZEN F, 1971, BRIT J OPHTHALMOL, V55, P248, DOI 10.1136/bjo.55.4.248; Simkin SK, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2018-000376; Togioka BM, 2009, J EMERG MED, V37, P98, DOI 10.1016/j.jemermed.2008.06.022; Vinekar A, 2015, ACTA OPHTHALMOL, V93, pE372, DOI 10.1111/aos.12685; Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012; WILLIAMS MC, 1993, OBSTET GYNECOL, V81, P688; Zhao Q, 2015, GRAEF ARCH CLIN EXP, V253, P1021, DOI 10.1007/s00417-015-3052-9	29	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259378	10.1371/journal.pone.0259378	http://dx.doi.org/10.1371/journal.pone.0259378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752467	gold, Green Published			2022-12-26	WOS:000754499700011
J	Boontem, P; Yamashima, T				Boontem, Piyakarn; Yamashima, Tetsumori			Hydroxynonenal causes Langerhans cell degeneration in the pancreas of Japanese macaque monkeys	PLOS ONE			English	Article							ENZYME GENE-EXPRESSION; FATTY-ACIDS; OXIDATIVE STRESS; LIPID-PEROXIDATION; NEURONAL DEATH; RECEPTOR GPR40; INSULIN-SECRETION; BETA-OXIDATION; PEROXISOMES; CALPAIN	Background For their functions of insulin biosynthesis and glucose- and fatty acid- mediated insulin secretion, Langerhans beta-cells require an intracellular milieu rich in oxygen. This requirement makes beta-cells, with their constitutively low antioxidative defense, susceptible to the oxidative stress. Although much progress has been made in identifying its molecular basis in experimental systems, whether the oxidative stress due to excessive fatty acids plays a crucial role in the Langerhans cell degeneration in primates is still debated. Methods Focusing on Hsp70.1, which has dual functions as molecular chaperone and lysosomal stabilizer, the mechanism of lipotoxicity to Langerhans cells was studied using macaque monkeys after the consecutive injections of the lipid peroxidation product 'hydroxynonenal'. Based on the 'calpain-cathepsin hypothesis' formulated in 1998, calpain activation, Hsp70.1 cleavage, and lysosomal integrity were studied by immunofluorescence histochemistry, electron microscopy, and Western blotting. Results Light microscopy showed more abundant vacuole formation in the hydroxynonenal-treated islet cells than the control cells. Electron microscopy showed that vacuolar changes, which were identified as enlarged rough ER, occurred mainly in beta-cells followed by delta-cells. Intriguingly, both cell types showed a marked decrease in insulin and somatostatin granules. Furthermore, they exhibited marked increases in peroxisomes, autophagosomes/autolysosomes, lysosomal and peroxisomal membrane rupture/permeabilization, and mitochondrial degeneration. Disrupted peroxisomes were often localized in the close vicinity of degenerating mitochondria or autolysosomes. Immunofluorescence histochemical analysis showed an increased co-localization of activated mu-calpain and Hsp70.1 with the extralysosomal release of cathepsin B. Western blotting showed increases in mu-calpain activation, Hsp70.1 cleavage, and expression of the hydroxynonenal receptor GPR109A. Conclusions Taken together, these data implicate hydroxynonenal in both oxidation of Hsp70.1 and activation of mu-calpain. The calpain-mediated cleavage of the carbonylated Hsp70.1, may cause lysosomal membrane rupture/permeabilization. The low defense of primate Langerhans cells against hydroxynonenal and peroxisomally-generated hydrogen peroxide, was presumably overwhelmed to facilitate cell degeneration.	[Boontem, Piyakarn; Yamashima, Tetsumori] Dept Cell Metab & Nutr, Kanazawa, Ishikawa, Japan; [Yamashima, Tetsumori] Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan		Yamashima, T (corresponding author), Dept Cell Metab & Nutr, Kanazawa, Ishikawa, Japan.; Yamashima, T (corresponding author), Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan.	yamashima215@gmail.com			Japanese Ministry of Education, Culture, Sports, Science and Technology [19H04029]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Kiban-Kenkyu (B) (19H04029) from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleynik SI, 1999, FREE RADICAL BIO MED, V26, P609, DOI 10.1016/S0891-5849(98)00246-9; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Balogi Z, 2019, PROG LIPID RES, V74, P18, DOI 10.1016/j.plipres.2019.01.004; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brereton MF, 2015, J HISTOCHEM CYTOCHEM, V63, P575, DOI 10.1369/0022155415583535; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Bruce-Keller AJ, 1998, J NEUROPATH EXP NEUR, V57, P257, DOI 10.1097/00005072-199803000-00007; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DEDUVE C, 1969, PROC R SOC SER B-BIO, V173, P71, DOI 10.1098/rspb.1969.0039; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Elsner M, 2011, DIABETES, V60, P200, DOI 10.2337/db09-1401; Fransen M, 2012, ISRN CELL BIOL, V2012, P1, DOI [10.5402/2012/714192, DOI 10.5402/2012/714192]; Fransen Marc, 2013, Subcell Biochem, V69, P45, DOI 10.1007/978-94-007-6889-5_3; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Gautam J, 2018, BRIT J PHARMACOL, V175, P2581, DOI 10.1111/bph.14174; Gehrmann W, 2010, DIABETES OBES METAB, V12, P149, DOI 10.1111/j.1463-1326.2010.01265.x; Islinger M, 2012, HISTOCHEM CELL BIOL, V137, P547, DOI 10.1007/s00418-012-0941-4; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Leonarduzzi G, 2005, MOL NUTR FOOD RES, V49, P1044, DOI 10.1002/mnfr.200500090; Lou BW, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101723; Lovell MA, 1997, NEUROBIOL AGING, V18, P457, DOI 10.1016/S0197-4580(97)00108-5; Lytrivi M, 2020, J MOL BIOL, V432, P1514, DOI 10.1016/j.jmb.2019.09.016; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Morquette B, 2006, ARTHRITIS RHEUM-US, V54, P271, DOI 10.1002/art.21559; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Odegaard AO, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0369-6; Oikawa S, 2009, FREE RADICAL BIO MED, V46, P1472, DOI 10.1016/j.freeradbiomed.2009.02.029; Petersen NHT, 2010, CELL CYCLE, V9, P2305, DOI 10.4161/cc.9.12.12052; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Rhodin J, 1954, CORRELATION ULTRASTR; Sahara S, 2010, BIOCHEM BIOPH RES CO, V393, P806, DOI 10.1016/j.bbrc.2010.02.087; Saitoh S, 2018, ACTA HISTOCHEM CYTOC, V51, P9, DOI 10.1267/ahc.17020; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Schonfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Till Andreas, 2012, Int J Cell Biol, V2012, P512721, DOI 10.1155/2012/512721; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Weir GC, 2020, DIABETES, V69, P273, DOI 10.2337/db19-0138; Xu J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.86; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yamashima T., 2020, J ALZHEIMERS DIS PAR, V10, P483; Yamashima T, 2020, ADV NUTR, V11, P1489, DOI 10.1093/advances/nmaa072; Yamashima T, 2016, AGEING RES REV, V32, P169, DOI 10.1016/j.arr.2016.05.008; Yamashima T, 2015, PROG LIPID RES, V58, P40, DOI 10.1016/j.plipres.2015.01.002; Yamashima T, 2013, PROG NEUROBIOL, V105, P1, DOI 10.1016/j.pneurobio.2013.02.004; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yokota S, 2001, J HISTOCHEM CYTOCHEM, V49, P613, DOI 10.1177/002215540104900508; Yokota S, 2009, HISTOCHEM CELL BIOL, V131, P455, DOI 10.1007/s00418-009-0564-6; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	72	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0245702	10.1371/journal.pone.0245702	http://dx.doi.org/10.1371/journal.pone.0245702			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748564	gold, Green Submitted, Green Published			2022-12-26	WOS:000755468000002
J	Wu, Q; Liu, FF; Ge, MM; Laster, KV; Wei, LX; Du, RJ; Jiang, M; Zhang, J; Zhi, YF; Jin, GG; Zhao, SM; Kim, DJ; Dong, ZG; Liu, KD				Wu, Qiong; Liu, Fangfang; Ge, Mengmeng; Laster, Kyle Vaughn; Wei, Lixiao; Du, Ruijuan; Jiang, Ming; Zhang, Jing; Zhi, Yafei; Jin, Guoguo; Zhao, Simin; Kim, Dong Joon; Dong, Zigang; Liu, Kangdong			BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression	ONCOGENE			English	Article							GENOMIC LANDSCAPE; GENE-EXPRESSION; TARGETING MYCN; P73 ISOFORMS; CANCER; OVEREXPRESSION; TRANSCRIPTION; INHIBITION; P53; SENSITIVITY	The low survival rate of esophageal squamous cell carcinoma patients is primarily attributed to technical limitations and a lack of insight regarding the molecular mechanisms contributing to its progression. Alterations in epigenetic modulators are critical to cancer development and prognosis. BRD4, a chromatin reader protein, plays an essential role in regulating oncogene expression. Here, we investigated the contributing role of BRD4 and its related mechanisms in the context of ESCC tumor progression. Our observations showed that BRD4 transcript and protein expression levels are significantly increased in ESCC patient tissues. Genetic or pharmacological inhibition of BRD4 suppressed ESCC cell proliferation in vitro and in vivo. Proteomic and transcriptomic analyses were subsequently used to deduce the potential targets of BRD4. Mechanistic studies showed that RCC2 is a downstream target of BRD4. Inhibition of either BRD4 or RCC2 resulted in decreased ESCC cell proliferation. The BRD4-TP73 interaction facilitated the binding of BRD4 complex to the promoter region of RCC2, and subsequently modulated RCC2 transcription. Furthermore, targeting BRD4 with inhibitors significantly decreased tumor volume in ESCC PDX models, indicating that BRD4 expression may contribute to tumor progression. Collectively, these findings suggest that BRD4 inhibition could be a promising strategy to treat ESCC by downregulating RCC2.	[Wu, Qiong; Liu, Fangfang; Du, Ruijuan; Zhang, Jing; Zhi, Yafei; Kim, Dong Joon; Dong, Zigang; Liu, Kangdong] Zhengzhou Univ, Sch Basic Med Sci, Pathophysiol Dept, Zhengzhou 450000, Peoples R China; [Wu, Qiong; Liu, Fangfang; Ge, Mengmeng; Laster, Kyle Vaughn; Wei, Lixiao; Du, Ruijuan; Jiang, Ming; Zhang, Jing; Zhi, Yafei; Jin, Guoguo; Zhao, Simin; Kim, Dong Joon; Dong, Zigang; Liu, Kangdong] China US Henan Hormel Canc Inst, Zhengzhou 450000, Peoples R China; [Jin, Guoguo] Henan Luoyang Orthoped Hosp, Zhengzhou 450000, Henan, Peoples R China; [Zhao, Simin] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou 450000, Henan, Peoples R China; [Dong, Zigang; Liu, Kangdong] State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450000, Henan, Peoples R China; [Dong, Zigang; Liu, Kangdong] Zhengzhou Univ, Prov Cooperat Innovat Ctr Canc Chemoprevent, Zhengzhou 450000, Henan, Peoples R China; [Liu, Kangdong] Canc Chemoprevent Int Collaborat Lab, Zhengzhou 450000, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Kim, DJ; Dong, ZG; Liu, KD (corresponding author), Zhengzhou Univ, Sch Basic Med Sci, Pathophysiol Dept, Zhengzhou 450000, Peoples R China.; Kim, DJ; Dong, ZG; Liu, KD (corresponding author), China US Henan Hormel Canc Inst, Zhengzhou 450000, Peoples R China.; Dong, ZG; Liu, KD (corresponding author), State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450000, Henan, Peoples R China.; Dong, ZG; Liu, KD (corresponding author), Zhengzhou Univ, Prov Cooperat Innovat Ctr Canc Chemoprevent, Zhengzhou 450000, Henan, Peoples R China.; Liu, KD (corresponding author), Canc Chemoprevent Int Collaborat Lab, Zhengzhou 450000, Henan, Peoples R China.	djkim@hci-cn.org; zgdong@hci-cn.org; kdliu@zzu.edu.cn			National Natural Science Foundations of China [81872335]; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China [2018ZX09711002]; Central Plains Science and Technology Innovation Leading Talents (KL)	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China; Central Plains Science and Technology Innovation Leading Talents (KL)	This research was funded by the National Natural Science Foundations of China (Grant no. 81872335), National Science & Technology Major Project Key New Drug Creation and Manufacturing Program, China (No. 2018ZX09711002) and Central Plains Science and Technology Innovation Leading Talents (KL). We thank all members of our team for critical input and suggestions.	Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruun J, 2015, CLIN CANCER RES, V21, P3759, DOI 10.1158/1078-0432.CCR-14-3294; Calderon-Aparicio A, 2020, MOL CANCER RES, V18, P1660, DOI 10.1158/1541-7786.MCR-19-1152; Cao W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13797-9; Carrasco G, 2010, CLIN CANCER RES, V16, P3253, DOI 10.1158/1078-0432.CCR-09-2491; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen QM, 2020, HUM CELL, V33, P709, DOI 10.1007/s13577-020-00353-7; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; Dominguez G, 2001, BREAST CANCER RES TR, V66, P183, DOI 10.1023/A:1010624717311; Donati B, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0915-9; Dullo I, 2015, NAT CELL BIOL, V17, P511, DOI 10.1038/ncb3130; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Faivre EJ, 2020, NATURE, V578, P306, DOI 10.1038/s41586-020-1930-8; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Fontanals-Cirera B, 2017, MOL CELL, V68, P731, DOI 10.1016/j.molcel.2017.11.004; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Henssen A, 2016, CLIN CANCER RES, V22, P2470, DOI 10.1158/1078-0432.CCR-15-1449; Hu N, 2016, CANCER RES, V76, P1714, DOI 10.1158/0008-5472.CAN-15-0338; Hu N, 2009, CANCER RES, V69, P5908, DOI 10.1158/0008-5472.CAN-08-4622; Hu XM, 2014, J BIOL CHEM, V289, P23154, DOI 10.1074/jbc.M114.570812; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jiang YA, 2016, ONCOL REP, V35, P785, DOI 10.3892/or.2015.4459; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Li L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05231-3; Lin DC, 2018, GASTROENTEROLOGY, V154, P374, DOI 10.1053/j.gastro.2017.06.066; Liu KD, 2013, CANCER RES, V73, P2181, DOI 10.1158/0008-5472.CAN-12-3408; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Matsuo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-15; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Nagarajan S, 2017, NUCLEIC ACIDS RES, V45, P3130, DOI 10.1093/nar/gkw1276; Nimura Y, 1998, INT J CANCER, V78, P437, DOI 10.1002/(SICI)1097-0215(19981109)78:4<437::AID-IJC8>3.0.CO;2-V; Novak U, 2001, ANN ONCOL, V12, P981, DOI 10.1023/A:1011153206003; Nozaki M, 2001, BRAIN PATHOL, V11, P296; Padmanabhan A, 2020, CIRCULATION, V142, P2338, DOI 10.1161/CIRCULATIONAHA.120.047753; Pang B, 2017, CLIN CANCER RES, V23, P5598, DOI 10.1158/1078-0432.CCR-16-2909; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sawada G, 2016, GASTROENTEROLOGY, V150, P1171, DOI 10.1053/j.gastro.2016.01.035; Shah MA, 2015, J CLIN ONCOL, V33, P1760, DOI 10.1200/JCO.2014.60.1799; Sharif T, 2019, CLIN CANCER RES, V25, P2001, DOI 10.1158/1078-0432.CCR-17-3177; Siu KT, 2017, LEUKEMIA, V31, P1760, DOI 10.1038/leu.2016.355; Smyth EC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.48; Soldevilla B, 2011, CLIN CANCER RES, V17, P6029, DOI 10.1158/1078-0432.CCR-10-2388; Song C, 2018, ONCOGENE, V37, P8, DOI 10.1038/onc.2017.306; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stiewe T, 2002, CELL DEATH DIFFER, V9, P237, DOI 10.1038/sj.cdd.4400995; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154; Thrumurthy SG, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4373; Tomkova K, 2004, CANCER RES, V64, P6390, DOI 10.1158/0008-5472.CAN-04-2176; Vikhanskaya F, 2007, NAT CELL BIOL, V9, P698, DOI 10.1038/ncb1598; Winter GE, 2017, MOL CELL, V67, P5, DOI 10.1016/j.molcel.2017.06.004; Yang H, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06901-6; Yu H, 2019, BIOCHEM BIOPH RES CO, V516, P999, DOI 10.1016/j.bbrc.2019.06.097; Zaika AI, 1999, CANCER RES, V59, P3257; Zanconato F, 2018, NAT MED, V24, P1599, DOI 10.1038/s41591-018-0158-8; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	65	3	3	7	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					347	360		10.1038/s41388-021-02099-4	http://dx.doi.org/10.1038/s41388-021-02099-4		NOV 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34750516				2022-12-26	WOS:000715670800003
J	Zerdzicki, K; Lemski, P; Klosowski, P; Skorek, A; Trzebiatowski, MZ; Koberda, M				Zerdzicki, Krzysztof; Lemski, Pawel; Klosowski, Pawel; Skorek, Andrzej; Trzebiatowski, Marcin Zmuda; Koberda, Mateusz			Tensile modulus of human orbital wall bones cut in sagittal and coronal planes	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BUCKLING MECHANISMS; TRABECULAR BONE; FLOOR; FRACTURES; BEHAVIOR; STRAIN; MODEL	In the current research, 68 specimens of orbital superior and/or medial walls taken from 33 human cadavers (12 females, 21 males) were subjected to uniaxial tension untill fracture. The samples were cut in the coronal (38 specimens) and sagittal (30 specimens) planes of the orbital wall. Apparent density (rho(app)), tensile Young's modulus (E-modulus) and ultimate tensile strength (UTS) were identified. Innovative test protocols were used to minimize artifacts and analyze the obtained data: (1) grips dedicated to non-symmetrical samples clamping were applied for mechanical testing, (2) non-contact measuring system of video-extensometer was employed for displacement registration, (3) ink imprint technique coupled with CAD analysis was applied to precisely access the cross-sectional areas of tested samples. With regard to a pooled group, apparent density for the coronal and sagittal cut plane was equal 1.53 g/cm(3) and 1.57 g/cm(3), tensile Young's modulus 2.36 GPa and 2.14 GPa, and ultimate tensile strength 12.66 MPa and 14.35 MPa, respectively. No significant statistical differences (p > 0.05) were found for all the analyzed parameters when comparing coronal and sagittal plane cut groups. These observations confirmed the hypothesis that direction of sample cut does not affect the mechanical response of the orbital wall tissue, thus suggesting that mechanical properties of orbital wall bone show isotropic character.	[Zerdzicki, Krzysztof; Klosowski, Pawel; Trzebiatowski, Marcin Zmuda] Gdansk Univ Technol, Fac Civil & Environm Engn, Gdansk, Poland; [Lemski, Pawel; Skorek, Andrzej] Med Univ Gdansk, Dept Otolaryngol, Gdansk, Poland; [Koberda, Mateusz] Med Univ Gdansk, Dept Ophtalmol, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zerdzicki, K (corresponding author), Gdansk Univ Technol, Fac Civil & Environm Engn, Gdansk, Poland.	krzysztof.zerdzicki@pg.edu.pl	; Zerdzicki, Krzysztof/B-2933-2018	Zmuda Trzebiatowski, Marcin/0000-0001-8356-3367; Zerdzicki, Krzysztof/0000-0003-2315-5358				Agnew AM, 2015, J MECH BEHAV BIOMED, V41, P302, DOI 10.1016/j.jmbbm.2014.09.002; Ahmad F, 2003, BRIT J PLAST SURG, V56, P3, DOI 10.1016/S0007-1226(02)00467-8; Al-sukhun J, 2012, J CRANIOFAC SURG, V23, P669, DOI 10.1097/SCS.0b013e31824db8a0; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Brown RHJ, 1971, Q REV BIOL, V46, P192; CONVERSE JM, 1950, ARCH OPHTHALMOL-CHIC, V44, P1; Delille R, 2007, INT J CRASHWORTHINES, V12, P101, DOI 10.1080/13588260701433081; Favier V, 2019, CLIN EXP OTORHINOLAR, V12, P231, DOI 10.21053/ceo.2018.01627; Foletti JM, 2019, J STOMATOL ORAL MAXI, V120, P16, DOI 10.1016/j.jormas.2018.09.002; Kim HS, 2012, PLAST RECONSTR SURG, V130, P898, DOI 10.1097/PRS.0b013e318262f3d9; Kimura Akiko, 2006, Keio Journal of Medicine, V55, P1; Morgan EF, 2001, J BIOMECH, V34, P569, DOI 10.1016/S0021-9290(01)00011-2; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Nagasao T, 2006, PLAST RECONSTR SURG, V117, P2373, DOI 10.1097/01.prs.0000218792.70483.1f; Nagasao T, 2010, J CRANIO MAXILL SURG, V38, P306, DOI 10.1016/j.jcms.2009.09.001; Nagasao T, 2010, ANN PLAS SURG, V64, P471, DOI 10.1097/SAP.0b013e3181a6c288; Nagasao T, 2009, AURIS NASUS LARYNX, V36, P431, DOI 10.1016/j.anl.2008.09.004; Pezowicz C, 2012, ACTA BIOENG BIOMECH, V14, P53, DOI 10.5277/abb120207; ROBBINS DH, 1969, EXP MECH, V9, P236, DOI 10.1007/BF02326542; Wills CR, 2019, BONE, V121, P89, DOI 10.1016/j.bone.2019.01.001; Schaller A, 2013, J CRANIO MAXILL SURG, V41, P710, DOI 10.1016/j.jcms.2012.02.008; Schutte S, 2006, VISION RES, V46, P1724, DOI 10.1016/j.visres.2005.11.022; Seong WJ, 2009, INT J ORAL MAX SURG, V38, P1088, DOI 10.1016/j.ijom.2009.06.025; Skorek A, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/231436; Trzebiatowski MAZ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72186-1; Verschueren P., 2006, PROC, P357; Warwar RE, 2000, OPHTHALMIC PLAST REC, V16, P188, DOI 10.1097/00002341-200005000-00005; Watanabe T, 2012, ENT-EAR NOSE THROAT, V91, P24, DOI 10.1177/014556131209100108; Wille H, 2016, J BIOMECH, V49, P520, DOI 10.1016/j.jbiomech.2015.11.013; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Young Barbara, PODRECZNIK ATLAS	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259363	10.1371/journal.pone.0259363	http://dx.doi.org/10.1371/journal.pone.0259363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739503	Green Published, gold			2022-12-26	WOS:000755000800026
J	Doepke, A; Streicher, RP				Doepke, Amos; Streicher, Robert P.			Source apportionment and quantification of liquid and headspace leaks from closed system drug-transfer devices via Selected Ion Flow Tube Mass Spectrometry (SIFT-MS)	PLOS ONE			English	Article							EXPOSURE; H3O+	A system to differentiate and quantify liquid and headspace vapor leaks from closed system drug-transfer devices (CSTDs) is presented. CSTDs are designed to reduce or eliminate hazardous drug (HD) exposure risk when compounding and administering HDs. CSTDs may leak liquid, headspace, or a mixture of the two. The amount of HD contained in liquid and headspace leaks may be substantially different. Use of a test solution containing two VOCs with differences in ratios of VOC concentrations in the headspace and liquid enables source apportionment of leaked material. SIFT-MS was used to detect VOCs from liquid and headspace leaks in the vapor phase. Included in this report is a novel method to determine the origin and magnitude of leaks from CSTDs. A limit of leak detection of 24 mu L of headspace vapor and 0.14 mu L of test liquid were found using Selected Ion Flow Tube Mass Spectrometry (SIFT-MS).	[Doepke, Amos; Streicher, Robert P.] NIOSH, Hlth Effects Lab Div HELD, Ctr Dis Control & Prevent CDC, Chem & Biochem Monitoring Branch CBMB,Alice Hamil, Cincinnati, OH 45226 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Doepke, A (corresponding author), NIOSH, Hlth Effects Lab Div HELD, Ctr Dis Control & Prevent CDC, Chem & Biochem Monitoring Branch CBMB,Alice Hamil, Cincinnati, OH 45226 USA.	adoepke@cdc.gov		Doepke, Amos/0000-0001-6284-0871				Besheer A, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-02784-1; Connor T, 2016, CDC20160090; Connor TH., 2016, DHHS NIOSH PUBLICATI; De Ausen L, 2013, AM J HEALTH-SYST PH, V70, P619, DOI 10.2146/ajhp110678; González-Haba Peña Eva, 2016, Farm Hosp., V40, P496, DOI 10.7399/fh.2016.40.6.10607; Gonzalez-Hada-Pena E, 2018, FARM HOSP, V42, P234, DOI 10.7399/fh.11024; Halloush S, 2020, HOSP PHARM, V55, P391, DOI 10.1177/0018578719848730; Ishimaru H, 2021, YAKUGAKU ZASSHI, V141, P143, DOI 10.1248/yakushi.20-00188; Ishimaru H, 2021, J ONCOL PHARM PRACT, V27, P1321, DOI 10.1177/1078155220952518; Jorgenson JA., 2008, HOSP PHARM, V43, P718; Massoomi F, 2015, PHARM PURCH PROD, V12, pS1; Mead KR, 2015, CDC20150075; NIOSH, 2004, PREVENTING OCCUPATIO; Nygren O, 2002, J ENVIRON MONITOR, V4, P739, DOI 10.1039/b205132j; Nygren O, 2008, ANN OCCUP HYG, V52, P95, DOI 10.1093/annhyg/mem067; Nygren O, 2009, ANN OCCUP HYG, V53, P549, DOI 10.1093/annhyg/mep030; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; PubChem, THIOT C6H12N3PS PUBC; Queruau Lamerie Thomas, 2012, J Oncol Pharm Pract, V18, P191, DOI 10.1177/1078155211416531; Siderov Jim, 2010, J Oncol Pharm Pract, V16, P19, DOI 10.1177/1078155209352543; Spanel P, 1998, INT J MASS SPECTROM, V172, P239, DOI 10.1016/S0168-1176(97)00277-2; SPANEL P, 1995, INT J MASS SPECTROM, V145, P177, DOI 10.1016/0168-1176(95)04164-G; The United States Pharmacopeial Convention, 2019, C225594M7808CHM2015; Turci R, 2006, TOXICOL LETT, V162, P256, DOI 10.1016/j.toxlet.2005.09.022; Vyas N, 2016, J Oncol Pharm Pract, V22, P10, DOI 10.1177/1078155214544993; Wilkinson AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205263	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258425	10.1371/journal.pone.0258425	http://dx.doi.org/10.1371/journal.pone.0258425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735484	gold, Green Published			2022-12-26	WOS:000755077100023
J	Yuan, H; Wang, YX; Liu, YJ; Zhang, MR; Zou, ZR				Yuan, Hang; Wang, Yuxian; Liu, Yanjuan; Zhang, Mengru; Zou, Zhurong			A novel dominant selection system for plant transgenics based on phosphite metabolism catalyzed by bacterial alkaline phosphatase	PLOS ONE			English	Article							SELECTABLE MARKER GENES; STARVATION RESPONSES; ESCHERICHIA-COLI; CROP PLANTS; PTXD GENE; MANAGEMENT; BIOSAFETY; SCIENCE; ENZYME	Selective markers are generally indispensable in plant genetic transformation, of which the frequently used are of antibiotic or herbicide resistance. However, the increasing concerns on transgenic biosafety have encouraged many new and safe selective markers emerging, with an eminent representative as phosphite (Phi) in combination to its dehydrogenase (PTDH, e.g. PtxD). As bacterial alkaline phosphatase (BAP) can resemble PtxD to oxidatively convert toxic Phi into metabolizable phosphate (Pi), herein we harnessed it as the substitute of PtxD to develop an alternative Phi-based selection system. We first validated the Escherichia coli BAP (EcBAP) did own an extra enzymatic activity of oxidizing Phi to Pi. We further revealed EcBAP could be used as a dominant selective marker for Agrobacterium-mediated tobacco transformation. Although the involved Phi selection for transformed tobacco cells surprisingly required the presence of Pi, it showed a considerable transformation efficiency and dramatically accelerated transformation procedure, as compared to the routine kanamycin selection and the well-known PtxD/Phi system. Moreover, the EcBAP transgenic tobaccos could metabolize toxic Phi as a phosphorus (P) fertilizer thus underlying Phi-resistance, and competitively possess a dominant growth over wild-type tobacco and weeds under Phi stress. Therefore, this novel BAP/Phi-coupled system, integrating multiple advantages covering biosafe dominant selective marker, plant P utilization and weed management, can provide a PTDH-bypass technological choice to engineer transgenic plant species, especially those of great importance for sustainable agriculture.	[Yuan, Hang; Wang, Yuxian; Liu, Yanjuan; Zou, Zhurong] Yunnan Normal Univ, Sch Life Sci, Minist Educ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Kunming, Yunnan, Peoples R China; [Zhang, Mengru] Kunming Med Univ, Affiliated Hosp 1, NHC Key Lab Drug Addict Med, Kunming, Yunnan, Peoples R China	Yunnan Normal University; Kunming Medical University	Zou, ZR (corresponding author), Yunnan Normal Univ, Sch Life Sci, Minist Educ, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Kunming, Yunnan, Peoples R China.; Zhang, MR (corresponding author), Kunming Med Univ, Affiliated Hosp 1, NHC Key Lab Drug Addict Med, Kunming, Yunnan, Peoples R China.	zouzr09@sina.com; zouzr09@sina.com		Zhang, Mengru/0000-0002-4264-3747				Achary VMM, 2017, PLANT BIOTECHNOL J, V15, P1493, DOI 10.1111/pbi.12803; Benedetti M, 2021, PLANT BIOTECHNOL J, V19, P124, DOI 10.1111/pbi.13447; Carpenter SR, 2008, P NATL ACAD SCI USA, V105, P11039, DOI 10.1073/pnas.0806112105; Carreras-Villasenor N, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01326-z; Changko S, 2020, APPL MICROBIOL BIOT, V104, P675, DOI 10.1007/s00253-019-10258-7; Che P, 2018, PLANT BIOTECHNOL J, V16, P1388, DOI 10.1111/pbi.12879; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Cook PJ, 2009, PLANT DIS, V93, P809, DOI 10.1094/PDIS-93-8-0809; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Cutolo E, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040473; Danova-Alt R, 2008, PLANT CELL ENVIRON, V31, P1510, DOI 10.1111/j.1365-3040.2008.01861.x; Dormatey R, 2021, PEERJ, V9, DOI 10.7717/peerj.11809; Gomez-Merino FC, 2015, SCI HORTIC-AMSTERDAM, V196, P82, DOI 10.1016/j.scienta.2015.09.035; Gonzalez-Morales SI, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01759-z; Goodwin JL, 2005, METH MOL B, V286, P191; Gordon-Kamm B, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8020038; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Jiang Yiming, 2014, Recent Pat Food Nutr Agric, V6, P3, DOI 10.2174/2212798406666141024104637; Kanda K, 2014, J BIOTECHNOL, V182, P68, DOI 10.1016/j.jbiotec.2014.04.012; Krawczun N, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01424-y; Kumar K, 2020, PLANTA, V251, DOI 10.1007/s00425-020-03372-8; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lee TM, 2005, J PHYCOL, V41, P975, DOI 10.1111/j.1529-8817.2005.00119.x; Lopez-Arredondo DL, 2012, NAT BIOTECHNOL, V30, P889, DOI 10.1038/nbt.2346; Loera-Quezada MM, 2016, PLANT BIOTECHNOL J, V14, P2066, DOI 10.1111/pbi.12564; Loera-Quezada MM, 2015, PLANT SCI, V231, P124, DOI 10.1016/j.plantsci.2014.11.015; Lopez-Arredondo DL, 2013, PLANT BIOTECHNOL J, V11, P516, DOI 10.1111/pbi.12063; Manimaran P, 2011, BIOTECHNOL ADV, V29, P703, DOI 10.1016/j.biotechadv.2011.05.019; Manna M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24941; Miki B, 2004, J BIOTECHNOL, V107, P193, DOI 10.1016/j.jbiotec.2003.10.011; Miki B, 2009, PLANT BIOTECHNOL J, V7, P211, DOI 10.1111/j.1467-7652.2009.00400.x; Motomura K, 2018, ACS SYNTH BIOL, V7, P2189, DOI 10.1021/acssynbio.8b00199; Nahampun HN, 2016, PLANT CELL REP, V35, P1121, DOI 10.1007/s00299-016-1942-x; Pandeya D, 2018, P NATL ACAD SCI USA, V115, pE6946, DOI 10.1073/pnas.1804862115; Pandeya D, 2017, PLANT MOL BIOL, V95, P567, DOI 10.1007/s11103-017-0670-0; Penna Suprasanna, 2010, GM Crops, V1, P128, DOI 10.4161/gmcr.1.3.12383; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Ram B, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00037; Ramessar K, 2007, TRANSGENIC RES, V16, P261, DOI 10.1007/s11248-007-9083-1; SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291; Stewart CN, 2000, BIOTECHNIQUES, V29, P832, DOI 10.2144/00294bi01; Stochaj Wayne R, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4577; Sundar IK, 2008, J PLANT PHYSIOL, V165, P1698, DOI 10.1016/j.jplph.2008.08.002; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.010396; Varadarajan DK, 2002, PLANT PHYSIOL, V129, P1232, DOI 10.1104/pp.010835; White AK, 2007, ANNU REV MICROBIOL, V61, P379, DOI 10.1146/annurev.micro.61.080706.093357; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Yu Guizhen, 2019, Sheng Wu Gong Cheng Xue Bao, V35, P327, DOI 10.13345/j.cjb.180158	48	0	0	8	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259600	10.1371/journal.pone.0259600	http://dx.doi.org/10.1371/journal.pone.0259600			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735551	Green Published, gold			2022-12-26	WOS:000755077100099
J	Dall, M; Hassing, AS; Niu, LL; Nielsen, TS; Ingerslev, LR; Sulek, K; Trammell, SAJ; Gillum, MP; Barres, R; Larsen, S; Poulsen, SS; Mann, M; Orskov, C; Treebak, JT				Dall, Morten; Hassing, Anna S.; Niu, Lili; Nielsen, Thomas S.; Ingerslev, Lars R.; Sulek, Karolina; Trammell, Samuel A. J.; Gillum, Matthew P.; Barres, Romain; Larsen, Steen; Poulsen, Steen S.; Mann, Matthias; Orskov, Cathrine; Treebak, Jonas T.			Hepatocyte-specific perturbation of NAD(+) biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis-like phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DATA-INDEPENDENT ACQUISITION; FATTY LIVER-DISEASE; NICOTINAMIDE RIBOSIDE; OXIDATIVE-METABOLISM; IDENTIFICATION; HOMEOSTASIS; DEFICIENCY; PACKAGE; IMPACT; NAMPT	Nicotinamide phosphoribosyltransferase (NAMPT) converts nicotinamide to NAD(+). As low hepatic NAD(+) levels have been linked to the development of nonalcoholic fatty liver disease, we hypothesized that ablation of hepatic Nampt would affect susceptibility to liver injury in response to diet-induced metabolic stress. Following 3 weeks on a low-methionine and choline-free 60% high-fat diet, hepatocyte-specific Nampt knockout (HNKO) mice accumulated less triglyceride than WT littermates but had increased histological scores for liver inflammation, necrosis, and fibrosis. Surprisingly, liver injury was also observed in HNKO mice on the purified control diet. This HNKO phenotype was associated with decreased abundance of mitochondrial proteins, especially proteins involved in oxidoreductase activity. High-resolution respirometry revealed lower respiratory capacity in purified control diet-fed HNKO liver. In addition, fibrotic area in HNKO liver sections correlated negatively with hepatic NAD(+), and liver injury was prevented by supplementation with NAD(+) precursors nicotinamide riboside and nicotinic acid. MS-based proteomic analysis revealed that nicotinamide riboside supplementation rescued hepatic levels of oxidoreductase and OXPHOS proteins. Finally, single-nucleus RNA-Seq showed that transcriptional changes in the HNKO liver mainly occurred in hepatocytes, and changes in the hepatocyte transcriptome were associated with liver necrosis. In conclusion, HNKO livers have reduced respiratory capacity, decreased abundance of mitochondrial proteins, and are susceptible to fibrosis because of low NAD(+) levels. Our data suggest a critical threshold level of hepatic NAD(+) that determines the predisposition to liver injury and supports that NAD(+) precursor supplementation can prevent liver injury and nonalcoholic fatty liver disease progression.	[Dall, Morten; Hassing, Anna S.; Nielsen, Thomas S.; Ingerslev, Lars R.; Sulek, Karolina; Trammell, Samuel A. J.; Gillum, Matthew P.; Barres, Romain; Treebak, Jonas T.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Niu, Lili; Sulek, Karolina; Mann, Matthias] Univ Copenhagen, Ctr Prot Res, Novo Nordisk Fdn, Copenhagen, Denmark; [Trammell, Samuel A. J.; Poulsen, Steen S.; Orskov, Cathrine] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Larsen, Steen] Univ Copenhagen, Ctr Hlth Aging, Dept Biomed Sci, Xlab, Copenhagen, Denmark; [Larsen, Steen] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland; [Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Martinsried, Germany; [Sulek, Karolina] Steno Diabet Ctr Copenhagen, Borgmester Ib Juuls Vej 83, DK-2730 Herlev, Denmark; [Trammell, Samuel A. J.] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Medical University of Bialystok; Max Planck Society; Steno Diabetes Center; University of Copenhagen	Treebak, JT (corresponding author), Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.	jttreebak@sund.ku.dk	Treebak, Jonas Thue/B-4521-2017; Sulek, Karolina/GLN-8212-2022; Larsen, Steen/L-2069-2013; BARRES, Romain/N-2501-2016	Treebak, Jonas Thue/0000-0003-1488-7012; Sulek, Karolina/0000-0002-7117-3756; Poulsen, Steen Seier/0000-0003-4419-4911; Dall, Morten/0000-0002-8577-3162; Niu, Lili/0000-0003-4571-4368; Trammell, Samuel/0000-0002-5941-4094; Ingerslev, Lars Roed/0000-0002-4164-7690; Gillum, Matthew/0000-0003-4893-012X; BARRES, Romain/0000-0002-0158-519X; Hassing, Anna Skab/0000-0003-1650-8784; Larsen, Steen/0000-0002-5170-4337; Orskov, Cathrine/0000-0002-7762-2372; Nielsen, Thomas Svava/0000-0002-9457-8000	Novo Nordisk Foundation [NNF15CC0001, NNF18CC0034900, NNF14OC0009315]; Danish Council for Independent Research [DFF 4004-00235, 0134-00217B]; Novo Nordisk Foundation Center of Basic Metabolic Research; Danish Diabetes Academy - Novo Nordisk Foundation; Danish Diabetes Academy [NNF17SA0031406]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation Center of Basic Metabolic Research(Novo Nordisk Foundation); Danish Diabetes Academy - Novo Nordisk Foundation; Danish Diabetes Academy	This work was funded by grants obtained by J. T. T. from the Novo Nordisk Foundation (Excellence Project Award, NNF14OC0009315) and the Danish Council for Independent Research (DFF 4004-00235 and 0134-00217B) . Support was also provided by the Novo Nordisk Foun-dation Center of Basic Metabolic Research (https://cbmr.ku.dk) , which is an independent research center at the University of Copenhagen, and partially funded by an unrestricted donation from the Novo Nordisk Foundation (NNF18CC0034900) . M. D. and A. S. H. were each awarded a PhD stipend from the Danish Diabetes Academy, supported by the Novo Nordisk Foundation. M. D. was awarded a postdoctoral stipend from the Danish Diabetes Academy (NNF17SA0031406) . This work was also supported by the Novo Nordisk Foundation for the Clinical Proteomics group (NNF15CC0001)	AEgidius HM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58059-7; Agerholm M, 2018, AM J PHYSIOL-ENDOC M, V314, pE377, DOI 10.1152/ajpendo.00213.2017; [Anonymous], 2021, ELIFE, V10; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Ben-Moshe S, 2019, NAT METAB, V1, P899, DOI 10.1038/s42255-019-0109-9; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bruderer R, 2016, PROTEOMICS, V16, P2246, DOI 10.1002/pmic.201500488; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Dall M, 2019, J BIOL CHEM, V294, P13304, DOI 10.1074/jbc.RA118.006756; Dall M, 2018, MOL CELL ENDOCRINOL, V473, P245, DOI 10.1016/j.mce.2018.01.025; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Fischer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045098; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Geyer PE, 2016, CELL SYST, V2, P185, DOI 10.1016/j.cels.2016.02.015; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jiang R, 2019, LIFE SCI, V225, P20, DOI 10.1016/j.lfs.2019.03.064; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Liao SL, 2021, OPEN MED-WARSAW, V16, P773, DOI 10.1515/med-2021-0286; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Matsumoto M, 2013, INT J EXP PATHOL, V94, P93, DOI 10.1111/iep.12008; Miwa S, 2016, FREE RADICAL BIO MED, V90, P173, DOI 10.1016/j.freeradbiomed.2015.11.011; Montgomery MK, 2013, J LIPID RES, V54, P3322, DOI 10.1194/jlr.M040451; Mukherjee S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.147193; Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912; Niu L, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188793; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pellizzon MA, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa031; PREISS J, 1958, J BIOL CHEM, V233, P488; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sambeat A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12262-x; Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150; Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192; Shi W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600878; Srivastava A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1670-y; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tag CG, 2015, JOVE-J VIS EXP, DOI 10.3791/52438; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Uddin GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14866-z; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang LF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0464-z; Wang X, 2017, MOLECULES, V22, DOI 10.3390/molecules22081315; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang ZF, 2014, BIOCHEM PHARMACOL, V91, P74, DOI 10.1016/j.bcp.2014.07.002; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	61	10	10	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101388	10.1016/j.jbc.2021.101388	http://dx.doi.org/10.1016/j.jbc.2021.101388			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34762911	gold, Green Published			2022-12-26	WOS:000748397200003
J	Huang, YY; Duan, XY; Wang, Z; Sun, YM; Guan, QQ; Kang, L; Zhang, Q; Fang, L; Li, JW; Wong, JM				Huang, Yuanyong; Duan, Xiaoya; Wang, Zhen; Sun, Yimei; Guan, Qingqing; Kang, Li; Zhang, Qiao; Fang, Lan; Li, Jiwen; Wong, Jiemin			An acetylation-enhanced interaction between transcription factor Sox2 and the steroid receptor coactivators facilitates Sox2 transcriptional activity and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPAIR COMPLEX; STEM; BROMODOMAIN; BINDING; DOMAIN; REGULATORS; CANCER; CBP; PHOSPHORYLATION; IDENTIFICATION	SRY-box 2 (Sox2) is a transcription factor with critical roles in maintaining embryonic stem (ES) cell and adult stem cell functions and in tumorigenesis. However, how Sox2 exerts its transcriptional function remains unclear. Here, we used an in vitro protein-protein interaction assay to discover transcriptional regulators for ES cell core transcription factors (Oct4, Sox2, Klf4, and c-Myc) and identified members of the steroid receptor coactivators (SRCs) as Sox2-specific interacting proteins. The SRC family coactivators have broad roles in transcriptional regulation, but it is unknown whether they also serve as Sox2 coactivators. We demonstrated that these proteins facilitate Sox2 transcriptional activity and act synergistically with p300. Furthermore, we uncovered an acetylation-enhanced interaction between Sox2 and SRC-2/3, but not SRC-1, demonstrating it is Sox2 acetylation that promotes the interaction. We identified putative Sox2 acetylation sites required for acetylation-enhanced interaction between Sox2 and SRC-3 and demonstrated that acetylation on these sites contributes to Sox2 transcriptional activity and recruitment of SRC-3. We showed that activation domains 1 and 2 of SRC-3 both display a preferential binding to acetylated Sox2. Finally, functional analyses in mouse ES cells demonstrated that knockdown of SRC-2/3 but not SRC-1 in mouse ES cells significantly downregulates the transcriptional activities of various Sox2 target genes and impairs ES cell stemness. Taken together, we identify specific SRC family proteins as novel Sox2 coactivators and uncover the role of Sox2 acetylation in promoting coactivator recruitment and Sox2 transcriptional function.	[Huang, Yuanyong; Duan, Xiaoya; Wang, Zhen; Sun, Yimei; Guan, Qingqing; Kang, Li; Zhang, Qiao; Fang, Lan; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Fengxian Dist Cent Hosp ECNU Joint Ctr Translat M, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Huang, Yuanyong; Duan, Xiaoya; Wang, Zhen; Sun, Yimei; Guan, Qingqing; Kang, Li; Zhang, Qiao; Fang, Lan; Li, Jiwen; Wong, Jiemin] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Wong, Jiemin] Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China	East China Normal University; East China Normal University	Wong, JM (corresponding author), East China Normal Univ, Fengxian Dist Cent Hosp ECNU Joint Ctr Translat M, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China.; Wong, JM (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.; Wong, JM (corresponding author), Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China.	jmweng@bio.ecnu.edu.cn	Wang, Zhen/GYI-9962-2022	Wang, Zhen/0000-0002-1215-1661; Wong, Jiemin/0000-0002-5311-842X	National Natural Science Foundation of China [32070643, 31730048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by Grants from the National Natural Science Foundation of China (32070643 to J. L. and 31730048 to J. W.).	Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bannister AJ, 2000, CELL MOL LIFE SCI, V57, P1184, DOI 10.1007/PL00000758; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cai WJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13608-1; Cattoglio C, 2015, P NATL ACAD SCI USA, V112, pE2317, DOI 10.1073/pnas.1505569112; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; DAILEY L, 1994, MOL CELL BIOL, V14, P7758, DOI 10.1128/MCB.14.12.7758; Dasgupta S, 2014, ANNU REV MED, V65, P279, DOI 10.1146/annurev-med-051812-145316; Dennler S, 2005, ONCOGENE, V24, P1936, DOI 10.1038/sj.onc.1208343; Fang L, 2016, STEM CELLS, V34, P565, DOI 10.1002/stem.2250; Fang L, 2014, MOL CELL, V55, P537, DOI 10.1016/j.molcel.2014.06.018; Fang XF, 2011, PROTEOMICS, V11, P921, DOI 10.1002/pmic.201000419; Fong YW, 2014, ELIFE, V3, DOI 10.7554/eLife.03573; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Heng JCD, 2010, ADV EXP MED BIOL, V695, P76, DOI 10.1007/978-1-4419-7037-4_6; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hou T, 2008, J BIOL CHEM, V283, P30725, DOI 10.1074/jbc.M805941200; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kim BR, 2017, MOL CELL PROTEOMICS, V16, P1864, DOI 10.1074/mcp.M116.064451; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Nowling T, 2003, J BIOL CHEM, V278, P13696, DOI 10.1074/jbc.M207567200; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; ONATE SA, 1995, SCIENCE, V270, P1354; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Percharde M, 2012, GENE DEV, V26, P2286, DOI 10.1101/gad.195545.112; Perez-Salvia M, 2017, EPIGENETICS-US, V12, P323, DOI 10.1080/15592294.2016.1265710; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schaefer T, 2020, ONCOGENE, V39, P278, DOI 10.1038/s41388-019-0997-x; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Stashi E, 2014, TRENDS ENDOCRIN MET, V25, P337, DOI 10.1016/j.tem.2014.05.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Tam WL, 2014, CANCER CELL, V26, P3, DOI 10.1016/j.ccr.2014.06.024; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wei W, 2017, CELL RES, V27, P898, DOI 10.1038/cr.2017.68; Wu ZT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373092; Wuebben EL, 2017, ONCOTARGET, V8, P44917, DOI 10.18632/oncotarget.16570; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Yang XJ, 2004, BIOESSAYS, V26, P1076, DOI 10.1002/bies.20104; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zaware N, 2019, NAT STRUCT MOL BIOL, V26, P870, DOI 10.1038/s41594-019-0309-8; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhao HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027026	61	0	0	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101389	10.1016/j.jbc.2021.101389	http://dx.doi.org/10.1016/j.jbc.2021.101389			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34762910	Green Published, gold			2022-12-26	WOS:000748084900004
J	Jameson, KH; Rudolph, CJ; Hawkins, M				Jameson, Katie H.; Rudolph, Christian J.; Hawkins, Michelle			Termination of DNA replication at Tus-ter barriers results in under-replication of template DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; UVRD HELICASE; PROTEIN; FORK; TRANSCRIPTION; TERMINUS; IDENTIFICATION; TRANSLOCATION; PROGRESSION; INHIBITION	The complete and accurate duplication of genomic information is vital to maintain genome stability in all domains of life. In Escherichia coli, replication termination, the final stage of the duplication process, is confined to the "replication fork trap" region by multiple unidirectional fork barriers formed by the binding of Tus protein to genomic ter sites. Termination typically occurs away from Tus-ter complexes, but they become part of the fork fusion process when a delay to one replisome allows the second replisome to travel more than halfway around the chromosome. In this instance, replisome progression is blocked at the nonpermissive interface of the Tus-ter complex, termination then occurs when a converging replisome meets the permissive interface. To investigate the consequences of replication fork fusion at Tus-ter complexes, we established a plasmid-based replication system where we could mimic the termination process at Tus-ter complexes in vitro. We developed a termination mapping assay to measure leading strand replication fork progression and demonstrate that the DNA template is under-replicated by 15 to 24 bases when replication forks fuse at Tus-ter complexes. This gap could not be closed by the addition of lagging strand processing enzymes or by the inclusion of several helicases that promote DNA replication. Our results indicate that accurate fork fusion at Tus-ter barriers requires further enzymatic processing, highlighting large gaps that still exist in our understanding of the final stages of chromosome duplication and the evolutionary advantage of having a replication fork trap.	[Jameson, Katie H.; Hawkins, Michelle] Univ York, Dept Biol, York, N Yorkshire, England; [Rudolph, Christian J.] Brunel Univ London, Coll Hlth Med & Life Sci, Div Biosci, Uxbridge, Middx, England	University of York - UK; Brunel University	Hawkins, M (corresponding author), Univ York, Dept Biol, York, N Yorkshire, England.	michelle.hawkins@york.ac.uk	Rudolph, Christian J./L-6525-2019	Rudolph, Christian J./0000-0003-2493-3748; Jameson, Katie/0000-0002-6445-8024; Hawkins, Michelle/0000-0001-9393-8206	Biotechnology and Biological Sciences Research Council [BB/N014995/1, BB/N014863/1]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by Research Grant BB/N014995/1 and BB/N014863/1 from the Biotechnology and Biological Sciences Research Council to C. J. R. and M. H respectively.	An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; Berghuis BA, 2018, CRIT REV BIOCHEM MOL, V53, P49, DOI 10.1080/10409238.2017.1394264; Berghuis BA, 2015, NAT CHEM BIOL, V11, P579, DOI [10.1038/NCHEMBIO.1857, 10.1038/nchembio.1857]; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; BOUCHE JP, 1982, J MOL BIOL, V154, P21, DOI 10.1016/0022-2836(82)90414-4; Deegan TD, 2020, ELIFE, V9, DOI 10.7554/eLife.60371; Dewar JM, 2017, NAT REV MOL CELL BIO, V18, P507, DOI 10.1038/nrm.2017.42; Dimude JU, 2018, GENES-BASEL, V9, DOI 10.3390/genes9080376; Dimude JU, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080040; Dimude JU, 2015, MBIO, V6, DOI 10.1128/mBio.01294-15; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Galli E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43795-2; Gambus A, 2017, ADV EXP MED BIOL, V1042, P163, DOI 10.1007/978-981-10-6955-0_8; Gao Y, 2019, SCIENCE, V363, P835, DOI 10.1126/science.aav7003; Gupta MK, 2013, P NATL ACAD SCI USA, V110, P7252, DOI 10.1073/pnas.1303890110; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hasebe T, 2018, LIFE-BASEL, V8, DOI 10.3390/life8040043; Hawkins M, 2019, NUCLEIC ACIDS RES, V47, P5100, DOI 10.1093/nar/gkz170; HIASA H, 1994, J BIOL CHEM, V269, P26959; HIASA H, 1992, J BIOL CHEM, V267, P11379; HIDAKA M, 1989, J BIOL CHEM, V264, P21031; HILL TM, 1988, J BACTERIOL, V170, P662, DOI 10.1128/jb.170.2.662-668.1988; HILL TM, 1987, P NATL ACAD SCI USA, V84, P1754, DOI 10.1073/pnas.84.7.1754; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Ivanova D, 2015, NUCLEIC ACIDS RES, V43, P7865, DOI 10.1093/nar/gkv704; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Midgley-Smith SL, 2019, NUCLEIC ACIDS RES, V47, P1847, DOI 10.1093/nar/gky1253; Midgley-Smith SL, 2018, NUCLEIC ACIDS RES, V46, P7701, DOI 10.1093/nar/gky566; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Moolman MC, 2016, NUCLEIC ACIDS RES, V44, P6262, DOI 10.1093/nar/gkw397; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parker MW, 2017, CRIT REV BIOCHEM MOL, V52, P107, DOI 10.1080/10409238.2016.1274717; Payne BTI, 2006, NUCLEIC ACIDS RES, V34, P5194, DOI 10.1093/nar/gkl682; ROECKLEIN B, 1991, RES MICROBIOL, V142, P169, DOI 10.1016/0923-2508(91)90026-7; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; Smelkova N, 2001, J BIOL CHEM, V276, P39186, DOI 10.1074/jbc.M104411200; Syeda AH, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00534; Pham TM, 2013, MOL MICROBIOL, V90, P584, DOI 10.1111/mmi.12386; Wenderl BM, 2018, P NATL ACAD SCI USA, V115, P349, DOI 10.1073/pnas.1715960114; WU CA, 1992, J BIOL CHEM, V267, P4030	50	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101409	10.1016/j.jbc.2021.101409	http://dx.doi.org/10.1016/j.jbc.2021.101409			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO9UJ	34780717	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000748277600006
J	Zimmermann, RC; Sardiu, ME; Manton, CA; Miah, MS; Banks, CAS; Adams, MK; Koestler, DC; Hurst, DR; Edmonds, MD; Washburn, MP; Welch, DR				Zimmermann, Rosalyn C.; Sardiu, Mihaela E.; Manton, Christa A.; Miah, Md. Sayem; Banks, Charles A. S.; Adams, Mark K.; Koestler, Devin C.; Hurst, Douglas R.; Edmonds, Mick D.; Washburn, Michael P.; Welch, Danny R.			Perturbation of BRMS1 interactome reveals pathways that impact metastasis	PLOS ONE			English	Article							DEACETYLASE COMPLEX; GENE-EXPRESSION; SUPPRESSOR-1 BRMS1; STABILITY CHANGES; HUMAN-MELANOMA; CANCER-CELLS; COREPRESSOR; IDENTIFICATION; COMPONENT; REPRESSION	Breast Cancer Metastasis Suppressor 1 (BRMS1) expression is associated with longer patient survival in multiple cancer types. Understanding BRMS1 functionality will provide insights into both mechanism of action and will enhance potential therapeutic development. In this study, we confirmed that the C-terminus of BRMS1 is critical for metastasis suppression and hypothesized that critical protein interactions in this region would explain its function. Phosphorylation status at S237 regulates BRMS1 protein interactions related to a variety of biological processes, phenotypes [cell cycle (e.g., CDKN2A), DNA repair (e.g., BRCA1)], and metastasis [(e.g., TCF2 and POLE2)]. Presence of S237 also directly decreased MDA-MB-231 breast carcinoma migration in vitro and metastases in vivo. The results add significantly to our understanding of how BRMS1 interactions with Sin3/HDAC complexes regulate metastasis and expand insights into BRMS1's molecular role, as they demonstrate BRMS1 C-terminus involvement in distinct protein-protein interactions.	[Zimmermann, Rosalyn C.; Manton, Christa A.; Washburn, Michael P.; Welch, Danny R.] Kansas Univ, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA; [Sardiu, Mihaela E.; Miah, Md. Sayem; Banks, Charles A. S.; Adams, Mark K.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Sardiu, Mihaela E.; Koestler, Devin C.] Kansas Univ, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS 66103 USA; [Sardiu, Mihaela E.; Koestler, Devin C.; Washburn, Michael P.; Welch, Danny R.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Manton, Christa A.; Hurst, Douglas R.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Manton, Christa A.] Baker Univ, Dept Biol, Baldwin City, KS USA; [Miah, Md. Sayem] Univ Arkansas Hlth Sci, Dept Biochem & Mol Biol, Little Rock, AR USA; [Edmonds, Mick D.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Alabama System; University of Alabama Birmingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Alabama System; University of Alabama Birmingham	Welch, DR (corresponding author), Kansas Univ, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA.; Sardiu, ME (corresponding author), Kansas Univ, Med Ctr, Dept Biostat & Data Sci, Kansas City, KS 66103 USA.; Sardiu, ME; Welch, DR (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.	msardiu@kumc.edu; dwelch@kumc.edu		Henn, Rosalyn/0000-0001-8611-2545; Miah, Md Sayem/0000-0002-5901-5181; Adams, Mark/0000-0002-1078-9514; Washburn, Michael/0000-0001-7568-2585; Edmonds, Micky/0000-0001-5049-7180	Stowers Institute for Medical Research; METAvivor Research and Support Inc.; National Institute for General Medical Sciences [GM112639, F32GM122215]; National Foundation for Cancer Research (DRW), USPHS National Cancer Institute [CA134981, CA168524]; American Cancer Society [PF-16-227-O1-CSM]; Susan G. Komen for the Cure [SAC110037]; National Institute of General Medical Science [P20-GM103418]; KU Cancer Center Biostatistics and Informatics Shared Resource - National Cancer Institute Cancer Center [P30-CA168524]; Kansas Institute for Precision Medicine COBRE - National Institute of General Medical Science [P20-GM130423]	Stowers Institute for Medical Research; METAvivor Research and Support Inc.; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Foundation for Cancer Research (DRW), USPHS National Cancer Institute; American Cancer Society(American Cancer Society); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); KU Cancer Center Biostatistics and Informatics Shared Resource - National Cancer Institute Cancer Center; Kansas Institute for Precision Medicine COBRE - National Institute of General Medical Science	This work was supported by the Stowers Institute for Medical Research (MPW, MES, MSM, CAB, MKA); METAvivor Research and Support Inc. (DRW), National Institute for General Medical Sciences [GM112639, F32GM122215 (MPW)]; National Foundation for Cancer Research (DRW), USPHS National Cancer Institute [CA134981, CA168524 (DRW)]; American Cancer Society [PF-16-227-O1-CSM (CAM)]; Susan G. Komen for the Cure [SAC110037 (DRW)]; The K-INBRE Bioinformatics Core supported in part by the National Institute of General Medical Science [P20-GM103418 (RCZ]; the KU Cancer Center Biostatistics and Informatics Shared Resource supported by the National Cancer Institute Cancer Center [P30-CA168524 (DK, DRW)]; and the Kansas Institute for Precision Medicine COBRE supported by the National Institute of General Medical Science [P20-GM130423 (DCK)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M. K., 2019, DIFFERENTIAL COMPLEX, DOI [10.1101/830828, DOI 10.1101/830828]; Adams MK, 2020, MOL CELL PROTEOMICS, V19, DOI 10.1074/mcp.RA120.002078; Anoosha P, 2015, ANAL BIOCHEM, V491, P18, DOI 10.1016/j.ab.2015.08.028; Banks CAS, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.080; Bucciarelli PR, 2018, J THORAC ONCOL, V13, P73, DOI 10.1016/j.jtho.2017.10.006; Buchner A, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.042; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Champine PJ, 2007, CLIN EXP METASTAS, V24, P551, DOI 10.1007/s10585-007-9092-8; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chaudhary P, 2015, BIOINFORMATICS, V31, P2091, DOI 10.1093/bioinformatics/btv091; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; DeWald DB, 2005, CANCER RES, V65, P713; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Frayling TM, 2008, DIABETOLOGIA, V51, P1757, DOI 10.1007/s00125-008-1114-9; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Gerami P, 2015, CLIN CANCER RES, V21, P175, DOI 10.1158/1078-0432.CCR-13-3316; Gkountela S, 2019, CELL, V176, P98, DOI 10.1016/j.cell.2018.11.046; Gong C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6406; Graham M. J., 2019, XIVIEW COMMON PLATFO, DOI [10.1101/561829, DOI 10.1101/561829]; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hauri S, 2016, CELL REP, V17, P583, DOI 10.1016/j.celrep.2016.08.096; Hedley BD, 2008, INT J CANCER, V123, P526, DOI 10.1002/ijc.23542; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hicks David G, 2010, BMC Cancer, V10, P108, DOI 10.1186/1471-2407-10-108; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hurst DR, 2008, J BIOL CHEM, V283, P7438, DOI 10.1074/jbc.M709446200; Hurst DR, 2006, BIOCHEM BIOPH RES CO, V348, P1429, DOI 10.1016/j.bbrc.2006.08.005; Hurst DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055966; Hurst DR, 2011, FEBS LETT, V585, P3185, DOI 10.1016/j.febslet.2011.07.045; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Khotskaya YB, 2014, MOL CARCINOGEN, V53, P1011, DOI 10.1002/mc.22068; Koyama R, 2017, CANCER SCI, V108, P2413, DOI 10.1111/cas.13420; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lewis MJ, 2016, ONCOTARGET, V7, P78713, DOI 10.18632/oncotarget.12805; Li J, 2011, ONCOGENE, V30, P896, DOI 10.1038/onc.2010.470; Liu W, 2014, CANCER MICROENVIRON, V7, P117, DOI 10.1007/s12307-014-0148-4; Liu Y, 2006, MOL CELL BIOL, V26, P8683, DOI 10.1128/MCB.00940-06; Liu Y, 2015, MOL CELL BIOL, V35, P303, DOI 10.1128/MCB.00869-14; Liu Y, 2013, CANCER RES, V73, P1308, DOI 10.1158/0008-5472.CAN-12-2489; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; McDonel P, 2012, DEV BIOL, V363, P62, DOI 10.1016/j.ydbio.2011.12.019; Meehan WJ, 2004, J BIOL CHEM, V279, P1562, DOI 10.1074/jbc.M307969200; Mei PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098544; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nagy A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84787-5; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Pantoja-Uceda D, 2019, ARCH BIOCHEM BIOPHYS, V664, P95, DOI 10.1016/j.abb.2019.01.035; Rivera J, 2010, J CELL BIOCHEM, V111, P1464, DOI 10.1002/jcb.22874; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Roesley SNA, 2016, CELL CYCLE, V15, P137, DOI 10.1080/15384101.2015.1121328; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sardiu ME, 2020, METHODS, V184, P13, DOI 10.1016/j.ymeth.2019.08.010; Sardiu ME, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09123-y; Sardiu ME, 2014, MOL CELL PROTEOMICS, V13, P3114, DOI 10.1074/mcp.M113.037127; Saunders A, 2017, CELL REP, V18, P1713, DOI 10.1016/j.celrep.2017.01.055; Seraj MJ, 2000, CANCER RES, V60, P2764; Seraj MJ, 2001, CLIN EXP METASTAS, V18, P519, DOI 10.1023/A:1011819621859; Shevde LA, 2002, EXP CELL RES, V273, P229, DOI 10.1006/excr.2001.5452; Shevde LA., 2001, PNAS, V42, P646; Skowyra D, 2001, J BIOL CHEM, V276, P8734, DOI 10.1074/jbc.M007664200; Smith PW, 2009, CANCER LETT, V276, P196, DOI 10.1016/j.canlet.2008.11.024; Spinola-Amilibia M, 2011, J MOL BIOL, V411, P1114, DOI 10.1016/j.jmb.2011.07.006; Steeg Patricia S, 2003, Clin Breast Cancer, V4, P51, DOI 10.3816/CBC.2003.n.012; Suryadinata R, 2011, J BIOL CHEM, V286, P5108, DOI 10.1074/jbc.M110.198473; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Welch DR, 2019, CANCER RES, V79, P3011, DOI 10.1158/0008-5472.CAN-19-0458; Zhang HM, 2017, EUR REV MED PHARMACO, V21, P68; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang ZH, 2006, CLIN CANCER RES, V12, P6410, DOI 10.1158/1078-0432.CCR-06-1347	81	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259128	10.1371/journal.pone.0259128	http://dx.doi.org/10.1371/journal.pone.0259128			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788285	Green Published, gold			2022-12-26	WOS:000735920500015
J	Chartier, KG; Guidry, JPD; Lee, CA; Buckley, TD				Chartier, Karen G.; Guidry, Jeanine P. D.; Lee, Catherine A.; Buckley, Thomas D.			At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of US adults	PLOS ONE			English	Article							SOCIAL MEDIA; DRINKING; NORMS; EXPOSURE; FACEBOOK	Introduction The current study aimed to understand the links between social media use and alcohol consumption during the early months of the COVID-19 pandemic. Method Data were from the national Understanding American Study, a probability-based Internet panel weighted to represent the U.S. population. Subjects (N = 5874; 51% female) were adults, 18 years and older, who completed a March survey (wave 1) and a follow-up survey one month later (wave 3). Analyses assessed the relationships of social media use at wave 1 with wave 3 alcohol use frequency, accounting for wave 1 alcohol use frequency and the sociodemographic characteristics of the sample. Two alcohol use change variables were also assessed as outcomes-increased and decreased alcohol use between waves. We considered the effect of work status changes (working/studying from home and job loss) as potential moderators. Results Twitter and Instagram users and users of multiple social media platforms, but not Facebook users, drank more frequently at wave 3. The results were similar when assessing relationships between social media use and increased alcohol use between waves. For Instagram users, more frequent alcohol use at wave 3 was at least partially attributed to drinking frequency at wave 1. Additionally, working/studying from home at wave 3 and employment (rather than job loss) were associated with greater consumption. The interaction effect between Twitter use and working/studying from home was statistically significant in association with alcohol use frequency at wave 3, as was the interaction effect between using multiple platforms and working/studying from home in association with decreased alcohol use between waves. Discussion Exposure to content about COVID-19 and increased alcohol consumption during the pandemic may have contributed to more frequent alcohol use for some social media users. The study of public health messaging via social media to change alcohol use behaviors during traumatic events is warranted.	[Chartier, Karen G.] Virginia Commonwealth Univ, Sch Social Work & Dept Psychiat, Richmond, VA 23284 USA; [Guidry, Jeanine P. D.] Virginia Commonwealth Univ, Robertson Sch Media & Culture, Richmond, VA USA; [Lee, Catherine A.] George Mason Univ, Schar Sch Policy & Govt, Fairfax, VA 22030 USA; [Buckley, Thomas D.] Virginia Commonwealth Univ, Sch Social Work, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; George Mason University; Virginia Commonwealth University	Chartier, KG (corresponding author), Virginia Commonwealth Univ, Sch Social Work & Dept Psychiat, Richmond, VA 23284 USA.	kgchartier@vcu.edu		Chartier, Karen/0000-0002-2410-2584				Andersen M., 2020, PEW RES CTR; [Anonymous], 2020, UNDERSTANDING AM SUR; [Anonymous], 2020, UNDERSTANDING CORONA; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Brailovskaia J, 2021, COMPUT HUM BEHAV, V119, DOI 10.1016/j.chb.2021.106720; Charles-Smith LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139701; Chodkiewicz J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134677; Davis JP, 2019, J YOUTH ADOLESCENCE, V48, P1311, DOI 10.1007/s10964-019-01024-z; Feuls M, 2014, WORK EMPLOY SOC, V28, P551, DOI 10.1177/0950017013519846; Fulmer M, 2020, WASH POST; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Greenfield TK, 2008, ADDICTION, V103, P1082, DOI 10.1111/j.1360-0443.2008.02197.x; Grossman ER, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249189; Hopwood TL, 2017, PSYCHOL VIOLENCE, V7, P316, DOI 10.1037/vio0000056; Johnston KL, 2003, PSYCHOL HEALTH, V18, P63, DOI 10.1080/0887044021000037835; Keyes KM, 2012, ALCOHOL RES-CURR REV, V34, P391; Killgore WDS, 2021, PSYCHIAT RES, V296, DOI 10.1016/j.psychres.2020.113676; Kiraly O, 2020, COMPR PSYCHIAT, V100, DOI 10.1016/j.comppsych.2020.152180; Lee H, 2019, CYBERPSYCH BEH SOC N, V22, P397, DOI 10.1089/cyber.2018.0381; MacMaster TJ, 2021, BIRM BYZANTINE OTTOM, V30, P1, DOI 10.1007/s11469-020-00482-y; Matassi M., 2021, INT J COMMUN-US, V15; McDowell CP, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.597619; Monteiro MG, 2020, J STUD ALCOHOL DRUGS, V81, P297; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; National Institute on Alcohol Abuse and Alcoholism, 2020, ALC SAL COVID 19 PAN; National Institute on Alcohol Abuse and Alcoholism, 2020, DRINK ALC DOES NOT P; Neill E, 2020, PSYCHIAT CLIN NEUROS, V74, P542, DOI 10.1111/pcn.13099; Panno A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.577135; Perkins HW, 2010, ADDICT BEHAV, V35, P866, DOI 10.1016/j.addbeh.2010.05.004; Perrin A., 2019, SHARE US ADULTS USIN; Pew Research Center, 2019, INTERNET TECHNOLOGY; Rehm J, 2020, DRUG ALCOHOL REV, V39, P301, DOI 10.1111/dar.13074; Ridout B, 2016, CURR OPIN PSYCHOL, V9, P83, DOI 10.1016/j.copsyc.2015.12.005; Ridout B, 2012, DRUG ALCOHOL REV, V31, P20, DOI 10.1111/j.1465-3362.2010.00277.x; Ryerson NC, 2021, TRANSL BEHAV MED, V11, P814, DOI 10.1093/tbm/ibab006; Sacks Jeffrey J, 2015, Am J Prev Med, V49, pe73, DOI 10.1016/j.amepre.2015.05.031; Schulenberg JE, 2019, MONITORING FUTURE NA; Sharma A, 2021, DRUG ALCOHOL REV, V40, P683, DOI 10.1111/dar.13163; Sherk A, 2020, J STUD ALCOHOL DRUGS, V81, P352, DOI 10.15288/jsad.2020.81.352; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; US Census Bureau, 2019, QUICK FACTS US; Wardell JD, 2020, ALCOHOL CLIN EXP RES, V44, P2073, DOI 10.1111/acer.14425; Westgate EC, 2016, CURR OPIN PSYCHOL, V9, P27, DOI 10.1016/j.copsyc.2015.10.014; Westgate EC, 2014, J STUD ALCOHOL DRUGS, V75, P390, DOI 10.15288/jsad.2014.75.390; White HR, 2020, J STUD ALCOHOL DRUGS, V81, P725, DOI 10.15288/jsad.2020.81.725; WHO, 2020, WHO COR COVID 19 DAS; Wiederhold BK, 2020, CYBERPSYCH BEH SOC N, V23, P275, DOI 10.1089/cyber.2020.29181.bkw; World Health Organization, 2021, NOV COR 2019 NCOV SI; Yang YT, 2013, J PUBLIC HEALTH RES, V2, P17, DOI 10.4081/jphr.2013.e4; Zucker RA, 2008, ADDICTION, V103, P100, DOI 10.1111/j.1360-0443.2008.02179.x	51	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259947	10.1371/journal.pone.0259947	http://dx.doi.org/10.1371/journal.pone.0259947			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784402	Green Published, gold, Green Submitted			2022-12-26	WOS:000755277300032
J	Kilbride, P; Meneghel, J; Fonseca, F; Morris, J				Kilbride, Peter; Meneghel, Julie; Fonseca, Fernanda; Morris, John			The transfer temperature from slow cooling to cryogenic storage is critical for optimal recovery of cryopreserved mammalian cells	PLOS ONE			English	Article							CYTOPLASM; EMBRYOS; SPERM; RATES	Cryopreservation is a key step for the effective delivery of many cell therapies and for the maintenance of biological materials for research. The preservation process must be carefully controlled to ensure maximum, post-thaw recovery using cooling rates slow enough to allow time for cells to cryodehydrate sufficiently to avoid lethal intracellular ice. This study focuses on determining the temperature necessary at the end of controlled slow cooling before transfer to cryogenic storage which ensures optimal recovery of the processed cell samples. Using nucleated, mammalian cell lines derived from liver (HepG2), ovary (CHO) and bone tissue (MG63) this study has shown that cooling must be controlled to -40 degrees C before transfer to long term storage to ensure optimal cell recovery. No further advantage was seen by controlling cooling to lower temperatures. These results are consistent with collected differential scanning calorimetry data, that indicated the cells underwent an intracellular, colloidal glass transition between -49 and -59 degrees C (Tg'i) in the presence of the cryoprotective agent dimethyl sulfoxide (DMSO). The glass forms at the point of maximum cryodehydration and no further cellular dehydration is possible. At this point the risk of lethal intracellular ice forming on transfer to ultra-low temperature storage is eliminated. In practice it may not be necessary to continue slow cooling to below this temperature as optimal recovery at -40 degrees C indicates that the cells have become sufficiently dehydrated to avoid further, significant damage when transferred into ultra-low temperature storage.	[Kilbride, Peter; Meneghel, Julie; Morris, John] Cytiva, Cambridge, England; [Fonseca, Fernanda] Univ Paris Saclay, UMR SayFood, AgroParisTech, INRAE, Thiverval Grignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Kilbride, P (corresponding author), Cytiva, Cambridge, England.	peter.kilbride@cytiva.com	FONSECA, FERNANDA/HDN-9451-2022	FONSECA, FERNANDA/0000-0002-0315-6479; Meneghel, Julie/0000-0002-1510-8642	European Union [777657]; Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK [6239]; Cytiva	European Union(European Commission); Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK; Cytiva	This work has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 777657. JM, PK and JGM received funding from the Advanced Treatment Therapy Centres (ATTC) programme - A Co-ordinated Strategy to Scale-up Advanced Therapies for Patients in Manchester, Innovate UK Project Number: 6239. Cytiva provided support in the form of salaries for JM, PK, and JGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Baboo J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39957-x; Bahsoun S, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02136-7; Benga G, 2013, EUR BIOPHYS J BIOPHY, V42, P33, DOI 10.1007/s00249-012-0868-7; Campbell LD, 2018, BIOPRESERV BIOBANK, V16, P3, DOI 10.1089/bio.2018.0001; Robert MC, 2016, CRYOBIOLOGY, V72, P191, DOI 10.1016/j.cryobiol.2016.05.003; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; Critser J K, 2000, ILAR J, V41, P197; Dalal J., 2018, INT J CURR MICROBIOL, V7, P1903, DOI [10.20546/ijcmas.2018.708.219, 10.20546/]; Devireddy RV, 2002, BIOL REPROD, V66, P222, DOI 10.1095/biolreprod66.1.222; Elliott GD, 2017, CRYOBIOLOGY, V76, P74, DOI 10.1016/j.cryobiol.2017.04.004; Eskandari N, 2018, CRYOBIOLOGY, V85, P63, DOI 10.1016/j.cryobiol.2018.10.001; Fonseca F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152939; Fuller BJ., 2004, LIFE FROZEN STAT; Gilmore JA, 2000, HUM REPROD, V15, P335, DOI 10.1093/humrep/15.2.335; Greening DW, 2010, J PROTEOMICS, V73, P386, DOI 10.1016/j.jprot.2009.07.011; Guan M, 2008, CRYOBIOLOGY, V56, P204, DOI 10.1016/j.cryobiol.2008.03.001; Hunt CJ, 2019, TRANSFUS MED HEMOTH, V46, P134, DOI 10.1159/000497289; Kilbride P, 2017, CRYOBIOLOGY, V76, P92, DOI 10.1016/j.cryobiol.2017.04.003; Kilbride P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183385; Konc J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/307268; Leibo SP, 2002, THERIOGENOLOGY, V57, P303, DOI 10.1016/S0093-691X(01)00673-2; Liu J, 2000, BIOL REPROD, V63, P1303, DOI 10.1095/biolreprod63.5.1303; Loss M, 2014, STANDARD TEST METHOD; Marquez-Curtis LA, 2016, CRYOBIOLOGY, V72, P183, DOI 10.1016/j.cryobiol.2016.05.005; MAZUR P, 1990, CELL BIOPHYS, V17, P53, DOI 10.1007/BF02989804; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Meneghel J, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.592242; Meneghel J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217304; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Morris GJ, 2007, THERIOGENOLOGY, V68, P804, DOI 10.1016/j.theriogenology.2007.06.009; Morris GJ, 2006, CRYOBIOLOGY, V52, P323, DOI 10.1016/j.cryobiol.2006.01.003; Mourao MA, 2014, BIOPHYS J, V107, P2761, DOI 10.1016/j.bpj.2014.10.051; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Pegg DE, 1997, CRYOBIOLOGY, V34, P183, DOI 10.1006/cryo.1996.1997; R Core Team, 2021, R LANG ENV STAT; Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779; Sputtek Andreas, 2007, Methods Mol Biol, V368, P283; Thorat AA, 2019, PHARM RES-DORDR, V36, DOI 10.1007/s11095-019-2619-2; Viveiros ATM, 2001, CRYOBIOLOGY, V43, P276, DOI 10.1006/cryo.2001.2362; Ware CB, 2005, BIOTECHNIQUES, V38, P879, DOI 10.2144/05386ST01	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259571	10.1371/journal.pone.0259571	http://dx.doi.org/10.1371/journal.pone.0259571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784361	Green Published, gold			2022-12-26	WOS:000755277300014
J	Trongjit, S; Chuanchuen, R				Trongjit, Suthathip; Chuanchuen, Rungtip			Whole genome sequencing and characteristics of Escherichia coli with co-existence of ESBL and mcr genes from pigs	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; RESISTANCE GENES; INCI2 PLASMIDS; SALMONELLA; IDENTIFICATION; DISSEMINATION; COOCCURRENCE; POULTRY	This study aimed to analyze three ESBL-producing E. coli co-harboring mcr and ESBL genes from a healthy fattening pig (E. 431) and two sick pigs (ECP.81 and ECP.82) in Thailand using Whole Genome Sequencing (WGS) using either Illumina MiSeq or HiSeq PE150 platforms to determine their genome and transmissible plasmids. E. 431 carrying mcr-2.1 and mcr-3.1 belonged to serotype O142:H31 with ST29 sequence type. ECP.81 and ECP.82 from sick pigs harboring mcr-1.1 and mcr-3.1 were serotype O9:H9 with ST10. Two mcr-1.1 gene cassettes from ECP.81 and ECP.82 were located on IncI2 plasmid with 98% identity to plasmid pHNSHP45. The mcr-2.1-carrying contig in E. 431 showed 100% identity to plasmid pKP37-BE with the upstream flanking sequence of IS1595. All three mcr-3.1-carrying contigs contained the Delta TnAs2-mcr-3.1-dgkA core segment and had high nucleotide similarity (85-100%) to mcr-3.1-carrying plasmid, pWJ1. The mobile elements i.e. IS4321, Delta TnAs2, ISKpn40 and IS3 were identified in the flanking regions of mcr-3. Several genes conferring resistance to aminoglycosides (aac(3)-IIa, aadA1, aadA2b, aph(3'')-Ib, aph(3')-IIa and aph(6)-Id), macrolides (mdf(A)), phenicols (cmlA1), sulphonamide (sul3) and tetracycline (tet(A) and tet(M)) were located on plasmids, of which their presence was well corresponded to the host's resistance phenotype. Amino acid substitutions S83L and D87G in GyrA and S80I and E62K in ParC were observed. The bla(CTX-M-14) and bla(CTX-M-55) genes were identified among these isolates additionally harbored bla(TEM-1B). Co-transfer of mcr-1.1/bla(TEM-1B) and mcr-3.1/bla(CTX-M-55) was observed in ECP.81 and ECP.82 but not located on the same plasmid. The results highlighted that application of advanced innovation technology of WGS in AMR monitoring and surveillance provide comprehensive information of AMR genotype that could yield invaluable benefits to development of control and prevention strategic actions plan for AMR.	[Trongjit, Suthathip; Chuanchuen, Rungtip] Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand	Chulalongkorn University	Chuanchuen, R (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Vet Publ Hlth, Res Unit Microbial Food Safety & Antimicrobial Re, Bangkok, Thailand.	chuanchuen.r@gmail.com			TRF Basic Research Grant - Thailand Research Fund (TRF) [BRG6080014]; Faculty of Veterinary Science; Chulalongkorn University; 90th Anniversary of Chulalongkorn University Fund (Ratchadaphisek Somphot Endowment Fund); Chulalongkorn University One Healthy Research Cluster; Royal Golden Jubilee Ph.D. Program [PHD/0158/2556]; TRF; Overseas Academic Presentation Scholarship	TRF Basic Research Grant - Thailand Research Fund (TRF); Faculty of Veterinary Science; Chulalongkorn University(Chulalongkorn University); 90th Anniversary of Chulalongkorn University Fund (Ratchadaphisek Somphot Endowment Fund)(Chulalongkorn University); Chulalongkorn University One Healthy Research Cluster; Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Overseas Academic Presentation Scholarship	This work was supported by TRF Basic Research Grant BRG6080014 co-funded by Thailand Research Fund (TRF), the Faculty of Veterinary Science and Chulalongkorn University. It was also partially supported by the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphisek Somphot Endowment Fund) and Chulalongkorn University One Healthy Research Cluster. ST is a recipient of the Royal Golden Jubilee Ph.D. Program (PHD/0158/2556), co-funded by TRF and Chulalongkorn University. We also thank the Overseas Academic Presentation Scholarship for Graduate Student from Chulalongkorn University to Suthathip Trongjit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuOun M, 2017, J ANTIMICROB CHEMOTH, V72, P2745, DOI 10.1093/jac/dkx286; Alba P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01217; Bai L, 2016, INT J ANTIMICROB AG, V48, P445, DOI 10.1016/j.ijantimicag.2016.06.021; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Bortolaia V, 2020, J ANTIMICROB CHEMOTH, V75, P3491, DOI 10.1093/jac/dkaa345; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Carattoli A, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.31.30589; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carroll LM, 2019, MBIO, V10, DOI 10.1128/mBio.00853-19; Chen S, 2004, APPL ENVIRON MICROB, V70, P1, DOI 10.1128/AEM.70.1.1-7.2004; CLSI, 2013, PERFORMANCE STANDARD; Egervarn M, 2014, INT J FOOD MICROBIOL, V171, P8, DOI 10.1016/j.ijfoodmicro.2013.11.005; El Garch F, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.08.033; Ellaby N, 2019, EUROSURVEILLANCE, V24, P17, DOI 10.2807/1560-7917.ES.2019.24.37.1800627; EUCAST, 2021, EUR COM ANT SUSC TES; Falgenhauer L, 2016, EMERG INFECT DIS, V22, P1689, DOI 10.3201/eid2209.160692; Feng Y, 2021, NUCLEIC ACIDS RES, V49, pD644, DOI 10.1093/nar/gkaa821; Flament-Simon SC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00387; Garcia V, 2018, INT J ANTIMICROB AG, V52, P104, DOI 10.1016/j.ijantimicag.2018.03.022; Garcia-Menino I, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02469; Gharaibeh MH, 2019, VET WORLD, V12, P1735, DOI 10.14202/vetworld.2019.1735-1746; Haenni M, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00007-4; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Hernandez M, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.31.30586; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Khanawapee A, 2021, MICROB DRUG RESIST, V27, P971, DOI 10.1089/mdr.2020.0242; Kim J, 2011, J ANTIMICROB CHEMOTH, V66, P1263, DOI 10.1093/jac/dkr106; Kovac J, 2017, TRAC-TREND ANAL CHEM, V96, P52, DOI 10.1016/j.trac.2017.06.001; Kwong JC, 2015, PATHOLOGY, V47, P199, DOI 10.1097/PAT.0000000000000235; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lekagul A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001918; Li RC, 2017, J ANTIMICROB CHEMOTH, V72, P393, DOI 10.1093/jac/dkw411; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Ling ZR, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01272-17, 10.1128/aac.01272-17]; Litrup E, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.31.30587; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Long HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37125-1; Luo QX, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02262; Lv LC, 2013, ANTIMICROB AGENTS CH, V57, P2824, DOI 10.1128/AAC.02155-12; Madec JY, 2018, PLASMID, V99, P72, DOI 10.1016/j.plasmid.2018.09.001; Matamoros S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15539-7; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Olaitan AO, 2016, INT J ANTIMICROB AG, V48, P581, DOI 10.1016/j.ijantimicag.2016.11.003; Paveenkittiporn W, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.586368; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Poirel L, 2016, LANCET INFECT DIS, V16, P281, DOI 10.1016/S1473-3099(16)00006-2; Quesada A, 2015, J ANTIMICROB CHEMOTH, V70, P71, DOI 10.1093/jac/dku320; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Snesrud E, 2018, MBIO, V9, DOI 10.1128/mBio.02381-17; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Trongjit S., 2020, RES UNIT MICROBIAL F; Walsh TR, 2016, LANCET INFECT DIS, V16, P1102, DOI 10.1016/S1473-3099(16)30329-2; Wang CC, 2020, EMERG MICROBES INFEC, V9, P508, DOI 10.1080/22221751.2020.1732231; Wang XM, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0124-z; Wang Z, 2019, VET MICROBIOL, V230, P56, DOI 10.1016/j.vetmic.2019.01.011; WHO, 2017, CRIT IMP ANT HUM MED; Wong MHY, 2015, ANTIMICROB AGENTS CH, V59, P5026, DOI 10.1128/AAC.00775-15; Wu RJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00331; Xavier BB, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.27.30280; Yang YQ, 2016, J ANTIMICROB CHEMOTH, V71, P2336, DOI 10.1093/jac/dkw243; Yin WJ, 2017, MBIO, V8, DOI 10.1128/mBio.00543-17; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22084-4; Zhou ZM, 2020, GENOME RES, V30, P138, DOI 10.1101/gr.251678.119	67	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260011	10.1371/journal.pone.0260011	http://dx.doi.org/10.1371/journal.pone.0260011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784400	gold, Green Published			2022-12-26	WOS:000755277300038
J	Sabbag, IP; Hohmann, FB; Assuncao, MSC; Chaves, RCD; Correa, TD; Menezes, PFL; Neto, AS; Malbouisson, LMS; Lobo, SMA; Amendola, CP; De Aguilar-Nascimento, JE; Silva, JM				Sabbag, Itajiba Paternosti; Hohmann, Fabio Barlem; Cesar Assuncao, Murillo Santucci; de Freitas Chaves, Renato Carneiro; Correa, Thiago Domingos; Menezes, Pedro Ferro L.; Neto, Ary Serpa; Sa Malbouisson, Luiz Marcelo; Ajeje Lobo, Suzana Margareth; Amendola, Cristina Prata; De Aguilar-Nascimento, Jose Eduardo; Silva Jr, Joao Manoel		BRASIS Study Grp	Postoperative hypothermia following non-cardiac high-risk surgery: A prospective study of temporal patterns and risk factors	PLOS ONE			English	Article							SURGICAL-WOUND INFECTION; PERIOPERATIVE HYPOTHERMIA; TEMPERATURE; COMPLICATIONS; MORTALITY; SCORE; CDC	Background and objectives Hypothermia occurs commonly during surgery and can cause postoperative complications. We aimed to describe the characteristics and outcomes of hypothermia in patients undergoing major surgeries. Methods This prospective, observational, multicenter study of a nationally representative sample included all patients over 18 years of age admitted to an intensive care unit (ICU). Thirty ICUs were selected randomly at national level. The main outcome measure was the proportion of patients who developed postoperative hypothermia in the first 24 hours of ICU admission. Patients were divided into three groups based on temperature: <35 degrees C, <36 degrees C, and >= 36 degrees C (no hypothermia). Patients' characteristics, postoperative complications, and risk factors were evaluated in all groups. To verify whether hypothermia was a strong risk factor for postoperative complications, a Kaplan-Meier curve was generated and adjusted using a Cox regression model. Results In total, 738 patients had their temperatures measured. The percentage of patients with temperature <35 degrees C (median [Q1-Q3], 34.7 degrees C [34.3-34.9 degrees C]) was 19.1% (95% confidence interval [CI] = 16.1-22.5) and that of patients with temperature <36 degrees C (median [Q1-Q3], 35.4 degrees C [35.0-35.8 degrees C]) was 64% (95% CI = 58.3-70.0). The percentage of surgical complications was 38.9%. Patients with hypothermia were older, had undergone abdominal surgeries, had undergone procedures of longer duration, and had more comorbidities. A postoperative temperature <= 35 degrees C was an independent risk for composite postoperative complications (hazard ratio = 1.523, 95% CI = 1.15-2.0), especially coagulation and infection. Conclusions Inadvertent hypothermia was frequent among patients admitted to the ICU and occurred more likely after abdominal surgery, after a long procedure, in elderly patients, and in patients with a higher number of comorbidities. Low postoperative temperature was associated with postoperative complications.	[Sabbag, Itajiba Paternosti; Menezes, Pedro Ferro L.; Sa Malbouisson, Luiz Marcelo; Silva Jr, Joao Manoel] Univ Sao Paulo, Hosp Clin, Med Sch, Sao Paulo, SP, Brazil; [Hohmann, Fabio Barlem; Cesar Assuncao, Murillo Santucci; de Freitas Chaves, Renato Carneiro; Correa, Thiago Domingos; Neto, Ary Serpa; Silva Jr, Joao Manoel] Hosp Israelita Albert Einstein, Dept Pacientes Graves, Sao Paulo, SP, Brazil; [Ajeje Lobo, Suzana Margareth] Hosp Base, Med Sch Sao Jose Rio Preto, Unidade Terapia Intens, Sao Jose Do Rio Preto, SP, Brazil; [Amendola, Cristina Prata] Hosp Canc Barretos, Pio XII Fdn, Unidade Terapia Intens, Barretos, SP, Brazil; [De Aguilar-Nascimento, Jose Eduardo] Univ Fed Mato Grosso, Unidade Terapia Intens, Cuiaba, MT USA	Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Hospital de Cancer de Barretos; Universidade Federal de Mato Grosso do Sul	Silva, JM (corresponding author), Univ Sao Paulo, Hosp Clin, Med Sch, Sao Paulo, SP, Brazil.; Silva, JM (corresponding author), Hosp Israelita Albert Einstein, Dept Pacientes Graves, Sao Paulo, SP, Brazil.	joao.s@usp.br	de Freitas Chaves, Renato Carneiro/P-6125-2019; Silva Jr, João Manoel/AAU-6551-2020; Sa Malbouisson, Luiz Marcelo/F-4819-2012	de Freitas Chaves, Renato Carneiro/0000-0001-7324-272X; Silva Jr, João Manoel/0000-0003-1494-0784; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603; Barlem Hohmann, Fabio/0000-0002-2863-8298				Abelha Fernando J, 2005, BMC Anesthesiol, V5, P7, DOI 10.1186/1471-2253-5-7; Akca O, 2002, Minerva Anestesiol, V68, P182; Akers JL, 2019, ASSOC OPER ROOM NURS, V109, P741, DOI 10.1002/aorn.12696; [Anonymous], 2016, PANORAMA MED INNTENS; Billeter AT, 2014, SURGERY, V156, P1245, DOI 10.1016/j.surg.2014.04.024; Campwala I, 2019, PLAST SURG-CHIR PLAS, V27, P93, DOI 10.1177/2292550319826095; Cho CK, 2021, INT J MED SCI, V18, P2197, DOI 10.7150/ijms.55023; Insler SR, 2000, ANN THORAC SURG, V70, P175, DOI 10.1016/S0003-4975(00)01415-6; Insler Steven R, 2006, Anesthesiol Clin, V24, P823, DOI 10.1016/j.atc.2006.09.001; Karalapillai D, 2013, ANAESTHESIA, V68, P605, DOI 10.1111/anae.12129; Karalapillai D, 2009, ANAESTHESIA, V64, P968, DOI 10.1111/j.1365-2044.2009.05989.x; Karalapillai Dharshi, 2008, Crit Care Resusc, V10, P116; Kleimeyer JP, 2018, J AM ACAD ORTHOP SUR, V26, pE497, DOI 10.5435/JAAOS-D-16-00742; Kongsayreepong S, 2003, ANESTH ANALG, V96, P826, DOI 10.1213/01.ANE.0000048822.27698.28; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Liu H, 2020, J THORAC DIS, V12, P7089, DOI 10.21037/jtd-20-1709; Mendonca FT, 2019, REV BRAS ANESTESIOL, V69, P122, DOI 10.1016/j.bjan.2018.10.001; Parvizi Javad, 2015, Am J Orthop (Belle Mead NJ), V44, P396; Sessler DI, 2016, LANCET, V387, P2655, DOI 10.1016/S0140-6736(15)00981-2; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Silva Júnior João Manoel, 2020, Rev. bras. ter. intensiva, V32, P17, DOI 10.5935/0103-507x.20200005; Silva JM, 2010, REV BRAS ANESTESIOL, V60, P20, DOI 10.1590/S0034-70942010000100003; Sun Z, 2015, ANESTHESIOLOGY, V122, P276, DOI 10.1097/ALN.0000000000000551; Sund-Levander M, 2002, SCAND J CARING SCI, V16, P122, DOI 10.1046/j.1471-6712.2002.00069.x; Todd B, 2017, AM J NURS, V117, P17, DOI 10.1097/01.NAJ.0000521963.77728.c0; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yi J, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0582-9	27	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259789	10.1371/journal.pone.0259789	http://dx.doi.org/10.1371/journal.pone.0259789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780517	gold, Green Published			2022-12-26	WOS:000755305800049
J	Borges, LM; Holliday, R; Barnes, SM; Bahraini, NH; Kinney, A; Forster, JE; Brenner, LA				Borges, Lauren M.; Holliday, Ryan; Barnes, Sean M.; Bahraini, Nazanin H.; Kinney, Adam; Forster, Jeri E.; Brenner, Lisa A.			A longitudinal analysis of the role of potentially morally injurious events on COVID-19-related psychosocial functioning among healthcare providers	PLOS ONE			English	Article							COMMITMENT THERAPY; ACCEPTANCE; ACT	Medical leaders have warned of the potential public health burden of a "parallel pandemic" faced by healthcare workers during the COVID-19 pandemic. These individuals may have experienced scenarios in which their moral code was violated resulting in potentially morally injurious events (PMIEs). In the present study, hierarchical linear modeling was utilized to examine the role of PMIEs on COVID-19 pandemic-related difficulties in psychosocial functioning among 211 healthcare providers (83% female, 89% White, and an average of 11.30 years in their healthcare profession [9.31]) over a 10-month span (May 2020 -March 2021). Reported exposure to PMIEs was associated with statistically significant poorer selfreported psychosocial functioning at baseline and over the course of 10-months of data collection. Within exploratory examinations of PMIE type, perceptions of transgressions by self or others (e.g., "I acted in ways that violated my own moral code or values"), but not perceived betrayal (e.g., "I feel betrayed by leaders who I once trusted"), was associated with poorer COVID-19 related psychosocial functioning (e.g., feeling connected to others, relationship with spouse or partner). Findings from this study speak to the importance of investing in intervention and prevention efforts to mitigate the consequences of exposure to PMIEs among healthcare providers. Interventions for healthcare providers targeting psychosocial functioning in the context of moral injury is an important area for future research.	[Borges, Lauren M.; Holliday, Ryan; Barnes, Sean M.; Bahraini, Nazanin H.; Kinney, Adam; Forster, Jeri E.; Brenner, Lisa A.] Rocky Mt Mental Illness Res Educ & Clin Ctr Vet S, Aurora, CO 80045 USA; [Borges, Lauren M.; Holliday, Ryan; Barnes, Sean M.; Bahraini, Nazanin H.; Brenner, Lisa A.] Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA; [Bahraini, Nazanin H.; Kinney, Adam; Forster, Jeri E.; Brenner, Lisa A.] Univ Colorado, Dept Phys Med & Rehabil, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Borges, LM (corresponding author), Rocky Mt Mental Illness Res Educ & Clin Ctr Vet S, Aurora, CO 80045 USA.; Borges, LM (corresponding author), Univ Colorado, Dept Psychiat, Anschutz Med Campus, Aurora, CO 80045 USA.	Lauren.Borges2@va.gov						Borges LM, 2020, J CONTEXT BEHAV SCI, V17, P95, DOI 10.1016/j.jcbs.2020.06.006; Borges LM, 2020, PSYCHOL TRAUMA-US, V12, pS138, DOI 10.1037/tra0000698; Borges LM, 2019, J CONTEXT BEHAV SCI, V13, P134, DOI 10.1016/j.jcbs.2019.08.002; Dowell EKP, 2018, CENSUS WEBSITE 1014, V2020; Dzau VJ, 2020, NEW ENGL J MED, V383, P513, DOI 10.1056/NEJMp2011027; Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D; Farnsworth JK, 2017, J CONTEXT BEHAV SCI, V6, P391, DOI 10.1016/j.jcbs.2017.07.003; Gaupp R, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00861; Haller M, 2020, PSYCHOL TRAUMA-US, V12, pS174, DOI 10.1037/tra0000742; Held P, 2021, EUR J PSYCHOTRAUMATO, V12, DOI 10.1080/20008198.2021.1877026; Hines SE, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020488; Hoffmire CA, ASCEND VETERAN SUICI; Kleiman SE, 2020, PSYCHOL SERV, V17, P187, DOI 10.1037/ser0000306; Kok N, 2020, INTENS CARE MED, V46, P1653, DOI 10.1007/s00134-020-06121-3; Kreh A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249609; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Litam SDA, 2021, TRAUMATOLOGY, V27, P14, DOI 10.1037/trm0000290; Litz BT, 2021, PSYCHIAT RES, V297, DOI 10.1016/j.psychres.2021.113761; Maguen S, 2022, PSYCHOL MED, V52, P2332, DOI 10.1017/S0033291720004249; Maguen S, 2020, PSYCHOL TRAUMA-US, V12, pS131, DOI 10.1037/tra0000780; Matfei A, 2021, EUR J PSYCHOTRAUMATO, V12, P1; McCoach BD, 2010, REV GUIDE QUANTITATI, P123; Mortier P, 2021, DEPRESS ANXIETY, V38, P528, DOI 10.1002/da.23129; Nash WP, 2013, MIL MED, V178, P646, DOI 10.7205/MILMED-D-13-00017; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spinhoven P, 2014, BEHAV THER, V45, P840, DOI 10.1016/j.beth.2014.07.001; Truog RD, 2020, NEW ENGL J MED, V382, P1973, DOI 10.1056/NEJMp2005689; Wang ZZ, 2022, PSYCHOL TRAUMA-US, V14, P250, DOI 10.1037/tra0001026; Waters CS, 2018, BRIT J CLIN PSYCHOL, V57, P82, DOI 10.1111/bjc.12155; Williamson V, 2021, LANCET PSYCHIAT, V8, P453, DOI 10.1016/S2215-0366(21)00113-9; Wisco BE, 2017, DEPRESS ANXIETY, V34, P340, DOI 10.1002/da.22614; Wood E, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044139	32	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0260033	10.1371/journal.pone.0260033	http://dx.doi.org/10.1371/journal.pone.0260033			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767617	gold, Green Published			2022-12-26	WOS:000755249300059
J	Amoah, J; Said, S; Rampal, L; Manaf, R; Ibrahim, N; Owusu-Agyei, S; Asante, KP				Amoah, John; Said, Salmiah; Rampal, Lekhraj; Manaf, Rosliza; Ibrahim, Normala; Owusu-Agyei, Seth; Asante, Kwaku Poku			Effects of a school-based intervention to reduce cardiovascular disease risk factors among secondary school students: A cluster- randomized, controlled trial	PLOS ONE			English	Article							BLOOD-PRESSURE; PREVENTION; ADOLESCENTS; PREVALENCE; TOBACCO	Background Cardiovascular diseases (CVDs) are the number cause of death worldwide. In Ghana CVD has been the leading cause of death since 2001. The prevalence of CVD risk factors among adolescents in Ghana has been increasing. This study seeks to develop, implement and evaluate the effects of a behavioral modification intervention program to reduce CVD risk factors among secondary school students in Brong Ahafo, Ghana. Methods A cluster-randomized controlled trial was conducted with schools as clusters over a period of six-months with pre and post intervention evaluations. Participants were public secondary school students (14-19 years) from four schools in Brong Ahafo, Ghana. Students in the intervention group were trained by the researchers whereas those of the control group received no intervention. The intervention included health education and physical activity modules. Follow-up data using same questionnaire were collected within two weeks after the intervention was completed. Intention-to-treat analysis was performed after replacing missing values using the multiple imputation method. The generalized linear mixed model (GLMM) was used to assess the effects of the intervention study. Results The GLMM analyses showed the intervention was effective in attaining 0.77(p<0.001), 0.72 (p<0.001), 0.47(p<0.001), 0.56(p<0.001), and 0.39(p = 0.045) higher total physical activity, fruits, vegetables, seafood, and water scores respectively for the intervention group over the control group. The intervention was also significant in reducing -0.15(p<0.001),-0.23(p<0.001),-0.50(p<0.001),-0.32(p<0.001),-0.90(p<0.001),-0.87(p<0.001),-0.38(p<0.001),-0.63(p<0.001), -1.63(p<0.001), 0.61(p<0.001), and -1.53(p = 0.005) carbohydrates, fats and oils, fried eggs, fried chicken, carbonated drinks, sugar, sweet snacks, salted fish, weight, BMI, and diastolic BP. The odds of quitting alcohol use in the intervention group were 1.06 times more than the control group. There was no significant effect on reducing smoking and systolic BP. Conclusion There is an urgent need for the intervention program to be integrated into the existing curriculum structure of secondary school schools. Implementing the intervention will allow for longer and more consistent impact on the reduction of CVD risk factors among secondary school students.	[Amoah, John; Asante, Kwaku Poku] Kintampo Hlth Res Ctr, Kintampo, Bono East, Ghana; [Amoah, John; Said, Salmiah; Rampal, Lekhraj; Manaf, Rosliza] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Selangor, Malaysia; [Ibrahim, Normala] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Psychiat, Serdang, Selangor, Malaysia; [Owusu-Agyei, Seth] Univ Hlth & Allied Sci, Dept Publ Hlth, Ho, Volta, Ghana	Kintampo Health Research Centre; Universiti Putra Malaysia; Universiti Putra Malaysia	Amoah, J (corresponding author), Kintampo Hlth Res Ctr, Kintampo, Bono East, Ghana.; Amoah, J (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Community Hlth, Serdang, Selangor, Malaysia.	johnny_amoah@yahoo.com						Afrifa-Anane E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1546-3; Amoah J, 2019, INT J HEAL SCI RES, V9, P234; Amoh I., 2017, INT J COMMUNITY MED, V4, DOI [10.18203/2394-6040.ijcmph20174247, DOI 10.18203/2394-6040.IJCMPH20174247]; Angelopoulos PD, 2009, EUR J PUBLIC HEALTH, V19, P319, DOI 10.1093/eurpub/ckp004; [Anonymous], 2017, 2016 ANN REP; Cai L, 2014, CIRCULATION, V129, P1832, DOI 10.1161/CIRCULATIONAHA.113.005666; Centers for Disease Control and Prevention, 2008, GLOB YOUTH TOB SURV; Ghana Health Service, 2015, 2014 ANN REP; Ghana Statistical Service, 2013, 2010 POP HOUS CENS R; Ghana Statistical Service Research, 2008, GHAN DEM HLTH SURV 2; Hormenu T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207093; Huang Shi-Hui, 2007, Acta Paediatrica Taiwanica, V48, P201; Juonala M, 2010, EUR HEART J, V31, P1745, DOI 10.1093/eurheartj/ehq141; Kim N, 2014, J ADOLESCENT HEALTH, V55, P521, DOI 10.1016/j.jadohealth.2014.04.011; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Laureati M, 2014, APPETITE, V83, P26, DOI 10.1016/j.appet.2014.07.031; MacArthur GJ, 2016, ADDICTION, V111, P391, DOI 10.1111/add.13224; Mamudu HM, 2013, NICOTINE TOB RES, V15, P1355, DOI 10.1093/ntr/nts269; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Ministry of Health, 2012, STRATEGY MANAGEMENT; Mohammed M, 2016, PREV MED, V90, P100, DOI 10.1016/j.ypmed.2016.06.032; Mozaffarian D, 2015, CIRCULATION, V127; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Nti Christina A, 2008, Nutr Res Pract, V2, P35, DOI 10.4162/nrp.2008.2.1.35; Philippi ST, 2015, NUTR FOOD SCI, V45, P954, DOI 10.1108/NFS-06-2015-0072; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rampal S, 2010, ASIA-PAC J PUBLIC HE, V22, P194, DOI 10.1177/1010539509334816; Smith SC, 2012, EUR HEART J, V33, P2910, DOI 10.1093/eurheartj/ehs313; Sutherland R, 2015, BRIT J SPORT MED, P1, DOI [10.1136/bjsports-2014-093604, DOI 10.1136/BJSPORTS-2014-093604]; World Health Organization, 2018, CARD DIS CVDS KEY FA; World Heart Federation, 2015, HEART FACT SHEET CAR; Yusuf S, 2015, LANCET, V386, P399, DOI 10.1016/S0140-6736(15)60265-3	33	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259581	10.1371/journal.pone.0259581	http://dx.doi.org/10.1371/journal.pone.0259581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762713	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000755316600028
J	Ma, Y; Sun, QW; Huang, LH; Luo, Q; Zeng, WH; Ou, Y; Ma, JW; Xu, HF				Ma, Yan; Sun, Qiwei; Huang, Lihua; Luo, Qin; Zeng, Wenhui; Ou, Yao; Ma, Jingwen; Xu, Hanfu			Genome-wide survey and characterization of transcription factors in the silk gland of the silkworm, Bombyx mori	PLOS ONE			English	Article							FIBROIN GENE-TRANSCRIPTION; SERICIN-1 GENE; EXPRESSION; ALIGNMENT; PROTEIN	Transcription factors (TFs) are key proteins that modulate gene transcription and thereby lead to changes in the gene expression profile and the subsequent alteration of cellular functions. In the silk gland (SG) of silkworm Bombyx mori, an important silk-producing insect, TFs are of vital importance in the regulation of silk protein synthesis in this organ. However, which TFs exist and express in the SG remains largely unknown. Here, we report the large-scale identification of TFs in the SG based on available full-length transcript sequences and the most recent version of silkworm genome data. In total, 348 candidate TFs were identified by strict filtration and were classified into 56 TF families. Chromosomal distribution, motif composition, and phylogenetic relationship analyses revealed the typical characteristics of these TFs. In addition, the expression patterns of 348 TFs in various tissues of B. mori, especially the SG of fourth-molt (4LM) and day-3 and day-4 fifth-instar (5L3D and 5L4D) larvae, were investigated based on public RNA-seq data and gene microarray data, followed by spatiotemporal verification of TF expression levels by quantitative real-time PCR (qRT-PCR). This report describes the first comprehensive analysis of TFs in the B. mori SG. The results can serve as a baseline for further studies of the roles of TFs in the B. mori SG.	[Ma, Yan; Luo, Qin; Zeng, Wenhui; Ou, Yao; Ma, Jingwen; Xu, Hanfu] Southwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Sun, Qiwei] Chinese Univ Hong Kong, Fac Med, Dept Paediat, Hong Kong, Peoples R China; [Huang, Lihua] Chinese Univ Hong Kong, Fac Med, Ctr Cardiovasc Genom & Med, Hong Kong, Peoples R China	Southwest University - China; Chinese University of Hong Kong; Chinese University of Hong Kong	Xu, HF (corresponding author), Southwest Univ, Coll Sericulture Text & Biomass Sci, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xuhf@swu.edu.cn		Ma, Yan/0000-0002-4033-2478	National Natural Science Foundation of China [31872291]; Special Fund for Guiding Scientific and Technological Innovation of Chongqing [cstc2020yszxjcyjX0003]; Science & Technology Talents and Independent Innovation Project of Beibei [2021-4]; Science and technology research project of Chongqing Municipal Education Commission [KJQN20210021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Guiding Scientific and Technological Innovation of Chongqing; Science & Technology Talents and Independent Innovation Project of Beibei; Science and technology research project of Chongqing Municipal Education Commission	This work was supported by the National Natural Science Foundation of China (No. 31872291), the Special Fund for Guiding Scientific and Technological Innovation of Chongqing (No. cstc2020yszxjcyjX0003), the Science & Technology Talents and Independent Innovation Project of Beibei (No. 2021-4) and the Science and technology research project of Chongqing Municipal Education Commission (No. KJQN20210021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Chang HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139424; Chen T, 2020, MOL GENET GENOMICS, V295, P1227, DOI 10.1007/s00438-020-01691-9; Cui Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4602-4; Dhawan S, 2003, DEV GENES EVOL, V213, P435, DOI 10.1007/s00427-003-0343-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAGE LP, 1974, J MOL BIOL, V86, P97; Hu WB, 2016, INSECT BIOCHEM MOLEC, V76, P95, DOI 10.1016/j.ibmb.2016.07.002; Kawamoto M, 2019, INSECT BIOCHEM MOLEC, V107, P53, DOI 10.1016/j.ibmb.2019.02.002; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002; Kokubo H, 1997, DEV BIOL, V186, P46, DOI 10.1006/dbio.1997.8578; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu LN, 2016, INT J BIOL MACROMOL, V86, P701, DOI 10.1016/j.ijbiomac.2016.02.016; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; MAEKAWA H, 1980, DEV BIOL, V78, P394, DOI 10.1016/0012-1606(80)90343-7; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; MATSUNO K, 1990, NUCLEIC ACIDS RES, V18, P1853, DOI 10.1093/nar/18.7.1853; Nagata T, 1996, GENES CELLS, V1, P555, DOI 10.1046/j.1365-2443.1996.d01-260.x; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Takiya S, 1997, BIOCHEM J, V321, P645, DOI 10.1042/bj3210645; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; Tsubota T, 2021, INSECT SCI, V28, P885, DOI 10.1111/1744-7917.12846; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Varshney A., 2021, SYSTEMS MED, P429, DOI [10.1016/B978-0-12-801238-3.11597-1, DOI 10.1016/B978-0-12-801238-3.11597]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Zhao XM, 2015, J BIOL CHEM, V290, P972, DOI 10.1074/jbc.M114.606921; Zhao XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094091; Zhou CY, 2016, BBA-GEN SUBJECTS, V1860, P2529, DOI 10.1016/j.bbagen.2016.07.025	40	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259870	10.1371/journal.pone.0259870	http://dx.doi.org/10.1371/journal.pone.0259870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762712	gold, Green Published			2022-12-26	WOS:000755316600051
J	Sheng, HP; Wilder, J; Walther, DB				Sheng, Heping; Wilder, John; Walther, Dirk B.			Where to draw the line?	PLOS ONE			English	Article							RECOGNITION; OBJECT	We often take people's ability to understand and produce line drawings for granted. But where should we draw lines, and why? We address psychological principles that underlie efficient representations of complex information in line drawings. First, 58 participants with varying degree of artistic experience produced multiple drawings of a small set of scenes by tracing contours on a digital tablet. Second, 37 independent observers ranked the drawings by how representative they are of the original photograph. Matching contours between drawings of the same scene revealed that the most consistently drawn contours tend to be drawn earlier. We generated half-images with the most- versus least-consistently drawn contours and asked 25 observers categorize the quickly presented scenes. Observers performed significantly better for the most compared to the least consistent half-images. The most consistently drawn contours were more likely to depict occlusion boundaries, whereas the least consistently drawn contours frequently depicted surface normals.	[Sheng, Heping] Boston Univ, Sch Med, Boston, MA 02118 USA; [Wilder, John; Walther, Dirk B.] Univ Toronto, Dept Psychol, Toronto, ON, Canada	Boston University; University of Toronto	Walther, DB (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	bernhardt-walther@psych.utoronto.ca		Walther, Dirk/0000-0001-8585-9858	Natural Sciences and Engineering Research Council of Canada [RGPIN-2020-04097]; Social Sciences and Humanities Research Council of Canada [430-2017-01189]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by grants by the Natural Sciences and Engineering Research Council of Canada (RGPIN-2020-04097) and the Social Sciences and Humanities Research Council of Canada (430-2017-01189) to DBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge WA, 2021, CORTEX, V135, P159, DOI 10.1016/j.cortex.2020.11.014; Bainbridge WA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07830-6; Bansal A, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOPS (ICCVW), P578, DOI 10.1109/ICCVW.2013.80; Berger I, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461964; Bhunia Ayan Kumar, 2020, SIGGRAPH ASIA, P1; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1988, COGNITIVE PSYCHOL, V20, P38, DOI 10.1016/0010-0285(88)90024-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brumm A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd4648; Choo H, 2016, NEUROIMAGE, V135, P32, DOI 10.1016/j.neuroimage.2016.04.021; Cole F, 2008, ACM T GRAPHIC, V27, DOI [10.1145/1360612.1360687, 10.1145/1360612.1360657]; Cole F, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1531326.1531334; Das A., 2020, B ZIERSKETCH GENERAT, P632; DeCarlo D, 2003, ACM T GRAPHIC, V22, P848, DOI 10.1145/882262.882354; Gao CY, 2020, PROC CVPR IEEE, P5173, DOI 10.1109/CVPR42600.2020.00522; Goodnow J., 1980, CHILDRENS DRAWING TH; Hertzmann A, 2020, PERCEPTION, V49, P439, DOI 10.1177/0301006620908207; HOCHBERG J, 1962, AM J PSYCHOL, V75, P624, DOI 10.2307/1420286; HUANG TS, 1979, IEEE T ACOUST SPEECH, V27, P13, DOI 10.1109/TASSP.1979.1163188; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; ITAKURA S, 1994, PERCEPT MOTOR SKILL, V79, P1288, DOI 10.2466/pms.1994.79.3.1288; Jahoda G., 1977, CHILDS REPRESENTATIO, P203; Kennedy J., 1974, PSYCHOL PICTURE PERC; KENNEDY JM, 1975, PERCEPTION, V4, P391, DOI 10.1068/p040391; KOENDERINK JJ, 1984, PERCEPTION, V13, P321, DOI 10.1068/p130321; Metzger W, 2006, LAWS OF SEEING; O'Connell TP, 2018, NEUROPSYCHOLOGIA, V117, P513, DOI 10.1016/j.neuropsychologia.2018.06.013; Perdreau F, 2014, I-PERCEPTION, V5, P101, DOI 10.1068/i0635; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Sanmiguel D., 2003, ART DRAWING COMPLETE, V2nd edition; Sayim B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00118; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Torralbo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058594; Walther DB, 2014, PSYCHOL SCI, V25, P851, DOI 10.1177/0956797613512662; Walther DB, 2011, P NATL ACAD SCI USA, V108, P9661, DOI 10.1073/pnas.1015666108; Wang Zeyu, 2021, ACM T GRAPHIC, V40, P1, DOI [10.1145/3450626.3459819, DOI 10.1145/3450626.3459819]; YONAS A, 1994, PERCEPTION, V23, P1427, DOI 10.1068/p231427	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258376	10.1371/journal.pone.0258376	http://dx.doi.org/10.1371/journal.pone.0258376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748556	Green Published, gold			2022-12-26	WOS:000755468000008
J	Bhandari, TR; Khatiwada, B; Rajbhandari, B; Bestman, A; Mistry, SK; Rayamajhee, B; Rawal, LB; Yadav, UN				Bhandari, Tulsi Ram; Khatiwada, Bhushan; Rajbhandari, Bibika; Bestman, Amy; Mistry, Sabuj Kanti; Rayamajhee, Binod; Rawal, Lal B.; Yadav, Uday Narayan			A qualitative study to understand drivers of psychoactive substance use among Nepalese youth	PLOS ONE			English	Article							ALCOHOL-USE; DRUG-USE; INITIATION	Background Psychoactive substance use among youth is an emerging public health issue in Nepal. This exploratory study aimed to better understand the drivers of psychoactive substance use among Nepalese youth in Rupandehi district of Nepal. Materials and methods This study used a qualitative approach for data collection. Both in-depth interviews (IDI, seven participants) and focus group discussions (FGD, 13 participants) were conducted among study participants who self-reported as psychoactive substance users or had history of psychoactive substance use. Participants for IDI were aged between 11 and 24 years and between 18 and 35 years old for FGDs. Semi-structured interview guides were prepared separately for IDIs and FDGs. Interviews were conducted in Nepali language and were audio recorded, which were there transcribed and translated into English for coding and analyses. In addition, interviews notes were taken by two research assistants. An inductive thematic analysis was used to analyze the data. Results This study identified a range of drivers of psychoactive substances use among Nepalese youths. Themes included (i) socio-cultural factors, (ii) individual factors, (iii) academic environment, (iv) physical environment and the (v) influence of media. The socio-cultural factors were categorized into sub-themes of family relationships, ethnic identity and psychoactive substance use and lack of social acceptance. Individual factors included peer pressure, stress relief and coping with financial challenges. Accessibility and availability of psychoactive substances in the surrounding environment and lack of monitoring and reinforcement of rules/ law and regulations were other drivers to psychoactive substance use among this Nepalese youth cohort. Conclusion Our study identified several important drivers of psychoactive substance use among youth in the Rupandehi district of Nepal. Future works are anticipated to further explore youth initiation and use of psychoactive substances and support the design of interventions that address these risk factors to reduce and prevent subsequent harms.	[Bhandari, Tulsi Ram] Pokhara Univ, Sch Hlth & Allied Sci, Dept Publ Hlth, Pokhara, Nepal; [Khatiwada, Bhushan; Rajbhandari, Bibika; Yadav, Uday Narayan] Torrens Univ, Pyrmont Campus, Sydney, NSW, Australia; [Khatiwada, Bhushan; Rajbhandari, Bibika; Yadav, Uday Narayan] Ctr Res Policy & Implementat, Biratnagar, Nepal; [Bestman, Amy] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Mistry, Sabuj Kanti; Yadav, Uday Narayan] Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Rayamajhee, Binod] UNSW, Sch Optometry & Vis Sci, Fac Med & Hlth, Sydney, NSW, Australia; [Rayamajhee, Binod] Kathmandu Res Inst Biol Sci, Dept Infect & Immunol, Lalitpur, Nepal; [Rawal, Lal B.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Sydney, NSW, Australia; [Yadav, Uday Narayan] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	Torrens University Australia; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Central Queensland University; Australian National University	Yadav, UN (corresponding author), Torrens Univ, Pyrmont Campus, Sydney, NSW, Australia.; Yadav, UN (corresponding author), Ctr Res Policy & Implementat, Biratnagar, Nepal.; Yadav, UN (corresponding author), Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia.; Yadav, UN (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	uday.yadav@anu.edu.au		Yadav, Uday Narayan/0000-0002-6626-1604				Ajayi AI, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7104-7; Albert D, 2013, CURR DIR PSYCHOL SCI, V22, P114, DOI 10.1177/0963721412471347; Alhyas Layla, 2015, JRSM Open, V6, p2054270414567167, DOI 10.1177/2054270414567167; [Anonymous], NARCOTIC DRUGS CONTR; Assari S, 2015, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00194; Bhandari S., 2015, HINDU, V99, P86; Bhaskar RK, 2016, TOB INDUC DIS, V14, DOI 10.1186/s12971-016-0075-x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Chen YT, 2016, SSM-POPUL HLTH, V2, P249, DOI 10.1016/j.ssmph.2016.03.003; Collins SE, 2016, ALCOHOL RES-CURR REV, V38, P83; Das JK, 2016, J ADOLESCENT HEALTH, V59, pS61, DOI 10.1016/j.jadohealth.2016.06.021; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dhungana M., 2018, J PSYCHIAT ASS NEPAL, V7, P42; Dom G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010122; Drope J., 2018, TOBACCO ATLAS; Elo S, 2014, SAGE OPEN, V4, DOI 10.1177/2158244014522633; Gimenez LB., 2016, OPEN J NURSING, V6, P921; Giovazolias T., 2014, EUROPEAN J COUNSELLI, V3, P69, DOI [10.5964/ejcop.v3i1.23, DOI 10.5964/EJCOP.V3I1.23]; Hammond Christopher J, 2014, Adolesc Med State Art Rev, V25, P15; Hannah R, 2019, DRUG USE OUR WORLD D; Jackson KM, 2016, PSYCHOL ADDICT BEHAV, V30, P450, DOI 10.1037/adb0000164; Jaiswal H, 2017, INT J RECENT SURG ME, V03, P98; Jorge KO, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00144316, 10.1590/0102-311x00144316]; Kahsay ZH, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-018-0190-1; Karki S, 2016, J SUBST USE, V21, P98, DOI 10.3109/14659891.2015.1005182; Kaur H, 2019, INT J RES REV, V6, P185; Kushwaha RP, 2019, J NEPAL MED ASSOC, V57, P315, DOI 10.31729/jnma.4605; Lijffijt M, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00083; Milena Z.R., 2008, EC SCI SERIES, V17, P1279; Mishra A, 2014, J PSYCHIATR ASS NEPA, V3, P16; Motyka MA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116000; National Institutes on drug abuse, INTRODUCTION; Ojha S., 2016, J GANDAKI MED COLL N, V10, P43, DOI 10.3126/jgmcn.v10i1.17915; Olapegba PO., 2021, NIGERIAN J EC SOCIAL, V63; Panthee B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4980-6; Pathak DC., 2017, J ADV ACAD RES, V4, P44; Pati S, 2018, SUBST ABUSE TREAT PR, V13, DOI 10.1186/s13011-018-0146-5; Patrick ME, 2012, J STUD ALCOHOL DRUGS, V73, P772, DOI 10.15288/jsad.2012.73.772; Pierce M, 2017, DRUG ALCOHOL DEPEN, V179, P309, DOI 10.1016/j.drugalcdep.2017.07.024; Pierce M, 2015, DRUG ALCOHOL DEPEN, V155, P52, DOI 10.1016/j.drugalcdep.2015.08.018; Poudel A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1191-0; Primack BA, 2009, SUBST USE MISUSE, V44, P722, DOI 10.1080/10826080802490097; Roberts G, 2017, ED SECTOR RESPONSES; Sadath A, 2019, INDIAN J PSYCHOL MED, V41, P516, DOI 10.4103/IJPSYM.IJPSYM_326_19; Sapkota S., 2016, J CHITWAN MED COLL, V6, P20; Schulte MT, 2013, PUBLIC HEALTH REV, V35; Scotland J., 2012, ENGLISH LANGUAGE TEA, V5, P9, DOI [DOI 10.5539/ELT.V5N9P9, 10.5539/elt.v5n9p9]; Subba S H, 2011, Indian J Community Med, V36, P128, DOI 10.4103/0970-0218.84132; Tamang KK, EFFORTS RECTIFYING C; The Government Public Relations Department, 2020, PRACTICAL CONSIDERAT, P1; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN DEP EC; United Nations Office on Drugs and Crime, 2013, INT STAND DRUG US PR; Upadhaya N, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0322-4; WHO, 2017, NEP GOV AD NEW ALC L; WHO, 2019, DIS BURDEN MORTALITY, DOI DOI 10.1111/1467-9876.00280; WHO, PSYCH SUBST; WHO The Global Health Observatory, GLOB HLTH EST LEAD C; World Health Organization, GLOB HLTH EST 2019 S	59	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259021	10.1371/journal.pone.0259021	http://dx.doi.org/10.1371/journal.pone.0259021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739508	Green Published, gold			2022-12-26	WOS:000755000800016
J	Bhukya, KK; Bhukya, B				Bhukya, Kiran Kumar; Bhukya, Bhima			Unraveling the probiotic efficiency of bacterium Pediococcus pentosaceus OBK05 isolated from buttermilk: An in vitro study for cholesterol assimilation potential and antibiotic resistance status	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOBACILLUS-PLANTARUM; SELECTION; STRAIN; TRANSFERABILITY; GENES; FOOD	The present study describes the probiotic potential and functional properties of the lactic acid bacterium Pediococcus pentosaceus OBK05 isolated from buttermilk. The isolate OBK05 was assessed for its probiotic properties. The isolate showed notable tolerance to pH 2.0 and 3.0 (8.44, 8.35 log CFU/mL), oxbile of 0.5% at 2 and 4 h of incubation (6.97, 6.35 log CFU/mL) and higher aggregation (auto-aggregation, adhesion to hydrocarbons) than the referral strain, Lactobacillus acidophilus MTCC 10307. The adhesion efficiency to HT-29 cells was found to be maximum, corresponding to 93.5% and 97% at 1 and 2 h incubation, respectively. In addition, the isolate OBK05 showed antagonistic solid activity against bacterial pathogens like Pseudomonas aeruginosa MTCC 424 and Bacillus subtilis MTCC 1133. The phenotypic antibiotic resistance of the isolate was examined before and after curing plasmids. Among the known five structural genes responsible for different antibiotic resistance, four genes indicating antibiotic resistance to kanamycin-Aph (3 '')-III, streptomycin-strA, vancomycin-vanA and ciprofloxacin-gyrA were detected by PCR amplification of genomic DNA. Further, the horizontal gene transfer from OBK05 isolate to pathogens was not found for these antibiotic resistance markers when filter and food mating were carried out as no transconjugants developed on media plates containing respective antibiotics. This indicates that the intrinsic resistance is harbored on chromosomal genes, and hence it is nontransferable to other microbes. In addition, strain OBK05 exhibited good DPPH scavenging activity of 56 to 77% and liberated free amino acid from conjugated bile acid. The strain OBK05 demonstrated a strong ability to reduce cholesterol at 12 h (17%), 24 h (27%) and 48 h (67%) of incubation.	[Bhukya, Kiran Kumar; Bhukya, Bhima] Osmania Univ, Univ Coll Sci, Ctr Microbial & Fermentat Technol, Dept Microbiol, Hyderabad, Telangana, India	Osmania University	Bhukya, B (corresponding author), Osmania Univ, Univ Coll Sci, Ctr Microbial & Fermentat Technol, Dept Microbiol, Hyderabad, Telangana, India.	bhima.ou@osmania.ac.in		Bhukya, Bhima/0000-0002-1343-3863				Adesulu-Dahunsi AT, 2018, FOOD CONTROL, V92, P225, DOI 10.1016/j.foodcont.2018.04.062; Allain T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00089; Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P809, DOI 10.1007/s00253-012-4241-7; Anuradha B., 2021, 3 BIOTECH, V11, P23, DOI [10.1007/s13205-020-02570-1, DOI 10.1007/S13205-020-02570-1]; Avaiyarasi ND, 2016, FOOD CONTROL, V69, P124, DOI 10.1016/j.foodcont.2016.04.036; Ayivi R. D., 2020, Dairy, V1, P202, DOI 10.3390/dairy1030015; Florez AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145203; Bintsis T, 2017, AIMS MICROBIOL, V3, P529, DOI 10.3934/microbiol.2017.3.529; Bonatsou S, 2018, INT J FOOD MICROBIOL, V271, P48, DOI 10.1016/j.ijfoodmicro.2018.02.018; Bordoni A, 2013, APPL MICROBIOL BIOT, V97, P8273, DOI 10.1007/s00253-013-5088-2; Cizeikiene D, 2013, FOOD CONTROL, V31, P539, DOI 10.1016/j.foodcont.2012.12.004; Damodharan K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00768; Das Arup Jyoti, 2019, Access Microbiol, V1, pe000028, DOI 10.1099/acmi.0.000028; Pereira GVD, 2018, BIOTECHNOL ADV, V36, P2060, DOI 10.1016/j.biotechadv.2018.09.003; Di Cagno R, 2020, INT J FOOD MICROBIOL, V323, DOI 10.1016/j.ijfoodmicro.2020.108591; DUNCAN IW, 1979, J CHROMATOGR, V162, P281, DOI 10.1016/S0378-4347(00)81515-7; Foley MH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017709118; Foley MH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007581; Garcia EF, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.01199, 10.3389/fmicb.2016.01371]; Gevers D, 2003, FEMS MICROBIOL LETT, V225, P125, DOI 10.1016/S0378-1097(03)00505-6; Ghosh T, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00502; Han Q, 2017, J FUNCT FOODS, V32, P391, DOI 10.1016/j.jff.2017.03.020; Hernandez-Alcantara AM, 2018, LWT-FOOD SCI TECHNOL, V91, P249, DOI 10.1016/j.lwt.2017.12.063; Hernandez-Gomez JG, 2021, FOODS, V10, DOI 10.3390/foods10030674; Indira M, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1841-2; Jung JH, 2019, FOOD SCI NUTR, V7, P2505, DOI 10.1002/fsn3.1075; Kodaikkal V., 2012, INT J APPL ANIMAL SC, V1, P01; Kumar M, 2012, EXP DIABETES RES, DOI 10.1155/2012/902917; Ladha G, 2018, FOOD BIOTECHNOL, V32, P60, DOI 10.1080/08905436.2017.1414700; Lee KW, 2014, ANAEROBE, V28, P199, DOI 10.1016/j.anaerobe.2014.06.013; Miremadi F, 2014, J FUNCT FOODS, V9, P295, DOI 10.1016/j.jff.2014.05.002; Mukherjee S, 2017, MICROBIOL-SGM, V163, P1822, DOI 10.1099/mic.0.000561; Oh YJ, 2015, LWT-FOOD SCI TECHNOL, V63, P437, DOI 10.1016/j.lwt.2015.03.005; Osmanagaoglu O, 2010, PROBIOTICS ANTIMICRO, V2, P162, DOI 10.1007/s12602-010-9050-7; Ouoba LII, 2008, INT J FOOD MICROBIOL, V121, P217, DOI 10.1016/j.ijfoodmicro.2007.11.018; Pammi N, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.683996; Rani RP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01004; Rosander A, 2008, APPL ENVIRON MICROB, V74, P6032, DOI 10.1128/AEM.00991-08; Seddik HA, 2017, RES MICROBIOL, V168, P244, DOI 10.1016/j.resmic.2016.12.003; Sellamani M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00890; Shukla R, 2014, PROBIOTICS ANTIMICRO, V6, P11, DOI 10.1007/s12602-013-9149-8; Silva BC, 2017, J APPL MICROBIOL, V122, P225, DOI 10.1111/jam.13339; Singla V, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1514-6; Somashekaraiah R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01382; Tiptiri-Kourpeti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147960; Toomey N, 2010, RES MICROBIOL, V161, P127, DOI 10.1016/j.resmic.2009.12.010; Vidhyasagar V, 2013, J FUNCT FOODS, V5, P235, DOI 10.1016/j.jff.2012.10.012; Xing JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119058; Xu YH, 2020, FOOD CONTROL, V111, DOI 10.1016/j.foodcont.2019.107057; Zommiti M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02607	50	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259702	10.1371/journal.pone.0259702	http://dx.doi.org/10.1371/journal.pone.0259702			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735552	Green Published, gold			2022-12-26	WOS:000755077100107
J	Busso, M; Camacho, J; Messina, J; Montenegro, G				Busso, Matias; Camacho, Juanita; Messina, Julian; Montenegro, Guadalupe			Social protection and informality in Latin America during the COVID-19 pandemic	PLOS ONE			English	Article							CONDITIONAL CASH TRANSFERS; HEALTH SHOCKS; CHILD HEALTH; EMPLOYMENT; INSURANCE; EDUCATION; OUTCOMES; HUNGER	Latin American governments swiftly implemented income assistance programs to sustain families' livelihoods during COVID-19 stay-at-home orders. This paper analyzes the potential coverage and generosity of these measures and assesses the suitability of current safety nets to deal with unexpected negative income shocks in 10 Latin American countries. The expansion of pre-existing programs (most notably conditional cash transfers and non-contributory pensions) during the COVID-19 crisis was generally insufficient to compensate for the inability to work among the poorest segments of the population. When COVID-19 ad hoc programs are analyzed, the coverage and replacement rates of regular labor income among households in the first quintile of the country's labor income distribution increase substantially. Yet, these programs present substantial coverage challenges among families composed of fundamentally informal workers who are non-poor, but are at a high risk of poverty. These results highlight the limitations of the fragmented nature of social protection systems in the region.	[Busso, Matias; Camacho, Juanita; Messina, Julian; Montenegro, Guadalupe] Inter Amer Dev Bank, Res Dept, Washington, DC 20577 USA	Inter-American Development Bank	Messina, J (corresponding author), Inter Amer Dev Bank, Res Dept, Washington, DC 20577 USA.	julianm@iadb.org		Busso, Matias/0000-0001-5632-9129				Aguero JM., 2010, ESTUDIOS EC, P247; Akresh R., 2016, Policy Research Working Paper - World Bank; Alvarez-Parra F, 2009, J MONETARY ECON, V56, P954, DOI 10.1016/j.jmoneco.2009.09.006; Angeles G, 2019, SOC SCI MED, V225, P108, DOI 10.1016/j.socscimed.2019.01.037; Attanasio OP, 2015, AM ECON J-APPL ECON, V7, P35, DOI 10.1257/app.20130126; Baird S, 2011, REV ECON STAT, V93, P847, DOI 10.1162/REST_a_00084; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Bebczuk RN, 2015, DOCUMENTOS TRABAJO C; Bonavida Foschiatti C, 2020, IMPACTO ASIMETRICO C; Bosch M, 2015, EUR ECON REV, V75, P1, DOI 10.1016/j.euroecorev.2014.10.010; Bottan N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239797; Brum M, 2020, SERIE DOCUMENTOS TRA; Busso M., 2020, INEQUALITY CRISIS LA; Delaporte I, 2021, DISTRIBUTIONAL CONSE; Delaporte I., 2020, EVIDENCE LATIN AM CA, V14; Demirguc-Kunt A., 2018, GLOBAL FINDEX DATABA; Dercon S, 2000, J POLIT ECON, V108, P688, DOI 10.1086/316098; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Dodlova M, 2017, EUR J POLIT ECON, V50, P141, DOI 10.1016/j.ejpoleco.2017.10.001; Faria-e Castro M, 2018, FISCAL MULTIPLIERS F, P2018; Fiszbein A., 2009, WORLD BANK POLICY RE; G?mez A, 2005, IMPACT CONDITIONAL E; Ganguli I, 2014, INT LABOUR REV, V153, P173, DOI 10.1111/j.1564-913X.2014.00007.x; Garcia-Gomez P, 2013, J HUM RESOUR, V48, P873; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Goni E, 2011, WORLD DEV, V39, P1558, DOI 10.1016/j.worlddev.2011.04.025; Guerrieri Veronica., 2020, NATL BUREAU EC RES; Hale T., 2020, OXFORD COVID 19 GOVT, V8, P30; Hatayama M., 2020, WORLD BANK POLICY RE, V9241, P1, DOI [10.1596/1813-9450-9241, DOI 10.1596/1813-9450-9241]; Huang C, 2017, HEALTH POLICY PLANN, V32, P943, DOI 10.1093/heapol/czw181; Ke J, 2015, PAED CHILD HEALT-CAN, V20, P89, DOI 10.1093/pch/20.2.89; Kilburn K, 2016, J ADOLESCENT HEALTH, V58, P223, DOI 10.1016/j.jadohealth.2015.09.023; Levy S, 2013, J ECON PERSPECT, V27, P193, DOI 10.1257/jep.27.2.193; Lindelow M., 2005, WORLD BANK POLICY RE; Lustig N., 2020, IMPACT COVID 19 LOCK; Maloney W., 2020, Policy Research Working Paper - World Bank; Mongey S, 2020, BECKER FRIEDMAN I EC; Nwosu CO, 2021, INT J EQUITY HEALTH, V20, DOI 10.1186/s12939-020-01361-7; Paxson C, 2010, ECON DEV CULT CHANGE, V59, P187, DOI 10.1086/655458; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Pruitt S, 2020, AM ECON REV INSIGHTS, V2, P237, DOI 10.1257/aeri.20190096; Riphahn RT, 1999, J POPUL ECON, V12, P363, DOI 10.1007/s001480050104; Robertson L, 2013, LANCET, V381, P1283, DOI 10.1016/S0140-6736(12)62168-0; Robinson J, 2012, AM ECON J-APPL ECON, V4, P140, DOI 10.1257/app.4.4.140; Robles M, 2019, DEV POLICY REV, V37, pO85, DOI 10.1111/dpr.12365; Roser M, 2020, WHY DID RENEWABLES B; Seidenfeld D., 2014, CHILD GRANT PROGRAMM; van den Berg GJ, 2016, ECON J, V126, P465, DOI 10.1111/ecoj.12250; Wagstaff A, 2007, J HEALTH ECON, V26, P82, DOI 10.1016/j.jhealeco.2006.07.001; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41	51	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259050	10.1371/journal.pone.0259050	http://dx.doi.org/10.1371/journal.pone.0259050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735496	Green Published, Green Submitted, gold			2022-12-26	WOS:000755077100044
J	Fernstrom, J; Ohlsson, L; Asp, M; Lavant, E; Holck, A; Grudet, C; Westrin, A; Lindqvist, D				Fernstrom, Johan; Ohlsson, Lars; Asp, Marie; Lavant, Eva; Holck, Amanda; Grudet, Cecile; Westrin, Asa; Lindqvist, Daniel			Plasma circulating cell-free mitochondrial DNA in depressive disorders	PLOS ONE			English	Article							LAMOTRIGINE; LITHIUM; RESPONSES; TRAUMA; DAMPS; ACID	Background Plasma circulating cell-free mitochondrial DNA (ccf-mtDNA) is an immunogenic molecule and a novel biomarker of psychiatric disorders. Some previous studies reported increased levels of ccf-mtDNA in unmedicated depression and recent suicide attempters, while other studies found unchanged or decreased ccf-mtDNA levels in depression. Inconsistent findings across studies may be explained by small sample sizes and between-study variations in somatic and psychiatric co-morbidity or medication status. Methods We measured plasma ccf-mtDNA in a cohort of 281 patients with depressive disorders and 49 healthy controls. Ninety-three percent of all patients were treated with one or several psychotropic medications. Thirty-six percent had a personality disorder, 13% bipolar disorder. All analyses involving ccf-mtDNA were a priori adjusted for age and sex. Results Mean levels in ccf-mtDNA were significantly different between patients with a current depressive episode (n = 236), remitted depressive episode (n = 45) and healthy controls (n = 49) (f = 8.3, p<0.001). Post-hoc tests revealed that both patients with current (p<0.001) and remitted (p = 0.002) depression had lower ccf-mtDNA compared to controls. Within the depressed group there was a positive correlation between ccf-mtDNA and "inflammatory depression symptoms" (r = 0.15, p = 0.02). We also found that treatment with mood stabilizers lamotrigine, valproic acid or lithium was associated with lower ccf-mtDNA (f = 8.1, p = 0.005). Discussion Decreased plasma ccf-mtDNA in difficult-to-treat depression may be partly explained by concurrent psychotropic medications and co-morbidity. Our findings suggest that ccf-mtDNA may be differentially regulated in different subtypes of depression, and this hypothesis should be pursued in future studies.	[Fernstrom, Johan; Asp, Marie; Holck, Amanda; Grudet, Cecile; Westrin, Asa; Lindqvist, Daniel] Lund Univ, Fac Med, Dept Clin Sci Lund, Psychiat, Lund, Sweden; [Fernstrom, Johan; Asp, Marie; Holck, Amanda] Off Psychiat & Habilitat, Psychiat Clin Lund, Region Skane, Sweden; [Ohlsson, Lars; Lavant, Eva] Malmo Univ, Dept Biomed Sci, Hlth & Soc, Malmo, Sweden; [Westrin, Asa; Lindqvist, Daniel] Off Psychiat & Habilitat, Psychiat Res Skane, Region Skane, Sweden	Lund University; Malmo University	Fernstrom, J (corresponding author), Lund Univ, Fac Med, Dept Clin Sci Lund, Psychiat, Lund, Sweden.; Fernstrom, J (corresponding author), Off Psychiat & Habilitat, Psychiat Clin Lund, Region Skane, Sweden.	johan.fernstrom@med.lu.se		Grudet, Cecile/0000-0001-6648-0236; Fernstrom, Johan/0000-0002-3346-0439				ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Asp M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227364; Boyapati Ray K, 2017, F1000Res, V6, P169, DOI 10.12688/f1000research.10397.1; Caiaffo V, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.231; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; de Oliveira MR, 2016, TOXICOL LETT, V258, P185, DOI 10.1016/j.toxlet.2016.07.001; de Sousa RT, 2014, PROG NEURO-PSYCHOPH, V48, P32, DOI 10.1016/j.pnpbp.2013.09.002; First M. B., 1997, STRUCTURED CLIN INTE; He J, 2009, CELL ADHES MIGR, V3, P129, DOI 10.4161/cam.3.1.7401; Hummel EM, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0264-x; Hunsberger Joshua, 2009, Dialogues Clin Neurosci, V11, P333; Jeong H, 2020, J PSYCHIATR RES, V123, P187, DOI 10.1016/j.jpsychires.2020.02.009; Jokela M, 2016, JAMA PSYCHIAT, V73, P87, DOI 10.1001/jamapsychiatry.2015.1977; Kageyama Y, 2018, J AFFECT DISORDERS, V233, P15, DOI 10.1016/j.jad.2017.06.001; Kato T, 2017, SCHIZOPHR RES, V187, P62, DOI 10.1016/j.schres.2016.10.037; Kumar P, 2012, EUR J PHARMACOL, V674, P265, DOI 10.1016/j.ejphar.2011.11.030; Lagrue E, 2007, PEDIATR RES, V62, P14, DOI 10.1203/PDR.0b013e31806790d7; Lam NYL, 2004, CLIN CHEM, V50, P213, DOI 10.1373/clinchem.2003.025783; Leng Y, 2013, INT J NEUROPSYCHOPH, V16, P607, DOI 10.1017/S1461145712000429; Lindqvist D, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.236; Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9; Liu J, 2016, J DIABETES INVEST, V7, P109, DOI 10.1111/jdi.12366; Lundberg M, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.586083; Maurer IC, 2009, BIPOLAR DISORD, V11, P515, DOI 10.1111/j.1399-5618.2009.00729.x; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miller AH, 2017, NEUROPSYCHOPHARMACOL, V42, P334, DOI 10.1038/npp.2016.167; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Nakahira K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001577; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Rush AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1841, DOI 10.1038/sj.npp.1301131; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simmons JD, 2013, ANN SURG, V258, P591, DOI 10.1097/SLA.0b013e3182a4ea46; Stertz L, 2015, ACTA PSYCHIAT SCAND, V132, P211, DOI 10.1111/acps.12417; Suneson K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041640; Trumpff C, 2021, MITOCHONDRION, V59, P225, DOI 10.1016/j.mito.2021.04.002; Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026; Valvassori SS, 2010, J PSYCHIATR RES, V44, P903, DOI 10.1016/j.jpsychires.2010.02.009; Wang ZF, 2011, ACTA PHARMACOL SIN, V32, P1433, DOI 10.1038/aps.2011.140; Wenceslau CF, 2013, MED HYPOTHESES, V81, P532, DOI 10.1016/j.mehy.2013.06.026; Yamanouchi S, 2013, J CRIT CARE, V28, P1027, DOI 10.1016/j.jcrc.2013.05.006; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259591	10.1371/journal.pone.0259591	http://dx.doi.org/10.1371/journal.pone.0259591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735532	Green Published, gold			2022-12-26	WOS:000755077100096
J	Pollard, M; Shachar-Hill, Y				Pollard, Mike; Shachar-Hill, Yair			Kinetic complexities of triacylglycerol accumulation in developing embryos from Camelina sativa provide evidence for multiple biosynthetic systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; DEVELOPING SEEDS; OIL CONTENT; LIPIDS; GLYCEROLIPIDS; COTYLEDONS; PLANT; CHOLINEPHOSPHOTRANSFERASE; DIACYLGLYCEROL; METABOLISM	Quantitative flux maps describing glycerolipid synthesis can be important tools for rational engineering of lipid content and composition in oilseeds. Lipid accumulation in cultured embryos of Camelina sativa is known to mimic that of seeds in terms of rate of lipid synthesis and composition. To assess the kinetic complexity of the glycerolipid flux network, cultured embryos were incubated with [C-14/C-13]glycerol, and initial and steady state rates of [C-14/(13)Cglyceryl] lipid accumulation were measured. At steady state, the linear accumulations of labeled lipid classes matched those expected from mass compositions. The system showed an apparently simple kinetic precursor-product relationship between the intermediate pool, dominated by diacylglycerol (DAG) and phosphatidylcholine (PC), and the triacylglycerol (TAG) product. We also conducted isotopomer analyses on hydrogenated lipid class species. [(13)C(3)glyceryl] labeling of DAG and PC, together with estimates of endogenous [(12)C(3)glyceryl] dilution, showed that each biosynthetically active lipid pool is similar to 30% of the total by moles. This validates the concept that lipid sub-pools can describe lipid biosynthetic networks. By tracking the kinetics of [(13)C(3)glyceryl] and [(13)C(2)acyl] labeling, we observed two distinct TAG synthesis components. The major TAG synthesis flux (similar to 75%) was associated with >95% of the DAG/PC intermediate pool, with little glycerol being metabolized to fatty acids, and with little dilution from endogenous glycerol; a smaller flux exhibited converse characteristics. This kinetic heterogeneity was further explored using postlabeling embryo dissection and differential lipid extractions. The minor flux was tentatively localized to surface cells across the whole embryo. Such heterogeneity must be recognized in order to construct accurate gene expression patterns and metabolic networks describing lipid biosynthesis in developing embryos.	[Pollard, Mike; Shachar-Hill, Yair] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University	Shachar-Hill, Y (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	yairhill@msu.edu	Shachar-Hill, Yair/B-6165-2013	Shachar-Hill, Yair/0000-0001-8793-5084	Office of Science (BER), US Department of Energy [DE-SC0018269]	Office of Science (BER), US Department of Energy(United States Department of Energy (DOE))	We thank Danielle Delamarter for technical assistance with plant growth, embryo culture, and lipid extractions, and Dr Tony Schilmiller and the Michigan State University Research Technology Support Facility, Mass Spectrometry, and Metabolomics Core for technical support and MS instrumentation. This research was supported by the Office of Science (BER), US Department of Energy, grant no DE-SC0018269.	Allen DK, 2009, PLANT CELL ENVIRON, V32, P1241, DOI 10.1111/j.1365-3040.2009.01992.x; An D, 2015, PLANT BIOTECHNOL REP, V9, P137, DOI 10.1007/s11816-015-0351-x; Aznar-Moreno JA, 2017, PLANT SCI, V263, P126, DOI 10.1016/j.plantsci.2017.07.007; BANNON CD, 1986, J AM OIL CHEM SOC, V63, P105, DOI 10.1007/BF02676134; Bansal S, 2016, BIOCHIMIE, V120, P9, DOI 10.1016/j.biochi.2015.06.009; Bassel GW, 2014, P NATL ACAD SCI USA, V111, P8685, DOI 10.1073/pnas.1404616111; Bates PD, 2013, CURR OPIN PLANT BIOL, V16, P358, DOI 10.1016/j.pbi.2013.02.015; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Beisson F, 2012, CURR OPIN PLANT BIOL, V15, P329, DOI 10.1016/j.pbi.2012.03.003; Borisjuk L, 2013, PLANT CELL, V25, P1625, DOI 10.1105/tpc.113.111740; Carey LM, 2020, PLANT PHYSIOL, V182, P493, DOI 10.1104/pp.19.00740; Chhikara S, 2018, PLANT BIOTECHNOL J, V16, P1034, DOI 10.1111/pbi.12847; Coleman RA, 2019, J LIPID RES, V60, P490, DOI 10.1194/jlr.S091843; CRASKE JD, 1987, J AM OIL CHEM SOC, V64, P1413, DOI 10.1007/BF02636990; Dalal J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0357-1; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Horn PJ, 2013, PLANT J, V76, P138, DOI 10.1111/tpj.12278; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Ichihara K, 1996, LIPIDS, V31, P535, DOI 10.1007/BF02522648; Klinska S, 2019, PLANTA, V250, P1655, DOI 10.1007/s00425-019-03248-6; Lager I, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.01144; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Malik MR, 2018, PLANT CELL REP, V37, P1367, DOI 10.1007/s00299-018-2308-3; MATSUZAKI T, 1983, PLANT CELL PHYSIOL, V24, P207, DOI 10.1093/pcp/24.2.207; Millar AA, 1997, PLANT J, V12, P121, DOI 10.1046/j.1365-313X.1997.12010121.x; Mubofu E. B., 2016, SUSTAINABLE CHEM PRO, V4, P1086, DOI DOI 10.1186/S40508-016-0055-8; Napier JA, 2014, CURR OPIN PLANT BIOL, V19, P68, DOI 10.1016/j.pbi.2014.04.001; OHLROGGE JB, 1978, LIPIDS, V13, P203, DOI 10.1007/BF02533401; Pollard M, 2015, PHYTOCHEMISTRY, V118, P23, DOI 10.1016/j.phytochem.2015.07.022; Pollard M, 2015, PHYTOCHEMISTRY, V118, P192, DOI 10.1016/j.phytochem.2015.07.021; POLLARD MR, 1980, PLANT PHYSIOL, V66, P649, DOI 10.1104/pp.66.4.649; POLLARD MR, 1980, PLANT PHYSIOL, V66, P641, DOI 10.1104/pp.66.4.641; Razeq FM, 2021, PHYTOCHEMISTRY, V184, DOI 10.1016/j.phytochem.2021.112665; Razeq FM, 2014, PHYTOCHEMISTRY, V106, P188, DOI 10.1016/j.phytochem.2014.06.018; Regmi A, 2020, PLANT PHYSIOL, V184, P720, DOI 10.1104/pp.20.00461; Simpson JP, 2016, PLANT CELL, V28, P248, DOI 10.1105/tpc.15.00900; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; SLACK CR, 1977, BIOCHEM J, V162, P289, DOI 10.1042/bj1620289; SLACK CR, 1978, BIOCHEM J, V170, P421, DOI 10.1042/bj1700421; SLACK CR, 1985, BIOCHIM BIOPHYS ACTA, V833, P438, DOI 10.1016/0005-2760(85)90101-8; STOBART AK, 1985, BIOCHEM J, V232, P217, DOI 10.1042/bj2320217; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Usher S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06838-0; Wang FL, 2020, PLANT MOL BIOL REP, V38, P531, DOI 10.1007/s11105-020-01217-y; Xu Y, 2019, J BIOL CHEM, V294, P14838, DOI 10.1074/jbc.AC119.010601; Yuan LX, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00011; Zhang YJ, 2021, PLANT COMMUN, V2, DOI 10.1016/j.xplc.2020.100081	50	4	4	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101396	10.1016/j.jbc.2021.101396	http://dx.doi.org/10.1016/j.jbc.2021.101396			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1JM	34774796	gold, Green Published			2022-12-26	WOS:000748384500007
J	Garima; Prem, R; Yadav, U; Sundd, M				Garima; Prem, Rashima; Yadav, Usha; Sundd, Monica			A GX(2)GX(3)G motif facilitates acyl chain sequestration by Saccharomyces cerevisiae acyl carrier protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID; CHEMICAL-SHIFTS; CRYSTAL-STRUCTURE; CARBONYL CARBONS; STRUCTURAL BASIS; GLYCINE HINGE; ALPHA-HELICES; WEB SERVER; PEPTIDES; FLEXIBILITY	Saccharomyces cerevisiae acyl carrier protein (ScACP) is a component of the large fungal fatty acid synthase I (FAS I) complex. ScACP comprises two subdomains: a conserved ACP domain that shares extensive structural homology with other ACPs and a unique structural domain. Unlike the metazoan type I ACP that does not sequester the acyl chain, ScACP can partially sequester the growing acyl chain within its hydrophobic core by a mechanism that remains elusive. Our studies on the acyl-ScACP intermediates disclose a unique (188)GX(2)GX(3)G(195) sequence in helix II important for ACP function. Complete loss of sequestration was observed upon mutation of the three glycines in this sequence to valine (G188V/G191V/G195V), while G191V and G188V/G191V double mutants displayed a faster rate of acyl chain hydrolysis. Likewise, mutation of Thr216 to Ala altered the size of the hydrophobic cavity, resulting in loss of C-12- chain sequestration. Combining NMR studies with insights from the crystal structure, we show that three glycines in helix II and a threonine in helix IV favor conformational change, which in turn generate space for acyl chain sequestration. Furthermore, we identified the primary hydrophobic cavity of ScACP, present between the carboxyl end of helix II and IV. The opening of the cavity lies between the second and third turns of helix II and loop II. Overall, the study highlights a novel role of the GX(2)GX(3)G motif in regulating acyl chain sequestration, vital for ScACP function.	[Garima; Prem, Rashima; Yadav, Usha; Sundd, Monica] Natl Inst Immunol, NMR Lab, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sundd, M (corresponding author), Natl Inst Immunol, NMR Lab, New Delhi, India.	monicasundd@nii.ac.in			Department of Biotechnology (D.B.T.), Govt. of India; University Grants Commission, Govt. of India	Department of Biotechnology (D.B.T.), Govt. of India(Department of Biotechnology (DBT) India); University Grants Commission, Govt. of India(University Grants Commission, India)	Authors thank the Department of Biotechnology (D.B.T.), Govt. of India for infrastructure and financial support. University Grants Commission, Govt. of India is duly acknowledged for providing fellowship to U. Y. The authors are grateful to Ms Shanta Sen, Mass Spectrometry facility, NII for helping with ESI-MS data. Our sincere thanks to Prof. Sneha Sudha Komath, SLS, JNU, for providing us the S. cerevisiae genome.	Akasaka K, 1999, PROTEIN SCI, V8, P1946, DOI 10.1110/ps.8.10.1946; Ambrosio C, 2000, MOL PHARMACOL, V57, P198; Arya R, 2019, BBA-PROTEINS PROTEOM, V1867, P163, DOI 10.1016/j.bbapap.2018.12.001; ASAKAWA N, 1992, J AM CHEM SOC, V114, P3261, DOI 10.1021/ja00035a016; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Nguyen C, 2014, NATURE, V505, P427, DOI 10.1038/nature12810; Cronan JE, 2014, BIOCHEM J, V460, P157, DOI 10.1042/BJ20140239; DEDIOS AC, 1994, J AM CHEM SOC, V116, P11485, DOI 10.1021/ja00104a031; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Scala C, 2014, BIOCHEMISTRY-US, V53, P4489, DOI 10.1021/bi500373k; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dongre M, 2011, J BIOL CHEM, V286, P15043, DOI 10.1074/jbc.M110.209346; Goddard D., 2008, SPARKY 3; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Grottesi A, 2005, BIOCHEMISTRY-US, V44, P14586, DOI 10.1021/bi0510429; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Hogel P, 2018, BIOCHEMISTRY-US, V57, P1326, DOI 10.1021/acs.biochem.7b01197; Hori S, 2002, INT J MOL SCI, V3, P907, DOI 10.3390/i3080907; Hu W, 2019, ELIFE, V8, DOI 10.7554/eLife.46689; Kumar P, 2012, J BIOMOL STRUCT DYN, V30, P773, DOI 10.1080/07391102.2012.689705; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Nguyen LN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002879; Lou JW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49261-3; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Pedetta A, 2017, BIOCHEMISTRY-US, V56, P3850, DOI 10.1021/acs.biochem.7b00455; Perez DR, 2015, BIOCHEMISTRY-US, V54, P2205, DOI 10.1021/bi5014563; Perez DR, 2009, BIOMOL NMR ASSIGN, V3, P133, DOI 10.1007/s12104-009-9158-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Revill WP, 1996, J BACTERIOL, V178, P5660, DOI 10.1128/jb.178.19.5660-5667.1996; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sztain T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025597118; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; VANAALTEN DMF, 1995, PROTEINS, V22, P45, DOI 10.1002/prot.340220107; vanAalten DMF, 1997, PROTEIN ENG, V10, P31, DOI 10.1093/protein/10.1.31; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wilman HR, 2014, PROTEINS, V82, P1960, DOI 10.1002/prot.24550; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhao XJ, 1996, MICROBIOL-UK, V142, P2509, DOI 10.1099/00221287-142-9-2509; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zhu ZW, 2017, NAT CHEM BIOL, V13, P360, DOI 10.1038/nchembio.2301; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	52	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101394	10.1016/j.jbc.2021.101394	http://dx.doi.org/10.1016/j.jbc.2021.101394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0HN	34767798	gold, Green Published			2022-12-26	WOS:000748311800014
J	Sun, ZD; Xu, B; Spisak, S; Kavran, JM; Rokita, SE				Sun, Zuodong; Xu, Bing; Spisak, Shaun; Kavran, Jennifer M.; Rokita, Steven E.			The minimal structure for iodotyrosine deiodinase function is defined by an outlier protein from the thermophilic bacterium Thermotoga neapolitana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVOPROTEIN; HYPERTHERMOPHILES; MECHANISM; PRODUCTS; ENZYMES; SWITCH; TOOLS; FORM	The nitroreductase superfamily of enzymes encompasses many flavin mononucleotide (FMN)-dependent catalysts promoting a wide range of reactions. All share a common core consisting of an FMN-binding domain, and individual subgroups additionally contain one to three sequence extensions radiating from defined positions within this core to support their unique catalytic properties. To identify the minimum structure required for activity in the iodotyrosine deiodinase subgroup of this superfamily, attention was directed to a representative from the thermophilic organism Thermotoga neapolitana (TnIYD). This representative was selected based on its status as an outlier of the subgroup arising from its deficiency in certain standard motifs evident in all homologues from mesophiles. We found that TnIYD lacked a typical N-terminal sequence and one of its two characteristic sequence extensions, neither of which was found to be necessary for activity. We also show that TnIYD efficiently promotes dehalogenation of iodo-, bromo-, and chlorotyrosine, analogous to related deiodinases (IYDs) from humans and other mesophiles. In addition, 2-iodophenol is a weak substrate for TnIYD as it was for all other IYDs characterized to date. Consistent with enzymes from thermophilic organisms, we observed that TnIYD adopts a compact fold and low surface area compared with IYDs from mesophilic organisms. The insights gained from our investigations on TnIYD demonstrate the advantages of focusing on sequences that diverge from conventional standards to uncover the minimum essentials for activity. We conclude that TnIYD now represents a superior starting structure for future efforts to engineer a stable dehalogenase targeting halophenols of environmental concern.	[Sun, Zuodong; Xu, Bing; Rokita, Steven E.] Johns Hopkins Univ, Dept Chem, Bloomberg Sch Publ Hlth, Charles & 34Th St, Baltimore, MD 21218 USA; [Spisak, Shaun] Johns Hopkins Univ, Chem Biol Interface Grad Program, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Rokita, SE (corresponding author), Johns Hopkins Univ, Dept Chem, Bloomberg Sch Publ Hlth, Charles & 34Th St, Baltimore, MD 21218 USA.	rokita@jhu.edu		Sun, Zuodong/0000-0002-4996-1553	National Science Foundation [SusChEM 90079121]; National Institutes of Health [GM130937, T32GM080189]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Janine Copp (Department of Biochemistry & Molecular Biology, University of British Columbia) for helpful discussions and the original plasmid encoding TnIYD. This work was supported in part by National Science Foundation (SusChEM 90079121) and National Institutes of Health (GM130937 and T32GM080189). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393).	Ackerley DF, 2004, ENVIRON MICROBIOL, V6, P851, DOI 10.1111/j.1462-2920.2004.00639.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afink G, 2008, J CLIN ENDOCR METAB, V93, P4894, DOI 10.1210/jc.2008-0865; Agarwal V, 2014, ACS CHEM BIOL, V9, P1980, DOI 10.1021/cb5004338; Akiva E, 2017, P NATL ACAD SCI USA, V114, pE9549, DOI 10.1073/pnas.1706849114; [Anonymous], 2021, PROT INT SURF ASS SE; Atomi H, 2011, CURR OPIN BIOTECH, V22, P618, DOI 10.1016/j.copbio.2011.06.010; Baker PJ, 2004, BIOCHEM SOC T, V32, P264, DOI 10.1042/BST0320264; Bobyk KD, 2015, BIOCHEMISTRY-US, V54, P4487, DOI 10.1021/acs.biochem.5b00410; Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Buss JM, 2012, PROTEIN SCI, V21, P351, DOI 10.1002/pro.2020; Copp JN, 2014, PROTEIN ENG DES SEL, V27, P399, DOI 10.1093/protein/gzu025; Copp JN, 2019, METHOD ENZYMOL, V620, P315, DOI 10.1016/bs.mie.2019.03.015; de la Cruz IP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004175; Durchschein K, 2013, GREEN CHEM, V15, P1764, DOI 10.1039/c3gc40588e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerlt JA, 2017, BIOCHEMISTRY-US, V56, P4293, DOI 10.1021/acs.biochem.7b00614; Hu JM, 2019, PROTEIN SCI, V28, P68, DOI 10.1002/pro.3479; Hu JM, 2015, J BIOL CHEM, V290, P590, DOI 10.1074/jbc.M114.605964; Ingavat N, 2017, BIOCHEMISTRY-US, V56, P1130, DOI 10.1021/acs.biochem.6b01308; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; Mathias JR, 2014, ZEBRAFISH, V11, P85, DOI 10.1089/zeb.2013.0937; MATTHEWS RG, 1975, J BIOL CHEM, V250, P9294; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McTamney PM, 2009, J AM CHEM SOC, V131, P14212, DOI 10.1021/ja906642n; Miller AF, 2018, MOLECULES, V23, DOI [10.3390/molecules23020211, 10.3390/molecules23071579]; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Petsko GA, 2001, METHOD ENZYMOL, V334, P469; Phatarphekar A, 2018, J BIOL CHEM, V293, P10314, DOI 10.1074/jbc.RA118.003364; Phatarphekar A, 2016, PROTEIN SCI, V25, P2187, DOI 10.1002/pro.3044; Phatarphekar A, 2014, MOL BIOSYST, V10, P86, DOI 10.1039/c3mb70398c; Rokita S. E., 2020, COMPREHENSIVE NATURA, P157; Rokita SE, 2010, BIOCHIMIE, V92, P1227, DOI 10.1016/j.biochi.2010.02.013; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; ROSENBERG IN, 1979, J BIOL CHEM, V254, P2318; Schrodinger LLC, 2017, PYMOL MOL GRAPHICS S; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174; Sun ZD, 2018, ACS CATAL, V8, P11783, DOI 10.1021/acscatal.8b03587; Sun ZD, 2017, ARCH BIOCHEM BIOPHYS, V632, P77, DOI 10.1016/j.abb.2017.07.019; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; Vetter W, 2006, REV ENVIRON CONTAM T, V188, P1, DOI 10.1007/978-0-387-32964-2_1; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; Williams EM, 2019, BIOCHEMISTRY-US, V58, P3700, DOI 10.1021/acs.biochem.9b00376; Zhai HY, 2014, ENVIRON SCI TECHNOL, V48, P2579, DOI 10.1021/es4034765; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	54	2	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101385	10.1016/j.jbc.2021.101385	http://dx.doi.org/10.1016/j.jbc.2021.101385			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34748729	Green Published, gold			2022-12-26	WOS:000748084900013
J	Monteiro, KS; Santino, TA; Pakhale, S; Balfour, L; de Mendonca, KMPP				Monteiro, Karolinne Souza; Santino, Thayla Amorim; Pakhale, Smita; Balfour, Louise; Pereira Pinto de Mendonca, Karla Morganna			Translation, cross-cultural adaptation and psychometric evaluation of the Brazilian version of the Cystic Fibrosis Knowledge Scale (CFKS)	PLOS ONE			English	Article							MEDICATION ADHERENCE; DISEASE KNOWLEDGE; ADULT PATIENTS; HEALTH; VALIDATION; QUESTIONNAIRE; RELIABILITY; GUIDELINES; CRITERIA; QUALITY	Background Information on the level of knowledge about cystic fibrosis (CF) among affected people and their families is still scarce. Objective This study aimed to translate, cross-culturally adapt and analyze the psychometric properties of the Brazilian version of Cystic Fibrosis Knowledge Scale (CFKS). Materials and methods The translation and cross-cultural adaptation involved the stages of translation, synthesis of translations, reverse translation, synthesis of reverse translations, review by a multi-professional committee of experts and pre-testing. The reliability, viability, construct, predictive, concurrent and discriminant validity were investigated. Results The sample consisted of 40 individuals with cystic CF, 47 individuals with asthma, 242 healthcare workers and 81 students from the health area. The Brazilian version of the CFKS presented high internal consistency (alpha = 0.91), moderate floor and ceiling effects, without differences in the test-retest scores. An analysis of factorial exploration identified three dimensions. Confirmatory factor analysis led to an acceptable data-model fit. There was good predictive validity, with a difference in the scores among all the evaluated groups (p < 0.001), as well as good discriminant validity since individuals with asthma had greater knowledge of asthma compared to CF (r = 0.401, p = 0.005; r(2) = 0.162). However, there was no difference between the diagnosis time and knowledge about CF (r = -0.25, p = 0.11; r(2) = 0.06), either between treatment adherence and knowledge about CF (r = -0.04, p = 0.77; r(2) = 0.002). Conclusion The Brazilian version of the CFKS indicated that the scale is able to provide valid, reliable and reproducible measures for evaluating the knowledge about CF.	[Monteiro, Karolinne Souza] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, Brazil; [Santino, Thayla Amorim; Pereira Pinto de Mendonca, Karla Morganna] Univ Fed Rio Grande do Norte, Grad Program Phys Therapy, Natal, RN, Brazil; [Pakhale, Smita; Balfour, Louise] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Pakhale, Smita] Ottawa Hosp, Clin Epidemiol, Res Inst, Ottawa, ON, Canada; [Pakhale, Smita] Ottawa Hosp, Dept Med, Div Respirol, Ottawa, ON, Canada; [Balfour, Louise] Ottawa Hosp, Chron Dis, Res Inst, Ottawa, ON, Canada; [Balfour, Louise] Ottawa Hosp, Dept Psychol, Ottawa, ON, Canada	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Monteiro, KS (corresponding author), Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi, Santa Cruz, Brazil.	karolsm@outlook.com.br		Monteiro, Karolinne/0000-0003-2254-8723; M.P.P de Mendonca, Karla/0000-0001-5734-3707	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) Finance Code 001.	Alcantara EC., 2017, REV ED SAUDE, V5, P6; Alexander S., 2017, CLIN GUIDELINES CARE, V7th edition; [Anonymous], 2014, NORM SCALE CALCULATO; Athanazio RA, 2017, J BRAS PNEUMOL, V43, P219, DOI [10.1590/S1806-37562017000000065, 10.1590/s1806-37562017000000065]; Awwad O, 2015, INT J CLIN PHARM-NET, V37, P504, DOI 10.1007/s11096-015-0086-3; Balfour L, 2014, RESPIROLOGY, V19, P1209, DOI 10.1111/resp.12379; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Borges MC, 2010, J BRAS PNEUMOL, V36, P8, DOI 10.1590/S1806-37132010000100004; Chomik S, 2014, ANN AGR ENV MED, V21, P420, DOI 10.5604/1232-1966.1108617; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conway SP, 1996, THORAX, V51, P29, DOI 10.1136/thx.51.1.29; Cystic Fibrosis Foundation Patient Registry, 2016, PAT REG ANN DAT REP, P1; European Cystic Fibrosis Society, 2013, ANN DAT REP 2013; Faint NR, 2017, J PAEDIATR CHILD H, V53, P488, DOI 10.1111/jpc.13458; FitzPatrick Beverly, 2017, Glob Pediatr Health, V4, p2333794X17719803, DOI 10.1177/2333794X17719803; Global Initiative for Asthma (GINA), 2018, GLOB STRAT ASTHM MAN, P1; Gregorich SE, 2006, MED CARE, V44, pS78, DOI 10.1097/01.mlr.0000245454.12228.8f; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Kamakura W, 2016, RAE-REV ADMIN EMPRES, V56, P55, DOI 10.1590/S0034-759020160106; Kettler LJ, 2002, THORAX, V57, P459, DOI 10.1136/thorax.57.5.459; KOOCHER GP, 1990, J DEV BEHAV PEDIATR, V11, P353; Lenhard W., 2016, PSYCHOMETRICA, DOI [10.13140/RG.2.2.17823.92329, DOI 10.13140/RG.2.1.3478.4245, DOI 10.13140/RG.2.2.17823.92329]; Lonabaugh KP, 2018, PATIENT EDUC COUNS, V101, P1865, DOI 10.1016/j.pec.2018.06.004; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Mikesell CL, 2017, RESP CARE, V62, P920, DOI 10.4187/respcare.05349; Miller TA, 2016, PATIENT EDUC COUNS, V99, P1079, DOI 10.1016/j.pec.2016.01.020; Mindrila D, 2010, INT J DIGITAL SOC, V1, P60, DOI [10.20533/ijds.2040.2570.2010.0010, DOI 10.20533/IJDS.2040.2570.2010.0010]; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Naqvi AA, 2019, J PAK MED ASSOC, V69, P216; Narayanan S, 2017, EXPERT REV RESP MED, V11, P129, DOI 10.1080/17476348.2017.1280399; Nash EF., 2009, J CYST FIBROS, V8, pS111; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Ohn M, 2018, PAEDIATR RESPIR REV, V25, P33, DOI 10.1016/j.prrv.2017.04.002; Pasquali L, 2009, REV ESC ENFERM USP, V43, P992, DOI 10.1590/S0080-62342009000500002; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Polit DF, 2015, INT J NURS STUD, V52, P1746, DOI 10.1016/j.ijnurstu.2015.07.002; Quittner AL, 2014, CHEST, V146, P142, DOI 10.1378/chest.13-1926; Radtke T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002768.pub4; Reichenheim ME, 2007, REV SAUDE PUBL, V41, P665, DOI 10.1590/S0034-89102006005000035; Dalcin PDR, 2009, J BRAS PNEUMOL, V35, P27, DOI 10.1590/S1806-37132009000100005; Sanders DB, 2016, PEDIATR CLIN N AM, V63, P567, DOI 10.1016/j.pcl.2016.04.001; Savage E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007641.pub2; Sawicki GS, 2013, J CYST FIBROS, V12, P461, DOI 10.1016/j.jcf.2012.12.009; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Siklosi KR, 2010, J CYST FIBROS, V9, P400, DOI 10.1016/j.jcf.2010.07.001; Swinscow T.D.V., 1997, CORRELATION REGRESSI; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259232	10.1371/journal.pone.0259232	http://dx.doi.org/10.1371/journal.pone.0259232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784376	gold, Green Published			2022-12-26	WOS:000755277300004
J	Hassan, FAM; Tolba, MEM; Abed, GH; Omar, HM; Abdel-Hakeem, SS				Hassan, Faten A. M.; Tolba, M. E. M.; Abed, Gamal H.; Omar, H. M.; Abdel-Hakeem, Sara S.			Contact lenses contamination by Acanthamoeba spp. in Upper Egypt	PLOS ONE			English	Article							RISK-FACTORS; KERATITIS; IDENTIFICATION; ENVIRONMENT; GENOTYPE; CAIRO; WATER	Background Acanthamoeba spp. are one of the free-living amoeba that spread worldwide causing keratitis. Owing to the increase in the use of lenses, whether for medical or cosmetic purposes, the incidence of disease increases every year. Contamination of the lenses with the Acanthamoeba trophozoites or cysts may lead to eye infection and cause sight-threatening keratitis in human. We isolated Acanthamoeba spp. from new lenses, used lenses, and contact lens disinfecting solutions and identified them based on morphological characteristics and molecular test. Methods New and used lenses and contact lens disinfecting solutions were cultured on monogenic media. Light and scanning electron microscope was used to identify Acanthamoeba spp. morphological features. Genotype identification was also evaluated using PCR sequencing of 18S rRNA gene specific primer pair JDP1 and JDP2. Results A hundred samples were examined, 29 (29%) were infected with Acanthamoeba spp. That belonged to two strains of Acanthamoeba (Acanthamoeba 41 and Acanthamoeba 68). 18S rRNA of the Acanthamoeba 41 had 99.69% sequence identity to Acanthamoeba castellanii clone HDU-JUMS-2, whereas Acanthamoeba 68 had 99.74% similar pattern to that of Acanthamoeba sp. isolate T4 clone ac2t4 that are morphologically identified as Acanthamoeba polyphaga. The obtained data revealed that the isolated strains belong to T4 genotype that was evolutionarily similar to strains isolated in Iran. Conclusions Cosmetic lenses and disinfectant solutions are a major transmissible mode for infection. This genotype is common as the cause of Acanthamoeba keratitis. To avoid infection, care must be taken to clean the lenses and their preservative solutions and prevent contamination with the parasite.	[Hassan, Faten A. M.] Taiz Univ, Fac Sci, Dept Microbiol, Taizi, Yemen; [Tolba, M. E. M.] Assiut Univ, Fac Med, Dept Parasitol, Assiut, Egypt; [Abed, Gamal H.; Abdel-Hakeem, Sara S.] Assiut Univ, Fac Sci, Dept Zool, Parasitol Lab, Assiut, Egypt; [Omar, H. M.] Assiut Univ, Fac Sci, Dept Zool, Physiol Lab, Assiut, Egypt; [Hassan, Faten A. M.] Assiut Univ, Fac Sci, Dept Zool, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Assiut University	Hassan, FAM (corresponding author), Taiz Univ, Fac Sci, Dept Microbiol, Taizi, Yemen.; Hassan, FAM (corresponding author), Assiut Univ, Fac Sci, Dept Zool, Assiut, Egypt.	fatenhassan28@yahoo.com		omar, hossam el-din/0000-0002-1456-0506; Abdel-Hakeem, Sara/0000-0003-1069-5806				Abd El Wahab WM, 2018, ACTA PARASITOL, V63, P826, DOI 10.1515/ap-2018-0101; Aghajani Ali, 2016, Turkiye Parazitoloji Dergisi, V40, P132, DOI 10.5152/tpd.2016.4428; Behera HS., 2017, ECON MICROBIOL, V6, P211; Bunsuwansakul C, 2019, KOREAN J PARASITOL, V57, P341, DOI 10.3347/kjp.2019.57.4.341; Casero RD, 2017, INFECT GENET EVOL, V54, P170, DOI 10.1016/j.meegid.2017.06.031; Cope JR, 2017, MMWR-MORBID MORTAL W, V66, P841, DOI 10.15585/mmwr.mm6632a2; Corsaro D, 2020, PARASITOL RES, V119, P3327, DOI 10.1007/s00436-020-06843-9; Dart JKG, 2009, AM J OPHTHALMOL, V148, P487, DOI 10.1016/j.ajo.2009.06.009; Duarte JL, 2013, EXP PARASITOL, V135, P9, DOI 10.1016/j.exppara.2013.05.013; El-Sayed NM, 2015, PARASITOL RES, V114, P823, DOI 10.1007/s00436-014-4190-4; Garajova M., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Gast RJ, 1996, J EUKARYOT MICROBIOL, V43, P498, DOI 10.1111/j.1550-7408.1996.tb04510.x; Ghani M. K. A, 2013, INT MED J, V20, P66; Gomes TD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154246; Gonzalez-Robles Arturo, 2014, Journal of Parasitology Research, P256310, DOI 10.1155/2014/256310; Hussain RHM, 2019, J WATER HEALTH, V17, P813, DOI 10.2166/wh.2019.214; Ibrahim Y.W., 2009, J OPTOM, V2, P60, DOI 10.3921/joptom.2009.60; JONES DB, 1986, AM J OPHTHALMOL, V102, P527, DOI 10.1016/0002-9394(86)90085-1; Khan, 2009, ACANTHAMOEBA BIOL PA; Khosravinia N, 2021, IRAN J PARASITOL, V16, P111, DOI 10.18502/ijpa.v16i1.5530; Koltas I.S., 2015, MIDDLE BLACK SEA J H, V1, P13; Lee SM, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e26; Lim CHL, 2016, EYE, V30, P447, DOI 10.1038/eye.2015.250; Lorenzo-Morales J, 2015, PARASITE, V22, DOI 10.1051/parasite/2015010; Maciver SK, 2013, EUR J PROTISTOL, V49, P217, DOI 10.1016/j.ejop.2012.11.004; Mahmoud GAE, 2020, MICROB PATHOGENESIS, V147, DOI 10.1016/j.micpath.2020.104404; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marouf M, 2017, INT J CLIN PHARMA RE, V9, P1, DOI [10.25258/ijpcr.v9i1.8259, DOI 10.25258/IJPCR.V9I1.8259]; Muchesa P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/575297; Muslim A., 2017, INT J HEALTHCARE BIO, V5, P178; Nagyova V, 2010, PARASITOL RES, V106, P861, DOI 10.1007/s00436-010-1731-3; Page MA, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/670242; Sampaotong Tanitta, 2016, Journal of Parasitic Diseases, V40, P369, DOI 10.1007/s12639-014-0511-x; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Solhjoo K., 2017, FREE LIVING AMOEBA I; Susanto I.K., 2020, OPEN ACCESS MACEDONI, V8, P333, DOI [10.3889/oamjms.2020.4551, DOI 10.3889/OAMJMS.2020.4551]; Taher EE, 2018, J INFECT PUBLIC HEAL, V11, P377, DOI 10.1016/j.jiph.2017.09.013; Tawfeek GM, 2016, PARASITOL RES, V115, P1871, DOI 10.1007/s00436-016-4927-3	38	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259847	10.1371/journal.pone.0259847	http://dx.doi.org/10.1371/journal.pone.0259847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780533	gold, Green Published			2022-12-26	WOS:000755305800059
J	Higaki, Y; Yamato, Y; Fujie, S; Inoue, K; Shimomura, M; Kato, S; Horii, N; Ogoh, S; Iemitsu, M				Higaki, Yuya; Yamato, Yosuke; Fujie, Shumpei; Inoue, Kenichiro; Shimomura, Mio; Kato, Shosaku; Horii, Naoki; Ogoh, Shigehiko; Iemitsu, Motoyuki			Acute effects of the different relaxation periods during passive intermittent static stretching on arterial stiffness	PLOS ONE			English	Article							FLOW-MEDIATED DILATION; ENDOTHELIAL FUNCTION; BRACHIAL-ARTERY; NITRIC-OXIDE; EXERCISE; SHEAR; OXYGENATION; STRESS; HUMANS	To clarify whether the relaxation period during stretching affects the degree of elevated shear rate and the degree of reduction of arterial stiffness, we examined relaxation duration to build an adequate stretching protocol. In Experiment 1, the changes in cardiac output, the shear rate in the posterior tibial artery, and blood volume in the calf muscle were measured during recovery (0-60 s) from a single bout of one-legged passive calf stretching in 12 healthy young men. In Experiment 2, the effects of different relaxation periods (5-, 10-, 20-, and 60-s) of passive one-legged intermittent calf stretching (30-s x 6 sets) on the femoral-ankle pulse wave velocity (faPWV) as an index of peripheral arterial stiffness were identified in 17 healthy young men. As a result, the stretched leg's shear rate significantly increased from 0 to 10(th) s after stretching. The muscle blood volume in the stretched leg significantly reduced during stretching, and then significantly increased during the recovery period after stretching; however, cardiac output remained unchanged during stretching and recovery. Additionally, the reduction in faPWV from the pre-stretching value in the stretched leg was significantly larger in the protocol with 10-s and 20-s relaxation periods than that in the non-stretched leg, but this did not differ in the 5-s and 60-s relaxation periods. These findings suggest that the relaxation periods of intermittent static stretching that cause a high transient increase in shear rate (via reperfusion after microvascular compression by the stretched calf muscles) are effective to reduce arterial stiffness.	[Higaki, Yuya; Yamato, Yosuke; Fujie, Shumpei; Inoue, Kenichiro; Shimomura, Mio; Kato, Shosaku; Horii, Naoki; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Yamato, Yosuke] Aino Univ, Dept Phys Therapy, Osaka, Japan; [Inoue, Kenichiro; Horii, Naoki] Japan Soc Promot Sci, Tokyo, Japan; [Ogoh, Shigehiko] Toyo Univ, Dept Biomed Engn, Saitama, Japan	Ritsumeikan University; Japan Society for the Promotion of Science; Toyo University	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI: 19K22828]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI: 19K22828 for M. Iemitsu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agewall S, 2001, CLIN PHYSIOL, V21, P9, DOI 10.1046/j.1365-2281.2001.00302.x; Bisconti AV, 2020, J PHYSIOL-LONDON, V598, P3645, DOI 10.1113/JP279866; Carter HH, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13285; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; Evanoff NG, 2016, J CLIN ULTRASOUND, V44, P182, DOI 10.1002/jcu.22324; Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016; Higashi Y, 2004, PHARMACOL THERAPEUT, V102, P87, DOI 10.1016/j.pharmthera.2004.02.003; Kingwell Bronwyn A., 1997, American Journal of Physiology, V273, pH2186; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Kruse NT, 2016, AM J PHYSIOL-HEART C, V310, pH1210, DOI 10.1152/ajpheart.00732.2015; Kruse NT, 2016, CLIN PHYSIOL FUNCT I, V36, P126, DOI 10.1111/cpf.12205; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; LEWIS JF, 1984, CIRCULATION, V70, P425, DOI 10.1161/01.CIR.70.3.425; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nishiwaki M, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1337-4; Schmitt M, 2005, HYPERTENSION, V46, P227, DOI 10.1161/01.HYP.0000164581.39811.bd; Shinno H, 2017, EUR J SPORT SCI, V17, P586, DOI 10.1080/17461391.2017.1284267; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Venturelli M, 2019, J APPL PHYSIOL, V127, P376, DOI 10.1152/japplphysiol.00823.2018; Wray DW, 2006, MED SCI SPORT EXER, V38, P1804, DOI 10.1249/01.mss.0000230342.86870.94; Yamamoto K, 2009, AM J PHYSIOL-HEART C, V297, pH1314, DOI 10.1152/ajpheart.00061.2009; Yamato Y, 2021, EUR J APPL PHYSIOL, V121, P331, DOI 10.1007/s00421-020-04524-0; Yamato Y, 2017, EUR J APPL PHYSIOL, V117, P1227, DOI 10.1007/s00421-017-3609-x; Yamato Y, 2016, AM J PHYS MED REHAB, V95, P764, DOI 10.1097/PHM.0000000000000498; Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259444	10.1371/journal.pone.0259444	http://dx.doi.org/10.1371/journal.pone.0259444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780500	Green Published, gold			2022-12-26	WOS:000755305800030
J	Wu, XN; Seraia, E; Hatch, SB; Wan, X; Ebner, DV; Aroldi, F; Jiang, YY; Ryan, AJ; Bogenrieder, T; Weyer-Czernilofsky, U; Rieunier, G; Macaulay, VM				Wu, Xiaoning; Seraia, Elena; Hatch, Stephanie B.; Wan, Xiao; Ebner, Daniel V.; Aroldi, Francesca; Jiang, Yanyan; Ryan, Anderson J.; Bogenrieder, Thomas; Weyer-Czernilofsky, Ulrike; Rieunier, Guillaume; Macaulay, Valentine M.			CHK1 inhibition exacerbates replication stress induced by IGF blockade	ONCOGENE			English	Article							DNA-DAMAGING AGENTS; BREAST-CANCER; H2AX PHOSPHORYLATION; CELLS; CHECKPOINT; EFFICACY; MK-8776; REPAIR; ATR; RADIOSENSITIVITY	We recently reported that genetic or pharmacological inhibition of insulin-like growth factor receptor (IGF-1R) slows DNA replication and induces replication stress by downregulating the regulatory subunit RRM2 of ribonucleotide reductase, perturbing deoxynucleotide triphosphate (dNTP) supply. Aiming to exploit this effect in therapy we performed a compound screen in five breast cancer cell lines with IGF neutralising antibody xentuzumab. Inhibitor of checkpoint kinase CHK1 was identified as a top screen hit. Co-inhibition of IGF and CHK1 caused synergistic suppression of cell viability, cell survival and tumour growth in 2D cell culture, 3D spheroid cultures and in vivo. Investigating the mechanism of synthetic lethality, we reveal that CHK1 inhibition in IGF-1R depleted or inhibited cells further downregulated RRM2, reduced dNTP supply and profoundly delayed replication fork progression. These effects resulted in significant accumulation of unreplicated single-stranded DNA and increased cell death, indicative of replication catastrophe. Similar phenotypes were induced by IGF:WEE1 co-inhibition, also via exacerbation of RRM2 downregulation. Exogenous RRM2 expression rescued hallmarks of replication stress induced by co-inhibiting IGF with CHK1 or WEE1, identifying RRM2 as a critical target of the functional IGF:CHK1 and IGF:WEE1 interactions. These data identify novel therapeutic vulnerabilities and may inform future trials of IGF inhibitory drugs.	[Wu, Xiaoning; Aroldi, Francesca] Univ Oxford, Dept Oncol, Oxford, England; [Seraia, Elena; Hatch, Stephanie B.; Wan, Xiao; Ebner, Daniel V.] Univ Oxford, Target Discovery Inst, Oxford, England; [Jiang, Yanyan; Ryan, Anderson J.] Univ Oxford, CRUK MRC Oxford Inst Radiat Oncol, Oxford, England; [Bogenrieder, Thomas; Weyer-Czernilofsky, Ulrike] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria; [Bogenrieder, Thomas] CO Fdn Recherches Med, AMAL Therapeut, CH-1205 Geneva, Switzerland; [Bogenrieder, Thomas] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Urol, Munich, Germany; [Macaulay, Valentine M.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Rieunier, Guillaume] Immunocore Ltd, Abingdon, Oxon, England	University of Oxford; University of Oxford; University of Oxford; Boehringer Ingelheim; University of Munich; University of Oxford	Macaulay, VM (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.; Rieunier, G (corresponding author), Immunocore Ltd, Abingdon, Oxon, England.	guillaume.rieunier@immunocore.com; valentine.macaulay@nds.ox.ac.uk	RYAN, Anderson/ACG-0319-2022	RYAN, Anderson/0000-0001-6241-7969; Jiang, Yanyan/0000-0001-6014-811X; Wu, Xiaoning/0000-0002-8279-1517; Ebner, Daniel/0000-0002-6495-7026; Hatch, Stephanie/0000-0002-7401-9279	Breast Cancer Now [2014NovPR364]; Cancer Research UK [C476/A27060]; Oxfordshire Health Services Research Committee [1326]; NIHR Oxford Biomedical Research Centre; Harrington Discovery Institute	Breast Cancer Now; Cancer Research UK(Cancer Research UK); Oxfordshire Health Services Research Committee; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Harrington Discovery Institute	We acknowledge the assistance and expertise provided by Rhodri Wilson and Graham Brown from the Microscopy core facility, Department of Oncology, University of Oxford. We thank Dr Anthony Kong for MCF7, ZR-75-1, T47D, and HCC1143 breast cancer cell lines, Prof. Adrian Harris for HeLa cells and Michael Sanderson (ex-Boehringer Ingelheim, now Merck) for the generous supply of BI885578. This study was supported by Breast Cancer Now (grant 2014NovPR364 to VMM), Cancer Research UK (grant C476/A27060 to VMM and GR), Oxfordshire Health Services Research Committee (grant 1326 to FA) and support to VMM from the NIHR Oxford Biomedical Research Centre and the Harrington Discovery Institute. We are grateful to Andrew Blackford, Tim Humphrey and Ian Mills for comments on the paper.	Amin O, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1803-y; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Booth L, 2018, CANCER BIOL THER, V19, P786, DOI 10.1080/15384047.2018.1472189; Borowiec AS, 2011, BBA-MOL CELL RES, V1813, P723, DOI 10.1016/j.bbamcr.2011.01.025; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Chitnis MM, 2014, ONCOGENE, V33, P5262, DOI 10.1038/onc.2013.460; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Conti C, 2007, MOL BIOL CELL, V18, P3059, DOI 10.1091/mbc.E06-08-0689; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Dai Y, 2013, MOL CANCER THER, V12, P878, DOI 10.1158/1535-7163.MCT-12-0902; de Bono J, 2020, BRIT J CANCER, V122, P1324, DOI 10.1038/s41416-020-0774-1; ELLWART JW, 1990, CYTOMETRY, V11, P239, DOI 10.1002/cyto.990110204; Ferte C, 2013, MOL CANCER THER, V12, P1213, DOI 10.1158/1535-7163.MCT-12-1067; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Friedbichler K, 2014, MOL CANCER THER, V13, P399, DOI 10.1158/1535-7163.MCT-13-0598; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; Gonzalez Besteiro MA, 2019, EMBO J, V38, DOI 10.15252/embj.2018101284; Hamelers IHL, 2002, J BIOL CHEM, V277, P47645, DOI 10.1074/jbc.M208727200; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Hill SJ, 2014, MOL CELL BIOL, V34, P3828, DOI 10.1128/MCB.01646-13; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; Koppenhafer SL, 2020, MOL CANCER RES, V18, P91, DOI 10.1158/1541-7786.MCR-19-0585; Landoni JC, 2018, BIOL METHODS PROTOC, V3; Lodhia KA, 2015, INT J CANCER, V136, P2961, DOI 10.1002/ijc.29327; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Ma XB, 2019, BREAST CANCER RES TR, V176, P109, DOI 10.1007/s10549-019-05189-w; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Mladenova V, 2008, Z NATURFORSCH C, V63, P289; Moeglin E, 2019, CANCERS, V11, DOI 10.3390/cancers11030355; Moiseeva T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01401-x; Montano R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-604; Nath S, 2016, PHARMACOL THERAPEUT, V163, P94, DOI 10.1016/j.pharmthera.2016.03.013; O'Flanagan CH, 2016, ONCOTARGET, V7, P56826, DOI 10.18632/oncotarget.10862; Parsels LA, 2018, CELL CYCLE, V17, P1076, DOI 10.1080/15384101.2018.1475827; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Rafiei S, 2020, CANCER RES, V80, P2094, DOI 10.1158/0008-5472.CAN-19-3126; Riesterer O, 2011, INT J RADIAT ONCOL, V79, P1179, DOI 10.1016/j.ijrobp.2010.10.003; Rieunier G, 2021, CANCER RES, V81, P2128, DOI 10.1158/0008-5472.CAN-20-2860; Rochester MA, 2005, CANCER GENE THER, V12, P90, DOI 10.1038/sj.cgt.7700775; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sanderson MP, 2015, MOL CANCER THER, V14, P2762, DOI 10.1158/1535-7163.MCT-15-0539; Sanjiv K, 2016, CELL REP, V17, P3407, DOI 10.1016/j.celrep.2016.12.031; Sant Shilpa, 2017, Drug Discov Today Technol, V23, P27, DOI 10.1016/j.ddtec.2017.03.002; Schmid P, 2021, BREAST CANCER RES, V23, DOI 10.1186/s13058-020-01382-8; Sen T, 2019, J THORAC ONCOL, V14, P2152, DOI 10.1016/j.jtho.2019.08.009; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Speroni J, 2012, P NATL ACAD SCI USA, V109, P7344, DOI 10.1073/pnas.1116345109; Stubbe JA, 1995, CHEM BIOL, V2, P793, DOI 10.1016/1074-5521(95)90084-5; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Toledo L, 2017, MOL CELL, V66, P735, DOI 10.1016/j.molcel.2017.05.001; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Turney BW, 2012, RADIOTHER ONCOL, V103, P402, DOI 10.1016/j.radonc.2012.03.009; Vesela E, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010019; Wang C, 2017, TRANSL ONCOL, V10, P190, DOI 10.1016/j.tranon.2017.01.007; Webster JA, 2017, LEUKEMIA RES, V61, P108, DOI 10.1016/j.leukres.2017.09.005; Yamaguchi R, 2015, FEBS LETT, V589, P4097, DOI 10.1016/j.febslet.2015.11.009; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhou ZR, 2017, ACTA PHARMACOL SIN, V38, P513, DOI 10.1038/aps.2016.136	66	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					476	488		10.1038/s41388-021-02080-1	http://dx.doi.org/10.1038/s41388-021-02080-1		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34773074	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000717915200003
J	Toth, DJA; Beams, AB; Keegan, LT; Zhang, Y; Greene, T; Orleans, B; Seegert, N; Looney, A; Alder, SC; Samore, MH				Toth, Damon J. A.; Beams, Alexander B.; Keegan, Lindsay T.; Zhang, Yue; Greene, Tom; Orleans, Brian; Seegert, Nathan; Looney, Adam; Alder, Stephen C.; Samore, Matthew H.			High variability in transmission of SARS-CoV-2 within households and implications for control	PLOS ONE			English	Article							COVID-19	Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a high risk of transmission in close-contact indoor settings, which may include households. Prior studies have found a wide range of household secondary attack rates and may contain biases due to simplifying assumptions about transmission variability and test accuracy. Methods We compiled serological SARS-CoV-2 antibody test data and prior SARS-CoV-2 test reporting from members of 9,224 Utah households. We paired these data with a probabilistic model of household importation and transmission. We calculated a maximum likelihood estimate of the importation probability, mean and variability of household transmission probability, and sensitivity and specificity of test data. Given our household transmission estimates, we estimated the threshold of non-household transmission required for epidemic growth in the population. Results We estimated that individuals in our study households had a 0.41% (95% CI 0.32%- 0.51%) chance of acquiring SARS-CoV-2 infection outside their household. Our household secondary attack rate estimate was 36% (27%- 48%), substantially higher than the crude estimate of 16% unadjusted for imperfect serological test specificity and other factors. We found evidence for high variability in individual transmissibility, with higher probability of no transmissions or many transmissions compared to standard models. With household transmission at our estimates, the average number of non-household transmissions per case must be kept below 0.41 (0.33-0.52) to avoid continued growth of the pandemic in Utah. Conclusions Our findings suggest that crude estimates of household secondary attack rate based on serology data without accounting for false positive tests may underestimate the true average transmissibility, even when test specificity is high. Our finding of potential high variability (overdispersion) in transmissibility of infected individuals is consistent with characterizing SARS-CoV-2 transmission being largely driven by superspreading from a minority of infected individuals. Mitigation efforts targeting large households and other locations where many people congregate indoors might curb continued spread of the virus.	[Toth, Damon J. A.; Beams, Alexander B.; Keegan, Lindsay T.; Zhang, Yue; Greene, Tom; Orleans, Brian; Samore, Matthew H.] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA; [Toth, Damon J. A.; Keegan, Lindsay T.; Samore, Matthew H.] Salt Lake City Healthcare Syst, Dept Vet Affairs, Salt Lake City, UT 84148 USA; [Toth, Damon J. A.; Beams, Alexander B.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Seegert, Nathan; Looney, Adam] Univ Utah, David Eccles Sch Business, Dept Finance, Salt Lake City, UT USA; [Alder, Stephen C.] Univ Utah, Sch Med, Dept Family & Prevent Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Toth, DJA (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84112 USA.; Toth, DJA (corresponding author), Salt Lake City Healthcare Syst, Dept Vet Affairs, Salt Lake City, UT 84148 USA.; Toth, DJA (corresponding author), Univ Utah, Dept Math, Salt Lake City, UT 84112 USA.	Damon.Toth@hsc.utah.edu						Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; [Anonymous], SARS COV 2 IGG ARCHI; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Ball F, 1997, ANN APPL PROBAB, V7, P46; BECKER N, 1980, BIOMETRICS, V36, P249, DOI 10.2307/2529976; Bi Q., 2020, HOUSEHOLD TRANSMISSI; Chen PZ, 2021, ELIFE, V10, DOI 10.7554/eLife.65774; Dawson P, 2021, CLIN INFECT DIS, V72, P682, DOI 10.1093/cid/ciaa799; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Frieden TR, 2020, EMERG INFECT DIS, V26, P1061, DOI 10.3201/eid2606.200495; Fung HF, 2021, CLIN INFECT DIS, V73, pS138, DOI 10.1093/cid/ciaa1558; Gomes M Gabriela M, 2022, medRxiv, DOI 10.1101/2020.04.27.20081893; Grijalva CG, 2020, MMWR-MORBID MORTAL W, V69, P1631, DOI [10.15585/mmwr.mm6944e1, 10.15585/mmwr. mm6944e1]; Kain MP, 2021, EPIDEMICS-NETH, V34, DOI [10.1101/2020.06.30.20143115, 10.1016/j.epidem.2020.100430]; Kim J, 2021, ARCH DIS CHILD, V106, P709, DOI 10.1136/archdischild-2020-319910; Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.1, 10.12688/wellcomeopenres.15889.2]; Lei H, 2020, J INFECTION, V81, P993, DOI 10.1016/j.jinf.2020.08.033; Li X, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.011101; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Lopez AS, 2020, MMWR-MORBID MORTAL W, V69, P1319, DOI 10.15585/mmwr.mm6937e3; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Mei S, 2020, Lancet Infect Dis, V20, P911; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Qian H, 2021, INDOOR AIR, V31, P639, DOI 10.1111/ina.12766; Rosenberg ES, 2020, CLIN INFECT DIS, V71, P1953, DOI 10.1093/cid/ciaa549; Russell TW, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01790-9; Samore M., 2020, SARS COV 2 SEROPREVA; Silveira MF, 2020, NAT MED, V26, P1196, DOI 10.1038/s41591-020-0992-3; Susswein Zachary, 2020, medRxiv, DOI 10.1101/2020.12.08.20246082; Wang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18836-4; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; Wong F, 2020, P NATL ACAD SCI USA, V117, P29416, DOI 10.1073/pnas.2018490117; Yousaf AR, 2021, CLIN INFECT DIS, V73, pE1841, DOI 10.1093/cid/ciaa1072; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381; Zhu Y, 2020, BRAIN BEHAV IMMUN, V87, P142, DOI 10.1016/j.bbi.2020.05.009	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0259097	10.1371/journal.pone.0259097	http://dx.doi.org/10.1371/journal.pone.0259097			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758042	gold, Green Published, Green Submitted			2022-12-26	WOS:000755112500019
J	Moussa, G; Kalogeropoulos, D; Ch'ng, SW; Lett, KS; Mitra, A; Tyagi, AK; Sharma, A; Andreatta, W				Moussa, George; Kalogeropoulos, Dimitrios; Ch'ng, Soon Wai; Lett, Kim Son; Mitra, Arijit; Tyagi, Ajai K.; Sharma, Ash; Andreatta, Walter			Effect of deprivation and ethnicity on primary macula-on retinal detachment repair success rate and clinical outcomes: A study of 568 patients	PLOS ONE			English	Article							CATARACT-SURGERY; VITRECTOMY; MANAGEMENT	Purpose Socio-economic deprivation and ethnic variation have been frequently linked to poorer health outcomes. We collected a large series of primary macula-on rhegmatogenous retinal detachment (RRD) cases and analysed the effect of socio-economic deprivation and ethnicity on both six-month retinal re-detachment rate and visual outcomes. Materials and methods Retrospective consecutive case series of 568 patients attending Birmingham and Midlands Eye Centre from January 2017-2020. Multiple Indices of Deprivation (IMD) deciles were used for deprivation status and split to two groups: IMD-A (Decile 1-5) and IMD-B (Decile 6-10). The two largest subgroups of ethnicities were compared, White and South Asians (SA). Results We report an overall retinal re-detachment rate of 8.5%. IMD-A re-detached significantly more than IMD-B (11.2% vs 6.0% respectively, p = 0.034). No statistical significance was found between White and SA re-detachment rate (9.1% and 5.6% respectively, p = 0.604). SA median age significantly lower at 49 years (IQR: 37-61) compared to White patients at 57 years (IQR: 50-65) (p = <0.001). IMD-A median age of 55 years (IQR: 46-64) was significantly lower to IMD-B median age of 58 years (IQR: 51-65) (p = 0.011). No differences in final visual outcomes were detected across all groups. Conclusion We demonstrated an increased retinal re-detachment rate in our more deprived patients according to IMD and a younger cohort of SA compared to White ethnicity. Further prospective studies are required to demonstrate the link between socio-economic deprivation and surgical success.	[Moussa, George; Kalogeropoulos, Dimitrios; Ch'ng, Soon Wai; Lett, Kim Son; Mitra, Arijit; Tyagi, Ajai K.; Sharma, Ash; Andreatta, Walter] Sandwell & West Birmingham Hosp NHS Trust, Birmingham Midlands Eye Ctr, Birmingham, W Midlands, England; [Moussa, George] Univ Birmingham, Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England; [Moussa, George] Univ Birmingham, Acad Unit Ophthalmol, Birmingham, W Midlands, England; [Kalogeropoulos, Dimitrios] Univ Ioannina, Sch Hlth Sci, Dept Ophthalmol, Fac Med, Ioannina, Greece; [Andreatta, Walter] Kantonsspital Winterthur, Winterthur, Switzerland; [Andreatta, Walter] Univ Zurich, Zurich, Switzerland	University of Birmingham; University of Birmingham; University of Ioannina; University of Zurich	Moussa, G (corresponding author), Sandwell & West Birmingham Hosp NHS Trust, Birmingham Midlands Eye Ctr, Birmingham, W Midlands, England.; Moussa, G (corresponding author), Univ Birmingham, Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England.; Moussa, G (corresponding author), Univ Birmingham, Acad Unit Ophthalmol, Birmingham, W Midlands, England.	george.moussa@nhs.net	Kalogeropoulos, Dimitrios/AAA-4586-2020	Kalogeropoulos, Dimitrios/0000-0001-6404-5409; Moussa, George/0000-0002-5136-6841				[Anonymous], 2017, ROYAL COLL OPHTHALMO, DOI [10.1097/IAE.0000000000001538, DOI 10.1097/IAE.0000000000001538]; Chandra A, 2015, EYE, V29, P803, DOI 10.1038/eye.2015.43; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Day AC, 2015, EYE, V29, P552, DOI 10.1038/eye.2015.3; GOV.UK, 2019, ETHN FACTS FIG; Goyal R, 2004, EYE, V18, P773, DOI 10.1038/sj.eye.6700724; GREY RHB, 1989, BRIT J OPHTHALMOL, V73, P88, DOI 10.1136/bjo.73.2.88; Gupta B, 2017, EUR J OPHTHALMOL, V27, P367, DOI 10.5301/ejo.5000894; Hajari JN, 2015, ACTA OPHTHALMOL, V93, P505, DOI 10.1111/aos.12756; Health Research Authority, NEED NHS ETH APPR; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Kirac FS, 2013, MOL IMAGING RADIONUC, V22, P73, DOI 10.4274/Mirt.80664; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; Lane M, 2018, SURV OPHTHALMOL, V63, P406, DOI 10.1016/j.survophthal.2017.10.009; Mahmoudi Sasan, 2016, J Ophthalmic Vis Res, V11, P100, DOI 10.4103/2008-322X.180696; Mason JO, 2016, RETINA-J RET VIT DIS, V36, P981, DOI 10.1097/IAE.0000000000000828; Ministry of Housing Communities and Local Government, 2019, NAT STAT; Mitry D, 2012, BRIT J OPHTHALMOL, V96, P730, DOI 10.1136/bjophthalmol-2011-300581; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Moussa G, 2022, ACTA OPHTHALMOL, V100, P96, DOI 10.1111/aos.14899; Moussa G, 2021, ACTA OPHTHALMOL, V99, pE963, DOI 10.1111/aos.14659; Moussa G, 2021, EYE, V35, P2146, DOI 10.1038/s41433-020-01333-9; O'Colmain U, 2020, EYE, V34, P2315, DOI 10.1038/s41433-020-0821-4; Orlin A, 2014, RETINA-J RET VIT DIS, V34, P1069, DOI 10.1097/IAE.0000000000000050; Saidkasimova S, 2009, BRIT J OPHTHALMOL, V93, P1591, DOI 10.1136/bjo.2009.162347; Silvester A, 2018, LANCET, V392, P81; Snellingen T, 1998, BRIT J OPHTHALMOL, V82, P1424, DOI 10.1136/bjo.82.12.1424; Thelen U, 2010, OPHTHALMOLOGY, V117, P785, DOI 10.1016/j.ophtha.2009.12.016; TIELSCH JM, 1991, ARCH OPHTHALMOL-CHIC, V109, P637, DOI 10.1001/archopht.1991.01080050051027; Yorston D, 2005, EYE, V19, P1083, DOI 10.1038/sj.eye.6701966	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259714	10.1371/journal.pone.0259714	http://dx.doi.org/10.1371/journal.pone.0259714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752493	Green Published, gold			2022-12-26	WOS:000754499700029
J	Dickinson, S; Chong, HY; Leslie, T; Rowland, M; Hansen, KS; Boyers, D				Dickinson, Simon; Chong, Huey Yi; Leslie, Toby; Rowland, Mark; Hansen, Kristian Schultz; Boyers, Dwayne			Cost-effectiveness of point-of-care C-Reactive Protein test compared to current clinical practice as an intervention to improve antibiotic prescription in malaria-negative patients in Afghanistan	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; FEBRILE ILLNESS; RESISTANCE; ETIOLOGY	Background Antimicrobial resistance (AMR) is a global health problem requiring a reduction in inappropriate antibiotic prescribing. Point-of-Care C-Reactive Protein (POCCRP) tests could distinguish between bacterial and non-bacterial causes of fever in malaria-negative patients and thus reduce inappropriate antibiotic prescribing. However, the cost-effectiveness of POCCRP testing is unclear in low-income settings. Methods A decision tree model was used to estimate cost-effectiveness of POCCRP versus current clinical practice at primary healthcare facilities in Afghanistan. Data were analysed from healthcare delivery and societal perspectives. Costs were reported in 2019 USD. Effectiveness was measured as correctly treated febrile malaria-negative patient. Cost, effectiveness and diagnostic accuracy parameters were obtained from primary data from a cost-effectiveness study on malaria rapid diagnostic tests in Afghanistan and supplemented with POCCRP-specific data sourced from the literature. Incremental cost-effectiveness ratios (ICERs) reported the additional cost per additional correctly treated febrile malaria-negative patient over a 28-day time horizon. Univariate and probabilistic sensitivity analyses examined the impact of uncertainty of parameter inputs. Scenario analysis included economic cost of AMR per antibiotic prescription. Results The model predicts that POCCRP intervention would result in 137 fewer antibiotic prescriptions (6%) with a 12% reduction (279 prescriptions) in inappropriate prescriptions compared to current clinical practice. ICERs were $14.33 (healthcare delivery), $11.40 (societal), and $9.78 (scenario analysis) per additional correctly treated case. Conclusions POCCRP tests could improve antibiotic prescribing among malaria-negative patients in Afghanistan. Cost-effectiveness depends in part on willingness to pay for reductions in inappropriate antibiotic prescribing that will only have modest impact on immediate clinical outcomes but may have long-term benefits in reducing overuse of antibiotics. A reduction in the overuse of antibiotics is needed and POCCRP tests may add to other interventions in achieving this aim. Assessment of willingness to pay among policy makers and donors and undertaking operational trials will help determine cost-effectiveness and assist decision making.	[Dickinson, Simon; Leslie, Toby] Mott MacDonald Ltd, London, England; [Dickinson, Simon; Chong, Huey Yi; Boyers, Dwayne] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Rowland, Mark] London Sch Hyg & Trop Med, Dept Dis Control, London, Scotland; [Hansen, Kristian Schultz] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	The Mott MacDonald Group; University of Aberdeen; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen	Dickinson, S (corresponding author), Mott MacDonald Ltd, London, England.; Dickinson, S (corresponding author), Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland.	simon.dickinson85@gmail.com		Hansen, Kristian Schultz/0000-0003-2976-4947	Chief Scientist's office of the Scottish government health directorates; Bill and Melinda Gates Foundation; UK Defence Science and Technology Laboratory	Chief Scientist's office of the Scottish government health directorates; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Defence Science and Technology Laboratory	Publication fees for the article are paid by Mott MacDonald Ltd. The authors received no additional funding for this article. Two of the authors (SD and TL) are affiliated to a commercial organisation (Mott MacDonald Ltd). We confirm there is no commercial affiliation between Mott MacDonald and this article. Aside from publication fees, no funding was provided for the production of the article. Three of the authors (SD, HYU and DB) are affiliated to the Health Economics Research Unit at the University of Aberdeen, which is funded by the Chief Scientist's office of the Scottish government health directorates. The primary data collection (2009-2012) for the malaria RDT IRT (Ref: 30) and CEA (Ref: 41) in Afghanistan was funded by the Bill and Melinda Gates Foundation through a grant to the London School of Hygiene and Tropical Medicine. Data on aetiological agents of disease (Ref: 14) was collected with funding from the UK Defence Science and Technology Laboratory. These funding organisations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	Althaus T, 2019, LANCET GLOB HEALTH, V7, pE119, DOI 10.1016/S2214-109X(18)30444-3; Aslam B, 2018, INFECT DRUG RESIST, V11, P1645, DOI 10.2147/IDR.S173867; Aslam Sadaf, 2010, Indian J Sex Transm Dis AIDS, V31, P47, DOI 10.4103/0253-7184.69003; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Bhatia R, 2018, NATL MED J INDIA, V31, P133, DOI 10.4103/0970-258X.255752; Briggs A, 2006, DECISION MODELLING H; Cals JWL, 2011, J EVAL CLIN PRACT, V17, P1059, DOI 10.1111/j.1365-2753.2010.01472.x; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Elfving K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146054; Gregory S., 2013, AGENCY HEALTHCARE RE; Hansen KS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0696-1; Hildenwall H, 2016, TROP MED INT HEALTH, V21, P149, DOI 10.1111/tmi.12635; Holmes EAF, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7040106; Hopkins H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1054; Hsu J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.141.1_MeetingAbstract.463; Huang YF, 2013, BRIT J GEN PRACT, V63, pE787, DOI 10.3399/bjgp13X674477; Hughes A., 2016, CLIN PHARMACIST; Hughes A., 2016, CLIN PHARMACIST, V8; Hunter R, 2015, ADV THER, V32, P69, DOI 10.1007/s12325-015-0180-x; International Monetary Fund, WORLD EC OUTLOOK APR; Jonas OB, 2017, REPORT NO 114679, V2; Leslie T., 2012, CAUSES NONMALARIAL C; Leslie T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3730; Leslie T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4389; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Lubell Y, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0414-1; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Michaelidis CI, 2014, J GEN INTERN MED, V29, P579, DOI 10.1007/s11606-013-2679-7; Ministry of Public Health GD of PA, 2013, NATL STANDARD TREATM; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; O'Neill J, 2014, ANTIMICROBIAL RESIST; Oanda, CURRENCY CONVERTER F; Oppong R, 2013, BRIT J GEN PRACT, V63, pE465, DOI 10.3399/bjgp13X669185; Petel D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022133; Phommasone K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1360-2; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Shrestha P, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0384-3; Tam PYI, 2016, J PEDIAT INF DIS SOC, V5, P190, DOI 10.1093/jpids/piw016; The World Bank, INFLATION CONSUMER P; van Stralen KJ, 2009, KIDNEY INT, V75, P1257, DOI 10.1038/ki.2009.92; Ward Caroline, 2018, BMJ Open Qual, V7, pe000391, DOI 10.1136/bmjoq-2018-000391; World Health Organization, 2018, REG DISS WORKSH GUID; World Health Organization, 2016, ROLE RDTS MALARIA CO; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2018, WHO REPORT SURVEILLA; Zecca E, 2009, CLIN CHEM LAB MED, V47, P1081, DOI 10.1515/CCLM.2009.246	47	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258299	10.1371/journal.pone.0258299	http://dx.doi.org/10.1371/journal.pone.0258299			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748558	gold, Green Published			2022-12-26	WOS:000755468000006
J	Gray, AN; Martin-Blais, R; Tobin, NH; Wang, Y; Brooker, SL; Li, F; Gadoth, A; Elliott, J; Faure-Kumar, E; Halbrook, M; Hofmann, C; Kashani, S; Kazan, C; Yang, OO; Fulcher, JA; Grovit-Ferbas, K; Rimoin, AW; Aldrovandi, GM				Gray, Ashley N.; Martin-Blais, Rachel; Tobin, Nicole H.; Wang, Yan; Brooker, Sarah L.; Li, Fan; Gadoth, Adva; Elliott, Julie; Faure-Kumar, Emmanuelle; Halbrook, Megan; Hofmann, Christian; Kashani, Saman; Kazan, Clayton; Yang, Otto O.; Fulcher, Jennifer A.; Grovit-Ferbas, Kathie; Rimoin, Anne W.; Aldrovandi, Grace M.			Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection	PLOS ONE			English	Article								Two mRNA vaccines (BNT162b2 and mRNA-1273) against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) are globally authorized as a two-dose regimen. Understanding the magnitude and duration of protective immune responses is vital to curbing the pandemic. We enrolled 461 high-risk health services workers at the University of California, Los Angeles (UCLA) and first responders in the Los Angeles County Fire Department (LACoFD) to assess the humoral responses in previously infected (PI) and infection naive (NPI) individuals to mRNA-based vaccines (BNT162b2/Pfizer- BioNTech or mRNA-1273/Moderna). A chemiluminescent microparticle immunoassay was used to detect antibodies against SARS-CoV-2 Spike in vaccinees prior to (n = 21) and following each vaccine dose (n = 246 following dose 1 and n = 315 following dose 2), and at days 31-60 (n = 110) and 61-90 (n = 190) following completion of the 2-dose series. Both vaccines induced robust antibody responses in all immunocompetent individuals. Previously infected individuals achieved higher median peak titers (p = 0.002) and had a slower rate of decay (p = 0.047) than infection-naive individuals. mRNA-1273 vaccinated infection-naive individuals demonstrated modestly higher titers following each dose (p = 0.005 and p = 0.029, respectively) and slower rates of antibody decay (p = 0.003) than those who received BNT162b2. A subset of previously infected individuals (25%) required both doses in order to reach peak antibody titers. The biologic significance of the differences between previously infected individuals and between the mRNA-1273 and BNT162b2 vaccines remains uncertain, but may have important implications for booster strategies.	[Gray, Ashley N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Los Angeles, CA 90095 USA; [Martin-Blais, Rachel; Tobin, Nicole H.; Brooker, Sarah L.; Li, Fan; Aldrovandi, Grace M.] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Dept Pediat, Los Angeles, CA 90095 USA; [Wang, Yan; Elliott, Julie; Faure-Kumar, Emmanuelle; Hofmann, Christian; Yang, Otto O.; Fulcher, Jennifer A.; Grovit-Ferbas, Kathie] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Gadoth, Adva; Halbrook, Megan; Rimoin, Anne W.] Univ Calif Los Angeles, Jonathan & Karin Fielding Sch Publ Hlth, Los Angeles, CA USA; [Faure-Kumar, Emmanuelle] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Kashani, Saman; Kazan, Clayton] Los Angeles Cty Fire Dept LACoFD, Emergency Med Serv Bur, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gray, AN (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Los Angeles, CA 90095 USA.	AshleyGray@fredhutch.org		Gray, Ashley/0000-0002-4355-2716; Halbrook, Megan/0000-0002-3892-2655; Martin-Blais, Rachel/0000-0001-5546-1072	AIDS Healthcare Foundation; Shurl and Kay Curci Foundation; Elizabeth R. Koch Foundation; Broad Stem Cell Research Center; Emerging Infectious Disease Rapid Research Fund; Steven & Alexandra Cohen Foundation; National Institute of Health (NIH) [T32 HL086345]; National Institute of Mental Health [T32 MH080634]	AIDS Healthcare Foundation; Shurl and Kay Curci Foundation; Elizabeth R. Koch Foundation; Broad Stem Cell Research Center; Emerging Infectious Disease Rapid Research Fund; Steven & Alexandra Cohen Foundation; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by AIDS Healthcare Foundation, The Shurl and Kay Curci Foundation, Elizabeth R. Koch Foundation, Marcy Gringlas and Joel Greenberg gift, Broad Stem Cell Research Center, Emerging Infectious Disease Rapid Research Fund, and Steven & Alexandra Cohen Foundation. A. Gray acknowledges support by the National Institute of Health (NIH) T32 Developmental Hematology Training grant (T32 HL086345). Y. Wang acknowledges support by the National Institute of Mental Health (T32 MH080634).	Abbott Alinity, SPIKE SARS COV 2 IGG; Altmann DM, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6160; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; CDC, COVID DAT TRACK 2021; CDC, COVID 19 VACC MOD SE; Doria-Rose N, 2021, NEW ENGL J MED, V384, P2259, DOI 10.1056/NEJMc2103916; Gadoth A, 2021, ANN INTERN MED, V174, P882, DOI 10.7326/M20-7580; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Huang Y, 2020, ACTA PHARMACOL SIN, V41, P1141, DOI 10.1038/s41401-020-0485-4; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Jagannathan P, 2021, NAT IMMUNOL, V22, P539, DOI 10.1038/s41590-021-00923-3; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Koyama T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050324; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Manisty C, 2021, LANCET, V397, P1057, DOI 10.1016/S0140-6736(21)00501-8; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Prendecki M, 2021, LANCET, V397, P1178, DOI 10.1016/S0140-6736(21)00502-X; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Winter L., 2021, US OFFICIALS DEBATE	21	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259703	10.1371/journal.pone.0259703	http://dx.doi.org/10.1371/journal.pone.0259703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748607	Green Published, gold			2022-12-26	WOS:000755468000049
J	Gressel, GM; Usyk, M; Frimer, M; Kuo, DYS; Burk, RD				Gressel, Gregory M.; Usyk, Mykhaylo; Frimer, Marina; Kuo, D. Y. S.; Burk, Robert D.			Characterization of the endometrial, cervicovaginal and anorectal microbiota in post-menopausal women with endometrioid and serous endometrial cancers	PLOS ONE			English	Article								Objective To characterize the microbiota of postmenopausal women undergoing hysterectomy for endometrioid (EAC) or uterine serous cancers (USC) compared to controls with non-malignant conditions. Methods Endometrial, cervicovaginal and anorectal microbial swabs were obtained from 35 postmenopausal women (10 controls, 14 EAC and 11 USC) undergoing hysterectomy. Extracted DNA was PCR amplified using barcoded 16S rRNA gene V4 primers. Sequenced libraries were processed using QIIME2. Phyloseq was used to calculate alpha- and beta- diversity measures. Biomarkers associated with case status were identified using ANCOM after adjustment for patient age, race and BMI. PICRUSt was used to identify microbial pathways associated with case status. Results Beta-diversity of microbial communities across each niche was significantly different (R2 = 0.25, p < 0.001). Alpha-diversity of the uterine microbiome was reduced in USC (Chao1, p = 0.004 and Fisher, p = 0.007) compared to EAC. Biomarkers from the three anatomical sites allowed samples to be clustered into two distinct clades that distinguished controls from USC cases (p = 0.042). The USC group was defined by 13 bacterial taxa across the three sites (W-stat>10, FDR<0.05) including depletion of cervicovaginal Lactobacillus and elevation of uterine Pseudomonas. PICRUSTt analysis revealed highly significant differences between the USC-associated clades within the cervicovaginal and uterine microbiota. Conclusions The microbial diversity of anatomic niches in postmenopausal women with EAC and USC is different compared to controls. Multiple bacteria are associated with USC case status including elevated levels of cervicovaginal Lactobacillus, depletion of uterine Pseudomonas, and substantially different functional potentials identified within cervicovaginal and uterine niches.	[Gressel, Gregory M.; Kuo, D. Y. S.; Burk, Robert D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Div Gynecol Oncol, 5, Bronx, NY 10461 USA; [Gressel, Gregory M.; Kuo, D. Y. S.; Burk, Robert D.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Usyk, Mykhaylo; Burk, Robert D.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Frimer, Marina] Zucker Sch Med Hofstra Northwell, Karches Ctr Oncol Res, Feinstein Inst Northwell Hlth, Dept Obstet & Gnyecol, Hempstead, NY USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Gressel, GM (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Div Gynecol Oncol, 5, Bronx, NY 10461 USA.; Gressel, GM (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA.	gregory.gressel@spectrumhealth.org	Gressel, Gregory/H-5408-2018	Gressel, Gregory/0000-0002-6729-4571				Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Amaya E, 2007, AQUACULTURE, V262, P419, DOI 10.1016/j.aquaculture.2006.11.001; Baker JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00208; Baker JM, 2017, MATURITAS, V103, P45, DOI 10.1016/j.maturitas.2017.06.025; Chase D, 2015, GYNECOL ONCOL, V138, P190, DOI 10.1016/j.ygyno.2015.04.036; Chatterjee S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091978; Chen XP, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1104-3; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; Engerud H, 2014, BRIT J CANCER, V111, P78, DOI 10.1038/bjc.2014.262; ESCHENBACH DA, 1986, J INFECT DIS, V153, P1038, DOI 10.1093/infdis/153.6.1038; Franasiak JM, 2016, J ASSIST REPROD GEN, V33, P129, DOI 10.1007/s10815-015-0614-z; Francescone R, 2014, CANCER J, V20, P181, DOI 10.1097/PPO.0000000000000048; Gall A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129055; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansen L.K, 2014, ACTA OBSTET GYN SCAN; Huang B, 2014, CLIN LAB MED, V34, P747, DOI 10.1016/j.cll.2014.08.006; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Laniewski P, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01049-16; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mert I, 2018, J OBSTET GYNAECOL RE, V44, P1693, DOI 10.1111/jog.13701; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Moss SF, 2017, CELL MOL GASTROENTER, V3, P183, DOI 10.1016/j.jcmgh.2016.12.001; Nene N.R, 2019, LANCET ONCOL; Novo T., 2009, PROGRAM-ELECTRON LIB; Parnell LA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11514-4; Rajagopala SV, 2017, CANCER PREV RES, V10, P226, DOI 10.1158/1940-6207.CAPR-16-0249; Rogers CJ, 2014, CANCER J, V20, P176, DOI 10.1097/PPO.0000000000000049; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Team RDC, 2013, R LANG ENV STAT COMP; Tissier H., 1900, RECHERCHES FLORE INT; Torgbor C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004170; Usyk M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008376; Van der Pol WJ, 2019, J INFECT DIS, V219, P305, DOI 10.1093/infdis/jiy508; Walsh DM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55720-8; Walther-Antonio MRS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0368-y; Wang Y, 2018, J MED MICROBIOL, V67, P1519, DOI 10.1099/jmm.0.000821; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wessels JM, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.035147; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winters AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46173-0	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259188	10.1371/journal.pone.0259188	http://dx.doi.org/10.1371/journal.pone.0259188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739493	Green Published, gold			2022-12-26	WOS:000755000800018
J	Kaur, M; Black, D; Fine, J; Wise, BL				Kaur, Manmeet; Black, Daniel; Fine, Jeffrey; Wise, Barton L.			Referrals for physical therapy for osteoarthritis during the COVID-19 pandemic: A retrospective analysis	PLOS ONE			English	Article							MANAGEMENT	Background Osteoarthritis (OA) is a leading cause of musculoskeletal pain and disability among Americans. Physical therapy (PT) is recommended per the 2019 ACR /Arthritis Foundation Guideline for Treatment of OA of the Hand, Hip, and Knee. During COVID-19, access to healthcare has been altered in a variety of clinical settings, with the pandemic creating delays in healthcare, with an unknown impact on access to PT care for OA. Objectives We sought to determine whether referrals to PT for OA were reduced in 2020 during the COVID-19 pandemic compared to 2019. Methods A retrospective analysis was done of 3586 PT referrals placed by the University of California, Davis for 206 OA ICD-10 codes from January to November 2019 and from January to November 2020. The numbers of PT referrals per month of each year were compared using both descriptive statistics and Poisson Regression analysis. Results A total of 1972 PT referrals for OA were placed from January to November 2019. Only 1614 referrals for OA were placed from January to November 2020, representing a significant decrease (p = 0.001). Month-by-month analysis of 2020 compared to 2019 revealed statistically significant drops in PT referrals for OA in April (p = 0.001), May (p = 0.001), and August (p = 0.001). Conclusions These findings reveal a significant reduction in the number of referrals for PT for OA placed in 2020 during the first year of the COVID-19 pandemic. These reductions were particularly evident in the months following state-mandated actions and closures. Factors associated with this outcome may include decreased access to primary care providers, perceptions of PT availability by health care providers, decreased mobility limiting access to both clinic and PT appointments, and/or willingness to engage in PT by patients during the pandemic.	[Kaur, Manmeet] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Black, Daniel] Univ Calif Davis, Dept Med, Div Clin Affairs Div Qual & Safety, Sacramento, CA 95817 USA; [Fine, Jeffrey] Univ Calif Davis, Dept Publ Hlth Sci, Sacramento, CA 95817 USA; [Wise, Barton L.] Univ Calif Davis, Dept Orthopaed Surg, Dept Med, Div Rheumatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kaur, M (corresponding author), Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA.	mmkaur@ucdavis.edu		Wise, Barton/0000-0002-6540-6031				[Anonymous], 2020, GOVERNOR NEWSOM PROV; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Brakke R, 2012, PM&R, V4, pS53, DOI 10.1016/j.pmrj.2012.02.017; California S of, COVID 19 RESTR; Deyle GD, 2020, NEW ENGL J MED, V382, P1420, DOI 10.1056/NEJMoa1905877; Kolasinski SL, 2020, ARTHRIT CARE RES, V72, P149, DOI 10.1002/acr.24131; Miller MJ, 2021, PHYS THER, V101, DOI 10.1093/ptj/pzaa193; Osteoarthritis, BMUS BURD MUSC DIS U; Poitras S, 2010, JOINT BONE SPINE, V77, P458, DOI 10.1016/j.jbspin.2010.08.001; Wosik J, 2020, J AM MED INFORM ASSN, V27, P957, DOI 10.1093/jamia/ocaa067	10	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259679	10.1371/journal.pone.0259679	http://dx.doi.org/10.1371/journal.pone.0259679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739521	Green Published, gold			2022-12-26	WOS:000755000800050
J	Hagras, M; Abutaleb, NS; Sayed, AM; Salama, EA; Seleem, MN; Mayhoub, AS				Hagras, Mohamed; Abutaleb, Nader S.; Sayed, Ahmed M.; Salama, Ehab A.; Seleem, Mohamed N.; Mayhoub, Abdelrahman S.			Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections	PLOS ONE			English	Article							CANDIDA-AURIS; AMPHOTERICIN-B; ANTIMICROBIAL THERAPY; METABOLISM; HEPATOTOXICITY; ANTIBIOTICS; DISEASE; BURDEN; AGENTS	To minimize the intrinsic toxicity of the antibacterial agent hydrazinyloxadiazole 1, the hydrazine moiety was replaced with ethylenediamine (compound 7). This replacement generated a potent antifungal agent with no antibacterial activity. Notably, use of a 1,2-diaminocyclohexane moiety, as a conformationally-restricted isostere for ethylenediamine, potentiated the antifungal activity in both the cis and trans forms of N-(5-(2-([1,1'-biphenyl]-4-yl)-4-methylthiazol-5-yl)-1,3,4-oxadiazol-2-yl)cyclohexane-1,2-diamine (compounds 16 and 17). Both compounds 16 and 17 were void of any antibacterial activity; nonetheless, they showed equipotent antifungal activity in vitro to that of the most potent approved antifungal agent, amphotericin B. The promising antifungal effects of compounds 16 and 17 were maintained when assessed against an additional panel of 26 yeast and mold clinical isolates, including the Candida auris and C. krusei. Furthermore, compound 17 showed superior activity to amphotericin B in vitro against Candida glabrata and Cryptococcus gattii. Additionally, neither compound inhibited the normal human microbiota, and both possessed excellent safety profiles and were 16 times more tolerable than amphotericin B.	[Hagras, Mohamed; Sayed, Ahmed M.; Mayhoub, Abdelrahman S.] Al Azhar Univ, Coll Pharm, Dept Pharmaceut Organ Chem, Cairo, Egypt; [Abutaleb, Nader S.; Salama, Ehab A.; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Abutaleb, Nader S.; Salama, Ehab A.; Seleem, Mohamed N.] Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Abutaleb, Nader S.] Zagazig Univ, Dept Microbiol & Immunol, Fac Pharm, Zagazig, Egypt; [Seleem, Mohamed N.] Virginia Polytech Inst & State Univ, Ctr Emerging Zoonot & Arthropodborne Pathogens, Blacksburg, VA 24061 USA; [Mayhoub, Abdelrahman S.] Univ Sci & Technol, Zewail City Sci & Technol, Nanosci Program, Giza, Egypt	Egyptian Knowledge Bank (EKB); Al Azhar University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Zagazig University; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology	Mayhoub, AS (corresponding author), Al Azhar Univ, Coll Pharm, Dept Pharmaceut Organ Chem, Cairo, Egypt.; Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Seleem, MN (corresponding author), Virginia Polytech Inst & State Univ, Virginia Maryland Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.; Seleem, MN (corresponding author), Virginia Polytech Inst & State Univ, Ctr Emerging Zoonot & Arthropodborne Pathogens, Blacksburg, VA 24061 USA.; Mayhoub, AS (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Nanosci Program, Giza, Egypt.	seleem@vt.edu; amayhoub@azhar.edu.eg						AbdelKhalek A, 2019, INT J ANTIMICROB AG, V53, P54, DOI 10.1016/j.ijantimicag.2018.09.018; Achkar JM, 2010, CLIN MICROBIOL REV, V23, P253, DOI 10.1128/CMR.00076-09; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Belkin A, 2018, EMERG INFECT DIS, V24, P801, DOI 10.3201/eid2404.171715; Berkow EL, 2017, INFECT DRUG RESIST, V10, P237, DOI 10.2147/IDR.S118892; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Canton E, 2003, DIAGN MICR INFEC DIS, V45, P203, DOI 10.1016/S0732-8893(02)00525-4; Chen YC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1023-8; Chowdhary A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006290; Clinical and Laboratory Standards Institute CLSI, METH DIL ANT SUSC TE, P2012; CLSI, 2008, REF METH BROTH DIL A; CLSI, 2012, METH DIL ANT SUSC TE; Eldesouky HE, 2018, INT J ANTIMICROB AG, V52, P754, DOI 10.1016/j.ijantimicag.2018.08.016; Elsebaei MM, 2019, EUR J MED CHEM, V175, P49, DOI 10.1016/j.ejmech.2019.04.063; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Flevari A, 2013, CLIN INTERV AGING, V8, P1199, DOI 10.2147/CIA.S39120; Franca FD., 2013, DRUGS, V5, P10; Fu JJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2423-8; Hager CL, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02319-17, 10.1128/aac.02319-17]; Hagras M, 2018, ACS INFECT DIS, V4, P1679, DOI 10.1021/acsinfecdis.8b00172; Hagras M, 2018, EUR J MED CHEM, V143, P1448, DOI 10.1016/j.ejmech.2017.10.048; Hammad A, 2019, J MED CHEM, V62, P7998, DOI 10.1021/acs.jmedchem.9b00720; Hernando-Ortiz A, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00824-20; Irfan M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175710; Johnson MD, 2010, CURR FUNGAL INFECT R, V4, P87, DOI 10.1007/s12281-010-0018-6; Kagan S, 2012, ANTIMICROB AGENTS CH, V56, P5603, DOI 10.1128/AAC.00612-12; Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918; Kotb A, 2018, EUR J MED CHEM, V151, P110, DOI 10.1016/j.ejmech.2018.03.044; Kumar D, 2015, J INFECT DEV COUNTR, V9, P435, DOI 10.3855/jidc.4582; Kushiro A, 2009, INT J FOOD MICROBIOL, V132, P54, DOI 10.1016/j.ijfoodmicro.2009.03.012; Lewis RE, 2011, MAYO CLIN PROC, V86, P805, DOI 10.4065/mcp.2011.0247; Lincopan N, 2005, J ANTIMICROB CHEMOTH, V55, P727, DOI 10.1093/jac/dki064; MartinezIrujo JJ, 1996, BIOCHEM PHARMACOL, V51, P635, DOI 10.1016/S0006-2952(95)02230-9; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mohammad H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142321; NELSON SD, 1978, J PHARMACOL EXP THER, V206, P574; Opoku-Temeng C, 2018, EUR J MED CHEM, V155, P797, DOI 10.1016/j.ejmech.2018.06.023; Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46; Pfaller MA, 2015, DIAGN MICR INFEC DIS, V82, P303, DOI 10.1016/j.diagmicrobio.2015.04.008; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; ROLLA AR, 1974, ANN INTERN MED, V80, P278, DOI 10.7326/0003-4819-80-2-278; Rybak MJ, 1996, DRUGS, V52, P390, DOI 10.2165/00003495-199652030-00005; SANDERS CV, 1991, PHARMACOTHERAPY, V11, pS72; Sarma S, 2013, INDIAN J MED MICROBI, V31, P90, DOI 10.4103/0255-0857.108746; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Seleem MA, 2016, J MED CHEM, V59, P4900, DOI 10.1021/acs.jmedchem.6b00233; Sharma C, 2015, MYCOSES, V58, P119; Sinko J, 2015, MYCOSES, V58, P29, DOI 10.1111/myc.12385; TIMBRELL JA, 1980, J PHARMACOL EXP THER, V213, P364; TOMASI A, 1987, TOXICOL PATHOL, V15, P178, DOI 10.1177/019262338701500208; Vallabhaneni S., 2015, OPEN FORUM INFECT DI; Vallabhaneni S, 2016, MMWR-MORBID MORTAL W, V65, P1234, DOI 10.15585/mmwr.mm6544e1; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226	53	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258465	10.1371/journal.pone.0258465	http://dx.doi.org/10.1371/journal.pone.0258465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735467	gold, Green Published			2022-12-26	WOS:000755077100024
J	Liu, KYP; Zhu, SY; Harrison, A; Chen, ZY; Guillaud, M; Poh, CF				Liu, Kelly Yi Ping; Zhu, Sarah Yuqi; Harrison, Alan; Chen, Zhao Yang; Guillaud, Martial; Poh, Catherine F.			Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma	PLOS ONE			English	Article							TISSUE PHENOTYPE; IMAGE-ANALYSIS; LYMPH-NODES; CANCER; INVASION; NECK; METASTASIS; DEPTH; MORPHOMETRY; MARGINS	Background Early-stage oral squamous cell carcinoma (OSCC) patients have a one-in-four risk of regional metastasis (LN+), which is also the most significant prognostic factor for survival. As there are no validated biomarkers for predicting LN+ in early-stage OSCC, elective neck dissection often leads to over-treatment and under-treatment. We present a machine-learning-based model using the quantitative nuclear phenotype of cancer cells from the primary tumor to predict the risk of nodal disease. Methods and findings Tumor specimens were obtained from 35 patients diagnosed with primary OSCC and received surgery with curative intent. Of the 35 patients, 29 had well (G1) or moderately (G2) differentiated tumors, and six had poorly differentiated tumors. From each, two consecutive sections were stained for hematoxylin & eosin and Feulgen-thionin staining. The slides were scanned, and images were processed to curate nuclear morphometric features for each nucleus, measuring nuclear morphology, DNA amount, and chromatin texture/organization. The nuclei (n = 384,041) from 15 G1 and 14 G2 tumors were randomly split into 80% training and 20% test set to build the predictive model by using Random Forest (RF) analysis which give each tumor cell a score, NRS. The area under ROC curve (AUC) was 99.6% and 90.7% for the training and test sets, respectively. At the cutoff score of 0.5 as the median NRS of each region of interest (n = 481), the AUC was 95.1%. We then developed a patient-level model based on the percentage of cells with an NRS >= 0.5. The prediction performance showed AUC of 97.7% among the 80% (n = 23 patient) training set and with the cutoff of 61% positive cells achieved 100% sensitivity and 91.7% specificity. When applying the 61% cutoff to the 20% test set patients, the model achieved 100% accuracy. Conclusions Our findings may have a clinical impact with an easy, accurate, and objective biomarker from routine pathology tissue, providing an unprecedented opportunity to improve neck management decisions in early-stage OSCC patients.	[Liu, Kelly Yi Ping; Zhu, Sarah Yuqi; Poh, Catherine F.] Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC, Canada; [Liu, Kelly Yi Ping; Zhu, Sarah Yuqi; Harrison, Alan; Chen, Zhao Yang; Guillaud, Martial; Poh, Catherine F.] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada	University of British Columbia; British Columbia Cancer Agency	Poh, CF (corresponding author), Univ British Columbia, Dept Oral Biol & Med Sci, Fac Dent, Vancouver, BC, Canada.; Poh, CF (corresponding author), BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC, Canada.	cpoh@dentistry.ubc.ca	chen, zhaoyang/GRS-1470-2022	guillaud, martial/0000-0001-8982-2489				Almangush A, 2014, HEAD NECK-J SCI SPEC, V36, P811, DOI 10.1002/hed.23380; [Anonymous], 2016, J MACH LEARN RES, V17, P5; [Anonymous], 1994, CYTO SAVANT SYSTEM A, P305; [Anonymous], 2014, OPERATIONS RES P, V2016, P7; Baik J, 2014, CELL ONCOL, V37, P193, DOI 10.1007/s13402-014-0172-x; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Brockhoff HC, 2017, HEAD NECK-J SCI SPEC, V39, P974, DOI 10.1002/hed.24724; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Doudkine A., 1995, Pathologica (Genoa), V87, P286; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fortin A, 2001, J CLIN ONCOL, V19, P4107, DOI 10.1200/JCO.2001.19.21.4107; FOX WA, 2014, inventorCytological Staining Compositions and Uses Thereof, Patent No. [US2014, 2014]; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goerkem M, 2010, ANN SURG ONCOL, V17, P527, DOI 10.1245/s10434-009-0755-3; Guillaud M, 2005, CYTOM PART A, V63A, P34, DOI 10.1002/cyto.a.20101; Guillaud M, 2008, CANCER RES, V68, P3099, DOI 10.1158/0008-5472.CAN-07-2113; Guillaud M, 2018, HEAD NECK-J SCI SPEC, V40, P1263, DOI 10.1002/hed.25106; Guillaud M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107088; Huang SH, 2009, CANCER-AM CANCER SOC, V115, P1489, DOI 10.1002/cncr.24161; Jung J, 2009, INT J ORAL MAX SURG, V38, P653, DOI 10.1016/j.ijom.2009.01.004; Karino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116452; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Ledgerwood LG, 2016, ONCOTARGET, V7, P27185, DOI 10.18632/oncotarget.8448; Leonhardt H, 2000, J CELL BIOCHEM, P78; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Liu KYP, 2018, J DENT RES, V97, P709, DOI 10.1177/0022034518758045; Liu Kelly Yi Ping, 2020, Oncotarget, V11, P2204, DOI 10.18632/oncotarget.27616; Liu KYP, 2016, JAMA OTOLARYNGOL, V142, P1111, DOI 10.1001/jamaoto.2016.2241; Lydiatt William, 2018, Am Soc Clin Oncol Educ Book, V38, P505, DOI 10.1200/EDBK_199697; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; McDonald C, 2019, BRIT J ORAL MAX SURG, V57, P649, DOI 10.1016/j.bjoms.2019.05.021; Natarajan S, 2010, INDIAN J CANCER, V47, P406, DOI 10.4103/0019-509X.73580; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Patel RS, 2008, LARYNGOSCOPE, V118, P780, DOI 10.1097/MLG.0b013e31816422bb; Poh CF, 2006, CLIN CANCER RES, V12, P6716, DOI 10.1158/1078-0432.CCR-06-1317; Poh CF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-462; R Core Team, 2021, R LANGUAGE ENV STAT; Sachs MC, 2017, J STAT SOFTW, V79, DOI 10.18637/jss.v079.c02; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Spalthoff S, 2017, J ORAL MAXIL SURG, V75, P839, DOI 10.1016/j.joms.2016.09.037; Tsui IFL, 2009, AM J SURG PATHOL, V33, P1732, DOI 10.1097/PAS.0b013e3181b669c2; VANVELTHOVEN R, 1995, CANCER-AM CANCER SOC, V75, P560, DOI 10.1002/1097-0142(19950115)75:2<560::AID-CNCR2820750220>3.0.CO;2-B; Veltri RW, 2004, CLIN CANCER RES, V10, P3465, DOI 10.1158/1078-0432.CCR-03-0635; Zarella MD, 2015, ANAL QUANT CYTOPATHO, V37, P273	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259529	10.1371/journal.pone.0259529	http://dx.doi.org/10.1371/journal.pone.0259529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735529	Green Published, gold			2022-12-26	WOS:000755077100087
J	Bruno, NE; Nwachukwu, JC; Hughes, DC; Srinivasan, S; Hawkins, R; Sturgill, D; Hager, GL; Hurst, S; Sheu, SS; Bodine, SC; Conkright, MD; Nettles, KW				Bruno, Nelson E.; Nwachukwu, Jerome C.; Hughes, David C.; Srinivasan, Sathish; Hawkins, Richard; Sturgill, David; Hager, Gordon L.; Hurst, Stephen; Sheu, Shey-Shing; Bodine, Sue C.; Conkright, Michael D.; Nettles, Kendall W.			Activation of Crtc2/Creb1 in skeletal muscle enhances weight loss during intermittent fasting	FASEB JOURNAL			English	Article						Creb1; Crtc2; intermittent fasting; skeletal muscle	CREB COACTIVATOR TORC2; WORK EFFICIENCY; MITOCHONDRIAL BIOGENESIS; INDUCE PGC-1-ALPHA; PHYSICAL-ACTIVITY; REGULAR EXERCISE; MESSENGER-RNA; BODY-WEIGHT; TRANSCRIPTION; KINASE	The Creb-Regulated Transcriptional Coactivator (Crtc) family of transcriptional coregulators drive Creb1-mediated transcription effects on metabolism in many tissues, but the in vivo effects of Crtc2/Creb1 transcription on skeletal muscle metabolism are not known. Skeletal muscle-specific overexpression of Crtc2 (Crtc2 mice) induced greater mitochondrial activity, metabolic flux capacity for both carbohydrates and fats, improved glucose tolerance and insulin sensitivity, and increased oxidative capacity, supported by upregulation of key metabolic genes. Crtc2 overexpression led to greater weight loss during alternate day fasting (ADF), selective loss of fat rather than lean mass, maintenance of higher energy expenditure during the fast and reduced binge-eating during the feeding period. ADF downregulated most of the mitochondrial electron transport genes, and other regulators of mitochondrial function, that were substantially reversed by Crtc2-driven transcription. Glucocorticoids acted with AMPK to drive atrophy and mitophagy, which was reversed by Crtc2/Creb1 signaling. Crtc2/Creb1-mediated signaling coordinates metabolic adaptations in skeletal muscle that explain how Crtc2/Creb1 regulates metabolism and weight loss.	[Bruno, Nelson E.; Nwachukwu, Jerome C.; Srinivasan, Sathish; Nettles, Kendall W.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 130 Scripps Way, Jupiter, FL 33458 USA; [Hughes, David C.; Bodine, Sue C.] Univ Iowa, Dept Internal Med, Sect Endocrinol & Metab, Iowa City, IA 52242 USA; [Hawkins, Richard; Conkright, Michael D.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Sturgill, David; Hager, Gordon L.] NCI, Lab Receptor Biol & Gene Express, NIH, Bethesda, MD 20892 USA; [Hurst, Stephen; Sheu, Shey-Shing] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Scripps Research Institute; University of Iowa; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Jefferson University	Bruno, NE; Nettles, KW (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 130 Scripps Way, Jupiter, FL 33458 USA.	nbruno@scripps.edu; knettles@scripps.edu		Hawkins, Richard/0000-0002-7481-5419; Hughes, David/0000-0002-5433-8782	Frenchman's Creek Women for Cancer Research	Frenchman's Creek Women for Cancer Research	JCN was supported by the Frenchman's Creek Women for Cancer Research. The authors thank Ana Lira (University of Iowa) for technical assistance on this project.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Baxter PS, 2011, J NEUROCHEM, V118, P365, DOI 10.1111/j.1471-4159.2011.07330.x; BLANCO CE, 1988, HISTOCHEM J, V20, P230, DOI 10.1007/BF01747468; Bordeaux R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00535; Brandt N, 2018, AM J PHYSIOL-ENDOC M, V314, pE1, DOI 10.1152/ajpendo.00082.2017; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Foright RM, 2018, PHYSIOL BEHAV, V188, P86, DOI 10.1016/j.physbeh.2018.01.025; Gilliat-Wimberly M, 2001, J AM DIET ASSOC, V101, P1181, DOI 10.1016/S0002-8223(01)00289-9; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Goldstein I, 2017, GENOME RES, V27, P427, DOI 10.1101/gr.212175.116; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grannell A, 2019, EXPERT REV ENDOCRINO, V14, P267, DOI 10.1080/17446651.2019.1618185; Grill MA, 2003, TRANSGENIC RES, V12, P33, DOI 10.1023/A:1022119005836; Heikkinen S., 2007, CURR PROTOC MOL BIOL; Higgins JA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-49; Hughes DC, 2021, AM J PHYSIOL-CELL PH, V320, pC45, DOI 10.1152/ajpcell.00432.2020; Kim SH, 2013, AM J PHYSIOL-ENDOC M, V304, pE844, DOI 10.1152/ajpendo.00581.2012; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu J, 2016, MOL PHARMACEUT, V13, P73, DOI 10.1021/acs.molpharmaceut.5b00516; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MacLean PS, 2009, AM J PHYSIOL-REG I, V297, pR793, DOI 10.1152/ajpregu.00192.2009; Margolis RN, 2005, MOL ENDOCRINOL, V19, P2433, DOI 10.1210/me.2004-0461; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Medvedeva YA, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav067; Meinken John, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav077; Melby CL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050468; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Nasta V, 2020, FEBS J, V287, P2312, DOI 10.1111/febs.15140; Ostendorf DM, 2019, OBESITY, V27, P496, DOI 10.1002/oby.22373; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perry RJ, 2019, P NATL ACAD SCI USA, V116, P13670, DOI 10.1073/pnas.1901795116; Popov DV, 2019, AM J PHYSIOL-ENDOC M, V316, pE605, DOI 10.1152/ajpendo.00449.2018; Popov DV, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13868; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ratman D, 2016, NUCLEIC ACIDS RES, V44, P10539, DOI 10.1093/nar/gkw742; Rosenbaum M, 2003, AM J PHYSIOL-REG I, V285, pR183, DOI 10.1152/ajpregu.00474.2002; Rosenbaum M, 2005, J CLIN INVEST, V115, P3579, DOI 10.1172/JCI25977; Rosenbaum M, 2018, OBESITY, V26, P1576, DOI 10.1002/oby.22274; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shook RP, 2014, MAYO CLIN PROC, V89, P763, DOI 10.1016/j.mayocp.2013.12.017; Sonntag T, 2019, ISCIENCE, V11, P134, DOI 10.1016/j.isci.2018.12.012; Springer ML, 1997, SOMAT CELL MOLEC GEN, V23, P203, DOI 10.1007/BF02721371; Steig AJ, 2011, AM J PHYSIOL-REG I, V301, pR656, DOI 10.1152/ajpregu.00212.2011; Stengel A, 2010, PHYSIOL BEHAV, V101, P614, DOI 10.1016/j.physbeh.2010.09.009; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Taub M, 2015, CELL SIGNAL, V27, P2568, DOI 10.1016/j.cellsig.2015.09.015; Than TA, 2011, J BIOL CHEM, V286, P22047, DOI 10.1074/jbc.M111.240481; Turk Y, 2017, OBES SCI PRACT, V3, P258, DOI 10.1002/osp4.109; Verheggen RJHM, 2016, OBES REV, V17, P664, DOI 10.1111/obr.12406; Voltarelli VA, 2014, J CELL MOL MED, V18, P1087, DOI 10.1111/jcmm.12253; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103	68	1	1	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e21999	10.1096/fj.202100171R	http://dx.doi.org/10.1096/fj.202100171R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748223	Green Published			2022-12-26	WOS:000722321300037
J	Mussarat, M; Jamal, WA; Muhammad, D; Ahmad, M; Saleem, A; Khan, S; Aman, F; Bibi, H; Shah, WA; Dawar, K; ul Akbar, N; Mian, IA; Waheed, M; Ali, I; Zia, A; Malik, W				Mussarat, Maria; Jamal, Waqar Ahmad; Muhammad, Dost; Ahmad, Manzoor; Saleem, Abida; Khan, Sowm; Aman, Faiza; Bibi, Hamida; Shah, Wajid Ali; Dawar, Khadim; ul Akbar, Noor; Mian, Ishaq Ahmad; Waheed, Muhammad; Ali, Irshad; Zia, Afia; Malik, Wasiullah			Risk of heavy metals accumulation in soil and wheat grains with waste water irrigation under different NPK levels in alkaline calcareous soil	PLOS ONE			English	Article							SEWAGE-SLUDGE; VEGETABLES; GROWTH; YIELD	A field study was conducted on the reuse of wastewater from Mardan city to evaluate its risk of contaminating soil and wheat grains at different NPK levels. Three irrigation sources i.e. waste water (WW), canal water (CW) and alternate waste + canal water (WW+CW) were applied to wheat (cv Atta Habib 2010) grown at 0, 50, 75 and 100% NPK levels of 120:90:60 kg N:P2O5:K2O ha(-1) at Palatoo Research Farm, Amir Muhammad Khan Campus, Mardan during 2015.The results showed higher grain and biomass yields in WW irrigated plots as compared to CW at NPK levels up to 50% of recommending dose revealing supplementing nutrient requirements in deficient conditions. However, irrigation of WW at higher NPK levels especially at or beyond 75% of recommended dose tended to reduce the crop yield that could be associated with heavy metals toxicity and nutritional imbalances. The use of WW substantially increased AB-DTPA extractable Zn, Mn, Pb, Ni and Cd indicating a potential threat to soil contamination. Similarly, WW irrigated wheat had higher concentrations of these heavy metals as compared to CW which limits its use for production purposes without any remediation measures. The alternate use of CW and WW as revealed by its comparative lower contamination in soil and wheat than sole WW could be one of the possible solutions and may increase the time required for threshold soil contamination.	[Mussarat, Maria; Muhammad, Dost; Saleem, Abida; Aman, Faiza; Bibi, Hamida; Mian, Ishaq Ahmad; Waheed, Muhammad; Ali, Irshad] Univ Agr, Dept Soil & Environm Sci, Peshawar, Pakistan; [Jamal, Waqar Ahmad] Univ Agr, Dept Soil & Environm Sci, Amir Muhammad Khan Campus, Peshawar, Pakistan; [Ahmad, Manzoor] Bacha Khan Univ, Dept Agr, Khyber, Pakhtunkhwa, Pakistan; [Khan, Sowm; Shah, Wajid Ali; Dawar, Khadim] Directorate Gen Soil Water Conservat, Peshawar, Pakistan; [ul Akbar, Noor] Kohat Univ Sci & Technol, Dept Zool, Kohat, Pakistan; [Zia, Afia] Univ Agr, Dept Agr Chem, Peshawar, Pakistan; [Malik, Wasiullah] Kohat Univ Sci & Technol, Kohat, Pakistan	Agricultural University Peshawar; University of Agriculture Faisalabad; Agricultural University Peshawar; University of Agriculture Faisalabad; Kohat University of Science & Technology; Agricultural University Peshawar; University of Agriculture Faisalabad; Kohat University of Science & Technology	Mussarat, M (corresponding author), Univ Agr, Dept Soil & Environm Sci, Peshawar, Pakistan.	drmaria@aup.edu.pk						Arora M, 2008, FOOD CHEM, V111, P811, DOI 10.1016/j.foodchem.2008.04.049; Asghar A., 2010, Pakistan Journal of Science, V62, P211; Ayers RS, 1994, WATER QUALITY AGR, V29, P1; Bhatti AM., 2009, SOC SOC MANAG SYST S, V9, P1; CAMPBELL WF, 1983, J ENVIRON QUAL, V12, P243, DOI 10.2134/jeq1983.00472425001200020019x; Chiu KK, 2006, BIORESOURCE TECHNOL, V97, P158, DOI 10.1016/j.biortech.2005.01.038; Day A., 1981, J ARIZ-NEV ACAD SCI, P85; Dougherty T., 1995, ENVIRON IMPACT ASSES; El-Sharkawi H., 2004, Acta Agronomica Hungarica, V52, P141, DOI 10.1556/AAgr.52.2004.2.4; Hussain A, 2019, APPL WATER SCI, V9, DOI 10.1007/s13201-019-0999-4; Kabata-Pendias A., 1984, TRACE ELEMENTS SOIL, P271; Khan S, 2008, J HAZARD MATER, V152, P506, DOI 10.1016/j.jhazmat.2007.07.014; KIRKHAM MB, 1986, HORTSCIENCE, V21, P24; Kisku GC, 2000, WATER AIR SOIL POLL, V120, P121, DOI 10.1023/A:1005202304584; Mapanda F, 2005, AGR ECOSYST ENVIRON, V107, P151, DOI 10.1016/j.agee.2004.11.005; Merian E, 1991, METALS THEIR COMPOUN, DOI DOI 10.1002/9783527619634; Mojid M. A., 2016, The Agriculturists, V14, P1, DOI 10.3329/agric.v14i1.29096; Organization WH, 1996, PERMISSIBLE LIMITS H; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; Rostami S. V., 2012, International Journal of Agriculture and Crop Sciences (IJACS), V4, P468; Ryan J., 2001, SOIL PLANT ANAL LAB, Vsecond; Sauve S, 1996, ENVIRON POLLUT, V94, P153, DOI 10.1016/S0269-7491(96)00081-4; Scientific J., 1991, TABLE CURVE 3 0 USER; Silva LVBD, 2016, REV BRAS ENG AGR AMB, V20, P308, DOI 10.1590/1807-1929/agriambi.v20n4p308-315; Singh RP, 2010, ECOL ENG, V36, P969, DOI 10.1016/j.ecoleng.2010.03.008; SOLTANPOUR PN, 1977, COMMUN SOIL SCI PLAN, V8, P195, DOI 10.1080/00103627709366714; Standards-NEQS NEQ., 2001, PAK ENV PROT COMM PE; Togay N, 2008, AFR J BIOTECHNOL, V7, P3026; Torabian A., 2002, J ENVIRONTAL STUDY S, V16, P255; Torrie J., 1981, PRINCIPLES PROCEDURE; Ul Hassan N, 2013, POL J ENVIRON STUD, V22, P115	31	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258724	10.1371/journal.pone.0258724	http://dx.doi.org/10.1371/journal.pone.0258724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788291	gold, Green Published			2022-12-26	WOS:000735920500006
J	Dong, XQ; Wang, W; Jiang, TY; Zhang, YM; Han, HY; Zhang, YG; Yang, CY				Dong, Xueqian; Wang, Wei; Jiang, Tianyi; Zhang, Yanmin; Han, Hongyu; Zhang, Yonggang; Yang, Chunyu			Construction and potential application of bacterial superoxide dismutase expressed in Bacillus subtilis against mycotoxins	PLOS ONE			English	Article							OXIDATIVE STRESS; ESCHERICHIA-COLI; DEOXYNIVALENOL; TRICHOTHECENES; CYTOTOXICITY; METABOLISM; STRATEGIES; TOXICITY; CULTURE; CLONING	Oxidative stress, which could be evoked by numerous inducements including mycotoxins like deoxynivalenol (DON), cause severe damages to organisms. Antioxidants are promising protectants against oxidative stress that could be applied in pharmaceutical, cosmetic, and food and feed industries. In this study, a thermostable and acidophilic superoxide dismutase (AaSOD) was used to develop an antioxidant product that can potentially protect organisms from oxidative stress related damages. The enzyme was successfully expressed as an extracelluar protein in Bacillus subtilis with a high yield. To obtain a feasible protocol for industrial production of AaSOD, the fermentation mediums that are commonly used for culturing B. subtilis were screened, the feasibility of expressing AaSOD without antibiotic as selection pressure was confirmed, and the effect of using lactose as an inducer instead of isopropyl-beta-d-thiogalactoside (IPTG) was investigated. Batch fermentation was conducted to validate the optimized conditions for AaSOD production, and 6530 U mL(-1) of SOD activity was obtained in the fermentation broth. The dry powder product of AaSOD with an activity of 22202 U g(-1) was prepared by spray-drying and was administrated on zebrafish to test its function as a protectant against DON, and thus gained a significant redress of the reactive oxygen species (ROS) accumulation induced by DON. Taken together, this study provides a feasible protocol to prepare the AaSOD-based antioxidant product that is potentially applied in livestock industry.	[Dong, Xueqian; Wang, Wei; Yang, Chunyu] Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Dong, Xueqian; Wang, Wei; Zhang, Yanmin; Han, Hongyu; Zhang, Yonggang] QiLu Univ Technol, Shandong Food Ferment Ind Res & Design Inst, Shandong Prov Key Lab Food & Fermentat Engingeeri, Shandong Acad Sci, Jinan, Peoples R China; [Jiang, Tianyi] Shandong Jianzhu Univ, Sch Municipal & Environm Engn, Jinan, Peoples R China	Shandong University; Qilu University of Technology; Shandong Jianzhu University	Yang, CY (corresponding author), Shandong Univ, Inst Microbial Technol, State Key Lab Microbial Technol, Qingdao, Peoples R China.	ycy21th@sdu.edu.cn			National Natural Science Foundations of China [42077214]; Youth Innovation Technology Project of Higher School in Shandong Province [2020KJF013]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Technology Project of Higher School in Shandong Province	This work was financially supported by the National Natural Science Foundations of China (42077214) and Youth Innovation Technology Project of Higher School in Shandong Province (2020KJF013). CY and TJ received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari P, 2015, J NUTR, V145, P1604, DOI 10.3945/jn.114.209486; Bafana A, 2011, CRIT REV BIOTECHNOL, V31, P65, DOI 10.3109/07388551.2010.490937; Borutova R., 2019, ALL FEED; Buettner GR, 2011, ANTI-CANCER AGENT ME, V11, P341; Cruz AG, 2012, LWT-FOOD SCI TECHNOL, V47, P512, DOI 10.1016/j.lwt.2012.01.037; De Walle JV, 2008, TOXICOL LETT, V177, P205, DOI 10.1016/j.toxlet.2008.01.018; DEBOER AS, 1991, APPL MICROBIOL BIOT, V36, P1; Dong XQ, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.577001; Donovan RS, 1996, J IND MICROBIOL, V16, P145, DOI 10.1007/BF01569997; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Gopal R.K., 2017, J PROB HLTH, V5, DOI [10.4172/2329-8901.1000179, 10.4172/2329-8901.1000179., DOI 10.4172/2329-8901.1000179]; Guo FX, 2008, MYCOLOGIA, V100, P375, DOI 10.3852/06-111R; HALLEWELL RA, 1987, BIO-TECHNOL, V5, P363, DOI 10.1038/nbt0487-363; He HJ, 2002, PROTEIN EXPRES PURIF, V24, P13, DOI 10.1006/prep.2001.1529; Hussein HS, 2001, TOXICOLOGY, V167, P101, DOI 10.1016/S0300-483X(01)00471-1; Ken CF, 2005, J AGR FOOD CHEM, V53, P1470, DOI 10.1021/jf048269f; Kilikian BV, 2000, PROCESS BIOCHEM, V35, P1019, DOI 10.1016/S0032-9592(00)00137-0; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Krishnaswamy R, 2010, FREE RADICAL BIO MED, V49, P50, DOI 10.1016/j.freeradbiomed.2010.03.016; Kumar A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00387; Liu J, 2020, RES VET SCI, V132, P308, DOI 10.1016/j.rvsc.2020.07.006; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Nauseef WM, 2008, SEMIN IMMUNOPATHOL, V30, P195, DOI 10.1007/s00281-008-0117-4; Pathak N, 2006, TOXICOLOGY, V220, P26, DOI 10.1016/j.tox.2005.11.027; Peskin AV, 2017, FREE RADICAL BIO MED, V103, P188, DOI 10.1016/j.freeradbiomed.2016.12.033; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Salimian J, 2014, IMMUNOPHARM IMMUNOT, V36, P275, DOI 10.3109/08923973.2014.931420; Strasser A, 2013, MYCOTOXIN RES, V29, P203, DOI 10.1007/s12550-013-0170-2; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Wang JZ, 2022, DRUG CHEM TOXICOL, V45, P1660, DOI 10.1080/01480545.2020.1853765; Wang X, 2008, J IND MICROBIOL BIOT, V35, P133, DOI 10.1007/s10295-007-0274-9; Wu QH, 2014, ARCH TOXICOL, V88, P1309, DOI 10.1007/s00204-014-1280-0; Wu QH, 2017, ONCOTARGET, V8, P110708, DOI 10.18632/oncotarget.22800; Wu SR, 2019, POULTRY SCI, V98, P828, DOI 10.3382/ps/pey393; Xia YZ, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1169; Yazdani SS, 2002, BIOPROC BIOSYST ENG, V24, P341, DOI 10.1007/s004490100221; Zhang Chaojie, 2003, Curr Protoc Toxicol, VChapter 1, DOI 10.1002/0471140856.tx0107s17; Zhang LN, 2018, ANN MICROBIOL, V68, P881, DOI 10.1007/s13213-018-1394-3; Zhang XZ, 2011, MICROB BIOTECHNOL, V4, P98, DOI 10.1111/j.1751-7915.2010.00230.x; Zhu H, 2013, EXTREMOPHILES, V17, P995, DOI 10.1007/s00792-013-0581-1; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	41	0	0	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260047	10.1371/journal.pone.0260047	http://dx.doi.org/10.1371/journal.pone.0260047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784394	gold, Green Published			2022-12-26	WOS:000755277300039
J	Papadopoulos, AO; Ealand, C; Gordhan, BG; VanNieuwenhze, M; Kana, BD				Papadopoulos, Andrea Olga; Ealand, Christopher; Gordhan, Bhavna Gowan; VanNieuwenhze, Michael; Kana, Bavesh Davandra			Characterisation of a putative M23-domain containing protein in Mycobacterium tuberculosis	PLOS ONE			English	Article							RESUSCITATION-PROMOTING FACTORS; M23B FAMILY METALLOPEPTIDASE; PEPTIDOGLYCAN CROSS-LINKING; DAUGHTER CELL-SEPARATION; ESCHERICHIA-COLI; DD-CARBOXYPEPTIDASE; GENE-EXPRESSION; SWISS-MODEL; DIVISION; AMIDASES	Mycobacterium tuberculosis, the causative agent of tuberculosis remains a global health concern, further compounded by the high rates of HIV-TB co-infection and emergence of multi- and extensive drug resistant TB, all of which have hampered efforts to eradicate this disease. As a result, novel anti-tubercular interventions are urgently required, with the peptidoglycan component of the M. tuberculosis cell wall emerging as an attractive drug target. Peptidoglycan M23 endopeptidases can function as active cell wall hydrolases or degenerate activators of hydrolases in a variety of bacteria, contributing to important processes such as bacterial growth, division and virulence. Herein, we investigate the function of the Rv0950-encoded putative M23 endopeptidase in M. tuberculosis. In silico analysis revealed that this protein is conserved in mycobacteria, with a zinc-binding catalytic site predictive of hydrolytic activity. Transcript analysis indicated that expression of Rv0950c was elevated during lag and log phases of growth and reduced in stationary phase. Deletion of Rv0950c yielded no defects in growth, colony morphology, antibiotic susceptibility or intracellular survival but caused a reduction in cell length. Staining with a monopeptide-derived fluorescent D-amino acid, which spatially reports on sites of active PG biosynthesis or repair, revealed an overall reduction in uptake of the probe in Delta Rv0950c. When stained with a dipeptide probe in the presence of cell wall damaging agents, the Delta Rv0950c mutant displayed reduced sidewall labelling. As bacterial peptidoglycan metabolism is important for survival and pathogenesis, the role of Rv0950c and other putative M23 endopeptidases in M. tuberculosis should be explored further.	[Papadopoulos, Andrea Olga; Ealand, Christopher; Gordhan, Bhavna Gowan; Kana, Bavesh Davandra] Univ Witwatersrand, Fac Hlth Sci, DSI NRF Ctr Excellence Biomed TB Res, Sch Pathol,Natl Hlth Lab Serv, Johannesburg, South Africa; [VanNieuwenhze, Michael] Indiana Univ, Dept Chem, Bloomington, IN USA	National Health Laboratory Service; University of Witwatersrand; Indiana University System; Indiana University Bloomington	Kana, BD (corresponding author), Univ Witwatersrand, Fac Hlth Sci, DSI NRF Ctr Excellence Biomed TB Res, Sch Pathol,Natl Hlth Lab Serv, Johannesburg, South Africa.	bavesh.kana@nhls.ac.za	Ealand, Christopher/GLU-0826-2022; Kana, Bavesh/HCH-3258-2022	Kana, Bavesh/0000-0001-9713-3480	Howard Hughes Medical Institute [HHMI000]; South African National Research Foundation; Department of Science and Innovation [DCOE015]; Department of Health; South African Medical Research Council; Medical Research Endowment grant from the Wits University Faculty of Health Sciences Research Office; National Institutes of Health [R35 GM136365]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); South African National Research Foundation(National Research Foundation - South Africa); Department of Science and Innovation; Department of Health; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Endowment grant from the Wits University Faculty of Health Sciences Research Office; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	BDK was supported by grants from the Howard Hughes Medical Institute (International Early Career Scientist Award, HHMI000, salary support and running expenses), The South African National Research Foundation and Department of Science and Innovation (DCOE015, salary support and running expenses) and the South African Medical Research Council with funds from the Department of Health. AOP was supported by a National Health Scholars Grant from the South African Medical Research Council with funds from the Department of Health, and a Medical Research Endowment grant from the Wits University Faculty of Health Sciences Research Office. MV was supported by a grant from the National Institutes of Health: The grant number is: R35 GM136365.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; An DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164243; Bansal A, 2015, MICROBIOL-SGM, V161, P1081, DOI 10.1099/mic.0.000074; Baranowski C, 2018, ELIFE, V7, DOI 10.7554/eLife.37516; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bhamidi S, 2011, J BIOL CHEM, V286, P23168, DOI 10.1074/jbc.M110.210534; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Boutte CC, 2016, ELIFE, V5, DOI 10.7554/eLife.14590; Chowdhury C, 2012, FEMS MICROBIOL LETT, V337, P73, DOI 10.1111/1574-6968.12009; Dorr T, 2013, MOL MICROBIOL, V89, P949, DOI 10.1111/mmi.12323; Ealand C, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00687-18, 10.1128/aem.00687-18]; Ealand CS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41001-x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ercoli G, 2015, MBIO, V6, DOI 10.1128/mBio.02575-14; Garcia-Heredia A, 2018, ELIFE, V7, DOI 10.7554/eLife.37243; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Gupta KR, 2016, J BACTERIOL, V198, P1414, DOI 10.1128/JB.00126-16; Healy C, 2020, MBIO, V11, DOI 10.1128/mBio.03315-19; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hugonnet JE, 2016, ELIFE, V5, DOI 10.7554/eLife.19469; Hugonnet JE, 2014, ANTIMICROB AGENTS CH, V58, P1749, DOI 10.1128/AAC.02329-13; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kana BD, 2010, J ANTIMICROB CHEMOTH, V65, P1583, DOI 10.1093/jac/dkq199; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kumar A, 2012, RES MICROBIOL, V163, P254, DOI 10.1016/j.resmic.2012.01.006; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2009, MOL MICROBIOL, V74, P650, DOI 10.1111/j.1365-2958.2009.06887.x; Lebar MD, 2014, J AM CHEM SOC, V136, P10874, DOI 10.1021/ja505668f; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Machowski EE, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-75; Mahapatra S, 2013, APPL ENVIRON MICROB, V79, P768, DOI 10.1128/AEM.02263-12; Miao JT, 2020, MICROB PATHOGENESIS, V140, DOI 10.1016/j.micpath.2019.103939; Minasov G., 2018, 1 93 ANGSTROM RESOLU; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; More N, 2019, MBIO, V10, DOI 10.1128/mBio.02729-18; Murphy SG, 2019, MBIO, V10, DOI 10.1128/mBio.02620-18; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nelson DE, 2001, J BACTERIOL, V183, P3055, DOI 10.1128/JB.183.10.3055-3064.2001; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Pandey SD, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00760-17; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Peters NT, 2011, J BACTERIOL, V193, P4973, DOI 10.1128/JB.00316-11; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Priyadarshini R, 2007, J BACTERIOL, V189, P5334, DOI 10.1128/JB.00415-07; Ramijan K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07560-9; Rocaboy M, 2013, MOL MICROBIOL, V90, P267, DOI 10.1111/mmi.12361; Sarkar S, 2016, ANGEW CHEM INT EDIT, V55, P8401, DOI 10.1002/anie.201603441; Senzani S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01184-7; Shaku MT, 2018, ELIFE, V7, DOI 10.7554/eLife.42033; Shin JH, 2020, P NATL ACAD SCI USA, V117, P11692, DOI 10.1073/pnas.2001661117; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Stohl EA, 2013, MBIO, V4, DOI 10.1128/mBio.00399-13; Stohl EA, 2012, J BIOL CHEM, V287, P11222, DOI 10.1074/jbc.M111.338830; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Turapov O, 2018, CELL REP, V25, P57, DOI 10.1016/j.celrep.2018.09.004; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Velayati AA, 2016, INT J MYCOBACT, V5, P66, DOI 10.1016/j.ijmyco.2015.12.001; Vijay S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02296; Vissa V. D., 2001, Genome Biology, V2, P1023, DOI 10.1186/gb-2001-2-8-reviews1023; Viswanathan G, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw294; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; World Health Organization, 2021, 10 THREATS GLOB HLTH	73	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259181	10.1371/journal.pone.0259181	http://dx.doi.org/10.1371/journal.pone.0259181			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784363	Green Published, gold			2022-12-26	WOS:000755277300003
J	Gholamalizadeh, T; Darkner, S; Sondergaard, PL; Erleben, K				Gholamalizadeh, Torkan; Darkner, Sune; Sondergaard, Peter Lempel; Erleben, Kenny			A multi-patient analysis of the center of rotation trajectories using finite element models of the human mandible	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT; TOOTH MOVEMENT; RESISTANCE; SIMULATION; STRESS; FORCE; REGISTRATION; MECHANICS	Studying different types of tooth movements can help us to better understand the force systems used for tooth position correction in orthodontic treatments. This study considers a more realistic force system in tooth movement modeling across different patients and investigates the effect of the couple force direction on the position of the center of rotation (CRot). The finite-element (FE) models of human mandibles from three patients are used to investigate the position of the CRots for different patients' teeth in 3D space. The CRot is considered a single point in a 3D coordinate system and is obtained by choosing the closest point on the axis of rotation to the center of resistance (CRes). A force system, consisting of a constant load and a couple (pair of forces), is applied to each tooth, and the corresponding CRot trajectories are examined across different patients. To perform a consistent inter-patient analysis, different patients' teeth are registered to the corresponding reference teeth using an affine transformation. The selected directions and applied points of force on the reference teeth are then transformed into the registered teeth domains. The effect of the direction of the couple on the location of the CRot is also studied by rotating the couples about the three principal axes of a patient's premolar. Our results indicate that similar patterns can be obtained for the CRot positions of different patients and teeth if the same load conditions are used. Moreover, equally rotating the direction of the couple about the three principal axes results in different patterns for the CRot positions, especially in labiolingual direction. The CRot trajectories follow similar patterns in the corresponding teeth, but any changes in the direction of the force and couple cause misalignment of the CRot trajectories, seen as rotations about the long axis of the tooth.	[Gholamalizadeh, Torkan; Darkner, Sune; Erleben, Kenny] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Gholamalizadeh, Torkan; Sondergaard, Peter Lempel] 3Shape AS, Copenhagen, Denmark	University of Copenhagen	Gholamalizadeh, T (corresponding author), Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark.; Gholamalizadeh, T (corresponding author), 3Shape AS, Copenhagen, Denmark.	torkan@di.ku.dk	Erleben, Kenny/AAZ-6556-2020	Erleben, Kenny/0000-0001-6808-4747; Sondergaard, Peter Lempel/0000-0002-6464-3086; Gholamalizadeh, Torkan/0000-0001-8060-2471	European Union [764644]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 764644 awarded to TG (https://cordis.europa.eu/project/id/ 764644). This paper only contains the author's views and the Research Executive Agency and the Commission are not responsible for any use that may be made of the information it contains. 3Shape A/S also provided financial support in the form of salaries for authors TG and PS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker TJ, 1989, 7 INT C FIN EL METH, P1018; Barone S, 2017, LECT N MECH ENG, P436, DOI 10.1007/978-3-319-45781-9_44; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Burstone C, 1964, VISTAS ORTHDONTICS, P197; Cattaneo PM, 2008, AM J ORTHOD DENTOFAC, V133, P681, DOI 10.1016/j.ajodo.2006.05.038; Cattaneo PM, 2005, J DENT RES, V84, P428, DOI 10.1177/154405910508400506; CAVENDISH JC, 1985, INT J NUMER METH ENG, V21, P329; Cervino G, 2020, MINERVA STOMATOL, V69, P55, DOI 10.23736/S0026-4970.19.04263-8; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Dorow C, 2003, J MECH MED BIOL, V3, P79, DOI 10.1142/S0219519403000661; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fill TS, 2012, J BIOMECH, V45, P9, DOI 10.1016/j.jbiomech.2011.09.020; Freitag LA, 1997, INT J NUMER METH ENG, V40, P3979, DOI 10.1002/(SICI)1097-0207(19971115)40:21<3979::AID-NME251>3.0.CO;2-9; Gholamalizadeh T, 2020, ARXIV PREPRINT ARXIV; Hohmann A, 2011, AM J ORTHOD DENTOFAC, V139, P775, DOI 10.1016/j.ajodo.2009.11.014; Kawarizadeh A, 2004, EUR J ORAL SCI, V112, P140, DOI 10.1111/j.1600-0722.2004.00116.x; Keilig L, 2016, ANN ANAT, V206, P80, DOI 10.1016/j.aanat.2015.08.004; Komatsu Koichiro, 2010, J Dent Biomech, V2010, DOI 10.4061/2010/502318; Lavorgna L, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245139; Li YN, 2018, KAOHSIUNG J MED SCI, V34, P207, DOI 10.1016/j.kjms.2018.01.007; Liao ZP, 2016, ARCH ORAL BIOL, V66, P98, DOI 10.1016/j.archoralbio.2016.02.012; LIU A, 1994, BIT, V34, P268, DOI 10.1007/BF01955874; Maas S. A, 2018, FEBIO 2 8 USER MANUA; Maas SA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005694; Melsen B., 2007, SEMIN ORTHOD, P220; Meyer BN, 2010, AM J ORTHOD DENTOFAC, V137, P354, DOI 10.1016/j.ajodo.2008.03.029; Misztal MK, 2014, IEEE T VIS COMPUT GR, V20, P4, DOI 10.1109/TVCG.2013.97; mudzki J., 2008, J ACHIEV MAT MANUF E, V27, P71; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Natali AN, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2900415; Nyashin Y, 2016, COMPUT METHOD BIOMEC, V19, P229, DOI 10.1080/10255842.2015.1007961; Oh MB, 2019, AM J ORTHOD DENTOFAC, V156, P365, DOI 10.1016/j.ajodo.2018.10.017; Ortun-Terrazas J, 2018, J MECH BEHAV BIOMED, V79, P135, DOI 10.1016/j.jmbbm.2017.12.022; Provatidis CG, 2001, INT J ENG SCI, V39, P1361, DOI 10.1016/S0020-7225(00)00098-7; Qian LH, 2009, DENT MATER, V25, P1285, DOI 10.1016/j.dental.2009.03.014; Roda-Casanova V, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11104329; Sambataro S, 2018, J CRANIOFAC SURG, V29, P1366, DOI 10.1097/SCS.0000000000004459; Sanctuary CS, 2005, J APPL PHYSIOL, V99, P2369, DOI 10.1152/japplphysiol.00486.2005; Savignano R, 2019, J HEALTHC ENG, V2019, DOI 10.1155/2019/9687127; Savignano R, 2020, ANGLE ORTHOD, V90, P811, DOI 10.2319/120919-781.1; Savignano R, 2016, AM J ORTHOD DENTOFAC, V149, P838, DOI 10.1016/j.ajodo.2015.11.025; Schmidt F, 2016, COMPUT METHOD BIOMEC, V19, P1673, DOI 10.1080/10255842.2016.1177822; Schmidt R, 2010, ACM SIGGRAPH 2010 TA, P6, DOI [10.1145/1837026.1837034, DOI 10.1145/1837026.1837034]; Schneider J, 2002, AM J ORTHOD DENTOFAC, V121, P257, DOI 10.1067/mod.2002.121007; Seo JH, 2021, MATERIALS, V14, DOI 10.3390/ma14020324; Shewchuk J., 2002, WHAT IS GOOD LINEAR; Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697; Sia S, 2007, ANGLE ORTHOD, V77, P999, DOI 10.2319/112206-478; Sia S, 2009, AM J ORTHOD DENTOFAC, V135, P36, DOI 10.1016/j.ajodo.2007.01.034; SMITH RJ, 1984, AM J ORTHOD DENTOFAC, V85, P294, DOI 10.1016/0002-9416(84)90187-8; Uhlir R, 2017, ANGLE ORTHOD, V87, P183, DOI 10.2319/092615-651.1; Van Schepdael A, 2013, MED ENG PHYS, V35, P403, DOI 10.1016/j.medengphy.2012.09.008; Viecilli RF, 2013, AM J ORTHOD DENTOFAC, V143, P163, DOI 10.1016/j.ajodo.2012.09.010; Yoshida N, 2001, MED ENG PHYS, V23, P567, DOI 10.1016/S1350-4533(01)00073-X; Yoshida N, 2001, AM J ORTHOD DENTOFAC, V120, P190, DOI 10.1067/mod.2001.115036; Ziegler A, 2005, EUR J ORTHODONT, V27, P333, DOI 10.1093/ejo/cji020	56	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259794	10.1371/journal.pone.0259794	http://dx.doi.org/10.1371/journal.pone.0259794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780529	Green Published, Green Submitted, gold			2022-12-26	WOS:000755305800051
J	Yang, HY; Tian, CP; Ji, SJ; Ni, FZ; Fan, XG; Yang, YQ; Sun, CC; Gong, HS; Zhang, AD				Yang, Haiying; Tian, Changping; Ji, Shujun; Ni, Fengzhu; Fan, Xinguang; Yang, Yanqing; Sun, Chanchan; Gong, Hansheng; Zhang, Aidi			Integrative analyses of metabolome and transcriptome reveals metabolomic variations and candidate genes involved in sweet cherry (Prunus avium L.) fruit quality during development and ripening	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHESIS; EXPRESSION; STRAWBERRY; HEALTH; SUGAR; SOUR; ACCUMULATION; TRANSPORTERS; DIVERSITY	Sweet cherry (Prunus avium L.), one of the most appreciated and most important commercial temperate fruits, has high sensory quality and nutritional value. Investigating its metabolic variations provides valuable information on the formation of fruit quality. In this study, widely targeted LC-MS/MS based metabolomics was used to identify and quantify metabolic changes during 'Black Pearl' sweet cherry development and ripening. A total of 263 significant differentially expressed metabolites (DEMs) were detected during the four fruit-development stages. Significant differences were observed in the composition and content of compounds in the four stages of cherry development, especially sugars, organic acids, and flavonoids. Moreover, transcriptome analysis provided a molecular basis for metabolic variations during fruit development. A total of 6724 significant differentially expressed genes (DEGs) were identified. Further correlation analysis of major DEMs and DEGs showed that 19 key DEGs were involved in sugar metabolism, 23 key DEGs in organic acid metabolism, and 13 key DEGs in flavonoid metabolism. The upregulated genes involved in the flavonoid pathway probably play an important role in regulating the rapid increase of anthocyanin content during fruit development. These comprehensive analysis data provide a better understanding to improve fruit quality traits based on molecular and metabolic levels.	[Yang, Haiying; Ji, Shujun; Ni, Fengzhu; Fan, Xinguang; Yang, Yanqing; Gong, Hansheng; Zhang, Aidi] Ludong Univ, Sch Food Engn, Yantai 264025, Shandong, Peoples R China; [Tian, Changping] Yantai Agr Sci & Technol Inst, Cherry Res Dept, 26 West Gangcheng St, Yantai 265500, Peoples R China; [Sun, Chanchan] Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China	Ludong University; Tianjin University Science & Technology	Zhang, AD (corresponding author), Ludong Univ, Sch Food Engn, Yantai 264025, Shandong, Peoples R China.	aidi2012@126.com			National Natural Science Foundation of China [31901737]; Special Fund for Innovation Teams of Fruit Trees in Agricultural Technology System of Shandong Province, China [SDAIT-0602]; Natural Science Foundation of Tianjin City,China [18JCQNJC84200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Innovation Teams of Fruit Trees in Agricultural Technology System of Shandong Province, China; Natural Science Foundation of Tianjin City,China(Natural Science Foundation of Tianjin)	This research was supported by the National Natural Science Foundation of China (31901737), the Special Fund for Innovation Teams of Fruit Trees in Agricultural Technology System of Shandong Province, China (SDAIT-0602), and Natural Science Foundation of Tianjin City,China (18JCQNJC84200). The funders had no role in the material creation, designing the study, analysis data and in writing the manuscript.	Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Arora I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184567; Aslam MM, 2019, SCI HORTIC-AMSTERDAM, V257, DOI 10.1016/j.scienta.2019.108633; Ballistreri G, 2013, FOOD CHEM, V140, P630, DOI 10.1016/j.foodchem.2012.11.024; Ban Y, 2009, PLANTA, V230, P871, DOI 10.1007/s00425-009-0993-4; BEAVER JA, 1995, THEOR APPL GENET, V90, P847, DOI 10.1007/BF00222021; Blando F, 2019, TRENDS FOOD SCI TECH, V86, P517, DOI 10.1016/j.tifs.2019.02.052; Breia R, 2021, PLANT PHYSIOL, V186, P836, DOI 10.1093/plphys/kiab127; Cao JP, 2015, FOOD CHEM, V173, P855, DOI 10.1016/j.foodchem.2014.10.094; Edwards CH, 2016, TRENDS FOOD SCI TECH, V56, P158, DOI 10.1016/j.tifs.2016.07.008; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Faienza MF, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103945; Ferraro G, 2015, J EXP BOT, V66, P3381, DOI 10.1093/jxb/erv150; Gabay G, 2019, J EXP BOT, V70, P1017, DOI 10.1093/jxb/ery405; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; GOLDSBROUGH A, 1994, PLANT PHYSIOL, V105, P491, DOI 10.1104/pp.105.2.491; Goulas V, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00959; Granot D, 2007, FUNCT PLANT BIOL, V34, P564, DOI 10.1071/FP06207; Guo WJ, 2014, PLANT PHYSIOL, V164, P777, DOI 10.1104/pp.113.232751; Hu PP, 2018, PEERJ, V6, DOI 10.7717/peerj.4976; Huang X, 2021, FOOD SCI NUTR, V9, P1780, DOI 10.1002/fsn3.2166; Jeena GS, 2019, PLANT MOL BIOL, V100, P351, DOI 10.1007/s11103-019-00872-4; Jiang CC, 2019, J SCI FOOD AGR, V99, P1010, DOI 10.1002/jsfa.9265; Jin WM, 2016, PLANT BIOTECHNOL J, V14, P2120, DOI 10.1111/pbi.12568; Karagiannis E, 2021, FOOD CHEM, V342, DOI 10.1016/j.foodchem.2020.128315; Klemens PAW, 2013, PLANT PHYSIOL, V163, P1338, DOI 10.1104/pp.113.224972; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Kschonsek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010020; Kumar V, 2011, INT J FOOD PROP, V14, P1142, DOI 10.1080/10942911003592761; Li MJ, 2016, J EXP BOT, V67, P5145, DOI 10.1093/jxb/erw277; Li MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033055; Li YK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051471; Li YK, 2018, GENE, V648, P31, DOI 10.1016/j.gene.2018.01.022; Liu Y, 2013, J PLANT GROWTH REGUL, V32, P901, DOI 10.1007/s00344-013-9355-3; Mei X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227225; Michailidis M, 2020, PLANT MOL BIOL, V104, P597, DOI 10.1007/s11103-020-01063-2; Montero TM, 1996, SCI HORTIC-AMSTERDAM, V65, P239, DOI 10.1016/0304-4238(96)00892-8; Nawirska-Olszanska A, 2017, FOOD CHEM, V228, P136, DOI 10.1016/j.foodchem.2017.01.154; O'Leary B, 2011, BIOCHEM J, V436, P15, DOI 10.1042/BJ20110078; Premathilake AT, 2020, PLANTA, V252, DOI 10.1007/s00425-020-03473-4; Sarker U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91157-8; Sarker U, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.587257; Sarker U, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02780-y; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71714-3; Sarker U, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02700-0; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66376-0; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71727-y; Sarker U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52033-8; Sarker U, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1484-1; Sarker U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30897-6; Shen XJ, 2014, PLANT CELL PHYSIOL, V55, P862, DOI 10.1093/pcp/pcu013; Shiraishi M, 2010, EUPHYTICA, V174, P1, DOI 10.1007/s10681-009-0084-4; Starkevic P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126991; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Umer MJ, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00416-8; Usenik V, 2008, FOOD CHEM, V107, P185, DOI 10.1016/j.foodchem.2007.08.004; Walker RP, 2011, J EXP BOT, V62, P5357, DOI 10.1093/jxb/err189; Wang Y, 2018, J AGR FOOD CHEM, V66, P12627, DOI 10.1021/acs.jafc.8b04284; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Xiao L., 2021, MOL SCI, V2, DOI [10.1016/j.fochms.2021.100016, DOI 10.1016/J.FOCHMS.2021.100016]; Xu JD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134797; Yang HY, 2021, HORTICULTURAE, V7, DOI 10.3390/horticulturae7060123; Yang YN, 2015, PLANT CELL REP, V34, P189, DOI 10.1007/s00299-014-1698-0; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhang X, 2020, MOLECULES, V25, DOI 10.3390/molecules25081968; Zhen QL, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0024-3; Zou SC, 2020, FOOD CHEM, V323, DOI 10.1016/j.foodchem.2020.126822	67	3	3	16	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260004	10.1371/journal.pone.0260004	http://dx.doi.org/10.1371/journal.pone.0260004			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780562	Green Published, gold			2022-12-26	WOS:000755305800083
J	Isabirye, N; Kisa, R; Santos, N; Shah, S; Mulowooza, J; Walker, D; Waiswa, P				Isabirye, Nathan; Kisa, Rose; Santos, Nicole; Shah, Sachita; Mulowooza, Jude; Walker, Dilys; Waiswa, Peter			Ultrasound at labour triage in eastern Uganda: A mixed methods study of patient perceptions of care and providers' implementation experience	PLOS ONE			English	Article							SAFE CHILDBIRTH CHECKLIST; MIDWIVES; PROGRAM	In settings where antenatal ultrasound is not offered routinely, ultrasound use when a woman first presents to the maternity ward for labour (i.e., triage) may be beneficial. This study investigated patients' perceptions of care and providers' experience with ultrasound implementation during labour triage at a district referral hospital (DH) and three primary health centers (HC) in eastern Uganda. This was a mixed methods study comprising questionnaires administered to women and key informant interviews among midwives pre- and post-ultrasound introduction. Bivariate analyses were conducted using chi-square tests. Qualitative themes were categorized as (1) workflow integration; (2) impact on clinical processes; (3) patient response to ultrasound; and (4) implementation barriers. A total of 731 and 815 women completed questionnaires from the HCs and DH, respectively. At the HC-level, triage quality of care, satisfaction and recommendation ratings increased with implementation of ultrasound. In contrast, satisfaction and recommendation ratings did not differ upon ultrasound introduction at the DH, whereas perceived triage quality of care increased. Most participants noted a perceived improvement in midwives' experience and knowledge upon introduction of ultrasound. Women who underwent a scan also reported diverse feelings, such as fear or worry about their delivery, fear of harm due to the ultrasound, or relief after knowing the baby's condition. For the midwives' perspective (n = 14), respondents noted that ultrasound led to more accurate diagnoses (e.g., fetal position, heart rate, multiple gestation) and improved decision-making. However, they noted health system barriers to ultrasound implementation, such as increased workload, not enough ultrasound-trained providers, and irregular electricity. While triage ultrasound in this context was seen as beneficial to mothers and useful in providers' clinical assessments, further investigation around provider-patient communication, system-level challenges, and fears or misconceptions among women are needed.	[Isabirye, Nathan; Kisa, Rose; Mulowooza, Jude; Waiswa, Peter] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Santos, Nicole; Walker, Dilys] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Shah, Sachita] Univ Washington, Sch Med, Dept Emergency Med, Seattle, WA USA; [Walker, Dilys] Univ Calif San Francisco, Dept Obstet Gynaecol & Reprod Sci, San Francisco, CA 94143 USA	Makerere University; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco	Isabirye, N (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.	isabiryenathan5@gmail.com			Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	DW as principal investigator for the PTBi study (parent study for this one) received funding for the study from the Bill and Melinda Gates Foundation. https://www.gatesfoundation.org/.The sponsors had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Ahman A, 2018, SEX REPROD HEALTHC, V15, P28, DOI 10.1016/j.srhc.2017.11.007; Ahman A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31062; Aliyu LD, 2016, J PERINAT MED, V44, P119, DOI 10.1515/jpm-2015-0224; [Anonymous], 2018, UGANDA DEMOGRAPHIC H; Bratt EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0610-4; Floyd L, 2018, MIDWIFERY, V61, P45, DOI 10.1016/j.midw.2018.02.003; Forshaw J, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1098-2; Goldenberg RL, 2018, BJOG-INT J OBSTET GY, V125, P1591, DOI 10.1111/1471-0528.15287; Gonzaga MA, 2009, PAN AFR MED J, V3; Groen RS, 2011, TROP MED INT HEALTH, V16, P1525, DOI 10.1111/j.1365-3156.2011.02868.x; Hall EA, 2021, ULTRASOUND J, V13, DOI 10.1186/s13089-021-00220-y; Holmlund S, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1350451; Kaasen A, 2010, BJOG-INT J OBSTET GY, V117, P1127, DOI 10.1111/j.1471-0528.2010.02622.x; Katutsi V., 2020, OPEN J ENERG EFFI, V09, P111, DOI [10.4236/ojee.2020.93008, DOI 10.4236/OJEE.2020.93008]; Kigenyi O, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-162; Kim ET, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0571-y; Kimberly HH, 2010, ULTRASOUND MED BIOL, V36, P1267, DOI 10.1016/j.ultrasmedbio.2010.05.017; Kinnevey Christina, 2016, Int J MCH AIDS, V5, P46; Molina RL, 2019, INT J GYNECOL OBSTET, V145, P101, DOI 10.1002/ijgo.12771; Mulowooza J, 2021, MIDWIFERY, V96, DOI 10.1016/j.midw.2021.102949; Namazzi G, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.24271; Oluoch DA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0565-5; Santos N, 2021, INT J GYNECOL OBSTET, V153, P130, DOI 10.1002/ijgo.13420; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Shah S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235269; Shah S, 2015, CRIT ULTRASOUND J, V7, DOI 10.1186/s13089-015-0028-2; Shah SP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-4; Sippel S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-72; Stanton K, 2013, WORLD J PREV MED, V1, P22; Steinmetz JP, 1999, AM J TROP MED HYG, V60, P119, DOI 10.4269/ajtmh.1999.60.119; Stolz LA, 2015, TROP MED INT HEALTH, V20, P1067, DOI 10.1111/tmi.12511; Swanson JO, 2014, J PERINATOL, V34, P508, DOI 10.1038/jp.2014.54; Tautz S, 2000, SOC SCI MED, V50, P689, DOI 10.1016/S0277-9536(99)00321-4; World Health Organization, 2018, WHO REC ANT CAR POS	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259770	10.1371/journal.pone.0259770	http://dx.doi.org/10.1371/journal.pone.0259770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767612	Green Published, gold			2022-12-26	WOS:000755249300043
J	Wu, D; Tan, H; Su, WJ; Cheng, DM; Wang, GW; Wang, J; Ma, DA; Dong, GM; Sun, PQ				Wu, Dan; Tan, Hua; Su, Weijun; Cheng, Dongmei; Wang, Guanwen; Wang, Juan; Ma, Ding A.; Dong, George M.; Sun, Peiqing			MZF1 mediates oncogene-induced senescence by promoting the transcription of p16(INK4A)	ONCOGENE			English	Article							CELLULAR SENESCENCE; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; RAS; CHROMATIN; CHD7; P53; OVEREXPRESSION; RETINOBLASTOMA	Oncogene induced senescence is a tumor suppressing defense mechanism, in which the cell cycle-dependent protein kinase (CDK) inhibitor p16(INK4A) (encoded by the CDKN2A gene) plays a key role. We previously reported that a transcriptional co-activator chromodomain helicase DNA binding protein 7 (CHD7) mediates oncogenic ras-induced senescence by inducing transcription of the p16(INK4A) gene. In the current study, we identified myeloid zinc finger 1 (MZF1) as the transcriptional factor that recruits CHD7 to the p16(INK4A) promoter, where it mediates oncogenic ras-induced p16(INK4A) transcription and senescence through CHD7, in primary human cells from multiple origins. Moreover, the expression of MZF1 is induced by oncogenic ras in senescent cells through the c-Jun and Ets1 transcriptional factors upon their activation by the Ras-Raf-1-MEK-ERK signaling pathway. In non-small cell lung cancer (NSCLC) and pancreatic adenocarcinoma (PAAD) where activating ras mutations occur frequently, reduced MZF1 expression is observed in tumors, as compared to corresponding normal tissues, and correlates with poor patient survival. Analysis of single cell RNA-sequencing data from PAAD patients revealed that among the tumor cells with normal RB expression levels, those with reduced levels of MZF1 are more likely to express lower p16(INK4A) levels. These findings have identified novel signaling components in the pathway that mediates induction of the p16(INK4A) tumor suppressor and the senescence response, and suggested that MZF1 is a potential tumor suppressor in at least some cancer types, the loss of which contributes to the inactivation of the p16(INK4A)/RB pathway and disruption of senescence in tumor cells with intact RB.	[Wu, Dan; Cheng, Dongmei; Wang, Guanwen; Wang, Juan; Ma, Ding A.; Dong, George M.; Sun, Peiqing] Wake Forest Baptist Med Ctr, Comprehens Canc Ctr, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Tan, Hua] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Su, Weijun; Wang, Guanwen; Wang, Juan] Nankai Univ Sch Med, Tianjin, Peoples R China	Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Health Science Center Houston	Sun, PQ (corresponding author), Wake Forest Baptist Med Ctr, Comprehens Canc Ctr, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	psun@wakehealth.edu		Sun, Peiqing/0000-0003-2255-6504	NIH/NCI [CA131231, CA172115, P30CA012197]; Anderson Oncology Research Professorship	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anderson Oncology Research Professorship	We thank the Cell Engineering and Cellular Imaging Shared Resources of WFBCCC. This study was supported by NIH/NCI grants CA131231, CA172115 and P30CA012197 (PS). PS is supported by the Anderson Oncology Research Professorship.	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Bastide K, 2009, LUNG CANCER, V63, P348, DOI 10.1016/j.lungcan.2008.06.007; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brix DM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010223; Brix DM, 2019, ONCOGENE, V38, P3170, DOI 10.1038/s41388-018-0653-x; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen Y, 2015, ONCOGENE, V34, P3839, DOI 10.1038/onc.2014.310; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Deng Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/868131; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; Eguchi T, 2015, J CELL BIOCHEM, V116, P2146, DOI 10.1002/jcb.25203; Eguchi T, 2019, CANCERS, V11, DOI 10.3390/cancers11060792; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Feng WJ, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00309; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; Gorgoulis VG, 1998, AM J PATHOL, V153, P1749, DOI 10.1016/S0002-9440(10)65690-8; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hellmich C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00230; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Iwasaki O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13604-5; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanojia D, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax2879; Kotake Y, 2015, ANTICANCER RES, V35, P4397; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Kwong J, 2013, MOL CELL BIOL, V33, P3780, DOI 10.1128/MCB.00784-13; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Lee JH, 2017, INT J ONCOL, V50, P272, DOI 10.3892/ijo.2016.3793; Lee S, 2019, BMB REP, V52, P35, DOI 10.5483/BMBRep.2019.52.1.294; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Li GQ, 2017, CELL PHYSIOL BIOCHEM, V44, P1242, DOI 10.1159/000485454; Li JJ, 2021, CANCER RES, V81, P114, DOI 10.1158/0008-5472.CAN-20-2270; Li WB, 2015, MOL CELL, V59, P188, DOI 10.1016/j.molcel.2015.06.002; Liu XP, 2015, ONCOTARGET, V6, P7930, DOI 10.18632/oncotarget.3181; Liu XL, 2018, ACTA PHARMACOL SIN, V39, P1553, DOI 10.1038/aps.2017.198; Murai K, 1997, GENES CELLS, V2, P581, DOI 10.1046/j.1365-2443.1997.1430341.x; Ohtani N, 2012, EXP DERMATOL, V21, P1, DOI 10.1111/j.1600-0625.2012.01493.x; Ouyang XS, 2002, CARCINOGENESIS, V23, P721, DOI 10.1093/carcin/23.5.721; Peng JY, 2019, CELL RES, V29, P725, DOI 10.1038/s41422-019-0195-y; Peterson MJ, 2000, GENE, V254, P105, DOI 10.1016/S0378-1119(00)00281-X; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; Roman M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0789-x; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Scaglioni PP, 2012, EMBO MOL MED, V4, P594, DOI 10.1002/emmm.201200233; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Schosserer M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00278; Schwartz B, 1998, MOL CELL BIOCHEM, V188, P21, DOI 10.1023/A:1006831330340; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Su WJ, 2018, ONCOGENE, V37, P5618, DOI 10.1038/s41388-018-0358-1; Sun LY, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040211; Tsai LH, 2015, ONCOGENE, V34, P1641, DOI 10.1038/onc.2014.118; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Tvingsholm SA, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0014-6; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; Vishwamitra D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0324-2; Waters AM, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031435; Yokoyama Y, 2015, CELL CYCLE, V14, P2160, DOI 10.1080/15384101.2015.1049778; Zhang SL, 2019, J BIOL CHEM, V294, P16756, DOI 10.1074/jbc.RA119.009779; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V453, P172, DOI 10.1016/j.bbrc.2014.09.092; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	71	2	2	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					414	426		10.1038/s41388-021-02110-y	http://dx.doi.org/10.1038/s41388-021-02110-y		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34773072	Green Accepted			2022-12-26	WOS:000717915200001
J	Asafo-Adjei, E; Boateng, E; Isshaq, Z; Idun, AAA; Owusu, P; Adam, AM				Asafo-Adjei, Emmanuel; Boateng, Ebenezer; Isshaq, Zangina; Idun, Anthony Adu-Asare; Owusu, Peterson Jr Jr; Adam, Anokye M.			Financial sector and economic growth amid external uncertainty shocks: Insights into emerging economies	PLOS ONE			English	Article							STOCK-MARKET DEVELOPMENT; EMPIRICAL-EVIDENCE; SOUTH-AFRICA; CAUSALITY; BANKS; COUNTRIES; CHINA; NEXUS	The study aims to shed new lights on the lead-lag relationships between the financial sector (RFSI) and economic growth (GDP) in the midst of global economic policy uncertainty (GEPU) shocks for BRICS economies. Hence, the bivariate, partial, and wavelet multiple correlations techniques are employed. From the bivariate analysis, we document positive bi-directional causality between the RFSI and economic growth over the sample period. The partial wavelet reveals that GEPU shocks distort the significance and directional comovements between the RFSI and GDP. Moreover, the outcome from the wavelet multiple cross correlations (WMCC) indicates that the RFSI is a first mover at most time scales for the BRICS economies. This is followed by GEPU which either leads or lags for most scales, especially for South Africa. The impact of GEPU on RFSI and GDP is worst for South Africa in about four cases in the medium-, and long-terms. This signifies that South Africa's financial markets and economic growth are vulnerable to GEPU. However, the impetus for GEPU to drive the comovements between the financial sector and economic activity was less pronounced in the pre-COVID analysis conducted with the WMCC. The study supports both the supply-leading and demand-following hypotheses. Our findings also underscore the need for policymakers, investors and academics alike to incessantly observe the dynamics between finance and growth across time and periodicity while considering adverse shocks from global economic policy uncertainty in tandem.	[Asafo-Adjei, Emmanuel; Boateng, Ebenezer; Isshaq, Zangina; Idun, Anthony Adu-Asare; Owusu, Peterson Jr Jr; Adam, Anokye M.] Univ Cape Coast, Sch Business, Dept Finance, Cape Coast, Ghana	University of Cape Coast	Asafo-Adjei, E (corresponding author), Univ Cape Coast, Sch Business, Dept Finance, Cape Coast, Ghana.	eaadjei12998@gmail.com	Asafo-Adjei, Emmanuel/AAB-1204-2021; Owusu Junior, Peterson/GPX-9651-2022	Asafo-Adjei, Emmanuel/0000-0002-4449-6285; Owusu Junior, Peterson/0000-0001-6253-5770; Adam, Anokye M./0000-0003-3830-1186; Boateng, Ebenezer/0000-0001-7297-7943				Acemoglu D, 2003, J EUR ECON ASSOC, V1, P630, DOI 10.1162/154247603322391260; Adam A.M., 2020, J OPEN INNOV-TECHNOL, V6, P71, DOI [10.3390/joitmc6030071, DOI 10.3390/JOITMC6030071]; Aghion P, 2018, HANDBOOK OF FINANCE AND DEVELOPMENT, P3; Agyemang OS, 2018, COGENT ECON FINANC, V6, DOI 10.1080/23322039.2018.1488342; Al-Thaqeb SA, 2019, J EC ASYMMETRIES, V20, DOI [10.1016/j.jeca.2019.e00133, DOI 10.1016/J.JECA.2019.E00133, 10.1016/J.JECA.2019.E00133]; Alexiou C, 2018, INT J FINANC ECON, V23, P155, DOI 10.1002/ijfe.1609; Allen F, 1997, J POLIT ECON, V105, P523, DOI 10.1086/262081; Allen F., 2000, COMP FINANCIAL SYSTE; Anser MK, 2021, FINANC INNOV, V7, DOI 10.1186/s40854-021-00226-4; Arize A, 2018, RES INT BUS FINANC, V45, P427, DOI 10.1016/j.ribaf.2017.07.174; Asafo-Adjei E., 2021, MACROECON FINANC EME, DOI [10.1080/17520843.2021.1953864, DOI 10.1080/17520843.2021.1953864]; Asafo-Adjei E, 2021, COMPLEXITY, V2021, DOI 10.1155/2021/4753753; Asafo-Adjei E, 2020, DISCRETE DYN NAT SOC, V2020, DOI 10.1155/2020/8846507; Aslan A, 2018, ECONOMIES, V6, DOI 10.3390/economies6020022; Bagehot Walter, 1873, LOMBARD STREET DESCR, V3rd; Baker SR, 2016, Q J ECON, V131, P1593, DOI 10.1093/qje/qjw024; Balcilar M, 2018, ECON SYST, V42, P637, DOI 10.1016/j.ecosys.2018.08.002; Bauer PT., 1984, PIONEERS DEV 2 SERIE; Beck T, 2013, J FINANC INTERMED, V22, P218, DOI 10.1016/j.jfi.2012.07.001; BENCIVENGA VR, 1993, J ECON DYN CONTROL, V17, P97, DOI 10.1016/0165-1889(93)90066-2; Berger A. N., 2017, IN PRESS, DOI [10.2139/ssrn.3030489, DOI 10.2139/SSRN.3030489]; Bhattarai S, 2020, J MONETARY ECON, V114, P71, DOI 10.1016/j.jmoneco.2019.05.008; Bloomfield DS, 2004, ASTROPHYS J, V617, P623, DOI 10.1086/425300; Boateng E, 2021, RESOUR POLICY, V74, DOI 10.1016/j.resourpol.2021.102389; Bosworth B, 2008, J ECON PERSPECT, V22, P45, DOI 10.1257/jep.22.1.45; Bouchrika A, 2019, EMPIR ECON, P1, DOI 10.1007/s00181-019-01670-z 14; Boyd JH, 1998, ECON THEOR, V12, P519, DOI 10.1007/s001990050234; Carre E, 2018, COMP ECON STUD, V60, P161, DOI 10.1057/s41294-018-0056-6; Chakraborty I., 2008, S ASIA EC J, V9, P109, DOI [10.1177/139156140700900105, DOI 10.1177/139156140700900105]; Chen Y., 2018, STATE CHINAS STATE C, P239; Choong CK., 2005, INVESTMENT MANAGEMEN, V2, P105; Chortareas G, 2015, REV DEV ECON, V19, P163, DOI 10.1111/rode.12132; Chow SC, 2019, PHYSICA A, V513, P536, DOI 10.1016/j.physa.2018.06.060; Cui X, 2021, PAC-BASIN FINANC J, V67, DOI 10.1016/j.pacfin.2021.101533; da Silva MS., 2015, BANCO CENTRAL BRASIL, P399; Phan DHB, 2021, ECON MODEL, V94, P1018, DOI 10.1016/j.econmod.2020.02.042; Fan JJ, 2018, CHINA INT J, V16, P170; Fernandez-Macho J, 2012, PHYSICA A, V391, P1097, DOI 10.1016/j.physa.2011.11.002; Fidrmuc J, 2015, OPEN ECON REV, V26, P479, DOI 10.1007/s11079-015-9352-1; Gencay R., 2001, INTRO WAVELETS OTHER; Goldsmith RW., FINANCIAL STRUCTURE; Goodell JW, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101625; Gouhier TarikC., 2013, SPECTRUM, V24, P2093; Grochowska A., 2014, ECFIN EC BRIEF, V33; Gungor B., 2008, ATAT RK U J EC ADM S, V22, P173; Guo F, 2020, APPL ECON LETT, V27, P1071, DOI 10.1080/13504851.2019.1659926; GURLEY JG, 1967, ECON DEV CULT CHANGE, V15, P257, DOI 10.1086/450226; Gurley JG, 1955, AM ECON REV, V45, P515; Guru Biplab Kumar, 2019, Journal of Economics, Finance and Administrative Science, V24, P113, DOI 10.1108/JEFAS-12-2017-0125; Haldane AG., 2015, COMMUNICATION, V17; Hassan MK, 2011, Q REV ECON FINANC, V51, P88, DOI 10.1016/j.qref.2010.09.001; Horvath J, 2019, ECON MODEL, V76, P31, DOI 10.1016/j.econmod.2018.07.017; Hye QMA, 2011, J RISK FINANC, V12, P98, DOI 10.1108/15265941111112820; Idun AnthonyAdu-Asare., 2021, J DEV AREAS, V55, P23, DOI [10.1353/jda.2021.0051, DOI 10.1353/JDA.2021.0051]; JENSEN MC, 1976, J FINANC ECON, V3, P305, DOI 10.1016/0304-405X(76)90026-X; Joshi S, 2016, FINANCIAL SECTOR DEV; Junior PO, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e08211; KING RG, 1993, J MONETARY ECON, V32, P513, DOI 10.1016/0304-3932(93)90028-E; Kirikkaleli D, 2016, EASTERN EUR ECON, V54, P208, DOI 10.1080/00128775.2016.1168704; Ko JH, 2015, ECON LETT, V134, P118, DOI 10.1016/j.econlet.2015.07.012; Lahmiri S, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22080833; Levine R, 1998, AM ECON REV, V88, P537; Levine R, 2005, HANDB ECON, V22, P865; Levine R, 1997, J ECON LIT, V35, P688; Levine R, 2000, J MONETARY ECON, V46, P31, DOI 10.1016/S0304-3932(00)00017-9; Levine R., 2018, FINANCE GROWTH; Li R, 2020, APPL ECON, V52, P4300, DOI 10.1080/00036846.2020.1734182; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; Luintel KB, 1999, J DEV ECON, V60, P381, DOI 10.1016/S0304-3878(99)00045-0; Menyah K, 2014, ECON MODEL, V37, P386, DOI 10.1016/j.econmod.2013.11.044; Miller M.H., 1998, J APPL CORPORATE FIN, V11, P8, DOI DOI 10.1111/J.1745-6622.1998.TB00498.X; Moyo C., 2018, FINANCIAL DEV EC GRO; Naik PK, 2015, REV ACCOUNT FINANC, V14, P363, DOI 10.1108/RAF-09-2014-0105; Nain MZ, 2014, ECON CHANG RESTRUCT, V47, P299, DOI 10.1007/s10644-014-9151-5; Nyasha S., 2017, S E EUR J ECON BUS, V12; Nyasha S, 2015, CONTEMP ECON, V9, P93, DOI 10.5709/ce.1897-9254.161; Odhiambo N. M, 2004, SAVINGS DEV, VXXVIII, P47; Odhiambo NM, 2014, INT REV APPL ECON, V28, P83, DOI 10.1080/02692171.2013.828681; Ono Shigeki, 2017, Russian Journal of Economics, V3, P321; Ono S, 2012, EUROPE-ASIA STUD, V64, P247, DOI 10.1080/09668136.2012.635484; Orhan A, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11236684; Osei PM, 2021, DISCRETE DYN NAT SOC, V2021, DOI 10.1155/2021/6656176; PATRICK HT, 1966, ECON DEV CULT CHANGE, V14, P174, DOI 10.1086/450153; Rajan RG, 1998, AM ECON REV, V88, P559; Robinson J, 1952, ECON J, V62, P42, DOI 10.2307/2227172; Rua A, 2009, J EMPIR FINANC, V16, P632, DOI 10.1016/j.jempfin.2009.02.002; Satrovic E., 2017, KAPADOKYA AKAD BAK, V1, P1; Schumpeter JA, 1935, REV ECON STATISTICS, V17, P2, DOI 10.2307/1927845; Sehrawat M, 2017, GLOB BUS REV, V18, P911, DOI 10.1177/0972150917692242; Shleifer A., 2013, BREACH TRUST HOSTILE, V2, P33; Siva Kiran Guptha K., 2018, J SOC EC DEV, V20, P308, DOI [10.1007/s40847-018-0071-5, DOI 10.1007/S40847-018-0071-5]; Smith A, 1986, WEALTH NATIONS; Stefani P, 2007, ECON BULL, V3; Stiglitz JE., 1994, Industrial and Corporate Change, V3, P65; Sunde Tafirenyika., 2012, INT J MONETARY EC FI, V5, P64, DOI 10.1504/IJMEF.2012.044467; Swamy V, 2018, INT J FINANC ECON, V23, P55, DOI 10.1002/ijfe.1604; Tadesse T., 2019, J EC FINANCIAL ANAL, V3, P87, DOI DOI 10.1991/JEFA.V3I1.A25; Tamakoshi G, 2016, RES INT BUS FINANC, V36, P288, DOI 10.1016/j.ribaf.2015.09.027; Tang CF, 2020, APPL ECON LETT, V27, P596, DOI 10.1080/13504851.2019.1644422; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tripathy N, 2019, QUANT FINANC ECON, V3, P508, DOI 10.3934/QFE.2019.3.508; Tweneboah G., 2019, ACAD ACCOUNT FINANC, V23, P1; Wu K, 2020, N AM J ECON FINANC, V53, DOI 10.1016/j.najef.2020.101194; Xiao JH, 2019, ENERG ECON, V80, P297, DOI 10.1016/j.eneco.2019.01.016; Xu SH, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042391; Xu YY, 2022, FINANC RES LETT, V45, DOI 10.1016/j.frl.2021.102119; Younsi Moheddine, 2018, EC GROWTH FINANCIAL; Yunita Y., 2018, JURNAL MANAJEMEN DAN, V20, P80	109	21	21	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259303	10.1371/journal.pone.0259303	http://dx.doi.org/10.1371/journal.pone.0259303			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762668	Green Published, gold			2022-12-26	WOS:000755316600019
J	Wami, AA; Hundie, GB; Ambachew, R; Berhe, ZG; Abrha, A; Abebe, W; Abeje, D; Geteneh, A; Mihret, A; Mulu, A				Wami, Ashenafi Alemu; Hundie, Gadissa Bedada; Ambachew, Rozina; Berhe, Zenebe Gebreyohannes; Abrha, Alem; Abebe, Workeabeba; Abeje, Dessalegen; Geteneh, Alene; Mihret, Adane; Mulu, Andargachew			High rate of human enteroviruses among clinically suspected meningitis cases at selected Hospitals in Addis Ababa, Ethiopia	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; VIRAL MENINGITIS; ASEPTIC-MENINGITIS; INFECTIONS; CHILDREN; INFANTS; DIAGNOSIS; ADULTS	Background Because of limited infrastructure and skilled human capital, the etiology of meningitis is rarely identified in developing countries like Ethiopia. This results in unnecessary antibiotics use, economic crisis, hospitalization, and related nosocomial infections. Thus, we aimed to assess the epidemiology of human enteroviruses (HEVs) among clinically suspected meningitis cases in Addis Ababa, Ethiopia. Method A cross-sectional study was conducted from January to August 2020 at selected Hospitals in Addis Ababa, Ethiopia. Reverse transcriptase-polymerase chain reaction (RT-PCR) was conducted on cerebrospinal fluid (CSF) collected from 146 clinically suspected meningitis and bacterial culture-negative patients. SPSS v 21.0 was used for data analysis and bivariate correlation was done for the association between variables of interest. Results HEVs were detected in 39 (26.7%) of the 146 clinically suspected meningitis cases. Most of the HEVs cases 28 (71.9%) were detected in younger-aged infants less than 1 year. The most commonly observed clinical manifestations were vomiting (75.5%) followed by fever (56.8%) and impaired consciousness or irritability (50.7%). The mean length of hospital stay for patients with enteroviral meningitis was 9 days. Many patients with HEVs were recovered with sequelae (46.2%), and HEVs has contributed for one out of the nine meningeal deaths (11.1%). Conclusions HEVs were found to be the commonest cause of morbidity and mortality in all age groups. Many of the patients were mistreated with antibiotics and hospitalized. The detection of HEVs in 26.7% of clinically suspected meningitis cases indicated the need for molecular tests in investigating the etiology of meningitis. Therefore, we suggest the introduction of molecular tests as a routine practice in referral hospitals and the need to further characterize circulating HEVs strains.	[Wami, Ashenafi Alemu; Abeje, Dessalegen; Mihret, Adane; Mulu, Andargachew] Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia; [Hundie, Gadissa Bedada; Ambachew, Rozina; Berhe, Zenebe Gebreyohannes] St Pauls Hosp, Dept Microbiol Immunol & Parasitol, Millennium Med Coll, Addis Ababa, Ethiopia; [Abrha, Alem; Abebe, Workeabeba] Addis Ababa Univ, Sch Med, Addis Ababa, Ethiopia; [Geteneh, Alene] Woldia Univ, Coll Hlth Sci, Dept Med Lab Sci, Woldia, Ethiopia	Addis Ababa University	Wami, AA (corresponding author), Armauer Hansen Res Inst AHRI, Addis Ababa, Ethiopia.	ashenafialemu07@gmail.com	Geteneh, Alene/ABH-1968-2020; Mulu, Andargachew/GMW-4823-2022; Hundie, Gadissa/GPF-9108-2022	Geteneh, Alene/0000-0002-7153-4849; Mulu, Andargachew/0000-0003-2862-0175; Hundie, Gadissa/0000-0002-5627-9675; Kalayu, Alem Abrha/0000-0002-5170-4898				Ai JH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2572-9; Anahita Izadi, 2018, Maedica (Bucur), V13, P213, DOI 10.26574/maedica.2018.13.3.213; Archimbaud C, 2009, J MED VIROL, V81, P42, DOI 10.1002/jmv.21330; Barnes GK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3589-4; Benjamin LA, 2013, INFECTION, V41, P27, DOI 10.1007/s15010-012-0292-z; Dalwai A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-236; dos Santos GPL, 2006, J MED VIROL, V78, P98, DOI 10.1002/jmv.20509; Dumaidi K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172357; Geteneh A, 2021, INFECT DRUG RESIST, V14, P1083, DOI 10.2147/IDR.S304521; Gomani P, 2015, CLIN LAB, V61, P101, DOI 10.7754/Clin.Lab.2014.140506; Han SH, 2016, J MED VIROL, V88, P175, DOI 10.1002/jmv.24316; Hristea A, 2012, INT J TUBERC LUNG D, V16, P793, DOI 10.5588/ijtld.11.0687; Jarrin I, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002372; Jin Dahee, 2015, Korean J Pediatr, V58, P446, DOI 10.3345/kjp.2015.58.11.446; Kaminski M, 2017, EUR J NEUROL, V24, P1062, DOI 10.1111/ene.13335; Kelly TA, 2013, EMERG INFECT DIS, V19, P1428, DOI 10.3201/eid1909.130201; Kumar Rashmi, 2005, Indian Journal of Pediatrics, V72, P57, DOI 10.1007/BF02760582; Lee BE, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-68; Lee BE, 2007, CURR OPIN INFECT DIS, V20, P272, DOI 10.1097/QCO.0b013e3280ad4672; Logan SAE, 2008, BMJ-BRIT MED J, V336, P36, DOI 10.1136/bmj.39409.673657.AE; Martin NG, 2016, LANCET INFECT DIS, V16, P1279, DOI 10.1016/S1473-3099(16)30201-8; McGill F, 2018, LANCET INFECT DIS, V18, P992, DOI 10.1016/S1473-3099(18)30245-7; McGill F, 2017, CURR OPIN INFECT DIS, V30, P248, DOI 10.1097/QCO.0000000000000355; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Messacar K, 2015, J MED VIROL, V87, P829, DOI 10.1002/jmv.24119; Michos AG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000674; Othman I, 2016, DIAGN MICR INFEC DIS, V84, P116, DOI 10.1016/j.diagmicrobio.2015.10.019; Pabbaraju K, 2015, MOL CELL PROBE, V29, P81, DOI 10.1016/j.mcp.2015.02.001; Page AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02741-w; Richter J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220938; Rudolph H, 2016, PEDIATR INFECT DIS J, V35, P567, DOI 10.1097/INF.0000000000001090; Shahroodi MJG, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.19955; Shaker OG, 2015, CLIN NEUROL NEUROSUR, V129, P67, DOI 10.1016/j.clineuro.2014.12.004; Sissay TM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244314; Smuts H, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3641-4; Tan NWH, 2016, J NEUROVIROL, V22, P213, DOI 10.1007/s13365-015-0387-2; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; Tattevin P, 2019, REV NEUROL-FRANCE, V175, P475, DOI 10.1016/j.neurol.2019.07.005; Tiruneh T, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02320-5; Verstrepen WA, 2001, J CLIN MICROBIOL, V39, P4093, DOI 10.1128/JCM.39.11.4093-4096.2001; Wright WF, 2019, J NEUROL SCI, V398, P176, DOI 10.1016/j.jns.2019.01.050; Yun KW, 2012, ARCH DIS CHILD, V97, P874, DOI 10.1136/archdischild-2012-301884; Zaoutis T, 1998, Pediatr Rev, V19, P183, DOI 10.1542/pir.19-6-183; Zhang XA, 2019, INT J LAB HEMATOL, V41, P331, DOI 10.1111/ijlh.12979	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0258652	10.1371/journal.pone.0258652	http://dx.doi.org/10.1371/journal.pone.0258652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762656	Green Published, gold			2022-12-26	WOS:000755316600006
J	Leulseged, TW; Hassen, IS; Maru, EH; Zewsde, WC; Chamiso, NW; Bayisa, AB; Abebe, DS; Ayele, BT; Yegle, KT; Edo, MG; Gurara, EK; Damete, DD; Tolera, YA				Leulseged, Tigist W.; Hassen, Ishmael S.; Maru, Endalkachew H.; Zewsde, Wuletaw C.; Chamiso, Negat W.; Bayisa, Abdi B.; Abebe, Daniel S.; Ayele, Birhanu T.; Yegle, Kalkidan T.; Edo, Mesay G.; Gurara, Eyosyas K.; Damete, Dereje D.; Tolera, Yared A.			Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context	PLOS ONE			English	Article							CORONAVIRUS DISEASE 2019; CLINICAL-FEATURES	Background The COVID-19 pandemic seems to have a different picture in Africa; the first case was identified in the continent after it had already caused a significant loss to the rest of the world and the reported number of cases and mortality rate has been low. Understanding the characteristics and outcome of the pandemic in the African setup is therefore crucial. Aim To assess the characteristics and outcome of Patients with COVID-19 and to identify determinants of the disease outcome among patients admitted to Millennium COVID-19 Care Center in Ethiopia. Methods A prospective cohort study was conducted among 1345 consecutively admitted RT-PCR confirmed Patients with COVID-19 from July to September, 2020. Frequency tables, KM plots, median survival times and Log-rank test were used to describe the data and compare survival distribution between groups. Cox proportional hazard survival model was used to identify determinants of time to clinical recovery and the independent variables, where adjusted hazard ratio, P-value and 95% CI for adjusted hazard ratio were used for testing significance and interpretation of results. Binary logistic regression model was used to assess the presence of a statistically significant association between disease outcome and the independent variables, where adjusted odds ratio, P-value and 95% CI for adjusted odds ratio were used for testing significance and interpretation of results. Results Among the study population, 71 (5.3%) died, 72 (5.4%) were transferred and the rest 1202 (89.4%) were clinically improved. The median time to clinical recovery was 14 days. On the multivariable Cox proportional hazard model; temperature (AHR = 1.135, 95% CI = 1.011, 1.274, p-value = 0.032), COVID-19 severity (AHR = 0.660, 95% CI = 0.501, 0.869, p-value = 0.003), and cough (AHR = 0.705, 95% CI = 0.519, 0.959, p-value = 0.026) were found to be significant determinants of time to clinical recovery. On the binary logistic regression, the following factors were found to be significantly associated with disease outcome; SPO2 (AOR = 0.302, 95% CI = 0.193, 0.474, p-value = 0.0001), shortness of breath (AOR = 0.354, 95% CI = 0.213, 0.590, p-value = 0.0001) and diabetes mellitus (AOR = 0.549, 95% CI = 0.337, 0.894, p-value = 0.016). Conclusions The average duration of time to clinical recovery was 14 days and 89.4% of the patients achieved clinical recovery. The mortality rate of the studied population is lower than reports from other countries including those in Africa. Having severe COVID-19 disease severity and presenting with cough were found to be associated with delayed clinical recovery of the disease. On the other hand, being hyperthermic is associated with shorter disease duration (faster time to clinical recovery). In addition, lower oxygen saturation, subjective complaint of shortness of breath and being diabetic were associated with unfavorable disease outcome. Therefore, patients with these factors should be followed cautiously for a better outcome.	[Leulseged, Tigist W.; Hassen, Ishmael S.; Maru, Endalkachew H.; Zewsde, Wuletaw C.; Chamiso, Negat W.; Bayisa, Abdi B.; Abebe, Daniel S.; Ayele, Birhanu T.; Yegle, Kalkidan T.; Edo, Mesay G.; Gurara, Eyosyas K.; Damete, Dereje D.; Tolera, Yared A.] St Pauls Hosp Millennium Med Coll, Millennium COVID 19 Care Ctr, Addis Ababa, Ethiopia; [Ayele, Birhanu T.] Stellenbosch Univ, Div Epidemiol & Biostat, Fac Med & Hlth Sci, Cape Town, South Africa	Stellenbosch University	Leulseged, TW (corresponding author), St Pauls Hosp Millennium Med Coll, Millennium COVID 19 Care Ctr, Addis Ababa, Ethiopia.	tigdolly@gmail.com	Leulseged, Tigist/DQR-5143-2022	Leulseged, Tigist/0000-0002-5767-1417; Damete, Dereje Derbew/0000-0002-1440-7958; Simeneh, Daniel/0000-0003-0041-9576				Abayomi A, 2021, INT J INFECT DIS, V102, P226, DOI 10.1016/j.ijid.2020.10.024; Abraha HE, 2021, INT J INFECT DIS, V105, P776, DOI 10.1016/j.ijid.2021.03.037; Aggarwal S, 2020, DIAGNOSIS, V7, P91, DOI 10.1515/dx-2020-0046; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077; Bellosta R, 2020, J VASC SURG, V72, P1864, DOI 10.1016/j.jvs.2020.04.483; Bezzio C, 2021, GUT, V70, P623, DOI 10.1136/gutjnl-2020-321760; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Elimian KO, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044079; Ethiopian Federal Ministry of Health, 2020, COVID19 MAN HDB; Gupta S, 2020, JAMA INTERN MED, V180, P1436, DOI 10.1001/jamainternmed.2020.3596; Hosmer DWJ., 2008, APPL SURVIVAL ANAL; Hu Y, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104371; Kim GU, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.04.040; Lechien JR, 2020, J INTERN MED, V288, P335, DOI 10.1111/joim.13089; Leulseged TW, 2021, PAN AFR MED J, V38, DOI 10.11604/pamj.2021.38.351.28831; Leulseged TW., 2020, MEDRXIV2020202010072; Leulseged TW., 2020, MEDRXIV2020100920209; Leulseged TW, 2020, MEDRXIV, V10, DOI [10.1101/2020, DOI 10.1101/2020, 10.08.20209122]; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Mi B., 2020, BONE JOINT SURG AM; Nachega JB, 2020, AM J TROP MED HYG, V103, P2419, DOI 10.4269/ajtmh.20-1240; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Sun LJ, 2020, J MED VIROL, V92, P2055, DOI 10.1002/jmv.25966; Taxonera C, 2020, ALIMENT PHARM THER, V52, P276, DOI 10.1111/apt.15804; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; World Health Organization, 2021, WEEKL COVID 19 EP UP; Xu TM, 2020, J MED VIROL, V92, P1884, DOI 10.1002/jmv.25944; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Yang F, 2020, J MED VIROL, V92, P2511, DOI 10.1002/jmv.25891; Yang Y, 2020, J ALLERGY CLIN IMMUN, V146, P119, DOI 10.1016/j.jaci.2020.04.027; Zangrillo A, 2020, CRIT CARE RESUSC, V22, P91	35	5	5	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259454	10.1371/journal.pone.0259454	http://dx.doi.org/10.1371/journal.pone.0259454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752481	Green Submitted, gold, Green Published			2022-12-26	WOS:000754499700016
J	Nagai, K; Ryuno, Y; Iwanami, Y; Omotani, S; Fukuno, S; Hatsuda, Y; Konishi, H; Myotoku, M				Nagai, Katsuhito; Ryuno, Yoshikazu; Iwanami, Yoshihito; Omotani, Sachiko; Fukuno, Shuhei; Hatsuda, Yasutoshi; Konishi, Hiroki; Myotoku, Michiaki			Effects of concurrent and staggered dosing of semi-solid enteral nutrients on pharmacokinetic behavior of antiepileptic drugs after oral administration in rats	PLOS ONE			English	Article							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; GASTROESOPHAGEAL-REFLUX; CARBAMAZEPINE; PHENYTOIN; NUTRITION; FOOD	Background The use of enteral nutrients plays a highly important role in accurate nutrition management, but limited information is currently available on the cautionary points of semi-solid enteral nutrients. Aim In this study, we examined whether the pharmacokinetic profiles of sodium valproate (SVA), levetiracetam (LEV), and carbamazepine (CBZ) are affected by altering the dosing time of RACOL (R)-NF Semi Solid for Enteral Use (RASS), a prescribed semi-solid formula. We also investigated whether the pharmacokinetic interaction observed in this study can be avoided by staggered dosing of the chemical drug and semi-solid enteral nutrient. Methods The plasma concentration of SVA, LEV and CBZ after oral administration was measured by LC-MS/MS method. Results There was no difference in pharmacokinetic characteristics of SVA and LEV when the dosing time of RASS was altered. On the other hand, the plasma concentration of CBZ after oral administration at all sampling points decreased with the extension of the dosing time of RASS, which was consistent with the C-max and AUC. However, no significant difference was observed in the pharmacokinetic profiles or parameters of CBZ between the short-term and long-term RASS dosing groups by prolonging the administered interval of CBZ and RASS for 2 hr. Conclusion We concluded that the pharmacokinetic profiles of CBZ, but not SVA and LEV, after its oral administration are affected by the dosing time of RASS, but staggered administration of CBZ and RASS prevented their interaction.	[Nagai, Katsuhito; Omotani, Sachiko; Fukuno, Shuhei; Hatsuda, Yasutoshi; Konishi, Hiroki; Myotoku, Michiaki] Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan; [Ryuno, Yoshikazu; Iwanami, Yoshihito] EN Otsuka Pharmaceut Co Ltd, Div Res & Dev, Tiyoda Ku, Tokyo, Japan		Myotoku, M (corresponding author), Osaka Ohtani Univ, Fac Pharm, Tondabayashi, Osaka, Japan.	myoutom@osaka-ohtani.ac.jp						Asahi H., 1984, JAP J GASTROENTEROL, V17, P1803, DOI [10.11405/nisshoshi1964.85.1353, DOI 10.11405/NISSHOSHI1964.85.1353]; Balan KK, 1998, AM J GASTROENTEROL, V93, P946, DOI 10.1111/j.1572-0241.1998.00284.x; CACEK AT, 1986, THER DRUG MONIT, V8, P166, DOI 10.1097/00007691-198606000-00007; CARTER JH, 1989, NEUROLOGY, V39, P552, DOI 10.1212/WNL.39.4.552; Chen LC, 2002, BIOL PHARM BULL, V25, P532, DOI 10.1248/bpb.25.532; Desai SV, 2014, CHEST, V145, P1148, DOI 10.1378/chest.13-1158; DUANE WC, 1979, AM J PHYSIOL, V236, pR175, DOI 10.1152/ajpregu.1979.236.3.R175; Finocchiaro C, 1997, NUTRITION, V13, P520, DOI 10.1016/S0899-9007(97)00030-0; Gentilcore D, 2006, J CLIN ENDOCR METAB, V91, P2062, DOI 10.1210/jc.2005-2644; Gezmen-Karadag M, 2018, ACTA NEUROBIOL EXP, V78, P187, DOI 10.21307/ane-2018-017; Hidaka M, 2005, DRUG METAB DISPOS, V33, P644, DOI 10.1124/dmd.104.002824; Kanie J, 2004, GERONTOLOGY, V50, P417, DOI 10.1159/000080181; Kuzuoka H., 2014, JPN PHARMACOL THER, V42, P405; LEVY RH, 1975, CLIN PHARMACOL THER, V17, P657; Miki S., 2007, JPN PHARMACOL THER, V35, P893; Myotoku M., 2016, JAP J PHARM HLTH CAR, V42, P364, DOI [10.5649/jjphcs.42.364, DOI 10.5649/JJPHCS.42.364]; Nagai K, 2019, DRUG RES, V69, P168, DOI 10.1055/a-0662-5701; Nagai K, 2018, NUTRITION, V46, P44, DOI 10.1016/j.nut.2017.08.006; NIMMO W S, 1976, Clinical Pharmacokinetics, V1, P189, DOI 10.2165/00003088-197601030-00002; Ohnishi N, 1999, BIOL PHARM BULL, V22, P527, DOI 10.1248/bpb.22.527; POIGER H, 1979, N-S ARCH PHARMACOL, V306, P89, DOI 10.1007/BF00515599; Reignier J, 2015, INTENS CARE MED, V41, P875, DOI 10.1007/s00134-015-3730-4; Shimomura H, 2016, BIOL PHARM BULL, V39, P49, DOI 10.1248/bpb.b15-00445; Tanishima Y, 2010, J SURG RES, V161, P272, DOI 10.1016/j.jss.2009.03.025; Urashima Y, 2019, PHARMAZIE, V74, P559, DOI 10.1691/ph.2019.9532; Whelan K, 2011, CURR OPIN GASTROEN, V27, P152, DOI 10.1097/MOG.0b013e32834353cb; Yamada F., 2015, JSPEN, V30, P1277	27	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259400	10.1371/journal.pone.0259400	http://dx.doi.org/10.1371/journal.pone.0259400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752482	gold, Green Published			2022-12-26	WOS:000754499700013
J	Tyumentseva, MA; Tyumentsev, AI; Akimkin, VG				Tyumentseva, Marina A.; Tyumentsev, Aleksandr I.; Akimkin, Vasiliy G.			Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells	PLOS ONE			English	Article							IN-VIVO; INTRACELLULAR DELIVERY; CAS9 RIBONUCLEOPROTEIN; NANOPARTICLE DELIVERY; BIOLISTIC DELIVERY; GENE KNOCKOUT; DISEASE; VECTORS; MACROMOLECULES; CHALLENGE	Background Delivery of CRISPR/Cas RNPs to target cells still remains the biggest bottleneck to genome editing. Many efforts are made to develop efficient CRISPR/Cas RNP delivery methods that will not affect viability of target cell dramatically. Popular current methods and protocols of CRISPR/Cas RNP delivery include lipofection and electroporation, transduction by osmocytosis and reversible permeabilization and erythrocyte-based methods. Methods In this study we will assess the efficiency and optimize current CRISPR/Cas RNP delivery protocols to target cells. We will conduct our work using molecular cloning, protein expression and purification, cell culture, flow cytometry (immunocytochemistry) and cellular imaging techniques. Discussion This will be the first extensive comparative study of popular current methods and protocols of CRISPR/Cas RNP delivery to human cell lines and primary cells. All protocols will be optimized and characterized using the following criteria i) protein delivery and genome editing efficacy; ii) viability of target cells after delivery (post-transduction recovery); iii) scalability of delivery process; iv) cost-effectiveness of the delivery process and v) intellectual property rights. Some methods will be considered 'research-use only', others will be recommended for scaling and application in the development of cell-based therapies.	[Tyumentseva, Marina A.; Tyumentsev, Aleksandr I.; Akimkin, Vasiliy G.] Cent Res Inst Epidemiol, Moscow, Russia		Tyumentseva, MA (corresponding author), Cent Res Inst Epidemiol, Moscow, Russia.	tyumentseva@cmd.su	Tiumentseva, Marina A./L-3376-2017	Tiumentseva, Marina A./0000-0002-3145-3702	Ministry of Science and Higher Education of the Russian Federation [075-15-2019-1666]	Ministry of Science and Higher Education of the Russian Federation	This work is supported by the Ministry of Science and Higher Education of the Russian Federation within the framework of a grant in the form of a subsidy for the creation and development of the "World-class Genomic Research Center for Ensuring Biological Safety and Technological Independence under the Federal Scientific and Technical Program for the Development of Genetic Technologies", agreement No. 075-15-2019-1666. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimkin VG., 2020, World Patent, Patent No. 2020197436; Alyami MZ, 2020, J AM CHEM SOC, V142, P1715, DOI 10.1021/jacs.9b11638; Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Anders C, 2014, METHOD ENZYMOL, V546, P1, DOI 10.1016/B978-0-12-801185-0.00001-5; Bhandawat A, 2020, METHODS MOL BIOL, V2124, P309, DOI 10.1007/978-1-0716-0356-7_17; Brandao KO, 2017, DIS MODEL MECH, V10, P1039, DOI 10.1242/dmm.030320; Carroll D, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0378-9; Chal J, 2017, DEVELOPMENT, V144, P2104, DOI 10.1242/dev.151035; Chen YP, 2020, ADV MATER, V32, DOI 10.1002/adma.202000036; Colella P, 2018, MOL THER-METH CLIN D, V8, P87, DOI 10.1016/j.omtm.2017.11.007; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Devalla HD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah5457; Ding F, 2019, NANOSCALE, V11, P17211, DOI 10.1039/c9nr05233j; Doudna JA, 2020, NATURE, V578, P229, DOI 10.1038/s41586-020-1978-5; Fiorotto R, 2019, BBA-MOL BASIS DIS, V1865, P920, DOI 10.1016/j.bbadis.2018.08.038; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Gustafsson O, 2021, PHARMACEUTICS, V13, DOI 10.3390/pharmaceutics13060878; Han X, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201600007; Hannoun Z, 2016, J HEPATOL, V65, P182, DOI 10.1016/j.jhep.2016.02.025; Hiatt J, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109105; Huang RS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01008; Huang XG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00140-3; Jang YY, 2016, HUM GENET, V135, P1041, DOI 10.1007/s00439-016-1691-5; Jarrell JA., 2020, GENOME EDITING HUMAN, DOI [10.1038/s41598-021-91307-y, DOI 10.1038/S41598-021-91307-Y]; Jeune VL, 2013, HUM GENE THER METHOD, V24, P59, DOI 10.1089/hgtb.2012.243; Just S, 2018, METHODS MOL BIOL, V1767, P147, DOI 10.1007/978-1-4939-7774-1_7; Kholosy WM, 2021, J BIOTECHNOL, V338, P71, DOI 10.1016/j.jbiotec.2021.07.006; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Kushwah N, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010132; Lee B, 2018, NAT BIOMED ENG, V2, P497, DOI 10.1038/s41551-018-0252-8; LEE G, 1993, CYTOMETRY, V14, P265, DOI 10.1002/cyto.990140305; Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2; Li L, 2018, BIOMATERIALS, V171, P207, DOI 10.1016/j.biomaterials.2018.04.031; Li SJ, 2019, ACS APPL MATER INTER, V11, P47762, DOI 10.1021/acsami.9b17598; Liang Z, 2019, METHODS MOL BIOL, V1917, P327, DOI 10.1007/978-1-4939-8991-1_24; Liu CY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8922; Liu J, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.6; Maeder ML, 2019, NAT MED, V25, P229, DOI 10.1038/s41591-018-0327-9; Magli A, 2017, SEMIN CELL DEV BIOL, V72, P87, DOI 10.1016/j.semcdb.2017.10.031; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Mock U, 2016, NAT PROTOC, V11, P598, DOI 10.1038/nprot.2016.027; Modarai SR, 2018, MOL THER-NUCL ACIDS, V11, P116, DOI 10.1016/j.omtn.2018.01.013; Mullins Christina Susanne, 2015, BMC Res Notes, V8, P472, DOI 10.1186/s13104-015-1446-8; Navarro-Serna S, 2020, J EQUINE VET SCI, V89, DOI 10.1016/j.jevs.2020.103025; O'Dea S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174779; OKADA CY, 1982, CELL, V29, P33, DOI 10.1016/0092-8674(82)90087-3; Qiao J, 2019, CHEM COMMUN, V55, P4707, DOI 10.1039/c9cc00010k; Riley RS, 2019, NAT REV DRUG DISCOV, V18, P175, DOI 10.1038/s41573-018-0006-z; Rossidis AC, 2018, NAT MED, V24, P1513, DOI 10.1038/s41591-018-0184-6; Santiago-Fernandez O, 2019, NAT MED, V25, P423, DOI 10.1038/s41591-018-0338-6; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Shahbazi R, 2019, NAT MATER, V18, P1124, DOI 10.1038/s41563-019-0385-5; Sharma P, 2017, NANOSCALE, V9, P15371, DOI 10.1039/c7nr05219g; Song XR, 2021, ADV DRUG DELIVER REV, V168, P158, DOI 10.1016/j.addr.2020.04.010; Sun YN, 2017, EUR J PHARM SCI, V96, P115, DOI 10.1016/j.ejps.2016.07.021; van der Wal E, 2018, STEM CELL REP, V10, P1975, DOI 10.1016/j.stemcr.2018.04.002; Villiger L, 2018, NAT MED, V24, P1519, DOI 10.1038/s41591-018-0209-1; Wan T, 2019, MATER TODAY, V26, P40, DOI 10.1016/j.mattod.2018.12.003; Wang HX, 2017, CHEM REV, V117, P9874, DOI 10.1021/acs.chemrev.6b00799; Wang H, 2016, ONCOTARGET, V7, P74648, DOI 10.18632/oncotarget.9448; Wei T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17029-3; Xu CL, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010028; Yen J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34601-6; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yue HH, 2018, NANOSCALE, V10, P1063, DOI 10.1039/c7nr07999k; Zhang S, 2021, THERANOSTICS, V11, P614, DOI 10.7150/thno.47007; Zhou WH, 2018, ANGEW CHEM INT EDIT, V57, P10268, DOI 10.1002/anie.201806941	73	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259812	10.1371/journal.pone.0259812	http://dx.doi.org/10.1371/journal.pone.0259812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752487	Green Published, gold			2022-12-26	WOS:000754499700035
J	Pereira, GMV; Juliato, CRT; de Almeida, CM; de Andrade, KC; Fante, JF; Martinho, N; Jales, RM; Silva, MPPE; Brito, LGO				Varella Pereira, Glaucia Miranda; Teatin Juliato, Cassia Raquel; de Almeida, Cristiane Martins; de Andrade, Kleber Cursino; Fante, Julia Ferreira; Martinho, Natalia; Jales, Rodrigo Menezes; Pinto e Silva, Marcela Ponzio; Oliveira Brito, Luiz Gustavo			Effect of radiofrequency and pelvic floor muscle training in the treatment of women with vaginal laxity: A study protocol	PLOS ONE			English	Article							FEMALE SEXUAL FUNCTION; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; ORGAN PROLAPSE; INTERNATIONAL CONSULTATION; INCONTINENCE QUESTIONNAIRE; URINARY-INCONTINENCE; NO TREATMENT; INDEX FSFI; VALIDATION	Background Vaginal laxity is an underreported condition that negatively affects women's sexual function and their relationships. Evidence-based studies are needed to better understand this complaint and to discuss its treatment options. Thus, we present a study protocol to compare the effect of radiofrequency and pelvic floor muscle training in the treatment of women with complaints of vaginal laxity. Methods/Design This is a prospective, parallel-group, two-arm, randomized clinical trial (Registry: RBR-2zdvfp-REBEC). Participants will be randomly assigned to one of the two groups of intervention (Radiofrequency or Pelvic Floor Muscle Training). The study will be performed in the Urogynecology outpatient clinic and in the physiotherapy outpatient clinic at the State University of Campinas-UNICAMP and will include women aged >= 18 years and with self-reported complaints of vaginal laxity. Participants will be assessed at baseline (pre-intervention period) and will be followed up in two periods: first follow-up (30 days after intervention) and second follow-up (six months after intervention). Expected results The results of this randomized clinical trial will have a positive impact on the participants' quality of life, as well as add value to the development of treatment options for women with complaints of vaginal laxity.	[Varella Pereira, Glaucia Miranda; Teatin Juliato, Cassia Raquel; Fante, Julia Ferreira; Jales, Rodrigo Menezes; Oliveira Brito, Luiz Gustavo] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil; [de Almeida, Cristiane Martins; de Andrade, Kleber Cursino; Pinto e Silva, Marcela Ponzio] Hosp Mulher Prof Dr Jose Aristodemo Pinotti UNICA, Ctr Atencao Integral Saude Mulher CAISM, Campinas, Brazil; [Martinho, Natalia] Ctr Univ Fac Associades Ensino UNIFAE, Sao Joao Da Boa Vista, Parana, Brazil; [Martinho, Natalia] Ctr Reg Univ Espirito Santo Pinhal UNIPINHAL, Santo Do Pinhal, Brazil	Universidade Estadual de Campinas	Brito, LGO (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil.	lgobrito@unicamp.br	Juliato, Cassia R T/D-4447-2012; Brito, Luiz Gustavo/H-3228-2012	Juliato, Cassia R T/0000-0003-3197-1195; Brito, Luiz Gustavo/0000-0002-7364-4718	Sao Paulo Research Foundation (FAPESP) [2019/26723-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The first author GMVP receives Scholarship Grant from the Sao Paulo Research Foundation (FAPESP) - Grant 2019/26723-5.	Abdool Z, 2018, INT UROGYNECOL J, V29, P369, DOI 10.1007/s00192-017-3530-1; Abdool Z, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.005; [Anonymous], 2019, BJU INT, V123, P777, DOI 10.1111/bju.14763; Aslan E, 2008, INT UROGYNECOL J, V19, P293, DOI 10.1007/s00192-007-0436-3; Avery K, 2004, NEUROUROL URODYNAM, V23, P322, DOI 10.1002/nau.20041; Balica A, 2017, MATURITAS, V102, P69, DOI 10.1016/j.maturitas.2017.02.017; Barrett G, 2000, BRIT J OBSTET GYNAEC, V107, P186, DOI 10.1111/j.1471-0528.2000.tb11689.x; Berenguer C, 2019, J SEX MARITAL THER, V45, P729, DOI 10.1080/0092623X.2019.1610128; Berman L., 2008, CURR SEX HEALTH REP, V5, P199, DOI [10.1007/S11930-008-0035-4, DOI 10.1007/S11930-008-0035-4]; Bo K, 2000, ACTA OBSTET GYN SCAN, V79, P598, DOI 10.1034/j.1600-0412.2000.079007598.x; Bo K, 1999, BMJ-BRIT MED J, V318, P487, DOI 10.1136/bmj.318.7182.487; Braekken IH, 2015, J SEX MED, V12, P470, DOI 10.1111/jsm.12746; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Campbell P, 2018, J SEX MED, V15, P1515, DOI 10.1016/j.jsxm.2018.08.015; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Thiel RDC, 2008, REV BRAS GINECOL OBS, V30, P504, DOI 10.1590/S0100-72032008001000005; DeRogatis L, 2008, J SEX MED, V5, P357, DOI 10.1111/j.1743-6109.2007.00672.x; Dietz HP, 2016, CURR OPIN OBSTET GYN, V28, P441, DOI 10.1097/GCO.0000000000000304; Dietz HP, 2018, INT UROGYNECOL J, V29, P723, DOI 10.1007/s00192-017-3426-0; Dietz HP, 2010, AM J OBSTET GYNECOL, V202, P321, DOI 10.1016/j.ajog.2009.08.018; Dietz HP., 2009, FETAL MATERNAL MED R, V20, P49; Digesu GA, 2019, NEUROUROL URODYNAM, V38, P1005, DOI 10.1002/nau.23927; Dumoulin C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2261-4; Dumoulin C, 2015, NEUROUROL URODYNAM, V34, P300, DOI 10.1002/nau.22700; FLEURY F J, 1981, Clinical Obstetrics and Gynecology, V24, P407, DOI 10.1097/00003081-198106000-00008; Garnham AP., 2014, INT UROGYNECOL J, P1; Graziottin A, 2005, J SEX MED, V2, P133, DOI 10.1111/j.1743-6109.2005.00129.x; Griffiths A, 2006, J Obstet Gynaecol, V26, P645; Haylen BT, 2016, INT UROGYNECOL J, V27, P655, DOI 10.1007/s00192-016-3003-y; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Jung SA, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.026; Kamilos MF, 2017, EINSTEIN-SAO PAULO, V15, P445, DOI [10.1590/S1679-45082017AO4051, 10.1590/s1679-45082017ao4051]; Kenton KS, 2015, OBSTET GYNECOL, V126, pE66, DOI 10.1097/AOG.0000000000001148; Krychman M, 2017, J SEX MED, V14, P215, DOI 10.1016/j.jsxm.2016.11.322; Krychman ML, 2016, J SEX MED, V13, P1445, DOI 10.1016/j.jsxm.2016.07.016; Laycock J, 1994, J NATL WOMEN HLTH GR, P40; Millheiser LS, 2010, J SEX MED, V7, P3088, DOI 10.1111/j.1743-6109.2010.01910.x; Moore Robert D, 2014, Surg Technol Int, V24, P253; Nambiar AK, 2018, EUR UROL, V73, P596, DOI 10.1016/j.eururo.2017.12.031; Tamanini JTN, 2008, INT UROGYNECOL J, V19, P1385, DOI 10.1007/s00192-008-0641-8; Panayi DC, 2010, INT UROGYNECOL J, V21, P1265, DOI 10.1007/s00192-010-1183-4; Pauls RN, 2012, INT UROGYNECOL J, V23, P1435, DOI 10.1007/s00192-012-1757-4; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Price N, 2006, BJOG-INT J OBSTET GY, V113, P700, DOI 10.1111/j.1471-0528.2006.00938.x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rowen TS, 2018, J SEX MED, V15, P1659, DOI 10.1016/j.jsxm.2018.09.007; Schnatz PF, 2020, OBSTET GYNECOL, V135, pE36, DOI 10.1097/AOG.0000000000003616; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sekiguchi Y, 2013, J WOMENS HEALTH, V22, P775, DOI 10.1089/jwh.2012.4123; Shafik A, 2000, INT UROGYNECOL J, V11, P361, DOI 10.1007/PL00004028; Tamanini JTN, 2004, REV SAUDE PUBL, V38, P438, DOI 10.1590/S0034-89102004000300015; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; Yang SH, 2008, J SEX MED, V5, P2871, DOI 10.1111/j.1743-6109.2008.00985.x; Zielinski R, 2012, NEUROUROL URODYNAM, V31, P1145, DOI 10.1002/nau.22205	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259650	10.1371/journal.pone.0259650	http://dx.doi.org/10.1371/journal.pone.0259650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY0QZ	34752494	gold, Green Published			2022-12-26	WOS:000754499700022
J	Bacurau, AGD; Sato, APS; Francisco, PMSB				de Macedo Bacurau, Aldiane Gomes; Sayuri Sato, Ana Paula; Stolses Bergamo Francisco, Priscila Maria			Reasons for nonadherence to vaccination for influenza among older people in Brazil	PLOS ONE			English	Article							SAO-PAULO; ADULTS; POPULATION; METAANALYSIS; INDIVIDUALS; PREVALENCE; COMMUNITY; MORTALITY; DISEASES; STATE	This study aimed to estimate the prevalence of non-vaccination and the reasons for nonadherence to the influenza vaccine among older Brazilians according to sociodemographic characteristics. A cross-sectional study was conducted with data from older people (>= 60 years of age; n = 23,815) who participated in the 2013 National Health Survey. Frequencies of non-vaccination and the main reasons for nonadherence were calculated with respective 95% confidence intervals. The prevalence of non-vaccination was 26.9% (approximately 7,106,730 older people). The reason rarely gets the flu was the most cited among the men (28.2%), the 60-to-69-year-old age group (29.6%), individuals with higher education (41.9%), and those with health insurance (32.3%). Fear of a reaction was the most cited reason in the northeastern region (25.4%), among women (29.3%), longer-lived individuals (>= 70 years; 28.7%), and those who did not know how to read/write (26.7%). A total of 12.1% reported not believing in the vaccine's protection, and 5.5% did not know that it was necessary to take vaccine. The proportions of the main reasons for non-vaccination varied by sociodemographic characteristics. This study's findings highlight the need to increase older people's knowledge regarding influenza and influenza vaccines. Healthcare providers should be encouraged to counsel older people-especially those in subgroups with lower adherence, such as residents in the Northeast region, those aged 60-69 years, those who do not know how to read/write, those without a spouse/companion, and those without health insurance-regarding the different aspects of the vaccine and formally indicate it for groups at risk.	[de Macedo Bacurau, Aldiane Gomes; Stolses Bergamo Francisco, Priscila Maria] Univ Estadual Campinas, Sch Med Sci, Dept Collect Hlth, Campinas, SP, Brazil; [Sayuri Sato, Ana Paula] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Bacurau, AGD (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Collect Hlth, Campinas, SP, Brazil.	aldianemacedo@gmail.com	Sato, Ana Paula Sayuri/D-4111-2016	Sato, Ana Paula Sayuri/0000-0001-8601-5884; Gomes de Macedo Bacurau, Aldiane/0000-0002-6671-2284				Agarwal D, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-018-0124-9; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Ang LW, 2017, EPIDEMIOL INFECT, V145, P775, DOI 10.1017/S0950268816002491; Gonzalez-Block MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243833; [Anonymous], 2016, DIARIO OFICIAL UNIAO; Bertoldo G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215978; Bonner WIA, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0595-x; de Souza PRB, 2015, EPIDEMIOL SERV SAUDE, V24, P207, DOI 10.5123/S1679-49742015000200003; Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007; Centers for Disease Control and Prevention (CDC), 2020, FLU SYMPT COMPL; Cheng YY, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101124; Coordenacao Geral do Programa Nacional de Imunizacoes  Departamento de Vigilancia Epidemiologica Secretaria de Vigilancia em Saude  Ministerio da Saude ., 2020, CAMP NAC VAC INFL IN, V22; Silva SPCE, 2013, CIENC SAUDE COLETIVA, V18, P2179, DOI 10.1590/S1413-81232013000800002; D'Angiolella LS, 2018, ANN I SUPER SANITA, V54, P49, DOI 10.4415/ANN_18_01_10; Daufenbach LZ, 2014, EPIDEMIOL SERV SAUDE, V23, P9, DOI 10.5123/S1679-49742014000100002; de Andrade FB, 2017, HUM VACC IMMUNOTHER, V13, P103, DOI 10.1080/21645515.2016.1228501; Passos VMD, 2020, POPUL HEALTH METR, V18, DOI 10.1186/s12963-020-00206-3; Bacurau AGD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00230518, 10.1590/0102-311x00230518]; Succi RCD, 2018, J PEDIAT-BRAZIL, V94, P574, DOI 10.1016/j.jped.2018.01.008; Demicheli V, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub4; Dhakal S, 2019, J VIROL, V93, DOI 10.1128/JVI.00797-19; Dip RM, 2010, CAD SAUDE PUBLICA, V26, P1035, DOI 10.1590/S0102-311X2010000500025; Doniec K, 2018, LANCET, V392, P731, DOI 10.1016/S0140-6736(18)30853-5; Farmanara N, 2018, CAN J PUBLIC HEALTH, V109, P369, DOI 10.17269/s41997-018-0018-9; Fink G, 2021, BMJ EVID-BASED MED, V26, DOI 10.1136/bmjebm-2020-111549; Gazibara T, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-018-0159-8; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Instituto brasileiro de Geografia e Estatistica (IBGE), 2021, PROJ EST POP BRAS UN; Jain A, 2017, VACCINE, V35, P2315, DOI 10.1016/j.vaccine.2017.03.013; Kajikawa N, 2019, INFECT DIS HEALTH, V24, P212, DOI 10.1016/j.idh.2019.07.002; Korkmaz P, 2019, CENT EUR J PUBL HEAL, V27, P44, DOI 10.21101/cejph.a5231; Lambert ND, 2012, EXPERT REV VACCINES, V11, P985, DOI [10.1586/erv.12.61, 10.1586/ERV.12.61]; Lima-Costa MF, 2008, REV SAUDE PUBL, V42, P100, DOI 10.1590/S0034-89102008000100013; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Malta DC, 2018, CIENC SAUDE COLETIVA, V23, P3115, DOI 10.1590/1413-812320182310.25222018; Malta DC, 2017, CIENC SAUDE COLETIVA, V22, P179, DOI 10.1590/1413-81232017221.16782015; Mansur AD, 2009, ARQ BRAS CARDIOL, V93, P395, DOI 10.1590/S0066-782X2009001000013; de Souza MDM, 2018, CIENC SAUDE COLETIVA, V23, P1737, DOI 10.1590/1413-81232018236.04822018; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Pinto CJM, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0366-2018; Ministerio da Saude (MS), 2020, SIST INF PROGR NAC I; Miranda Gabriella Morais Duarte, 2016, Rev. bras. geriatr. gerontol., V19, P507, DOI 10.1590/1809-98232016019.150140; Moura E., 2012, PERFIL SITUACAO SAUD; Moura RF, 2015, CAD SAUDE PUBLICA, V31, P2157, DOI 10.1590/0102-311X00065414; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Neves RG, 2016, EPIDEMIOL SERV SAUDE, V25, P755, DOI [10.5123/S1679-49742016000400009, 10.5123/s1679-49742016000400009]; Organisation for Economic Co-operation and Development (OECD), 2020, INFL VACC RAT IND; Pan American Health Organization (PAHO), 2019, US IND MAP INTERNET; Pan American Health Organization (PAHO), 2019, MASC HLTH REG AM EX; Russell K, 2018, VACCINE, V36, P1272, DOI 10.1016/j.vaccine.2018.01.045; Salem ML, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109752; Santos AJ, 2017, EPIDEMIOL INFECT, V145, P1786, DOI 10.1017/S0950268817000814; Sato APS, 2020, J INFECT PUBLIC HEAL, V13, P211, DOI 10.1016/j.jiph.2019.07.022; Sato APS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123840; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Sellers SA, 2017, INFLUENZA OTHER RESP, V11, P372, DOI 10.1111/irv.12470; Smetana J, 2018, HUM VACC IMMUNOTHER, V14, P540, DOI 10.1080/21645515.2017.1343226; StataCorp LP.,, 2015, STAT SURV DAT REF MA; Cruzeta APS, 2013, INT J INFECT DIS, V17, pE1194, DOI 10.1016/j.ijid.2013.07.013; Francisco PMSB, 2006, REV PANAM SALUD PUBL, V19, P259, DOI 10.1590/S1020-49892006000400006; Francisco PMSB, 2013, REV PANAM SALUD PUBL, V34, P155; Francisco PMSB, 2011, CAD SAUDE PUBLICA, V27, P417, DOI 10.1590/S0102-311X2011000300003; World Health Organization, 2019, TEN THREATS GLOB HLT; World Health Organization (WHO), 2021, INFL SEAS FACT SHEET; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259640	10.1371/journal.pone.0259640	http://dx.doi.org/10.1371/journal.pone.0259640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748598	Green Published, gold			2022-12-26	WOS:000755468000044
J	Hall, MK; Burch, AP; Schwalbe, RA				Hall, M. Kristen; Burch, Adam P.; Schwalbe, Ruth A.			Functional analysis of N-acetylglucosaminyltransferase-I knockdown in 2D and 3D neuroblastoma cell cultures	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CANCER; EXPRESSION; VIMENTIN; PROLIFERATION; PALLADIN	Tumor development can be promoted/suppressed by certain N-glycans attached to proteins at the cell surface. Here we examined aberrant neuronal properties in 2D and 3D rat neuroblastoma (NB) cell cultures with different N-glycan populations. Lectin binding studies revealed that the engineered N-glycosylation mutant cell line, NB_1(-Mgat1), expressed solely oligomannose N-glycans, and verified that the parental cell line, NB_1, and a previous engineered N-glycosylation mutant, NB_1(-Mgat2), expressed significant levels of higher order N-glycans, complex and hybrid N-glycans, respectively. NB_1 grew faster than mutant cell lines in monolayer and spheroid cell cultures. A 2-fold difference in growth between NB_1 and mutants occurred much sooner in 2D cultures relative to that observed in 3D cultures. Neurites and spheroid cell sizes were reduced in mutant NB cells of 2D and 3D cultures, respectively. Cell invasiveness was highest in 2D cultures of NB_1 cells compared to that of NB_1(-Mgat1). In contrast, NB_1 spheroid cells were much less invasive relative to NB_1(-Mgat1) spheroid cells while they were more invasive than NB_1(-Mgat2). Gelatinase activities supported the ranking of cell invasiveness in various cell lines. Both palladin and HK2 were more abundant in 3D than 2D cultures. Levels of palladin, vimentin and EGFR were modified in a different manner under 2D and 3D cultures. Thus, our results support variations in the N-glycosylation pathway and in cell culturing to more resemble in vivo tumor environments can impact the aberrant cellular properties, particularly cell invasiveness, of NB.	[Hall, M. Kristen; Burch, Adam P.; Schwalbe, Ruth A.] East Carolina Univ, Dept Biochem & Mol Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Schwalbe, RA (corresponding author), East Carolina Univ, Dept Biochem & Mol Biol, Greenville, NC 27858 USA.	schwalber@ecu.edu		Schwalbe, Ruth/0000-0002-6839-7863	National Institute of Health [GM129679]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institute of Health Grant GM129679 (to R.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Battaglia Rachel A, 2018, F1000Res, V7, DOI 10.12688/f1000research.15967.1; Berens EB, 2015, JOVE-J VIS EXP, DOI 10.3791/53409; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Cummings RD, 2009, ESSENTIALS GLYCOBIOL, P1857; Dubey M, 2004, J NEUROSCI RES, V78, P245, DOI 10.1002/jnr.20146; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; FREYER JP, 1980, CANCER RES, V40, P3956; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hall MK, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9040071; Hall M Kristen, 2017, J Glycobiol, V6, DOI 10.4172/2168-958X.1000128; Hall MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199202; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Ho WL, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0334-6; Hu YL, 2015, J PROTEOME RES, V14, P2074, DOI 10.1021/pr5011718; Inamori K, 2006, FEBS LETT, V580, P627, DOI 10.1016/j.febslet.2005.12.089; Jiang YM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030844; Kamijo T, 2012, INT J CLIN ONCOL, V17, P190, DOI 10.1007/s10147-012-0415-7; Kumar HR, 2009, EXPERT REV PROTEOMIC, V6, P387, DOI 10.1586/EPR.09.58; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Li XY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00975; LOTTICH SC, 1985, BREAST CANCER RES TR, V6, P49, DOI 10.1007/BF01806010; Najm P, 2014, CELL ADHES MIGR, V8, P29, DOI 10.4161/cam.28024; Nakamura Y, 2000, GENES CELLS, V5, P823, DOI 10.1046/j.1365-2443.2000.00372.x; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Wassmer CH, 2020, CELL TRANSPLANT, V29, DOI 10.1177/0963689720937292; Xu XH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11417-4; Zheng C, 2016, ACTA BIOCH BIOPH SIN, V48, P762, DOI 10.1093/abbs/gmw064	33	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259743	10.1371/journal.pone.0259743	http://dx.doi.org/10.1371/journal.pone.0259743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748597	gold, Green Published			2022-12-26	WOS:000755468000052
J	Ito, Y; Furuya, F; Taki, K; Suzuki, H; Shimura, H				Ito, Yuko; Furuya, Fumihiko; Taki, Katsumi; Suzuki, Hideaki; Shimura, Hiroki			NKX2-1 re-expression induces cell death through apoptosis and necrosis in dedifferentiated thyroid carcinoma cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-I; HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION; GROWTH-INHIBITION; ARGINASE I; CANCER; PROTEIN; REGULATOR; ADENOCARCINOMA; PROLIFERATION	NK2 homeobox 1 (NKX2-1) is a thyroid transcription factor essential for proper thyroid formation and maintaining its physiological function. In thyroid cancer, NKX2-1 expression decreases in parallel with declined differentiation. However, the molecular pathways and mechanisms connecting NKX2-1 to thyroid cancer phenotypes are largely unknown. This study aimed to examine the effects of NKX2-1 re-expression on dedifferentiated thyroid cancer cell death and explore the underlying mechanisms. A human papillary thyroid carcinoma cell line lacking NKX2-1 expression was infected with an adenoviral vector containing Nkx21. Cell viability decreased after Nkx2-1 transduction and apoptosis and necrosis were detected. Arginase 2 (ARG2), regulator of G protein signaling 4 (RGS4), and RGS5 mRNA expression was greatly increased in Nkx2-1-transducted cells. After suppressing these genes by siRNA, cell death, apoptosis, and necrosis decreased in RGS4 knockdown cells. These findings demonstrated that cell death was induced via apoptosis and necrosis by NKX2-1 re-expression and involves RGS4.	[Ito, Yuko; Suzuki, Hideaki; Shimura, Hiroki] Fukushima Med Univ, Sch Med, Dept Lab Med, Fukushima, Japan; [Furuya, Fumihiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo, Yamanashi, Japan; [Taki, Katsumi] Fujiyoshida Municipal Med Ctr, Dept Internal Med, Fujiyoshida, Yamanashi, Japan; [Suzuki, Hideaki] Fukushima Med Univ, Sch Hlth Sci, Dept Clin Lab Sci, Fukushima, Fukushima, Japan	Fukushima Medical University; University of Yamanashi; Fukushima Medical University	Shimura, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Lab Med, Fukushima, Japan.	hshimura@fmu.ac.jp		Taki, Katsumi/0000-0002-7158-1653	JSPS KAKENHI [JP16K08971, JP17K15779]; Roche Diagnostics K.K	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Roche Diagnostics K.K	This work was supported by JSPS KAKENHI Grant Number JP16K08971 and JP17K15779, and by research grant from Roche Diagnostics K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JSPS website: https://www.jsps.go.jp.Roche Diagnostics K.K. website: https://www.roche-diagnostics.jp.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Altman MK, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/518437; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Blagosklonny MV, 2000, LEUKEMIA, V14, P1502, DOI 10.1038/sj.leu.2401864; Caramel J, 2018, CANCER RES, V78, P30, DOI 10.1158/0008-5472.CAN-17-2476; Ding L, 2007, GENE, V401, P46, DOI 10.1016/j.gene.2007.07.002; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Fernandez LP, 2015, NAT REV ENDOCRINOL, V11, P29, DOI 10.1038/nrendo.2014.186; Fugazzola L, 2019, EUR THYROID J, V8, P227, DOI 10.1159/000502229; Furuya F, 2004, ENDOCRINOLOGY, V145, P5397, DOI 10.1210/en.2004-0631; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Griesing S, 2017, CANCER SCI, V108, P1394, DOI 10.1111/cas.13271; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; He Z, 2019, ONCOTARGETS THER, V12, P8701, DOI 10.2147/OTT.S221657; Hernandez CP, 2010, BLOOD, V115, P5214, DOI 10.1182/blood-2009-12-258822; Hoshi S, 2009, CARCINOGENESIS, V30, P1614, DOI 10.1093/carcin/bgp167; Ibrahimpasic T, 2019, THYROID, V29, P311, DOI 10.1089/thy.2018.0509; Ichijo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116252; Ji LL, 2020, J CELL PHYSIOL, V235, P3669, DOI 10.1002/jcp.29256; Khoury O, 2015, J NEURO-ONCOL, V122, P75, DOI 10.1007/s11060-014-1698-5; Kimura S, 2011, J THROID RES, V2011, DOI 10.4061/2011/710213; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kusakabe T, 2006, MOL ENDOCRINOL, V20, P1796, DOI 10.1210/me.2005-0327; Lam TL, 2011, PIGM CELL MELANOMA R, V24, P366, DOI 10.1111/j.1755-148X.2010.00798.x; Lee DY, 2016, THYROID, V26, P404, DOI 10.1089/thy.2015.0316; Lee EK, 2013, CANCER-AM CANCER SOC, V119, P1643, DOI 10.1002/cncr.27871; Li CMC, 2015, GENE DEV, V29, P1850, DOI 10.1101/gad.267393.115; Lin CY, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.65; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Mitsiades CS, 2005, CLIN CANCER RES, V11, P3958, DOI 10.1158/1078-0432.CCR-03-0776; Mumenthaler SM, 2008, PROSTATE, V68, P1561, DOI 10.1002/pros.20816; Myong NH, 2003, J KOREAN MED SCI, V18, P494, DOI 10.3346/jkms.2003.18.4.494; Nagel S, 2019, CANCERS, V11, DOI 10.3390/cancers11121874; Nehs MA, 2011, SURGERY, V150, P1032, DOI 10.1016/j.surg.2011.09.012; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; Park HJ, 2017, ONCOL LETT, V13, P4357, DOI 10.3892/ol.2017.6009; Patil MD, 2016, ONCOGENE, V35, P4957, DOI 10.1038/onc.2016.37; Phelps CA, 2018, VITAM HORM, V106, P517, DOI 10.1016/bs.vh.2017.05.007; Primon M, 2019, CANCERS, V11, DOI 10.3390/cancers11040508; Ros P, 1999, BIOCHIMIE, V81, P389, DOI 10.1016/S0300-9084(99)80086-8; San Jose-Eneriz E, 2019, CANCERS, V11, DOI 10.3390/cancers11111794; Shimura H, 2001, CANCER RES, V61, P3640; Silberschmidt D, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-9; Singh R, 2000, CANCER RES, V60, P3305; Sousa MSA, 2010, FREE RADICAL BIO MED, V49, P997, DOI 10.1016/j.freeradbiomed.2010.06.006; Squires KE, 2018, PHARMACOL REV, V70, P446, DOI 10.1124/pr.117.015354; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Wang Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317712512; Xiao D, 2019, ONCOL LETT, V18, P5145, DOI 10.3892/ol.2019.10857; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Xu ZM, 2015, ONCOL REP, V33, P2899, DOI 10.3892/or.2015.3917; Xue XT, 2017, ONCOTARGET, V8, P78530, DOI 10.18632/oncotarget.20825; Yamaguchi T, 2013, CANCER CELL, V23, P718, DOI 10.1016/j.ccr.2013.04.002; Zhang P, 2006, PATHOL INT, V56, P240, DOI 10.1111/j.1440-1827.2006.01959.x; Zu YF, 2012, ONCOL REP, V28, P1544, DOI 10.3892/or.2012.2009	57	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259558	10.1371/journal.pone.0259558	http://dx.doi.org/10.1371/journal.pone.0259558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748583	Green Published, gold			2022-12-26	WOS:000755468000035
J	Wasim, M; Ali, A; Choudhry, MA; Saleem, F; Shaikh, IU; Iqbal, J				Wasim, Muhammad; Ali, Ahsan; Choudhry, Mohammad Ahmad; Saleem, Faisal; Shaikh, Inam Ul Hasan; Iqbal, Jamshed			Unscented Kalman filter for airship model uncertainties and wind disturbance estimation	PLOS ONE			English	Article							TRAJECTORY TRACKING; NEURAL-NETWORK	An airship is lighter than an air vehicle with enormous potential in applications such as communication, aerial inspection, border surveillance, and precision agriculture. An airship model is made up of dynamic, aerodynamic, aerostatic, and propulsive forces. However, the computation of aerodynamic forces remained a challenge. In addition to aerodynamic model deficiencies, airship mass matrix suffers from parameter variations. Moreover, due to the lighter-than-air nature, it is also susceptible to wind disturbances. These modeling issues are the key challenges in developing an efficient autonomous flight controller for an airship. This article proposes a unified estimation method for airship states, model uncertainties, and wind disturbance estimation using Unscented Kalman Filter (UKF). The proposed method is based on a lumped model uncertainty vector that unifies model uncertainties and wind disturbances in a single vector. The airship model is extended by incorporating six auxiliary state variables into the lumped model uncertainty vector. The performance of the proposed methodology is evaluated using a nonlinear simulation model of a custom-developed UETT airship and is validated by conducting a kind of error analysis. For comparative studies, EKF estimator is also developed. The results show the performance superiority of the proposed estimator over EKF; however, the proposed estimator is a bit expensive on computational grounds. However, as per the requirements of the current application, the proposed estimator can be a preferred choice.	[Wasim, Muhammad; Ali, Ahsan; Choudhry, Mohammad Ahmad; Shaikh, Inam Ul Hasan] Univ Engn & Technol, Dept Elect Engn, Taxila, Pakistan; [Saleem, Faisal] Riphah Int Univ, Dept Elect Engn, Islamabad, Pakistan; [Iqbal, Jamshed] Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, England	University of Engineering & Technology Taxila; University of Hull	Iqbal, J (corresponding author), Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, England.	j.iqbal@hull.ac.uk	Iqbal, Jamshed/AER-0153-2022; Shaikh, Inam Ul Hasan/GSD-9159-2022	Iqbal, Jamshed/0000-0002-0795-0282; 				Ahsan M, 2017, INT J CONTROL AUTOM, V15, P1384, DOI 10.1007/s12555-015-0409-0; Alharbi M, 2020, IEEE INT CONF INF VI, P98, DOI 10.1109/IV51561.2020.00026; Allen HJ, 1951, CHARACTERISTICS FLOW; Ashraf MZ, 2013, AEROSP SCI TECHNOL, V25, P56, DOI 10.1016/j.ast.2011.08.014; Azinheira JR, 2002, J GUID CONTROL DYNAM, V25, P1116, DOI 10.2514/2.4991; Carlile D.E., 2014, INSTRUMENTATION METH; Curtiss HC., 1976, J AIRCRAFT, V13, P835; Din SU, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203667; do Valle RC, 2015, J GUID CONTROL DYNAM, V38, P53, DOI 10.2514/1.G000453; Freeman HB, 1932, PRESSURE DISTRIBUTIO; Funk P, 2003, AEROSP SCI TECHNOL, V7, P603, DOI 10.1016/S1270-9638(03)00058-0; Gomes S., 1990, THESIS; Han D, 2016, P I MECH ENG G-J AER, V230, P45, DOI 10.1177/0954410015586861; Iqbal Jamshed, 2014, Rev.fac.ing.univ. Antioquia, P58; Jones R, 1927, DISTRIBUTION PRESSUR; JONES SP, 1983, J AIRCRAFT, V20, P120, DOI 10.2514/3.44840; Julier SJ, 2002, P AMER CONTR CONF, V1-6, P887, DOI 10.1109/ACC.2002.1023128; Julier SJ, 1997, P SOC PHOTO-OPT INS, V3068, P182, DOI 10.1117/12.280797; Kazmier LJ, 1996, SCHAUMS OUTLINE THEO, V4th; [李扬 Li Yang], 2019, [电工技术学报, Transactions of China Electrotechnical Society], V34, P3651; Li Y, 2019, IEEE ACCESS, V7, P29139, DOI 10.1109/ACCESS.2019.2900228; Liu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175730; Lou WJ, 2019, ADV SPACE RES, V63, P1111, DOI 10.1016/j.asr.2018.10.017; Mazhar F, 2019, P I MECH ENG G-J AER, V233, P2549, DOI 10.1177/0954410018783131; Meterological data of pakistan, 2021, NREL TRANSF EN; Mueller J., 2004, AIAA 3 UNM UNL TECHN, P6479; Munk MM, 1924, TR184 NACA; Nayler A, 2003, AIAA 3 ANN AV TECHN, P6727; Neal T.P., 1969, MILITARY SPECIFICATI; Qaisar SM, 2014, SIGNAL PROCESS, V94, P620, DOI 10.1016/j.sigpro.2013.07.019; Solaque L, 2007, SPRINGER TRAC ADV RO, V37, P147; Thales SA, 2019, United States patent, Patent No. [10,212,610, 10212610]; Tuckerman LB, 1926, INTERTIA FACTORS ELL; Wasim M, 2021, INT BHURBAN C APPL S, P568, DOI 10.1109/IBCAST51254.2021.9393193; Wasim M, 2020, J SYST ENG ELECTRON, V31, P1318, DOI 10.23919/JSEE.2020.000102; Wasim M, 2020, IEEE ACCESS, V8, P70204, DOI 10.1109/ACCESS.2020.2986190; Wasim M, 2016, 2016 INTERNATIONAL CONFERENCE ON COMPUTING, ELECTRONIC AND ELECTRICAL ENGINEERING (ICE CUBE), P307, DOI 10.1109/ICECUBE.2016.7495243; Wasim M, 2016, IEEE INT CONF INTELL, P236, DOI 10.1109/INTELSE.2016.7475127; Yang YN, 2016, AEROSP SCI TECHNOL, V54, P192, DOI 10.1016/j.ast.2016.04.021; Yao SY, 2018, CHIN CONTR CONF, P3955; Yuan JC, 2020, IEEE ACCESS, V8, P31453, DOI 10.1109/ACCESS.2020.2973236; Zhu M, 2016, CHIN CONTR CONF, P10801, DOI 10.1109/ChiCC.2016.7555069; Zuo ZY, 2019, IEEE T AERO ELEC SYS, V55, P1483, DOI 10.1109/TAES.2018.2873054	43	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0257849	10.1371/journal.pone.0257849	http://dx.doi.org/10.1371/journal.pone.0257849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739486	Green Published, gold			2022-12-26	WOS:000755000800005
J	Ahmad, T; Van Looy, A				Ahmad, Tahir; Van Looy, Amy			Development and testing of an explorative BPM acceptance model: Insights from the COVID-19 pandemic	PLOS ONE			English	Article							SUPPLY CHAIN MANAGEMENT; USER ACCEPTANCE; INFORMATION-TECHNOLOGY; BUSINESS; ORGANIZATION; IMPACT; FLEXIBILITY; PERFORMANCE; ADOPTION; AGILITY	When emerging technologies transform an organization's way of working, explorative business process management (BPM) becomes a new challenge. Although digital innovations can boost process efficacy and business productivity, employees do not necessarily accept the implied work changes. We therefore looked at the increased digitalization efforts during the COVID-19 lockdowns, during which employees were forced to drastically rethink work by heavily depending on technology for communication and almost all business tasks. This global setting allowed us to scrutinize disruptive work changes and how employees can cope with disruptive work adaptations. We also looked into the explorative skillset needed to adapt to these changes. To theorize about an explorative BPM acceptance model, eleven hypotheses were supported based on a solid theoretical foundation. We followed a quantitative research design using partial least squares for structural equation modeling (PLS-SEM) at the university administration settings in two regions, including purposive sampling. Data analysis covered both a measurement model assessment and structural model assessment. Our findings reveal that employees' perceived work modalities, feeling creative and feeling flexible are more promising features than perceived influence and attitude related to explorative work and skill development. We also offer novel insights into explorative business process management (BPM) skills, and which skills are more productive in uncertain or dynamic working conditions. This research is a learning path for managers struggling with flexible or competitive business environments, and more specifically to facilitate employee willingness.	[Ahmad, Tahir; Van Looy, Amy] Univ Ghent, Dept Business Informat & Operat Management, Fac Econ & Business Adm, Ghent, Belgium	Ghent University	Ahmad, T (corresponding author), Univ Ghent, Dept Business Informat & Operat Management, Fac Econ & Business Adm, Ghent, Belgium.	Tahir.Ahmad@UGent.be	; Van Looy, Amy/G-1072-2019	Ahmad, Tahir/0000-0003-0765-7059; Van Looy, Amy/0000-0002-7992-1528				Abbasi FK, 2018, EDUC TRAIN, V60, P354, DOI 10.1108/ET-08-2017-0120; Ahmad T, 2019, IEEE 13 INT C RES CH, P75; Alaqra AS, 2020, INFLUENCE WORKING HO; Andersen TK, 2018, J CHANG MANAG, V18, P327, DOI 10.1080/14697017.2018.1491482; Badakhshan P, 2020, BUS PROCESS MANAG J, V26, P1505, DOI 10.1108/BPMJ-12-2018-0347; Baker J, 2010, INTEGR SER INFORM SY, V28, P231, DOI 10.1007/978-1-4419-6108-2_12; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bergmann H, 2017, J TECHNOL TRANSFER, V42, P116, DOI 10.1007/s10961-015-9458-z; Binci D, 2019, BUS PROCESS MANAG J, V26, P1, DOI 10.1108/BPMJ-06-2018-0158; Birnir A., 2021, 10 REASONS WORKING R; Blok M., 2009, P 17 WORLD C ERG IEA, P368; Chauhan S, 2016, INT J MANAG EDUC-OXF, V14, P248, DOI 10.1016/j.ijme.2016.05.005; Chin WW, 1998, QUANT METH SER, P295; Chountalas PT, 2019, BUS PROCESS MANAG J, V25, P1040, DOI 10.1108/BPMJ-01-2018-0023; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dahlgrun PW, 2019, J INT MANAG, V25, P81, DOI 10.1016/j.intman.2018.08.001; Das KK, 2008, INDIAN J MED RES, V128, P412; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Dijkstra TK, 2015, COMPUT STAT DATA AN, V81, P10, DOI 10.1016/j.csda.2014.07.008; Duxbury LE, 1996, J VOCAT BEHAV, V49, P1, DOI 10.1006/jvbe.1996.0030; Dwivedi YK, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102211; Edwards JR, 2000, PSYCHOL METHODS, V5, P155, DOI 10.1037//1082-989X.5.2.155; Fagerland MW, 2009, STAT MED, V28, P1487, DOI 10.1002/sim.3561; Ferraris A, 2018, BUS PROCESS MANAG J, V24, P1077, DOI 10.1108/BPMJ-07-2017-0201; Gangwar H, 2015, J ENTERP INF MANAG, V28, P107, DOI 10.1108/JEIM-08-2013-0065; Gaspar D., 2015, UNIVERSAL J ED RES, V3, P598, DOI [10.13189/ujer.2015.030903, DOI 10.13189/UJER.2015.030903]; GEISSER S, 1974, BIOMETRIKA, V61, P101, DOI 10.1093/biomet/61.1.101; Gong YW, 2012, GOV INFORM Q, V29, pS61, DOI 10.1016/j.giq.2011.08.004; Grisold T., 2019, LECT NOTES COMPUTER, P23, DOI [10.1007/978-3-030-26619-6_4, DOI 10.1007/978-3-030-26619-6_4]; Haar JM, 2007, QUAL RES ACCOUNT MAN, V4, P69, DOI 10.1108/11766090710732514; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hair JF, 2020, J BUS RES, V109, P101, DOI 10.1016/j.jbusres.2019.11.069; Hair JF, 2014, EUR BUS REV, V26, P106, DOI 10.1108/EBR-10-2013-0128; Hair JF, 2019, EUR BUS REV, V31, P2, DOI 10.1108/EBR-11-2018-0203; Hair Jr J.F., 2017, INT J MULTIVARIATE D, V1, P107, DOI [10.1504/ijmda.2017.10008574, DOI 10.1504/IJMDA.2017.10008574, 10.1504/IJMDA.2017.087624]; Handley M, 2020, WHAT CORONAVIRUS MEA; HARWELL MR, 1988, J COUNS DEV, V67, P35, DOI 10.1002/j.1556-6676.1988.tb02007.x; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Hsu H-H, 2013, EXTENDED TAM MODEL I; Huang YC, 2019, J HOSP MARKET MANAG, V28, P957, DOI 10.1080/19368623.2019.1580172; JORESKOG KG, 1971, PSYCHOMETRIKA, V36, P409, DOI 10.1007/BF02291366; Kabra G, 2016, RISK HAZARDS CRISIS, V7, P79, DOI 10.1002/rhc3.12096; Ketchen DJ, 2013, LONG RANGE PLANN, V46, P184, DOI 10.1016/j.lrp.2013.01.002; Kim JH, 2021, ABACUS, V57, P27, DOI 10.1111/abac.12172; Kohlborn T, 2014, BUS PROCESS MANAG J, V20, P634, DOI 10.1108/BPMJ-02-2014-0012; Kumar P., 2003, J COMPUTING TEACHER, V19; Lubatkin MH, 2006, J MANAGE, V32, P646, DOI 10.1177/0149206306290712; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; Mehravani S, 2011, INT P ECON DEV RES, V5, P33; Mohanty AK, 2011, USING TAM MODEL EXPL; Muninger MI, 2019, J BUS RES, V95, P116, DOI 10.1016/j.jbusres.2018.10.012; Nagy S, 2021, AMFITEATRU ECON, V23, P155, DOI 10.24818/EA/2021/56/155; Natalia I., 2019, INT J RES CULTURE SO, V3, P10; Natoli R, 2014, PEDAGOGIES, V9, P116, DOI 10.1080/1554480X.2014.912519; Nejati M, 2017, J CLEAN PROD, V168, P163, DOI 10.1016/j.jclepro.2017.08.213; Nordstokke D.W., 2011, PRACT ASSESMENT RES, V16, P1, DOI DOI 10.7275/5T99-ZV93; Pathak B, 2020, INT J INFORM MANAGE, V52, DOI 10.1016/j.ijinfomgt.2020.102093; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ramayah T., 2018, PARTIAL LEAST SQUARE, V1st ed.; Ramli NA, 2018, INT SER OPER RES MAN, V267, P171, DOI 10.1007/978-3-319-71691-6_6; Reeves Martin., 2020, NIKOLAUS LANG PC S L; Rialti R, 2018, BUS PROCESS MANAG J, V24, P1091, DOI 10.1108/BPMJ-07-2017-0210; Ritter T, 2020, IND MARKET MANAG, V88, P214, DOI 10.1016/j.indmarman.2020.05.014; Robbins MW, 2019, BLENDING PROBABILITY; Rosemann M., 2014, LNBIP, V181, P1, DOI [10.1007/978-3-319-08222-6_1, DOI 10.1007/978-3-319-08222-6_1]; Sahu P, 2020, CUREUS, V12, DOI 10.7759/cureus.7541; Savic D, 2020, COVID 19 WORK HOME D; Schipper M, 2018, IEEE GLOB ENG EDUC C, P217; Shao Z, 2022, INFORM SYST J, V32, P544, DOI 10.1111/isj.12361; Shmueli G, 2011, MIS QUART, V35, P553; Sik Chang H, 2016, INT J MOBILE COMMUNI; Stanton JM, 2000, HUM PERFORM, V13, P85, DOI 10.1207/S15327043HUP1301_4; Stierand M, 2015, MANAGE LEARN, V46, P598, DOI 10.1177/1350507614560302; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sudarsono H, 2020, J ASIAN FINANC ECON, V7, P789, DOI 10.13106/jafeb.2020.vol7.no11.789; Valentine S, 2006, J BUS RES, V59, P582, DOI 10.1016/j.jbusres.2005.06.004; Van Hecke T, 2012, J STAT MANAG SYST, V15, P241, DOI 10.1080/09720510.2012.10701623; Van Looy A, 2021, KNOWL PROCESS MANAG, V28, P107, DOI 10.1002/kpm.1659; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Yli-Ojanpera M, 2019, J IND INF INTEGR, V15, P147, DOI 10.1016/j.jii.2018.12.002; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; Ziyadin S., 2020, Digital Age: Chances, Challenges and Future. Lecture Notes in Networks and Systems (LNNS 84), P408, DOI 10.1007/978-3-030-27015-5_49	85	1	1	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259226	10.1371/journal.pone.0259226	http://dx.doi.org/10.1371/journal.pone.0259226			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735499	Green Published, gold			2022-12-26	WOS:000755077100055
J	Brindle, E; Lillis, L; Barney, R; Bansil, P; Hess, SY; Wessells, KR; Ouedraogo, CT; Arredondo, F; Barker, MK; Craft, NE; Fischer, C; Graham, JL; Havel, PJ; Karakochuk, CD; Zhang, M; Mussai, EX; Mapango, C; Randolph, JM; Wander, K; Pfeiffer, CM; Murphy, E; Boyle, DS				Brindle, Eleanor; Lillis, Lorraine; Barney, Rebecca; Bansil, Pooja; Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.; Arredondo, Francisco; Barker, Mikaela K.; Craft, Neal E.; Fischer, Christina; Graham, James L.; Havel, Peter J.; Karakochuk, Crystal D.; Zhang, Mindy; Mussai, Ei-Xia; Mapango, Carine; Randolph, Jody M.; Wander, Katherine; Pfeiffer, Christine M.; Murphy, Eileen; Boyle, David S.			A multicenter analytical performance evaluation of a multiplexed immunoarray for the simultaneous measurement of biomarkers of micronutrient deficiency, inflammation and malarial antigenemia	PLOS ONE			English	Article							ENZYME-IMMUNOASSAY; NUTRITION; ANTIBODIES; PROTEIN; PLASMA; SERUM	A lack of comparative data across laboratories is often a barrier to the uptake and adoption of new technologies. Furthermore, data generated by different immunoassay methods may be incomparable due to a lack of harmonization. In this multicenter study, we describe validation experiments conducted in a single lab and cross-lab comparisons of assay results to assess the performance characteristics of the Q-plex((TM)) 7-plex Human Micronutrient Array (7-plex), an immunoassay that simultaneously quantifies seven biomarkers associated with micronutrient (MN) deficiencies, inflammation and malarial antigenemia using plasma or serum; alpha-1-acid glycoprotein, C-reactive protein, ferritin, histidine-rich protein 2, retinol binding protein 4, soluble transferrin receptor, and thyroglobulin. Validations included repeated testing (n = 20 separately prepared experiments on 10 assay plates) in a single lab to assess precision and linearity. Seven independent laboratories tested 76 identical heparin plasma samples collected from a cohort of pregnant women in Niger using the same 7-plex assay to assess differences in results across laboratories. In the analytical validation experiments, intra- and inter-assay coefficients of variation were acceptable at <6% and <15% respectively and assay linearity was 96% to 99% with the exception of ferritin, which had marginal performance in some tests. Cross-laboratory comparisons showed generally good agreement between laboratories in all analyte results for the panel of 76 plasma specimens, with Lin's concordance correlation coefficient values averaging >= 0.8 for all analytes. Excluding plates that would fail routine quality control (QC) standards, the inter-assay variation was acceptable for all analytes except sTfR, which had an average inter-assay coefficient of variation of >= 20%. This initial cross-laboratory study demonstrates that the 7-plex test protocol can be implemented by users with some experience in immunoassay methods, but familiarity with the multiplexed protocol was not essential.	[Brindle, Eleanor] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Lillis, Lorraine; Barney, Rebecca; Bansil, Pooja; Murphy, Eileen; Boyle, David S.] PATH, Seattle, WA 98121 USA; [Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.; Graham, James L.; Havel, Peter J.; Randolph, Jody M.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Hess, Sonja Y.; Wessells, K. Ryan; Ouedraogo, Cesaire T.; Graham, James L.; Havel, Peter J.; Randolph, Jody M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Ouedraogo, Cesaire T.] Helen Keller Int, Niamey, Niger; [Arredondo, Francisco] Duke Univ, Med Ctr, Durham, NC USA; [Barker, Mikaela K.; Karakochuk, Crystal D.; Mussai, Ei-Xia] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada; [Craft, Neal E.] Craft Nutr Consulting, Elm City, NC USA; [Fischer, Christina; Zhang, Mindy; Mapango, Carine; Pfeiffer, Christine M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Wander, Katherine] Binghamton Univ SUNY, Binghamton, NY USA	University of Washington; University of Washington Seattle; University of California System; University of California Davis; University of California System; University of California Davis; Duke University; University of British Columbia; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Boyle, DS (corresponding author), PATH, Seattle, WA 98121 USA.	dboyle@path.org	Wander, Katherine/AAL-1551-2020	Wander, Katherine/0000-0002-4913-5075; Hess, Sonja/0000-0002-4661-277X				Almekinder J, 2000, SCAND J CLIN LAB INV, V60, P199, DOI 10.1080/003655100750044848; Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Arndt MB, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008711; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biesalski HK, 2016, WORLD REV NUTR DIET; Brindle E., DRIED BLOOD SPOTS; Brindle E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210212; Brindle E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185868; Brindle E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115164; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; COOPER GJS, 1984, NEW ZEAL MED J, V97, P142; Darnton-Hill I, 2005, AM J CLIN NUTR, V81, p1198S; DERUYTER MGM, 1976, CLIN CHEM, V22, P1593; Esmaeili R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215782; Holle JU, 2005, ANN RHEUM DIS, V64, P1773, DOI 10.1136/ard.2005.035279; Institute of Medicine (US) Committee on Micronutrient Deficiencies, 1998, PREV MICR DEF TOOLS; Jang IK, 2020, AM J TROP MED HYG, V102, P1366, DOI 10.4269/ajtmh.19-0763; Karakochuk CD, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8010013; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lynch S, 2018, J NUTR, V148, p1001S, DOI 10.1093/jn/nxx036; Miller WG, 2011, CLIN CHEM, V57, P1670, DOI 10.1373/clinchem.2011.168641; Ng DS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45081; Pardina A., 2018, INT J HEMATOLOGY THE, P36; RODBARD D, 1974, CLIN CHEM, V20, P1255; Rohner F, 2014, J NUTR, V144, p1322S, DOI 10.3945/jn.113.181974; Salvante KG, 2012, AM J HUM BIOL, V24, P81, DOI 10.1002/ajhb.21229; Silubonde TM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030633; Symington EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221299; Tanumihardjo SA, 2016, J NUTR, V146, P1816, DOI 10.3945/jn.115.229708; USFDA, 2018, BIOAN METH VAL GUID; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Wessells KR, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050430; World Health Organization and Food and Agricultural Organization of the United Nations, 2009, EV PUBL HLTH SIGN MI; Zimmermann MB, 2013, J CLIN ENDOCR METAB, V98, P1271, DOI 10.1210/jc.2012-3952	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259509	10.1371/journal.pone.0259509	http://dx.doi.org/10.1371/journal.pone.0259509			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735520	Green Submitted, Green Published, gold			2022-12-26	WOS:000755077100082
J	Benitez-Sillero, JD; Corredor-Corredor, D; Ortega-Ruiz, R; Cordoba-Alcaide, F				de Dios Benitez-Sillero, Juan; Corredor-Corredor, Diego; Ortega-Ruiz, Rosario; Cordoba-Alcaide, Francisco			Behaviours involved in the role of victim and aggressor in bullying: Relationship with physical fitness in adolescents	PLOS ONE			English	Article							CHILDREN; HEALTH; SCHOOL; ASSOCIATIONS; WEIGHT; VICTIMIZATION; STRENGTH; OBESITY; SAMPLE	Physical fitness is related to well-being and health. Adolescence is a key period in the psychological and social development of the person, in which interpersonal relationships gain strength, being bullying a type of violence that can affect the personality of those involved. At present, there is not enough research to determine the relationships between bullying and physical condition. The purpose of this study is to find out if there are any relationships among physical fitness, victimisation, and aggression in bullying, and to identify these behaviours. This is a descriptive study done in 1035 adolescents aged 12 to 17 years (M = 14.67, SD = 1.49). The European Bullying Intervention Project Questionnaire (EBIPQ) scale was used, and anthropometric characteristics of weight and height were measured. In addition, physical fitness tests from the Eurofit battery, sit-and-reach, 30-second sit-ups, horizontal jump, manual dynamometry, and 20-meter Multistage Shuttle Run Test (SRT) were included. The relationships between variables were analysed using Spearman correlations, linear regressions, and ordinal regressions. The most relevant findings indicate an inverse relationship between being a victim of bullying and having a better cardiorespiratory cardiovascular endurance. These also show a direct relationship between being a bully and skeletal muscle strength measured through the horizontal jump, 30-second sit-ups, and manual dynamometry tests. Theoretically, we can conclude that physical condition can be considered a predictor to consider in bullying. Specifically, cardiorespiratory fitness, in addition to its multiple physical and mental benefits, may be a protective element against bullying victimisation. In contrast, muscular strength, especially in boys, may be an important predictor, especially in the physical component, of aggression in bullying.	[de Dios Benitez-Sillero, Juan] Univ Cordoba, Dept Specif Didact, Cordoba, Spain; [de Dios Benitez-Sillero, Juan; Ortega-Ruiz, Rosario; Cordoba-Alcaide, Francisco] Lab Studies Coexistence & Prevent Violence LAECOV, Cordoba, Spain; [Corredor-Corredor, Diego] Junta Andalucia, Counseling Educ, Andalucia, Spain; [Ortega-Ruiz, Rosario; Cordoba-Alcaide, Francisco] Univ Cordoba, Dept Psychol, Cordoba, Spain	Universidad de Cordoba; Universidad de Cordoba	Benitez-Sillero, JD (corresponding author), Univ Cordoba, Dept Specif Didact, Cordoba, Spain.; Benitez-Sillero, JD (corresponding author), Lab Studies Coexistence & Prevent Violence LAECOV, Cordoba, Spain.	eo1besij@uco.es		Benitez-Sillero, Juan de Dios/0000-0003-1861-2913				Aime A, 2017, EUR REV APPL PSYCHOL, V67, P163, DOI 10.1016/j.erap.2017.02.001; [Anonymous], 1993, HDB EUROFIT TESTS PH; Belcher BR, 2021, BIOL PSYCHIAT-COGN N, V6, P225, DOI 10.1016/j.bpsc.2020.08.005; Benitez-Sillero JD, 2021, PHYS EDUC SPORT PEDA, V26, P36, DOI 10.1080/17408989.2020.1799968; Berger C, 2016, J ADOLESCENCE, V46, P45, DOI 10.1016/j.adolescence.2015.10.020; Beunen G, 2000, PEDIATR EXERC SCI, V12, P174, DOI 10.1123/pes.12.2.174; Cerezo F, 2015, REV PSICODIDACT, V20, P139, DOI 10.1387/RevPsicodidact.11097; Chen HC, 2016, CHILD INDIC RES, V9, P565, DOI 10.1007/s12187-015-9330-6; Corredor-Corredor D, 2019, SCI SPORT, V34, P228, DOI 10.1016/j.scispo.2018.10.014; Benitez-Sillero JD, 2020, MOVIMENTO-PORTO ALEG, V26, DOI 10.22456/1982-8918.105169; Deryol R, 2020, VICTIMS OFFENDERS, V15, P520, DOI 10.1080/15564886.2020.1732510; Deuster Patricia A, 2013, US Army Med Dep J, P24; Elipe P, 2012, BEHAV PSYCHOL, V20, P169; Evelein AMV, 2011, AM J CLIN NUTR, V93, P712, DOI 10.3945/ajcn.110.002980; Ganley KJ, 2011, PEDIATR PHYS THER, V23, P208, DOI 10.1097/PEP.0b013e318227b3fc; Garaigordobil M, 2009, J ADOLESCENT HEALTH, V44, P468, DOI 10.1016/j.jadohealth.2008.09.014; Fernandez CMG, 2015, PSICOTHEMA, V27, P347, DOI 10.7334/psicothema2015.35; Garcia-Hermoso A, 2019, INT J CLIN HLTH PSYC, V19, P134, DOI 10.1016/j.ijchp.2019.02.006; Greenleaf C, 2014, J SCHOOL HEALTH, V84, P49, DOI 10.1111/josh.12118; Fernandez-Bustos JG, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17061890; Halfon N, 2013, ACAD PEDIATR, V13, P6, DOI 10.1016/j.acap.2012.10.007; Hartin SN, 2020, J AGGRESS MALTREAT T, V29, P1059, DOI 10.1080/10926771.2019.1685043; Hormazabal-Aguayo I, 2019, INT J CLIN HLTH PSYC, V19, P237, DOI 10.1016/j.ijchp.2019.05.001; Hymel S, 2015, AM PSYCHOL, V70, P293, DOI 10.1037/a0038928; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Jimenez-Moral JA, 2013, REV PSICOL DEPORTE, V22, P429; LaVigne T, 2016, J CLIN SPORT PSYCHOL, V10, P32, DOI 10.1123/jcsp.2014-0053; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Llorente-Cantarero FJ, 2012, FREE RADICAL BIO MED, V53, P415, DOI 10.1016/j.freeradbiomed.2012.05.017; Martinez VR., 2015, PSYCHOL SOC EDUC, V7, P201; Menesini E, 2017, PSYCHOL HEALTH MED, V22, P240, DOI 10.1080/13548506.2017.1279740; Menin D, 2021, INT J CLIN HLTH PSYC, V21, DOI 10.1016/j.ijchp.2021.100221; Mikkelsson LO, 2006, BRIT J SPORT MED, V40, P107, DOI 10.1136/bjsm.2004.017350; Moreno-Bataller C.B., 2019, ESTUDIOS EDUCACI N, V37, P113, DOI [10.15581/004.37.113-134, DOI 10.15581/004.37.113-134]; Mucke M, 2021, J PSYCHOPHYSIOL, V35, P23, DOI 10.1027/0269-8803/a000258; Oliva A, 2013, J CHILD ADOL PS NURS, V4, P129; OLWEUS D, 1994, J CHILD PSYCHOL PSYC, V35, P1171, DOI 10.1111/j.1469-7610.1994.tb01229.x; Olweus D, 1993, BULLYING SCH WHAT WE, DOI DOI 10.1007/978-1-4757-9116-7_5; Olweus D., 2006, CONDUCTAS ACOSO AMEN, V3a; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2005, REV ESP CARDIOL, V58, P898, DOI 10.1016/S1885-5857(06)60372-1; Ortega Ruiz R., 2010, AGRESIVIDAD INJUSTIF, V4, P416; Ortega-Ruiz R, 2016, PSICOL EDUC, V22, P71, DOI 10.1016/j.pse.2016.01.004; PERRY DG, 1988, DEV PSYCHOL, V24, P807, DOI 10.1037/0012-1649.24.6.807; Piko BF, 2006, PERS INDIV DIFFER, V40, P885, DOI 10.1016/j.paid.2005.08.012; Ruiz LR, 2006, J HAND SURG-AM, V31A, P1367, DOI 10.1016/j.jhsa.2006.06.014; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Smith PK, 2019, AGGRESS VIOLENT BEH, V45, P33, DOI 10.1016/j.avb.2018.04.006; Thakkar N, 2021, AGGRESSIVE BEHAV, V47, P236, DOI 10.1002/ab.21942; Tomkinson GR, 2018, BRIT J SPORT MED, V52, P1445, DOI 10.1136/bjsports-2017-098253; Tomkinson Grant R, 2007, Med Sport Sci, V50, P104, DOI 10.1159/000101355; Tremblay RE, 1998, INT J BEHAV DEV, V22, P753, DOI 10.1080/016502598384153; Waasdorp TE, 2018, AM J ORTHOPSYCHIAT, V88, P483, DOI 10.1037/ort0000294; Zeller MH, 2008, OBESITY, V16, P755, DOI 10.1038/oby.2008.4; Zych I, 2019, AGGRESS VIOLENT BEH, V45, P4, DOI 10.1016/j.avb.2018.06.008	55	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259087	10.1371/journal.pone.0259087	http://dx.doi.org/10.1371/journal.pone.0259087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735472	Green Published, gold			2022-12-26	WOS:000755077100045
J	Flood, MW; Grimm, B				Flood, Matthew W.; Grimm, Bernd			EntropyHub: An open-source toolkit for entropic time series analysis	PLOS ONE			English	Article							HEART PERIOD VARIABILITY; APPROXIMATE ENTROPY; MULTISCALE ENTROPY; PERMUTATION ENTROPY; DISPERSION ENTROPY; APPROPRIATE USE; SAMPLE ENTROPY; IRREGULARITY; COMPLEXITY; REGULARITY	An increasing number of studies across many research fields from biomedical engineering to finance are employing measures of entropy to quantify the regularity, variability or randomness of time series and image data. Entropy, as it relates to information theory and dynamical systems theory, can be estimated in many ways, with newly developed methods being continuously introduced in the scientific literature. Despite the growing interest in entropic time series and image analysis, there is a shortage of validated, open-source software tools that enable researchers to apply these methods. To date, packages for performing entropy analysis are often run using graphical user interfaces, lack the necessary supporting documentation, or do not include functions for more advanced entropy methods, such as cross-entropy, multiscale cross-entropy or bidimensional entropy. In light of this, this paper introduces EntropyHub, an open-source toolkit for performing entropic time series analysis in MATLAB, Python and Julia. EntropyHub (version 0.1) provides an extensive range of more than forty functions for estimating cross-, multiscale, multiscale cross-, and bidimensional entropy, each including a number of keyword arguments that allows the user to specify multiple parameters in the entropy calculation. Instructions for installation, descriptions of function syntax, and examples of use are fully detailed in the supporting documentation, available on the EntropyHub website- www.EntropyHub.xyz. Compatible with Windows, Mac and Linux operating systems, EntropyHub is hosted on GitHub, as well as the native package repository for MATLAB, Python and Julia, respectively. The goal of EntropyHub is to integrate the many established entropy methods into one complete resource, providing tools that make advanced entropic time series analysis straightforward and reproducible.	[Flood, Matthew W.; Grimm, Bernd] Luxembourg Inst Hlth, Human Mot Orthopaed Sports Med & Digital Methods, Luxembourg, Luxembourg	Luxembourg Institute of Health	Flood, MW (corresponding author), Luxembourg Inst Hlth, Human Mot Orthopaed Sports Med & Digital Methods, Luxembourg, Luxembourg.	matthew.flood@lih.lu	Flood, Matthew W./AAE-9833-2020	Flood, Matthew W./0000-0002-5674-424X				Abasolo D, 2005, CLIN NEUROPHYSIOL, V116, P1826, DOI 10.1016/j.clinph.2005.04.001; Azami H, 2019, SIGNAL PROCESS-IMAGE, V75, P178, DOI 10.1016/j.image.2019.04.013; Azami H, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20030210; Azami H, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20020138; Azami H, 2017, IEEE SIGNAL PROC LET, V24, P1338, DOI 10.1109/LSP.2017.2723505; Azami H, 2016, COMPUT METH PROG BIO, V128, P40, DOI 10.1016/j.cmpb.2016.02.008; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bian CH, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021906; Castiglioni P, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19110590; Chanwimalueang T, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19120652; Chen WT, 2007, IEEE T NEUR SYS REH, V15, P266, DOI 10.1109/TNSRE.2007.897025; Chen Z., 2019, COMPLEXITY, V2019, DOI [10.1155/2019/4203158, DOI 10.1155/2019/4203158]; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.089804; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Frau DC, 2019, MATH BIOSCI ENG, V16, P6842, DOI 10.3934/mbe.2019342; Cuesta-Frau D, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21121167; Cuesta-Frau D, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21040385; Drake F. L, PYTHON REFERENCE MAN; Dunki RM., 1991, B MATH BIOL, DOI [10.1007/BF02461547, DOI 10.1007/BF02461547]; Fadlallah B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022911; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Flood MW, 2019, CLIN NEUROPHYSIOL, V130, P259, DOI 10.1016/j.clinph.2018.10.023; Fu WL, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21040404; Gao JB, 2012, NONLINEAR DYNAM, V68, P431, DOI 10.1007/s11071-011-0281-2; Gao L, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036023; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Guzik P, 2006, BIOMED TECH, V51, P272, DOI 10.1515/BMT.2006.054; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Hilal M., 2019, 2019 5 INT C ADV BIO; Hsu CF, 2019, PHYSICA A, V529, DOI 10.1016/j.physa.2019.121533; Hsu CF, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19100550; Hu M, 2011, COGN NEURODYNAMICS, V5, P277, DOI 10.1007/s11571-011-9159-8; Humeau-Heurtier A, 2019, IEEE ACCESS, V7, P8975, DOI 10.1109/ACCESS.2018.2890743; Humeau-Heurtier A, 2015, IEEE SIGNAL PROC LET, V22, P2364, DOI 10.1109/LSP.2015.2482603; Humeau-Heurtier A, 2015, ENTROPY-SWITZ, V17, P3110, DOI 10.3390/e17053110; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Huo ZQ, 2020, IEEE T INSTRUM MEAS, V69, P2607, DOI 10.1109/TIM.2020.2981220; Huo ZQ, 2019, IEEE IND ELEC, P5998, DOI 10.1109/IECON.2019.8927449; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Jamin A, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22010045; Jamin A, 2019, IEEE ENG MED BIO, P733, DOI 10.1109/EMBC.2019.8856815; Jiang Y, 2011, J COMPUT APPL MATH, V236, P728, DOI 10.1016/j.cam.2011.06.007; Joppa LN, 2013, SCIENCE, V340, P814, DOI 10.1126/science.1231535; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Karmakar CK, 2015, PHYSIOL MEAS, V36, P303, DOI 10.1088/0967-3334/36/2/303; Kostic MM, 2014, ENTROPY-SWITZ, V16, P953, DOI 10.3390/e16020953; Kuntzelman K, 2018, BRAIN COGNITION, V123, P126, DOI 10.1016/j.bandc.2018.03.010; Laszuk D., PYEMD PYTHON IMPLEME; Li P, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0650-5; Li P, 2015, MED BIOL ENG COMPUT, V53, P77, DOI 10.1007/s11517-014-1216-0; Li WS, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21070694; Li YB, 2018, IEEE ACCESS, V6, P66723, DOI 10.1109/ACCESS.2018.2873782; Li YB, 2017, MECH SYST SIGNAL PR, V91, P295, DOI 10.1016/j.ymssp.2016.12.040; Li YX, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19235203; Liu XF, 2009, CHINESE PHYS B, V18, P2690, DOI 10.1088/1674-1056/18/7/011; Liu XF, 2018, COMPUT BIOL MED, V95, P13, DOI 10.1016/j.compbiomed.2018.01.009; Liu XF, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18010022; Manis G, 2017, IEEE T BIO-MED ENG, V64, P2711, DOI 10.1109/TBME.2017.2664105; Marwaha P, 2015, CARDIOVASC ENG TECHN, V6, P557, DOI 10.1007/s13239-015-0242-x; Mayor D, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23030321; McManus L, 2019, J NEUROPHYSIOL, V122, P1147, DOI 10.1152/jn.00228.2019; Moody GB, 2001, IEEE ENG MED BIOL, V20, P70, DOI 10.1109/51.932728; Nikulin VV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.089803; Pham TD, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19060257; Piccolo SR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0135-4; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus S, 2008, ECONOMET REV, V27, P329, DOI 10.1080/07474930801959750; Popovic ME, 2018, THERM SCI, V22, P1163, DOI 10.2298/TSCI180115012P; Porta A, 2008, AM J PHYSIOL-REG I, V295, pR550, DOI 10.1152/ajpregu.00129.2008; Porta A, 1999, BIOL CYBERN, V81, P119, DOI 10.1007/s004220050549; POWELL GE, 1979, J PHYS A-MATH GEN, V12, P2053, DOI 10.1088/0305-4470/12/11/017; Rajagopalan V, 2006, SIGNAL PROCESS, V86, P3309, DOI 10.1016/j.sigpro.2006.01.014; Ramdani S, 2009, CHAOS, V19, DOI 10.1063/1.3081406; Ribeiro M, 2021, ENTROPY-SWITZ, V23, DOI 10.3390/e23020222; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riedl M, 2013, EUR PHYS J-SPEC TOP, V222, P249, DOI 10.1140/epjst/e2013-01862-7; Rohila A, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab499e; Rostaghi M, 2016, IEEE SIGNAL PROC LET, V23, P610, DOI 10.1109/LSP.2016.2542881; Rui Yan, 2009, Proceedings of the 2009 Fifth International Conference on Natural Computation (ICNC 2009), P411, DOI 10.1109/ICNC.2009.118; dos Santos LFS, 2018, COMPUT BIOL MED, V103, P148, DOI 10.1016/j.compbiomed.2018.10.013; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shi WB, 2015, NONLINEAR DYNAM, V79, P2439, DOI 10.1007/s11071-014-1823-1; Silva LEV, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/4/045002; Thuraisingham RA, 2006, PHYSICA A, V366, P323, DOI 10.1016/j.physa.2005.10.008; Silva LEV, 2020, COMPUT METH PROG BIO, V197, DOI 10.1016/j.cmpb.2020.105718; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang J, 2015, 2015 IEEE INT C SIGN, P1, DOI DOI 10.1109/ICSPCC.2015.7338844; Wang YY, 2018, NONLINEAR DYNAM, V94, P1361, DOI 10.1007/s11071-018-4429-1; Wu HT, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/231762; Wu SD, 2014, PHYS LETT A, V378, P1369, DOI 10.1016/j.physleta.2014.03.034; Wu SD, 2013, ENTROPY-SWITZ, V15, P1069, DOI 10.3390/e15031069; Xie HB, 2010, INFORM SCIENCES, V180, P1715, DOI 10.1016/j.ins.2010.01.004; Xie HB, 2008, PHYS LETT A, V372, P7140, DOI 10.1016/j.physleta.2008.10.049; Xiong WT, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.062114; Xu M, 2019, PHYSICA A, V536, DOI 10.1016/j.physa.2019.04.152; Yan C, 2019, COMPUT BIOL MED, V109, P280, DOI 10.1016/j.compbiomed.2019.04.015; Yan C, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0402-3; Yang J., 2020, IEEE T AFFECT COMPUT, DOI [10.1109/TAFFC.2017.2784832, DOI 10.1109/TAFFC.2017.2784832]; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3; Yin Y, 2016, APPL MATH COMPUT, V289, P98, DOI 10.1016/j.amc.2016.05.013; Yin Y, 2015, PHYSICA A, V433, P17, DOI 10.1016/j.physa.2015.03.055; Zhang XS, 2001, IEEE T BIO-MED ENG, V48, P1424, DOI 10.1109/10.966601; Zhou RX, 2013, ENTROPY-SWITZ, V15, P4909, DOI 10.3390/e15114909	105	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259448	10.1371/journal.pone.0259448	http://dx.doi.org/10.1371/journal.pone.0259448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735497	gold, Green Published			2022-12-26	WOS:000755077100076
J	Haendiges, J; Davidson, GR; Pettengill, JB; Reed, E; Ramachandran, P; Blessington, T; Miller, JD; Anderson, N; Myoda, S; Brown, EW; Zheng, J; Tikekar, R; Hoffmann, M				Haendiges, Julie; Davidson, Gordon R.; Pettengill, James B.; Reed, Elizabeth; Ramachandran, Padmini; Blessington, Tyann; Miller, Jesse D.; Anderson, Nathan; Myoda, Sam; Brown, Eric W.; Zheng, Jie; Tikekar, Rohan; Hoffmann, Maria			Genomic evidence of environmental and resident Salmonella Senftenberg and Montevideo contamination in the pistachio supply-chain	PLOS ONE			English	Article							FOOD-BORNE OUTBREAK; SURVIVAL KINETICS; ENTERITIDIS; CHICKENS; HEALTH; GROWTH; NUTS	Pistachios have been implicated in two salmonellosis outbreaks and multiple recalls in the U.S. This study performed an in-depth retrospective data analysis of Salmonella associated with pistachios as well as a storage study to evaluate the survivability of Salmonella on inoculated inshell pistachios to further understand the genetics and microbiological dynamics of this commodity-pathogen pair. The retrospective data analysis on isolates associated with pistachios was performed utilizing short-read and long-read sequencing technologies. The sequence data were analyzed using two methods: the FDA's Center for Food Safety and Applied Nutrition Single Nucleotide Polymorphism (SNP) analysis and Whole Genome Multilocus Sequence Typing (wgMLST). The year-long storage study evaluated the survival of five strains of Salmonella on pistachios stored at 25 degrees C at 35% and 54% relative humidity (RH). Our results demonstrate: i) evidence of persistent Salmonella Senftenberg and Salmonella Montevideo strains in pistachio environments, some of which may be due to clonal resident strains and some of which may be due to preharvest contamination; ii) presence of the Copper Homeostasis and Silver Resistance Island (CHASRI) in Salmonella Senftenberg and Montevideo strains in the pistachio supply chain; and iii) the use of metagenomic analysis is a novel tool for determining the composition of serovar survival in a cocktail inoculated storage study.	[Haendiges, Julie; Davidson, Gordon R.; Pettengill, James B.; Reed, Elizabeth; Ramachandran, Padmini; Blessington, Tyann; Brown, Eric W.; Zheng, Jie; Hoffmann, Maria] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20993 USA; [Haendiges, Julie; Tikekar, Rohan] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Miller, Jesse D.] Neogen Corp, Lansing, MI USA; [Anderson, Nathan] Food & Drug Adm, Ctr Food Safety & Appl Nutr, Bedford Pk, IL USA; [Myoda, Sam] IEH Inc, Seattle, WA USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Haendiges, J (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD 20993 USA.; Haendiges, J (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	Julie.haendiges@fda.hhs.gov; Maria.hoffmann@fda.hhs.gov		Reed, Elizabeth/0000-0001-7767-9435; Tikekar, Rohan/0000-0002-7915-3848; Zheng, Jie/0000-0003-3447-9681; Haendiges, Julie/0000-0003-0109-9711				Adaskaveg J E, 2017, EFFICACY TIMING FUNG; Agriculture Marketing Resource Center, 2018, PIST; Akande Taiwo O., 2015, Journal of Animal Science and Technology, V57, P17, DOI 10.1186/s40781-015-0051-7; Alikhan NF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007261; Allard MW, 2016, J CLIN MICROBIOL, V54, P1975, DOI 10.1128/JCM.00081-16; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; American Pistachio Growers, 2017, GROW HARV AM PIST; Andrews EM, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11070580; Antony L, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0279-0; Arai N, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00429-19; Arndt D, 2019, BRIEF BIOINFORM, V20, P1560, DOI 10.1093/bib/bbx121; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beede R H, 2017, PISTACHIO MICRONUTRI; Beede RH., 2016, PISTACHIO PRODUCTION, DOI [10.1152/ajpregu.00528.2015, DOI 10.1152/AJPREGU.00528.2015]; Beuchat LR, 2013, J FOOD PROTECT, V76, P150, DOI 10.4315/0362-028X.JFP-12-211; Brar PK, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.PFS-0023-2018; Brown E, 2019, FOODBORNE PATHOG DIS, V16, P441, DOI 10.1089/fpd.2019.2662; California Pistachio Review Board, GOOD ALGR PRACT MAN; Campos J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.26.30270; Carroll LM, 2019, MBIO, V10, DOI 10.1128/mBio.00853-19; CDC, 2016, MULT OUTBR SALM MONT; CDC (Center for Disease Control and Prevention), 2009, MULT OUTBR SALM INF; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Esmaeili A., 2020, J CLEAN PROD, V242; Farakos SMS, 2018, J FOOD PROTECT, V81, P1001, DOI 10.4315/0362-028X.JFP-17-379; Farakos SMS, 2017, J FOOD PROTECT, V80, P879, DOI 10.4315/0362-028X.JFP-16-392; Farakos SMS, 2016, INT J FOOD MICROBIOL, V227, P41, DOI [10.1016/j.ijfoodmicro.2016.03.014, 10.1016/j.ijfoodmicro.2016.03:014]; FDA, 2016, FDA INV MULT OUTBR S; Fernandez-Bayo JD, 2020, WASTE MANAGE, V101, P74, DOI 10.1016/j.wasman.2019.09.028; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Food and Drug Administration (FDA), 2009, FDA WARNS CONS EAT C; Food and Drug Administration (FDA), 2014, FDA INV SUMM MULT OU; Haendiges J., 2019, MICROBIOL RESOUR ANN, V8; Haendiges J, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00975-19; Haendiges J, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00630-18, 10.1128/genomea.00630-18]; Harris LJ, 2016, J FOOD PROTECT, V79, P1304, DOI 10.4315/0362-028X.JFP-16-054; Harris LJ, 2019, OUTBREAKS FOODBORNE; Hoffmann M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00478; Hoffmann M, 2016, J INFECT DIS, V213, P502, DOI 10.1093/infdis/jiv297; Jalili M, 2019, ECOTOX ENVIRON SAFE, V171, P798, DOI 10.1016/j.ecoenv.2019.01.056; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Karagoktas M, 2014, 9 INT SOIL SCI C; Keller SE, 2013, FOOD MICROBIOL, V34, P182, DOI 10.1016/j.fm.2012.12.002; Kieffer N, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00965-19; Kimber MA, 2012, J FOOD PROTECT, V75, P1394, DOI 10.4315/0362-028X.JFP-12-023; Lee L. E., 2011, Food Protection Trends, V31, P18; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; McQuiston JR, 2011, J CLIN MICROBIOL, V49, P565, DOI 10.1128/JCM.01323-10; Mourao J, 2020, ENVIRON MICROBIOL, V22, P2829, DOI 10.1111/1462-2920.15016; Moussavi M, 2019, J FOOD PROTECT, V82, P815, DOI 10.4315/0362-028X.JFP-18-450; National Library of Medicine (US) National Center for Biotechnology, NCBI PATH PROJ; Octavia S, 2015, J CLIN MICROBIOL, V53, P1063, DOI 10.1128/JCM.03235-14; Patro JN, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00057-16; Pearce ME, 2018, INT J FOOD MICROBIOL, V274, P1, DOI 10.1016/j.ijfoodmicro.2018.02.023; Pettengill JB, 2020, LANCET MICROBE, V1, pE233, DOI 10.1016/S2666-5247(20)30122-1; Pightling AW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01482; Podolak R, 2010, J FOOD PROTECT, V73, P1919, DOI 10.4315/0362-028X-73.10.1919; Rock M, 2009, SOC SCI MED, V68, P991, DOI 10.1016/j.socscimed.2008.12.047; Setton Farms, 2013, SUSTAINABLITY; Simon S, 2018, FOOD MICROBIOL, V71, P46, DOI 10.1016/j.fm.2017.08.017; Staehlin BM, 2016, GENOME BIOL EVOL, V8, P811, DOI 10.1093/gbe/evw031; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sym-Agro, CAL TREE NUT GROW SY; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Taylor AJ, 2015, J CLIN MICROBIOL, V53, P3334, DOI 10.1128/JCM.01280-15; Theofel CG, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00573-20; Touchstone Pistachio Co, 2020, SUSTAINABILITY-BASEL; Uesugi AR, 2007, J FOOD PROTECT, V70, P1784, DOI 10.4315/0362-028X-70.8.1784; United States Department of Agriculture, AGR STAT 2019; Villaverde C, 2008, POULTRY SCI, V87, P497, DOI 10.3382/ps.2007-00292; Wahl A, 2019, MOL MICROBIOL, V111, P303, DOI 10.1111/mmi.14167; Wang J, 2021, POULTRY SCI, V100, DOI 10.1016/j.psj.2020.12.049; Wang Y, 2018, J FOOD PROTECT, V81, P2082, DOI 10.4315/0362-028X.JFP-18-093; Wilson MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146929; Wuyts Veronique, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.aa5372d90826e6cb0136ff66bb7a62fc; Yada S, RECALLS TREE NUTS PE	78	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259471	10.1371/journal.pone.0259471	http://dx.doi.org/10.1371/journal.pone.0259471			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735518	Green Published, gold, Green Submitted			2022-12-26	WOS:000755077100079
J	Jabbour, E; Futterer, C; Zach, S; Kalsch, AI; Keese, M; Rahbari, NN; Kramer, BK; Schwenke, KG				Jabbour, Elizabeth; Fuetterer, Carsten; Zach, Sebastian; Kaelsch, Anna-Isabelle; Keese, Michael; Rahbari, Nuh N.; Kraemer, Bernhard K.; Schwenke, Kay G.			Implantation of a peritoneal dialysis catheter in patients with ESRD using local anesthesia and Remifentanil	PLOS ONE			English	Article							ABDOMINIS PLANE BLOCK; PLACEMENT; INSERTION; HEMODIALYSIS	Study objective The main objective of this study is to test the feasibility of the local anesthetic (LA) Mepivacaine 1% and sedation with Remifentanil as the primary anesthetic technique for the insertion of a peritoneal dialysis (PD) catheter, without the need to convert to general anesthesia. Methods We analyzed 27 consecutive end-stage renal disease (ESRD) patients who underwent the placement of a peritoneal catheter at our center between March 2015 and January 2019. The procedures were all performed by a general or vascular surgeon, and the postoperative care and follow-up were all conducted by the same peritoneal dialysis team. Results All of the 27 subjects successfully underwent the procedure without the need of conversion to general anesthesia. The catheter was deemed prone to usage in all patients and was found to be leak-proof in 100% of the patients. Conclusion This study describes a safe and successful approach for insertion of a PD catheter by combined infiltration of the local anesthetic Mepivacaine 1% and sedation with Remifentanil. Hereby, ESRD patients can be treated without general anesthesia, while ensuring functionality of the PD catheter.	[Jabbour, Elizabeth; Rahbari, Nuh N.] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Surg, Mannheim, Germany; [Fuetterer, Carsten] Heidelberg Univ, Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Anesthesiol, Mannheim, Germany; [Zach, Sebastian; Keese, Michael; Schwenke, Kay G.] Heidelberg Univ, Univ Med Mannheim, Dept Vasc Surg, Med Fac Mannheim, Mannheim, Germany; [Kaelsch, Anna-Isabelle; Kraemer, Bernhard K.] Heidelberg Univ, Med Fac Mannheim, Univ Med Ctr Mannheim, Dept Med 5, Mannheim, Germany; [Kaelsch, Anna-Isabelle; Keese, Michael; Kraemer, Bernhard K.; Schwenke, Kay G.] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim Transplantat Ctr, Mannheim, Germany; [Keese, Michael; Kraemer, Bernhard K.] Heidelberg Univ, Med Fac Mannheim, European Ctr Angiosci, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schwenke, KG (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Vasc Surg, Med Fac Mannheim, Mannheim, Germany.; Schwenke, KG (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Mannheim Transplantat Ctr, Mannheim, Germany.	kay.schwenke@umm.de						Al-Hwiesh AK, 2014, PERITON DIALYSIS INT, V34, P204, DOI 10.3747/pdi.2012.00160; Chatterjee S, 2015, SAUDI J ANAESTH, V9, P132, DOI 10.4103/1658-354X.152838; Crabtree JH, 2000, PERITON DIALYSIS INT, V20, P757; Crabtree JH, 2019, PERITON DIALYSIS INT, V39, P414, DOI 10.3747/pdi.2018.00232; da R Videira R.L, 2007, REV BRAS ANESTESIOL, V54, P114; Dogra PM, 2018, INDIAN J NEPHROL, V28, P291, DOI 10.4103/ijn.IJN_144_17; Dogra PM, 2018, INDIAN J NEPHROL, V28, P265, DOI 10.4103/ijn.IJN_281_17; Fenton SSA, 1997, AM J KIDNEY DIS, V30, P334, DOI 10.1016/S0272-6386(97)90276-6; Henderson S, 2009, NEPHROL DIAL TRANSPL, V24, P3499, DOI 10.1093/ndt/gfp312; Henshaw DS, 2016, J CLIN ANESTH, V31, P182, DOI 10.1016/j.jclinane.2016.01.028; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Kanda H, 2017, J CARDIOTHOR VASC AN, V31, P2251, DOI 10.1053/j.jvca.2017.04.019; Kastanis G, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/7096245; Li Q, 2018, BLOOD PURIFICAT, V45, P8, DOI 10.1159/000479083; Li Z., 2018, ULTRASOUND GUIDED OB, V38, P192; Markic D, 2015, BLOOD PURIFICAT, V39, P274, DOI 10.1159/000381005; MCCAUGHEY W, 1992, DRUG SAFETY, V7, P178, DOI 10.2165/00002018-199207030-00003; Noman TA, 2001, SAUDI MED J, V22, P58; Ozener C, 2001, NEPHROL DIAL TRANSPL, V16, P1893, DOI 10.1093/ndt/16.9.1893; Restrepo CA, 2014, INT J NEPHROL RENOV, V7, P383, DOI 10.2147/IJNRD.S68888; RUBIN J, 1982, NEPHRON, V32, P370, DOI 10.1159/000182882; Selby NM, 2019, SEMIN DIALYSIS, V32, P3, DOI 10.1111/sdi.12752; Selby NM, 2011, PERITON DIALYSIS INT, V31, P27, DOI 10.3747/pdi.2010.00007; Shetty A, 2000, DIALYSIS TRANSPLANT, V29, P71; Tagariello V, 2001, Minerva Anestesiol, V67, P5; Yang PJ, 2010, PERITON DIALYSIS INT, V30, P513, DOI 10.3747/pdi.2009.00033; Zazzeroni L, 2017, KIDNEY BLOOD PRESS R, V42, P717, DOI 10.1159/000484115	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259351	10.1371/journal.pone.0259351	http://dx.doi.org/10.1371/journal.pone.0259351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735524	gold, Green Published			2022-12-26	WOS:000755077100067
J	Littler, DR; Liu, MM; McAuley, JL; Lowery, SA; Illing, PT; Gully, BS; Purcell, AW; Chandrashekaran, IR; Perlman, S; Purcell, DFJ; Quinn, RJ; Rossjohn, J				Littler, Dene R.; Liu, Miaomiao; McAuley, Julie L.; Lowery, Shea A.; Illing, Patricia T.; Gully, Benjamin S.; Purcell, Anthony W.; Chandrashekaran, Indu R.; Perlman, Stanley; Purcell, Damian F. J.; Quinn, Ronald J.; Rossjohn, Jamie			A natural product compound inhibits coronaviral replication in vitro to the conserved SARS-CoV-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; NSP9	The Nsp9 replicase is a conserved coronaviral protein that acts as an essential accessory component of the multi-subunit viral replication/transcription complex. Nsp9 is the predominant substrate for the essential nucleotidylation activity of Nsp12. Compounds specifically interfering with this viral activity would facilitate its study. Using a native mass spectrometry-based approach to screen a natural product library for Nsp9 binders, we identified an ent-kaurane natural product, oridonin, capable of binding to purified SARS-CoV-2 Nsp9 with micromolar affinities. By determining the crystal structure of the Nsp9-oridonin complex, we showed that oridonin binds through a conserved site near Nsp9's C-terminal GxxxG-helix. In enzymatic assays, oridonin's binding to Nsp9 reduces its potential to act as substrate for Nsp12's Nidovirus RdRp-Associated Nucleotidyl transferase (NiRAN) domain. We also showed using in vitro cellular assays oridonin, while cytotoxic at higher doses has broad antiviral activity, reducing viral titer following infection with either SARS-CoV-2 or, to a lesser extent, MERS-CoV. Accordingly, these preliminary findings suggest that the oridonin molecular scaffold may have the potential to be developed into an antiviral compound to inhibit the function of Nsp9 during coronaviral replication.	[Littler, Dene R.; Illing, Patricia T.; Gully, Benjamin S.; Purcell, Anthony W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Littler, Dene R.; Illing, Patricia T.; Gully, Benjamin S.; Purcell, Anthony W.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Liu, Miaomiao; Quinn, Ronald J.] Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia; [McAuley, Julie L.; Purcell, Damian F. J.; Quinn, Ronald J.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Lowery, Shea A.; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Chandrashekaran, Indu R.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Perlman, Stanley] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales	Monash University; Monash University; Griffith University; University of Melbourne; University of Iowa; Monash University; University of Iowa; Cardiff University	Littler, DR; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Littler, DR; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Quinn, RJ (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Brisbane, Qld, Australia.; Quinn, RJ (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales.	dene.littler@monash.edu; r.quinn@griffith.edu.au; jamie.rossjohn@monash.edu	Illing, Patricia/AAP-6045-2021; Quinn, Ronald J/A-7931-2008; Liu, Miaomiao/O-7830-2017	Illing, Patricia/0000-0002-3870-0796; Quinn, Ronald J/0000-0002-4022-2623; Liu, Miaomiao/0000-0003-0930-3617; Purcell, Anthony/0000-0003-0532-8331; Chandrashekaran, Indu/0000-0002-7080-427X; Littler, Dene/0000-0001-5904-1905; Gully, Benjamin/0000-0002-8197-0871	National Institutes of Health (USA) [PO1 AI060699, RO1 AI129269]; NHMRC PRF [APP1137739]; Monash University Faculty of Medicine, Nursing and Health Sciences Senior Postdoctoral Fellowship; Australian Research Council Laureate Fellowship; DHHS COVID-19 Victorian Consortium; Australian Research Council Centre of Excellence for Advanced Molecular Imaging	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC PRF(National Health and Medical Research Council (NHMRC) of Australia); Monash University Faculty of Medicine, Nursing and Health Sciences Senior Postdoctoral Fellowship; Australian Research Council Laureate Fellowship(Australian Research Council); DHHS COVID-19 Victorian Consortium; Australian Research Council Centre of Excellence for Advanced Molecular Imaging(Australian Research Council)	Funding for the work originated from the Australian Research Council Centre of Excellence for Advanced Molecular Imaging and the National Institutes of Health (USA) (PO1 AI060699, RO1 AI129269) (S. P.). A. W. P. is supported by a NHMRC PRF (APP1137739). P. T. I. was supported by a Monash University Faculty of Medicine, Nursing and Health Sciences Senior Postdoctoral Fellowship. J. R. is supported by an Australian Research Council Laureate Fellowship. D. F. J. P. and J. L. M. received antiviral program support from the DHHS COVID-19 Victorian Consortium. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Garcia PA, 2007, MOLECULES, V12, P455, DOI 10.3390/12030455; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Bruno M, 2002, J NAT PROD, V65, P1594, DOI 10.1021/np020029b; Caly L, 2020, MED J AUSTRALIA, V212, P459, DOI 10.5694/mja2.50569; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Daczkowski CM, 2017, J MOL BIOL, V429, P1661, DOI 10.1016/j.jmb.2017.04.011; Douangamath A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18709-w; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; Elnaas AR, 2020, MOLECULES, V25, DOI 10.3390/molecules25102384; Ferreira AC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00428-w; Gunther S, 2021, SCIENCE, V372, P642, DOI 10.1126/science.abf7945; Hu X, 2020, MINI-REV MED CHEM, V20, P483, DOI 10.2174/1389557519666191029121809; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kjer-Nielsen L, 2018, IMMUNOL CELL BIOL, V96, P573, DOI 10.1111/imcb.12057; Klemm T, 2020, EMBO J, V39, DOI 10.15252/embj.2020106275; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lei YQ, 2021, J NAT PROD, V84, P1478, DOI 10.1021/acs.jnatprod.0c01231; Li WF, 2015, INT J MOL SCI, V16, P27978, DOI 10.3390/ijms161126071; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Littler DR, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101018; Littler DR, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101258; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Modi V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56499-4; Osipiuk J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21060-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ponnusamy R, 2008, J MOL BIOL, V383, P1081, DOI 10.1016/j.jmb.2008.07.071; Rut W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4596; Slanina H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022310118; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; Sutton G, 2004, STRUCTURE, V12, P341, DOI 10.1016/j.str.2004.01.016; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang B, 2021, NUCLEIC ACIDS RES, V49, P8822, DOI 10.1093/nar/gkab677; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu F, 2020, NATURE, V580, pE7; Wu YC, 1996, J NAT PROD, V59, P635, DOI 10.1021/np960416j; Yan LM, 2021, CELL, V184, P3474, DOI 10.1016/j.cell.2021.05.033; Yan LM, 2021, CELL, V184, P184, DOI 10.1016/j.cell.2020.11.016; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4; Zhang ZR, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00343-z; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	48	10	10	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101362	10.1016/j.jbc.2021.101362	http://dx.doi.org/10.1016/j.jbc.2021.101362			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756886	Green Published, Green Accepted, gold			2022-12-26	WOS:000765319800008
J	Takeji, Y; Shiomi, H; Morimoto, T; Yamamoto, K; Matsumura-Nakano, Y; Nagao, K; Taniguchi, R; Yamaji, K; Tada, T; Kato, ET; Yoshikawa, Y; Obayashi, Y; Suwa, S; Inoko, M; Ehara, N; Tamura, T; Onodera, T; Watanabe, H; Toyofuku, M; Nakatsuma, K; Sakamoto, H; Ando, K; Furukawa, Y; Sato, Y; Nakagawa, Y; Kadota, K; Kimura, T				Takeji, Yasuaki; Shiomi, Hiroki; Morimoto, Takeshi; Yamamoto, Ko; Matsumura-Nakano, Yukiko; Nagao, Kazuya; Taniguchi, Ryoji; Yamaji, Kyohei; Tada, Tomohisa; Kato, Eri Toda; Yoshikawa, Yusuke; Obayashi, Yuki; Suwa, Satoru; Inoko, Moriaki; Ehara, Natsuhiko; Tamura, Toshihiro; Onodera, Tomoya; Watanabe, Hiroki; Toyofuku, Mamoru; Nakatsuma, Kenji; Sakamoto, Hiroki; Ando, Kenji; Furukawa, Yutaka; Sato, Yukihito; Nakagawa, Yoshihisa; Kadota, Kazushige; Kimura, Takeshi		CREDO Kyoto AMI Registry Wav	Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; LONG-TERM MORTALITY; ST-ELEVATION; OUTCOMES; REVASCULARIZATION; ASSOCIATION; SURVIVAL; REGISTRY; TRENDS; RATES	Background The detailed causes of death in non-ST-segment-elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those in ST-segment elevation myocardial infarction (STEMI). Methods The study population was 6,228 AMI patients who underwent percutaneous coronary intervention (STEMI: 4,625 patients and NSTEMI: 1,603 patients). The primary outcome was all-cause death. Results Within 6 months after AMI, the adjusted mortality risk was not significantly different between NSTEMI patients and STEMI patients (HR: 0.83, 95%CI: 0.67-1.03, P = 0.09). Regarding the causes of death within 6 months after AMI, mechanical complications more frequently occurred in STEMI patients than in NSTEMI patients, while proportions of post resuscitation status on arrival and heart failure were higher in in NSTEMI patients than in STEMI patients. Beyond 6 months after AMI, the adjusted mortality risk of NSTEMI relative to STEMI was not significantly different. (HR: 1.04, 95%CI: 0.90-1.20, P = 0.59). Regarding causes of death beyond 6 months after AMI, almost half of deaths were cardiovascular causes in both groups, and breakdown of causes of death was similar between NSTEMI and STEMI. Conclusion The mortality risk within and beyond 6 months after AMI were not significantly different between STEMI patients and NSTEMI patients after adjusting confounders. Deaths due to post resuscitation status and heart failure were more frequent in NSTEMI within 6 months after AMI.	[Takeji, Yasuaki; Shiomi, Hiroki; Yamamoto, Ko; Matsumura-Nakano, Yukiko; Kato, Eri Toda; Yoshikawa, Yusuke; Obayashi, Yuki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Dept Cardiovasc Med, Osaka, Japan; [Taniguchi, Ryoji; Sato, Yukihito] Hyogo Kenritsu Amagasaki Hosp, Dept Cardiol, Amagasaki, Hyogo, Japan; [Yamaji, Kyohei; Ando, Kenji] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan; [Tada, Tomohisa; Sakamoto, Hiroki] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan; [Suwa, Satoru] Juntendo Univ, Dept Cardiovasc Med, Shizuoka Hosp, Izunokuni, Japan; [Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Osaka, Japan; [Ehara, Natsuhiko; Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Tamura, Toshihiro] Tenri Hosp, Dept Cardiol, Tenri, Nara, Japan; [Onodera, Tomoya] Shizuoka City Shizuoka Hosp, Dept Cardiol, Shizuoka, Japan; [Watanabe, Hiroki; Toyofuku, Mamoru] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan; [Ando, Kenji] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan; [Nakagawa, Yoshihisa] Shiga Univ Med Sci Hosp, Dept Cardiovasc Med, Otsu, Shiga, Japan; [Kadota, Kazushige] Kurashiki Cent Hosp, Dept Cardiol, Kurashiki, Okayama, Japan	Kyoto University; Hyogo College of Medicine; Osaka Red Cross Hospital; Kokura Memorial Hospital; Shizuoka General Hospital; Juntendo University; Kitano Hospital; Kobe City Medical Center General Hospital; Tenri Hospital; Shiga University of Medical Science; Kurashiki Central Hospital	Shiomi, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	hishiomi@kuhp.kyoto-u.ac.jp	Shiomi, Hiroki/ADJ-9510-2022	Shiomi, Hiroki/0000-0001-7234-023X; Nakatsuma, Kenji/0000-0001-8894-7538; Yoshikawa, Yusuke/0000-0001-8082-2036	Research Institute for Production Development (Kyoto, Japan)	Research Institute for Production Development (Kyoto, Japan)	This study was supported by an educational grant from the Research Institute for Production Development (Kyoto, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2006, AM HEART J, V151, P1065, DOI 10.1016/j.ahj.2005.05.019; Case BC, 2020, AM J CARDIOL, V134, P24, DOI 10.1016/j.amjcard.2020.08.010; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Darling Chad E, 2013, Clin Epidemiol, V5, P229, DOI 10.2147/CLEP.S45646; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Gale CP, 2014, HEART, V100, P582, DOI 10.1136/heartjnl-2013-304517; Garcia-Garcia C, 2011, AM J CARDIOL, V108, P1061, DOI 10.1016/j.amjcard.2011.06.003; Ishihara M, 2017, CIRC J, V81, P958, DOI 10.1253/circj.CJ-17-0033; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kimura T, 2008, CIRCULATION, V118, pS199, DOI 10.1161/CIRCULATIONAHA.107.735902; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Noc M, 2014, EUROINTERVENTION, V10, P31, DOI 10.4244/EIJV10I1A7; Nozoe M, 2014, J CARDIOL, V63, P14, DOI 10.1016/j.jjcc.2013.06.012; Poulsen SH, 2008, ANN THORAC SURG, V85, P1591, DOI 10.1016/j.athoracsur.2008.01.010; Puymirat E, 2017, CIRCULATION, V136, P1908, DOI 10.1161/CIRCULATIONAHA.117.030798; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosengren A, 2006, EUR HEART J, V27, P789, DOI 10.1093/eurheartj/ehi774; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Yamashita Y, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.002790	20	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259268	10.1371/journal.pone.0259268	http://dx.doi.org/10.1371/journal.pone.0259268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788296	Green Published, gold			2022-12-26	WOS:000735920500019
J	Zhang, L; Yan, SS; Zhang, SF; Yan, PY; Wang, JH; Zhang, HG				Zhang, Lei; Yan, Shanshan; Zhang, Sufang; Yan, Pingyu; Wang, Junhui; Zhang, Hanguo			Glutathione, carbohydrate and other metabolites of Larix olgensis A. Henry reponse to polyethylene glycol-simulated drought stress	PLOS ONE			English	Article							TOLERANCE; GENE; TEMPERATURE; EXPRESSION; RESPONSES; PROLINE; PLANTS; ROLES; SALT; RNA	Drought stress in trees limits their growth, survival, and productivity and it negatively affects the afforestation survival rate. Our study focused on the molecular responses to drought stress in a coniferous species Larix olgensis A. Henry. Drought stress was simulated in one-year-old seedlings using 25% polyethylene glycol 6000. The drought stress response in these seedlings was assessed by analyzing select biochemical parameters, along with gene expression and metabolite profiles. The soluble protein content, peroxidase activity, and malondialdehyde content of L. olgensis were significantly changed during drought stress. Quantitative gene expression analysis identified a total of 8172 differentially expressed genes in seedlings processed after 24 h, 48 h, and 96 h of drought stress treatment. Compared with the gene expression profile of the untreated control, the number of up-regulated genes was higher than that of down-regulated genes, indicating that L. olgensis mainly responded to drought stress through positive regulation. Metabolite analysis of the control and stress-treated samples showed that under drought stress, the increased abundance of linoleic acid was the highest among up-regulated metabolites, which also included some saccharides. A combined analysis of the transcriptome and metabolome revealed that genes dominating the differential expression profile were involved in glutathione metabolism, galactose metabolism, and starch and sucrose metabolism. Moreover, the relative abundance of specific metabolites of these pathways was also altered. Thus, our results indicated that L. olgensis prevented free radical-induced damage through glutathione metabolism and responded to drought through sugar accumulation.	[Zhang, Lei; Yan, Shanshan; Zhang, Sufang; Yan, Pingyu; Zhang, Hanguo] Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China; [Wang, Junhui] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China	Northeast Forestry University - China; Chinese Academy of Forestry; State Key Laboratory of Tree Genetics & Breeding, CAF	Zhang, HG (corresponding author), Northeast Forestry Univ, State Key Lab Tree Genet & Breeding, Harbin, Peoples R China.	hanguozhang1@sina.com			National Science and Technology Major Project [2018ZX08020003-001-001]; National Natural Science Foundation of China [31700595]; Fundamental Research Funds for the Central Universities [2572019BA13]; Heilongjiang Touyan Innovation Team Program	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Heilongjiang Touyan Innovation Team Program	This manuscript was supported by the National Science and Technology Major Project (2018ZX08020003-001-001); the National Natural Science Foundation of China (31700595); the Fundamental Research Funds for the Central Universities (2572019BA13); and the Heilongjiang Touyan Innovation Team Program (Tree Genetics and Breeding Innovation Team).	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; An X, 2015, PLANT GROWTH REGUL, V76, P211, DOI 10.1007/s10725-014-9991-z; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashihara H, 2014, NAT PROD COMMUN, V9, P795; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang EM, 2016, ELECTRON J BIOTECHN, V23, P21, DOI 10.1016/j.ejbt.2016.08.003; Chen SM, 2011, ENVIRON EXP BOT, V74, P255, DOI 10.1016/j.envexpbot.2011.06.007; Cuellar-Ortiz SM, 2008, PLANT CELL ENVIRON, V31, P1399, DOI 10.1111/j.1365-3040.2008.01853.x; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; Du BG, 2016, TREE PHYSIOL, V36, P148, DOI 10.1093/treephys/tpv105; Esch L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071592; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; Fox H, 2018, TREE PHYSIOL, V38, P423, DOI 10.1093/treephys/tpx137; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo YM, 2017, PLANT MOL BIOL REP, V35, P416, DOI 10.1007/s11105-017-1032-4; Hamanishi ET, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1535-z; He Xiaosan., 2020, CHANGES PHYSL GROWTH, P7, DOI [10.1371/journal.pone.0235795, DOI 10.1371/JOURNAL.PONE.0235795]; Jain M, 2001, PLANT CELL REP, V20, P463, DOI 10.1007/s002990100353; Ji XY, 2016, TREE PHYSIOL, V36, P193, DOI 10.1093/treephys/tpv139; Jia X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2554-0; Kendall EC, 1929, J BIOL CHEM, V84, P657; KETTERER B, 1983, ENVIRON HEALTH PERSP, V49, P59, DOI 10.2307/3429581; Knaupp M, 2011, PLANTA, V234, P477, DOI 10.1007/s00425-011-1413-0; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mao LY, 2005, MICROBIOL-SGM, V151, P3197, DOI 10.1099/mic.0.28167-0; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Meyer E, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-527; Mutlu S, 2016, TREE PHYSIOL, V36, P479, DOI 10.1093/treephys/tpv135; Nahar K, 2015, BIOL PLANTARUM, V59, P745, DOI 10.1007/s10535-015-0542-x; Nahar K, 2017, PROTOPLASMA, V254, P445, DOI 10.1007/s00709-016-0965-z; Niinemets U, 2016, TREE PHYSIOL, V36, P129, DOI 10.1093/treephys/tpv128; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Per TS, 2017, PLANT PHYSIOL BIOCH, V115, P126, DOI 10.1016/j.plaphy.2017.03.018; Seth CS, 2012, PLANT CELL ENVIRON, V35, P334, DOI 10.1111/j.1365-3040.2011.02338.x; Taibi K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01202; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Wang P, 2017, SCI REP-UK, V7, DOI 10.1038/srep40532; Xiang JH, 2018, PLANT CELL REP, V37, P1585, DOI 10.1007/s00299-018-2331-4; Xue LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33655; You J, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1880-1; Zhang L, 2015, GENET MOL RES, V14, P15577, DOI 10.4238/2015.December.1.9	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0253780	10.1371/journal.pone.0253780	http://dx.doi.org/10.1371/journal.pone.0253780			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788320	Green Published, gold			2022-12-26	WOS:000735920500001
J	Hayashi, K; Noguchi-Shinohara, M; Sato, T; Hosomichi, K; Kannon, T; Abe, C; Domoto, C; Yuki-Nozaki, S; Mori, A; Horimoto, M; Yokogawa, M; Sakai, K; Iwasa, K; Komai, K; Ishimiya, M; Nakamura, H; Ishida, N; Suga, Y; Ishizaki, J; Ishigami, A; Tajima, A; Yamada, M				Hayashi, Koji; Noguchi-Shinohara, Moeko; Sato, Takehiro; Hosomichi, Kazuyoshi; Kannon, Takayuki; Abe, Chiemi; Domoto, Chiaki; Yuki-Nozaki, Sohshi; Mori, Ayaka; Horimoto, Mai; Yokogawa, Masami; Sakai, Kenji; Iwasa, Kazuo; Komai, Kiyonobu; Ishimiya, Mai; Nakamura, Hiroyuki; Ishida, Natsuko; Suga, Yukio; Ishizaki, Junko; Ishigami, Akihito; Tajima, Atsushi; Yamada, Masahito			Effects of functional variants of vitamin C transporter genes on apolipoprotein E E4-associated risk of cognitive decline: The Nakajima study	PLOS ONE			English	Article							OXIDATIVE STRESS; VASCULAR DEMENTIA; ALZHEIMER-DISEASE; MOUSE MODEL; IMPAIRMENT; ANTIOXIDANT; MILD; SUPPLEMENTS; APP/PSEN1; GENOTYPE	Apolipoprotein E E4 (APOE4) is a risk factor for cognitive decline. A high blood vitamin C (VC) level reduces APOE4-associated risk of developing cognitive decline in women. In the present study, we aimed to examine the effects of functional variants of VC transporter genes expressed in the brain (SLC2A1, SLC2A3, and SLC23A2) on APOE4-associated risk of developing cognitive decline. This case-control study involved 393 Japanese subjects: 252 cognitively normal and 141 cognitively impaired individuals (87 mild cognitive impairment and 54 dementia). Database searches revealed that rs1279683 of SLC23A2, and rs710218 and rs841851 of SLC2A1 are functional variants that are significantly associated with the altered expression of the respective genes and genotyped as three single nucleotide variants (SNVs). When stratified by SNV genotype, we found a significant association between APOE4 and cognitive decline in minor allele carriers of rs1279683 (odds ratio [OR] 2.02, 95% CI, 1.05-3.87, p = 0.035) but not in the homozygote carriers of the major allele. Significant associations between APOE4 and cognitive decline were also observed in participants with major allele homozygotes of rs710218 (OR 2.35, 95% CI, 1.05-5.23, p = 0.037) and rs841851 (OR 3.2, 95% CI, 1.58-6.46, p = 0.0012), but not in minor allele carriers of the respective SNVs. In contrast, the three functional SNVs showed no significant effect on cognitive decline. Our results imply that functional SNVs of VC transporter genes can affect APOE4-associated risk of developing cognitive decline via altered VC levels in the brain.	[Hayashi, Koji; Noguchi-Shinohara, Moeko; Abe, Chiemi; Domoto, Chiaki; Yuki-Nozaki, Sohshi; Mori, Ayaka; Horimoto, Mai; Sakai, Kenji; Iwasa, Kazuo; Yamada, Masahito] Kanazawa Univ, Dept Neurol & Neurobiol Aging, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Hayashi, Koji; Sato, Takehiro; Hosomichi, Kazuyoshi; Kannon, Takayuki; Tajima, Atsushi] Kanazawa Univ, Grad Sch Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa, Japan; [Noguchi-Shinohara, Moeko] Kanazawa Univ, Grad Sch Med Sci, Dept Preempt Med Dementia, Kanazawa, Ishikawa, Japan; [Yokogawa, Masami] Kanazawa Univ, Dept Phys Therapy, Div Hlth Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Iwasa, Kazuo] Ishikawa Prefectural Nursing Univ, Kahoku, Ishikawa, Japan; [Komai, Kiyonobu] Iou Hosp Natl Hosp Org, Dept Neurol, Kanazawa, Ishikawa, Japan; [Ishimiya, Mai; Nakamura, Hiroyuki] Kanazawa Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Nakamura, Hiroyuki] Ryukyu Univ Hosp, Dept Oral & Maxillofacial Surg, Nishihara, Okinawa, Japan; [Ishida, Natsuko; Suga, Yukio; Ishizaki, Junko] Kanazawa Univ, Clin Pharm & Healthcare Sci, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Mol Regulat Aging, Tokyo, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; University of the Ryukyus; Kanazawa University; Tokyo Metropolitan Institute of Gerontology	Yamada, M (corresponding author), Kanazawa Univ, Dept Neurol & Neurobiol Aging, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.; Tajima, A (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa, Japan.	atajima@med.kanazawa-u.ac.jp; m-yamada@med.kanazawa-u.ac.jp	Tajima, Atsushi/C-1053-2008; Hosomichi, Kazuyoshi/K-9477-2015	Tajima, Atsushi/0000-0001-6808-5491; Sato, Takehiro/0000-0001-9866-0346; Hayashi, Koji/0000-0003-3446-0913; Hosomichi, Kazuyoshi/0000-0003-2712-1825	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Agency for Medical Research and Development [JP18dk0207021, JP21dk0207047, JP20dk0207025, JP21dk0207053]; JSPS KAKEN [19K22753]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKEN	This study was partially supported by a grant for the Hokuriku Innovation Cluster for Health Science (to MYa) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [URL, https://www.mext.go.jp/en/], by a grant for Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development [URL, https://www.amed.go.jp/en/] (JP18dk0207021 (to MYa, to MN-S), JP21dk0207047 (to MYa, to MN-S), JP20dk0207025 (to MYa), and JP21dk0207053 (to MN-S)), and by JSPS KAKEN [URL, https://www.jsps.go.jp/english/index.html] (19K22753) (to AT). There was no additional external funding received for this study. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Angelow S, 2003, BRAIN RES, V988, P105, DOI 10.1016/S0006-8993(03)03350-X; Chaudhari K, 2016, J NUTR HEALTH AGING, V20, P841, DOI 10.1007/s12603-016-0705-2; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Corpe CP, 2010, J CLIN INVEST, V120, P1069, DOI 10.1172/JCI39191; Delrobaei F, 2019, PHARMACOL REP, V71, P133, DOI 10.1016/j.pharep.2018.10.001; Devore EE, 2010, ARCH NEUROL-CHICAGO, V67, P819, DOI 10.1001/archneurol.2010.144; Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021; Dixit S, 2015, ACS CHEM NEUROSCI, V6, P570, DOI 10.1021/cn500308h; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotuhi M, 2008, ALZHEIMERS DEMENT, V4, P223, DOI 10.1016/j.jalz.2008.01.004; Frontinan-Rubio J, 2018, MOL CELL NEUROSCI, V92, P67, DOI 10.1016/j.mcn.2018.06.005; Gale CR, 1996, BRIT MED J, V312, P608; Grodstein F, 2003, AM J CLIN NUTR, V77, P975, DOI 10.1093/ajcn/77.4.975; Guerreiro R, 2020, NEUROBIOL DIS, V142, DOI 10.1016/j.nbd.2020.104946; Guerreiro R, 2018, LANCET NEUROL, V17, P64, DOI 10.1016/S1474-4422(17)30400-3; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Harrison FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035623; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010; JACOB RA, 1990, J NUTR, V120, P1480, DOI 10.1093/jn/120.suppl_11.1480; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kook SY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.26; Langa KM, 2014, JAMA-J AM MED ASSOC, V312, P2551, DOI 10.1001/jama.2014.13806; Langlois PL, 2019, NUTRITION, V60, P185, DOI 10.1016/j.nut.2018.10.009; Lykkesfeldt J, 2007, BRIT J NUTR, V98, P1116, DOI 10.1017/S0007114507787457; Lykkesfeldt J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102412; May James M, 2012, Subcell Biochem, V56, P85, DOI 10.1007/978-94-007-2199-9_6; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Murakami K, 2011, J ALZHEIMERS DIS, V26, P7, DOI [10.3233/JAD-2011-101971, 10.1177/1533317510395375]; Ninomiya T, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-020-00903-3; Noguchi-Shinohara M, 2018, J ALZHEIMERS DIS, V63, P1289, DOI [10.3233/JAD-170971, 10.3233/jad-170971]; Noguchi-Shinohara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096013; Noguchi-Shinohara M, 2013, J ALZHEIMERS DIS, V37, P691, DOI 10.3233/JAD-130398; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; Perrig WJ, 1997, J AM GERIATR SOC, V45, P718, DOI 10.1111/j.1532-5415.1997.tb01476.x; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Safieh M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1299-4; Skrobot OA, 2016, J ALZHEIMERS DIS, V53, P981, DOI 10.3233/JAD-150862; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Sugano K, 2012, DEMENT GER COGN D EX, V2, P69, DOI 10.1159/000337224; Sun JH, 2015, J ALZHEIMERS DIS, V46, P611, DOI 10.3233/JAD-143102; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yoshihara H, 2020, HUM GENOME VAR, V7, DOI 10.1038/s41439-020-0106-2; Zandi PP, 2004, ARCH NEUROL-CHICAGO, V61, P82, DOI 10.1001/archneur.61.1.82	51	2	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259663	10.1371/journal.pone.0259663	http://dx.doi.org/10.1371/journal.pone.0259663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780525	gold, Green Published			2022-12-26	WOS:000755305800037
J	Jang, DH; Cho, HC; Shin, SU; Kim, EM; Park, YJ; Hwang, S; Park, J; Choi, KS				Jang, Dong-Hun; Cho, Hyung-Chul; Shin, Seung-Uk; Kim, Eun-Mi; Park, Yu-Jin; Hwang, Sunwoo; Park, Jinho; Choi, Kyoung-Seong			Prevalence and distribution pattern of Cryptosporidium spp. among pre-weaned diarrheic calves in the Republic of Korea	PLOS ONE			English	Article							N. SP APICOMPLEXA; DAIRY CALVES; MOLECULAR CHARACTERIZATION; GENETIC DIVERSITY; PARVUM SUBTYPES; GP60 GENOTYPES; FECAL SAMPLES; NEONATAL CALF; CATTLE; HUMANS	Cryptosporidium spp. are protozoan parasites that belong to subphylum apicomplexa and cause diarrhea in humans and animals worldwide. Data on the prevalence of Cryptosporidium spp. and its subtypes among calves in the Republic of Korea (KOR) are sparse. Hence, our study aimed to investigate the prevalence and association between the age of calf and the identified Cryptosporidium spp. and to determine the genotypes/subtypes of Cryptosporidium spp. in pre-weaned calves with diarrhea in the KOR. A total of 460 diarrheic fecal samples were collected from calves aged 1-60 days and screened for Cryptosporidium spp. by the 18S rRNA gene. Species identification was determined using the sequencing analysis of the 18S rRNA gene, and C. parvum-positive samples were subtyped via the sequence analysis of the 60-kDa glycoprotein (gp60) gene. Sequence analysis based on the 18S rRNA gene revealed the presence of three Cryptosporidium spp., namely, C. parvum (n = 72), C. ryanae (n = 12), and C. bovis (n = 2). Co-infection by these species was not observed. The infection rate was the highest in calves aged 11-20 days (26.1%, 95% CI 17.1-35.1), whereas the lowest rate was observed in calves aged 21-30 days (7.7%, 95% CI 0.0-16.1). The prevalence of C. parvum was detected exclusively in calves aged <= 20 days, and the highest infection rate of C. ryanae was seen in calves >= 31 days of age. The occurrence of C. parvum (chi(2) = 25.300, P = 0.000) and C. ryanae (chi(2) = 18.020, P = 0.001) was significantly associated with the age of the calves. Eleven different subtypes of the IIa family that belonging to C. parvum were recognized via the sequence analyses of the gp60 gene. Except for two (IIaA18G3R1 and IIaA15G2R1) subtypes, nine subtypes were first identified in calves with diarrhea in the KOR. IIaA18G3R1 was the most frequently detected subtype (72.2% of calves), followed by IIaA17G3R1 (5.6%), IIaA15G2R1 (4.2%), IIaA19G4R1 (4.2%), IIaA16G4R1 (2.8%), IIaA17G4R1 (2.8%), IIaA19G3R (2.8%), IIaA14G1R1 (1.4%), IIaA14G3R1 (1.4%), IIaA15G1R1 (1.4%), and IIaA19G1R1 (1.4%) These results suggest that the prevalence of Cryptosporidium spp. is significantly associated with calf age. Furthermore, the findings demonstrate the high genetic diversity of C. parvum and the widespread occurrence of zoonotic C. parvum in pre-weaned calves. Hence, calves are a potential source of zoonotic transmission with considerable public health implications.	[Jang, Dong-Hun; Cho, Hyung-Chul; Shin, Seung-Uk; Kim, Eun-Mi; Park, Yu-Jin; Hwang, Sunwoo; Choi, Kyoung-Seong] Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Anim Sci & Biotechnol, Sangju, South Korea; [Park, Jinho] Jeonbuk Natl Univ, Coll Vet Med, Iksan, South Korea	Kyungpook National University; Jeonbuk National University	Choi, KS (corresponding author), Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Anim Sci & Biotechnol, Sangju, South Korea.	kschoi3@knu.ac.kr		Choi, Kyoung-Seong/0000-0002-2271-5360; Park, Jinho/0000-0001-5235-5717	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) [321016-01-1-HD020]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET)	Kyoung-Seong Choi: This research was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET) (Grant No. 321016-01-1-HD020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests:	Aberg M, 2020, VET PARASITOL REG ST, V20, DOI 10.1016/j.vprsr.2020.100400; Abeywardena H, 2012, INFECT GENET EVOL, V12, P1984, DOI 10.1016/j.meegid.2012.08.004; Al Mawly J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0855-9; Al-Habsi Khalid, 2017, Vet Parasitol Reg Stud Reports, V7, P32, DOI 10.1016/j.vprsr.2016.11.006; Avendano C, 2018, PARASITOL RES, V117, P1317, DOI 10.1007/s00436-018-5818-6; Bin Kabir MH, 2020, PARASITOL INT, V79, DOI 10.1016/j.parint.2020.102163; Bin Kabir MH, 2020, PARASITOL INT, V78, DOI 10.1016/j.parint.2020.102153; Bjorkman C, 2015, PARASITOLOGY, V142, P1108, DOI 10.1017/S0031182015000426; Caffarena RD, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00562; Cai M, 2017, VET PARASITOL, V241, P14, DOI 10.1016/j.vetpar.2017.05.005; Chalmers RM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3354-6; Cheun HI, 2007, J VET MED SCI, V69, P1099, DOI 10.1292/jvms.69.1099; Connelly L, 2013, APPL ENVIRON MICROB, V79, P2240, DOI 10.1128/AEM.02823-12; Del Chierico F, 2011, ANN TROP MED PARASIT, V105, P339, DOI 10.1179/1364859411Y.0000000025; Del Coco VF, 2014, RES VET SCI, V96, P311, DOI 10.1016/j.rvsc.2013.12.010; Deshpande AP, 2015, PARASITOLOGY, V142, P318, DOI 10.1017/S0031182014001346; Dessi G, 2020, PARASITOL RES, V119, P4211, DOI 10.1007/s00436-020-06947-2; Diaz P, 2018, PARASITOL RES, V117, P3081, DOI 10.1007/s00436-018-6000-x; Faubert GM, 2000, J PARASITOL, V86, P495, DOI 10.1645/0022-3395(2000)086[0495:NTOCPB]2.0.CO;2; Fayer R, 2005, J PARASITOL, V91, P624, DOI 10.1645/GE-3435; Fayer R, 2004, VET PARASITOL, V126, P37, DOI 10.1016/j.vetpar.2004.09.004; Fayer R, 2008, VET PARASITOL, V156, P191, DOI 10.1016/j.vetpar.2008.05.024; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2018, TRENDS PARASITOL, V34, P997, DOI 10.1016/j.pt.2018.07.009; Feng YY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01701; Feng YY, 2013, INT J PARASITOL, V43, P1141, DOI 10.1016/j.ijpara.2013.09.002; Giangaspero A, 2014, INT J FOOD MICROBIOL, V171, P62, DOI 10.1016/j.ijfoodmicro.2013.11.022; Glaberman S, 2002, EMERG INFECT DIS, V8, P631, DOI 10.3201/eid0806.010368; Grinberg A, 2008, J CLIN MICROBIOL, V46, P2396, DOI 10.1128/JCM.00936-08; Holzhausen I, 2019, PARASITOL RES, V118, P1549, DOI 10.1007/s00436-019-06266-1; Ichikawa-Seki M, 2015, PARASITOL INT, V64, P161, DOI 10.1016/j.parint.2014.11.007; Inacio SV, 2017, VET PARASITOL, V233, P48, DOI 10.1016/j.vetpar.2016.11.021; Kaupke A, 2015, PARASITOL RES, V114, P4709, DOI 10.1007/s00436-015-4719-1; Khan A, 2018, ACTA TROP, V184, P1, DOI 10.1016/j.actatropica.2017.10.023; Koinari M, 2014, EXP PARASITOL, V141, P134, DOI 10.1016/j.exppara.2014.03.021; Koinari M, 2013, VET PARASITOL, V198, P1, DOI 10.1016/j.vetpar.2013.08.031; Lee SH, 2016, VET PARASITOL, V229, P81, DOI 10.1016/j.vetpar.2016.09.019; Lee SH, 2019, J VET SCI, V20, DOI 10.4142/jvs.2019.20.e64; Lee YJ, 2019, PARASITOL RES, V118, P3509, DOI 10.1007/s00436-019-06482-9; Li N, 2019, INT J PARASITOL, V49, P569, DOI 10.1016/j.ijpara.2019.02.006; Liang N, 2019, PARASITOLOGY, V146, P28, DOI 10.1017/S0031182018001129; Lichtmannsperger K, 2020, PARASITOL RES, V119, P4291, DOI 10.1007/s00436-020-06928-5; Lombardelli JA, 2019, PARASITOL RES, V118, P2079, DOI 10.1007/s00436-019-06366-y; Mahfouz ME, 2014, J VET MED SCI, V76, P1569, DOI 10.1292/jvms.14-0272; Mammeri M, 2019, VET PARASITOL REG ST, V18, DOI 10.1016/j.vprsr.2019.100323; McLaughlin J, 2000, J CLIN MICROBIOL, V38, P3984, DOI 10.1128/JCM.38.11.3984-3990.2000; Meganck V, 2015, PREV VET MED, V118, P64, DOI 10.1016/j.prevetmed.2014.11.007; Mercado R, 2015, PARASITOL RES, V114, P1985, DOI 10.1007/s00436-015-4364-8; Mi RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111164; Mirhashemi ME, 2016, VET PARASITOL, V216, P18, DOI 10.1016/j.vetpar.2015.12.002; Muhid A, 2011, EXP PARASITOL, V127, P534, DOI 10.1016/j.exppara.2010.10.015; Naguib D, 2018, PARASITOL INT, V67, P736, DOI 10.1016/j.parint.2018.07.012; Ng JSY, 2010, EXP PARASITOL, V125, P325, DOI 10.1016/j.exppara.2010.02.012; Nolan MJ, 2013, WATER RES, V47, P1726, DOI 10.1016/j.watres.2012.12.027; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Osman Marwan, 2018, J Infect Dev Ctries, V12, p34S, DOI 10.3855/jidc.10014; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Qi M, 2020, PARASITOL RES, V119, P3839, DOI 10.1007/s00436-020-06904-z; Quilez J, 2008, PARASITOLOGY, V135, P1613, DOI 10.1017/S0031182008005088; Ramo A, 2015, INFECT GENET EVOL, V31, P190, DOI 10.1016/j.meegid.2015.01.023; Rieux A, 2013, VET PARASITOL, V197, P7, DOI 10.1016/j.vetpar.2013.05.001; Santin M, 2004, VET PARASITOL, V122, P103, DOI 10.1016/j.vetpar.2004.03.020; Santin M, 2013, NEW ZEAL VET J, V61, P1, DOI 10.1080/00480169.2012.731681; Santin M, 2008, VET PARASITOL, V155, P15, DOI 10.1016/j.vetpar.2008.04.018; Santin M, 2009, VET PARASITOL, V166, P32, DOI 10.1016/j.vetpar.2009.07.039; Santoro A, 2019, PARASITOLOGY, V146, P261, DOI 10.1017/S0031182018001348; Seppa-Lassila L, 2015, COMP IMMUNOL MICROB, V41, P10, DOI 10.1016/j.cimid.2015.05.004; Shrestha RD, 2014, VET PARASITOL, V202, P287, DOI 10.1016/j.vetpar.2014.03.034; Silverlas C, 2013, EPIDEMIOL INFECT, V141, P529, DOI 10.1017/S0950268812000830; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Soba B, 2008, PARASITOLOGY, V135, P1263, DOI 10.1017/S0031182008004800; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tao W, 2018, J PARASITOL, V104, P10, DOI 10.1645/17-140; Taylan-Ozkan A, 2016, EXP PARASITOL, V170, P16, DOI 10.1016/j.exppara.2016.06.014; Thompson HP, 2007, PARASITOL RES, V100, P619, DOI 10.1007/s00436-006-0305-x; Thomson S, 2019, PARASITOLOGY, V146, P1404, DOI 10.1017/S0031182019000829; Thomson S, 2017, VET RES, V48, DOI 10.1186/s13567-017-0447-0; Trotz-Williams LA, 2006, PARASITOL RES, V99, P346, DOI 10.1007/s00436-006-0157-4; Valenzuela O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096128; Waldron LS, 2011, INFECT GENET EVOL, V11, P1388, DOI 10.1016/j.meegid.2011.05.008; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Wang RJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01823; Wells B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0684-x; Wu YY, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9090692; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2004, CURR OPIN INFECT DIS, V17, P483, DOI 10.1097/00001432-200410000-00014; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu Zhixiao, 2020, Microb Genom, V6, DOI 10.1099/mgen.0.000379; Yildirim A, 2020, COMP IMMUNOL MICROB, V69, DOI 10.1016/j.cimid.2020.101425; Zintl A, 2009, EPIDEMIOL INFECT, V137, P270, DOI 10.1017/S0950268808000769	92	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259824	10.1371/journal.pone.0259824	http://dx.doi.org/10.1371/journal.pone.0259824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780521	Green Published, gold			2022-12-26	WOS:000755305800054
J	Addis, T; Mekonnen, Y; Ayenew, Z; Fentaw, S; Biazin, H				Addis, Tesfa; Mekonnen, Yonas; Ayenew, Zeleke; Fentaw, Surafel; Biazin, Habtamu			Bacterial uropathogens and burden of antimicrobial resistance pattern in urine specimens referred to Ethiopian Public Health Institute	PLOS ONE			English	Article							TRACT-INFECTIONS; ANTIBIOTIC-RESISTANCE; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; PATHOGENS	Background Urinary tract infections (UTIs) are the leading causes of morbidity in the general population, and is the second most common infectious disease after respiratory infections. Appropriate antibiotic therapy is essential to achieving good therapeutic results. Therefore, the purpose of this study was to investigate the profile of pathogens cultured from urinary tract infections and to determine their resistance profiles to commonly prescribed antibiotics. Method A cross-sectional study was carried out at the National Referral Laboratory of the Ethiopian Institute of Public Health from January 2017 to December 2018. All positive cultures were characterized by colony morphology, Gram stain, and standard biochemical tests. The antimicrobial susceptibility test of the isolate was performed using the Kirby- Bauer disk diffusion test on Muller-Hinton agar. In addition, bacterial identification, antimicrobial susceptibility testing and phenotypic detection of MDR were performed with VITEK 2 Compact according to the manufacturer's instructions. Result Out of 1012 cultured urine specimens, 325 (32.1%) was showed significant bacteriuria. The overall prevalence of UTIs was 325(32.1%) and the highest prevalence rate was obtained from 21-30 years age group 73(22.5%). Among UTIs patients, 583(57.6%) were females and 429(42.4%) were males. The UTIs of 179 (55%) women is relatively higher than that of men 146 (45%). Among 325 isolates, Gram-negative bacteria (GNB) appeared more frequently 252 (51.7%) than Gram-positive bacteria 63 (19.4%). In GNB, E. coli 168(66.7%), Klebsiella species 32(12.7%), and Enterobacter species 13 (5.2%) were dominated isolates whereas in GPB accounted for coagulase-negative staphylococcus (CoNS) 33(52.4%), Enterococcus species 16(25.4%), and Staphylococcus aureus 10(15.9%). Major of the isolates showed high levels of antibiotic resistance to commonly prescribed antimicrobials. Imipenem, Amikacin, and Nitrofurantoin were the most sensitive antibiotics for Gram-negative isolates while Nitrofurantoin, clindamycin, and Gentamycin were effective against gram-positive uropathogens. Overall, 156/256(60.9%), 56/256(22.4%), 10/256(4%) of gram-negative isolates were MDR, XDR, and PDR respectively while among the GPB isolates, 34/63(53.1%), 10/63(15.8%), and 1/63(1.6%) were MDR, XDR, and PDR isolates respectively. Among the tested bacterial strains, 190/319 (59.5%) were MDR, 66/319 (20.7%) strains were XDR, and 11/319 (3.45%) were PDR isolated. Conclusion The prevalence of urinary tract infection was high, and Gram-negative organisms were the most common causes of UTIs in this study. It was found that the resistance to commonly used antibiotics is very high. Early detection and close monitoring of MDR, XDR, or even PDR bacterial strains must be started by all clinical microbiology laboratories to reduce the menace of antimicrobial resistance that is now a global problem.	[Addis, Tesfa; Mekonnen, Yonas; Ayenew, Zeleke; Fentaw, Surafel] Ethiopian Publ Hlth Inst, Dept Clin Bacteriol & Mycol, Addis Ababa, Ethiopia; [Biazin, Habtamu] Addis Ababa Univ, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia		Biazin, H (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	habtamu.biazin@aau.edu.et	Kebede, Habtamu Biazin/ABG-2536-2021	Kebede, Habtamu Biazin/0000-0002-1914-1992; ayenew, zeleke/0000-0003-4216-6634				Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75914-9; Algammal AM, 2020, INFECT DRUG RESIST, V13, P3255, DOI 10.2147/IDR.S272733; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030238; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; BENDALL MJ, 1984, J ANTIMICROB CHEMOTH, V13, P69, DOI 10.1093/jac/13.suppl_B.69; Beyene G, 2011, ETHIOP J HEALTH SCI, V21, P141; Boehm BW., 1975, NBS SPEC PUBL, P1; CDC Antibiotic Resistance, 2019, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute(CLSI), M100 PERF STAND ANT; Dada-Adegbola H O, 2010, Afr J Med Med Sci, V39, P173; Ekwealor Perpetua A, 2016, Int J Microbiol, V2016, P9740273, DOI 10.1155/2016/9740273; Eshetie S., 2015, NW ETHIOPIA, P1; Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9; Gessese YA, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0289-6; Getachew T., 2010, BACTERIAL PATHOGENS; Grigoryan L, 2014, JAMA-J AM MED ASSOC, V312, P1677, DOI 10.1001/jama.2014.12842; Gul N., ISOLATION IDENTIFICA; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; Holloway KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152020; Ibrahim NashwanM.R., 2015, INT J PURE APPL SCI, V30, P54; Kabew G., 2011, ETHIOP J HLTH DEV, V27, P111; Karah N, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10100832; Kibret Mulugeta, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P164, DOI 10.1016/S2221-1691(14)60226-4; Makharita RR, 2020, INFECT DRUG RESIST, V13, P3991, DOI 10.2147/IDR.S276975; Mandracchia VJ., 2000, NAT REV MICROBIOL, V13, P269; Mehboob M., 2021, BIOSCIENTIFIC REV; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Omoregie Richard, 2008, New Zealand Journal of Medical Laboratory Science, V62, P29; Ouno G. A., 2013, Journal of Natural Sciences Research, V3, P150; Planson AG, 2011, BIOTECHNOL J, V6, P812, DOI 10.1002/biot.201100085; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Schaeffer AJ, 2001, INT J ANTIMICROB AG, V17, P245, DOI 10.1016/S0924-8579(01)00302-8; Seifu WD, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2911-x; Shah L. J., 2015, National Journal of Medical Research, V5, P71; Shaifali I, 2012, N AM J MED SCI, V4, P163, DOI 10.4103/1947-2714.94940; Sime WT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243474; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; State N., 2014, INT RES J MED MED SC, V5, P163; Tuem KB, 2019, J GLOB ANTIMICROB RE, V18, P109, DOI 10.1016/j.jgar.2019.01.022; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; Wutayd O Al, ANTIBIOTIC SUSCEPTIB; Yang X., 2021, OVERCOMING MULTIDRUG, V9	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259602	10.1371/journal.pone.0259602	http://dx.doi.org/10.1371/journal.pone.0259602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767605	gold, Green Published			2022-12-26	WOS:000755249300036
J	Haberthur, D; Yao, E; Barre, SF; Cremona, TP; Tschanz, SA; Schittny, JC				Haberthur, David; Yao, Eveline; Barre, Sebastien F.; Cremona, Tiziana P.; Tschanz, Stefan A.; Schittny, Johannes C.			Pulmonary acini exhibit complex changes during postnatal rat lung development	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; MORPHOMETRY; RECONSTRUCTION; ALVEOLI; NUMBER; GROWTH	Pulmonary acini represent the functional gas-exchanging units of the lung. Due to technical limitations, individual acini cannot be identified on microscopic lung sections. To overcome these limitations, we imaged the right lower lobes of instillation-fixed rat lungs from postnatal days P4, P10, P21, and P60 at the TOMCAT beamline of the Swiss Light Source synchrotron facility at a voxel size of 1.48 mu m. Individual acini were segmented from the three-dimensional data by closing the airways at the transition from conducting to gas exchanging airways. For a subset of acini (N = 268), we followed the acinar development by stereologically assessing their volume and their number of alveoli. We found that the mean volume of the acini increases 23 times during the observed time-frame. The coefficients of variation dropped from 1.26 to 0.49 and the difference between the mean volumes of the fraction of the 20% smallest to the 20% largest acini decreased from a factor of 27.26 (day 4) to a factor of 4.07 (day 60), i.e. shows a smaller dispersion at later time points. The acinar volumes show a large variation early in lung development and homogenize during maturation of the lung by reducing their size distribution by a factor of 7 until adulthood. The homogenization of the acinar sizes hints at an optimization of the gas-exchange region in the lungs of adult animals and that acini of different size are not evenly distributed in the lungs. This likely leads to more homogeneous ventilation at later stages in lung development.	[Haberthur, David; Yao, Eveline; Barre, Sebastien F.; Cremona, Tiziana P.; Tschanz, Stefan A.; Schittny, Johannes C.] Univ Bern, Inst Anat, Bern, Switzerland	University of Bern	Schittny, JC (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	schittny@ana.unibe.ch	Haberthür, David/K-2105-2014; Schittny, Johannes C./U-2956-2017	Haberthür, David/0000-0003-3388-9187; Schittny, Johannes C./0000-0003-4025-3961	Swiss National Science Foundation [310030_153468, 310030_175953]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are thankful for the support by the Swiss National Science Foundation (grants 310030_153468 and 310030_175953). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Barre SF, 2016, AM J PHYSIOL-LUNG C, V311, pL1082, DOI 10.1152/ajplung.00325.2016; Barre SF, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12063; Borisova E, 2021, HISTOCHEM CELL BIOL, V155, P215, DOI 10.1007/s00418-020-01868-8; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; Cruz-Orive LM, 1999, J MICROSC-OXFORD, V193, P182, DOI 10.1046/j.1365-2818.1999.00460.x; Das GK, 2016, NANOSCALE, V8, P11518, DOI 10.1039/c6nr00897f; Dutta A, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039680; Erhardt W., 2012, ANASTHESIE ANALGESIE; Fishler R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14071; Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73; Haberthur D, 2013, J APPL PHYSIOL, V115, P1379, DOI 10.1152/japplphysiol.00642.2013; Haberthur D, 2010, J SYNCHROTRON RADIAT, V17, P590, DOI 10.1107/S0909049510019618; Haberthur D., 2021, OPEN SCI FRAMEWORK, DOI [10.17605/osf.io/jkune, DOI 10.17605/OSF.IO/JKUNE]; Haberthur D., 2020, Zenodo, DOI 10.5281/zenodo.3768407; Haberthur David, GIST; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; Hasler D, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007079; Henry FS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007949; Himmelstein DS, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007128; Hofemeier P, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027328; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; KAUFFMAN SL, 1974, ANAT RECORD, V180, P63, DOI 10.1002/ar.1091800108; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Kolanjiyil AV, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/5952941; Kreyling WG, 2018, ACS NANO, V12, P7771, DOI 10.1021/acsnano.8b01826; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marone F, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012042; Marone F., 2011, SYNCHROTRON RAD NEWS, V24, P24, DOI [10.1080/08940886.2011.634315, DOI 10.1080/08940886.2011.634315]; MERCER RR, 1987, J APPL PHYSIOL, V63, P785, DOI 10.1152/jappl.1987.63.2.785; Osmanagic E, 2010, J APPL PHYSIOL, V109, P1592, DOI 10.1152/japplphysiol.00736.2010; Puliyakote ASK, 2016, J APPL PHYSIOL, V121, P115, DOI 10.1152/japplphysiol.00317.2016; RODRIGUEZ M, 1987, AM J ANAT, V180, P143, DOI 10.1002/aja.1001800204; SCHERLE W, 1970, Mikroskopie, V26, P57; SCHITTNY JC, 2008, FISHMANS PULMONARY D, P91; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schittny JC, 2018, HISTOCHEM CELL BIOL, V150, P677, DOI 10.1007/s00418-018-1749-7; Schittny JC, 2017, CELL TISSUE RES, V367, P427, DOI 10.1007/s00441-016-2545-0; Semmler-Behnke M, 2012, P NATL ACAD SCI USA, V109, P5092, DOI 10.1073/pnas.1119339109; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STOREY WF, 1962, J APPL PHYS, V17, P391; Sznitman J, 2010, J VISUAL-JAPAN, V13, P337, DOI 10.1007/s12650-010-0043-0; Sznitman J., 2006, J BIOMECH, V39, pS441, DOI [10.1016/s0021-9290(06)84801-3, DOI 10.1016/S0021-9290(06)84801-3]; Sznitman J, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049481; Sznitman J, 2009, J BIOMECH, V42, P789, DOI 10.1016/j.jbiomech.2008.12.022; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Tschanz SA, 2014, J APPL PHYSIOL, V117, P89, DOI 10.1152/japplphysiol.01355.2013; Tsuda A, 2008, J APPL PHYSIOL, V105, P964, DOI 10.1152/japplphysiol.90546.2008; Vasilescu DM, 2012, P NATL ACAD SCI USA, V109, P17105, DOI 10.1073/pnas.1215112109; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; Woodward JD, 2005, J ANAT, V206, P477, DOI 10.1111/j.1469-7580.2005.00413.x; Yang L, 2019, ACS NANO, V13, P1029, DOI 10.1021/acsnano.8b07524; ZELTNER TB, 1990, EXP LUNG RES, V16, P145, DOI 10.3109/01902149009087879	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0257349	10.1371/journal.pone.0257349	http://dx.doi.org/10.1371/journal.pone.0257349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748555	Green Published, gold, Green Submitted			2022-12-26	WOS:000755468000003
J	Langenfeld, NJ; Payne, LE; Bugbee, B				Langenfeld, Noah James; Payne, Lauren Elizabeth; Bugbee, Bruce			Colorimetric determination of urea using diacetyl monoxime with strong acids	PLOS ONE			English	Article							AMMONIA; OPTIMIZATION; NITROGEN; SOIL; MS	Urea is a byproduct of the urea cycle in metabolism and is excreted through urine and sweat. Ammonia, which is toxic at low levels, is converted to the safe storage form of urea, which represents the largest efflux of nitrogen from many organisms. Urea is an important nitrogen source in agriculture, is added to many industrial products, and is a large component in wastewater. The enzyme urease hydrolyzes urea to ammonia and bicarbonate. This reaction is microbially mediated in soils, hydroponic solutions, and wastewater recycling and is catalyzed in vivo in plants using native urease, making measurement of urea environmentally important. Both direct and indirect methods to measure urea exist. This protocol uses diacetyl monoxime to directly determine the concentration of urea in solution. The protocol provides repeatable results and stable reagents with good color stability and simple measurement techniques for use in any lab with a spectrophotometer. The reaction between diacetyl monoxime and urea in the presence of sulfuric acid, phosphoric acid, thiosemicarbazide, and ferric chloride produces a chromophore with a peak absorbance at 520 nm and a linear relationship between concentration and absorbance from 0.4 to 5.0 mM urea in this protocol. The lack of detectable interferences makes this protocol suitable for the determination of millimolar levels of urea in wastewater streams and hydroponic solutions.	[Langenfeld, Noah James; Payne, Lauren Elizabeth; Bugbee, Bruce] Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Langenfeld, NJ (corresponding author), Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA.	noah.langenfeld@usu.edu		Langenfeld, Noah/0000-0002-0267-2965	Utah Agricultural Experiment Station, Utah State University; NASA, Center for the Utilization of Biological Engineering in Space [NNX17AJ31G]	Utah Agricultural Experiment Station, Utah State University; NASA, Center for the Utilization of Biological Engineering in Space	This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 9459; NASA, Center for the Utilization of Biological Engineering in Space (grant number NNX17AJ31G). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 2017, J OCEANOGR, V73, P249, DOI 10.1007/s10872-016-0400-2; ANDERSON DJ, 1989, CLIN CHEM, V35, P2152; Anderson M.S., 2018, LIFE SUPPORT BASELIN; ARCHIBALD RM, 1945, J BIOL CHEM, V157, P507; Bhavadasan M. K., 1982, Indian Journal of Dairy Science, V35, P263; BOLLETER WT, 1961, ANAL CHEM, V33, P592, DOI 10.1021/ac60172a034; Bowden RST., 1962, J SMALL ANIMAL PRACT, V3, P217, DOI [10.1111/j.1748-5827.1962.tb04191.x, DOI 10.1111/J.1748-5827.1962.TB04191.X]; BOYDE TRC, 1980, ANAL BIOCHEM, V107, P424, DOI 10.1016/0003-2697(80)90404-2; Chen L, 2015, LIMNOL OCEANOGR-METH, V13, P303, DOI 10.1002/lom3.10026; Clark S, 2007, J CHROMATOGR A, V1161, P207, DOI 10.1016/j.chroma.2007.05.085; Cozzi S, 2004, MAR BIOL, V145, P843, DOI 10.1007/s00227-004-1366-y; ELLIOTT GC, 1986, J AM SOC HORTIC SCI, V111, P862; Fearon WR, 1939, BIOCHEM J, V33, P902, DOI 10.1042/bj0330902; GOULD WD, 1986, ADV AGRON, V40, P209; Gutmann I., 1974, METHODS ENZYMATIC AN, V4, P1791, DOI [10.1016/B978-0-12-091304-6.50030-6, DOI 10.1016/B978-0-12-091304-6.50030-6]; HUIZENGA JR, 1994, ANN CLIN BIOCHEM, V31, P529, DOI 10.1177/000456329403100602; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kaspar H, 2009, J CHROMATOGR B, V877, P1838, DOI 10.1016/j.jchromb.2009.05.019; Kumar V., 2018, BASIC CONCEPTS CLIN, P67; Langenfeld NJ, 2021, FRONT ASTRON SPACE, V8, DOI 10.3389/fspas.2021.699688; LIDDICOAT MI, 1975, LIMNOL OCEANOGR, V20, P131, DOI 10.4319/lo.1975.20.1.0131; NEWELL BS, 1967, J MAR RES, V25, P201; Reay MK, 2019, SOIL BIOL BIOCHEM, V135, P127, DOI 10.1016/j.soilbio.2019.04.015; ROIJERS AFM, 1964, CLIN CHIM ACTA, V9, P197, DOI 10.1016/0009-8981(64)90094-4; ROSENTHAL HL, 1955, ANAL CHEM, V27, P1980, DOI 10.1021/ac60108a039; Van Slyke DD, 1927, J BIOL CHEM, V73, P695; Witte CP, 2011, PLANT SCI, V180, P431, DOI 10.1016/j.plantsci.2010.11.010; WYBENGA DR, 1971, CLIN CHEM, V17, P891; Yao DM, 2018, RSC ADV, V8, P29008, DOI 10.1039/c8ra05269g; Zhou L, 2016, AQUACULTURE, V450, P187, DOI 10.1016/j.aquaculture.2015.07.022	30	4	4	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259760	10.1371/journal.pone.0259760	http://dx.doi.org/10.1371/journal.pone.0259760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748601	Green Published, gold			2022-12-26	WOS:000755468000053
J	Konig, M; Winkler, A				Koenig, Michael; Winkler, Adalbert			The impact of government responses to the COVID-19 pandemic on GDP growth: Does strategy matter?	PLOS ONE			English	Article								We analyze whether and to what extent strategies employed by governments to fight the COVID-19 pandemic made a difference for GDP growth developments in 2020. Based on the strength and speed with which governments imposed non-pharmaceutical interventions (NPIs) when confronted with waves of infections we distinguish between countries pursuing an elimination strategy and countries following a suppression / mitigation strategy. For a sample of 44 countries fixed effect panel regression results show that NPI changes conducted by elimination strategy countries had a less severe effect on GDP growth than NPI changes in suppression / mitigation strategy countries: strategy matters. However, this result is sensitive to the countries identified as "elimination countries" and to the sample composition. Moreover, we find that exogenous country characteristics drive the choice of strategy. At the same time our results show that countries successfully applying the elimination strategy achieved better health outcomes than their peers without having to accept lower growth.	[Koenig, Michael] Frankfurt Sch Finance & Management, FS UNEP Collaborating Ctr Climate & Sustainable E, Frankfurt, Germany; [Winkler, Adalbert] Frankfurt Sch Finance & Management, Ctr Dev Finance, Frankfurt, Germany	Frankfurt School Finance & Management; Frankfurt School Finance & Management	Konig, M (corresponding author), Frankfurt Sch Finance & Management, FS UNEP Collaborating Ctr Climate & Sustainable E, Frankfurt, Germany.	m.koenig@fs.de		Konig, Michael/0000-0003-3278-2679				Abbey EJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239398; Assenza T., 2020, HAMMER DANCE EQUILIB; Baker M.G., 2021, GUARDIAN 0121; Baker MG, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4907; Barro R.J., 2020, 26866 NAT BUR EC RES, Vw26866, DOI [10.3386/w26866, DOI 10.3386/W26866]; Baumann M., 2021, NEUE PROAKTIVE ZIELS; Bodenstein M., 2021, COVID EC, V71, P1; Boone L., 2021, COVID EC, V73, P1; Broughel J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252729; Carillo M., 2020, CEPR COVID EC VETTED, V10; Dave D, 2021, ECON INQ, V59, P29, DOI 10.1111/ecin.12944; Dorn F, 2020, MEDRXIV, DOI 10.1101/2020.08.14.20175224; Eichenbaum MS, 2021, REV FINANC STUD, V34, P5149, DOI 10.1093/rfs/hhab040; Farboodi M., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Fotiou A., 2021, COVID EC, V74, P94; Fratzscher Marcel, 2021, Wirtschaftsdienst, V101, P70, DOI 10.1007/s10273-021-2838-0; Goldstein P., 2021, COVID EC, V67, P1, DOI DOI 10.21203/RS.3.RS-621368/V1; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Gros D., 2020, GREAT LOCKDOWN WAS I; Hale T., 2020, VARIATION GOVT RESPO; Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8; Hasell J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00688-8; International Monetary Fund, 2018, WORLD EC OUTLOOK; Killeen G.F., 2020, LONG THIN TRANSMISSI; Konig Michael, 2021, Inter Econ, V56, P32, DOI 10.1007/s10272-021-0948-y; Ku┬nig M., 2020, COVID EC, V57, P132; Li F., 2021, COVID EC, V67, P53; Middleton J, 2020, INT J PUBLIC HEALTH, V65, P1525, DOI 10.1007/s00038-020-01455-7; Murphy N, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.42.2001624; OECD, 2021, INTERIM REPORT, DOI [10.1787/34bfd999-en, DOI 10.1787/34BFD999-EN]; Oraby T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82873-2; Scudellari M, 2020, NATURE, V587, P536, DOI 10.1038/d41586-020-03284-3; Sebhatu A, 2020, P NATL ACAD SCI USA, V117, P21201, DOI 10.1073/pnas.2010625117; Taylor A. M, 2020, LONGER RUN EC CONSEQ, V1, P1, DOI 10.3386/w26934.URL; Winkler Adalbert, 2020, Wirtschaftsdienst, V100, P344, DOI 10.1007/s10273-020-2655-x; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Yohe G., 2020, ENV CHANGE SUSTAINAB	37	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259362	10.1371/journal.pone.0259362	http://dx.doi.org/10.1371/journal.pone.0259362			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739509	Green Published, gold			2022-12-26	WOS:000755000800025
J	Ngongo, NM; Darcis, G; Nanituna, HS; Mambimbi, MM; Maes, N; Mashi, ML; Izizag, BB; Moutschen, M; Bompeka, FL				Ngongo, Nadine Mayasi; Darcis, Gilles; Nanituna, Hippolyte Situakibanza; Mambimbi, Marcel Mbula; Maes, Nathalie; Mashi, Murielle Longokolo; Izizag, Ben Bepouka; Moutschen, Michel; Bompeka, Francois Lepira			Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CD4(+) CELL COUNT; CARE; DISEASE; TRENDS; PREDICTORS	Background The benefits of antiretroviral therapy (ART) underpin the recommendations for the early detection of HIV infection and ART initiation. Late initiation (LI) of antiretroviral therapy compromises the benefits of ART both individually and in the community. Indeed, it promotes the transmission of infection and higher HIV-related morbidity and mortality with complicated and costly clinical management. This study aims to analyze the evolutionary trends in the median CD4 count, the median time to initiation of ART, the proportion of patients with advanced HIV disease at the initiation of ART between 2006 and 2017 and their factors. Methods and findings HIV-positive adults (>= 16 years old) who initiated ART between January 1, 2006 and December 31, 2017 in 25 HIV care facilities in Kinshasa, the capital of DRC, were eligible. The data were processed anonymously. LI is defined as CD4 <= 350 cells/mu l and/or WHO clinical stage III or IV and advanced HIV disease (AHD), as CD4 <= 200 cells/mu l and/or stage WHO clinic IV. Factors associated with advanced HIV disease at ART initiation were analyzed, irrespective of year of enrollment in HIV care, using logistic regression models. A total of 7278 patients (55% admitted after 2013) with an average age of 40.9 years were included. The majority were composed of women (71%), highly educated women (68%) and married or widowed women (61%). The median CD4 was 213 cells/mu l, 76.7% of patients had CD4 <= 350 cells/mu l, 46.1% had CD4 <= 200 cells/mu l, and 59% of patients were at WHO clinical stages 3 or 4. Men had a more advanced clinical stage (p <0.046) and immunosuppression (p<0.0007) than women. Overall, 70% of patients started ART late, and 25% had AHD. Between 2006 and 2017, the median CD4 count increased from 190 cells/mu l to 331 cells/mu l (p<0.0001), and the proportions of patients with LI and AHD decreased from 76% to 47% (p< 0.0001) and from 18.7% to 8.9% (p<0.0001), respectively. The median time to initiation of ART after screening for HIV infection decreased from 40 to zero months (p<0.0001), and the proportion of time to initiation of ART in the month increased from 39 to 93.3% (p<0.0001) in the same period. The probability of LI of ART was higher in married couples (OR: 1.7; 95% CI: 1.3-2.3) (p<0.0007) and lower in patients with higher education (OR: 0.74; 95% CI: 0.64-0.86) (p<0.0001). Conclusion Despite increasingly rapid treatment, the proportions of LI and AHD remain high. New approaches to early detection, the first condition for early ART and a key to ending the HIV epidemic, such as home and work HIV testing, HIV self-testing and screening at the point of service, must be implemented.	[Ngongo, Nadine Mayasi; Nanituna, Hippolyte Situakibanza; Mambimbi, Marcel Mbula; Mashi, Murielle Longokolo; Izizag, Ben Bepouka; Bompeka, Francois Lepira] Univ Clin Kinshasa, Dept Internal Med Infect & Trop Dis, Kinshasa, DEM REP CONGO; [Darcis, Gilles; Moutschen, Michel] Liege Univ Hosp, Dept Internal Med & Infect Dis, Liege, Belgium; [Maes, Nathalie] Univ Hosp Liege, Biostat & Medicoecon Informat Dept, Liege, Belgium; [Moutschen, Michel] Univ Liege, AIDS Reference Lab, Liege, Belgium	University of Liege; University of Liege; University of Liege	Ngongo, NM (corresponding author), Univ Clin Kinshasa, Dept Internal Med Infect & Trop Dis, Kinshasa, DEM REP CONGO.	nadiamayas02@gmail.com						Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Amanyire G, 2016, LANCET HIV, V3, pE539, DOI 10.1016/S2352-3018(16)30090-X; Anderegg N, 2017, 21 INT WORKSH HIV HE; Angdembe MR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215776; Assen A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3263-y; Auld AF, 2016, JAIDS-J ACQ IMM DEF, V73, pE11, DOI 10.1097/QAI.0000000000001137; Ayalew MB, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/5415298; Belay GM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4156-3; Benzekri NA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3826-5; Beyene MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140004; Blankley S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214739; Bor J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178249; Carmona S, 2018, CLIN INFECT DIS, V66, pS111, DOI 10.1093/cid/ciy045; Chihana ML, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2019.1679472; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Darcis G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26852-0; Deeks SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002466; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Fomundam HN, 2017, SAMJ S AFR MED J, V107, P1058, DOI [10.7196/SAMJ.2017.v107i12.12358, 10.7196/samj.2017.v107i12.12358]; Ford N, 2018, AIDS, V32, P17, DOI [10.1097/QAD.0000000000001671, 10.1097/qad.0000000000001671]; Ford N, 2017, NEW ENGL J MED, V377, P283, DOI 10.1056/NEJMe1707598; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gadisa T, 2017, AIDS BEHAV, V21, P70, DOI 10.1007/s10461-016-1290-4; Gelaw YA, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0079-2; Gesesew HA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2971-6; Gesesew HA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173928; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Hakim J, 2017, NEW ENGL J MED, V377, P233, DOI 10.1056/NEJMoa1615822; Hoffman S, 2014, AIDS, V28, P2429, DOI 10.1097/QAD.0000000000000427; Honge BL, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.40.8329; Jeong SJ, 2016, AIDS RES HUM RETROV, V32, P255, DOI [10.1089/aid.2015.0058, 10.1089/AID.2015.0058]; Johnson LF, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002468; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kiragga AN, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3724-x; Kujawski SA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx156; Kulkarni Sarah, 2016, J Int Assoc Provid AIDS Care, V15, P291, DOI 10.1177/2325957415593635; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lilian Rivka R., 2019, South. Afr. j. HIV med. (Online), V20, P1, DOI 10.4102/sajhivmed.v20i1.963; Luma HN, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3204-8; Makhema MJ., 2018, AIDS 2018; May MT, 2016, CLIN INFECT DIS, V62, P1571, DOI 10.1093/cid/ciw183; Ministere de la Sante publique Republique democratique du Congo, PROGR NAT LUTT VIH S; Ministere de la Sante publique Republique Democratique du Congo, 2018, PLAN STRAT NAT RIP V; Misgina KH, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0194-0; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Mutimura E, 2015, AIDS, V29, P67, DOI 10.1097/QAD.0000000000000520; Nash D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20637; Ngongo NM, 2021, AIDS RES THER, V18, DOI 10.1186/s12981-021-00366-8; Ngongo NM, 2021, AIDS, V35, P841, DOI 10.1097/QAD.0000000000002802; Nyika H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3044-7; Owusu KK, 2019, HIV AIDS-RES PALLIAT, V11, P321, DOI 10.2147/HIV.S216093; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Ruzagira E, 2017, TROP MED INT HEALTH, V22, P807, DOI 10.1111/tmi.12888; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Silverman RA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223411; Sogbanmu OO, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014664; Tanuma J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150781; Tymejczyk O, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002534; World Health Organization, 2017, GUID MAN ADV HIV DIS; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2010, ANT THER HIV INF AD; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; Yendewa GA, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy208	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259073	10.1371/journal.pone.0259073	http://dx.doi.org/10.1371/journal.pone.0259073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739506	Green Published, gold			2022-12-26	WOS:000755000800017
J	Arias-Cartin, R; Uzel, A; Seduk, F; Gerbaud, G; Pierrel, F; Broc, M; Lebrun, R; Guigliarelli, B; Magalon, A; Grimaldi, S; Walburger, A				Arias-Cartin, Rodrigo; Uzel, Alexandre; Seduk, Farida; Gerbaud, Guillaume; Pierrel, Fabien; Broc, Marianne; Lebrun, Regine; Guigliarelli, Bruno; Magalon, Axel; Grimaldi, Stephane; Walburger, Anne			Identification and characterization of a noncanonical menaquinone-linked formate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPLASMIC NITRATE REDUCTASE; ELECTRON-PARAMAGNETIC-RESONANCE; STABLE SEMIQUINONE INTERMEDIATE; HIGH-FIELD EPR; ESCHERICHIA-COLI; MOLYBDENUM COFACTOR; NAD(+)-DEPENDENT FORMATE; RHODOBACTER-CAPSULATUS; STRUCTURAL-ANALYSIS; REACTION CENTERS	The molybdenum/tungsten-bis-pyranopterin guanine dinucleotide family of formate dehydrogenases (FDHs) plays roles in several metabolic pathways ranging from carbon fixation to energy harvesting because of their reaction with a wide variety of redox partners. Indeed, this metabolic plasticity results from the diverse structures, cofactor content, and substrates used by partner subunits interacting with the catalytic hub. Here, we unveiled two noncanonical FDHs in Bacillus subtilis, which are organized into two-subunit complexes with unique features, ForCE1 and ForCE2. We show that the formate oxidoreductase catalytic subunit interacts with an unprecedented partner subunit, formate oxidoreductase essential subunit, and that its amino acid sequence within the active site deviates from the consensus residues typically associated with FDH activity, as a histidine residue is naturally substituted with a glutamine. The formate oxidoreductase essential subunit mediates the utilization of menaquinone as an electron acceptor as shown by the formate:menadione oxidoreductase activity of both enzymes, their copurification with menaquinone, and the distinctive detection of a protein-bound neutral menasemiquinone radical by multi frequency electron paramagnetic resonance (EPR) experiments on the purified enzymes. Moreover, EPR characterization of both FDHs reveals the presence of several [Fe-S] clusters with distinct relaxation properties and a weakly anisotropic Mo(V) EPR signature, consistent with the characteristic molybdenum/bispyranopterin guanine dinucleotide cofactor of this enzyme family. Altogether, this work enlarges our knowledge of the FDH family by identifying a noncanonical FDH, which differs in terms of architecture, amino acid conservation around the molybdenum cofactor, and reactivity.	[Arias-Cartin, Rodrigo; Seduk, Farida; Broc, Marianne; Magalon, Axel; Walburger, Anne] Aix Marseille Univ, CNRS, Lab Chim Bacterienne UMR7283, IMM,IM2B, Marseille, France; [Arias-Cartin, Rodrigo; Uzel, Alexandre; Gerbaud, Guillaume; Guigliarelli, Bruno; Grimaldi, Stephane] Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Proteines UMR7281, IMM,IM2B, Marseille, France; [Pierrel, Fabien] Grenoble Alpes Univ, CNRS, Grenoble INP, TIMC, Grenoble, France; [Lebrun, Regine] Aix Marseille Univ, CNRS, Plateforme Proteom IMM, IM2B Marseille Proteom MaP, Marseille, France; [Arias-Cartin, Rodrigo] Pasteur Inst, CNRS, Microbiol Integrat & Mol UMR 2001, Stress Adaptat & Metab Unit,Dept Microbiol, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arias-Cartin, R; Walburger, A (corresponding author), Aix Marseille Univ, CNRS, Lab Chim Bacterienne UMR7283, IMM,IM2B, Marseille, France.; Arias-Cartin, R; Grimaldi, S (corresponding author), Aix Marseille Univ, CNRS, Lab Bioenerget & Ingn Proteines UMR7281, IMM,IM2B, Marseille, France.; Arias-Cartin, R (corresponding author), Pasteur Inst, CNRS, Microbiol Integrat & Mol UMR 2001, Stress Adaptat & Metab Unit,Dept Microbiol, Paris, France.	rodrigo.ariascartin@pasteur.fr; stephane.grimaldi@univ-amu.fr; walburger@imm.cnrs.fr	PIERREL, Fabien/M-6016-2014	PIERREL, Fabien/0000-0003-2083-3002; Arias-Cartin, Rodrigo/0000-0001-5008-6437; Grimaldi, Stephane/0000-0002-9559-6112; Gerbaud, Guillaume/0000-0002-7320-9839; Uzel, Alexandre/0000-0001-7481-4427	French MESR fellowship; ANR MOLYERE project post-doctoral fellowship	French MESR fellowship; ANR MOLYERE project post-doctoral fellowship(French National Research Agency (ANR))	A. U. and M. B. were supported by a French MESR fellowship and R. A.-C. by an ANR MOLYERE project post-doctoral fellowship.	Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Arnoux P, 2003, NAT STRUCT BIOL, V10, P928, DOI 10.1038/nsb994; Arnoux P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7148; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; BARBER MJ, 1986, BIOCHEMISTRY-US, V25, P8150, DOI 10.1021/bi00373a004; Biaso F, 2012, INORG CHEM, V51, P3409, DOI 10.1021/ic201533p; Blaza JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40165; Bohmer N, 2014, FEBS LETT, V588, P531, DOI 10.1016/j.febslet.2013.12.033; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Brondino CD, 2004, J BIOL INORG CHEM, V9, P145, DOI 10.1007/s00775-003-0506-z; BURGHAUS O, 1993, J PHYS CHEM-US, V97, P7639, DOI 10.1021/j100131a037; Butler CS, 2000, BIOCHEM J, V352, P859, DOI 10.1042/0264-6021:3520859; Butler CS, 1999, BIOCHEMISTRY-US, V38, P9000, DOI 10.1021/bi990402n; Catling DC, 2020, SCI ADV, V6, DOI [10.1126/sciadv.aaX1420, 10.1126/sciadv.aax1420]; Covian R, 2007, J BIOL CHEM, V282, P24198, DOI 10.1074/jbc.M700662200; De Causmaecker S, 2019, P NATL ACAD SCI USA, V116, P19458, DOI 10.1073/pnas.1910675116; DEATON JC, 1987, BIOCHEM BIOPH RES CO, V149, P424, DOI 10.1016/0006-291X(87)90384-6; Dementin S, 2007, BIOCHEMISTRY-US, V46, P9713, DOI 10.1021/bi700928m; Dermoun Z, 2002, BBA-BIOENERGETICS, V1556, P217, DOI 10.1016/S0005-2728(02)00364-X; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; GANGESWARAN R, 1993, BIOCHEM J, V289, P335, DOI 10.1042/bj2890335; Gardiner AT, 1999, BIOCHEMISTRY-US, V38, P11773, DOI 10.1021/bi990661c; George GN, 1999, J AM CHEM SOC, V121, P1256, DOI 10.1021/ja982843k; Giordani R, 1997, EUR J BIOCHEM, V250, P567, DOI 10.1111/j.1432-1033.1997.0567a.x; GLASER P, 1995, J BACTERIOL, V177, P1112, DOI 10.1128/jb.177.4.1112-1115.1995; Grimaldi S, 2005, BIOCHEMISTRY-US, V44, P1300, DOI 10.1021/bi048009r; Grimaldi S, 2003, BIOCHEMISTRY-US, V42, P5632, DOI 10.1021/bi034010z; Grimaldi S, 2017, RSC METALLOBIO SER, V7, P68; Grimaldi S, 2013, BBA-BIOENERGETICS, V1827, P1048, DOI 10.1016/j.bbabio.2013.01.011; Gumerov VM, 2020, NUCLEIC ACIDS RES, V48, pW72, DOI 10.1093/nar/gkaa243; Hartmann T, 2016, BIOCHEMISTRY-US, V55, P2381, DOI 10.1021/acs.biochem.6b00002; Hartmann T, 2015, BBA-PROTEINS PROTEOM, V1854, P1090, DOI 10.1016/j.bbapap.2014.12.006; Hartmann T, 2013, FEBS J, V280, P6083, DOI 10.1111/febs.12528; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; Heikal A, 2014, MOL MICROBIOL, V91, P950, DOI 10.1111/mmi.12507; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; INGLEDEW WJ, 1995, EUR J BIOCHEM, V227, P903, DOI 10.1111/j.1432-1033.1995.tb20217.x; Jepson BJN, 2004, J BIOL CHEM, V279, P32212, DOI 10.1074/jbc.M402669200; Jepson BJN, 2007, J BIOL CHEM, V282, P6425, DOI 10.1074/jbc.M607353200; JOLLIE DR, 1991, J BIOL CHEM, V266, P21853; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; Lanciano P, 2007, BIOCHEMISTRY-US, V46, P5323, DOI 10.1021/bi700074y; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LIEBL U, 1992, J BIOL CHEM, V267, P14068; Magalon A., 2016, MOLYBDENUM TUNGSTEN, P143; Magalon Axel, 2015, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0006-2013; Maia LB, 2017, INORG CHIM ACTA, V455, P350, DOI 10.1016/j.ica.2016.07.010; Maia LB, 2015, J BIOL INORG CHEM, V20, P287, DOI 10.1007/s00775-014-1218-2; McMillan DGG, 2012, J BIOL CHEM, V287, P14215, DOI 10.1074/jbc.M112.348813; Najmudin S, 2008, J BIOL INORG CHEM, V13, P737, DOI 10.1007/s00775-008-0359-6; Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nielsen CF, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.06.007; Niks D, 2019, PROTEIN SCI, V28, P111, DOI 10.1002/pro.3498; Niks D, 2016, J BIOL CHEM, V291, P1162, DOI 10.1074/jbc.M115.688457; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Oh JL, 1999, MOL MICROBIOL, V34, P365, DOI 10.1046/j.1365-2958.1999.01613.x; Oliveira AR, 2020, ACS CATAL, V10, P3844, DOI 10.1021/acscatal.0c00086; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pelosi L, 2019, MBIO, V10, DOI 10.1128/mBio.01319-19; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Pinske Constanze, 2016, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0011-2016; POPOV VO, 1994, BIOCHEM J, V301, P625, DOI 10.1042/bj3010625; Prisner T, 2003, J BIOL INORG CHEM, V8, P419, DOI 10.1007/s00775-002-0432-5; Radon C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15614-0; Rendon J, 2015, BBA-BIOENERGETICS, V1847, P739, DOI 10.1016/j.bbabio.2015.05.001; Rivas MG, 2007, J INORG BIOCHEM, V101, P1617, DOI 10.1016/j.jinorgbio.2007.04.011; ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758; Santin YG, 2018, NAT MICROBIOL, V3, P1304, DOI 10.1038/s41564-018-0234-3; Sato T, 2001, J BIOSCI BIOENG, V91, P16, DOI 10.1263/jbb.91.16; SATOWATANABE M, 1995, FEBS LETT, V374, P265, DOI 10.1016/0014-5793(95)01125-X; Schoepp-Cothenet B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00263; Schrapers P, 2015, INORG CHEM, V54, P3260, DOI 10.1021/ic502880y; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Simpson PJL, 2010, BIOCHEM BIOPH RES CO, V398, P13, DOI 10.1016/j.bbrc.2010.06.002; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Szyttenholm J, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148252; Thome R, 2012, J BIOL CHEM, V287, P4671, DOI 10.1074/jbc.M111.327122; Un S, 2001, APPL MAGN RESON, V21, P341, DOI 10.1007/BF03162413; Wagner T, 2016, SCIENCE, V354, P114, DOI 10.1126/science.aaf9284; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Yilmazer B, 2020, J STRUCT BIOL, V212, DOI 10.1016/j.jsb.2020.107657; Young T, 2020, J BIOL CHEM, V295, P6570, DOI 10.1074/jbc.RA120.013264; Zhu BY, 2018, NUCLEIC ACIDS RES, V46, pD743, DOI 10.1093/nar/gkx908; Zuchan K, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2021.148401	89	3	3	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2022	298	2							101384	10.1016/j.jbc.2021.101384	http://dx.doi.org/10.1016/j.jbc.2021.101384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZI1YB	34748728	Green Published, Green Submitted, gold			2022-12-26	WOS:000761423400001
J	Wang, SJ; Chen, C; Yu, LN; Mueller, J; Rausch, V; Mueller, S				Wang, Shijin; Chen, Cheng; Yu, Linna; Mueller, Johannes; Rausch, Vanessa; Mueller, Sebastian			Bone morphogenetic protein 6-mediated crosstalk between endothelial cells and hepatocytes recapitulates the iron-sensing pathway in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPCIDIN EXPRESSION; HOMEOSTASIS; BMP6; ANEMIA; MICE; REGULATOR; HEMOCHROMATOSIS; FERROPORTIN; MACROPHAGES; SUPPRESSION	Liver sinusoidal endothelial cell-derived bone morphogenetic protein 6 (BMP6) and the BMP6-small mothers against decapentaplegic homolog (SMAD) signaling pathway are essential for the expression of hepcidin, the secretion of which is considered the systemic master switch of iron homeostasis. However, there are continued controversies related to the strong and direct suppressive effect of iron on hepatocellular hepcidin in vitro in contrast to in vivo conditions. Here, we directly studied the crosstalk between endothelial cells (ECs) and hepatocytes using in vitro coculture models that mimic hepcidin signaling in vivo. Huh7 cells were directly cocultured with ECs, and EC conditioned media (CM) were also used to culture Huh7 cells and primary mouse hepatocytes. To explore the reactions of ECs to surrounding iron, they were grown in the presence of ferric ammonium citrate and heme, two iron-containing molecules. We found that both direct coculture with ECs and EC-CM significantly increased hepcidin expression in Huh7 cells. The upstream SMAD pathway, including phosphorylated SMAD1/5/8, SMAD1, and inhibitor of DNA binding 1, was induced by EC-CM, promoting hepcidin expression. Efficient blockage of this EC-mediated hepcidin upregulation by an inhibitor of the BMP6 receptor ALK receptor tyrosine kinase 2/3 or BMP6 siRNA identified BMP6 as a major hepcidin regulator in this coculture system, which highly fits the model of hepcidin regulation by iron in vivo. In addition, EC-derived BMP6 and hepcidin were highly sensitive to levels of not only ferric iron but also heme as low as 500 nM. We here establish a hepatocyte-endothelial coculture system to fully recapitulate iron regulation by hepcidin using EC-derived BMP6.	[Mueller, Sebastian] Heidelberg Univ, Ctr Alcohol Res, Heidelberg, Germany; Heidelberg Univ, Salem Med Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mueller, S (corresponding author), Heidelberg Univ, Ctr Alcohol Res, Heidelberg, Germany.	sebastian.mueller@urz.uni-heildelberg.de		Mueller, Johannes/0000-0002-5205-4129	DFG [RA 2677/1-2]; China Scholarship Council (CSC)	DFG(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council)	This study was funded by a grant of the DFG to S. M. (RA 2677/1-2). S. W., C. C., and L. Y. are also grateful for the financial support of the China Scholarship Council (CSC).	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Baumann BH, 2019, EXP EYE RES, V187, DOI 10.1016/j.exer.2019.107728; Blazquez AG, 2013, BIOORGAN MED CHEM, V21, P4432, DOI 10.1016/j.bmc.2013.04.059; Canali S, 2017, AM J HEMATOL, V92, P1204, DOI 10.1002/ajh.24888; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; Chen HY, 2016, HAEMATOLOGICA, V101, P297, DOI 10.3324/haematol.2015.127902; Chen N, 2007, FREE RADICAL RES, V41, P990, DOI 10.1080/10715760701468740; Chiou B, 2019, J CEREBR BLOOD F MET, V39, P2117, DOI 10.1177/0271678X18783372; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Colucci S, 2021, HEPATOLOGY, V74, P2186, DOI 10.1002/hep.31900; Core AB, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00104; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; Erdei J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4310816; Eun JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110744; Fillebeen C, 2018, BLOOD, V132, P1829, DOI 10.1182/blood-2018-03-841197; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P8160, DOI 10.1073/pnas.161296298; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Han M, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2295-5; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Kamanna VS, 2012, AM J NEPHROL, V35, P114, DOI 10.1159/000334939; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2015, BLOOD, V126, P2031, DOI 10.1182/blood-2015-07-658419; Kawabata H, 2018, INT J HEMATOL, V107, P31, DOI 10.1007/s12185-017-2365-3; Khan ZA, 2005, FREE RADICAL RES, V39, P1203, DOI 10.1080/10715760500143254; Latour C, 2017, BLOOD, V130, P2339, DOI 10.1182/blood-2017-07-795658; Li H, 2017, BLOOD, V129, P1514, DOI 10.1182/blood-2016-09-742387; Lim PJ, 2019, NAT METAB, V1, P519, DOI 10.1038/s42255-019-0063-6; Liu J, 2019, HAEMATOLOGICA, V104, P1768, DOI 10.3324/haematol.2018.209874; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Millonig G, 2012, J BIOL CHEM, V287, P37472, DOI 10.1074/jbc.M112.358911; Mueller S, 2015, ADV EXP MED BIOL, V815, P89, DOI 10.1007/978-3-319-09614-8_6; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Noguchi T, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129610; Patel N, 2012, J BIOL CHEM, V287, P4099, DOI 10.1074/jbc.M111.310789; PONKA P, 1988, BIOCHIM BIOPHYS ACTA, V967, P122, DOI 10.1016/0304-4165(88)90197-3; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Ross SL, 2012, CELL METAB, V15, P905, DOI 10.1016/j.cmet.2012.03.017; Silva I, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101209; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Takayama G, 2007, TISSUE ENG, V13, P159, DOI 10.1089/ten.2006.0143; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Wahidiyat PA, 2018, ACTA MED INDONES, V50, P230; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Yamaguchi H, 1998, LEUKEMIA LYMPHOMA, V31, P61, DOI 10.3109/10428199809057585; Yu LN, 2021, WORLD J HEPATOL, V13, P1378, DOI 10.4254/wjh.v13.i10.1378; Zhang W, 2017, COLLOID SURFACE B, V151, P215, DOI 10.1016/j.colsurfb.2016.12.025	52	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101378	10.1016/j.jbc.2021.101378	http://dx.doi.org/10.1016/j.jbc.2021.101378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34740612	gold, Green Published			2022-12-26	WOS:000748084900006
J	Avalos-Mejia, AM; Garcia-Cruz, JC; de la Pena, JE; Garrido-Acosta, O; Juarez-Cedillo, T				Marisol Avalos-Mejia, Annia; Carlos Garcia-Cruz, Juan; Escobedo de la Pena, Jorge; Garrido-Acosta, Osvaldo; Juarez-Cedillo, Teresa			Reduction of inappropriate prescriptions in older adults through the support of Asynchronous Geriatric Counseling Online (AGAlink): Implemented in primary care	PLOS ONE			English	Article							PRESCRIBING OMISSIONS; ELDERLY-PATIENTS; SCREENING TOOL; CRITERIA; ALERTS	Background/Aim Medication prescription is a fundamental component in the care of the elderly. Several characteristics of aging and geriatric medicine affect prescriptions for these people and make the selection of drug therapy a difficult and complex process. The objective of this study is to develop a geriatric portal for asynchronous online counseling (AGAlink) for use by physicians specializing in family medicine to reduce medication problems among older adult patients in the first level of care. Method A qualitative study was carried out in the first level of care at the Mexican Institute of Social Security (IMSS), 31 family doctors were interviewed to identify attitudes, preferences about the use of the AGAlink geriatric portal, as well as their recommendations for the implementation of this tool in their daily practice. For the analysis of the data obtained, a qualitative thematic content analysis was used. Results 90% of the physicians used the geriatric portal outside office hours without the need for the patient to be present. The perception of the physician towards the use of the AGAlink geriatric portal was favorable, provided relevant information and had several positive effects on the process of care for medical prescription. The barriers identified to accept the change in medication were not having the proposed therapeutic option, lack of any laboratory analysis, continuing to consider their experience for the prescription of the medication. Conclusions The AGAlink geriatric portal was a tool that was well received by physicians who expressed a positive attitude, considered an investment of a short time that allowed them to update and learn about strategies to reduce the prescription problems presented among the elderly population. However, the main barrier was the use of technology, especially in the doctors with more seniority in the service.	[Marisol Avalos-Mejia, Annia; Juarez-Cedillo, Teresa] Hosp Gen Reg, Unidad Invest Epidemiol Clin, Ctr Med Nacl Siglo 21, Actualmente Comisionada Unidad Invest, 1 Dr Carlos Mac Gregor Sanchez Navarro,IMSS, Ciudad Mexico, Mexico; [Carlos Garcia-Cruz, Juan] Hosp Especialidades Ctr Med La Raza, Hosp Especialidades, Dept Med, Ctr Med Nacl Siglo 21,Div Med Geriatr,MISS, Ciudad De Mexico, Mexico; [Escobedo de la Pena, Jorge] Hosp Gen Reg, Unidad Invest Epidemiol Clin, 1 Dr Carlos Mac Gregor Sanchez Navarro, Ciudad De Mexico, Mexico; [Garrido-Acosta, Osvaldo] UNAM, Fac Estudios Super Zaragoza, Estado De Mexico, Mexico	Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico	Juarez-Cedillo, T (corresponding author), Hosp Gen Reg, Unidad Invest Epidemiol Clin, Ctr Med Nacl Siglo 21, Actualmente Comisionada Unidad Invest, 1 Dr Carlos Mac Gregor Sanchez Navarro,IMSS, Ciudad Mexico, Mexico.	terezillo@exalumno.unam.mx	Garrido-Acosta, Osvaldo/GQH-1784-2022	Garrido-Acosta, Osvaldo/0000-0003-4065-6322; Juarez-Cedillo, Teresa/0000-0002-9442-3471	Fund for the Promotion of Research in Health, Mexican Institute of Social Security [FIS / IMSS /PROT/G11/938]	Fund for the Promotion of Research in Health, Mexican Institute of Social Security	This project was supported by donations from the Fund for the Promotion of Research in Health, Mexican Institute of Social Security, FIS / IMSS /PROT/G11/938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Batuwitage BT, 2007, POSTGRAD MED J, V83, P66, DOI 10.1136/pgmj.2006.051151; Creswell J.W., 2018, RES DESIGN, V5th; dos Santos NS, 2019, REV SAUDE PUBL, V53, DOI [10.11606/S1518-8787.2019053000781, 10.11606/s1518-8787.2019053000781]; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Gallagher P, 2008, AGE AGEING, V37, P673, DOI 10.1093/ageing/afn197; Garcia C., 2008, DERMATOLOGIA REV MEX, V52, P77; Garcia Gomez J. C., 2001, El Profesional de la Informacion, V10, P4, DOI 10.1076/epri.10.7.4.9047; Garcia RM, 2006, J FAM PRACTICE, V55, P305; Hamilton Hilary J, 2009, BMC Geriatr, V9, P5, DOI 10.1186/1471-2318-9-5; Humphries TL, 2007, ANN PHARMACOTHER, V41, P1979, DOI 10.1345/aph.1K349; Kaur S, 2009, DRUG AGING, V26, P1013, DOI 10.2165/11318890-000000000-00000; Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679; Komiya H, 2018, GERIATR GERONTOL INT, V18, P33, DOI 10.1111/ggi.13132; Krause M, 1995, REV TEMAS EDUCACION, V7, P19; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Kuckartz U., 2014, QUALITATIVE TEXT ANA, DOI [10.1002/hbm.22668, DOI 10.1002/HBM.22668]; Lavan AH, 2016, CLIN INTERV AGING, V11, P857, DOI 10.2147/CIA.S80280; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Motter FR, 2018, EUR J CLIN PHARMACOL, V74, P679, DOI 10.1007/s00228-018-2446-0; O'Mahony D, 2020, EXPERT REV CLIN PHAR, V13, P15, DOI 10.1080/17512433.2020.1697676; Patton M. Q., 1990, QUALITATIVE EVALUATI; Raebel MA, 2007, J AM GERIATR SOC, V55, P977, DOI 10.1111/j.1532-5415.2007.01202.x; Tamblyn R, 2003, CAN MED ASSOC J, V169, P549; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258414	10.1371/journal.pone.0258414	http://dx.doi.org/10.1371/journal.pone.0258414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	34788287	Green Published, gold			2022-12-26	WOS:000735920500004
J	Nejtek, VA; James, RN; Salvatore, MF; Alphonso, HM; Boehm, GW				Nejtek, Vicki A.; James, Rachael N.; Salvatore, Michael F.; Alphonso, Helene M.; Boehm, Gary W.			Premature cognitive decline in specific domains found in young veterans with mTBI coincide with elder normative scores and advanced-age subjects with early-stage Parkinson's disease	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FALSE DISCOVERY RATE; MINI-MENTAL-STATE; HEAD-INJURY; TRAIL; VALIDATION; SCALE; RISK; PERFORMANCE; IMPAIRMENT	Importance Epidemiologists report a 56% increased risk of veterans with (+) mild traumatic brain injury (mTBI) developing Parkinson's disease (PD) within 12-years post-injury. The most relevant contributors to this high risk of PD in veterans (+) mTBI is unknown. As cognitive problems often precede PD diagnosis, identifying specific domains most involved with mTBI-related PD onset is critical. Objectives To discern which cognitive domains underlie the mTBI-PD risk relationship proposed in epidemiology studies. Design and setting This exploratory match-controlled, cross-sectional study was conducted in a medical school laboratory from 2017-2020. Participants Age- and IQ-matched veterans with (+) and without mTBI, non-veteran healthy controls, and IQ-matched non-demented early-stage PD were compared. Chronic neurological, unremitted/debilitating diseases, disorders, dementia, and substance use among others were excluded. Exposure Veterans were or were not exposed to non-penetrating combat-related mTBI occurring within the past 7-years. No other groups had recent military service or mTBI. Main outcomes / measures Cognitive flexibility, attention, memory, visuospatial ability, and verbal fluency were examined with well-known standardized neuropsychological assessments. Results Out of 200 volunteers, 114 provided evaluable data. Groups significantly differed on cognitive tests [F (21,299) = 3.09, p<0.0001]. Post hoc tests showed veterans (+) mTBI performed significantly worse than matched-control groups on four out of eight cognitive tests (range: p = .009 to .049), and more often than not performed comparably to early-stage PD (range: p = .749 to .140). Conclusions and relevance We found subtle, premature cognitive decline occurring in very specific cognitive domains in veterans (+) mTBI that would typically be overlooked in a clinic setting, This result potentially puts them at-risk for continual cognitive decline that may portend to the eventual onset of PD or some other neurodegenerative disease.	[Nejtek, Vicki A.; James, Rachael N.; Salvatore, Michael F.; Alphonso, Helene M.] Univ North Texas Hlth Sci Ctr, Ft Worth, TX 76107 USA; [Alphonso, Helene M.] John Peter Smith Hlth Network, Ft Worth, TX 76107 USA; [Boehm, Gary W.] Texas Christian Univ, Ft Worth, TX 76129 USA	Texas Christian University	Nejtek, VA (corresponding author), Univ North Texas Hlth Sci Ctr, Ft Worth, TX 76107 USA.	vicki.nejtek@unthsc.edu		Nejtek, Vicki/0000-0001-6935-1739	Graham and Caroline Holloway Family Foundation; JES Edwards Foundation [RP20007]; Institute for Translational Research at UNT Health Science Center [RI10024]	Graham and Caroline Holloway Family Foundation; JES Edwards Foundation; Institute for Translational Research at UNT Health Science Center	VAN was the Principal Investigator funded, in part, by the Graham and Caroline Holloway Family Foundation, the JES Edwards Foundation under Grant # RP20007, and the Institute for Translational Research (formerly the Center for Alzheimer's and Neurodegenerative Disease Research) at UNT Health Science Center under Grant # RI10024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo-Rodriguez I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010783.pub2; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg D, 2018, J PARKINSON DIS, V8, pS19, DOI 10.3233/JPD-181457; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crowe M, 2010, ARCH CLIN NEUROPSYCH, V25, P610, DOI 10.1093/arclin/acq047; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Darweesh SKL, 2017, JAMA NEUROL, V74, P1431, DOI 10.1001/jamaneurol.2017.2248; Durcan R, 2019, EUR J NEUROL, V26, P979, DOI 10.1111/ene.13919; Fengler S, 2017, MOVEMENT DISORD, V32, P1655, DOI 10.1002/mds.27135; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Goldman JG, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0055-3; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kalbe E, 2018, J PARKINSON DIS, V8, pS107, DOI 10.3233/JPD-181473; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lesiuk T, 2018, HEALTHCARE-BASEL, V6, DOI 10.3390/healthcare6020035; Lezak MD., 2004, LORING DW NEUROPSYCH, V4th; Marchand DG, 2018, ANN NEUROL, V83, P1016, DOI 10.1002/ana.25239; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McInnes K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218423; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; Numbers for Traumatic Brain Injury Worldwide Totals, 2019, DEF MED SURV SYST DM; Pfeiffer HCV, 2014, ACTA NEUROL SCAND, V129, P307, DOI 10.1111/ane.12189; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; De Roy J, 2020, J PARKINSON DIS, V10, P1033, DOI 10.3233/JPD-191857; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; Salvatore MF, 2021, J PARKINSON DIS, V11, P405, DOI 10.3233/JPD-202449; Schwab KA, 2006, NEUROLOGY, V66, pA235; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Silveira CRA, 2018, BRAIN COGNITION, V122, P1, DOI 10.1016/j.bandc.2018.01.002; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wilmoth K, 2018, CLIN NEUROPSYCHOL, V32, P524, DOI 10.1080/13854046.2017.1378371; Writer BW, 2010, J REHABIL RES DEV, V47, P841, DOI 10.1682/JRRD.2009.10.0162; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	55	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258851	10.1371/journal.pone.0258851	http://dx.doi.org/10.1371/journal.pone.0258851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	34788310	Green Published, gold			2022-12-26	WOS:000735920500007
J	Jiang, CC; Marsland, M; Wang, YF; Dowdell, A; Eden, E; Gao, FF; Faulkner, S; Jobling, P; Li, X; Liu, LH; He, ZY; Hondermarck, H				Jiang, Chen Chen; Marsland, Mark; Wang, Yufang; Dowdell, Amiee; Eden, Edward; Gao, Fangfang; Faulkner, Sam; Jobling, Phillip; Li, Xiang; Liu, Lihua; He, Zhangyu; Hondermarck, Hubert			Tumor innervation is triggered by endoplasmic reticulum stress	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; GENE; CANCER; MICROENVIRONMENT; EXPRESSION; SURVIVAL	Nerve infiltration in the tumor microenvironment is emerging as a promoter of cancer progression that could be targeted in therapies, but the mechanisms initiating tumor innervation remain to be elucidated. Here we report that endoplasmic reticulum (ER) stress in cancer cells is transmitted to neuronal cells, resulting in neurite outgrowth and tumor innervation. In vitro, the induction of ER stress in various human cancer cells resulted in the synthesis and release of the precursor for brain-derived neurotrophic factor (proBDNF) through a mechanism dependent on the transcription factor X-box binding protein 1 (XBP1). Cancer cell-released proBDNF was found to mediate the transmission of ER stress to neurons, resulting in the stimulation of neurite outgrowth. Next-generation sequencing indicated the increased expression of the Egl-9 family hypoxia inducible factor 3 (EGLN3) that was mediated by c-MYC and necessary to neurite outgrowth induced by proBDNF. In orthotopic tumor xenograft, ER stress stimulated XBP1 and proBDNF expression as well as tumor innervation. Anti-proBDNF antibody inhibited both tumor innervation and cancer progression induced by ER stress. Interestingly, the chemotherapeutic drug 5-Fluorouracil (5-FU) was found to induce ER stress and tumor innervation, and this effect was inhibited by anti-proBDNF antibody. Finally, in human tumors, cancer tissues with nerve infiltration expressed high XBP1 and proBDNF while EGLN3 was upregulated in infiltrated nerves. This study reveals that ER stress participates in tumor innervation through the release of proBDNF and that targeting this pathway could be used in future therapies.	[Jiang, Chen Chen; Marsland, Mark; Dowdell, Amiee; Eden, Edward; Gao, Fangfang; Faulkner, Sam; Jobling, Phillip; Li, Xiang; Hondermarck, Hubert] Univ Newcastle, Sch Biomed Sci & Pharm, Canc Neurobiol Grp, Callaghan, NSW 2308, Australia; [Jiang, Chen Chen; Marsland, Mark; Dowdell, Amiee; Eden, Edward; Gao, Fangfang; Faulkner, Sam; Jobling, Phillip; Li, Xiang; Hondermarck, Hubert] Hunter Med Res Inst, New Lambton, NSW 2305, Australia; [Jiang, Chen Chen] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Wang, Yufang; Liu, Lihua; He, Zhangyu] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Chengdu 610041, Sichuan, Peoples R China; [Gao, Fangfang] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou 450000, Henan, Peoples R China	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Sichuan University; Zhengzhou University	Hondermarck, H (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Canc Neurobiol Grp, Callaghan, NSW 2308, Australia.; Hondermarck, H (corresponding author), Hunter Med Res Inst, New Lambton, NSW 2305, Australia.	hubert.hondermarck@newcastle.edu.au		Faulkner, Sam/0000-0002-4732-8252; Li, Xiang/0000-0003-1199-7152	University of Newcastle (Australia); Hunter Cancer Research Alliance; Hunter Medical Research Institute; Maitland Cancer Appeal Committee (NSW Australia)	University of Newcastle (Australia); Hunter Cancer Research Alliance; Hunter Medical Research Institute; Maitland Cancer Appeal Committee (NSW Australia)	Y This work was supported by the University of Newcastle (Australia), the Hunter Cancer Research Alliance, the Hunter Medical Research Institute, and the Maitland Cancer Appeal Committee (NSW Australia). We thank Kristen McEwan for excellent technical contribution. We also thank Kathryn Leaney from Cancer Voice NSW for her excellent consumer contribution.	Allen JK, 2018, CANCER RES, V78, P3233, DOI 10.1158/0008-5472.CAN-16-1701; Bai YY, 2016, NEUROPSYCHOPHARMACOL, V41, P2882, DOI 10.1038/npp.2016.100; Cao ZY, 2014, ONCOL LETT, V7, P1260, DOI 10.3892/ol.2014.1856; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Demir IE, 2020, CANCER CELL, V38, P11, DOI 10.1016/j.ccell.2020.05.023; Evans JP, 2019, LAB ANIM-UK, V53, P598, DOI 10.1177/0023677219826165; Faulkner S, 2019, CANCER DISCOV, V9, P702, DOI 10.1158/2159-8290.CD-18-1398; Griffin N, 2020, AM J PATHOL, V190, P1921, DOI 10.1016/j.ajpath.2020.05.012; Guo ST, 2016, ONCOGENE, V35, P3049, DOI 10.1038/onc.2015.361; Haberberger RV, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00184; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Henze AT, 2010, CANCER RES, V70, P357, DOI 10.1158/0008-5472.CAN-09-1876; Hetz C, 2020, NAT REV MOL CELL BIO, V21, P421, DOI 10.1038/s41580-020-0250-z; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamiya A, 2019, NAT NEUROSCI, V22, P1289, DOI 10.1038/s41593-019-0430-3; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; Kim JK, 2016, ENVIRON TOXICOL PHAR, V44, P128, DOI 10.1016/j.etap.2016.05.005; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; LUNDBERG LM, 1988, HISTOCHEMISTRY, V90, P9, DOI 10.1007/BF00495700; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Monje M, 2020, CELL, V181, P219, DOI 10.1016/j.cell.2020.03.034; Murao N, 2017, J BIOCHEM, V162, P155, DOI 10.1093/jb/mvx047; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; Peterson SC, 2015, CELL STEM CELL, V16, P400, DOI 10.1016/j.stem.2015.02.006; Pundavela J, 2015, MOL ONCOL, V9, P1626, DOI 10.1016/j.molonc.2015.05.001; Renz BW, 2018, CANCER DISCOV, V8, P1458, DOI 10.1158/2159-8290.CD-18-0046; Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007; Saloman JL, 2016, P NATL ACAD SCI USA, V113, P3078, DOI 10.1073/pnas.1512603113; Sheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08152-3; Sloan EK, 2010, CANCER RES, V70, P7042, DOI 10.1158/0008-5472.CAN-10-0522; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Urra H, 2016, TRENDS CANCER, V2, P252, DOI 10.1016/j.trecan.2016.03.007; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; WAX SD, 1994, J BIOL CHEM, V269, P13041; Wiatrak B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040958; Xie H, 2018, J CLIN INVEST, V128, P1300, DOI 10.1172/JCI95864; Yin XY, 2001, ONCOGENE, V20, P2908, DOI 10.1038/sj.onc.1204417; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	44	0	0	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					586	599		10.1038/s41388-021-02108-6	http://dx.doi.org/10.1038/s41388-021-02108-6		NOV 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785777				2022-12-26	WOS:000719277200001
J	Jin, X; Zhang, B; Zhang, H; Yu, HX				Jin, Xin; Zhang, Bin; Zhang, Hao; Yu, Haixin			Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma	ONCOGENE			English	Article							PANCREATIC-CANCER; RHO-GTPASES; METHYLATION; RESISTANCE; CELLS; BRD4	Although tobacco smoking is a risk factor for lung adenocarcinoma (LUAD), the mechanisms by which tobacco smoking induces LUAD development remain elusive. Histone methylation levels in human bronchial epithelial cells have been reported to increase after exposure to cigarettes. In this study, we explored the mechanisms regulating histone methylation in LUAD in response to smoking. We found that the histone H3K9 methylation reader CBX3 was upregulated in current smokers with LUAD, and that CBX3 overexpression promoted LUAD progression. Functional enrichment analyses revealed that CBX3 regulated the activation of Rho GTPases in LUAD. We also found that by forming a complex with TRIM28, TRIM24, and RBBP4, CBX3 repressed the expression of ARHGAP24 and increased the amount of active Rac1 in LUAD cells. Collectively, these results suggest that smoking associated upregulation of CBX3 promotes LUAD progression by activating the ARHGAP24/Rac1 pathway. Hence, the CBX3/ARHGAP24/Rac1 axis may represent a promising therapeutic target in smoking-induced LUAD.	[Jin, Xin] Cent South Univ, Xiangya Hosp 2, Dept Urol, Changsha 410011, Hunan, Peoples R China; [Jin, Xin] Cent South Univ, Urooncol Inst, Changsha 410011, Hunan, Peoples R China; [Zhang, Bin; Yu, Haixin] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China; [Zhang, Hao] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Surg, Changsha 410011, Hunan, Peoples R China	Central South University; Central South University; Huazhong University of Science & Technology; Central South University	Yu, HX (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan 430022, Peoples R China.; Zhang, H (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Surg, Changsha 410011, Hunan, Peoples R China.	zhanghao7106@csu.edu.cn; haixin.y@outlook.com		Yu, Haixin/0000-0002-0245-2102; Jin, Xin/0000-0001-6461-6005	Chinese National Natural Science Foundation [82073321]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese National Natural Science Foundation Grant No. 82073321 (XJ).	Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Alam H, 2018, CANCER RES, V78, P3834, DOI 10.1158/0008-5472.CAN-17-3571; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Bot C, 2017, J CELL SCI, V130, P1134, DOI 10.1242/jcs.197236; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cai HP, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03247-6; Chang C, 2018, ONCOGENE, V37, P415, DOI 10.1038/onc.2017.332; Cho EJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091037; Fong KW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07475-5; Glancy E, 2021, CURR OPIN STRUC BIOL, V67, P135, DOI 10.1016/j.sbi.2020.10.017; Gray JL, 2020, ANGEW CHEM INT EDIT, V59, P6342, DOI 10.1002/anie.201900585; Haga Raquel B, 2016, Small GTPases, V7, P207; He X, 2017, INT J CHRONIC OBSTR, V12, P3245, DOI 10.2147/COPD.S144881; He ZS, 2021, J CELL PHYSIOL, V236, P107, DOI 10.1002/jcp.29631; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Huang CY, 2017, GENE DEV, V31, P241, DOI 10.1101/gad.292169.116; Itsumi M, 2013, J MOL ENDOCRINOL, V50, P401, DOI 10.1530/JME-13-0024; Jin X, 2017, CANCER RES, V77, P4328, DOI 10.1158/0008-5472.CAN-16-3143; Jin X, 2017, J BIOL CHEM, V292, P6269, DOI 10.1074/jbc.M116.764407; Johan MZ, 2019, BIOCHEM SOC T, V47, P101, DOI 10.1042/BST20180334; Kang NX, 2015, INT IMMUNOPHARMACOL, V24, P95, DOI 10.1016/j.intimp.2014.10.029; Kaur G, 2019, ARCH TOXICOL, V93, P2715, DOI 10.1007/s00204-019-02562-y; Li H, 2015, LUNG CANCER, V88, P1, DOI 10.1016/j.lungcan.2015.01.017; Lin HX, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/2412741; Liu HL, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5000; Maeda T, 2018, CANCER RES, V78, P205, DOI 10.1158/0008-5472.CAN-17-1636; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Oyama K, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0187-z; Porazinski S, 2020, ADV EXP MED BIOL, V1223, P99, DOI 10.1007/978-3-030-35582-1_6; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Singh PB, 2010, RUSS J GENET+, V46, P1257, DOI 10.1134/S1022795410100297; Stueve TR, 2017, HUM MOL GENET, V26, P3014, DOI 10.1093/hmg/ddx188; Sundar IK, 2014, J PROTEOME RES, V13, P982, DOI 10.1021/pr400998n; Svensmark JH, 2019, ONCOGENE, V38, P7447, DOI 10.1038/s41388-019-0963-7; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yang C, 2020, AM J CANCER RES, V10, P523; Yang JZ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1107-y; Yu HX, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00872-y; Zaidan NZ, 2020, NUCLEIC ACIDS RES, V48, P12660, DOI 10.1093/nar/gkaa1091; Zhang B, 2021, MOL ONCOL, V15, P3062, DOI 10.1002/1878-0261.12955; Zhang Y, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0292-4; Zhong XP, 2019, AGING-US, V11, P5483, DOI 10.18632/aging.102132	45	4	4	4	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					538	549		10.1038/s41388-021-02114-8	http://dx.doi.org/10.1038/s41388-021-02114-8		NOV 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785774	hybrid, Green Published			2022-12-26	WOS:000719277200003
J	Appiah, PK; Amu, H; Osei, E; Konlan, KD; Mumuni, IH; Verner, ON; Maalman, RSE; Kim, E; Kim, S; Bukari, M; Jung, H; Kofie, P; Ayanore, MA; Amenuvegbe, GK; Adjuik, M; Tarkang, EE; Alhassan, RK; Donkor, ES; Zotor, FB; Kweku, M; Amuna, P; Gyapong, JO; Kim, SY				Appiah, Prince Kubi; Amu, Hubert; Osei, Eric; Konlan, Kennedy Diema; Mumuni, Iddris Hadiru; Verner, Orish Ndudiri; Maalman, Raymond Saa-Eru; Kim, Eunji; Kim, Siwoo; Bukari, Mohammed; Jung, Hajun; Kofie, Philip; Ayanore, Martin Amogre; Amenuvegbe, Gregory Kofi; Adjuik, Martin; Tarkang, Elvis Enowbeyang; Alhassan, Robert Kaba; Donkor, Ernestina Safoa; Zotor, Francis Bruno; Kweku, Margaret; Amuna, Paul; Gyapong, John Owusu; Kim, So Yoon			Breastfeeding and weaning practices among mothers in Ghana: A population-based cross-sectional study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NUTRITION EDUCATION; HEALTH-EDUCATION; FAMILY SUPPORT; PREGNANCY; KNOWLEDGE; PROMOTION; WOMEN; DETERMINANTS; TEMPERATURE	Background Children need good nutrition to develop proper immune mechanisms and psychosocial maturity, but malnutrition can affect their ability to realize this. Apart from the national demographic and health survey, which is carried out every 5 years, there have not been enough documented studies on child breastfeeding and weaning practices of caregivers in the Volta Region. We, therefore, examined child breastfeeding and weaning practices of mothers in the Volta Region of Ghana. Methods A sub-national survey method was adopted and a semi-structured questionnaire was used to collect data from 396 mothers and their children. Descriptive and inferential statistics comprising frequency, percentage, chi-square, and logistic regression were employed in analysing the data. We defined exclusive breastfeeding as given only breast milk to an infant from a mother or a wet nurse for six months of life except drops or syrups consisting of vitamins, minerals, supplements, or medicines on medical advice, and prolonged breastfeeding as breastfeeding up to 24 months of age. Results The prevalence of exclusive breastfeeding (EBF) was 43.7%. Mothers constituting 61.1% started breastfeeding within an hour of giving birth. In addition to breast milk, 5.1% gave fluids to their children on the first day of birth. About 66.4% started complementary feeding at 6 months, 22.0% breastfed for 24 months or beyond, while 40.4% fed their children on-demand. Child's age (AOR: 0.23, 95% CI:0.12-0.43, p<0.0001), prolonged breastfeeding (AOR: 0.41, 95%CI: 0.12-0.87, p = 0.001), mother's religion (AOR: 3.92, 95%CI: 1.23-12.61, p = 0.021), feeding practices counselled on (AOR: 1.72, 95%CI: 1.96-3.09, p = 0.023), mother ever heard about EBF (AOR: 0.43, 95%CI: 1.45-2.41, p = 0.039), child being fed from the bottle with a nipple (AOR: 1.53, 95%CI: 1.94-2.48, p = 0.003), and age at which complementary feeding was started (AOR: 17.43, 95%CI: 3.47-87.55, p = 0.008) were statistically associated with EBF. Conclusion Breastfeeding education has been ongoing for decades, yet there are still gaps in the breastfeeding practices of mothers. To accelerate progress towards attainment of the sustainable development goal 3 of ensuring healthy lives and promoting well-being for all at all ages by the year 2030, we recommend innovative policies that include extensive public education to improve upon the breastfeeding and weaning practices of mothers.	[Appiah, Prince Kubi; Amu, Hubert; Osei, Eric; Bukari, Mohammed; Ayanore, Martin Amogre; Amenuvegbe, Gregory Kofi; Adjuik, Martin; Tarkang, Elvis Enowbeyang; Zotor, Francis Bruno; Kweku, Margaret; Amuna, Paul] Univ Hlth & Allied Sci, Sch Publ Hlth, Hohoe, Ghana; [Appiah, Prince Kubi; Kim, Siwoo; Jung, Hajun; Kim, So Yoon] Yonsei Univ, Coll Med, Asian Inst Bioeth & Hlth Law, Dept Med Law & Eth, Seoul, South Korea; [Osei, Eric] Yonsei Univ, Grad Sch Publ Hlth, Dept Publ Hlth, Seoul, South Korea; [Konlan, Kennedy Diema; Mumuni, Iddris Hadiru; Donkor, Ernestina Safoa] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Ho, Ghana; [Konlan, Kennedy Diema] Yonsei Univ, Coll Nursing, Yonsei Grad Sch, Seoul, South Korea; [Verner, Orish Ndudiri; Maalman, Raymond Saa-Eru] Univ Hlth & Allied Sci, Sch Med, Ho, Ghana; [Kim, Eunji] Korea Fdn Int Healthcare, Ghana Off, Accra, Ghana; [Kofie, Philip] Yonsei Univ, Univ Hlth & Allied Sci, Partnership Project Off, Ho, Ghana; [Alhassan, Robert Kaba] Univ Hlth & Allied Sci, Directorate Int Affairs, Ho, Ghana; [Gyapong, John Owusu] Univ Hlth & Allied Sci, Off Vice Chancellor, Ho, Ghana	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Appiah, PK (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Hohoe, Ghana.; Appiah, PK (corresponding author), Yonsei Univ, Coll Med, Asian Inst Bioeth & Hlth Law, Dept Med Law & Eth, Seoul, South Korea.	pappiah@uhas.edu.gh	Amu, Hubert/H-9446-2019	Amu, Hubert/0000-0003-0218-3843; Maalman, Raymond/0000-0002-6939-8198; Appiah, Prince Kubi/0000-0003-4825-2162; , EUNJI/0000-0003-0731-0143; Kim, So Yoon/0000-0001-7015-357X; Gyapong, John/0000-0002-8415-1468; OSEI, ERIC/0000-0001-6567-1591; Ayanore, Martin/0000-0002-4095-3047	National Research Foundation of Korea (NRF)	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	The study was part of a partnership project between the University of Health and Allied Sciences (UHAS) in Ghana, and the Yonsei University in South Korea. The 4-year Public Health Educational Capacity Development collaborative project financed by the National Research Foundation of Korea (NRF) started between the two universities in April 2017 and aimed at empowering UHAS to train health care professionals who can contribute to the advancement of healthcare in Ghana. The specific objectives of the Yonsei-UHAS project include the development of faculty teaching and research capacity, remodelling of educational curriculum, and reorganizing of vocational training of UHAS. The School of Public Health (SPH), School of Nursing and Midwifery (SONAM), and School of Medicine (SOM) were schools that participated in the project out of the six schools in UHAS. This manuscript emanated from the community health needs assessment conducted between 13th October 2018 and 8th February 2019 to understand the health needs of the Volta Region, Ghana.	[Anonymous], 2014, POPULATION PROJECTIO; Appiah P.K., 2017, EUROPEAN SCI J, V13, P183; Arrish J, 2016, WOMEN BIRTH, V29, P455, DOI 10.1016/j.wombi.2016.03.001; Arrish J, 2014, WOMEN BIRTH, V27, P2, DOI 10.1016/j.wombi.2013.02.003; Asare BYA, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0156-y; Asoba GN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219386; Asundep NN, 2014, MATERN CHILD HLTH J, V18, P1085, DOI 10.1007/s10995-013-1338-2; Baffour-Awuah A., 2015, INT J AFRICA NURS SC, V2, P59, DOI DOI 10.1016/J.IJANS.2015.02.001; Balogun OO, 2015, MATERN CHILD NUTR, V11, P433, DOI 10.1111/mcn.12180; Bhutta ZA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.67; Burdette AM, 2012, AM J PUBLIC HEALTH, V102, P1865, DOI 10.2105/AJPH.2012.300737; Chang SM, 2014, INT J NURS PRACT, V20, P293, DOI 10.1111/ijn.12148; Daelmans Bernadette, 2003, Food and Nutrition Bulletin, V24, P126; do Nascimento MBR, 2010, BREASTFEED MED, V5, P79, DOI 10.1089/bfm.2009.0008; Doherty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-105; Edmond KM, 2007, AM J CLIN NUTR, V86, P1126, DOI 10.1093/ajcn/86.4.1126; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Ertem IO, 2001, PEDIATRICS, V107, P543, DOI 10.1542/peds.107.3.543; Fanzo J, 2018, GLOBAL NUTR REPORT S; Ghana Statistical Service, 2013, 2010 POP HOUS CENS N; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF International, 2015, GHAN DEM HLTH SURV; Giugliani Elsa R. J., 2004, J. Pediatr. (Rio J.), V80, ps147, DOI 10.1590/S0021-75572004000700006; Greiner T, 1991, Dialogue Diarrhoea, P4; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Kassier SM, 2013, S AFR J CLIN NUTR, V26, P17; Kisuule I, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-121; Kok G, 1997, PATIENT EDUC COUNS, V30, P19, DOI 10.1016/S0738-3991(96)00953-6; Kuo AA, 2011, MATERN CHILD HLTH J, V15, P1185, DOI 10.1007/s10995-010-0669-5; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S4; Lucas C, 2014, MATERN CHILD HLTH J, V18, P2465, DOI 10.1007/s10995-014-1485-0; Lyon AJ, 1997, ARCH DIS CHILD-FETAL, V76, pF47, DOI 10.1136/fn.76.1.F47; MEIER P, 1988, NURS RES, V37, P36; Mekuria G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0027-0; Mensah Kofi Akohene, 2017, BMC Res Notes, V10, P466, DOI 10.1186/s13104-017-2774-7; Mogre V., 2018, MED SCI EDUC, V28, P815; More J, 2010, WEANING INFANTS ONTO; Motee A, 2014, CURR RES NUTR FOOD S, V2, P56, DOI 10.12944/CRNFSJ.2.2.02; Mututho LN, 2017, FACTORS ASS EXCLUSIV, V4, P4358, DOI [10.18203/2394-6040.ijcmph20175305, DOI 10.18203/2394-6040.IJCMPH20175305]; Nankunda J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-16; Nsiah-Asamoah C, 2018, PED HLTH RES, V3, P8; Odetola TD, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.151.5845; Okafor AE, 2018, SOC WORK PUBLIC HLTH, V33, P140, DOI 10.1080/19371918.2017.1415182; Ratnasari D, 2017, ASIA PAC J CLIN NUTR, V26, pS31, DOI 10.6133/apjcn.062017.s8; Smith ER, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180722; Stroope S, 2018, ANN BEHAV MED, V52, P319, DOI 10.1093/abm/kax013; Sunguya BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098308; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; Tampah-Naah AM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-13; Tuthill EL, 2017, PUBLIC HEALTH NUTR, V20, P1481, DOI 10.1017/S1368980016003657; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; UNICEF, 2019, KEY DEM IND COUNTR P; UNICEF, 2017, LEVELS TRENDS CHILD; United Nations International Children`s Emergency Fund-UNICEF, 2019, INF YOUNG CHILD FEED; Wallenborn JT, 2017, BREASTFEED MED, V12, P156, DOI 10.1089/bfm.2016.0170; Walson JL, 2018, CURR OPIN INFECT DIS, V31, P231, DOI 10.1097/QCO.0000000000000448; Woldeamanuel BT, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-019-0248-3; Yalcin SS, 2016, PAEDIATR PERINAT EP, V30, P439, DOI 10.1111/ppe.12305; Yamane T, 1967, STAT INTRO ANAL; Young DR, 1996, AM J EPIDEMIOL, V144, P264; Yue A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153385	61	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259442	10.1371/journal.pone.0259442	http://dx.doi.org/10.1371/journal.pone.0259442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767566	Green Published, gold			2022-12-26	WOS:000755249300029
J	Deng, MY; Guo, YS; Wang, C; Wu, FW				Deng, Mingyang; Guo, Yingshi; Wang, Chang; Wu, Fuwei			An oversampling method for multi-class imbalanced data based on composite weights	PLOS ONE			English	Article							ALGORITHM; CLASSIFICATION; SMOTE	To solve the oversampling problem of multi-class small samples and to improve their classification accuracy, we develop an oversampling method based on classification ranking and weight setting. The designed oversampling algorithm sorts the data within each class of dataset according to the distance from original data to the hyperplane. Furthermore, iterative sampling is performed within the class and inter-class sampling is adopted at the boundaries of adjacent classes according to the sampling weight composed of data density and data sorting. Finally, information assignment is performed on all newly generated sampling data. The training and testing experiments of the algorithm are conducted by using the UCI imbalanced datasets, and the established composite metrics are used to evaluate the performance of the proposed algorithm and other algorithms in comprehensive evaluation method. The results show that the proposed algorithm makes the multi-class imbalanced data balanced in terms of quantity, and the newly generated data maintain the distribution characteristics and information properties of the original samples. Moreover, compared with other algorithms such as SMOTE and SVMOM, the proposed algorithm has reached a higher classification accuracy of about 90%. It is concluded that this algorithm has high practicability and general characteristics for imbalanced multi-class samples.	[Deng, Mingyang; Guo, Yingshi; Wang, Chang; Wu, Fuwei] Changan Univ, Sch Automobile, Xian, Peoples R China; [Deng, Mingyang] Changchun Univ Technol, Coll Automobile Engn, Coll Humanities & Informat, Changchun, Peoples R China	Chang'an University; Changchun University of Technology	Guo, YS (corresponding author), Changan Univ, Sch Automobile, Xian, Peoples R China.	chd_guo@163.com			National Key R&D Program of China [2019YFB1600500]; National Natural Science Foundation of China [51908054, 52072046]; Changjiang Scholars and Innovative Research Team in University [IRT_17R95]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was jointly supported by the National Key R&D Program of China under Grant 2019YFB1600500, the National Natural Science Foundation of China under Grants (51908054, 52072046), and the Changjiang Scholars and Innovative Research Team in University under Grant IRT_17R95.	ANAND R, 1993, IEEE T NEURAL NETWOR, V4, P962, DOI 10.1109/72.286891; [Anonymous], 2020, Computer Engineering and Applications, V56, P220; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Desai P., 2021, SN COMPUT SCI, V2, P170; Dong S, 2021, EXPERT SYST APPL, V176, DOI 10.1016/j.eswa.2021.114885; Elyan E, 2021, NEURAL COMPUT APPL, V33, P2839, DOI 10.1007/s00521-020-05130-z; Feng D, 2021, ADV ENG INFORM, V47, DOI 10.1016/j.aei.2021.101256; Gosain A, 2019, ADV INTELL SYST COMP, V711, P309, DOI 10.1007/978-981-10-8055-5_28; Han H, 2005, LECT NOTES COMPUT SC, V3644, P878, DOI 10.1007/11538059_91; Jin M., 2021, FRONTIERS ANIMAL SCI, V2, P17, DOI [10.3389/FANIM.2021.666855, DOI 10.3389/FANIM.2021.666855]; Kaewwichian P, 2021, PROMET-ZAGREB, V33, P361; Konno T., COMPUTER SCI, V2019, P1; Krawczyk B, 2019, KNOWL INF SYST, V59, P601, DOI 10.1007/s10115-018-1220-z; Liu XY, 2009, IEEE T SYST MAN CY B, V39, P539, DOI 10.1109/TSMCB.2008.2007853; Mayo M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225613; Mohammed RA, 2018, LECT NOTES ARTIF INT, V11013, P237, DOI 10.1007/978-3-319-97310-4_27; Nekooeimehr I, 2016, EXPERT SYST APPL, V46, P405, DOI 10.1016/j.eswa.2015.10.031; Ng WWY, 2022, IEEE T CYBERNETICS, V52, P1269, DOI 10.1109/TCYB.2020.3000754; Piri S, 2018, DECIS SUPPORT SYST, V106, P15, DOI 10.1016/j.dss.2017.11.006; Puri A, 2021, EXPERT SYST APPL, V181, DOI 10.1016/j.eswa.2021.115179; Rajput DS, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03154-4; Ren RN, 2020, APPL INTELL, V50, P2465, DOI 10.1007/s10489-020-01644-0; Rizwan-ul-Hassan, 2021, INT J ELEC POWER, V125, DOI 10.1016/j.ijepes.2020.106429; Rybak L, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11114970; Sanchez AI, 2013, INT J ARTIF INTELL T, V22, DOI 10.1142/S0218213013500085; Seiffert C, 2009, INTEGR COMPUT-AID E, V16, P193, DOI 10.3233/ICA-2009-0314; Tahir A, 2021, EMPIR SOFTW ENG, V26, DOI 10.1007/s10664-021-09991-3; Tahir MA, 2012, PATTERN RECOGN, V45, P3738, DOI 10.1016/j.patcog.2012.03.014; Tao Lu, 2019, 2019 IEEE 7th International Conference on Computer Science and Network Technology (ICCSNT). Proceedings, P370, DOI 10.1109/ICCSNT47585.2019.8962430; Tsai J, 2018, J ANXIETY DISORD, V55, P63, DOI 10.1016/j.janxdis.2018.02.002; Vapnik NV., NATURE STAT LEARNING; Vuttipittayamongkol P, 2020, INFORM SCIENCES, V509, P47, DOI 10.1016/j.ins.2019.08.062; Wang X, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P950, DOI 10.1145/3292500.3330989; Wenhao Xie, 2019, Journal of Physics: Conference Series, V1237, DOI 10.1088/1742-6596/1237/2/022150; Xu ZZ, 2020, J BIOMED INFORM, V107, DOI 10.1016/j.jbi.2020.103465; Yan YT, 2019, INT J APPROX REASON, V107, P1, DOI 10.1016/j.ijar.2018.12.011; Yen SJ, 2009, EXPERT SYST APPL, V36, P5718, DOI 10.1016/j.eswa.2008.06.108; Yue He., 2021, PLOS ONE, V16, DOI [10.1371/journal.pone.0248503, DOI 10.1371/JOURNAL.PONE.0248503]; Zhu M, 2018, IEEE ACCESS, V6, P4641, DOI 10.1109/ACCESS.2018.2789428	41	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259227	10.1371/journal.pone.0259227	http://dx.doi.org/10.1371/journal.pone.0259227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767567	Green Published, gold			2022-12-26	WOS:000755249300024
J	Heireman, L; Abrams, S; Bruynseels, P; Cartuyvels, R; Cuypers, L; De Schouwer, P; Laffut, W; Lagrou, K; Hens, N; Ho, E; Padalko, E; Reynders, M; Vandamme, S; Van der Moeren, N; Verstrepen, W; Willems, P; Naesens, R				Heireman, Laura; Abrams, Steven; Bruynseels, Peggy; Cartuyvels, Reinoud; Cuypers, Lize; De Schouwer, Pieter; Laffut, Wim; Lagrou, Katrien; Hens, Niel; Ho, Erwin; Padalko, Elizaveta; Reynders, Marijke; Vandamme, Sarah; Van der Moeren, Nathalie; Verstrepen, Walter; Willems, Philippe; Naesens, Reinout			Evaluation of the SARS-CoV-2 positivity ratio and upper respiratory tract viral load among asymptomatic individuals screened before hospitalization or surgery in Flanders, Belgium	PLOS ONE			English	Article							COVID-19	Introduction The incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections in the Belgian community is mainly estimated based on test results of patients with coronavirus disease (COVID-19)-like symptoms. The aim of this study was to investigate the evolution of the SARS-CoV-2 reverse transcriptase polymerase chain reaction (RTPCR) positivity ratio and distribution of viral loads within a cohort of asymptomatic patients screened prior hospitalization or surgery, stratified by age category. Materials/Methods We retrospectively studied data on SARS-CoV-2 real-time RT-PCR detection in respiratory tract samples of asymptomatic patients screened pre-hospitalization or pre-surgery in nine Belgian hospitals located in Flanders over a 12-month period (1 April 2020-31 March 2021). Results In total, 255925 SARS-CoV-2 RT-PCR test results and 2421 positive results for which a viral load was reported, were included in this study. An unweighted overall SARS-CoV-2 real-time RT-PCR positivity ratio of 1.27% was observed with strong spatiotemporal differences. SARS-CoV-2 circulated predominantly in 80+ year old individuals across all time periods except between the first and second COVID-19 wave and in 20-30 year old individuals before the second COVID-19 wave. In contrast to the first wave, a significantly higher positivity ratio was observed for the 20-40 age group in addition to the 80+ age group compared to the other age groups during the second wave. The median viral load follows a similar temporal evolution as the positivity rate with an increase ahead of the second wave and highest viral loads observed for 80+ year old individuals. Conclusion There was a high SARS-CoV-2 circulation among asymptomatic patients with a predominance and highest viral loads observed in the elderly. Moreover, ahead of the second COVID-19 wave an increase in median viral load was noted with the highest overall positivity ratio observed in 20-30 year old individuals, indicating they could have been the hidden drivers of this wave.	[Heireman, Laura; Bruynseels, Peggy; De Schouwer, Pieter; Van der Moeren, Nathalie; Verstrepen, Walter; Naesens, Reinout] ZiekenhuisNetwerk Antwerpen, Dept Lab Med, Antwerp, Belgium; [Abrams, Steven; Hens, Niel] UHasselt, Interuniv Inst Biostat & Stat Bioinformat I BioS, Data Sci Inst, Hasselt, Belgium; [Abrams, Steven] Univ Antwerp, Global Hlth Inst, Family Med & Populat Hlth, Antwerp, Belgium; [Cartuyvels, Reinoud] Jessa Hosp, Dept Lab Med, Hasselt, Belgium; [Cuypers, Lize; Lagrou, Katrien] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium; [Cuypers, Lize; Lagrou, Katrien] Univ Hosp Leuven, Natl Reference Ctr Resp Pathogens, Leuven, Belgium; [Laffut, Wim] Heilig Hart Hosp, Dept Lab Med, Lier, Belgium; [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Ho, Erwin] Sint Maarten Hosp, Dept Lab Med, Mechelen, Belgium; [Padalko, Elizaveta] Univ Hosp Ghent, Dept Lab Med, Ghent, Belgium; [Reynders, Marijke] Sint Jan Hosp, Dept Lab Med, Brugge, Belgium; [Vandamme, Sarah] Antwerp Univ Hosp, Dept Lab Med, Antwerp, Belgium; [Willems, Philippe] GasthuisZusters Antwerpen, Dept Lab Med, Antwerp, Belgium	Hasselt University; University of Antwerp; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of Antwerp; Ghent University; Ghent University Hospital; University of Antwerp	Naesens, R (corresponding author), ZiekenhuisNetwerk Antwerpen, Dept Lab Med, Antwerp, Belgium.	reinout.naesens@zna.be	Hens, Niel/M-4445-2017	Hens, Niel/0000-0003-1881-0637; Abrams, Steven/0000-0001-7353-9304				Abrams S, 2021, EPIDEMICS-NETH, V35, DOI 10.1016/j.epidem.2021.100449; Al-Sadeq DW, 2020, INT J INFECT DIS, V98, P372, DOI 10.1016/j.ijid.2020.06.098; Alwan NA, 2020, LANCET, V396, pE24, DOI 10.1016/S0140-6736(20)31823-7; [Anonymous], 2021, COVID 19 SURVEILLANC; [Anonymous], 2021, BSG WORKING PAPER SE; [Anonymous], 2020, INCREASE FATAL CASES; [Anonymous], 2021, SURVEILLANCE WOONZOR; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Colson P, 2020, EUR J CLIN MICROBIOL, V39, P1983, DOI 10.1007/s10096-020-03900-0; Dobrovolny HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236976; Furukawa Nathan W, 2020, Emerg Infect Dis, V26, DOI 10.3201/eid2607.201595; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Ingelbeen B, 2021, EUROSURVEILLANCE, V26, P2, DOI 10.2807/1560-7917.ES.2021.26.7.2100065; Jones T.C., 2020, ANAL SARS COV 2 VIRA, DOI [10.1101/2020.06.08.20125484, DOI 10.1101/2020.06.08.20125484]; Kim SE, 2020, INT J INFECT DIS, V95, P441, DOI 10.1016/j.ijid.2020.04.083; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kociolek LK, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02593-20; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Li W, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.07.008; Maltezou HC, 2020, PEDIATR INFECT DIS J, V39, pE388, DOI 10.1097/INF.0000000000002899; Nikolai LA, 2020, INT J INFECT DIS, V100, P112, DOI 10.1016/j.ijid.2020.08.076; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Our World in Data, COVID 19 STRINGENCY; Passarelli VC, 2021, INFECT CONT HOSP EP, V42, P1158, DOI 10.1017/ice.2020.441; Patteet L, 2020, SEROPREVALENCE IGG A; R Core Team, 2020, R LANG ENV STAT COMP; Rijksinstituut voor Volksgezondheid en Milieu, ANALYSE THUISBLIJVEN; Salvatore PP, 2021, CLIN INFECT DIS, V72, pE761, DOI 10.1093/cid/ciaa1469; Sciensano, COVID 19; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Uhm JS, 2020, INT J INFECT DIS, V99, P279, DOI 10.1016/j.ijid.2020.07.070; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4; Xiao TY, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.595773; Zhou R, 2020, INT J INFECT DIS, V96, P288, DOI 10.1016/j.ijid.2020.05.030	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259908	10.1371/journal.pone.0259908	http://dx.doi.org/10.1371/journal.pone.0259908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762704	Green Published, gold			2022-12-26	WOS:000755316600054
J	Stahl, EC; Gopez, AR; Tsuchida, CA; Fan, VB; Moehle, EA; Witkowsky, LB; Hamilton, JR; Lin-Shiao, E; McElroy, M; McDevitt, SL; Ciling, A; Tsui, CK; Pestal, K; Gildea, HK; Keller, A; Sylvain, IA; Williams, C; Hirsh, A; Ehrenberg, AJ; Kantor, R; Metzger, M; Nelson, KL; Urnov, FD; Ringeisen, BR; Giannikopoulos, P; Doudna, JA				Stahl, Elizabeth C.; Gopez, Allan R.; Tsuchida, Connor A.; Fan, Vinson B.; Moehle, Erica A.; Witkowsky, Lea B.; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McElroy, Matthew; McDevitt, Shana L.; Ciling, Alison; Tsui, C. Kimberly; Pestal, Kathleen; Gildea, Holly K.; Keller, Amanda; Sylvain, Iman A.; Williams, Clara; Hirsh, Ariana; Ehrenberg, Alexander J.; Kantor, Rose; Metzger, Matthew; Nelson, Kara L.; Urnov, Fyodor D.; Ringeisen, Bradley R.; Giannikopoulos, Petros; Doudna, Jennifer A.		IGI Testing Consortium	LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples	PLOS ONE			English	Article								Clinical and surveillance testing for the SARS-CoV-2 virus relies overwhelmingly on RT-qPCR-based diagnostics, yet several popular assays require 2-3 separate reactions or rely on detection of a single viral target, which adds significant time, cost, and risk of false-negative results. Furthermore, multiplexed RT-qPCR tests that detect at least two SARS-CoV-2 genes in a single reaction are typically not affordable for large scale clinical surveillance or adaptable to multiple PCR machines and plate layouts. We developed a RT-qPCR assay using the Luna Probe Universal One-Step RT-qPCR master mix with publicly available primers and probes to detect SARS-CoV-2 N gene, E gene, and human RNase P (LuNER) to address these shortcomings and meet the testing demands of a university campus and the local community. This cost-effective test is compatible with BioRad or Applied Biosystems qPCR machines, in 96 and 384-well formats, with or without sample pooling, and has a detection sensitivity suitable for both clinical reporting and wastewater surveillance efforts.	[Stahl, Elizabeth C.; Tsuchida, Connor A.; Fan, Vinson B.; Moehle, Erica A.; Witkowsky, Lea B.; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McDevitt, Shana L.; Ciling, Alison; Tsui, C. Kimberly; Pestal, Kathleen; Gildea, Holly K.; Hirsh, Ariana; Ehrenberg, Alexander J.; Kantor, Rose; Metzger, Matthew; Nelson, Kara L.; Urnov, Fyodor D.; Ringeisen, Bradley R.; Doudna, Jennifer A.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Stahl, Elizabeth C.; Gopez, Allan R.; Tsuchida, Connor A.; Moehle, Erica A.; Witkowsky, Lea B.; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McElroy, Matthew; McDevitt, Shana L.; Ciling, Alison; Keller, Amanda; Sylvain, Iman A.; Williams, Clara; Hirsh, Ariana; Nelson, Kara L.; Urnov, Fyodor D.; Ringeisen, Bradley R.; Giannikopoulos, Petros; Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Kantor, Rose; Metzger, Matthew; Nelson, Kara L.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Ehrenberg, Alexander/N-9533-2019	Ehrenberg, Alexander/0000-0003-4334-9424; Tamborski, Janina/0000-0001-9252-4319				Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], NOVEL 2019 CORONAVIR; [Anonymous], RISK IN RES THERM FI; Bio-Rad Reliance SARS-CoV-2 RT-PCR Assay Kit-FDA, 2020, EMERGENCY USE AUTHOR; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Carter LJ, 2020, ACS CENTRAL SCI, V6, P591, DOI 10.1021/acscentsci.0c00501; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Crawford ED, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008966; Dekker RJ, 2020, BIORXIV2020061214781, V2020, DOI [10.1101/2020.06.12.147819, DOI 10.1101/2020.06.12.147819]; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Exact Sciences Laboratory, SARS COV 2 TEST EUA; FDA, 2020, POL COR DIS 2019 TES; Hamilton JR, 2021, PLOS ONE, V16, DOI [10.1101/2021.01.10.21249151, 10.1371/journal.pone.0255690]; Jaeger LH, 2021, INT J INFECT DIS, V102, P437, DOI 10.1016/j.ijid.2020.10.079; Johns Hopkins Coronavirus Resource Center, COVID 19 GLOB CAS; Kudo E, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000867; Makarenkov V, 2021, BMC ECOL EVOL, V21, DOI 10.1186/s12862-020-01732-2; Stahl Elizabeth C, 2020, medRxiv, DOI 10.1101/2020.12.10.20247338; Vanaerschot M, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02369-20; Vogels CBF, 2021, MED-CAMBRIDGE, V2, P263, DOI 10.1016/j.medj.2020.12.010; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6; Whitney ON, 2021, ENVIRON SCI TECHNOL, V55, P4880, DOI 10.1021/acs.est.0c08129; WHO, 2020, COR DIS COVID 19 PAN; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	26	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258263	10.1371/journal.pone.0258263	http://dx.doi.org/10.1371/journal.pone.0258263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758033	Green Published, gold			2022-12-26	WOS:000755112500003
J	Zhang, Z; Liu, RY; Wang, YF; Wang, Y; Shuai, YJ; Ke, CW; Jin, R; Wang, XD; Luo, JT				Zhang, Ze; Liu, Ruoyan; Wang, Yafei; Wang, Yun; Shuai, Yanjie; Ke, Chuangwu; Jin, Rui; Wang, Xudong; Luo, Jingtao			Phosphorylation of MICAL2 by ARG promotes head and neck cancer tumorigenesis by regulating skeletal rearrangement	ONCOGENE			English	Article							CELL-MIGRATION; ACTIN; INVASION; KINASES; METASTASIS; TRANSITION; CCG-1423; FAMILY; GROWTH	The actin cytoskeletal architecture provides the structural underpinnings for crucial cellular behaviors. In cancer cells, changes in the actin cytoskeleton may serve as prerequisites for proliferation, invasion, and metastatic dissemination. However, the underlying mechanisms remain largely unknown. Here, we show that MICAL2, which is increased in head and neck squamous cell carcinoma (HNSCC) and inversely associated with patient survival, promotes HNSCC growth, invasion, and migration. MICAL2 serves as a flavoprotein monooxygenase and directly induces actin filament depolymerization by specifically oxidizing the methionine 44 and 47 residues of F-actin. The kinase ARG interacts with MICAL2 and augments MICAL2-mediated actin disassembly. Direct phosphorylation assay and mass spectrometry confirmed that ARG phosphorylates MICAL2 at Tyr445, Tyr463, and Tyr488. Substitution of the Tyr445 or Tyr463 residue of purified recombinant MICAL2-redox with phenylalanine (generating a non-phosphorylatable mutant) abolishes the enhanced MICAL2-mediated F-actin disassembly induced by ARG. Consistently, ectopic expression of non-phosphorylatable MICAL2 mutants (MICAL2(Y445F) and MICAL2(Y463F), not MICAL2(Y488F)) failed to ameliorate HNSCC cell growth, whereas expression of wild-type MICAL2 or MICAL2(Y488F) rescued the impaired proliferation induced by MICAL2 knockdown. Moreover, CCG-1423, an inhibitor of MICAL2, was shown to inhibit HNSCC cell proliferation, invasion, and migration. Taken together, our findings indicate that phosphorylation of MICAL2 at Tyr445 and Tyr463 by ARG mediates F-actin disassembly and promotes HNSCC progression.	[Zhang, Ze; Wang, Yafei; Wang, Yun; Shuai, Yanjie; Ke, Chuangwu; Jin, Rui; Wang, Xudong; Luo, Jingtao] Tianjin Med Univ Canc Inst & Hosp, Dept Maxillofacial & Otorhinolaryngol Oncol, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Zhang, Ze; Wang, Yafei; Wang, Yun; Shuai, Yanjie; Ke, Chuangwu; Jin, Rui; Wang, Xudong; Luo, Jingtao] Tianjin Med Univ Canc Inst & Hosp, Dept Head & Neck Oncol, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Zhang, Ze; Liu, Ruoyan; Wang, Yafei; Wang, Yun; Shuai, Yanjie; Ke, Chuangwu; Jin, Rui; Wang, Xudong; Luo, Jingtao] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Zhang, Ze; Liu, Ruoyan; Wang, Yafei; Wang, Yun; Shuai, Yanjie; Ke, Chuangwu; Jin, Rui; Wang, Xudong; Luo, Jingtao] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Liu, Ruoyan] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Gynecol Oncol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Luo, JT (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Maxillofacial & Otorhinolaryngol Oncol, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.; Luo, JT (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Head & Neck Oncol, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.; Luo, JT (corresponding author), Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.; Luo, JT (corresponding author), Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.	jluo@tmu.edu.cn			Natural Science Foundation of China [81902757, 82073006, 82002757]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Our sincere appreciation goes out to Professor Ren and Dr. Zhu of the State Key Laboratory of Plant Physiology and Biochemistry of China Agricultural University, for providing technical guidance. We thank the TCGA project for its valuable contributions to HNSCC research. This study was supported by the Natural Science Foundation of China (nos. 81902757, 82073006, and 82002757).	Alto LT, 2018, CURR BIOL, V28, pR538, DOI 10.1016/j.cub.2018.01.025; [Anonymous], 2020, Nat Rev Dis Primers, V6, P93, DOI 10.1038/s41572-020-00233-2; Ashida S, 2006, CLIN CANCER RES, V12, P2767, DOI 10.1158/1078-0432.CCR-05-1995; Barravecchia I, 2019, BBA-MOL BASIS DIS, V1865, P2111, DOI 10.1016/j.bbadis.2019.04.008; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Brabletz T, 2018, NAT REV CANCER, V18, P128, DOI 10.1038/nrc.2017.118; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fremont S, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14528; Gau D, 2017, ANGIOGENESIS, V20, P663, DOI 10.1007/s10456-017-9560-y; Giridharan SSP, 2012, J CELL SCI, V125, P614, DOI 10.1242/jcs.089367; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Grintsevich EE, 2016, NAT CELL BIOL, V18, P876, DOI 10.1038/ncb3390; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes KE, 2013, ONCOGENE, V32, P4766, DOI 10.1038/onc.2012.513; Hellweg R, 2018, HORM CANCER-US, V9, P326, DOI 10.1007/s12672-018-0337-6; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; IKKAI T, 1966, SCIENCE, V152, P1756, DOI 10.1126/science.152.3730.1756; Kobayashi M, 2019, INVEST OPHTH VIS SCI, V60, P528, DOI 10.1167/iovs.18-25678; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Li CF, 2019, NAT CELL BIOL, V21, P251, DOI 10.1038/s41556-018-0268-z; Liu L, 2018, BBA-MOL BASIS DIS, V1864, P3109, DOI 10.1016/j.bbadis.2018.05.026; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; Mariotti S, 2016, ONCOTARGET, V7, P1808, DOI 10.18632/oncotarget.6577; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Orr BO, 2017, NATURE, V550, P109, DOI 10.1038/nature24017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; Shaul YD, 2014, CELL, V158, P1094, DOI 10.1016/j.cell.2014.07.032; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Wang J, 2015, TRENDS CANCER, V1, P110, DOI 10.1016/j.trecan.2015.07.004; Wang Y, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12920; Wu H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17943-5; Wu H, 2016, PROTEIN EXPRES PURIF, V127, P116, DOI 10.1016/j.pep.2016.05.008; Ye GT, 2017, THERANOSTICS, V7, P3338, DOI 10.7150/thno.20512; Yoon J, 2017, DEV CELL, V42, P117, DOI 10.1016/j.devcel.2017.06.007; Zhang Z, 2020, BRIT J CANCER, V122, P82, DOI 10.1038/s41416-019-0637-9; Zhang Z, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00434; Zhou WL, 2020, CANCER LETT, V483, P75, DOI 10.1016/j.canlet.2020.04.019	47	2	2	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					334	346		10.1038/s41388-021-02101-z	http://dx.doi.org/10.1038/s41388-021-02101-z		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34750518				2022-12-26	WOS:000715670800001
J	Cho, SY; Choi, JH; Lee, SH; Choi, YS; Hwang, SW; Kim, YJ				Cho, Sun Young; Choi, Jeong-Hyun; Lee, Seung Hyeun; Choi, Yong-Sung; Hwang, Sung Wook; Kim, Young Jin			Metataxonomic investigation of the microbial community in the trachea and oropharynx of healthy controls and diabetic patients using endotracheal tubes	PLOS ONE			English	Article							PEOPLE	Background Although the study of respiratory microbiota has been an active field of research, obtaining the appropriate respiratory samples for healthy controls remains to be a challenge. As such, this study aims to evaluate the use of endotracheal tube washing as a viable control for sputum samples. Methods A total of 14 subjects, including 8 healthy respiratory controls and 6 diabetic patients without any respiratory disease, were enrolled in this study, during which the endotracheal tubes used in their scheduled routine surgery were collected. Pre-operative oral gargles were also collected from non-diabetic subjects. Results 16S amplicon sequencing revealed similar taxa composition in endotracheal tube washings and oral gargles in the healthy control subjects, although the relative abundance of 11 genus level operational taxonomic units was significantly different between the two sample sources. The diabetic subjects showed relatively lower diversity than those of non-diabetic subjects. The proportion range of the most abundant taxa detected in each endotracheal tube washings were 10.1-33.2%. Conclusion Endotracheal tube washing fluid may provide healthy control samples for upper respiratory investigations without incurring any additional risk to the subject.	[Cho, Sun Young; Kim, Young Jin] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Lab Med, Sch Med, Seoul, South Korea; [Choi, Jeong-Hyun] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Anesthesiol, Sch Med, Seoul, South Korea; [Lee, Seung Hyeun] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Sch Med, Seoul, South Korea; [Choi, Yong-Sung] Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Pediat, Sch Med, Seoul, South Korea; [Hwang, Sung Wook] Kyung Hee Univ Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital	Kim, YJ (corresponding author), Kyung Hee Univ, Kyung Hee Univ Hosp, Dept Lab Med, Sch Med, Seoul, South Korea.	khmclab@gmail.com		Kim, Young Jin/0000-0001-8182-2433; Lee, Seung Hyeun/0000-0002-7666-313X				Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Clooney AG, 2016, ALIMENT PHARM THER, V43, P974, DOI 10.1111/apt.13568; CLSI, 2008, MM18A CLSI; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dickson RP, 2017, MBIO, V8, DOI 10.1128/mBio.02287-16; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Drengenes C, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-020-07252-z; Earl JP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0569-2; Eddy A VA., 2013, ESSENTIALS GEN SURG, P1; Faner R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02086-2016; Garza DR, 2015, CELL MOL LIFE SCI, V72, P4287, DOI 10.1007/s00018-015-2004-1; Graspeuntner S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27757-8; Hang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188461; Harrigan JJ, 2022, CLIN INFECT DIS, V74, P1564, DOI 10.1093/cid/ciab678; Hauptmann M, 2016, FEBS LETT, V590, P3721, DOI 10.1002/1873-3468.12421; Hong BY, 2016, CLIN MICROBIOL REV, V29, P915, DOI 10.1128/CMR.00096-15; Hornik K., 2018, R FAQ; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kameoka S, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07746-4; Kelly BJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0151-8; Kitsios GD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01413; Kulagina EV, 2012, BIOSCI BIOTECH BIOCH, V76, P169, DOI 10.1271/bbb.110434; Kumpitsch C, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0703-z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Lim YW, 2014, J CLIN MICROBIOL, V52, P425, DOI 10.1128/JCM.02204-13; Lin DZ, 2021, INT J MED SCI, V18, P1935, DOI 10.7150/ijms.53492; Macian MC, 2004, SYST APPL MICROBIOL, V27, P535, DOI 10.1078/0723202041748127; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Perrone F, 2021, CRIT REV ONCOL HEMAT, V164, DOI 10.1016/j.critrevonc.2021.103404; Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13; Sabat AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03458-6; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Singh N, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0277-3; Tolman KG, 2007, DIABETES CARE, V30, P734, DOI 10.2337/dc06-1539; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; van Woerden HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-69; Wang G, 2021, AM J PATHOL, V191, P838, DOI 10.1016/j.ajpath.2021.02.019; WHO, 2011, WHO TECH REP SER, V959, P1; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC; Zheng DP, 2020, CELL RES, V30, P492, DOI 10.1038/s41422-020-0332-7; Zou XZ, 2017, PULM PHARMACOL THER, V44, P70, DOI 10.1016/j.pupt.2017.03.012	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259596	10.1371/journal.pone.0259596	http://dx.doi.org/10.1371/journal.pone.0259596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739518	Green Published, gold			2022-12-26	WOS:000755000800041
J	Gellis, J; Foley, R				Gellis, Jason; Foley, Robert			A novel system for classifying tooth root phenotypes	PLOS ONE			English	Article							SHAPED CANAL SYSTEM; MANDIBULAR 1ST; 2ND MOLAR; MORPHOLOGICAL INTEGRATION; PERMANENT TEETH; PREMOLAR ROOT; MODERN HUMANS; POPULATION; BIOMECHANICS; EVOLUTION	Human root and canal number and morphology are highly variable, and internal root canal form and count does not necessarily co-vary directly with external morphology. While several typologies and classifications have been developed to address individual components of teeth, there is a need for a comprehensive system, that captures internal and external root features across all teeth. Using CT scans, the external and internal root morphologies of a global sample of humans are analysed (n = 945). From this analysis a method of classification that captures external and internal root morphology in a way that is intuitive, reproducible, and defines the human phenotypic set is developed. Results provide a robust definition of modern human tooth root phenotypic diversity. The method is modular in nature, allowing for incorporation of past and future classification systems. Additionally, it provides a basis for analysing hominin root morphology in evolutionary, ecological, genetic, and developmental contexts.	[Gellis, Jason; Foley, Robert] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol, Cambridge, England	University of Cambridge	Gellis, J (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol, Cambridge, England.	jg760@cam.ac.uk		Gellis, Jason Jacob/0000-0002-9929-789X				Abbott SA., 1984, COMP STUDY TOOTH ROO; Abrahams LC., 1947, J DENT ASS S AFRICA, V1, P5; ACKERMAN JL, 1973, AM J PHYS ANTHROPOL, V38, P681, DOI 10.1002/ajpa.1330380305; Ahmed HMA, 2017, INT ENDOD J, V50, P761, DOI 10.1111/iej.12685; Ahmed HMA, 2016, INT ENDOD J, V49, P724, DOI 10.1111/iej.12508; Ahmed HMA, 2012, AUST DENT J, V57, P123, DOI 10.1111/j.1834-7819.2012.01678.x; Al-Ani AH, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9378325; Albuquerque DV, 2012, INT J DENT, V2012, DOI 10.1155/2012/814789; Alexandersen, 1963, DENTAL ANTHR, P235, DOI [10.1016/B978-0-08-009823-4.50017-3, 10.1016/b978-0-08-009823-4.50017-3, DOI 10.1016/B978-0-08-009823-4.50017-3]; [Anonymous], 2016, HOROS DICOM VIEWER; Bailey SE, 2019, P NATL ACAD SCI USA, V116, P14806, DOI 10.1073/pnas.1907557116; Ballullaya Srinidhi V, 2013, J Conserv Dent, V16, P99, DOI 10.4103/0972-0707.108176; Barker B C, 1974, Aust Dent J, V19, P408; BARNES DS, 1969, AM J PHYS ANTHROPOL, V30, P183, DOI 10.1002/ajpa.1330300204; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Benazzi S, 2015, J ANAT, V226, P180, DOI 10.1111/joa.12260; Black GV, 1890, DESCRIPTIVE ANATOMY; Brabant HE., 1964, B GROUP INT RECH SCI, P11; Calberson FL, 2007, J ENDODONT, V33, P58, DOI 10.1016/j.joen.2006.05.007; CALISKAN MK, 1995, J ENDODONT, V21, P200, DOI 10.1016/S0099-2399(06)80566-2; Campbell, 1925, THESIS U ADELAIDE AD; CARLSEN O, 1991, SCAND J DENT RES, V99, P189; CARNS EJ, 1973, ORAL SURG ORAL MED O, V36, P880, DOI 10.1016/0030-4220(73)90340-X; Chen Jiangtian, 2012, Hum Biol, V84, P555; CHRISTIE WH, 1991, J ENDODONT, V17, P80, DOI 10.1016/S0099-2399(06)81613-4; Cleghorn BM, 2006, J ENDODONT, V32, P813, DOI 10.1016/j.joen.2006.04.014; COOKE HG, 1979, J AM DENT ASSOC, V99, P836, DOI 10.14219/jada.archive.1979.0402; Copes L., 2012, COMP EXPT INVESTIGAT; CORRUCCINI RS, 1986, AM J PHYS ANTHROPOL, V70, P293, DOI 10.1002/ajpa.1330700304; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; Daito M, 1992, J Osaka Dent Univ, V26, P91; Dempsey PJ, 2001, HEREDITY, V86, P685, DOI 10.1046/j.1365-2540.2001.00878.x; DRENNAN M. R., 1929, ANN SO AFRICAN MUS, V24, P61; Emonet EG, 2012, J HUM EVOL, V62, P146, DOI 10.1016/j.jhevol.2011.11.011; FAHID A, 1988, J ENDODONT, V14, P181, DOI 10.1016/S0099-2399(88)80261-9; Fan B, 2004, J ENDODONT, V30, P904, DOI 10.1097/01.don.0000136206.73115.93; Fan B, 2004, J ENDODONT, V30, P899, DOI 10.1097/01.don.0000136207.12204.e4; Fathi Zahra, 2014, J Dent Res Dent Clin Dent Prospects, V8, P184, DOI 10.5681/joddd.2014.034; Fernandes Marina, 2014, J Conserv Dent, V17, P312, DOI 10.4103/0972-0707.136437; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Gomez-Robles A, 2012, EVOLUTION, V66, P1024, DOI 10.1111/j.1558-5646.2011.01508.x; Gu LS, 2009, J ENDODONT, V35, P353, DOI 10.1016/j.joen.2008.11.029; Gu Y, 2016, ARCH ORAL BIOL, V63, P75, DOI 10.1016/j.archoralbio.2015.12.001; Hsu Y Y, 1997, Dent Clin North Am, V41, P529; Kakkar Pooja, 2012, Iran Endod J, V7, P207; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Keith A, 1913, Proc R Soc Med, V6, P103; Kirilova J, 2014, J IMAB, V20, P584, DOI 10.5272/jimab.2014203.584; Kottoor J, 2012, INT J DENT, V2012, DOI 10.1155/2012/120565; Kovacs I., 1971, DENT MORPHOLOGY EVOL, P211; Kullmer O, 2011, J HUM EVOL, V61, P617, DOI 10.1016/j.jhevol.2011.07.003; Kupczik K, 2019, J HUM EVOL, V130, P83, DOI 10.1016/j.jhevol.2019.03.007; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Ledogar JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2242; Lee C, 2011, AM J PHYS ANTHROPOL, V146, P481, DOI 10.1002/ajpa.21585; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Marean CW, 2015, ANNU REV ANTHROPOL, V44, P533, DOI 10.1146/annurev-anthro-102313-025954; Matsumura H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35426-z; McGhee GR, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0034; McKeown HF, 2002, EUR J ORTHODONT, V24, P131, DOI 10.1093/ejo/24.2.131; Mitteroecker Philipp, 2009, Biology Theory, V4, P54, DOI 10.1162/biot.2009.4.1.54; Miyabara T., 1994, DENT COSM, V58, P739; Moore NC, 2016, J HUM EVOL, V93, P46, DOI 10.1016/j.jhevol.2015.12.002; Moore NC, 2015, AM J PHYS ANTHROPOL, V158, P209, DOI 10.1002/ajpa.22776; Moore NC, 2013, AM J PHYS ANTHROPOL, V150, P632, DOI 10.1002/ajpa.22239; Moorrees CFA., 1957, ALEUT DENTITION, DOI [10.1177/00220345570360011501, DOI 10.1177/00220345570360011501]; MOSS ML, 1967, AM J PHYS ANTHROPOL, V27, P125, DOI 10.1002/ajpa.1330270204; Nanci A., 2012, 10 CATES ORAL HISTOL, V8th, DOI [10.1038/sj.bdj.2012.772, DOI 10.1038/SJ.BDJ.2012.772]; Nelson CT, 1938, AM J PHYS ANTHROPOL, V23, P261, DOI 10.1002/ajpa.1330230303; Nelson S.J., 2010, WHEELERS DENT ANATOM, V9th; Novacek MJ., 1986, SOURCE J VERTEBR PAL; Pagani L, 2015, AM J HUM GENET, V96, P986, DOI 10.1016/j.ajhg.2015.04.019; PEDERSEN P. O., 1949, MEDDELELSER OM GRONLAND, V142, P1; POMERANZ HH, 1981, J ENDODONT, V7, P565, DOI 10.1016/S0099-2399(81)80216-6; Prado-Simon L, 2012, AM J PHYS ANTHROPOL, V147, P452, DOI 10.1002/ajpa.22015; Rakhshan Vahid, 2015, Dent Res J (Isfahan), V12, P1; Rathmann H, 2020, P NATL ACAD SCI USA, V117, P10769, DOI 10.1073/pnas.1914330117; Rathmann H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12621-y; Reich D, 2018, WHO WE ARE WE GOT HE; Reyes-Centeno H, 2017, CURR ANTHROPOL, V58, pS406, DOI 10.1086/694423; Rivera F, 2017, AM J PHYS ANTHROPOL, V164, P76, DOI 10.1002/ajpa.23258; Robinson J.T., 1956, TRANSVAAL MUSEUM MEM, V9, P158; Roy A, 2013, J CLIN DIAGN RES, V7, P2637, DOI 10.7860/JCDR/2013/6172.3635; Savell KRR, 2016, P NATL ACAD SCI USA, V113, P9492, DOI 10.1073/pnas.1603632113; Scott G. R., 2018, ANTHR MODERN HUMAN T, V2nd, P1, DOI [10.1017/9781316795859, DOI 10.1017/9781316795859]; Scott GR, 2020, P NATL ACAD SCI USA, V117, P37, DOI 10.1073/pnas.1918004116; Selmer-Olsen R., 1949, ODONTOMETRICAL STUDY; Shaw J.C.M., 1931, TEETH BONY PALATE MA; Shields ED, 2005, AM J PHYS ANTHROPOL, V128, P299, DOI 10.1002/ajpa.20110; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Stringer CB, 1997, J HUM EVOL, V32, P389, DOI 10.1006/jhev.1996.0112; Taylor A E, 1899, J Anat Physiol, V33, P268; Taylor AB, 2006, J HUM EVOL, V50, P377, DOI 10.1016/j.jhevol.2005.10.006; Tomes CS., 1889, MANUAL DENT ANATOMY; Tratman EK, 1938, BRIT DENT J, V64, P26474; Turner, 1997, ANTHR MODERN HUMAN T, DOI [10.1017/CBO9781316529843, DOI 10.1017/CBO9781316529843]; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; TURNER CG, 1971, AM J PHYS ANTHROPOL, V34, P229, DOI 10.1002/ajpa.1330340207; de Pablo OV, 2010, J ENDODONT, V36, P1919, DOI 10.1016/j.joen.2010.08.055; Velmurugan N, 2009, INT ENDOD J, V42, P54, DOI 10.1111/j.1365-2591.2008.01494.x; Versiani MA, 2019, ROOT CANAL ANATOMY P, DOI [10.1007/978-3-319-73444-6, DOI 10.1007/978-3-319-73444-6]; VERTUCCI F, 1974, ORAL SURG ORAL MED O, V38, P456, DOI 10.1016/0030-4220(74)90374-0; VERTUCCI FJ, 1979, J AM DENT ASSOC, V99, P194, DOI 10.14219/jada.archive.1979.0255; WALKER A, 1981, PHILOS T ROY SOC B, V292, P57, DOI 10.1098/rstb.1981.0013; WARD SC, 1982, AM J PHYS ANTHROPOL, V57, P605, DOI 10.1002/ajpa.1330570407; White T.D., 2012, HUMAN OSTEOLOGY, P101, DOI [10.1016/B978-0-12-374134-9.50005-2, DOI 10.1016/B978-0-12-374134-9.50005-2]; Wolf AB, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007349; WOOD BA, 1988, J ANAT, V156, P107; Wright T, 2007, CELLS TISSUES ORGANS, V186, P86, DOI 10.1159/000102684; Zheng Q, 2011, INT ENDOD J, V44, P857, DOI 10.1111/j.1365-2591.2011.01896.x; Zichello JM, 2018, P NATL ACAD SCI USA, V115, P11501, DOI 10.1073/pnas.1802651115	111	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0251953	10.1371/journal.pone.0251953	http://dx.doi.org/10.1371/journal.pone.0251953			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739489	gold, Green Published, Green Submitted			2022-12-26	WOS:000755000800002
J	Naugle, KE; Hackett, J; Aqeel, D; Naugle, KM				Naugle, Keith E.; Hackett, Jason; Aqeel, Dania; Naugle, Kelly M.			Effect of different Kinesio tape tensions on experimentally-induced thermal and muscle pain in healthy adults	PLOS ONE			English	Article							LOW-BACK-PAIN; METAANALYSIS; MECHANISMS; DISABILITY; EFFICACY	Athletes and rehabilitation specialists have used Kinesio tape (KT) to help alleviate pain symptoms. Currently, no clear mechanism exists as to why pain is relieved with the use of KT and whether the pain relieving effect is simply a placebo effect. Additionally, the most effective taping parameters (tension of tape) for pain reduction remain unknown. We used quantitative sensory testing to address these key gaps in the KT and pain literature. Using a repeated-measures laboratory design, we examined whether KT applied at different tensions reduces experimentally-induced pain compared to a no tape condition and KT with minimal tension. Heat pain thresholds (HPT's), pressure pain thresholds (PPT's), and pressure pain suprathreshold (PPS: 125% of PPT) tests were administered to the forearm prior to and during KT and no tape conditions. Tape was applied to the ventral forearm at 25% of max tension, 75% of max tension, and no tension (placebo). Repeated measures ANOVA's evaluated the pain outcomes between conditions and across time. KT had no significant effect on PPT's and HPT's (p's >0.05). The ANOVA on PPS revealed that KT applied at 25% of tension significantly reduced pain ratings from the pretest (M = 34.4, SE = 5.5) to post-test 1 (M = 30.3, SE = 4.7) and post-test 2 (M = 30.4, SE = 4.7). No other conditions significantly reduced suprathreshold pressure pain. However, pain ratings at posttest-1 during the no-tape condition (M = 36.4, SE = 5.3) were significantly greater than pain ratings during post-test 1 and post-test 2 of all three tape conditions. In conclusion, the current study revealed that KT applied at low tension is the optimal tension to reduce pressure-evoked muscle pain. Additionally, the results suggested that KT applied at low, high, or no tension may acutely prevent increased muscle sensitivity with repeated pressure stimulation.	[Naugle, Keith E.; Naugle, Kelly M.] Indiana Univ Purdue Univ, Sch Hlth & Human Sci, Dept Kinesiol, Indianapolis, IN 46202 USA; [Hackett, Jason] Indiana Univ, Regenstrief Inst, Ctr Aging Res, Indianapolis, IN USA; [Aqeel, Dania] Indiana Univ, Sch Med, Dept Neurol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis	Naugle, KE (corresponding author), Indiana Univ Purdue Univ, Sch Hlth & Human Sci, Dept Kinesiol, Indianapolis, IN 46202 USA.	kenaugle@iupui.edu						Alahmari KA, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03681-9; Anandkumar S, 2014, PHYSIOTHER THEOR PR, V30, P375, DOI 10.3109/09593985.2014.896963; Bae SH, 2014, INT J BIOSCIENCE BIO, V6, P133; Banerjee G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226109; Cheatham SW, 2019, J BODYW MOV THER, V23, P555, DOI 10.1016/j.jbmt.2019.05.002; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cruz-Almeida Y, 2014, PAIN MED, V15, P61, DOI 10.1111/pme.12230; Freedman SR, 2014, SPORTS HEALTH, V6, P294, DOI 10.1177/1941738114537793; Ghozy S, 2020, PHYSIOTHERAPY, V107, P176, DOI 10.1016/j.physio.2019.12.001; Jassi FJ, 2021, ARCH PHYS MED REHAB, V102, P1352, DOI 10.1016/j.apmr.2021.03.007; Kafa N, 2015, PHYSIOTHER THEOR PR, V31, P556, DOI 10.3109/09593985.2015.1062943; Kalichman L, 2018, J BODYW MOV THER, V22, P700, DOI 10.1016/j.jbmt.2017.11.005; Kanik ZH, 2019, J SPORT REHABIL, V28, P781, DOI 10.1123/jsr.2018-0040; Kase K., 2013, CLIN THERAPEUITIC AP, V3rd; Kelle B, 2016, CLIN REHABIL, V30, P997, DOI 10.1177/0269215515603218; Kim J, 2016, J EXERC REHABIL, V12, P456, DOI 10.12965/jer.1632702.351; Kocyigit F, 2016, PHYSIOTHER THEOR PR, V32, P501, DOI 10.1080/09593985.2016.1219434; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lim ECW, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094151; Lin JP, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6692828; Liu K, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.596159; Liu K, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00488; Magora F, 2006, ISR MED ASSOC J, V8, P261; Castro-Sanchez AM, 2012, J PHYSIOTHER, V58, P89, DOI 10.1016/S1836-9553(12)70088-7; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Ozmen T, 2016, J SPORT REHABIL, V25, P7, DOI [10.1123/jsr.2014-0243, 10-1123/jsr.2014-0243]; Pamuk U, 2015, J BIOMECH, V48, P4262, DOI 10.1016/j.jbiomech.2015.10.036; Ramirez-Velez R, 2019, PHYSIOTHERAPY, V105, P412, DOI 10.1016/j.physio.2019.04.001; Parreira PDS, 2014, J PHYSIOTHER, V60, P90, DOI 10.1016/j.jphys.2014.05.003; Staud R, 2007, PAIN, V130, P177, DOI 10.1016/j.pain.2007.03.015; WALL PD, 1978, BRAIN, V101, P1, DOI 10.1093/brain/101.1.1; Williams S, 2012, SPORTS MED, V42, P153, DOI 10.2165/11594960-000000000-00000; [余波 Yu Bo], 2016, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V31, P296	34	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259433	10.1371/journal.pone.0259433	http://dx.doi.org/10.1371/journal.pone.0259433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739522	Green Published, gold			2022-12-26	WOS:000755000800033
J	Spilling, CA; Dhillon, MPK; Burrage, DR; Ruickbie, S; Baker, EH; Barrick, TR; Jones, PW				Spilling, Catherine A.; Dhillon, Mohani-Preet K.; Burrage, Daniel R.; Ruickbie, Sachelle; Baker, Emma H.; Barrick, Thomas R.; Jones, Paul W.			Factors affecting brain structure in smoking-related diseases: Chronic Obstructive Pulmonary Disease (COPD) and coronary artery disease	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; SMALL-VESSEL DISEASE; WHITE-MATTER HYPERINTENSITIES; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; ACUTE EXACERBATION; CIGARETTE-SMOKING; HEALTHY-ADULTS; OLDER-ADULTS; INFLAMMATION	Background Changes in brain structure and cognitive decline occur in Chronic Obstructive Pulmonary Disease (COPD). They also occur with smoking and coronary artery disease (CAD), but it is unclear whether a common mechanism is responsible. Methods Brain MRI markers of brain structure were tested for association with disease markers in other organs. Where possible, principal component analysis (PCA) was used to group markers within organ systems into composite markers. Univariate relationships between brain structure and the disease markers were explored using hierarchical regression and then entered into multivariable regression models. Results 100 participants were studied (53 COPD, 47 CAD). PCA identified two brain components: brain tissue volumes and white matter microstructure, and six components from other organ systems: respiratory function, plasma lipids, blood pressure, glucose dysregulation, retinal vessel calibre and retinal vessel tortuosity. Several markers could not be grouped into components and were analysed as single variables, these included brain white matter hyperintense lesion (WMH) volume. Multivariable regression models showed that less well organised white matter microstructure was associated with lower respiratory function (p = 0.028); WMH volume was associated with higher blood pressure (p = 0.036) and higher C-Reactive Protein (p = 0.011) and lower brain tissue volume was associated with lower cerebral blood flow (p<0.001) and higher blood pressure (p = 0.001). Smoking history was not an independent correlate of any brain marker. Conclusions Measures of brain structure were associated with a range of markers of disease, some of which appeared to be common to both COPD and CAD. No single common pathway was identified, but the findings suggest that brain changes associated with smoking-related diseases may be due to vascular, respiratory, and inflammatory changes.	[Spilling, Catherine A.; Dhillon, Mohani-Preet K.; Barrick, Thomas R.] St Georges Univ London, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England; [Burrage, Daniel R.; Baker, Emma H.; Jones, Paul W.] St Georges Univ London, Inst Infect & Immun, London, England; [Ruickbie, Sachelle] St Georges Univ Hosp NHS Fdn Trust, Resp Med, London, England	St Georges University London; University of London; King's College London; St Georges University London	Barrick, TR (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Neurosci Res Ctr, London, England.	tbarrick@sgul.ac.uk	Burrage, Daniel/GQA-9551-2022	Baker, Emma/0000-0002-0871-3721; Spilling, Catherine/0000-0002-6908-5079				Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Alosco ML, 2013, BRAIN BEHAV, V3, P626, DOI 10.1002/brb3.171; Andreou Georgia, 2014, Sleep Disord, V2014, P768210, DOI 10.1155/2014/768210; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Aseervatham GSG, 2017, BIOMED PHARMACOTHER, V85, P79, DOI 10.1016/j.biopha.2016.11.118; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Bezerra DC, 2012, NEUROLOGY, V78, P102, DOI 10.1212/WNL.0b013e31823efc42; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; Daher A, 2020, HERZ, V45, P110, DOI 10.1007/s00059-020-04893-4; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P20, DOI [DOI 10.7275/DA8T-4G52, 10.7275/da8t-4g52]; Dodd JW, 2013, CHEST, V144, P119, DOI 10.1378/chest.12-2099; Dodd JW, 2012, AM J RESP CRIT CARE, V186, P240, DOI 10.1164/rccm.201202-0355OC; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Elbejjani M, 2019, J CEREBR BLOOD F MET, V39, P1247, DOI 10.1177/0271678X18754973; Esenwa CC, 2016, NAT REV NEUROL, V12, P594, DOI 10.1038/nrneurol.2016.125; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Fisk M, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0792-1; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Fritz HC, 2014, NEUROPSYCHOPHARMACOL, V39, P2594, DOI 10.1038/npp.2014.112; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Heringa SM, 2013, J CEREBR BLOOD F MET, V33, P983, DOI 10.1038/jcbfm.2013.58; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang SJ, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1364; Hudkins M, 2012, PSYCHOPHARMACOLOGY, V221, P285, DOI 10.1007/s00213-011-2621-9; Kifley A, 2007, AM J EPIDEMIOL, V166, P1288, DOI 10.1093/aje/kwm255; Koutsokera A, 2009, RESP MED, V103, P919, DOI 10.1016/j.rmed.2008.12.006; Maclay JD, 2011, THORAX, V66, P769, DOI 10.1136/thx.2010.157529; McEvoy LK, 2015, HYPERTENSION, V66, P317, DOI 10.1161/HYPERTENSIONAHA.115.05336; Mckay GJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227175; Murray AD, 2005, RADIOLOGY, V237, P251, DOI 10.1148/radiol.2371041496; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; Ottens TH, 2017, INT J CARDIOL, V230, P80, DOI 10.1016/j.ijcard.2016.12.079; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Quick S, 2021, TRENDS NEUROSCI, V44, P289, DOI 10.1016/j.tins.2020.11.003; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Spilling CA, 2019, INT J CHRONIC OBSTR, V14, P1855, DOI 10.2147/COPD.S213607; Sutherland MT, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0100-5; van Dijk EJ, 2008, STROKE, V39, P2712, DOI 10.1161/STROKEAHA.107.513176; Walker KA, 2018, NEUROBIOL AGING, V68, P26, DOI 10.1016/j.neurobiolaging.2018.03.031; Wardlaw JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001140; Wardlaw JM, 2014, NEUROLOGY, V82, P1331, DOI 10.1212/WNL.0000000000000312; Westerik JAM, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0512-2; Xie F, 2019, INT J CHRONIC OBSTR, V14, P403, DOI 10.2147/COPD.S194277	48	1	3	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259375	10.1371/journal.pone.0259375	http://dx.doi.org/10.1371/journal.pone.0259375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739504	Green Accepted, Green Published, gold			2022-12-26	WOS:000755000800029
J	Dupont-Lucas, C; Marion-Letellier, R; Pala, M; Guerin, C; Bole-Feysot, C; Salameh, E; Goichon, A; Nicol, L; Aziz, M; Savoye-Collet, C; Savoye, G				Dupont-Lucas, Claire; Marion-Letellier, Rachel; Pala, Mathilde; Guerin, Charlene; Bole-Feysot, Christine; Salameh, Emmeline; Goichon, Alexis; Nicol, Lionel; Aziz, Moutaz; Savoye-Collet, Celine; Savoye, Guillaume			Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats	PLOS ONE			English	Article							DEXTRAN SODIUM-SULFATE; TNBS-INDUCED COLITIS; ORAL POLYMERIC DIET; CHRONIC INFLAMMATION; MURINE MODEL; CHILDREN; THERAPY; INDUCTION; NUTRITION; DECREASE	Pre-pubertal murine models of acute colitis are lacking. Magnetic resonance colonography (MRC) is a promising minimally invasive tool to assess colitis. We aimed to: 1/ Adapt a model of acute experimental colitis to pre-pubertal rats and determine whether MRC characteristics correlate with histological inflammation. 2/ Test this model by administering a diet supplemented in transforming growth factor beta 2 to reverse inflammation. Twenty-four rats were randomized at weaning to one of 3 groups: Trinitrobenzene Sulfonic Acid (TNBS) group (n = 8) fed a standard diet, that received an intra-rectal 60 mg/kg dose of TNBS-ethanol; Control group (n = 8) fed standard diet, that received a dose of intra-rectal PBS; TNBS+MODULEN group (n = 8) that received a dose of TNBS and were exclusively fed MODULEN-IBD (R) after induction of colitis. One week after induction of colitis, rats were assessed by MRC, colon histopathology and inflammation markers (Interleukin 1 beta, Tumor necrosis factor alpha, Nitric Oxide Synthase 2 and Cyclooxygenase 2). TNBS induced typical features of acute colitis on histopathology and MRC (increased colon wall thickness, increased colon intensity on T2-weighted images, target sign, ulcers). Treatment with MODULEN-IBD (R) did not reduce signs of colitis on MRC. Inflammatory marker expression did not differ among study groups.	[Dupont-Lucas, Claire; Marion-Letellier, Rachel; Pala, Mathilde; Guerin, Charlene; Bole-Feysot, Christine; Salameh, Emmeline; Goichon, Alexis] Rouen Univ, Inst Biomed Res, INSERM, UMR 1073, Rouen, France; [Nicol, Lionel] Rouen Univ, Inst Biomed Res, INSERM, UMR 1096, Rouen, France; [Aziz, Moutaz] Rouen Univ Hosp, Dept Pathol, Rouen, France; [Savoye-Collet, Celine] Rouen Univ, QUANTIF LITIS EA 4108, Rouen, France; [Savoye, Guillaume] Rouen Univ Hosp, Dept Gastroenterol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen Normandie; CHU de Rouen	Dupont-Lucas, C (corresponding author), Rouen Univ, Inst Biomed Res, INSERM, UMR 1073, Rouen, France.	dupont-c@chu-caen.fr		Dupont-Lucas, Claire/0000-0002-7355-6515				Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019; Ballinger AB, 2000, GUT, V46, P694, DOI 10.1136/gut.46.5.695; BEATTIE RM, 1994, ALIMENT PHARM THERAP, V8, P609; Beaupel N, 2017, SCAND J GASTROENTERO, V52, P5, DOI 10.1080/00365521.2016.1221994; Bramhall M, 2015, INFLAMM BOWEL DIS, V21, P1248, DOI 10.1097/MIB.0000000000000369; Brenna O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054543; Charpentier C, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8430614; Charpentier C, 2012, INFLAMM BOWEL DIS, V18, P1940, DOI 10.1002/ibd.22897; de Bie CI, 2013, INFLAMM BOWEL DIS, V19, P378, DOI 10.1002/ibd.23008; Di Paola R, 2019, PHARMACOL RES, V141, P591, DOI 10.1016/j.phrs.2019.01.041; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fell JME, 2000, ALIMENT PHARM THERAP, V14, P281; Fitzpatrick LR, 2010, J PEDIATR GASTR NUTR, V50, P240, DOI 10.1097/MPG.0b013e3181cb8f4a; Fumery M, 2019, DIGEST LIVER DIS, V51, P496, DOI 10.1016/j.dld.2018.11.033; Gadaleta Raffaella Maria, 2017, Curr Protoc Mouse Biol, V7, P13, DOI 10.1002/cpmo.20; Ghione S, 2018, AM J GASTROENTEROL, V113, P265, DOI 10.1038/ajg.2017.228; Guan QD, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7247238; Hartman C, 2008, ISR MED ASSOC J, V10, P503; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lawrance IC, 2003, GASTROENTEROLOGY, V125, P1750, DOI 10.1053/j.gastro.2003.08.027; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mbodji K, 2013, J NUTR BIOCHEM, V24, P700, DOI 10.1016/j.jnutbio.2012.03.022; Melchior C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100921; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Neurath M, 2000, Int Rev Immunol, V19, P51, DOI 10.3109/08830180009048389; Pigneur B, 2019, J CROHNS COLITIS, V13, P846, DOI 10.1093/ecco-jcc/jjy207; Pigneur B, 2010, INFLAMM BOWEL DIS, V16, P953, DOI 10.1002/ibd.21152; Rashidian A, 2016, INFLAMMOPHARMACOLOGY, V24, P109, DOI 10.1007/s10787-016-0263-6; Rimola J, 2018, ALIMENT PHARM THER, V48, P1232, DOI 10.1111/apt.15013; Salameh E, 2019, AM J PHYSIOL-GASTR L, V316, pG692, DOI 10.1152/ajpgi.00248.2018; Shimizu T, 2003, J PEDIATR GASTR NUTR, V37, P481, DOI 10.1097/00005176-200310000-00015; Siracusa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030834; Sykora J, 2018, WORLD J GASTROENTERO, V24, P2741, DOI 10.3748/wjg.v24.i25.2741; van Rheenen PF, 2021, J CROHNS COLITIS, V15, P171, DOI 10.1093/ecco-jcc/jjaa161; Vicario M, 2005, DIGEST DIS SCI, V50, P143, DOI 10.1007/s10620-005-1292-y	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259135	10.1371/journal.pone.0259135	http://dx.doi.org/10.1371/journal.pone.0259135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735489	Green Published, gold			2022-12-26	WOS:000755077100047
J	Foster, SD; Feutry, P; Grewe, P; Davies, C				Foster, Scott D.; Feutry, Pierre; Grewe, Peter; Davies, Campbell			Sample size requirements for genetic studies on yellowfin tuna	PLOS ONE			English	Article								In population genetics, the amount of information for an analytical task is governed by the number of individuals sampled and the amount of genetic information measured on each of those individuals. In this work, we assessed the numbers of individual yellowfin tuna (Thunnus albacares) and genetic markers required for ocean-basin scale inferences. We assessed this for three distinct data analysis tasks that are often employed: testing for differences between genetic profiles; stock delineation, and; assignment of individuals to stocks. For all analytical tasks, we used real (not simulated) data from four sampling locations that span the tropical Pacific Ocean. Whilst spatially separated, the genetic differences between the sampling sites were not substantial, a maximum of approximately F-st = 0.02, which is quite typical of large pelagic fish. We repeatedly sub-sampled the data, mimicking a new survey, and performed the analyses. False positive rates were also assessed by re-sampling and randomly assigning fish to groups. Varying the sample sizes indicated that some analytical tasks, namely profile testing, required relatively few individuals per sampling location (n greater than or similar to 10) and single nucleotide polymorphisms (SNPs, m greater than or similar to 256). Stock delineation required more individuals per sampling location (n greater than or similar to 25). Assignment of fish to sampling locations required substantially more individuals, more in fact than we had available (n > 50), although this sample size could be reduced to n greater than or similar to 30 when individual fish were assumed to belong to one of the groups sampled. With these results, designers of molecular ecological surveys for yellowfin tuna, and users of information from them, can assess whether the information content is adequate for the required inferential task.	[Foster, Scott D.] CSIROs Data61, Hobart, Tas, Australia; [Feutry, Pierre; Grewe, Peter; Davies, Campbell] CSIROs Oceans & Atmospheres, Hobart, Tas, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Foster, SD (corresponding author), CSIROs Data61, Hobart, Tas, Australia.	scott.foster@data61.csiro.au						Aguirre-Liguori JA, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00870; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; EXCOFFIER L, 1992, GENETICS, V131, P479; Flesch EP, 2018, MOL ECOL RESOUR, V18, P1077, DOI 10.1111/1755-0998.12898; Foster S. D ., 2018, R PACKAGE VERSION 10; Foster SD, 2018, MOL ECOL RESOUR, V18, P1310, DOI 10.1111/1755-0998.12920; FOURNIER DA, 1984, CAN J FISH AQUAT SCI, V41, P400, DOI 10.1139/f84-047; Gelman A., 2007, DATA ANAL USING REGR; Gosselin T., 2020, RADIATOR RADSEQ DATA; Grewe PM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16916; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hoban S, 2013, METHODS ECOL EVOL, V4, P299, DOI 10.1111/2041-210x.12025; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; Lou RN, 2021, MOL ECOL, V30, P5966, DOI 10.1111/mec.16077; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; Murphy K. R., 2009, STAT POWER ANAL SIMP; Nazareno AG, 2017, MOL ECOL RESOUR, V17, P1136, DOI 10.1111/1755-0998.12654; Nei M., 1987, MOL EVOLUTIONARY GEN; Neter J., 1996, APPL LINEAR STAT MOD; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Rosenberg NA, 2005, J COMPUT BIOL, V12, P1183, DOI 10.1089/cmb.2005.12.1183; Selmoni O, 2020, MOL ECOL RESOUR, V20, P154, DOI 10.1111/1755-0998.13095; Sinclair EA, 2009, RESTOR ECOL, V17, P837, DOI 10.1111/j.1526-100X.2008.00420.x	29	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259113	10.1371/journal.pone.0259113	http://dx.doi.org/10.1371/journal.pone.0259113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735482	Green Published, gold			2022-12-26	WOS:000755077100046
J	Lamberti, O; Kabatereine, NB; Tukahebwa, EM; Chami, GF				Lamberti, Olimpia; Kabatereine, Narcis B.; Tukahebwa, Edridah M.; Chami, Goylette F.			Schistosoma mansoni infection risk for school-aged children clusters within households and is modified by distance to freshwater bodies	PLOS ONE			English	Article							INTESTINAL SCHISTOSOMIASIS; LAKE ALBERT; EPIDEMIOLOGY; COMMUNITY; PATTERNS; EXPOSURE; PRAZIQUANTEL; CONTACT; UGANDA	Background The interaction of socio-demographic and ecological factors with Schistosoma mansoni (S. mansoni) infection risk by age and the household clustering of infections between individuals are poorly understood. Methods This study examined 1,832 individuals aged 5-90 years across 916 households in Mayuge District, Uganda. S. mansoni infection status and intensity were measured using Kato-Katz microscopy. Socio-demographic and ecological factors were examined as predictors of infection status and intensity using logistic and negative binomial regression models, respectively, with standard errors clustered by household. A subgroup analysis of children was conducted to examine the correlation of infection status between children and their caretakers. Findings Infection varied within age groups based on the distance to Lake Victoria. Children aged 9-17 years and young adults aged 18-29 years who lived <= 0.50km from Lake Victoria were more likely to be infected compared to individuals of the same age who lived further away from the lake. Infections clustered within households. Children whose caretakers were heavily infected were 2.67 times more likely to be infected. Conclusion These findings demonstrate the focality of schistosome transmission and its dependence on socio-demographic, ecological and household factors. Future research should investigate the sampling of households within communities as a means of progressing towards precision mapping of S. mansoni infections.	Univ Oxford, Big Data Inst, Clin Trial Serv Unit, Oxford, England; [Lamberti, Olimpia; Chami, Goylette F.] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England; [Kabatereine, Narcis B.; Tukahebwa, Edridah M.] Minist Hlth, Div Vector Borne Dis & Neglected Trop Dis, Kampala, Uganda	University of Oxford; University of Oxford	Chami, GF (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Oxford, England.	goylette.chami@ndph.ox.ac.uk						Adriko M, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3040111; Anderson RM, 2016, ADV PARASIT, V94, P199, DOI 10.1016/bs.apar.2016.06.003; Arnold BF, 2020, P NATL ACAD SCI USA, V117, P23174, DOI 10.1073/pnas.2008951117; Barenbold O, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006941; Bethony J, 2001, TROP MED INT HEALTH, V6, P136, DOI 10.1046/j.1365-3156.2001.00685.x; BUNDY DAP, 1988, PARASITOL TODAY, V4, P186, DOI 10.1016/0169-4758(88)90076-2; Campbell SJ, 2018, TRENDS PARASITOL, V34, P53, DOI 10.1016/j.pt.2017.09.004; Chami GF, 2016, CLIN INFECT DIS, V62, P200, DOI 10.1093/cid/civ829; Chami GF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004193; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; de Moira AP, 2007, TROP MED INT HEALTH, V12, P724, DOI 10.1111/j.1365-3156.2007.01842.x; de Moira AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000820; Deol AK, 2019, NEW ENGL J MED, V381, P2519, DOI 10.1056/NEJMoa1812165; EVERITT B, 1980, QUAL QUANT, V14, P75, DOI 10.1007/BF00154794; Exum NG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007617; Faust CL, 2020, TRENDS PARASITOL, V36, P582, DOI 10.1016/j.pt.2020.04.012; French MD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000897; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Kabatereine NB, 2004, T ROY SOC TROP MED H, V98, P711, DOI 10.1016/j.trstmh.2004.06.003; Kabatereine NB, 1999, PARASITOLOGY, V118, P101, DOI 10.1017/S0031182098003576; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Kibira SPS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3803-z; Li EY, 2019, LANCET GLOB HEALTH, V7, pE1414, DOI 10.1016/S2214-109X(19)30346-8; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Mitra AK, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030036; Mnkugwe RH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228770; Nalugwa A, 2015, ACTA TROP, V142, P115, DOI 10.1016/j.actatropica.2014.11.014; Naus CWA, 2003, TROP MED INT HEALTH, V8, P561, DOI 10.1046/j.1365-3156.2003.01056.x; Navas ALA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005208; Odiere MR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-278; Oettle RC, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2030042; Onkanga IO, 2016, INT J PARASITOL, V46, P439, DOI 10.1016/j.ijpara.2016.01.006; Richards L, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0543-7; Sama Martyn T, 2007, Int J Environ Res Public Health, V4, P101, DOI 10.3390/ijerph2007040003; Schistosomiasis Control Intitiative, 2020, WAT SAN BEH CHANG SC, P14; Seto EYW, 2012, GEOSPATIAL HEALTH, V7, P1; Sow S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-198; Tchuente LAT, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006563; Tchuente LAT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0256-8; Toor J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006717; Trienekens SCM, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008266; Tukahebwa EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002268; UNICEF, 2016, SIT AN CHILDR UG 201, P116; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Vos T, 2020, LANCET, V396, P1562; WHO, 2019, BENCH AIDS DIAGN INT; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0	48	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258915	10.1371/journal.pone.0258915	http://dx.doi.org/10.1371/journal.pone.0258915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735487	Green Published, gold, Green Accepted			2022-12-26	WOS:000755077100039
J	Pollock, BH; Kilpatrick, AM; Eisenman, DP; Elton, KL; Rutherford, GW; Boden-Albala, BM; Souleles, DM; Polito, LE; Martin, NK; Byington, CL				Pollock, Brad H.; Kilpatrick, A. Marm; Eisenman, David P.; Elton, Kristie L.; Rutherford, George W.; Boden-Albala, Bernadette M.; Souleles, David M.; Polito, Laura E.; Martin, Natasha K.; Byington, Carrie L.			Safe reopening of college campuses during COVID-19: The University of California experience in Fall 2020	PLOS ONE			English	Article								Background Epidemics of COVID-19 in student populations at universities were a key concern for the 2020-2021 school year. The University of California (UC) System developed a set of recommendations to reduce campus infection rates. SARS-CoV-2 test results are summarized for the ten UC campuses during the Fall 2020 term. Methods UC mitigation efforts included protocols for the arrival of students living on-campus students, non-pharmaceutical interventions, daily symptom monitoring, symptomatic testing, asymptomatic surveillance testing, isolation and quarantine protocols, student ambassador programs for health education, campus health and safety pledges, and lowered density of on-campus student housing. We used data from UC campuses, the UC Health-California Department of Public Health Data Modeling Consortium, and the U.S. Census to estimate the proportion of each campus' student populations that tested positive for SARS-CoV-2 and compared it to the fraction individuals aged 20-29 years who tested positive in their respective counties. Results SARS-CoV-2 cases in campus populations were generally low in September and October 2020, but increased in November and especially December, and were highest in early to mid-January 2021, mirroring case trajectories in their respective counties. Many students were infected during the Thanksgiving and winter holiday recesses and were detected as cases upon returning to campus. The proportion of students who tested positive for SARS-CoV-2 during Fall 2020 ranged from 1.2% to 5.2% for students living on campus and was similar to students living off campus. For most UC campuses the proportion of students testing positive was lower than that for the 20-29-year-old population in which campuses were located. Conclusions The layered mitigation approach used on UC campuses, informed by public health science and augmented perhaps by a more compliant population, likely minimized campus transmission and outbreaks and limited transmission to surrounding communities. University policies that include these mitigation efforts in Fall 2020 along with SARS-CoV-2 vaccination, may alleviate some local concerns about college students returning to communities and facilitate resumption of normal campus operations and in-person instruction.	[Pollock, Brad H.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Eisenman, David P.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Eisenman, David P.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Ctr Publ Hlth & Disasters, Los Angeles, CA USA; [Elton, Kristie L.; Byington, Carrie L.] Univ Calif, Off President, Oakland, CA USA; [Rutherford, George W.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Boden-Albala, Bernadette M.; Souleles, David M.] Univ Calif Irvine, Susan & Henry Samueli Coll Hlth Sci, Sch Med, Dept Neurol,Dept Hlth Soc & Behav,Program Publ Hl, Irvine, CA USA; [Polito, Laura E.] Univ Calif Santa Barbara, Student Hlth, Santa Barbara, CA 93106 USA; [Martin, Natasha K.] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA; [Byington, Carrie L.] Univ Calif San Francisco, Dept Pediat, Div Pediat Infect Dis, San Francisco, CA 94143 USA; [Polito, Laura E.] Sansum Clin, Santa Barbara, CA USA	University of California System; University of California Davis; University of California System; University of California Santa Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Irvine; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; University of California System; University of California San Francisco	Pollock, BH (corresponding author), Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA.	bpollock@ucdavis.edu		Rutherford, George/0000-0002-0707-8287; Byington, Carrie/0000-0002-7350-9495; Pollock, Brad/0000-0003-4415-8638				Andersen M.S., 2020, COLL OPENINGS MOBILI, DOI [10.1101/2020.09.22.20196048, DOI 10.1101/2020.09.22.20196048]; Brooks-Pollock E., 2020, HIGH COVID 19 TRANSM, DOI [10.1101/2020.09.10.20189696, DOI 10.1101/2020.09.10.20189696]; California Department of Industrial Relations, 2021, CALT PERF MEAS SY ST; Cashore JM, 2020, COVID 19 MATH MODELI; CDC, 2020, SCREEN K 12 STUD SYM; Diep F., 2021, WHATS GOING ON CHRON; Fausset R., 2020, NY TIMES; Health UoC, 2021, U CAL HLTH CDPH ACC; Health UoC, 2020, U CAL HLTH COORD COM; Leidner AJ, 2021, MMWR-MORBID MORTAL W, V70, P14, DOI 10.15585/mmwr.mm7001a4; Losina E, 2021, ANN INTERN MED, V174, P472, DOI 10.7326/M20-6558; Lu H, 2021, COMPUT METHOD BIOMEC, V24, P1136, DOI 10.1080/10255842.2020.1869221; McGough M., 2021, SACRAMENTO BEE 0323; Salte I., 2021, J TEACHER ED SUSTAIN, V23, P150, DOI [10.2478/jtes-2021-0011, DOI 10.2478/JTES-2021-0011]; Stankiewicz K., 2020, STUDENTS ARE HEADING; University of California, 2021, UCH COORD COMM GUID	16	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258738	10.1371/journal.pone.0258738	http://dx.doi.org/10.1371/journal.pone.0258738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735480	gold, Green Published			2022-12-26	WOS:000755077100030
J	Getter, T; Kemp, A; Vinberg, F; Palczewski, K				Getter, Tamar; Kemp, Albert; Vinberg, Frans; Palczewski, Krzysztof			Identification of small-molecule allosteric modulators that act as enhancers/disrupters of rhodopsin oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; VISUAL PIGMENT; HETERODIMERIZATION; PHOTORESPONSES; DIMERS; RODS; PHOTOTRANSDUCTION; SPECTROSCOPY; ORGANIZATION; DISRUPTION	The elongated cilia of the outer segment of rod and cone photoreceptor cells can contain concentrations of visual pigments of up to 5 mM. The rod visual pigments, G protein- coupled receptors called rhodopsins, have a propensity to self-aggregate, a property conserved among many G protein- coupled receptors. However, the effect of rhodopsin oligomerization on G protein signaling in native cells is less clear. Here, we address this gap in knowledge by studying rod phototransduction. As the rod outer segment is known to adjust its size proportionally to overexpression or reduction of rhodopsin expression, genetic perturbation of rhodopsin cannot be used to resolve this question. Therefore, we turned to highthroughput screening of a diverse library of 50,000 small molecules and used a novel assay for the detection of rhodopsin dimerization. This screen identified nine small molecules that either disrupted or enhanced rhodopsin dimer contacts in vitro. In a subsequent cell-free binding study, we found that all nine compounds decreased intrinsic fluorescence without affecting the overall UV-visible spectrum of rhodopsin, supporting their actions as allosteric modulators. Furthermore, ex vivo electrophysiological recordings revealed that a disruptive, hit compound #7 significantly slowed down the light response kinetics of intact rods, whereas compound #1, an enhancing hit candidate, did not substantially affect the photoresponse kinetics but did cause a significant reduction in light sensitivity. This study provides a monitoring tool for future investigation of the rhodopsin signaling cascade and reports the discovery of new allosteric modulators of rhodopsin dimerization that can also alter rod photoreceptor physiology.	[Getter, Tamar; Palczewski, Krzysztof] Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA 92697 USA; [Kemp, Albert; Vinberg, Frans] Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Palczewski, Krzysztof] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Palczewski, K (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Dept Ophthalmol, Irvine, CA 92697 USA.; Vinberg, F (corresponding author), Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84112 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA.; Palczewski, K (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	frans.vinberg@utah.edu; kpalczew@uci.edu	Vinberg, Frans/AAK-8615-2021	Vinberg, Frans/0000-0003-3439-4979	National Institutes of Health [R01EY014800, P30EY026651, R01EY009339, R24EY027283]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by the National Institutes of Health Grants R01EY014800 and P30EY026651 (to F. V.) and R01EY009339 and R24EY027283 (to K. P.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Azevedo AW, 2011, J NEUROSCI, V31, P3670, DOI 10.1523/JNEUROSCI.4750-10.2011; Baker BY, 2015, METHOD ENZYMOL, V557, P439, DOI 10.1016/bs.mie.2014.11.045; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Congreve M, 2020, CELL, V181, P81, DOI 10.1016/j.cell.2020.03.003; Dijkman PM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03727-6; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Frederiksen R, 2021, J NEUROSCI, V41, P3320, DOI 10.1523/JNEUROSCI.2817-20.2021; Getter T, 2019, FASEB J, V33, P9526, DOI 10.1096/fj.201900443RR; Getter T, 2019, J BIOL CHEM, V294, P9461, DOI 10.1074/jbc.RA119.008697; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gulati S, 2017, P NATL ACAD SCI USA, V114, pE2608, DOI 10.1073/pnas.1617446114; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hofmann L, 2016, ANAL BIOCHEM, V499, P63, DOI 10.1016/j.ab.2016.01.016; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jastrzebska B, 2015, J BIOL CHEM, V290, P25728, DOI 10.1074/jbc.M115.662684; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Kent T, 2007, CURR OPIN DRUG DISC, V10, P580; Kilpatrick LE, 2021, BIOCHEM SOC T, V49, P1547, DOI 10.1042/BST20201001; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leinonen H, 2020, ELIFE, V9, DOI 10.7554/eLife.59422; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Levi J, 2007, J AM CHEM SOC, V129, P11900, DOI 10.1021/ja073936h; Lezoualc'h F, 2009, CURR PHARM DESIGN, V15, P719, DOI 10.2174/138161209787315602; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mao CY, 2020, CELL RES, V30, P564, DOI 10.1038/s41422-020-0350-5; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Miranda OR, 2010, J AM CHEM SOC, V132, P5285, DOI 10.1021/ja1006756; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Munk C, 2019, NAT METHODS, V16, P151, DOI 10.1038/s41592-018-0302-x; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Pahlberg J, 2017, J PHYSIOL-LONDON, V595, P3459, DOI 10.1113/JP273398; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Panetta R, 2008, DRUG DISCOV TODAY, V13, P1059, DOI 10.1016/j.drudis.2008.09.002; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Robson JG, 2014, PROG RETIN EYE RES, V39, P1, DOI 10.1016/j.preteyeres.2013.12.003; Sarkar P, 2021, ARCH BIOCHEM BIOPHYS, V701, DOI 10.1016/j.abb.2021.108794; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Sundermeier TR, 2014, FASEB J, V28, P3780, DOI 10.1096/fj.14-254292; Teitler M, 2012, PHARMACOL THERAPEUT, V133, P205, DOI 10.1016/j.pharmthera.2011.10.007; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Velazhahan V, 2021, NATURE, V589, P148, DOI 10.1038/s41586-020-2994-1; Vinberg F, 2015, J GEN PHYSIOL, V146, P307, DOI 10.1085/jgp.201511412; Vinberg F, 2014, VISION RES, V101, P108, DOI 10.1016/j.visres.2014.06.003; Vinberg FJ, 2009, J VISION, V9, DOI 10.1167/9.12.9; Wen XH, 2009, BIOPHYS J, V96, P939, DOI 10.1016/j.bpj.2008.10.016; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao DY, 2019, J BIOL CHEM, V294, P14215, DOI 10.1074/jbc.RA119.010089	65	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101401	10.1016/j.jbc.2021.101401	http://dx.doi.org/10.1016/j.jbc.2021.101401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774799	Green Published, gold			2022-12-26	WOS:000748397200009
J	Mehmood, Y; Aslam, J; Ullah, N; Alsheikhy, AA; Din, EU; Iqbal, J				Mehmood, Yasir; Aslam, Jawad; Ullah, Nasim; Alsheikhy, Ahmed A.; Din, Emad Ud; Iqbal, Jamshed			Robust fuzzy sliding mode controller for a skid-steered vehicle subjected to friction variations	PLOS ONE			English	Article							FRACTIONAL-ORDER CONTROLLER; MOBILE ROBOT; SPEED; TRACKING; DESIGN	Skid-steered vehicles (SSV) are gaining huge importance in the market due to their applications like construction, agricultural work, material handling etc. The accuracy of performing such tasks require a robust control algorithm. The design of such controller is very challenging task due to external disturbances caused by wheel-ground interaction and aerodynamic effects. This paper proposes robust fractional and integral order fuzzy sliding mode controllers (FSMC, FFSMC) for a skid-steered vehicles with varying coefficient of friction and a displaced center of gravity (CG). FFSMC controller reduces the outcome of forces generated as a result of ground tire interaction during skidding and friction variations. The proposed controllers are implemented for a four-wheel SSV under high-speed turning motion. A simulation environment is constructed by implementing the SSV dynamics with wheel-road model and the performance of the proposed algorithms is tested. The simulation test is conducted for a Pioneer-3AT (P-3AT) robot SSV vehicle with displaced CG and variable coefficient of tires friction. Simulation results demonstrate the efficiency of the proposed FFSMC algorithm in term of reduced state errors and minimum chattering. The proposed controller compensates the effect of different responses of the wheels generated as a result of variable CG. The chattering phenomenon generated by conventional SMCs is also minimized by fuzzy tuning approach.	[Mehmood, Yasir; Aslam, Jawad; Din, Emad Ud] Natl Univ Sci & Technol, Sch Mech & Mfg Engn, Islamabad, Pakistan; [Ullah, Nasim] Taif Univ, Coll Engn, Dept Elect Engn, At Taif, Saudi Arabia; [Alsheikhy, Ahmed A.] Northern Border Univ, Coll Engn, Dept Elect Engn, Ar Ar, Saudi Arabia; [Iqbal, Jamshed] Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, N Humberside, England	National University of Sciences & Technology - Pakistan; Taif University; Northern Borders University; University of Hull	Iqbal, J (corresponding author), Univ Hull, Fac Sci & Engn, Dept Comp Sci & Technol, Kingston Upon Hull, N Humberside, England.	j.iqbal@hull.ac.uk	Iqbal, Jamshed/AER-0153-2022; Ullah, Nasim/AEP-0711-2022	Iqbal, Jamshed/0000-0002-0795-0282; Ullah, Nasim/0000-0001-7208-6374; Aslam, Jawad/0000-0002-8151-5457				Ajwad SA, 2018, CYBERNET SYST, V49, P77, DOI 10.1080/01969722.2017.1412905; Al-Mayyahi A, 2016, J CONTROL AUTOM ELEC, V27, P29, DOI 10.1007/s40313-015-0214-2; Ali M.A, MODELING SIMULATION; [Anonymous], PIONEER 3 AT MOBILE; Aslam J, 2014, J MECH SCI TECHNOL, V28, P3301, DOI 10.1007/s12206-014-0741-y; Bascetta L, 2017, ELECTRONICS-SWITZ, V6, DOI 10.3390/electronics6020039; Brach R.M., 2000, MODELING COMBINED BR; Cajo R, 2019, IEEE ACCESS, V7, P66864, DOI 10.1109/ACCESS.2019.2918578; Caracciolo L, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P2632, DOI 10.1109/ROBOT.1999.773994; Feliu-Talegon D, 2017, IFAC PAPERSONLINE, V50, P6043, DOI 10.1016/j.ifacol.2017.08.1450; Galvagno E., 2017, SAE TECHNICAL PAPER; Galvagno E, 2017, SAE INT J PASSEN CAR, V10, P721, DOI 10.4271/2017-01-2496; Gariepy R, 2010, P AMER CONTR CONF, P6943; Guercioni G., 2018, SAE TECHNICAL PAPER; Hirschberg W, 2007, VEHICLE SYST DYN, V45, P101, DOI 10.1080/00423110701776284; Hirschberg W, 2002, VEHICLE SYST DYN, V38, P103, DOI 10.1076/vesd.38.2.103.5620; Huskic G, 2019, INT J ROBOT RES, V38, P1124, DOI 10.1177/0278364919859634; Khan H, 2015, FRONT INFORM TECH EL, V16, P166, DOI 10.1631/FITEE.1400183; Kim T, 2018, IEEE INT C INT ROBOT, P2418, DOI 10.1109/IROS.2018.8593843; Kim T, 2017, IFAC PAPERSONLINE, V50, P5755, DOI 10.1016/j.ifacol.2017.08.1140; Kumar V, 2017, INT J AUTOM COMPUT, V14, P474, DOI 10.1007/s11633-016-0981-7; Liao JF, 2019, IEEE T IND INFORM, V15, P1742, DOI 10.1109/TII.2018.2869573; Lucet E, 2010, ADV INTEL SOFT COMPU, V83, P247; Lucet E, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P4220, DOI 10.1109/IROS.2009.5354373; Nasri A, 2009, J ELECTR ENG TECHNOL, V4, P499, DOI 10.5370/JEET.2009.4.4.499; Nazari V, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P549, DOI 10.1109/ICARCV.2008.4795577; Nazari V, 2008, 2008 10TH INTERNATIONAL CONFERENCE ON CONTROL AUTOMATION ROBOTICS & VISION: ICARV 2008, VOLS 1-4, P378, DOI 10.1109/ICARCV.2008.4795549; Orman K, 2016, ELEKTRON ELEKTROTECH, V22, P14, DOI 10.5755/j01.eie.22.5.16337; Pentzer J, 2016, P AMER CONTR CONF, P2110, DOI 10.1109/ACC.2016.7525230; Pentzer J, 2014, J FIELD ROBOT, V31, P455, DOI 10.1002/rob.21509; Renqiang Wang, 2020, Data Processing Techniques and Applications for Cyber-Physical Systems (DPTA 2019). Advances in Intelligent Systems and Computing (AISC 1088), P1081, DOI 10.1007/978-981-15-1468-5_126; Slotine J.J.E., 1991, APPL NONLINEAR CONTR; Tian J, 2020, IEEE ACCESS, V8, P152963, DOI 10.1109/ACCESS.2020.3017759; Ullah Nasim., 2016, ADAPTIVE FUZZY FRACT, V38	34	0	0	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0258909	10.1371/journal.pone.0258909	http://dx.doi.org/10.1371/journal.pone.0258909			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784368	Green Published, gold			2022-12-26	WOS:000755277300002
J	Papazoglou, DD; Baretella, O; Feller, M; Del Giovane, C; Moutzouri, E; Aujesky, D; Schwenkglenks, M; O'Mahony, D; Knol, W; Dalleur, O; Rodondi, N; Baumgartner, C				Papazoglou, Dimitrios David; Baretella, Oliver; Feller, Martin; Del Giovane, Cinzia; Moutzouri, Elisavet; Aujesky, Drahomir; Schwenkglenks, Matthias; O'Mahony, Denis; Knol, Wilma; Dalleur, Olivia; Rodondi, Nicolas; Baumgartner, Christine			Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients	PLOS ONE			English	Article							POLYSACCHARIDE VACCINE; PNEUMONIA; RATES; POPULATION; COVERAGE; DISEASE; PEOPLE	Background Older adults with chronic conditions are at high risk of complications from influenza and pneumococcal infections. Evidence about factors associated with influenza and pneumococcal vaccination among older multimorbid persons in Europe is limited. The aim of this study was to investigate the prevalence and determinants of these vaccinations in this population. Methods Multimorbid patients aged >= 70 years with polypharmacy were enrolled in 4 European centers in Switzerland, Belgium, the Netherlands, and Ireland. Data on vaccinations, demographics, health care contacts, and comorbidities were obtained from self-report, general practitioners and medical records. The association of comorbidities or medical contacts with vaccination status was assessed using multivariable adjusted log-binomial regression models. Results Among 1956 participants with available influenza vaccination data (median age 79 years, 45% women), 1314 (67%) received an influenza vaccination within the last year. Of 1400 patients with available pneumococcal vaccination data (median age 79 years, 46% women), prevalence of pneumococcal vaccination was 21% (n = 291). The prevalence of vaccination remained low in high-risk populations with chronic respiratory disease (34%) or diabetes (24%), but increased with an increasing number of outpatient medical contacts. Chronic respiratory disease was independently associated with the receipt of both influenza and pneumococcal vaccinations (prevalence ratio [PR] 1.09, 95% confidence interval [CI] 1.03-1.16; and PR 2.03, 95%CI 1.22-3.40, respectively), as was diabetes (PR 1.06, 95%CI 1.03-1.08; PR 1.24, 95%CI 1.16-1.34, respectively). An independent association was found between number of general practitioner visits and higher prevalence of pneumococcal vaccination (p for linear trend <0.001). Conclusion Uptake of influenza and particularly of pneumococcal vaccination in this population of European multimorbid older inpatients remains insufficient and is determined by comorbidities and number and type of health care contacts, especially outpatient medical visits. Hospitalization may be an opportunity to promote vaccination, particularly targeting patients with few outpatient physician contacts.	[Papazoglou, Dimitrios David; Baretella, Oliver; Feller, Martin; Del Giovane, Cinzia; Moutzouri, Elisavet; Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Papazoglou, Dimitrios David; Baretella, Oliver; Moutzouri, Elisavet; Aujesky, Drahomir; Rodondi, Nicolas; Baumgartner, Christine] Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Del Giovane, Cinzia] Univ Fribourg, Populat Hlth Lab, Fribourg, Switzerland; [Schwenkglenks, Matthias] Univ Basel, Inst Pharmaceut Med ECPM, Basel, Switzerland; [O'Mahony, Denis] Natl Univ Ireland, Dept Med Cork, Univ Coll Cork, Munster, IE, Ireland; [O'Mahony, Denis] Cork Univ Hosp Grp, Dept Geriatr Med Cork, Munster, IE, Ireland; [Knol, Wilma] Univ Utrecht, Univ Med Ctr Utrecht, Dept Geriatr, Utrecht, Netherlands; [Knol, Wilma] Univ Utrecht, Univ Med Ctr Utrecht, Expertise Ctr Pharmacotherapy Old Persons EPHOR, Utrecht, Netherlands; [Dalleur, Olivia] Catholic Univ Louvain, Louvain Drug Res Inst, Clin Univ St Luc, Brussels, Belgium; [Dalleur, Olivia] Catholic Univ Louvain, Pharm Dept, Clin Univ St Luc, Brussels, Belgium	University of Bern; University of Bern; University Hospital of Bern; University of Fribourg; University of Basel; University College Cork; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Papazoglou, DD (corresponding author), Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland.; Papazoglou, DD (corresponding author), Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland.	papazoglou2019@gmail.com		Del Giovane, Cinzia/0000-0002-5028-932X; Schwenkglenks, Matthias/0000-0001-7217-1173; Baumgartner, Christine/0000-0003-2296-9632; Papazoglou, Dimitrios David/0000-0001-9544-105X; Rodondi, Nicolas/0000-0001-9083-6896	European Union [634238]; Swiss State Secretariat for Education, Research and Innovation (SERI) [15.0137]; Swiss National Scientific Foundation [SNSF 320030_188549]	European Union(European Commission); Swiss State Secretariat for Education, Research and Innovation (SERI); Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF))	This work is part of the project "OPERAM: OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly" supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No 634238, and by the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 15.0137. The opinions expressed and arguments employed herein are those of the authors and do not necessarily reflect the official views of the European Commission and the Swiss government. This project was also partially funded by the Swiss National Scientific Foundation (SNSF 320030_188549). The funder of the study had no role in study design, data collection, data analysis, data interpretation or writing of the report.	Adam L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026769; Ajani UA, 2005, AM HEART J, V149, P254, DOI 10.1016/j.ahj.2004.07.028; Andrade LF, 2020, PHARMACOECONOMICS, V38, P413, DOI 10.1007/s40273-019-00876-4; Australian Institute of Health and Welfare, 2016, AUSTR BURD DIS STUD; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bekkat-Berkani R, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0420-8; Berry BB, 2001, VACCINE, V19, P3493, DOI 10.1016/S0264-410X(01)00068-8; Blumenfeld O, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004734; Bonnave C, 2019, EUR J CLIN MICROBIOL, V38, P785, DOI 10.1007/s10096-019-03485-3; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Bundesamt fur Gesundheit, 2019, EIDG KOMM IMPFFR SCH; Burns VE, 2005, VACCINE, V23, P3604, DOI 10.1016/j.vaccine.2004.12.031; Chan Denise P C, 2015, Prev Med Rep, V2, P803, DOI 10.1016/j.pmedr.2015.09.002; Charlson Mary, 2019, CHARLSON COMORBIDITY; Christiansen CF, 2014, AM J MED, V127, P871, DOI 10.1016/j.amjmed.2014.05.002; Collet TH, 2011, J GEN INTERN MED, V26, P724, DOI 10.1007/s11606-011-1674-0; Control ECfDPa, 2020, PNEUM DIS REC VACC; Costello R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153848; Department of Health, 2019, NHS LONG TERM PLAN; Dominguez A, 2005, CLIN INFECT DIS, V40, P1250, DOI 10.1086/429236; Dominguez A, 2010, EUR RESPIR J, V36, P608, DOI 10.1183/09031936.00171309; Dominguez A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147931; ECDC, 2018, ANT CONS ANN EP REP; European Centre for Disease Prevention and Control, 2019, FACTSH SEAS INFL; European Centre for Disease Prevention and Control, ANN EPIDEMIOLOGICAL; European Centre for Disease Prevention and Control, 2020, PNEUM DIS REC VACC; Ganczak M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060665; Han LF, 2019, EPIDEMIOLOGY, V30, P405, DOI 10.1097/EDE.0000000000000984; Kamal Khalid M, 2003, J Am Pharm Assoc (2003), V43, P403, DOI 10.1331/154434503321831120; Kawakami K, 2010, VACCINE, V28, P7063, DOI 10.1016/j.vaccine.2010.08.010; Ludwig K, 2018, PHARMACOECONOMICS, V36, P663, DOI 10.1007/s40273-018-0615-8; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Maruyama T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1004; McFadden K, 2021, VACCINE, V39, P658, DOI 10.1016/j.vaccine.2020.12.042; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nowalk MP, 2003, INFECT CONT HOSP EP, V24, P526, DOI 10.1086/502240; Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL; Pearson WS, 2009, PREV MED, V48, P180, DOI 10.1016/j.ypmed.2008.11.001; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rehmet S, 2002, EMERG INFECT DIS, V8, P1442, DOI 10.3201/eid0812.010497; Ridda I, 2007, HUM VACCINES, V3, P83, DOI 10.4161/hv.3.3.3925; Santaularia J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2884-5; Schmedt N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220848; Service public federal de la sante de Belgique, 2020, VACC ANT AD; Szilagyi PG, 2020, JAMA INTERN MED, V180, P962, DOI 10.1001/jamainternmed.2020.1602; Szucs TD, 2005, VACCINE, V23, P5055, DOI 10.1016/j.vaccine.2005.06.005; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Troeger C, 2018, LANCET INFECT DIS, V18, P1191, DOI 10.1016/S1473-3099(18)30310-4; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; UNAIDS, 2021, GLOB HIV AIDS STAT F; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Vila-Corcoles A, 2006, CLIN INFECT DIS, V43, P860, DOI 10.1086/507340; Vila-Corcoles A, 2019, EUROSURVEILLANCE, V24, P22, DOI 10.2807/1560-7917.ES.2019.24.29.1800446; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang Q, 2018, VACCINE, V36, P7262, DOI 10.1016/j.vaccine.2018.10.045; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211; Zurcher K, 2019, SWISS MED WKLY, V149, DOI 10.4414/smw.2019.14705	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260112	10.1371/journal.pone.0260112	http://dx.doi.org/10.1371/journal.pone.0260112			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784405	Green Published, gold			2022-12-26	WOS:000755277300044
J	Sekhon, M; van der Straten, A				Sekhon, Mandeep; van der Straten, Ariane		MTN-041 MAMMA Study Team	Pregnant and breastfeeding women's prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability	PLOS ONE			English	Article							DAPIVIRINE VAGINAL RING; MICROBICIDE ACCEPTABILITY; SAFETY; PREP	HIV infection during pregnancy and breastfeeding has implications for maternal health. Between May- November 2018, we explored prospective acceptability of two novel HIV Pre-exposure Prophylaxis (PrEP) products, oral pills and vaginal rings, through focus group discussions with 65 pregnant and breastfeeding women in Malawi, South Africa, Uganda, Zimbabwe. Qualitative analysis was completed, guided by the Theoretical Framework of Acceptability (TFA). First, a deductive thematic analysis was applied to relevant coded data, into the seven TFA constructs (Affective Attitude; Burden; Ethicality, Intervention Coherence; Opportunity Costs; Perceived Effectiveness; Self-efficacy). Next, an iterative analysis was completed to generate themes within each of the TFA constructs. Women's positive attitudes towards daily oral PrEP highlighted the familiarity of taking pills, understanding the purpose of taking pills, and the perception that it is an effective method to protect mothers and babies from HIV during pregnancy and breastfeeding. Women emphasized the ease of using the ring given its monthly duration that lowers burden on the user, its discreetness and invisibility once in place. The TFA analysis highlighted how acceptability of both methods could be enhanced by focusing on perceptions of the end users (i.e. the women) and not just the products themselves. This approach provided insights into how to refine the intervention materials and plans for implementation.	[Sekhon, Mandeep] Kings Coll London, Fac Life Sci & Med, Sch Populat Hlth & Environm Sci, Dept Populat Hlth Sci, London, England; [van der Straten, Ariane] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [van der Straten, Ariane] RTI Int, Womens Global Hlth Imperat, Berkeley, CA USA	University of London; King's College London; University of California System; University of California San Francisco; Research Triangle Institute	Sekhon, M (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Populat Hlth & Environm Sci, Dept Populat Hlth Sci, London, England.	Mandeep.sekhon@kcl.ac.uk		van der Straten, Ariane/0000-0001-8536-648X	National Institute of Allergy and Infectious Diseases [UM1AI068633, UM1AI068615, UM1AI106707]; Eunice Kennedy Shriver National Institute of Child Health and Human Development component of the U.S. National Institutes of Health (NIH); National Institute of Mental Health, component of the U.S. National Institutes of Health (NIH)	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development component of the U.S. National Institutes of Health (NIH); National Institute of Mental Health, component of the U.S. National Institutes of Health (NIH)	The MTN-041 study was designed and implemented by the Microbicide Trials Network (MTN) funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2021, LANCET HIV, V8, pE87, DOI 10.1016/S2352-3018(20)30304-0; Balan IC, 2021, AIDS BEHAV, V25, P447, DOI 10.1007/s10461-020-03011-z; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coly A, 2008, CURR OPIN HIV AIDS, V3, P581, DOI 10.1097/COH.0b013e32830aba00; Davey DLJ, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25426; Davies N, 2018, SEX HEALTH, V15, P501, DOI 10.1071/SH18067; Dettinger JC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25378; Dinh TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125525; Eakle R, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25306; Griffin JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224898; Hodges-Mameletzis I, 2019, DRUGS, V79, P1263, DOI 10.1007/s40265-019-01143-8; International Partnership for Microbicides, 2020, IPMS DEP RING WOM HI; International RTI, 2020, WORKSH PART RAP QUAL; Joseph Davey Dvora L, 2017, AIDS, V31, P2193, DOI 10.1097/QAD.0000000000001604; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Makanani B., 2017, 2017 CROI C FEBR, P13; Mensch BS, 2012, CURR OPIN HIV AIDS, V7, P534, DOI 10.1097/COH.0b013e3283590632; Minnis AM, 2018, AIDS BEHAV, V22, P2662, DOI 10.1007/s10461-018-2078-5; Mofenson LM, 2017, AIDS, V31, P213, DOI 10.1097/QAD.0000000000001313; Montgomery ET, 2018, AIDS BEHAV, V22, P402, DOI 10.1007/s10461-017-1811-9; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Mugwanya KK, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002132; Nel A, 2016, NEW ENGL J MED, V375, P2133, DOI 10.1056/NEJMoa1602046; Noguchi LM, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.01930-18, 10.1128/aac.01930-18]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pintye J, 2020, LANCET HIV, V7, pE582, DOI 10.1016/S2352-3018(20)30102-8; Schiele JT, 2014, ANN FAM MED, V12, P550, DOI 10.1370/afm.1693; Seidman DL, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.2.21295; Sekhon M, 2018, BRIT J HEALTH PSYCH, V23, P519, DOI 10.1111/bjhp.12295; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; UNAIDS, UNAIDS2000; van Der Straten A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25536; Velloza J, 2019, CURR OPIN HIV AIDS, V14, P423, DOI 10.1097/COH.0000000000000567; Woodsong C, 2008, AIDS EDUC PREV, V20, P171, DOI 10.1521/aeap.2008.20.2.171; World Health Organisation, 2017, CARD DIS CVDS; Zimba C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223487	38	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259779	10.1371/journal.pone.0259779	http://dx.doi.org/10.1371/journal.pone.0259779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784355	Green Published, gold			2022-12-26	WOS:000755277300017
J	Turska, E; Stepien-Lampa, N				Turska, Elzbieta; Stepien-Lampa, Natalia			Well-being of Polish university students after the first year of the coronavirus pandemic: The role of core self-evaluations, social support and fear of COVID-19	PLOS ONE			English	Article							QUALITY-OF-LIFE; JOB; SATISFACTION; WHOQOL; SCALE	Background The SARS-CoV-2 pandemic represents an unprecedented situation in the most recent history. It has had a number of negative consequences for individuals and for whole societies. Individual effects of the pandemic include not only loss of life and of physical health, but also deteriorated quality of life. Objective This study examines the effect of core self-evaluations (CSE), social support and fear of COVID-19 on the well-being of university students in Poland during the COVID-19 pandemic. Methods We conducted an online survey on a nationwide group of 1,000 students of Polish universities. The survey was carried out between 1 and 15 March 2021. The respondents filled out the following set of tools: World Health Organization Quality of Life Scale, Core Self-Evaluations Scale, Multidimensional Scale of Perceived Social Support and The Fear of COVID-19 Scale. Results The findings showed that core self-evaluations (CSE) were significantly positively associated with well-being in each of the four domains studied: physical health (r = 0.519), psychological (r = 0.763), social relationships (r = 0.465) and environment (r = 0.496). Similarly, social support correlated positively with physical health (r = 0.277), psychological health (r = 0.306), social relationships (r = 0.552) and environment (r = 0.496). Fear of COVID-19 correlated negatively with well-being in the domain of physical health (r = 0.188), in social relationships (r = 0.042) and with regard to the environment (r = 0.071), the correlations were weak. However, the relationship between fear of COVID-19 and well-being in the psychological domain was not confirmed. Conclusion The findings point to the significant role of CSE and the role of social support in the perceived quality of life of young people during the pandemic. They provide valuable data concerning individuals who are particularly vulnerable to the adverse psychological effects at the time of the pandemic. They also prove that research conducted to explore other factors protecting individual well-being in difficult situations, including that of the pandemic, should be continued.	[Turska, Elzbieta] Univ Silesia, Fac Social Sci, Inst Psychol, Katowice, Poland; [Stepien-Lampa, Natalia] Univ Silesia, Fac Social Sci, Inst Polit Sci, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Stepien-Lampa, N (corresponding author), Univ Silesia, Fac Social Sci, Inst Polit Sci, Katowice, Poland.	natalia.stepien-lampa@us.edu.pl		Stepien-Lampa, Natalia/0000-0001-6282-5655	Research Excellence Initiative of the University of Silesia in Katowice Natalia Stepien-Lampa	Research Excellence Initiative of the University of Silesia in Katowice Natalia Stepien-Lampa	Publication supported by the Research Excellence Initiative of the University of Silesia in Katowice Natalia Stepien-Lampa in the form of funds to NSL.	Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Alimoradi Z, 2022, J SLEEP RES, V31, DOI 10.1111/jsr.13432; Alimoradi Z, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100916; Borecka D, 2017, POLSKIE FORUM PSYCHO, V22, P600, DOI [10.14656/PFP20170405, DOI 10.14656/PFP20170405]; Broche-Perez Y, 2022, INT J MENT HEALTH AD, V20, P83, DOI 10.1007/s11469-020-00343-8; Brodeur A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104346; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; CBOS, 2020, KOM BAD OB POL CZAS; Chang CH, 2012, J MANAGE, V38, P81, DOI 10.1177/0149206311419661; Diener E., 2008, PSYCHOLOGIA POZYTYWN, P35; Dlugosz P., 2020, RAPORT BADAN; Efi G.O., 2021, GADJAH MADA J PSYCHO, V7, DOI [10.22146/gamajop.59844, DOI 10.22146/GAMAJOP.59844]; Fitzpatrick KM, 2020, PSYCHOL TRAUMA-US, V12, pS17, DOI 10.1037/tra0000924; Gawrych M, 2021, PSYCHOL HEALTH MED, V26, P107, DOI 10.1080/13548506.2020.1861314; Grey I, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113452; Grzelak Sz, 2020, AKCJA NAWIGACJA CHRO; Guo K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253891; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hasanah C I, 2003, Med J Malaysia, V58, P79; Hawthorne G, 2006, SOC INDIC RES, V77, P37, DOI 10.1007/s11205-005-5552-1; Hobfoll S. E., 2006, STRES KULTURA SPOLEC; Jaracz K, 2006, SCAND J CARING SCI, V20, P251, DOI 10.1111/j.1471-6712.2006.00401.x; Juczynski Z., 2016, SZTUKA LECZENIA, V1, P19; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 2005, J APPL PSYCHOL, V90, P257, DOI 10.1037/0021-9010.90.2.257; Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Klag S, 2004, BRIT J HEALTH PSYCH, V9, P137, DOI 10.1348/135910704773891014; Krystyna B., 2017, POL FORUM PSYCHOL, V4, P581, DOI [10.14656/PFP20170404, DOI 10.14656/PFP20170404]; Lazarus R.S., 1986, PSYCHOL NEWS, V3-4, P2; Li X., 2020, FRONT PSYCHIATRY, V11, DOI [10.1111/aphw.12211, DOI 10.1111/APHW.12211]; Lin CY, 2021, NURS OPEN, V8, P1892, DOI 10.1002/nop2.855; Marques G, 2021, INT J MED INFORM, V147, DOI 10.1016/j.ijmedinf.2020.104369; Meng H, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.112983; Min SK, 2002, QUAL LIFE RES, V11, P593, DOI 10.1023/A:1016351406336; Morrissey JL, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0265-6; Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0; Oginska-Bulik N., 2008, PSYCHOL ZDROWIA, P89; Olashore AA, 2021, ASIAN J SOC HEAL BEH, V4, P85, DOI 10.4103/shb.shb_32_21; Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004; ORMEL J, 1991, J PERS SOC PSYCHOL, V60, P288, DOI 10.1037/0022-3514.60.2.288; Pakpour AH, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.740333; Patel VK, 2021, ASIAN J SOC HEAL BEH, V4, P30, DOI 10.4103/shb.shb_1_21; Patil ST, 2021, ASIAN J SOC HEAL BEH, V4, P62, DOI 10.4103/shb.shb_5_21; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Piccolo RF, 2005, J ORGAN BEHAV, V26, P965, DOI 10.1002/job.358; Pilch I, 2021, PEERJ, V9, DOI 10.7717/peerj.11263; Power M, 1999, HEALTH PSYCHOL, V18, P495, DOI 10.1037/0278-6133.18.5.495; Rajabimajd N, 2021, ASIAN J SOC HEAL BEH, V4, P51, DOI 10.4103/shb.shb_24_21; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Saravanan C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.582189; Sek H., 2012, WSPARCIE SPOLECZNE S, P11; Sharma R, 2021, ASIAN J SOC HEAL BEH, V4, P98, DOI 10.4103/shb.shb_9_21; Smith GL, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0509-8; Srivastava A, 2010, J VOCAT BEHAV, V77, P255, DOI 10.1016/j.jvb.2010.04.008; Szkody E, 2021, FAM PROCESS, V60, P1002, DOI 10.1111/famp.12618; Walczak R., 2017, CZASOPISMO PSYCHOL, V23, P147, DOI [10.14691/CPPJ.23.1.147, DOI 10.14691/CPPJ.23.1.147]; Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Wu CH, 2012, J APPL PSYCHOL, V97, P331, DOI 10.1037/a0025673; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549; Yal?in I., 2015, TURKISH PSYCHOL COUN, V5, P35, DOI DOI 10.1080/21507686.2018.1556171; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	66	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259296	10.1371/journal.pone.0259296	http://dx.doi.org/10.1371/journal.pone.0259296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784369	Green Published, gold			2022-12-26	WOS:000755277300006
J	Guntur, RD; Kingsley, J; Islam, FMA				Guntur, Robertus Dole; Kingsley, Jonathan; Islam, Fakir M. Amirul			Malaria awareness of adults in high, moderate and low transmission settings: A cross-sectional study in rural East Nusa Tenggara Province, Indonesia	PLOS ONE			English	Article							PUBLIC AWARENESS; KNOWLEDGE	Introduction The 2009 Indonesian roadmap to malaria elimination indicated that the nation had been progressing towards achieving malaria elimination by 2030. Currently, most of the districts in the western part of Indonesia have eliminated malaria; however, none of the districts in the East Nusa Tenggara Province (ENTP) have met these set targets. This study aimed to investigate the status of malaria awareness of rural adults in the ENTP. Methods A community-based cross-sectional study was conducted between October and December 2019 in high, moderate, and low malaria-endemic settings (MESs) in the ENTP. After obtaining informed consent, data were collected using an interviewer-administered structure questionnaire among 1503 participants recruited by a multi-stage cluster sampling method. A malaria awareness index was developed based on ten questions. A binary logistic regression method was applied to investigate the significance of any association between malaria awareness and the different MESs. Results The participation rate of the study was 99.5%. Of this number, 51.4% were female and 45.5% had completed primary education. The malaria awareness index was significantly low (48.8%, 95% confidence interval [CI]: 45.2-52.4). Malaria awareness of rural adults residing in low endemic settings was two times higher than for those living in high endemic settings (adjusted odds ratio [AOR]: 2.41, 95% CI: 1.81-3.21) and the basic malaria knowledge of participants living in low malaria-endemic settings was almost four times higher than that in high endemic settings (AOR: 3.75, 95% CI: 2.75-5.11). Of the total participants, 81.3% (95% CI: 79.1-83.5) were aware that malaria could be prevented and 75.1% (95% CI: 72.6-77.6) knew at least one prevention measure. Overall, the awareness of fever as the main symptom of malaria, mosquito bites as the transmission mode of malaria, and seeking treatment within 24 hours of suffering from malaria was poor at 37.9% (95% CI: 33.9-41.9), 59.1% (95% CI: 55.9-62.3), and 46.0% (95% CI: 42.3-49.7), respectively. The poor level of awareness was significantly different amongst the three MESs, with the lowest levels of awareness in the high endemic setting. Conclusion Malaria awareness of rural adults needs to be improved to address Indonesia's national roadmap for malaria elimination. Results indicated that public health programs at a local government level should incorporate the malaria awareness index in their key strategic intervention to address malaria awareness.	[Guntur, Robertus Dole; Islam, Fakir M. Amirul] Swinburne Univ Technol, Dept Hlth Sci & Biostat, Hawthorn, Vic, Australia; [Guntur, Robertus Dole] Nusa Cendana Univ, Fac Sci & Engn, Dept Math, NTT, Kupang, Ntt, Indonesia; [Kingsley, Jonathan] Swinburne Univ Technol, Dept Hlth & Med Sci, Hawthorn, Vic, Australia; [Kingsley, Jonathan] Swinburne Univ Technol, Ctr Urban Transit, Hawthorn, Vic, Australia	Swinburne University of Technology; Nippon Telegraph & Telephone Corporation; Universitas Nusa Cendana; Swinburne University of Technology; Swinburne University of Technology	Guntur, RD (corresponding author), Swinburne Univ Technol, Dept Hlth Sci & Biostat, Hawthorn, Vic, Australia.; Guntur, RD (corresponding author), Nusa Cendana Univ, Fac Sci & Engn, Dept Math, NTT, Kupang, Ntt, Indonesia.	rguntur@swin.edu.au	Guntur, Robertus Dole/AAQ-6765-2021; Guntur, Robertus/AAD-3303-2022	Guntur, Robertus Dole/0000-0002-1597-3644; 	Australia Awards Scholarship [ST000TBK6]	Australia Awards Scholarship	PhD scholarship for RDG was supported by the Australia Awards Scholarship (ST000TBK6). The Faculty of Health, Arts and Design (FHAD) of the Swinburne University Technology supported for the primary data collection. The funders had no role in the design of the study, data collection, analysis, or interpretation of data or writing the manuscripts.	ACT watch Group PSI/Cambodia, 2011, KINGDOM CAMBODIA HOU; Ahmed SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-173; Alam MS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1603-0; [Anonymous], 2019, INDONESIA MINISTRY H; Asia Pacific Malaria Elimination Network, 2020, INDONESIA NATL STRAT; Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98; Bambo F., 2018, INTEGRATING MALARIA; Berhane A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0992-9; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Birhanu Z, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2731-z; Blanch-Hartigan D, 2015, J HEALTH COMMUN, V20, P204, DOI 10.1080/10810730.2014.921742; DePina AJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7130-5; Devine A, 2018, AM J TROP MED HYG, V98, P543, DOI 10.4269/ajtmh.17-0680; Dhiman S, 2014, J INFECT PUBLIC HEAL, V7, P457, DOI 10.1016/j.jiph.2014.06.002; Diaz GF., 2017, RELATIONSHIP KNOWLED; Dlamini SV, 2017, J MICROBIOL IMMUNOL, V50, P245, DOI 10.1016/j.jmii.2015.05.003; Elmosaad YM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1551-8; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Guntur RD, 2017, J PHYS CONF SER, V812, DOI 10.1088/1742-6596/812/1/012073; Guntur RD, 2021, JMIR RES PROTOC, V10, DOI 10.2196/23545; He CH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-273; Health Department of ENTP, 2017, REGULATION GOVERNOR; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Indonesia Ministry of Health, 2017, GUIDELINES IMPLEMENT; Indonesia Ministry of Health, 2020, CURRENT DEV SITUATIO; Indonesia Ministry of Health, 2019, NATL REPORT BASIC HL; Indonesia Ministry of Health, 2013, BAS HLTH RES RISK 20; Ipa M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232909; Kanyangarara M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2178-8; Lorga T, 2013, INT J GEN MED, V6, P519, DOI 10.2147/IJGM.S44902; Lu SH, 2009, INT J TUBERC LUNG D, V13, P1493; Mading M., 2014, J HLTH ECOLOGY, V13, P279; Manana PN, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4583-2; Ministry of Health of the Slovak Republic, 2009, DECR MIN HLTH SLOV R; Munisi DZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220501; Naing PA, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0070-9; National health and family planning commission of the People's Republic of China, 2010, ACTION PLAN CHINA MA; National Population and Family Planning Board Statistics Indonesia Ministry of Health ICF, 2018, INDONESIA DEMOGRAPHI; Nejati Jalil, 2018, J Parasit Dis, V42, P62, DOI 10.1007/s12639-017-0965-8; Patanduk Y., 2019, EVALUATION INSECTICI; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Roll Back Malaria Partnership, 2008, GLOBAL MALARIA ACTIO; Saha A, 2019, CURR CANCER RES, P1, DOI [10.1007/978-3-030-04155-7_1, 10.1186/s12936-019-2849-0]; Sanjana P, 2006, AM J TROP MED HYG, V75, P783, DOI 10.4269/ajtmh.2006.75.783; Singh MP, 2020, J BIOSOC SCI, V52, P317, DOI 10.1017/S0021932019000440; Sixpence A, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03294-6; Soleimani-Ahmadi M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-511; Spjeldnaes AO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-200; Syafruddin D, 2014, AM J TROP MED HYG, V91, P1079, DOI 10.4269/ajtmh.13-0735; Tang SF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1428-x; Tanjung N, 2019, INDIAN J PUBLIC HLTH, V10, P416, DOI [10.5958/0976-5506.2019.00530.8, DOI 10.5958/0976-5506.2019.00530.8]; Thaha RM, 2014, INT J HLTH SCI RES, V4, P188; The Central Bureau of Statistics East Nusa Tenggara Province, 2020, NUSA TENGGARA TIMUR; The Central Bureau of Statistics Indonesia, 2016, STAT MIGRATION NUSA; The Central Bureau of Statistics Indonesia, 2016, STAT MIGRATION INDON; The Central Bureau of Statistics Indonesia, INDONESIAN TOTAL POP; Tong SL, 2001, ANN EPIDEMIOL, V11, P38, DOI 10.1016/S1047-2797(00)00176-9; Trapsilowati W., 2018, J VECTOR BORNE DIS S, V10, P9; van Eer ED, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2204-x; Vilay P, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0138-9; Wangdi K, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2783-y; Whittaker M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0931-9; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2018, WORLD MAL REP 2018; Willa RW., 2013, J HLTH ECOLOGY, V12, P34; World Health Organization, 2015, WORLD MAL REP 2015; World health Organization, 2015, GLOBAL TECHNICAL STR; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization. Regional Office for the Eastern Mediterranean, 2017, REGIONAL ACTION PLAN; Yadav S. P., 2013, Southern African Journal of Epidemiology & Infection, V28, P41; Yasuoka J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6123-0; Yin JH, 2015, J INFECT DEV COUNTR, V9, P416, DOI 10.3855/jidc.5307; Yulidar WilyaV., 2016, J HLTH EPIDEMIOLOGY, V2, P28; Zafar SN, 2013, WORLD J SURG, V37, P1470, DOI 10.1007/s00268-012-1732-8; Zhang SS, 2018, MALARIA ELIMINATION, P233, DOI [DOI 10.5772/INTECHOPEN.77282, 10.5772/intechopen.77282]	76	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259950	10.1371/journal.pone.0259950	http://dx.doi.org/10.1371/journal.pone.0259950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780554	Green Published, Green Submitted, gold			2022-12-26	WOS:000755305800072
J	Hassler, EM; Deutschmann, H; Almer, G; Renner, W; Mangge, H; Herrmann, M; Leber, S; Michenthaler, M; Staszewski, A; Gunzer, F; Partl, R; Reishofer, G				Hassler, Eva Maria; Deutschmann, Hannes; Almer, Gunter; Renner, Wilfried; Mangge, Harald; Herrmann, Markus; Leber, Stefan; Michenthaler, Manuela; Staszewski, Alexander; Gunzer, Felix; Partl, Richard; Reishofer, Gernot			Distribution of subcutaneous and intermuscular fatty tissue of the mid-thigh measured by MRI-A putative indicator of serum adiponectin level and individual factors of cardio-metabolic risk	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; INSULIN SENSITIVITY; CHOLESTEROL EFFLUX; ACID OXIDATION; MUSCLE; LEPTIN; RESISTANCE; OBESITY; ASSOCIATIONS; EXPRESSION	Obesity and metabolic syndrome (MetS) are associated with hypoadiponectinemia. On the contrary, studies revealed correlations between the amount of subcutaneous adipose tissue (SAT) and higher serum adiponectin levels. Furthermore, independent association of intermuscular adipose tissue (IMAT) deposit in the thigh with cardiometabolic risk factors (including total blood cholesterol, low-density lipoprotein (LDL), and triglycerides), and decreased insulin sensitivity, as MetS components, are sufficiently described. The combined relationship of thigh IMAT and SAT with serum adiponectin, leptin levels, and cardiometabolic risk factors have not been investigated till date. Since both SAT and IMAT play a role in fat metabolism, we hypothesized that the distribution pattern of SAT and IMAT in the mid-thigh might be related to adiponectin, leptin levels, and serum lipid parameters. We performed adipose tissue quantification using magnetic resonance imaging (MRI) of the mid-thigh in 156 healthy volunteers (78 male/78 female). Laboratory measurements of lipid panel, serum adiponectin, and leptin levels were conducted. Total serum adiponectin level showed a significant correlation with the percentage of SAT of the total thigh adipose tissue (SAT/ (IMAT+SAT)) for the whole study population and in sex-specific analysis. Additionally, SAT/(IMAT+SAT) was negatively correlated with known cardiometabolic risk factors such as elevated total blood cholesterol, LDL, and triglycerides; but positively correlated with serum high-density lipoprotein. In multiple linear regression analysis, (SAT/(IMAT+SAT)) was the most strongly associated variable with adiponectin. Interestingly, leptin levels did not show a significant correlation with this ratio. Adipose tissue distribution in the mid-thigh is not only associated to serum adiponectin levels, independent of sex. This proposed quantitative parameter for adipose tissue distribution could be an indicator for individual factors of a person`s cardiometabolic risk and serve as additional non-invasive imaging marker to ensure the success of lifestyle interventions.	[Hassler, Eva Maria; Deutschmann, Hannes; Leber, Stefan; Michenthaler, Manuela; Gunzer, Felix] Med Univ Graz, Dept Radiol, Div Neuroradiol Vasc & Intervent Radiol, Graz, Austria; [Almer, Gunter; Renner, Wilfried; Mangge, Harald; Herrmann, Markus] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Mangge, Harald; Reishofer, Gernot] BioTechMed Graz, Graz, Austria; [Staszewski, Alexander; Reishofer, Gernot] Med Univ Graz, Dept Radiol, Graz, Austria; [Partl, Richard] Med Univ Graz, Dept Therapeut Radiol & Oncol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Reishofer, G (corresponding author), BioTechMed Graz, Graz, Austria.; Reishofer, G (corresponding author), Med Univ Graz, Dept Radiol, Graz, Austria.	gernot.reishofer@medunigraz.at	Reishofer, Gernot/E-9215-2011	Reishofer, Gernot/0000-0002-3068-6475; Mangge, Harald/0000-0003-4067-247X				Ahlstrom P, 2017, J MOL ENDOCRINOL, V59, P339, DOI 10.1530/JME-17-0096; Bakhtiarizadeh MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45665-3; Bergia RE, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/2751250; Bidulescu A, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-9; Boettcher M, 2009, J MAGN RESON IMAGING, V29, P1340, DOI 10.1002/jmri.21754; Chait A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00022; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Dube MC, 2011, OBESITY, V19, P953, DOI 10.1038/oby.2010.348; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; Fang H, 2018, COMPR PHYSIOL, V8, P1031, DOI 10.1002/cphy.c170046; Feng XL, 2018, MUSCLE NERVE, V58, P536, DOI 10.1002/mus.26169; Fisher FM, 2002, HORM METAB RES, V34, P650, DOI 10.1055/s-2002-38246; Frederiksen L, 2009, J CLIN ENDOCR METAB, V94, P4010, DOI 10.1210/jc.2009-0980; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Friedman JM, 2019, NAT METAB, V1, P754, DOI 10.1038/s42255-019-0095-y; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gallagher D, 2005, AM J CLIN NUTR, V81, P903, DOI 10.1093/ajcn/81.4.903; Goodpaster BH, 2000, AM J CLIN NUTR, V71, P885; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Goss AM, 2012, METABOLISM, V61, P1817, DOI 10.1016/j.metabol.2012.05.016; Grimm A, 2018, EUR J RADIOL, V103, P57, DOI 10.1016/j.ejrad.2018.04.011; Guenther M, 2014, TRANSL RES, V164, P270, DOI 10.1016/j.trsl.2014.04.008; Hafiane A, 2019, METABOLISM, V100, DOI 10.1016/j.metabol.2019.153953; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kelly S.D., ASIA PAC J CLIN NUTR, DOI [10.3316/informit.682420607164472, DOI 10.3316/INFORMIT.682420607164472]; Kovacova Z, 2012, INT J OBESITY, V36, P1360, DOI 10.1038/ijo.2011.223; Kwon H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09723-y; Lemieux S, 2011, CLIN ENDOCRINOL, V74, P340, DOI 10.1111/j.1365-2265.2010.03933.x; Li BJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4747-1; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Mangge H, 2015, ALIMENT PHARM THER, V42, P99, DOI 10.1111/apt.13232; Mangge H, 2010, CURR MED CHEM, V17, P4511, DOI 10.2174/092986710794183006; Mangge H, 2008, OBESITY, V16, P2578, DOI 10.1038/oby.2008.439; Mangge H, 2009, ATHEROSCLEROSIS, V203, P277, DOI 10.1016/j.atherosclerosis.2008.06.013; Marsche G, 2017, J CLIN ENDOCR METAB, V102, P4117, DOI 10.1210/jc.2017-00933; Mercuri E, 2003, NEUROMUSCULAR DISORD, V13, P554, DOI 10.1016/S0960-8966(03)00091-9; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Muller W, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095641; Olczyk P, 2017, MOLECULES, V22, DOI 10.3390/molecules22081274; Pilz S, 2005, J CLIN ENDOCR METAB, V90, P4792, DOI 10.1210/jc.2005-0167; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P4277, DOI 10.1210/jc.2006-0836; Pilz S, 2006, STROKE, V37, P1642, DOI 10.1161/01.STR.0000227260.24490.56; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Reneau J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198889; Roman JH, 2020, GASTROENTEROL CLIN N, V49, P95, DOI 10.1016/j.gtc.2019.10.001; Sachs S, 2019, AM J PHYSIOL-ENDOC M, V316, pE866, DOI 10.1152/ajpendo.00243.2018; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scuteri A, 2015, EUR J PREV CARDIOL, V22, P486, DOI 10.1177/2047487314525529; Sparrenberger K, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0435-9; Tore F., 2007, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V7, P149, DOI 10.2174/187152207780363712; Wang M, 2013, ATHEROSCLEROSIS, V229, P62, DOI 10.1016/j.atherosclerosis.2013.01.017; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yanai H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051190; Yang LL, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1168-3; Yim JE, 2007, INT J OBESITY, V31, P1400, DOI 10.1038/sj.ijo.0803621; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; Zhang R, 2017, BRIT POULTRY SCI, V58, P151, DOI 10.1080/00071668.2016.1268252; Zhang YY, 2018, COMPR PHYSIOL, V8, P351, DOI 10.1002/cphy.c160041	63	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259952	10.1371/journal.pone.0259952	http://dx.doi.org/10.1371/journal.pone.0259952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780545	Green Published, gold			2022-12-26	WOS:000755305800073
J	Rees, N; Howitt, J; Breyley, N; Geoghegan, P; Powel, C				Rees, Nigel; Howitt, Jeremy; Breyley, Nigel; Geoghegan, Phil; Powel, Carl			A simulation study of drone delivery of Automated External Defibrillator (AED) in Out of Hospital Cardiac Arrest (OHCA) in the UK	PLOS ONE			English	Article							RESUSCITATION	Background Drones are increasingly used in healthcare, and feasibility studies of deployment of Automated External Defibrillators (AED) in Out-of-hospital cardiac arrest (OHCA) have been conducted. Despite the potential contribution of drones to healthcare, regulatory barriers exist, including limits on flights beyond visual line-of-sight (BVLOS). The aim of this project was to deliver an AED BVLOS in Wales. Methods We developed of a Concept of Operations (CONOPS) to identify requirements, constraints, organisation and roles and responsibilities associated with deploying a drone to deliver an AED BVLOS. We equipped a Penguin B drone with satellite-enabled technology to enhance situational awareness and safety for the remote pilot. A BVLOS Operating Safety Case and three-week flight test programme was conducted with an AED attached directly to parachute for deployment to simulated OHCA. Results We completed six flights totalling 92km, 1:02.5 hours of flight time and four successful parachute payload drops. We conducted a successful end-to-end flight demonstration of an AED delivered via BVLOS by drone to a simulated OHCA and resuscitation by lay responder's in a remote location; the final delivery of 4.5km was completed in 2:50 minutes. Conclusion We have delivered an AED by parachute, from fixed wing drone BVLOS in the UK in simulated OHCA. This project adds to the body of knowledge required for regulatory assurance on drone use BVLOS. Further research is needed before routine use of this technology.	[Rees, Nigel; Powel, Carl] Swansea Univ, Pre Hosp Emergency Res Unit PERU, Inst Life Sci, Welsh Ambulance Serv NHS Trust WAST, Singleton Pk, Swansea, W Glam, Wales; [Howitt, Jeremy] Cadair Consulting Ltd, Bristol, Avon, England; [Breyley, Nigel] Cyclops Air Cyclops Air Ltd, Lincoln, England; [Geoghegan, Phil] SwiftFlight Av Ltd, Altrincham, England	Swansea University	Rees, N (corresponding author), Swansea Univ, Pre Hosp Emergency Res Unit PERU, Inst Life Sci, Welsh Ambulance Serv NHS Trust WAST, Singleton Pk, Swansea, W Glam, Wales.	nigel.rees5@wales.nhs.uk		Rees, Nigel/0000-0001-8799-5335	UK Space Agency; Snowdonia Aerospace LLP; Swiftflight Avionics Ltd.; University of Manchester	UK Space Agency; Snowdonia Aerospace LLP; Swiftflight Avionics Ltd.; University of Manchester	The project was 80% funded by the UK Space Agency and 20% funded by Snowdonia Aerospace LLP, Swiftflight Avionics Ltd. and the University of Manchester. UK Space Agency did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OUT HOSP CARDIAC ARR; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Cheskes S, 2019, CIRCULATION, V140, DOI 10.1161/circ.140.suppl_2.147; Civil Aviation Authority, 2016, GUIDANCE FLYING DRON; Civil Aviation Authority, 2019, VISUAL LINE SIGHT BV; Civil Aviation Authority, 2019, INNOVATION HUB VISUA; Claesson A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0313-5; Claesson A, 2017, JAMA-J AM MED ASSOC, V317, P2332, DOI 10.1001/jama.2017.3957; Deakin CD, 2014, HEART, V100, P619, DOI 10.1136/heartjnl-2013-305030; Fancher J.C., 2017, FAC WORCEST POLYTECH, V1, P1; Grasner JT, 2011, RESUSCITATION, V82, P989, DOI 10.1016/j.resuscitation.2011.02.047; Guner S., 2017, AVIATION, V1, P1; Haidari LA, 2016, VACCINE, V34, P4062, DOI 10.1016/j.vaccine.2016.06.022; HRA, 2019, HLTH RES AUTHORITY I; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; Mackle C, 2020, IEEE J TRANSL ENG HE, V8, DOI 10.1109/JTEHM.2020.2987008; NHS England, 2018, AMBULANCE RESPONSE P; NHS England, 2015, AMBULANCE QUALITY IN; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Pulver A, 2016, PREHOSP EMERG CARE, V20, P378, DOI 10.3109/10903127.2015.1115932; Rosamond WD, 2020, NEW ENGL J MED, V383, P1186, DOI 10.1056/NEJMc1915956; Sanfridsson J, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0622-6; SAS, 2019, SCOTTISH AMBULANCE S; Starks M.A., 2020, JACC, V75; Taniguchi D, 2012, EMERG MED CLIN N AM, V30, P1, DOI 10.1016/j.emc.2011.09.003; Thiels Cornelius A, 2015, Air Med J, V34, P104, DOI 10.1016/j.amj.2014.10.011; Van de Voorde P, 2017, RESUSCITATION, V116, P46, DOI 10.1016/j.resuscitation.2017.04.037; WG, 2019, AMBULANCE SERVICES W; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zegre-Hemsey JK, 2020, RESUSCITATION, V157, P83, DOI 10.1016/j.resuscitation.2020.10.006	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259555	10.1371/journal.pone.0259555	http://dx.doi.org/10.1371/journal.pone.0259555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780477	gold, Green Published			2022-12-26	WOS:000755305800031
J	Silva, V; Alaoui, A; Schlunssen, V; Vested, A; Graumans, M; van Dael, M; Trevisan, M; Suciu, N; Mol, H; Beekmann, K; Figueiredo, D; Harkes, P; Hofman, J; Kandeler, E; Abrantes, N; Campos, I; Martinez, MA; Pereira, JL; Goossens, D; Gandrass, J; Debler, F; Lwanga, EH; Jonker, M; van Langevelde, F; Sorensen, MT; Wells, JM; Boekhorst, J; Huss, A; Mandrioli, D; Sgargi, D; Nathanail, P; Nathanail, J; Tamm, L; Fantke, P; Mark, J; Grovermann, C; Frelih-Larsen, A; Herb, I; Chivers, CA; Mills, J; Alcon, F; Contreras, J; Baldi, I; Paskovic, I; Matjaz, G; Norgaard, T; Aparicio, V; Ritsema, CJ; Geissen, V; Scheepers, PTJ				Silva, Vera; Alaoui, Abdallah; Schlunssen, Vivi; Vested, Anne; Graumans, Martien; van Dael, Maurice; Trevisan, Marco; Suciu, Nicoleta; Mol, Hans; Beekmann, Karsten; Figueiredo, Daniel; Harkes, Paula; Hofman, Jakub; Kandeler, Ellen; Abrantes, Nelson; Campos, Isabel; Martinez, Maria Angeles; Pereira, Joana Luisa; Goossens, Dirk; Gandrass, Juergen; Debler, Freya; Lwanga, Esperanza Huerta; Jonker, Marlot; van Langevelde, Frank; Sorensen, Martin T.; Wells, Jerry M.; Boekhorst, Jos; Huss, Anke; Mandrioli, Daniele; Sgargi, Daria; Nathanail, Paul; Nathanail, Judith; Tamm, Lucius; Fantke, Peter; Mark, Jennifer; Grovermann, Christian; Frelih-Larsen, Ana; Herb, Irina; Chivers, Charlotte-Anne; Mills, Jane; Alcon, Francisco; Contreras, Josefina; Baldi, Isabelle; Paskovic, Igor; Matjaz, Glavan; Norgaard, Trine; Aparicio, Virginia; Ritsema, Coen J.; Geissen, Violette; Scheepers, Paul T. J.			Collection of human and environmental data on pesticide use in Europe and Argentina: Field study protocol for the SPRINT project	PLOS ONE			English	Article							AGRICULTURAL SOILS; EXPOSURE; RESIDUES; RISK; CHROMATOGRAPHY; UNCERTAINTY	Current farm systems rely on the use of Plant Protection Products (PPP) to secure high productivity and control threats to the quality of the crops. However, PPP use may have considerable impacts on human health and the environment. A study protocol is presented aiming to determine the occurrence and levels of PPP residues in plants (crops), animals (livestock), humans and other non-target species (ecosystem representatives) for exposure modelling and impact assessment. To achieve this, we designed a cross-sectional study to compare conventional and organic farm systems across Europe. Environmental and biological samples were/are being/will be collected during the 2021 growing season, at 10 case study sites in Europe covering a range of climate zones and crops. An additional study site in Argentina will inform the impact of PPP use on growing soybean which is an important European protein-source in animal feed. We will study the impact of PPP mixtures using an integrated risk assessment methodology. The fate of PPP in environmental media (soil, water and air) and in the homes of farmers will be monitored. This will be complemented by biomonitoring to estimate PPP uptake by humans and farm animals (cow, goat, sheep and chicken), and by collection of samples from non-target species (earthworms, fish, aquatic and terrestrial macroinvertebrates, bats, and farm cats). We will use data on PPP residues in environmental and biological matrices to estimate exposures by modelling. These exposure estimates together with health and toxicity data will be used to predict the impact of PPP use on environment, plant, animal and human health. The outcome of this study will then be integrated with socio-economic information leading to an overall assessment used to identify transition pathways towards more sustainable plant protection and inform decision makers, practitioners and other stakeholders regarding farming practices and land use policy.	[Silva, Vera; Harkes, Paula; Goossens, Dirk; Lwanga, Esperanza Huerta; Ritsema, Coen J.; Geissen, Violette] Wageningen Univ & Res, Soil Phys & Land Management Grp, Wageningen, Netherlands; [Alaoui, Abdallah] Univ Bern, Inst Geog, Bern, Switzerland; [Alaoui, Abdallah] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Schlunssen, Vivi; Vested, Anne] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Schlunssen, Vivi] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Graumans, Martien; van Dael, Maurice; Scheepers, Paul T. J.] Radboudumc, Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Trevisan, Marco; Suciu, Nicoleta] Univ Cattolica Sacro Cuore, Dept Sustainable Food Proc DISTAS, Piacenza, Italy; [Mol, Hans; Beekmann, Karsten] Wageningen Univ & Res, Wageningen Food Safety Res, Wageningen, Netherlands; [Figueiredo, Daniel; Huss, Anke] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Hofman, Jakub] Masaryk Univ, Fac Sci, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Kandeler, Ellen] Univ Hohenheim, Inst Soil Sci & Land Evaluat, Soil Biol Dept, Stuttgart, Germany; [Abrantes, Nelson; Campos, Isabel; Pereira, Joana Luisa] Univ Aveiro, Ctr Environm & Marine Studies, Aveiro, Portugal; [Abrantes, Nelson; Campos, Isabel] Univ Aveiro, Dept Environm & Planning, Aveiro, Portugal; [Martinez, Maria Angeles] Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain; [Pereira, Joana Luisa] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Goossens, Dirk] KU Leuven Dept Earth & Environm Sci, Geoinst, Celestijnenlaan, Leuven, Belgium; [Gandrass, Juergen; Debler, Freya] Helmholtz Zentrum Hereon, Inst Coastal Environm Chem, Organ Environm Chem, Geesthacht, Germany; [Jonker, Marlot] Dutch Mammal Soc, Nijmegen, Netherlands; [van Langevelde, Frank] Wageningen Univ & Res, Wildlife Ecol & Conservat Grp, Wageningen, Netherlands; [Sorensen, Martin T.] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark; [Wells, Jerry M.; Boekhorst, Jos] Wageningen Univ & Res, Anim Sci Grp, Host Microbe Interact, Wageningen, Netherlands; [Mandrioli, Daniele; Sgargi, Daria] Cesare Maltoni Canc Res Ctr, Ramazzini Inst, Bologna, Italy; [Nathanail, Paul; Nathanail, Judith] Land Qual Management LQM, Nottingham, England; [Tamm, Lucius; Mark, Jennifer; Grovermann, Christian] Res Inst Organ Agr FIBL, Frick, Switzerland; [Fantke, Peter] Tech Univ Denmark, Dept Technol Management & Econ, Quantitat Sustainabil Assessment, Lyngby, Denmark; [Frelih-Larsen, Ana; Herb, Irina] Ecol Inst, Berlin, Germany; [Chivers, Charlotte-Anne; Mills, Jane] Univ Gloucestershire, Countryside & Community Res Inst, Cheltenham, Glos, England; [Alcon, Francisco; Contreras, Josefina] Univ Politecn Cartagena, Cartagena, Spain; [Baldi, Isabelle] Bordeaux Univ, EPICENE Team, INSERM U1219, Nouvelle Aquitaine, France; [Paskovic, Igor] Inst Agr & Tourism, Dept Agr & Nutr, Porec, Croatia; [Matjaz, Glavan] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Norgaard, Trine] Aarhus Univ, Dept Agroecol, Aarhus, Denmark; [Aparicio, Virginia] Inst Nacl Tecnol Agr INTA, Buenos Aires, DF, Argentina	Wageningen University & Research; University of Bern; University of Bern; Aarhus University; National Research Centre for the Working Environment; Radboud University Nijmegen; Catholic University of the Sacred Heart; Wageningen University & Research; Utrecht University; Masaryk University Brno; University Hohenheim; Universidade de Aveiro; Universidade de Aveiro; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Universidade de Aveiro; KU Leuven; Wageningen University & Research; Aarhus University; Animal Sciences Group of Wageningen UR; Wageningen University & Research; Technical University of Denmark; University of Gloucestershire; Universidad Politecnica de Cartagena; Institut National de la Sante et de la Recherche Medicale (Inserm); Institute of Agriculture & Tourism Porec; University of Ljubljana; Aarhus University; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Scheepers, PTJ (corresponding author), Radboudumc, Radboud Inst Hlth Sci, Nijmegen, Netherlands.	Paul.Scheepers@radboudumc.nl	Pereira, Joana Luísa/A-5003-2009; Nørgaard, Trine/C-5646-2015; Fantke, Peter/N-2704-2015; Fantke, Peter/N-3617-2019; BALDI, Isabelle/T-1465-2019; de los Ángeles Martínez, María/L-1722-2014; Fantke, Peter/GRO-6285-2022; Paskovic, Igor/S-5153-2018; Campos, Isabel/T-7099-2017; Abrantes, Nelson/C-5331-2009	Pereira, Joana Luísa/0000-0001-7573-6184; Nørgaard, Trine/0000-0001-7669-3841; Fantke, Peter/0000-0001-7148-6982; BALDI, Isabelle/0000-0003-0738-2673; de los Ángeles Martínez, María/0000-0002-3927-3183; Fantke, Peter/0000-0001-7148-6982; Silva, Vera/0000-0002-9511-6588; Boekhorst, Jos/0000-0002-4807-7838; Graumans, Martien H.F./0000-0002-3003-6632; van Dael, Maurice/0000-0003-3905-6485; Paskovic, Igor/0000-0002-3937-3926; Chivers, Charlotte-Anne/0000-0002-5171-2484; Campos, Isabel/0000-0001-7975-8954; Martins Figueiredo, Daniel/0000-0001-6080-0956; Suciu, Nicoleta Alina/0000-0002-3183-4169; Mills, Jane/0000-0003-3835-3058; Abrantes, Nelson/0000-0003-0241-2896; Gandrass, Juergen/0000-0001-6083-4494; Schlunssen, Vivi/0000-0003-4915-1734	European Union [862568]	European Union(European Commission)	The SPRINT project leading to this publication has received funding from the European Union's Horizon 2020 Programme for research & innovation under grant agreement no 862568.	Aerts R, 2018, ENVIRON SCI TECHNOL, V52, P298, DOI 10.1021/acs.est.7b05039; Alengebawy A, 2021, TOXICS, V9, DOI 10.3390/toxics9030042; Arbuckle TE, 2006, J EXPO SCI ENV EPID, V16, P98, DOI 10.1038/sj.jea.7500441; Bedi JS, 2018, J ANIM FEED SCI, V27, P18, DOI 10.22358/jafs/82623/2018; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Boithias L, 2014, CHEMOSPHERE, V99, P134, DOI 10.1016/j.chemosphere.2013.10.050; Carvalho FP, 2017, FOOD ENERGY SECUR, V6, P48, DOI 10.1002/fes3.108; Casado J, 2019, SCI TOTAL ENVIRON, V670, P1204, DOI 10.1016/j.scitotenv.2019.03.207; Chovanec A, 2003, TRACE METALS OTHER, V6, P639; Ciffroy P, 2016, SCI TOTAL ENVIRON, V568, P770, DOI 10.1016/j.scitotenv.2016.03.191; Dhingra N, 2010, WB, V381; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3874; EUROSTAT, PEST SAL; Figueiredo D.M., 2021, ATMOS ENVIRON, V262; Figueiredo DM, 2021, JMIR RES PROTOC, V10, DOI 10.2196/27883; FOCUS, 2008, SANCO105532006 FOCUS; Geissen V, 2021, ENVIRON POLLUT, V278, DOI 10.1016/j.envpol.2021.116827; Guvvala PR, 2020, ENVIRON SCI POLLUT R, V27, P3819, DOI 10.1007/s11356-019-06980-4; Hauck M, 2011, ENVIRON TOXICOL CHEM, V30, P403, DOI 10.1002/etc.393; Hofmann F, 2020, 29092020 TIEM; Kim SK, 2020, ENVIRON ENG RES, V25, P43, DOI 10.4491/eer.2019.003; Letinois L, 2020, LCSQA INERIS DRC 20; MacLachlan DJ, 2009, ANIM FEED SCI TECH, V149, P307, DOI 10.1016/j.anifeedsci.2008.06.007; Marsala RZ, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139730; Medina-Pastor P, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.6057; Mol HGJ, 2016, ANAL CHIM ACTA, V935, P161, DOI 10.1016/j.aca.2016.06.017; Mol JGJ., 2014, 2014006 RIKILT; Nag SK, 2011, ENVIRON MONIT ASSESS, V174, P327, DOI 10.1007/s10661-010-1460-1; Nishioka MG, 2001, ENVIRON HEALTH PERSP, V109, P1185, DOI 10.2307/3454867; O'Connell SG, 2014, ENVIRON SCI TECHNOL, V48, P3327, DOI 10.1021/es405022f; Oerlemans A, 2021, ENVIRON RES, V199, DOI 10.1016/j.envres.2021.111282; Oliveira J. M., 2021, Braz. J. Biol., V81, P499, DOI 10.1590/1519-6984.225330; Palma P, 2015, ENVIRON SCI POLLUT R, V22, P7665, DOI 10.1007/s11356-015-4390-1; Pelosi C, 2021, AGR ECOSYST ENVIRON, V305, DOI 10.1016/j.agee.2020.107167; Pelosi C, 2014, AGRON SUSTAIN DEV, V34, P199, DOI 10.1007/s13593-013-0151-z; Popp J, 2013, AGRON SUSTAIN DEV, V33, P243, DOI 10.1007/s13593-012-0105-x; PPDB, PESTICIDE PROPERTIES; Riedo J, 2021, ENVIRON SCI TECHNOL, V55, P2919, DOI 10.1021/acs.est.0c06405; Roeben V, 2020, SCI TOTAL ENVIRON, V722, DOI 10.1016/j.scitotenv.2020.137673; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sabatier P, 2014, P NATL ACAD SCI USA, V111, P15647, DOI 10.1073/pnas.1411512111; Salomons W., 2004, CONTAMINATED SEDIMEN; Silva V, 2019, SCI TOTAL ENVIRON, V653, P1532, DOI 10.1016/j.scitotenv.2018.10.441; Socorro J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33456; Stout DM, 2000, J ENVIRON SCI HEAL B, V35, P477, DOI 10.1080/03601230009373284; Streit Bruno, 1998, EXS, V86, P353; Suciu NA, 2019, TRENDS FOOD SCI TECH, V84, P49, DOI 10.1016/j.tifs.2018.12.008; U.S. EPA, 2000, GUIDELINES ASSESSING, V1; van Langevelde F, 2020, ECOL APPL, V30, DOI 10.1002/eap.2019; Wagner DL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023989118; Wee SY, 2017, CHEMOSPHERE, V188, P575, DOI 10.1016/j.chemosphere.2017.09.035; WFSR, 2021, VUURWERKAANKOOP ENGE; Yang C, 2021, PESTIC BIOCHEM PHYS, V175, DOI 10.1016/j.pestbp.2021.104850; Zomer P, 2015, FOOD ADDIT CONTAM A, V32, P1628, DOI 10.1080/19440049.2015.1085652	54	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259748	10.1371/journal.pone.0259748	http://dx.doi.org/10.1371/journal.pone.0259748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780516	Green Accepted, Green Published, gold			2022-12-26	WOS:000755305800045
J	Madiha, S; Batool, Z; Tabassum, S; Liaquat, L; Sadir, S; Shahzad, S; Naqvi, F; Saleem, S; Yousuf, S; Nawaz, A; Ahmad, S; Sajid, I; Afzal, A; Haider, S				Madiha, Syeda; Batool, Zehra; Tabassum, Saiqa; Liaquat, Laraib; Sadir, Sadia; Shahzad, Sidrah; Naqvi, Fizza; Saleem, Sadia; Yousuf, Sarwat; Nawaz, Amber; Ahmad, Saara; Sajid, Irfan; Afzal, Asia; Haider, Saida			Quercetin exhibits potent antioxidant activity, restores motor and non-motor deficits induced by rotenone toxicity	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; PESTICIDE EXPOSURE; COGNITIVE DECLINE; MEMORY DEFICITS; DEPRESSIVE-LIKE; CELL-DEATH; RAT MODEL; SYMPTOMS	The rotenone-induced animal model of Parkinson's disease (PD) has been used to investigate the pathogenesis of PD. Oxidative stress is one of the main contributors of neurodegeneration in PD. Flavonoids have the potential to modulate neuronal function and combat various neurodegenerative diseases. The pre- and post-supplementation of quercetin (50 mg/kg, p.o) was done in rats injected with rotenone (1.5 mg/kg, s.c). After the treatment, behavioral activities were monitored for motor activity, depression-like behavior, and cognitive changes. Rats were decapitated after behavioral analysis and the brain samples were dissected out for neurochemical and biochemical estimation. Results showed that supplementation of quercetin significantly (p<0.01) restored rotenone-induced motor and nonmotor deficits (depression and cognitive impairments), enhanced antioxidant enzyme activities (p<0.01), and attenuated neurotransmitter alterations (p<0.01). It is suggested that quercetin supplementation improves neurotransmitter levels by mitigating oxidative stress via increasing antioxidant enzyme activity and hence improves motor activity, cognitive functions, and reduces depressive behavior. The results of the present study showed that quercetin pre-supplementation produced more significant results as compared to post-supplementation. These findings show that quercetin can be a potential therapeutic agent to reduce the risk and progression of PD.	[Madiha, Syeda; Sadir, Sadia; Shahzad, Sidrah; Naqvi, Fizza; Saleem, Sadia; Yousuf, Sarwat; Afzal, Asia; Haider, Saida] Univ Karachi, Dept Biochem, Neurochem & Biochem Neuropharmacol Res Unit, Karachi, Pakistan; [Batool, Zehra] Univ Karachi, Dr Panjwani Ctr Mol Med & Drug Res, Int Ctr Chem & Biol Sci, Karachi, Pakistan; [Tabassum, Saiqa] Shaheed Zulfiqar Ali, Bhutto Inst Sci & Technol Szabist, Dept Biosci, Fac Life Sci, Karachi, Pakistan; [Liaquat, Laraib] Bahria Univ, Med & Dent Coll, Multidisciplinary Res Lab, Karachi, Pakistan; [Shahzad, Sidrah] PNS Shifa, Pakistan Navy Med Training Sch & Coll, Karachi, Pakistan; [Nawaz, Amber] Sir Syed Univ Engn & Technol, Dept Biomed Engn, Karachi, Pakistan; [Ahmad, Saara] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Sajid, Irfan] Fed Urdu Univ Arts Sci & Technol, Dept Biochem, Karachi, Pakistan	University of Karachi; University of Karachi; Sir Syed University of Engineering & Technology; Aga Khan University; Federal Urdu University of Arts Science & Technology	Haider, S (corresponding author), Univ Karachi, Dept Biochem, Neurochem & Biochem Neuropharmacol Res Unit, Karachi, Pakistan.	saida-h1@hotmail.com			Higher Education Commission, Pakistan [NRPU-3766]	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	Haider S received financial support from Higher Education Commission, Pakistan (http://www.hec.gov.pk/english/pages/home.aspx), under the approved project NRPU-3766. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JE, 2005, MOVEMENT DISORD, V20, P271, DOI 10.1002/mds.20362; Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; Anandhan A, 2012, BRAIN RES, V1433, P104, DOI 10.1016/j.brainres.2011.11.021; Andrade S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092313; Anjaneyulu Muragundla, 2003, Journal of Medicinal Food, V6, P391; Batool Z, 2016, BRAIN RES BULL, V120, P63, DOI 10.1016/j.brainresbull.2015.11.001; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bhullar KS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/891748; Bocarsly ME, 2012, PHYSIOL BEHAV, V107, P568, DOI 10.1016/j.physbeh.2012.04.024; Bohnen NI, 2011, BEHAV BRAIN RES, V221, P564, DOI 10.1016/j.bbr.2009.12.048; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Checkoway H, 2002, AM J EPIDEMIOL, V155, P732, DOI 10.1093/aje/155.8.732; CHOW CK, 1972, LIPIDS, V7, P518, DOI 10.1007/BF02533017; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Cools R, 2001, CEREB CORTEX, V11, P1136, DOI 10.1093/cercor/11.12.1136; Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796; COSTALL B, 1974, PSYCHOPHARMACOLOGIA, V34, P233, DOI 10.1007/BF00421964; Dai Q, 2006, AM J MED, V119, P751, DOI 10.1016/j.amjmed.2006.03.045; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Das Sanchari, 2008, Curr Aging Sci, V1, P169; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2002, NAT NEUROSCI, V5, P1058, DOI 10.1038/nn941; De Leonibus E, 2009, NEUROPSYCHOPHARMACOL, V34, P729, DOI 10.1038/npp.2008.129; Deffains M, 2015, MOVEMENT DISORD, V30, P1014, DOI 10.1002/mds.26300; El-Horany HE, 2016, J BIOCHEM MOL TOXIC, V30, P360, DOI 10.1002/jbt.21821; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferro MM, 2005, J NEUROSCI METH, V148, P78, DOI 10.1016/j.jneumeth.2005.04.005; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Foltynie T, 2014, ALZHEIMERS DEMENT, V10, pS38, DOI 10.1016/j.jalz.2013.12.005; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; Greenamyre JT, 2010, TRENDS PHARMACOL SCI, V31, P141, DOI 10.1016/j.tips.2009.12.006; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Haider S, 2016, BRAIN RES BULL, V127, P234, DOI 10.1016/j.brainresbull.2016.10.002; Haider S, 2014, AGE, V36, P1291, DOI 10.1007/s11357-014-9653-0; Haleem DJ, 2007, PHARMACOL BIOCHEM BE, V87, P115, DOI 10.1016/j.pbb.2007.04.007; Huebbe P, 2010, PHARMACOL RES, V61, P242, DOI 10.1016/j.phrs.2009.08.006; Iarkov A, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00004; Ishisaka A, 2011, FREE RADICAL BIO MED, V51, P1329, DOI 10.1016/j.freeradbiomed.2011.06.017; German-Ponciano LJ, 2018, SCIENTIFICA, V2018, DOI 10.1155/2018/2963565; Jover R, 2006, HEPATOLOGY, V43, P1257, DOI 10.1002/hep.21180; Karuppagounder SS, 2013, NEUROSCIENCE, V236, P136, DOI 10.1016/j.neuroscience.2013.01.032; Kaur H, 2011, NEUROCHEM RES, V36, P1435, DOI 10.1007/s11064-011-0469-3; Khan H, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010059; KONDZIEL.W, 1964, ARCH INT PHARMACOD T, V152, P277; Lang AE, 2004, ANN NEUROL, V55, P761, DOI 10.1002/ana.20102; Lang AE, 2011, MOVEMENT DISORD, V26, P775, DOI 10.1002/mds.23609; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; Letenneur L, 2007, AM J EPIDEMIOL, V165, P1364, DOI 10.1093/aje/kwm036; Liaquat L., 2016, PAK J BIOCH MOL BIOL, V49, P53; Liaquat L, 2018, LIFE SCI, V194, P213, DOI 10.1016/j.lfs.2017.12.034; Lv CF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/928643; Madiha S, 2019, METAB BRAIN DIS, V34, P297, DOI 10.1007/s11011-018-0352-x; Madiha S, 2018, PAK J ZOOL, V50, P1245, DOI 10.17582/journal.pjz/2018.50.4.1245.1256; Madiha S, 2017, PAK J PHARM SCI, V30, P943; Magalingam KB, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/314560; Manchanda S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1652-0; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; Mazarati A, 2007, EPILEPSY BEHAV, V10, P377, DOI 10.1016/j.yebeh.2007.02.001; Melo KM, 2015, ENVIRON SCI POLLUT R, V22, P13926, DOI 10.1007/s11356-015-4596-2; Michel PP, 2016, NEURON, V90, P675, DOI 10.1016/j.neuron.2016.03.038; Morais LH, 2012, PHARMACOL REP, V64, P1081, DOI 10.1016/S1734-1140(12)70905-2; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Murthy KNC, 2002, J AGR FOOD CHEM, V50, P4791, DOI 10.1021/jf0255735; Nagata Hidetaka, 1999, Tokai Journal of Experimental and Clinical Medicine, V24, P1; Nascimento-Ferreira I, 2013, BRAIN, V136, P2173, DOI 10.1093/brain/awt144; Obeso JA, 2017, MOVEMENT DISORD, V32, P1264, DOI 10.1002/mds.27115; Pezzoli G, 2013, NEUROLOGY, V80, P2035, DOI 10.1212/WNL.0b013e318294b3c8; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Rehman MU, 2019, CURR NEUROPHARMACOL, V17, P247, DOI 10.2174/1570159X16666180911124605; Santiago RM, 2010, PROG NEURO-PSYCHOPH, V34, P1104, DOI 10.1016/j.pnpbp.2010.06.004; Singh S, 2017, NEURAL REGEN RES, V12, P1137, DOI 10.4103/1673-5374.211194; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Solanki I, 2016, NEUROCHEM INT, V95, P100, DOI 10.1016/j.neuint.2015.11.001; Sriraksa N, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/823206; Stempak D, 2001, THER DRUG MONIT, V23, P542, DOI 10.1097/00007691-200110000-00008; Strac DS, 2016, TRANSL NEUROSCI, V7, P35, DOI 10.1515/tnsci-2016-0007; Tanimura A, 2018, EUR J NEUROSCI, V47, P1148, DOI 10.1111/ejn.13638; Tanner CM, 2014, ALZHEIMERS DEMENT, V10, pS213, DOI 10.1016/j.jalz.2014.04.014; Vauzour D, 2008, GENES NUTR, V3, P115, DOI 10.1007/s12263-008-0091-4; Wang YL, 2017, NEUROTOXICOLOGY, V58, P103, DOI 10.1016/j.neuro.2016.11.006; Yanpallewar SU, 2004, PHARMACOL BIOCHEM BE, V79, P155, DOI 10.1016/j.pbb.2004.07.008; Yoshino S, 2011, NUTRITION, V27, P847, DOI 10.1016/j.nut.2010.09.002; Yuan YH, 2015, TOXICOL LETT, V233, P163, DOI 10.1016/j.toxlet.2014.11.029	88	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258928	10.1371/journal.pone.0258928	http://dx.doi.org/10.1371/journal.pone.0258928			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767546	Green Published, gold			2022-12-26	WOS:000755249300017
J	Ota, Y; Kubota, Y; Hotta, Y; Matsumoto, M; Matsuyama, N; Kato, T; Hamakawa, T; Kataoka, T; Kimura, K; Sawamoto, K; Yasui, T				Ota, Yuya; Kubota, Yasue; Hotta, Yuji; Matsumoto, Mami; Matsuyama, Nayuka; Kato, Taiki; Hamakawa, Takashi; Kataoka, Tomoya; Kimura, Kazunori; Sawamoto, Kazunobu; Yasui, Takahiro			Change in the central control of the bladder function of rats with focal cerebral infarction induced by photochemically-induced thrombosis	PLOS ONE			English	Article							URGE INCONTINENCE; STROKE; ISCHEMIA; OVERACTIVITY; BRAIN; MECHANISMS; PLASTICITY; FOREBRAIN; SYMPTOMS; THERAPY	The photochemically-induced thrombosis (photothrombosis) method can create focal cerebral infarcts anywhere in the relatively superficial layers of the cerebrum; it is easy to implement and minimally invasive. Taking advantage of this versatility, we aimed to establish a new rat model of urinary frequency with focal cerebral infarction, which was characterized by its simplicity, nonlethal nature, and high reproducibility. The prefrontal cortex and the anterior cingulate cortex, which are involved in lower urinary tract control, were targeted for focal cerebral infarction, and urinary parameters were measured by cystometrogram. Cystometric analysis indicated that micturition intervals significantly shortened in photothrombosis-treated rats compared with those in the sham operative group on Days 1 and 7 (P < 0.01), but prolonged after 14 days, with no difference between the two groups. Immunopathological evaluation showed an accumulation of activated microglia, followed by an increase in reactive astrocytes at the peri-infarct zone after photothrombotic stroke. Throughout this study, all postphotothrombosis rats showed cerebral infarction in the prefrontal cortex and anterior cingulate cortex; there were no cases of rats with fatal cerebral infarction. This model corresponded to the clinical presentation, in that the micturition status changed after stroke. In conclusion, this novel model combining nonlethality and high reproducibility may be a suitable model of urinary frequency after focal cerebral infarction.	[Ota, Yuya; Kubota, Yasue; Matsuyama, Nayuka; Kato, Taiki; Hamakawa, Takashi; Yasui, Takahiro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Ota, Yuya; Kubota, Yasue; Matsuyama, Nayuka; Kato, Taiki; Hamakawa, Takashi; Kataoka, Tomoya; Kimura, Kazunori; Yasui, Takahiro] Nagoya City Univ, Med Sch, Nagoya, Aichi, Japan; [Kubota, Yasue] Nagoya City Univ, Grad Sch Nursing, Dept Clin Physiol, Nagoya, Aichi, Japan; [Hotta, Yuji; Kimura, Kazunori] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Hosp Pharm, Nagoya, Aichi, Japan; [Matsumoto, Mami; Sawamoto, Kazunobu] Nagoya City Univ, Grad Sch Med Sci, Inst Brain Sci, Dept Dev & Regenerat Neurobiol, Nagoya, Aichi, Japan; [Kataoka, Tomoya; Kimura, Kazunori] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Pharmaceut, Nagoya, Aichi, Japan; [Sawamoto, Kazunobu] Natl Inst Physiol Sci, Div Neural Dev & Regenerat, Okazaki, Aichi, Japan	Nagoya City University; Nagoya City University; Nagoya City University; Nagoya City University; Nagoya City University; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Ota, Y; Kubota, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan.; Ota, Y; Kubota, Y (corresponding author), Nagoya City Univ, Med Sch, Nagoya, Aichi, Japan.; Kubota, Y (corresponding author), Nagoya City Univ, Grad Sch Nursing, Dept Clin Physiol, Nagoya, Aichi, Japan.	y-ota@med.nagoya-cu.ac.jp		Yasui, Takahiro/0000-0003-2197-2477; Kataoka, Tomoya/0000-0001-9683-4680	GSK Japan Research Grant 2019; Japan Society for the Promotion of Science [19k18568]	GSK Japan Research Grant 2019; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by GSK Japan Research Grant 2019 (https://jp.gsk.com/jp/ research/glaxosmithkline-research-grant-2019/) and a grant awarded by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/jgrantsinaid/), Grant Number 19k18568, all to Y.O..	Abolhasanpour N, 2019, INT J UROL, V26, P917, DOI 10.1111/iju.14059; Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P636, DOI 10.1002/nau.21108; ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233; Benedek A, 2006, BRAIN RES, V1116, P159, DOI 10.1016/j.brainres.2006.07.123; Brunkhorst R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070124; Cardozo L, 2013, BJU INT, V111, P804, DOI 10.1111/j.1464-410X.2012.11654.x; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cotrina ML, 2017, NEUROSCIENCE, V343, P483, DOI 10.1016/j.neuroscience.2016.12.012; DasGupta R, 2007, BJU INT, V99, P731, DOI 10.1111/j.1464-410X.2007.06749.x; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Hosseini SM, 2018, J PHARMACOL TOX MET, V94, P77, DOI 10.1016/j.vascn.2018.06.003; Hotta Y, 2020, NEUROUROL URODYNAM, V39, P1922, DOI 10.1002/nau.24449; Kao YCJ, 2014, NEUROBIOL DIS, V71, P131, DOI 10.1016/j.nbd.2014.07.005; Kuhtz-Buschbeck JR, 2009, NEUROIMAGE, V47, P18, DOI 10.1016/j.neuroimage.2009.04.020; Kuroiwa T, 2009, STROKE, V40, P248, DOI 10.1161/STROKEAHA.108.527853; Li HL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-58; Liepert J, 1998, NEUROSCI LETT, V250, P5, DOI 10.1016/S0304-3940(98)00386-3; Liu NW, 2017, TRANSL STROKE RES, V8, P244, DOI 10.1007/s12975-016-0512-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Mares J, 2016, PHYSIOL RES, V65, P853, DOI 10.33549/physiolres.933124; Morrison HW, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-4; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Nagasaka Y, 2007, INT J UROL, V14, P226, DOI 10.1111/j.1442-2042.2007.01700.x; Nakayama H, 1997, STROKE, V28, P58, DOI 10.1161/01.STR.28.1.58; Paxions G., 2013, RAT BRAIN STEREOTAXI; Pyo H, 2017, ANN REHABIL MED-ARM, V41, P935, DOI 10.5535/arm.2017.41.6.935; Sakakibara R, 1996, J NEUROL SCI, V137, P47, DOI 10.1016/0022-510X(95)00322-S; SCHROETER M, 1995, EXP BRAIN RES, V106, P1; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Tsuyama J, 2018, SEMIN IMMUNOPATHOL, V40, P523, DOI 10.1007/s00281-018-0707-8; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Yao H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102123; Yokoyama O, 1998, J UROLOGY, V159, P577, DOI 10.1016/S0022-5347(01)63987-9; Yokoyama O, 1998, J UROLOGY, V159, P571, DOI 10.1016/S0022-5347(01)63986-7; Yokoyama O, 2000, EXP NEUROL, V163, P469, DOI 10.1006/exnr.2000.7391; Yokoyama O, 2001, NEUROPHARMACOLOGY, V41, P629, DOI 10.1016/S0028-3908(01)00102-2; Zachariou A, 2021, CLIN INTERV AGING, V16, P291, DOI 10.2147/CIA.S283737	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0255200	10.1371/journal.pone.0255200	http://dx.doi.org/10.1371/journal.pone.0255200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752461	Green Published, gold			2022-12-26	WOS:000754499700003
J	Wakiya, T; Ishido, K; Kimura, N; Nagase, H; Kubota, S; Fujita, H; Hagiwara, Y; Kanda, T; Matsuzaka, M; Sasaki, Y; Hakamada, K				Wakiya, Taiichi; Ishido, Keinosuke; Kimura, Norihisa; Nagase, Hayato; Kubota, Shunsuke; Fujita, Hiroaki; Hagiwara, Yusuke; Kanda, Taishu; Matsuzaka, Masashi; Sasaki, Yoshihiro; Hakamada, Kenichi			Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree	PLOS ONE			English	Article							PERIOPERATIVE BLOOD-TRANSFUSION; CELL TRANSFUSION; CANCER SURGERY; IMPACT; PANCREATICODUODENECTOMY; SURVIVAL; OUTCOMES; ADENOCARCINOMA; CENTRALIZATION; RESECTION	Massive intraoperative blood loss (IBL) negatively influence outcomes after surgery for pancreatic ductal adenocarcinoma (PDAC). However, few data or predictive models are available for the identification of patients with a high risk for massive IBL. This study aimed to build a model for massive IBL prediction using a decision tree algorithm, which is one machine learning method. One hundred and seventy-five patients undergoing curative surgery for resectable PDAC at our facility between January 2007 and October 2020 were allocated to training (n = 128) and testing (n = 47) sets. Using the preoperatively available data of the patients (34 variables), we built a decision tree classification algorithm. Of the 175 patients, massive IBL occurred in 88 patients (50.3%). Binary logistic regression analysis indicated that alanine aminotransferase and distal pancreatectomy were significant predictors of massive IBL occurrence with an overall correct prediction rate of 70.3%. Decision tree analysis automatically selected 14 predictive variables. The best predictor was the surgical procedure. Though massive IBL was not common, the outcome of patients with distal pancreatectomy was secondarily split by glutamyl transpeptidase. Among patients who underwent PD (n = 83), diabetes mellitus (DM) was selected as the variable in the second split. Of the 21 patients with DM, massive IBL occurred in 85.7%. Decision tree sensitivity was 98.5% in the training data set and 100% in the testing data set. Our findings suggested that a decision tree can provide a new potential approach to predict massive IBL in surgery for resectable PDAC.	[Wakiya, Taiichi; Ishido, Keinosuke; Kimura, Norihisa; Nagase, Hayato; Kubota, Shunsuke; Fujita, Hiroaki; Hagiwara, Yusuke; Kanda, Taishu; Hakamada, Kenichi] Hirosaki Univ, Dept Gastroenterol Surg, Grad Sch Med, Hirosaki, Aomori, Japan; [Matsuzaka, Masashi; Sasaki, Yoshihiro] Hirosaki Univ Hosp, Dept Med Informat, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University; Hiroshima University	Wakiya, T (corresponding author), Hirosaki Univ, Dept Gastroenterol Surg, Grad Sch Med, Hirosaki, Aomori, Japan.	wakiya1979@hirosaki-u.ac.jp	Wakiya, Taiichi/F-4792-2015	Wakiya, Taiichi/0000-0003-3681-7736				Abe T, 2017, ANTICANCER RES, V37, P5863, DOI 10.21873/anticanres.12031; Agha R, 2019, INT J SURG, V72, P156, DOI 10.1016/j.ijsu.2019.11.002; Ahola R, 2019, PANCREATOLOGY, V19, P769, DOI 10.1016/j.pan.2019.06.007; Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Bilimoria KY, 2007, ANN SURG, V246, P173, DOI 10.1097/SLA.0b013e3180691579; Braga M, 2011, ANN SURG, V254, P702, DOI 10.1097/SLA.0b013e31823598fb; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Callery MP, 2013, J AM COLL SURGEONS, V216, P1, DOI 10.1016/j.jamcollsurg.2012.09.002; Casciani F, 2021, SURGERY, V169, P708, DOI 10.1016/j.surg.2020.11.022; de Wilde RF, 2012, BRIT J SURG, V99, P404, DOI 10.1002/bjs.8664; Doi R, 2008, SURG TODAY, V38, P1021, DOI 10.1007/s00595-007-3745-8; Ecker BL, 2016, JAMA SURG, V151, P518, DOI 10.1001/jamasurg.2015.5094; Gooiker GA, 2014, BRIT J SURG, V101, P1000, DOI 10.1002/bjs.9468; Hachey K, 2018, ANN SURG ONCOL, V25, P3795, DOI 10.1245/s10434-018-6732-y; Hwang HK, 2016, J HEPATO-BIL-PAN SCI, V23, P497, DOI 10.1002/jhbp.368; Kanda T., 2021, PANCREAS; Kazanjian KK, 2008, ARCH SURG-CHICAGO, V143, P1166, DOI 10.1001/archsurg.143.12.1166; Kim SY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030689; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Kneuertz PJ, 2011, ANN SURG ONCOL, V18, P1327, DOI 10.1245/s10434-010-1476-3; Lakshmi BN, 2016, PROC TECH, V24, P1542, DOI 10.1016/j.protcy.2016.05.128; Lee B, 2021, J HEPATO-BIL-PAN SCI, V28, P1069, DOI 10.1002/jhbp.858; Lundsgaard-Hansen P, 1980, Bibl Haematol, P147; Mavros MN, 2015, ANN SURG ONCOL, V22, P4382, DOI 10.1245/s10434-015-4823-6; Nakanishi K, 2019, WORLD J GASTROENTERO, V25, P2743, DOI 10.3748/wjg.v25.i22.2743; Onete VG, 2015, HPB, V17, P736, DOI 10.1111/hpb.12425; OPELZ G, 1973, TRANSPLANT P, V5, P253; OPELZ G, 1978, NEW ENGL J MED, V299, P799, DOI 10.1056/NEJM197810122991503; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Remy KE, 2018, TRANSFUSION, V58, P804, DOI 10.1111/trf.14488; Ren XS, 2011, AM J PATHOL, V179, P2845, DOI 10.1016/j.ajpath.2011.08.028; Rystedt J, 2019, HPB, V21, P268, DOI 10.1016/j.hpb.2018.07.024; Schmidt CM, 2010, ARCH SURG-CHICAGO, V145, P634, DOI 10.1001/archsurg.2010.118; Seykora TF, 2019, ANN SURG, V270, P147, DOI 10.1097/SLA.0000000000002714; Snyder RA, 2019, HPB, V21, P841, DOI 10.1016/j.hpb.2018.10.018; Sutton JM, 2014, J GASTROINTEST SURG, V18, P1575, DOI 10.1007/s11605-014-2567-4; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259682	10.1371/journal.pone.0259682	http://dx.doi.org/10.1371/journal.pone.0259682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752505	gold, Green Published			2022-12-26	WOS:000754499700025
J	Ding, SS; Yuan, ZP; Chen, F; Xiong, XH; Lu, Z; Cui, TX				Ding, Shusheng; Yuan, Zhipan; Chen, Fan; Xiong, Xihan; Lu, Zheng; Cui, Tianxiang			Impact persistence of stock market risks in commodity markets: Evidence from China	PLOS ONE			English	Article							VOLATILITY SPILLOVERS; OIL PRICE; LIQUIDITY; ILLIQUIDITY; UNCERTAINTY; COINTEGRATION; RETURNS; FUTURES	The risk spillover among financial markets has been noticeably investigated in a burgeoning number of literature. Given those doctrines, we scrutinize the impact persistence of volatility spillover and illiquidity spillover of Chinese commodity markets in this paper. Based on the sample from 2010 to 2020, we reveal that there is a cross-market spillover of volatility and illiquidity in China and also, interactions between volatility and illiquidity in different financial markets are pronounced. More importantly, we demonstrate that different commodity markets have different responsiveness to stock market shocks, which embeds their market characteristics. Specifically, we discover that the majority of the traders in gold market might be hedger and therefore gold market is more sensitive to stock market illiquidity shock and thus the shock impact in persistent. On the other hand, agricultural markets like corn and soybean markets might be dominated by investors and thus those markets respond to the stock market volatility shocks and the shock impact in persistent over 10 periods given the first period of risk shock happening. In fact, different Chinese commodity markets' responsiveness towards Chinese stock market risk shocks indicates the stock market risk impact persistence in Chinese commodity markets. This result can help policymakers to understand the policy propagation effect according to this risk spillover channel and risk impact persistence mechanism in China.	[Ding, Shusheng; Chen, Fan] Ningbo Univ, Sch Business, Ningbo, Zhejiang, Peoples R China; [Yuan, Zhipan] Northeast Agr Univ, Sch Econ & Management, Harbin, Heilongjiang, Peoples R China; [Xiong, Xihan] Imperial Coll London, Dept Comp, London, England; [Lu, Zheng; Cui, Tianxiang] Univ Nottingham Ningbo China, Sch Comp Sci, Ningbo, Zhejiang, Peoples R China	Ningbo University; Northeast Agricultural University - China; Imperial College London; University of Nottingham Ningbo China	Cui, TX (corresponding author), Univ Nottingham Ningbo China, Sch Comp Sci, Ningbo, Zhejiang, Peoples R China.	tianxiang.cui@nottingham.edu.cn		Cui, Tianxiang/0000-0002-0102-2581				Ahmed AD, 2021, ENERG ECON, V93, DOI 10.1016/j.eneco.2020.104741; Alsalman Z, 2016, ENERG ECON, V59, P251, DOI 10.1016/j.eneco.2016.08.015; Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Amihud Y, 2021, REV FINANC STUD, V34, P2101, DOI 10.1093/rfs/hhaa080; Andrikopoulos A, 2014, INT REV FINANC ANAL, V35, P118, DOI 10.1016/j.irfa.2014.07.013; Arouri ME, 2012, ENERG ECON, V34, P611, DOI 10.1016/j.eneco.2011.08.009; Bao J, 2013, REV FINANC STUD, V26, P3068, DOI 10.1093/rfs/hht037; Barbi M, 2016, APPL ECON, V48, P1271, DOI 10.1080/00036846.2015.1096008; Barinov A, 2014, MANAGE SCI, V60, P2478, DOI 10.1287/mnsc.2014.1913; Cespa G, 2014, REV FINANC STUD, V27, P1615, DOI 10.1093/rfs/hhu016; Chan K, 2013, J FINANC MARK, V16, P414, DOI 10.1016/j.finmar.2012.09.007; Chiou-Wei SZ, 2019, ENERG J, V40, P265, DOI 10.5547/01956574.40.2.schi; Chung KH, 2018, J FINANC MARK, V37, P17, DOI 10.1016/j.finmar.2017.07.002; Chung KH, 2014, J FINANC ECON, V113, P476, DOI 10.1016/j.jfineco.2014.05.008; Diaz A, 2020, RES INT BUS FINANC, V51, DOI 10.1016/j.ribaf.2019.101079; Diebold FX, 2012, INT J FORECASTING, V28, P57, DOI 10.1016/j.ijforecast.2011.02.006; Diebold FX, 2009, ECON J, V119, P158, DOI 10.1111/j.1468-0297.2008.02208.x; Ding SS, 2020, ECON MODEL, V91, P455, DOI 10.1016/j.econmod.2020.06.019; Dolatabadi S, 2018, J FUTURES MARKETS, V38, P219, DOI 10.1002/fut.21866; Du XD, 2011, ENERG ECON, V33, P497, DOI 10.1016/j.eneco.2010.12.015; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Frommel M, 2022, EMERG MARK REV, V50, DOI 10.1016/j.ememar.2021.100832; George EI, 2008, J ECONOMETRICS, V142, P553, DOI 10.1016/j.jeconom.2007.08.017; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Iwatsubo K, 2018, J COMMOD MARK, V11, P59, DOI 10.1016/j.jcomm.2018.05.001; Jacks DS, 2011, REV ECON STAT, V93, P800, DOI 10.1162/REST_a_00091; Ji Q, 2018, ENERG ECON, V75, P14, DOI 10.1016/j.eneco.2018.08.015; Kang SH, 2017, ENERG ECON, V62, P19, DOI 10.1016/j.eneco.2016.12.011; Kang WJ, 2014, PAC-BASIN FINANC J, V27, P49, DOI 10.1016/j.pacfin.2014.02.001; Khalfaoui R, 2015, ENERG ECON, V49, P540, DOI 10.1016/j.eneco.2015.03.023; Lutkepohl H., 1991, INTRO MULTIPLE TIME; Marcondes  D, 2020, EUR J OPER RES, V285, P296, DOI 10.1016/j.ejor.2019.12.038; Marshall BR, 2012, REV FINANC STUD, V25, P599, DOI 10.1093/rfs/hhr075; Massa R, 2020, ENERG POLICY, V142, DOI 10.1016/j.enpol.2020.111476; Mensi W, 2021, RESOUR POLICY, V71, DOI 10.1016/j.resourpol.2021.102002; Morana C, 2008, EMPIR ECON, V35, P333, DOI 10.1007/s00181-007-0161-2; Nazlioglu S, 2013, ENERG ECON, V36, P658, DOI 10.1016/j.eneco.2012.11.009; Nazlioglu S, 2012, ENERG ECON, V34, P1098, DOI 10.1016/j.eneco.2011.09.008; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Richter W, 2020, POSTMORTEM INFAMOUS; Shahzad SJH, 2018, ENERG POLICY, V118, P182, DOI 10.1016/j.enpol.2018.03.074; SIMS CA, 1980, ECONOMETRICA, V48, P1, DOI 10.2307/1912017; Sinha A, 2016, J MACROECON, V47, P188, DOI 10.1016/j.jmacro.2015.12.001; Smimou K, 2016, INT REV FINANC ANAL, V48, P388, DOI 10.1016/j.irfa.2015.03.009; Tuaneh G.L, 2018, ASIAN J EC BUSINESS, P1; Umar Z, 2021, RESOUR POLICY, V73, DOI 10.1016/j.resourpol.2021.102164; Umar Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246886; Valenzuela M, 2015, J FINANC MARK, V24, P25, DOI 10.1016/j.finmar.2015.03.001; Xu WJ, 2019, ENERG ECON, V80, P310, DOI 10.1016/j.eneco.2019.01.014; Zhang YM, 2021, INT REV FINANC ANAL, V76, DOI 10.1016/j.irfa.2021.101796; Zhang YJ, 2019, INT REV FINANC ANAL, V66, DOI 10.1016/j.irfa.2019.101395	51	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259308	10.1371/journal.pone.0259308	http://dx.doi.org/10.1371/journal.pone.0259308			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ4ST	34748595	gold, Green Published			2022-12-26	WOS:000755468000023
J	Kitaw, TM; Taye, BT; Tadese, M; Getaneh, T				Kitaw, Tebabere Moltot; Taye, Birhan Tsegaw; Tadese, Mesfin; Getaneh, Temesgen			Effect of decision to delivery interval on perinatal outcomes during emergency cesarean deliveries in Ethiopia: A prospective cohort study	PLOS ONE			English	Article							SECTIONS; TIME	Background The National guidelines of most developed countries suggest a target of 30 minutes of the decision to delivery interval for emergency cesarean section. Such guidelines may not be feasible in poorly resourced countries and busy obstetric settings. It is generally accepted that the decision to delivery interval should be kept to the minimum time achievable to prevent adverse outcomes. Therefore, this study aimed to determine the average decision to delivery interval and its effect on perinatal outcomes in emergency cesarean section. Methods A prospective cohort study was conducted from May to July 2020 at Bahir Dar City Public Hospitals. A total of 182 participants were enrolled, and data were collected using a structured and pre-tested questionnaire. A systematic sampling technique was applied to select the study subjects. Data were cleaned and entered into Epi-Data version 4.6 and exported to SPSS version 25 software for analysis. Logistic regression analysis was performed to identify predictors of outcome variables, and variables with a p-value of <0.05 were considered statistically significant. Results The average decision to delivery interval was 43.73 10.55 minutes. Anesthesia time [AOR = 2.1, 95%CI = (1.3-8.4)], and category of emergency cesarean section [AOR = 3, 95% CI = (2.1-11.5)] were predictors of decision to delivery interval. The prolonged decision to delivery interval had a statistically significant association with composite adverse perinatal outcomes (odds ratio [OR] = 1.8, 95% confidence interval [CI] = (1.2-6.5). Conclusion The average decision to delivery interval was longer than the recommended time. It should always be considered an important factor contributing to perinatal outcomes. Therefore, to prevent neonatal morbidity and mortality, a time-dependent action is needed.	[Kitaw, Tebabere Moltot; Taye, Birhan Tsegaw; Tadese, Mesfin] Debre Berhan Univ, Dept Midwifery, Debre Berhan, Ethiopia; [Getaneh, Temesgen] Debre Markos Univ, Dept Midwifery, Debre Markos, Ethiopia		Kitaw, TM (corresponding author), Debre Berhan Univ, Dept Midwifery, Debre Berhan, Ethiopia.	mtebabere@gmail.com	Taye, Birhan Tsegaw/AAX-6617-2021	Taye, Birhan Tsegaw/0000-0003-2174-3797; Tadese, Mesfin/0000-0001-6288-9771				Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Ayele AD, 2021, INT J WOMENS HEALTH, V13, P395, DOI 10.2147/IJWH.S295348; Bello FA, 2015, INT J GYNECOL OBSTET, V130, P279, DOI 10.1016/j.ijgo.2015.03.036; Boehm FH, 2012, AM J OBSTET GYNECOL, V206, P97, DOI 10.1016/j.ajog.2011.09.009; Csa I. . Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV; Dashe JS, 2018, WILLIAMS OBSTET; Fesseha N, 2011, INT J GYNECOL OBSTET, V115, P106, DOI 10.1016/j.ijgo.2011.07.011; Heller G, 2017, DTSCH ARZTEBL INT, V114, P589, DOI 10.3238/arztebl.2017.0589; Hirani BA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1608-x; Hughes NJ, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03010-x; Kamotho D, 2016, INT J REPROD CONTRAC, V7, P2574; Khemworapong Khemanat, 2018, Obstet Gynecol Sci, V61, P48, DOI 10.5468/ogs.2018.61.1.48; Mishra N, 2018, J OBSTET GYN INDIA, V68, P20, DOI 10.1007/s13224-017-0991-6; Nakintu E., 2016, J GYNECOL, V1, P122; Obstetricians ACo Safety GCoP, 2011, OBSTET GYNECOL, V117, P1032, DOI [10.1097/AOG.0b013e31821922eb, DOI 10.1097/AOG.0B013E31821922EB]; Owonikoko K., 2018, CLIN MOTHER CHILD HL, V15; Radhakrishnan G., 2013, INT J REPROD CONTRAC, V2, P651, DOI [DOI 10.5455/2320-1770.IJRCOG20131231, 10.5455/2320-1770.ijrcog20131231]; Rashid N, 2007, IEJSME, V1, P61; Sait KH, 2011, J KING ABDULAZIZ U M, V98, P1; Singh R, 2012, TROP DOCT, V42, P67, DOI 10.1258/td.2012.110315; Soltanifar S, 2012, INT J OBSTET ANESTH, V21, P264, DOI 10.1016/j.ijoa.2012.03.004; Tashfeen Kaukab, 2017, Sultan Qaboos Univ Med J, V17, pe38, DOI 10.18295/squmj.2016.17.01.008; Temesgen MM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2828-z; Weiner E, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.007	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258742	10.1371/journal.pone.0258742	http://dx.doi.org/10.1371/journal.pone.0258742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748563	gold, Green Published			2022-12-26	WOS:000755468000013
J	Levorson, RE; Christian, E; Hunter, B; Sayal, J; Sun, JY; Bruce, SA; Garofalo, S; Southerland, M; Ho, S; Levy, S; Defillipi, C; Peake, L; Place, FC; Hourigan, SK				Levorson, Rebecca E.; Christian, Erica; Hunter, Brett; Sayal, Jasdeep; Sun, Jiayang; Bruce, Scott A.; Garofalo, Stephanie; Southerland, Matthew; Ho, Svetlana; Levy, Shira; Defillipi, Christopher; Peake, Lilian; Place, Frederick C.; Hourigan, Suchitra K.			A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States	PLOS ONE			English	Article							ANTIBODIES	Background Pediatric SARS-CoV-2 data remain limited and seropositivity rates in children were reported as <1% early in the pandemic. Seroepidemiologic evaluation of SARS-CoV-2 in children in a major metropolitan region of the US was performed. Methods Children and adolescents <= 19 years were enrolled in a cross-sectional, observational study of SARS-CoV-2 seroprevalence from July-October 2020 in Northern Virginia, US. Demographic, health, and COVID-19 exposure information was collected, and blood analyzed for SARS-CoV-2 spike protein total antibody. Risk factors associated with SARS-CoV-2 seropositivity were analyzed. Orthogonal antibody testing was performed, and samples were evaluated for responses to different antigens. Results In 1038 children, the anti-SARS-CoV-2 total antibody positivity rate was 8.5%. After multivariate logistic regression, significant risk factors included Hispanic ethnicity, public or absent insurance, a history of COVID-19 symptoms, exposure to person with COVID-19, a household member positive for SARS-CoV-2 and multi-family or apartment dwelling without a private entrance. 66% of seropositive children had no symptoms of COVID-19. Secondary analysis included orthogonal antibody testing with assays for 1) a receptor binding domain specific antigen and 2) a nucleocapsid specific antigen had concordance rates of 80.5% and 79.3% respectively. Conclusions A much higher burden of SARS-CoV-2 infection, as determined by seropositivity, was found in children than previously reported; this was also higher compared to adults in the same region at a similar time. Contrary to prior reports, we determined children shoulder a significant burden of COVID-19 infection. The role of children's disease transmission must be considered in COVID-19 mitigation strategies including vaccination.	[Levorson, Rebecca E.] Inova Childrens Hosp, Div Pediat Infect Dis, Falls Church, VA 22042 USA; [Levorson, Rebecca E.] Pediat Specialists Virginia, Div Pediat Infect Dis, Fairfax, VA 22042 USA; [Christian, Erica; Sayal, Jasdeep; Ho, Svetlana; Levy, Shira; Hourigan, Suchitra K.] Inova Childrens Hosp, Div Pediat Res, Falls Church, VA USA; [Hunter, Brett; Sun, Jiayang; Bruce, Scott A.] George Mason Univ, Dept Stat, Fairfax, VA USA; [Garofalo, Stephanie; Southerland, Matthew; Defillipi, Christopher] Inova Heart & Vasc Inst, Inova Hlth Syst, Falls Church, VA USA; [Peake, Lilian] Virginia Dept Hlth, Div Epidemiol, Richmond, VA USA; [Place, Frederick C.] Inova Childrens Hosp, Div Pediat Emergency Med, Falls Church, VA USA; [Hourigan, Suchitra K.] NIAID, Lab Host Immun & Microbiome, 9000 Rockville Pike, Bethesda, MD 20892 USA	Inova Fairfax Hospital; Inova Fairfax Hospital; George Mason University; Inova Fairfax Hospital; Inova Health System; Inova Fairfax Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levorson, RE (corresponding author), Inova Childrens Hosp, Div Pediat Infect Dis, Falls Church, VA 22042 USA.; Levorson, RE (corresponding author), Pediat Specialists Virginia, Div Pediat Infect Dis, Fairfax, VA 22042 USA.	RLevorson@psvcare.org	Bruce, Scott Alan/K-9090-2019	Bruce, Scott Alan/0000-0002-7904-4211	Virginia Department of Health; National Institute of Child Health and Human Development [K23HD099240]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR003015]	Virginia Department of Health; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The Virginia Department of Health provided funding for this study. The Virginia Department of Health, in conjunction with the authors of this manuscript, were involved in study design, the writing of the report and the decision to submit the paper for publication. The Virginia Department of Health were not involved in collection, analysis or interpretation of the data. Research reported in this publication was also supported in part by the National Institute of Child Health and Human Development under Award Number K23HD099240 (Hourigan) and by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (Hourigan), of the National Institutes of Health. Research reported in this publication was also supported in part via a subcontract from the parent award by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR003015 (Hunter, Sun, Bruce). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar B, 2021, PEDIATR INFECT DIS J, V40, pE272, DOI 10.1097/INF.0000000000003140; Bailey LC, 2021, JAMA PEDIATR, V175, P176, DOI 10.1001/jamapediatrics.2020.5052; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; DeBiasi RL, 2021, JAMA PEDIATR, V175, P16, DOI 10.1001/jamapediatrics.2020.3996; DeBiasi RL, 2020, J PEDIATR-US, V223, P199, DOI 10.1016/j.jpeds.2020.05.007; Grijalva CG, 2020, MMWR-MORBID MORTAL W, V69, P1631, DOI [10.15585/mmwr.mm6944e1, 10.15585/mmwr. mm6944e1]; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Hachim Asmaa, 2021, medRxiv, DOI 10.1101/2021.01.03.21249180; Han MS, 2021, JAMA PEDIATR, V175, P73, DOI 10.1001/jamapediatrics.2020.3988; Hobbs CV, 2020, MMWR-MORBID MORTAL W, V69, P1925, DOI 10.15585/mmwr.mm6950e3; Khan T, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144499; Link-Gelles R, 2020, MMWR-MORBID MORTAL W, V69, P1170, DOI [10.15585/mmwr.mm6934e2, 10.15585/mmwr.mm6934e2externalicon]; Madewell ZJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.31756; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Pan YB, 2021, CLIN MICROBIOL INFEC, V27, P253, DOI 10.1016/j.cmi.2020.09.044; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; McQuade ETR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35234; Self WH, 2020, MMWR-MORBID MORTAL W, V69, P1762, DOI 10.15585/mmwr.mm6947a2; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Tonshoff B, 2021, JAMA PEDIATR, V175, P586, DOI 10.1001/jamapediatrics.2021.0001; Torres JP, 2021, CLIN INFECT DIS, V73, pE458, DOI 10.1093/cid/ciaa955; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P355, DOI 10.1097/INF.0000000000002660	26	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259823	10.1371/journal.pone.0259823	http://dx.doi.org/10.1371/journal.pone.0259823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748615	Green Published, gold			2022-12-26	WOS:000755468000057
J	Shava, E; Bogart, LM; Manyake, K; Mdluli, C; Maribe, K; Monnapula, N; Nkomo, B; Mosepele, M; Moyo, S; Mmalane, M; Barnighausen, T; Makhema, J; Lockman, S				Shava, Emily; Bogart, Laura M.; Manyake, Kutlo; Mdluli, Charlotte; Maribe, Kamogelo; Monnapula, Neo; Nkomo, Bornapate; Mosepele, Mosepele; Moyo, Sikhulile; Mmalane, Mompati; Barnighausen, Till; Makhema, Joseph; Lockman, Shahin			Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ACCEPTABILITY; PREVALENCE; CARE	Background Oral HIV self-testing (HIVST) may be useful for increasing testing in persons at elevated risk of acquiring HIV. Methods We conducted a pilot study to evaluate the feasibility (defined by uptake) of HIVST among FSW in Gaborone, Botswana. FSW age 18 years and above were recruited through a non-governmental organization serving FSW. FSW with unknown or negative HIV status at screening performed HIVST in the study clinic following brief training. FSW testing HIV-negative were each given two test kits to take home: one kit to perform unassisted HIVST and another to share with others. Feasibility (use) of HIVST (and sharing of test kits with others) was assessed in these women at a study visit four months later. Results Two hundred FSW were screened. Their average age was 34 years (range 18-59), and 115 (58%) were HIV-positive. Eighty-five (42%) tested HIV-negative at entry and were eligible to take part in the HIVST pilot study. All 85 (100%) agreed to take home HIVST kits. Sixty-nine (81%) of these 85 participants had a follow-up visit, 56 (81%) of whom reported performing HIVST at a mean of three and half months after the initial visit. All 56 participants who performed HIVST reported negative HIVST results. Fifty (73%) of the 69 participants who took HIVST kits home shared them with others. Of the 50 women sharing HIVST kits, 25 (50%) shared with their non-client partners, 15 with a family member, 8 with friends, and 3 with a client. One participant did not test herself but shared both her test kits. Most participants 53/56 (95%) found oral HIVST very easy to use whilst 3/56 (5%) felt it was fairly easy. Conclusion Oral HIVST is feasible among FSW in Gaborone, Botswana. The majority of FSW used the HIVST kits themselves and also shared extra HIVST kits with other individuals.	[Shava, Emily; Manyake, Kutlo; Mdluli, Charlotte; Mosepele, Mosepele; Moyo, Sikhulile; Mmalane, Mompati; Makhema, Joseph; Lockman, Shahin] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Shava, Emily; Mosepele, Mosepele; Moyo, Sikhulile; Barnighausen, Till; Makhema, Joseph; Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA; [Maribe, Kamogelo; Monnapula, Neo] Nkaikela Youth Grp, Gaborone, Botswana; [Nkomo, Bornapate] Minist Hlth & Wellness, Gaborone, Botswana; [Mosepele, Mosepele] Univ Botswana, Gaborone, Botswana; [Barnighausen, Till] Heidelberg Univ, Heidelberg, Germany; [Barnighausen, Till] Wellcome Trust Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Lockman, Shahin] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation; University of Botswana; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital	Shava, E (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.; Shava, E (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	emakunike@gmail.com	Moyo, Sikhulile/E-1464-2015	Moyo, Sikhulile/0000-0003-3821-4592; Shava, Emily/0000-0001-9288-7881	Harvard University Center for AIDS Research Harvard University CFAR NIH/NIAID fund [5P30AI060354-15]; NIH/Fogarty International Center [R21TW011069]; NIH/NIMH [P30MH058107]	Harvard University Center for AIDS Research Harvard University CFAR NIH/NIAID fund; NIH/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Harvard University Center for AIDS Research Harvard University CFAR NIH/NIAID fund 5P30AI060354-15. Bogart's work on the project was supported by R21TW011069 (from NIH/Fogarty International Center) and P30MH058107 (from NIH/NIMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration UFaD, 2020, FACTS HOM HIV TEST; Balan I, 2017, AIDS BEHAV, V21, P501, DOI 10.1007/s10461-016-1497-4; Baral S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115465; Buthelezi UE, 2016, AJAR-AFR J AIDS RES, V15, P89, DOI 10.2989/16085906.2016.1196223; Chanda MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002442; Chanda MM, 2017, AIDS PATIENT CARE ST, V31, P290, DOI 10.1089/apc.2017.0016; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Cowan FM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21101; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Duby Z, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.701; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Hargreaves JR, 2016, HEALTH POLICY PLANN, V31, P1342, DOI 10.1093/heapol/czw071; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Hladik W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4428-z; Indravudh PP, 2018, CURR OPIN INFECT DIS, V31, P14, DOI 10.1097/QCO.0000000000000426; Johnson LF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49109-w; Katirayi L, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0387-1; Kelvin EA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6345-1; Kelvin EA, 2019, AIDS BEHAV, V23, P116, DOI 10.1007/s10461-018-2248-5; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kitchen PJ, 2020, AJAR-AFR J AIDS RES, V19, P186, DOI 10.2989/16085906.2020.1790399; Korte JE, 2020, JAIDS-J ACQ IMM DEF, V84, P271, DOI 10.1097/QAI.0000000000002341; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Kurth AE, 2016, AIDS BEHAV, V20, P870, DOI 10.1007/s10461-015-1213-9; Malawi Go, 2017, MAL COUNTR OPER PLAN; Maman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174629; Mantell JE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25403; Matovu JKB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236141; Matovu JKB, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1503784; Mbokazi N, 2020, J INT ASS PROVID AID, V19; Merrigan MB, 2015, AIDS BEHAV, V19, P899, DOI 10.1007/s10461-014-0858-0; Mettert K., 2020, IMPLEMENTATION RES P, V1, p263348952093664, DOI [10.1177/2633489520936644, DOI 10.1177/2633489520936644]; Moyo Tuckler M M, 2017, PULA BOTSWANA J AFRI, V31; Mugo NR, 2016, CURR OPIN HIV AIDS, V11, P80, DOI 10.1097/COH.0000000000000224; Nakanwagi Sharon, 2016, J Sex Transm Dis, V2016, P7673014, DOI 10.1155/2016/7673014; Napierala S, 2019, B WORLD HEALTH ORGAN, V97, P764, DOI 10.2471/BLT.18.223560; Ngure K, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21234; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Oldenburg CE, 2018, AIDS, V32, P645, DOI [10.1097/QAD.0000000000001740, 10.1097/qad.0000000000001740]; Ortblad K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002458; Ortblad KF, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01852-y; Ortblad KF, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022652; Ortblad KF, 2018, LANCET HIV, V5, pE406, DOI 10.1016/S2352-3018(18)30136-X; Overs C., 2002, 115 WHO; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Ritchwood TD, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6402-4; Sally Hendriks L, 2017, AIDS FONDS; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shannon K, 2014, CURR OPIN HIV AIDS, V9, P174, DOI 10.1097/COH.0000000000000042; Shava E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236052; Stevens DR, 2018, AIDS BEHAV, V22, P497, DOI 10.1007/s10461-017-1707-8; UNAIDS, 2020, GLOB HIV AIDS STAT; UNAIDS, 2020, SEIZ MOM TACKL ENTR; Ward H, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25319; WHO, 2016, GUID HIV SELF TEST P; World Health Organization, 2019, HIV AIDS	56	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259508	10.1371/journal.pone.0259508	http://dx.doi.org/10.1371/journal.pone.0259508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748576	gold, Green Published			2022-12-26	WOS:000755468000033
J	Kim, NS; Cha, JY; Lim, CH				Kim, Nam Shin; Cha, Jin Yeol; Lim, Chi Hong			Hierarchical landform delineation for the habitats of biological communities on the Korean Peninsula	PLOS ONE			English	Article							CLASSIFICATION	Landforms determine the locations of particular biological communities based on their components and spatial positions. This study hierarchically classified the topographic spaces serving as habitats for biological communities in the Korean Peninsula and established the habitat types that occur on the classified landform types. We classified landform types by applying cell-based modeling, map algebra, and spatial query techniques to spatial data, including digital elevation model (DEM), Sentinel 2 image, land use, and field survey data to model their ecological characteristics. Landforms were classified into four categories (designated Category 1 through 4) according to their spatial scale based on topographical characteristics such as mountains, plains, alluvial landforms, coastal landforms, islands, and special areas (Baekdudaegan, DMZ), which are found throughout the Korean Peninsula. The landforms of the Korean Peninsula were classified into 47 subcategories in Category 1, 16 in Category 2, 36 in Category 3, and 63 in Category 4. There were 62 main types of habitats that were classified based on their topographic spatial units, and there were 437 types of sub-habitats, for which soil weathering, biodiversity, and geodiversity were combined with the main habitat types. When factor analysis was conducted for the environmental factors used to determine the main and sub-habitats, the first primary components were temperature-related factors, followed by biodiversity, geodiversity, aspect, and slope. When the indicator species were analyzed by habitat type, indicator species diversity was high in Jeju Province, Gangwon Province, and Gaema Plateau. Based on these results, landform elements for species habit conservation were assigned conservation values and classified into (I) absolute conservation areas, (II) transition areas, and (III) areas for coexistence with humans. Topographic spaces are being degraded as biological habitats as a result of climate change and human development; our proposed classifications can be applied to the conservation of landforms and biodiversity.	[Kim, Nam Shin; Cha, Jin Yeol; Lim, Chi Hong] Natl Inst Ecol, Div Ecol Survey Res, Seocheon, Chungnam, South Korea	National Institute of Ecology	Lim, CH (corresponding author), Natl Inst Ecol, Div Ecol Survey Res, Seocheon, Chungnam, South Korea.	sync03@nie.re.kr						Allison RJ, 2002, APPL GEOMORPHOLOGY T; Bailey R. G., 1996, ECOSYSTEM GEOGRAPHY, DOI [10.1007/9781-46122358-0, DOI 10.1007/978-1-4612-2358-0]; Bailey RG., 2002, ECOREGION BASED DESI, DOI [10.1007/b97607, DOI 10.1007/B97607]; Budel J., 1982, CLIMATIC GEOMORPHOLO; Caceres MD., 2020, PACKAGE INDICSPECIES; Camiz S, 2018, EARTH SCI INFORM, V11, P287, DOI 10.1007/s12145-018-0337-7; Chukwuocha A., 2016, 11 INT C AFR ASS REM; De Reu J, 2013, GEOMORPHOLOGY, V186, P39, DOI 10.1016/j.geomorph.2012.12.015; Do B., 1976, BOOK FLORA; Doke A, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-017-3358-5; Duchaufour R., 2012, PEDOLOGY PEDOGENESIS, DOI [10.1007/978-94-011-6003-2, DOI 10.1007/978-94-011-6003-2]; Evans D.A., 2016, J GEOSPATIAL APPL NA, V1; Garcia GPB, 2019, J S AM EARTH SCI, V93, P14, DOI 10.1016/j.jsames.2019.04.013; Goes ER, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00047; 김진석, 2013, [KOREAN JOURNAL OF ENVIRONMENT AND ECOLOG, 한국환경생태학회지], V27, P357; Ho Bae Kwan, 2014, [KOREAN JOURNAL OF ENVIRONMENT AND ECOLOG, 한국환경생태학회지], V28, P161; Hyeun J, 2000, HANGEUL SANGYEONGPYO; Im R., 1975, FLORA COREANA; Im R., 1999, FLORA COREANA; Im R, 1998, FLORA COREANA; Im R, 1976, FLORA COREANA; Im R., 2000, FLORA COREANA; Im R.J, 1996, FLORA COREANA; Iwahashi J, 2018, PROG EARTH PLANET SC, V5, DOI 10.1186/s40645-017-0157-2; Jasiewicz J, 2013, GEOMORPHOLOGY, V182, P147, DOI 10.1016/j.geomorph.2012.11.005; Jiang L, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7110443; Karagulle D., 2017, IMPROVED HAMMONDS LA; Kim J., 2006, ALGIFIC TALUS KOREA, P337; Kim Jin-Seok, 2016, KOREAN JOURNAL OF PLANT TAXONOMY, V46, P213, DOI 10.11110/kjpt.2016.46.2.213; Kim L., 2007, FAUNA COREANA FISH; Kim L., 2011, FAUNA COREANA BIRD 2; Kim L., 2008, FAUNA COREANA FISH 3; Kim L., 2009, FAUNA COREANA AMPHIB; Kim L., 2006, FAUNA COREANA FISH; Kim NS., 2004, J GEOMORPHOLOGICAL A, V11, P47; Kong W., 2006, GLOBAL CHANGE MOUNTA, P174; Kong WooSeok, 1999, Journal of Environmental Sciences, V11, P243; Korea National Institute of Biological Resources, 2019, NAT LIST IND SPEC KO; Lee CS., 2018, CONIFERS INTECHOPEN, DOI [10.5772/intechopen.80236, DOI 10.5772/INTECHOPEN.80236]; Lidmar-Bergstrom K., 2015, PLAINS STEPS HILLY R; Liu JJ, 2018, LANDSCAPE ECOL, V33, P341, DOI 10.1007/s10980-018-0620-5; Meybeck M, 2001, MT RES DEV, V21, P34, DOI 10.1659/0276-4741(2001)021[0034:ANTFMA]2.0.CO;2; Mo Y, 2017, FORESTS, V8, DOI 10.3390/f8120466; Mokarram M, 2015, MODEL EARTH SYST ENV, V1, DOI 10.1007/s40808-015-0055-9; Mokarram M, 2016, OPEN GEOSCI, V8, P302, DOI 10.1515/geo-2016-0027; National Institute of Ecology, 2019, GUID EC SERV ASS WET; Oh K., 2006, J GEOMORPHOLOGICAL A, V13, P1; Oh KS., 1996, J GEOMORPHOLOGICAL A, V3, P1; Oh KS, 1989, KOREAN J QUATERNARY, V3, P35; Park Soo Jin, 2004, [Journal of The Korean Geomorphological Association, 한국지형학회지], V11, P113; PECK J.E, 2010, MULTIVARIATE ANAL CO; Peltier LC, 1950, ANN ASSOC AM GEOGR, V40, P214; PENNOCK DJ, 1987, GEODERMA, V40, P297, DOI 10.1016/0016-7061(87)90040-1; Piloyan A, 2017, QUAEST GEOGR, V36, P93, DOI 10.1515/quageo-2017-0007; Pullar D, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P1560; Saadat H, 2008, GEOMORPHOLOGY, V100, P453, DOI 10.1016/j.geomorph.2008.01.011; Strahler A. H., 1992, MODERN PHYS GEOGRAPH; Tricart J., 1992, LONGMAN SCI TECHNICA; Tricart J., 1972, INTRO CLIMATIC GEOMO; Wang DM, 2010, INT J GEOGR INF SCI, V24, P305, DOI 10.1080/13658810802467969; Weiss A.D., 2001, TOPOGRAPHIC POSITION; Wendi D, 2016, J ADV MODEL EARTH SY, V8, P691, DOI 10.1002/2015MS000536; Wilson MC, 2016, LANDSCAPE ECOL, V31, P219, DOI 10.1007/s10980-015-0312-3; WorldClim, WORLDCLIM DAT; Wright RG, 1998, BIOL CONSERV, V86, P207, DOI 10.1016/S0006-3207(98)00002-0; Zhao K, 2015, J MT SCI-ENGL, V12, P1025, DOI 10.1007/s11629-014-3069-2; Zimmermann N., 2000, ZIMMERMANNS TOPOGRAP	67	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259651	10.1371/journal.pone.0259651	http://dx.doi.org/10.1371/journal.pone.0259651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739531	gold, Green Published			2022-12-26	WOS:000755000800046
J	Paul, A; Srivastava, AP; Subrahmanya, S; Shen, GX; Mishra, N				Paul, Abhirup; Srivastava, Anurag P.; Subrahmanya, Shreya; Shen, Guoxin; Mishra, Neelam			In-silico genome wide analysis of Mitogen activated protein kinase kinase kinase gene family in C. sinensis	PLOS ONE			English	Article							ABSCISIC-ACID; MAPKKK GENE; TOLERANCE; PATHWAY; EXPRESSION; DROUGHT; CASCADE; STRESS; SALT; RESISTANCE	Mitogen activated protein kinase kinase kinase (MAPKKK) form the upstream component of MAPK cascade. It is well characterized in several plants such as Arabidopsis and rice however the knowledge about MAPKKKs in tea plant is largely unknown. In the present study, MAPKKK genes of tea were obtained through a genome wide search using Arabidopsis thaliana as the reference genome. Among 59 candidate MAPKKK genes in tea, 17 genes were MEKK-like, 31 genes were Raf-like and 11 genes were ZIK- like. Additionally, phylogenetic relationships were established along with structural analysis, which includes gene structure, its location as well as conserved motifs, cis-acting regulatory elements and functional domain signatures that were systematically examined. Also, on the basis of one orthologous gene found between tea and Arabidopsis, functional interaction was carried out in C. sinensis based on an Arabidopsis association model. The expressional profiles indicated major involvement of MAPKKK genes from tea in response to various abiotic stress factors. Taken together, this study provides the targets for additional inclusive identification, functional study, and provides comprehensive knowledge for a better understanding of the MAPKKK cascade regulatory network in C. sinensis.	[Paul, Abhirup] REVA Univ, Dept Biochem, Bangalore, Karnataka, India; [Srivastava, Anurag P.] Garden City Univ, Dept Life Sci, Bangalore, Karnataka, India; [Subrahmanya, Shreya; Mishra, Neelam] St Josephs Coll Autonomous, Dept Bot, Bangalore, Karnataka, India; [Shen, Guoxin] Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Peoples R China	REVA University; Zhejiang Academy of Agricultural Sciences	Mishra, N (corresponding author), St Josephs Coll Autonomous, Dept Bot, Bangalore, Karnataka, India.; Shen, GX (corresponding author), Zhejiang Acad Agr Sci, Sericultural Res Inst, Hangzhou, Peoples R China.	guoxin.shen@ttu.edu; neelammishra@sjc.ac.in	Shen, Guoxin/GPT-2191-2022	Mishra, Neelam/0000-0001-6191-5392				An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bordoloi KS, 2021, PHYSIOL MOL BIOL PLA, V27, P369, DOI 10.1007/s12298-021-00947-x; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chao Jiangtao, 2015, Yichuan, V37, P91, DOI [10.16288/j.yezz.2015.01.013, 10.16288/j.yczz.2015.01.013]; Chatterjee A, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07030-x; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Doczi R, 2012, TRENDS PLANT SCI, V17, P518, DOI 10.1016/j.tplants.2012.05.009; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Gan HH, 2002, BIOPHYS J, V83, P2781, DOI 10.1016/S0006-3495(02)75287-9; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Goyal RK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4545-9; Hadiarto T, 2006, PLANTA, V223, P708, DOI 10.1007/s00425-005-0126-7; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Jia HH, 2016, PLANT SCI, V252, P267, DOI 10.1016/j.plantsci.2016.07.014; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kong Q, 2012, PLANT CELL, V24, P2225, DOI 10.1105/tpc.112.097253; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098189; Liu YK, 2017, REDOX BIOL, V11, P192, DOI 10.1016/j.redox.2016.12.009; Liu ZJ, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10030570; Liu ZG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4259-4; Liu ZQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00780; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; Mukhopadhyay M, 2016, PLANT CELL REP, V35, P255, DOI 10.1007/s00299-015-1884-8; Murakami-Kojima M, 2002, PLANT CELL PHYSIOL, V43, P675, DOI 10.1093/pcp/pcf084; Nicole MC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-223; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Pearson William R, 2013, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0301s42; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Pitzschke A, 2006, PLANT PHYSIOL, V141, P351, DOI 10.1104/pp.106.079160; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Rao KP, 2010, DNA RES, V17, P139, DOI 10.1093/dnares/dsq011; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Shitamichi N, 2013, PLANT BIOTECHNOL-NAR, V30, P111, DOI 10.5511/plantbiotechnology.13.0108a; Shou HX, 2004, J EXP BOT, V55, P1013, DOI 10.1093/jxb/erh129; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun MH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13627-2; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Takahashi F, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.556972; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Virk N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133975; Wang G, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0219-1, 10.1186/s12862-014-0186-z]; Wang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1621-2; Wang LZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01357-4; Wang XC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-415; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Wu AM, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00824; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103032; Xia EH, 2019, PLANT BIOTECHNOL J, V17, P1938, DOI 10.1111/pbi.13111; Ye JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13988-8; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang Q, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1161-9; Zhang Rui., 2020, BMC GENOMICS	74	1	1	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258657	10.1371/journal.pone.0258657	http://dx.doi.org/10.1371/journal.pone.0258657			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735479	Green Published, gold			2022-12-26	WOS:000755077100027
J	Lindsay, A; Trewin, AJ; Sadler, KJ; Laird, C; Della Gatta, PA; Russell, AP				Lindsay, Angus; Trewin, Adam J.; Sadler, Kate J.; Laird, Claire; Della Gatta, Paul A.; Russell, Aaron P.			Sensitivity to behavioral stress impacts disease pathogenesis in dystrophin-deficient mice	FASEB JOURNAL			English	Article						blood pressure; dystrophin; estrogen; hypothalamic pituitary adrenal axis; skeletal muscle	DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; SOCIAL STRESS; MDX MODEL; DYSFUNCTION; EXPRESSION; UTROPHIN; RESTRAINT; PATHOLOGY; BRAIN	Mutation to the gene encoding dystrophin can cause Duchenne muscular dystrophy (DMD) and increase the sensitivity to stress in vertebrate species, including the mdx mouse model of DMD. Behavioral stressors can exacerbate some dystrophinopathy phenotypes of mdx skeletal muscle and cause hypotension-induced death. However, we have discovered that a subpopulation of mdx mice present with a wildtype-like response to mild (forced downhill treadmill exercise) and moderate (scruff restraint) behavioral stressors. These "stress-resistant" mdx mice are more physically active, capable of super-activating the hypothalamic-pituitary-adrenal and renin-angiotensin-aldosterone pathways following behavioral stress and they express greater levels of mineralocorticoid and glucocorticoid receptors in striated muscle relative to "stress-sensitive" mdx mice. Stress-resistant mdx mice also presented with a less severe striated muscle histopathology and greater exercise and skeletal muscle oxidative capacity at rest. Most interestingly, female mdx mice were more physically active following behavioral stressors compared to male mdx mice; a response abolished after ovariectomy and rescued with estradiol. We demonstrate that the response to behavioral stress greatly impacts disease severity in mdx mice suggesting the management of stress in patients with DMD be considered as a therapeutic approach to ameliorate disease progression.	[Lindsay, Angus; Trewin, Adam J.; Sadler, Kate J.; Della Gatta, Paul A.; Russell, Aaron P.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Laird, Claire] Deakin Univ, Researcher Dev, Deakin Res, Geelong, Vic, Australia	Deakin University; Deakin University	Lindsay, A (corresponding author), Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	a.lindsay@deakin.edu.au		Lindsay, Angus/0000-0002-5195-1901	Deakin University; Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation	Deakin University; Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation	Deakin University, Grant/Award Number: HAtCH Grant, Seed Funding, (Institute for Physical Activity and Nutrition) and Alfred Deakin Postdoctoral Research Fellowship; Neurological Foundation, Grant/Award Number: Philip Wrightson Fellowship	Acin-Perez R, 2020, EMBO J, V39, DOI 10.15252/embj.2019104073; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Belanto JJ, 2016, HUM MOL GENET, V25, P4951, DOI 10.1093/hmg/ddw318; Belanto JJ, 2014, P NATL ACAD SCI USA, V111, P5723, DOI 10.1073/pnas.1323842111; Bostick B, 2012, J MOL CELL CARDIOL, V53, P217, DOI 10.1016/j.yjmcc.2012.05.002; Bostick B, 2010, MUSCLE NERVE, V42, P600, DOI 10.1002/mus.21763; Bowden SA, 2019, J NEUROMUSCULAR DIS, V6, P31, DOI 10.3233/JND-180346; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; Chaussenot R, 2015, NEUROBIOL LEARN MEM, V124, P111, DOI 10.1016/j.nlm.2015.07.006; Della Gatta PA, 2014, EUR J APPL PHYSIOL, V114, P2157, DOI 10.1007/s00421-014-2936-4; Demirci H, 2020, MUSCLE NERVE, V62, P710, DOI 10.1002/mus.27057; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Fragapane P, 2020, EXP CELL RES, V386, DOI 10.1016/j.yexcr.2019.111715; Fresard L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-551; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Guiraud S, 2018, EXPERT OPIN ORPHAN D, V6, P179, DOI 10.1080/21678707.2018.1438261; Hagg U, 2005, AM J PHYSIOL-HEART C, V289, pH1627, DOI 10.1152/ajpheart.00135.2005; Han TK, 2015, METAB BRAIN DIS, V30, P711, DOI 10.1007/s11011-014-9624-2; Hauck JS, 2019, HUM MOL GENET, V28, P2030, DOI 10.1093/hmg/ddz039; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Johansen IB, 2017, J EXP BIOL, V220, P2545, DOI 10.1242/jeb.135046; Johansen IB, 2011, J EXP BIOL, V214, P1313, DOI 10.1242/jeb.053058; Kinnett K, 2017, PLOS CURR-TREE LIFE, P9, DOI [10.1371/currents.md.d18deef7dac96ed135e0dc8739917b6e, DOI 10.1371/CURRENTS.MD.D18DEEF7DAC96ED135E0DC8739917B6E]; Klingler Werner, 2012, Acta Myol, V31, P184; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Kodippili K, 2021, J PATHOL, V254, P589, DOI 10.1002/path.5704; Lagunas N, 2010, HORM BEHAV, V58, P786, DOI 10.1016/j.yhbeh.2010.07.014; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Lindsay A, 2021, FASEB J, V35, DOI 10.1096/fj.202002500R; Lindsay A, 2019, FEBS J, V286, P2562, DOI 10.1111/febs.14831; Lindsay A, 2019, J APPL PHYSIOL, V126, P363, DOI 10.1152/japplphysiol.00948.2018; Lindsay A, 2019, HUM MOL GENET, V28, P942, DOI 10.1093/hmg/ddy404; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Masukagami Y, 2019, VET MICROBIOL, V234, P8, DOI 10.1016/j.vetmic.2019.05.008; Matsuzaka Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01805-5; McDonald CM, 2018, LANCET, V391, P451, DOI 10.1016/S0140-6736(17)32160-8; Meadows E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016184; Meyers TA, 2019, J MOL CELL CARDIOL, V128, P51, DOI 10.1016/j.yjmcc.2019.01.013; Moran AL, 2007, J APPL PHYSIOL, V102, P1387, DOI 10.1152/japplphysiol.01305.2006; Naarding KJ, 2020, NEUROLOGY, V94, pE1386, DOI 10.1212/WNL.0000000000008939; Naidoo M, 2020, MOL NEUROBIOL, V57, P1748, DOI 10.1007/s12035-019-01845-w; Nelson DM, 2018, HUM MOL GENET, V27, P2090, DOI 10.1093/hmg/ddy113; OGASAWARA A, 1989, AM J MENT RETARD, V93, P544; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; Polavarapu K, 2016, NEUROMUSCULAR DISORD, V26, P768, DOI 10.1016/j.nmd.2016.09.002; PRATT NC, 1989, J REPROD FERTIL, V87, P763, DOI 10.1530/jrf.0.0870763; Quattrocelli M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.132402; Quattrocelli M, 2017, J CLIN INVEST, V127, P2418, DOI 10.1172/JCI91445; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Razzoli M, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102700; ROMANUL FCA, 1965, ARCH NEUROL-CHICAGO, V12, P497, DOI 10.1001/archneur.1965.00460290053007; Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763; Sekiguchi M, 2009, BRAIN, V132, P124, DOI 10.1093/brain/awn253; Selye H, 1950, PHYSL PATHOLOGY EXPO; Shimizu-Motohashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120325; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Trewin AJ, 2018, AM J PHYSIOL-REG I, V315, pR1003, DOI 10.1152/ajpregu.00096.2018; Trewin AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188421; Vaillend C, 2017, HUM MOL GENET, V26, P1041, DOI 10.1093/hmg/ddx013; Vang P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249472; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Wicksell RK, 2004, DEV MED CHILD NEUROL, V46, P154, DOI 10.1017/S0012162204000283; Yamamoto K, 2010, NEUROMUSCULAR DISORD, V20, P505, DOI 10.1016/j.nmd.2010.05.006	65	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22034	10.1096/fj.202101163RR	http://dx.doi.org/10.1096/fj.202101163RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34780665				2022-12-26	WOS:000722321300005
J	Scherrer, JF; Salas, J; Wiemken, TL; Hoft, DF; Jacobs, C; Morley, JE				Scherrer, Jeffrey F.; Salas, Joanne; Wiemken, Timothy L.; Hoft, Daniel F.; Jacobs, Christine; Morley, John E.			Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts	PLOS ONE			English	Article							INFLUENZA VACCINATION; ALZHEIMERS-DISEASE; INFECTION; ADULTS; RISK	Background Herpes zoster (HZ) infection increases dementia risk, but it is not known if herpes zoster vaccination is associated with lower risk for dementia. We determined if HZ vaccination, compared to no HZ vaccination, is associated with lower risk for incident dementia. Methods and findings Data was obtained from Veterans Health Affairs (VHA) medical records (10/1/2008-9/30/2019) with replication in MarketScan (R) commercial and Medicare claims (1/1/2009-12/31/2018). Eligible patients were >= 65 years of age and free of dementia for two years prior to baseline (VHA n = 136,016; MarketScan n = 172,790). Two index periods (either start of 2011 or 2012) were defined, where patients either had or did not have a HZ vaccination. Confounding was controlled with propensity scores and inverse probability of treatment weighting. Competing risk (VHA) and Cox proportional hazard (MarketScan) models estimated the association between HZ vaccination and incident dementia in all patients and in age (65-69, 70-74, >= 75) and race (White, Black, Other) sub-groups. Sensitivity analysis measured the association between HZ vaccination and incident Alzheimer's dementia (AD). HZ vaccination at index versus no HZ vaccination throughout follow-up. VHA patients mean age was 75.7 (SD7.4) years, 4.0% were female, 91.2% white and 20.2% had HZ vaccination. MarketScan patients mean age was 69.9 (SD +/- 5.7) years, 65.0% were female and 14.2% had HZ vaccination. In both cohorts, HZ vaccination compared with no vaccination, was significantly associated with lower dementia risk (VHA HR = 0.69; 95%CI: 0.67-0.72; MarketScan HR = 0.65; 95%CI: 0.57-0.74). HZ vaccination was not related to dementia risk in MarketScan patients aged 65-69 years. No difference in HZ vaccination to dementia effects were found by race. HZ vaccination was associated with lower risk for AD. Conclusions HZ vaccination is associated with reduced risk of dementia. Vaccination may provide nonspecific neuroprotection by training the immune system to limit damaging inflammation, or specific neuroprotection that prevents viral cytopathic effects.	[Scherrer, Jeffrey F.; Salas, Joanne; Jacobs, Christine] St Louis Univ, Sch Med, Dept Family & Community Med, St Louis, MO 63103 USA; [Scherrer, Jeffrey F.; Salas, Joanne] Harry S Truman Mem Vet Hosp, Columbia, MO USA; [Scherrer, Jeffrey F.; Salas, Joanne; Wiemken, Timothy L.; Jacobs, Christine] St Louis Univ, Sch Med, AHEAD Inst, St Louis, MO 63103 USA; [Wiemken, Timothy L.] St Louis Univ, Sch Med, Dept Hlth & Clin Outcomes Res, St Louis, MO 63103 USA; [Wiemken, Timothy L.; Hoft, Daniel F.] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, Dept Internal Med, St Louis, MO USA; [Wiemken, Timothy L.; Hoft, Daniel F.] St Louis Univ, Syst Infect Prevent Ctr, Ctr Specialized Med, St Louis, MO 63103 USA; [Hoft, Daniel F.] St Louis Univ, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Morley, John E.] St Louis Univ, Sch Med, Div Geriatr Med, St Louis, MO 63103 USA	Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University; Saint Louis University	Scherrer, JF (corresponding author), St Louis Univ, Sch Med, Dept Family & Community Med, St Louis, MO 63103 USA.; Scherrer, JF (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO USA.; Scherrer, JF (corresponding author), St Louis Univ, Sch Med, AHEAD Inst, St Louis, MO 63103 USA.	jeffrey.scherrer@health.slu.edu		Scherrer, Jeffrey/0000-0002-9148-2863	Benter Foundation [2020-01]	Benter Foundation	Benter Foundation award 2020-01 to JFS https://benterfoundation.org/ The sponsor played no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2019, RISK REDUCTION COGNI; Aris E, 2020, VACCINE, V38, P2984, DOI 10.1016/j.vaccine.2020.02.057; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bae S, 2021, EUR ARCH PSY CLIN N, V271, P987, DOI 10.1007/s00406-020-01157-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Chen VCH, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.16m11312; Ellawanda F, 2013, EPIDEMIOL REV, V35, P161, DOI 10.1093/epirev/mxs007; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fogelberg S, 2018, PHARMACOEPIDEM DR S, V27, P1159, DOI 10.1002/pds.4653; Fulop T, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00362; Haneuse S, 2019, JAMA-J AM MED ASSOC, V321, P602, DOI 10.1001/jama.2018.21554; Harding BN, 2020, HEALTHCARE-J DEL SCI, V8, DOI 10.1016/j.hjdsi.2020.100430; Honjo K, 2009, ALZHEIMERS DEMENT, V5, P348, DOI 10.1016/j.jalz.2008.12.001; Islas CD, 2018, STAT MED, V37, P1788, DOI 10.1002/sim.7625; Jain A, 2017, VACCINE, V35, P2315, DOI 10.1016/j.vaccine.2017.03.013; Lindman KL, 2019, ALZH DEMENT-TRCI, V5, P697, DOI 10.1016/j.trci.2019.09.014; Liu JC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002868; Lindman KL, 2021, ALZH DEMENT-TRCI, V7, DOI 10.1002/trc2.12119; Lovheim H, 2015, ALZHEIMERS DEMENT, V11, P587, DOI 10.1016/j.jalz.2014.07.157; Lu PJ, 2020, AM J PREV MED, V59, P21, DOI 10.1016/j.amepre.2020.01.017; Luo CS, 2020, J INVEST MED, V68, P838, DOI 10.1136/jim-2019-001155; Mayeda ER, 2016, ALZHEIMERS DEMENT, V12, P216, DOI 10.1016/j.jalz.2015.12.007; Scherrer JF, 2019, ANN FAM MED, V17, P352, DOI 10.1370/afm.2415; Smith LH, 2019, EPIDEMIOLOGY, V30, P509, DOI 10.1097/EDE.0000000000001032; Sochocka M, 2017, CURR NEUROPHARMACOL, V15, P996, DOI 10.2174/1570159X15666170313122937; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; Tsai MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188490; Verreault R, 2001, CAN MED ASSOC J, V165, P1495; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Wang XX, 2020, EUR REV MED PHARMACO, V24, P9601, DOI 10.26355/eurrev_202009_23048; World Health Organization, DEM KEY FACTS	33	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0257405	10.1371/journal.pone.0257405	http://dx.doi.org/10.1371/journal.pone.0257405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788293	Green Published, gold			2022-12-26	WOS:000735920500003
J	Birras, J; White, SJ; Jonsdottir, S; Novotny, EN; Ziegler, A; Wilson, AD; Frey, R; Torsteinsdottir, S; Alcocer, M; Marti, E				Birras, Jasmin; White, Samuel J.; Jonsdottir, Sigridur; Novotny, Ella N.; Ziegler, Anja; Wilson, A. Douglas; Frey, Rebecka; Torsteinsdottir, Sigurbjorg; Alcocer, Marcos; Marti, Eliane			First clinical expression of equine insect bite hypersensitivity is associated with co-sensitization to multiple Culicoides allergens	PLOS ONE			English	Article							ICELANDIC HORSES; DOUBLE-BLIND; IMMUNOTHERAPY; IGE; IDENTIFICATION; DIAGNOSIS; OBSOLETUS; RELEVANT	Background Insect bite hypersensitivity (IBH) is an IgE-mediated allergic dermatitis in horses incited by salivary allergens from Culicoides spp. IBH does not occur in Iceland, as the causative agents are absent, however a high prevalence is seen in horses exported to Culicoides-rich environments. Aims To study the natural course of sensitization to Culicoides allergens and identify the primary sensitizing allergen(s) in horses exported from Iceland utilizing a comprehensive panel of Culicoides recombinant (r-) allergens. Method IgE microarray profiling to 27 Culicoides r-allergens was conducted on 110 serological samples from horses imported to Switzerland from Iceland that subsequently developed IBH or remained healthy. Furthermore, a longitudinal study of 31 IBH horses determined IgE profiles the summer preceding first clinical signs of IBH (T-IBH-1), the summer of first clinical signs (T-IBH) and the following summer (T-IBH+1). In a group of Icelandic horses residing in Sweden, effects of origin (born in Iceland or Sweden) and duration of IBH (<4 years, 4-7 years, >7 years) on Culicoides-specific IgE was evaluated. Sero-positivity rates and IgE levels were compared. Results At T-IBH, horses were sensitized to a median of 11 r-allergens (range = 0-21), of which nine were major allergens. This was significantly higher than T-IBH-1 (3, 0-16), as well as the healthy (1, 0-14) group. There was no significant increase between T-IBH and T-IBH+1(12, 0-23). IBH-affected horses exported from Iceland had a significantly higher degree of sensitization than those born in Europe, while duration of IBH did not significantly affect degree of sensitization. Conclusion Significant sensitization is only detected in serum the year of first clinical signs of IBH. Horses become sensitized simultaneously to multiple Culicoides r-allergens, indicating that IgE-reactivity is due to co-sensitization rather than cross-reactivity between Culicoides allergens. Nine major first sensitizing r-allergens have been identified, which could be used for preventive allergen immunotherapy.	[Birras, Jasmin; Jonsdottir, Sigridur; Novotny, Ella N.; Ziegler, Anja; Marti, Eliane] Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland; [White, Samuel J.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, England; [White, Samuel J.; Alcocer, Marcos] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Jonsdottir, Sigridur; Torsteinsdottir, Sigurbjorg] Univ Iceland, Biomed Ctr, Inst Expt Pathol, Reykjavik, Iceland; [Wilson, A. Douglas] Univ Bristol, Div Vet Pathol Infect & Immun, Langford, England; [Frey, Rebecka] AniCura Norsholms Djursjukhus, Norsholm, Sweden	University of Bern; Nottingham Trent University; University of Nottingham; University of Iceland; University of Bristol	Marti, E (corresponding author), Univ Bern, Vetsuisse Fac, Dept Clin Res & Vet Publ Hlth, Bern, Switzerland.	eliane.marti@vetsuisse.unibe.ch		Jonsdottir, Sigridur/0000-0001-5562-7650; Marti, Eliane/0000-0003-1284-4350; White, Samuel/0000-0002-3675-7545; Ziegler, Anja/0000-0002-8178-9159	Swiss National Science Foundation [310030160196/1]; Morris Animal Foundation [D16EQ-039]; Stiftung Forschung fur das Pferd; Icelandic Research Fund [141071-05]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Morris Animal Foundation; Stiftung Forschung fur das Pferd; Icelandic Research Fund	This study was supported by the Swiss National Science Foundation grant no 310030160196/1, by the Morris Animal Foundation grant no D16EQ-039 and by the Stiftung Forschung fur das Pferd and by the Icelandic Research Fund grant no 141071-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinfenwa O, 2021, CURR OPIN ALLERGY CL, V21, P86, DOI 10.1097/ACI.0000000000000706; BARBET JL, 1990, EQUINE VET J, V22, P232, DOI 10.1111/j.2042-3306.1990.tb04258.x; Bjornsdottir S, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-3; Campana R, 2019, J ALLERGY CLIN IMMUN, V143, P1258, DOI 10.1016/j.jaci.2018.11.011; Eckl-Dorna J, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03131; Frey R, 2008, VET IMMUNOL IMMUNOP, V126, P102, DOI 10.1016/j.vetimm.2008.06.010; Ginel PJ, 2014, VET DERMATOL, V25, P29, DOI 10.1111/vde.12092; Hamza E, 2013, CLIN EXP ALLERGY, V43, P889, DOI 10.1111/cea.12131; Hamza E, 2008, VET IMMUNOL IMMUNOP, V122, P65, DOI 10.1016/j.vetimm.2007.10.018; Hamza E, 2010, VET IMMUNOL IMMUNOP, V133, P40, DOI 10.1016/j.vetimm.2009.07.002; Heimann M, 2011, VET IMMUNOL IMMUNOP, V140, P63, DOI 10.1016/j.vetimm.2010.11.016; Jonsdottir S, 2019, CURR DERMATOL REP, V8, P303, DOI 10.1007/s13671-019-00279-w; Langner KFA, 2009, INT J PARASITOL, V39, P243, DOI 10.1016/j.ijpara.2008.06.008; Lewis MJ, 2008, MOL IMMUNOL, V45, P818, DOI 10.1016/j.molimm.2007.06.158; Meulenbroeks C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122090; Novotny EN, 2021, ALLERGY, V76, P1147, DOI 10.1111/all.14556; Peeters LM, 2013, VET J, V198, P141, DOI 10.1016/j.tvjl.2013.06.010; Raza F, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02499-w; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; Schaffartzik A, 2010, VET IMMUNOL IMMUNOP, V137, P76, DOI 10.1016/j.vetimm.2010.04.012; Schaffartzik A, 2011, VET IMMUNOL IMMUNOP, V139, P200, DOI 10.1016/j.vetimm.2010.10.015; Shamji MH, 2017, J ALLERGY CLIN IMMUN, V140, P1485, DOI 10.1016/j.jaci.2017.10.010; Sommer-Locher B, 2012, J EQUINE VET SCI, V32, P158, DOI 10.1016/j.jevs.2011.08.013; Torsteinsdottir S, 2018, ACTA VET SCAND, V60, DOI 10.1186/s13028-018-0425-1; Tulaeva I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01368; van der Meide NMA, 2013, VET IMMUNOL IMMUNOP, V153, P227, DOI 10.1016/j.vetimm.2013.03.005; van der Meide NMA, 2012, VET IMMUNOL IMMUNOP, V149, P245, DOI 10.1016/j.vetimm.2012.07.007; White SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51820-7; White S, 2019, J VET INTERN MED, V33, P2327, DOI 10.1111/jvim.15564; Wilson AD, 2008, VET IMMUNOL IMMUNOP, V122, P94, DOI 10.1016/j.vetimm.2007.10.011; Wilson AD, 2006, VET IMMUNOL IMMUNOP, V112, P156, DOI 10.1016/j.vetimm.2006.02.003; Ziegler A, 2018, VET DERMATOL, V29, DOI 10.1111/vde.12493	32	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0257819	10.1371/journal.pone.0257819	http://dx.doi.org/10.1371/journal.pone.0257819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780496	gold, Green Published			2022-12-26	WOS:000755305800010
J	Cloer, C; Roudsari, L; Rochelle, L; Petrie, T; Welch, M; Charest, J; Tan, K; Li, FG; Petersen, T; Ilagan, R; Hogan, S				Cloer, Caryn; Roudsari, Laila; Rochelle, Lauren; Petrie, Timothy; Welch, Michaela; Charest, Joseph; Tan, Kelly; Li Fugang; Petersen, Thomas; Ilagan, Roger; Hogan, Sarah			Mesenchymal stromal cell-derived extracellular vesicles reduce lung inflammation and damage in nonclinical acute lung injury: Implications for COVID-19	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MICROVESICLES; EPITHELIUM; DISEASE	Mesenchymal stem cell derived extracellular vesicles (MSC-EVs) are bioactive particles that evoke beneficial responses in recipient cells. We identified a role for MSC-EV in immune modulation and cellular salvage in a model of SARS-CoV-2 induced acute lung injury (ALI) using pulmonary epithelial cells and exposure to cytokines or the SARS-CoV-2 receptor binding domain (RBD). Whereas RBD or cytokine exposure caused a pro-inflammatory cellular environment and injurious signaling, impairing alveolar-capillary barrier function, and inducing cell death, MSC-EVs reduced inflammation and reestablished target cell health. Importantly, MSC-EV treatment increased active ACE2 surface protein compared to RBD injury, identifying a previously unknown role for MSC-EV treatment in COVID-19 signaling and pathogenesis. The beneficial effect of MSC-EV treatment was confirmed in an LPS-induced rat model of ALI wherein MSC-EVs reduced pro-inflammatory cytokine secretion and respiratory dysfunction associated with disease. MSC-EV administration was dose-responsive, demonstrating a large effective dose range for clinical translation. These data provide direct evidence of an MSC-EV-mediated improvement in ALI and contribute new insights into the therapeutic potential of MSC-EVs in COVID-19 or similar pathologies of respiratory distress.	[Cloer, Caryn; Roudsari, Laila; Rochelle, Lauren; Petersen, Thomas; Ilagan, Roger; Hogan, Sarah] United Therapeut Corp, Dept Regenerat Med, Durham, NC 27709 USA; [Petrie, Timothy; Welch, Michaela; Charest, Joseph; Tan, Kelly] Draper, Cambridge, MA USA; [Li Fugang] HD Biosci, Shanghai, Peoples R China		Hogan, S (corresponding author), United Therapeut Corp, Dept Regenerat Med, Durham, NC 27709 USA.	sseiler@unither.com		Rochelle, Lauren/0000-0002-0669-1362	United Therapeutics	United Therapeutics	United Therapeutics provided support for this study in the form of salaries for CMC, LCR, LKR, RMI, THP, and SEH as well as project funding to TAP, MW, JC, KT, LF. The specific roles of these authors are articulated in the `author contributions' section. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar JA, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01123-2020; Anas A, 2010, CRIT CARE, V14, DOI 10.1186/cc8850; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Azizgolshani H, 2021, LAB CHIP, V21, P1454, DOI 10.1039/d1lc00067e; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Birra D, 2020, IMMUNOL RES, V68, P161, DOI 10.1007/s12026-020-09137-5; Bonniaud P, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02133-2017; Coperchini F, 2020, CYTOKINE GROWTH F R, V53, P25, DOI 10.1016/j.cytogfr.2020.05.003; Crimi Ettore, 2004, Best Pract Res Clin Anaesthesiol, V18, P477, DOI 10.1016/S1521-6896(03)00121-6; De Batista PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104020; Delgado-Roche L, 2020, ARCH MED RES, V51, P384, DOI 10.1016/j.arcmed.2020.04.019; Deng XQ, 2015, CELL PHYSIOL BIOCHEM, V36, P937, DOI 10.1159/000430268; Gard AL., 2020, HIGH THROUGHPUT HUMA, P1; Hogan SE, 2019, AM J PHYSIOL-LUNG C, V316, pL723, DOI 10.1152/ajplung.00058.2018; Inal JM, 2020, CLIN SCI, V134, P1301, DOI 10.1042/CS20200623; Iwasaki M, 2021, INFLAMMATION, V44, P13, DOI 10.1007/s10753-020-01337-3; Jiang ZL, 2017, AM J PHYSIOL-LUNG C, V312, pL231, DOI 10.1152/ajplung.00389.2016; Jung YJ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.48; Kallet RH, 2007, RESP CARE, V52, P989; Khatri M, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0774-8; Komanduri KV, 2006, BIOL BLOOD MARROW TR, V12, P1, DOI 10.1016/j.bbmt.2005.11.003; Lee S, 2020, TRENDS IMMUNOL, V41, P1083, DOI 10.1016/j.it.2020.10.005; Li GP, 2020, J AUTOIMMUN, V112, DOI 10.1016/j.jaut.2020.102463; Li L, 2020, CLIN TRANSL MED, V10, P20, DOI 10.1002/ctm2.16; Li WH, 2004, J VIROL, V78, P11429, DOI 10.1128/JVI.78.20.11429-11433.2004; Liang B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021429; Liu MY, 2020, J TRANSL INTERN MED, V8, P9, DOI 10.2478/jtim-2020-0003; Malik YS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070519; Manicone AM, 2009, EXPERT REV CLIN IMMU, V5, P63, DOI 10.1586/1744666X.5.1.63; Matuschak George M, 2010, Mo Med, V107, P252; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Monsel A, 2015, AM J RESP CRIT CARE, V192, P324, DOI 10.1164/rccm.201410-1765OC; Morris G, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118166; Niederman MS, 2020, AM J RESP CRIT CARE, V201, P1019, DOI 10.1164/rccm.202003-0741ED; Pandolfi L, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01343-z; Pocsfalvi G, 2020, KIDNEY BLOOD PRESS R, V45, P661, DOI 10.1159/000511402; Scala S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01201; Scherr SM, 2016, ACS NANO, V10, P2827, DOI 10.1021/acsnano.5b07948; Shu L, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01875-5; Skotland T, 2017, PROG LIPID RES, V66, P30, DOI 10.1016/j.plipres.2017.03.001; Suratt BT, 2009, CRIT CARE MED, V37, P1322, DOI 10.1097/CCM.0b013e31819c14fa; Tsiapalis D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040991; Tzotzos SJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03240-7; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Worthington EN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072318; Zhang HY, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-69; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu YG, 2014, STEM CELLS, V32, P116, DOI 10.1002/stem.1504; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	49	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259732	10.1371/journal.pone.0259732	http://dx.doi.org/10.1371/journal.pone.0259732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780505	gold, Green Published			2022-12-26	WOS:000755305800043
J	Devi, YD; Goswami, HB; Konwar, S; Doley, C; Dolley, A; Devi, A; Chongtham, C; Dowerah, D; Biswa, V; Jamir, L; Kumar, A; Satapathy, SS; Ray, SK; Deka, RC; Doley, R; Mandal, M; Das, S; Singh, CS; Borah, PP; Nath, P; Namsa, ND				Devi, Yengkhom Damayanti; Goswami, Himanshu Ballav; Konwar, Sushmita; Doley, Chandrima; Dolley, Anutee; Devi, Arpita; Chongtham, Chen; Dowerah, Dikshita; Biswa, Vashkar; Jamir, Latonglila; Kumar, Aditya; Satapathy, Siddhartha Shankar; Ray, Suvendra Kumar; Deka, Ramesh Chandra; Doley, Robin; Mandal, Manabendra; Das, Sandeep; Singh, Chongtham Shyamsunder; Borah, Partha Pratim; Nath, Pabitra; Namsa, Nima D.			Immunoinformatics mapping of potential epitopes in SARS-CoV-2 structural proteins	PLOS ONE			English	Article							NCOV-19 AZD1222 VACCINE; SYNDROME CORONAVIRUS 2; B-CELL EPITOPES; MHC CLASS-I; SARS CORONAVIRUS; T-CELLS; PREDICTION; ANTIBODIES; CANDIDATE; PEPTIDES	All approved coronavirus disease 2019 (COVID-19) vaccines in current use are safe, effective, and reduce the risk of severe illness. Although data on the immunological presentation of patients with COVID-19 is limited, increasing experimental evidence supports the significant contribution of B and T cells towards the resolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Despite the availability of several COVID-19 vaccines with high efficacy, more effective vaccines are still needed to protect against the new variants of SARS-CoV-2. Employing a comprehensive immunoinformatic prediction algorithm and leveraging the genetic closeness with SARS-CoV, we have predicted potential immune epitopes in the structural proteins of SARS-CoV-2. The S and N proteins of SARS-CoV-2 and SARS-CoVs are main targets of antibody detection and have motivated us to design four multi-epitope vaccines which were based on our predicted B- and T-cell epitopes of SARS-CoV-2 structural proteins. The cardinal epitopes selected for the vaccine constructs are predicted to possess antigenic, non-allergenic, and cytokine-inducing properties. Additionally, some of the predicted epitopes have been experimentally validated in published papers. Furthermore, we used the C-ImmSim server to predict effective immune responses induced by the epitope-based vaccines. Taken together, the immune epitopes predicted in this study provide a platform for future experimental validations which may facilitate the development of effective vaccine candidates and epitope-based serological diagnostic assays.	[Devi, Yengkhom Damayanti; Goswami, Himanshu Ballav; Konwar, Sushmita; Doley, Chandrima; Dolley, Anutee; Devi, Arpita; Chongtham, Chen; Kumar, Aditya; Ray, Suvendra Kumar; Doley, Robin; Mandal, Manabendra; Namsa, Nima D.] Tezpur Univ, Dept Mol Biol & Biotechnol, Napaam, Assam, India; [Chongtham, Chen] Jawaharlal Nehru Univ, Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi, India; [Dowerah, Dikshita; Deka, Ramesh Chandra] Tezpur Univ, Dept Chem Sci, Napaam, Assam, India; [Biswa, Vashkar; Das, Sandeep] Bodoland Univ, Dept Biotechnol, Kokrajhar, Assam, India; [Jamir, Latonglila] Nagaland Univ Cent, Dept Environm Sci, Lumami, India; [Satapathy, Siddhartha Shankar] Tezpur Univ, Dept Comp Sci & Engn, Napaam, Assam, India; [Satapathy, Siddhartha Shankar; Ray, Suvendra Kumar; Deka, Ramesh Chandra; Mandal, Manabendra; Namsa, Nima D.] Tezpur Univ, Ctr Multidisciplinary Res, Napaam, Assam, India; [Singh, Chongtham Shyamsunder] Reg Inst Med Sci, Dept Paediat, Imphal, Manipur, India; [Borah, Partha Pratim] Pratiksha Hosp, Dept Paediat & Neonatol, Gauhati, Assam, India; [Nath, Pabitra] Tezpur Univ, Dept Phys, Napaam, Assam, India	Tezpur University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi; Tezpur University; Nagaland University; Tezpur University; Tezpur University; Regional Institute of Medical Sciences, Imphal; Tezpur University	Namsa, ND (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, Napaam, Assam, India.; Namsa, ND (corresponding author), Tezpur Univ, Ctr Multidisciplinary Res, Napaam, Assam, India.	namsa@tezu.ernet.in	Kumar, Aditya/T-9863-2019	Kumar, Aditya/0000-0002-6474-8830; Devi, Arpita/0000-0003-1718-4005	UGC-CSIR Senior Research Fellowship [2121530642, 20/12/2015(ii)EU-V]; Ministry of Science and Technology, Department of Biotechnology (DBT), Govt. of India	UGC-CSIR Senior Research Fellowship; Ministry of Science and Technology, Department of Biotechnology (DBT), Govt. of India	YDD is a recipient of UGC-CSIR Senior Research Fellowship (Sr. No. 2121530642, Ref. No: 20/12/2015(ii)EU-V) support for pursuing PhD work. SKR, RCD, SSS, and NDN duly acknowledged the use of computational facility at Centre for Computational Biology and Bioinformatics, Tezpur University, Assam supported by the Ministry of Science and Technology, Department of Biotechnology (DBT), Govt. of India.	Al Kaabi N, 2021, JAMA-J AM MED ASSOC, V326, P35, DOI 10.1001/jama.2021.8565; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Ashik AI, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04865; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Burbelo PD, 2020, J INFECT DIS, V222, P206, DOI 10.1093/infdis/jiaa273; Crooke SN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70864-8; Das BK, 2020, J PHYS CHEM LETT, V11, P9920, DOI 10.1021/acs.jpclett.0c02846; Devi YD, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05760; Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30; Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Emary KRW, 2021, LANCET, V397, P1351, DOI 10.1016/S0140-6736(21)00628-0; Flaxman A, 2021, LANCET, V398, P981, DOI 10.1016/S0140-6736(21)01699-8; Friberg H, 2011, IMMUNOL CELL BIOL, V89, P122, DOI 10.1038/icb.2010.61; Giguere S, 2013, J IMMUNOL METHODS, V400, P30, DOI 10.1016/j.jim.2013.10.003; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Grzelak L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc3103; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Haveri A, 2020, EUROSURVEILLANCE, V25, P16, DOI 10.2807/1560-7917.ES.2020.25.11.2000266; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kar T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67749-1; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Leung DTM, 2004, J INFECT DIS, V190, P379, DOI 10.1086/422040; Li L, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198082; Li Y, 2020, CELL MOL IMMUNOL, V17, P1095, DOI 10.1038/s41423-020-00523-5; Liang SD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-381; Liu SJ, 2006, VACCINE, V24, P3100, DOI 10.1016/j.vaccine.2006.01.058; Liu WB, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00461-20; Lon JR, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01437-4; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Martins VT, 2017, CELL IMMUNOL, V313, P32, DOI 10.1016/j.cellimm.2016.12.008; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; Naz A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01663; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Oliveira SC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.587615; Paris C, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.06.043; Paul Sinu, 2016, Curr Protoc Immunol, V114, DOI 10.1002/cpim.12; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Perera RAPM, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.16.2000421; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Poh CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16638-2; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Rakib A, 2020, COMPUT BIOL MED, V124, DOI 10.1016/j.compbiomed.2020.103967; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; Reynisson B, 2020, J PROTEOME RES, V19, P2304, DOI 10.1021/acs.jproteome.9b00874; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Tehrani ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237828; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Tripp RA, 2005, J VIROL METHODS, V128, P21, DOI 10.1016/j.jviromet.2005.03.021; Vali B, 2011, J VIROL, V85, P254, DOI 10.1128/JVI.01743-10; Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.07.038; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y; Wang DL, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030355; Wang HY, 2020, ACS CENTRAL SCI, V6, P2238, DOI 10.1021/acscentsci.0c00742; Wang JQ, 2003, CLIN CHEM, V49, P1989, DOI 10.1373/clinchem.2003.023184; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu Qingfa, 2003, Genomics Proteomics & Bioinformatics, V1, P131; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yang XF, 2020, J CELL MOL MED, V24, P12457, DOI 10.1111/jcmm.15771; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang BZ, 2020, CELL RES, V30, P702, DOI 10.1038/s41422-020-0366-x; Zhang YJ, 2021, LANCET INFECT DIS, V21, P181, DOI 10.1016/S1473-3099(20)30843-4; Zhao DM, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1052-1; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3; Zheng M, 2020, CELL MOL IMMUNOL, V17, P536, DOI 10.1038/s41423-020-0385-z; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	90	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0258645	10.1371/journal.pone.0258645	http://dx.doi.org/10.1371/journal.pone.0258645			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780495	Green Submitted, gold, Green Published			2022-12-26	WOS:000755305800015
J	Mihelic, A; Jelovcan, L; Prislan, K				Mihelic, Anze; Jelovcan, Luka; Prislan, Kaja			Internal and external drivers for compliance with the COVID-19 preventive measures in Slovenia: The view from general deterrence and protection motivation	PLOS ONE			English	Article							FEAR APPEALS; SELF-EFFICACY; HUMAN-RIGHTS; HEALTH; BEHAVIORS; PUNISHMENT; INTENTION; IMPACT; CRIME; LEGAL	The emergence of a pandemic is usually accompanied by different measures-economic, social, preventive, and (self)protective. In the case of the COVID-19, several preventive measures were formally enforced by state authorities in the majority of countries worldwide. Thus, during the COVID-19 pandemic, the intertwining of formal and informal social control could be observed. Hence, in this study a cross-sectional design was chosen to explore the issue in Slovenia. To the best of our knowledge, this research is the first in the current literature to empirically test the general deterrence theory in pandemic circumstances (as external factors predicting individuals' compliance with the COVID-19 preventive measures). The results suggest an important role of informal punishment, with perceived informal severity being the only statistically significant factor from the general deterrence theory. In contrast to external factors, internal factors play a significantly greater role in promoting people's self-protective behavior in pandemic circumstances. During the unknown, the uncertain and delicate situations with which people have no previous experience, both personal beliefs about the effectiveness of measures and perceived self-efficacy are more important than fear of formal sanctions.	[Mihelic, Anze; Jelovcan, Luka; Prislan, Kaja] Univ Maribor, Fac Criminal Justice & Secur, Ljubljana, Slovenia	University of Maribor	Mihelic, A (corresponding author), Univ Maribor, Fac Criminal Justice & Secur, Ljubljana, Slovenia.	anze.mihelic@um.si		Mihelic, Anze/0000-0002-5925-4262				Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Al-Rasheed M, 2020, SOC WORK PUBLIC HLTH, V35, P546, DOI 10.1080/19371918.2020.1806171; Allen S, 2017, POLIC SOC, V27, P884, DOI 10.1080/10439463.2015.1115502; Ambroz M, 2016, REV KRIMINALISTIKO K, V67, P5; Balachandar V, 2020, EUR REV MED PHARMACO, V24, P3422, DOI 10.26355/eurrev_202003_20713; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; BISHOP DM, 1984, CRIMINOLOGY, V22, P403, DOI 10.1111/j.1745-9125.1984.tb00307.x; Boer H, 1996, PREDICTING HLTH BEHA, P95, DOI [10.1080/13548506.2011.579983, DOI 10.1080/13548506.2011.579983]; Boss SR, 2015, MIS Q, V39, P1; D'Arcy J, 2009, INFORM SYST RES, V20, P79, DOI 10.1287/isre.1070.0160; Darren G., 2002, SPSS WINDOWS STEP ST; De Coninck D, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106060; FLYNN MF, 1995, J SOC CLIN PSYCHOL, V14, P61, DOI 10.1521/jscp.1995.14.1.61; Fofana NK, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113230; Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903; GIBBS JP, 1968, SOUTHWEST SOC SCI Q, V48, P515; Gostin LO, 2003, J LAW MED ETHICS, V31, P524, DOI 10.1111/j.1748-720X.2003.tb00120.x; Government of the Republic of Serbia, 2020, GOV AD NEW MEAS COVI; Hart PS, 2020, SCI COMMUN, V42, P679, DOI 10.1177/1075547020950735; Heo M, 2019, JOURNALISM, V20, P1611, DOI 10.1177/1464884916688928; Hirsch V A, 1999, CRIMINAL DETERRENCE; Hirtenlehner H, 2014, BRIT J CRIMINOL, V54, P128, DOI 10.1093/bjc/azt053; Ho HSW, 2012, PUBLIC HEALTH, V126, P1001, DOI 10.1016/j.puhe.2012.09.010; Jansen J., 2015, P 9 INT S HUM ASP IN, P120; Johnston AC, 2010, MIS QUART, V34, P549; Kohm SA, 2009, CRIME MEDIA CULT, V5, P188, DOI 10.1177/1741659009335724; Kuo KM, 2017, J MED SYST, V41, DOI 10.1007/s10916-017-0833-1; Lambert EG, 2012, ASIAN J CRIMINOL, V7, P239, DOI 10.1007/s11417-011-9108-9; Lazarus R.S., 1984, EMOTION ADAPTATION; LeFebvre R, 2012, PROCEEDINGS OF THE 2012 INFORMATION SECURITY CURRICULUM DEVELOPMENT CONFERENCE (INFOSEC CD '12), P1; Li ZH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008584; MACCOUN RJ, 1993, PSYCHOL BULL, V113, P497, DOI 10.1037/0033-2909.113.3.497; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Martens M, 2019, COMPUT HUM BEHAV, V92, P139, DOI 10.1016/j.chb.2018.11.002; Mesko G, 2015, REV KRIMINALISTIKO K, V66, P33; Miheli A, 2017, ADV CYBERSECURITY; Miheli A., 2017, SAMOVAROVANJE PRED S; Miller S, 2012, PSYCHOL HEALTH MED, V17, P59, DOI 10.1080/13548506.2011.564188; Milne S, 2002, BRIT J HEALTH PSYCH, V7, P163, DOI 10.1348/135910702169420; Moody GD, 2018, MIS QUART, V42, P285, DOI 10.25300/MISQ/2018/13853; Mortada E, 2021, RISK MANAG HEALTHC P, V14, P685, DOI 10.2147/RMHP.S289837; Myers LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-15; Nagin DS, 2001, CRIMINOLOGY, V39, P865, DOI 10.1111/j.1745-9125.2001.tb00943.x; Neuwirth K, 2000, RISK ANAL, V20, P721, DOI 10.1111/0272-4332.205065; Olcer S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09079-5; Okuhara T, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040475; PETEE TA, 1994, CRIMINOLOGY, V32, P85, DOI 10.1111/j.1745-9125.1994.tb01147.x; Pogarsky G, 2002, JUSTICE Q, V19, P431, DOI 10.1080/07418820200095301; Prosser AMB, 2020, BRIT J SOC PSYCHOL, V59, P653, DOI 10.1111/bjso.12399; Rad RE, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10500-w; Rogers R.W., 1983, SOCIAL PSYCHOPHYSIOL; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Savage M., 2020, BBC NEWS 0425; SHERMAN LW, 1993, J RES CRIME DELINQ, V30, P445, DOI 10.1177/0022427893030004006; Siedner MJ, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003244; SILBERMAN M, 1976, AM SOCIOL REV, V41, P442, DOI 10.2307/2094253; Suligoj B, 2020, NOVA PONUDBA PORTORO; Tang KHD, 2022, J PUBLIC HEALTH-HEID, V30, P583, DOI 10.1007/s10389-020-01316-w; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; Thrasher JF, 2016, HEALTH COMMUN, V31, P1517, DOI 10.1080/10410236.2015.1089456; Toelstede B, 2019, DEMOCR SECUR, V15, P137, DOI 10.1080/17419166.2018.1493992; Prasetyo YT, 2020, INT J INFECT DIS, V99, P312, DOI 10.1016/j.ijid.2020.07.074; Vance A, 2012, J ORGAN END USER COM, V24, P21, DOI 10.4018/joeuc.2012010102; Velez ME, 2014, ENCY CRIMINOLOGY CRI, DOI [10.1007/978-1-4614-5690-2, DOI 10.1007/978-1-4614-5690-2]; Wenzel M, 2004, LAW HUMAN BEHAV, V28, P547, DOI 10.1023/B:LAHU.0000046433.57588.71; Weston J, 2019, CULT SOC HIST, V16, P225, DOI 10.1080/14780038.2019.1585012; Williams L, 2015, PSYCHOL HEALTH MED, V20, P832, DOI 10.1080/13548506.2015.1028946; Wilson K, 2010, HEALTH POLICY PLANN, V25, P505, DOI 10.1093/heapol/czq026; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Wong CY, 2005, J ADOLESCENT HEALTH, V36, P193, DOI 10.1016/j.jadohealth.2004.02.024; Yan QL, 2018, STAT MED, V37, P948, DOI 10.1002/sim.7548; Yang ZJ, 2015, J HEALTH COMMUN, V20, P69, DOI 10.1080/10810730.2014.904023; Zhang CQ, 2019, ASIA-PAC J PUBLIC HE, V31, P246, DOI 10.1177/1010539519844082; Zhang XJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010197; Zhang Y, 2020, HUM ECOL RISK ASSESS, V26, P190, DOI 10.1080/10807039.2018.1503931	77	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259675	10.1371/journal.pone.0259675	http://dx.doi.org/10.1371/journal.pone.0259675			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780530	Green Published, gold			2022-12-26	WOS:000755305800039
J	Serra, FE; Francisco, RPV; de Rossi, P; Brizot, MD; Rodrigues, AS				Serra, Fabiano Elisei; Vieira Francisco, Rossana Pulcineli; de Rossi, Patricia; Brizot, Maria de Lourdes; Rodrigues, Agatha Sacramento			COVID-19 outcomes in hospitalized puerperal, pregnant, and neither pregnant nor puerperal women	PLOS ONE			English	Article							DEATH; RISK	Objective To compare hospitalized reproductive age women with COVID-19 who were pregnant, puerperal, or neither one nor the other in terms of demographic and clinical characteristics and disease progression using Brazilian epidemiological data. Methods A retrospective analysis of the records of the Information System of the Epidemiological Surveillance of Influenza of the Health Ministry of Brazil was performed. It included the data of female patients aged 10 to 49 years hospitalized because of severe COVID-19 disease (RT-PCR+ for SARS-CoV-2), from February 17, 2020 to January 02, 2021. They were separated into 3 groups: pregnant, puerperal, and neither pregnant nor puerperal. General comparisons and then adjustments for confounding variables (propensity score matching [PSM]) were made, using demographic and clinical characteristics, disease progression (admission to the intensive care unit [ICU] and invasive or noninvasive ventilatory support), and outcome (cure or death). Deaths were analyzed in each group according to comorbidities, invasive or noninvasive ventilatory support, and admission to the ICU. Results As many as 40,640 reproductive age women hospitalized for COVID-19 were identified: 3,372 were pregnant, 794 were puerperal, and 36,474 were neither pregnant nor puerperal. Groups were significantly different in terms of demographic data and comorbidities (p<0.0001). Pregnant and puerperal women were less likely to be symptomatic than the women who were neither one nor the other (72.1%, 69.7% and 88.8%, respectively). Pregnant women, however, had a higher frequency of anosmia, and ageusia than the others. After PSM, puerperal women had a worse prognosis than pregnant women with respect to admission to the ICU, invasive ventilatory support, and death, with OR (95% CI) 1.97 (1.55 - 2.50), 2.71 (1.78 - 4.13), and 2.51 (1.79 - 3.52), respectively. Conclusion Puerperal women were at a higher risk for serious outcomes (need for the ICU, need for invasive and noninvasive ventilatory support, and death) than pregnant women.	[Serra, Fabiano Elisei; Vieira Francisco, Rossana Pulcineli; Brizot, Maria de Lourdes; Rodrigues, Agatha Sacramento] Univ Sao Paulo, Fac Med, Dept Obstetricia & Ginecol, Disciplina Obstetricia, Sao Paulo, SP, Brazil; [de Rossi, Patricia] Univ Santo Amaro UNISA, Curso Med, Sao Paulo, SP, Brazil; [de Rossi, Patricia] Conjunto Hosp Mandaqui, Gerencia Med Perinatal & Ginecol, Sao Paulo, SP, Brazil; [Rodrigues, Agatha Sacramento] Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil	Universidade de Sao Paulo; Universidade de Santo Amaro (UNISA); Universidade Federal do Espirito Santo	Francisco, RPV; Rodrigues, AS (corresponding author), Univ Sao Paulo, Fac Med, Dept Obstetricia & Ginecol, Disciplina Obstetricia, Sao Paulo, SP, Brazil.; Rodrigues, AS (corresponding author), Univ Fed Espirito Santo, Dept Estat, Vitoria, ES, Brazil.	rossana.francisco@hc.fm.usp.br; agatha.rodrigues@ufes.br	Francisco, Rossana PV/C-5648-2012; de Lourdes Brizot, Maria/C-5706-2013	Francisco, Rossana PV/0000-0002-9981-8069; de Lourdes Brizot, Maria/0000-0002-6135-4844; Serra, Fabiano/0000-0002-5623-4936; de Rossi, Patricia/0000-0002-2971-9401	Bill & Melinda Gates Foundation [INV-027961]; CNPq [445881/2020-8]; FAPES [007/2021]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPES(Fundacao de Amparo a Pesquisa do Estado de Espiritu Santo (FAPES))	This work was supported, in whole or in part, by the Bill & Melinda Gates Foundation [INV-027961]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. This work is also funded by CNPq (Award Number: 445881/2020-8) and FAPES (Award Number: 007/2021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Badr DA, 2020, AM J OBSTET GYNECOL, V223, P764, DOI 10.1016/j.ajog.2020.07.045; Brasil. Ministerio da Saude, 2019, DATASUS SIST INF NAS; Brasil. Ministerio da Saude, DEF CAS NOT; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Collin J, 2020, ACTA OBSTET GYN SCAN, V99, P819, DOI 10.1111/aogs.13901; Di Toro F, 2021, CLIN MICROBIOL INFEC, V27, P36, DOI 10.1016/j.cmi.2020.10.007; Elshafeey F, 2020, INT J GYNECOL OBSTET, V150, P47, DOI 10.1002/ijgo.13182; Finlayson K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231415; Greifer N., 2020, R package version 0.10.2 [software]; Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Huntley BJF, 2020, OBSTET GYNECOL, V136, P303, DOI 10.1097/AOG.0000000000004010; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Kasraeian M, 2022, J MATERN-FETAL NEO M, V35, P1652, DOI 10.1080/14767058.2020.1763952; Kayem G, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101826; Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107; Lee K, 2009, GLOB INST, P1; Lumbreras-Marquez MI, 2020, INT J GYNECOL OBSTET, V150, P266, DOI 10.1002/ijgo.13250; Martinez-Portilla RJ, 2021, ULTRASOUND OBST GYN, V57, P224, DOI 10.1002/uog.23575; Menezes MO, 2020, INT J GYNECOL OBSTET, V151, P415, DOI 10.1002/ijgo.13407; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; R Core Team, 2021, R LANGUAGE ENV STAT; Amorim MMR, 2020, AM J OBSTET GYNECOL, V223, P298, DOI 10.1016/j.ajog.2020.04.023; Sentilhes L, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.06.022; Sobhy S, 2019, LANCET, V393, P1973, DOI 10.1016/S0140-6736(18)32386-9; Takemoto MLS, 2020, BJOG-INT J OBSTET GY, V127, P1618, DOI 10.1111/1471-0528.16470; Takemoto MLS, 2020, INT J GYNECOL OBSTET, V151, P154, DOI 10.1002/ijgo.13300; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Vallejo V, 2020, OBSTET GYNECOL, V136, P52, DOI 10.1097/AOG.0000000000003950; World Health Organization, WHO DIR GEN OP REM M; Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259911	10.1371/journal.pone.0259911	http://dx.doi.org/10.1371/journal.pone.0259911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780549	gold, Green Published			2022-12-26	WOS:000755305800068
J	Song, P; Xu, W; Wang, KM; Zhang, Y; Wang, F; Zhou, XL; Shi, HY; Feng, W				Song, Peng; Xu, Wei; Wang, Kuiming; Zhang, Yang; Wang, Fei; Zhou, Xiuling; Shi, Haiying; Feng, Wei			Cloning, expression and characterization of metalloproteinase HypZn from Aspergillus niger	PLOS ONE			English	Article							PICHIA-PASTORIS; PROTEIN; PURIFICATION; SERRALYSINS; INHIBITORS; ASTACINS; ORYZAE	A predicted metalloproteinase gene, HypZn, was cloned from Aspergillus nigerCGMCC 3.7193 and expressed in Pichia pastoris GS115, and the physicochemical characteristics of recombinant HypZn were investigated after separation and purification. The results showed that the specific activity of the purified HypZn reached 1859.2 U/mg, and the optimum temperature and pH value of HypZn were 35 degrees C and 7.0, respectively. HypZn remained stable both at 40 degrees C and at pH values between 5.0 and 8.0. The preferred substrate of HypZn was soybean protein isolates, and the K-m and V-max values were 21.5 mu mol/mL and 4926.6 mu mol/(mL center dot min), respectively. HypZn was activated by Co2+ and Zn2+ and inhibited by Cu2+ and Fe2+. The degree of soybean protein isolate hydrolysis reached 14.7%, and the hydrolysates were of uniform molecular weight. HypZn could tolerate 5000 mM NaCI and completely lost its activity after 30 min at 50 degrees C. The enzymological characterizations indicated that HypZn has great application potential in the food industry, especially in fermented food processing.	[Song, Peng; Xu, Wei; Wang, Kuiming; Zhang, Yang; Wang, Fei; Zhou, Xiuling; Shi, Haiying; Feng, Wei] Liaocheng Univ, Sch Life Sci, Liaocheng, Shandong, Peoples R China	Liaocheng University	Feng, W (corresponding author), Liaocheng Univ, Sch Life Sci, Liaocheng, Shandong, Peoples R China.	fengwei01@lcu.edu.cn						[Anonymous], 1993, QBT1803 1993 GEN MET; Balaban NP, 2012, BIOCHEMISTRY-MOSCOW+, V77, P119, DOI 10.1134/S0006297912020010; Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Chang CY, 2010, J BIOL CHEM, V285, P39500, DOI 10.1074/jbc.M110.139683; Dongre M, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1219, DOI 10.1016/B978-0-12-382219-2.00273-8; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu RuCui, 2018, Food Research and Development, V39, P22; Ma XJ, 2016, PROTEIN EXPRES PURIF, V128, P52, DOI 10.1016/j.pep.2016.08.008; Velez-Gomez JM, 2019, INT J BIOL MACROMOL, V135, P97, DOI 10.1016/j.ijbiomac.2019.05.122; Meena M, 2018, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: PENICILLIUM SYSTEM PROPERTIES AND APPLICATIONS, P167, DOI 10.1016/B978-0-444-63501-3.00009-0; Minaev M., 2019, PotravinArstvo: Slovak Journal of Food Sciences, V13, P628, DOI 10.5219/1087; Nemoto W, 2013, NEUROPEPTIDES, V47, P187, DOI 10.1016/j.npep.2012.11.002; Nielsen PM, 2001, J FOOD SCI, V66, P642, DOI 10.1111/j.1365-2621.2001.tb04614.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Poleto MD, 2019, FOOD CHEM, V286, P309, DOI 10.1016/j.foodchem.2019.01.204; Rawlings N.D., 2004, HDB PROTEOLYTIC ENZY, P231; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Saha BC, 2001, BIOTECHNOL ADV, V19, P355, DOI 10.1016/S0734-9750(01)00070-2; SARKAR I., 2015, COMPUTATIONAL ADV CO, V335; Schwettmann L, 2001, PROTEIN EXPRES PURIF, V21, P65, DOI 10.1006/prep.2000.1374; Silva BA, 2011, MYCOSES, V54, P105, DOI 10.1111/j.1439-0507.2009.01767.x; Singh AK, 2014, BIOCHEMISTRY-US, V53, P7870, DOI 10.1021/bi501263u; Song JK, 2006, ENZYME MICROB TECH, V39, P1190, DOI 10.1016/j.enzmictec.2006.02.030; SONG Y., 2015, THESIS DALIAN POLYTE; Sorapukdee S, 2020, LWT-FOOD SCI TECHNOL, V126, DOI 10.1016/j.lwt.2020.109307; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; STOCKER W, 1995, PROTEIN SCI, V4, P823; Tapader R, 2016, INT J MED MICROBIOL, V306, P554, DOI 10.1016/j.ijmm.2016.06.003; TATSUMI H, 1991, MOL GEN GENET, V228, P97, DOI 10.1007/BF00282453; Thomas NN, 2021, MATER TODAY-PROC, V41, P685, DOI 10.1016/j.matpr.2020.05.435; Volk V, 2021, J DAIRY SCI, V104, P5185, DOI 10.3168/jds.2020-19790; Wang Ling, 2018, Shipin Kexue / Food Science, V39, P99; Wang XY, 2004, BIOCHEM CELL BIOL, V82, P329, DOI 10.1139/o03-082; Wood TE, 2019, CELL REP, V29, P187, DOI 10.1016/j.celrep.2019.08.094; Wu JW, 2011, APPL MICROBIOL BIOT, V92, P253, DOI 10.1007/s00253-011-3532-8; Yang ZL, 2018, BIOTECHNOL ADV, V36, P182, DOI 10.1016/j.biotechadv.2017.11.002; Yavuz S, 2017, INT J BIOL MACROMOL, V94, P106, DOI 10.1016/j.ijbiomac.2016.10.006; Zhang Zhijie, 2020, Enzyme Microb Technol, V142, P109679, DOI 10.1016/j.enzmictec.2020.109679	39	0	0	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259809	10.1371/journal.pone.0259809	http://dx.doi.org/10.1371/journal.pone.0259809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762700	Green Published, gold			2022-12-26	WOS:000755316600041
J	Yang, I; Wakamatsu, T; Sacho, IBI; Fazzi, JH; de Aquino, AC; Ayub, G; Rebello, PA; Gomes, JAP; Alves, M				Yang, Isabela; Wakamatsu, Tais; Inhesta Sacho, Isabella Batistela; Fazzi, Jose Henrique; de Aquino, Asafe Cesar; Ayub, Gabriel; Rebello, Pedro Albuquerque; Pereira Gomes, Jose Alvaro; Alves, Monica			Prevalence and associated risk factors for dry eye disease among Brazilian undergraduate students	PLOS ONE			English	Article								Purpose Dry eye is a common, complex, and multifactorial disease of the ocular surface and tear film that results in discomfort and visual disturbances. Prevalence rates vary and largely rely on studies involving older populations. This study sought to evaluate dry eye among a sample of young students in Brazil. Methods Cross-sectional survey included 2,140 students using 2 self-applicable questionnaires of dry eye symptoms: the Ocular Surface Disease Index (OSDI) and the Women's Health Study (WHS) questionnaire and a list of risk factors associated with dry eye. Participants with dry eye symptoms underwent a clinical evaluation. Results Participants were 23.4 +/- 5.2 years of age, 56.1% female and 43.9% male, 34.4% had an OSDI score greater than 22, and 23.5% had dry eye according to the WHS. Dry eye frequency differed consistently between the sexes: 42.6% women and 24.0% men based on the OSDI, and 27.1% women and 18.5% men based on the WHS. Univariate and multivariate analyses demonstrated that female sex, contact lens wear, the screen use for more than 6 hours per day, less than 6 hours of sleep a night, and certain medications were relevant related risk factors for dry eye. Despite symptoms, clinical evaluations demonstrated mild signs of dry eye. Conclusions Dry eye symptoms were found to be a prevalent condition among Brazilian undergraduate students. Compared to the rates of dry eye among the general Brazilian population over 40 years of age, students present at higher dry eye symptoms rates and distinct odds for related risk factors were identified.	[Yang, Isabela; Inhesta Sacho, Isabella Batistela; Ayub, Gabriel; Rebello, Pedro Albuquerque; Alves, Monica] Univ Campinas UNICAMP, Sch Med Sci, Dept Ophthalmol & Otorhinolaryngol, Campinas, SP, Brazil; [Wakamatsu, Tais; Fazzi, Jose Henrique; de Aquino, Asafe Cesar; Pereira Gomes, Jose Alvaro] Fed Univ Sao Paulo UNIFESP, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	Alves, M (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Ophthalmol & Otorhinolaryngol, Campinas, SP, Brazil.	monicalves@me.com	Alves, Monica/J-1499-2014; Wakamatsu, Tais/E-9300-2012	Alves, Monica/0000-0001-7940-0194; Yang, Isabela/0000-0002-1912-3954	Fapesp [2014/19138-5]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fapesp grant MA as PI Grant number 2014/19138-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rashidi SH, 2017, INT J HEALTH SCI-IJH, V11, P17; Alves M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097921; Asiedu K, 2017, EYE CONTACT LENS, V43, P262, DOI 10.1097/ICL.0000000000000256; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Caffery B, 2019, OCUL SURF, V17, P526, DOI 10.1016/j.jtos.2019.02.011; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; de Castro JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20273-9; de Castro JS, 2017, ARQ BRAS OFTALMOL, V80, P14, DOI 10.5935/0004-2749.20170005; Farrand KF, 2017, AM J OPHTHALMOL, V182, P90, DOI 10.1016/j.ajo.2017.06.033; Garza-Leon M, 2016, J OPHTHALMIC INFLAMM, V6, DOI 10.1186/s12348-016-0114-z; Lee W, 2015, SLEEP MED, V16, P1327, DOI 10.1016/j.sleep.2015.06.021; Lee YB, 2014, INVEST OPHTH VIS SCI, V55, P3525, DOI 10.1167/iovs.14-13881; Li SS, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0825-z; Lopez-Miguel A, 2014, AM J OPHTHALMOL, V157, P788, DOI 10.1016/j.ajo.2014.01.001; Moon JH, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0364-4; Nelson JD, 2017, OCUL SURF, V15, P269, DOI 10.1016/j.jtos.2017.05.005; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Santo RM, 2015, J CLIN EPIDEMIOL, V68, P370, DOI 10.1016/j.jclinepi.2014.07.009; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Uchino M, 2008, AM J OPHTHALMOL, V146, P925, DOI 10.1016/j.ajo.2008.06.030; Uchino M, 2018, INT J OPHTHALMOL-CHI, V11, P1691, DOI 10.18240/ijo.2018.10.18; Vehof J, 2021, OCUL SURF, V19, P83, DOI 10.1016/j.jtos.2020.04.005; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001; Zhang Y, 2012, OPHTHAL EPIDEMIOL, V19, P226, DOI 10.3109/09286586.2012.670742	25	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259399	10.1371/journal.pone.0259399	http://dx.doi.org/10.1371/journal.pone.0259399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762686	Green Published, gold			2022-12-26	WOS:000755316600023
J	Berberoglu, E; Stoeck, CT; Moireau, P; Kozerke, S; Genet, M				Berberoglu, Ezgi; Stoeck, Christian T.; Moireau, Philippe; Kozerke, Sebastian; Genet, Martin			In-silico study of accuracy and precision of left-ventricular strain quantification from 3D tagged MRI	PLOS ONE			English	Article							MYOCARDIAL MOTION; CARDIAC MOTION; HEART; DEFORMATION; INFARCTION; TRACKING; FORMULATION; FLOW	Cardiac Magnetic Resonance Imaging (MRI) allows quantifying myocardial tissue deformation and strain based on the tagging principle. In this work, we investigate accuracy and precision of strain quantification from synthetic 3D tagged MRI using equilibrated warping. To this end, synthetic biomechanical left-ventricular tagged MRI data with varying tag distance, spatial resolution and signal-to-noise ratio (SNR) were generated and processed to quantify errors in radial, circumferential and longitudinal strains relative to ground truth. Results reveal that radial strain is more sensitive to image resolution and noise than the other strain components. The study also shows robustness of quantifying circumferential and longitudinal strain in the presence of geometrical inconsistencies of 3D tagged data. In conclusion, our study points to the need for higher-resolution 3D tagged MRI than currently available in practice in order to achieve sufficient accuracy of radial strain quantification.	[Berberoglu, Ezgi; Stoeck, Christian T.; Kozerke, Sebastian] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Berberoglu, Ezgi; Stoeck, Christian T.; Kozerke, Sebastian] Swiss Fed Inst Technol, Zurich, Switzerland; [Moireau, Philippe; Genet, Martin] INRIA, M DISIM Team, Palaiseau, France; [Moireau, Philippe; Genet, Martin] Inst Polytech Paris, Lab Mecan Solides LMS, CNRS, Ecole Polytech, Palaiseau, France	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Inria; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Genet, M (corresponding author), INRIA, M DISIM Team, Palaiseau, France.; Genet, M (corresponding author), Inst Polytech Paris, Lab Mecan Solides LMS, CNRS, Ecole Polytech, Palaiseau, France.	martin.genet@polytechnique.edu	Genet, Martin/H-4247-2015	Genet, Martin/0000-0003-2204-201X; Berberoglu, Ezgi/0000-0002-4607-8845				Aletras AH, 1999, J MAGN RESON, V137, P247, DOI 10.1006/jmre.1998.1676; Alnaes M. S., 2015, ARCH NUMER SOFTW, V3, P9, DOI 10.11588/ans.2015.100.20553; Arts T, 2010, IEEE T MED IMAGING, V29, P1114, DOI 10.1109/TMI.2009.2037955; AXEL L, 1989, RADIOLOGY, V172, P349, DOI 10.1148/radiology.172.2.2748813; Bogaert J, 2001, AM J PHYSIOL-HEART C, V280, pH610; BRYANT DJ, 1984, J COMPUT ASSIST TOMO, V8, P588, DOI 10.1097/00004728-198408000-00002; Chapelle D, 2012, INT J MULTISCALE COM, V10, P189, DOI 10.1615/IntJMultCompEng.2011002360; CIARLET PG, 1982, CR ACAD SCI II, V295, P423; Claire D, 2004, INT J NUMER METH ENG, V61, P189, DOI 10.1002/nme.1057; Ersboll M, 2012, J AM SOC ECHOCARDIOG, V25, P1280, DOI 10.1016/j.echo.2012.09.006; Fallah-Rad N, 2011, J AM COLL CARDIOL, V57, P2263, DOI 10.1016/j.jacc.2010.11.063; FISCHER SE, 1993, MAGNET RESON MED, V30, P191, DOI 10.1002/mrm.1910300207; Genet M, 2018, MED IMAGE ANAL, V50, P1, DOI 10.1016/j.media.2018.07.007; Genet M., 2016, P 24 ISMRM, P3136; Huttin O., 2016, PREDICTION LEFT VENT; Imperiale A, 2011, LECT NOTES COMPUT SC, V6666, P409, DOI 10.1007/978-3-642-21028-0_52; Kozerke S, 1999, MAGNET RESON MED, V42, P970, DOI 10.1002/(SICI)1522-2594(199911)42:5<970::AID-MRM18>3.0.CO;2-I; KRAITCHMAN DL, 1995, IEEE T MED IMAGING, V14, P422, DOI 10.1109/42.414606; Kraitchman DL, 2003, CIRCULATION, V107, P2025, DOI 10.1161/01.CIR.0000062684.47526.47; KRAMER CM, 1993, CIRCULATION, V88, P1279, DOI 10.1161/01.CIR.88.3.1279; Lee LC, 2019, LECT NOTES COMPUT SC, V11504, P334, DOI 10.1007/978-3-030-21949-9_36; Liu W, 2004, MAGN RESON MED, V52, P1282, DOI 10.1002/mrm.20276; Mansi T, 2011, INT J COMPUT VISION, V92, P92, DOI 10.1007/s11263-010-0405-z; Marcus JT, 1997, MAGNET RESON MED, V38, P803, DOI 10.1002/mrm.1910380517; McLeod Kristin, 2012, Statistical Atlases and Computational Models of the Heart. Imaging and Modelling Challenges. Second International Workshop, STACOM 2011 Held in Conjunction with MICCAI 2011. Revised Selected Papers, P55, DOI 10.1007/978-3-642-28326-0_6; Moore C C, 2000, Top Magn Reson Imaging, V11, P359, DOI 10.1097/00002142-200012000-00005; Moore CC, 2000, RADIOLOGY, V214, P453, DOI 10.1148/radiology.214.2.r00fe17453; Osman NF, 1999, MAGN RESON MED, V42, P1048, DOI 10.1002/(SICI)1522-2594(199912)42:6<1048::AID-MRM9>3.0.CO;2-M; Osman NF, 2001, MAGNET RESON MED, V46, P324, DOI 10.1002/mrm.1195; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Reindl M, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.119.009404; Rutz AK, 2008, MAGN RESON MED, V59, P755, DOI 10.1002/mrm.21363; Rutz AK, 2009, EUR HEART J, V30, P2117, DOI 10.1093/eurheartj/ehp212; Ryf S, 2002, J MAGN RESON IMAGING, V16, P320, DOI 10.1002/jmri.10145; Sainte-Marie J, 2006, COMPUT STRUCT, V84, P1743, DOI 10.1016/j.compstruc.2006.05.003; Schrauben EM, 2018, J MAGN RESON IMAGING, V47, P787, DOI 10.1002/jmri.25819; Sermesant M, 2003, MED IMAGE ANAL, V7, P475, DOI 10.1016/S1361-8415(03)00068-9; Shehata ML, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-55; Shi WZ, 2012, IEEE T MED IMAGING, V31, P1263, DOI 10.1109/TMI.2012.2188104; Simpson RM, 2013, J MAGN RESON IMAGING, V37, P576, DOI 10.1002/jmri.23756; Skardova Katerina, 2019, VipIMAGE 2019. Proceedings of the VII ECCOMAS Thematic Conference on Computational Vision and Medical Image Processing. Lecture Notes in Computational Vision and Biomechanics (LNCVB 34), P77, DOI 10.1007/978-3-030-32040-9_9; Stoeck CT, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-60; Stuber M, 1999, CIRCULATION, V100, P361, DOI 10.1161/01.CIR.100.4.361; Tobon-Gomez C, 2013, MED IMAGE ANAL, V17, P632, DOI 10.1016/j.media.2013.03.008; Wang H, 2013, IEEE ENG MED BIO, P4386, DOI 10.1109/EMBC.2013.6610518; Wang H, 2012, IEEE T MED IMAGING, V31, P487, DOI 10.1109/TMI.2011.2171706; Young AA, 2001, CARDIOVASC RES, V49, P308, DOI 10.1016/S0008-6363(00)00248-0; YOUNG AA, 1994, CIRCULATION, V90, P854, DOI 10.1161/01.CIR.90.2.854; ZERHOUNI EA, 1988, RADIOLOGY, V169, P59, DOI 10.1148/radiology.169.1.3420283; Zou H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01295	50	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0258965	10.1371/journal.pone.0258965	http://dx.doi.org/10.1371/journal.pone.0258965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739495	Green Published, gold			2022-12-26	WOS:000755000800013
J	De La Rosa-Reyes, V; Duprey-Diaz, MV; Blagburn, JM; Blanco, RE				De La Rosa-Reyes, Valeria; Duprey-Diaz, Mildred, V; Blagburn, Jonathan M.; Blanco, Rosa E.			Retinoic acid treatment recruits macrophages and increases axonal regeneration after optic nerve injury in the frog Rana pipiens	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; SPINAL-CORD; NEURITE OUTGROWTH; RECEPTOR BETA-2; CELL-SURVIVAL; MYELIN DEBRIS; DEGENERATION; ASTROCYTES; RECOVERY; ACTIVATION	Retinoic acid (RA) plays major roles during nervous system development, and during regeneration of the adult nervous system. We have previously shown that components of the RA signaling pathway are upregulated after optic nerve injury, and that exogenous application of all-trans retinoic acid (ATRA) greatly increases the survival of axotomized retinal ganglion cells (RGCs). The objective of the present study is to investigate the effects of ATRA application on the macrophages in the optic nerve after injury, and to determine whether this affects axonal regeneration. The optic nerve was crushed and treated with PBS, ATRA and/or clodronate-loaded liposomes. Nerves were examined at one and two weeks after axotomy with light microscopy, immunocytochemistry and electron microscopy. ATRA application to the optic nerve caused transient increases in the number of macrophages and microglia one week after injury. The macrophages are consistently labeled with M2-type markers, and have considerable phagocytic activity. ATRA increased ultrastructural features of ongoing phagocytic activity in macrophages at one and two weeks. ATRA treatment also significantly increased the numbers of regenerating GAP-43-labeled axons. Clodronate liposome treatment depleted macrophage numbers by 80%, completely eliminated the ATRA-mediated increase in axonal regeneration, and clodronate treatment alone decreased axonal numbers by 30%. These results suggest that the success of axon regeneration is partially dependent on the presence of debris-phagocytosing macrophages, and that the increases in regeneration caused by ATRA are in part due to their increased numbers. Further studies will examine whether macrophage depletion affects RGC survival.	[De La Rosa-Reyes, Valeria; Duprey-Diaz, Mildred, V; Blanco, Rosa E.] Univ Puerto Rico, Dept Anat & Neurobiol, Sch Med, San Juan, PR 00936 USA; [De La Rosa-Reyes, Valeria; Blagburn, Jonathan M.; Blanco, Rosa E.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Blanco, RE (corresponding author), Univ Puerto Rico, Dept Anat & Neurobiol, Sch Med, San Juan, PR 00936 USA.; Blanco, RE (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	rosa.blanco@upr.edu		De La Rosa-Reyes, Valeria/0000-0002-4824-9847				BATTISTI WP, 1995, J COMP NEUROL, V354, P306, DOI 10.1002/cne.903540211; Blanco RE, 1996, CELL TISSUE RES, V286, P337, DOI 10.1007/s004410050703; Blanco RE, 2000, J COMP NEUROL, V423, P646; Blanco RE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209733; Cen LP, 2007, INVEST OPHTH VIS SCI, V48, P4257, DOI 10.1167/iovs.06-0791; Chadzinska M, 2004, FOLIA BIOL-KRAKOW, V52, P225, DOI 10.3409/1734916044527557; Corcoran J, 2002, J CELL SCI, V115, P3779, DOI 10.1242/jcs.00046; Corcoran J, 2000, J CELL SCI, V113, P2567; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dmetrichuk JM, 2006, DEV BIOL, V294, P39, DOI 10.1016/j.ydbio.2006.02.018; Dubovy P, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00040; Duprey-Diaz MV, 2016, J CHEM NEUROANAT, V77, P80, DOI 10.1016/j.jchemneu.2016.05.008; Duprey-Diaz MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162626; Elberg G, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1679-x; Fischer D, 2001, EXP NEUROL, V172, P257, DOI 10.1006/exnr.2001.7822; Goodman T, 2012, HIPPOCAMPUS, V22, P2171, DOI 10.1002/hipo.22037; Haskell GT, 2002, J COMP NEUROL, V452, P228, DOI 10.1002/cne.10369; Hellmann-Regen J, 2013, J NEUROIMMUNOL, V256, P1, DOI 10.1016/j.jneuroim.2012.11.005; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jiang R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/787023; Jokic N, 2007, J NEUROCHEM, V103, P1821, DOI 10.1111/j.1471-4159.2007.04893.x; Kawahara K, 2014, J ALZHEIMERS DIS, V42, P587, DOI 10.3233/JAD-132720; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kolarcik Christi L, 2012, Am J Neurodegener Dis, V1, P130; Kolseth IBM, 2012, J INNATE IMMUN, V4, P176, DOI 10.1159/000332375; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; LIUZZI FJ, 1990, J NEUROCYTOL, V19, P224, DOI 10.1007/BF01217300; Machado-Pereira M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6742427; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; McCaffery P, 1999, MECH DEVELOP, V85, P201; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Morales RA., 2019, FRONT IMMUNOL FRONTI, P10, DOI [10.3389/fimmu.2019.00010, DOI 10.3389/FIMMU.2019.00010]; Morishita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084387; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Peng SX, 2017, NEUROSCIENCE, V351, P36, DOI 10.1016/j.neuroscience.2017.03.030; Ransom J, 2014, J NEUROCHEM, V129, P366, DOI 10.1111/jnc.12620; Rauh MJ, 2003, BIOCHEM SOC T, V31, P286, DOI 10.1042/bst0310286; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Stoney PN, 2016, BRAIN STRUCT FUNCT, V221, P3315, DOI 10.1007/s00429-015-1102-z; Taskinen HS, 1997, ACTA NEUROPATHOL, V93, P252, DOI 10.1007/s004010050611; van Neerven S, 2010, J NEUROCHEM, V114, P1511, DOI 10.1111/j.1471-4159.2010.06867.x; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Vega-Melendez GS, 2014, J NEUROSCI RES, V92, P13, DOI 10.1002/jnr.23303; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; WILSON MA, 1992, ANAT EMBRYOL, V186, P75, DOI 10.1007/BF00710404; Wu SY, 2021, J CELL PHYSIOL, V236, P3929, DOI 10.1002/jcp.30137; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yip PK, 2006, HUM MOL GENET, V15, P3107, DOI 10.1093/hmg/ddl251; ZAMMIT PS, 1993, NEUROSCIENCE, V54, P781, DOI 10.1016/0306-4522(93)90247-D; Zhelyaznik N, 2006, NEUROSCIENCE, V141, P1761, DOI 10.1016/j.neuroscience.2006.05.021; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x; Zigrnond RE, 2019, PROG NEUROBIOL, V173, P102, DOI 10.1016/j.pneurobio.2018.12.001	57	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0255196	10.1371/journal.pone.0255196	http://dx.doi.org/10.1371/journal.pone.0255196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739478	gold, Green Published, Green Submitted			2022-12-26	WOS:000755000800003
J	Watanabe, K; Nagata, Y; Nitta, G; Okata, S; Nagase, M; Miyazaki, R; Nagamine, S; Kaneko, M; Lee, T; Nozato, T; Ashikaga, T; Goya, M; Sasano, T				Watanabe, Keita; Nagata, Yasutoshi; Nitta, Giichi; Okata, Shinichiro; Nagase, Masashi; Miyazaki, Ryoichi; Nagamine, Sho; Kaneko, Masakazu; Lee, Tetsumin; Nozato, Toshihiro; Ashikaga, Takashi; Goya, Masahiko; Sasano, Tetsuo			Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation	PLOS ONE			English	Article							DYSFUNCTION; PACEMAKER	Background Although long sinus arrest is occasionally observed during atrial fibrillation (AF) catheter ablation when the fibrillation was terminated, its meaning and prognosis have not yet been clearly elucidated. We hypothesized that sinus node recovery time (SNRT) after termination of AF (time from termination of AF to the earliest sinus node activation) could reflect the extent of atrial remodeling, influencing the formation of non-pulmonary vein (non-PV) triggers and post-ablation outcomes. Method The participants were 157 consecutive patients with persistent AF (male: 77.1%, age: 63.311.2 years) who underwent catheter ablation. We recorded SNRT after terminating AF by radiofrequency delivery or electrical cardioversion during the first ablation and evaluated the relationships between SNRT and atrial tachyarrhythmia recurrence and between SNRT and non-PV triggers after repeat ablation. Results Forty-five patients (28.7%) experienced recurrence of atrial tachyarrhythmias. Patients with recurrence had longer SNRTs (1738 ms vs. 1394 ms, p = 0.012). In the multivariate logistic regression analysis, only SNRT >= 2128ms was a significant independent predictor of clinical AF recurrence (hazard ratio 7.48; 95% confidence interval 2.94-19.00; P<0.001). Kaplan-Meier estimator showed that the recurrence-free rate was significantly lower if >= 2128ms (log-rank, p<0.001). Thirty-five patients (77.8%) underwent a second ablation. Although there was no difference in the rate of pulmonary vein reconnections (78.6% vs. 71.4%, p = 0.712), non-PV triggers were observed more frequently in the longer SNRT group (57.1% vs. 14.3%, p = 0.012). Conclusions Patients with a prolonged SNRT had a higher prevalence of AF recurrence after the first ablation and higher inducibility of non-PV triggers. Measuring SNRT might be used for the stratification of patients with persistent AF.	[Watanabe, Keita; Nagata, Yasutoshi; Nitta, Giichi; Okata, Shinichiro; Nagase, Masashi; Miyazaki, Ryoichi; Nagamine, Sho; Kaneko, Masakazu; Lee, Tetsumin; Nozato, Toshihiro; Ashikaga, Takashi] Japanese Red Cross Musashino Hosp, Dept Cardiol, Musashino, Tokyo, Japan; [Watanabe, Keita; Goya, Masahiko; Sasano, Tetsuo] Tokyo Med & Dent Univ, Dept Cardiol, Bunkyo Ku, Tokyo, Japan	Musashino RedCross Hospital; Tokyo Medical & Dental University (TMDU)	Watanabe, K (corresponding author), Japanese Red Cross Musashino Hosp, Dept Cardiol, Musashino, Tokyo, Japan.; Watanabe, K (corresponding author), Tokyo Med & Dent Univ, Dept Cardiol, Bunkyo Ku, Tokyo, Japan.	keita.w.tmdu@gmail.com						Akoum N, 2012, J CARDIOVASC ELECTR, V23, P44, DOI 10.1111/j.1540-8167.2011.02140.x; Chang HY, 2013, EUROPACE, V15, P205, DOI 10.1093/europace/eus219; Hayashi K, 2016, CIRC J, V80, P887, DOI 10.1253/circj.CJ-15-1384; Hocini M, 2003, CIRCULATION, V108, P1172, DOI 10.1161/01.CIR.0000090685.13169.07; Ikenouchi T, 2019, HEART RHYTHM, V16, P838, DOI 10.1016/j.hrthm.2018.12.019; Inamura Y, 2021, IJC HEART VASC, V32, DOI 10.1016/j.ijcha.2021.100717; Inoue K, 2012, CIRC-ARRHYTHMIA ELEC, V5, P295, DOI 10.1161/CIRCEP.111.964080; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato N, 2020, J CARDIOVASC ELECTR, V31, P174, DOI 10.1111/jce.14314; Kurotobi T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P39, DOI 10.1161/CIRCEP.109.885095; Narayan SM, 2013, J AM COLL CARDIOL, V62, P138, DOI 10.1016/j.jacc.2013.03.021; Park J, 2013, INT J CARDIOL, V168, P1937, DOI 10.1016/j.ijcard.2012.12.095; Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; SPACH MS, 1989, CIRC RES, V65, P1594, DOI 10.1161/01.RES.65.6.1594; Sparks PB, 2000, CIRCULATION, V102, P1807; Takigawa M, 2017, INT J CARDIOL, V227, P407, DOI 10.1016/j.ijcard.2016.11.028; Tse HF, 2005, HEART, V91, P362, DOI 10.1136/hrt.2003.027219; Watanabe K, 2021, J INTERV CARD ELECTR, V61, P71, DOI 10.1007/s10840-020-00779-x; Yamaguchi N, 2018, INT HEART J, V59, P497, DOI 10.1536/ihj.17-097	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259750	10.1371/journal.pone.0259750	http://dx.doi.org/10.1371/journal.pone.0259750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739524	Green Published, gold			2022-12-26	WOS:000755000800054
J	Li, YL; Sha, YQ; Wang, HT; He, LP; Li, LJ; Wen, S; Sheng, L; Hu, WG; Zhou, H				Li, Yinling; Sha, Yeqin; Wang, Haitao; He, Lianping; Li, Longjun; Wen, Shuang; Sheng, Liang; Hu, Weiguo; Zhou, Hong			Intracellular C3 prevents hepatic steatosis by promoting autophagy and very-low-density lipoprotein secretion	FASEB JOURNAL			English	Article						C3(-); mice; lipophagy; liver; triglyceride	COMPLEMENT-SYSTEM; TRANSFER PROTEIN; ER STRESS; APO-B; OBESITY; PATHWAY	Complement component C3, mainly synthesized by hepatocytes, acts as the convergence point of three different pathways in activating the complement cascade. Besides its well-established roles in the extracellular milieu, C3 performs various intracellular functions such as immunomodulation and pathogen recognition. Although C3 is present at extremely high concentrations in hepatocytes, little is known about its intrahepatic function. In this study, we found that C3 knockout (C3(-/-)) mice displayed accelerated hepatic triglyceride (TG) accumulation compared with C57BL/6J wild type mice. Mechanistically, C3 deficiency impaired lipophagy in hepatocytes, owing to the disrupted interaction between C3 and autophagy-related 16 like 1, which is essential for autolysosome assembly. Furthermore, lipophagy deficiency affected the function of the endoplasmic reticulum in C3(-/-) mice, subsequently affecting the expression of protein disulfide isomerase and activity of microsomal TG transfer protein, and ultimately impairing the production of hepatic very-low-density lipoproteins (VLDLs). Rapamycin and thapsigargin treatment accelerated VLDL secretion and alleviated hepatic lipid accumulation in C3(-/-) mice. Our study demonstrates that C3 promotes lipophagy to facilitate VLDL secretion in hepatocytes, thus playing an essential role in balancing TG levels in the liver.	[Li, Yinling; Sha, Yeqin; Wang, Haitao; He, Lianping; Li, Longjun; Wen, Shuang; Zhou, Hong] Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China; [Sheng, Liang] Nanjing Med Univ, Sch Basic Med Sci, Dept Pharmacol, Nanjing, Peoples R China; [Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai, Peoples R China; [Hu, Weiguo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai, Peoples R China; [Zhou, Hong] Anhui Med Univ, Sch Life Sci, Dept Cell Biol, Hefei, Peoples R China	Nanjing Medical University; Nanjing Medical University; Fudan University; Fudan University; Anhui Medical University	Zhou, H (corresponding author), Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China.	hongzhou@live.com	Hu, Weiguo/AAP-2239-2021	Hu, Weiguo/0000-0002-7397-6800	National Natural Science Foundation of China [81871241, 82071849]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81871241 and 82071849)	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Baiceanu A, 2016, NAT REV ENDOCRINOL, V12, P710, DOI 10.1038/nrendo.2016.124; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Barbier-Torres L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01970-x; Carroll M, 2006, NATURE, V444, P159, DOI 10.1038/nature05307; Chen J, 2020, AGING-US, V12, P24242, DOI 10.18632/aging.104160; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Cui W, 2007, AM J PHYSIOL-ENDOC M, V293, pE1482, DOI 10.1152/ajpendo.00565.2006; Fas BA, 2021, AUTOPHAGY, V17, P2818, DOI 10.1080/15548627.2020.1847443; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He SQ, 2009, J CLIN INVEST, V119, P2304, DOI 10.1172/JCI38289; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Kloska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176113; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lebeaupin C, 2018, J HEPATOL, V69, P927, DOI 10.1016/j.jhep.2018.06.008; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03264-5; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Madrigal-Matute J, 2016, GASTROENTEROLOGY, V150, P328, DOI 10.1053/j.gastro.2015.09.042; Martinez-Lopez N, 2015, ANNU REV NUTR, V35, P215, DOI 10.1146/annurev-nutr-071813-105336; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORRIS KM, 1982, SCIENCE, V215, P399, DOI 10.1126/science.7199205; Park HS, 2021, AUTOPHAGY, V17, P2549, DOI 10.1080/15548627.2020.1834711; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Reis ES, 2019, NAT REV IMMUNOL, V19, P503, DOI 10.1038/s41577-019-0168-x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085; Sheng Y, 2018, CELL DEATH DIFFER, V25, P918, DOI 10.1038/s41418-017-0023-1; Shenkman M, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0174-8; Singh BK, 2020, AGING-US, V12, P13958, DOI 10.18632/aging.103740; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sorbara MT, 2018, CELL HOST MICROBE, V23, P644, DOI 10.1016/j.chom.2018.04.008; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Wang SY, 2012, CELL METAB, V16, P473, DOI 10.1016/j.cmet.2012.09.003; Wang YL, 2022, ACTA PHARMACOL SIN, V43, P10, DOI 10.1038/s41401-021-00629-0; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	43	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22037	10.1096/fj.202100856R	http://dx.doi.org/10.1096/fj.202100856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34762761				2022-12-26	WOS:000722321300001
J	Lim, SC; Geleta, B; Maleki, S; Richardson, D; Kovacevic, Z				Lim, Syer C.; Geleta, Bekesho; Maleki, Sanaz; Richardson, Des R.; Kovacevic, Zaklina			The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-CELL MIGRATION; KAPPA-B ACTIVITY; IRON CHELATORS; C-JUN; GENE-EXPRESSION; UP-REGULATION; TGF-BETA; CYCLIN D1	N-myc-downregulated gene 1 (NDRG1) has potent anticancer effects and inhibits cell growth, survival, metastasis, and angiogenesis. Previous studies suggested that NDRG1 is linked to the androgen signaling network, but this mechanistic relationship is unclear. Considering the crucial role of the androgen receptor (AR) in prostate cancer (PCa) progression, here we examined for the first time the effect of NDRG1 on AR expression, activation, and downstream signaling in LNCaP, 22Rv1, and C4-2B PCa cell types. We demonstrate that NDRG1 effectively promotes interaction of AR with the chaperone HSP90, which in turn stabilizes the AR while decreasing its androgen-mediated activation. The expression of NDRG1 suppressed: (1) AR activation, as measured by p-ARSer213 and p-ARSer81; (2) expression of a major AR transcriptional target, prostate-specific antigen (PSA); and (3) AR transcriptional activity, probably via inhibiting the c-Jun-AR interaction by reducing c-Jun phosphorylation (p-c-JunSer63). NDRG1 was also demonstrated to inhibit multiple key molecules involved in androgen-dependent and -independent signaling (namely EGFR, HER2, HER3, PI3K, STAT3, and NF-KB), which promote the development of castration-resistant prostate cancer. We also identified the cysteine-rich secretory protein/antigen 5/pathogenesis related-1 (CAP) domain of NDRG1 as vital for inhibition of AR activity. Examining NDRG1 and p-NDRG1 in PCa patient specimens revealed a significant negative correlation between NDRG1 and PSA levels in prostatectomy patients that went on to develop metastasis. These results highlight a vital role for NDRG1 in androgen signaling and its potential as a key therapeutic target and biomarker in PCa.	[Lim, Syer C.; Geleta, Bekesho; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Sch Med Sci, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia; [Lim, Syer C.; Geleta, Bekesho; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW, Australia; [Lim, Syer C.; Geleta, Bekesho; Kovacevic, Zaklina] Univ Sydney, Sch Med Sci, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW, Australia; [Maleki, Sanaz] Univ Sydney, Sch Med Sci, Dept Pathol, Histopathol Lab, Sydney, NSW, Australia; [Richardson, Des R.] Nagoya Univ, Dept Pathol & Biol Responses, Grad Sch Med, Nagoya, Aichi, Japan; [Richardson, Des R.] Griffith Univ, Griffith Inst Drug Discovery, Ctr Canc Cell Biol & Drug Discovery, Brisbane, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Nagoya University; Griffith University	Kovacevic, Z (corresponding author), Univ Sydney, Sch Med Sci, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia.; Kovacevic, Z (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW, Australia.; Kovacevic, Z (corresponding author), Univ Sydney, Sch Med Sci, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW, Australia.	zaklina.kovacevic@sydney.edu.au	Lim, Syer Choon/AAN-7043-2021	Lim, Syer Choon/0000-0002-5648-9453; Kovacevic, Zaklina/0000-0002-4742-4690; Richardson, Des/0000-0002-5506-3274; Wendimu, Bekesho Geleta/0000-0002-4546-9692	Priority-driven Collaborative Cancer Research Scheme (PdCCRS) Young Investigator Grant [1086449]; Cure Cancer Australia Foundation; Cancer Australia; University of Sydney (USYD) Bridging Fellowship; National Health and Medical Research Council (NHMRC) RD Wright Fellowship [1140447]; Cancer Institute New South Wales (CINSW) Career Development Fellowship [CDF171126]; USYD Equity Fellowship; NHMRC Senior Principal Research Fellowships [APP1159596, APP1062607]; NHMRC [APP1144456]; NHMRC/PdCCRS Grant [APP1146599]	Priority-driven Collaborative Cancer Research Scheme (PdCCRS) Young Investigator Grant; Cure Cancer Australia Foundation; Cancer Australia; University of Sydney (USYD) Bridging Fellowship; National Health and Medical Research Council (NHMRC) RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales (CINSW) Career Development Fellowship; USYD Equity Fellowship; NHMRC Senior Principal Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/PdCCRS Grant	This project was supported by a Priority-driven Collaborative Cancer Research Scheme (PdCCRS) Young Investigator Grant (#1086449) awarded to Z. K., which was cofunded by Cure Cancer Australia Foundation and Cancer Australia. Z. K. is grateful for a University of Sydney (USYD) Bridging Fellowship, a National Health and Medical Research Council (NHMRC) RD Wright Fellowship [1140447], a Cancer Institute New South Wales (CINSW) Career Development Fellowship [CDF171126] and USYD Equity Fellowship. D. R. R. appreciates NHMRC Senior Principal Research Fellowships [APP1159596; APP1062607], NHMRC Project Grant [APP1144456], and NHMRC/PdCCRS Grant [APP1146599].	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Assinder SJ, 2009, BIOCHEM J, V417, P411, DOI 10.1042/BJ20081610; Bae DH, 2013, J CLIN PATHOL, V66, P911, DOI 10.1136/jclinpath-2013-201692; Bandyopadhyay S, 2004, CANCER RES, V64, P7655, DOI 10.1158/0008-5472.CAN-04-1623; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bandyopadhyay S, 2006, CANCER RES, V66, P11983, DOI 10.1158/0008-5472.CAN-06-0943; Bishop JL, 2014, CANCERS, V6, P829, DOI 10.3390/cancers6020829; Bonaccorsi L, 2004, STEROIDS, V69, P549, DOI 10.1016/j.steroids.2004.05.011; Bonaccorsi L, 2008, STEROIDS, V73, P1030, DOI 10.1016/j.steroids.2008.01.028; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brinkmann AO, 1999, J STEROID BIOCHEM, V69, P307, DOI 10.1016/S0960-0760(99)00049-7; Bubulya A, 2001, J BIOL CHEM, V276, P44704, DOI 10.1074/jbc.M107346200; Caruso RP, 2004, CLIN CANCER RES, V10, P222, DOI 10.1158/1078-0432.CCR-0604-3; Centenera MM, 2015, ENDOCR-RELAT CANCER, V22, P805, DOI 10.1530/ERC-14-0541; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chandrasekar T, 2015, TRANSL ANDROL UROL, V4, P365, DOI 10.3978/j.issn.2223-4683.2015.05.02; Chekmarev J, 2021, CELLS-BASEL, V10, DOI [10.1158/0008-5472.CAN-20-2017, 10.3390/cells10092382]; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Chen TS, 2000, CANCER RES, V60, P2132; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Cheng L, 2012, HISTOPATHOLOGY, V60, P87, DOI 10.1111/j.1365-2559.2011.04025.x; Chlenski A, 2001, PROSTATE, V47, P66; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Crumbaker M, 2017, CANCERS, V9, DOI 10.3390/cancers9040034; CULIG Z, 1994, CANCER RES, V54, P5474; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Edwards J, 2004, J PATHOL, V204, P153, DOI 10.1002/path.1605; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Evans MJ, 2011, P NATL ACAD SCI USA, V108, P9578, DOI 10.1073/pnas.1106383108; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Frieling JS, 2015, CANCER CONTROL, V22, P109, DOI 10.1177/107327481502200114; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ge DX, 2012, PROSTATE, V72, P1306, DOI 10.1002/pros.22479; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Ha S, 2013, ONCOGENE, V32, P3992, DOI 10.1038/onc.2012.412; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; He YD, 2018, NUCLEIC ACIDS RES, V46, P1895, DOI 10.1093/nar/gkx1306; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hille C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091067; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Hsu CC, 2013, MOL CELL ENDOCRINOL, V372, P12, DOI 10.1016/j.mce.2013.03.004; Hsu FN, 2013, AM J PHYSIOL-ENDOC M, V305, pE975, DOI 10.1152/ajpendo.00615.2012; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jia L, 2005, CANCER RES, V65, P8003, DOI 10.1158/0008-5472.CAN-04-3679; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Jin D, 2009, CURR CANCER DRUG TAR, V9, P500; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kim KH, 2007, PROSTATE CANCER P D, V10, P30, DOI 10.1038/sj.pcan.4500915; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Koryakina Y, 2014, ENDOCR-RELAT CANCER, V21, pT131, DOI 10.1530/ERC-13-0472; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Krajewska M, 1996, AM J PATHOL, V148, P1567; Kurdistani SK, 1998, CANCER RES, V58, P4439; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Li YL, 2015, INT J ONCOL, V47, P1001, DOI 10.3892/ijo.2015.3086; Li YR, 2017, BIOMED PHARMACOTHER, V92, P140, DOI 10.1016/j.biopha.2017.05.058; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lim SC, 2020, FASEB J, V34, P11511, DOI 10.1096/fj.201903167R; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Liu WS, 2015, ONCOTARGET, V6, P8851, DOI 10.18632/oncotarget.3316; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Lui GYL, 2015, MOL PHARMACOL, V87, P543, DOI 10.1124/mol.114.096529; Maggiolini M, 2002, MOL PHARMACOL, V62, P1027, DOI 10.1124/mol.62.5.1027; Malinowska K, 2009, ENDOCR-RELAT CANCER, V16, P155, DOI 10.1677/ERC-08-0174; Mandel A, 2018, MOL MED, V24, P1, DOI 10.1186/s10020-018-0035-4; Manin M, 2002, BIOCHEM J, V366, P729, DOI 10.1042/BJ20020585; Marques N, 2014, ONCOGENE, V33, P1124, DOI 10.1038/onc.2013.51; Masuda K, 2005, J MOL BIOL, V353, P763, DOI 10.1016/j.jmb.2005.09.009; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Menezes SV, 2019, J BIOL CHEM, V294, P4045, DOI 10.1074/jbc.RA118.006279; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Menezes SV, 2017, J BIOL CHEM, V292, P12772, DOI 10.1074/jbc.R117.776393; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Mustonen V, 2021, FEBS J, V288, P3507, DOI 10.1111/febs.15660; Nadiminty N, 2013, MOL CANCER THER, V12, P1629, DOI 10.1158/1535-7163.MCT-13-0027; Nunes JJ, 2017, NEOPLASIA, V19, P333, DOI 10.1016/j.neo.2017.02.002; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Park KC, 2020, FREE RADICAL BIO MED, V157, P154, DOI 10.1016/j.freeradbiomed.2019.05.020; Park KC, 2018, BBA-MOL BASIS DIS, V1864, P2644, DOI 10.1016/j.bbadis.2018.04.011; Poovassery JS, 2015, INT J CANCER, V137, P267, DOI 10.1002/ijc.29378; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Quan YJ, 2021, INT J BIOL SCI, V17, P3288, DOI 10.7150/ijbs.63300; Quan YJ, 2020, AM J CANCER RES, V10, P1608; Rawla P, 2019, WORLD J ONCOL, V10, P63, DOI 10.14740/wjon1191; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; REMMELE W, 1987, PATHOLOGE, V8, P138; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Sahni S, 2019, BBA-MOL BASIS DIS, V1865, P1361, DOI 10.1016/j.bbadis.2019.02.008; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Saxena P, 2012, PROSTATE, V72, P769, DOI 10.1002/pros.21482; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Sharifii N, 2016, ONCOL LETT, V12, P4651, DOI 10.3892/ol.2016.5235; Sharma A, 2017, MOL ONCOL, V11, P655, DOI 10.1002/1878-0261.12059; Shi XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075473; Soler M, 2009, INT J CANCER, V125, P2565, DOI 10.1002/ijc.24651; Souder C, 2006, CANCER, V107, P2337, DOI 10.1002/cncr.22255; Sun C, 2006, ONCOGENE, V25, P3905, DOI 10.1038/sj.onc.1209424; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Tinzl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079573; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Tu LC, 2007, MOL CELL PROTEOMICS, V6, P575, DOI 10.1074/mcp.M600249-MCP200; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Wang PP, 2014, MOL CELL, V54, P378, DOI 10.1016/j.molcel.2014.03.007; Wangpu XZ, 2016, MOL PHARMACOL, V89, P521, DOI 10.1124/mol.115.103044; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Worroll D, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/ab073a; Xi RX, 2017, MOL PHARMACOL, V91, P499, DOI 10.1124/mol.116.107870; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yang SX, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112074; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Zhang L, 2015, ONCOTARGET, V6, P6281, DOI 10.18632/oncotarget.3366; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhao FL, 2019, EUR REV MED PHARMACO, V23, P1055, DOI 10.26355/eurrev_201902_16993	135	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101414	10.1016/j.jbc.2021.101414	http://dx.doi.org/10.1016/j.jbc.2021.101414			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO9UJ	34785213	Green Published, gold			2022-12-26	WOS:000748277600003
J	Zang, YX; Kahsai, AW; Pakharukova, N; Huang, LY; Lefkowitz, RJ				Zang, Yunxiang; Kahsai, Alem W.; Pakharukova, Natalia; Huang, Li-Yin; Lefkowitz, Robert J.			The GPCR-beta-arrestin complex allosterically activates C-Raf by binding its amino terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENERGIC-RECEPTOR; PROTEIN-KINASES; CONFORMATION; DESENSITIZATION; SRC	G protein-coupled receptors (GPCRs) convert external stimuli into cellular signals through heterotrimeric guanine nucleotide-binding proteins (G-proteins) and beta-arrestins (beta-arrs). In a beta arr-dependent signaling pathway, beta arrs link GPCRs to various downstream signaling partners, such as the regulated kinase-extracellular signal-regulated kinase cascade. Agonist-stimulated GPCR-beta arr complexes have been shown to interact with C-Raf and are thought to initiate the mitogen-activated protein kinase pathway through simple tethering of these signaling partners. However, recent evidence shows that in addition to canonical scaffolding functions, beta arrs can allosterically activate downstream targets, such as the nonreceptor tyrosine kinase Src. Here, we demonstrate the direct allosteric activation of C-Raf by GPCR-beta arr1 complexes in vitro. Furthermore, we show that beta arr1 in complex with a synthetic phosphopeptide mimicking the human V2 vasopressin receptor tail that binds and functionally activates beta arrs also allosterically activates C-Raf. We reveal that the interaction between the phosphorylated GPCR C terminus and beta arr1 is necessary and sufficient for C-Raf activation. Interestingly, the interaction between beta arr1 and C-Raf was considerably reduced in the presence of excess activated H-Ras, a small GTPase known to activate C-Raf, suggesting that H-Ras and beta arr1 bind to the same region on C-Raf. Furthermore, we found that beta arr1 interacts with the Ras-binding domain of C-Raf. Taken together, these data suggest that in addition to canonical scaffolding functions, GPCR-beta arr complexes directly allosterically activate C-Raf by binding to its amino terminus. This work provides novel insights into how beta arrs regulate effector molecules to activate downstream signaling pathways.	[Zang, Yunxiang; Kahsai, Alem W.; Pakharukova, Natalia; Huang, Li-Yin; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Zang, Yunxiang; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Pakharukova, Natalia/U-7382-2019	Pakharukova, Natalia/0000-0002-8363-6105	National Institutes of Health [R01 HL16037]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the National Institutes of Health grant R01 HL16037 (to R. J. L.). R. J. L. is a Howard Hughes Medical Institute investigator. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bourquard T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10760; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; He QT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22731-x; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Kahsai AW, 2018, CELL RES, V28, P783, DOI 10.1038/s41422-018-0067-x; Lally CCM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14258; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Pakharukova N, 2020, J BIOL CHEM, V295, P16773, DOI 10.1074/jbc.RA120.015400; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Rizk SS, 2011, NAT STRUCT MOL BIOL, V18, P437, DOI 10.1038/nsmb.2002; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Staus DP, 2020, NATURE, V579, P297, DOI 10.1038/s41586-020-1954-0; Staus DP, 2018, P NATL ACAD SCI USA, V115, P3834, DOI 10.1073/pnas.1722336115; Terrell EM, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a033746; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Yang F, 2018, NAT CHEM BIOL, V14, P876, DOI 10.1038/s41589-018-0115-3	39	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101369	10.1016/j.jbc.2021.101369	http://dx.doi.org/10.1016/j.jbc.2021.101369			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34757127	Green Published, gold			2022-12-26	WOS:000765319800004
J	Shin, GT; Park, JE; Lee, MJ				Shin, Gyu-Tae; Park, Ji Eun; Lee, Min-Jeong			MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis	PLOS ONE			English	Article							GENE FAMILY; EXPRESSION; PROTEIN; MEMBERS; GADD45-GAMMA	Background Melanoma-associated antigen H1 (MAGEH1) is a protein that belongs to melanoma-associated antigen (MAGE) superfamily. Growth arrest and DNA damage 45G (GADD45G) is a member of the DNA damage-inducible gene family which responds to environmental stresses. We have previously shown that GADD45G is a protein that promotes apoptosis of renal tubular cells in response to a nephrotoxic injury. In this study, we show evidence that MAGEH1 interacts with GADD45G and is involved in the induction of nephrotoxin-induced apoptosis of renal tubular cells. Methods Primary human renal tubular epithelial (HRE) cells and human kidney 2 (HK-2) cells were used in this study. To produce stable cell lines in which MAGEH1 expression was silenced, HRE cells were transduced with a lentiviral vector encoding a single guide RNA construct targeting the MAGEH1 gene. To knockdown GADD45G expression in HRE cells, a vector containing short hairpin RNA (shRNA) was used. We used short interfering RNAs (siRNA) to achieve transient silencing of genes in HK-2 cells. Recombinant adenoviruses were synthesized to overexpress MAGEH1 and GADD45G proteins. Human protein microarray was used to identify proteins that binds to GADD45G. Co-immunoprecipitation assays were then performed to confirm microarray results. Cell death was induced by cyclosporine A (CsA). Real-time quantitative PCR assay was used to evaluate gene expression levels. The degree of apoptosis and necrosis of cultured cells was evaluated by flow cytometry. Expression levels of caspases were examined using western blot analysis. Results We found that GADD45G bound to one protein spotted in the protein microarray, which was subsequently identified as MAGEH1. We confirmed the interaction between GADD45G and MAGEH1 protein using the co-immunoprecipitation assay. MAGEH1 gene expression was not altered by CsA-induced cytotoxic injury, whereas GADD45G gene expression was increased significantly upon CsA treatment. MAGEH1 expression was significantly downregulated in GADD45G knockdown HRE stable cells suggesting that MAGEH1 expression may be dependent on GADD45G expression. CsA-induced apoptosis was significantly reduced in MAGEH1 knockdown HRE stable cells which led to an increased survival of these cells. Similar results were observed in GADD45G knockdown HRE stable cells. Accordingly, CsA-induced apoptosis was significantly decreased in MAGEH1 siRNA and GADD45G siRNA transfected HK-2 cells. CsA-induced activation of caspase-7 and caspase-9 was inhibited in MAGEH1 knockdown HRE stable cells, and similarly in GADD45G knockdown HRE stable cells. Conclusions To the best of our knowledge, this is the first study to show that MAGEH1 interacts with GADD45G and that MAGEH1 is involved in caspase-dependent apoptosis of renal tubular cells induced by nephrotoxic drugs.	[Shin, Gyu-Tae; Park, Ji Eun; Lee, Min-Jeong] Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea	Ajou University	Shin, GT (corresponding author), Ajou Univ, Dept Nephrol, Sch Med, Suwon, South Korea.	gtshin@ajou.ac.kr		Lee, Min-Jeong/0000-0002-2611-7333				Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; Chomez P, 2001, CANCER RES, V61, P5544; Gee RRF, 2020, J BIOL CHEM, V295, P16121, DOI 10.1074/jbc.REV120.008029; Gao XP, 2020, AM J TRANSL RES, V12, P3596; Gillespie AM, 1999, CANCER TREAT REV, V25, P219, DOI 10.1053/ctrv.1999.0126; KOPP JB, 1990, J AM SOC NEPHROL, V1, P162; Laghmani K, 2016, NEW ENGL J MED, V374, P1853, DOI 10.1056/NEJMoa1507629; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas S, 2000, INT J CANCER, V87, P55, DOI 10.1002/1097-0215(20000701)87:1<55::AID-IJC8>3.3.CO;2-A; Lurquin C, 1997, GENOMICS, V46, P397, DOI 10.1006/geno.1997.5052; Mei Anna Huo-Chang, 2020, Oncotarget, V11, P727, DOI 10.18632/oncotarget.27488; Peikert T, 2006, CANCER RES, V66, P4693, DOI 10.1158/0008-5472.CAN-05-3327; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Shin GT, 2008, KIDNEY INT, V73, P1251, DOI 10.1038/ki.2008.93; Shin GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212818; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Thomas SE, 1998, KIDNEY INT, V53, P897, DOI 10.1046/j.1523-1755.1998.00835.x; Valino-Rivas L, 2019, NEPHROL DIAL TRANSPL, V34, P1498, DOI 10.1093/ndt/gfy367; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yu S, 2009, AM J NEPHROL, V30, P135, DOI 10.1159/000209317; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0260135	10.1371/journal.pone.0260135	http://dx.doi.org/10.1371/journal.pone.0260135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788311	Green Published, gold			2022-12-26	WOS:000735920500057
J	Faci, M; Douzane, M; Hedjal, M; Daas, MS; Fougere, L; Lesellier, E				Faci, Massinissa; Douzane, Malika; Hedjal, Mariem; Daas, Mohamed Seghir; Fougere, Laetitia; Lesellier, Eric			Changes in secoiridoids content and chemical characteristics of cultivated and wild Algerian olive oil, in term of fruit maturation	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ANTIOXIDANT ACTIVITY; PHENOLIC COMPOSITION; OXIDATIVE STABILITY; QUALITY; YIELD; EXTRACTS; HARVEST; L.	Wild varieties in nature are known to be better adapted to climate change and more resistant to arid conditions common in some regions of the world. Oil samples of two cultivated varieties, Chemlal and Lemli, and one sylvestris variety were collected at four different harvesting periods in the semi-arid region of Bouira, Algeria. The aim of this study was to determine the influence of the genetic and maturity factors on the quality indices (acidity, peroxides value, and the parameters K232, K270), fatty acids profile, phenolic composition, and antioxidant activity of monovarietal olive oils. The study showed that early harvest dates of the fruits produced oils richer in pigments and phenolic compounds, with high antioxidant activity registered in both wild and cultivated varieties. Moreover, all oil samples showed high values of secoiridoids exceeding 60-90% of total biophenols, with higher values found in oleaster oils, which are correlated with high resistance to oxidation attacks. UHPLC-DAD and UHPLC-HRMS analyses showed that the secoiridoids composition is dominated by a profile rich in several isomers of oleuropein and ligstroside aglycons, which in turn represent more than 60% of the total secoiridoids in olive and Oleaster oils. Furthermore, chemometric analysis on the data allowed a better appreciation of the sensitivity of the virgin olive oil composition to the changes in genetic and ripening factors. According to the principal component analysis, phenolic and fatty acid profiles were the most important components contributing to the discrimination between olive oil samples.	[Faci, Massinissa; Hedjal, Mariem] Mouloud Mammeri Univ Tizi Ouzou, Dept Biol Sci, Tizi Ouzou, Algeria; [Douzane, Malika; Daas, Mohamed Seghir] Natl Inst Agron Res Algeria, Agrifood Technol Res Div, Algiers, Algeria; [Fougere, Laetitia; Lesellier, Eric] Univ Orleans, Natl Ctr Sci Res, Inst Organ & Analyt Chem, Orleans, France	Universite Mouloud Mammeri de Tizi Ouzou; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Lesellier, E (corresponding author), Univ Orleans, Natl Ctr Sci Res, Inst Organ & Analyt Chem, Orleans, France.	eric.lesellier@univ-orleans.fr		Faci, Massinissa/0000-0002-9282-3164	EU OliveNet project [H2020-MSCA-RISE-EU/734899]	EU OliveNet project	This study was funded by the EU OliveNet project to EL and MD (OLIVE NET, H2020-MSCA-RISE-EU/734899).	Abbattista R, 2020, J AGR FOOD CHEM, V68, P12310, DOI 10.1021/acs.jafc.0c04925; Abbattista R, 2019, TALANTA, V205, DOI 10.1016/j.talanta.2019.07.002; Baccouri O, 2008, FOOD CHEM, V109, P743, DOI 10.1016/j.foodchem.2008.01.034; Beltran G, 2004, J AGR FOOD CHEM, V52, P3434, DOI 10.1021/jf049894n; Bengana M, 2013, FOOD RES INT, V54, P1868, DOI 10.1016/j.foodres.2013.08.037; Bouarroudj K, 2016, IND CROP PROD, V83, P484, DOI 10.1016/j.indcrop.2015.12.081; Boucheffa S, 2017, GENET RESOUR CROP EV, V64, P379, DOI 10.1007/s10722-016-0365-4; Cardoso SM, 2011, FOOD CHEM, V129, P291, DOI 10.1016/j.foodchem.2011.04.049; Casas R, 2018, ENDOCR METAB IMMUNE, V18, P23, DOI 10.2174/1871530317666171114115632; Celano R, 2018, J AGR FOOD CHEM, V66, P6053, DOI 10.1021/acs.jafc.8b01751; Commission Regulation (EEC), OFFICIAL J EUROPEAN; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Dabbou S, 2010, CHEM BIODIVERS, V7, P898, DOI 10.1002/cbdv.200900215; Dag A, 2011, SCI HORTIC-AMSTERDAM, V127, P358, DOI 10.1016/j.scienta.2010.11.008; Desouky I. M., 2009, World Journal of Agricultural Sciences, V5, P760; Dierkes G, 2012, J AGR FOOD CHEM, V60, P7597, DOI 10.1021/jf3020574; Djelloul M. C. E. B., 2020, Comunicata Scientiae, V11, DOI 10.14295/cs.v11i0.3247; Douzane M., 2012, African Journal of Agricultural Research, V7, P4738; Guasch-Ferre M, 2019, CIRC RES, V124, P1266, DOI 10.1161/CIRCRESAHA.118.313996; Guerrini L, 2019, ITAL J FOOD SCI, V31, P451, DOI 10.14674/IJFS-1393; Hbaieb RH, 2016, FOOD CHEM, V203, P548, DOI 10.1016/j.foodchem.2016.01.089; International Organization for Standardization, 2009, 6602009 ISO; IOC, 2017, COIT2029 IOC; IOC, 2016, COIT20 IOC; IOC, 2015, COIT2019 IOC; IOC, 2015, COIT15NC3 IOC; IOC, 2011, COIOH1 IOC; Oliveras-Lopez MJ, 2007, TALANTA, V73, P726, DOI 10.1016/j.talanta.2007.04.045; Laincer F, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.035713; Lozano-Castellon J, 2020, CRIT REV FOOD SCI, V60, P2532, DOI 10.1080/10408398.2019.1650715; Machado M, 2013, FOOD RES INT, V51, P412, DOI 10.1016/j.foodres.2012.12.056; Mafrica R, 2021, AGRICULTURE-BASEL, V11, DOI 10.3390/agriculture11020147; MINGUEZMOSQUERA MI, 1991, J AM OIL CHEM SOC, V68, P332, DOI 10.1007/BF02657688; Obied HK, 2007, ANAL CHIM ACTA, V603, P176, DOI 10.1016/j.aca.2007.09.044; Perez AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092898; Romero-Segura C, 2012, FOOD RES INT, V45, P191, DOI 10.1016/j.foodres.2011.10.024; Rondanini DP, 2014, EUR J AGRON, V52, P237, DOI 10.1016/j.eja.2013.09.002; Rotondi A, 2004, J AGR FOOD CHEM, V52, P3649, DOI 10.1021/jf049845a; Salvador MD, 2001, FOOD CHEM, V73, P45, DOI 10.1016/S0308-8146(00)00276-4; de Medina VS, 2017, TALANTA, V162, P24, DOI 10.1016/j.talanta.2016.09.056; Silenzi A., 2020, PROPERTIES ANTIOXIDA, P225, DOI 10.1016/b978-0-12-815972-9.00022-6; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Summerhill V, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00188; Tepe B, 2005, FOOD CHEM, V90, P333, DOI 10.1016/j.foodchem.2003.09.013; Tura D, 2007, SCI HORTIC-AMSTERDAM, V112, P108, DOI 10.1016/j.scienta.2006.12.036; Valenzuela R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020499; Yorulmaz A, 2013, J AM OIL CHEM SOC, V90, P647, DOI 10.1007/s11746-013-2210-7; Zaringhalami S, 2015, INT FOOD RES J, V22, P1961	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260182	10.1371/journal.pone.0260182	http://dx.doi.org/10.1371/journal.pone.0260182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784391	gold, Green Published			2022-12-26	WOS:000755277300046
J	Perugia, E; BinKhamis, G; Schlittenlacher, J; Kluk, K				Perugia, Emanuele; BinKhamis, Ghada; Schlittenlacher, Josef; Kluk, Karolina			On prediction of aided behavioural measures using speech auditory brainstem responses and decision trees	PLOS ONE			English	Article							ENVELOPE FOLLOWING RESPONSES; TEMPORAL FINE-STRUCTURE; COMPLEX SOUNDS; HEARING; PERCEPTION; INFERENCE; SELECTION	Current clinical strategies to assess benefits from hearing aids (HAs) are based on self-reported questionnaires and speech-in-noise (SIN) tests; which require behavioural cooperation. Instead, objective measures based on Auditory Brainstem Responses (ABRs) to speech stimuli would not require the individuals' cooperation. Here, we re-analysed an existing dataset to predict behavioural measures with speech-ABRs using regression trees. Ninety-two HA users completed a self-reported questionnaire (SSQ-Speech) and performed two aided SIN tests: sentences in noise (BKB-SIN) and vowel-consonant-vowels (VCV) in noise. Speech-ABRs were evoked by a 40 ms [da] and recorded in 2x2 conditions: aided vs. unaided and quiet vs. background noise. For each recording condition, two sets of features were extracted: 1) amplitudes and latencies of speech-ABR peaks, 2) amplitudes and latencies of speech-ABR F0 encoding. Two regression trees were fitted for each of the three behavioural measures with either feature set and age, digit-span forward and backward, and pure tone average (PTA) as possible predictors. The PTA was the only predictor in the SSQ-Speech trees. In the BKB-SIN trees, performance was predicted by the aided latency of peak F in quiet for participants with PTAs between 43 and 61 dB HL. In the VCV trees, performance was predicted by the aided F0 encoding latency and the aided amplitude of peak VA in quiet for participants with PTAs. 47 dB HL. These findings indicate that PTA was more informative than any speech-ABR measure, as these were relevant only for a subset of the participants. Therefore, speech-ABRs evoked by a 40 ms [da] are not a clinical predictor of behavioural measures in HA users.	[Perugia, Emanuele; BinKhamis, Ghada; Schlittenlacher, Josef; Kluk, Karolina] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Ctr Audiol & Deafness,Sch Hlth Sci, Manchester, Lancs, England; [BinKhamis, Ghada] King Fahad Med City, Dept Commun & Swallowing Disorders, Rehabil Hosp, Riyadh, Saudi Arabia	University of Manchester; King Fahad Medical City	Perugia, E; Kluk, K (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Manchester Ctr Audiol & Deafness,Sch Hlth Sci, Manchester, Lancs, England.	emanuele.perugia@manchester.ac.uk; karolina.kluk@manchester.ac.uk	; Kluk, Karolina/F-9512-2010	Binkhamis, Ghada/0000-0002-7696-1073; Perugia, Emanuele/0000-0002-4392-6933; Kluk, Karolina/0000-0003-3638-2787	NIHR (National Institute for Health Research) Manchester Biomedical Research Centre; Engineering and Physical Sciences Research Council (EPSRC) [EP/M026728/1]	NIHR (National Institute for Health Research) Manchester Biomedical Research Centre; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EP, GB, JS, KK. NIHR (National Institute for Health Research) Manchester Biomedical Research Centre. EP, GB, KK. Engineering and Physical Sciences Research Council (EPSRC grant No. EP/M026728/1).	Abrams D., 2015, HDB CLIN AUDIOLOGY, P527; Aiken SJ, 2006, AUDIOL NEURO-OTOL, V11, P213, DOI 10.1159/000092589; ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Anderson S, 2013, J SPEECH LANG HEAR R, V56, P31, DOI 10.1044/1092-4388(2012/12-0043); Anderson Samira, 2013, Int J Otolaryngol, V2013, P604729, DOI 10.1155/2013/604729; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Bench J, 1979, Br J Audiol, V13, P108, DOI 10.3109/03005367909078884; BinKhamis G, 2019, TRENDS HEAR, V23, DOI 10.1177/2331216519848297; BinKhamis G, 2019, EAR HEARING, V40, P659, DOI 10.1097/AUD.0000000000000648; Breiman L., 2001, MACH LEARN, V45, P5; British Society of Audiology, 2013, TYMP; British Society of Audiology, 2016, RECOMMENDED PROCEDUR; British Society of Audiology, 2018, GUID VER HEAR DEV US; British Society of Audiology, 2019, RECOMMENDED PROCEDUR; BSA (British Society of Audiology), 2018, RECOMMENDED PROCEDUR; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; Clinard CG, 2013, J AM ACAD AUDIOL, V24, P590, DOI 10.3766/jaaa.24.7.7; Coffey EBJ, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00479; Easwar V, 2015, EAR HEARING, V36, P635, DOI 10.1097/AUD.0000000000000199; Eaves JM, 2011, J ACOUST SOC AM, V130, P501, DOI 10.1121/1.3592237; Forte AE, 2017, ELIFE, V6, DOI 10.7554/eLife.27203; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fullgrabe C, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00347; Gatehouse S, 2004, INT J AUDIOL, V43, P85, DOI 10.1080/14992020400050014; Hall JW., 2015, EHANDBOOK AUDITORY E; Hastie T., 2009, UNSUPERVISED LEARNIN; Heidari A, 2018, J AUDIOL OTOL, V22, P134, DOI 10.7874/jao.2017.00304; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Howell DC., 2012, STAT METHODS PSYCHOL; Howell DC, 2007, SAGE HDB SOCIAL SCI, P212, DOI DOI 10.4135/9781848607958; James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8; Jamison C, 2016, AM J AUDIOL, V25, P344, DOI 10.1044/2016_AJA-15-0080; Karawani H, 2018, CLIN NEUROPHYSIOL, V129, P1254, DOI 10.1016/j.clinph.2018.03.024; Keidser G, 2011, AUDIOL RES, V1, P88, DOI 10.4081/audiores.2011.e24; Lv J, 2007, MED ENG PHYS, V29, P191, DOI 10.1016/j.medengphy.2006.03.001; Mamo SK, 2019, INT J AUDIOL, V58, P441, DOI 10.1080/14992027.2019.1587179; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; R Core Team, 2020, R LANG ENV STAT COMP; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Seol HY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66970-2; Shannon RV, 1999, J ACOUST SOC AM, V106, pL71, DOI 10.1121/1.428150; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Song JH, 2011, J COGNITIVE NEUROSCI, V23, P2268, DOI 10.1162/jocn.2010.21556; Sperrin M, 2020, J CLIN EPIDEMIOL, V125, P183, DOI 10.1016/j.jclinepi.2020.03.028; Strobl C, 2007, COMPUT STAT DATA AN, V52, P483, DOI 10.1016/j.csda.2006.12.030; Tarpey T, 2000, AM STAT, V54, P116, DOI 10.2307/2686028; Therneau T., 2019, PACKAGE RPART; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth	52	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260090	10.1371/journal.pone.0260090	http://dx.doi.org/10.1371/journal.pone.0260090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784399	gold, Green Published			2022-12-26	WOS:000755277300043
J	Redaelli, V; Bosi, A; Luzi, F; Cappella, P; Zerbi, P; Ludwig, N; Di Lernia, D; Roughan, JV; Porcu, L; Soranna, D; Parati, G; Calvillo, L				Redaelli, Veronica; Bosi, Alice; Luzi, Fabio; Cappella, Paolo; Zerbi, Pietro; Ludwig, Nicola; Di Lernia, Daniele; Roughan, John Vincent; Porcu, Luca; Soranna, Davide; Parati, Gianfranco; Calvillo, Laura			Neuroinflammation, body temperature and behavioural changes in CD1 male mice undergoing acute restraint stress: An exploratory study	PLOS ONE			English	Article							SOCIAL DEFEAT STRESS; BLOOD-BRAIN-BARRIER; BONE-MARROW; BROWN FAT; ANXIETY; PAIN; MODELS; SYSTEM; TOUCH; RATS	Background Animal models used to study pathologies requiring rehabilitation therapy, such as cardiovascular and neurologic disorders or oncologic disease, must be as refined and translationally relevant as possible. Sometimes, however, experimental procedures such as those involving restraint may generate undesired effects which may act as a source of bias. However, the extent to which potentially confounding effects derive from such routine procedures is currently unknown. Our study was therefore aimed at exploring possible undesirable effects of acute restraint stress, whereby animals were exposed to a brightly lit enclosed chamber (R&L) similar to those that are commonly used for substance injection. We hypothesised that this would induce a range of unwanted physiological alterations [such as neuroinflammatory response and changes in body weight and in brown adipose tissue (BAT)] and behavioural modification, and that these might be mitigated via the use of non-aversive handling methods: Tunnel Handling (NAH-T) and Mechanoceptive Handling (NAH-M)) as compared to standard Tail Handling (TH). Methods Two indicators of physiological alterations and three potentially stress sensitive behavioural parameters were assessed. Physiological alterations were recorded via body weight changes and assessing the temperature of Brown Adipose Tissue (BAT) using infra-red thermography (IRT), and at the end of the experiment we determined the concentration of cytokines CXCL12 and CCL2 in bone marrow (BM) and activated microglia in the brain. Nest complexity scoring, automated home-cage behaviour analysis (HCS) and Elevated Plus Maze testing (EPM) were used to detect any behavioural alterations. Recordings were made before and after a 15-minute period of R&L in groups of mice handled via TH, NAH-T or NAH-M. Results BAT temperature significantly decreased in all handling groups following R&L regardless of handling method. There was a difference, at the limit of significance (p = 0.06), in CXCL12 BM content among groups. CXCL12 content in BM of NAH-T animals was similar to that found in Sentinels, the less stressed group of animals. After R&L, mice undergoing NAH-T and NAH-M showed improved body-weight maintenance compared to those exposed to TH. Mice handled via NAH-M spent a significantly longer time on the open arms of the EPM. The HCS results showed that in all mice, regardless of handling method, R&L resulted in a significant reduction in walking and rearing, but not in total distance travelled. All mice also groomed more. No difference among the groups was found in Nest Score, in CCL2 BM content or in brain activated microglia. Conclusions Stress induced by a common restraint procedure caused metabolic and behavioural changes that might increase the risk of unexpected bias. In particular, the significant decrease in BAT temperature could affect the important metabolic pathways controlled by this tissue. R&L lowered the normal frequency of walking and rearing, increased grooming and probably carried a risk of low-grade neuro-inflammation. Some of the observed alterations can be mitigated by Non-aversive handlings.	[Redaelli, Veronica; Luzi, Fabio] Univ Milan, Dept Biomed, Surg & Dent Sci Hlth Unit 1, Milan, Italy; [Bosi, Alice; Parati, Gianfranco; Calvillo, Laura] San Luca Hosp, Dept Cardiovasc Neural & Metab Sci, IRCCS, Ist Auxol Italiano, Milan, Italy; [Cappella, Paolo] EmC2 Srl, Res & Serv Dept, Varese, Italy; [Zerbi, Pietro] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy; [Ludwig, Nicola] Univ Milan, Dipartimento Fis, Milan, Italy; [Di Lernia, Daniele] Univ Cattolica Sacro Cuore, Humane Technol Lab, Dipartimento Psicol, Milan, Italy; [Roughan, John Vincent] Newcastle Univ, Comparat Biol Ctr, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Porcu, Luca] Ist Ric Farmacol Mario Negri IRCCS, Lab Methodol Clin Res, Oncol Dept, Milan, Italy; [Soranna, Davide] Ist Auxol Italiano, IRCCS, Biostat Unit, Milan, Italy; [Parati, Gianfranco] Univ Milano Bicocca, Dept Med & Surg, Milan, Italy	University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan; University of Milan; Catholic University of the Sacred Heart; Newcastle University - UK; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Istituto Auxologico Italiano; University of Milano-Bicocca	Calvillo, L (corresponding author), San Luca Hosp, Dept Cardiovasc Neural & Metab Sci, IRCCS, Ist Auxol Italiano, Milan, Italy.	l.calvillo@auxologico.it	calvillo, laura/K-1901-2019; Cappella, Paolo/ABI-2298-2020; redaelli, veronica/O-6864-2017	calvillo, laura/0000-0002-5151-8243; Cappella, Paolo/0000-0002-3401-4246; redaelli, veronica/0000-0001-6884-112X; Roughan, John/0000-0002-0031-3918	Italian Ministry of Health; UK NC3R's [NC/S000887/1]	Italian Ministry of Health(Ministry of Health, Italy); UK NC3R's(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This publication was made possible by funds of the Italian Ministry of Health and by grant number NC/S000887/1 provided to Dr Johnny Roughan by the UK NC3R's. The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Paolo Cappella is a full-time employee in E.M.C2 S.r.l. and has supported in vivo laboratory activities in accordance with authors requests. The Company has no commercial interests in the therapeutic area of this study and did not play any role in the study design, providing only financial support in the form of author Paolo Cappella' salary.	[Anonymous], 2020, SCI REP, DOI DOI 10.1038/S41598-020-74279-3; [Anonymous], 2019, SCI REP-UK, DOI DOI 10.1038/S41598-018-37186-2; [Anonymous], 2018, SENSORS-BASEL, DOI DOI 10.3390/S18082469; [Anonymous], 2020, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0231454; [Anonymous], 2020, J PERS MED; Ataka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081744; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BARTLETT RG, 1954, AM J PHYSIOL, V179, P343, DOI 10.1152/ajplegacy.1954.179.2.343; BARTLETT RG, 1956, J APPL PHYSIOL, V8, P661, DOI 10.1152/jappl.1956.8.6.661; Borghans B, 2015, WORLD J PSYCHIATR, V5, P387, DOI 10.5498/wjp.v5.i4.387; Botker HE, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0696-8; Bouwknecht JA, 2007, BRAIN RES BULL, V72, P32, DOI 10.1016/j.brainresbull.2006.12.009; Calvillo L, 2019, NAT REV CARDIOL, V16, P476, DOI 10.1038/s41569-019-0178-1; Cohen J.E., 1988, STAT POWER ANAL BEHA; David J., 2013, J NUCL MED, V54, P1120; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Devlin MJ, 2015, AM J PHYS ANTHROPOL, V156, P98, DOI 10.1002/ajpa.22661; Di Lernia Daniele, 2018, Pervasive Computing Paradigms for Mental Health. 7th International Conference, MindCare 2018. Proceedings. Lecture Notes of the Institute for Computer Sciences, Social Informatics and Telecommunications Engineering (LNICST 253), P42, DOI 10.1007/978-3-030-01093-5_6; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Frommlet F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76398-3; Gameiro GH, 2006, PHYSIOL BEHAV, V87, P643, DOI 10.1016/j.physbeh.2005.12.007; Ghosal S, 2015, PHYSIOL BEHAV, V150, P31, DOI 10.1016/j.physbeh.2015.06.021; Gordon I, 2013, HUM BRAIN MAPP, V34, P914, DOI 10.1002/hbm.21480; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Hager C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006159; Henderson LJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71476-y; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Hu P, 2013, AM J PATHOL, V183, P1608, DOI 10.1016/j.ajpath.2013.07.009; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Kilkenny C., 2010, ARRIVE GUIDELINES CH; Kilkenny C., 2010, ARRIVE GUIDELINES AN, P1; Lampron A, 2013, J COMP NEUROL, V521, P3863, DOI 10.1002/cne.23363; Law J, 2018, J NUCL MED, V59, P516, DOI 10.2967/jnumed.117.190546; Lee P, 2011, DIABETES OBES METAB, V13, P92, DOI 10.1111/j.1463-1326.2010.01318.x; Liljencrantz J, 2017, EUR J PAIN, V21, P1173, DOI 10.1002/ejp.1018; Madaan A., 2014, J BIOL METHODS, V1, pe1, DOI [10.14440/jbm.2014.12, DOI 10.14440/JBM.2014.12]; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Mella JR, 2014, SHOCK, V42, P337, DOI 10.1097/SHK.0000000000000222; Nakamura Y, 2018, J VET MED SCI, V80, P886, DOI 10.1292/jvms.18-0044; Niraula A, 2018, J NEUROSCI, V38, P2328, DOI 10.1523/JNEUROSCI.2568-17.2018; Nummenmaa L, 2016, NEUROIMAGE, V138, P242, DOI 10.1016/j.neuroimage.2016.05.063; Oka T, 2018, HAND CLINIC, V157, P599, DOI 10.1016/B978-0-444-64074-1.00035-5; Olausson H., 2016, AFFECTIVE TOUCH NEUR; Panksepp JB, 2007, GENES BRAIN BEHAV, V6, P661, DOI 10.1111/j.1601-183X.2006.00295.x; Panksepp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021236; Reader BF, 2015, NEUROSCIENCE, V289, P429, DOI 10.1016/j.neuroscience.2015.01.001; Redaelli V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224337; Roughan JV, 2009, LAB ANIM-UK, V43, P17, DOI 10.1258/la.2008.007156; Roughan JV, 2019, J AM ASSOC LAB ANIM, V58, P142, DOI [10.30802/aalas-jaalas-18-000057, 10.30802/AALAS-JAALAS-18-000057]; Sadler AM, 2016, PHYSIOL BEHAV, V167, P313, DOI 10.1016/j.physbeh.2016.09.014; Sharp JL, 2002, CONTEMP TOP LAB ANIM, V41, P8; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19; Triscoli C, 2017, BIOL PSYCHOL, V128, P71, DOI 10.1016/j.biopsycho.2017.07.007; Troletti CD, 2016, BBA-MOL BASIS DIS, V1862, P452, DOI 10.1016/j.bbadis.2015.10.010; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; Vrontou S, 2013, NATURE, V493, P669, DOI 10.1038/nature11810; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Walker SC, 2022, EUR J NEUROSCI, V55, P2925, DOI 10.1111/ejn.14951; Wang GX, 2015, TRENDS ENDOCRIN MET, V26, P231, DOI 10.1016/j.tem.2015.03.002; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423; Zhang Q, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2391; Zhu YQ, 2019, NEUROL RES, V41, P762, DOI 10.1080/01616412.2019.1615670; Zubcevic J, 2014, HYPERTENSION, V63, pE129, DOI 10.1161/HYPERTENSIONAHA.114.02440	65	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259938	10.1371/journal.pone.0259938	http://dx.doi.org/10.1371/journal.pone.0259938			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780550	Green Published, gold			2022-12-26	WOS:000755305800070
J	Polet, J; Schneider, J; Hassandra, M; Lintunen, T; Laukkanen, A; Hankonen, N; Hirvensalo, M; Tammelin, TH; Hamilton, K; Hagger, MS				Polet, Juho; Schneider, Jekaterina; Hassandra, Mary; Lintunen, Taru; Laukkanen, Arto; Hankonen, Nelli; Hirvensalo, Mirja; Tammelin, Tuija H.; Hamilton, Kyra; Hagger, Martin S.			Predictors of school students' leisure-time physical activity: An extended trans-contextual model using Bayesian path analysis	PLOS ONE			English	Article							PERCEIVED AUTONOMY SUPPORT; SELF-DETERMINATION THEORY; HEALTH BEHAVIOR; PLANNED BEHAVIOR; PAST BEHAVIOR; CONTINUATION INTENTIONS; HABIT; METAANALYSIS; PERSONALITY; MOTIVATION	The present study aimed to examine effects of motivational and social cognition constructs on children's leisure-time physical activity participation alongside constructs representing implicit processes using an extended trans-contextual model. The study adopted a correlational prospective design. Secondary-school students (N = 502) completed self-report measures of perceived autonomy support from physical education (PE) teachers, autonomous motivation in PE and leisure-time contexts, and social cognition constructs (attitudes, subjective norms, perceived behavioral control), intentions, trait self-control, habits, and past behavior in a leisure-time physical activity context. Five weeks later, students (N = 298) selfreported their leisure-time physical activity participation. Bayesian path analyses supported two key premises of the model: perceived autonomy support was related to autonomous motivation in PE, and autonomous motivation in PE was related to autonomous motivation in leisure time. Indirect effects indicated that both forms of autonomous motivation were related to social cognition constructs and intentions. However, intention was not related to leisure-time physical activity participation, so model variables reflecting motivational processes did not account for substantive variance in physical activity participation. Self-control, attitudes, and past behavior were direct predictors of intentions and leisure-time physical activity participation. There were indirect effects of autonomous motivation in leisure time on intentions and physical activity participation mediated by self-control. Specifying informative priors for key model relations using Bayesian analysis yielded greater precision for some model effects. Findings raise some questions on the predictive validity of constructs from the original trans-contextual model in the current sample, but highlight the value of extending the model to incorporate additional constructs representing non-conscious processes.	[Polet, Juho; Schneider, Jekaterina; Lintunen, Taru; Laukkanen, Arto; Hirvensalo, Mirja; Hagger, Martin S.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Hassandra, Mary] Univ Thessaly, Dept Phys Educ & Sport Sci, Trikala, Greece; [Hankonen, Nelli] Univ Helsinki, Fac Social Sci, Helsinki, Finland; [Tammelin, Tuija H.] LIKES Res Ctr Phys Act & Hlth, Jyvaskyla, Finland; [Hamilton, Kyra] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Hagger, Martin S.] Univ Calif Merced, Psychol Sci, Merced, CA 95343 USA	University of Jyvaskyla; University of Thessaly; University of Helsinki; Griffith University; University of California System; University of California Merced	Hagger, MS (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.; Hagger, MS (corresponding author), Univ Calif Merced, Psychol Sci, Merced, CA 95343 USA.	mhagger@ucmerced.edu	Hagger, Martin S./G-5211-2012; Hassandra, Mary/N-3038-2016; Hankonen, Nelli/K-1189-2012; Lintunen, Taru/G-2838-2011	Hagger, Martin S./0000-0002-2685-1546; Hassandra, Mary/0000-0001-8046-3547; Hankonen, Nelli/0000-0002-8464-2478; Polet, Juho/0000-0002-5305-127X; Schneider, Jekaterina/0000-0002-6069-4783; Lintunen, Taru/0000-0001-5191-2251; Hamilton, Kyra/0000-0001-9975-685X	Finnish Ministry of Education and Culture [OKM/62/626/2016]; Finland Distinguished Professor (FiDiPro) award from Business Finland [1801/31/2105]	Finnish Ministry of Education and Culture; Finland Distinguished Professor (FiDiPro) award from Business Finland	This project was supported by the Finnish Ministry of Education and Culture under grant number OKM/62/626/2016) awarded to MSH and TL; and a Finland Distinguished Professor (FiDiPro) award from Business Finland under grant number 1801/31/2105 awarded to MSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen, 2006, CONSTRUCTING TPB QUE, DOI DOI 10.1002/HEP.22759; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Arnautovska U, 2019, AUST PSYCHOL, V54, P46, DOI 10.1111/ap.12346; Ashton MC, 2007, PERS INDIV DIFFER, V42, P1515, DOI 10.1016/j.paid.2006.10.027; Bogg T, 2008, J PERS, V76, P775, DOI 10.1111/j.1467-6494.2008.00504.x; Brown DJ, 2018, APPETITE, V121, P326, DOI 10.1016/j.appet.2017.11.106; Chan DKC, 2015, J SCI MED SPORT, V18, P315, DOI 10.1016/j.jsams.2014.04.001; Chan DKC, 2020, PSYCHOL SPORT EXERC, V48, DOI 10.1016/j.psychsport.2020.101660; Chatzisarantis NLD, 2008, PSYCHOL HEALTH, V23, P347, DOI 10.1080/14768320601185866; Chatzisarantis NLD, 2008, PSYCHOL SPORT EXERC, V9, P27, DOI 10.1016/j.psychsport.2006.12.003; Chatzisarantis NLD, 2009, CURR PSYCHOL, V28, P55, DOI 10.1007/s12144-009-9043-4; Chatzisarantis NLD, 2004, BRIT J SOC PSYCHOL, V43, P551, DOI 10.1348/0144666042565399; Conner M, 2015, HEALTH PSYCHOL, V34, P642, DOI 10.1037/hea0000143; Conroy DE, 2017, EXERC SPORT SCI REV, V45, P230, DOI 10.1249/JES.0000000000000120; Cooke R, 2004, BRIT J SOC PSYCHOL, V43, P159, DOI 10.1348/0144666041501688; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Danner UN, 2008, BRIT J SOC PSYCHOL, V47, P245, DOI 10.1348/014466607X230876; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Deci EL, 1985, INTRINSIC MOTIVATION; Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102; Gardner B, 2011, ANN BEHAV MED, V42, P174, DOI 10.1007/s12160-011-9282-0; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Hagger M.S., 2020, HDB BEHAV CHANGE, DOI 10.1017/9781108677318; Hagger MS, 2007, PSYCHOL SPORT EXERC, V8, P632, DOI 10.1016/j.psychsport.2006.09.001; Hagger MS, 2007, PSYCHOL SPORT EXERC, V8, P597, DOI 10.1016/j.psychsport.2007.06.003; Hagger MS, 2021, PSYCHOL HEALTH, V36, P307, DOI 10.1080/08870446.2020.1784420; Hagger MS, 2020, PSYCHOL SPORT EXERC, V46, DOI 10.1016/j.psychsport.2019.101606; Hagger MS, 2019, BRIT J HEALTH PSYCH, V24, P764, DOI 10.1111/bjhp.12378; Hagger MS, 2019, PSYCHOL SPORT EXERC, V42, P118, DOI 10.1016/j.psychsport.2018.12.007; Hagger MS, 2019, APPL PSYCHOL-HLTH WE, V11, P407, DOI 10.1111/aphw.12153; Hagger MS, 2019, BRIT J EDUC PSYCHOL, V89, P324, DOI 10.1111/bjep.12241; Hagger MS, 2018, SOC SCI MED, V213, P85, DOI 10.1016/j.socscimed.2018.07.038; Hagger MS, 2017, PSYCHOL BULL, V143, P1117, DOI 10.1037/bul0000118; Hagger MS, 2017, APPETITE, V116, P147, DOI 10.1016/j.appet.2017.04.032; Hagger MS, 2016, REV EDUC RES, V86, P360, DOI 10.3102/0034654315585005; Hagger MS, 2015, HEALTH PSYCHOL REV, V9, P296, DOI 10.1080/17437199.2014.959728; Hagger MS, 2009, BRIT J HEALTH PSYCH, V14, P275, DOI 10.1348/135910708X373959; Hagger MS, 2001, PSYCHOL HEALTH, V16, P391, DOI 10.1080/08870440108405515; Hagger MS, 2003, J EDUC PSYCHOL, V95, P784, DOI 10.1037/0022-0663.95.4.784; Hamilton K, 2020, BRIT J HEALTH PSYCH, V25, P189, DOI 10.1111/bjhp.12401; Hamilton K, 2017, HEALTH PSYCHOL, V36, P916, DOI 10.1037/hea0000533; Hamilton K, 2012, J SPORT EXERCISE PSY, V34, P124, DOI 10.1123/jsep.34.1.124; Hardcastle SJ, 2017, HEALTH PSYCHOL REV, V11, P1, DOI 10.1080/17437199.2016.1190659; IPAQ Group, 2012, INT PHYS ACT QUEST; IPIP, 2017, SELF DISCIPLINE SCAL; Jacobs N, 2011, BRIT J HEALTH PSYCH, V16, P113, DOI 10.1348/135910710X519305; Kalajas-Tilga H, 2022, PSYCHOL HEALTH, V37, P62, DOI 10.1080/08870446.2020.1869741; Kaushal N, 2021, BRIT J HEALTH PSYCH, V26, P1155, DOI 10.1111/bjhp.12525; Knittle K, 2020, NAT HUM BEHAV, V4, P215, DOI 10.1038/s41562-019-0798-9; Kurdaningsih SV, 2016, INT J COMMUNITY MED, V3, P630, DOI DOI 10.18203/2394-6040.IJCMPH20160623; Lawton R, 2009, HEALTH PSYCHOL, V28, P56, DOI 10.1037/a0013424; Lim BSC, 2009, PSYCHOL SPORT EXERC, V10, P52, DOI 10.1016/j.psychsport.2008.06.003; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Moller AC, 2006, PERS SOC PSYCHOL B, V32, P1024, DOI 10.1177/0146167206288008; Muraven M, 2008, J RES PERS, V42, P763, DOI 10.1016/j.jrp.2007.08.002; Muraven M, 2008, J EXP SOC PSYCHOL, V44, P573, DOI 10.1016/j.jesp.2007.10.008; Muthen B, 2012, PSYCHOL METHODS, V17, P313, DOI 10.1037/a0026802; Orbell S, 2010, HEALTH PSYCHOL, V29, P374, DOI 10.1037/a0019596; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; Pate RR, 2019, EXERC SPORT SCI REV, V47, P3, DOI 10.1249/JES.0000000000000171; Phipps DJ, 2020, APPETITE, V150, DOI 10.1016/j.appet.2020.104668; Polet J, 2020, J APPL SOC PSYCHOL, V50, P512, DOI 10.1111/jasp.12691; Polet J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6478-x; Powell Emma, 2016, Prev Med Rep, V3, P7, DOI 10.1016/j.pmedr.2015.11.007; RYAN RM, 1989, J PERS SOC PSYCHOL, V57, P749, DOI 10.1037/0022-3514.57.5.749; Salmon J., 2020, HDB BEHAV CHANGE, P237, DOI [DOI 10.1017/9781108677318.017, 10.1017/9781108677318.017]; Savalei V, 2019, PSYCHOL METHODS, V24, P352, DOI 10.1037/met0000181; Shen B, 2008, CONTEMP EDUC PSYCHOL, V33, P841, DOI 10.1016/j.cedpsych.2007.09.002; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Tak NI, 2011, APPETITE, V56, P503, DOI 10.1016/j.appet.2011.01.013; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2; van Bree RJH, 2015, PSYCHOL SPORT EXERC, V19, P95, DOI 10.1016/j.psychsport.2015.03.006; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Wood W, 2017, PERS SOC PSYCHOL REV, V21, P389, DOI 10.1177/1088868317720362; Wood W, 2016, ANNU REV PSYCHOL, V67, P289, DOI 10.1146/annurev-psych-122414-033417; Yuan Y, 2009, PSYCHOL METHODS, V14, P301, DOI 10.1037/a0016972; Zhang CQ, 2019, APPETITE, V141, DOI 10.1016/j.appet.2019.104332; Zhang Z, 2018, PRACTICAL STAT POWER	82	1	1	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258829	10.1371/journal.pone.0258829	http://dx.doi.org/10.1371/journal.pone.0258829			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767569	Green Submitted, Green Published, gold			2022-12-26	WOS:000755249300015
J	Schreier, J; Rautenschlein, S; Jung, A				Schreier, Jana; Rautenschlein, Silke; Jung, Arne			Different virulence levels of Enterococcus cecorum strains in experimentally infected meat-type chickens	PLOS ONE			English	Article							BROILER; SPONDYLITIS; LESIONS; IDENTIFICATION; OSTEOMYELITIS; ARTHRITIS; BONE	In recent years, pathogenic strains of Enterococcus cecorum (EC) have emerged as a causing agent of septicemia and skeletal infection in broiler chickens with a high economic impact worldwide. Although research has been conducted, many aspects of the pathogenesis of the EC-associated disease are still unknown. In the present study, an experimental infection model was established in broiler chickens. Two different EC strains (EC14 and EC15) were compared in two different concentrations of each strain (2 x 10(6) and 2 x 10(8) colony-forming units per milliliter (CFU/mL)) after oral infection of one-day-old chicks. Clinical signs and gross lesions of the EC-associated disease were monitored in the following seven weeks. Although both EC strains were originally isolated from clinical disease outbreaks and had a high embryonic lethality, only EC14 successfully induced the typical course of the EC-associated disease with characteristic clinical signs and gross lesions. In total, 23% of the birds in the two EC14-groups were EC-positive in extraintestinal organs on culture, and no differences were found between the two infectious doses. EC14 was frequently detected via real-time PCR in the free thoracic vertebra (FTV) and femoral heads without any detectable gross lesions. The number of EC positive spleens from infected broilers was comparable using bacterial isolation and a specific real-time PCR. Interestingly, EC15 was not detected in extraintestinal organs, although birds in the EC15 groups were colonized by EC in the ceca after experimental infection. The present study represents first proof that virulence differs among EC strains in experimentally infected chickens, and emphasizes the need to further characterize virulence factors and pathogenic mechanisms of EC. The strain EC14 at a dose of 10(6) CFU is suitable for reproduction of the EC-associated disease. The experimental infection model reported here provides the basis for further research on the EC pathogenesis and possible prevention and intervention strategies.	[Schreier, Jana; Rautenschlein, Silke; Jung, Arne] Univ Vet Med Hannover, Clin Poultry, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Jung, A (corresponding author), Univ Vet Med Hannover, Clin Poultry, Hannover, Germany.	arne.jung@tiho-hannover.de			QS Fachgesellschaft Geflugel GmbH; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	QS Fachgesellschaft Geflugel GmbH; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing	This study was funded by the QS Fachgesellschaft Geflugel GmbH. The publication of the study was supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison H, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.1077; Aviagen, 2019, ROSS 308 PERF OBJ AV; Aziz T., 2007, World Poultry, V23, P44; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; Borst LB, 2019, ANIM FEED SCI TECH, V250, P59, DOI 10.1016/j.anifeedsci.2018.09.014; Borst LB, 2017, VET PATHOL, V54, P61, DOI 10.1177/0300985816658098; Borst LB, 2014, AVIAN DIS, V58, P244, DOI 10.1637/10687-101113-Reg.1; Borst LB, 2012, AVIAN PATHOL, V41, P479, DOI 10.1080/03079457.2012.718070; De Herdt P, 2009, VLAAMS DIERGEN TIJDS, V78, P44; DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46; DEVRIESE LA, 1983, INT J SYST BACTERIOL, V33, P772, DOI 10.1099/00207713-33-4-772; Devriese LA, 2002, VLAAMS DIERGEN TIJDS, V71, P219; Dolka B, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0761-1; Ekesi NS., 2021, EMBRYO LETHALITY ASS; HOLM S, 1979, SCAND J STAT, V6, P65; Jackson CR, 2015, LETT APPL MICROBIOL, V60, P111, DOI 10.1111/lam.12374; Jiang TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124403; Jung A, 2018, AVIAN DIS, V62, P261, DOI 10.1637/11825-030618-Review.1; Jung A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1021-7; Jung A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0949-y; Jung Arne, 2014, BMC Vet Res, V10, P311, DOI 10.1186/s12917-014-0311-7; Kense M, 2012, 83 DVG FACHGESPRACH; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Logue CM., 2020, DIS POULTRY, V14, P995; Martin LT, 2011, AVIAN DIS, V55, P273, DOI 10.1637/9614-121410-Reg.1; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Patel JB, 2001, MOL DIAGN, V6, P313, DOI 10.1054/modi.2001.29158; Remiot P., 2019, ENTEROCOCCUS CECORUM, P116; Robbins KM, 2012, AVIAN DIS, V56, P768, DOI 10.1637/10253-052412-Case.1; Snoeijen L., 2021, PILOT BIOTYPING CECO; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; Talebi A., 2016, SPONDYLITIS BROILER; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wood AM, 2002, VET REC, V150, P27	35	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259904	10.1371/journal.pone.0259904	http://dx.doi.org/10.1371/journal.pone.0259904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767595	gold, Green Published			2022-12-26	WOS:000755249300054
J	Flint, SW; Brown, A; Sanders, G; Tahrani, A				Flint, Stuart W.; Brown, Adrian; Sanders, George; Tahrani, Abd A.			Exploring the awareness, attitudes, and actions (AAA) of UK adults at high risk of severe illness from COVID-19	PLOS ONE			English	Article							SCIENCE	Background People at high risk of severe illness from COVID-19 have experienced greater restrictions during the pandemic, yet there is a paucity of research exploring their lived experience. Objectives This study explored the impact of COVID-19 on people identified as at high risk of severe illness by UK Government, and in particular, the impact of the first lockdown on access to healthcare, medications and use of technological platforms. Methods 1038 UK adults who identified as at high risk of severe illness from COVID-19 in line with UK Government guidance or self-identified with acute or other chronic health conditions, completed the Awareness, Attitudes and Actions survey which explored the impact of COVID-19 on access to healthcare, management of long-term health condition, mental health, and health behaviours. Results Most participants reported feelings of vulnerability, anxiety and isolation, noticed that other people changed their behaviour towards them including a feeling of being stigmatised by people not categorised as high risk. Participants described the largely negative impact that the COVID-19 lockdown had on to health-related behaviours and access to healthcare, which had resulted in large declines in mental health and wellbeing. Participants also indicated disappointment at the UK Governments response and handling of the COVID-19 lockdown.	[Flint, Stuart W.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Flint, Stuart W.] Univ Leeds, Nexus, Scaled Insights, Leeds, W Yorkshire, England; [Brown, Adrian] UCL, Ctr Obes Res, London, England; [Brown, Adrian] UCL, Natl Inst Hlth Res, London, England; [Sanders, George] Leeds Beckett Univ, Sch Sport, Leeds, W Yorkshire, England; [Tahrani, Abd A.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Tahrani, Abd A.] Univ Hosp Birmingham NHS Fdn Trust, Dept Diabet & Endocrinol, Birmingham, W Midlands, England; [Tahrani, Abd A.] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England	University of Leeds; University of Leeds; University of London; University College London; University of London; University College London; Leeds Beckett University; University of Birmingham; University of Birmingham	Brown, A (corresponding author), UCL, Ctr Obes Res, London, England.; Brown, A (corresponding author), UCL, Natl Inst Hlth Res, London, England.	a.c.brown@ucl.ac.uk	; Tahrani, Abd/C-6939-2014	Sanders, George/0000-0001-6458-7312; Tahrani, Abd/0000-0001-9037-1937	Ethicon, Johnson Johnson [202004001]	Ethicon, Johnson Johnson	This study was partly supported by an investigator-initiated grant from Ethicon, Johnson & Johnson to SWF; the funder had no role in study design, data analysis, data interpretation, or writing of the report (grant number: 202004001).	Abbott S, 2021, J HUM NUTR DIET, V34, P480, DOI 10.1111/jhn.12850; Aggio D, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0115-2; Beaunoyer E, 2020, COMPUT HUM BEHAV, V111, DOI 10.1016/j.chb.2020.106424; Bonell C, 2020, J EPIDEMIOL COMMUN H, V74, P617, DOI 10.1136/jech-2020-214290; Brown A, 2021, ECLINICALMEDICINE, V34, DOI 10.1016/j.eclinm.2021.100796; Bussu S, 2020, J HEALTH ORGAN MANAG, V34, P603, DOI 10.1108/JHOM-10-2019-0294; Chaix B, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100349; Department of Health and Social Care, 1 WAV NONM BAS LAT F; Dineen-Griffin S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220116; Emerson E, 2020, DISABIL HEALTH J, V13, DOI 10.1016/j.dhjo.2020.100889; Erlingsdottir G., 2018, J HEALTH ORGAN MANAG; Fancourt D, 2020, LANCET, V396, P464, DOI 10.1016/S0140-6736(20)31690-1; Flint SW, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-045309; Foad CMG, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.210678; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; Glasgow RE, 2012, AM J PREV MED, V42, P646, DOI 10.1016/j.amepre.2012.02.016; Hodge H, 2017, J RURAL STUD, V54, P469, DOI 10.1016/j.jrurstud.2016.06.016; Kremers SPJ, 2010, PATIENT EDUC COUNS, V79, P291, DOI 10.1016/j.pec.2010.03.002; Marsland N., 2000, DRAFT BEST PRACTICE; Michie S, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7126; NHS England, 2019, SAV BAB LIV CAR BUND; Public Health England, COR COVID 19 UK; Public Health England, 2020, INV NOV SARS COV 2 V, V5; Roth T, 2019, J BUS RES, V101, P83, DOI 10.1016/j.jbusres.2019.04.014; Sallis A, 2019, PREV MED, V121, P128, DOI 10.1016/j.ypmed.2019.01.023; Sanders GJ, 2022, PERSPECT PUBLIC HEAL, V142, P278, DOI 10.1177/1757913920986205; Singhal R, 2021, OBES RES CLIN PRACT, V15, P395, DOI 10.1016/j.orcp.2021.04.005; Torous J, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/18848; Valentijn PP, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0634-x; Wind TR, 2020, INTERNET INTERV, V20, DOI 10.1016/j.invent.2020.100317; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Zahle J, 2020, SYNTHESE, V25, P1	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259376	10.1371/journal.pone.0259376	http://dx.doi.org/10.1371/journal.pone.0259376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762659	Green Published, gold, Green Accepted			2022-12-26	WOS:000755316600020
J	Pukale, DD; Farrag, M; Leipzig, ND				Pukale, Dipak D.; Farrag, Mahmoud; Leipzig, Nic D.			Detection of locomotion deficit in a post-traumatic syringomyelia rat model using automated gait analysis technique	PLOS ONE			English	Article							SPINAL-CORD-INJURY; AQUAPORIN-4 EXPRESSION; MOUSE MODEL; RECOVERY; PATHOGENESIS; LESIONS; GENDER	Syringomyelia (SM) is a spinal cord disorder in which a cyst (syrinx) filled with fluid forms in the spinal cord post-injury/disease, in patients syrinx symptoms include loss of pain and temperature sensation or locomotion deficit. Currently, there are no small animal models and connected tools to help study the functional impacts of SM. The objective of this study was to determine the detectability of subtle locomotion deficits due to syrinx formation/expansion in post-traumatic syringomyelia (PTSM) rat model using the recently reported method of Gait Analysis Instrumentation, and Technology Optimized for Rodents (GAITOR) with Automated Gait Analysis Through Hues and Areas (AGATHA) technique. First videos of the rats were collected while walking in an arena (using GAITOR) followed by extracting meaningful locomotion information from collected videos using AGATHA protocol. PTSM injured rats demonstrated detectable locomotion deficits in terms of duty factor imbalance, paw placement accuracy, step contact width, stride length, and phase dispersion parameters compared to uninjured rats due to SM. We concluded that this technique could detect mild and subtle locomotion deficits associated with PTSM injury, which also in future work could be used further to monitor locomotion responses after different treatment strategies for SM.	[Pukale, Dipak D.; Leipzig, Nic D.] Univ Akron, Dept Chem Biomol & Corros Engn, Akron, OH 44325 USA; [Farrag, Mahmoud; Leipzig, Nic D.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Leipzig, ND (corresponding author), Univ Akron, Dept Chem Biomol & Corros Engn, Akron, OH 44325 USA.; Leipzig, ND (corresponding author), Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.	nl21@uakron.edu	Pukale, Dipak/GLS-4139-2022	Leipzig, Nic/0000-0002-6356-7691	Conquer Chiari, USA; Column of Hope, USA	Conquer Chiari, USA; Column of Hope, USA	This work was sponsored by the Conquer Chiari, USA, and Column of Hope, USA The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghayev K, 2011, J NEUROSURG-SPINE, V15, P428, DOI 10.3171/2011.5.SPINE10303; Agrawal Amit, 2007, Indian J Orthop, V41, P398, DOI 10.4103/0019-5413.37006; Banik RK, 2013, J NEUROSCI METH, V219, P41, DOI 10.1016/j.jneumeth.2013.06.005; BOIARDI A, 1991, ITAL J NEUROL SCI, V12, P575, DOI 10.1007/BF02336954; Brodbelt AR, 2003, J NEUROTRAUM, V20, P883, DOI 10.1089/089771503322385818; Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Deuis JR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00284; Dorchies OM, 2013, AM J PATHOL, V182, P485, DOI 10.1016/j.ajpath.2012.10.018; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Farrag M, 2021, NEURAL REGEN RES, V16, P2293, DOI 10.4103/1673-5374.310690; Feng QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091512; Fouad K, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113410; Guilford BL, 2011, EXP DIABETES RES, DOI 10.1155/2011/848307; Ham TR, 2020, MAT SCI ENG C-MATER, V110, DOI 10.1016/j.msec.2020.110656; Ham TR, 2019, ANN BIOMED ENG, V47, P744, DOI 10.1007/s10439-019-02198-0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harvey VL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-18; Hemley SJ, 2013, J NEUROTRAUM, V30, P1457, DOI 10.1089/neu.2012.2614; Hemley SJ, 2012, J NEUROSURG-SPINE, V17, P602, DOI 10.3171/2012.9.SPINE1265; Jacobs BY., 2018, SCI REP-UK, V8, P18, DOI [10.1038/s41598-017-18535-z, DOI 10.1038/S41598-017-18535-Z]; Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233; Kloefkorn HE, 2017, ANN BIOMED ENG, V45, P711, DOI 10.1007/s10439-016-1717-0; Ko HY, 2012, SPINAL CORD, V50, P695, DOI 10.1038/sc.2012.35; Levine DN, 2004, J NEUROL SCI, V220, P3, DOI 10.1016/j.jns.2004.01.014; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Mohrman AE, 2018, J BIOMATER APPL, V33, P435, DOI 10.1177/0885328218792824; Mohrman AE, 2017, J NEUROTRAUM, V34, P720, DOI 10.1089/neu.2015.4341; O'Brien DE, 2013, J PAIN, V14, P628, DOI 10.1016/j.jpain.2013.01.770; Olsen E, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1077-5; Pukale DD, 2021, ACS CHEM NEUROSCI, V12, P3567, DOI 10.1021/acschemneuro.1c00056; Roome RB, 2015, JOVE-J VIS EXP, DOI 10.3791/52701; Rusbridge C, 2006, J VET INTERN MED, V20, P469, DOI 10.1892/0891-6640(2006)20[469:SCCIPD]2.0.CO;2; Sabharwal S., 2020, SPINAL CORD INJURY C, P902, DOI [10.1016/b978-0-323-54947-9.00156-5, DOI 10.1016/B978-0-323-54947-9.00156]; Schurch B, 1996, J NEUROL NEUROSUR PS, V60, P61, DOI 10.1136/jnnp.60.1.61; Seki T, 2008, J NEUROSURG-SPINE, V8, P365, DOI 10.3171/SPI/2008/8/4/365; Shields Christopher B, 2012, Handb Clin Neurol, V109, P355, DOI 10.1016/B978-0-444-52137-8.00022-X; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Sixt C, 2009, J CLIN NEUROSCI, V16, P1599, DOI 10.1016/j.jocn.2009.04.019; Tu J, 2011, J NEUROSURG-SPINE, V14, P573, DOI 10.3171/2011.1.SPINE09491; Whishaw Ian Q, 2008, J Vis Exp, DOI 10.3791/1030; Wong JHY, 2016, J NEUROSURG-SPINE, V24, P797, DOI 10.3171/2015.10.SPINE15742	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0252559	10.1371/journal.pone.0252559	http://dx.doi.org/10.1371/journal.pone.0252559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762669	Green Submitted, Green Published, gold			2022-12-26	WOS:000755316600002
J	Nix, J; Shjarback, JA				Nix, Justin; Shjarback, John A.			Factors associated with police shooting mortality: A focus on race and a plea for more comprehensive data	PLOS ONE			English	Article							LAW-ENFORCEMENT; UNITED-STATES; DEADLY FORCE; DEATH	Objectives To quantify nonfatal injurious police shootings of people and examine the factors associated with victim mortality. Methods We gathered victim-level data on fatal and nonfatal injurious police shootings from four states that have such information publicly available: Florida (2009-14), Colorado (2010-19), Texas (2015-19), and California (2016-19). For each state, we examined bivariate associations between mortality and race/ethnicity, gender, age, weapon, and access to trauma care. We also estimated logistic regression models predicting victim mortality in each state. Results Forty-five percent of these police shooting victims (N = 1,322) did not die. Black-white disparities were more pronounced in nonfatal injurious police shootings than in fatal police shootings. Overall, Black victims were less likely than white victims to die from their wound(s). Younger victims were less likely to die from their wound(s), as well as those who were unarmed. Conclusions Racial and age disparities in police shootings are likely more pronounced than previous estimates suggest. Policy implications Other states should strongly consider compiling data like that which is currently being gathered in California. Absent data on nonfatal injurious police shootings-which account for a large share of deadly force incidents-researchers and analysts must be cautious about comparing and/or ranking jurisdictions in terms of their police-involved fatality rates.	[Nix, Justin] Univ Nebraska, Sch Criminol & Criminal Justice, Omaha, NE 68182 USA; [Shjarback, John A.] Rowan Univ, Dept Law & Justice Studies, Glassboro, NJ USA	University of Nebraska System; Rowan University	Nix, J (corresponding author), Univ Nebraska, Sch Criminol & Criminal Justice, Omaha, NE 68182 USA.	jnix@unomaha.edu	Nix, Justin/GMW-9882-2022	Shjarback, John/0000-0001-7416-3388; Nix, Justin/0000-0002-3812-8590				Alpert GP, 2016, CRIMINOL PUBLIC POL, V15, P237, DOI 10.1111/1745-9133.12178; Amelia Thomson-DeVeaux, 2021, FIVETHIRTYEIGHT 0222; Ang D, 2021, Q J ECON, V136, P115, DOI 10.1093/qje/qjaa027; [Anonymous], 2017, WHEN POLICE KILL; Associated Press, 2020, ASS PRESS; Band RA, 2014, ANN EMERG MED, V63, P608, DOI 10.1016/j.annemergmed.2013.11.008; Banks D, 2016, ARREST RELATED DEATH; Braga AA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0833; Carr BG, 2017, INJURY, V48, P332, DOI 10.1016/j.injury.2017.01.008; Circo GM, 2019, INJURY PREV, V25, pi39, DOI 10.1136/injuryprev-2019-043180; Clark TS, 2020, ARE POLICE RACIALLY; Conner A, 2019, AM J PUBLIC HEALTH, V109, P578, DOI 10.2105/AJPH.2018.304904; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Edwards F, 2018, AM J PUBLIC HEALTH, V108, P1241, DOI 10.2105/AJPH.2018.304559; Federal Bureau of Investigation, LAW ENF OFF KILL ASS; Feldman JM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002399; Feldman JM, 2017, AM J PUBLIC HEALTH, V107, P1624, DOI 10.2105/AJPH.2017.303940; Fyfe J.J., 1979, J CRIM JUST, V7, P303, DOI [10.1016/0047-2352(79)90065-5, DOI 10.1016/0047-2352(79)90065-5]; Fyfe JJ, 1978, THESIS U MICROFILMS; Galovski TE, 2016, J TRAUMA STRESS, V29, P283, DOI 10.1002/jts.22105; Geller W., 1992, DEADLY FORCE WHAT WE; Goldstein J., 2017, NEW YORK TIMES; Hatten DN, 2020, HOMICIDE STUD, V24, P377, DOI 10.1177/1088767920916900; Hemenway D, 2020, PREV MED, V134, DOI 10.1016/j.ypmed.2020.106046; Hemenway D, 2019, J URBAN HEALTH, V96, P63, DOI 10.1007/s11524-018-0313-z; Hipple NK, 2020, JUSTICE EVAL J, V3, P94, DOI 10.1080/24751979.2019.1689152; Jennings JT, 2017, PUBLIC ADMIN REV, V77, P217, DOI 10.1111/puar.12738; Kivisto AJ, 2017, AM J PUBLIC HEALTH, V107, P1068, DOI 10.2105/AJPH.2017.303770; Klinger D., 2004, KILL ZONE COPS EYE V; Klinger D, 2016, CRIMINOL PUBLIC POL, V15, P193, DOI 10.1111/1745-9133.12174; Knox D, 2020, AM POLIT SCI REV, V114, P619, DOI 10.1017/S0003055420000039; Lurie J, TRUE COST GUN VIOLEN; Mapping Police Violence, STAT COMP TOOL; McCann A., 2017, VICE NEWS; Miller J, 2022, J QUANT CRIMINOL, V38, P723, DOI 10.1007/s10940-021-09513-w; Nicholson-Crotty S, 2017, PUBLIC ADMIN REV, V77, P206, DOI 10.1111/puar.12734; Nix J, 2017, CRIMINOL PUBLIC POL, V16, P309, DOI 10.1111/1745-9133.12269; Raice S., 2020, WALL STR J; Ray R, 2020, SOCIOL FORUM, V35, P806, DOI 10.1111/socf.12618; Ross CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141854; Schwartz GL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229686; Sewell AA, 2021, ETHNIC RACIAL STUD, V44, P1089, DOI 10.1080/01419870.2020.1781913; Shane JM, 2017, J CRIM JUST, V52, P101, DOI 10.1016/j.jcrimjus.2017.05.001; Sherman LW, 2018, ANNU REV CRIMINOL, V1, P421, DOI 10.1146/annurev-criminol-032317-092409; Shjarback JA, 2021, INJURY PREV, V27, P508, DOI 10.1136/injuryprev-2020-043932; Shjarback JA, 2019, J CRIME JUSTICE, V42, P3, DOI 10.1080/0735648X.2018.1547353; Sierra-Arevalo M, 2020, CRIMINOL PUBLIC POL, V19, P1041, DOI 10.1111/1745-9133.12507; Skoy E, 2021, CONTEMP ECON POLICY, V39, P280, DOI 10.1111/coep.12508; Sullivan J., 2019, WASH POST; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Taylor PL, 2019, CRIMINOL PUBLIC POL, V18, P807, DOI 10.1111/1745-9133.12460; Trauma Center Association of America, 2020, TRAUM CTR US; USDA: Economic Research Service, EC RES SERV RUR URB	53	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0259024	10.1371/journal.pone.0259024	http://dx.doi.org/10.1371/journal.pone.0259024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9NU	34758026	gold, Green Published, Green Submitted			2022-12-26	WOS:000755112500016
J	Zhang, BY; Zhang, MP; Yang, YJ; Li, Q; Yu, JP; Zhu, SM; Niu, YJ; Shang, ZQ				Zhang, Boya; Zhang, Mingpeng; Yang, Yanjie; Li, Qi; Yu, Jianpeng; Zhu, Shimiao; Niu, Yuanjie; Shang, Zhiqun			Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC	ONCOGENE			English	Article							RESISTANT PROSTATE-CANCER; ANDROGEN-RECEPTOR; PROTEASOMAL DEGRADATION; SPLICE VARIANTS; NONCODING RNA; PROGRESSION; MECHANISMS; EXPRESSION; THERAPY; GROWTH	Castration-resistant prostate cancer (CRPC) is a highly malignant type of advanced cancer resistant to androgen deprivation therapy. One of the important mechanisms for the development of CRPC is the persistent imbalanced regulation of AR and AR splice variants (AR/AR-Vs). In this study, we reported KDM4A-AS1, a recently discovered lncRNA, as a tumor promoter that was significantly increased in CRPC cell lines and cancer tissues. Depletion of KDM4A-AS1 significantly reduced cell viability, proliferation, migration in vitro, and tumor growth in vivo. We found that by binding to the NTD domain, KDM4A-AS1 enhances the stability of USP14-AR/AR-Vs complex, and promoted AR/AR-Vs deubiquitination to protect it from MDM2-mediated ubiquitin-proteasome degradation. Moreover, KDM4A-AS1 was found to enhance CRPC drug resistance to enzalutamide by repressing AR/AR-Vs degradation; antisense oligonucleotide drugs targeting KDM4A-AS1 significantly reduced the growth of tumors with enzalutamide resistance. Taken together, our results indicated that KDM4A-AS1 played an important role in the progression of CRPC and enzalutamide resistance by regulating AR/AR-Vs deubiquitination; targeting KDM4A-AS1 has broad clinical application potential.	[Zhang, Boya; Zhang, Mingpeng; Yang, Yanjie; Li, Qi; Yu, Jianpeng; Zhu, Shimiao; Niu, Yuanjie; Shang, Zhiqun] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin 300211, Peoples R China	Tianjin Medical University	Shang, ZQ (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin 300211, Peoples R China.	zhiqun_shang@tmu.edu.cn	zhang, boya/GRO-7325-2022; shang, zhiqun/N-9995-2015	shang, zhiqun/0000-0001-8263-707X	National Natural Science Foundation of China [81872100, 81772756]; Natural Science Foundation of Tianjin [18PTLCSY00030, 19JCYBJC24900]; Tianjin Research Innovation Project for Postgraduate Students	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Tianjin Research Innovation Project for Postgraduate Students	This work was supported by National Natural Science Foundation of China (grants 81872100 and 81772756), Natural Science Foundation of Tianjin (18PTLCSY00030 and 19JCYBJC24900), and Tianjin Research Innovation Project for Postgraduate Students.	Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Davey Rachel A, 2016, Clin Biochem Rev, V37, P3; Geng C, 2014, CANCER RES, V74, P5631, DOI 10.1158/0008-5472.CAN-14-0476; Grillone K, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01622-x; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Kim TD, 2016, J CLIN INVEST, V126, P706, DOI 10.1172/JCI78132; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kwegyir-Afful AK, 2015, ONCOTARGET, V6, P27440, DOI 10.18632/oncotarget.4578; Li B, 2014, PROSTATE, V74, P421, DOI 10.1002/pros.22763; Li YA, 2015, ONCOTARGET, V6, P33743, DOI 10.18632/oncotarget.5608; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Li ZW, 2017, CELL DEATH DIFFER, V24, P59, DOI 10.1038/cdd.2016.95; Liao YN, 2018, ONCOGENE, V37, P1896, DOI 10.1038/s41388-017-0069-z; Liao YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.477; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Liu CF, 2019, MOL CANCER THER, V18, P1875, DOI 10.1158/1535-7163.MCT-18-1322; Liu CF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07178-x; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Ni W, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1079-y; Peng WX, 2017, ONCOGENE, V36, P5661, DOI 10.1038/onc.2017.184; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sarkar S, 2014, ONCOGENE, V33, P26, DOI 10.1038/onc.2012.561; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Shang ZQ, 2019, NUCLEIC ACIDS RES, V47, P4211, DOI 10.1093/nar/gkz108; Shipley WU, 2017, NEW ENGL J MED, V376, P417, DOI 10.1056/NEJMoa1607529; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Yang R, 2019, ONCOGENE, V38, P7133, DOI 10.1038/s41388-019-0909-0; Yin Y, 2017, CANCER RES, V77, P4745, DOI 10.1158/0008-5472.CAN-17-0164; Yoon JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3939; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Zhang A, 2015, CELL REP, V13, P209, DOI 10.1016/j.celrep.2015.08.069; Zhang H, 2015, CANCER RES, V75, P2363, DOI 10.1158/0008-5472.CAN-14-2928	49	5	5	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					387	399		10.1038/s41388-021-02103-x	http://dx.doi.org/10.1038/s41388-021-02103-x		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34759344	Green Published, hybrid			2022-12-26	WOS:000716867900002
J	Almeida, NCOS; Silva, FRP; Carneiro, ALB; Lima, ES; Barcellos, JFM; Furtado, SC				Almeida, Nayanne C. O. S.; Silva, Felipe R. P.; Carneiro, Ana Lucia B.; Lima, Emerson S.; Barcellos, Jose Fernando M.; Furtado, Silvania C.			Libidibia ferrea (juca) anti-inflammatory action: A systematic review of in vivo and in vitro studies	PLOS ONE			English	Review							CAESALPINIA-FERREA; MEDICINAL-PLANTS; EXTRACTS	Libidibia ferrea (Mart. ex Tul.) L. P. Queiroz (juca) is a plant extensively used in the Brazilian folk medicine for the treatment of the inflammatory process. Primary studies have focused on the verification of these biological activities, highlighting the role of this plant in inflammatory conditions. This systematic review aimed to critically establish which part of the plant and what type of plant extract present the highest evidence of anti-inflammatory activity as in vivo and in vitro experimental models. This study has followed the recommendations by PRISMA and was registered in the PROSPERO database under number CRD42020159934. The literature review was carried out in several medical and scientific databases (Google Scholar, LILACS, ProQuest, PubMed, ScienceDirect, Scopus and Web of Science) in studies published up to February 2020 and updated on March 2021. No language restriction was made to this search. Eligibility criteria were adopted instead. The risk of bias was evaluated through SYRCLE's RoB tool for the in vivo studies. 609 studies were initiated to identify the whole and the subsequent steps of screening. 13 studies remained in the results (10 in vivo and 3 in vitro). In most studies the risk of bias was low or unclear. The high risk of bias was related to the risk of attrition and reporting bias. The fruit and the aqueous extract were identified as the most used in the studies carried out on the qualitative analysis and the results of the in vivo and in vitro studies were conducive to the anti-inflammatory action, a meta-analysis could not be performed due to heterogeneity between studies and the potential risk of bias to estimate the side effects. Therefore, the implementation of in vivo studies following the international guidelines could collaborate with analyses of the anti-inflammatory effect of juca.	[Almeida, Nayanne C. O. S.; Silva, Felipe R. P.] Univ Fed Amazonas, Grad Program Basic & Appl Immunol, Manaus, Amazonas, Brazil; [Carneiro, Ana Lucia B.] Univ Fed Paraiba, Paraiba, Brazil; [Lima, Emerson S.] Univ Fed Amazonas, Fac Member Pharmaceut Sci, Manaus, Amazonas, Brazil; [Barcellos, Jose Fernando M.; Furtado, Silvania C.] Univ Fed Amazonas, Inst Biol Sci, Dept Morphol, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Universidade Federal da Paraiba; Universidade Federal de Amazonas; Universidade Federal de Amazonas	Almeida, NCOS (corresponding author), Univ Fed Amazonas, Grad Program Basic & Appl Immunol, Manaus, Amazonas, Brazil.	nayannebiologia@yahoo.com.br	Basilio Carneiro, Ana Lucia/F-7486-2010	Basilio Carneiro, Ana Lucia/0000-0003-2035-8328				Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021; Barros AO., 2014, INT J PHARM PHARM SC, V6, P71; Cardenas JDR, 2017, GEEA GRUPO ESTUDOS E, V10, P59; Carvalho JCT, 1996, J ETHNOPHARMACOL, V53, P175, DOI 10.1016/0378-8741(96)01441-9; Comandolli-Wyrepkowski CD, 2017, ACTA AMAZON, V47, P331, DOI 10.1590/1809-4392201700871; das C Neto FC, 2018, THESIS U FEDERAL CEA; de Araujo AA, 2014, J ETHNOPHARMACOL, V156, P88, DOI 10.1016/j.jep.2014.07.031; Dias AMA, 2013, J SUPERCRIT FLUID, V74, P34, DOI 10.1016/j.supflu.2012.12.007; Duchman Kyle R, 2019, Iowa Orthop J, V39, P107; Eze FI., 2019, INNOSC THERANOST PHA, V2, P3, DOI [10.36922/itps.v2i2.775, DOI 10.36922/ITPS.V2I2.775]; Falcao TR, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/6064805; Falcao TR, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2454-3; Fedele M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/764618; Ferreira M. R. A., 2015, Journal of Medicinal Plants Research, V9, P140; Vasquez SPF, 2014, ACTA AMAZON, V44, P457, DOI 10.1590/1809-4392201400423; Freitas ACC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/514134; Gomes TMF., 2017, GAIA SCI, V11, P253, DOI [10.21707/gs.v11.n01a17, DOI 10.21707/GS.V11.N01A17]; GRADEpro GDT., 2020, GRADEPRO GUID DEV TO; Holanda BF, 2021, J ETHNOPHARMACOL, V267, DOI 10.1016/j.jep.2020.113501; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187271; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Kahkeshani N, 2019, IRAN J BASIC MED SCI, V22, P225, DOI 10.22038/ijbms.2019.32806.7897; Karygianni L, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01529; Kobayashi Y. T. S., 2015, BRAZ J VET RES ANIM, V52, P34, DOI https%3A//doi.org/10.11606/issn.1678-4456.v52i1p34-40; Lima CNF., 2020, J MED PLANTS RES, V14, P62, DOI DOI 10.5897/JMPR2019.6855; Lima SMA, 2012, REV BRAS FARMACOGN, V22, P169, DOI 10.1590/S0102-695X2011005000197; Lins MA., 2020, THESIS U FEDERAL AMA; Liu HY, 2018, ONCOTARGET, V9, P2887, DOI 10.18632/oncotarget.20812; Nakamura ES, 2002, J ETHNOPHARMACOL, V81, P135, DOI 10.1016/S0378-8741(02)00047-8; Nakamura ES, 2002, CANCER LETT, V177, P119, DOI 10.1016/S0304-3835(01)00708-X; Pedrosa TD, 2016, ARCH DERMATOL RES, V308, P643, DOI 10.1007/s00403-016-1685-0; Pereira LD, 2016, J ETHNOPHARMACOL, V187, P213, DOI 10.1016/j.jep.2016.04.043; Pereira LD, 2012, J ETHNOPHARMACOL, V139, P642, DOI 10.1016/j.jep.2011.12.012; Prazeres LDKT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1983137; Ribeiro VP, 2018, PHARM BIOL, V56, P253, DOI 10.1080/13880209.2018.1454480; Santos KAdos., 2017, SCI PLENA, V13, P1, DOI [10.14808/sci.plena.2017.034501, DOI 10.14808/SCI.PLENA.2017.034501]; Sawada LA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/508725; SciRAP.org, 2018, INSTR EV REL REL IN, P1; Sena ES, 2014, J CEREBR BLOOD F MET, V34, P737, DOI 10.1038/jcbfm.2014.28; Silva MFda., 1989, ACTA BOT BRAS, V2, P193	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259545	10.1371/journal.pone.0259545	http://dx.doi.org/10.1371/journal.pone.0259545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739501	Green Published, gold			2022-12-26	WOS:000755000800038
J	Tahir, MJ; Malik, NI; Ullah, I; Khan, HR; Perveen, S; Ramalho, R; Siddiqi, AR; Waheed, S; Shalaby, MMM; De Berardis, D; Jain, S; Vetrivendan, GL; Chatterjee, H; Franco, WXG; Shafiq, MA; Fatima, NT; Abeysekera, M; Sayyeda, Q; Shamat, SF; Aiman, W; Akhtar, Q; Devi, A; Aftab, A; Shoib, S; Lin, CY; Pakpour, AH				Tahir, Muhammad Junaid; Malik, Najma Iqbal; Ullah, Irfan; Khan, Hamza Rafique; Perveen, Shahida; Ramalho, Rodrigo; Siddiqi, Ahsun Rizwan; Waheed, Summaiya; Shalaby, Mahmoud Mohamed Mohamed; De Berardis, Domenico; Jain, Samiksha; Vetrivendan, Gautham Lakshmipriya; Chatterjee, Harshita; Franco, William Xochitun Gopar; Shafiq, Muhammad Ahsan; Fatima, Naira Taiba; Abeysekera, Maria; Sayyeda, Qudsia; Shamat, Shamat Fathi; Aiman, Wajeeha; Akhtar, Qirat; Devi, Arooj; Aftab, Anam; Shoib, Sheikh; Lin, Chung-Ying; Pakpour, Amir H.			Internet addiction and sleep quality among medical students during the COVID-19 pandemic: A multinational cross-sectional survey	PLOS ONE			English	Article							PROBLEMATIC INTERNET; DISTURBANCES	Background The emergence of the COVID-19 pandemic has affected the lives of many people, including medical students. The present study explored internet addiction and changes in sleep patterns among medical students during the pandemic and assessed the relationship between them. Methods A cross-sectional study was carried out in seven countries, the Dominican Republic, Egypt, Guyana, India, Mexico, Pakistan, and Sudan, using a convenience sampling technique, an online survey comprising demographic details, information regarding COVID-19, the Pittsburgh Sleep Quality Index (PSQI), and the Internet Addiction Test (IAT). Results In total, 2749 participants completed the questionnaire. Of the total, 67.6% scored above 30 in the IAT, suggesting the presence of an Internet addiction, and 73.5% scored equal and above 5 in the PSQI, suggesting poor sleep quality. Internet addiction was found to be significant predictors of poor sleep quality, causing 13.2% of the variance in poor sleep quality. Participants who reported COVID-19 related symptoms had disturbed sleep and higher internet addiction levels when compared with those who did not. Participants who reported a diagnosis of COVID-19 reported poor sleep quality. Those living with a COVID-19 diagnosed patient reported higher internet addiction and worse sleep quality compared with those who did not have any COVID-19 patients in their surroundings. Conclusion The results of this study suggest that internet addiction and poor sleep quality are two issues that require addressing amongst medical students. Medical training institutions should do their best to minimize their negative impact, particularly during the current COVID-19 pandemic.	[Tahir, Muhammad Junaid] Univ Hlth & Sci, Ameer Ud Din Med Coll, Lahore, Pakistan; [Tahir, Muhammad Junaid] Lahore Gen Hosp, Lahore, Pakistan; [Malik, Najma Iqbal; Perveen, Shahida] Univ Sargodha, Sargodha, Pakistan; [Ullah, Irfan] Gandhara Univ, Kabir Med Coll, Peshawar, Pakistan; [Khan, Hamza Rafique] Quaid E Azam Med Coll, Bahawalpur, Pakistan; [Ramalho, Rodrigo] Univ Auckland, Sch Populat Hlth, Dept Social & Community Hlth, Auckland, New Zealand; [Siddiqi, Ahsun Rizwan] Univ Hlth Sci, Wah Med Coll, Wah, Pakistan; [Waheed, Summaiya; Aftab, Anam] Dow Univ Hlth Sci, Dow Med Coll, Karachi, Pakistan; [Shalaby, Mahmoud Mohamed Mohamed] Ain Shams Univ, Fac Med, Cairo, Egypt; [De Berardis, Domenico] Hosp G Mazzini, Dept Mental Hlth, Psychiat Serv Diag & Treatment, NHS, Teramo, Italy; [Jain, Samiksha] Guntur Med Coll, Guntur, Andhra Pradesh, India; [Vetrivendan, Gautham Lakshmipriya] Karpaga Vinayaga Inst Med Sci & Res Ctr, Maduranthagam, Tamil Nadu, India; [Chatterjee, Harshita] Texila Amer Univ, Georgetown, Guyana; [Franco, William Xochitun Gopar] Univ Guadalajara, Puerto Vallarta, Mexico; [Shafiq, Muhammad Ahsan] Holy Family Hosp, Rawalpindi, Pakistan; [Fatima, Naira Taiba] Changsha Med Univ, Changsha, Hunan, Peoples R China; [Abeysekera, Maria] Autonomous Univ Santo Domingo, Santo Domingo, Dominica; [Sayyeda, Qudsia] Red Crescent Clin Tampa Bay, Tampa, FL USA; [Shamat, Shamat Fathi] Natl Ribat Univ, Med Sch, Khartoum, Sudan; [Aiman, Wajeeha] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Akhtar, Qirat] Aziz Bhatti Shaheed Hosp, Gujrat, Punjab, Pakistan; [Devi, Arooj] Ghulam Muhammad Mahar Med Coll, Sukkur, Pakistan; [Shoib, Sheikh] Jawahar Lal Nehru Mem Hosp, Dept Psychiat, Srinagar, India; [Lin, Chung-Ying] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan; [Pakpour, Amir H.] Jonkoping Univ, Sch Hlth & Welf, Dept Nursing, Jonkoping, Sweden; [Pakpour, Amir H.] Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Prevent Noncommunicable Dis, ShahidBahounar BLV, Qazvin, Iran	University of Health Science - Pakistan; University of Sargodha; University of Auckland; Dow University of Health Sciences; Egyptian Knowledge Bank (EKB); Ain Shams University; Universidad de Guadalajara; Changsha Medical University; Harvard University; Beth Israel Deaconess Medical Center; National Cheng Kung University; National Cheng Kung University Hospital; Jonkoping University; Qazvin University of Medical Sciences (QUMS)	Lin, CY (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan.; Pakpour, AH (corresponding author), Jonkoping Univ, Sch Hlth & Welf, Dept Nursing, Jonkoping, Sweden.; Pakpour, AH (corresponding author), Qazvin Univ Med Sci, Social Determinants Hlth Res Ctr, Res Inst Prevent Noncommunicable Dis, ShahidBahounar BLV, Qazvin, Iran.	cylin36933@gmail.com; amir.pakpour@ju.se	De Berardis, Domenico/HII-7444-2022; Pakpour, Amir H./C-6160-2014; Ramalho, Rodrigo/ADL-2819-2022; malik, najma iqbal/K-7738-2019; Lin, Chung-Ying/I-5434-2016; Ullah, Irfan/X-2858-2019; De Berardis, Domenico/F-9343-2018	Pakpour, Amir H./0000-0002-8798-5345; Ramalho, Rodrigo/0000-0002-2372-6854; malik, najma iqbal/0000-0002-3521-1014; Lin, Chung-Ying/0000-0002-2129-4242; Ullah, Irfan/0000-0003-1100-101X; De Berardis, Domenico/0000-0003-4415-5058; Shoib, Sheikh/0000-0002-3739-706X; Waheed, Summaiya/0000-0003-1199-3039; Rizwan Siddiqi, Ahsun/0000-0003-4699-6221				Alheneidi H, 2021, BEHAV SCI-BASEL, V11, DOI 10.3390/bs11010005; Alimoradi Z, 2022, J SLEEP RES, V31, DOI 10.1111/jsr.13432; Alimoradi Z, 2021, ECLINICALMEDICINE, V36, DOI 10.1016/j.eclinm.2021.100916; Alimoradi Z, 2019, SLEEP MED REV, V47, P51, DOI 10.1016/j.smrv.2019.06.004; Azad MC, 2015, J CLIN SLEEP MED, V11, P69, DOI 10.5664/jcsm.4370; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Canan F, 2013, SLEEP BIOL RHYTHMS, V11, P210, DOI 10.1111/sbr.12022; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Chaudhari Bhushan, 2015, Ind Psychiatry J, V24, P158, DOI 10.4103/0972-6748.181729; Cheng SH, 2012, PSYCHIAT RES, V197, P270, DOI 10.1016/j.psychres.2011.08.011; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dixit A, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113089; Fernandes B, 2020, REV PSICOL CLIN NINO, V7, P59, DOI 10.21134/rpcna.2020.mon.2056; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Haque M, 2016, PSYCHOL RES BEHAV MA, V9, P297, DOI 10.2147/PRBM.S119275; Hashemi SGS, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05135; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-183; Jahan SM, 2019, SLEEP BIOL RHYTHMS, V17, P323, DOI 10.1007/s41105-019-00219-y; Jenaro C, 2007, ADDICT RES THEORY, V15, P309, DOI 10.1080/16066350701350247; Kim JH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008766; Kim K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174619; Kuss DJ, 2016, WORLD J PSYCHIATR, V6, P143, DOI 10.5498/wjp.v6.i1.143; Kwon JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072507; Lai CM, 2013, J PEDIATR PSYCHOL, V38, P794, DOI 10.1093/jpepsy/jst022; Lam LT, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0444-1; Lin CY, 2020, INTERNET INTERV, V21, DOI 10.1016/j.invent.2020.100345; Lin MP, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228547; Lin PH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00599; Liu JT, 2013, J FORMOS MED ASSOC, V112, P287, DOI 10.1016/j.jfma.2011.12.006; Meo SA, 2020, PAK J MED SCI, V36, pS43, DOI 10.12669/pjms.36.COVID19-S4.2809; Mulyadi S., 2020, IEOM SOC INT, V3, P2199; Oluwole LO, 2021, ASIAN J SOC HEAL BEH, V4, P56, DOI 10.4103/shb.shb_76_20; Priego-Parra B.A., 2020, ANXIETY DEPRESSION A; Raniti MB, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy066; Romero-Blanco C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145222; Samaha AA, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00365; Sharma R, 2021, ASIAN J SOC HEAL BEH, V4, P98, DOI 10.4103/shb.shb_9_21; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; Siste K, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.580977; Tsitsika A, 2014, CYBERPSYCH BEH SOC N, V17, P528, DOI 10.1089/cyber.2013.0382; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Verma A, 2020, INDIAN J SURG, V82, P299, DOI 10.1007/s12262-020-02487-2; WHO, PUBLIC HLTH IMPLICAT; Yang S.-Y., 2019, SOC HLTH BEHAV, V2, P26, DOI 10.4103/SHB.SHB-44-18; Young K., 1998, CAUGHT NET RECOGNIZE; Yuan Kai, 2011, Commun Integr Biol, V4, P637; Zhang C., 2020, FRONT PSYCHIATRY, V11, P886; Zhang MWB, 2017, ASIAN J PSYCHIATR, V28, P15, DOI 10.1016/j.ajp.2017.03.025	48	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259594	10.1371/journal.pone.0259594	http://dx.doi.org/10.1371/journal.pone.0259594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739502	gold, Green Published			2022-12-26	WOS:000755000800040
J	Vandervelden, S; Wauters, L; Breuls, J; Fieuws, S; Vanhove, P; Hubloue, I; Bartiaux, M; Creteur, J; Stifkens, F; Monsieurs, K; Desruelles, D				Vandervelden, Stefanie; Wauters, Lina; Breuls, Jan; Fieuws, Steffen; Vanhove, Philippe; Hubloue, Ives; Bartiaux, Magali; Creteur, Jacques; Stifkens, Francois; Monsieurs, Koen; Desruelles, Didier			Early administration of Vitamin C in patients with sepsis or septic shock in emergency departments: A multicenter, double blinded, randomized controlled trial: The C-EASIE trial protocol	PLOS ONE			English	Article							ASCORBIC-ACID; ORGAN FAILURE; THIAMINE; INJURY; MICE	Background Sepsis is a potentially life-threatening condition characterized by a deregulated body's response to infection causing injury to its own tissues and organs. Sepsis is the primary cause of death from infection. If not recognized and treated timely, it can evolve within minutes/hours to septic shock. Sepsis is associated with an acute deficiency of Vitamin C. Despite the proof-of-concept of the benefit of administering Vitamin C in patients with sepsis or septic shock, Vitamin C administration is not yet current practice. Objective To investigate the potential benefit of early administration of high doses of Vitamin C in addition to standard of care in patients with sepsis or septic shock. Methods This phase 3b multi-center trial is conducted in 8 hospitals throughout Belgium. In total 300 patients will be randomly assigned to one of two groups in a 1:1 allocation ratio. The intervention group will receive 1.5 g Vitamin C 4 times a day during 4 days, started within 6 hours after admission. The primary outcome is the average post-baseline patient SOFA score. Conclusion This trial will determine whether the early administration of Vitamin C in patients with sepsis or septic shock can lead to a more rapid solution of shock and less deterioration from sepsis to septic shock, hereby reducing morbidity and mortality as well as the length of hospital stay in this patient population. Trial registration The C-EASIE trial has been registered on the ClinicalTrials.gov website on 10 February 2021 with registration number NCT04747795.	[Vandervelden, Stefanie; Wauters, Lina; Desruelles, Didier] Univ Hosp Leuven, Dept Emergency Med, Leuven, Belgium; [Breuls, Jan] Algemeen Ziekenhuis Turnhout, Dept Emergency Med, Rubensstr, Turnhout, Belgium; [Fieuws, Steffen] Leuven Biostat & Stat Bioinformat Ctr BioStat, Leuven, Belgium; [Vanhove, Philippe] GZA Ziekenhuizen, Dept Intens Care, Antwerp, Belgium; [Hubloue, Ives] Univ Hosp Brussel, Dept Emergency Med, Jette, Belgium; [Bartiaux, Magali] Univ Med Ctr St Pierre, Dept Emergency Med, Brussels, Belgium; [Creteur, Jacques] Erasme Hosp Brussels, Dept Intens Care, Brussels, Belgium; [Stifkens, Francois] Ctr Hosp Univ Liege, Dept Emergency Med, Liege, Belgium; [Monsieurs, Koen] Univ Hosp Antwerp, Dept Emergency Med, Edegem, Belgium	KU Leuven; University Hospital Leuven; Universite Libre de Bruxelles; University of Liege; University of Antwerp	Vandervelden, S (corresponding author), Univ Hosp Leuven, Dept Emergency Med, Leuven, Belgium.	stefanie.vandervelden@uzleuven.be	Vandervelden, Stefanie/AAV-4835-2020; Hubloue, Ives/GYR-0901-2022	Vandervelden, Stefanie/0000-0001-5664-8373; Bartiaux, Magali/0000-0001-9877-9240				Bornstein SR, 2003, FASEB J, V17, P1928, DOI 10.1096/fj.02-1167fje; Brock GN., 2011, BMC MED RES METHODOL, P11, DOI [10.1186/1471-2288-11-11, DOI 10.1186/1471-2288-11-11]; Carr AC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1891-y; Chang P, 2020, CHEST, V158, P174, DOI 10.1016/j.chest.2020.02.065; Churpek MM, 2017, AM J RESP CRIT CARE, V195, P906, DOI 10.1164/rccm.201604-0854OC; Fisher BJ, 2014, JPEN-PARENTER ENTER, V38, P825, DOI 10.1177/0148607113497760; Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825; Fowler AA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-32; Fujii T, 2020, JAMA-J AM MED ASSOC, V323, P423, DOI 10.1001/jama.2019.22176; Ge ZZ, 2021, EUR J EMERG MED, V28, P189, DOI 10.1097/MEJ.0000000000000812; Hwang SY, 2020, INTENS CARE MED, V46, P2015, DOI 10.1007/s00134-020-06191-3; Iglesias J, 2020, CHEST, V158, P164, DOI 10.1016/j.chest.2020.02.049; Khoshnam-Rad N, 2019, CURR OPIN CRIT CARE, V25, P329, DOI 10.1097/MCC.0000000000000622; Kieser M, 2003, STAT MED, V22, P3571, DOI 10.1002/sim.1585; Liang K-Y., 1960, INDIAN J STAT B, V62, P134, DOI [10.2307/25053123, DOI 10.2307/25053123]; Long Oztekin, 2008, BONE, V23, P1, DOI [10.1097/CCM.0b013e31819cefa9.Derivation, DOI 10.1097/CCM.0B013E31819CEFA9.DERIVATION]; Marik PE, 2018, PHARMACOL THERAPEUT, V189, P63, DOI 10.1016/j.pharmthera.2018.04.007; Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036; May JM, 2013, ANTIOXID REDOX SIGN, V19, P2068, DOI 10.1089/ars.2013.5205; Moskowitz A, 2020, JAMA-J AM MED ASSOC, V324, P642, DOI 10.1001/jama.2020.11946; Oudemans-van Straaten HM, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0460-x; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Schorah CJ, 1996, AM J CLIN NUTR, V63, P760, DOI 10.1093/ajcn/63.5.760; Sevransky JE, 2021, JAMA-J AM MED ASSOC, V325, P742, DOI 10.1001/jama.2020.24505; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith GB, 2013, RESUSCITATION, V84, P465, DOI 10.1016/j.resuscitation.2012.12.016; Somagutta MKR, 2021, ACUTE CRIT CARE, V36, P185, DOI 10.4266/acc.2021.00108; Stroup W. W, 1999, MIXED MODEL PROCEDUR, P15; Wani SJ., 2020, COMBINATION VITAMIN, V52, P271; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; World Health Organization, 2011, REP BURD END HLTH CA; Zabet MH, 2016, J RES PHARM PRACT, V5, P94, DOI 10.4103/2279-042X.179569	33	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259699	10.1371/journal.pone.0259699	http://dx.doi.org/10.1371/journal.pone.0259699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739527	Green Published, gold			2022-12-26	WOS:000755000800051
J	Kim, J; Shin, SJ; Kang, HT				Kim, Joungyoun; Shin, Sang-Jun; Kang, Hee-Taik			The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; PRODUCT	Background The triglyceride-glucose (TyG) index is a reliable indicator of insulin resistance. We aimed to investigate the TyG index in relation to cardio-cerebrovascular diseases (CCVDs and mortality. Methods This retrospective study included 114,603 subjects. The TyG index was categorized into four quartiles by sex: Q(1), <8.249 and <8.063; Q(2), 8.249<8.614 and 8.063<8.403; Q(3), 8.614< 8.998 and 8.403<8.752; and Q(4), >= 8.998 and >= 8.752, in men and women, respectively. To calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the primary outcomes (CCVDs and all-cause mortality) and secondary outcomes (cardiovascular diseases [CVDs], cerebrovascular diseases [CbVDs], CCVD-related deaths, or all-cause deaths), Cox proportional hazards regression models were adopted. Results Compared to Q(1), the HRs (95% CIs) for the primary outcomes of Q(2), Q(3), and Q(4) were 1.062 (0.9811.150), 1.110 (1.024-1.204), and 1.151 (1.058-1.252) in men and 1.099 (0.986-1.226), 1.046 (0.938-1.166), and 1.063 (0.954-1.184) in women, respectively, after adjusted for age, smoking status, drinking status, physical activity, body mass index, systolic blood pressure, low-density lipoprotein cholesterol, economic status, and anti-hypertensive medications. Fully adjusted HRs (95% CIs) for CVDs of Q(2), Q(3), and Q(4) were 1.114 (0.969-1.282), 1.185 (1.031-1.363), and 1.232 (1.068-1.422) in men and 1.238 (1.017-1.508), 1.183 (0.971-1.440), and 1.238 (1.018-1.505) in women, respectively. The adjusted HRs (95% CIs) for ischemic CbVDs of Q(2), Q(3), and Q(4) were 1.005 (0.850-1.187), 1.225 (1.041-1.441), and 1.232 (1.039-1.460) in men and 1.040 (0.821-1.316), 1.226 (0.981-1.532), and 1.312 (1.054-1.634) in women, respectively, while the TyG index was negatively associated with hemorrhagic CbVDs in women but not in men. The TyG index was not significantly associated with CCVD-related death or all-cause death in either sex. Conclusions Elevated TyG index was positively associated with the primary outcomes (CCVDs and all-cause mortality) in men and predicted higher risk of CVDs and ischemic CbVDs in both sexes.	[Kim, Joungyoun] Yonsei Univ, Mo Kim Nursing Res Inst, Coll Nursing, Seoul, South Korea; [Shin, Sang-Jun] Chungbuk Natl Univ, Dept Informat & Stat, Cheongju, South Korea; [Kang, Hee-Taik] Chungbuk Natl Univ Hosp, Dept Family Med, Cheongju, South Korea; [Kang, Hee-Taik] Chungbuk Natl Univ, Dept Family Med, Coll Med, Cheongju, South Korea	Yonsei University; Yonsei University Health System; Chungbuk National University; Chungbuk National University; Chungbuk National University Hospital; Chungbuk National University	Kang, HT (corresponding author), Chungbuk Natl Univ Hosp, Dept Family Med, Cheongju, South Korea.; Kang, HT (corresponding author), Chungbuk Natl Univ, Dept Family Med, Coll Med, Cheongju, South Korea.	kanght0818@gmail.com		Kang, Hee-Taik/0000-0001-8048-6247				Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Ausk KJ, 2010, DIABETES CARE, V33, P1179, DOI 10.2337/dc09-2110; Cho YR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42700-1; Committee of Clinical Practice Guideline of the Korean Society of Lipid and Atherosclerosis (KSoLA), 2018, KOR GUID MAN DYSL, V4th; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Du TT, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0146-3; Fukushima M, 1999, DIABETES CARE, V22, P1911, DOI 10.2337/diacare.22.11.1911; Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288; Irace C, 2013, INT J CLIN PRACT, V67, P665, DOI 10.1111/ijcp.12124; Jung CH, 2021, DIABETES METAB J, V45, P1, DOI 10.4093/dmj.2020.0254; Jung CH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040322; Kouvari M, 2021, CLIN NUTR, V40, P3314, DOI 10.1016/j.clnu.2020.10.058; Kwon HS., 2019, TREATMENT GUIDELINE, V6th, P33; Kwon YJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142555; Lee SB, 2019, ENDOCRINOL METAB, V34, P179, DOI 10.3803/EnM.2019.34.2.179; Lee SB, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0692-1; Lee SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090430; Lee YC, 2021, ALCOHOL ALCOHOLISM, V56, P393, DOI 10.1093/alcalc/agaa122; Moon S, 2017, J KOREAN MED SCI, V32, P427, DOI 10.3346/jkms.2017.32.3.427; Nam KW, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01031-6; Ormazabal V, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0762-4; Pan K, 2020, JNCI-J NATL CANCER I, V112, P170, DOI 10.1093/jnci/djz069; Park B, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01186-2; Park B, 2021, TRANSL RES, V228, P42, DOI 10.1016/j.trsl.2020.08.003; Pu D, 2017, CLIMACTERIC, V20, P583, DOI 10.1080/13697137.2017.1386649; Si SC, 2021, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.583473; Simental-Mendia Luis E., 2008, Metabolic Syndrome and Related Disorders, V6, P299, DOI 10.1089/met.2008.0034; Statistics Korea, CAUS DEATH STAT 2018; Wang AX, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01238-1; WHO,, 2021, CARD DIS CVDS FACT S; Yu XW, 2019, J DIABETES INVEST, V10, P1050, DOI 10.1111/jdi.12975; Zhao Q, 2021, J ATHEROSCLER THROMB, V28, P1175, DOI 10.5551/jat.59840	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259212	10.1371/journal.pone.0259212	http://dx.doi.org/10.1371/journal.pone.0259212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735502	Green Published, gold			2022-12-26	WOS:000755077100053
J	Hao, JZ; Brosse, L; Bonnet, C; Ducrocq, M; Padilla, F; Penalba, V; Desplat, A; Ruel, J; Delmas, P				Hao, Jizhe; Brosse, Lucie; Bonnet, Caroline; Ducrocq, Myriam; Padilla, Francoise; Penalba, Virginie; Desplat, Angelique; Ruel, Jerome; Delmas, Patrick			The widely used antihistamine mepyramine causes topical pain relief through direct blockade of nociceptor sodium channels	FASEB JOURNAL			English	Article							GAIN-OF-FUNCTION; INTERNATIONAL-UNION; FUNCTION MUTATIONS; ION-CHANNEL; HISTAMINE; PYRILAMINE; NA(V)1.7; ELECTROGENESIS; INACTIVATION; EXCITABILITY	Mepyramine, a first-generation antihistamine targeting the histamine H(1) receptor, was extensively prescribed to patients suffering from allergic reactions and urticaria. Serious adverse effects, especially in case of overdose, were frequently reported, including drowsiness. impaired thinking, convulsion, and coma. Many of these side effects were associated with the blockade of histaminergic or cholinergic receptors. Here we show that mepyramine directly inhibits a variety of voltage-gated sodium channels, including the Tetrodotoxin-sensitive isoforms and the main isoforms (Nav1.7, Nav1.8, and Nav1.9) of nociceptors. Estimated IC50 were within the range of drug concentrations detected in poisoned patients. Mepyramine inhibited sodium channels through fast- or slow-inactivated state preference depending on the isoform. Moreover, mepyramine inhibited the firing responses of C- and A beta-type nerve fibers in ex vivo skin-nerve preparations. Locally applied mepyramine had analgesic effects on the scorpion toxin-induced excruciating pain and produced pain relief in acute, inflammatory, and chronic pain models. Collectively, these data provide evidence that mepyramine has the potential to be developed as a topical analgesic agent.	[Hao, Jizhe; Brosse, Lucie; Bonnet, Caroline; Ducrocq, Myriam; Padilla, Francoise; Penalba, Virginie; Desplat, Angelique; Ruel, Jerome; Delmas, Patrick] Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR 7291, CS80011,Bd Pierre Dramard, F-13344 Marseille 15, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Delmas, P (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Cognit, UMR 7291, CS80011,Bd Pierre Dramard, F-13344 Marseille 15, France.	patrick.delmas@univ-amu.fr	hao, jizhe/AFS-9867-2022	Ruel, Jerome/0000-0003-2871-7321	Fondation pour la Recherche Medicale (FRM) [DEQ20130326482]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	Fondation pour la Recherche Medicale (FRM), Grant/Award Number: DEQ20130326482	Abbas N, 2013, PAIN, V154, P1204, DOI 10.1016/j.pain.2013.03.037; Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Amsalem M, 2018, EMBO J, V37, DOI 10.15252/embj.201797349; BAIN WA, 1948, LANCET, V252, P964, DOI 10.1016/S0140-6736(48)91644-4; Bonnet C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12197-3; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CHEN NBW, 1983, J FORENSIC SCI, V28, P398; Chevrier P, 2004, BRIT J PHARMACOL, V142, P576, DOI 10.1038/sj.bjp.0705796; Coste B, 2004, MOL CELL NEUROSCI, V26, P123, DOI 10.1016/j.mcn.2004.01.015; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0001.1999; De Sutter AIM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004976.pub3; DEWS PB, 1946, BRIT J PHARM CHEMOTH, V1, P278, DOI 10.1111/j.1476-5381.1946.tb00048.x; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Emery EC, 2016, EXPERT OPIN THER TAR, V20, P975, DOI 10.1517/14728222.2016.1162295; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Gawali VS, 2015, MOL PHARMACOL, V88, P866, DOI 10.1124/mol.115.099580; GELGOR L, 1986, PAIN, V26, P353, DOI 10.1016/0304-3959(86)90063-1; Gilman AG., 1990, GOODMAN GILMANS PHAR, V8th, P586; Habib AM, 2015, HANDB EXP PHARMACOL, V227, P39, DOI 10.1007/978-3-662-46450-2_3; HALEY TJ, 1983, J PHARM SCI, V72, P3, DOI 10.1002/jps.2600720103; Hao JZ, 2013, NEURON, V77, P899, DOI 10.1016/j.neuron.2012.12.035; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; Hill SJ, 1997, PHARMACOL REV, V49, P253; HOOPER RG, 1979, JACEP-J AM COLL EMER, V8, P98, DOI 10.1016/S0361-1124(79)80150-1; Huang JY, 2014, BRAIN, V137, P1627, DOI 10.1093/brain/awu079; JOHNSON EA, 1956, J PHARMACOL EXP THER, V117, P237; JOHNSON EA, 1957, J PHARMACOL EXP THER, V120, P460; JOHNSON GR, 1981, CLIN TOXICOL, V18, P907, DOI 10.3109/15563658108990317; KUBO N, 1987, JPN J PHARMACOL, V43, P277, DOI 10.1254/jjp.43.277; Leipold E, 2013, NAT GENET, V45, P1399, DOI 10.1038/ng.2767; Lolignier S, 2015, CELL REP, V11, P1067, DOI 10.1016/j.celrep.2015.04.027; Ma RSY, 2019, J PAIN RES, V12, P2709, DOI 10.2147/JPR.S207610; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; Mojtahedin A, 2008, Pak J Biol Sci, V11, P2573, DOI 10.3923/pjbs.2008.2573.2578; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Osorio N, 2014, J NEUROSCI, V34, P5233, DOI 10.1523/JNEUROSCI.0057-14.2014; Panula P, 2015, PHARMACOL REV, V67, P601, DOI 10.1124/pr.114.010249; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Paudel G, 2011, PEDIATR EMERG CARE, V27, P945, DOI 10.1097/PEC.0b013e3182309ae2; Raouf R, 2010, J CLIN INVEST, V120, P3745, DOI 10.1172/JCI43158; Renganathan M, 2002, MOL BRAIN RES, V106, P70, DOI 10.1016/S0169-328X(02)00411-4; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Sangalli BC, 1997, PROG NEUROBIOL, V52, P145, DOI 10.1016/S0301-0082(97)00011-7; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Waxman SG, 2014, NAT NEUROSCI, V17, P153, DOI 10.1038/nn.3602; Yokoyama H, 1996, CNS DRUGS, V5, P321, DOI 10.2165/00023210-199605050-00002; Zhang XY, 2013, AM J HUM GENET, V93, P957, DOI 10.1016/j.ajhg.2013.09.016; Zimmermann K, 2009, NAT PROTOC, V4, P174, DOI 10.1038/nprot.2008.223	52	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22025	10.1096/fj.202100976RR	http://dx.doi.org/10.1096/fj.202100976RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34758144				2022-12-26	WOS:000722321300022
J	Spliid, CB; Toledo, AG; Sanderson, P; Mao, Y; Gatto, F; Gustavsson, T; Choudhary, S; Saldanha, AL; Vogelsang, RP; Gogenur, I; Theander, TG; Leach, FE; Amster, IJ; Esko, JD; Salanti, A; Clausen, TM				Spliid, Charlotte B.; Toledo, Alejandro Gomez; Sanderson, Patience; Mao, Yang; Gatto, Francesco; Gustavsson, Tobias; Choudhary, Swati; Saldanha, Ana L.; Vogelsang, Rasmus P.; Gogenur, Ismail; Theander, Thor G.; Leach, Franklin E.; Amster, I. Jonathan; Esko, Jeffrey D.; Salanti, Ali; Clausen, Thomas Mandel			The specificity of the malarial VAR2CSA protein for chondroitin sulfate depends on 4-O-sulfation and ligand accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; ENDOTHELIAL GLYCOCALYX; HUMAN PLACENTA; ADHERENCE; BINDING; PROTEOGLYCANS; ADHESION; CELLS; IDENTIFICATION	Placental malaria infection is mediated by the binding of the malarial VAR2CSA protein to the placental glycosaminoglycan, chondroitin sulfate. Recombinant subfragments of VAR2CSA (rVAR2) have also been shown to bind specifically and with high affinity to cancer cells and tissues, suggesting the presence of a shared type of oncofetal chondroitin sulfate (ofCS) in the placenta and in tumors. However, the exact structure of ofCS and what determines the selective tropism of VAR2CSA remains poorly understood. In this study, ofCS was purified by affinity chromatography using rVAR2 and subjected to detailed structural analysis. We found high levels of N-acetylgalactosamine 4-O-sulfation (similar to 80-85%) in placenta- and tumor-derived ofCS. This level of 4-O-sulfation was also found in other tissues that do not support parasite sequestration, suggesting that VAR2CSA tropism is not exclusively determined by placenta- and tumor-specific sulfation. Here, we show that both placenta and tumors contain significantly more chondroitin sulfate moieties of higher molecular weight than other tissues. In line with this, CHPF and CHPF2, which encode proteins required for chondroitin polymerization, are significantly upregulated in most cancer types. CRISPR/Cas9 targeting of CHPF and CHPF2 in tumor cells reduced the average molecular weight of cell-surface chondroitin sulfate and resulted in a marked reduction of rVAR2 binding. Finally, utilizing a cell-based glycocalyx model, we showed that rVAR2 binding correlates with the length of the chondroitin sulfate chains in the cellular glycocalyx. These data demonstrate that the total amount and cellular accessibility of chondroitin sulfate chains impact rVAR2 binding and thus malaria infection.	[Spliid, Charlotte B.; Toledo, Alejandro Gomez; Esko, Jeffrey D.; Clausen, Thomas Mandel] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Spliid, Charlotte B.; Toledo, Alejandro Gomez; Esko, Jeffrey D.; Clausen, Thomas Mandel] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Spliid, Charlotte B.; Gustavsson, Tobias; Choudhary, Swati; Saldanha, Ana L.; Theander, Thor G.; Salanti, Ali; Clausen, Thomas Mandel] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol, Copenhagen, Denmark; [Spliid, Charlotte B.; Gustavsson, Tobias; Choudhary, Swati; Saldanha, Ana L.; Theander, Thor G.; Salanti, Ali; Clausen, Thomas Mandel] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Toledo, Alejandro Gomez] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Sanderson, Patience; Amster, I. Jonathan] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Mao, Yang] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Peoples R China; [Mao, Yang] Guangdong Prov Key Lab Drug Nonclin Evaluat & Res, Guangzhou, Peoples R China; [Gatto, Francesco] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Vogelsang, Rasmus P.; Gogenur, Ismail] Zealand Univ Hosp, Ctr Surg Sci, Dept Surg, Koege, Denmark; [Leach, Franklin E.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Copenhagen; University of Copenhagen; Lund University; University System of Georgia; University of Georgia; Sun Yat Sen University; Chalmers University of Technology; University System of Georgia; University of Georgia	Clausen, TM (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Clausen, TM (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.; Clausen, TM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Dept Immunol & Microbiol, Copenhagen, Denmark.; Clausen, TM (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark.	tmandelclausen@health.ucsd.edu	Gatto, Francesco/AAA-6682-2020; Theander, Thor G./F-6714-2015	Gatto, Francesco/0000-0002-9031-9562; Goncalves Saldanha, Ana Luisa/0000-0003-2341-1446; Choudhary, Swati/0000-0001-5928-8529; Amster, Jonathan/0000-0001-7523-5144; Salanti, Ali/0000-0003-2207-5575; Theander, Thor G./0000-0002-3509-7514; Spliid, Charlotte B/0000-0002-6811-3891; Mao, Yang/0000-0002-9674-1158	Gangstedfonden; Louis-Hansen Fonden; TOmrermester JOrgen Holm og Hustru Elisa f. Hansens Mindelegat; National Institutes of Health [CA199292, HL131474, GM33063]; National Natural Science Foundation of China [91853131, 81872786]; Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research [2018B030323024]; Alfred Benzon Foundation; Lundbeck Foundation	Gangstedfonden; Louis-Hansen Fonden; TOmrermester JOrgen Holm og Hustru Elisa f. Hansens Mindelegat; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research; Alfred Benzon Foundation; Lundbeck Foundation(Lundbeckfonden)	Funding and additional information-This work was supported in part by grants Gangstedfonden, Louis-Hansen Fonden, and TOmrermester JOrgen Holm og Hustru Elisa f. Hansens Mindelegat to C. B. S., the National Institutes of Health CA199292, HL131474 and GM33063 grants to J. D. E, the National Natural Science Foundation of China (91853131 and 81872786) , and Guangdong Provincial Key Laboratory of Drug Nonclinical Evaluation and Research (2018B030323024) grants to Y. M., grants from the Alfred Benzon Foundation and Lundbeck Foundation to T. M. C.	Achur RN, 2008, BIOCHEMISTRY-US, V47, P12635, DOI 10.1021/bi801643m; Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Agerbaek MO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05793-2; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Bang-Christensen SR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090998; Barker AL, 2004, PHYS CHEM CHEM PHYS, V6, P1006, DOI 10.1039/b312189e; Beeson JG, 2007, J BIOL CHEM, V282, P22426, DOI 10.1074/jbc.M700231200; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Cao CS, 2020, BRAZ J MED BIOL RES, V53, DOI [10.1590/1414-431X20209021, 10.1590/1414-431x20209021]; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chai WG, 2002, J BIOL CHEM, V277, P22438, DOI 10.1074/jbc.M111401200; Chen YH, 2018, NAT METHODS, V15, P881, DOI 10.1038/s41592-018-0086-z; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Esko J.D., 2015, ESSENTIALS GLYCOBIOL; Fan YH, 2017, ONCOL REP, V38, P1149, DOI 10.3892/or.2017.5731; Frey A, 1996, J EXP MED, V184, P1045, DOI 10.1084/jem.184.3.1045; Fried M, 2000, EXP PARASITOL, V95, P75, DOI 10.1006/expr.2000.4510; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Honigfort DJ, 2019, FARADAY DISCUSS, V219, P138, DOI 10.1039/c9fd00024k; Hou XM, 2019, PATHOL RES PRACT, V215, P988, DOI 10.1016/j.prp.2019.02.005; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Lin L, 2017, ANAL BIOANAL CHEM, V409, P411, DOI 10.1007/s00216-016-9662-1; Matejevic D, 2001, GYNECOL OBSTET INVES, V52, P257, DOI 10.1159/000052986; Mizumoto S, 2017, CLIN BIOCHEM, V50, P670, DOI 10.1016/j.clinbiochem.2017.02.018; Nakano T., 2012, RECENT PATENTS FOOD, V2, P61; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Nieuwdorp M, 2008, J APPL PHYSIOL, V104, P845, DOI 10.1152/japplphysiol.00440.2007; OOHIRA A, 1983, J BIOL CHEM, V258, P2014; Pereira MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005831; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rieger H, 2015, BLOOD, V125, P383, DOI 10.1182/blood-2014-03-561019; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salanti A, 2015, CANCER CELL, V28, P500, DOI 10.1016/j.ccell.2015.09.003; Sanderson P, 2018, J CHROMATOGR A, V1545, P75, DOI 10.1016/j.chroma.2018.02.052; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Spliid CB, 2021, GLYCOBIOLOGY, V31, P103, DOI 10.1093/glycob/cwaa056; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Sugiura N, 2016, GLYCOCONJUGATE J, V33, P985, DOI 10.1007/s10719-016-9685-z; Sugiura N, 2012, J BIOL CHEM, V287, P43390, DOI 10.1074/jbc.M112.412676; Sun LL, 2015, J PROTEOME RES, V14, P2312, DOI 10.1021/acs.jproteome.5b00100; Sun LL, 2013, ANGEW CHEM INT EDIT, V52, P13661, DOI 10.1002/anie.201308139; Sun W, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2526-9; Toledo AG, 2020, GLYCOBIOLOGY, V30, P989, DOI 10.1093/glycob/cwaa039; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; WHO, 2011, WORLD MALARIA REPORT 2011, P1	62	2	2	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101391	10.1016/j.jbc.2021.101391	http://dx.doi.org/10.1016/j.jbc.2021.101391			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34762909	Green Published, gold			2022-12-26	WOS:000748397200006
J	Ichioka, A; Ooto, S; Uji, A; Manabe, S; Shiragami, C; Tsujikawa, A				Ichioka, Ai; Ooto, Sotaro; Uji, Akihito; Manabe, Saki; Shiragami, Chieko; Tsujikawa, Akitaka			Correlations among age, sex, axial length, and subfoveal choroidal thickness in the choriocapillaris structure analyzed using multiple en face image averaging optical coherence tomography angiography	PLOS ONE			English	Article							3-DIMENSIONAL PROFILE; HUMAN EYES; NEOVASCULARIZATION; MEMBRANE; DENSITY; FLOW	Purpose To analyze the structure of the choriocapillaris in healthy eyes by using averaged en face images acquired using swept source optical coherence tomography angiography and to examine the changes in the macular profile in relation to age, sex, axial length, and choroidal thickness. Methods This prospective, cross-sectional study included 81 eyes of 81 subjects without ophthalmologic or systemic diseases who underwent a full ophthalmologic examination, including 3 x 3-mm macular optical coherence tomography angiography. Four to nine choriocapillaris en face images were registered and averaged. The averaged images were then binarized and analyzed. Results The averaged choriocapillaris images showed a continuous capillary meshwork, whereas the unaveraged images had a granular appearance. The mean total area and size of flow voids were 0.99 0.20 mm(2) and 567.8 +/- 201.5 mu m(2), respectively, and these values correlated positively with age (p = 0.002, R = 0.336 and p = 0.026, R = 0.247, respectively). Age-related gains in the mean total area and flow void size were 4.20 x 10(-3) mm(2) and 3.07 mu m(2) per year, respectively. However, the mean total area and flow void size had no significant correlation with axial length, subfoveal choroidal thickness, or sex. Conclusions Multiple averaged en face swept source optical coherence tomography angiography is more effective than a single optical coherence tomography angiography scan for better visualizing the choriocapillaris. The total area and size of flow voids within a 3 x 3-mm macular area positively correlated with age. This technique can be useful for investigating the changes arising in macular diseases.	[Ichioka, Ai; Ooto, Sotaro; Uji, Akihito; Tsujikawa, Akitaka] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Manabe, Saki; Shiragami, Chieko] Kagawa Univ, Fac Med, Dept Ophthalmol, Miki, Kagawa, Japan	Kyoto University; Kagawa University	Ooto, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [16K11321]	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	design, data collection and analysis, decision to publish, or preparation of the manuscript.This study was supported in part by the Japan Society for the Promotion of Science, Tokyo, Japan (Grant-in-Aid for Scientific Research, No. 16K11321). The funders had no role in study	Al-Sheikh M, 2017, INVEST OPHTH VIS SCI, V58, P2063, DOI 10.1167/iovs.16-21289; Almeida DRP, 2015, JAMA OPHTHALMOL, V133, P297, DOI 10.1001/jamaophthalmol.2014.5168; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; BERNSTEIN M. H., 1965, INVEST OPHTHAL MOL, V4, P1016; Carnevali A, 2017, ACTA DIABETOL, V54, P695, DOI 10.1007/s00592-017-0996-8; Choi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081499; Guyer D.R., 2006, RETINA-J RET VIT DIS, Vfourth, P33; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Klufas MA, 2017, OPHTHALMOL RETINA, V1, P77, DOI 10.1016/j.oret.2016.08.008; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Mo S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169385; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Mullins RF, 2014, AM J PATHOL, V184, P3142, DOI 10.1016/j.ajpath.2014.07.017; Nagiel A, 2015, JAMA OPHTHALMOL, V133, P629, DOI 10.1001/jamaophthalmol.2015.0668; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Ooto S, 2010, INVEST OPHTH VIS SCI, V51, P465, DOI 10.1167/iovs.09-4047; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Roisman L, 2016, OPHTHALMOLOGY, V123, P1309, DOI 10.1016/j.ophtha.2016.01.044; Shahlaee A, 2016, AM J OPHTHALMOL, V165, P39, DOI 10.1016/j.ajo.2016.02.018; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P45, DOI 10.1001/jamaophthalmol.2014.3616; Staurenghi G, 2002, AM J OPHTHALMOL, V133, P801, DOI 10.1016/S0002-9394(02)01436-8; Uji A, 2017, JAMA OPHTHALMOL, V135, P1197, DOI 10.1001/jamaophthalmol.2017.3904; Uji A, 2017, OPHTHALMOLOGY, V124, P944, DOI 10.1016/j.ophtha.2017.02.006; Von Sallmann L, 1961, ARCH OPHTHALMOL-CHIC, V66, P920; Vujosevic S, 2019, ACTA OPHTHALMOL, V97, pE919, DOI 10.1111/aos.14088; Yanoff M., 2009, OPHTHALMOLOGY; YONEYA S, 1987, ARCH OPHTHALMOL-CHIC, V105, P681; Zheng F, 2019, AM J OPHTHALMOL, V200, P110, DOI 10.1016/j.ajo.2018.12.025	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259880	10.1371/journal.pone.0259880	http://dx.doi.org/10.1371/journal.pone.0259880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780537	gold, Green Published			2022-12-26	WOS:000755305800062
J	Sudadech, P; Roytrakul, S; Kaewprasert, O; Sirichoat, A; Chetchotisakd, P; Kanthawong, S; Faksri, K				Sudadech, Phantitra; Roytrakul, Sittiruk; Kaewprasert, Orawee; Sirichoat, Auttawit; Chetchotisakd, Ploenchan; Kanthawong, Sakawrat; Faksri, Kiatichai			Assessment of in vitro activities of novel modified antimicrobial peptides against clarithromycin resistant Mycobacterium abscessus	PLOS ONE			English	Article							HUMAN NEUTROPHIL PEPTIDE-1; DIFFERENT MALDI BIOTYPE; TUBERCULOSIS; GENERATION; POTENT; AVIUM	Mycobacterium abscessus (Mab) is one of the most drug resistant bacteria with a high treatment failure rate. Antimicrobial peptides (AMPs) are alternative therapeutic agents against this infection. This study was aimed to assess the in vitro activities of thirteen AMPs (S5, S52, S6, S61, S62, S63, KLK, KLK1, KLK2, Pug-1, Pug-2, Pug-3 and Pug-4) that have never been investigated against drug resistant Mab isolates. Only four novel modified AMPs (S61, S62, S63 and KLK1) provided the lowest minimum inhibitory concentration (MIC) values ranging from 200-400 mu g/ml against the Mab ATCC19977 strain. These four potential AMPs were further tested with 16 clinical isolates of clarithromycin resistant Mab. The majority of the tested strains (10/16 isolates, 62.5%) showed similar to 99% kill by all four AMPs within 24 hours with an MIC <50 mu g/ml. Only two isolates (12.5%) with acquired clarithromycin resistance, however, exhibited values <50 mu g/ml of four potential AMPs, S61, S62, S63 and KLK1 after 3-days-incubation. At the MICs level, S63 showed the lowest toxicity with 1.50% hemolysis and 100% PBMC viability whereas KLK1 showed the highest hemolysis (10.21%) and lowest PBMC viability (93.52%). S61, S62 and S63 were further tested with clarithromycin-AMP interaction assays and found that 5/10 (50%) of selected isolates exhibited a synergistic interaction with 0.02-0.41 FICI values. This present study demonstrated the potential application of novel AMPs as an adjunctive treatment with clarithromycin against drug resistant Mab infection.	[Sudadech, Phantitra; Kaewprasert, Orawee; Sirichoat, Auttawit; Kanthawong, Sakawrat; Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Sudadech, Phantitra; Kaewprasert, Orawee; Sirichoat, Auttawit; Chetchotisakd, Ploenchan; Kanthawong, Sakawrat; Faksri, Kiatichai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand; [Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy NSTDA, Genome Inst, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Chetchotisakd, Ploenchan] Khon Kaen Univ, Fac Med, Dept Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Khon Kaen University	Faksri, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Faksri, K (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand.	kiatichai@kku.ac.th	Sirichoat, Auttawit/GQA-9663-2022	Kaewprasert, Orawee/0000-0001-6268-2914; Faksri, Kiatichai/0000-0001-5022-4182; Sirichoat, Auttawit/0000-0001-7681-4295	Invitation Research, Faculty of Medicine, Khon Kaen University [IN62307]; National Research Council of Thailand [NRC MHESI 483/2563]	Invitation Research, Faculty of Medicine, Khon Kaen University; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study was supported by the Invitation Research, Faculty of Medicine, Khon Kaen University (Grant number: IN62307) and National Research Council of Thailand (Grant number: NRC MHESI 483/2563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananta P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208053; Andrews S., 2010, FASTQC QUALITY CONTR; Arpornsuwan T, 2019, INT J PEPT RES THER, V25, P951, DOI 10.1007/s10989-018-9743-4; Arpornsuwan T, 2014, PEPTIDES, V53, P315, DOI 10.1016/j.peptides.2013.10.020; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Carroll James, 2010, Bioeng Bugs, V1, P408, DOI 10.4161/bbug.1.6.13642; Chen J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00508; Choules MP, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02204-18, 10.1128/AAC.02204-18]; Clary G, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/aac.01782-17, 10.1128/AAC.01782-17]; Clinical and Laboratory Standards Institute (CLSI), 2011, M24A2 CLSI; Courvalin P, 2003, CURR OPIN MICROBIOL, V6, P425, DOI 10.1016/j.mib.2003.09.012; das Neves RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149729; De Almeida Isabela Neves, 2013, BMC Res Notes, V6, P561, DOI 10.1186/1756-0500-6-561; Fattorini L, 2004, PEPTIDES, V25, P1075, DOI 10.1016/j.peptides.2004.04.003; Findlay B, 2010, ANTIMICROB AGENTS CH, V54, P4049, DOI 10.1128/AAC.00530-10; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Huang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16559-z; Jantaruk P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183852; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; Jiang ZQ, 2011, PROTEIN PEPTIDE LETT, V18, P241, DOI 10.2174/092986611794578288; Jung CJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86844-5; Kalita A, 2004, J INFECT DIS, V190, P1476, DOI 10.1086/424463; Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3058, DOI 10.1128/AAC.01667-10; Kham-ngam I, 2019, INFECT GENET EVOL, V68, P35, DOI 10.1016/j.meegid.2018.12.001; Khara JS, 2014, BIOMATERIALS, V35, P2032, DOI 10.1016/j.biomaterials.2013.11.035; Kokilakanit P, 2020, LETT APPL MICROBIOL, V70, P151, DOI 10.1111/lam.13265; Lan Y, 2014, TUBERCULOSIS, V94, P678, DOI 10.1016/j.tube.2014.08.001; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Linde CMA, 2001, J ANTIMICROB CHEMOTH, V47, P575, DOI 10.1093/jac/47.5.575; Marques-Neto LM, 2018, TOXINS, V10, DOI 10.3390/toxins10060219; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; OGATA K, 1992, INFECT IMMUN, V60, P4720, DOI 10.1128/IAI.60.11.4720-4725.1992; Philley Julie V, 2016, Curr Treat Options Infect Dis, V8, P275, DOI 10.1007/s40506-016-0086-4; Pulido D, 2013, ANTIMICROB AGENTS CH, V57, P3797, DOI 10.1128/AAC.00428-13; Qasim M, 2018, MOL PHYLOGENET EVOL, V126, P173, DOI 10.1016/j.ympev.2018.04.028; Ramon-Garcia S, 2013, ANTIMICROB AGENTS CH, V57, P2295, DOI 10.1128/AAC.00175-13; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Rivas-Santiago B, 2013, INT J ANTIMICROB AG, V41, P143, DOI 10.1016/j.ijantimicag.2012.09.015; Rubio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140166; Santos P, 2012, PEPTIDES, V36, P121, DOI 10.1016/j.peptides.2012.04.018; Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359; Sato E, 2013, J DERMATOL SCI, V70, P166, DOI 10.1016/j.jdermsci.2013.01.011; Sharma A, 2015, CHEM-EUR J, V21, P3540, DOI 10.1002/chem.201404650; Sharma S, 2000, EUR RESPIR J, V16, P112, DOI 10.1034/j.1399-3003.2000.16a20.x; Silva JP, 2016, J CONTROL RELEASE, V235, P112, DOI 10.1016/j.jconrel.2016.05.064; Silva T, 2014, ANTIMICROB AGENTS CH, V58, P3461, DOI 10.1128/AAC.02728-13; Sosunov V, 2007, J ANTIMICROB CHEMOTH, V59, P919, DOI 10.1093/jac/dkm053; Strnad L, 2018, SEMIN RESP CRIT CARE, V39, P362, DOI 10.1055/s-0038-1651494; Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08; Takagi S, 2014, ANIM SCI J, V85, P342, DOI 10.1111/asj.12109; Teerapo K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218479; Trentini MM., 2017, FRONT MICROBIOL, V8, P1, DOI [10.3389/fmicb.2017.00001, DOI 10.3389/FMICB.2017.00001]; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Welsh KJ, 2011, TUBERCULOSIS, V91, pS105, DOI 10.1016/j.tube.2011.10.019; Weng YW, 2020, J FORMOS MED ASSOC, V119, pS58, DOI 10.1016/j.jfma.2020.05.028; Wu MY, 2019, J GLOB ANTIMICROB RE, V19, P188, DOI 10.1016/j.jgar.2019.05.016	65	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260003	10.1371/journal.pone.0260003	http://dx.doi.org/10.1371/journal.pone.0260003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780520	gold, Green Published			2022-12-26	WOS:000755305800082
J	Pajenda, S; Zawedde, F; Kapps, S; Wagner, L; Schmidt, A; Winnicki, W; O'Connell, D; Gerges, D				Pajenda, Sahra; Zawedde, Florence; Kapps, Sebastian; Wagner, Ludwig; Schmidt, Alice; Winnicki, Wolfgang; O'Connell, David; Gerges, Daniela			Urinary C3 levels associated with sepsis and acute kidney injury-A pilot study	PLOS ONE			English	Article							COMPLEMENT C3; GENE-EXPRESSION; AUTOPHAGY; RECEPTOR	Acute kidney injury (AKI) is an abrupt deterioration of renal function often caused by severe clinical disease such as sepsis, and patients require intensive care. Acute-phase parameters for systemic inflammation are well established and used in routine clinical diagnosis, but no such parameters are known for AKI and inflammation at the local site of tissue damage, namely the nephron. Therefore, we sought to investigate complement factors C3a/C3 in urine and urinary sediment cells. After the development of a C3a/C3-specific mouse monoclonal antibody (3F7E2), urine excretion from ICU sepsis patients was examined by dot blot and immunoblotting. This C3a/C3 ELISA and a C3a ELISA were used to obtain quantitative data over 24 hours for 6 consecutive days. Urine sediment cells were analyzed for topology of expression. Patients with severe infections (n = 85) showed peak levels of C3a/C3 on the second day of ICU treatment. The majority (n = 59) showed C3a/C3 levels above 20 mu g/ml at least once in the first 6 days after admission. C3a was detectable on all 6 days. Peak C3a/C3 levels correlated negatively with peak C-reactive protein (CRP) levels. No relationship was found between peak C3a/C3 with peak leukocyte count, age, or AKI stage. Analysis of urine sediment cells identified C3a/C3-producing epithelial cells with reticular staining patterns and cells with large-granular staining. Opsonized bacteria were detected in patients with urinary tract infections. In critically ill sepsis patients with AKI, urinary C3a/C3 inversely correlated with serum CRP. Whether urinary C3a/C3 has a protective function through autophagy, as previously shown for cisplatin exposure, or is a by-product of sepsis caused by pathogenic stimuli to the kidney must remain open in this study. However, our data suggest that C3a/C3 may function as an inverse acute-phase parameter that originates in the kidney and is detectable in urine.	[Pajenda, Sahra; Zawedde, Florence; Kapps, Sebastian; Wagner, Ludwig; Schmidt, Alice; Winnicki, Wolfgang; Gerges, Daniela] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria; [O'Connell, David] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland	Medical University of Vienna; University College Dublin	Gerges, D (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria.	daniela.gerges@meduniwien.ac.at		O'Connell, David/0000-0002-6461-7750; Winnicki, Wolfgang/0000-0002-0511-6120; Gerges, Daniela/0000-0001-6810-615X				Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bernardi MH, 2021, EUR J ANAESTH, V38, P13, DOI 10.1097/EJA.0000000000001321; Braun MC, 2004, J IMMUNOL, V173, P4190, DOI 10.4049/jimmunol.173.6.4190; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; De Rechter S, 2016, PEDIATR NEPHROL, V31, P737, DOI 10.1007/s00467-015-3134-2; Famulski KS, 2012, J AM SOC NEPHROL, V23, P948, DOI 10.1681/ASN.2011090887; Farrar CA, 2006, FASEB J, V20, P217, DOI 10.1096/fj.05-4747com; Funk D, 2009, CURR OPIN CRIT CARE, V15, P301, DOI 10.1097/MCC.0b013e32832e3825; Garam N, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1237-8; Gerritsma JSJ, 1996, MOL IMMUNOL, V33, P847, DOI 10.1016/0161-5890(96)84610-4; Huang LP, 2012, KIDNEY INT, V82, P867, DOI 10.1038/ki.2012.223; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Lameire N, 2005, LANCET, V365, P417; Lee HW, 2018, MAR DRUGS, V16, DOI 10.3390/md16110398; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; McCullough JW, 2013, SEMIN NEPHROL, V33, P543, DOI 10.1016/j.semnephrol.2013.08.005; Morgan BP, 1997, CLIN EXP IMMUNOL, V107, P1, DOI 10.1046/j.1365-2249.1997.d01-890.x; Naesens M, 2009, J AM SOC NEPHROL, V20, P1839, DOI 10.1681/ASN.2008111145; Neziri Dashurie, 2016, J Nephropathol, V5, P65, DOI 10.15171/jnp.2016.13; Pajenda S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0587-5; Pajenda S, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0203-5; Periyasamy-Thandavan S, 2008, KIDNEY INT, V74, P631, DOI 10.1038/ki.2008.214; SACKS S, 1993, CLIN EXP IMMUNOL, V93, P411, DOI 10.1111/j.1365-2249.1993.tb08193.x; SACKS SH, 1993, IMMUNOLOGY, V79, P348; SACKS SH, 1993, LANCET, V342, P1273, DOI 10.1016/0140-6736(93)92362-W; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Stevens JS, 2020, KIDNEY INT REP, V5, P1982, DOI 10.1016/j.ekir.2020.09.006; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Wagner L, 1996, J IMMUNOL, V156, P1989; Winnicki W, 2019, PEERJ, V7, DOI 10.7717/peerj.8218; Zahedi R, 2000, CLIN EXP IMMUNOL, V121, P226, DOI 10.1046/j.1365-2249.2000.01249.x	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259777	10.1371/journal.pone.0259777	http://dx.doi.org/10.1371/journal.pone.0259777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767613	gold, Green Published			2022-12-26	WOS:000755249300045
J	Ihsan, A; Khan, KA; Sagir, M; Nawaz, A; Fiaz, S; Yasmin, F; Rasheed, M; Ali, H; Shaheen, M; Mahmoud, SF; Sayed, S; Rahman, SU; Bilal, Y; Ramzan, M; Nazir, T; Khan, S; Waqas, MM; Tayyib, M; Hussain, F; Ali, MY				Ihsan, Arbab; Khan, Khalid Ali; Sagir, Muhammad; Nawaz, Ahmad; Fiaz, Sajid; Yasmin, Farkhanda; Rasheed, Majeeda; Ali, Habib; Shaheen, Musarrat; Mahmoud, Samy F.; Sayed, Samy; Rahman, Shafeeq Ur; Bilal, Yasir; Ramzan, Muhammad; Nazir, Talha; Khan, Shumaila; Waqas, Muhammad Mohsin; Tayyib, Muhammad; Hussain, Fiaz; Ali, Muhammad Yousaf			Diet impacts on the biological aspects of pink bollworm, Pectinophora gossypiella (Lepidoptera: Gelechiidae) under controlled laboratory conditions	PLOS ONE			English	Article							TRANSGENIC COTTON; PATTERN	Background Pink bollworm, Pectinophora gossypiella (Lepidoptera: Gelechiidae) is a native pest of Asia and preferably invasion on cotton (Gossypium hirsutum L.) crop as a commendatory host plant. Commercially, G. hirsutum is known as white gold and is an important cash crop all over the globe. Limited studies were published to focus on certain dietary compositions against different cotton pests. Therefore, the present study was undertaken in the laboratory under controlled conditions (temperature: 27 +/- 2 degrees C and relative humidity: 60 +/- 10%) to determine the impact of three different treatment diets (wheat germ meal, okra, and chickpea) on the biological aspects (lifetime, developmental period) of P. gossypiella. Results Results revealed that the shortest larval time of P. gossypiella was observed on the okra feed diet while the longest period was recorded on the wheat germ diet. Meanwhile, the pupation delay was noted on the wheat germ diet. The dietary influence was also observed on adult stages of female and male P. gossypiella (43.00 and 37.50 days respectively) and compared with a standard diet (56.50 and 52.50 days respectively). Furthermore, larval weighed more on the okra and chickpea diet followed by the wheat germ diet, whereas highest pupal weight was observed on the standard diet followed by the chickpea diet and okra diet. Conclusion Developmental parameters were significantly variant across all treatment diets, whereas the higher significant difference was reported on the okra diet. Therefore, the existing data of this study offers fruitful interventions for the future as a modified diet for large-scale and rapid mass production of P. gossypiella larvae.	[Ihsan, Arbab; Nawaz, Ahmad; Ali, Habib; Tayyib, Muhammad] Univ Agr Faisalabad, Dept Entomol, Integrated Pest Management Lab, Faisalabad, Pakistan; [Khan, Khalid Ali] King Khalid Univ, Fac Sci, Res Ctr Adv Mat Sci RCAMS, Biol Dept,Unit Bee Res & Honey Prod, Abha, Saudi Arabia; [Sagir, Muhammad] Khwaja Fareed Univ Engn & Informat Technol KFUEIT, Dept Chem Engn, Rahim Yar Khan, Punjab, Pakistan; [Fiaz, Sajid] Haripur Univ, Haripur, Pakistan; [Yasmin, Farkhanda] Khawja Fareed Univ Engn & Informat Technol, Dept Biosci & Technol, Rahim Yar Khan, Pakistan; [Rasheed, Majeeda] Khawja Fareed Univ Engn & Informat Technol, Dept Life Sci, Rahim Yar Khan, Pakistan; [Ali, Habib; Khan, Shumaila; Waqas, Muhammad Mohsin] Khwaja Fareed Univ Engn & Informat Technol, Dept Agr Sci Engn, Rahim Yar Khan, Pakistan; [Shaheen, Musarrat] Cotton Res Inst, Rahim Yar Khan, Pakistan; [Mahmoud, Samy F.] Taif Univ, Coll Sci, Dept Biotechnol, At Taif, Saudi Arabia; [Sayed, Samy] Taif Univ, Univ Coll Ranyah, Dept Sci & Technol, At Taif, Saudi Arabia; [Rahman, Shafeeq Ur] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang, Henan, Peoples R China; [Bilal, Yasir] Govt Coll Univ, Dept Environm Sci & Engn, Faisalabad, Pakistan; [Ramzan, Muhammad] Aridzone Res Inst, Bhakkar, Pakistan; [Nazir, Talha] Ghazi Univ, Fac Agr Sci, Dept Plant Protect, Punjab, Pakistan; [Hussain, Fiaz] Bahauddin Zakariya Univ Sub Campus Bahadur Layyah, Punjab, Pakistan; [Ali, Muhammad Yousaf] Rural Educ & Econ Dev Soc REEDS, Res & Educ Dev, Punjab, Pakistan	University of Agriculture Faisalabad; King Khalid University; Khwaja Fareed University of Engineering & Information Technology, Pakistan; Khwaja Fareed University of Engineering & Information Technology, Pakistan; Taif University; Taif University; Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Government College University Faisalabad	Nawaz, A; Ali, H (corresponding author), Univ Agr Faisalabad, Dept Entomol, Integrated Pest Management Lab, Faisalabad, Pakistan.; Ali, H (corresponding author), Khwaja Fareed Univ Engn & Informat Technol, Dept Agr Sci Engn, Rahim Yar Khan, Pakistan.	nawazrajpoot@yahoo.com; habib.ali1417@kfueit.edu.pk	Khan, Khalid Ali/AAR-5403-2020; Sayed, Samy/AAD-2389-2020; Ahmad, Nawaz/AAE-4968-2019; Ali, Muhammad Yousaf/AAG-7650-2019; Ali, Habib/J-7526-2019; Ur Rahman, Shafeeq/GQG-9782-2022	Khan, Khalid Ali/0000-0002-4734-6338; Sayed, Samy/0000-0002-7002-568X; Ali, Habib/0000-0003-4650-0345; Ur Rahman, Shafeeq/0000-0003-4736-5229	Higher Education Commission (HEC), Pakistan; Taif University, Saudi Arabia [TURSP-2020/138]	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); Taif University, Saudi Arabia	This study was supported by the Higher Education Commission (HEC), Pakistan and Taif University Researcher Supporting Project number (TURSP-2020/138); Taif University, Saudi Arabia.	ADKISSON PL, 1960, J ECON ENTOMOL, V53, P759, DOI 10.1093/jee/53.5.759; Ali H, 2015, AFR J AGR SCI TECHNO, V3, P310; Ali H, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00466; Arif Muhammad, 2017, Acta Entomologica Sinica, V60, P1457, DOI 10.16380/j.kcxb.2017.12.012; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Cacayorin N.D., 1993, COTTON RES J PHILIPP, V5, P66; Carriere Y, 2001, J ECON ENTOMOL, V94, P935, DOI 10.1603/0022-0493-94.4.935; Cohen Allen Carson, 2001, American Entomologist, V47, P198; Dahake AB., 2017, AGR ENG TODAY, V41, P32; Fand BB, 2020, PHYTOPARASITICA, V48, P25, DOI 10.1007/s12600-019-00779-2; Gebremedhin T, 1974, LIFE SEASONAL HIST P, P1; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Gull-e-Fareen A, 2021, PAK J ZOOL, V53, P1153, DOI 10.17582/journal.pjz/20190527120512; HENNEBERRY TJ, 1986, SOUTHWEST ENTOMOL, V11, P101; Hughes PR, 1998, SIM NEWS, V48, P105; Islam W, 2021, INT J TROP INSECT SC, V41, P915, DOI 10.1007/s42690-020-00370-x; Jothi B. D., 2016, Journal of Basic and Applied Zoology, V73, P9, DOI 10.1016/j.jobaz.2015.09.004; KABISSA JCB, 1990, TROP PEST MANAGE, V36, P356, DOI 10.1080/09670879009371510; Kandil MA., 2013, ANN AGR SCI-CAIRO, V51, P472; Malthankar P. A., 2014, Biopesticides International, V10, P152; MCMORRAN A, 1965, CAN ENTOMOL, V97, P58, DOI 10.4039/Ent9758-1; Muralimohan K., 2009, International Journal of Tropical Insect Science, V29, P102, DOI 10.1017/S1742758409990129; Nawaz A, 2021, INT J TROP INSECT SC, V41, P2883, DOI 10.1007/s42690-021-00472-0; Nawaz A, 2020, EGYPT J BIOL PEST CO, V30, DOI 10.1186/s41938-020-00258-5; Noble LW., 1969, 50 YEARS RES PINK BO, P357; OUYE MT, 1962, J ECON ENTOMOL, V55, P854, DOI 10.1093/jee/55.6.854; Qasim M, 2018, MICROB PATHOGENESIS, V119, P109, DOI 10.1016/j.micpath.2018.04.019; Reda AMA, 2008, EGYPT J BIOL PEST CO, V18, P65; Sabry K.H., 2016, AMERICAN EURASIAN JO, V10, P8; Sarwar M., 2017, INT J RES AGR FOREST, V4, P25; Shah MA., 2013, U RES J SCI SER, P321; Sorensen JG, 2012, CROP PROT, V38, P87, DOI 10.1016/j.cropro.2012.03.023; UMER M, 2019, ACTA SCI AGR, V3, P82; VANDERZANT ES, 1957, J ECON ENTOMOL, V50, P219, DOI 10.1093/jee/50.2.219; Venilla S., 2007, CROP PROT FOLDER SER, P7; Wan P, 2004, CROP PROT, V23, P463, DOI 10.1016/j.cropro.2003.09.017; Wu JP., 2008, HUBEI AGR SCI, V47, P7; Zaynab M, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103728; Zinzuvadiya H. D., 2017, Trends in Biosciences, V10, P5363	39	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0258431	10.1371/journal.pone.0258431	http://dx.doi.org/10.1371/journal.pone.0258431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762679	Green Published, gold			2022-12-26	WOS:000755316600004
J	Qian, YY; Zhang, JJ; Li, JY; Weng, ZY				Qian, Yiyi; Zhang, Jiajun; Li, Jiangya; Weng, Zhiying			A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation	PLOS ONE			English	Article							STROKE PREVENTION; EPIDEMIOLOGY; MANAGEMENT; BURDEN; RISK	Background The incidence of atrial fibrillation (AF) is increasing, and effective anticoagulation therapy can prevent adverse events. Selecting the appropriate OAC based on patient characteristics has become a challenge. Interventions are going to be a potential area of focus. Objectives To explore the discrepancies between clinician prescriptions and recommended guidelines of oral anticoagulants (OACs) for patients with atrial fibrillation (AF), and to provide direction for improving anticoagulation strategies for treating patients with AF. Materials and methods Data were collected from the electronic medical record system of Fuwai Yunnan Cardiovascular Hospital between July 2019 and January 2020. The suitability of prescribed OACs for patients with AF was assessed according to the Rules for Avoiding Prescription Inappropriateness, the prescribed medicine label, and any relevant antithrombotic guidelines for treating patients with AF. Results A total of 460 patients met the inclusion criteria. Of these, 53.7% received an appropriate prescription and 46.3% received an inappropriate prescription. Of the patients who received inappropriate prescriptions, 15.4% were prescribed without the presenting appropriate indicators, 1.3% were prescribed inappropriate drug selection, and 29.6% were prescribed inappropriate drug doses. For patients prescribed without providing appropriate indicators, 2.2% had no indication for medication and 13.3% had an indication for medication, but not a specific OAC. For patients with inappropriate drug selection, 1, 5 patients were on rivaroxaban, dabigatran respectively. The distribution of NOAC doses was as follows: dabigatran standard dose (45.2%), the low dose (54.8%). Rivaroxaban standard dose (58.9%), low dose (36.8%), high dose (4.3%). A total of 44 patients (9.6%) experienced bleeding events, 12 patients (2.6%) experienced embolic events, and 7 patients experienced other adverse events after dosing. Conclusions In clinical practice, it is common for patients with AF to receive inappropriate prescriptions of OACs. Therefore there is a need to enhance anticoagulation management in patients with AF to improve the appropriate use of OACs.	[Qian, Yiyi] Fuwai Yunnan Cardiovasc Hosp, Dept Pharm, Kunming, Yunnan, Peoples R China; [Zhang, Jiajun] Yunnan Med Hlth Coll, Sch Pharmaceut Sci, Kunming, Yunnan, Peoples R China; [Li, Jiangya; Weng, Zhiying] Kunming Med Univ, Sch Pharmaceut Sci, Yunnan Key Lab Pharmacol Nat Prod, Kunming, Yunnan, Peoples R China	Kunming Medical University	Qian, YY (corresponding author), Fuwai Yunnan Cardiovasc Hosp, Dept Pharm, Kunming, Yunnan, Peoples R China.; Weng, ZY (corresponding author), Kunming Med Univ, Sch Pharmaceut Sci, Yunnan Key Lab Pharmacol Nat Prod, Kunming, Yunnan, Peoples R China.	qian_yiyi@qq.com; weng_zy@sina.com			Scientific Research Fund Project of Yunnan Provincial Department of Education [2018JS245]; Hospital-level scientific research fund project of Fuwai Yunnan Cardiovascular Hospital [2019YFKT08]	Scientific Research Fund Project of Yunnan Provincial Department of Education; Hospital-level scientific research fund project of Fuwai Yunnan Cardiovascular Hospital	This research was funded by Scientific Research Fund Project of Yunnan Provincial Department of Education (Program No.2018JS245) and Hospital-level scientific research fund project of Fuwai Yunnan Cardiovascular Hospital (Program No.2019YFKT08).	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Chang TY, 2018, IJC HEART VASC, V20, P56, DOI 10.1016/j.ijcha.2018.08.003; Chen. Wenwen, 2017, CHIN J HOSP PHARM, V37, P2072, DOI DOI 10.13286/j.cnki.chinhosppharmacyj.2017.20.15; Cheng WH, 2019, STROKE, V50, P2574, DOI 10.1161/STROKEAHA.119.025623; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Franchi C, 2018, BRIT J CLIN PHARMACO, V84, P2010, DOI 10.1111/bcp.13631; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kakkar AK, 2012, AM HEART J, V163, P13, DOI 10.1016/j.ahj.2011.09.011; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lee SR, 2019, STROKE, V50, P1140, DOI 10.1161/STROKEAHA.118.024210; Lip GYH, 2018, CHEST, V154, P1121, DOI 10.1016/j.chest.2018.07.040; Lippi G, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.65; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Moudallel S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01220; Pritchett RV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232484; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Steinberg BA, 2017, AM HEART J, V194, P132, DOI 10.1016/j.ahj.2017.08.011; Zhang. Shu, 2017, CHINESE J ARRHYTHMIA, V2018, P17	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259199	10.1371/journal.pone.0259199	http://dx.doi.org/10.1371/journal.pone.0259199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762667	Green Published, gold			2022-12-26	WOS:000755316600016
J	Schneider, JA; Taylor, BG; Hotton, AL; Lamuda, PA; Ozik, J; Lin, QY; Flanagan, E; Pho, MT; Kolak, M; Brewer, R; Pagkas-Bather, J; Pollack, HA				Schneider, John A.; Taylor, Bruce G.; Hotton, Anna L.; Lamuda, Phoebe A.; Ozik, Jonathan; Lin, Qinyun; Flanagan, Elizabeth; Pho, Mai Tuyet; Kolak, Marynia; Brewer, Russell; Pagkas-Bather, Jade; Pollack, Harold A.			National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out	PLOS ONE			English	Article								Protective behaviors such as mask wearing and physical distancing are critical to slow the spread of COVID-19, even in the context of vaccine scale-up. Understanding the variation in self-reported COVID-19 protective behaviors is critical to developing public health messaging. The purpose of the study is to provide nationally representative estimates of five self-reported COVID-19 protective behaviors and correlates of such behaviors. In this cross-sectional survey study of US adults, surveys were administered via internet and telephone. Adults were surveyed from April 30-May 4, 2020, a time of peaking COVID-19 incidence within the US. Participants were recruited from the probability-based AmeriSpeak (R) national panel. Brief surveys were completed by 994 adults, with 73.0% of respondents reported mask wearing, 82.7% reported physical distancing, 75.1% reported crowd avoidance, 89.8% reported increased hand-washing, and 7.7% reported having prior COVID-19 testing. Multivariate analysis (p critical value .05) indicates that women were more likely to report protective behaviors than men, as were those over age 60. Respondents who self-identified as having low incomes, histories of criminal justice involvement, and Republican Party affiliation, were less likely to report four protective behaviors, though Republicans and individuals with criminal justice histories were more likely to report having received COVID-19 testing. The majority of Americans engaged in COVID-19 protective behaviors, with low-income Americans, those with histories of criminal justice involvement, and self-identified Republicans less likely to engage in these preventive behaviors. Culturally competent public health messaging and interventions might focus on these latter groups to prevent future infections. These findings will remain highly relevant even with vaccines widely available, given the complementarities between vaccines and protective behaviors, as well as the many challenges in delivering vaccines.	[Schneider, John A.; Hotton, Anna L.; Pho, Mai Tuyet; Brewer, Russell; Pagkas-Bather, Jade] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Taylor, Bruce G.; Lamuda, Phoebe A.] NORC, Chicago, IL 60603 USA; [Ozik, Jonathan; Flanagan, Elizabeth] Argonne Natl Lab, Chicago, IL USA; [Lin, Qinyun; Kolak, Marynia] Univ Chicago, Ctr Spatial Data Sci, Chicago, IL USA; [Pollack, Harold A.] Univ Chicago, Crown Family Sch Social Work Policy & Practice, Chicago, IL USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago	Taylor, BG (corresponding author), NORC, Chicago, IL 60603 USA.	taylor-bruce@norc.org		Flanagan, Elizabeth/0000-0002-6326-2628; Ozik, Jonathan/0000-0002-3495-6735; Taylor, Bruce/0000-0002-8115-1438; Lin, Qinyun/0000-0001-9792-3351				[Anonymous], 2020, COR DIS 2019 PROT YO; [Anonymous], 2020, NOV COR 2019 NCOV AD; [Anonymous], 2020, US CORONAVIRUS CASES; [Anonymous], 2020, 2019 NOV COR; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L, 2019, J GEOGR SYST, V21, P189, DOI 10.1007/s10109-019-00299-x; Anselin L, 2019, GEOGR ANAL, V51, P133, DOI 10.1111/gean.12164; Bethlehem J., 2011, HDB NONRESPONSE HOUS, P327; Bilgen I., 2018, NONRESPONSE FOLLOW I; Butt C., 2014, P INT C MOD SIM VIS; Cawthon PM, 2020, J GERONTOL A-BIOL, V75, pE123, DOI 10.1093/gerona/glaa099; Clements John M, 2020, JMIR Public Health Surveill, V6, pe19161, DOI 10.2196/19161; Dennis J.M., 2019, AMERISPEAK OMNIBUS F; Dubey MJ, 2020, DIABETES METAB SYND, V14, P817, DOI 10.1016/j.dsx.2020.06.008; Gamma A., 2019, EBOLA PREVENTION RES; Gil RM, 2020, J INFECT DIS, V222, P1592, DOI 10.1093/infdis/jiaa474; Guiahi M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17008; Hamel LS A., 2020, IS THERE WIDENING GE; Holuka C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145094; Iwamura Y, 2018, PHYSICA A, V494, P236, DOI 10.1016/j.physa.2017.11.148; Jenkins WD, 2021, J RURAL HEALTH, V37, P172, DOI 10.1111/jrh.12442; Kabir KMA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92094-2; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; Leininger LP H, 2020, WASH POST; Litwin H, 2021, INNOV AGING, V5, DOI 10.1093/geroni/igab015; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Montgomery R., 2016, RESPONSE RATE CALCUL; Mumford EA PJ., 2019, TOB REGUL SCI, V5; Nafilyan V., 2020, ETHNICITY HOUSEHOLD; NORC, 2020, TECHN OV AMERISPEAK; Paltiel AD, 2021, HEALTH AFFAIR, V40, P42, DOI 10.1377/hlthaff.2020.02054; Pradhan D, 2020, ARCH MED RES, V51, P363, DOI 10.1016/j.arcmed.2020.04.020; Schneider J., 2020, Grant Number, Patent No. [1DA050066, 1050066]; Thornberry TP., CRIMINAL JUSTICE MEA, V2000, P33; van der Pligt J, 1996, EUR PSYCHOL, V1, P34, DOI 10.1027/1016-9040.1.1.34; Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212; Wang QQ, 2021, MOL PSYCHIATR, V26, P30, DOI 10.1038/s41380-020-00880-7; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259257	10.1371/journal.pone.0259257	http://dx.doi.org/10.1371/journal.pone.0259257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739498	Green Published, gold			2022-12-26	WOS:000755000800021
J	Hakizimana, B; Kalimba, E; Ndatinya, A; Saint, G; van Miert, C; Cartledge, PT				Hakizimana, Boniface; Kalimba, Edgar; Ndatinya, Augustin; Saint, Gemma; van Miert, Clare; Cartledge, Peter Thomas			Field testing two existing, standardized respiratory severity scores (LIBSS and ReSViNET) in infants presenting with acute respiratory illness to tertiary hospitals in Rwanda - a validation and inter-rater reliability study	PLOS ONE			English	Article							CLINICAL SCORE; BRONCHIOLITIS; CHILDREN; PREDICT; DIAGNOSIS; VALIDITY; SCALE; MODEL; TOOL; NEED	Introduction There is a substantial burden of respiratory disease in infants in the sub-Saharan Africa region. Many health care providers (HCPs) that initially receive infants with respiratory distress may not be adequately skilled to differentiate between mild, moderate and severe respiratory symptoms, which may contribute to poor management and outcome. Therefore, respiratory severity scores have the potential to contributing to address this gap. Objectives to field-test the use of two existing standardized bronchiolitis severity scores (LIBSS and ReSViNET) in a population of Rwandan infants (1-12 months) presenting with respiratory illnesses to urban, tertiary, pediatric hospitals and to assess the severity of respiratory distress in these infants and the treatments used. Methods A cross-sectional, validation study, was conducted in four tertiary hospitals in Rwanda. Infants presenting with difficulty in breathing were included. The LIBSS and ReSViNET scores were independently employed by nurses and residents to assess the severity of disease in each infant. Results 100 infants were recruited with a mean age of seven months. Infants presented with pneumonia (n = 51), bronchiolitis (n = 36) and other infectious respiratory illnesses (n = 13). Thirty-three infants had severe disease and survival was 94% using nurse applied LIBSS. Regarding inter-rater reliability, the intra-class correlation coefficient (ICC) for LIBSS and ReSViNET between nurses and residents was 0.985 (95% CI: 0.98-0.99) and 0.980 (0.97-0.99). The convergent validity (Pearson's correlation) between LIBSS and ReSViNET for nurses and residents was R = 0.836 (p<0.001) and R = 0.815 (p<0.001). The area under the Receiver Operator Curve (aROC) for admission to PICU or HDU was 0.956 (CI: 0.92-0.99, p<0.001) and 0.880 (CI: 0.80-0.96, p<0.001) for nurse completed LIBSS and ReSViNET respectively. Conclusion LIBSS and ReSViNET were designed for infants with bronchiolitis in resource-rich settings. Both LIBSS and ReSViNET demonstrated good reliability and validity results, in this cohort of patients presenting to tertiary level hospitals. This early data demonstrate that these two scores have the potential to be used in conjunction with clinical reasoning to identify infants at increased risk of clinical deterioration and allow timely admission, treatment escalation and therefore support resource allocation in Rwanda.	[Hakizimana, Boniface; Kalimba, Edgar; Cartledge, Peter Thomas] Univ Rwanda, Sch Med, Dept Pediat, Kigali, Rwanda; [Hakizimana, Boniface] Univ Teaching Hosp Kigali, Dept Pediat, Kigali, Rwanda; [Kalimba, Edgar] King Faisal Hosp, Kigali, Rwanda; [Ndatinya, Augustin] Rwanda Mil Hosp, Kigali, Rwanda; [Saint, Gemma] Univ Liverpool, Inst Child Hlth, Liverpool, Merseyside, England; [Saint, Gemma] Alder Hey Childrens NHS Fdn Trust, Dept Resp Pediat, Liverpool, Merseyside, England; [van Miert, Clare] Liverpool John Moores Univ, Sch Nursing & Allied Hlth, Liverpool, Merseyside, England; [Cartledge, Peter Thomas] Yale Univ, Dept Emergency Med, New Haven, CT 06511 USA; [Cartledge, Peter Thomas] Rwanda Human Resources Hlth HRH Program, Minist Hlth, Kigali, Rwanda	University of Rwanda; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Liverpool John Moores University; Yale University	Cartledge, PT (corresponding author), Univ Rwanda, Sch Med, Dept Pediat, Kigali, Rwanda.; Cartledge, PT (corresponding author), Yale Univ, Dept Emergency Med, New Haven, CT 06511 USA.; Cartledge, PT (corresponding author), Rwanda Human Resources Hlth HRH Program, Minist Hlth, Kigali, Rwanda.	peterthomascartledge@gmail.com		Hakizimana, Boniface/0000-0002-9858-6470; Cartledge, Peter Thomas/0000-0003-2523-763X				Alario AJ, 1995, PEDIATR EMERG CARE, V11, P331, DOI 10.1097/00006565-199512000-00001; Amat F, 2014, J MED VIROL, V86, P1944, DOI 10.1002/jmv.23850; Balaguer M, 2017, PEDIATR PULM, V52, P533, DOI 10.1002/ppul.23546; Beckman TJ, 2009, TEACH LEARN MED, V21, P188, DOI 10.1080/10401330903014137; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Brown J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053622; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; Caserta MT, 2017, J INFECT DIS, V215, P750, DOI 10.1093/infdis/jiw624; Chin Ho Jen, 2004, Malays J Med Sci, V11, P34; Collins GS, 2015, EUR UROL, V67, P1142, DOI 10.1016/j.eururo.2014.11.025; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3186; Destino Lauren, 2012, Hosp Pediatr, V2, P202; Donoghue AJ, 2005, ANN EMERG MED, V46, P512, DOI 10.1016/j.annemergmed.2005.05.028; Downing SM, 2003, MED EDUC, V37, P830, DOI 10.1046/j.1365-2923.2003.01594.x; Duarte-Dorado DM, 2013, J ASTHMA, V50, P1056, DOI 10.3109/02770903.2013.834504; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092968; Fernandes RM, 2015, PEDIATRICS, V135, pE1399, DOI 10.1542/peds.2014-3557; Gajdos V, 2009, PEDIATR PULM, V44, P754, DOI 10.1002/ppul.21016; Gowraiah V, 2014, ARCH DIS CHILD, V99, P899, DOI 10.1136/archdischild-2013-305740; Griffiths B, 2020, ARCH DIS CHILD, V105, P483, DOI 10.1136/archdischild-2018-315199; Hakizimana B., 2019, J TROP PEDIAT, P1, DOI [10.1093/tropej/fmy002, DOI 10.1093/TROPEJ/FMY002]; Hazinski MF SR., 2010, AM HEAR ASS, V122, pS639; Hooli S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168126; Justicia-Grande AJ, 2019, AM J PERINAT, V36, pS48, DOI 10.1055/s-0039-1691800; Justicia-Grande AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157665; King C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136839; Kirolos A, 2020, J INFECT DIS, V222, pS672, DOI 10.1093/infdis/jiz240; Liu LL, 2004, PEDIATR PULM, V37, P243, DOI 10.1002/ppul.10425; Mamtani M, 2009, PEDIATR PULM, V44, P379, DOI 10.1002/ppul.21014; Marlais M, 2011, ARCH DIS CHILD, V96, P648, DOI 10.1136/adc.2010.201079; McCallum GB, 2013, PEDIATR PULM, V48, P797, DOI 10.1002/ppul.22627; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Mosalli R, 2015, J MED VIROL, V87, P1285, DOI 10.1002/jmv.24189; Mussman Grant M, 2017, Hosp Pediatr, V7, P279, DOI 10.1542/hpeds.2016-0090; NICE, 2015, BRONCH CHILDR DIAGN; Oymar K, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-23; Pavon D, 1999, PEDIATR PULM, V27, P423, DOI 10.1002/(SICI)1099-0496(199906)27:6<423::AID-PPUL10>3.0.CO;2-5; Portney LG, 2009, FDN CLIN RES APPL PR; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rwanda National Institute of Statistics, 2016, DEM HLTH SURV EY 201, P1; Singh Varinder, 2005, Paediatr Respir Rev, V6, P88, DOI 10.1016/j.prrv.2005.03.002; Streiner D. L., 2008, HLTH MEASUREMENT SCA, DOI [DOI 10.1093/ACPROF:OSO/9780199231881.001.0001, 10.1093/acprof:oso/9780199231881.001.0001]; Sullivan Gail M, 2011, J Grad Med Educ, V3, P119, DOI 10.4300/JGME-D-11-00075.1; Swinscow T., 2019, STAT SQUARE ONE, V9th, P1; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; van Miert C., 2015, THESIS U LIVERPOOL; Walsh P, 2006, PEDIATR EMERG CARE, V22, P316, DOI 10.1097/01.pec.0000215136.44286.8f; Walsh P, 2004, EUR J EMERG MED, V11, P265, DOI 10.1097/00063110-200410000-00005; WHO;UNICEF, 2006, PNEUMONIA FORGOTTEN	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258882	10.1371/journal.pone.0258882	http://dx.doi.org/10.1371/journal.pone.0258882			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735488	gold, Green Published, Green Accepted			2022-12-26	WOS:000755077100037
J	Walcheck, MT; Matkowskyj, KA; Turco, A; Blaine-Sauer, S; Nukaya, M; Noel, J; Ronnekleiv, OK; Ronnekleiv-Kelly, SM				Walcheck, Morgan T.; Matkowskyj, Kristina A.; Turco, Anne; Blaine-Sauer, Simon; Nukaya, Manabu; Noel, Jessica; Ronnekleiv, Oline K.; Ronnekleiv-Kelly, Sean M.			Sex-dependent development of Kras-induced anal squamous cell carcinoma in mice	PLOS ONE			English	Article							PROGRESSION; COOPERATE; MUTATIONS; REVEALS; CANCER; TIME; ER	Anal squamous cell carcinoma (SCC) will be diagnosed in an estimated 9,080 adults in the United States this year, and rates have been rising over the last several decades. Most people that develop anal SCC have associated human papillomavirus (HPV) infection (similar to 85-95%), with approximately 5-15% of anal SCC cases occurring in HPV-negative patients from unknown etiology. This study identified and characterized the Kras-driven, female sex hormone-dependent development of anal squamous cell carcinoma (SCC) in the LSL-Kras(G12D); Pdx1-Cre (KC) mouse model that is not dependent on papillomavirus infection. One hundred percent of female KC mice develop anal SCC, while no male KC mice develop tumors. Both male and female KC anal tissue express Pdx1 and Cre-recombinase mRNA, and the activated mutant Kras(G12D) gene. Although the driver gene mutation Kras(G12D) is present in anus of both sexes, only female KC mice develop Kras-mutant induced anal SCC. To understand the sex-dependent differences, KC male mice were castrated and KC female mice were ovariectomized. Castrated KC males displayed an unchanged phenotype with no anal tumor formation. In contrast, ovariectomized KC females demonstrated a marked reduction in anal SCC development, with only 15% developing anal SCC. Finally, exogenous administration of estrogen rescued the tumor development in ovariectomized KC female mice and induced tumor development in castrated KC males. These results confirm that the anal SCC is estrogen mediated. The delineation of the role of female sex hormones in mediating mutant Kras to drive anal SCC pathogenesis highlights a subtype of anal SCC that is independent of papillomavirus infection. These findings may have clinical applicability for the papillomavirus-negative subset of anal SCC patients that typically respond poorly to standard of care chemoradiation.	[Walcheck, Morgan T.; Blaine-Sauer, Simon; Noel, Jessica; Ronnekleiv-Kelly, Sean M.] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA; [Matkowskyj, Kristina A.; Ronnekleiv-Kelly, Sean M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab Med, Sch Med & Publ Hlth, Madison, WI USA; [Matkowskyj, Kristina A.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Turco, Anne; Nukaya, Manabu; Ronnekleiv-Kelly, Sean M.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Surg Oncol, Madison, WI 53726 USA; [Ronnekleiv, Oline K.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University	Ronnekleiv-Kelly, SM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.; Ronnekleiv-Kelly, SM (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA.; Ronnekleiv-Kelly, SM (corresponding author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Surg Oncol, Madison, WI 53726 USA.	ronnekleiv-kelly@surgery.wisc.edu		Blaine-Sauer, Simon/0000-0001-6027-1409; Walcheck, Morgan/0000-0002-0095-2197				Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Baker BB, 2016, ZEBRAFISH, V13, P413, DOI 10.1089/zeb.2016.1275; Baricevic I, 2015, EUR J CANCER, V51, P776, DOI 10.1016/j.ejca.2015.01.058; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bernardi MP, 2015, LANCET ONCOL, V16, pE611, DOI 10.1016/S1470-2045(15)00292-2; Blaine-Sauer S, 2021, MBIO, V12, DOI 10.1128/mBio.01611-21; Bu LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06643-9; Chang HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184455; Chung JH, 2016, ANN ONCOL, V27, P1336, DOI 10.1093/annonc/mdw152; Cladel NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17089-4; D'Amico S, 2018, GENE DEV, V32, P1175, DOI 10.1101/gad.311852.118; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; Dziennis S, 2007, J NEUROSCI, V27, P7268, DOI 10.1523/JNEUROSCI.1558-07.2007; Friend KE, 1997, MOL CELL ENDOCRINOL, V131, P147, DOI 10.1016/S0303-7207(97)00098-1; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kato K, 1997, ONCOGENE, V15, P3037, DOI 10.1038/sj.onc.1201497; Kato S, 2021, ONCOLOGIST, V26, pE530, DOI 10.1002/onco.13702; Koebele SV, 2016, MATURITAS, V87, P5, DOI 10.1016/j.maturitas.2016.01.015; Mazur PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013578; Meulendijks D, 2015, BRIT J CANCER, V112, P1358, DOI 10.1038/bjc.2015.20; Morris VK, 2015, ONCOLOGIST, V20, P1247, DOI 10.1634/theoncologist.2015-0091; Osborne MC, 2014, WORLD J GASTROENTERO, V20, P13052, DOI 10.3748/wjg.v20.i36.13052; Paterni I, 2014, STEROIDS, V90, P13, DOI 10.1016/j.steroids.2014.06.012; Ramesh Pushkal Sinduvadi, 2019, World J Methodol, V9, P32, DOI 10.5662/wjm.v9.i3.32; Ring KL, 2017, INT J GYNECOL CANCER, V27, P854, DOI 10.1097/IGC.0000000000000960; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Souza V.R., PRECLINICAL MODELS M; Tien JCY, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026104118; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Valkenburg KC, 2016, JOVE-J VIS EXP, DOI 10.3791/53984; VANSTEENBRUGGE GJ, 1984, PROSTATE, V5, P639, DOI 10.1002/pros.2990050610; Wang XY, 2021, AM J PATHOL, V191, P1281, DOI 10.1016/j.ajpath.2021.03.013; Wong NACS, 2018, HISTOPATHOLOGY, V73, P1039, DOI 10.1111/his.13720; Zhang DY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017954	40	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259245	10.1371/journal.pone.0259245	http://dx.doi.org/10.1371/journal.pone.0259245			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735515	Green Published, Green Submitted, gold			2022-12-26	WOS:000755077100058
J	Li, XH; Li, HY; Jing, Q; Wang, MX; Hu, TT; Li, L; Zhang, QP; Liu, MX; Fu, YC; Han, JH; Su, D				Li, Xuehui; Li, Huiyan; Jing, Qian; Wang, Mengxue; Hu, Tingting; Li, Li; Zhang, Qiuping; Liu, Mengxin; Fu, Yu Vincent; Han, Junhong; Su, Dan			Structural insights into multifunctionality of human FACT complex subunit hSSRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATES CHROMATIN TRANSCRIPTION; HISTONE CHAPERONE FACT; DOMAIN PROTEIN SSRP1; NUCLEAR-LOCALIZATION; CK2 PHOSPHORYLATES; CRYSTAL-STRUCTURE; DNA-BINDING; YEAST; RECOGNITION; POB3	Human structure-specific recognition protein 1 (hSSRP1) is an essential component of the facilitates chromatin transcription complex, which participates in nucleosome disassembly and reassembly during gene transcription and DNA replication and repair. Many functions, including nuclear localization, histone chaperone activity, DNA binding, and interaction with cellular proteins, are attributed to hSSRP1, which contains multiple well-defined domains, including four pleckstrin homology (PH) domains and a high-mobility group domain with two flanking disordered regions. However, little is known about the mechanisms by which these domains cooperate to carry out hSSRP1's functions. Here, we report the biochemical characterization and structure of each functional domain of hSSRP1, including the N-terminal PH1, PH2, PH3/4 tandem PH, and DNA-binding high-mobility group domains. Furthermore, two casein kinase II binding sites in hSSRP1 were identified in the PH3/4 domain and in a disordered region (Gly(617)-Glu(709)) located in the C-terminus of hSSRP1. In addition, a histone H2A-H2B binding motif and a nuclear localization signal (Lys(677)-Asp(687)) of hSSRP1 are reported for the first time. Taken together, these studies provide novel insights into the structural basis for hSSRP1 functionality.	[Li, Xuehui; Li, Huiyan; Li, Li; Zhang, Qiuping; Liu, Mengxin; Su, Dan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu, Sichuan, Peoples R China; [Li, Xuehui; Li, Huiyan; Li, Li; Zhang, Qiuping; Liu, Mengxin; Su, Dan] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China; [Jing, Qian; Han, Junhong] Sichuan Univ, Res Lab Tumor Epigenet & Genom, West China Hosp,State Key Lab Biotherapy, Dept Gen Surg,Frontiers Sci Ctr Dis Related Mol N, Chengdu, Peoples R China; [Jing, Qian; Han, Junhong] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China; [Wang, Mengxue; Fu, Yu Vincent] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Hu, Tingting] Neijiang Normal Univ, Coll Life Sci, Neijiang, Sichuan, Peoples R China; [Su, Dan] Tianjin Int Joint Acad Biotechnol & Med, Infect Dis Drug Discovery Inst, Tianjin, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Neijiang Normal University; Tianjin International Joint Academy of Biomedicine	Su, D (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy & Canc Ctr, Chengdu, Sichuan, Peoples R China.; Su, D (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China.; Han, JH (corresponding author), Sichuan Univ, Res Lab Tumor Epigenet & Genom, West China Hosp,State Key Lab Biotherapy, Dept Gen Surg,Frontiers Sci Ctr Dis Related Mol N, Chengdu, Peoples R China.; Han, JH (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu, Peoples R China.; Su, D (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Infect Dis Drug Discovery Inst, Tianjin, Peoples R China.	hjunhong@scu.edu.cn; sudan@scu.edu.cn	su, dan/GYJ-1940-2022; zhang, qiu/GXG-5600-2022	Li, xuehui/0000-0002-9644-2422; Han, Junhong/0000-0002-3371-8698	National Science Foundation of China [31370735, 31670737]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China (General Program 31370735 and 31670737 to D. S.) .	Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Anderson M, 2010, PROTEIN EXPRES PURIF, V72, P194, DOI 10.1016/j.pep.2010.03.013; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Birch JL, 2009, EMBO J, V28, P854, DOI 10.1038/emboj.2009.33; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; Burgess RJ, 2010, PROTEIN CELL, V1, P607, DOI 10.1007/s13238-010-0086-y; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chereji RV, 2015, BRIEF FUNCT GENOMICS, V14, P50, DOI 10.1093/bfgp/elu038; Dyer MA, 1998, MOL CELL BIOL, V18, P2617, DOI 10.1128/MCB.18.5.2617; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falbo L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15180-5; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2020, NUCLEIC ACIDS RES, V48, P11929, DOI 10.1093/nar/gkaa912; Gariglio M, 1997, EXP CELL RES, V236, P472, DOI 10.1006/excr.1997.3742; Grasser KD, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00085; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hoffmann C, 2015, ACS CHEM BIOL, V10, P2753, DOI 10.1021/acschembio.5b00493; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Hossan T, 2016, STEM CELLS, V34, P1369, DOI 10.1002/stem.2287; Hu JH, 2009, J VIROL, V83, P11051, DOI 10.1128/JVI.00907-09; Ivic N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189040; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Krohn NM, 2003, J BIOL CHEM, V278, P12710, DOI 10.1074/jbc.M300250200; Li YP, 2005, J BIOL CHEM, V280, P11869, DOI 10.1074/jbc.M413944200; Liu Y, 2020, NATURE, V577, P426, DOI 10.1038/s41586-019-1820-0; Lolli G, 2017, BIOCHEM J, V474, P2405, DOI 10.1042/BCJ20170189; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marciano G, 2018, J BIOL CHEM, V293, P10071, DOI 10.1074/jbc.RA117.000994; Michl-Holzinger P, 2019, J PLANT PHYSIOL, V236, P105, DOI 10.1016/j.jplph.2019.03.006; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pfab A, 2018, J MOL BIOL, V430, P2747, DOI 10.1016/j.jmb.2018.06.046; Rickards B, 2007, MOL CELL BIOL, V27, P937, DOI 10.1128/MCB.01584-06; Rottgers K, 2000, PLANT J, V23, P395, DOI 10.1046/j.1365-313x.2000.00801.x; Safina A, 2017, NUCLEIC ACIDS RES, V45, P1925, DOI 10.1093/nar/gkw1366; Schlesinger MB, 2000, GENETICS, V155, P1593; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Studts JM, 1999, PROTEIN EXPRES PURIF, V16, P109, DOI 10.1006/prep.1999.1067; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Suggs BZ, 2018, DEV BIOL, V444, P71, DOI 10.1016/j.ydbio.2018.10.002; Svejstrup JQ, 2002, CURR OPIN GENET DEV, V12, P156, DOI 10.1016/S0959-437X(02)00281-2; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Wang PJ, 2021, CELL CYCLE, V20, P465, DOI 10.1080/15384101.2021.1881726; Wang Y, 2017, NUCLEIC ACIDS RES, V45, pW400, DOI 10.1093/nar/gkx410; Wang Y, 2021, METHODS MOL BIOL, V2196, P199, DOI 10.1007/978-1-0716-0868-5_15; Warren C, 2017, J MOL BIOL, V429, P2401, DOI 10.1016/j.jmb.2017.06.005; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Xue HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02062; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yen YM, 1998, J BIOL CHEM, V273, P4424, DOI 10.1074/jbc.273.8.4424; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18688; Zheng W, 2020, BIOINFORMATICS, V36, P3749, DOI 10.1093/bioinformatics/btaa217	73	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101360	10.1016/j.jbc.2021.101360	http://dx.doi.org/10.1016/j.jbc.2021.101360			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756889	gold, Green Published			2022-12-26	WOS:000765319800013
J	Hajek, P; Przulj, D; Pesola, F; McRobbie, H; Peerbux, S; Phillips-Waller, A; Bisal, N; Smith, KM				Hajek, Peter; Przulj, Dunja; Pesola, Francesca; McRobbie, Hayden; Peerbux, Sarrah; Phillips-Waller, Anna; Bisal, Natalie; Smith, Katie Myers			A randomised controlled trial of the 5:2 diet	PLOS ONE			English	Article							CONTINUOUS ENERGY RESTRICTION; DISEASE RISK MARKERS; WEIGHT-LOSS; INTERMITTENT ENERGY; OVERWEIGHT; MORTALITY; REGIMEN; FAT	Objective The 5:2 diet is a popular intermittent energy restriction method of weight management that awaits further evaluation. We compared the effects of one-off 5:2 instructions with the effects of one-off standard multicomponent weight-management advice; and also examined whether additional behavioural support enhances 5:2 adherence and efficacy compared to one-off instructions. Methods Three hundred adults with obesity were randomised to receive a Standard Brief Advice (SBA) covering diet and physical activity (N = 100); 5:2 self-help instructions (5:2SH) (N = 100); or 5:2SH plus six once-weekly group support sessions (N = 100). Participants were followed up for one year. Results Adherence to 5:2SH was initially high (74% at 6 weeks), but it declined over time (31% at 6 months and 22% at one year). 5:2SH and SBA achieved similar weight-loss at six months (-1.8kg (SD = 3.5) vs -1.7kg (SD = 4.4); b = 0.23, 95%CI:-0.79-1.27, p = 0.7) and at one year (-1.9kg (SD = 4.9) vs -1.8kg (SD = 5.7), b = 0.20, 95%CI:-1.21-1.60, p = 0.79), with 18% vs 15% participants losing >= 5% of their body weight with 5:2SH and SBA, respectively at one year (RR = 0.83, 95%CI:0.44-1.54, p = 0.55). Both interventions received positive ratings, but 5:2SH ratings were significantly higher. 5:2SH had no negative effect on fat and fiber intake and physical activity compared to SBA. Compared to 5:2SH, 5:2G generated a greater weight loss at 6 weeks (-2.3kg vs -1.5kg; b = 0.74, 95%CI:1.37-0.11, p = 0.02), but by one year, the difference was no longer significant (-2.6kg vs -1.9kg, p = 0.37; >= 5% body weight loss 28% vs 18%, p = 0.10). Conclusions Simple 5:2 advice and multicomponent weight management advice generated similar modest results. The 5:2 diet did not undermine other health behaviours, and it received more favourable ratings. Adding initial group support enhanced 5:2 adherence and effects, but the impact diminished over time. Health professionals who provide brief weight management advice may consider including the 5:2 advice as an option.	[Hajek, Peter; Przulj, Dunja; Pesola, Francesca; McRobbie, Hayden; Peerbux, Sarrah; Phillips-Waller, Anna; Bisal, Natalie; Smith, Katie Myers] Queen Mary Univ London, Wolfson Inst Populat Hlth, Hlth & Lifestyle Res Unit, London, England	University of London; Queen Mary University London	Smith, KM (corresponding author), Queen Mary Univ London, Wolfson Inst Populat Hlth, Hlth & Lifestyle Res Unit, London, England.	Katie.smith@qmul.ac.uk	Smith, Katie Elizabeth/GXH-2114-2022; McRobbie, Hayden/B-4552-2018	Bisal, Natalie/0000-0002-5938-0349; McRobbie, Hayden/0000-0002-7777-1845; Myers Smith, Katherine/0000-0003-1837-3924; Peerbux, Sarrah/0000-0001-5560-0749	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BBC 0806; Antoni R, 2018, BRIT J NUTR, V119, P507, DOI [10.1017/s0007114517003890, 10.1017/S0007114517003890]; Arguin H, 2012, MENOPAUSE, V19, P870, DOI 10.1097/gme.0b013e318250a287; Ayala-Marin AM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00423; Batterham MJ, 2013, NUTRITION, V29, P1024, DOI 10.1016/j.nut.2013.01.017; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Brown A, 2019, NUTR BULL, V44, P7, DOI 10.1111/nbu.12372; Brown JE, 2013, BR J DIABETES VASC D, V13, P68, DOI [DOI 10.1177/1474651413486496, 10.1177/1474651413486496]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davis CS, 2016, EUR J CLIN NUTR, V70, P292, DOI 10.1038/ejcn.2015.195; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Eshghinia S, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-4; Fisher R., 2019, BBC GOOD FOOD 0916; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; Harper H, 2016, COUNTING CALORIES; Harris Leanne, 2018, JBI Database System Rev Implement Rep, V16, P507, DOI 10.11124/JBISRIR-2016-003248; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; He SS, 2021, OBESITY, V29, P108, DOI 10.1002/oby.23023; Headland ML, 2019, INT J OBESITY, V43, P2028, DOI 10.1038/s41366-018-0247-2; HILL JO, 1989, AM J CLIN NUTR, V50, P248, DOI 10.1093/ajcn/50.2.248; Jorgensen AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111964; Klempel MC, 2013, METABOLISM, V62, P137, DOI 10.1016/j.metabol.2012.07.002; Klempel MC, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-98; Klempel MC, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-35; Kroeger CM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-98; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; Lewis E, 2019, INT J BEHAV MED, V26, P580, DOI 10.1007/s12529-019-09815-1; Mosley M., 2013, FAST DIET; Office for National Statistics, 2016, GOVT STAT SERV PERSP; Poobalan AS, 2007, OBES REV, V8, P503, DOI 10.1111/j.1467-789X.2007.00393.x; Shannon J, 1997, CANCER EPIDEM BIOMAR, V6, P355; Trepanowski JF, 2017, JAMA INTERN MED, V177, P930, DOI 10.1001/jamainternmed.2017.0936; Varady KA, 2011, OBES REV, V12, pE593, DOI 10.1111/j.1467-789X.2011.00873.x; Varady KA, 2009, AM J CLIN NUTR, V90, P1138, DOI 10.3945/ajcn.2009.28380; Welton S, 2020, CAN FAM PHYSICIAN, V66, P117; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williams KV, 1998, DIABETES CARE, V21, P2, DOI 10.2337/diacare.21.1.2; WING RR, 1984, BEHAV RES THER, V22, P445, DOI 10.1016/0005-7967(84)90086-X; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	40	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258853	10.1371/journal.pone.0258853	http://dx.doi.org/10.1371/journal.pone.0258853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788298	Green Published, gold			2022-12-26	WOS:000735920500008
J	Abe, M; Kinjo, Y; Sadamoto, S; Shinozaki, M; Negri, M; Shibuya, K; Miyazaki, Y				Abe, Masahiro; Kinjo, Yuki; Sadamoto, Sota; Shinozaki, Minoru; Negri, Minoru; Shibuya, Kazutoshi; Miyazaki, Yoshitsugu			alpha-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans	PLOS ONE			English	Article							NKT CELLS; SUSCEPTIBILITY; INNATE; GAMMA; EPIDEMIOLOGY; ACTIVATION; INFECTION	Background Vulvovaginal candidiasis is a common superficial candidiasis; however, a host's immunological mechanism against vaginal Candida infection remains unknown. Objectives In this study, we aimed to elucidate the effect of iNKT cell activation on vulvovaginal candidiasis. Methods Using a vulvovaginal candidiasis model with estrogenized mice, we evaluated the fungal burden and number of leukocyte infiltrations in the vaginal lavage of wild-type C57BL/6J mice after Candida albicans inoculation. One day before C. albicans inoculation, alpha-galactosylceramide (the alpha-GalCer group) or sterile phosphate-buffered saline (the sham group) was intraperitoneally injected into the mice. We also evaluated the level of antimicrobial peptide S100A8 in the vaginal lavage and analyzed the correlation between S100A8 concentration and the number of vaginal leukocyte infiltrations. Moreover, the number of uterine and vaginal immune cells were evaluated using flow cytometry. Results The number of vaginal leukocyte infiltrations was significantly higher in the alpha-GalCer group than in the sham group 3 days after C. albicans inoculation. In addition, the fungal burden was significantly lower in the alpha-GalCer group than the sham group at 7 days after inoculation. In the analysis of S100A8 concentration of vaginal lavage, there were no significant differences between these two groups, although S100A8 concentration and the number of vaginal leukocyte infiltrations were positively correlated in the alpha-GalCer group. Moreover, the number of vaginal iNKT cells, NK cells and CD8(+) T-cells was significantly higher in the alpha-GalCer group 3 days after inoculation. Conclusions alpha-GalCer-stimulated iNKT cells likely play a protective role against vulvovaginal candidiasis.	[Abe, Masahiro; Sadamoto, Sota; Negri, Minoru; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Kinjo, Yuki] Jikei Univ, Dept Bacteriol, Sch Med, Tokyo, Japan; [Kinjo, Yuki] Jikei Univ, Jikei Ctr Biofilm Sci & Technol, Sch Med, Tokyo, Japan; [Kinjo, Yuki] Tohoku Univ, Dept Intelligent Network Infect Control, Grad Sch Med, Sendai, Miyagi, Japan; [Sadamoto, Sota; Shinozaki, Minoru; Shibuya, Kazutoshi] Toho Univ, Dept Surg Pathol, Sch Med, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Jikei University; Jikei University; Tohoku University; Toho University	Miyazaki, Y (corresponding author), Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Tokyo, Japan.	ym46@niid.go.jp		Abe, Masahiro/0000-0002-6355-716X	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED) [JP21fk0108135, JP21fk0108139, JP21fk0108094]; Japan Society for the Promotion of Science [KAKENHI] [18K19529, 20K17477]	Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.M. received funding from the Research Program on Emerging and Re-emerging Infectious Diseases of the Japan Agency for Medical Research and Development (AMED) Grant Number (JP21fk0108135, JP21fk0108139, and JP21fk0108094) https://www.amed.go.jp/en/index.html M.A. and Y.K. received funding from Japan Society for the Promotion of Science [KAKENHI] Grant Number 18K19529. https://www.jsps.go.jp/english/index.html M.A. received funding from Japan Society for the Promotion of Science [KAKENHI] Grant Number 20K17477. https://www.jsps.go.jp/english/index.html These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkar AA, 2003, J VIROL, V77, P10168, DOI 10.1128/JVI.77.18.10168-10171.2003; Bae EA, 2019, ARCH PHARM RES, V42, P543, DOI 10.1007/s12272-019-01139-8; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Calderon L, 2003, MED MYCOL, V41, P143, DOI 10.1080/mmy.41.2.143.147; Denning DW, 2018, LANCET INFECT DIS, V18, pE339, DOI [10.1016/s1473-3099(18)30103-8, 10.1016/S1473-3099(18)30103-8]; Dominguez-Andres J, 2017, IMMUNITY, V46, P1059, DOI 10.1016/j.immuni.2017.05.009; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; Goncalves B, 2016, CRIT REV MICROBIOL, V42, P905, DOI 10.3109/1040841X.2015.1091805; Grigoriou O, 2006, EUR J OBSTET GYN R B, V126, P121, DOI 10.1016/j.ejogrb.2005.09.015; Habbeddine M, 2013, MICROBES INFECT, V15, P928, DOI 10.1016/j.micinf.2013.08.006; Hoya M, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12813; Ichikawa T, 2016, EUR J IMMUNOL, V46, P1867, DOI 10.1002/eji.201545923; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Iversen MB, 2015, IMMUNOBIOLOGY, V220, P762, DOI 10.1016/j.imbio.2014.12.019; Jin YM, 2019, J CELL PHYSIOL, V234, P13894, DOI 10.1002/jcp.28071; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kim EY, 2020, J CLIN INVEST, V130, P3238, DOI 10.1172/JCI128075; Kumaresan PR, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01939; Lines A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1995; Marquis M, 2006, INFECT IMMUN, V74, P2382, DOI 10.1128/IAI.74.4.2382-2391.2006; Monin L, 2020, MUCOSAL IMMUNOL, V13, P969, DOI 10.1038/s41385-020-0305-7; Mosci P, 2013, MYCOPATHOLOGIA, V175, P1, DOI 10.1007/s11046-012-9589-9; Nguyen NZN, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e49; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peters BM, 2020, J INFECT DIS, V221, P1554, DOI 10.1093/infdis/jiz649; Peters BM, 2014, INFECT IMMUN, V82, P532, DOI 10.1128/IAI.01417-13; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Ranson T, 2005, J IMMUNOL, V175, P1137, DOI 10.4049/jimmunol.175.2.1137; Rezaei-Matehkolaei A, 2016, IRAN J MICROBIOL, V8, P410; Richter SS, 2005, J CLIN MICROBIOL, V43, P2155, DOI 10.1128/JCM.43.5.2155-2162.2005; Robertson FC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00543; Scott NR, 2020, J CLIN INVEST, V130, P3098, DOI 10.1172/JCI130546; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Taniguchi M, 2010, INT IMMUNOL, V22, P1, DOI 10.1093/intimm/dxp104; Tarumoto N, 2014, J INFECT DIS, V209, P799, DOI 10.1093/infdis/jit534; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Wang S, 2002, CELL IMMUNOL, V215, P98, DOI 10.1016/S0008-8749(02)00009-6; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Willems HME, 2020, J FUNGI, V6, DOI 10.3390/jof6010027; Willems HME, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00527-18; Yano J, 2017, MBIO, V8, DOI [10.1128/mBio.00211-17, 10.1128/mbio.00211-17]; Yano J, 2014, INFECT IMMUN, V82, P783, DOI 10.1128/IAI.00861-13	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259306	10.1371/journal.pone.0259306	http://dx.doi.org/10.1371/journal.pone.0259306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784362	gold, Green Published			2022-12-26	WOS:000755277300007
J	Mekonnen, H; Seid, A; Fenta, GM; Gebrecherkos, T				Mekonnen, Habtamu; Seid, Abdurahaman; Fenta, Genet Molla; Gebrecherkos, Teklay			Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RISK-FACTORS; SUSCEPTIBILITY PATTERNS; TEACHING HOSPITALS; POINT PREVALENCE; BAUMANNII; UNIVERSITY; BACTERIA	Introduction Hospital admitted patients are at increased risk of nosocomial infections (NIs) with multi-drug resistant (MDR) pathogens which are prevalent in the hospital environment. Pseudomonas aeruginosa (P. aeruginosa) and Acinetobacter baumannii (A. baumannii) are common causes of NIs worldwide. The objective of this study is to determine antimicrobial resistance profiles and associated factors of Acinetobacter spp and P. aeruginosa NIs among hospitalized patients. Methods A cross-sectional study was conducted at Dessie comprehensive specialized hospital, North-East Ethiopia, from February 1 to April 30, 2020. A total of 254 patients who were suspected of the bloodstream, urinary tract, or surgical site nosocomial infections were enrolled consecutively. Socio-demographic and other variables of interest were collected using a structured questionnaire. Specimens were collected and processed following standard microbiological procedures. Antimicrobial susceptibility was determined using the Kirby-Bauer disk diffusion method following Clinical and Laboratory Standards Institute guidelines. Data were analyzed with SPSS version 23 and p-value < 0.05 was considered statistically significant. Results Overall, 13% of patients had nosocomial Acinetobacter spp and/or P. aeruginosa infections. The culture positivity rate was 16(6.3%) for Acinetobacter spp and 18(7.1%) for P. aeruginosa. Patients admitted in the surgical ward (Adjusted odds ratio (AOR):10.66;95% confidence interval (CI):1.22-93.23), pediatric ward (AOR:14.37;95%CI:1.4-148.5), intensive care unit (AOR:41.93;95%CI:4.7-374.7) and orthopedics (AOR:52.21;95%CI:7.5-365) were significantly at risk to develop NIs compared to patients admitted in the medical ward. Patients who took more than two antimicrobial types at admission were 94% (AOR:0.06; 95% CI:0.004-0.84) times more protected from NIs compared to those who did not take any antimicrobial. About 81% of Acinetobacter spp and 83% of P. aeruginosa isolates were MDR. Amikacin and meropenem showed promising activity against Acinetobacter spp and P. aeruginosa isolates. Conclusion The high prevalence of MDR Acinetobacter spp and P. aeruginosa nosocomial isolates enforce treating of patients with NIs based on antimicrobial susceptibility testing results.	[Mekonnen, Habtamu] Amhara Publ Hlth Inst, Dept Med Microbiol, Dessie Branch, Dessie, Ethiopia; [Seid, Abdurahaman; Fenta, Genet Molla] Wollo Univ, Coll Med & Hlth Sci, Dept Med Microbiol, Dessie, Ethiopia; [Gebrecherkos, Teklay] Univ Gondar, Coll Med & Hlth Sci, Dept Med Microbiol, Gondar, Ethiopia	University of Gondar	Seid, A (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Med Microbiol, Dessie, Ethiopia.	gechdk2000@yahoo.com						Agaba Peter, 2017, BMC Res Notes, V10, P349, DOI 10.1186/s13104-017-2695-5; Al-Gethamy MM, 2017, J INT MED RES, V45, P1181, DOI 10.1177/0300060517706284; AL-Rawajfah OM, 2013, AM J INFECT CONTROL, V41, P607, DOI 10.1016/j.ajic.2012.08.014; Alemayehu T., 2019, ETHIOPIAN MED J, V58; Alemu AY, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00263-2; Ayobami Olaniyi, 2019, Emerg Microbes Infect, V8, P1747, DOI 10.1080/22221751.2019.1698273; Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Chernet AZ, 2020, DRUG HEALTHC PATIENT, V12, P177, DOI 10.2147/DHPS.S251827; Clinical and Laboratory Standards Institute, 2019, CLSI SUPPLEMENT M100, V28th; Cobos-Trigueros N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0916-7; Dash M, 2014, SAUDI J HLTH SCI, V3, P15; Davoudi AR, 2014, CASP J INTERN MED, V5, P227; De Francesco MA, 2013, J INFECT PUBLIC HEAL, V6, P179, DOI 10.1016/j.jiph.2012.11.006; Deptula A, 2015, J HOSP INFECT, V90, P310, DOI 10.1016/j.jhin.2015.03.005; European Centre for Disease Prevention and Control, 2016, POINT PREV SURV HEAL; Gailiene G, 2012, MED LITH, V48, P399; Gashaw M, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0431-0; Gomez-Zorrilla S, 2015, ANTIMICROB AGENTS CH, V59, P5213, DOI 10.1128/AAC.04636-14; Gootz TD, 2008, EXPERT REV ANTI-INFE, V6, P309, DOI 10.1586/14787210.6.3.309; Hoang S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193300; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang HP, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2932-5; Kateete DP, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2986-7; Kolpa M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010112; Kumar P, 2017, NAT CHEM BIOL, V13, P54, DOI [10.1038/NCHEMBIO.2237, 10.1038/nchembio.2237]; LEVINE NS, 1976, J TRAUMA, V16, P89, DOI 10.1097/00005373-197602000-00002; Lin MF, 2014, WORLD J CLIN CASES, V2, P787, DOI 10.12998/wjcc.v2.i12.787; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mahmoud A.B., 2013, J VIROLOGY MICROBIOL, V2013, P1, DOI [10.5171/2013.290047, DOI 10.5171/2013.290047]; Mirzaei B, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05224-w; Morales E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-122; Motbainor H, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4811-8; Nasiri MJ, 2019, NBM, V7, P64; Ozdemir H, 2011, TURKISH J PEDIATR, V53, P255; Petignat C, 2006, INFECT CONT HOSP EP, V27, P953, DOI 10.1086/506409; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; Ramazanzadeh R., 2016, PAJOUHAN SCI J, V14, P11; Rezai MS, 2017, CASP J INTERN MED, V8, P76, DOI 10.22088/cjim.8.2.76; Rods GP., 2014, PUBLIC HEALTH; Shaifali I, 2012, N AM J MED SCI, V4, P163, DOI 10.4103/1947-2714.94940; Sharma D., 2014, Nepal Journal of Medical Sciences, V3, P101, DOI 10.3126/njms.v3i2.13452; Shi XH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247418; Shlaes David M, 2018, Pathog Immun, V3, P19, DOI 10.20411/pai.v3i1.231; Strateva T, 2009, J MED MICROBIOL, V58, P1133, DOI 10.1099/jmm.0.009142-0; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Tolera Moti, 2018, Adv Med, V2018, P2127814, DOI 10.1155/2018/2127814; Tran GM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2529-z; Uwingabiye Jean, 2017, Germs, V7, P193, DOI 10.18683/germs.2017.1126; WHO, 2011, WHO LIB CAT PUBL DAT; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0257272	10.1371/journal.pone.0257272	http://dx.doi.org/10.1371/journal.pone.0257272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780494	gold, Green Submitted, Green Published			2022-12-26	WOS:000755305800007
J	Needham, L; Evans, M; Cosker, DP; Colyer, SL				Needham, Laurie; Evans, Murray; Cosker, Darren P.; Colyer, Steffi L.			Development, evaluation and application of a novel markerless motion analysis system to understand push-start technique in elite skeleton athletes	PLOS ONE			English	Article							VELOCITY; KINEMATICS; STRENGTH; EVENTS; TIME	This study describes the development, evaluation and application of a computer vision and deep learning system capable of capturing sprinting and skeleton push start step characteristics and mass centre velocities (sled and athlete). Movement data were captured concurrently by a marker-based motion capture system and a custom markerless system. High levels of agreement were found between systems, particularly for spatial based variables (step length error 0.001 +/- 0.012 m) while errors for temporal variables (ground contact time and flight time) were on average within +/- 1.5 frames of the criterion measures. Comparisons of sprinting and pushing revealed decreased mass centre velocities as a result of pushing the sled but step characteristics were comparable to sprinting when aligned as a function of step velocity. There were large asymmetries between the inside and outside leg during pushing (e.g. 0.22 m mean step length asymmetry) which were not present during sprinting (0.01 m step length asymmetry). The observed asymmetries suggested that force production capabilities during ground contact were compromised for the outside leg. The computer vision based methods tested in this research provide a viable alternative to marker-based motion capture systems. Furthermore, they can be deployed into challenging, real world environments to non-invasively capture data where traditional approaches are infeasible.	[Needham, Laurie; Evans, Murray; Cosker, Darren P.; Colyer, Steffi L.] Univ Bath, Ctr Anal Mot Entertainment Res & Applicat, Bath, Avon, England; [Needham, Laurie; Colyer, Steffi L.] Univ Bath, Dept Hlth, Bath, Avon, England; [Evans, Murray; Cosker, Darren P.] Univ Bath, Dept Comp Sci, Bath, Avon, England	University of Bath; University of Bath; University of Bath	Needham, L (corresponding author), Univ Bath, Ctr Anal Mot Entertainment Res & Applicat, Bath, Avon, England.; Needham, L (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	ln424@bath.ac.uk		Colyer, Steffi/0000-0002-4973-6591; Needham, Laurie/0000-0002-8675-4684; Cosker, Darren/0000-0001-5177-4741	CAMERA; RCUK Centre for the Analysis of Motion, Entertainment Research and Applications [EP/M023281/1, EP/T014865/1]; British Bobsleigh; Skeleton Association	CAMERA; RCUK Centre for the Analysis of Motion, Entertainment Research and Applications; British Bobsleigh; Skeleton Association	This research was funded by CAMERA, the RCUK Centre for the Analysis of Motion, Entertainment Research and Applications, EP/M023281/1 and EP/T014865/1 and in collaboration with the British Bobsleigh and Skeleton Association who we thank for their continued time and support with this project. There was no additional external funding received for this study.	Bezodis NE, 2012, INT J SPORTS MED, V33, P439, DOI 10.1055/s-0031-1301313; Botzel K, 2016, J BIOMECH, V49, P332, DOI 10.1016/j.jbiomech.2015.12.035; Brazil A, 2020, J SPORT SCI, V38, P1140, DOI 10.1080/02640414.2020.1743065; Bruggemann GP, 1997, J APPL BIOMECH, V13, P98, DOI 10.1123/jab.13.1.98; Cahill MJ, 2019, STRENGTH COND J, V41, P94, DOI 10.1519/SSC.0000000000000460; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colyer SL., 2018, SPORTS MED-OPEN, P4; Colyer SL, 2016, P 34 INT C BIOM SPOR; Colyer SL, 2018, J SPORT SCI, V36, P1930, DOI 10.1080/02640414.2018.1426352; Colyer SL, 2018, SPORT BIOMECH, V17, P168, DOI 10.1080/14763141.2016.1261183; Colyer SL, 2017, INT J SPORT PHYSIOL, V12, P81, DOI 10.1123/ijspp.2015-0631; Cosker D.P., 2020, ISBS P ARCH, V38, P756; Cross MR, 2018, EUR J APPL PHYSIOL, V118, P563, DOI 10.1007/s00421-017-3796-5; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Efron B, 1989, CURRENT CONTENTS ENG, P16; Evans M, 2020, P IEEE CVF C COMP VI; Evans M, 2018, 18 IEEE WINT C APPL; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guler RA, 2018, PROC CVPR IEEE, P7297, DOI 10.1109/CVPR.2018.00762; Handsaker JC, 2016, J BIOMECH, V49, P4128, DOI 10.1016/j.jbiomech.2016.10.013; Healy R, 2015, ISBS C P ARCH; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Hunter JP, 2005, J APPL BIOMECH, V21, P31, DOI 10.1123/jab.21.1.31; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; Irwin G, 2005, J SPORT SCI, V23, P1089, DOI 10.1080/02640410500130763; Lin K, 2021, IEEE T CIRC SYST VID, V31, P1066, DOI 10.1109/TCSVT.2020.2995122; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Martini E, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20051448; Maulder PS, 2008, J STRENGTH COND RES, V22, P1992, DOI 10.1519/JSC.0b013e31818746fe; Purcell B., 2006, BIOMEMS NANOTECHNOLO; Triggs B, 2003, VISION ALGORITHMS TH; Watari R, 2016, J APPL BIOMECH, V32, P306, DOI 10.1123/jab.2015-0200; Wilson GJ, 1996, EUR J APPL PHYSIOL O, V73, P346, DOI 10.1007/BF02425497; Young WB, 2006, INT J SPORT PHYSIOL, V1, P74, DOI 10.1123/ijspp.1.2.74; Zanoletti C, 2006, J STRENGTH COND RES, V20, P579; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	37	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259624	10.1371/journal.pone.0259624	http://dx.doi.org/10.1371/journal.pone.0259624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780514	gold, Green Published			2022-12-26	WOS:000755305800034
J	Gimeno-Miguel, A; Bliek-Bueno, K; Poblador-Plou, B; Carmona-Pirez, J; Poncel-Falco, A; Gonzalez-Rubio, F; Ioakeim-Skoufa, I; Pico-Soler, V; Aza-Pascual-Salcedo, M; Prados-Torres, A; Gimeno-Feliu, LA				Gimeno-Miguel, Antonio; Bliek-Bueno, Kevin; Poblador-Plou, Beatriz; Carmona-Pirez, Jonas; Poncel-Falco, Antonio; Gonzalez-Rubio, Francisca; Ioakeim-Skoufa, Ignatios; Pico-Soler, Victoria; Aza-Pascual-Salcedo, Mercedes; Prados-Torres, Alexandra; Andres Gimeno-Feliu, Luis		PRECOVID Grp	Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SINGLE-CENTER; RISK-FACTORS; CORONAVIRUS; PNEUMONIA; SEVERITY	Background Clinical outcomes among COVID-19 patients vary greatly with age and underlying comorbidities. We aimed to determine the demographic and clinical factors, particularly baseline chronic conditions, associated with an increased risk of severity in COVID-19 patients from a population-based perspective and using data from electronic health records (EHR). Methods Retrospective, observational study in an open cohort analyzing all 68,913 individuals (mean age 44.4 years, 53.2% women) with SARS-CoV-2 infection between 15 June and 19 December 2020 using exhaustive electronic health registries. Patients were followed for 30 days from inclusion or until the date of death within that period. We performed multivariate logistic regression to analyze the association between each chronic disease and severe infection, based on hospitalization and all-cause mortality. Results 5885 (8.5%) individuals showed severe infection and old age was the most influencing factor. Congestive heart failure (odds ratio -OR- men: 1.28, OR women: 1.39), diabetes (1.37, 1.24), chronic renal failure (1.31, 1.22) and obesity (1.21, 1.26) increased the likelihood of severe infection in both sexes. Chronic skin ulcers (1.32), acute cerebrovascular disease (1.34), chronic obstructive pulmonary disease (1.21), urinary incontinence (1.17) and neoplasms (1.26) in men, and infertility (1.87), obstructive sleep apnea (1.43), hepatic steatosis (1.43), rheumatoid arthritis (1.39) and menstrual disorders (1.18) in women were also associated with more severe outcomes. Conclusions Age and specific cardiovascular and metabolic diseases increased the risk of severe SARS-CoV-2 infections in men and women, whereas the effects of certain comorbidities are sex specific. Future studies in different settings are encouraged to analyze which profiles of chronic patients are at higher risk of poor prognosis and should therefore be the targets of prevention and shielding strategies.	[Gimeno-Miguel, Antonio; Bliek-Bueno, Kevin; Poblador-Plou, Beatriz; Carmona-Pirez, Jonas; Poncel-Falco, Antonio; Gonzalez-Rubio, Francisca; Ioakeim-Skoufa, Ignatios; Pico-Soler, Victoria; Aza-Pascual-Salcedo, Mercedes; Prados-Torres, Alexandra; Andres Gimeno-Feliu, Luis] Miguel Servet Univ Hosp, Aragon Hlth Sci Inst IACS, IIS Aragon, EpiChron Res Grp, Zaragoza, Spain; [Gimeno-Miguel, Antonio; Poblador-Plou, Beatriz; Carmona-Pirez, Jonas; Poncel-Falco, Antonio; Gonzalez-Rubio, Francisca; Pico-Soler, Victoria; Aza-Pascual-Salcedo, Mercedes; Prados-Torres, Alexandra; Andres Gimeno-Feliu, Luis] ISCIII, Hlth Serv Res Chron Patients Network REDISSEC, Madrid, Spain; [Bliek-Bueno, Kevin] Miguel Servet Univ Hosp, Prevent Med & Publ Hlth Teaching Unit, Zaragoza, Spain; [Carmona-Pirez, Jonas; Gonzalez-Rubio, Francisca] Aragon Hlth Serv SALUD, Delicias Sur Primary Care Hlth Ctr, Zaragoza, Spain; [Poncel-Falco, Antonio] Aragon Hlth Serv SALUD, Zaragoza, Spain; [Gonzalez-Rubio, Francisca; Ioakeim-Skoufa, Ignatios] Spanish Soc Family & Community Med SemFYC, Drug Utilizat Work Grp, Barcelona, Spain; [Ioakeim-Skoufa, Ignatios] Norwegian Inst Publ Hlth, WHO Collaborating Ctr Drug Stat Methodol, Dept Drug Stat, Div Hlth Data & Digitalisat, Oslo, Norway; [Pico-Soler, Victoria] Aragon Hlth Serv SALUD, Torrero La Paz Primary Care Hlth Ctr, Zaragoza, Spain; [Aza-Pascual-Salcedo, Mercedes] Aragon Hlth Serv SALUD, Primary Care Pharm Serv Zaragoza 3, Zaragoza, Spain; [Andres Gimeno-Feliu, Luis] Univ Zaragoza, San Pablo Primary Care Hlth Ctr, Aragon Hlth Serv SALUD, Zaragoza, Spain	Miguel Servet University Hospital; Instituto de Salud Carlos III; Miguel Servet University Hospital; Norwegian Institute of Public Health (NIPH); University of Zaragoza	Bliek-Bueno, K (corresponding author), Miguel Servet Univ Hosp, Aragon Hlth Sci Inst IACS, IIS Aragon, EpiChron Res Grp, Zaragoza, Spain.; Bliek-Bueno, K (corresponding author), Miguel Servet Univ Hosp, Prevent Med & Publ Hlth Teaching Unit, Zaragoza, Spain.	kbliek@salud.aragon.es	Aza-Pascual-Salcedo, Mercedes/AAY-6534-2021; Ioakeim-Skoufa, Ignatios/AAX-4807-2020; Carmona Pirez, Jonas/AAE-8594-2022; Prados-Torres, Alexandra/P-5818-2017; Rubio, Francisca Gonzalez/ABD-1444-2020; Gonzalez Rubio, Francisca/GPT-3556-2022	Aza-Pascual-Salcedo, Mercedes/0000-0002-8937-5559; Ioakeim-Skoufa, Ignatios/0000-0002-6518-749X; Carmona Pirez, Jonas/0000-0002-6268-8803; Prados-Torres, Alexandra/0000-0002-5704-6056; Rubio, Francisca Gonzalez/0000-0001-5939-4436; Gonzalez Rubio, Francisca/0000-0001-5939-4436; Bliek-Bueno, Kevin/0000-0002-4812-4657	Gobierno de Aragon [B01_20R, DECRETOLEY 3/2020]	Gobierno de Aragon(Gobierno de Aragon)	This research was funded by Gobierno de Aragon (Grant numbers B01_20R and DECRETOLEY 3/2020, de 3 de junio, del Gobierno de Aragon), which provided financial support to the EpiChron Research Group and financed the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksova A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094526; Ancin Ducay J.M., 2014, CORRELACION CODIGOS, V8th; Angelousi AG, 2011, EUR J ENDOCRINOL, V164, P147, DOI 10.1530/EJE-10-0695; Azevedo RB, 2021, J HUM HYPERTENS, V35, P4, DOI 10.1038/s41371-020-0387-4; Braunstein SL, 2021, CLIN INFECT DIS, V72, pE1021, DOI 10.1093/cid/ciaa1793; Buicu AL, 2021, J CLIN MED, V10, DOI 10.3390/jcm10081545; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Curci C, 2021, EUR J PHYS REHAB MED, V57, P443, DOI 10.23736/S1973-9087.20.06660-5; Daraei M, 2020, INTERN MED J, V50, P1410, DOI 10.1111/imj.15000; del Amo J, 2020, ANN INTERN MED, V173, P536, DOI 10.7326/M20-3689; Du Pengqiang, 2021, Can J Infect Dis Med Microbiol, V2021, P6660930, DOI 10.1155/2021/6660930; Elixhauser A., 2009, CLIN CLASSIFICATIONS; Emmi G, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102575; England BR, 2021, ARTHRITIS RHEUMATOL, V73, P2179, DOI 10.1002/art.41800; Fabregues F, 2020, REPROD BIOMED ONLINE, V41, P361, DOI 10.1016/j.rbmo.2020.06.013; Flook M, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05992-1; Fredi M, 2020, LANCET RHEUMATOL, V2, pE549, DOI 10.1016/S2665-9913(20)30169-7; Gao YD, 2021, ALLERGY, V76, P428, DOI 10.1111/all.14657; Gulsen A, 2021, RESPIROLOGY, V26, P552, DOI 10.1111/resp.14049; Hariyanto TI, 2021, SLEEP MED, V82, P47, DOI 10.1016/j.sleep.2021.03.029; Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321; Hosseinzadeh R, 2021, CLIN HYPERTENS, V27, DOI 10.1186/s40885-021-00161-7; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018; Hyrich KL, 2021, NAT REV RHEUMATOL, V17, P71, DOI 10.1038/s41584-020-00562-2; Inciarte A, 2020, AIDS, V34, P1775, DOI 10.1097/QAD.0000000000002643; Li J, 2021, AM J INFECT CONTROL, V49, P82, DOI 10.1016/j.ajic.2020.06.008; Li J, 2021, J MED VIROL, V93, P1449, DOI 10.1002/jmv.26424; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Li XY, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250602; Maas MB, 2021, SLEEP BREATH, V25, P1155, DOI [10.1007/s11325-020-02203-0, 10.1007/s11325-020-02271-2]; Martin-Jimenez P, 2020, J ALZHEIMERS DIS, V78, P1367, DOI 10.3233/JAD-200937; Negrini F, 2021, ARCH PHYS MED REHAB, V102, P155, DOI 10.1016/j.apmr.2020.09.376; Pan L, 2021, DIGEST LIVER DIS, V53, P153, DOI 10.1016/j.dld.2020.09.007; Peng YH, 2014, THROMB RES, V134, P340, DOI 10.1016/j.thromres.2014.06.009; Poblador-Plou B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145171; Pranata R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104949; Savoia C, 2021, CIRC RES, V128, P1062, DOI 10.1161/CIRCRESAHA.121.318054; Schneider C, 2010, EUR J EPIDEMIOL, V25, P253, DOI 10.1007/s10654-010-9435-7; Shetty R, 2008, J THROMB THROMBOLYS, V26, P35, DOI 10.1007/s11239-007-0157-y; South AM, 2020, AM J PHYSIOL-HEART C, V318, pH1084, DOI 10.1152/ajpheart.00217.2020; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Thachil J, 2020, J THROMB HAEMOST, V18, P1023, DOI 10.1111/jth.14810; Thakur B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88130-w; Toraldo DM, 2013, LUNG, V191, P1, DOI 10.1007/s00408-012-9427-3; van Gerwen M, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00565; World Health Organization, COR DIS COVID 19 WEE; Wu YY, 2021, ANN PALLIAT MED, V10, P5069, DOI 10.21037/apm-20-2557; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhao QW, 2020, J MED VIROL, V92, P1915, DOI 10.1002/jmv.25889; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259822	10.1371/journal.pone.0259822	http://dx.doi.org/10.1371/journal.pone.0259822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767594	Green Published, gold			2022-12-26	WOS:000755249300051
J	Gurzeler, E; Ruotsalainen, AK; Laine, A; Valkama, T; Kettunen, S; Laakso, M; Yla-Herttuala, S				Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Laakso, Markku; Yla-Herttuala, Seppo			SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; INFLAMMASOME; INHIBITION; MECHANISMS; EXPRESSION; LESIONS; RABBIT; GENE	Background and aims Diabetes is a major risk factor of atherosclerosis and its complications. The loss-of-function mutation E1506K in the sulfonylurea receptor 1 (SUR1-E1506K) induces hyperinsulinemia in infancy, leading to impaired glucose tolerance and increased risk of type 2 diabetes. In this study, we investigate the effect of SUR1-E1506K mutation on atherogenesis in hypercholesterolemic LDLR-/- mice. Methods SUR1-E1506K mutated mice were cross-bred with LDLR-/- mice (SUR1 Delta/LDLR-/-), 6 months old mice were fed a western-diet (WD) for 6 months to induce advanced atherosclerotic plaques. At the age of 12 months, atherosclerosis and plaque morphology were analyzed and mRNA gene expression were measured from aortic sections and macrophages. Glucose metabolism was characterized before and after WD. Results were compared to age-matched LDLR-/- mice. Results Advanced atherosclerotic plaques did not differ in size between the two strains. However, in SUR1 Delta/LDLR-/- mice, plaque necrotic area was increased and smooth muscle cell number was reduced, resulting in higher plaque vulnerability index in SUR1 Delta/LDLR-/- mice compared to LDLR-/- mice. SUR1 Delta/LDLR-/- mice exhibited impaired glucose tolerance and elevated fasting glucose after WD. The positive staining area of IL-1 beta and NLRP3 inflammasome were increased in aortic sections in SUR1 Delta/LDLR-/- mice compared to LDLR-/- mice, and IL-18 plasma level was elevated in SUR1 Delta/LDLR-/- mice. Finally, the mRNA expression of IL-1 beta and IL-18 were increased in SUR1 Delta/LDLR-/- bone marrow derived macrophages in comparison to LDLR-/- macrophages in response to LPS. Conclusions SUR1-E1506K mutation impairs glucose tolerance and increases arterial inflammation, which promotes a vulnerable atherosclerotic plaque phenotype in LDLR-/- mice.	[Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Yla-Herttuala, Seppo] Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Yla-Herttuala, S (corresponding author), Univ Eastern Finland, AI Virtanen Inst, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland.; Yla-Herttuala, S (corresponding author), Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland.	seppo.ylaherttuala@uef.fi			Academy of Finland [319187]; European Research Council [GA670951]; Diabetes Research Foundation	Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Diabetes Research Foundation	This work was supported by Academy of Finland (319187, SYH), European Research Council (GA670951, SYH) and The Diabetes Research Foundation (2019, AKR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Finnish Academy: www.aka.fi ERC: https://erc.europa.eu Diabetes Research Foundation: www.diabetes.fi.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Booth G, 2002, DIABETES, V51, P1556, DOI 10.2337/diabetes.51.5.1556; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Dagenais M, 2012, CELL DEATH DIFFER, V19, P5, DOI 10.1038/cdd.2011.159; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Lima LCF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00304; Gargiulo S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091511; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hartwig H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141019; Heinonen SE, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/404085; Hoseini Z, 2018, J CELL PHYSIOL, V233, P2116, DOI 10.1002/jcp.25930; Huang D, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7839101; Huopio H, 2003, LANCET, V361, P301, DOI 10.1016/S0140-6736(03)12325-2; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Katakami N, 2018, J ATHEROSCLER THROMB, V25, P27, DOI 10.5551/jat.RV17014; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Laukkanen O, 2004, J CLIN ENDOCR METAB, V89, P6286, DOI 10.1210/jc.2004-1204; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Sharma A, 2021, DIABETES, V70, P772, DOI 10.2337/db20-0357; Shi X, 2015, J STROKE CEREBROVASC, V24, P2455, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.024; Shimomura K, 2013, DIABETES, V62, P3797, DOI 10.2337/db12-1611; Shiomi M, 2001, ATHEROSCLEROSIS, V157, P75, DOI 10.1016/S0021-9150(00)00708-5; Sluimer JC, 2015, METHODS MOL BIOL, V1339, P339, DOI 10.1007/978-1-4939-2929-0_24; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Veseli BE, 2017, EUR J PHARMACOL, V816, P3, DOI 10.1016/j.ejphar.2017.05.010; Yla-Herttuala S, 2013, EUR HEART J, V34, P3251, DOI 10.1093/eurheartj/eht301; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YLAHERTTUALA S, 1988, J LIPID RES, V29, P563; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258408	10.1371/journal.pone.0258408	http://dx.doi.org/10.1371/journal.pone.0258408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767557	gold, Green Published			2022-12-26	WOS:000755249300010
J	Rivolo, S; Di Fusco, M; Polanco, C; Kang, A; Dhanda, D; Savone, M; Skandamis, A; Kongnakorn, T; Soto, J				Rivolo, Simone; Di Fusco, Manuela; Polanco, Carlos; Kang, Amiee; Dhanda, Devender; Savone, Mirko; Skandamis, Aristeidis; Kongnakorn, Thitima; Soto, Javier			Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain	PLOS ONE			English	Article							LONG-TERM SURVIVAL; ORAL ANTICOAGULANTS; ATHEROTHROMBOTIC EVENTS; MYOCARDIAL-INFARCTION; NETWORK METAANALYSIS; SECONDARY PREVENTION; STROKE PREVENTION; GROUP PERSPECTIVE; ISCHEMIC-STROKE; OPEN-LABEL	Background/Objective AUGUSTUS trial demonstrated that, for patients with atrial fibrillation (AF) having acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI), an antithrombotic regimen with apixaban and P2Y12 resulted in less bleeding, fewer hospitalizations, and similar ischemic events than regimens including a vitamin K antagonist (VKA), aspirin, or both. This study objective was to evaluate long-term health and economic outcomes and the cost-effectiveness of apixaban over VKA, as a treatment option for patients with AF having ACS/PCI. Methods A lifetime Markov cohort model was developed comparing apixaban versus VKA across multiple treatment strategies (triple [with P2Y12 + aspirin] or dual [with P2Y12] therapy followed by monotherapy [apixaban or VKA]; triple followed by dual and then monotherapy; dual followed by monotherapy). The model adopted the Spanish healthcare perspective, with a 3-month cycle length and costs and health outcomes discounted at 3%. Results Treatment with apixaban resulted in total cost savings of Euro883 and higher life years (LYs) and quality-adjusted LYs (QALYs) per patient than VKA (net difference, LYs: 0.13; QALYs: 0.11). Bleeding and ischemic events (per 100 patients) were lower with apixaban than VKA (net difference, -13.9 and -1.8, respectively). Incremental net monetary benefit for apixaban was Euro3,041, using a willingness-to-pay threshold of Euro20,000 per QALY. In probabilistic sensitivity analysis, apixaban was dominant in the majority of simulations (92.6%), providing additional QALYs at lower costs than VKA. Conclusions Apixaban was a dominant treatment strategy than VKA from both the Spanish payer's and societal perspectives, regardless of treatment strategy considered.	[Rivolo, Simone] Evidera PPD, Modeling & Simulat, Milan, Italy; [Di Fusco, Manuela; Savone, Mirko] Pfizer Inc, New York, NY USA; [Polanco, Carlos] Bristol Myers Squibb, Madrid, Spain; [Kang, Amiee; Dhanda, Devender] Bristol Myers Squibb, Lawrenceville, NJ USA; [Skandamis, Aristeidis; Kongnakorn, Thitima] Evidera, Modeling & Simulat, London, England; [Soto, Javier] Pfizer, Madrid, Spain	Pfizer; Bristol-Myers Squibb; Bristol-Myers Squibb; Evidera; Pfizer	Rivolo, S (corresponding author), Evidera PPD, Modeling & Simulat, Milan, Italy.	simone.rivolo@evidera.com		Rivolo, Simone/0000-0002-8431-9611	BMS/Pfizer Inc.	BMS/Pfizer Inc.	This study was funded by BMS/Pfizer Inc. https://www.bms.com/and https://www.pfizer.com/.BMS provided support in the form of salaries for authors CP, AK, DD. Pfizer Inc. provided support in the form of salaries for authors MDF, MS, and JS. Authors SR, AS, and TK are employees of Evidera, which received funding from BMS/Pfizer Inc., for the conduct of the study. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; Esquivias GB, 2015, REV ESP CARDIOL, V68, P680, DOI 10.1016/j.rec.2014.08.010; Barrios V, 2015, REV ESP CARDIOL, V68, P1181, DOI 10.1016/j.rec.2015.07.024; Briggs A, 2006, DECISION MODELLING H; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2019, J AM COLL CARDIOL, V74, P83, DOI 10.1016/j.jacc.2019.05.016; Carta A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.569500; Bahit MC, 2013, INT J CARDIOL, V170, P215, DOI 10.1016/j.ijcard.2013.10.062; Collet J.P, 2020, EUR HEART J; Cowie MR, 2020, CARDIOVASC RES, V116, P1918, DOI 10.1093/cvr/cvz278; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Dorian P, 2014, EUR HEART J, V35, P1897, DOI 10.1093/eurheartj/ehu006; Fang MC, 2014, NEUROLOGY, V82, P1033, DOI 10.1212/WNL.0000000000000248; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Garcia-Sempere A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211681; Garg L, 2018, AM J CARDIOL, V121, P684, DOI 10.1016/j.amjcard.2017.12.003; Gho JMIH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018331; Ghushchyan V, 2015, VASC HEALTH RISK MAN, V11, P25, DOI 10.2147/VHRM.S72331; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Giner-Soriano M, 2020, ATEN PRIM, V52, P529, DOI 10.1016/j.aprim.2020.05.016; Gitsels LA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013570; Gobierno de Espana-Ministerio de Sanidad Consumo y Bienestar Social, INF PROD INCL PREST; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hwang KK, 2017, INT HEART J, V58, P486, DOI 10.1536/ihj.16-286; Forcadell MJ, 2018, EUR J PREV CARDIOL, V25, P1822, DOI 10.1177/2047487318788396; Gomez-Doblas JJ, 2014, REV ESP CARDIOL, V67, P259, DOI [10.1016/j.rec.2013.07.014, 10.1016/j.recesp.2013.07.015]; Kea B, 2016, CURR EMERG HOSP ME R, V4, P107, DOI 10.1007/s40138-016-0105-2; Koziel M, 2020, RES PRACT THROMB HAE, V4, P357, DOI 10.1002/rth2.12319; Kwong E, 2019, OPEN HEART, V6, DOI 10.1136/openhrt-2018-000920; Lefevre C, 2015, VALUE HEALTH, V18, pA403, DOI 10.1016/j.jval.2015.09.938; Lekuona I, 2019, REV ESP CARDIOL, V72, P398, DOI 10.1016/j.rec.2018.03.024; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Lopes RD, 2018, AM HEART J, V200, P17, DOI 10.1016/j.ahj.2018.03.001; Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4; Luengo-Fernandez R, 2013, NEUROLOGY, V81, P1588, DOI 10.1212/WNL.0b013e3182a9f45f; Mar J, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0230-8; Oyaguez I, 2020, PHARMACOECON-OPEN, V4, P485, DOI 10.1007/s41669-019-00186-7; Panaccio MP, 2015, CLIN EPIDEMIOL, V7, P77, DOI 10.2147/CLEP.S64936; Pandor A, 2016, PHARMACOECONOMICS, V34, P463, DOI 10.1007/s40273-015-0351-2; Pockett RD, 2018, J MED ECON, V21, P616, DOI 10.1080/13696998.2018.1454453; Pouwels XGLV, 2018, PHARMACOECONOMICS, V36, P533, DOI 10.1007/s40273-017-0607-0; Rodriguez-Bernal CL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00063; Rubenstein Jason C, 2012, J Atr Fibrillation, V5, P551, DOI 10.4022/jafib.551; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Sutton NR, 2016, J AM COLL CARDIOL, V68, P895, DOI 10.1016/j.jacc.2016.05.085; Tawfik A, 2016, CLIN PHARMACOL-ADV A, V8, P93, DOI 10.2147/CPAA.S105165; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Velleca M., 2019, EMJ CARDIOL, V7, P110; Vranckx P, 2020, EUR HEART J, V41, P4497, DOI 10.1093/eurheartj/ehaa617; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0; Wang KJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006703	53	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259251	10.1371/journal.pone.0259251	http://dx.doi.org/10.1371/journal.pone.0259251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767564	Green Published, gold			2022-12-26	WOS:000755249300025
J	Omobowale, MO; Bamgboye, EA; Akinyode, A; Falase, OS; Ladipo, TO; Salami, O; Adebiyi, AO				Omobowale, Mofeyisara Oluwatoyin; Bamgboye, Eniola Adetola; Akinyode, Akinfemi; Falase, Olugbenga Samuel; Ladipo, Taiwo Olabode; Salami, Olufunmilayo; Adebiyi, Akindele Olupelumi			Contextual interpretation of COVID-19 pandemic among public space users in Ibadan Metropolis, Oyo State, Nigeria: An ethnographic review	PLOS ONE			English	Review							MARKET	The COVID-19 pandemic has affected all dimensions of lives and has become a social problem as it continues to spread widely through the continuous interactions of people in public spaces where they earn a living. Curbing the spread of COVID-19 requires restrictions in these public spaces, however, the compliance to these measures depends largely on the understanding and interpretations of COVID 19 by users of these public spaces. This study examined the contextual interpretations of public space users about COVID-19 prevention in Ibadan Metropolis, Oyo State. The study was a rapid ethnographic survey in selected public spaces (markets and commercial motor parks) in Ibadan metropolis. Data were collected through participant observation, key informant interviews (3 females; 3 males) and in-depth interviews (30) with, traders, head porters, clients/buyers and commercial vehicle drivers in these public spaces. Interviews conducted were transcribed, sorted into themes using Atlas-ti 7.5.7 and subjected to interpretive-content analysis. Findings revealed that some respondents felt COVID-19 was brought into Nigeria by rich frequent global voyagers, others felt it was through "uncultured" sexual life or wrath of God. Some also doubted the existence of the disease and many of the respondents perceived COVID-19 as a disease reported by the government or a political propaganda to siphon funds. The users of the public spaces in Ibadan Metropolis have variegated perception about the existence and severity of this rapidly spreading virus and this has grave implications for COVID-19 control in the State. Thus, regular interaction with public space users are essential for control efforts.	[Omobowale, Mofeyisara Oluwatoyin] Univ Ibadan, Coll Med, Inst Child Hlth, Ibadan, Nigeria; [Bamgboye, Eniola Adetola] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Akinyode, Akinfemi; Ladipo, Taiwo Olabode] Oyo State Minist Hlth, Ibadan, Nigeria; [Falase, Olugbenga Samuel] Lead City Univ, Dept Sociol, Ibadan, Nigeria; [Salami, Olufunmilayo] Baylor Coll Med, Houston, TX 77030 USA; [Adebiyi, Akindele Olupelumi] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria	University of Ibadan; University of Ibadan; Baylor College of Medicine; University of Ibadan	Bamgboye, EA (corresponding author), Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria.	dr_enip@yahoo.co.uk	salami, olufunmilayo/AGX-5679-2022	salami, olufunmilayo/0000-0003-4951-5999				Abel T, 2020, IJPH; Agbiji O.M., 2015, RELIG SOCIAL TRANSFO, V114, P1; [Anonymous], 2020, TRIBUNE 0328; COCKBURN WC, 1969, B WORLD HEALTH ORGAN, V41, P345; Cubeta R.L., 2020, NEW MODELS NEW DIS S, V10, P07; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Fischer J, 2012, FRONT ECOL ENVIRON, V10, P153, DOI 10.1890/110079; Henderson DA, 2016, AM J EPIDEMIOL, V183, P381, DOI 10.1093/aje/kwv229; Honey-Roses J., 2020, IMPACT COVID 19 PUBL, DOI [10.31219/osf.io/rf7xa, DOI 10.31219/OSF.IO/RF7XA]; Lawrence RJ, 2020, J URBAN HEALTH, V97, P583, DOI 10.1007/s11524-020-00456-4; Lawuyi O.B ., 2015, SCENARIO VISIBILITY, DOI [10.2147/OPTH.S72321, DOI 10.2147/OPTH.S72321]; Mbachu D ., 2020, TRAPPED CORONAVIRUS; Mbamalu S ., LAGOS MASKS ARE GONE; Mensch J, 2007, CONT PHILOS REV, V40, P31, DOI 10.1007/s11007-006-9038-x; National Centre for Disease Control, 2020, COVID 19 NIG 1 MAY 2; Nzeadibe T.C., 2018, PALGRAVE HDB SUSTAIN, P313; Olaniyi R ., 2015, EC HIST IBADAN 1830; Omobowale MO, 2019, J ANTHROPOL RES, V75, P235, DOI 10.1086/702708; Omobowale MO, 2019, J BLACK STUD, V50, P401, DOI 10.1177/0021934719840721; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; UNESCO, 2017, INCL ACC PUBL SPAC; WHO, 2020, NAM COR DIS COVID 19; World Bank, 2019, JUMPST INCL GROWTH U, DOI [10.1596/32795, DOI 10.1596/32795]; World Bank, 2020, GLOB EC OUTL COV 19	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259631	10.1371/journal.pone.0259631	http://dx.doi.org/10.1371/journal.pone.0259631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762710	gold, Green Published			2022-12-26	WOS:000755316600031
J	Wheeler, RJ				Wheeler, Richard John			A resource for improved predictions of Trypanosoma and Leishmania protein three- dimensional structure	PLOS ONE			English	Article							GENERATION; ACCURATE	AlphaFold2 and RoseTTAfold represent a transformative advance for predicting protein structure. They are able to make very high-quality predictions given a high-quality alignment of the protein sequence with related proteins. These predictions are now readily available via the AlphaFold database of predicted structures and AlphaFold or RoseTTAfold Colaboratory notebooks for custom predictions. However, predictions for some species tend to be lower confidence than model organisms. Problematic species include Trypanosoma cruzi and Leishmania infantum: important unicellular eukaryotic human parasites in an early-branching eukaryotic lineage. The cause appears to be due to poor sampling of this branch of life (Discoba) in the protein sequences databases used for the AlphaFold database and ColabFold. Here, by comprehensively gathering openly available protein sequence data for Discoba species, significant improvements to AlphaFold2 protein structure prediction over the AlphaFold database and ColabFold are demonstrated. This is made available as an easy-to-use tool for the parasitology community in the form of Colaboratory notebooks for generating multiple sequence alignments and AlphaFold2 predictions of protein structure for Trypanosoma, Leishmania and related species.	[Wheeler, Richard John] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England	University of Oxford	Wheeler, RJ (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England.	richard.wheeler@ndm.ox.ac.uk		Wheeler, Richard/0000-0002-4270-8360	Wellcome Trust [211075/Z/18/Z]	Wellcome Trust(Wellcome Trust)	RJW 211075/Z/18/Z Wellcome Trust https://wellcome.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; AlphaFold, 2021, ALPHAFOLD; [Anonymous], NCBI SEQUENCING READ; [Anonymous], 2021, VELVET; [Anonymous], 2021, CD HIT; [Anonymous], 2021, TRINITY RNA SEQ; [Anonymous], ALPHAFOLD PROTEIN ST; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Baek M, 2021, SCIENCE, V373, P871, DOI 10.1126/science.abj8754; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Buchfink B, 2021, NAT METHODS, V18, P366, DOI 10.1038/s41592-021-01101-x; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Butenko A, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-0754-1; Chowdhury R., SINGLE SEQUENCE PROT, V2021, DOI [10.1101/2021.08.02.454840, DOI 10.1101/2021.08.02.454840]; Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Dean S, 2019, ELIFE, V8, DOI 10.7554/eLife.42282; Delmont T.O., 2020, BIORXIV, DOI [DOI 10.1101/2020.10.15.341214, 10.1101/2020.10.15.341214]; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Erdos Gabor, 2020, Curr Protoc Bioinformatics, V70, pe99, DOI 10.1002/cpbi.99; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Ghedin E, 2004, MOL BIOCHEM PARASIT, V134, P183, DOI 10.1016/j.molbiopara.2003.11.012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karin EL, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00808-x; Krueger F, 2021, TRIM GALORE; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li H., 2013, ARXIV13033997 Q BIO; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maslov DA, 2019, PARASITOLOGY, V146, P1, DOI 10.1017/S0031182018000951; Mirdita Milot, 2021, Zenodo, DOI [10.1038/s41592-022-01488-1, 10.5281/ZENODO.5123297]; Mirdita M, 2019, BIOINFORMATICS, V35, P2856, DOI 10.1093/bioinformatics/bty1057; Mirdita M, 2017, NUCLEIC ACIDS RES, V45, pD170, DOI 10.1093/nar/gkw1081; Mitchell AL, 2020, NUCLEIC ACIDS RES, V48, pD570, DOI 10.1093/nar/gkz1035; Ovchinnikov S., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5123297; Pereira J, 2021, PROTEINS, V89, P1687, DOI 10.1002/prot.26171; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Steinegger M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3019-7; Wheeler RJ., 2021, **DATA OBJECT**, DOI 10.5281/zenodo.5563074; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	47	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259871	10.1371/journal.pone.0259871	http://dx.doi.org/10.1371/journal.pone.0259871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762696	Green Published, Green Submitted, gold			2022-12-26	WOS:000755316600052
J	Li, T; Chen, FJ; Zhang, SW; Feng, XL; Zeng, WQ				Li, Tao; Chen, Fajin; Zhang, Shuwen; Feng, Xiaoli; Zeng, Weiqiang			Possible linkage between asymmetry of atmospheric meridional circulation and tropical cyclones in the Central Pacific during El Nino years	PLOS ONE			English	Article							HADLEY CIRCULATION; INTERANNUAL VARIABILITY; CLIMATE; ENSO; IMPACTS; GENESIS; EVENTS; FUTURE	The El Nino-Southern Oscillation is one of the most important drivers of climate change on Earth, and is characterised by warmer (El Nino) or colder (La Nina) ocean surface temperatures in the equatorial Pacific. Tropical cyclones (TCs) and meridional circulation are the most influential weather events and climate phenomena, respectively. However, the link between TCs and meridional circulation anomalies (MCA) during El Nino years is unclear. Therefore, we calculated the accumulated cyclone energy index of TCs and the mass stream function of MCA from 1980 to 2018. Our results showed that TCs were closely related to the asymmetry of the MCA in the Central Pacific during El Nino years. An updraft anomaly in the North Pacific was found, which affected the response of MCA to El Nino from May to October during El Nino years. Therefore, the MCA intensity difference between the North and South Pacific increased, and the asymmetry was strengthened. This phenomenon may be strengthened by the combined effects of the equatorial westerly wind, relative vorticity, and warm ocean surfaces, which are controlled by El Nino. The equatorial westerly wind produces positive shear north of the equator, which increases the relative vorticity. The increase in relative vorticity is accompanied by a monsoon trough, leading to increased precipitation and updrafts. The background of the relative vorticity, updraft, and monsoon trough may be conducive to the generation and development of TCs. Our results prove that the possible link between TCs and the asymmetry of the MCA during El Nino years is derived from the combined effect of the equatorial westerly wind, relative vorticity, and warm ocean surfaces, thus providing a partial explanation for the link between TCs and the MCA.	[Li, Tao; Chen, Fajin; Feng, Xiaoli; Zeng, Weiqiang] Guangdong Ocean Univ, Coll Ocean & Meteorol, Zhanjiang, Guangdong, Peoples R China; [Li, Tao; Zhang, Shuwen] Shantou Univ, Inst Marine Sci, Shantou, Guangdong, Peoples R China	Guangdong Ocean University; Shantou University	Zhang, SW (corresponding author), Shantou Univ, Inst Marine Sci, Shantou, Guangdong, Peoples R China.	zhangsw@stu.edu.cn						[Anonymous], 2016, NIN HLTH GLOB OV; [Anonymous], 2010, GLOBAL PERSPECTIVES; Authority GBRMP, 2016, INT REP 2016 COR BLE; BJERKNES J, 1969, MON WEATHER REV, V97, P163, DOI 10.1175/1520-0493(1969)097<0163:ATFTEP>2.3.CO;2; Byron N., 1998, COMMONW FOREST REV, V77, P236; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Camargo SJ, 2007, J CLIMATE, V20, P4819, DOI 10.1175/JCLI4282.1; Cao X, 2018, ATMOS SCI LETT, V19, DOI 10.1002/asl.801; Diaz HF, 2004, ADV GLOB CHANGE RES, V21, P1; Dube S.K., 1997, MAUSAM, V48, P283, DOI DOI 10.1109/ICENT.2017.18; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2008, B AM METEOROL SOC, V89, P347, DOI 10.1175/BAMS-89-3-347; Feng J, 2016, J CLIMATE, V29, P8949, DOI 10.1175/JCLI-D-16-0171.1; Feng J, 2013, J CLIMATE, V26, P4773, DOI 10.1175/JCLI-D-12-00298.1; Gall JS, 2010, MON WEATHER REV, V138, P1383, DOI 10.1175/2009MWR3115.1; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Gray WM., 1979, HURRICANES THEIR FOR, P155; Guo YP, 2018, J CLIMATE, V31, P5319, DOI 10.1175/JCLI-D-17-0788.1; Guo YP, 2018, J CLIMATE, V31, P1361, DOI [10.1175/jcli-d-17-0422.1, 10.1175/JCLI-D-17-0422.1]; Guo YP, 2016, ADV CLIM CHANG RES, V7, P35, DOI 10.1016/j.accre.2016.04.005; Guo YP, 2016, J CLIMATE, V29, P5625, DOI 10.1175/JCLI-D-15-0025.1; HELD IM, 1980, J ATMOS SCI, V37, P515, DOI 10.1175/1520-0469(1980)037<0515:NASCIA>2.0.CO;2; Held IM, 2001, J ATMOS SCI, V58, P943, DOI 10.1175/1520-0469(2001)058<0943:TPOTPE>2.0.CO;2; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Kossin JP, 2013, J CLIMATE, V26, P9960, DOI 10.1175/JCLI-D-13-00262.1; Lenzen M, 2019, NAT HAZARD EARTH SYS, V19, P137, DOI 10.5194/nhess-19-137-2019; LINDZEN RS, 1987, J ATMOS SCI, V44, P2418, DOI 10.1175/1520-0469(1987)044<2418:OTROSS>2.0.CO;2; Matsuura T, 2003, CLIM DYNAM, V21, P105, DOI 10.1007/s00382-003-0327-3; Molinari J, 2013, MON WEATHER REV, V141, P499, DOI 10.1175/MWR-D-12-00165.1; Oort AH, 1996, J CLIMATE, V9, P2751, DOI 10.1175/1520-0442(1996)009<2751:OIVITH>2.0.CO;2; SCHNEIDER EK, 1977, J ATMOS SCI, V34, P263, DOI 10.1175/1520-0469(1977)034<0263:ASSSMO>2.0.CO;2; Sharmila S, 2017, J CLIMATE, V30, P8865, DOI [10.1175/JCLI-D-16-0900.1, 10.1175/jcli-d-16-0900.1]; Sun Y, 2014, J CLIMATE, V27, P2622, DOI 10.1175/JCLI-D-13-00277.1; Timmermann A, 2018, NATURE, V559, P535, DOI 10.1038/s41586-018-0252-6; Trenberth KE, 2003, J CLIMATE, V16, P3706, DOI 10.1175/1520-0442(2003)016<3706:SPAETA>2.0.CO;2; Walsh KJE, 2015, B AM METEOROL SOC, V96, P997, DOI 10.1175/BAMS-D-13-00242.1; Wang B, 2002, J CLIMATE, V15, P1643, DOI 10.1175/1520-0442(2002)015<1643:HSEEAT>2.0.CO;2; Wang C, 2018, EARTHS FUTURE, V6, P919, DOI 10.1029/2018EF000858; Wang CZ, 2002, J CLIMATE, V15, P399, DOI 10.1175/1520-0442(2002)015<0399:ACCAWT>2.0.CO;2; Wu L, 2012, MON WEATHER REV, V140, P140, DOI 10.1175/MWR-D-11-00078.1	42	0	0	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259599	10.1371/journal.pone.0259599	http://dx.doi.org/10.1371/journal.pone.0259599			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739511	Green Published, gold			2022-12-26	WOS:000755000800042
J	Hu, YL; Liu, S; Liu, WY; Zhang, ZY; Liu, YX; Sun, DL; Zhang, MY; Fang, JA				Hu, Yaling; Liu, Shuang; Liu, Wenyuan; Zhang, Ziyuan; Liu, Yuxiang; Sun, Dalin; Zhang, Mingyu; Fang, Jingai			Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approaches	PLOS ONE			English	Article							COMPLEX DISEASES; EPITHELIAL-CELLS; FERROPTOSIS; PROLIFERATION; INFLAMMATION; MECHANISMS; RECEPTORS; RESPONSES; GLUCOSE; C5A	Diabetic nephropathy is one of the common microvascular complications of diabetes. Iron death is a recently reported way of cell death. To explore the effects of iron death on diabetic nephropathy, iron death score of diabetic nephropathy was analyzed based on the network and pathway levels. Furthermore, markers related to iron death were screened. Using RNA-seq data of diabetic nephropathy, samples were clustered uniformly and the disease was classified. Differentially expressed gene analysis was conducted on the typed disease samples, and the WGCNA algorithm was used to obtain key modules. String database was used to perform protein interaction analysis on key module genes for the selection of Hub genes. Moreover, principal component analysis method was applied to get transcription factors and non-coding genes, which interact with the Hub gene. All samples can be divided into two categories and principal component analysis shows that the two categories are significantly different. Hub genes (FPR3, C3AR1, CD14, ITGB2, RAC2 and ITGAM) related to iron death in diabetic nephropathy were obtained through gene expression differential analysis between different subtypes. Non-coding genes that interact with Hub genes, including hsa-miR-572, hsa-miR-29a-3p, hsa-miR-29b-3p, hsa-miR-208a-3p, hsa-miR-153-3p and hsa-miR-29c-3p, may be related to diabetic nephropathy. Transcription factors HIF1 alpha, KLF4, KLF5, RUNX1, SP1, VDR and WT1 may be related to diabetic nephropathy. The above factors and Hub genes are collectively involved in the occurrence and development of diabetic nephropathy, which can be further studied in the future. Moreover, these factors and genes may be potential target for therapeutic drugs.	[Hu, Yaling; Liu, Yuxiang; Zhang, Mingyu] Shanxi Med Univ, Taiyuan, Shanxi, Peoples R China; [Hu, Yaling; Liu, Wenyuan; Zhang, Ziyuan; Sun, Dalin; Fang, Jingai] Shanxi Med Univ, Hosp 1, Dept Nephrol, Taiyuan, Shanxi, Peoples R China; [Liu, Shuang] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Fang, JA (corresponding author), Shanxi Med Univ, Hosp 1, Dept Nephrol, Taiyuan, Shanxi, Peoples R China.	jingaifang2017003@126.com	Zhang, mingyu/HGB-1069-2022; liu, wen/HGE-3071-2022	Fang, Jingai/0000-0002-2659-6477				Altamura S, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100872; Asfahani RI, 2018, KIDNEY INT, V93, P903, DOI 10.1016/j.kint.2017.11.014; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Cao F, 2021, CELL SIGNAL, V87, DOI 10.1016/j.cellsig.2021.110098; Cao JY, 2016, CELL MOL LIFE SCI, V73, P2195, DOI 10.1007/s00018-016-2194-1; Carstanjen D, 2005, J IMMUNOL, V174, P4613, DOI 10.4049/jimmunol.174.8.4613; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Dahan I, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/7163652; Ding H, 2021, ADV CLIN CHEM, V104, P233, DOI 10.1016/bs.acc.2020.09.005; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Jiang N, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12909; Jin L, 2016, MOL MED REP, V13, P5386, DOI 10.3892/mmr.2016.5205; Kajarabille N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194968; Kim S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03452-x; Kiyanpour F, 2020, J RES MED SCI, V25, DOI 10.4103/jrms.JRMS_289_19; Klaver D, 2020, J ALLERGY CLIN IMMUN, V145, P654, DOI 10.1016/j.jaci.2019.07.008; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Kragstrup TW, 2017, CLIN EXP IMMUNOL, V190, P258, DOI 10.1111/cei.13016; Lee WC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041220; Lei M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4137268; Li SW, 2021, FREE RADICAL BIO MED, V162, P435, DOI 10.1016/j.freeradbiomed.2020.10.323; Liang JY, 2020, INT J BIOL SCI, V16, P2430, DOI 10.7150/ijbs.45050; Liang WW, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/4178639; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Liu L, 2014, J CLIN IMMUNOL, V34, P224, DOI 10.1007/s10875-013-9970-6; Liu Q, 2021, AGING-US, V13, P21385, DOI 10.18632/aging.203472; Liu TY, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.661663; Liu YN, 2019, INT J ONCOL, V55, P645, DOI 10.3892/ijo.2019.4849; Liu Z, 2015, J HUAZHONG U SCI-MED, V35, P206, DOI 10.1007/s11596-015-1412-7; Magee C, 2017, CARDIOVASC DRUG THER, V31, P579, DOI 10.1007/s10557-017-6755-9; Martin-Sanchez D, 2017, J AM SOC NEPHROL, V28, P218, DOI 10.1681/ASN.2015121376; Morais C, 2005, AM J PHYSIOL-RENAL, V289, pF401, DOI 10.1152/ajprenal.00408.2004; Morrissey J, 2000, J AM SOC NEPHROL, V11, P1681, DOI 10.1681/ASN.V1191681; Mou YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0720-y; Mreich E, 2015, CLIN EXP PHARMACOL P, V42, P680, DOI 10.1111/1440-1681.12405; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Portilla D, 2021, BRIT J PHARMACOL, V178, P2880, DOI 10.1111/bph.15408; Qi JA, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.593247; Rezzola S, 2017, DIABETOLOGIA, V60, P719, DOI 10.1007/s00125-016-4204-0; Schreiber R, 2019, J AM SOC NEPHROL, V30, P228, DOI 10.1681/ASN.2018010039; Sharma I, 2017, AM J PATHOL, V187, P724, DOI 10.1016/j.ajpath.2016.12.011; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su T, 2019, ACS NANO, V13, P2450, DOI 10.1021/acsnano.8b09375; Tang SM, 2020, INT UROL NEPHROL, V52, P497, DOI 10.1007/s11255-019-02335-7; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Torus Bora, 2020, Minerva Endocrinol, DOI 10.23736/S0391-1977.20.03278-2; Umanath K, 2018, AM J KIDNEY DIS, V71, P884, DOI 10.1053/j.ajkd.2017.10.026; van Swelm RPL, 2020, NAT REV NEPHROL, V16, P77, DOI 10.1038/s41581-019-0197-5; Wang CC, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab286; Wang LY, 2020, CELL DEATH DIFFER, V27, P662, DOI 10.1038/s41418-019-0380-z; Wang Y, 2020, EUR J PHARMACOL, V888, DOI 10.1016/j.ejphar.2020.173574; Wu Y, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20202924; Xu YM., 2021, CHINESE J GERONTOLOG, V41, P1283, DOI [10.3969/j.issn.1005-9202.2021.06.045, DOI 10.3969/J.ISSN.1005-9202.2021.06.045]; Yang Mengxue, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P578, DOI 10.3969/j.issn.1672-7347.2012.06.007; Yang WH, 2019, CELL REP, V28, P2501, DOI 10.1016/j.celrep.2019.07.107; Zhang L, 2021, INTERDISCIP SCI, V13, P535, DOI 10.1007/s12539-021-00458-z; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhang RHY., 2000, CHINESE OPHTHALMIC R, V18, P427; Zhang RL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175477; Zhou T, 2018, EBIOMEDICINE, V31, P217, DOI 10.1016/j.ebiom.2018.04.023; Zhu L, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01821-2; Zou CB, 2017, J DIABETES, V9, P332, DOI 10.1111/1753-0407.12420	68	1	1	9	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259436	10.1371/journal.pone.0259436	http://dx.doi.org/10.1371/journal.pone.0259436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735495	gold, Green Published			2022-12-26	WOS:000755077100074
J	Islam, R; Rahaman, M; Hoque, H; Hasan, N; Prodhan, SH; Ruhama, A; Jewel, NA				Islam, Rahatul; Rahaman, Mashiur; Hoque, Hammadul; Hasan, Nazmul; Prodhan, Shamsul H.; Ruhama, Asfia; Jewel, Nurnabi Azad			Computational and structural based approach to identify malignant nonsynonymous single nucleotide polymorphisms associated with CDK4 gene	PLOS ONE			English	Article							PROTEIN-STRUCTURE; CELL-CYCLE; GERMLINE MUTATIONS; STABILITY CHANGES; AMPLIFICATION; CANCER; PREDICTION; ALGORITHM; SEQUENCES; INFERENCE	Cycline-dependent kinase 4 (CDK4), an enzyme of the cycline dependent or Ser/Thr protein kinase family, plays a role in cell cycle progression (G1 phase) by phosphorylating a tumor suppressor protein called pRB. Alteration of this enzyme due to missense mutation/ nonsynonymous single nucleotide polymorphisms (nsSNPs) are responsible for various types of cancer progression, e.g. melanoma, lung cancer, and breast cancer. Hence, this study is designed to identify the malignant missense mutation of CDK4 from the single nucleotide polymorphism database (dbSNP) by incorporating computational algorithms. Out of 239 nsSNPs; G15S, D140Y and D140H were predicted to be highly malignant variants which may have a devastating impact on protein structure or function. We also found defective binding motif of these three mutants with the CDK4 inhibitor ribociclib and ATP. However, by incorporating molecular dynamic simulation, our study concludes that the superiority of G15S than the other two mutants (D140Y and D140H) in destabilizing proteins nature.	[Islam, Rahatul; Rahaman, Mashiur; Hoque, Hammadul; Hasan, Nazmul; Prodhan, Shamsul H.; Ruhama, Asfia; Jewel, Nurnabi Azad] Shahjalal Univ Sci & Technol, Sch Life Sci, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh	Shahjalal University of Science & Technology (SUST)	Jewel, NA (corresponding author), Shahjalal Univ Sci & Technol, Sch Life Sci, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh.	najewel-geb@sust.edu		Rahaman, Md. Mashiur/0000-0002-5089-8707; Hasan, Md. Nazmul/0000-0002-0658-5551; Islam, Rahatul/0000-0002-1889-3316				Amir M, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00041; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker Stacey J, 2012, Genes Cancer, V3, P658, DOI 10.1177/1947601913478972; Baynes C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1669; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chen P, 2016, MOL CANCER THER, V15, P2273, DOI 10.1158/1535-7163.MCT-16-0300; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; COLLINS VP, 1995, GLIA, V15, P289, DOI 10.1002/glia.440150309; Das SS, 2020, GENOMICS, V112, P397, DOI 10.1016/j.ygeno.2019.03.002; DEMETRICK DJ, 1994, CYTOGENET CELL GENET, V66, P72, DOI 10.1159/000133669; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Doss CGP, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-10; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Garrigos C, 2017, ONCOTARGET, V8, P106551, DOI 10.18632/oncotarget.22533; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Graf F, 2010, MINI-REV MED CHEM, V10, P527, DOI 10.2174/138955710791384072; Greene LH, 2001, PROTEIN SCI, V10, P2301, DOI 10.1110/ps.22901; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hoque H, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06396; Huggins DJ, 2012, J MED CHEM, V55, P1424, DOI 10.1021/jm2010332; Hussain MRM, 2012, GENE, V508, P188, DOI 10.1016/j.gene.2012.07.014; Islam R., 2020, DELINEATING BLUEPRIN, V20; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liu W.S.A, 2020, REV CDK4 6 INHIBITOR; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McInnes C, 2004, CHEM BIOL, V11, P525, DOI 10.1016/j.chembiol.2004.03.022; Molven A, 2005, GENE CHROMOSOME CANC, V44, P10, DOI 10.1002/gcc.20202; Mustafa HA, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-020-0258-1; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Niroula A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117380; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Rahaman M.M, IMPLEMENTATION COMPU, V2021, P1; REIFENBERGER G, 1994, CANCER RES, V54, P4299; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; Systemes D., 2015, BIOVIA DISC STUD MOD; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tripathy D, 2017, CLIN CANCER RES, V23, P3251, DOI 10.1158/1078-0432.CCR-16-3157; Turner, 2005, XMGRACE VERSION 51 1; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	65	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259691	10.1371/journal.pone.0259691	http://dx.doi.org/10.1371/journal.pone.0259691			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735543	gold, Green Published			2022-12-26	WOS:000755077100105
J	Lee, KI; In, SM; Kim, JY; Hong, JY; Han, KD; Kim, JS; Jung, YG				Lee, Ki-Il; In, Seung Min; Kim, Jong-Yeup; Hong, Jee-Young; Han, Kyung-Do; Kim, Jung-Soo; Jung, Yong Gi			Association of nasal septal deviation with the incidence of anxiety, depression, and migraine: A national population-based study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; UVULOPALATOPHARYNGOPLASTY; OBESITY; MUCOSA	Background & aims Nasal obstruction caused by nasal septal deviation is very bothersome and, therefore, can affect the patient's emotional state. However, little is known about the effect of nasal septal deviation (NSD) on the neuropsychiatric aspects of patients. Therefore, this study aims to verify the higher incidence of anxiety, depression, and migraine in patients diagnosed with NSD compared to general populations using big data. Methods This retrospective cohort study collected subjects from the Korean National Health Insurance Service (NHIS) database. Adjustments were made to minimize the confounding of variables for age, sex, residence type, income levels, hypertension, diabetes, dyslipidemia, rhinitis, and chronic rhinosinusitis between the two groups. The primary endpoint of this study was newly diagnosed anxiety, depression, and migraine between January 2009 and December 2018. Kaplan-Meier survival curves, logarithmic rank test, and Cox proportional regression test were used for statistical analysis. Results Among a total of 135,769 subjects in the NHIS database, 48,495 patients with NSD (NSD group) and 54,475 control subjects (control group) were selected. Patients with NSD had an increased risk of anxiety, depression, and migraine compared to the control group. In the NSD group, the adjusted hazard ratios (HR) were 1.236 (95% CI, 1.198-1.276) for anxiety, 1.289 (95% CI, 1.238-1.343) for depression, and 1.251 (95% CI, 1.214-1.290) for migraine. Conclusion NSD is associated with a higher incidence of anxiety, depression, and migraine. Therefore, it is suggested that physicians carefully consider psychoneurological distress and employ therapeutic strategies to minimize these conditions.	[Lee, Ki-Il; In, Seung Min; Kim, Jong-Yeup] Konyang Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea; [Lee, Ki-Il] Konyang Univ, Myunggok Med Res Inst, Coll Med, Daejeon, South Korea; [Kim, Jong-Yeup; Hong, Jee-Young] Konyang Univ, Coll Med, Dept Biomed Informat, Daejeon, South Korea; [Han, Kyung-Do] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Kim, Jung-Soo] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea; [Jung, Yong Gi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Soongsil University; Kyungpook National University; Kyungpook National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center	Jung, YG (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	ent.jyg@gmail.com	Lee, Ki-Il/GZA-6791-2022	Lee, Ki-Il/0000-0002-2069-7912; Jung, Yong gi/0000-0001-7456-849X				Akkoca O, 2020, ENT-EAR NOSE THROAT, V99, P448, DOI 10.1177/0145561319900747; Altin F, 2019, AM J OTOLARYNG, V40, P364, DOI 10.1016/j.amjoto.2019.02.002; Bigal ME, 2007, NEUROLOGY, V68, P1851, DOI 10.1212/01.wnl.0000262045.11646.b1; Bollen J, 2017, J PSYCHOSOM RES, V94, P47, DOI 10.1016/j.jpsychores.2017.01.002; Cho JH, 2019, LARYNGOSCOPE, V129, P1005, DOI 10.1002/lary.27294; Cho JH, 2018, J CLIN SLEEP MED, V14, P1749, DOI 10.5664/jcsm.7388; Clark DW, 2018, ENT-EAR NOSE THROAT, V97, P173, DOI 10.1177/014556131809700615; Cocuzza S, 2020, J BIOL REG HOMEOS AG, V34, P1203, DOI 10.23812/19-522-L-4; Elvan O, 2019, J CRANIOFAC SURG, V30, pE529, DOI 10.1097/SCS.0000000000005480; Faravelli C, 2013, PSYCHIAT RES, V210, P1301, DOI 10.1016/j.psychres.2013.09.027; Fidan Tulin, 2011, Kulak Burun Bogaz Ihtis Derg, V21, P312, DOI 10.5606/kbbihtisas.2011.048; Folic MM, 2021, ENT-EAR NOSE THROAT, DOI 10.1177/01455613211019706; Harrison L, 2013, CLIN OTOLARYNGOL, V38, P8, DOI 10.1111/coa.12081; Jang YJ, 2002, ARCH OTOLARYNGOL, V128, P421, DOI 10.1001/archotol.128.4.421; Kamani T, 2014, EUR ARCH OTO-RHINO-L, V271, P2969, DOI 10.1007/s00405-014-2990-x; Kara M, 2016, J CRANIOFAC SURG, V27, P1738, DOI 10.1097/SCS.0000000000003008; Kim JY, 2020, J ALLER CL IMM-PRACT, V8, P721, DOI 10.1016/j.jaip.2019.09.001; Kim JY, 2019, JAMA OTOLARYNGOL, V145, P313, DOI 10.1001/jamaoto.2018.4103; Kou HH, 2018, BRAIN RES, V1693, P218, DOI 10.1016/j.brainres.2018.01.023; Kwon SH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020337; La Mantia I, 2018, J CRANIOFAC SURG, V29, pE228, DOI 10.1097/SCS.0000000000004211; Lavie P, 2005, EUR RESPIR J, V25, P514, DOI 10.1183/09031936.05.00051504; Lee HM, 2018, SLEEP MED, V45, P11, DOI 10.1016/j.sleep.2017.12.019; Lee M, 2017, PLAST RECONSTR SURG, V139, P184, DOI 10.1097/PRS.0000000000002888; Lee TJ, 2016, LARYNGOSCOPE, V126, P1284, DOI 10.1002/lary.25814; Lee WH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193886; Ma Q, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102450; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Maniaci A, 2021, EUR ARCH OTO-RHINO-L, V278, P1743, DOI 10.1007/s00405-021-06724-6; Moffa A, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4602651; Most SP, 2017, FACIAL PLAST SURG CL, V25, P161, DOI 10.1016/j.fsc.2016.12.002; Resta O, 2005, RESP MED, V99, P91, DOI 10.1016/j.rmed.2004.05.014; Rhee TM, 2021, J ALLER CL IMM-PRACT, V9, P872, DOI 10.1016/j.jaip.2020.09.008; Shah N, 2013, SLEEP BREATH, V17, P819, DOI 10.1007/s11325-012-0770-7; Song SJ, 2018, J DIABETES INVEST, V9, P173, DOI 10.1111/jdi.12655; Stewart MG, 2004, OTOLARYNG HEAD NECK, V130, P157, DOI 10.1016/j.otohns.2003.09.016; Tietjen GE, 2007, HEADACHE, V47, P866, DOI 10.1111/j.1526-4610.2007.00810.x; Valsamidis K, 2019, EUR ARCH OTO-RHINO-L, V276, P429, DOI 10.1007/s00405-018-5229-4; Wang DP, 2016, PSYCHOL HEALTH MED, V21, P67, DOI 10.1080/13548506.2015.1051064	39	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259468	10.1371/journal.pone.0259468	http://dx.doi.org/10.1371/journal.pone.0259468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735521	gold, Green Published			2022-12-26	WOS:000755077100078
J	Krantz, S; Kim, YM; Srivastava, S; Leasure, JW; Toth, PT; Marsboom, G; Rehman, J				Krantz, Sarah; Kim, Young-Mee; Srivastava, Shubhi; Leasure, Joseph W.; Toth, Peter T.; Marsboom, Glenn; Rehman, Jalees			Mitophagy mediates metabolic reprogramming of induced pluripotent stem cells undergoing endothelial differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIA; PARKIN; ACQUISITION	Pluripotent stem cells are known to shift their mitochondrial metabolism upon differentiation, but the mechanisms underlying such metabolic rewiring are not fully understood. We hypothesized that during differentiation of human induced mitophagy and are then replenished by the biogenesis of new mitochondria adapted to the metabolic needs of the differentiated cell. To evaluate mitophagy during iPSC differentiation, we performed live cell imaging of mitochondria and lysosomes in hiPSCs differentiating into vascular endothelial cells using confocal microscopy. We observed a burst of mitophagy during the initial phases of hiPSC differentiation into the endothelial lineage, followed by subsequent mitochondrial biogenesis as assessed by the mitochondrial biogenesis biosensor MitoTimer. Furthermore, hiPSCs undergoing differentiation showed greater mitochondrial oxidation of fatty acids and an increase in ATP levels as assessed by an ATP biosensor. We also found that during mitophagy, the mitochondrial phosphatase PGAM5 is cleaved in hiPSC-derived endothelial progenitor cells and in turn activates beta-catenin-mediated transcription of the transcriptional coactivator PGC-1 alpha, which upregulates mitochondrial biogenesis. These data suggest that mitophagy itself initiates the increase in mitochondrial biogenesis and oxidative metabolism through transcriptional changes during endothelial cell differentiation. In summary, these findings reveal a mitophagy-mediated mechanism for metabolic rewiring and maturation of differentiating cells via the beta-catenin signaling pathway. We propose that such mitochondrialnuclear cross talk during hiPSC differentiation could be leveraged to enhance the metabolic maturation of differentiated cells.	[Krantz, Sarah; Kim, Young-Mee; Srivastava, Shubhi; Leasure, Joseph W.; Toth, Peter T.; Marsboom, Glenn; Rehman, Jalees] Univ Illinois, Coll Med, Dept Pharmacol & Regenerat Med, Chicago, IL 60612 USA; [Kim, Young-Mee; Rehman, Jalees] Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA; [Kim, Young-Mee; Rehman, Jalees] Univ Illinois, Canc Ctr, Chicago, IL 60612 USA; [Toth, Peter T.] Univ Illinois, Res Resources Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kim, YM; Rehman, J (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol & Regenerat Med, Chicago, IL 60612 USA.; Kim, YM; Rehman, J (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA.; Kim, YM; Rehman, J (corresponding author), Univ Illinois, Canc Ctr, Chicago, IL 60612 USA.	jalees@uic.edu	Rehman, Jalees/GVU-1981-2022; Srivastava, Shubhi/C-7048-2018	Rehman, Jalees/0000-0002-2787-9292; Krantz, Sarah/0000-0001-8451-2238; Toth, Peter/0000-0003-2168-0124; KIM, YOUNG-MEE/0000-0001-6616-2393; Srivastava, Shubhi/0000-0001-9922-1943	NIH [P01-HL60678, T32-HL007829, T32-HL139439, R01-HL126516]; AHA CDA grant [19CDA34680000]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA CDA grant	The studies were supported in part by NIH grants P01-HL60678 (J. R.), T32-HL007829 (to S. K. and J. W. L.), T32-HL139439 (S. K.), R01-HL126516 (to J. R.), and AHA CDA grant 19CDA34680000 (to Y.-M. K.). We were assisted by the Fluorescence Imaging Core at the Research Resources Center of the University of Illinois at Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernkopf DB, 2018, J CELL BIOL, V217, P1383, DOI 10.1083/jcb.201708191; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Esteban-Martinez L, 2018, AUTOPHAGY, V14, P915, DOI 10.1080/15548627.2017.1332567; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Falkenberg KD, 2019, NAT METAB, V1, P937, DOI 10.1038/s42255-019-0117-9; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gladkova C, 2018, NATURE, V559, P411, DOI 10.1038/s41586-018-0224-x; Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459; Gureev AP, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00435; Hernandez G, 2013, AUTOPHAGY, V9, P1852, DOI 10.4161/auto.26501; Jedrzejas MJ, 2000, PROG BIOPHYS MOL BIO, V73, P263, DOI 10.1016/S0079-6107(00)00007-9; Kim Young-Mee, 2021, Nat Commun, V12, P2736, DOI 10.1038/s41467-021-23047-6; Kwon Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-02033-7; Lahiri V, 2019, CELL METAB, V29, P803, DOI 10.1016/j.cmet.2019.03.003; Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095; Li XR, 2019, ANNU REV PHYSIOL, V81, P483, DOI 10.1146/annurev-physiol-020518-114731; Li YJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12912-0; Marsboom G, 2016, CELL REP, V16, P323, DOI 10.1016/j.celrep.2016.05.089; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768; Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009; Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Rocha AG, 2018, SCIENCE, V360, P336, DOI 10.1126/science.aao1785; Schofield JH, 2021, ANTIOXID REDOX SIGN, V34, P517, DOI 10.1089/ars.2020.8058; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Zhang LH, 2017, CIRCULATION, V135, P2505, DOI 10.1161/CIRCULATIONAHA.116.025722; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	39	0	0	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101410	10.1016/j.jbc.2021.101410	http://dx.doi.org/10.1016/j.jbc.2021.101410			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO9UJ	34785214	gold, Green Published			2022-12-26	WOS:000748277600004
J	Li, XY; Kang, JN; Lv, H; Liu, RH; Chen, JA; Zhang, YN; Zhang, Y; Yu, GL; Zhang, XD; Ning, B				Li, Xinyu; Kang, Jianning; Lv, Hong; Liu, Ronghan; Chen, Jianan; Zhang, Yining; Zhang, Ying; Yu, Guilian; Zhang, Xiaodi; Ning, Bin			CircPrkcsh, a circular RNA, contributes to the polarization of microglia towards the M1 phenotype induced by spinal cord injury and acts via the JNK/p38 MAPK pathway	FASEB JOURNAL			English	Article						circPrkcsh; inflammation; JNK; p38; M1 polarization; spinal cord injury	FUNCTIONAL RECOVERY; KAPPA-B; ACTIVATION; KINASE; MECHANISMS; DEFICITS; SYSTEM; TARGET; JNK	Spinal cord injury (SCI) is a complex pathological change that includes primary SCI and gradually evolves into secondary SCI. Accumulating evidence demonstrates that circular RNAs (circRNAs) are involved in the pathology of a variety of neurological diseases and injuries. However, the characteristics and function of circRNAs in SCI have yet to be elucidated. Although previous research demonstrated that circPrkcsh induces astrocytes to produce inflammatory factors and chemokines, the precise function and mechanism of circPrkcsh in microglia after SCI remains unknown. In this study, we constructed a mouse model of SCI by applying a SCI impactor. Quantitative Real-time PCR and Fluorescence in situ hybridization analysis revealed that circPrkcsh was upregulated in the microglia of SCI mice when compared to sham-operated mice. Gain- or loss-of-function experiments and in vivo assays further indicated that circPrkcsh promotes microglia M1 polarization both in vivo and in vitro. Furthermore, bioinformatics analysis, dual-luciferase assays, and RNA immunoprecipitation assays, confirmed that circPrkcsh serves as a competing endogenous RNA (ceRNA) to promote the expression of MEKK1 mRNA by sponging miR-488. Double knockout rescue experiments further showed that circPrkcsh regulates the MEKK1/JNK/p38 MAPK pathway via miR-488. Our research provides a better understanding of the mechanism of circPrkcsh in SCI and demonstrates that the circPrkcsh/miR-488/Mekk1 axis is a promising regulatory method for the treatment of SCI.	[Li, Xinyu; Kang, Jianning; Lv, Hong; Liu, Ronghan; Chen, Jianan; Zhang, Yining; Zhang, Ying; Yu, Guilian; Zhang, Xiaodi; Ning, Bin] Shandong Univ, Jinan Cent Hosp, Cheeloo Coll Med, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Ning, B (corresponding author), Shandong Univ, Jinan Cent Hosp, Cheeloo Coll Med, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.	ningbin@sdu.edu.cn	Liu, Ronghan/ABH-1619-2021	Liu, Ronghan/0000-0002-6897-0279; Ning, Bin/0000-0002-7592-9485	National Natural Science Foundation of China (NSFC) [81771346, 82071383]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81771346 and 82071383	Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen JN, 2022, NEURAL REGEN RES, V17, P144, DOI 10.4103/1673-5374.314114; Chen LL, 2020, NAT REV MOL CELL BIO, V21, P475, DOI 10.1038/s41580-020-0243-y; Chen SP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1140-6; Chen SB, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1193-6; Correa F, 2011, GLIA, V59, P785, DOI 10.1002/glia.21151; Das A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0644-1; Fan H, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1613-2; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He ZW, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1065-7; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Huang RR, 2017, AUTOPHAGY, V13, P1722, DOI 10.1080/15548627.2017.1356975; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Li XY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/9494352; Liu JF, 2020, J CELL PHYSIOL, V235, P4766, DOI 10.1002/jcp.29354; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehta SL, 2020, PROG NEUROBIOL, V186, DOI 10.1016/j.pneurobio.2020.101746; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Morton PE, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw2418; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Plastira I, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01809-1; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; Tramullas M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6299; Tsarouchas TM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07036-w; Wang D, 2018, CLIN SCI, V132, P943, DOI 10.1042/CS20180083; Wang WZ, 2019, AGING-US, V11, P2352, DOI 10.18632/aging.101919; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Wang ZC, 2017, BIOMATERIALS, V112, P62, DOI 10.1016/j.biomaterials.2016.10.002; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Xia XH, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101694; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Zeng H, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1658-2; Zeng KW, 2014, PHYTOMEDICINE, V21, P298, DOI 10.1016/j.phymed.2013.08.016; Zhang SB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12049-0; Zhong J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.102; Zhou JH, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01805-5; Zhou WD, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1418-6; Zhou ZB, 2018, MOL THER-NUCL ACIDS, V12, P718, DOI 10.1016/j.omtn.2018.07.011	50	7	7	3	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22014	10.1096/fj.202100993R	http://dx.doi.org/10.1096/fj.202100993R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34751973				2022-12-26	WOS:000722321300031
J	Stairs, DB; Landmesser, ME; Aliaga, C; Chen, KM; Sun, YW; El-Bayoumy, K				Stairs, Douglas B.; Landmesser, Mary E.; Aliaga, Cesar; Chen, Kun-Ming; Sun, Yuan-Wan; El-Bayoumy, Karam			Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide	PLOS ONE			English	Article							P120-CATENIN DOWN-REGULATION; ENVIRONMENTAL-POLLUTANT; DNA-DAMAGE; CANCER; MUTAGENESIS; EXTRACT; HEAD; RAT; GEL	One of the major risk factors for head and neck squamous cell carcinoma (HNSCC) is tobacco smoke exposure, but the mechanisms that can account for disease development remain to be fully defined. Utilizing our HNSCC mouse model, we analyzed oral squamous cell carcinomas (OSCC) induced by the active metabolite of a common smoke constituent, dibenzo[a,l]pyrene diol-epoxide (DBPDE). Analyzing protein expression by either immunofluorescence or immunohistochemistry, we identified biologic processes that are dysregulated in premalignant and invasive cancer lesions induced by DBPDE. Interestingly, p120ctn expression is downregulated in both stages of the disease. In addition to decreased p120ctn expression, there was also increased proliferation (as measured by Ki67), inflammation (as measured by NFkB (p65) expression), neovascularization (as measured by CD31) and recruitment of Ly6G-positive immune cells as well as strong EGFR expression. We also examined the effect of the chemopreventive agent black raspberry (BRB) on p120ctn and EGFR protein expression in DBPDE treated mice. p120ctn, but not EGFR, protein expression increased in mice treated with BRB. Our results suggest that modulation of p120ctn may, in part, account for the mechanism by which BRB inhibits DBPDE induced OSCC in mice.	[Stairs, Douglas B.; Landmesser, Mary E.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 16802 USA; [Stairs, Douglas B.; Landmesser, Mary E.; Aliaga, Cesar; Chen, Kun-Ming; Sun, Yuan-Wan; El-Bayoumy, Karam] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 16802 USA; [Aliaga, Cesar; Chen, Kun-Ming; Sun, Yuan-Wan; El-Bayoumy, Karam] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Stairs, DB (corresponding author), Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 16802 USA.; Stairs, DB (corresponding author), Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 16802 USA.	dbs18@psu.edu		Stairs, Douglas/0000-0002-4875-6582	Penn State Cancer Institute Program Project Development Award - Highmark Community Health Reinvestment Fund; American Cancer Society [RSG-16-219-01 -TBG]; NIH NCI [R01-CA173465]	Penn State Cancer Institute Program Project Development Award - Highmark Community Health Reinvestment Fund; American Cancer Society(American Cancer Society); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following: Penn State Cancer Institute Program Project Development Award sponsored by the Highmark Community Health Reinvestment Fund; Research Scholar Grant, RSG-16-219-01 -TBG, from the American Cancer Society (DBS) and NIH NCI Grant R01-CA173465 (KEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ACS website:www.cancer.org NCI website: www.cancer.gov.	Chen KM, 2020, CANCER PREV RES, V13, P357, DOI 10.1158/1940-6207.CAPR-19-0496; Chen KM, 2018, CANCER PREV RES, V11, P157, DOI 10.1158/1940-6207.CAPR-17-0278; Chen KM, 2017, J ENVIRON SCI HEAL C, V35, P213, DOI 10.1080/10590501.2017.1391514; Chen KM, 2013, INT J CANCER, V133, P1300, DOI 10.1002/ijc.28152; Chow LQM, 2020, NEW ENGL J MED, V382, P60, DOI 10.1056/NEJMra1715715; El-Bayoumy K, 2020, CANCER PREV RES, V13, P649, DOI 10.1158/1940-6207.CAPR-20-0096; El-Bayoumy K, 2017, CHEM RES TOXICOL, V30, P126, DOI 10.1021/acs.chemrestox.6b00306; Ferris RL, 2015, J CLIN ONCOL, V33, P3293, DOI 10.1200/JCO.2015.61.1509; Guttenplan JB, 2017, CHEM RES TOXICOL, V30, P2159, DOI 10.1021/acs.chemrestox.7b00242; Guttenplan JB, 2016, CANCER PREV RES, V9, P704, DOI 10.1158/1940-6207.CAPR-16-0003; Guttenplan JB, 2012, INT J CANCER, V130, P2783, DOI 10.1002/ijc.26344; IARC, 2019, MON ID CARC HAZ HUM; Kidacki M, 2017, MOL CANCER RES, V15, P1398, DOI 10.1158/1541-7786.MCR-17-0108; Knobloch TJ, 2016, CANCER PREV RES, V9, P159, DOI 10.1158/1940-6207.CAPR-15-0187; Landmesser ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241299; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lee TY, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10081150; Lehman HL, 2015, AM J PATHOL, V185, P240, DOI 10.1016/j.ajpath.2014.09.008; Lo Muzio L, 2013, OR SURG OR MED OR PA, V115, P789, DOI 10.1016/j.oooo.2013.03.006; Mallery SR, 2007, PHARM RES-DORDR, V24, P728, DOI 10.1007/s11095-006-9192-1; Mallery SR, 2014, CLIN CANCER RES, V20, P1910, DOI 10.1158/1078-0432.CCR-13-3159; Peiffer DS, 2014, CANCER PREV RES, V7, P574, DOI 10.1158/1940-6207.CAPR-14-0003; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Sun YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186873; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Wang ZY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13471-0; Zhang LL, 2013, J PATHOL, V229, P74, DOI 10.1002/path.4070	28	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259998	10.1371/journal.pone.0259998	http://dx.doi.org/10.1371/journal.pone.0259998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784403	Green Published, gold			2022-12-26	WOS:000755277300036
J	Bradfield, Z; Wynter, K; Hauck, Y; Sweet, L; Wilson, AN; Szabo, RA; Vasilevski, V; Kuliukas, L; Homer, CSE				Bradfield, Zoe; Wynter, Karen; Hauck, Yvonne; Sweet, Linda; Wilson, Alyce N.; Szabo, Rebecca A.; Vasilevski, Vidanka; Kuliukas, Lesley; Homer, Caroline S. E.			COVID-19 vaccination perceptions and intentions of maternity care consumers and providers in Australia	PLOS ONE			English	Article							PREGNANCY	Introduction Vaccination against COVID-19 is a key global public health strategy. Health professionals including midwives and doctors support and influence vaccination uptake by childbearing women. There is currently no evidence regarding the COVID-19 vaccination perceptions and intentions of those who receive or provide maternity care in Australia. The aim of this study was to address this gap in knowledge and explore the perceptions and intentions regarding COVID-19 vaccination from consumers and providers of maternity care in Australia. Methods A national cross-sectional online study conducted in early 2021 in Australia, a country that has had a very low number of COVID-19 cases and deaths. Recruitment was undertaken through parenting and health professional social media sites and professional college distribution lists. A total of 853 completed responses, from women (n = 326), maternity care providers including doctors (n = 58), midwives (n = 391) and midwifery students (n = 78). Findings Personal intention to be vaccinated ranged from 48-89% with doctors most likely and women least likely. Doctors and midwifery students were significantly more likely to recommend the vaccine to pregnant women in their care than midwives (p<0.001). Fewer doctors (2%) felt that women should wait until breastfeeding had concluded before being vaccinated compared with 24% of midwives and 21% of midwifery students (p<0.001). More than half of the midwives (53%) had concerns about the COVID-19 vaccine for the women in their care compared with 35% of doctors and 46% of midwifery students. Despite national guidelines recommending vaccination of breastfeeding women, 54% of practitioners were unlikely to recommend vaccination for this group. Conclusion This is the first study to explore the perceptions and intentions regarding COVID-19 vaccination from the perspective of those who receive and provide maternity care in Australia. Findings have utility to support targeted public health messaging for these and other cohorts.	[Bradfield, Zoe; Hauck, Yvonne; Kuliukas, Lesley] Curtin Univ, Sch Nursing, Bentley, WA, Australia; [Bradfield, Zoe] King Edward Mem Hosp, Dept Nursing Midwifery Educ & Res, Subiaco, WA, Australia; [Wynter, Karen; Sweet, Linda; Vasilevski, Vidanka] Deakin Univ, Sch Nursing & Midwifery, Burwood, Vic, Australia; [Wynter, Karen; Sweet, Linda; Vasilevski, Vidanka] Western Hlth Partnership, Ctr Qual & Patient Safety Res, Albans, Vic, Australia; [Wilson, Alyce N.; Homer, Caroline S. E.] Burnet Inst, Maternal Child & Adolescent Hlth Program, Melbourne, Vic, Australia; [Szabo, Rebecca A.] Univ Melbourne, Melbourne Med Sch, Dept Med Educ, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Szabo, Rebecca A.] Univ Melbourne, Melbourne Med Sch, Dept Crit Care, Parkville, Vic, Australia; [Szabo, Rebecca A.] Royal Womens Hosp, Gandel Simulat Serv, Parkville, Vic, Australia	Curtin University; King Edward Memorial Hospital; University of Western Australia; Deakin University; Burnet Institute; University of Melbourne; University of Melbourne	Bradfield, Z (corresponding author), Curtin Univ, Sch Nursing, Bentley, WA, Australia.; Bradfield, Z (corresponding author), King Edward Mem Hosp, Dept Nursing Midwifery Educ & Res, Subiaco, WA, Australia.	zoe.bradfield@curtin.edu.au	Vasilevski, Vidanka/AEO-7913-2022	Kuliukas, Lesley/0000-0002-4585-8209; Wynter, Karen/0000-0003-4620-7691; Bradfield, Zoe/0000-0002-1013-0461; Sweet, Linda/0000-0003-0605-1186	Curtin University	Curtin University	Curtin University provided funding for APCs for this work and had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AnadoluAgency, 2021, JORD BEG COVID 19 VA; ATAGI, CLIN GUID US COVID 1; Attwood A., 2021, AUSTR BROADCASTING C; Biswas N, 2021, J COMMUN HEALTH, V46, P1244, DOI 10.1007/s10900-021-00984-3; Blakeway H, 2022, AM J OBSTET GYNECOL, V226, DOI 10.1016/j.ajog.2021.08.007; Bradfield Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248488; CDC, 2021, COVID 19 VACC WHIL P; Clinicaltrials.gov, 2021, STUD EV SAF TOL IMM; Dodd RH, 2021, LANCET INFECT DIS, V21, P318, DOI 10.1016/S1473-3099(20)30559-4; Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004; Gencer H, 2022, WOMEN BIRTH, V35, P317, DOI 10.1016/j.wombi.2021.05.003; Government U, 2021, COR COVID 19 UK UK G; Hutchinson AF, 2020, MIDWIFERY, V87, DOI 10.1016/j.midw.2020.102734; JHU, 2021, CORONAVIRUS RESOURCE; Johnston I, 2020, AUST NZ J PUBL HEAL, V44, P440, DOI 10.1111/1753-6405.13051; Kadiwar S, 2021, LANCET, V397, P1539, DOI 10.1016/S0140-6736(21)00716-9; Karlsson LC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224330; Kesmodel US, 2018, ACTA OBSTET GYN SCAN, V97, P388, DOI 10.1111/aogs.13331; Kilich E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234827; Latiff R., 2021, MALAYSIA MAKES COVID, DOI 10.1016/S1473-3099(21)00200-0; NHS, 2021, COR COVID 19 VACC NA; Rhodes A, 2021, LANCET INFECT DIS, V21, pE110, DOI 10.1016/S1473-3099(20)30724-6; Royal College of Pathologists of Australasia, 2021, CORONAVIRUS COVID 19; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2979; Shimabukuro TT, 2021, NEW ENGL J MED, V384, P2273, DOI 10.1056/NEJMoa2104983; Skirrow H, 2021, HUM VACC IMMUNOTHER, V17, P237, DOI 10.1080/21645515.2020.1770515; Vasilevski V, 2022, WOMEN BIRTH, V35, P298, DOI 10.1016/j.wombi.2021.04.012; Vassallo A, 2021, LANCET GLOB HEALTH, V9, pE593, DOI 10.1016/S2214-109X(21)00044-9; Volpp KG, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMp2107719; Wei SQ, 2021, CAN MED ASSOC J, V193, pE540, DOI 10.1503/cmaj.202604; Whitehead CL, 2020, LANCET, V395, pE92, DOI 10.1016/S0140-6736(20)31029-1	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260049	10.1371/journal.pone.0260049	http://dx.doi.org/10.1371/journal.pone.0260049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780555	Green Published, gold			2022-12-26	WOS:000755305800088
J	Nalugwa, A; Tukahebwa, EM; Olsen, A; Nuwaha, F				Nalugwa, Allen; Tukahebwa, Edridah Muheki; Olsen, Annette; Nuwaha, Fred			Regression of Schistosoma mansoni associated morbidity among Ugandan preschool children following praziquantel treatment: A randomised trial	PLOS ONE			English	Article							PERIPORTAL FIBROSIS; AGED CHILDREN; INTESTINAL SCHISTOSOMIASIS; AFRICAN INFANTS; YOUNG-CHILDREN; REVERSIBILITY; INFECTION; LIVER	Preschool children suffer from morbidity attributable to Schistosoma mansoni. We compared a single and double dose of praziquantel treatment on the regression of S. mansoni associated morbidity in children less than six years in Uganda. We measured the sizes of spleen and liver as well as liver fibrosis before treatment and 8 months after treatment among children who either received one dose (n = 201) or two doses (n = 184) of praziquantel (standard oral dose of 40 mg/kg body weight). Heamoglobin measurements were also taken. Overall, liver enlargement reduced from 52.2% (95% CI (Confidence interval) 45.1, 59.3) to 17.9% (95% CI 12.9, 23.9) with a single dose and from 48.4 (95% CI 40.9, 55.8) to 17.9% (95% CI 12.7, 24.3) with a double dose and there was no significant difference between the changes in proportion of children with enlarged liver between the two treatment groups. The proportion of children with enlarged spleen was not significantly reduced in the group treated with either one or two doses, 47.8% (95% CI 41.7, 54.9) to 45.3% (95% CI 38.3, 52.4) and 48.4% (95% CI 40.9,55.8) to 40.8% 95% CI 33.6, 48.2), respectively. Liver fibrosis detected among children getting single dose (n = 9) or double doses (n = 13) resolved after treatment with praziquantel. The number of children with low heamoglobin significantly reduced from 51.2% (95% CI 44.1, 58.3) to 0.5% (0.2, 0.8) and 61.4% (95% CI 53.9,68.5) to 1.1% (95% CI 0.1, 3.9) after single and double dose treatment, respectively. These results suggest that there is no evidence of a difference in effect between one dose of praziquantel and two doses in reversing morbidity attributable to S. mansoni among children less than six years of age.	[Nalugwa, Allen] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Tukahebwa, Edridah Muheki] Minist Hlth, Vector Control Div, Neglected Trop Dis, Kampala, Uganda; [Olsen, Annette] Univ Copenhagen, Fac Hlth & Med Sci, Parasitol & Aquat Dis, Copenhagen, Denmark; [Nuwaha, Fred] Makerere Univ, Dis Control & Prevent, Kampala, Uganda	Makerere University; University of Copenhagen; Makerere University	Nalugwa, A (corresponding author), Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda.	allennalugwa@yahoo.co.uk		Olsen, Annette/0000-0001-9352-621X	Danish Ministry of Foreign Affairs-Project [09-100KU]	Danish Ministry of Foreign Affairs-Project	This study was supported by the Danish Ministry of Foreign Affairs-Project No. 09-100KU. The funders had no role in the study design, data collection and anaysis, decision to publish, or preparation of the manuscript.	Abaasa Andrew, 2015, BMC Res Notes, V8, P815, DOI 10.1186/s13104-015-1804-6; Balen J, 2006, T ROY SOC TROP MED H, V100, P1039, DOI 10.1016/j.trstmh.2005.12.013; Barakat R, 2011, PARASITOLOGY, V138, P440, DOI 10.1017/S003118201000154X; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; Coulibaly JT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001917; Davis SM, 2015, AM J TROP MED HYG, V92, P952, DOI 10.4269/ajtmh.14-0346; DOEHRINGSCHWERDTFEGER E, 1992, AM J TROP MED HYG, V46, P409, DOI 10.4269/ajtmh.1992.46.409; Ekpo UF, 2012, PARASITOLOGY, V139, P835, DOI 10.1017/S0031182012000029; Exum NG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007617; Garba A, 2013, ACTA TROP, V128, P318, DOI 10.1016/j.actatropica.2012.12.003; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; HOMEIDA MA, 1988, LANCET, V2, P437; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2011, PARASITOLOGY, V138, P1620, DOI 10.1017/S0031182011000023; Mbah MLN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003234; Mes THM, 2001, PARASITOLOGY, V123, P309, DOI 10.1017/S0031182001008496; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Meyer T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000357; MOHAMEDALI Q, 1991, AM J TROP MED HYG, V44, P444, DOI 10.4269/ajtmh.1991.44.444; Muhumuza S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001640; Nalugwa A, 2015, ACTA TROP, V142, P115, DOI 10.1016/j.actatropica.2014.11.014; Nalugwa A, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2040058; Nalugwa A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003796; Namwanje H, 2011, PARASITOLOGY, V138, P1586, DOI 10.1017/S0031182011000138; Poole H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-153; Richter J, 2000, ULTR SCHIST PRACT GU; Savioli L, 2015, LANCET, V386, P739, DOI 10.1016/S0140-6736(15)61536-7; Seto EYW, 2012, GEOSPATIAL HEALTH, V7, P1; Sousa-Figueiredo JC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001864; Sousa-Figueiredo JC, 2012, INT HEALTH, V4, P95, DOI 10.1016/j.inhe.2012.03.003; Statistics UBo International I., 2015, UG MAL IND SURV 2014; Stothard JR, 2013, TRENDS PARASITOL, V29, P197, DOI 10.1016/j.pt.2013.02.001; Stothard JR, 2011, PARASITOLOGY, V138, P1593, DOI 10.1017/S0031182011001235; Strahan R, 2013, TROP DOCT, V43, P71, DOI 10.1177/0049475513490422; Tukahebwa EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002268; Vennervald BJ, 2005, T ROY SOC TROP MED H, V99, P150, DOI 10.1016/j.trstmh.2004.06.009; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2002, PREV CONTR SCH SOIL; WHO, 2011, REP M REV RES STUD T; WHO. UNU, 2001, GUIDE PROGRAMME MANA; Yazdanpanah Y, 1997, AM J TROP MED HYG, V57, P245, DOI 10.4269/ajtmh.1997.57.245	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259338	10.1371/journal.pone.0259338	http://dx.doi.org/10.1371/journal.pone.0259338			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780499	Green Published, gold			2022-12-26	WOS:000755305800026
J	Liew, BXW; Rugamer, D; Duffy, K; Taylor, M; Jackson, J				Liew, Bernard X. W.; Rugamer, David; Duffy, Kim; Taylor, Matthew; Jackson, Jo			The mechanical energetics of walking across the adult lifespan	PLOS ONE			English	Article							POTSDAM GAIT; OLD ADULTS; AGE; POWER; WORK; REDISTRIBUTION; BIOMECHANICS; LOCOMOTION; STRENGTH; LEVEL	Purpose Understanding what constitutes normal walking mechanics across the adult lifespan is crucial to the identification and intervention of early decline in walking function. Existing research has assumed a simple linear alteration in peak joint powers between young and older adults. The aim of the present study was to quantify the potential (non)linear relationship between age and the joint power waveforms of the lower limb during walking. Methods This was a pooled secondary analysis of the authors' (MT, KD, JJ) and three publicly available datasets, resulting in a dataset of 278 adults between the ages of 19 to 86 years old. Three-dimensional motion capture with synchronised force plate assessment was performed during self-paced walking. Inverse dynamics were used to quantity joint power of the ankle, knee, and hip, which were time-normalized to 100 stride cycle points. Generalized Additive Models for location, scale and shape (GAMLSS) was used to model the effect of cycle points, age, walking speed, stride length, height, and their interaction on the outcome of each joint's power. Results At both 1m/s and 1.5 m/s, A2 peaked at the age of 60 years old with a value of 3.09 (95% confidence interval [CI] 2.95 to 3.23) W/kg and 3.05 (95%CI 2.94 to 3.16), respectively. For H1, joint power peaked with a value of 0.40 (95%CI 0.31 to 0.49) W/kg at 1m/s, and with a value of 0.78 (95%CI 0.72 to 0.84) W/kg at 1.5m/s, at the age of 20 years old. For H3, joint power peaked with a value of 0.69 (95%CI 0.62 to 0.76) W/kg at 1m/s, and with a value of 1.38 (95%CI 1.32 to 1.44) W/kg at 1.5m/s, at the age of 70 years old. Conclusions Findings from this study do not support a simple linear relationship between joint power and ageing. A more in-depth understanding of walking mechanics across the lifespan may provide more opportunities to develop early clinical diagnostic and therapeutic strategies for impaired walking function. We anticipate that the present methodology of pooling data across multiple studies, is a novel and useful research method to understand motor development across the lifespan.	[Liew, Bernard X. W.; Duffy, Kim; Taylor, Matthew; Jackson, Jo] Univ Essex, Sch Sport Rehabil & Exercise Sci, Colchester, Essex, England; [Rugamer, David] Ludwig Maximilians Univ Munchen, Dept Stat, Munich, Germany	University of Essex; University of Munich	Liew, BXW (corresponding author), Univ Essex, Sch Sport Rehabil & Exercise Sci, Colchester, Essex, England.	bl19622@essex.ac.uk		Liew, Bernard/0000-0002-7057-7548				Beijersbergen CMI, 2017, GAIT POSTURE, V52, P338, DOI 10.1016/j.gaitpost.2016.12.024; Beijersbergen CMI, 2016, GERONTOLOGY, V62, P597, DOI 10.1159/000444752; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Boyer KA, 2017, EXP GERONTOL, V95, P63, DOI 10.1016/j.exger.2017.05.005; Browne MG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171673; Buddhadev HH, 2016, GAIT POSTURE, V50, P131, DOI 10.1016/j.gaitpost.2016.08.034; Caldwell GE., 2000, ENERGETICS HUMAN ACT, P66; Cofre Lizama LE, 2011, GAIT POSTURE, V33, P484, DOI 10.1016/j.gaitpost.2010.12.030; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Farris DJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160901; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Fickey SN, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.182113; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Fukuchi CA, 2018, PEERJ, V6, DOI 10.7717/peerj.4640; Fukuchi CA, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1063-z; Grimmer M, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-018-0458-8; Hanson S, 2015, BRIT J SPORT MED, V49, P710, DOI 10.1136/bjsports-2014-094157; Horst F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38748-8; Hortobagyi T, 2016, EUR J APPL PHYSIOL, V116, P805, DOI 10.1007/s00421-015-3312-8; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; Ko SU, 2009, J BIOMECH, V42, P1834, DOI 10.1016/j.jbiomech.2009.05.037; Ko SU, 2012, ARCH GERONTOL GERIAT, V55, P474, DOI 10.1016/j.archger.2012.04.004; Kulmala JP, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0858; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Lewis CL, 2008, J BIOMECH, V41, P2082, DOI 10.1016/j.jbiomech.2008.05.013; Liew BXW, 2019, J BIOMECH, V90, P133, DOI 10.1016/j.jbiomech.2019.04.035; Lindemann I, 2020, J BIOMECH, V112, DOI 10.1016/j.jbiomech.2020.110067; McGibbon CA, 2004, J APPL PHYSIOL, V96, P149, DOI 10.1152/japplphysiol.00422.2003; McGibbon CA, 2003, EXERC SPORT SCI REV, V31, P102, DOI 10.1097/00003677-200304000-00009; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neptune RR, 2009, J BIOMECH, V42, P1282, DOI 10.1016/j.jbiomech.2009.03.009; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Ortega JD, 2015, J ELECTROMYOGR KINES, V25, P193, DOI 10.1016/j.jelekin.2014.09.003; Qiao M, 2016, J BIOMECH, V49, P66, DOI 10.1016/j.jbiomech.2015.11.022; Rasmussen LJH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13123; Ren L, 2008, J BIOMECH, V41, P2750, DOI 10.1016/j.jbiomech.2008.06.001; Robinson MA, 2015, J ELECTROMYOGR KINES, V25, P14, DOI 10.1016/j.jelekin.2014.10.018; Sawicki GS, 2009, EXERC SPORT SCI REV, V37, P130, DOI 10.1097/JES.0b013e31819c2df6; Schache AG, 2015, J EXP BIOL, V218, P2472, DOI 10.1242/jeb.119156; Schreiber C, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0124-4; Sinclair J, 2013, J HUM KINET, V39, P25, DOI 10.2478/hukin-2013-0065; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Vicon, 2013, PROD GUID FDN NOT 20; Waanders JB, 2019, MED SCI SPORT EXER, V51, P615, DOI 10.1249/MSS.0000000000001828; WINTER DA, 1990, PHYS THER, V70, P340, DOI 10.1093/ptj/70.6.340; Wirth B, 2011, FOOTWEAR SCI, V3, P159, DOI 10.1080/19424280.2011.633104; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259817	10.1371/journal.pone.0259817	http://dx.doi.org/10.1371/journal.pone.0259817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767611	gold, Green Accepted, Green Published			2022-12-26	WOS:000755249300050
J	Andrade, LDB; Guedes, GR; Noronha, KVMD; Silva, CMSE; Andrade, JP; Martins, ASFS				Barbosa Andrade, Lara de Melo; Guedes, Gilvan Ramalho; Micaela de Souza Noronha, Kenya Valeria; Santos e Silva, Claudio Moises; Andrade, Jeferson Pereira; Feitosa Suassuna Martins, Albert Smith			& para;Health-related vulnerability to climate extremes in homoclimatic zones of Amazonia and Northeast region of Brazil	PLOS ONE			English	Article							INFECTIOUS-DISEASES; AIR-TEMPERATURE; HEALTH; PRECIPITATION; HOTSPOTS; PREPAREDNESS; EDUCATION; OUTCOMES; MALARIA	Amazonia and the Northeast region of Brazil exhibit the highest levels of climate vulnerability in the country. While Amazonia is characterized by an extremely hot and humid climate and hosts the world largest rainforest, the Northeast is home to sharp climatic contrasts, ranging from rainy areas along the coast to semiarid regions that are often affected by droughts. Both regions are subject to extremely high temperatures and are susceptible to many tropical diseases. This study develops a multidimensional Extreme Climate Vulnerability Index (ECVI) for Brazilian Amazonia and the Northeast region based on the Alkire-Foster method. Vulnerability is defined by three components, encompassing exposure (proxied by seven climate extreme indicators), susceptibility (proxied by sociodemographic indicators), and adaptive capacity (proxied by sanitation conditions, urbanization rate, and healthcare provision). In addition to the estimated vulnerability levels and intensity, we break down the ECVI by indicators, dimensions, and regions, in order to explore how the incidence levels of climate-sensitive infectious and parasitic diseases correlate with regional vulnerability. We use the Grade of Membership method to reclassify the mesoregions into homoclimatic zones based on extreme climatic events, so climate and population/health data can be analyzed at comparable resolutions. We find two homoclimatic zones: Extreme Rain (ER) and Extreme Drought and High Temperature (ED-HT). Vulnerability is higher in the ED-HT areas than in the ER. The contribution of each dimension to overall vulnerability levels varies by homoclimatic zone. In the ER zone, adaptive capacity (39%) prevails as the main driver of vulnerability among the three dimensions, in contrast with the approximately even dimensional contribution in the ED-HT. When we compare areas by disease incidence levels, exposure emerges as the most influential dimension. Our results suggest that climate can exacerbate existing infrastructure deficiencies and socioeconomic conditions that are correlated with tropical disease incidence in impoverished areas.	[Barbosa Andrade, Lara de Melo; Santos e Silva, Claudio Moises; Feitosa Suassuna Martins, Albert Smith] Univ Fed Rio Grande Norte UFRN, Dept Atmospher & Climate Sci, Natal, RN, Brazil; [Guedes, Gilvan Ramalho] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, Dept Demog, Belo Horizonte, MG, Brazil; [Micaela de Souza Noronha, Kenya Valeria] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, Dept Econ, Belo Horizonte, MG, Brazil; [Andrade, Jeferson Pereira] Univ Fed Minas Gerais, Dept Stat, Belo Horizonte, MG, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Andrade, LDB (corresponding author), Univ Fed Rio Grande Norte UFRN, Dept Atmospher & Climate Sci, Natal, RN, Brazil.; Noronha, KVMD (corresponding author), Univ Fed Minas Gerais, Ctr Dev & Reg Planning, Dept Econ, Belo Horizonte, MG, Brazil.	lara.ufm@gmail.com; knoronha@cedeplar.ufmg.br	Moisés, Cláudio/ABD-7578-2021	Moisés, Cláudio/0000-0002-2251-7348; Noronha, Kenya/0000-0002-7174-6710	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304632/2019-8, 314392/2018-1, 310781/2020-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors KVMSN, GRG, and CMSS thanks to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the Research Productivity Scholarships (processes number 304632/2019-8 for KVMSN, 314392/2018-1 for GRG, and 310781/2020-5 for CMSS).	Alcantara CR, 2011, ATMOS RES, V100, P36, DOI 10.1016/j.atmosres.2010.12.023; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], 2009, MUDANCAS CLIMATICAS; [Anonymous], 2011, MAPA VULNERABILIDADE; Araujo P., 2020, SPRINGER SERIES DEMO, V50, P395, DOI [10.1007/978-3-030-44695-6_26, DOI 10.1007/978-3-030-44695-6_26]; Barbieri A., 2008, MUDANCAS CLIMATICAS; Barbieri Alisson F., 2015, Rev. bras. estud. popul., V32, P461, DOI 10.1590/S0102-3098201500000028; Barbieri AF, 2021, ENVIRON DEV, V38, DOI 10.1016/j.envdev.2020.100587; Barbosa HA, 2019, ISPRS J PHOTOGRAMM, V148, P235, DOI 10.1016/j.isprsjprs.2018.12.014; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Bourguignon F., 2019, POVERTY SOCIAL EXCLU, P83, DOI [10.1007/978-981-13-3432-0_7, DOI 10.1007/978-981-13-3432-0_7]; Bouwer LM, 2019, CLIM RISK MANAGE POL, P63, DOI 10.1007/978-3-319-72026-5_3; Rao VB, 2016, INT J CLIMATOL, V36, P291, DOI 10.1002/joc.4345; Brondizio ES, 2016, ANN HUM BIOL, V43, P405, DOI 10.1080/03014460.2016.1193222; Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034; Espinoza JC, 2013, J HYDROMETEOROL, V14, P1000, DOI 10.1175/JHM-D-12-0100.1; Confalonieri U, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P391; Crowley K, 2012, GEOGR J, V178, P208, DOI 10.1111/j.1475-4959.2011.00453.x; Barcellos PDL, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11080834; Paiva RFDD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00017316, 10.1590/0102-311X00017316]; Da Silva PE, 2018, THESIS U FEDERAL RIO; da Silva PE, 2021, INT J BIOMETEOROL, V65, P325, DOI 10.1007/s00484-020-02034-4; Da Silva PE, 2019, INT J CLIMATOL, V39, P579, DOI 10.1002/joc.5829; Darela JP, 2016, CLIMATIC CHANGE, V136, P413, DOI 10.1007/s10584-016-1635-z; de Aguiar JT, 2020, REMOTE SENS APPL, V18, DOI 10.1016/j.rsase.2020.100301; de Sherbinin A, 2014, CLIMATIC CHANGE, V123, P23, DOI 10.1007/s10584-013-0900-7; Dias AP, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/8159354; Erosheva EA, 2007, ANN APPL STAT, V1, P502, DOI 10.1214/07-AOAS126; Espinoza JC, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024008; Fedorova N, 2016, PURE APPL GEOPHYS, V173, P1403, DOI 10.1007/s00024-015-1166-y; FILIZOLA N., 2006, T C AMAZONIA, V9, P42; Forbes C., 2011, STAT DISTRIBUTIONS; Guedes Gilvan, 2019, Estud. Econ., V49, P235, DOI 10.1590/0101-41614922grl; Guedes GR., 2016, SERIES POPULATION EC, V1st; Hand MS., 2018, RMRSGTR383, V100, P383; Hastenrath S, 2012, CLIMATIC CHANGE, V112, P243, DOI 10.1007/s10584-011-0227-1; Hoffmann R, 2017, WORLD DEV, V96, P32, DOI 10.1016/j.worlddev.2017.02.016; Howell J, 2019, SOC PROBL, V66, P448, DOI 10.1093/socpro/spy016; Instituto Brasileiro de Geografia e Estatistica, 2018, PERF MUN BRAS 2017 I; Islam TMT, 2014, ECON LETT, V122, P365, DOI 10.1016/j.econlet.2013.12.032; Laurenti Ruy, 2004, Ciênc. saúde coletiva, V9, P909, DOI 10.1590/S1413-81232004000400012; Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003; Lutz W, 2014, SCIENCE, V346, P1061, DOI 10.1126/science.1257975; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Manton KG., 1994, WILEY INTERSCIENCE, V225; Marengo JA, 2008, PHILOS T R SOC B, V363, P1773, DOI 10.1098/rstb.2007.0015; Marengo JA, 2012, INT J CLIMATOL, V32, P1, DOI 10.1002/joc.2254; Marengo J.A, 2010, PARCERIAS ESTRATEGIC, V13, P149; Marengo JA., 2014, 73 CCAFS CGIAR; Marengo JA., 2015, GEOUSP ESPACO TEMPO, V3, P485; Marengo JA, 2011, RECURSOS HIDRICOS RE, V1, P385; Marengo JA, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00228; Marengo JA, 2017, THEOR APPL CLIMATOL, V129, P1189, DOI 10.1007/s00704-016-1840-8; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Marengo JA, 2012, THEOR APPL CLIMATOL, V107, P73, DOI 10.1007/s00704-011-0465-1; Marteleto LJ, 2020, DEMOGRAPHY, V57, P843, DOI 10.1007/s13524-020-00871-x; McMichael AJ, 2009, ECOHEALTH, V6, P163, DOI 10.1007/s10393-009-0262-9; Menezes JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190808; Lapouble OMM, 2015, REV PANAM SALUD PUBL, V38, P300; Michel-Kerjan EO, 2010, J ECON PERSPECT, V24, P165, DOI 10.1257/jep.24.4.165; Ministerio Da Saude, 2010, BANC DAD SIST UN SAU; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Myrrha LJD, 2014, THESIS U FEDERAL MIN; Oliveira PT, 2017, THEOR APPL CLIMATOL, V130, P77, DOI 10.1007/s00704-016-1865-z; Oliveira U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42881-9; Paredes-Trejo F, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11091113; Patz J.A., 2003, CLIMATE CHANGE HUMAN, V6, P103; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Pizzitutti F., 2015, MALARIA J, V1, P1, DOI [10.1186/1475-2875-14-1, DOI 10.1186/1475-2875-14-1]; Quintao AF, 2017, BRAZIL J ENV PUBLIC, V2017, P1; Rocha MS, 2020, EPIDEMIOL SERV SAUDE, V29, DOI 10.5123/S1679-49742020000100009; Rodrigues DT, 2020, INT J CLIMATOL, V40, P5098, DOI 10.1002/joc.6507; Rodrigues DT, 2020, INT J REMOTE SENS, V41, P549, DOI 10.1080/01431161.2019.1643940; Santos EB, 2016, THEOR APPL CLIMATOL, V126, P585, DOI 10.1007/s00704-015-1605-9; Santos EB, 2015, ATMOS SCI LETT, V16, P185, DOI 10.1002/asl2.535; Schmidlin TW, 2006, B AM METEOROL SOC, V87, P754, DOI 10.1175/BAMS-87-6-754; Sena A., 2018, PLOS CURR-TREE LIFE, V10; Sena A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181394; Marinho KFS, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11111217; Siqueira AHB., 2010, REV AMBIENT, V2, P147; Souza MLA, 2018, URBAN CLIM, V26, P198, DOI 10.1016/j.uclim.2018.09.003; Stanke Carla, 2013, PLoS Curr, V5, DOI 10.1371/currents.dis.7a2cee9e980f91ad7697b570bcc4b004; Stennett-Brown RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219250; Teixeira MD, 2011, J CLIMATE, V24, P1913, DOI 10.1175/2011JCLI3511.1; Terpstra T, 2013, ENVIRON BEHAV, V45, P993, DOI 10.1177/0013916512452427; Tomasella J, 2011, HYDROL PROCESS, V25, P1228, DOI 10.1002/hyp.7889; VanWey LK, 2012, POPUL ENVIRON, V34, P44, DOI 10.1007/s11111-011-0161-1; WHO, 2017, CLIM RES WAT SAF PLA; Xavier AC, 2016, INT J CLIMATOL, V36, P2644, DOI 10.1002/joc.4518; Zeng N, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014002	93	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259780	10.1371/journal.pone.0259780	http://dx.doi.org/10.1371/journal.pone.0259780			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762688	Green Published, gold			2022-12-26	WOS:000755316600037
J	Mokhtar, MM; Alsamman, AM; Abd-Elhalim, HM; El Allali, A				Mokhtar, Morad M.; Alsamman, Alsamman M.; Abd-Elhalim, Haytham M.; El Allali, Achraf			CicerSpTEdb: A web-based database for high- resolution genome-wide identification of transposable elements in Cicer species	PLOS ONE			English	Article							FOXTAIL MILLET; SEQUENCE; CHICKPEA; EVOLUTION; MAIZE; GENE; RETROTRANSPOSONS; TRANSCRIPTION; DIVERSITY; MICRORNAS	Recently, Cicer species have experienced increased research interest due to their economic importance, especially in genetics, genomics, and crop improvement. The Cicer arietinum, Cicer reticulatum, and Cicer echinospermum genomes have been sequenced and provide valuable resources for trait improvement. Since the publication of the chickpea draft genome, progress has been made in genome assembly, functional annotation, and identification of polymorphic markers. However, work is still needed to identify transposable elements (TEs) and make them available for researchers. In this paper, we present CicerSpTEdb, a comprehensive TE database for Cicer species that aims to improve our understanding of the organization and structural variations of the chickpea genome. Using structure and homology-based methods, 3942 C. echinospermum, 3579 C. reticulatum, and 2240 C. arietinum TEs were identified. Comparisons between Cicer species indicate that C. echinospermum has the highest number of LTR-RT and hAT TEs. C. reticulatum has more Mutator, PIF Harbinger, Tc1 Mariner, and CACTA TEs, while C. arietinum has the highest number of Helitron. CicerSpTEdb enables users to search and visualize TEs by location and download their results. The database will provide a powerful resource that can assist in developing TE target markers for molecular breeding and answer related biological questions.	[Mokhtar, Morad M.; Alsamman, Alsamman M.; El Allali, Achraf] Mohammed VI Polytech Univ, African Genome Ctr, Ben Guerir, Morocco; [Abd-Elhalim, Haytham M.] Agr Res Ctr, Agr Genet Engn Res Inst, Giza, Egypt	Mohammed VI Polytechnic University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt	Mokhtar, MM; El Allali, A (corresponding author), Mohammed VI Polytech Univ, African Genome Ctr, Ben Guerir, Morocco.	morad.mokhtar@um6p.ma; Achraf.ELALLALl@um6p.ma	El Allali, Achraf/AAM-6468-2021; Mokhtar, Morad/GWV-2705-2022; Alsamman, Alsamman M/AAC-6126-2022	Alsamman, Alsamman M/0000-0002-7765-5035; El Allali, Achraf/0000-0002-4561-2161; Mokhtar, Morad/0000-0002-9540-0458				Amselem J, 2019, MOBILE DNA-UK, V10, DOI 10.1186/s13100-019-0150-y; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bennetzen JL, 2014, ANNU REV PLANT BIOL, V65, P505, DOI 10.1146/annurev-arplant-050213-035811; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Britten R, 2006, P NATL ACAD SCI USA, V103, P1798, DOI 10.1073/pnas.0510007103; Bucher E, 2012, CURR OPIN PLANT BIOL, V15, P503, DOI 10.1016/j.pbi.2012.08.006; Buels R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0924-1; Butelli E, 2012, PLANT CELL, V24, P1242, DOI 10.1105/tpc.111.095232; Chaparro C, 2007, NUCLEIC ACIDS RES, V35, pD66, DOI 10.1093/nar/gkl780; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; CRESSE AD, 1995, GENETICS, V140, P315; da Costa ZP, 2019, MOL BIOL REP, V46, P6117, DOI 10.1007/s11033-019-05047-4; Doddamani D, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav078; Doddamani D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-212; DOEBLEY J, 1995, GENETICS, V141, P333; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Doyle O, 2002, J STRUCT BIOL, V140, P154, DOI 10.1016/S1047-8477(02)00547-6; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; FINNEGAN DJ, 1985, INT REV CYTOL, V93, P281, DOI 10.1016/S0074-7696(08)61376-5; Gaur R, 2020, FUNCT INTEGR GENOMIC, V20, P763, DOI 10.1007/s10142-020-00751-y; Gayali S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0860-y; Gonzalez LG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-644; Gupta S, 2017, DNA RES, V24, P1, DOI 10.1093/dnares/dsw042; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Hollister JD, 2009, GENOME RES, V19, P1419, DOI 10.1101/gr.091678.109; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jain M, 2014, J EXP BOT, V65, P5945, DOI 10.1093/jxb/eru333; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawase M, 2005, MOL GENET GENOMICS, V274, P131, DOI 10.1007/s00438-005-0013-8; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kunze R, 1997, ADV BOT RES, V27, P331; LADIZINSKY G, 1976, EUPHYTICA, V25, P211, DOI 10.1007/BF00041547; Lehti-Shiu MD, 2017, BBA-GENE REGUL MECH, V1860, P3, DOI 10.1016/j.bbagrm.2016.08.005; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Lin LF, 2011, GENOMICS, V97, P313, DOI 10.1016/j.ygeno.2011.02.007; Lipatov M, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-24; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Lockton S, 2009, J MOL EVOL, V68, P80, DOI 10.1007/s00239-008-9190-5; Lorenzetti APR, 2016, FUNCT INTEGR GENOMIC, V16, P235, DOI 10.1007/s10142-016-0480-5; Ma B, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav004; Marcon HS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0550-1; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Murukarthick Jayakodi, 2014, BMC Res Notes, V7, P379, DOI 10.1186/1756-0500-7-379; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; Nussbaumer T, 2013, NUCLEIC ACIDS RES, V41, pD1144, DOI 10.1093/nar/gks1153; Ou SJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1905-y; Ou SJ, 2018, PLANT PHYSIOL, V176, P1410, DOI 10.1104/pp.17.01310; Parween S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12806; Paszkowski J, 2015, CURR OPIN BIOTECH, V32, P200, DOI 10.1016/j.copbio.2015.01.003; Peng YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200047; Pereira V, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r79; Rey O, 2016, TRENDS ECOL EVOL, V31, P514, DOI 10.1016/j.tree.2016.03.013; Rossi M, 2001, GENET MOL BIOL, V24, P147, DOI 10.1590/S1415-47572001000100020; Sahebi M, 2018, GENE, V665, P155, DOI 10.1016/j.gene.2018.04.050; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Satheesh V, 2021, GENES GENOM, V43, P289, DOI 10.1007/s13258-021-01040-z; Sawicka A, 2021, EMBO J, V40, DOI 10.15252/embj.2020107015; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JM, 2019, PLANT PHYSIOL, V180, P1803, DOI 10.1104/pp.19.00386; Singh U, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx866; Smit A., 2018, REPEATMODELER OPEN 1; Su WJ, 2021, METHODS MOL BIOL, V2250, P55, DOI 10.1007/978-1-0716-1134-0_4; Su WJ, 2019, MOL PLANT, V12, P447, DOI 10.1016/j.molp.2019.02.008; Sun FL, 2013, GENE, V522, P1, DOI 10.1016/j.gene.2013.03.101; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang C, 2017, BIOCHEM SYST ECOL, V70, P168, DOI 10.1016/j.bse.2016.11.011; Thieme M, 2018, ADV BOT RES, V88, P165, DOI 10.1016/bs.abr.2018.09.001; Thieme M, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1265-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toker C, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.662891; Varshney RK, 2019, NAT GENET, V51, P857, DOI 10.1038/s41588-019-0401-3; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2017, COMPEND PL GENOME, P1, DOI 10.1007/978-3-319-66117-9; Verma M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136880; Vieira Lucas Maciel, 2017, Non-Coding RNA, V3, P11, DOI 10.3390/ncrna3010011; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12790; Xiong WW, 2014, P NATL ACAD SCI USA, V111, P10263, DOI 10.1073/pnas.1410068111; Xu HE, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat055; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yadav CB, 2015, DNA RES, V22, P79, DOI 10.1093/dnares/dsu039; Yandim C, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5803-1; Yao JL, 2001, P NATL ACAD SCI USA, V98, P1306, DOI 10.1073/pnas.031502498; Yi F, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay131; Yi F, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay024; Zhang LY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09518-x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao DY, 2016, BBA-GENE REGUL MECH, V1859, P366, DOI 10.1016/j.bbagrm.2015.12.005	103	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259540	10.1371/journal.pone.0259540	http://dx.doi.org/10.1371/journal.pone.0259540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762703	Green Published, gold			2022-12-26	WOS:000755316600025
J	Boudhraa, Z; Zaoui, K; Fleury, H; Cahuzac, M; Gilbert, S; Tchakarska, G; Kendall-Dupont, J; Carmona, E; Provencher, D; Mes-Masson, AM				Boudhraa, Zied; Zaoui, Kossay; Fleury, Hubert; Cahuzac, Maxime; Gilbert, Sophie; Tchakarska, Guergana; Kendall-Dupont, Jennifer; Carmona, Euridice; Provencher, Diane; Mes-Masson, Anne-Marie			NR1D1 regulation by Ran GTPase via miR4472 identifies an essential vulnerability linked to aneuploidy in ovarian cancer	ONCOGENE			English	Article							DNA-DAMAGE; CELL-CYCLE; ACTIVATION; METABOLISM; EXPRESSION; SURVIVIN; GRADE	While aneuploidy is a main enabling characteristic of cancers, it also creates specific vulnerabilities. Here we demonstrate that Ran inhibition targets epithelial ovarian cancer (EOC) survival through its characteristic aneuploidy. We show that induction of aneuploidy in rare diploid EOC cell lines or normal cells renders them highly dependent on Ran. We also establish an inverse correlation between Ran and the tumor suppressor NR1D1 and reveal the critical role of Ran/NR1D1 axis in aneuploidy-associated endogenous DNA damage repair. Mechanistically, we show that Ran, through the maturation of miR4472, destabilizes the mRNA of NR1D1 impacting several DNA repair pathways. We showed that NR1D1 interacts with both PARP1 and BRCA1 leading to the inhibition of DNA repair. Concordantly, loss of Ran was associated with NR1D1 induction, accumulation of DNA damages, and lethality of aneuploid EOC cells. Our findings suggest a synthetic lethal strategy targeting aneuploid cells based on their dependency to Ran.	[Boudhraa, Zied; Zaoui, Kossay; Fleury, Hubert; Cahuzac, Maxime; Gilbert, Sophie; Tchakarska, Guergana; Kendall-Dupont, Jennifer; Carmona, Euridice; Provencher, Diane; Mes-Masson, Anne-Marie] Univ Montreal CRCHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada; [Boudhraa, Zied; Zaoui, Kossay; Fleury, Hubert; Cahuzac, Maxime; Gilbert, Sophie; Tchakarska, Guergana; Kendall-Dupont, Jennifer; Carmona, Euridice; Provencher, Diane; Mes-Masson, Anne-Marie] Inst Canc Montreal ICM, Montreal, PQ, Canada; [Provencher, Diane] Univ Montreal, Div Gynecol Oncol, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Mes-Masson, AM (corresponding author), Univ Montreal CRCHUM, Ctr Hosp, Ctr Rech, Montreal, PQ, Canada.; Mes-Masson, AM (corresponding author), Inst Canc Montreal ICM, Montreal, PQ, Canada.; Mes-Masson, AM (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	anne-marie.mes-masson@umontreal.ca			Canadian Institute for Health Research (CIHR) [MOP142724, PJT148642]; ICM (Fonds Defi Spyder and Anne-Marie Chagnon); Ovarian Cancer Canada (OCC); Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS; Canadian Tumor Repository Network (CTRNet)	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); ICM (Fonds Defi Spyder and Anne-Marie Chagnon); Ovarian Cancer Canada (OCC); Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS; Canadian Tumor Repository Network (CTRNet)	This work was supported by the Canadian Institute for Health Research (CIHR MOP142724 and PJT148642) and the ICM (Fonds Defi Spyder and Anne-Marie Chagnon). Cell lines used in this study were provided by the CRCHUM ovarian tumor bank, which is supported by Ovarian Cancer Canada (OCC) and by the Banque de tissus et de donnees of the Reseau de recherche sur le cancer of the FRQS affiliated with the Canadian Tumor Repository Network (CTRNet).	Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Boudhraa Z, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00345; Brodeur MN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97434-w; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Caceres-Gorriti KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091000; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cekan P, 2016, MOL BIOL CELL, V27, P1346, DOI 10.1091/mbc.E16-01-0025; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Deng L, 2013, BIOCHEM BIOPH RES CO, V440, P322, DOI 10.1016/j.bbrc.2013.09.079; Fleury H, 2017, ONCOTARGET, V8, P40152, DOI 10.18632/oncotarget.10308; Fleury Hubert, 2015, Genes Cancer, V6, P378; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasegawa K, 2013, J CELL BIOL, V200, P151, DOI 10.1083/jcb.201206142; Ka NL, 2017, MOL CELL ENDOCRINOL, V454, P87, DOI 10.1016/j.mce.2017.06.004; Ka NL, 2017, CANCER RES, V77, P2453, DOI 10.1158/0008-5472.CAN-16-2099; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Letourneau IJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-379; Levine MS, 2017, DEV CELL, V40, P313, DOI 10.1016/j.devcel.2016.12.022; Mocellin S, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1010-1; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sulli G, 2018, NATURE, V553, P351, DOI 10.1038/nature25170; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Wang YJ, 2015, BIOCHEM PHARMACOL, V96, P315, DOI 10.1016/j.bcp.2015.06.010; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Xia F, 2008, MOL CELL BIOL, V28, P5299, DOI 10.1128/MCB.02039-07; Zhu J, 2018, DEV CELL, V44, P420, DOI 10.1016/j.devcel.2018.02.002	38	2	2	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					309	320		10.1038/s41388-021-02082-z	http://dx.doi.org/10.1038/s41388-021-02082-z		NOV 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34743206	Green Published, hybrid			2022-12-26	WOS:000715015000003
J	Chen, Q; Bao, CY; Xu, F; Ma, CX; Huang, L; Guo, QG; Luo, M				Chen, Qian; Bao, Chaoya; Xu, Fan; Ma, Caixia; Huang, Li; Guo, Qigao; Luo, Ming			Silencing GhJUB1L1 (JUB1-like 1) reduces cotton (Gossypium hirsutum) drought tolerance	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; ABIOTIC STRESS RESPONSES; SIGNAL-TRANSDUCTION; EXPRESSION ANALYSIS; TRANSGENIC TOBACCO; FACTOR FAMILY; GENE; ARABIDOPSIS; PROTEIN; BIOSYNTHESIS	Drought stress massively restricts plant growth and the yield of crops. Reducing the deleterious effects of drought is necessary for agricultural industry. The plant-specific NAC (NAM, ATAF1/2 and CUC2) transcription factors (TFs) are widely involved in the regulation of plant development and stress response. One of the NAC TF, JUNGBRUNNEN1 (JUB1), has been reported to involve in drought resistance in Arabidopsis. However, little is known of how the JUB1 gene respond to drought stress in cotton. In the present study, we cloned GhJUB1L1, a homologous gene of JUB1 in upland cotton. GhJUB1L1 is preferentially expressed in stem and leaf and could be induced by drought stress. GhJUB1L1 protein localizes to the cell nucleus, and the transcription activation region of which is located in the C-terminal region. Silencing GhJUB1L1 gene via VIGS () reduced cotton drought tolerance, and retarded secondary cell wall (SCW) development. Additionally, the expression of some drought stress-related genes and SCW synthesis-related genes were altered in the GhJUB1L1 silencing plants. Collectively, our findings indicate that GhJUB1L1 may act as a positive regulator in response to drought stress and SCW development in cotton. Our results enriched the roles of NAC TFs in cotton drought tolerance and laid a foundation for the cultivation of transgenic cotton with higher drought tolerance.	[Chen, Qian; Guo, Qigao] Southwest Univ, Coll Hort & Landscape Architecture, Minist Educ, Key Lab Hort Sci Southern Mt Reg, Chongqing, Peoples R China; [Chen, Qian; Guo, Qigao] Southwest Univ, Acad Agr Sci, State Cultivat Base Crop Stress Biol Southern Mt, Chongqing, Peoples R China; [Chen, Qian; Bao, Chaoya; Xu, Fan; Ma, Caixia; Huang, Li; Luo, Ming] Southwest Univ, Biotechnol Res Ctr, Minist Agr, Key Lab Biotechnol & Crop Qual Improvement, Chongqing, Peoples R China	Southwest University - China; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Guo, QG (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Minist Educ, Key Lab Hort Sci Southern Mt Reg, Chongqing, Peoples R China.; Guo, QG (corresponding author), Southwest Univ, Acad Agr Sci, State Cultivat Base Crop Stress Biol Southern Mt, Chongqing, Peoples R China.; Luo, M (corresponding author), Southwest Univ, Biotechnol Res Ctr, Minist Agr, Key Lab Biotechnol & Crop Qual Improvement, Chongqing, Peoples R China.	qgguo@126.com; luo0424@126.com		Luo, Ming/0000-0003-2281-8324; Chen, Qian/0000-0002-4210-054X				Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Babula-Skowronska D, 2015, PLANT MOL BIOL, V88, P445, DOI 10.1007/s11103-015-0334-x; Basu Supratim, 2016, F1000Res, V5, DOI 10.12688/f1000research.7678.1; Borrill P, 2017, G3-GENES GENOM GENET, V7, P3019, DOI 10.1534/g3.117.043679; Butt HI, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1078-3; Chen HY, 2016, NEW PHYTOL, V211, P599, DOI 10.1111/nph.13914; Daviere JM, 2016, MOL PLANT, V9, P10, DOI 10.1016/j.molp.2015.09.011; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hu P, 2019, PLANT PHYSIOL, V179, P700, DOI 10.1104/pp.18.01167; Huang JF, 2021, NEW PHYTOL, V232, P1718, DOI 10.1111/nph.17612; Huang JF, 2016, SCI CHINA LIFE SCI, V59, P194, DOI 10.1007/s11427-015-4991-4; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Joshi R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01029; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li C, 2014, J EXP BOT, V65, P5415, DOI 10.1093/jxb/eru302; Ling L, 2017, PHYSIOL MOL BIOL PLA, V23, P343, DOI 10.1007/s12298-017-0421-3; Liu QL, 2011, BIOTECHNOL LETT, V33, P2073, DOI 10.1007/s10529-011-0659-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; Park SC, 2011, PLANTA, V233, P621, DOI 10.1007/s00425-010-1326-3; Rabara RC, 2014, OMICS, V18, P601, DOI 10.1089/omi.2013.0177; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakuraba Y, 2015, PLANT CELL, V27, P1771, DOI 10.1105/tpc.15.00222; Shahnejat-Bushehri S, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.13, 10.1038/nplants.2016.13]; Shahnejat-Bushehri S, 2012, PLANT SIGNAL BEHAV, V7, P1518, DOI 10.4161/psb.22092; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Sun H, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1367-5; Tak H, 2017, PROTOPLASMA, V254, P803, DOI 10.1007/s00709-016-0991-x; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Thirumalaikumar VP, 2018, PLANT BIOTECHNOL J, V16, P354, DOI 10.1111/pbi.12776; Todaka D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00084; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Vermeirssen V, 2014, PLANT CELL, V26, P4656, DOI 10.1105/tpc.114.131417; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Yamchi A, 2007, J PLANT BIOCHEM BIOT, V16, P9, DOI 10.1007/BF03321922; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	50	3	3	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259382	10.1371/journal.pone.0259382	http://dx.doi.org/10.1371/journal.pone.0259382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739505	gold, Green Published			2022-12-26	WOS:000755000800030
J	Wang, ZY; Liu, Y; Zhang, JN; Lin, MM; Xiao, CF; Bai, HY; Liu, C				Wang, Ziyan; Liu, Yang; Zhang, Jianing; Lin, Minmin; Xiao, Chufan; Bai, Haoying; Liu, Chao			Mechanical loading alleviated the inhibition of beta 2-adrenergic receptor agonist terbutaline on bone regeneration	FASEB JOURNAL			English	Article						biomechanics; bone regeneration; osteoblast; periostin; terbutaline	MESENCHYMAL STEM-CELLS; ANGIOGENESIS; ACTIVATION; PERIOSTIN; MASS; FRACTURE; EXPRESSION; INDUCTION; PROTEIN; LEPTIN	The long-term use of adrenergic medication in treating various conditions, such as asthma, increases the chances of bone fracture. Dynamic mechanical loading at a specific time is a method for improving bone quality and promoting healing. Therefore, we hypothesized that precisely controlling the mechanical environment can contribute to the alleviation of the negative effects of chronic treatment with the common asthma drug terbutaline, which is a beta 2-adrenergic receptor agonist that facilitates bone homeostasis and defect repair through its anabolic effect on osteogenic cells. Our in vitro results showed that terbutaline can directly inhibit osteogenesis by impairing osteogenic differentiation and mineralization. Chronic treatment in vivo was simulated by administering terbutaline to C57BL/6J mice for 4 weeks before bone defect surgery and mechanical loading. We utilized a stabilized tibial defect model, which allowed the application of anabolic mechanical loading. During homeostasis, chronic terbutaline treatment reduced the bone formation rate, the fracture toughness of long bones, and the concentrations of bone formation markers in the sera. During defect repair, terbutaline decreased the bone volume, type H vessel, and total blood vessel volume. Terbutaline treatment reduced the number of osteogenic cells. Periostin, which was secreted mainly by Prrx1+ osteoprogenitors and F4/80+ macrophages, was inhibited by treating the bone defect with terbutaline. Interestingly, controlled mechanical loading facilitated the recovery of bone volume and periostin expression and the number of osteogenic cells within the defect. In conclusion, mechanical loading can rescue negative effects on new bone accrual and repair induced by chronic terbutaline treatment.	[Wang, Ziyan; Liu, Yang; Zhang, Jianing; Lin, Minmin; Xiao, Chufan; Bai, Haoying; Liu, Chao] Southern Univ Sci & Technol, Dept Biomed Engn, Coll Engn, 1088 Xueyuan Ave,Coll Engn Bldg South 732, Shenzhen 518055, Peoples R China	Southern University of Science & Technology	Liu, C (corresponding author), Southern Univ Sci & Technol, Dept Biomed Engn, Coll Engn, 1088 Xueyuan Ave,Coll Engn Bldg South 732, Shenzhen 518055, Peoples R China.	liuc33@sustech.edu.cn	Wang, Ziyan/HII-8458-2022	Liu, Yang/0000-0002-2226-0941	Shenzhen Science and Technology Innovation Commission [JCYJ20190809114209434]; SUSTech Core Research Core Research Facilities	Shenzhen Science and Technology Innovation Commission; SUSTech Core Research Core Research Facilities	The work was supported by Shenzhen Science and Technology Innovation Commission (Grant No. JCYJ20190809114209434) for financial support. We acknowledge the assistance of Ying Wang for the Micro-CT imaging and Yilin Wang for the confocal imaging from the SUSTech Core Research Core Research Facilities.	Acevedo C, 2018, NAT BIOMED ENG, V2, P62, DOI 10.1038/s41551-017-0183-9; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Bonnet N, 2005, BONE, V37, P622, DOI 10.1016/j.bone.2005.07.012; Bonnet N., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P94; Bonnet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078347; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Bordon Y, 2016, NAT REV IMMUNOL, V16, P129, DOI 10.1038/nri.2016.21; Bouxsein ML, 2009, ENDOCRINOLOGY, V150, P144, DOI 10.1210/en.2008-0843; Buettmann EG, 2019, J BONE MINER RES, V34, P1690, DOI 10.1002/jbmr.3755; Chen J, 2020, STEM CELL REP, V15, P110, DOI 10.1016/j.stemcr.2020.06.007; Chiarella SE, 2014, J CLIN INVEST, V124, P2935, DOI 10.1172/JCI75157; Chu SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09402-8; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dam TT, 2010, OSTEOPOROSIS INT, V21, P1341, DOI 10.1007/s00198-009-1076-x; de Lageneste OD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03124-z; de Vries F, 2007, PHARMACOEPIDEM DR S, V16, P612, DOI 10.1002/pds.1318; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Elefteriou F, 2004, PATHOL BIOL, V52, P148, DOI 10.1016/j.patbio.2003.05.006; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; Fang TD, 2005, J BONE MINER RES, V20, P1114, DOI 10.1359/JBMR.050301; Gao B, 2019, J CLIN INVEST, V129, P2578, DOI 10.1172/JCI98857; Gerbaix M, 2015, BONE, V71, P94, DOI 10.1016/j.bone.2014.10.011; Gohin S, 2020, J APPL PHYSIOL, V128, P838, DOI 10.1152/japplphysiol.00416.2019; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; James AW, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/684736; Jenei-Lanzl Z, 2014, ARTHRITIS RHEUMATOL, V66, P2472, DOI 10.1002/art.38695; King C, 2020, PHARMACOGENOMICS J, V20, P621, DOI 10.1038/s41397-019-0140-y; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kondo H, 2011, CALCIFIED TISSUE INT, V88, P23, DOI 10.1007/s00223-010-9421-9; Kormann R, 2020, J AM SOC NEPHROL, V31, P85, DOI 10.1681/ASN.2019020113; Langhammer Arnulf, 2009, Int J Chron Obstruct Pulmon Dis, V4, P365; Le Provost GS, 2015, J INVEST DERMATOL, V135, P279, DOI 10.1038/jid.2014.312; Lee J, 2021, NAT BIOMED ENG, V5, P89, DOI 10.1038/s41551-020-00674-w; Lemmens S, 2017, J CELL PHYSIOL, V232, P298, DOI 10.1002/jcp.25483; Li DD, 2019, J MOL HISTOL, V50, P493, DOI 10.1007/s10735-019-09843-x; Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021; Li HF, 2010, ARCH BIOCHEM BIOPHYS, V496, P77, DOI 10.1016/j.abb.2010.01.016; Li W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0218-2; Liu C, 2019, J BONE MINER RES, V34, P896, DOI 10.1002/jbmr.3668; Liu C, 2018, BONE, V108, P145, DOI 10.1016/j.bone.2017.12.027; Liu S., 2021, GENET MOL BIOL, V3; Makela MJ, 2013, RESP MED, V107, P1481, DOI 10.1016/j.rmed.2013.04.005; Mansur AH, 2014, J ASTHMA, V51, P1076, DOI 10.3109/02770903.2014.939281; Matsumoto H, 2019, ADV EXP MED BIOL, V1132, P145, DOI 10.1007/978-981-13-6657-4_15; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Moore ER, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/3094154; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Noh H, 2017, KIDNEY INT, V92, P101, DOI 10.1016/j.kint.2017.02.013; Osman L, 2007, CIRCULATION, V116, pI282, DOI 10.1161/CIRCULATIONAHA.106.681072; Panchamanon P, 2019, CELL BIOL INT, V43, P506, DOI 10.1002/cbin.11116; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Ruehle MA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb6351; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Soriano JB, 2020, LANCET RESP MED, V8, P585, DOI 10.1016/S2213-2600(20)30105-3; Sutter SA, 2016, CURR OSTEOPOROS REP, V14, P106, DOI 10.1007/s11914-016-0308-1; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Tang Y, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12369; van Staa TP, 2006, CALCIFIED TISSUE INT, V79, P129, DOI 10.1007/s00223-006-0019-1; Veldhuis-Vlug AG, 2015, BONE, V71, P196, DOI 10.1016/j.bone.2014.10.024; Vestergaard P, 2007, CHEST, V132, P1599, DOI 10.1378/chest.07-1092; Vi L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07666-0; Walsh LJ, 2001, THORAX, V56, P279, DOI 10.1136/thorax.56.4.279; Wang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072962; Wang XT, 2021, FASEB J, V35, DOI 10.1096/fj.202001080RR; Yamada T, 2015, J CELL BIOCHEM, V116, P1144, DOI 10.1002/jcb.25071; Zhang F, 2017, SCI REP-UK, V7, DOI 10.1038/srep41634; Zhang M, 2017, IN VIVO, V31, P87, DOI 10.21873/invivo.11029	74	1	1	4	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22033	10.1096/fj.202101045RR	http://dx.doi.org/10.1096/fj.202101045RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34739146				2022-12-26	WOS:000722321300004
J	Jimenez, JL; Niewczas, J; Bore, A; Burman, CF				Jimenez, Jose L.; Niewczas, Julia; Bore, Alexander; Burman, Carl-Fredrik			A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching	PLOS ONE			English	Article							CLINICAL-TRIALS; NONPROPORTIONAL HAZARDS; VERSATILE TESTS; CANCER TRIALS; SURVIVAL; MODEL; EVEROLIMUS	In confirmatory cancer clinical trials, overall survival (OS) is normally a primary endpoint in the intention-to-treat (ITT) analysis under regulatory standards. After the tumor progresses, it is common that patients allocated to the control group switch to the experimental treatment, or another drug in the same class. Such treatment switching may dilute the relative efficacy of the new drug compared to the control group, leading to lower statistical power. It would be possible to decrease the estimation bias by shortening the follow-up period but this may lead to a loss of information and power. Instead we propose a modified weighted log-rank test (mWLR) that aims at balancing these factors by down-weighting events occurring when many patients have switched treatment. As the weighting should be pre-specified and the impact of treatment switching is unknown, we predict the hazard ratio function and use it to compute the weights of the mWLR. The method may incorporate information from previous trials regarding the potential hazard ratio function over time. We are motivated by the RECORD-1 trial of everolimus against placebo in patients with metastatic renal-cell carcinoma where almost 80% of the patients in the placebo group received everolimus after disease progression. Extensive simulations show that the new test gives considerably higher efficiency than the standard log-rank test in realistic scenarios.	[Jimenez, Jose L.] Novartis Pharma AG, Global Drug Dev, Basel, Switzerland; [Niewczas, Julia; Bore, Alexander; Burman, Carl-Fredrik] AstraZeneca R&D, Data Sci & AI, Stat Innovat, Gothenburg, Sweden	Novartis; AstraZeneca	Jimenez, JL (corresponding author), Novartis Pharma AG, Global Drug Dev, Basel, Switzerland.	jose_luis.jimenez@novartis.com	Jiménez, José L./GPP-7074-2022	Jiménez, José L./0000-0002-8809-2717				Alexander BM, 2018, NEW ENGL J MED, V378, P1158, DOI 10.1056/NEJMc1716612; Amato RJ, 2006, J CLIN ONCOL, V24, p224S; ANDERSON KM, 1991, BIOMETRICS, V47, P281, DOI 10.2307/2532512; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bartlett JW, 2020, STAT BIOPHARM RES, V12, P518, DOI 10.1080/19466315.2020.1755722; Bowden J, 2016, STAT MED, V35, P1423, DOI 10.1002/sim.6801; BROWN M, 1984, BIOMETRIKA, V71, P65, DOI 10.2307/2336398; Burman CF, 2011, PHARM STAT, V10, P508, DOI 10.1002/pst.523; Campbell MJ., 2011, NRD SITE I ARC UNPUB; Carneiro Leao I, 2018, ACCELERATED VS REGUL; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; European Medicines Agency, 2018, REFL PAP PHYS FRAILT; FLEMING TR, 1981, COMMUN STAT A-THEOR, V10, P763, DOI 10.1080/03610928108828073; Food Administration D, 2018, CLIN TRIAL ENDP APPR; Food Administration D, 2013, GOOD REV PRACTICE CL; Gregson J, 2019, J AM COLL CARDIOL, V74, P2102, DOI 10.1016/j.jacc.2019.08.1034; Henshall C, 2016, INT J TECHNOL ASSESS, V32, P167, DOI 10.1017/S026646231600009X; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Ison G, 2018, CLIN CANCER RES, V24, P4066, DOI 10.1158/1078-0432.CCR-18-0042; Jimenez JL, 2019, PHARM STAT, V18, P287, DOI 10.1002/pst.1923; Jimenez-Diaz J, 2021, J MOTOR BEHAV, V53, P385, DOI 10.1080/00222895.2020.1782825; Karrison TG, 2016, STATA J, V16, P678, DOI 10.1177/1536867X1601600308; Kazandjian D, 2016, CLIN CANCER RES, V22, P1307, DOI 10.1158/1078-0432.CCR-15-2266; Korhonen P, 2012, J BIOPHARM STAT, V22, P1258, DOI 10.1080/10543406.2011.592233; Latimer NR, 2017, STAT METHODS MED RES, V26, P724, DOI 10.1177/0962280214557578; Latimer NR, 2018, STAT METHODS MED RES, V27, P765, DOI 10.1177/0962280216642264; Latimer NR, 2016, INT J TECHNOL ASSESS, V32, P160, DOI 10.1017/S026646231600026X; Latimer NR, 2014, NICE DSU TECHNICAL S; Lee JW, 1996, BIOMETRICS, V52, P721, DOI 10.2307/2532911; Leton E, 2001, COMMUN STAT-THEOR M, V30, P591, DOI 10.1081/STA-100002138; Magirr D, ARXIV PREPRINT ARXIV; Magirr D, 2021, PHARM STAT, V20, P512, DOI 10.1002/pst.2091; Magirr D, 2019, STAT MED, V38, P3782, DOI 10.1002/sim.8186; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Morden JP, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-4; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; PEPE MS, 1989, BIOMETRICS, V45, P497, DOI 10.2307/2531492; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; R Core Team, 2020, R LANG ENV STAT COMP; Rahman R, 2019, CLIN CANCER RES, V25, P6339, DOI 10.1158/1078-0432.CCR-18-3999; Robins J., 1993, P BIOPH SECT AM STAT, P24; ROBINS JM, 1994, J AM STAT ASSOC, V89, P737, DOI 10.1080/01621459.1994.10476807; ROBINS JM, 1991, COMMUN STAT THEORY, V20, P2609, DOI 10.1080/03610929108830654; Roychoudhury S, 2019, ARXIV PREPRINT ARXIV; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; SCHOENFELD D, 1981, BIOMETRIKA, V68, P316, DOI 10.1093/biomet/68.1.316; TEConomy, 2019, BIOPH IND SPONS CLIN; Yamaguchi T, 2004, STAT MED, V23, P1991, DOI 10.1002/sim.1816	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259178	10.1371/journal.pone.0259178	http://dx.doi.org/10.1371/journal.pone.0259178			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780488	Green Submitted, Green Published, gold			2022-12-26	WOS:000755305800022
J	Mills, MS; Schils, T				Mills, Matthew S.; Schils, Tom			The habitat-modifying red alga Ramicrusta on Pacific reefs: A new generic record for the Tropical Northwestern Pacific and the description of four new species from Guam	PLOS ONE			English	Article							SP-NOV PEYSSONNELIACEAE; PUERTO-RICO; RHODOPHYTA; DIVERSITY; CORALLINALES; PATTERNS; INCENDIA; BARCODE; CRUSTS; SP.	The genus Ramicrusta (order Peyssonneliales) is a new record for Micronesia, with range expansions of Ramicrusta fujiiana and R. lateralis to Guam. In addition, four species (Ramicrusta adjoulanensis, R. asanitensis, R. labtasiensis, and R. taogamensis) are newly described from Guam using molecular and anatomical characters. Ramicrusta lateralis specimens from Guam share most anatomical features with the holotype description from Vanuatu, but the plants from Guam are more tightly adherent, rigid, and robust than those of Vanuatu. Ramicrusta adjoulanensis possesses a well-developed epithallus with frequent cell fusions, secondary pit connections, and lacking hair bases or trichocytes, similar to Ramicrusta bonairensis. Ramicrusta adjoulanensis differs from other Ramicrusta species in having occasionally free margins and being attached by frequently produced, relatively long rhizoids (75-100 mu m long). Ramicrusta asanitensis shares features with many other species, but the thickness of the crust (upwards of 2 mm thick), heavy calcification in the epithallus, and the extent of secondary, tertiary, and quaternary growth, differentiate it from other Ramicrusta species. Ramicrusta labtasiensis shares features with its close relative Ramicrusta lateralis but possesses frequent, robust, and relatively long rhizoids (75-95 mu m long) throughout its entire undersurface. Ramicrusta taogamensis resembles its close relative Ramicrusta appressa but is primarily distinguished by its generally well-developed epithallus with occasional secondary pit connections and cell fusions. The six species reported here make Guam equal to Vanuatu in currently having the highest known species richness of Ramicrusta in the world.	[Mills, Matthew S.; Schils, Tom] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Mills, Matthew S.] Univ Sunshine Coast, Sch Sci Technol & Engn, Sippy Downs, Qld, Australia	University of Guam; University of the Sunshine Coast	Mills, MS (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.; Mills, MS (corresponding author), Univ Sunshine Coast, Sch Sci Technol & Engn, Sippy Downs, Qld, Australia.	millsm@triton.uog.edu		Mills, Matthew S./0000-0001-5596-6935	National Aeronautics and Space Administration (NASA); National Science Foundation (NSF) [80NSSC17M0052, OIA-1946352]; National Oceanic and Atmospheric Administration (NOAA) - University of Guam Sea Grant from NOAA Office of Sea Grant, Department of Commerce [NA14OAR4170116]	National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Oceanic and Atmospheric Administration (NOAA) - University of Guam Sea Grant from NOAA Office of Sea Grant, Department of Commerce	This research is based upon work supported by the National Aeronautics and Space Administration (NASA; nasa.gov) and the National Science Foundation (NSF; nsf.gov) under grant numbers 80NSSC17M0052 and OIA-1946352 awarded to TS and managed through the Guam EPSCoR offices of NASA and NSF. The work for this paper was also partly funded as an award to MM by a cooperative agreement with the National Oceanic and Atmospheric Administration (NOAA; noaa.gov), Project NA14OAR4170116, which is sponsored by the University of Guam Sea Grant from NOAA Office of Sea Grant, Department of Commerce. Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the authors and do not necessarily reflect the views of NASA, NSF, NOAA or any of their subagencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantine DL, 2016, BOT MAR, V59, P417, DOI 10.1515/bot-2016-0086; Ballantine DL, 2014, PHYCOL RES, V62, P197, DOI 10.1111/pre.12051; Ballantine DL, 2011, BOT MAR, V54, P293, DOI 10.1515/BOT.2011.039; Ballantine DL, 2011, CRYPTOGAMIE ALGOL, V32, P19; Caragnano A, 2009, CORAL REEFS, V28, P881, DOI 10.1007/s00338-009-0524-6; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DETHIER MN, 1991, BOT MAR, V34, P201, DOI 10.1515/botm.1991.34.3.201; Dixon K.R., 2018, ALGAE AUSTR MARINE B, P208; Dixon KR, 2013, PHYCOLOGIA, V52, P82, DOI 10.2216/12-62.1; Pestana EMD, 2020, PHYTOTAXA, V439, P39, DOI 10.11646/phytotaxa.439.1.2; Eckrich CE, 2011, CORAL REEFS, V30, P131, DOI 10.1007/s00338-010-0683-5; Eckrich CE, 2013, CORAL REEFS, V32, P81, DOI 10.1007/s00338-012-0961-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRESHWATER DW, 1994, PHYCOLOGIA, V33, P187, DOI 10.2216/i0031-8884-33-3-187.1; Guiry MD, ALGAEBASE WORLD WIDE; Hernandez-Kantun JJ, 2014, PHYTOTAXA, V190, P331, DOI 10.11646/phytotaxa.190.1.20; Hind KR, 2014, PHYCOLOGIA, V53, P443, DOI 10.2216/13-239.1; Huisman JM., 2018, RED ALGAE, V1st ed.; Judson BL, 2002, PHYCOLOGIA, V41, P68, DOI 10.2216/i0031-8884-41-1-68.1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krayesky DM, 2009, P BIOL SOC WASH, V122, P364, DOI 10.2988/08-43.1; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LITTLER MM, 1985, SCIENCE, V227, P57, DOI 10.1126/science.227.4682.57; Manghisi A, 2019, CRYPTOGAMIE ALGOL, V40, P13, DOI 10.5252/cryptogamie-algologie2019v40a3; Nash MC, 2015, J PHYCOL, V51, P403, DOI 10.1111/jpy.12299; Nieder C, 2019, B MAR SCI, V95, P459, DOI 10.5343/bms.2019.0010; Pueschel CM, 2009, PHYCOLOGIA, V48, P480, DOI 10.2216/09-04.1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raymundo LJ, 2019, CORAL REEFS, V38, P677, DOI 10.1007/s00338-019-01836-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saunders GW, 2013, ALGAE, V28, P31, DOI 10.4490/algae.2013.28.1.031; Saunders Gary W, 2012, Methods Mol Biol, V858, P207, DOI 10.1007/978-1-61779-591-6_10; Sherwood AR, 2021, PAC SCI, V75, P185, DOI 10.2984/75.2.2; Sherwood AR, 2020, ALGAE-SEOUL, V35, P145, DOI 10.4490/algae.2020.35.5.20; Sherwood AR, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-258; Sissini MN, 2014, PHYTOTAXA, V190, P299, DOI 10.11646/phytotaxa.190.1.18; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Stockton L, 2021, J EXP MAR BIOL ECOL, V541, DOI 10.1016/j.jembe.2021.151569; Verlaque M, 2000, BOT MAR, V43, P191, DOI 10.1515/BOT.2000.020; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P11724, DOI 10.1073/pnas.172234799; Zhang D., 1981, OCEANOL LIMNOL SINIC, V12, P538	43	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259336	10.1371/journal.pone.0259336	http://dx.doi.org/10.1371/journal.pone.0259336			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780513	Green Published, gold			2022-12-26	WOS:000755305800025
J	Wasche, H; Wolbring, L; Woll, A				Waesche, Hagen; Wolbring, Laura; Woll, Alexander			Physical activity promotion in an urban district: Analyzing the mechanisms of interorganizational cooperation	PLOS ONE			English	Article							SOCIAL NETWORK ANALYSIS; P-ASTERISK MODELS; PUBLIC-HEALTH; COMMUNITY COALITIONS; SPORT; COLLABORATION; PARTNERSHIPS; PARTICIPATION; PERSPECTIVE; GOVERNANCE	Past research has identified the importance of cooperation among community-based organizations from different sectors to address public health problems such as insufficient physical activity. However, little is known about how and why interorganizational cooperation occurs. The present study sought to analyze the structure and emergent patterns of interorganizational cooperation within a network promoting physical activity based in an urban district neighborhood of a city in Southwestern Germany. Survey data on cooperative relations among 61 network organizations and organizational attributes (e.g., possession of sport facilities) were collected. Social network analysis was applied to examine network properties and exponential random graph models were estimated to test hypotheses concerning mechanisms and conditions of cooperative tie formation. The results show that the network of cooperation is sparse but characterized by a tendency for cooperation to occur in triangular structures. Other significant mechanisms of cooperative tie formation are preferential attachment, with the community department for education and sports being the most central network actor, and heterophily regarding the cooperation of organizations from different sectors. This study provides valid and reliable findings on conditions of network formation and significant mechanisms of interorganizational cooperation in the field of physical activity promotion. Knowledge about these mechanisms can help to manage networks effectively and efficiently and reveal potentials for improvement and intensification of interorganizational cooperation in both the present and other research areas of health promotion.	[Waesche, Hagen; Wolbring, Laura; Woll, Alexander] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Wolbring, L (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci, Karlsruhe, Germany.	laura.wolbring@kit.edu		Wolbring, Laura/0000-0001-9596-1119	Ministry of Science, Research and Arts of BadenWurttemberg, a federal state of Germany; Karlsruhe Institute of Technology	Ministry of Science, Research and Arts of BadenWurttemberg, a federal state of Germany; Karlsruhe Institute of Technology(Helmholtz Association)	The study was funded by the Ministry of Science, Research and Arts of BadenWurttemberg, a federal state of Germany, within a research program to increase the contribution of science to sustainable development that started in 2015 (https://mwk.baden-wuerttemberg.de/de/forschung/forschungspolitik/wissenschaft-fuernachhaltigkeit/).We acknowledge support by the KIT-Publication Fund of the Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff R., 2003, LEVERAGING NETWORKS, DOI [10.1002/jmv.10253, DOI 10.1002/JMV.10253]; An RP, 2017, AM J HEALTH BEHAV, V41, P127, DOI [10.5993/AJHB.41.2.3, 10.5993/ajhb.41.2.3]; An Ruopeng, 2017, Prev Med Rep, V6, P294, DOI 10.1016/j.pmedr.2017.03.007; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnes M, 2010, HEALTH PROMOT INT, V25, P238, DOI 10.1093/heapro/daq002; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bevc CA, 2015, INT J ENV RES PUB HE, V12, P12412, DOI 10.3390/ijerph121012412; Bevc CA, 2015, AM J PUBLIC HEALTH, V105, pS230, DOI 10.2105/AJPH.2014.302256; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Borgatti SP., 2021, ANALYTIC TECHNOLOGIE; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Brandes U., 2021, VISONE VISUAL SOCIAL; Brownson RC, 2010, J PHYS ACT HEALTH, V7, pS242, DOI 10.1123/jpah.7.s2.s242; Buchthal OV, 2013, J PHYS ACT HEALTH, V10, P19, DOI 10.1123/jpah.10.1.19; Burt R. S, 1992, STRUCTURAL HOLES; Butterfoss FD, 1996, HEALTH EDUC QUART, V23, P65, DOI 10.1177/109019819602300105; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Emirbayer M, 1997, AM J SOCIOL, V103, P281, DOI 10.1086/231209; Erlhofer S., 2010, NETZWERKANALYSE NETZ, P251; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Hall JA, 2007, ADDICT BEHAV, V32, P3054, DOI 10.1016/j.addbeh.2007.04.008; Hambrick ME, 2019, SPORT MANAG REV, V22, P708, DOI 10.1016/j.smr.2018.12.002; Hamer M, 2017, ADV EXP MED BIOL, V999, P3, DOI 10.1007/978-981-10-4307-9_1; Hennig M., 2012, STUDYING SOCIAL NETW; Jones GJ, 2018, EUR SPORT MANAG Q, V18, P133, DOI 10.1080/16184742.2017.1322625; Jones GJ, 2017, J SPORT MANAGE, V31, P148, DOI 10.1123/jsm.2016-0118; Kadushin C., 2012, UNDERSTANDING SOCIAL; Koskinen J., 2013, EXPONENTIAL RANDOM G; Lasker RD, 2003, J URBAN HEALTH, V80, P14, DOI 10.1093/jurban/jtg014; Loitz CC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4661-5; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Mays GP, 2010, PREV CHRONIC DIS, V7; McCullough J Mac, 2016, BMC Public Health, V16, P566, DOI 10.1186/s12889-016-3194-7; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Meisel Jose D, 2014, Am J Health Promot, V28, pe127, DOI 10.4278/ajhp.120912-QUAN-443; Moreno J. L., 1934, WHO SHALL SURVIVE NE, DOI DOI 10.1037/10648; Mouttapa M, 2004, ADOLESCENCE, V39, P315; Parra DC, 2011, SOC SCI MED, V73, P1365, DOI 10.1016/j.socscimed.2011.08.020; Pfeffer J, 1978, EXTERNAL CONTROL ORG; POWELL WW, 1990, RES ORGAN BEHAV, V12, P295; Provan KG, 2008, J PUBL ADM RES THEOR, V18, P229, DOI 10.1093/jopart/mum015; Provan KG, 2005, PUBLIC ADMIN REV, V65, P603, DOI 10.1111/j.1540-6210.2005.00487.x; Provan KG, 2001, PUBLIC ADMIN REV, V61, P414, DOI 10.1111/0033-3352.00045; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Retrum JH, 2013, HEALTH EDUC BEHAV, V40, p13S, DOI 10.1177/1090198113492759; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robins G, 2012, POLICY STUD J, V40, P375, DOI 10.1111/j.1541-0072.2012.00458.x; Rowe K, 2013, SPORT MANAG REV, V16, P364, DOI 10.1016/j.smr.2012.12.003; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schoen MW, 2014, SOC SCI MED, V123, P90, DOI 10.1016/j.socscimed.2014.10.057; Thibault L., 2004, COMMERCIALISATION SP, P22; Timm I, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147306; Valente TW, 2007, AM J PUBLIC HEALTH, V97, P880, DOI 10.2105/AJPH.2005.063644; Valente TW, 2010, AM J PUBLIC HEALTH, V100, P1319, DOI 10.2105/AJPH.2009.171116; Varda D, 2012, AM J PUBLIC HEALTH, V102, P564, DOI 10.2105/AJPH.2011.300286; Varda DM, 2012, J PUBLIC HEALTH RES, V1, P170, DOI 10.4081/jphr.2012.e27; Varda Danielle M, 2008, J Public Health Manag Pract, V14, pE1, DOI 10.1097/01.PHH.0000333889.60517.46; Wasche H, 2017, EUR J SPORT SOC, V14, P138, DOI 10.1080/16138171.2017.1318198; Wasche H, 2015, SPORT MANAG REV, V18, P542, DOI 10.1016/j.smr.2015.01.003; Waitz C., 2017, BERICHTE GEOGRAPHIE, V91, P67; Wang P., 2009, MELBOURNE SCH PSYCHO; Wasche H, 2019, RES HANDB BUS MANAG, P202; Wasche H, 2021, INT J SPORT MARK SPO, V22, P816, DOI 10.1108/IJSMS-05-2020-0081; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolbring L, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-021-00729-7; World Health Organization, 2018, MOR ACT PEOPL HEALTH; Yessis J, 2013, HEALTH EDUC BEHAV, V40, p43S, DOI 10.1177/1090198113490724	70	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260053	10.1371/journal.pone.0260053	http://dx.doi.org/10.1371/journal.pone.0260053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780572	Green Published, gold			2022-12-26	WOS:000755305800089
J	Yu, L; Lang, Y; Hsu, CC; Chen, WM; Chiang, JC; Hsieh, JT; Story, MD; Shang, ZF; Chen, BPC; Saha, D				Yu, Lan; Lang, Yue; Hsu, Ching-Cheng; Chen, Wei-Min; Chiang, Jui-Chung; Hsieh, Jer-Tsong; Story, Michael D.; Shang, Zeng-Fu; Chen, Benjamin P. C.; Saha, Debabrata			Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex	ONCOGENE			English	Article							PROSTATE-CANCER; ANAPHASE; CDC20; MPS1; DRIVES; CELLS; UBIQUITINATION; LOCALIZATION; INACTIVATION; INSTABILITY	Chromosomal instability (CIN) is a driving force for cancer development. The most common causes of CIN include the dysregulation of the spindle assembly checkpoint (SAC), which is a surveillance mechanism that prevents premature chromosome separation during mitosis by targeting anaphase-promoting complex/cyclosome (APC/C). DAB2IP is frequently silenced in advanced prostate cancer (PCa) and is associated with aggressive phenotypes of PCa. Our previous study showed that DAB2IP activates PLK1 and functions in mitotic regulation. Here, we report the novel mitotic phosphorylation of DAB2IP by Cdks, which mediates DAB2IP's interaction with PLK1 and the activation of the PLK1-Mps1 pathway. DAB2IP interacts with Cdc20 in a phosphorylation-independent manner. However, the phosphorylation of DAB2IP inhibits the ubiquitylation of Cdc20 in response to SAC, and blocks the premature release of the APC/C-MCC. The PLK1-Mps1 pathway plays an important role in mitotic checkpoint complex (MCC) assembly. It is likely that DAB2IP acts as a scaffold to aid PLK1-Mps1 in targeting Cdc20. Depletion or loss of the Cdks-mediated phosphorylation of DAB2IP destabilizes the MCC, impairs the SAC, and increases chromosome missegregation and subsequent CIN, thus contributing to tumorigenesis. Collectively, these results demonstrate the mechanism of DAB2IP in SAC regulation and provide a rationale for targeting the SAC to cause lethal CIN against DAB2IP-deficient aggressive PCa, which exhibits a weak SAC.	[Yu, Lan; Hsu, Ching-Cheng; Chen, Wei-Min; Chiang, Jui-Chung; Story, Michael D.; Shang, Zeng-Fu; Chen, Benjamin P. C.; Saha, Debabrata] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Yu, Lan] Nanjing Med Univ, Suzhou Digest Dis & Nutr Res Ctr, Affiliated Suzhou Hosp, Suzhou 215008, Peoples R China; [Lang, Yue; Shang, Zeng-Fu] Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Med Coll, State Key Lab Radiat Med & Protect,Sch Radiat Med, Suzhou 215123, Peoples R China; [Hsieh, Jer-Tsong] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Hsieh, Jer-Tsong; Story, Michael D.; Chen, Benjamin P. C.; Saha, Debabrata] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Hsieh, Jer-Tsong] Natl Taiwan Univ, Dept Oncol, Natl Taiwan Univ Hosp, Coll Med, Taipei 10048, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Nanjing Medical University; Soochow University - China; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Taiwan University; National Taiwan University Hospital	Shang, ZF; Chen, BPC; Saha, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.; Shang, ZF (corresponding author), Soochow Univ, Collaborat Innovat Ctr Radiat Med Jiangsu Higher, Med Coll, State Key Lab Radiat Med & Protect,Sch Radiat Med, Suzhou 215123, Peoples R China.; Chen, BPC; Saha, D (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.	zengfu.shang@utsouthwestern.edu; benjamin.chen@utsouthwestern.edu; debabrata.saha@utsouthwestern.edu		Shang, Zeng-Fu/0000-0002-2396-1416; Saha, Debabrata/0000-0003-3477-4111; Chen, Wei-min/0000-0002-5247-7826; Chiang, Jui-Chung/0000-0001-9979-8347; HSU, CHING-CHENG/0000-0002-8804-6171; Chen, Benjamin/0000-0001-6958-8816	National Institutes of Health [CA233594, CA175879]; National Natural Science Foundation of China [81872546]; Natural Science Foundation of Jiangsu Province [BK20181180]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	The authors are grateful to Jonathan Feinberg and John Squire for editing the manuscript. National Institutes of Health [CA175879] to DS; National Institutes of Health [CA233594] to BPC; National Natural Science Foundation of China [#81872546] and Natural Science Foundation of Jiangsu Province [BK20181180] to LY.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Combes G, 2017, ONCOGENE, V36, P4819, DOI 10.1038/onc.2017.113; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; de Carcer G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05429-5; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Eytan E, 2014, P NATL ACAD SCI USA, V111, P12019, DOI 10.1073/pnas.1412901111; Faesen AC, 2017, NATURE, V542, P498, DOI 10.1038/nature21384; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Gao YF, 2011, NAT CELL BIOL, V13, P924, DOI 10.1038/ncb2287; Giam M, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0009-7; Guo ZY, 2021, ONCOGENE, V40, P1821, DOI 10.1038/s41388-020-01601-8; Ji ZJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22513; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kong ZL, 2010, CANCER RES, V70, P2829, DOI 10.1158/0008-5472.CAN-09-2919; London N, 2012, CURR BIOL, V22, P900, DOI 10.1016/j.cub.2012.03.052; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miniowitz-Shemtov S, 2012, P NATL ACAD SCI USA, V109, P8056, DOI 10.1073/pnas.1204081109; Moura M, 2017, ELIFE, V6, DOI 10.7554/eLife.25366; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musacchio A, 2012, NAT STRUCT MOL BIOL, V19, P1059, DOI 10.1038/nsmb.2429; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Orr B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00164; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Plumb LA, 2004, METH MOLEC MED, V88, P165; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Shepperd LA, 2012, CURR BIOL, V22, P891, DOI 10.1016/j.cub.2012.03.051; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Weichert W, 2004, PROSTATE, V60, P240, DOI 10.1002/pros.20050; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Wu KJ, 2013, CLIN CANCER RES, V19, P4740, DOI 10.1158/1078-0432.CCR-13-0954; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xie DX, 2009, P NATL ACAD SCI USA, V106, P19878, DOI 10.1073/pnas.0908458106; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Yu L, 2016, NUCLEIC ACIDS RES, V44, P8842, DOI 10.1093/nar/gkw746; Yu L, 2012, NEOPLASIA, V14, P1203, DOI 10.1593/neo.121310; Yun EJ, 2015, ONCOGENE, V34, P2741, DOI 10.1038/onc.2014.215; Yun EJ, 2019, CLIN CANCER RES, V25, P4542, DOI 10.1158/1078-0432.CCR-18-3004	51	1	1	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					489	501		10.1038/s41388-021-02106-8	http://dx.doi.org/10.1038/s41388-021-02106-8		NOV 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34775484	Green Published, hybrid			2022-12-26	WOS:000718063600001
J	Dowsett, J; Didriksen, M; Larsen, MH; Dinh, KM; Kaspersen, KA; Mikkelsen, S; Thorner, LW; Sorensen, E; Erikstrup, C; Pedersen, OB; Eugen-Olsen, J; Banasik, K; Ostrowski, SR				Dowsett, Joseph; Didriksen, Maria; Larsen, Margit Horup; Dinh, Khoa Manh; Kaspersen, Kathrine Agergard; Mikkelsen, Susan; Thorner, Lise Wegner; Sorensen, Erik; Erikstrup, Christian; Pedersen, Ole Birger; Eugen-Olsen, Jesper; Banasik, Karina; Ostrowski, Sisse Rye			Investigating the inflammation marker neutrophil-to-lymphocyte ratio in Danish blood donors with restless legs syndrome	PLOS ONE			English	Article							ASSOCIATION; POPULATION; PREVALENCE	Background Restless Legs Syndrome (RLS) is a neurological sensorimotor disorder that occurs in the evening and night, thereby impacting quality of sleep in sufferers. The pathophysiology of RLS is poorly understood but inflammation has been proposed as possibly being involved. The neutrophil-to-lymphocyte ratio (NLR) can be used as an inflammation marker but results from small studies have been inconclusive in determining whether NLR is associated with RLS. We aimed to assess whether an association between NLR and RLS exists in a large cohort of healthy individuals. Methods Neutrophils and lymphocytes were measured in blood samples of 13,055 individuals from the Danish Blood Donor Study, all of whom completed the validated Cambridge-Hopkins RLS-questionnaire for RLS assessment. Results In the sample, 661 individuals were determined as current RLS cases (5.1%). A higher proportion of individuals with RLS were females (62.5% vs 47.5%; P<0.001) and RLS cases were older than controls (P<0.001), but no differences in body mass index (BMI), smoking or alcohol consumption were found between the two groups. An increased NLR was observed in RLS cases compared to controls (median NLR: 1.80 vs 1.72; P = 0.033). In an unadjusted logistic regression model, increased NLR was associated with RLS (OR = 1.10 per NLR unit increase [95%CI:1.01-1.20]; P = 0.032); however, the association was not significant in multivariate models adjusting for sex and age (P = 0.094) or sex, age, alcohol consumption, smoking status and BMI (P = 0.107). Conclusion We found no association between RLS and NLR among Danish blood donors after adjusting for sex, age, alcohol consumption, smoking status and BMI. Further studies are needed to determine whether inflammation is a risk factor for RLS.	[Dowsett, Joseph; Didriksen, Maria; Larsen, Margit Horup; Thorner, Lise Wegner; Sorensen, Erik; Ostrowski, Sisse Rye] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Dinh, Khoa Manh; Kaspersen, Kathrine Agergard; Mikkelsen, Susan; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Kaspersen, Kathrine Agergard] Aarhus Univ, Danish Big Data Ctr Environm & Hlth BERTHA, Roskilde, Denmark; [Pedersen, Ole Birger] Zealand Univ Hosp, Dept Immunol, Koge, Denmark; [Eugen-Olsen, Jesper] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Hvidovre, Denmark; [Banasik, Karina] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Aarhus University; Aarhus University; University of Copenhagen	Dowsett, J (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark.	joseph.dowsett@regionh.dk	Dowsett, Joseph/AAT-7800-2020; Ostrowski, Sisse R/E-7423-2011; Banasik, Karina/S-3475-2019	Dowsett, Joseph/0000-0001-5381-2633; Ostrowski, Sisse R/0000-0001-5288-3851; Banasik, Karina/0000-0003-2489-2499; Mikkelsen, Susan/0000-0001-7806-1143; Dinh, Khoa Manh/0000-0003-1881-5673; Erikstrup, Christian/0000-0001-6551-6647; Pedersen, Ole Birger/0000-0003-2312-5976; Thorner, Lise Wegner/0000-0003-4391-4956; Kaspersen, Kathrine Agergard/0000-0002-7973-3623	Danish Council for Independent Research [09-069412, 0602-02634B]; Novo Nordisk Foundation [NNF17OC0027594, NNF14CC0001]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by: -the Danish Council for Independent Research (09-069412 and 0602-02634B), https://dff.dk/en -the Bio-and Genome Bank Denmark https://www.regioner.dk/rbgben -the Novo Nordisk Foundation (NNF17OC0027594) https://novonordiskfonden.dk/en/-K.B.acknowledges the Novo Nordisk Foundation (NNF14CC0001). https://novonordiskfonden.dk/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2014, SLEEP MED, V15, P860, DOI 10.1016/j.sleep.2014.03.025; Allen RP, 2011, MOVEMENT DISORD, V26, P114, DOI 10.1002/mds.23430; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Benediktsdottir B, 2010, SLEEP MED, V11, P1043, DOI 10.1016/j.sleep.2010.08.006; Burgdorf KS, 2016, COMPUT METH PROG BIO, V135, P101, DOI 10.1016/j.cmpb.2016.07.023; Didriksen M, 2018, SLEEP MED, V45, P124, DOI 10.1016/j.sleep.2018.02.007; Didriksen M, 2017, SLEEP MED, V36, P55, DOI 10.1016/j.sleep.2017.04.014; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Gossard TR, 2021, NEUROTHERAPEUTICS, V18, P140, DOI 10.1007/s13311-021-01019-4; Guo SY, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00171; Higuchi T, 2015, SLEEP MED, V16, P941, DOI 10.1016/j.sleep.2015.03.025; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Lv Q, 2021, CURR NEUROPHARMACOL, V19, P372, DOI 10.2174/1570159X19666201230150127; Pedrazzini B, 2014, VOX SANG, V107, P44, DOI 10.1111/vox.12123; Romero-Peralta S, 2020, CHEST, V158, P1218, DOI 10.1016/j.chest.2020.03.035; Tak AZA, 2018, TURK J NEUROL, V24, P259, DOI 10.4274/tnd.98474; Uslu FI, 2021, SLEEP BREATH, V25, P1581, DOI 10.1007/s11325-020-02218-7; Varim C, 2016, SINGAP MED J, V57, P514, DOI 10.11622/smedj.2016154; Weinstock LB, 2012, SLEEP MED REV, V16, P341, DOI 10.1016/j.smrv.2011.09.003; Winkelmann J, 2018, MOVEMENT DISORD, V33, P1077, DOI 10.1002/mds.27260; Yazar HO, 2019, SLEEP MED, V58, P61, DOI 10.1016/j.sleep.2019.02.022; Yeh P, 2012, SLEEP BREATH, V16, P987, DOI 10.1007/s11325-011-0606-x	22	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259681	10.1371/journal.pone.0259681	http://dx.doi.org/10.1371/journal.pone.0259681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767616	Green Published, gold			2022-12-26	WOS:000755249300039
J	Kenmochi, M; Ochi, K; Kinoshita, H; Miyamoto, Y; Koizuka, I				Kenmochi, Mutsumi; Ochi, Kentaro; Kinoshita, Hirotsugu; Miyamoto, Yasuhiro; Koizuka, Izumi			The effect of systemic administration of salicylate on the auditory cortex of guinea pigs	PLOS ONE			English	Article							RAT INFERIOR COLLICULUS; NEURAL ACTIVITY; QUININE; TINNITUS; NEURONS; SLICES	Objective To investigate the effect of systemic administration of salicylate as a tinnitus inducing drug in the auditory cortex of guinea pigs. Methods Extracellular recording of spikes of the primary auditory cortex and dorsocaudal areas in healthy male albino Hartley guinea pigs was continuously performed (pre- and post-salicylate). Results We recorded 160 single units in the primary auditory cortex from five guinea pigs and 156 single units in the dorsocaudal area from another five guinea pigs. The threshold was significantly elevated after the administration of salicylate in both the primary auditory cortex and dorsocaudal areas. The Q(10dB) value was significantly increased in the primary auditory cortex, whereas it has significantly decreased in the dorsocaudal area. Spontaneous firing activity was significantly decreased in the primary auditory cortex, whereas it has significantly increased in the dorsocaudal area. Conclusion Salicylate induces significant changes in single units of both stimulated and spontaneous activity in the auditory cortex of guinea pigs. The spontaneous activity changed differently depending on its cortical areas, which may be due to the neural elements that generate tinnitus.	[Kenmochi, Mutsumi; Ochi, Kentaro; Kinoshita, Hirotsugu; Miyamoto, Yasuhiro; Koizuka, Izumi] St Marianna Univ, Dept Otolaryngol, Sch Med, Kawasaki, Kanagawa, Japan	Saint Marianna University	Ochi, K (corresponding author), St Marianna Univ, Dept Otolaryngol, Sch Med, Kawasaki, Kanagawa, Japan.	k2ochi@w6.dion.ne.jp		Ochi, Kentaro/0000-0003-4817-4117	 [JP17591807]		This investigation was supported by a Grant-in-Aid for Scientific Research (C) (JP17591807) to K.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Basta D, 2008, HEARING RES, V240, P42, DOI 10.1016/j.heares.2008.02.005; Berger JI, 2017, HEARING RES, V356, P51, DOI 10.1016/j.heares.2017.10.012; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-2; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kenmochi M, 1997, HEARING RES, V113, P110, DOI 10.1016/S0378-5955(97)00137-8; Liu JX, 2003, HEARING RES, V175, P45, DOI 10.1016/S0378-5955(02)00708-6; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Manabe Y, 1997, HEARING RES, V103, P192, DOI 10.1016/S0378-5955(96)00181-5; Moller AR, 2007, PROG BRAIN RES, V166, P37, DOI 10.1016/S0079-6123(07)66003-8; MONGAN E, 1973, JAMA-J AM MED ASSOC, V226, P142, DOI 10.1001/jama.226.2.142; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-8; Ochi K, 2002, ANN OTO RHINOL LARYN, V111, P1092, DOI 10.1177/000348940211101206; Ochi K, 1996, HEARING RES, V95, P63, DOI 10.1016/0378-5955(96)00019-6; Su YY, 2009, HEARING RES, V253, P60, DOI 10.1016/j.heares.2009.03.007; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Wei L, 2010, HEARING RES, V267, P54, DOI 10.1016/j.heares.2010.03.088; Yanagawa Y, 2017, HEARING RES, V351, P98, DOI 10.1016/j.heares.2017.06.003; Zhang X, 2011, NEUROSCIENCE, V172, P232, DOI 10.1016/j.neuroscience.2010.10.073	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259055	10.1371/journal.pone.0259055	http://dx.doi.org/10.1371/journal.pone.0259055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762664	Green Published, gold			2022-12-26	WOS:000755316600011
J	Rodrigues, FS; Amat, HRA; Fortaleza, CMCB				Rodrigues, Fernanda Saad; Aiello Amat, Helena Ribeiro; Castelo Branco Fortaleza, Carlos Magno			Impact of restriction of over-the-counter sales of antimicrobials on antimicrobial resistance in Escherichia coli from community-onset urinary tract infections in inner SAo Paulo State, Brazil	PLOS ONE			English	Article								Background Antimicrobial resistance in community-associated infections is an increasing worldwide concern. In low-to-middle income countries, over-the-counter (OTC) sales of antimicrobials without medical prescription have been blamed for increasing consumption and resistance. We studied the impact of restriction of OTC sales of antimicrobials in Brazil (instituted in October 2010) on resistance trends of Escherichia coli from community-onset urinary tract infections. Methods We analyzed monthly resistance trend of Escherichia coli from community-onset urinary tract infections from 2005 through 2018. The data were submitted to interrupted time series analysis in both linear and Poisson regression models. Results We found impact on cefazolin (p<0.001) and amikacin (p<0.001) resistance as immediate impact of the intervention, and no beneficial impact on resistance to ciprofloxacin, ceftriaxone or sulfamethoxazole-trimethoprim. Conclusion At the present study, we found that OTC sales restriction did not generally impact on antimicrobial resistance.	[Rodrigues, Fernanda Saad; Aiello Amat, Helena Ribeiro; Castelo Branco Fortaleza, Carlos Magno] Sao Paulo State Univ UNESP, Botucatu Sch Med, Dept Infect Dis, City Of Botucatu, SP, Brazil	Universidade Estadual Paulista	Fortaleza, CMCB (corresponding author), Sao Paulo State Univ UNESP, Botucatu Sch Med, Dept Infect Dis, City Of Botucatu, SP, Brazil.	carlos.fortaleza@unesp.br	Fortaleza, Carlos Magno C. B./C-3807-2013	Fortaleza, Carlos Magno C. B./0000-0003-4120-1258				Aminov R, 2017, BIOCHEM PHARMACOL, V133, P4, DOI 10.1016/j.bcp.2016.10.001; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; CLSI, 2020, M100ED30 CLSI, DOI DOI 10.1016/S0196-4399(01)88009-0; David S, 2019, NAT MICROBIOL, V4, P1919, DOI 10.1038/s41564-019-0492-8; HELFENSTEIN U, 1986, STAT MED, V5, P37, DOI 10.1002/sim.4780050107; Jacobs TG, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4359-8; Kang CI, 2018, INFECT CHEMOTHER, V50, P67, DOI 10.3947/ic.2018.50.1.67; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Kliemann BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167885; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Moura ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001605; Munkholm L, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00639-3; Martinez EP, 2020, J ANTIMICROB CHEMOTH, V75, P2314, DOI 10.1093/jac/dkaa165; Ruppe E, 2018, TRAVEL MED INFECT DI, V21, P28, DOI 10.1016/j.tmaid.2017.11.007; Sakeena MHF, 2018, INT J ANTIMICROB AG, V52, P771, DOI 10.1016/j.ijantimicag.2018.09.022; Wallinga D, 2015, PUBLIC HEALTH, V129, P1314, DOI 10.1016/j.puhe.2015.08.012; WHO, 2015, ANTIMICROBIAL RESIST; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0259632	10.1371/journal.pone.0259632	http://dx.doi.org/10.1371/journal.pone.0259632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758027	Green Published, gold			2022-12-26	WOS:000755112500022
J	Hairol, MI; Ahmad, S; Sharanjeet-Kaur, S; Wee, LH; Abdullah, F; Ahmad, M				Hairol, Mohd Izzuddin; Ahmad, Sha'ari; Sharanjeet-Kaur, Sharanjeet; Wee, Lei Hum; Abdullah, Fauziah; Ahmad, Mahadir			Incidence and predictors of postpartum depression among postpartum mothers in Kuala Lumpur, Malaysia: A cross-sectional study	PLOS ONE			English	Article							HELP-SEEKING; RISK-FACTORS; POSTNATAL DEPRESSION; PERINATAL-PERIOD; PREVALENCE; WOMEN	Postpartum depression (PPD) is one of the mental health complications that may arise following childbirth. This cross-sectional study explores the association between socioeconomic factors and PPD literacy with PPD incidence in 350 participants (mean age: 30.58 +/- 4.72 years) at one to six months postpartum, who attended the Kuala Lumpur Health Clinic from May to October 2020. PPD incidence and literacy were assessed using the validated Malay versions of the Edinburgh Postpartum Depression Scale (EPDS) and the Postpartum Depression Literacy Scale (PoDLiS), respectively. The participants' socioeconomic characteristics were collected using a self-administered questionnaire. Chi-square tests were performed to determine the association between these factors and PPD incidence. Binary logistic regression models were used to determine the odds ratios (OR). The incidence of postpartum depressive symptoms was 14.29%. Those with low household income were twice likely to have PPD symptoms (OR:2.58, 95% CI:1.23-5.19; p = 0.01) than those with higher incomes. Unemployment (i.e., participants who were housewives/homemakers) was associated with higher PPD incidence (Chi(2)((2, 350)) = 6.97, p = 0.03), but it was not a significant PPD predictor. In conclusion, PPD incidence in the sample of Kuala Lumpur postpartum mothers is significantly associated with low household income. Other socioeconomic characteristics, including PPD literacy, were not significant predictors of PPD incidence.	[Hairol, Mohd Izzuddin; Ahmad, Sha'ari; Wee, Lei Hum; Ahmad, Mahadir] Univ Kebangsaan Malaysia, Ctr Community Hlth Studies ReaCH, Fac Hlth Sci, Kuala Lumpur, Malaysia; [Sharanjeet-Kaur, Sharanjeet] Univ Kebangsaan Malaysia, Ctr Rehabil & Special Needs Studies, Fac Hlth Sci, Kuala Lumpur, Malaysia; [Abdullah, Fauziah] Fed Terr Kuala Lumpur, Jabatan Kesihatan Wilayah Persekutuan Kuala Lumpu, Kuala Lumpur, Malaysia; [Abdullah, Fauziah] Putrajaya Hlth Dept, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Hairol, MI (corresponding author), Univ Kebangsaan Malaysia, Ctr Community Hlth Studies ReaCH, Fac Hlth Sci, Kuala Lumpur, Malaysia.	izzuddin.hairol@ukm.edu.my	Hairol, Mohd Izzuddin/C-4159-2017		Tun Fatimah Hashim Women's Leadership Centre, Universiti Kebangsaan Malaysia; Ministry of Women, Family, and Community Development, Malaysia [PKW-2019-004]	Tun Fatimah Hashim Women's Leadership Centre, Universiti Kebangsaan Malaysia; Ministry of Women, Family, and Community Development, Malaysia	Author MIH received funding from the Tun Fatimah Hashim Women's Leadership Centre, Universiti Kebangsaan Malaysia (https://www.ukm. my/pkwtfh/ms/), and the Ministry of Women, Family, and Community Development, Malaysia (https://www.kpwkm.gov.my/), grant number PKW-2019-004. The funders had no role in the study design; data collection, analysis, and interpretation; report writing; and in the decision to submit the article for publication.	Ab Razak A, 2017, MALAYS J MED SCI, V24, P1, DOI 10.21315/mjms2017.24.2.1; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Asikin N, 2019, IIUM MED J MALAYSIA, V18, DOI [10.31436/imjm.v18i1.226, DOI 10.31436/IMJM.V18I1.226]; Azidah A K, 2006, Med J Malaysia, V61, P76; Bodnar-Deren S, 2017, MATERN CHILD HLTH J, V21, P1457, DOI 10.1007/s10995-017-2263-6; Bottino MN, 2012, J AFFECT DISORDERS, V142, P219, DOI 10.1016/j.jad.2012.04.030; Branquinho M, 2020, COMMUNITY MENT HLT J, V56, P1436, DOI 10.1007/s10597-020-00587-7; Branquinho M, 2019, MIDWIFERY, V77, P86, DOI 10.1016/j.midw.2019.06.016; Department of Statistics Malaysia, HOUS INC EXP; Evagorou O, 2016, PSYCHIAT QUART, V87, P129, DOI 10.1007/s11126-015-9367-1; Farias-Anumez S, 2020, SOC PSYCH PSYCH EPID, V55, P635, DOI 10.1007/s00127-019-01827-2; Field T, 2018, INFANT BEHAV DEV, V51, P24, DOI 10.1016/j.infbeh.2018.02.005; Fonseca A, 2017, MIDWIFERY, V50, P78, DOI 10.1016/j.midw.2017.04.001; Fonseca A, 2015, MIDWIFERY, V31, P1177, DOI 10.1016/j.midw.2015.09.002; Goker Asli, 2012, ISRN Obstet Gynecol, V2012, P616759, DOI 10.5402/2012/616759; Grace J, 2001, TRANSCULT PSYCHIATRY, V38, P27, DOI [10.1177/136346150103800103, DOI 10.1177/136346150103800103]; Green Katherine, 2006, Psychol Health Med, V11, P425, DOI 10.1080/13548500600678164; Guy S, 2014, ARCH PSYCHIAT NURS, V28, P256, DOI 10.1016/j.apnu.2014.04.001; Hahn-Holbrook J, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00248; Harian Sinar., 2018, KEMURUNGAN SELEPAS B; Kadir AA., 2005, INT MED J TOKYO, V12, P105; Kementerian Kesihatan Malaysia, 2015, MAN PENJ POSTN BAG P, P1; Koo V, 2003, J OBSTET GYNAECOL RE, V29, P246, DOI 10.1046/j.1341-8076.2003.00104.x; Labrague LJ, 2020, PERSPECT PSYCHIATR C, V56, P308, DOI 10.1111/ppc.12428; Lewis BA, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-017-0496-6; Matsumura K, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2401-3; Mirsalimi F, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2705-9; Muhd Ramli ER., 2012, PENYAKIT MENTAL SELE; Ozcan NK, 2017, ARCH PSYCHIAT NURS, V31, P420, DOI 10.1016/j.apnu.2017.04.006; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Razali SM, 2000, INT J SOC PSYCHIATR, V46, P281, DOI 10.1177/002076400004600405; Stewart DE, 2019, ANNU REV MED, V70, P183, DOI 10.1146/annurev-med-041217-011106; Sword W, 2011, BJOG-INT J OBSTET GY, V118, P966, DOI 10.1111/j.1471-0528.2011.02950.x; Do TKL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4028913; Valdes V, 2021, INT J PSYCHOL, V56, P729, DOI 10.1002/ijop.12735; Vogel DL, 2007, J CLIN PSYCHOL, V63, P233, DOI 10.1002/jclp.20345; Wan Mahmud Wan Mohd Rushidi, 2002, Malays J Med Sci, V9, P41; Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388; Xiao-hu Z, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102353; Xiong RB, 2020, PERSPECT PSYCHIATR C, V56, P316, DOI 10.1111/ppc.12430; Yaacob MJ., 2004, ASIA PAC FAM MED, V3; Yagmur Y, 2010, INT J PUBLIC HEALTH, V55, P543, DOI 10.1007/s00038-010-0182-z; Yusuff ASM, 2015, WOMEN BIRTH, V28, P25, DOI 10.1016/j.wombi.2014.11.002; Zainal NZ, 2012, ASIA-PAC PSYCHIAT, V4, P144, DOI 10.1111/j.1758-5872.2011.00173.x	44	1	1	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259782	10.1371/journal.pone.0259782	http://dx.doi.org/10.1371/journal.pone.0259782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY0QZ	34752486	Green Published, gold			2022-12-26	WOS:000754499700034
J	Foley, H; Steel, A; McIntyre, E; Harnett, J; Sibbritt, D; Adams, J				Foley, Hope; Steel, Amie; McIntyre, Erica; Harnett, Joanna; Sibbritt, David; Adams, Jon			Disclosure of conventional and complementary medicine use to medical doctors and complementary medicine practitioners: A survey of rates and reasons amongst those with chronic conditions	PLOS ONE			English	Article							PERCEPTIONS; CARE	Chronic conditions are prolonged and complex, leading patients to seek multiple forms of care alongside conventional treatment, including complementary medicine (CM). These multiple forms of care are often used concomitantly, requiring patient-provider communication about treatments used in order to manage potential risks. In response, this study describes rates and reasons for disclosure/non-disclosure of conventional medicine use to CM practitioners, and CM use to medical doctors, by individuals with chronic conditions. A survey was conducted online in July and August 2017 amongst the Australian adult population. Participants with chronic conditions were asked about their disclosure-related communication with CM practitioners (massage therapist, chiropractor, acupuncturist, naturopath) and medical doctors. Patients consulting different professions reported varying disclosure rates and reasons. Full disclosure (disclosed ALL) to medical doctors was higher (62.7%-79.5%) than full disclosure to CM practitioners (41.2%-56.9%). The most strongly reported reason for disclosing to both MDs and CM practitioners was I wanted them to fully understand my health status, while for non-disclosure it was They did not ask me about my CM/medicine use. Reasons regarding concerns or expectations around the consultation or patient-provider relationship were also influential. The findings suggest that patient disclosure of treatment use in clinical consultation for chronic conditions may be improved through patient education about its importance, direct provider inquiry, and supportive patient-provider partnerships. Provision of optimal patient care for those with chronic conditions requires greater attention to patient-provider communication surrounding patients' wider care and treatment use.	[Foley, Hope; Steel, Amie; McIntyre, Erica; Harnett, Joanna; Sibbritt, David; Adams, Jon] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW, Australia; [Harnett, Joanna] Univ Sydney, Sch Pharm, Fac Med & Hlth, Sydney, NSW, Australia	University of Technology Sydney; University of Sydney	Foley, H (corresponding author), Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW, Australia.	hope.m.foley@student.uts.edu.au		Steel, Amie/0000-0001-6643-9444; Foley, Hope/0000-0003-4901-8300				Australian Health Ministers' Advisory Council, 2017, NATL STRATEGIC FRAME, P11643; Australian Institute of Health and Welfare, 2018, AUSTR HLTH SER, V16; Batavia M., 2004, J BODYW MOV THER, V8, P48, DOI [10.1016/S1360-8592(03)00084-6, DOI 10.1016/S1360-8592(03)00084-6]; Ben-Arye E, 2014, COMPLEMENT THER MED, V22, P304, DOI 10.1016/j.ctim.2014.01.005; Bishop FL, 2008, AM J PUBLIC HEALTH, V98, P1700, DOI 10.2105/AJPH.2007.110072; Boullata JI, 2012, J ACAD NUTR DIET, V112, P506, DOI 10.1016/j.jada.2011.09.002; Busse JW, 2005, MAYO CLIN PROC, V80, P616, DOI 10.4065/80.5.616; Foley H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38279-8; Foley H, 2017, PATIENT EDUC COUNS, V100, P212, DOI 10.1016/j.pec.2016.09.015; Fortune LD, 2015, J BODYW MOV THER, V19, P25, DOI 10.1016/j.jbmt.2014.01.005; Fox S, 2008, J AM ACAD NURSE PRAC, V20, P109, DOI 10.1111/j.1745-7599.2007.00295.x; Grace S, 2010, J ALTERN COMPLEM MED, V16, P945, DOI 10.1089/acm.2009.0437; Granello DH, 2004, J COUNS DEV, V82, P387, DOI 10.1002/j.1556-6678.2004.tb00325.x; Griffith LE, 2017, J EPIDEMIOL COMMUN H, V71, P381, DOI 10.1136/jech-2016-207982; Levine MAH, 2009, AM J GERIATR PHARMAC, V7, P383, DOI 10.1016/j.amjopharm.2009.12.003; Lin V, 2015, HEALTH EXPECT, V18, P2651, DOI 10.1111/hex.12239; Mamindla S, 2016, INT J PHARM SCI RES, V7, P3576, DOI 10.13040/IJPSR.0975-8232.7(9).3576-86; Matthews SM, 2009, PATIENT EDUC COUNS, V76, P31, DOI 10.1016/j.pec.2008.11.022; McIntyre E, 2021, RES SOC ADMIN PHARM, V17, P1791, DOI 10.1016/j.sapharm.2021.01.015; McIntyre E, 2020, PATIENT EDUC COUNS, V103, P1237, DOI 10.1016/j.pec.2020.01.008; Reid R, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1143-8; Sherman Karen J, 2005, BMC Complement Altern Med, V5, P13, DOI 10.1186/1472-6882-5-13; Steel A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35508-y; Tilburt JC, 2007, J AM BOARD FAM MED, V20, P489, DOI 10.3122/jabfm.2007.05.060205; Wardle J, 2017, J INTERPROF CARE, V31, P734, DOI 10.1080/13561820.2017.1351424; Wardle J, 2016, VACCINE, V34, P4484, DOI 10.1016/j.vaccine.2016.07.026; Wardle JL, 2013, CHIROPR MAN THER, V21, DOI 10.1186/2045-709X-21-5; White A, 2014, EUR J INTEGR MED, V6, P404, DOI 10.1016/j.eujim.2013.09.006; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2015, WHO GLOB STRAT PEOPL; World Health Organization, 2016, WHO TRADITIONAL MED	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258901	10.1371/journal.pone.0258901	http://dx.doi.org/10.1371/journal.pone.0258901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735474	Green Published, gold			2022-12-26	WOS:000755077100038
J	Lee, BH; Park, SW; Jo, S; Kim, MK				Lee, Byung Ho; Park, Soon Woo; Jo, Soojin; Kim, Moon Ki			Protein conformational transitions explored by a morphing approach based on normal mode analysis in internal coordinates	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; 3-DIMENSIONAL FOURIER SYNTHESIS; RIBOSE-BINDING PROTEIN; SMALL GLOBULAR PROTEIN; ADENYLATE KINASE; DYNAMICS; RESOLUTION; PREDICTION; CATALYSIS; TERMS	Large-scale conformational changes are essential for proteins to function properly. Given that these transition events rarely occur, however, it is challenging to comprehend their underlying mechanisms through experimental and theoretical approaches. In this study, we propose a new computational methodology called internal coordinate normal mode-guided elastic network interpolation (ICONGENI) to predict conformational transition pathways in proteins. Its basic approach is to sample intermediate conformations by interpolating the interatomic distance between two end-point conformations with the degrees of freedom constrained by the low-frequency dynamics afforded by normal mode analysis in internal coordinates. For validation of ICONGENI, it is applied to proteins that undergo open-closed transitions, and the simulation results (i.e., simulated transition pathways) are compared with those of another technique, to demonstrate that ICONGENI can explore highly reliable pathways in terms of thermal and chemical stability. Furthermore, we generate an ensemble of transition pathways through ICONGENI and investigate the possibility of using this method to reveal the transition mechanisms even when there are unknown metastable states on rough energy landscapes.	[Lee, Byung Ho; Park, Soon Woo; Kim, Moon Ki] Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea; [Jo, Soojin] Sungkyunkwan Univ, Dept Phys & Inst Basic Sci, Suwon, South Korea; [Kim, Moon Ki] Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotechnol SAINT, Suwon, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Kim, MK (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea.; Kim, MK (corresponding author), Sungkyunkwan Univ, Sungkyunkwan Adv Inst Nanotechnol SAINT, Suwon, South Korea.	mkkim1212@skku.edu		Jo, Soojin/0000-0002-5100-316X				Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Berry MB, 1998, PROTEINS, V32, P276, DOI 10.1002/(SICI)1097-0134(19980815)32:3<276::AID-PROT3>3.0.CO;2-G; Bjorkman AJ, 1998, J MOL BIOL, V279, P651, DOI 10.1006/jmbi.1998.1785; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; BRAUN W, 1984, J PHYS SOC JPN, V53, P3269, DOI 10.1143/JPSJ.53.3269; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; Cui Q., 2006, NORMAL MODE ANAL THE; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Eckart C, 1935, PHYS REV, V47, P552, DOI 10.1103/PhysRev.47.552; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Frezza E, 2019, J PHYS CHEM B, V123, P1294, DOI 10.1021/acs.jpcb.8b11913; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Goodsell DS, 2020, PROTEIN SCI, V29, P52, DOI 10.1002/pro.3730; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Gur M, 2013, BIOPHYS J, V105, P1643, DOI 10.1016/j.bpj.2013.07.058; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ikebe Jinzen, 2016, Biophys Rev, V8, P45, DOI 10.1007/s12551-015-0189-z; Jana B, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3516588; Jensen MR, 2014, CHEM REV, V114, P6632, DOI 10.1021/cr400688u; Kamiya K, 2003, J COMPUT CHEM, V24, P826, DOI 10.1002/jcc.10247; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2; KITAO A, 1994, BIOPHYS CHEM, V52, P107, DOI 10.1016/0301-4622(94)00070-0; Kong JY, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.052409; Lee BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185658; Lin CY, 2013, J PHYS CHEM B, V117, P13947, DOI 10.1021/jp4019537; Lu MY, 2006, J CHEM THEORY COMPUT, V2, P464, DOI 10.1021/ct050307u; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Mertens HDT, 2017, ARCH BIOCHEM BIOPHYS, V628, P33, DOI 10.1016/j.abb.2017.05.005; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; NOGUTI T, 1983, J PHYS SOC JPN, V52, P3283, DOI 10.1143/JPSJ.52.3283; Orellana L, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00117; Oshima H, 2019, J CHEM THEORY COMPUT, V15, P5199, DOI 10.1021/acs.jctc.9b00761; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Pietrucci F., 2017, REV PHYS, V2, P32, DOI DOI 10.1016/J.REVIP.2017.05.001; Lopez-Blanco JR, 2011, BIOINFORMATICS, V27, P2843, DOI 10.1093/bioinformatics/btr497; Saldano TE, 2020, J CHEM INF MODEL, V60, P3068, DOI 10.1021/acs.jcim.9b01136; Schlauderer GJ, 1996, J MOL BIOL, V256, P223, DOI 10.1006/jmbi.1996.0080; Schuler B, 2016, ANNU REV BIOPHYS, V45, P207, DOI 10.1146/annurev-biophys-062215-010915; SCHULZ GE, 1990, J MOL BIOL, V213, P627, DOI 10.1016/S0022-2836(05)80250-5; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi YG, 2014, CELL, V159, P995, DOI 10.1016/j.cell.2014.10.051; Tekpinar M, 2010, PROTEINS, V78, P2469, DOI 10.1002/prot.22755; Uversky VN, 2012, ANAL CHEM, V84, P2096, DOI 10.1021/ac203096k; Uyar A, 2014, BIOPHYS J, V106, P2656, DOI 10.1016/j.bpj.2014.05.017; Wang Y, 2013, J CHEM THEORY COMPUT, V9, P84, DOI 10.1021/ct300720s; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	52	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258818	10.1371/journal.pone.0258818	http://dx.doi.org/10.1371/journal.pone.0258818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735476	Green Published, gold			2022-12-26	WOS:000755077100035
J	Baraldo, M; Nogara, L; Dumitras, GA; Dondjang, AHT; Geremia, A; Scalabrin, M; Turk, C; Telkamp, F; Zentilin, L; Giacca, M; Kruger, M; Blaauw, B				Baraldo, Martina; Nogara, Leonardo; Dumitras, Georgia Ana; Tchampda Dondjang, Achille Homere; Geremia, Alessia; Scalabrin, Marco; Turk, Clara; Telkamp, Frederik; Zentilin, Lorena; Giacca, Mauro; Kruger, Marcus; Blaauw, Bert			Raptor is critical for increasing the mitochondrial proteome and skeletal muscle force during hypertrophy	FASEB JOURNAL			English	Article						hypertrophy; mitochondria; mTOR; rapamycin; Raptor; skeletal muscle	PATHWAY; GROWTH; REGENERATION; ABLATION; RICTOR; 4E-BP1	Loss of skeletal muscle mass and force is of critical importance in numerous pathologies, like age-related sarcopenia or cancer. It has been shown that the Akt-mTORC1 pathway is critical for stimulating adult muscle mass and function, however, it is unknown if mTORC1 is the only mediator downstream of Akt and which intracellular processes are required for functional muscle growth. Here, we show that loss of Raptor reduces muscle hypertrophy after Akt activation and completely prevents increases in muscle force. Interestingly, the residual hypertrophy after Raptor deletion can be completely prevented by administration of the mTORC1 inhibitor rapamycin. Using a quantitative proteomics approach we find that loss of Raptor affects the increases in mitochondrial proteins, while rapamycin mainly affects ribosomal proteins. Taken together, these results suggest that mTORC1 is the key mediator of Akt-dependent muscle growth and its regulation of the mitochondrial proteome is critical for increasing muscle force.	[Baraldo, Martina; Nogara, Leonardo; Geremia, Alessia; Blaauw, Bert] Venetian Inst Mol Med VIMM, Via Orus 2, I-35129 Padua, Italy; [Baraldo, Martina; Nogara, Leonardo; Dumitras, Georgia Ana; Tchampda Dondjang, Achille Homere; Geremia, Alessia; Scalabrin, Marco; Blaauw, Bert] Univ Padua, Dept Biomed Sci, Padua, Italy; [Turk, Clara; Telkamp, Frederik; Kruger, Marcus] Univ Cologne, Inst Genet, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Zentilin, Lorena] Int Ctr Genet Engn & Biotechnol ICGEB, AAV Vector Unit, Trieste, Italy; [Giacca, Mauro] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr Res Excellence, London, England; [Kruger, Marcus] Univ Cologne, Ctr Mol Med CMMC, Cologne, Germany	Veneto Institute Molecular Medicine; University of Padua; University of Cologne; International Center for Genetic Engineering & Biotechnology (ICGEB); University of London; King's College London; University of Cologne	Blaauw, B (corresponding author), Venetian Inst Mol Med VIMM, Via Orus 2, I-35129 Padua, Italy.; Blaauw, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	bert.blaauw@unipd.it	Tellkamp, Frederik/D-8027-2014	Tellkamp, Frederik/0000-0002-0473-7320; BLAAUW, BERT/0000-0002-4167-5106; BARALDO, MARTINA/0000-0002-3838-0526	Associazione Italiana per la Ricerca sul Cancro (AIRC) [20406]; Association Francaise contre les Myopathies (AFM) [21865]; University of Padova	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); University of Padova	Associazione Italiana per la Ricerca sul Cancro (AIRC), Grant/Award Number: 20406; Association Francaise contre les Myopathies (AFM), Grant/Award Number: 21865; University of Padova	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Baraldo M, 2020, J CACHEXIA SARCOPENI, V11, P208, DOI 10.1002/jcsm.12496; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blaauw B, 2010, J APPL PHYSIOL, V108, P105, DOI 10.1152/japplphysiol.00803.2009; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Kallabis S, 2020, SKELET MUSCLE, V10, DOI 10.1186/s13395-020-00226-5; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lossie J, 2014, BIOCHEM BIOPH RES CO, V450, P464, DOI 10.1016/j.bbrc.2014.05.142; Marabita M, 2016, CELL REP, V17, P501, DOI 10.1016/j.celrep.2016.09.020; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nolte H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31154-6; Ogasawara R, 2018, FASEB J, V32, P5824, DOI 10.1096/fj.201701422R; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Pansters NAM, 2015, BBA-MOL BASIS DIS, V1852, P490, DOI 10.1016/j.bbadis.2014.12.006; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pereira MG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00963; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Raffaello A, 2010, J CELL BIOL, V191, P101, DOI 10.1083/jcb.201001136; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Wang Y, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00591-0; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; You JS, 2019, FASEB J, V33, P4021, DOI 10.1096/fj.201801653RR; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008	35	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22031	10.1096/fj.202101054RR	http://dx.doi.org/10.1096/fj.202101054RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34767636				2022-12-26	WOS:000722321300009
J	Liu, YH; Zhang, LS; Guo, MC; Chen, L; Wu, BX; Huang, HD				Liu, Yanhong; Zhang, Linsheng; Guo, Maochao; Chen, Liu; Wu, Baixing; Huang, Hongda			Structural basis for anti-CRISPR repression mediated by bacterial operon proteins Aca1 and Aca2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; CLASSIFICATION; BACTERIOPHAGE; DEGRADATION; CLEAVAGE; BINDING	It has been shown that phages have evolved anti-CRISPR (Acr) proteins to inhibit host CRISPR-Cas systems. Most acr genes are located upstream of anti-CRISPR-associated (aca) genes, which is instrumental for identifying these acr genes. Thus far, eight Aca families (Aca1-Aca8) have been identified, all proteins of which share low sequence homology and bind to different target DNA sequences. Recently, Aca1 and Aca2 proteins were discovered to function as repressors by binding to acr-aca promoters, thus implying a potential anti-antiCRISPR mechanism. However, the structural basis for the repression roles of Aca proteins is still unknown. Here, we elucidated apo-structures of Aca1 and Aca2 proteins and their complex structures with their cognate operator DNA in two model systems, the Pseudomonas phage JBD30 and the Pecto-bacterium carotovorum template phage ZF40. In combination with biochemical and cellular assays, our study unveils dimerization and DNA-recognition mechanisms of Aca1 and Aca2 family proteins, thus revealing the molecular basis for Aca1-and Aca2-mediated anti-CRISPR repression. Our results also shed light on understanding the repression roles of other Aca family proteins and autoregulation roles of acr-aca operons.	[Liu, Yanhong] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Liu, Yanhong; Zhang, Linsheng; Guo, Maochao; Chen, Liu; Huang, Hongda] Southern Univ Sci & Technol, Sch Life Sci, Key Lab Mol Design Plant Cell Factory Guangdong H, Dept Biol, Shenzhen, Peoples R China; [Wu, Baixing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, RNA Biomed Inst,Guangdong Prov Key Lab Malignant, Guangzhou, Peoples R China	Harbin Institute of Technology; Southern University of Science & Technology; Sun Yat Sen University	Huang, HD (corresponding author), Southern Univ Sci & Technol, Sch Life Sci, Key Lab Mol Design Plant Cell Factory Guangdong H, Dept Biol, Shenzhen, Peoples R China.; Wu, BX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, RNA Biomed Inst,Guangdong Prov Key Lab Malignant, Guangzhou, Peoples R China.	wubx28@mail.sysu.edu.cn; huanghd@sustech.edu.cn		Liu, Yanhong/0000-0002-3595-0554; Zhang, Linsheng/0000-0001-7484-6939	National Key R&D Program of China [2018YFC1004500]; Shenzhen Government `Peacock Plan' [Y01226136]; Thousand Young Talents Program; Chinese National Natural Science Foundation of China [31900435]; Guangdong Science and Technology Department [2020B1212060018, 2020B1212030004]	National Key R&D Program of China; Shenzhen Government `Peacock Plan'; Thousand Young Talents Program(Chinese Academy of Sciences); Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This work was supported by the National Key R&D Program of China (2018YFC1004500); the Shenzhen Government `Peacock Plan' (Y01226136 to H. H.); Thousand Young Talents Program (to H. H.); Chinese National Natural Science Foundation of China (31900435 to B. W.); and Guangdong Science and Technology Department (2020B1212060018 and 2020B1212030004 to B. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Birkholz N, 2019, NUCLEIC ACIDS RES, V47, P9658, DOI 10.1093/nar/gkz721; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Csorgo B, 2020, NAT METHODS, V17, P1183, DOI 10.1038/s41592-020-00980-w; Davidson AR, 2020, ANNU REV BIOCHEM, V89, P309, DOI 10.1146/annurev-biochem-011420-111224; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Hadzi S, 2017, NUCLEIC ACIDS RES, V45, P4972, DOI 10.1093/nar/gkx138; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hampton HG, 2020, NATURE, V577, P327, DOI 10.1038/s41586-019-1894-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hwana S, 2019, CRISPR J, V2, P23, DOI 10.1089/crispr.2018.0052; Jackson SA, 2017, SCIENCE, V356, DOI 10.1126/science.aal5056; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kantonen SA, 2017, BBA-GEN SUBJECTS, V1861, P485, DOI 10.1016/j.bbagen.2016.09.002; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Marino ND, 2018, SCIENCE, V362, P240, DOI 10.1126/science.aau5174; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Osuna BA, 2020, CELL HOST MICROBE, V28, P23, DOI 10.1016/j.chom.2020.04.002; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pawluk A, 2016, CELL, V167, P1829, DOI 10.1016/j.cell.2016.11.017; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; PEREZMARTIN J, 1994, MICROBIOL REV, V58, P268; Rostol JT, 2019, CELL HOST MICROBE, V25, P184, DOI 10.1016/j.chom.2019.01.009; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Stanley SY, 2019, CELL, V178, P1452, DOI 10.1016/j.cell.2019.07.046; Stanley SY, 2018, ANNU REV GENET, V52, P445, DOI 10.1146/annurev-genet-120417-031321; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Watters KE, 2020, P NATL ACAD SCI USA, V117, P6531, DOI 10.1073/pnas.1917668117; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin YB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00455-19	43	5	5	5	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101357	10.1016/j.jbc.2021.101357	http://dx.doi.org/10.1016/j.jbc.2021.101357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1HP	34756887	gold, Green Published			2022-12-26	WOS:000748379600010
J	Brubaker, J; Kilic, T; Wollburg, P				Brubaker, Joshua; Kilic, Talip; Wollburg, Philip			Representativeness of individual-level data in COVID-19 phone surveys: Findings from Sub-Saharan Africa	PLOS ONE			English	Article							SMS	The COVID-19 pandemic has created urgent demand for timely data, leading to a surge in mobile phone surveys for tracking the impacts of and responses to the pandemic. Using data from national phone surveys implemented in Ethiopia, Malawi, Nigeria and Uganda during the pandemic and the pre-COVID-19 national face-to-face surveys that served as the sampling frames for the phone surveys, this paper documents selection the biases in individual-level analyses based on phone survey data. In most cases, individual-level data are available only for phone survey respondents, who we find are more likely to be household heads or their spouses and non-farm enterprise owners, and on average, are older and better educated vis-a-vis the general adult population. These differences are the result of uneven access to mobile phones in the population and the way that phone survey respondents are selected. To improve the representativeness of individual-level analysis using phone survey data, we recalibrate the phone survey sampling weights based on propensity score adjustments that are derived from a model of an individual's likelihood of being interviewed as a function of individual- and household-level attributes. We find that reweighting improves the representativeness of the estimates for phone survey respondents, moving them closer to those of the general adult population. This holds for both women and men and for a range of demographic, education, and labor market outcomes. However, reweighting increases the variance of the estimates and, in most cases, fails to overcome selection biases. This indicates limitations to deriving representative individual-level estimates from phone survey data. Obtaining reliable data on men and women through future phone surveys will require random selection of adult interviewees within sampled households.	[Brubaker, Joshua; Kilic, Talip] World Bank, Living Stand Measurement Study, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA; [Wollburg, Philip] World Bank, Dev Data Grp, Living Stand Measurement Study, Rome, Italy	The World Bank; The World Bank	Wollburg, P (corresponding author), World Bank, Dev Data Grp, Living Stand Measurement Study, Rome, Italy.	pwollburg@worldbank.org			World Bank Multi-Donor Trust Fund for Integrated Household and Agricultural Surveys in Low and Middle-Income Countries [TF072496]	World Bank Multi-Donor Trust Fund for Integrated Household and Agricultural Surveys in Low and Middle-Income Countries	Funding for data collection and analysis comes from the World Bank Multi-Donor Trust Fund for Integrated Household and Agricultural Surveys in Low and Middle-Income Countries (TF072496). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amankwah A., 2021, IMPACT COVID 19 CRIS; Amankwah A., 2020, HIGH FREQUENCY MOBIL; Amankwah A., 2021, LSMS INTEGRATED SURV; Ambel A., 2021, POLICY RES WORKING P; [Anonymous], HIGH FREQ PHON SURV; [Anonymous], 2020, HIGH FREQ MOB PHON S; Ballivian A, 2013, MOBILE RES METHODS O, DOI [10.5334/bar.c, DOI 10.5334/BAR.C]; Dabalen A., 2016, MOBILE PHONE PANEL S, DOI [10.1596/978-1-4648-0904-0, DOI 10.1596/978-1-4648-0904-0]; Etang A, 2020, DATA COLLECTION IN FRAGILE STATES: INNOVATIONS FROM AFRICA AND BEYOND, P15, DOI 10.1007/978-3-030-25120-8_2; Fu H., 2020, DATA BLOG; Fu H., 2020, MAY; Furbush A., 2021, 9556 WORLD BANK, DOI [10.1111/cobi.13569, DOI 10.1111/COBI.13569]; Gibson DG, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001604; Glazerman S., 2020, INNOVATION POVERTY A; Greenleaf AR, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/17891; Henderson S., 2020, INNOVATION POVERTY A; Himelein K., 2020, GUIDELINES SAMPLING, DOI [10.1186/s12942-020-00205-5, DOI 10.1186/S12942-020-00205-5]; Himelein K, 2014, STAT PUBLIC POLICY, V1, P40, DOI 10.1080/2330443X.2013.856170; IPA, 2020, INN POV ACT; Josephson A., 2020, 9466 WORLD BANK; Josephson A, 2021, NAT HUM BEHAV, V5, P557, DOI 10.1038/s41562-021-01096-7; Kanyanda SSE., 9739 WORLD BANK; Khamis M., 2021, 9510 WORLD BANK; Kilic T., 2020, WORLD BANK POLICY RE; Kilic T, 2021, WORLD DEV, V146, DOI 10.1016/j.worlddev.2021.105545; L'Engle K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190902; Lau C., 2018, SURV PRACT, P11; Lau CQ, 2019, SURV RES METHODS-GER, V13, P305, DOI 10.18148/srm/2019.v13i3.7375; Lau CQ, 2019, FIELD METHOD, V31, P214, DOI 10.1177/1525822X19862506; Leo B., 2015, CTR GLOBAL DEV WORKI, DOI [10.2139/ssrn.2623097, DOI 10.2139/SSRN.2623097]; Little RJA, 1997, AM J EPIDEMIOL, V146, P439, DOI 10.1093/oxfordjournals.aje.a009297; Lives Young, LIST YOUNG LIV WORK; McKenzie D., 2012, HELPS ATTRITION IS J; Okoro S., 2020, WILL COVID 19 WIDEN; Ozler B., 2019, REDUCING ATTRITION P; Palacios-Lopez A., 2020, HIGH FREQUENCY MOBIL; Quisumbing AR., 2020, WHY GENDER MATTERS C, DOI [10.2499/p15738coll2.133762_20, DOI 10.2499/P15738COLL2.133762_20]; Ringler, 2020, PHONE SURVEYS UNDERS; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Roy Mathur M., 2020, REFLECTIONS REACHING; Tille Y., 2006, SPR S STAT; United Nations and World Bank, 2020, MON STAT STAT OP UND; United Nations World Bank., 2020, MON STAT STAT OP COV, P18; Women Count,, 2020, UNL LOCKD GEND EFF C; Zezza Alberto, 2021, Food Policy, V105, P102153, DOI 10.1016/j.foodpol.2021.102153	45	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258877	10.1371/journal.pone.0258877	http://dx.doi.org/10.1371/journal.pone.0258877			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788292	Green Published, gold			2022-12-26	WOS:000735920500009
J	Oyamada, Y; Ozuru, R; Masuzawa, T; Miyahara, S; Nikaido, Y; Obata, F; Saito, M; Villanueva, SYAM; Fujii, J				Oyamada, Yuji; Ozuru, Ryo; Masuzawa, Toshiyuki; Miyahara, Satoshi; Nikaido, Yasuhiko; Obata, Fumiko; Saito, Mitsumasa; Villanueva, Sharon Yvette Angelina M.; Fujii, Jun			A machine learning model of microscopic agglutination test for diagnosis of leptospirosis	PLOS ONE			English	Article							CANCER; CATTLE	Leptospirosis is a zoonosis caused by the pathogenic bacterium Leptospira. The Microscopic Agglutination Test (MAT) is widely used as the gold standard for diagnosis of leptospirosis. In this method, diluted patient serum is mixed with serotype-determined Leptospires, and the presence or absence of aggregation is determined under a dark-field microscope to calculate the antibody titer. Problems of the current MAT method are 1) a requirement of examining many specimens per sample, and 2) a need of distinguishing contaminants from true aggregates to accurately identify positivity. Therefore, increasing efficiency and accuracy are the key to refine MAT. It is possible to achieve efficiency and standardize accuracy at the same time by automating the decision-making process. In this study, we built an automatic identification algorithm of MAT using a machine learning method to determine agglutination within microscopic images. The machine learned the features from 316 positive and 230 negative MAT images created with sera of Leptospira-infected (positive) and non-infected (negative) hamsters, respectively. In addition to the acquired original images, wavelet-transformed images were also considered as features. We utilized a support vector machine (SVM) as a proposed decision method. We validated the trained SVMs with 210 positive and 154 negative images. When the features were obtained from original or wavelet-transformed images, all negative images were misjudged as positive, and the classification performance was very low with sensitivity of 1 and specificity of 0. In contrast, when the histograms of wavelet coefficients were used as features, the performance was greatly improved with sensitivity of 0.99 and specificity of 0.99. We confirmed that the current algorithm judges the positive or negative of agglutinations in MAT images and gives the further possibility of automatizing MAT procedure.	[Oyamada, Yuji] Tottori Univ, Fac Engn, Dept Elect Engn & Comp Sci, Tottori, Japan; [Ozuru, Ryo; Obata, Fumiko; Fujii, Jun] Tottori Univ, Fac Med, Dept Microbiol & Immunol, Div Bacteriol, Yonago, Tottori, Japan; [Masuzawa, Toshiyuki] Chiba Inst Sci, Fac Pharmaceut Sci, Lab Microbiol & Immunol, Choshi, Chiba, Japan; [Miyahara, Satoshi; Nikaido, Yasuhiko; Saito, Mitsumasa] Univ Occupat & Environm Hlth, Sch Med, Dept Microbiol, Kitakyushu, Fukuoka, Japan; [Villanueva, Sharon Yvette Angelina M.] Univ Philippines Manila, Coll Publ Hlth, Dept Med Microbiol, Manila, Philippines; [Ozuru, Ryo] Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka, Japan	Tottori University; Tottori University; University of Occupational & Environmental Health - Japan; University of the Philippines System; University of the Philippines Manila; Fukuoka University	Ozuru, R (corresponding author), Tottori Univ, Fac Med, Dept Microbiol & Immunol, Div Bacteriol, Yonago, Tottori, Japan.; Ozuru, R (corresponding author), Fukuoka Univ, Fac Med, Dept Microbiol & Immunol, Fukuoka, Japan.	ozuru@fukuoka-u.ac.jp		Ozuru, Ryo/0000-0002-0616-0190; Miyahara, Satoshi/0000-0001-8522-860X; Obata, Fumiko/0000-0001-6260-9426	JSPS KAKENHI [18K16174, 21K16320]; Tottori University President; Research Program of the International Platform for Dryland Research and Education, Tottori University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tottori University President; Research Program of the International Platform for Dryland Research and Education, Tottori University	This work was partially supported by JSPS KAKENHI Grant Number 18K16174 and 21K16320 to R.O., the discretionary fund of Tottori University President to Y.O. and R.O, and the Research Program of the International Platform for Dryland Research and Education, Tottori University to J.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bishop C. M, 2006, PATTERN RECOGNITION; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Brandao AP, 1998, J CLIN MICROBIOL, V36, P3138; Chappel RJ, 2004, J CLIN MICROBIOL, V42, P5484, DOI 10.1128/JCM.42.12.5484-5488.2004; Chirathaworn Chintana, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1111; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Derdour SY, 2017, J VET RES, V61, P337, DOI 10.1515/jvetres-2017-0044; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Faine S., 1982, GUIDELINE CONTROL LE, V67, P129; FRIEDMAN RJ, 1985, CA-CANCER J CLIN, V35, P130, DOI 10.3322/canjclin.35.3.130; GALTON MM, 1958, AM J VET RES, V19, P505; Goris Marga G A, 2014, Curr Protoc Microbiol, V32, DOI 10.1002/9780471729259.mc12e05s32; Guedes IB, 2019, J MICROBIOL METH, V166, DOI 10.1016/j.mimet.2019.105737; Lee G.R., 2019, J OPEN SOURCE SOFTW, V4, P1237, DOI [10.21105/joss.01237, DOI 10.21105/JOSS.01237]; Levett PN, 2015, CURR TOP MICROBIOL, V387, P11, DOI 10.1007/978-3-662-45059-8_2; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lilenbaum Walter, 2002, Rev Latinoam Microbiol, V44, P124; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Majumder S, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0786-8; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Ngbede EO, 2013, REV MED VET-TOULOUSE, V164, P85; Peiffer-Smadja N, 2020, CLIN MICROBIOL INFEC, V26, P584, DOI 10.1016/j.cmi.2019.09.009; SOLORZANO RF, 1967, CORNELL VET, V57, P239; Sumathi G, 1997, INDIAN J MED MICROBI, V15, P84; Terpstra W.J., 2003, HUM LEPT GUID DIAGN; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; William W, 2018, COMPUT METH PROG BIO, V164, P15, DOI 10.1016/j.cmpb.2018.05.034; Yin XX, 2017, HEALTH INFOR SCI, DOI 10.1007/978-3-319-57027-3; Zheng A., 2018, FEATURE ENG MACHINE	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259907	10.1371/journal.pone.0259907	http://dx.doi.org/10.1371/journal.pone.0259907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784387	gold, Green Submitted, Green Published			2022-12-26	WOS:000755277300027
J	Kruger, K; Fricke, LM; Dilger, EM; Thiele, A; Schaubert, K; Hoekstra, D; Heidenreich, F; Brutt, AL; Stahmeyer, JT; Stahmann, A; Roper, AL; Kubiak, KP; Hemmerling, M; Grau, A; Eichstadt, K; Behrens, S; Krauth, C				Krueger, Kathrin; Fricke, Lara Marleen; Dilger, Elise-Marie; Thiele, Annett; Schaubert, Kristina; Hoekstra, Dyon; Heidenreich, Fedor; Bruett, Anna Levke; Stahmeyer, Jona T.; Stahmann, Alexander; Roper, Anna-Lena; Kubiak, Klaus-Peter; Hemmerling, Melissa; Grau, Anja; Eichstaedt, Kerstin; Behrens, Sabine; Krauth, Christian			How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV)	PLOS ONE			English	Article							DISABILITY ASSESSMENT; DISEASE STEPS; 1ST WAVE; MOBILITY; QUALITY; COSTS; PARTICIPATION; INTERVIEW; VALIDITY; INSIGHTS	Background Multiple sclerosis (MS) is the most common autoimmune inflammatory disease of the central nervous system in Europe, often causing severe physical, cognitive and emotional impairments. Currently, it is unclear whether the healthcare provisions of people with MS (PwMS) are in line with the recommendations for treatment based on guidelines or patients' needs. The main objectives of the study are as follows: (a) to investigate how well PwMS are treated; and (b) to develop a needs-oriented, patient-centred care model. Methods This mixed-methods study focuses on adult PwMS living in Lower Saxony, a federal state in Germany. The qualitative study comprises focus groups with PwMS, physicians and people involved in the healthcare process as well as a future workshop. The quantitative study comprises a cross-sectional online survey and addresses the patient-relevant outcomes and needs, as previously determined by literature searches and focus groups. It will be administered to all PwMS who are insured by the statutory health insurance company involved in the project (n similar to 7,000). The survey data will be linked to the longitudinal secondary data from the statutory health insurance company and data from the German MS registry where available. The linked and single data sources will be statistically analysed. Discussion By comprehensively comparing the current healthcare provisions with the needs and requirements of PwMS, the strengths and weaknesses of the overall healthcare process and provision of assistive devices can be identified. The barriers and facilitators of the health service providers and their impact on daily life will be explored (qualitative analyses). Reliable recommendations for improvements will be given based on a study population drawn from the largest statutory health insurance company in Lower Saxony (quantitative analyses). However, the inherent advantages and limitations of the qualitative and quantitative research approaches need to be considered.	[Krueger, Kathrin; Fricke, Lara Marleen; Schaubert, Kristina; Krauth, Christian] Hannover Med Sch MHH, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Krueger, Kathrin; Fricke, Lara Marleen; Schaubert, Kristina; Krauth, Christian] Ctr Hlth Econ Res CHERH, Hannover, Germany; [Dilger, Elise-Marie; Bruett, Anna Levke] Carl von Ossietzky Univ Oldenburg, Dept Versorgungsforsch, Oldenburg, Germany; [Thiele, Annett; Hoekstra, Dyon] Carl von Ossietzky Univ Oldenburg, Inst Sonder & Rehabilitationspadagog, Oldenburg, Germany; [Heidenreich, Fedor] DIAKOVERE Henriettenstift, Klin Neurol & Klin Neurophysiol, Hannover, Germany; [Heidenreich, Fedor; Kubiak, Klaus-Peter; Grau, Anja; Behrens, Sabine] Deutsch Multiple Sklerose Gesell DMSG Landesverba, Hannover, Germany; [Stahmeyer, Jona T.; Hemmerling, Melissa] AOK Niedersachsen, Hlth Serv Res Unit, Hannover, Germany; [Stahmann, Alexander; Roper, Anna-Lena; Eichstaedt, Kerstin] MS Forschungs & Projektentwicklungs gGmbH, Hannover, Germany	Hannover Medical School; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Fricke, LM (corresponding author), Hannover Med Sch MHH, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany.; Fricke, LM (corresponding author), Ctr Hlth Econ Res CHERH, Hannover, Germany.	fricke.lara@mh-hannover.de		Fricke, Lara Marleen/0000-0001-7508-0840	German Federal Joint Committee's Innovation Fund [01VSF19046]	German Federal Joint Committee's Innovation Fund	This study is funded (on the basis of a peer review) by the German Federal Joint Committee's Innovation Fund (grant number 01VSF19046) from 1 April 2020 to 31 March 2023 (URL to sponsors' website: https:// innovationsfonds.g-ba.de/). The funding body had no role in study design, preparation of the manuscript or decision to publish. The funding body is not and will not be involved in the collection, analysis or interpretation of the study data.	Berger U, 2020, PSYCHOTHER PSYCH MED, V70, P396, DOI 10.1055/a-1088-1354; Beutel ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186516; Bruckmann N., 2014, MPT ATD PA MATCHING; Bundesministerium fur Gesundheit, 2020, DAT GES; Cohen J.E., 1988, STAT POWER ANAL BEHA; Demers L., 2000, QUEBEC USER EVALUATI; Dijcks BPJ, 2006, DISABIL REHABIL, V28, P909, DOI 10.1080/09638280500301527; Dobson R, 2019, EUR J NEUROL, V26, P27, DOI 10.1111/ene.13819; Drennan J, 2003, J ADV NURS, V42, P57, DOI 10.1046/j.1365-2648.2003.02579.x; Egger B, 2012, PFLEGE, V25, P329, DOI 10.1024/1012-5302/a000229; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flachenecker P., 2021, NR, V27, P37, DOI [10.14624/NR2101005, DOI 10.14624/NR2101005]; Flachenecker P, 2017, MULT SCLER J, V23, P78, DOI 10.1177/1352458517708141; Gosswald A, 2013, BUNDESGESUNDHEITSBLA, V56, P611, DOI 10.1007/s00103-013-1671-z; Gugiu C, 2010, J EVAL CLIN PRACT, V16, P509, DOI 10.1111/j.1365-2753.2009.01151.x; Gugiu PC, 2009, CHRONIC ILLN, V5, P268, DOI 10.1177/1742395309348072; Haghikia A, 2021, LEITLINIEN DIAGNOSTI; Hemmer B., 2012, LEITLINIEN DIAGNOSTI, V5th ed; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1177/135245859900500508; Holstiege J., EPIDEMIOLOGIE MULTIP; Howard J, 2016, NEUROL CLIN, V34, P919, DOI 10.1016/j.ncl.2016.06.016; Iverson D, 2010, J OCCUP ENVIRON MED, V52, P1206, DOI 10.1097/JOM.0b013e3181fd276a; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Jaunzeme J, 2013, BUNDESGESUNDHEITSBLA, V56, P447, DOI 10.1007/s00103-012-1626-9; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Jungk R., 1989, PHANTASIE GEGEN ROUT; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Kingwell E, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-128; Kobelt G, 2017, MULT SCLER J, V23, P1123, DOI 10.1177/1352458517694432; Kuckartz U., 2012, METHODEN PRAXIS COMP; Kuhn T., 2018, GRUPPENDISKUSSIONEN; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Marasinghe KM, 2016, DISABIL REHABIL-ASSI, V11, P353, DOI 10.3109/17483107.2015.1087061; Marrie RA, 2007, MULT SCLER J, V13, P1176, DOI 10.1177/1352458507078388; Ness NH, 2020, J MED INTERNET RES, V22, DOI 10.2196/17921; Nothacker M, 2014, Z EVIDENZ FORTBILD Q, V108, P550, DOI 10.1016/j.zefq.2014.10.012; Ohle LM, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92722-x; Perotti L, 2020, DISABIL REHABIL-ASSI, DOI 10.1080/17483107.2020.1841837; Pfeiffer K., 2008, QUEST 2 0 G; Pottgen J, 2018, J NEUROL NEUROSUR PS, V89, P970, DOI 10.1136/jnnp-2017-317463; Roelands M, 2002, GERONTOLOGIST, V42, P39, DOI 10.1093/geront/42.1.39; Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427; Schenk L, 2006, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V49, P853, DOI 10.1007/s00103-006-0018-4; Scherer M., 1998, MATCHING PERSON TECH; Scherer MJ., 2005, MATCHING PERSON TECH; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Seidl H, 2015, GESUNDHEITSWESEN, V77, P46, DOI 10.1055/s-0034-1372618; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Solari A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066127; Souza A, 2010, J REHABIL RES DEV, V47, P213, DOI 10.1682/JRRD.2009.07.0096; Sozialgesetzbuch (SGB), 2021, SGB; Squires LA, 2019, J HEALTH PSYCHOL, V24, P480, DOI 10.1177/1359105316677293; Sterz C., 2016, EDORIUM J DISABIL RE, V2, P1, DOI [10.5348/D05-2016-8-OA-4, DOI 10.5348/D05-2016-8-OA-4]; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Verza R, 2006, MULT SCLER J, V12, P88, DOI 10.1191/1352458506ms1233oa; Weinman J., 1995, CAUSAL CONTROL BELIE; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wicks P, 2011, J MED INTERNET RES, V13, P117, DOI 10.2196/jmir.1687; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	64	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259855	10.1371/journal.pone.0259855	http://dx.doi.org/10.1371/journal.pone.0259855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2MY	34762697	Green Published, gold			2022-12-26	WOS:000755316600048
J	Gorji-Bahri, G; Moradtabrizi, N; Hashemi, A				Gorji-Bahri, Gilar; Moradtabrizi, Niloofar; Hashemi, Atieh			Uncovering the stability status of the reputed reference genes in breast and hepatic cancer cell lines	PLOS ONE			English	Article							HOUSEKEEPING GENES; PCR DATA; EXPRESSION; NORMALIZATION; SELECTION; VALIDATION; MCF-7; ALPHA; MODEL	Accurate and reliable relative gene expression analysis via the Reverse Transcription-quantitative Real Time PCR (RT-qPCR) method strongly depends on employing several stable reference genes as normalizers. Utilization of the reference genes without analyzing their expression stability under each experimental condition causes RT-qPCR analysis error as well as false output. Similar to cancerous tissues, cancer cell lines also exhibit various gene expression profiles. It is crucial to recognize stable reference genes for well-known cancer cell lines to minimize RT-qPCR analysis error. In this study, we showed the expression level and investigated the expression stability of eight common reference genes that are ACTB, YWHAZ, HPRT1, RNA18S, TBP, GAPDH, UBC, and B2M, in two sets of cancerous cell lines. One set contains MCF7, SKBR3, and MDA-MB231 as breast cancer cell lines. Another set includes three hepatic cancer cell lines, including Huh7, HepG2, and PLC-PRF5. Three excel-based softwares comprising geNorm, BestKeeper, and NormFinder, and an online tool, namely RefFinder were used for stability analysis. Although all four algorithms did not show the same stability ranking of nominee genes, the overall results showed B2M and ACTB as the least stable reference genes for the studied breast cancer cell lines. While TBP had the lowest expression stability in the three hepatic cancer cell lines. Moreover, YWHAZ, UBC, and GAPDH showed the highest stability in breast cancer cell lines. Besides that, a panel of five nominees, including ACTB, HPRT1, UBC, YWHAZ, and B2M showed higher stability than others in hepatic cancer cell lines. We believe that our results would help researchers to find and to select the best combination of the reference genes for their own experiments involving the studied breast and hepatic cancer cell lines. To further analyze the reference genes stability for each experimental condition, we suggest researchers to consider the provided stability ranking emphasizing the unstable reference genes.	[Gorji-Bahri, Gilar; Moradtabrizi, Niloofar; Hashemi, Atieh] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran	Shahid Beheshti University Medical Sciences	Hashemi, A (corresponding author), Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran.	at_hashemi@sbmu.ac.ir		Gorji Bahri, Gilar/0000-0003-4994-593X	Shahid Beheshti University of Medical Sciences, Tehran, Iran [IR.SBMU. PHARMACY.REC.1397.233]	Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was supported by the research deputy of Shahid Beheshti University of Medical Sciences, Tehran, Iran under Grant IR.SBMU. PHARMACY.REC.1397.233. atieh hashemi received the grant The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alotaibi Moureq R, 2018, Asian Pac J Cancer Prev, V19, P777; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2020, CANC TODAY WHO; Berardocco M, 2017, ONCOTARGET, V8, P82920, DOI 10.18632/oncotarget.20503; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Chua SL, 2011, CYTOTECHNOLOGY, V63, P645, DOI 10.1007/s10616-011-9383-4; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; Ferreira E, 2012, MOL BIOTECHNOL, V50, P121, DOI 10.1007/s12033-011-9425-3; Gomez V, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax4585; Gorji-Bahri G, 2021, CELL BIOL INT, V45, P1098, DOI 10.1002/cbin.11556; Gorji-bahri G, 2021, J CELL BIOCHEM, V122, P425, DOI 10.1002/jcb.29871; Hashemi A, 2012, BIOCHEM BIOPH RES CO, V426, P649, DOI 10.1016/j.bbrc.2012.09.009; Hassan N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59057-5; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hernandez-Segura A, 2019, AGING CELL, V18, DOI 10.1111/acel.12911; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang PS, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040961; Jain N, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00313-x; Karimi Z, 2018, J CLUST SCI, V29, P159, DOI 10.1007/s10876-017-1313-y; Kilic Y, 2014, CLIN TRANSL ONCOL, V16, P184, DOI 10.1007/s12094-013-1058-5; Lee S, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101210; Leng EN, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2189-6; Li TY, 2017, ONCOL LETT, V14, P7384, DOI 10.3892/ol.2017.7154; Liu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117058; Majidzadeh-A Keivan, 2011, BMC Res Notes, V4, P215, DOI 10.1186/1756-0500-4-215; Maltseva Diana V, 2013, J Clin Bioinforma, V3, P13, DOI 10.1186/2043-9113-3-13; Marin DE, 2019, N-S ARCH PHARMACOL, V392, P937, DOI 10.1007/s00210-019-01644-z; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Nourbakhsh Nooshin, 2018, Adv Biomed Res, V7, P42, DOI 10.4103/abr.abr_252_16; Nwosu ZC, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0872-6; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pourani Z, 2017, J CLUST SCI, V28, P2623, DOI 10.1007/s10876-017-1243-8; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Shah UK, 2018, MUTAT RES-GEN TOX EN, V825, P51, DOI 10.1016/j.mrgentox.2017.12.005; Su HC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68835-0; Suchanek KM, 2002, MOL CARCINOGEN, V34, P165, DOI 10.1002/mc.10061; Tang JM, 2018, ONCOGENE, V37, P4723, DOI 10.1038/s41388-018-0310-4; Valenti MT, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-49; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vydra N, 2019, CANCERS, V11, DOI 10.3390/cancers11101533; Wang JL, 2019, GYNECOL ONCOL, V152, P194, DOI 10.1016/j.ygyno.2018.10.002; Wang Y, 2017, BIOCHEM BIOPH RES CO, V493, P429, DOI 10.1016/j.bbrc.2017.09.005; Whitley SK, 2016, J INVEST DERMATOL, V136, pE77, DOI 10.1016/j.jid.2016.06.003; Wu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-506; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yamada A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18407-6; Yan WY, 2020, ONCOTARGETS THER, V13, P7423, DOI 10.2147/OTT.S249733; Zhang CZ, 2020, ONCOGENE, V39, P4507, DOI 10.1038/s41388-020-1303-7; Zhang GJ, 2020, ONCOGENE, V39, P3229, DOI 10.1038/s41388-020-1215-6	52	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259669	10.1371/journal.pone.0259669	http://dx.doi.org/10.1371/journal.pone.0259669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752497	Green Published, gold			2022-12-26	WOS:000754499700024
J	Nascimento, PC; Aragao, WAB; Bittencourt, LO; Dionizio, A; Buzalaf, MAR; Crespo-Lopez, ME; Lima, RR				Nascimento, Priscila Cunha; Braganca Aragao, Walessa Alana; Bittencourt, Leonardo Oliveira; Dionizio, Aline; Buzalaf, Marilia A. R.; Crespo-Lopez, Maria Elena; Lima, Rafael Rodrigues			Maternal methylmercury exposure changes the proteomic profile of the offspring's salivary glands: Prospects on translational toxicology	PLOS ONE			English	Article							MERCURY; KALLIKREIN; INTOXICATION; PROTEINS; DAMAGE	Background Methylmercury (MeHg) remains a public health issue since developing organisms are particularly vulnerable to this environmental contaminant. This study investigated the effect of maternal MeHg exposure on the modulation of proteomic profile of parotid (PA), submandibular (SM), and sublingual (SL) glands of offspring rats. Materials and methods Pregnant Wistar rats were daily exposed to 40 mu g/kg MeHg during both gestational and lactation periods. The proteomic profiles of the major salivary glands of the offspring rats were analyzed through mass spectrometry. Results The offspring rats exposed to MeHg showed significant alterations in the proteomic profiles of the PA, SM, and SL glands. Altered proteins were associated with cytoskeleton components, tissue morphogenesis, and response to stimulus and stress. Conclusion This original study showed that maternal MeHg exposure significantly modulates the expression of proteins and induces alterations in the proteomic profiles of developing salivary glands.	[Nascimento, Priscila Cunha; Braganca Aragao, Walessa Alana; Bittencourt, Leonardo Oliveira; Lima, Rafael Rodrigues] Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil; [Dionizio, Aline; Buzalaf, Marilia A. R.] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [Crespo-Lopez, Maria Elena] Fed Univ Para, Inst Biol Sci, Lab Mol Pharmacol, Belem, Para, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Universidade Federal do Para	Lima, RR (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil.	rafalima@ufpa.br	Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Lima, Rafael Rodrigues/M-7726-2019; Bittencourt, Leonardo O/N-4526-2017; Dionizio, Aline/N-6464-2016	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Lima, Rafael Rodrigues/0000-0003-1486-4013; Bittencourt, Leonardo O/0000-0002-9525-2723; Dionizio, Aline/0000-0002-8687-0124; Nascimento, Priscila/0000-0003-4949-2870	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq) [435093/2018-5]; Coordination of Personal Improvement of Higher Education (CAPES) [001]; Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESPUFPA)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Personal Improvement of Higher Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESPUFPA)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -Brasil (CNPq) (grant no. 435093/2018-5) and the Coordination of Personal Improvement of Higher Education (CAPES -Finance Code 001). The APC was funded by Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para ' (PROPESPUFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdoosh M, 2017, BIOINFORMATICS, V33, P414, DOI 10.1093/bioinformatics/btw623; Farias PMA, 2017, METALLOMICS, V9, P1778, DOI 10.1039/c7mt00168a; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arrifano GPF, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00285; Arrifano GPF, 2018, ECOTOX ENVIRON SAFE, V147, P299, DOI 10.1016/j.ecoenv.2017.08.048; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bittencourt LO, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5653291; Bjorklund G, 2017, ENVIRON RES, V159, P545, DOI 10.1016/j.envres.2017.08.051; Bjornberg KA, 2005, ENVIRON HEALTH PERSP, V113, P1381, DOI 10.1289/ehp.7856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charone S, 2016, CARIES RES, V50, P24, DOI 10.1159/000442301; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Council NR., 2011, ANIMALS CUGCUL GUIDE, VEighth, DOI [10.1258/la.2010.010031 21123303, DOI 10.1258/LA.2010.01003121123303]; Crespo-Lopez ME, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106223; Lima LAD, 2018, BIOL TRACE ELEM RES, V185, P135, DOI 10.1007/s12011-017-1230-9; de Oliveira Lopes Gessica, 2021, Biol Trace Elem Res, V199, P3707, DOI 10.1007/s12011-020-02492-2; Melo CGD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01090-y; Dionizio A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140419; Dionizio AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21533-4; du Sert NP, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000411; Esdaile LJ, 2018, CHEM-EUR J, V24, P6905, DOI 10.1002/chem.201704840; Fabian TK., 2008, CHEM BIOL WILEY ENCY, P1; Arrifano GDF, 2018, NEUROTOXICOLOGY, V68, P151, DOI 10.1016/j.neuro.2018.07.018; Gad S.C., 2014, ENCY TOXICOLOGY, P318, DOI 10.1016/b978-0-12-386454-3.00881-2; GARRETT JR, 1982, HISTOCHEM J, V14, P967, DOI 10.1007/BF01005237; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Ghosh S., 2018, HEAT SHOCK PROT STRE, V6, P109, DOI [10.1007/978-3-319-90725-3_6, DOI 10.1007/978-3-319-90725-3_6]; Greabu Maria, 2009, J Med Life, V2, P124; Hand AR., 2015, FUNDAMENTALS ORAL HI; Hughes C, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-51; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Kong HK, 2013, J PROTEOME RES, V12, P5233, DOI 10.1021/pr400356v; Kucera Mike, 2016, F1000Res, V5, P1717; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Leite AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106646; Levine M, 2011, INT J DENT, V2011, DOI 10.1155/2011/953412; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Marti-Alamo Silvia, 2012, J Clin Exp Dent, V4, pe237, DOI 10.4317/jced.50865; Ferreira MKM, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111437; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Michalke B, 2015, INT ARCH OCC ENV HEA, V88, P1, DOI 10.1007/s00420-014-0938-5; Miller DJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00821; Nanci A., 2019, 10 CATE HISTOLOGIA O; Nascimento PC, 2021, BIOL TRACE ELEM RES, V199, P2983, DOI 10.1007/s12011-020-02409-z; Nogueira LS, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8470857; Olsvik PA, 2011, CHEMOSPHERE, V83, P552, DOI 10.1016/j.chemosphere.2010.12.019; Pesch A, 2002, J EXPO ANAL ENV EPID, V12, P252, DOI 10.1038/sj.jea.7500228; Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Pollard KM, 2019, BBA-GEN SUBJECTS, V1863, DOI 10.1016/j.bbagen.2019.02.001; Porcheri C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090976; Program UNE., 2019, GLOBAL MERCURY ASSES; R Core Team, 2021, R LANGUAGE ENV STAT; Ree R, 2020, J BIOL CHEM, V295, P16713, DOI 10.1074/jbc.RA120.015468; Reichmann D, 2018, MOL CELL, V69, P203, DOI 10.1016/j.molcel.2017.12.021; Santos-Sacramento L, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111686; TAGA R, 1979, ARCH HISTOL JAPON, V42, P427, DOI 10.1679/aohc1950.42.427; Thapa M, 2013, MOL BIOL CELL, V24, P3620, DOI 10.1091/mbc.E13-02-0097; Ursinyova M, 2019, BIOL TRACE ELEM RES, V191, P16, DOI 10.1007/s12011-018-1585-6; van de Bor Margot, 2019, Handb Clin Neurol, V162, P31, DOI 10.1016/B978-0-444-64029-1.00002-3; WHO, 2008, GUIDANCE IDENTIFYING; WHO, 2017, MERCURY HLTH WHO; WONG RSC, 1983, BIOCHEM J, V211, P35, DOI 10.1042/bj2110035; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Yahiro J, 1996, ARCH ORAL BIOL, V41, P225, DOI 10.1016/0003-9969(95)00116-6; Yang JP, 2021, MICROVASC RES, V135, DOI 10.1016/j.mvr.2021.104144; Yang LX, 2020, CHEMOSPHERE, V245, DOI 10.1016/j.chemosphere.2019.125586	66	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258969	10.1371/journal.pone.0258969	http://dx.doi.org/10.1371/journal.pone.0258969			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748590	gold, Green Published			2022-12-26	WOS:000755468000016
J	Nam, KW; Kwon, HM; Lee, YS				Nam, Ki-Woong; Kwon, Hyung-Min; Lee, Yong-Seok			Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer	PLOS ONE			English	Article							SUBTYPE; DETERIORATION; SURVIVAL	Background In ischemic stroke patients with active cancer, cryptogenic stroke has worse prognosis than stroke by conventional mechanisms. However, the individual effects of intracranial atherosclerosis (ICAS) or atrial fibrillation (AF) on the prognosis of these patients have not been studied. Aims Therefore, we aimed to investigate the effects of ICAS and AF on the prognosis of ischemic stroke patients with active cancer. Methods We included ischemic stroke patients with active cancer between 2010 and 2020. Early neurological deterioration (END) was defined as an increase of >= 1 in the motor NIHSS score, or >= 2 in the total NIHSS score within 72 hours of admission. Unfavorable outcomes were defined as a score of >= 3 on the 3-month modified Rankin Scale. Results In total, 116 ischemic stroke patients with active cancer were evaluated. In multivariable analysis, ICAS was positively associated with END (adjusted odds ratio [aOR] = 4.56, 95% confidence interval [CI]: 1.52-13.70), and this association showed a quantitative relationship according to the degree of stenosis of ICAS (stenosis group: aOR = 4.24, 95% CI: 1.31-13.72; occlusion group, aOR = 5.74, 95% CI: 1.05-31.30). ICAS was also closely related to unfavorable outcomes (aOR = 6.33, 95% CI: 1.15-34.79). In contrast, AF showed no significant association with END or unfavorable outcomes. Our data showed that patients with ICAS had larger and more severe initial stroke lesions, and poorer prognosis than those without. Conclusions ICAS, but not AF, was closely associated with poor prognosis in ischemic stroke patients with active cancer.	[Nam, Ki-Woong; Kwon, Hyung-Min; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Nam, Ki-Woong; Kwon, Hyung-Min; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea.; Kwon, HM (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	hmkwon@snu.ac.kr						ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bang OY, 2020, J STROKE, V22, P1, DOI 10.5853/jos.2019.02278; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Jannini TB, 2022, NEUROL SCI, V43, P1167, DOI 10.1007/s10072-021-05449-y; Kim BS, 2017, STROKE, V48, P2819, DOI 10.1161/STROKEAHA.117.017806; Kim JS, 2017, J STROKE, V19, P261, DOI 10.5853/jos.2017.01830; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Kneihsl M, 2016, J NEUROL, V263, P150, DOI 10.1007/s00415-015-7954-6; Lee JS, 2018, J STROKE, V20, P394, DOI 10.5853/jos.2018.01627; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Nam KW, 2017, EUR J NEUROL, V24, P205, DOI 10.1111/ene.13184; Nam KW, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01031-6; Nam KW, 2018, ATHEROSCLEROSIS, V269, P117, DOI 10.1016/j.atherosclerosis.2017.12.035; Nam KW, 2017, ATHEROSCLEROSIS, V265, P179, DOI 10.1016/j.atherosclerosis.2017.09.010; Nam KW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172793; Navi BB, 2021, STROKE, V52, P1121, DOI 10.1161/STROKEAHA.120.032002; Navi BB, 2018, NEUROLOGY, V90, pE2025, DOI 10.1212/WNL.0000000000005636; Navi BB, 2018, ANN NEUROL, V83, P873, DOI 10.1002/ana.25227; Navi BB, 2017, J AM COLL CARDIOL, V70, P927, DOI 10.1016/j.jacc.2017.06.047; Navi BB, 2014, STROKE, V45, P2292, DOI 10.1161/STROKEAHA.114.005784; Schwarzbach CJ, 2015, CEREBROVASC DIS EXTR, V5, P139, DOI 10.1159/000439549; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; Shin YW, 2016, J NEURO-ONCOL, V128, P277, DOI 10.1007/s11060-016-2106-0; Siegler JE, 2011, INT J STROKE, V6, P211, DOI 10.1111/j.1747-4949.2011.00596.x; Toscano M, 2015, EUR NEUROL, V74, P171, DOI 10.1159/000441056	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259627	10.1371/journal.pone.0259627	http://dx.doi.org/10.1371/journal.pone.0259627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739530	Green Published, gold			2022-12-26	WOS:000755000800044
J	Gamage, NW; Bamforth, J; Ashfaq, T; Bernard, K; Grafenhan, T; Walkowiak, S				Gamage, Niradha Withana; Bamforth, Janice; Ashfaq, Tehreem; Bernard, Kathryn; Grafenhan, Tom; Walkowiak, Sean			Profiling of Bacillus cereus on Canadian grain	PLOS ONE			English	Article							SP NOV.; FOOD; STRAINS; GENE; PSYCHROTOLERANT; PRODUCTS; SEQUENCE; PLASMID; SOIL	Microorganisms that cause foodborne illnesses challenge the food industry; however, environmental studies of these microorganisms on raw grain, prior to food processing, are uncommon. Bacillus cereus sensu lato is a diverse group of bacteria that is common in our everyday environment and occupy a wide array of niches. While some of these bacteria are beneficial to agriculture due to their entomopathogenic properties, others can cause foodborne illness; therefore, characterization of these bacteria is important from both agricultural and food safety standpoints. We performed a survey of wheat and flax grain samples in 2018 (n = 508) and 2017 (n = 636) and discovered that B. cereus was present in the majority of grain samples, as 56.3% and 85.2%, in two years respectively. Whole genome sequencing and comparative genomics of 109 presumptive B. cereus isolates indicates that most of the isolates were closely related and formed two genetically distinct groups. Comparisons to the available genomes of reference strains suggested that the members of these two groups are not closely related to strains previously reported to cause foodborne illness. From the same data set, another, genetically more diverse group of B. cereus was inferred, which had varying levels of similarity to previously reported strains that caused disease. Genomic analysis and PCR amplification of genes linked to toxin production indicated that most of the isolates carry the genes nheA and hbID, while other toxin genes and gene clusters, such as ces, were infrequent. This report of B. cereus on grain from Canada is the first of its kind and demonstrates the value of surveillance of bacteria naturally associated with raw agricultural commodities such as cereal grain and oilseeds.	[Gamage, Niradha Withana; Bamforth, Janice; Ashfaq, Tehreem; Grafenhan, Tom; Walkowiak, Sean] Govt Canada, Canadian Grain Commiss, Winnipeg, MB, Canada; [Bernard, Kathryn; Grafenhan, Tom; Walkowiak, Sean] Publ Hlth Agcy Canada, Natl Microbiol Lab, Govt Canada, Winnipeg, MB, Canada	Public Health Agency of Canada	Grafenhan, T; Walkowiak, S (corresponding author), Govt Canada, Canadian Grain Commiss, Winnipeg, MB, Canada.; Grafenhan, T; Walkowiak, S (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Govt Canada, Winnipeg, MB, Canada.	tom.graefenhan@canada.ca; sean.walkowiak@grainscanada.gc.ca						Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BEECHER DJ, 1995, INFECT IMMUN, V63, P4423, DOI 10.1128/IAI.63.11.4423-4428.1995; Berghofer LK, 2003, INT J FOOD MICROBIOL, V85, P137, DOI 10.1016/S0168-1605(02)00507-X; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; Biesta-Peters EG, 2016, J FOOD PROTECT, V79, P230, DOI 10.4315/0362-028X.JFP-15-217; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonis M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246885; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Carroll LM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00144; Ceuppens S, 2013, FEMS MICROBIOL ECOL, V84, P433, DOI 10.1111/1574-6941.12110; Chang YH, 2003, APPL ENVIRON MICROB, V69, P4502, DOI 10.1128/AEM.69.8.4502-4510.2003; Daczkowska-Kozon Elzbieta G., 2009, Polish Journal of Food and Nutrition Sciences, V59, P53; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; Ehling-Schulz M, 2005, APPL ENVIRON MICROB, V71, P105, DOI 10.1128/AEM.71.1.105-113.2005; Ehling-Schulz M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00704; Ehling-Schulz M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00032; Fricker M, 2007, APPL ENVIRON MICROB, V73, P1892, DOI 10.1128/AEM.02219-06; Glasset B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194346; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Guinebretiere MH, 2006, FEMS MICROBIOL LETT, V259, P74, DOI 10.1111/j.1574-6968.2006.00247.x; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Jimenez G, 2013, SYST APPL MICROBIOL, V36, P383, DOI 10.1016/j.syapm.2013.04.008; Jung MY, 2011, J MICROBIOL, V49, P1027, DOI 10.1007/s12275-011-1049-6; Jung MY, 2010, J MICROBIOL, V48, P867, DOI 10.1007/s12275-010-0148-0; Kindle P, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz240; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lechner S, 1998, INT J SYST BACTERIOL, V48, P1373, DOI 10.1099/00207713-48-4-1373; Liu B, 2014, ANTON LEEUW INT J G, V105, P501, DOI 10.1007/s10482-013-0102-3; Liu C, 2007, PLASMID, V57, P44, DOI 10.1016/j.plasmid.2006.06.002; Liu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14082; Lotte R, 2017, EMERG INFECT DIS, V23, P845, DOI 10.3201/eid2305.161788; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Mallick I, 2014, ECOTOX ENVIRON SAFE, V107, P236, DOI 10.1016/j.ecoenv.2014.06.007; Marcais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944; Messelhausser U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/465603; Miller RA, 2016, INT J SYST EVOL MICR, V66, P4744, DOI 10.1099/ijsem.0.001421; Molva C, 2009, FOOD CONTROL, V20, P829, DOI 10.1016/j.foodcont.2008.10.016; Organji Sameer Rushdi, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P515, DOI 10.1016/j.apjtb.2015.04.004; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Reyes JE, 2007, FOOD MICROBIOL, V24, P1, DOI 10.1016/j.fm.2006.04.004; Reyes-Ramirez A, 2008, APPL ENVIRON MICROB, V74, P125, DOI 10.1128/AEM.02133-07; Ruan LF, 2015, TRENDS MICROBIOL, V23, P341, DOI 10.1016/j.tim.2015.02.011; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Wehrle E, 2010, MOL CELL PROBE, V24, P124, DOI 10.1016/j.mcp.2009.11.004; Zeng QC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35300-y; Zhou C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060976	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259209	10.1371/journal.pone.0259209	http://dx.doi.org/10.1371/journal.pone.0259209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735500	Green Published, gold			2022-12-26	WOS:000755077100052
J	Placheta-Gyorl, E; Brandstetter, LM; Zemann-Schalss, J; Wolf, S; Radtke, C				Placheta-Gyoerl, Eva; Brandstetter, Lea Maria; Zemann-Schaelss, Jakob; Wolf, Sonja; Radtke, Christine			Myelination, axonal loss and Schwann cell characteristics in axonal polyneuropathy compared to controls	PLOS ONE			English	Article							SURAL NERVE BIOPSY; DIABETIC-NEUROPATHY; REGENERATION; MOTOR; EXPRESSION; APOPTOSIS; TERM	Introduction Polyneuropathy is a debilitating condition characterized by distal sensory and motor deficits. Schwann cell dysfunction and axonal loss are integral factors in pathophysiology and disease progression of polyneuropathy. Aims The aim of this study was the assessment of Schwann cell characteristics, nerve fibers and myelination parameters in polyneuropathy patients compared to controls. Methods Nerve tissue was obtained from polyneuropathy patients (n = 10) undergoing diagnostic sural nerve biopsies. Biopsies of healthy peripheral nerves (n = 5) were harvested during elective sural nerve grafting for chronic peripheral nerve lesions. Exclusion criteria for the healthy control group were recent neurological trauma, diabetes, neurological and cardiovascular disease, as well as active malignancies and cytotoxic medication within the last 12 months. The over-all architecture of nerve sections and myelination parameters were histomorphometrically analyzed. Immunofluorescent imaging was used to evaluate Schwann cell phenotypes, senescence markers and myelination parameters. Results Histomorphometric analysis of nerve biopsies showed significant axonal loss in polyneuropathy patients compared to controls, which was in accordance with the neuropathological findings. Immunofluorescent staining of Schwann cells and myelin basic protein indicated a significant impairment of myelination and lower Schwann cell counts compared to controls. Phenotypic alterations and increased numbers of non-myelinating p75-positive Schwann cells were found in polyneuropathy patients. Discussion This study provided quantitative data of axonal loss, reduced myelination and Schwann cell dysfunction of polyneuropathy patients compared to neurologically healthy controls. Phenotypic alterations of Schwann cells were similar to those seen after peripheral nerve injury, highlighting the clinical relevance of Schwann cell dysfunction.	[Placheta-Gyoerl, Eva; Brandstetter, Lea Maria; Zemann-Schaelss, Jakob; Wolf, Sonja; Radtke, Christine] Med Univ Vienna, Dept Plast & Reconstruct Surg, Vienna, Austria	Medical University of Vienna	Placheta-Gyorl, E (corresponding author), Med Univ Vienna, Dept Plast & Reconstruct Surg, Vienna, Austria.	eva.placheta-gyoeri@meduniwien.ac.at	; Radtke, Christine/B-8491-2018	Placheta-Gyoeri, Eva/0000-0002-6234-0284; Radtke, Christine/0000-0001-6877-5038				Allen MD, 2015, CLIN NEUROPHYSIOL, V126, P794, DOI 10.1016/j.clinph.2014.07.018; ASBURY AK, 1973, J NEUROSURG, V38, P391, DOI 10.3171/jns.1973.38.3.0391; Bonhof GJ, 2019, ENDOCR REV, V40, P153, DOI 10.1210/er.2018-00107; Burns TM, 2011, NEUROLOGY, V76, pS6, DOI 10.1212/WNL.0b013e31820c3622; Callaghan BC, 2015, JAMA-J AM MED ASSOC, V314, P2172, DOI 10.1001/jama.2015.13611; Duchesne M, 2018, J NEUROPATH EXP NEUR, V77, P88, DOI 10.1093/jnen/nlx111; Dupuis JE, 2019, MUSCLE NERVE, V60, P305, DOI 10.1002/mus.26616; Eckersley L, 2002, INT REV NEUROBIOL, V50, P293; Eckersley L, 2001, MOL BRAIN RES, V92, P128, DOI 10.1016/S0169-328X(01)00163-2; England JD, 2005, MUSCLE NERVE, V31, P113, DOI 10.1002/mus.20233; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; Giovanoli P, 2000, PLAST RECONSTR SURG, V106, P383, DOI 10.1097/00006534-200008000-00021; Goncalves NP, 2017, NAT REV NEUROL, V13, P135, DOI 10.1038/nrneurol.2016.201; Gordon T, 2015, EUR J NEUROSCI, V42, P2783, DOI 10.1111/ejn.13070; Gordon T, 2014, EXP NEUROL, V254, P99, DOI 10.1016/j.expneurol.2014.01.012; Gumy LF, 2008, MOL CELL NEUROSCI, V37, P298, DOI 10.1016/j.mcn.2007.10.004; Hanewinckel R, 2016, EUR J EPIDEMIOL, V31, P5, DOI 10.1007/s10654-015-0094-6; Hendry JM, 2016, ANN NEUROL, V80, P112, DOI 10.1002/ana.24688; Hoffman EM, 2015, NEUROLOGY, V84, P1644, DOI 10.1212/WNL.0000000000001492; Jia LF, 2018, FASEB J, V32, P6911, DOI 10.1096/fj.201800597R; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Liu YP, 2020, LIFE SCI, V248, DOI 10.1016/j.lfs.2020.117459; Luigetti M, 2020, NEUROL SCI, V41, P341, DOI 10.1007/s10072-019-04082-0; Mizisin Andrew P, 2014, Handb Clin Neurol, V126, P401, DOI 10.1016/B978-0-444-53480-4.00029-1; Obrosova IG, 2009, BBA-MOL BASIS DIS, V1792, P931, DOI 10.1016/j.bbadis.2008.11.005; Park HT, 2019, GLIA, V67, P571, DOI 10.1002/glia.23509; Quan D, 2002, MUSCLE NERVE, V26, P417, DOI 10.1002/mus.10208; Radtke C, 2013, MED HYPOTHESES, V81, P500, DOI 10.1016/j.mehy.2013.06.020; Ronchi G, 2017, J NEUROSURG, V127, P843, DOI 10.3171/2016.9.JNS16140; Said G, 2008, J NEUROL, V255, P1693, DOI 10.1007/s00415-008-0999-z; SCARPINI E, 1992, INT J CLIN PHARM RES, V12, P211; Schmeichel AM, 2003, DIABETES, V52, P165, DOI 10.2337/diabetes.52.1.165; Shi XH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-69; Sulaiman OAR, 2019, J NEUROSURG, V131, P622, DOI 10.3171/2018.3.JNS172357; Valentine WM, 2020, TOXICOL PATHOL, V48, P152, DOI 10.1177/0192623319854326; Vincent AM, 2005, FASEB J, V19, P638, DOI 10.1096/fj.04-2513fje; YAGIHASHI S, 1979, TOHOKU J EXP MED, V129, P357, DOI 10.1620/tjem.129.357; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; You SJ, 1997, GLIA, V20, P87, DOI 10.1002/(SICI)1098-1136(199706)20:2<87::AID-GLIA1>3.0.CO;2-1	39	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259654	10.1371/journal.pone.0259654	http://dx.doi.org/10.1371/journal.pone.0259654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735549	gold, Green Published			2022-12-26	WOS:000755077100102
J	Vuttaradhi, VK; Ezhil, I; Ramani, D; Kanumuri, R; Raghavan, S; Balasubramanian, V; Saravanan, R; Kanakarajan, A; Joseph, LD; Pitani, RS; Sundaram, S; Sjolander, A; Venkatraman, G; Rayala, SK				Vuttaradhi, Veena Kumari; Ezhil, Inemai; Ramani, Divya; Kanumuri, Rahul; Raghavan, Swetha; Balasubramanian, Vaishnavi; Saravanan, Roshni; Kanakarajan, Archana; Joseph, Leena Dennis; Pitani, Ravi Shankar; Sundaram, Sandhya; Sjolander, Anita; Venkatraman, Ganesh; Rayala, Suresh Kumar			Inflammation-induced PELP1 expression promotes tumorigenesis by activating GM-CSF paracrine secretion in the tumor microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER; DIFFERENTIATION; MACROPHAGES; CYTOKINES; CLONING; BREAST; MODEL	The inflammatory tumor microenvironment has been implicated as a major player fueling tumor progression and an enabling characteristic of cancer, proline, glutamic acid, and leucine-rich protein 1 (PELP1) is a novel nuclear receptor coregulator that signals across diverse signaling networks, and its expression is altered in several cancers. However, investigations to find the role of PELP1 in inflammation-driven oncogenesis are limited. Molecular studies here, utilizing macrophage cell lines and animal models upon stimulation with lipopolysaccharide (LPS) or necrotic cells, showed that PELP1 is an inflammation-inducible gene. Studies on the PELP1 promoter and its mutant identified potential binding of c-Rel, an NF-kappa B transcription factor subunit, to PELP1 promoter upon LPS stimulation in macrophages. Recruitment of c-Rel onto the PELP1 promoter was validated by chromatin immunoprecipitation, further confirming LPS mediated PELP1 expression through c-Rel-specific transcriptional regulation. Macrophages that overexpress PELP1 induces granulocyte-macrophage colony-stimulating factor secretion, which mediates cancer progression in a paracrine manner. Results from preclinical studies with normal-inflammatory-tumor progression models demonstrated a progressive increase in the PELP1 expression, supporting this link between inflammation and cancer. In addition, animal studies demonstrated the connection of PELP1 in inflammation-directed cancer progression. Taken together, our findings provide the first report on c-Rel-specific transcriptional regulation of PELP1 in inflammation and possible granulocyte-macrophage colony-stimulating factor-mediated transformation potential of activated macrophages on epithelial cells in the inflammatory tumor microenvironment, reiterating the link between PELP1 and inflammation-induced oncogenesis. Understanding the regulatory mechanisms of PELP1 may help in designing better therapeutics to cure various inflammation-associated malignancies.	[Vuttaradhi, Veena Kumari; Ezhil, Inemai; Ramani, Divya; Kanumuri, Rahul; Raghavan, Swetha; Rayala, Suresh Kumar] Indian Inst Technol Madras, Dept Biotechnol, Mol Oncol Lab, Chennai, Tamil Nadu, India; [Ramani, Divya; Kanumuri, Rahul; Balasubramanian, Vaishnavi; Saravanan, Roshni; Venkatraman, Ganesh] Sri Ramachandra Fac Biomed Sci & Technol, Sri Ramachandra Inst Higher Educ & Res, Dept Human Genet, Chennai, Tamil Nadu, India; [Kanakarajan, Archana; Joseph, Leena Dennis; Sundaram, Sandhya] Sri Ramachandra Med Coll, Sri Ramachandra Inst Higher Educ & Res, Dept Pathol, Chennai, Tamil Nadu, India; [Pitani, Ravi Shankar] Sri Ramachandra Med Coll, Sri Ramachandra Inst Higher Educ & Res, Dept Community Med, Chennai, Tamil Nadu, India; [Sjolander, Anita] Lund Univ, Skane Univ Hosp, Clin Res Ctr, Cell Pathol,Dept Translat Med, Malmo, Sweden	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Lund University; Skane University Hospital	Rayala, SK (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Mol Oncol Lab, Chennai, Tamil Nadu, India.; Venkatraman, G (corresponding author), Sri Ramachandra Fac Biomed Sci & Technol, Sri Ramachandra Inst Higher Educ & Res, Dept Human Genet, Chennai, Tamil Nadu, India.	ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	Kanumuri, Rahul Sankrityayan/AGF-8012-2022	Kanumuri, Rahul Sankrityayan/0000-0001-6039-461X; Vuttaradhi, Veena Kumari/0000-0002-3422-0509	National Bioscience Award by the Department of Biotechnology [grant-BT/HRD/NBA/39/13/2018-19]	National Bioscience Award by the Department of Biotechnology	National Bioscience Award by the Department of Biotechnology grant-BT/HRD/NBA/39/13/2018-19 (to S. K. R.).	Aliper AM, 2014, CANCER MED-US, V3, P737, DOI 10.1002/cam4.239; Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Basson MD, 1996, EXP CELL RES, V225, P301, DOI 10.1006/excr.1996.0180; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Chung STM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0606-y; Clapper ML, 2007, ACTA PHARMACOL SIN, V28, P1450, DOI 10.1111/j.1745-7254.2007.00695.x; Cortez V, 2014, CANCER RES, V74, P7395, DOI 10.1158/0008-5472.CAN-14-0993; Crofford LJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4174; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Gao F, 2014, CURR CANCER DRUG TAR, V14, P30, DOI 10.2174/15680096113136660107; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; Girard BJ, 2017, J BIOL CHEM, V292, P339, DOI 10.1074/jbc.M116.739847; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; Gonugunta VK, 2014, ENDOCR-RELAT CANCER, V21, pT79, DOI 10.1530/ERC-13-0502; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Gunaydin C, 2018, EURASIAN J MED, V50, P116, DOI 10.5152/eurasianjmed.2018.0010; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Krah NM, 2016, TRENDS CANCER, V2, P723, DOI 10.1016/j.trecan.2016.11.005; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lea T., 2015, IMPACT FOOD BIOACTIV, P103; Liu S, 2018, CANCER RES, V78, P2040, DOI 10.1158/0008-5472.CAN-17-2761; Maiuri AR, 2017, CANCER RES, V77, P3467, DOI 10.1158/0008-5472.CAN-17-0056; Manavathi B, 2005, CANCER RES, V65, P5571, DOI 10.1158/0008-5472.CAN-04-4664; Mann M, 2014, MOL ONCOL, V8, P389, DOI 10.1016/j.molonc.2013.12.012; Mann M, 2013, CARCINOGENESIS, V34, P1468, DOI 10.1093/carcin/bgt091; McDonald B, 2016, GASTROENTEROLOGY, V151, P1087, DOI 10.1053/j.gastro.2016.09.048; Mehdawi L, 2016, ACTA ONCOL, V55, P1434, DOI 10.1080/0284186X.2016.1198493; Mishra SK, 2004, GENE, V330, P115, DOI 10.1016/j.gene.2004.01.011; Murphy CG, 2008, MUCOSAL IMMUNOL, V1, P297, DOI 10.1038/mi.2008.13; Ning ZF, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/193523; Osman J, 2017, ONCOTARGET, V8, P34773, DOI 10.18632/oncotarget.16718; Porta C, 2018, CANCER IMMUNOL RES, V6, P578, DOI 10.1158/2326-6066.CIR-17-0036; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Sareddy GR, 2016, GENE, V585, P128, DOI 10.1016/j.gene.2016.03.017; Sever R, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a006098; Sokolova O, 2017, TOXINS, V9, DOI 10.3390/toxins9040119; Sun X, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0796-z; Toig C, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2915; Tomita T, 2000, CANCER LETT, V156, P83, DOI 10.1016/S0304-3835(00)00446-8; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Vinogradov S, 2014, NANOMEDICINE-UK, V9, P695, DOI [10.2217/nnm.14.13, 10.2217/NNM.14.13]; Wan J, 2012, ONCOL REP, V28, P2035, DOI 10.3892/or.2012.2038; Wang DZ, 2015, CARCINOGENESIS, V36, P1085, DOI 10.1093/carcin/bgv123; Wang WH, 1997, IMMUNITY, V6, P165, DOI 10.1016/S1074-7613(00)80423-9; Wang YF, 2018, BIOCHEM BIOPH RES CO, V501, P313, DOI 10.1016/j.bbrc.2018.05.024; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2	52	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101406	10.1016/j.jbc.2021.101406	http://dx.doi.org/10.1016/j.jbc.2021.101406			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1JM	34774800	gold, Green Published			2022-12-26	WOS:000748384500004
J	Jindra, M; McKinstry, WJ; Nebl, T; Bittova, L; Ren, B; Shaw, J; Phan, T; Lu, L; Low, JKK; Mackay, JP; Sparrow, LG; Lovrecz, GO; Hill, RJ				Jindra, Marek; McKinstry, William J.; Nebl, Thomas; Bittova, Lenka; Ren, Bin; Shaw, Jan; Phan, Tram; Lu, Louis; Low, Jason K. K.; Mackay, Joel P.; Sparrow, Lindsay G.; Lovrecz, George O.; Hill, Ronald J.			Purification of an insect juvenile hormone receptor complex enables insights into its post-translational phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHOPRENE-TOLERANT MET; DROSOPHILA ECDYSONE RECEPTOR; SHOCK-PROTEIN HSP90; KRUPPEL HOMOLOG 1; LIGAND-BINDING; NUCLEAR IMPORT; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR-LOCALIZATION; DIOXIN RECEPTOR; GENE-PRODUCT	Juvenile hormone (JH) plays vital roles in insect reproduction, development, and in many aspects of physiology. JH primarily acts at the gene-regulatory level through interaction with an intracellular receptor (JH receptor [JHR]), a ligand-activated complex of transcription factors consisting of the JH-binding protein methoprene-tolerant (MET) and its partner taiman (TAI). Initial studies indicated significance of post-transcriptional phosphorylation, subunit assembly, and nucleocytoplasmic transport of JHR in JH signaling. However, our knowledge of JHR regulation at the protein level remains rudimentary, partly because of the difficulty of obtaining purified and functional JHR proteins. Here, we present a method for high-yield expression and purification of JHR complexes from two insect species, the beetle T. castaneum and the mosquito Aedes aegypti. Recombinant JHR subunits from each species were coexpressed in an insect cell line using a baculovirus system. MET-TAI complexes were purified through affinity chromatography and anion exchange columns to yield proteins capable of binding both the hormonal ligand (JH III) and DNA bearing cognate JH-response elements. We further examined the beetle JHR complex in greater detail. Biochemical analyses and MS confirmed that T. castaneum JHR was a 1:1 heterodimer consisting of MET and Taiman proteins, stabilized by the JHR agonist ligand methoprene. Phosphoproteomics uncovered multiple phosphorylation sites in the MET protein, some of which were induced by methoprene treatment. Finally, we report a functional bipartite nuclear localization signal, straddled by phosphorylated residues, within the disordered C-terminal region of MET. Our present characterization of the recombinant JHR is an initial step toward understanding JHR structure and function.	[Jindra, Marek; Bittova, Lenka] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic; [McKinstry, William J.; Nebl, Thomas; Ren, Bin; Phan, Tram; Lu, Louis; Sparrow, Lindsay G.; Lovrecz, George O.] CSIRO, CSIRO Mfg, Parkville, Vic, Australia; [Shaw, Jan; Hill, Ronald J.] CSIRO, CSIRO Hlth & Biosecur, N Ryde, NSW, Australia; [Low, Jason K. K.; Mackay, Joel P.; Hill, Ronald J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	Jindra, M (corresponding author), Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic.; Hill, RJ (corresponding author), CSIRO, CSIRO Hlth & Biosecur, N Ryde, NSW, Australia.; Hill, RJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	jindra@entu.cas.cz; ronald.hill@sydney.edu.au	Bittova, Lenka/K-4375-2015; Jindra, Marek/H-2082-2014; Ren, Bin/D-1868-2013; Nebl, Thomas/N-1620-2017	Bittova, Lenka/0000-0002-3556-5234; Jindra, Marek/0000-0002-2196-9924; Ren, Bin/0000-0003-2227-9623; Nebl, Thomas/0000-0003-4003-9340; Low, Jason/0000-0003-0862-0012	Czech Science Foundation [20-05151X]; Marie Sklodowska-Curie Actions of the European Union [276569, 708832]	Czech Science Foundation(Grant Agency of the Czech Republic); Marie Sklodowska-Curie Actions of the European Union	The work was supported by the Czech Science Foundation project 20-05151X (to M. J.) and individual fellowships from the Marie Sklodowska-Curie Actions of the European Union, grant agreements 276569 (to M. J.) and 708832 (to L. B.).	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belles X, 2020, INSECT METAMORPHOSIS: FROM NATURAL HISTORY TO REGULATION OF DEVELOPMENT AND EVOLUTION, P1, DOI 10.1016/C2016-0-04530-8; Bern M, 2018, J PROTEOME RES, V17, P1216, DOI 10.1021/acs.jproteome.7b00839; Billas IML, 2003, NATURE, V426, P91, DOI 10.1038/nature02112; Bittova L, 2019, J BIOL CHEM, V294, P410, DOI 10.1074/jbc.RA118.005992; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Carmichael JA, 2005, J BIOL CHEM, V280, P22258, DOI 10.1074/jbc.M500661200; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen D, 2014, J PROTEOME RES, V13, P4184, DOI 10.1021/pr500525e; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; Davey KG, 1996, INVERTEBR REPROD DEV, V30, P249, DOI 10.1080/07924259.1996.9672551; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Folta-Stogniew Ewa, 2006, V328, P97; Graham LD, 2007, INSECT BIOCHEM MOLEC, V37, P611, DOI 10.1016/j.ibmb.2007.03.006; Greb-Markiewicz B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194746; Greb-Markiewicz B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133307; Greb-Markiewicz B, 2011, MOL CELL ENDOCRINOL, V345, P16, DOI 10.1016/j.mce.2011.06.035; He QY, 2017, INSECT BIOCHEM MOLEC, V81, P10, DOI 10.1016/j.ibmb.2016.12.005; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hill RJ, 2013, ANNU REV ENTOMOL, V58, P251, DOI 10.1146/annurev-ento-120811-153610; Hill RJ, 2012, ADV INSECT PHYSIOL, V43, P299, DOI 10.1016/B978-0-12-391500-9.00004-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Ikuta T, 2004, BIOCHEM BIOPH RES CO, V317, P545, DOI 10.1016/j.bbrc.2004.03.076; Jindra M, 2021, ADV INSECT PHYSIOL, V60, P37, DOI 10.1016/bs.aiip.2021.03.001; Jindra M, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0064; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Jing YP, 2018, J BIOL CHEM, V293, P20112, DOI 10.1074/jbc.RA118.005692; Jones G, 2010, J INSECT PHYSIOL, V56, P1456, DOI 10.1016/j.jinsphys.2010.06.001; Kayukawa T, 2017, P NATL ACAD SCI USA, V114, P1057, DOI 10.1073/pnas.1615423114; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kazlauskas A, 2001, MOL CELL BIOL, V21, P2594, DOI 10.1128/MCB.21.7.2594-2607.2001; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim K, 2021, J PROTEOMICS, V242, DOI 10.1016/j.jprot.2021.104257; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kolonko M, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00662-2; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Li YX, 2021, INSECT BIOCHEM MOLEC, V130, DOI 10.1016/j.ibmb.2021.103519; Liu PC, 2015, P NATL ACAD SCI USA, V112, pE1871, DOI 10.1073/pnas.1423204112; Lozano J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004769; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Miyakawa H, 2017, J APPL TOXICOL, V37, P1082, DOI 10.1002/jat.3459; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Nijhout H.F., 1994, INSECT HORMONES; Ojani R, 2016, INSECT BIOCHEM MOLEC, V70, P44, DOI 10.1016/j.ibmb.2015.12.001; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; PONGRATZ I, 1992, J BIOL CHEM, V267, P13728; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; Ren B, 2014, ACTA CRYSTALLOGR D, V70, P1954, DOI 10.1107/S1399004714009626; Riddiford LM, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00679; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Santos CG, 2019, CURR OPIN INSECT SCI, V31, P43, DOI 10.1016/j.cois.2018.07.010; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Silver K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06840; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; Soshilov AA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072474; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; Truman JW, 2019, CURR BIOL, V29, pR1252, DOI 10.1016/j.cub.2019.10.009; WHITELAW ML, 1995, P NATL ACAD SCI USA, V92, P4437, DOI 10.1073/pnas.92.10.4437; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yokoi T, 2020, PEST MANAG SCI, V76, P2316, DOI 10.1002/ps.5766; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	87	3	3	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101387	10.1016/j.jbc.2021.101387	http://dx.doi.org/10.1016/j.jbc.2021.101387			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34758356	gold, Green Published			2022-12-26	WOS:000748084900001
J	Yoshizawa-Sugata, N; Yamazaki, S; Mita-Yoshida, K; Ono, T; Nishito, Y; Masai, H				Yoshizawa-Sugata, Naoko; Yamazaki, Satoshi; Mita-Yoshida, Kaoru; Ono, Tomio; Nishito, Yasumasa; Masai, Hisao			Loss of full-length DNA replication regulator Rif1 in two-cell embryos is associated with zygotic transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; ENDOGENOUS RETROVIRUSES; POISED ENHANCERS; SELF-RENEWAL; S-PHASE; PLURIPOTENCY; PROTEIN; DIFFERENTIATION; NETWORK; HETEROCHROMATIN	Rif1 regulates DNA replication timing and double-strand break repair, and its depletion induces transcriptional bursting of two-cell (2C) zygote-specific genes in mouse ES cells. However, how Rif1 regulates zygotic transcription is unclear. We show here that Rif1 depletion promotes the formation of a unique Zscan4 enhancer structure harboring both histone H3 lysine 27 acetylation (H3K27ac) and moderate levels of silencing chromatin mark H3K9me3. Curiously, another enhancer mark H3K4me1 is missing, whereas DNA methylation is still maintained in the structure, which spreads across gene bodies and neighboring regions within the Zscan4 gene cluster. We also found by function analyses of Rif1 domains in ES cells that ectopic expression of Rif1 lacking N-terminal domain results in upregulation of 2C transcripts. This appears to be caused by dominant negative inhibition of endogenous Rif1 protein localization at the nuclear periphery through formation of hetero-oligomers between the N-terminally truncated and endogenous forms. Strikingly, in murine 2C embryos, most of Rif1-derived polypeptides are expressed as truncated forms in soluble nuclear or cytosolic fraction and are likely nonfunctional. Toward the morula stage, the full-length form of Rif1 gradually increased. Our results suggest that the absence of the functional full-length Rif1 due to its instability or alternative splicing and potential inactivation of Rif1 through dominant inhibition by N-terminally truncated Rif1 polypeptides may be involved in 2C-specific transcription program.	[Yoshizawa-Sugata, Naoko; Yamazaki, Satoshi; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Tokyo, Japan; [Mita-Yoshida, Kaoru; Ono, Tomio; Nishito, Yasumasa] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Yoshizawa-Sugata, N; Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Tokyo, Japan.	yoshizawa-nk@igakuken.or.jp; masai-hs@igakuken.or.jp		Masai, Hisao/0000-0003-1268-5302; Yoshizawa-Sugata, Naoko/0000-0001-8792-8669	JSPS KAKENHI [17H01418, 26251004, 19H05277, 15K07164, 23570243]; JSPS [IZLJZ2_183660]; SNSF [IZLJZ2_183660]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SNSF(Swiss National Science Foundation (SNSF))	This work was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (A)) (grant numbers 17H01418 and 26251004), Grant-in-Aid for Scientific Research on Innovative Areas (Chromatin potential for gene regulation) (grant number 19H05277), and JSPS and SNSF under the Joint Research Projects (JRPs) (grant number IZLJZ2_183660) to H. M., and JSPS KAKENHI (Grant-in-Aid for Scientific Research (C)) (grant numbers 15K07164 and 23570243) to N. Y.-S.. The authors declare no competing financial interests.	Aanes H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-331; Abe K, 2015, EMBO J, V34, P1523, DOI 10.15252/embj.201490648; Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Akiyama T, 2015, DNA RES, V22, P307, DOI 10.1093/dnares/dsv013; Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Atashpaz S, 2020, ELIFE, V9, DOI 10.7554/eLife.54756; Bernhofer M, 2021, NUCLEIC ACIDS RES, V49, pW535, DOI 10.1093/nar/gkab354; Boersma V, 2015, NATURE, V521, P537, DOI 10.1038/nature14216; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Choi YJ, 2017, SCIENCE, V355, DOI 10.1126/science.aag1927; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Czechanski A, 2014, NAT PROTOC, V9, P559, DOI 10.1038/nprot.2014.030; Dan JM, 2014, DEV CELL, V29, P7, DOI 10.1016/j.devcel.2014.03.004; Darst Russell P, 2010, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0709s91; De Iaco A, 2017, NAT GENET, V49, P941, DOI 10.1038/ng.3858; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckersley-Maslin MA, 2016, CELL REP, V17, P179, DOI 10.1016/j.celrep.2016.08.087; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Fujii S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09146; Fujii-Yamamoto H, 2005, J BIOL CHEM, V280, P12976, DOI 10.1074/jbc.M412224200; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Guallar D, 2012, NUCLEIC ACIDS RES, V40, P8993, DOI 10.1093/nar/gks686; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hu ZH, 2020, NAT CELL BIOL, V22, P175, DOI 10.1038/s41556-019-0453-8; Inoue A, 2012, CELL RES, V22, P1640, DOI 10.1038/cr.2012.160; Ishiguro K, 2017, IN VITRO CELL DEV-AN, V53, P179, DOI 10.1007/s11626-016-0097-y; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Israel S, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6106-2; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang EJ, 2014, NATURE, V509, P101, DOI 10.1038/nature13134; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kobayashi S, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00364-18; Koenecke N, 2017, GENOME RES, V27, P64, DOI 10.1101/gr.209486.116; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li PS, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx884; Liu HB, 2019, ADV SCI, V6, DOI 10.1002/advs.201900295; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maksakova IA, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-15; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Moriyama K, 2018, J BIOL CHEM, V293, P3607, DOI 10.1074/jbc.RA117.000446; Nagy A., 2014, MANIPULATING MOUSE E, V4 th, P604; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Shin SW, 2010, J REPROD DEVELOP, V56, P655, DOI 10.1262/jrd.10-104M; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Storm MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089821; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Whiddon JL, 2017, NAT GENET, V49, P935, DOI 10.1038/ng.3846; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yang Y, 2017, EMBO REP, V18, P205, DOI 10.15252/embr.201642573; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zdzieblo D, 2014, STEM CELLS, V32, P3112, DOI 10.1002/stem.1826; Zhang WY, 2019, NUCLEIC ACIDS RES, V47, P8485, DOI 10.1093/nar/gkz594	90	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101367	10.1016/j.jbc.2021.101367	http://dx.doi.org/10.1016/j.jbc.2021.101367			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0HN	34736895	Green Published, gold			2022-12-26	WOS:000748311800009
J	Zheng, M; Karki, R; Kancharana, B; Berns, H; Pruett-Miller, SM; Kanneganti, TD				Zheng, Min; Karki, Rajendra; Kancharana, Balabhaskararao; Berns, Hartmut; Pruett-Miller, Shondra M.; Kanneganti, Thirumala-Devi			Caspase-6 promotes activation of the caspase-11-NLRP3 inflammasome during gram-negative bacterial infections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATOR; PROTEASE; GSDMD	The innate immune system acts as the first line of defense against infection. One key component of the innate immune response to gram-negative bacterial infections is inflammasome activation. The caspase-11 (CASP11)-nucleotide-binding oligomerization domain-like receptor pyrin domain-containing 3 (NLRP3) inflammasome is activated by cytosolic lipopolysaccharide, a gram-negative bacterial cell wall component, to trigger pyroptosis and host defense during infection. Although several cellular signaling pathways have been shown to regulate CASP11-NLRP3 inflammasome activation in response to lipopolysaccharide, the upstream molecules regulating CASP11 activation during infection with live pathogens remain unclear. Here, we report that the understudied caspase-6 (CASP6) contributes to the activation of the CASP11-NLRP3 inflammasome in response to infections with gram-negative bacteria. Using in vitro cellular systems with bone marrow-derived macrophages and 293T cells, we found that CASP6 can directly process CASP11 by cleaving at Asp59 and Asp285, the CASP11 auto-cleavage sites, which could contribute to the activation of CASP11 during gram-negative bacterial infection. Thus, the loss of CASP6 led to impaired CASP11-NLRP3 inflammasome activation in response to gram-negative bacteria. These results demonstrate that CASP6 potentiates activation of the CASP11-NLRP3 inflammasome to produce inflammatory cytokines during gram-negative bacterial infections.	[Zheng, Min; Karki, Rajendra; Kancharana, Balabhaskararao; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Berns, Hartmut; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zheng, Min] Shenzhen Bay Lab, Inst Infect Dis, Shenzhen, Peoples R China	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Shenzhen Bay Laboratory	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kancharana, Balabhaskararao/0000-0002-1362-4942	US National Institutes of Health [AI101935, AI124346, AI160179, AR056296, CA253095]; American Lebanese Syrian Associated Charities	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	The work from our laboratory is supported by the US National Institutes of Health (AI101935, AI124346, AI160179, AR056296, and CA253095 to T.-D. K.) and the American Lebanese Syrian Associated Charities (to T.-D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Balakrishnan A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0068-z; Benaoudia S, 2019, EMBO REP, V20, DOI 10.15252/embr.201948235; Berta T, 2014, J CLIN INVEST, V124, P1173, DOI 10.1172/JCI72230; Christgen S, 2020, CELL RES, V30, P315, DOI 10.1038/s41422-020-0295-8; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Finethy R, 2017, MBIO, V8, DOI 10.1128/mBio.01188-17; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karki R, 2020, J IMMUNOL, V204, P2514, DOI 10.4049/jimmunol.1901508; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lee BL, 2018, J EXP MED, V215, P2279, DOI 10.1084/jem.20180589; Man SM, 2016, CELL, V167, P382, DOI 10.1016/j.cell.2016.09.012; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ning XH, 2019, MOL CELL, V74, P19, DOI 10.1016/j.molcel.2019.02.013; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Santos JC, 2018, EMBO J, V37, DOI 10.15252/embj.201798089; Sentmanat MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19441-8; Sharma BR, 2021, NAT IMMUNOL, V22, P550, DOI 10.1038/s41590-021-00886-5; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Srinivasula SM, 1996, P NATL ACAD SCI USA, V93, P14486, DOI 10.1073/pnas.93.25.14486; Wang K, 2020, CELL, V180, P941, DOI 10.1016/j.cell.2020.02.002; Yao YF, 2016, J BIOL CHEM, V291, P17450, DOI 10.1074/jbc.M116.717868; Zheng M, 2020, IMMUNOL REV, V297, P26, DOI 10.1111/imr.12909; Zheng M, 2020, CELL, V181, P674, DOI 10.1016/j.cell.2020.03.040	32	4	4	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101379	10.1016/j.jbc.2021.101379	http://dx.doi.org/10.1016/j.jbc.2021.101379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34740613	gold, Green Published			2022-12-26	WOS:000748084900008
J	Schneider, CR; Freeman, ALJ; Spiegelhalter, D; van der Linden, S				Schneider, Claudia R.; Freeman, Alexandra L. J.; Spiegelhalter, David; van der Linden, Sander			The effects of quality of evidence communication on perception of public health information about COVID-19: Two randomised controlled trials	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; NONPHARMACEUTICAL INTERVENTIONS; RISK COMMUNICATION; LOSS AVERSION; IMPACT; TRUST; GRADE; KNOWLEDGE; CERTAINTY; BENEFITS	Background The quality of evidence about the effectiveness of non-pharmaceutical health interventions is often low, but little is known about the effects of communicating indications of evidence quality to the public. Methods In two blinded, randomised, controlled, online experiments, US participants (total n = 2140) were shown one of several versions of an infographic illustrating the effectiveness of eye protection in reducing COVID-19 transmission. Their trust in the information, understanding, feelings of effectiveness of eye protection, and the likelihood of them adopting it were measured. Findings Compared to those given no quality cues, participants who were told the quality of the evidence on eye protection was 'low', rated the evidence less trustworthy (p = .001, d = 0.25), and rated it as subjectively less effective (p = .018, d = 0.19). The same effects emerged compared to those who were told the quality of the evidence was 'high', and in one of the two studies, those shown 'low' quality of evidence said they were less likely to use eye protection (p = .005, d = 0.18). Participants who were told the quality of the evidence was 'high' showed no statistically significant differences on these measures compared to those given no information about evidence quality. Conclusions Without quality of evidence cues, participants responded to the evidence about the public health intervention as if it was high quality and this affected their subjective perceptions of its efficacy and trust in the provided information. This raises the ethical dilemma of weighing the importance of transparently stating when the evidence base is actually low quality against evidence that providing such information can decrease trust, perception of intervention efficacy, and likelihood of adopting it.	[Schneider, Claudia R.; Freeman, Alexandra L. J.; Spiegelhalter, David; van der Linden, Sander] Univ Cambridge, Winton Ctr Risk & Evidence Commun, Cambridge, England; [Schneider, Claudia R.; van der Linden, Sander] Univ Cambridge, Dept Psychol, Cambridge, England	University of Cambridge; University of Cambridge	Schneider, CR (corresponding author), Univ Cambridge, Winton Ctr Risk & Evidence Commun, Cambridge, England.; Schneider, CR (corresponding author), Univ Cambridge, Dept Psychol, Cambridge, England.	cs2025@cam.ac.uk		Schneider, Claudia R/0000-0002-6612-5186; Freeman, Alexandra/0000-0002-4115-161X; Spiegelhalter, David J/0000-0001-9350-6745	Winton Centre for Risk & Evidence Communication	Winton Centre for Risk & Evidence Communication	This project was carried out using core funding from The Winton Centre for Risk & Evidence Communication, which comprises a donation from the David & Claudia Harding Foundation.	Akl EA, 2007, J CLIN EPIDEMIOL, V60, P1298, DOI 10.1016/j.jclinepi.2007.03.011; Ancker JS, 2006, J AM MED INFORM ASSN, V13, P608, DOI 10.1197/jamia.M2115; Armijo-Olivo S, 2012, J EVAL CLIN PRACT, V18, P12, DOI 10.1111/j.1365-2753.2010.01516.x; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bauer A, 2021, APPL ECON LETT, V28, P1053, DOI 10.1080/13504851.2020.1789544; Bennett S, 2020, COVID 19 PREVENTION; Blastland M, 2020, NATURE, V587, P362, DOI 10.1038/d41586-020-03189-1; Broomell S.B., 2020, BEHAV SCI POLICY, V6, P43, DOI [10.1353/bsp.2020.0014, DOI 10.1353/BSP.2020.0014]; Buchter RB, 2020, J MED INTERNET RES, V22, DOI 10.2196/15899; Chen KP, 2020, JCOM-J SCI COMMUN, V19, DOI 10.22323/2.19050211; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Djulbegovic B, 2021, J CLIN EPIDEMIOL, V136, P1, DOI 10.1016/j.jclinepi.2021.02.025; Flahault A, 2020, LANCET, V395, P1037, DOI 10.1016/S0140-6736(20)30491-8; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Geneen LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011279.pub3; Georgiou IT, 2021, PSYCHOL HEALTH MED, DOI 10.1080/13548506.2021.2019806; Gibson J., 2020, NZ EC PAPERS, DOI [10.1080/00779954.2020.1844786, DOI 10.1080/00779954.2020.1844786]; Glenton C, 2010, MED DECIS MAKING, V30, P566, DOI 10.1177/0272989X10375853; Gustafson A, 2020, PUBLIC UNDERST SCI, V29, P614, DOI 10.1177/0963662520942122; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hamstra DA, 2015, MED DECIS MAKING, V35, P27, DOI 10.1177/0272989X14551639; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P448, DOI 10.1016/j.pec.2008.07.023; Hultcrantz M, 2017, J CLIN EPIDEMIOL, V87, P4, DOI 10.1016/j.jclinepi.2017.05.006; Kabir KMA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92094-2; Kabir KMA, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201095; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228666; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Melan?on J., 2021, TRANSFORMING POLITIC; Meloncon L, 2017, IEEE INT PROF COMMUN; Mevorach T, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18062852; Nikolov P, 2020, IZA I LABOR EC; Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370; O'Neill O, 2018, INT J PHILOS STUD, V26, P293, DOI 10.1080/09672559.2018.1454637; Oxman AD, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036348; Papageorge NW, 2021, J POPUL ECON, V34, P691, DOI 10.1007/s00148-020-00818-x; Robert A, 2020, LANCET PUBLIC HEALTH, V5, pE569, DOI 10.1016/S2468-2667(20)30237-1; Santesso N, 2015, J CLIN EPIDEMIOL, V68, P182, DOI 10.1016/j.jclinepi.2014.04.009; Seale H, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05340-9; Shah Y, 2021, PHYS FLUIDS, V33, DOI 10.1063/5.0057100; Tait AR, 2010, ANESTH ANALG, V111, P718, DOI 10.1213/ANE.0b013e3181e8570a; Thompson Dennis, 2020, MASK USE AM NOW TOPS; Tingley D, 2014, J STAT SOFTW, V59; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trivedi MM., 2021, DID TIMING STATE MAN, P238; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van der Bles AM, 2020, P NATL ACAD SCI USA, V117, P7672, DOI 10.1073/pnas.1913678117; van der Bles AM, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181870; Veit W, 2021, AM J BIOETHICS, V21, P22, DOI 10.1080/15265161.2020.1845861; Wang DN, 2021, SOC WORK HEALTH CARE, V60, P240, DOI 10.1080/00981389.2020.1871157; Wegwarth O, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.32335; Wright AL, 2020, J ECON BEHAV ORGAN, V180, P544, DOI 10.1016/j.jebo.2020.10.008; Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199; Zhu Z, 2021, TRAVEL MED INFECT DI, V41, DOI 10.1016/j.tmaid.2021.102044; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295	62	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259048	10.1371/journal.pone.0259048	http://dx.doi.org/10.1371/journal.pone.0259048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	34788299	Green Submitted, Green Published, gold			2022-12-26	WOS:000735920500012
J	Song, DW; Cismas, S; Crudden, C; Trocme, E; Worrall, C; Suleymanova, N; Lin, TT; Zheng, HY; Seregard, S; Girnita, A; Girnita, L				Song, Dawei; Cismas, Sonia; Crudden, Caitrin; Trocme, Eric; Worrall, Claire; Suleymanova, Naida; Lin, Tingting; Zheng, Huiyuan; Seregard, Stefan; Girnita, Ada; Girnita, Leonard			IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma	ONCOGENE			English	Article							FACTOR-I RECEPTOR; DOWN-REGULATION; BETA-ARRESTIN; MALIGNANT-MELANOMA; UVEAL MELANOMA; GROWTH; EXPRESSION; MDM2; UBIQUITINATION; ACTIVATION	As the p53 tumor suppressor is rarely mutated in conjunctival melanoma (CM), we investigated its activation as a potential therapeutic strategy. Preventing p53/Mdm2 interaction by Nutlin-3, the prototypical Mdm2 antagonist, or via direct siRNA Mdm2 depletion, increased p53 and inhibited viability in CM cell lines. The sensitivity to Nutlin-3 p53 reactivation with concomitant Mdm2 stabilization was higher than that achieved by siRNA, indicative of effects on alternative Mdm2 targets, identified as the cancer-protective IGF-1R. Nutlin-3 treatment increased the association between IGF-1R and beta-arrestin1, the adaptor protein that brings Mdm2 to the IGF-1R, initiating receptor degradation in a ligand-dependent manner. Controlled expression of beta-arrestin1 augmented inhibitory Nutlin-3 effects on CM survival through enhanced IGF-1R degradation. Yet, the effect of IGF-1R downregulation on cell proliferation is balanced by beta-arrestin1-induced p53 inhibition. As mitomycin (MMC) is a well-established adjuvant treatment for CM, and it triggers p53 activation through genotoxic stress, we evaluated how these alternative p53-targeting strategies alter the cancer-relevant bioactivities of CM. In 2D and 3D in vitro models, Nutlin-3 or MMC alone, or in combination, reduces the overall cell tumor growth similar to 30%, with double treatment inhibition rate only marginally higher than single-drug regimens. However, histopathological evaluation of the 3D models revealed that Nutlin-3 was the most effective, causing necrotic areas inside spheroids and complete loss of nuclear staining for the proliferative marker Ki67. These findings were further validated in vivo; zebrafish xenografts demonstrate that Nutlin-3 alone has higher efficacy in restraining CM tumor cell growth and preventing metastasis. Combined, these results reveal that beta-arrestin1 directs Mdm2 toward different substrates, thus balancing IGF-1R pro-tumorigenic and p53-tumor suppressive signals. This study defines a potent dual-hit strategy: simultaneous control of a tumor-promoter (IGF-1R) and tumor-suppressor (p53), which ultimately mitigates recurrent and metastatic potential, thus opening up targeted therapy to CM.	[Song, Dawei; Cismas, Sonia; Crudden, Caitrin; Trocme, Eric; Worrall, Claire; Suleymanova, Naida; Lin, Tingting; Zheng, Huiyuan; Girnita, Ada; Girnita, Leonard] Karolinska Inst, Dept Oncol & Pathol, BioClinicum, Stockholm, Sweden; [Song, Dawei; Cismas, Sonia; Crudden, Caitrin; Trocme, Eric; Worrall, Claire; Suleymanova, Naida; Lin, Tingting; Zheng, Huiyuan; Girnita, Ada; Girnita, Leonard] Karolinska Univ Hosp, Stockholm, Sweden; [Crudden, Caitrin] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Dept Pathol, Amsterdam UMC, De Boelelaan 1117, Amsterdam, Netherlands; [Trocme, Eric; Seregard, Stefan; Girnita, Leonard] St Erik Eye Hosp, Ophthalm Pathol & Oncol Serv, Stockholm, Sweden; [Lin, Tingting] Tianjin Med Univ Eye Hosp, Tianjin Int Joint Res & Dev Ctr Ophthalmol & Vis, Eye Inst, Tianjin, Peoples R China; [Lin, Tingting] Tianjin Med Univ Eye Hosp, Sch Optometry, Tianjin, Peoples R China; [Zheng, Huiyuan] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Seregard, Stefan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Girnita, Ada] Karolinska Univ Hosp, Skin Canc Ctr, Theme Canc, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Vrije Universiteit Amsterdam; Tianjin Medical University; Tianjin Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Girnita, L (corresponding author), Karolinska Inst, Dept Oncol & Pathol, BioClinicum, Stockholm, Sweden.; Girnita, L (corresponding author), Karolinska Univ Hosp, Stockholm, Sweden.; Girnita, L (corresponding author), St Erik Eye Hosp, Ophthalm Pathol & Oncol Serv, Stockholm, Sweden.	leonard.girnita@ki.se	Song, Dawei/HGC-7852-2022; Crudden, Caitrin/Q-5172-2018	Crudden, Caitrin/0000-0002-7786-112X; Song, Dawei/0000-0001-7707-7207	Swedish Research Council; Swedish Cancer Society; Swedish Childhood Cancer Foundation; Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; China Scholarship Council [201700260284]; Stockholm Cancer Society; Karolinska Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Childhood Cancer Foundation(European Commission); Crown Princess Margareta's Foundation for the Visually Impaired; Welander Finsen Foundation; King Gustaf V Jubilee Foundation; China Scholarship Council(China Scholarship Council); Stockholm Cancer Society; Karolinska Institute(Karolinska Institutet)	We gratefully acknowledge Prof. Robert J Lefkowitz, Prof. Gerasimos Anastassiou, Prof. Rob J W de Keizer, Prof. Rolf Kiessling, and Prof. A. Ciechanover for providing cell lines and reagents. We thank Anna Malmerfelt at the histology core facility, Karolinska Institutet, for technical assistance. Research support was received from the Swedish Research Council, Swedish Cancer Society, The Swedish Childhood Cancer Foundation, Crown Princess Margareta's Foundation for the Visually Impaired, Welander Finsen Foundation, King Gustaf V Jubilee Foundation, China Scholarship Council (Grant no. 201700260284), Stockholm Cancer Society, Stockholm County and Karolinska Institute. Schematics were partially created with BioRender.com.	All-Ericsson C, 2002, INVEST OPHTH VIS SCI, V43, P1; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Burkhart CG, 2005, INT J DERMATOL, V44, P340, DOI 10.1111/j.1365-4632.2004.02556.x; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Cisarova K, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009201; Crudden C, 2021, CANCER RES, V81, P501, DOI 10.1158/0008-5472.CAN-20-1662; Crudden C, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abb7887; Crudden C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101223; Crudden C, 2018, INT REV CEL MOL BIO, V339, P1, DOI 10.1016/bs.ircmb.2018.02.006; Crudden C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00064; Crudden C, 2015, GROWTH HORM IGF RES, V25, P2, DOI 10.1016/j.ghir.2014.10.002; de Waard NE, 2015, INVEST OPHTH VIS SCI, V56, P2325, DOI 10.1167/iovs.14-15239; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Economou MA, 2005, INVEST OPHTH VIS SCI, V46, P4372, DOI 10.1167/iovs.05-0322; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2337, DOI 10.1167/iovs.07-0819; Fiorentzis M, 2019, ACTA OPHTHALMOL, V97, pE632, DOI 10.1111/aos.13993; Froment P, 2008, CELL CYCLE, V7, P3098, DOI 10.4161/cc.7.19.6807; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gardrat S, 2021, CANCERS, V13, DOI 10.3390/cancers13153836; Gaudy-Marqueste C, 2022, J AM ACAD DERMATOL, V86, P312, DOI 10.1016/j.jaad.2021.07.011; Girnita L, 2000, CANCER RES, V60, P5278; Girnita L, 2016, PROG MOL BIOL TRANSL, V141, P277, DOI 10.1016/bs.pmbts.2016.04.001; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Girnita L, 2005, J BIOL CHEM, V280, P24412, DOI 10.1074/jbc.M501129200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; Jain P, 2021, BRIT J OPHTHALMOL, V105, P1358, DOI 10.1136/bjophthalmol-2020-316293; Jay V, 1996, ARCH PATHOL LAB MED, V120, P378; JRC, 2020, 2020 CANC INC MORT E; Kanter-Lewensohn L, 1998, MELANOMA RES, V8, P389, DOI 10.1097/00008390-199810000-00002; Keijser S, 2007, BRIT J OPHTHALMOL, V91, P1566, DOI 10.1136/bjo.2006.110841; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Maures T, 2002, ENDOCRINOLOGY, V143, P1858, DOI 10.1210/en.143.5.1858; Mihajlovic M, 2012, INT J CLIN EXP PATHO, V5, P739; Mikkelsen LH, 2020, ACTA OPHTHALMOL, V98, P1, DOI 10.1111/aos.14536; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mundra PA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20432-5; Nareyeck G, 2005, EXP EYE RES, V81, P361, DOI 10.1016/j.exer.2005.04.018; Newel F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11107-x; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pacheco RR, 2022, EYE, V36, P603, DOI 10.1038/s41433-021-01508-y; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; Ren J, 2017, JOVE-J VIS EXP, DOI 10.3791/55459; Rivolta C, 2016, J HUM GENET, V61, P361, DOI 10.1038/jhg.2015.152; Sehat B, 2008, CANCER RES, V68, P5669, DOI 10.1158/0008-5472.CAN-07-6364; Sekulic A, 2008, MAYO CLIN PROC, V83, P825, DOI 10.4065/83.7.825; Seregard S, 1998, SURV OPHTHALMOL, V42, P321, DOI 10.1016/S0039-6257(97)00122-7; Seregard S, 1996, J CLIN PATHOL, V49, P338, DOI 10.1136/jcp.49.4.338; Shields CL, 2021, ASIA-PAC J OPHTHALMO, V10, P146, DOI 10.1097/APO.0000000000000343; Shields CL, 2020, JAMA OPHTHALMOL, V138, P608, DOI 10.1001/jamaophthalmol.2020.0522; Shields CL, 2000, ARCH OPHTHALMOL-CHIC, V118, P1497; Suleymanova N, 2017, ONCOGENE, V36, P5734, DOI 10.1038/onc.2017.179; Suleymanova N, 2017, ONCOTARGET, V8, P82256, DOI 10.18632/oncotarget.19286; Triay E, 2009, BRIT J OPHTHALMOL, V93, P1524, DOI 10.1136/bjo.2009.157933; Tuomaala S, 2002, INVEST OPHTH VIS SCI, V43, P3399; Vasilcanu D, 2006, ONCOGENE, V25, P3186, DOI 10.1038/sj.onc.1209339; Vasilcanu R, 2008, ONCOGENE, V27, P1629, DOI 10.1038/sj.onc.1210797; Vasilcanu R, 2008, MOL PHARMACOL, V73, P930, DOI 10.1124/mol.107.040014; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Virgili G, 2020, JAMA OPHTHALMOL, V138, P601, DOI 10.1001/jamaophthalmol.2020.0531; Wood JM, 1999, EXP DERMATOL, V8, P153, DOI 10.1111/j.1600-0625.1999.tb00365.x; Worrall C, 2017, ONCOGENE, V36, P3274, DOI 10.1038/onc.2016.472; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Yoshihara H, 2012, BIOCHEM BIOPH RES CO, V423, P122, DOI 10.1016/j.bbrc.2012.05.093	67	4	4	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					600	611		10.1038/s41388-021-02111-x	http://dx.doi.org/10.1038/s41388-021-02111-x		NOV 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785779				2022-12-26	WOS:000719276900001
J	Acevedo-Villanueva, KY; Renu, S; Shanmugasundaram, R; Akerele, GO; Gourapura, RJ; Selvaraj, RK				Acevedo-Villanueva, Keila Y.; Renu, Sankar; Shanmugasundaram, Revathi; Akerele, Gabriel O.; Gourapura, Renukaradhy J.; Selvaraj, Ramesh K.			Salmonella chitosan nanoparticle vaccine administration is protective against Salmonella Enteritidis in broiler birds	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFECTION; CHALLENGE; CHICKENS; POULTRY	Salmonella control strategies include vaccines that help reduce the spread of Salmonella in poultry flocks. In this study we evaluated the efficacy of administering a live Salmonella vaccine followed by a killed Salmonella chitosan nanoparticle (CNP) vaccine booster on the cellular and humoral immunity of broilers. The CNP vaccine was synthesized with Salmonella Enteritidis (S. Enteritidis) outer-membrane-proteins (OMPs) and flagellin-proteins. At d1-of-age, one-hundred-sixty-eight chicks were allocated into treatments: 1) No vaccine, 2) Live vaccine (Poulvac (R) ST), 3) CNP vaccine, 4) Live+CNP vaccine. At d1-of-age, birds were orally vaccinated with PBS, Live vaccine, or CNP. At d7-of-age, the No vaccine, Live vaccine and CNP vaccine groups were boosted with PBS and the Live+CNP vaccine group was boosted with CNP. At d14-of-age, birds were challenged with 1x10(9) CFU/bird S. Enteritidis. There were no significant differences in body-weight-gain (BWG) or feed-conversion-ratio (FCR). At 8h-post-challenge, CNP and Live+CNP-vaccinated birds had 17% and 24% greater levels (P<0.05) of anti-Salmonella OMPs IgA in bile, respectively, compared to control. At d28-of-age, CNP, Live, and Live+CNP-vaccinated birds had 33%, 18%, and 24% greater levels (P<0.05) of anti-Salmonella OMPs IgA in bile, respectively, compared to control. At d14-of-age, Live+CNP-vaccinated birds had 46% greater levels (P<0.05) of anti-Salmonella OMPs IgY in serum, compared to control. At d21-of-age, splenocytes from CNP and Live-vaccinated birds had increased (P<0.05) T-lymphocyte proliferation at 0.02 mg/mL OMPs stimulation compared to the control. At d28-of-age, CNP and Live+CNP-vaccinated birds had 0.9 Log10 CFU/g and 1 Log10 CFU/g decreased S. Enteritidis cecal loads (P<0.05), respectively, compared to control. The CNP vaccine does not have adverse effects on bird's BWG and FCR or IL-1 beta, IL-10, IFN-gamma, or iNOS mRNA expression levels. It can be concluded that the CNP vaccine, as a first dose or as a booster vaccination, is an alternative vaccine candidate against S. Enteritidis in broilers.	[Acevedo-Villanueva, Keila Y.; Akerele, Gabriel O.; Selvaraj, Ramesh K.] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Renu, Sankar; Gourapura, Renukaradhy J.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Ctr Food Anim Hlth, Dept Vet Preventat Med, Columbus, OH 43210 USA; [Shanmugasundaram, Revathi] USDA ARS, Toxicol & Mycotoxins Res Unit, Athens, GA 30613 USA	University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA)	Selvaraj, RK (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	selvaraj@uga.edu		Acevedo-Villanueva, Keila Yanis/0000-0002-4164-7658; /0000-0003-0546-6902	Hatch grant, USDA-NIFA [2017-05035, 58-6040-8-034 USDA-ARS]	Hatch grant, USDA-NIFA	This research was partially supported by Hatch grant, USDA-NIFA grant 2017-05035, and 58-6040-8-034 USDA-ARS awarded to R.K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abul K., 2015, CELL MOL IMMUNOL, V8; Acevedo-Villanueva KY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231998; Acevedo-villanueva KY., 2021, NOVEL APPROACH SALMO; Akerele G, 2020, VET IMMUNOL IMMUNOP, V224, DOI 10.1016/j.vetimm.2020.110059; Andino A, 2015, ScientificWorldJournal, V2015, P520179, DOI 10.1155/2015/520179; Boyaka PN, 2017, J IMMUNOL, V199, P9, DOI 10.4049/jimmunol.1601775; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Buncic S, 2012, FOOD RES INT, V45, P641, DOI 10.1016/j.foodres.2011.10.018; Edelblum KL., 2015, MUCOSAL IMMUNOL, V4 th; Han Y, 2020, VET IMMUNOL IMMUNOP, V228, DOI 10.1016/j.vetimm.2020.110111; Hansen KR, 2006, J APPL MICROBIOL, V100, P144, DOI 10.1111/j.1365-2672.2005.02758.x; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE; Jia SY, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040696; Kaiser P, 2003, J VIROL, V77, P762, DOI 10.1128/JVI.77.1.762-768.2003; Klochko A., 2019, SALMONELLA INFECT SA, P1; Li Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2032057; Marangon S, 2007, REV SCI TECH OIE, V26, P265, DOI 10.20506/rst.26.1.1742; Markazi A, 2018, POULTRY SCI, V97, P3510, DOI 10.3382/ps/pey234; McNeill E, 2015, FREE RADICAL BIO MED, V79, P206, DOI 10.1016/j.freeradbiomed.2014.10.575; Methner U., 2007, VACCINATION POULTRY; Morris A, 2014, POULTRY SCI, V93, P1951, DOI 10.3382/ps.2014-03939; Natl Advisory Comm Microbiological, 2019, J FOOD PROTECT, V82, P645, DOI 10.4315/0362-028X.JFP-18-500; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Okamura M, 2012, POULTRY SCI, V91, P2444, DOI 10.3382/ps.2012-02303; Oklahoma State Department of Health, 2012, INT LIV VACC OTH RUL; Renu S, 2020, CARBOHYD POLYM, V243, DOI 10.1016/j.carbpol.2020.116434; Renu S, 2020, INT J NANOMED, V15, P761, DOI 10.2147/IJN.S238445; Renu S, 2018, INT J NANOMED, V13, P8195, DOI 10.2147/IJN.S185588; Renu Sankar, 2017, [No title captured], Patent No. [10336-342WO1, 10336342]; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Saif YM., 2008, DIS POULTRY DISSEASE; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Selvaraj RK, 2006, J NUTR, V136, P1610, DOI 10.1093/jn/136.6.1610; Setyohadi DPS, 2018, J PHYS CONF SER, V953, DOI 10.1088/1742-6596/953/1/012118; Shanmugasundaram R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223577; Shanmugasundaram R, 2015, POULTRY SCI, V94, P1828, DOI 10.3382/ps/pev161; Singh Lakhmir., 2021, FDN COURSE NEET 3, V9; Stern NJ, 2001, POULTRY SCI, V80, P156, DOI 10.1093/ps/80.2.156; Stewart-Brown Bruce., 2019, MERCK VET MANUAL VAC; Tellez G, 2012, FOOD RES INT, V45, P628, DOI 10.1016/j.foodres.2011.03.047; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P443, DOI 10.1111/j.1574-695X.2007.00329.x; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314	43	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259334	10.1371/journal.pone.0259334	http://dx.doi.org/10.1371/journal.pone.0259334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784366	gold, Green Published			2022-12-26	WOS:000755277300008
J	Hidalgo, BA; Minniefield, B; Patki, A; Tanner, R; Bagheri, M; Tiwari, HK; Arnett, DK; Irvin, MR				Hidalgo, Bertha A.; Minniefield, Bre; Patki, Amit; Tanner, Rikki; Bagheri, Minoo; Tiwari, Hemant K.; Arnett, Donna K.; Irvin, Marguerite Ryan			A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; DIFFERENTIAL DNA METHYLATION; LIPID-LOWERING DRUGS; BODY-MASS INDEX; BLOOD; GENETICS; LOCI; SOCS3	There has been great interest in genetic risk prediction using risk scores in recent years, however, the utility of scores developed in European populations and later applied to non-European populations has not been successful. The goal of this study was to create a methylation risk score (MRS) for metabolic syndrome (MetS), demonstrating the utility of MRS across race groups using cross-sectional data from the Hypertension Genetic Epidemiology Network (HyperGEN, N = 614 African Americans (AA)) and the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN, N = 995 European Americans (EA)). To demonstrate this, we first selected cytosine-guanine dinucleotides (CpG) sites measured on Illumina Methyl450 arrays previously reported to be significantly associated with MetS and/or component conditions in more than one race/ethnic group (CPT1A cg00574958, PHOSPHO1 cg02650017, ABCG1 cg06500161, SREBF1 cg11024682, SOCS3 cg18181703, TXNIP cg19693031). Second, we calculated the parameter estimates for the 6 CpGs in the HyperGEN data (AA) and used the beta estimates as weights to construct a MRS in HyperGEN (AA), which was validated in GOLDN (EA). We performed association analyses using logistic mixed models to test the association between the MRS and MetS, adjusting for covariates. Results showed the MRS was significantly associated with MetS in both populations. In summary, a MRS for MetS was a strong predictor for the condition across two race groups, suggesting MRS may be useful to examine metabolic disease risk or related complications across race/ethnic groups.	[Hidalgo, Bertha A.; Minniefield, Bre; Tanner, Rikki; Irvin, Marguerite Ryan] Univ Alabama Birmingham, Ryals Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Patki, Amit; Tiwari, Hemant K.] Univ Alabama Birmingham, Ryals Sch Publ Hlth, Dept Biostat, Birmingham, AL USA; [Bagheri, Minoo] Vanderbilt Univ, Med Ctr, Ctr Precis Med, Nashville, TN USA; [Arnett, Donna K.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; University of Kentucky	Hidalgo, BA (corresponding author), Univ Alabama Birmingham, Ryals Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	bhidalgo@uab.edu		Hidalgo, Bertha/0000-0002-2556-1969				Akinyemiju T, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0483-2; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Ali O, 2016, EPIGENETICS-US, V11, P699, DOI 10.1080/15592294.2016.1216284; [Anonymous], 2016, GENOME BIOL, V17; [Anonymous], 2021, NAT GENET; [Anonymous], 2019, REV ENDOCR METAB DIS, V20; [Anonymous], 2016, TRANSLATIONAL RES J, V178; [Anonymous], 2019, NAT GENET, V51; [Anonymous], 2017, J DIABETES COMPLICAT, V31; [Anonymous], 2017, SCI REP-UK, V7; Aslibekyan S, 2017, NUTR METAB CARDIOVAS, V27, P225, DOI 10.1016/j.numecd.2016.11.004; Aslibekyan S, 2015, OBESITY, V23, P1493, DOI 10.1002/oby.21111; Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Boyraz M, 2016, J CLIN RES PEDIATR E, V8, P452, DOI 10.4274/jcrpe.3167; Braun KVE, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0304-4; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Clark SL, 2018, ALCOHOL CLIN EXP RES, V42, P2360, DOI 10.1111/acer.13905; Cortright DN, 2009, CURR EYE RES, V34, P57, DOI 10.1080/02713680802546658; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Das M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145789; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Fernandez-Sanles A, 2018, ARTERIOSCL THROM VAS, V38, P645, DOI 10.1161/ATVBAHA.117.310340; Frazier-Wood AC, 2014, J LIPID RES, V55, P1324, DOI 10.1194/jlr.M048504; Hamilton OKL, 2019, INT J OBESITY, V43, P1795, DOI 10.1038/s41366-018-0262-3; Hannon E, 2015, EPIGENETICS-US, V10, P1024, DOI 10.1080/15592294.2015.1100786; Hedman AK, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001487; Hidalgo B, 2014, DIABETES, V63, P801, DOI 10.2337/db13-1100; Houseman E Andres, 2015, Curr Environ Health Rep, V2, P145, DOI 10.1007/s40572-015-0050-3; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Huls A, 2020, EPIGENETICS-US, V15, P1, DOI 10.1080/15592294.2019.1644879; Irvin MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099509; Irvin MR, 2014, CIRCULATION, V130, P565, DOI 10.1161/CIRCULATIONAHA.114.009158; Krause C, 2019, EPIGENOMICS-UK, V11, P885, DOI 10.2217/epi-2018-0159; Lai CQ, 2016, J LIPID RES, V57, P2200, DOI 10.1194/jlr.M069948; Lewis CM, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00742-5; Ma BS, 2014, NUCLEIC ACIDS RES, V42, P3515, DOI 10.1093/nar/gkt1380; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Matsuo M, 2010, BIOSCI BIOTECH BIOCH, V74, P899, DOI 10.1271/bbb.90921; Mendelson MM, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002215; Musunuru K, 2019, CELL, V177, P132, DOI 10.1016/j.cell.2019.02.015; Niu Dayan, 2015, Yichuan, V37, P1204, DOI 10.16288/j.yczz.15-228; Nuotio ML, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77506-z; Palmieri V, 2001, CIRCULATION, V103, P102; Pennells L, 2019, EUR HEART J, V40, P621, DOI 10.1093/eurheartj/ehy653; Pfeiffer L, 2015, CIRC-CARDIOVASC GENE, V8, P334, DOI 10.1161/CIRCGENETICS.114.000804; Qayyum N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052754; Richard MA, 2017, AM J HUM GENET, V101, P888, DOI 10.1016/j.ajhg.2017.09.028; Sayols-Baixeras S, 2016, HUM MOL GENET, V25, P4556, DOI 10.1093/hmg/ddw285; Schlaepfer Isabel R, 2020, Endocrinology, V161, DOI 10.1210/endocr/bqz046; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Suchacki KJ, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00880-7; Wahl S, 2017, NATURE, V541, P81, DOI 10.1038/nature20784; Williams RR, 2000, ANN EPIDEMIOL, V10, P389, DOI 10.1016/S1047-2797(00)00063-6; Xu K, 2018, BIOL PSYCHOL, V131, P63, DOI 10.1016/j.biopsycho.2016.11.001; Zhang XY, 2016, EPIGENETICS-US, V11, P750, DOI 10.1080/15592294.2016.1221569	57	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259836	10.1371/journal.pone.0259836	http://dx.doi.org/10.1371/journal.pone.0259836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780523	Green Published, gold, Green Submitted			2022-12-26	WOS:000755305800056
J	Xu, H; Liu, BH; Qi, WY; Xu, M; Cui, XY; Liu, J; Li, Q				Xu, Han; Liu, Binghua; Qi, Wenyu; Xu, Meng; Cui, Xiaoyu; Liu, Jun; Li, Qiang			Combined impact of TiO2 nanoparticles and antibiotics on the activity and bacterial community of partial nitrification system	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL COMMUNITY; PARTIAL-NITRITATION; ZNO NANOPARTICLES; WASTE-WATER; ANAMMOX; REMOVAL; SLUDGE; TETRACYCLINE; PCR	The effects of TiO2 nanoparticles (nano-TiO2) together with antibiotics leaking into wastewater treatment plants (WWTPs), especially the partial nitrification (PN) process remain unclear. To evaluate the combined impact and mechanisms of nano-TiO2 and antibiotics on PN systems, batch experiments were carried out with six bench-scale sequencing batch reactors. Nano-TiO2 at a low level had minimal effects on the PN system. In combination with tetracycline and erythromycin, the acute impact of antibiotics was enhanced. Both steps of nitrification were retarded due to the decrease of bacterial activity and abundance, while nitrite-oxidizing bacteria were more sensitive to the inhibition than ammonia-oxidizing bacteria. Proteobacteria at the phylum level and Nitrosospira at the genus level remained predominant under single and combined impacts. The flow cytometry analysis showed that nano-TiO2 enhanced the toxicity of antibiotics through increasing cell permeability. Our results can help clarify the risks of nano-TiO2 combined with antibiotics to PN systems and explaining the behavior of nanoparticles in WWTPs.	[Xu, Han; Liu, Binghua; Xu, Meng; Cui, Xiaoyu; Li, Qiang] Linyi Univ, Coll Agr & Forestry Sci, Linyi, Shandong, Peoples R China; [Qi, Wenyu; Liu, Jun; Li, Qiang] Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China	Linyi University; Shandong University	Li, Q (corresponding author), Linyi Univ, Coll Agr & Forestry Sci, Linyi, Shandong, Peoples R China.; Li, Q (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan, Shandong, Peoples R China.	liqiang67@lyu.edu.cn			Natural Science Foundation of China [32001459]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by Natural Science Foundation of China (Grant Nos. 32001459) and the funder took on the role of preparation of the manuscript.	ABELING U, 1992, WATER SCI TECHNOL, V26, P1007, DOI 10.2166/wst.1992.0542; ANTHONISEN AC, 1976, J WATER POLLUT CON F, V48, P835; APHA, 1998, STANDARD METHODS EXA, V20th; Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Aslan S, 2011, APPL BIOCHEM BIOTECH, V165, P1543, DOI 10.1007/s12010-011-9374-0; Chu LB, 2021, J HAZARD MATER, V415, DOI 10.1016/j.jhazmat.2021.125724; Cycon M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00338; Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8; Di HJ, 2009, NAT GEOSCI, V2, P621, DOI 10.1038/NGEO613; Ding S, 2015, CHEMOSPHERE, V140, P174, DOI 10.1016/j.chemosphere.2015.03.057; Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031; Du R, 2017, WATER RES, V108, P46, DOI 10.1016/j.watres.2016.10.051; Ge Y, 2013, ENVIRON SCI TECHNOL, V47, P14411, DOI 10.1021/es403385c; Gomez-Alvarez V, 2014, ENVIRON SCI TECHNOL, V48, P5448, DOI 10.1021/es5005208; Gonzalez-Martinez A, 2014, SCI TOTAL ENVIRON, V476, P276, DOI 10.1016/j.scitotenv.2014.01.012; Guo Q, 2016, BIORESOURCE TECHNOL, V214, P253, DOI 10.1016/j.biortech.2016.04.116; Horz HP, 2000, J MICROBIOL METH, V39, P197, DOI 10.1016/S0167-7012(99)00119-0; Jelic A, 2011, WATER RES, V45, P1165, DOI 10.1016/j.watres.2010.11.010; Katipoglu-Yazan T, 2013, BIORESOURCE TECHNOL, V144, P410, DOI 10.1016/j.biortech.2013.06.121; Kowalchuk GA, 1997, APPL ENVIRON MICROB, V63, P1489, DOI 10.1128/AEM.63.4.1489-1497.1997; Li DP, 2016, CHEMOSPHERE, V144, P1334, DOI 10.1016/j.chemosphere.2015.10.002; Li K, 2020, J HAZARD MATER, V384, DOI 10.1016/j.jhazmat.2019.121388; Li Q, 2013, BIORESOURCE TECHNOL, V136, P148, DOI 10.1016/j.biortech.2013.02.081; Li ZW, 2017, BIORESOURCE TECHNOL, V238, P361, DOI 10.1016/j.biortech.2017.04.069; Liang JH, 2013, CURR TOP MED CHEM, V13, P3131, DOI 10.2174/15680266113136660223; Liang ZW, 2011, BIORESOURCE TECHNOL, V102, P710, DOI 10.1016/j.biortech.2010.08.054; Luo ZX, 2015, ENVIRON SCI POLLUT R, V22, P2891, DOI 10.1007/s11356-014-3545-9; May S, 2000, CURR OPIN COLLOID IN, V5, P244, DOI 10.1016/S1359-0294(00)00062-5; Okano Y, 2004, APPL ENVIRON MICROB, V70, P1008, DOI 10.1128/AEM.70.2.1008-1016.2004; Piccinno F, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1109-9; Sarker DC, 2015, WATER RES, V84, P190, DOI 10.1016/j.watres.2015.07.019; Shalini SS, 2012, WASTE MANAGE, V32, P2385, DOI 10.1016/j.wasman.2012.06.006; Shi YJ, 2013, BIORESOURCE TECHNOL, V139, P170, DOI 10.1016/j.biortech.2013.03.037; Sui QW, 2016, APPL MICROBIOL BIOT, V100, P4177, DOI 10.1007/s00253-015-7183-z; Van Hulle SWH, 2007, J CHEM TECHNOL BIOT, V82, P471, DOI 10.1002/jctb.1692; Vazquez-Munoz R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224904; Vlaeminck SE, 2012, MICROB BIOTECHNOL, V5, P433, DOI 10.1111/j.1751-7915.2012.00341.x; Wan CL, 2014, BIORESOURCE TECHNOL, V152, P1, DOI 10.1016/j.biortech.2013.10.112; Wang B, 2016, BIORESOURCE TECHNOL, V207, P118, DOI 10.1016/j.biortech.2016.01.072; Wang DX, 2019, ENVIRON POLLUT, V248, P834, DOI 10.1016/j.envpol.2019.02.084; Wang JP, 2021, BIODEGRADATION, V32, P229, DOI 10.1007/s10532-021-09938-x; Wang W, 2021, SCI TOTAL ENVIRON, V759, DOI 10.1016/j.scitotenv.2020.143542; Wang XL, 2018, NANOIMPACT, V10, P61, DOI 10.1016/j.impact.2017.11.006; Wang Y, 2019, ISME J, V13, P509, DOI 10.1038/s41396-018-0275-x; Wen X, 2016, BIORESOURCE TECHNOL, V222, P309, DOI 10.1016/j.biortech.2016.09.132; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Yang GF, 2012, BIORESOURCE TECHNOL, V126, P187, DOI 10.1016/j.biortech.2012.09.023; Yu R, 2015, CHEMOSPHERE, V128, P207, DOI 10.1016/j.chemosphere.2015.02.002; Yu ZG, 2021, ISME J, V15, P2117, DOI 10.1038/s41396-021-00909-x; Yuan BL, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111634; Zepeda A, 2013, BIODEGRADATION, V24, P377, DOI 10.1007/s10532-012-9595-0; Zhang B, 2010, BIORESOURCE TECHNOL, V101, P3054, DOI 10.1016/j.biortech.2009.12.048; Zhang J, 2016, CHEMOSPHERE, V144, P1837, DOI 10.1016/j.chemosphere.2015.10.084	53	1	1	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259671	10.1371/journal.pone.0259671	http://dx.doi.org/10.1371/journal.pone.0259671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780518	gold, Green Published			2022-12-26	WOS:000755305800038
J	Ambreen, A; Tahseen, S; Wali, A; Jamil, M; Naqvi, SZH; Safdar, N; Mustafa, T				Ambreen, Atiqa; Tahseen, Sabira; Wali, Ahmad; Jamil, Muhammad; Naqvi, Syed Zeeshan Haider; Safdar, Nauman; Mustafa, Tehmina			Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study	PLOS ONE			English	Article							CULTURE CONVERSION; TOBACCO SMOKING; RISK-FACTORS; RELAPSE; SMEAR; TIME	The optimal duration of treatment in different forms of extrapulmonary tuberculosis (EPTB) is not clearly defined. This study aimed to identify predictors of slow clinical response and extended anti-TB treatment in EPTB patients. Socio-demographic, clinical, and microbiological characteristics of EPTB patients registered for anti-TB treatment at a tertiary care hospital, were analysed for identification of predictors of extended treatment. A total of 251 patients (137 lymphadenitis, and 114 pleuritis) were included in the analysis. Treatment was extended to more than 6 months in 58/251 (23%) patients. In the multivariate regression analysis, culture-positive EPTB (p = 0.007) [OR (95% CI) = 3.81 (1.43, 10.11)], history of diabetes (p = 0.014) [OR (95% CI) = 25.18 (1.94, 325.83)], smokeless tobacco use (p = 0.002) [OR (95% CI) = 17.69 (2.80, 111.72)], and slow regression of local signs and symptoms after 2 months of treatment (p < 0.001) [OR (95% CI) = 17.09 [(5.79, 50.39)] were seen to be significantly associated with treatment extension. Identification of predictors of extended treatment can help clinical decisions regarding optimal duration of treatment. Further studies are needed to identify subgroups of EPTB patients who can benefit from a shorter or longer treatment regimen.	[Ambreen, Atiqa] Gulab Devi Hosp, Dept Microbiol, Lahore, Pakistan; [Ambreen, Atiqa; Naqvi, Syed Zeeshan Haider] Univ Lahore, Inst Mol Biol & Biotechnol IMBB, Def Rd Campus, Lahore, Pakistan; [Tahseen, Sabira] Natl TB Control Program, Natl TB Reference Lab, Islamabad, Pakistan; [Tahseen, Sabira; Wali, Ahmad; Mustafa, Tehmina] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Jamil, Muhammad] Gulab Devi Hosp, Dept TB & Chest Med, Lahore, Pakistan; [Safdar, Nauman] Social & Hlth Inequal Network SHINe, Sindh, Pakistan; [Mustafa, Tehmina] Haukeland Hosp, Dept Thorac Med, Bergen, Norway	University of Lahore; University of Bergen; University of Bergen; Haukeland University Hospital	Mustafa, T (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Mustafa, T (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.	tehmina.mustafa@uib.no	Tahseen, Sabira/AAV-8653-2020	Tahseen, Sabira/0000-0002-6887-8149	Research Council of Norway through the Global Health and Vaccination Programme [234457]; European Union	Research Council of Norway through the Global Health and Vaccination Programme(Research Council of Norway); European Union(European Commission)	TM received funding. This work was partly supported by the Research Council of Norway through the Global Health and Vaccination Programme [Grant number 234457]. This project is part of the EDCTP2 programme supported by the European Union.	Ambreen A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4561-7; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; [Anonymous], 1979, Tubercle, V60, P201; Atif M, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00227-1; Behnaz Fatemah, 2015, Tuberc Res Treat, V2015, P609083, DOI 10.1155/2015/609083; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Benova L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035948; Bernabe-Ortiz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018474; Chabala C, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2608-5; Chang KC, 2004, AM J RESP CRIT CARE, V170, P1124, DOI 10.1164/rccm.200407-905OC; Churchyard GJ, 2018, NAT MED, V24, P1639, DOI 10.1038/s41591-018-0244-y; Das Shukla A, 2017, J EVOL MED DENT SCI-, V6, P4515, DOI [10.14260/jemds/2017/976, 10.14260/Jemds/2017/976]; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Gegia M, 2015, B WORLD HEALTH ORGAN, V93, P390, DOI 10.2471/BLT.14.147439; Guler M, 2007, INT J CLIN PRACT, V61, P231, DOI 10.1111/j.1742-1241.2006.01131.x; Harries AD, 2003, TROP DOCT, V33, P7, DOI 10.1177/004947550303300106; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Hu YM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00641; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Jo KW, 2014, RESP MED, V108, P654, DOI 10.1016/j.rmed.2014.01.010; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Jorstad MD, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4034-z; Khan A, 2006, AM J RESP CRIT CARE, V174, P344, DOI 10.1164/rccm.200511-1834OC; Khanbodaghi A, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0861-y; Kolappan C, 2002, THORAX, V57, P964, DOI 10.1136/thorax.57.11.964; Mohd Saleem S, 2019, IJFCM, V6, P1; National Tuberculosis Control Programme Pakistan, 2019, NAT TB GUID; O'Toole RF, 2018, TUBERCULOSIS, V113, P26, DOI 10.1016/j.tube.2018.08.015; Oemar M., 2013, EQ 5D 5L USER GUIDE, P28; Sabiiti W, 2020, THORAX, V75, P606, DOI 10.1136/thoraxjnl-2019-214238; Sharma SK, 2021, EXPERT REV RESP MED, V15, P931, DOI 10.1080/17476348.2021.1927718; Siddiqui AN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7273935; Stinson K., 2014, GLOBAL LAB INITIATIV; Tahseen S, 2019, INT J TUBERC LUNG D, V23, P900, DOI 10.5588/ijtld.18.0531; Viswanathan V, 2014, J DIABETES COMPLICAT, V28, P162, DOI 10.1016/j.jdiacomp.2013.12.003; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918; WHO, 2020, GLOB TB REP; WHO, 2017, GLOB TUB REP; WHO, 2017, GUIDELINES TREATMENT; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, WHOHTMTB20141; World Health organization (WHO), 2020, TUB FACT SHEETS; World Health Organization (WHO), 2020, TUB COUNTR REG GLOB; Yoon YS, 2017, THORAX, V72, P263, DOI 10.1136/thoraxjnl-2015-207686; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259801	10.1371/journal.pone.0259801	http://dx.doi.org/10.1371/journal.pone.0259801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767601	gold, Green Published			2022-12-26	WOS:000755249300047
J	Muhajarine, N; Adeyinka, DA; McCutcheon, J; Green, KL; Fahlman, M; Kallio, N				Muhajarine, Nazeem; Adeyinka, Daniel A.; McCutcheon, Jessica; Green, Kathryn L.; Fahlman, Miles; Kallio, Natalie			COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling	PLOS ONE			English	Article							HERD-IMMUNITY	Background A high population level of vaccination is required to control the COVID-19 pandemic, but not all Canadians are convinced of the value and safety of vaccination. Understanding more about these individuals can aid in developing strategies to increase their acceptance of a COVID-19 vaccine. The objectives of this study were to describe COVID-19 vaccine acceptance, hesitancy and refusal rates and associated factors in Saskatchewan, Canada. Methods This is a cross-sequential study that consisted of pooled responses from weighted samples of 9,252 Saskatchewan adults (>= 18 years) across nine rounds of data collection between May 4, 2020 and April 3, 2021. The outcome variable was vaccine intention: vaccine acceptance, hesitancy, and refusal. The independent variables were layered into socio-demographic factors, risk of exposure to coronavirus, mitigating behaviours, and perceptions of COVID-19. Data were analyzed using multinomial logistic regression and a classification and regression tree. Results Seventy-six percent of the respondents indicated that they had been or were willing to be vaccinated, 13% had not yet decided, and the remaining 11% said they would not be vaccinated. Factors that increased the likelihood of vaccine refusal and hesitancy were lower education level, financial instability, Indigenous status, and not being concerned about spreading the coronavirus. Perceiving COVID-19 to be more of a threat to one's community and believing that one had a higher risk of illness or death from COVID-19 decreased the likelihood of both vaccine refusal and hesitancy. Women and newcomers to Canada were more likely to be unsure about getting vaccinated. Respondents who did not plan to be vaccinated were less likely to wear face masks and practice physical distancing. Conclusion While many Canadians have voluntarily and eagerly become vaccinated already, reaching sufficient coverage of the population is likely to require targeted efforts to convince those who are resistant or unsure. Identifying and overcoming any barriers to vaccination that exist within the socio-demographic groups we found were least likely to be vaccinated is a crucial component.	[Muhajarine, Nazeem; Adeyinka, Daniel A.; Kallio, Natalie] Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK, Canada; [Muhajarine, Nazeem; Adeyinka, Daniel A.; Kallio, Natalie] Saskatchewan Populat Hlth & Evaluat Res Unit, Saskatoon, SK, Canada; [McCutcheon, Jessica] Univ Saskatchewan, Canadian Hub Appl & Social Res, Saskatoon, SK, Canada; [Green, Kathryn L.] Univ Saskatchewan, Dept Community Hlth & Epidemiol, Saskatoon, SK, Canada; [Fahlman, Miles] HACAN Consulting Ltd, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Muhajarine, N (corresponding author), Univ Saskatchewan, Coll Med, Dept Community Hlth & Epidemiol, Saskatoon, SK, Canada.; Muhajarine, N (corresponding author), Saskatchewan Populat Hlth & Evaluat Res Unit, Saskatoon, SK, Canada.	nazeem.muhajarine@usask.ca		Kallio, Natalie/0000-0001-5344-6610; Muhajarine, Nazeem/0000-0001-6781-5421	2020 Rapid Response COVID-19 Research Award, College of Medicine, University of Saskatchewan [423181]	2020 Rapid Response COVID-19 Research Award, College of Medicine, University of Saskatchewan	Social Contours and COVID-19 received funding from 2020 Rapid Response COVID-19 Research Award, College of Medicine, University of Saskatchewan (Fund ID: 423181). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2020, LANCET, V396, P1614, DOI 10.1016/S0140-6736(20)32318-7; Angus Reid Institute, 2021, COVID 19 CAN WILL BE; Angus Reid Institute, 2021, DESP MONTHS MIX MESS; [Anonymous], 2020, CBC NEWS; [Anonymous], 2021, CBC NEWS; [Anonymous], 2020, COVID 19 SCI 5 EPISO; [Anonymous], 2021, CTV NEWS; [Anonymous], 2020, STATA VERSION 16 1; Aschwanden C, 2021, NATURE, V591, P520, DOI 10.1038/d41586-021-00728-2; Bartsch SM, 2020, AM J PREV MED, V59, P493, DOI 10.1016/j.amepre.2020.06.011; Beleites C, 2013, CHEMOMETR INTELL LAB, V122, P12, DOI 10.1016/j.chemolab.2012.12.003; BEworks, 2021, COVID 19 VACC HES BE; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dzieciolowska S, 2021, AM J INFECT CONTROL, V49, P1152, DOI 10.1016/j.ajic.2021.04.079; Edwards B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248892; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Frank K., 2020, CANADIANS WILLINGNES; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; Government of Canada, COR DIS COVID 19 OUT; Government of Canada, 2021, VACC COMM INN CHALL; Government of Canada, 2021, COVID 19 VACC COV CA; Griffith J, 2021, J MED INTERNET RES, V23, DOI 10.2196/26874; Kino S, 2021, SSM-POPUL HLTH, V15, DOI 10.1016/j.ssmph.2021.100836; Lavery R., 2012, ANIMATED GUIDE REGRE; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Metis Nation Saskatchewan, 2021, VACC MET STRONG; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; SAGE, 2014, REP SAGE WORK GROUP; Sarasty O, 2020, VACCINE, V38, P8090, DOI 10.1016/j.vaccine.2020.11.013; SAS,, JMP STAT PRED MOD DA; Saskatoon StarPhoenix, 2021, IND LEAD TAK RAD SOC; Smith TC, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx146; Statistics Canada, 2021, TABL 17 10 0009 01 P, DOI [10.25318/1710000901-eng, DOI 10.25318/1710000901-ENG]; Statistics Canada, 2021, COVID 19 VACC WILL C; Stonechild B., INDIGENOUS PEOPLES S; Vacondio M, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.577992; Vescera Z., 2021, SASKATOON STARPHOENI; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang JH, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030482; WHO, 2020, WHO COR COVID 19 DAS; Witteveen D, 2020, P NATL ACAD SCI USA, V117, P27277, DOI 10.1073/pnas.2009609117	41	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259513	10.1371/journal.pone.0259513	http://dx.doi.org/10.1371/journal.pone.0259513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767603	gold, Green Submitted, Green Published			2022-12-26	WOS:000755249300033
J	Pessoa, DM; Sancassani, A; Siqueira, LOD; Massini, DA; Santos, LGA; Neiva, CM; DiMenna, FJ				Pessoa Filho, Dalton Muller; Sancassani, Andrei; da Cruz Siqueira, Leandro Oliveira; Massini, Danilo Alexandre; Almeida Santos, Luiz Gustavo; Neiva, Cassiano Merussi; DiMenna, Fred J.			Energetics contribution during no-gi Brazilian jiu jitsu sparring and its association with regional body composition	PLOS ONE			English	Article							INTENSITY; RESPONSES; DEMANDS; COMBAT	We used measurements of metabolic perturbation obtained after sparring to estimate energetics contribution during no-gi Brazilian jiu-jitsu. Ten advanced grapplers performed two six-minute sparring bouts separated by 24 hours. Kinetics of recovery rate of oxygen uptake was modelled and post-combat-sparring blood-lactate concentration measured to estimate oxygen equivalents for phospholytic and glycolytic components of anaerobic energetics, respectively. Linear regression was used to estimate end-combat-sparring rate of oxygen uptake. Regional and whole-body composition were assessed using dual X-ray absorptiometry with associations between these measurements and energy turnover explored using Pearson's correlation coefficient (significance, P < 0.05). Estimated oxygen equivalents for phospholytic and glycolytic contributions to anaerobic metabolism were 16.9 +/- 8.4 (similar to 28%) and 44.6 +/- 13.5 (similar to 72%) mL.kg(-1), respectively. Estimated end-exercise rate of oxygen uptake was 44.2 +/- 7.0 mL.kg(-1).min(-1). Trunk lean mass was positively correlated with both total anaerobic and glycolytic-specific energetics (total, R = 0.645, p = 0.044; glycolytic, R = 0.692, p = 0.027) and negatively correlated with end-exercise rate of oxygen uptake (R = -0.650, p = 0.042). There were no correlations for any measurement of body composition and phospholytic-specific energetics. Six minutes of no-gi Brazilian jiu-jitsu sparring involves high relative contribution from the glycolytic component to total anaerobic energy provision and the link between this energetics profile and trunk lean mass is consistent with the predominance of ground-based combat that is unique for this combat sport. Training programs for Brazilian jiu-jitsu practitioners should be designed with consideration given to these specific energetics characteristics.	[Pessoa Filho, Dalton Muller; Sancassani, Andrei; da Cruz Siqueira, Leandro Oliveira; Massini, Danilo Alexandre; Almeida Santos, Luiz Gustavo; Neiva, Cassiano Merussi] Sao Paulo State Univ UNESP, Inst Biosci, Grad Program Human Dev & Technol, Rio Claro, Brazil; [Pessoa Filho, Dalton Muller; Sancassani, Andrei; da Cruz Siqueira, Leandro Oliveira; Massini, Danilo Alexandre; Almeida Santos, Luiz Gustavo; Neiva, Cassiano Merussi] Sao Paulo State Univ UNESP, Dept Phys Educ, Bauru, SP, Brazil; [DiMenna, Fred J.] Icahn Sch Med Mt Sinai, Dept Med, Div Endocrinol Diabet & Bone, New York, NY 10029 USA	Universidade Estadual Paulista; Universidade Estadual Paulista; Icahn School of Medicine at Mount Sinai	DiMenna, FJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Endocrinol Diabet & Bone, New York, NY 10029 USA.	fjdimenna2020@gmail.com	Massini, Danilo Alexandre/V-3845-2018; Filho, Dalton M Pessôa/B-9649-2012; Merussi Neiva, Cassiano/M-5273-2016	Massini, Danilo Alexandre/0000-0003-1088-0040; Filho, Dalton M Pessôa/0000-0003-3975-9260; Merussi Neiva, Cassiano/0000-0003-1635-3209; Sancassani, Andrei/0000-0002-6332-7823; DiMenna, Fred/0000-0003-3018-8094; Siqueira, Leandro/0000-0003-0585-4593	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]; Sao Paulo Research Foundation -FAPESP [2016/04544-3, 2018/16706-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DMPF received funding for this study from: 1.) Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior -Brazil (CAPES) Finance Code 001 https://www.gov.br/capes/2.) Sao Paulo Research Foundation -FAPESP (grant number 2016/04544-3 and 2018/16706-3). https://fapesp.br/en/about.	Andreato Leonardo V, 2013, Asian J Sports Med, V4, P137; Andreato LV, 2015, J STRENGTH COND RES, V29, P2538, DOI 10.1519/JSC.0000000000000918; Andreato LV, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-016-0069-5; Andreato LV, 2016, SPORTS MED, V46, P1963, DOI 10.1007/s40279-016-0587-9; Andreato LV, 2012, KINESIOLOGY, V44, P173; Artioli Guilherme G, 2012, J Vis Exp, DOI 10.3791/3413; Baez E, 2014, INT J MORPHOL, V32, P1043, DOI 10.4067/S0717-95022014000300048; Barley OR, 2019, SPORTS, V7, DOI 10.3390/sports7050123; Beneke R, 2004, EUR J APPL PHYSIOL, V92, P518, DOI 10.1007/s00421-004-1073-x; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Coswig VS, 2018, ARCH BUDO, V14, P291; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; DiMenna FJ., 2016, STRENGTH CONDITIONIN, P372; Campos FAD, 2012, EUR J APPL PHYSIOL, V112, P1221, DOI 10.1007/s00421-011-2071-4; Doria C, 2009, EUR J APPL PHYSIOL, V107, P603, DOI 10.1007/s00421-009-1154-y; Durkalec-Michalski K, 2015, ARCH BUDO, V11, P251; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Marinho BF, 2016, SCI SPORT, V31, P129, DOI 10.1016/j.scispo.2015.12.001; Ford SJ, 2015, SPORT BUS MANAG, V5, P31, DOI 10.1108/SBM-11-2011-0083; Franchini E, 2019, J STRENGTH COND RES, V33, P242, DOI 10.1519/JSC.0000000000002957; Franchini E, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-52; HAGBERG JM, 1980, J APPL PHYSIOL, V48, P540, DOI 10.1152/jappl.1980.48.3.540; James LP, 2017, INT J SPORT PHYSIOL, V12, P612, DOI 10.1123/ijspp.2016-0373; Diaz-Lara FJ, 2015, INT J PERF ANAL SPOR, V15, P489, DOI 10.1080/24748668.2015.11868808; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Julio UF, 2017, INT J SPORT PHYSIOL, V12, P676, DOI 10.1123/ijspp.2015-0750; Ratamess NA, 2011, STRENGTH COND J, V33, P18, DOI 10.1519/SSC.0b013e31823732c5; Reilly T, 2009, J SPORT SCI, V27, P575, DOI 10.1080/02640410902729741; Rodrigues-Krause J, 2020, INT J PERF ANAL SPOR, V20, P1092, DOI 10.1080/24748668.2020.1829429; Silva BVC., 2013, J EXERCISE PHYSL ONL, V16, P63; Villar R, 2018, J STRENGTH COND RES, V32, P432, DOI 10.1519/JSC.0000000000001536; Weber CL, 2006, MED SCI SPORT EXER, V38, P129, DOI 10.1249/01.mss.0000179902.31527.2c; Whipp BJ., 2005, OXYGEN UPTAKE KINETI, V62, P94	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259027	10.1371/journal.pone.0259027	http://dx.doi.org/10.1371/journal.pone.0259027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767563	Green Published, gold			2022-12-26	WOS:000755249300019
J	Singh, A; Kumar, A; Mehrotra, A; Karthikeyan, A; Pandey, AK; Mishra, BP; Dutt, T				Singh, Akansha; Kumar, Amit; Mehrotra, Arnav; Karthikeyan, A.; Pandey, Ashwni Kumar; Mishra, B. P.; Dutt, Triveni			Estimation of linkage disequilibrium levels and allele frequency distribution in crossbred Vrindavani cattle using 50K SNP data	PLOS ONE			English	Article								The objective of this study was to calculate the extent and decay of linkage disequilibrium (LD) in 96 crossbred Vrindavani cattle genotyped with Bovine SNP50K Bead Chip. After filtering, 43,821 SNPs were retained for final analysis, across 2500.3 Mb of autosome. A significant percentage of SNPs was having minor allele frequency of less than 0.20. The extent of LD between autosomal SNPs up to 10 Mb apart across the genome was measured using r(2) statistic. The mean r(2) value was 0.43, if pairwise distance of marker was less than10 kb and it decreased further to 0.21 for 25-50 kb markers distance. Further, the effect of minor allele frequency and sample size on LD estimate was investigated. The LD value decreased with the increase in inter-marker distance, and increased with the increase of minor allelic frequency. The estimated inbreeding coefficient and effective population size were 0.04, and 46 for present generation, which indicated small and unstable population of Vrindavani cattle. These findings suggested that a denser or breed specific SNP panel would be required to cover all genome of Vrindavani cattle for genome wide association studies (GWAS).	[Singh, Akansha; Kumar, Amit; Mehrotra, Arnav; Karthikeyan, A.; Pandey, Ashwni Kumar] ICAR Indian Vet Res Inst, Anim Genet Div, Bareilly, Uttar Pradesh, India; [Mishra, B. P.] ICAR Indian Vet Res Inst, Anim Biotechnol Div, Bareilly, Uttar Pradesh, India; [Dutt, Triveni] ICAR Indian Vet Res Inst, Livestock Prod & Management Div, Bareilly, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Kumar, A (corresponding author), ICAR Indian Vet Res Inst, Anim Genet Div, Bareilly, Uttar Pradesh, India.	vetamitchandan07@gmail.com		KUMAR, AMIT/0000-0002-4423-7881	CAAST-ACLH project of NAHEP [40246]	CAAST-ACLH project of NAHEP	The work was funded by CAAST-ACLH project of NAHEP (Scheme code 40246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Chhotaray S., 2019, BIOL RHYTHM RES, P1; Espigolan R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-305; Goddard ME., 2012, BOVINE GENOMICS OXFO, V1, P192; Karimi Karim, 2015, Journal of Animal Science and Technology, V57, P1, DOI 10.1186/s40781-015-0080-2; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Lu Duc, 2012, Frontiers in Genetics, V3, P152, DOI 10.3389/fgene.2012.00152; Makina SO, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00337; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Singh A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.589496; Wray NR, 2005, TWIN RES HUM GENET, V8, P87; Zhao FP, 2014, LIVEST SCI, V170, P22, DOI 10.1016/j.livsci.2014.10.015; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259572	10.1371/journal.pone.0259572	http://dx.doi.org/10.1371/journal.pone.0259572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762692	Green Published, gold			2022-12-26	WOS:000755316600026
J	Nga, HS; Palma, LMP; Neto, ME; Fernandes-Charpiot, IMM; Garcia, VD; Kist, R; Miranda, SMC; de Souza, PAM; Pereira, GM; de Andrade, LGM				Nga, Hong Si; Pereira Palma, Lilian Monteiro; Ernandes Neto, Miguel; Maximina Fernandes-Charpiot, Ida Maria; Garcia, Valter Duro; Kist, Roger; Carvalho Miranda, Silvana Maria; Macedo de Souza, Pedro Augusto; Pereira, Gerson Marques; Modelli de Andrade, Luis Gustavo			Thrombotic microangiopathy after kidney transplantation: Analysis of the Brazilian Atypical Hemolytic Uremic Syndrome cohort	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; AHUS	Background Atypical Hemolytic Uremic Syndrome (aHUS) is an ultra-rare disease that potentially leads to kidney graft failure due to ongoing Thrombotic Microangiopathy (TMA). The aim was evaluating the frequency of TMA after kidney transplantation in patients with aHUS in a Brazilian cohort stratified by the use of the specific complement-inhibitor eculizumab. Methods This was a multicenter retrospective cohort study including kidney transplant patients diagnosed with aHUS. We collected data from 118 transplant centers in Brazil concerning aHUS transplanted patients between 01/01/2007 and 12/31/2019. Patients were stratified into three groups: no use of eculizumab (No Eculizumab Group), use of eculizumab for treatment of after transplantation TMA (Therapeutic Group), and use of eculizumab for prophylaxis of aHUS recurrence (Prophylactic Group). Results Thirty-eight patients with aHUS who received kidney transplantation were enrolled in the study. Patients' mean age was 30 years (24-40), and the majority of participants was women (63% of cases). In the No Eculizumab Group (n = 11), there was a 91% graft loss due to the TMA. The hazard ratio of TMA graft loss was 0.07 [0.01-0.55], p = 0.012 in the eculizumab Prophylactic Group and 0.04 [0.00-0.28], p = 0.002 in the eculizumab Therapeutic Group. Conclusion The TMA graft loss in the absence of a specific complement-inhibitor was higher among the Brazilian cohort of kidney transplant patients. This finding reinforces the need of eculizumab use for treatment of aHUS kidney transplant patients. Cost optimization analysis and the early access to C5 inhibitors are suggested, especially in low-medium income countries.	[Nga, Hong Si; Ernandes Neto, Miguel; Modelli de Andrade, Luis Gustavo] Univ Estadual Paulista, Dept Internal Med UNESP, Botucatu, SP, Brazil; [Pereira Palma, Lilian Monteiro] Univ Estadual Campinas, Dept Pediat Hosp Clin, Campinas, SP, Brazil; [Maximina Fernandes-Charpiot, Ida Maria] Transplant Unit Sao Jose Rio Preto FAMERP, Sao Paulo, Brazil; [Garcia, Valter Duro; Kist, Roger] Transplant Unit Santa Casa Misericordia Porto Ale, Porto Alegre, RS, Brazil; [Carvalho Miranda, Silvana Maria; Macedo de Souza, Pedro Augusto; Pereira, Gerson Marques] Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas	de Andrade, LGM (corresponding author), Univ Estadual Paulista, Dept Internal Med UNESP, Botucatu, SP, Brazil.	gustavo.modelli@unesp.br	de Andrade, Luis Gustavo Modelli/I-4146-2013	Marques Pereira Jr, Gerson/0000-0002-5716-1185; Augusto Macedo de Souza, Pedro/0000-0001-5436-3956				Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Boff SO., 2018, PROTECAO DADOS PRIVA, P258; Caetano R, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054001693; Campistol JM, 2015, NEFROLOGIA, V35, P421, DOI 10.1016/j.nefro.2015.07.005; de Andrade LGM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188155; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Teodoro CRD, 2017, EXPERT REV PHARM OUT, V17, P607, DOI 10.1080/14737167.2017.1311209; Fakhouri F, 2021, BLOOD, V137, P2438, DOI 10.1182/blood.2020009280; Foresto RD, 2020, REV ASSOC MED BRAS, V66, P708, DOI 10.1590/1806-9282.66.6.708; Fremeaux-Bacchi V, 2013, CLIN J AM SOC NEPHRO, V8, P554, DOI 10.2215/CJN.04760512; Goodship THJ, 2017, KIDNEY INT, V91, P539, DOI 10.1016/j.kint.2016.10.005; Greenbaum LA, 2016, KIDNEY INT, V89, P701, DOI 10.1016/j.kint.2015.11.026; Hollenbeck M, 1998, NEPHROL DIAL TRANSPL, V13, P76, DOI 10.1093/ndt/13.1.76; Kavanagh David, 2014, F1000Prime Rep, V6, P119, DOI 10.12703/P6-119; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Loirat C, 2016, PEDIATR NEPHROL, V31, P15, DOI 10.1007/s00467-015-3076-8; Loupy MHA, BANFF 2017 KIDNEY M, DOI [10.1111/ajt.14625, DOI 10.1111/AJT.14625]; Mallett A, 2015, INTERN MED J, V45, P1054, DOI 10.1111/imj.12864; Meehan SM, 2011, CLIN J AM SOC NEPHRO, V6, P395, DOI 10.2215/CJN.05870710; Montauez-Palma LF, 2020, THESIS U AUTONOMA ES, P1, DOI DOI 10.1093/CKJ/SFAA062; Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246; Neto ME, 2021, J NEPHROL, V34, P1373, DOI 10.1007/s40620-020-00920-z; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Santos RV, 2015, BIOSOCIETIES, V10, P48, DOI 10.1057/biosoc.2014.21; Sheerin NS, 2016, QJM-INT J MED, V109, P27, DOI 10.1093/qjmed/hcv082; Siedlecki AM, 2019, KIDNEY INT REP, V4, P434, DOI 10.1016/j.ekir.2018.11.010; Suarez MLG, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070919; Teixeira CM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227445; van den Brand JAJG, 2017, NEPHROL DIAL TRANSPL, V32, P115, DOI 10.1093/ndt/gfw353; Verhave JC, 2014, NEPHROL DIAL TRANSPL, V29, P131, DOI 10.1093/ndt/gfu235; Zuber J, 2012, AM J TRANSPLANT, V12, P3337, DOI 10.1111/j.1600-6143.2012.04252.x; Zuber J, ECULIZUMAB ATYPICAL, DOI [10.1111/j.1600-6143.2012.04252.x, DOI 10.1111/J.1600-6143.2012.04252.X]; Zuber J, 2019, J AM SOC NEPHROL, V30, P2449, DOI 10.1681/ASN.2019040331; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Zuber J, 2011, NAT REV NEPHROL, V7, P23, DOI 10.1038/nrneph.2010.155	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258319	10.1371/journal.pone.0258319	http://dx.doi.org/10.1371/journal.pone.0258319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748552	Green Published, gold			2022-12-26	WOS:000755468000007
J	Tiwary, S; Nandwani, A; Khan, R; Datta, M				Tiwary, Shweta; Nandwani, Arun; Khan, Rukshar; Datta, Malabika			GRP75 mediates endoplasmic reticulum-mitochondria coupling during palmitate-induced pancreatic beta-cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MAM INTEGRITY; ER STRESS; MORTALIN; DISRUPTION; INTERFACE; INTERACTS; PROTEINS; MUSCLE; DEATH; ACID	The endoplasmic reticulum (ER) and mitochondria are structurally connected with each other at specific sites termed mitochondria-associated membranes (MAMs). These physical links are composed of several tethering proteins and are important during varied cellular processes, such as calcium homeostasis, lipid metabolism and transport, membrane biogenesis, and organelle remodeling. However, the attributes of specific tethering proteins in these cellular functions remain debatable. Here, we present data to show that one such tether protein, glucose regulated protein 75 (GRP75), is essential in increasing ER-mitochondria contact during palmitate-induced apoptosis in pancreatic insulinoma cells. We demonstrate that palmitate increased GRP75 levels in mouse and rat pancreatic insulinoma cells as well as in mouse primary islet cells. This was associated with increased mitochondrial Ca2+ transfer, impaired mitochondrial membrane potential, increased ROS production, and enhanced physical coupling between the ER and mitochondria. Interestingly, GRP75 inhibition prevented these palmitate-induced cellular aberrations. Additionally, GRP75 overexpression alone was sufficient to impair mitochondrial membrane potential, increase mitochondrial Ca2+ levels and ROS generation, augment ER-mitochondria contact, and induce apoptosis in these cells. In vivo injection of palmitate induced hyperglycemia and hypertriglyceridemia, as well as impaired glucose and insulin tolerance in mice. These animals also exhibited elevated GRP75 levels accompanied by enhanced apoptosis within the pancreatic islets. Our findings suggest that GRP75 is critical in mediating palmitate-induced ER-mitochondrial interaction leading to apoptosis in pancreatic islet cells.	[Tiwary, Shweta; Nandwani, Arun; Khan, Rukshar; Datta, Malabika] CSIR, Integrat & Funct Biol Grp, Inst Genom & Integrat Biol, Mall Rd, Delhi, India; [Tiwary, Shweta; Nandwani, Arun; Datta, Malabika] Acad Sci & Innovat Res AcSIR, Ghaziabad, India; [Khan, Rukshar] Jamia Millia Islamia, Dept Biosci, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR); Jamia Millia Islamia	Datta, M (corresponding author), CSIR, Integrat & Funct Biol Grp, Inst Genom & Integrat Biol, Mall Rd, Delhi, India.; Datta, M (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.	mdatta@igib.res.in			University Grants Commission (UGC); Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR), New Delhi, India	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	S. T., A. N. and R. K. acknowledge the University Grants Commission (UGC), the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR), New Delhi, India, for their fellowships.	Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Cardenas-Perez R.E., 2016, MED U, V18, P23, DOI [10.1016/j.rmu.2015.10.004, DOI 10.1016/J.RMU.2015.10.004]; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Carta G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00902; Chen E, 2017, SCI REP-UK, V7, DOI 10.1038/srep40855; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Cunha DA, 2012, DIABETES, V61, P2763, DOI 10.2337/db12-0123; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Deocaris CC, 2009, PROTEIN PEPTIDE LETT, V16, P517, DOI 10.2174/092986609788167770; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dingreville F, 2019, DIABETES, V68, P1778, DOI 10.2337/db18-1112; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; GORDON ES, 1960, AM J CLIN NUTR, V8, P740, DOI 10.1093/ajcn/8.5.740; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Honrath B, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.76; June CH, 2004, CURRENT PROTOCOLS IM, V64, P551, DOI [10.1002/0471142735, DOI 10.1002/0471142735]; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Lee S, 2019, P NATL ACAD SCI USA, V116, P16074, DOI 10.1073/pnas.1818830116; Lee S, 2018, MOL CELLS, V41, P1000, DOI 10.14348/molcells.2018.0438; Litwak SA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/280615; Liu Y, 2019, P NATL ACAD SCI USA, V116, P25322, DOI 10.1073/pnas.1906565116; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Lopez-Crisosto C, 2015, BBA-MOL BASIS DIS, V1852, P2096, DOI 10.1016/j.bbadis.2015.07.011; Lv YH, 2018, J CELL BIOCHEM, V119, P4205, DOI 10.1002/jcb.26653; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Missiroli S, 2016, CELL REP, V16, P2415, DOI 10.1016/j.celrep.2016.07.082; Mizukoshi E, 1999, BIOCHEM J, V343, P461, DOI 10.1042/0264-6021:3430461; Oh YS, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00384; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Pauly M, 2017, BBA-MOL BASIS DIS, V1863, P2229, DOI 10.1016/j.bbadis.2017.06.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096089; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Sacht G, 1999, BIOFACTORS, V9, P49, DOI 10.1002/biof.5520090107; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Shinjo S, 2017, EXP CELL RES, V359, P86, DOI 10.1016/j.yexcr.2017.08.006; Silva Figueiredo P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101158; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Takano S, 2001, BIOCHEM J, V357, P393, DOI 10.1042/0264-6021:3570393; Thivolet C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182027; Thoudam T, 2019, DIABETES, V68, P571, DOI 10.2337/db18-0363; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tubbs E, 2018, DIABETES, V67, P636, DOI 10.2337/db17-0316; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Varshney R, 2018, J NUTR BIOCHEM, V57, P212, DOI 10.1016/j.jnutbio.2018.02.017; Verma G, 2013, MOL BIOL CELL, V24, P2058, DOI 10.1091/mbc.E12-12-0885; Verma G, 2010, APOPTOSIS, V15, P864, DOI 10.1007/s10495-010-0498-4; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2003, BIOCHEM BIOPH RES CO, V302, P735, DOI 10.1016/S0006-291X(03)00226-2; Xu H, 2018, BMC NEPHROL, V19, DOI [10.1186/S12882-018-0940-3, 10.1186/s12882-018-0940-3]; Yin Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166692; Zhao LH, 2017, J ANIM SCI BIOTECHNO, V8, DOI [10.1186/s40104-017-0195-z, 10.22143/HSS21.8.6.1]	54	5	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101368	10.1016/j.jbc.2021.101368	http://dx.doi.org/10.1016/j.jbc.2021.101368			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756890	gold, Green Published			2022-12-26	WOS:000765319800006
J	Irak, K; Bayram, M; Cifci, S; Sener, G				Irak, Kader; Bayram, Mehmet; Cifci, Sami; Sener, Gulsen			Serum levels of NLRC4 and MCP-2/CCL8 in patients with active Crohn's disease	PLOS ONE			English	Article							CHEMOKINE EXPRESSION; EXPERIMENTAL COLITIS; INFLAMMASOMES; INFLAMMATION; CYTOKINE; IMMUNE; CCL8; CCR5; IBD	Crohn's disease (CD) is characterized by malfunction of immune-regulatory mechanisms with disturbed intestinal mucosal homeostasis and increased activation of mucosal immune cells, leading to abnormal secretion of numerous pro- and anti-inflammatory mediators. MCP2/CCL8 is produced by intestinal epithelial cells and macrophages, and is a critical regulator of mucosal inflammation. NLRC4 is expressed in phagocytes and intestinal epithelial cells and is involved in intestinal homeostasis and host defense. However, no study to date has assessed the circulating levels of NLRC4 and MCP2/CCL8 in patients with CD. The study was aimed to investigate the serum levels of MCP2/CCL8 and NLRC4 in patients with active CD. Sixty-nine patients with active CD and 60 healthy participants were included in the study. Serum levels of NLRC4 and MCP2/CCL8 were determined using an enzyme-linked immunosorbent assay. The median serum NLRC4 levels were lower in the patient group than in the controls (71.02 (range, 46.59-85.51) pg/mL vs. 99.43 (range 83.52-137.79) pg/mL) (P < 0.001). The median serum levels of MCP2/CCL8 were decreased in patients with CD (28.68 (range, 20.16-46.0) pg/mL) compared with the controls (59.96 (range, 40.22-105.59) pg/mL) (P < 0.001). Cut-off points of NLRC4 (<81 pg/mL) and MCP2/CCL8 (<40 pg/mL) showed high sensitivity and specificity for identifying active CD. In conclusion, this is the first study to examine circulating levels of MCP2/CCL8 and NLRC4 in patients with active CD. Our results suggest that serum NLRC4 and MCP2/CCL8 levels may be involved in the pathogenesis of CD and may have a protective effect on intestinal homeostasis and inflammation. Serum levels of MCP2/CCL8 and NLRC4 could be used as a diagnostic tool and therapeutic target for CD.	[Irak, Kader; Bayram, Mehmet; Cifci, Sami] Basaksehir Cam & Sakura City Hosp, Dept Gastroenterol, Istanbul, Turkey; [Sener, Gulsen] Basaksehir Cam & Sakura City Hosp, Dept Biochem, Istanbul, Turkey		Irak, K (corresponding author), Basaksehir Cam & Sakura City Hosp, Dept Gastroenterol, Istanbul, Turkey.	drkaderirak@hotmail.com		Irak, Kader/0000-0002-0019-3207				Asano K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8802; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Canna SW, 2017, J ALLERGY CLIN IMMUN, V139, P1698, DOI 10.1016/j.jaci.2016.10.022; Chen YM, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919530; Choy MC, 2017, INFLAMM BOWEL DIS, V23, P2, DOI 10.1097/MIB.0000000000000955; Cibor D, 2020, POL ARCH INTERN MED, V130, P598, DOI 10.20452/pamw.15463; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Gong WH, 1998, J BIOL CHEM, V273, P4289, DOI 10.1074/jbc.273.8.4289; Grimm MC, 1996, J LEUKOCYTE BIOL, V59, P804, DOI 10.1002/jlb.59.6.804; Hao LY, 2013, CURR OPIN GASTROEN, V29, P363, DOI 10.1097/MOG.0b013e32836157a4; Hori T, 2008, BLOOD, V111, P4403, DOI 10.1182/blood-2007-06-097287; Kesavardhana S, 2017, INT IMMUNOL, V29, P201, DOI 10.1093/intimm/dxx018; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Lewis GJ, 2011, INFLAMM BOWEL DIS, V17, P1387, DOI 10.1002/ibd.21499; Lu Y, 2017, BRAIN RES BULL, V135, P170, DOI 10.1016/j.brainresbull.2017.10.009; McCormack G, 2001, INFLAMM RES, V50, P491, DOI 10.1007/PL00000223; Opipari A, 2015, INFLAMM BOWEL DIS, V21, P173, DOI 10.1097/MIB.0000000000000230; Park JH, 2017, AUTOIMMUN REV, V16, P416, DOI 10.1016/j.autrev.2017.02.013; Roda G, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0156-2; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; Singh UP, 2016, CYTOKINE, V77, P44, DOI 10.1016/j.cyto.2015.10.008; Torres J, 2020, J CROHNS COLITIS, V14, P4, DOI 10.1093/ecco-jcc/jjz180; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Yuk JM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134714	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0260034	10.1371/journal.pone.0260034	http://dx.doi.org/10.1371/journal.pone.0260034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788319	Green Published, gold			2022-12-26	WOS:000735920500046
J	Demetriadou, C; Raoukka, A; Charidemou, E; Mylonas, C; Michael, C; Parekh, S; Koufaris, C; Skourides, P; Papageorgis, P; Tessarz, P; Kirmizis, A				Demetriadou, Christina; Raoukka, Anastasia; Charidemou, Evelina; Mylonas, Constantine; Michael, Christina; Parekh, Swati; Koufaris, Costas; Skourides, Paris; Papageorgis, Panagiotis; Tessarz, Peter; Kirmizis, Antonis			Histone N-terminal acetyltransferase NAA40 links one-carbon metabolism to chemoresistance	ONCOGENE			English	Article							CANCER; EPIGENETICS; TRANSCRIPTION; GUIDELINES; MECHANISMS	Aberrant function of epigenetic modifiers plays an important role not only in the progression of cancer but also the development of drug resistance. N-alpha-acetyltransferase 40 (NAA40) is a highly specific epigenetic enzyme catalyzing the transfer of an acetyl moiety at the N-terminal end of histones H4 and H2A. Recent studies have illustrated the essential oncogenic role of NAA40 in various cancer types but its role in chemoresistance remains unclear. Here, using transcriptomic followed by metabolomic analysis in colorectal cancer (CRC) cells, we demonstrate that NAA40 controls key one-carbon metabolic genes and corresponding metabolites. In particular, through its acetyltransferase activity NAA40 regulates the methionine cycle thereby affecting global histone methylation and CRC cell survival. Importantly, NAA40-mediated metabolic rewiring promotes resistance of CRC cells to antimetabolite chemotherapy in vitro and in xenograft models. Specifically, NAA40 stimulates transcription of the one-carbon metabolic gene thymidylate synthase (TYMS), whose product is targeted by 5-fluorouracil (5-FU) and accordingly in primary CRC tumours NAA40 expression associates with TYMS levels and poorer 5-FU response. Mechanistically, NAA40 activates TYMS by preventing enrichment of repressive H2A/H4S1ph at the nuclear periphery. Overall, these findings define a novel regulatory link between epigenetics and cellular metabolism mediated by NAA40, which is harnessed by cancer cells to evade chemotherapy.	[Demetriadou, Christina; Raoukka, Anastasia; Charidemou, Evelina; Koufaris, Costas; Skourides, Paris; Kirmizis, Antonis] Univ Cyprus, Dept Biol Sci, CY-2109 Nicosia, Cyprus; [Mylonas, Constantine; Parekh, Swati; Tessarz, Peter] Max Planck Inst Biol Ageing, Cologne, Germany; [Michael, Christina; Papageorgis, Panagiotis] European Univ Cyprus, Dept Life Sci, CY-2404 Nicosia, Cyprus; [Tessarz, Peter] Cologne Excellence Cluster Stress Responses Agein, Joseph Stelzmann Str 26, D-50931 Cologne, Germany	University of Cyprus; Max Planck Society; European University Cyprus	Kirmizis, A (corresponding author), Univ Cyprus, Dept Biol Sci, CY-2109 Nicosia, Cyprus.	kirmizis@ucy.ac.cy	Koufaris, Costas/ABW-5036-2022; Tessarz, Peter/I-9035-2014	Koufaris, Costas/0000-0002-1222-5130; CHARIDEMOU, EVELINA/0000-0002-2299-9471; Tessarz, Peter/0000-0002-6953-9835				Benson A, 2018, J NATL COMPR CANC NE, V16, P874, DOI 10.6004/jnccn.2018.0061; Buchwalter A, 2019, NAT REV GENET, V20, P39, DOI 10.1038/s41576-018-0063-5; Campbell SL, 2018, MOL CELL, V71, P398, DOI 10.1016/j.molcel.2018.07.015; Carrer A, 2015, CURR OPIN BIOTECH, V34, P23, DOI 10.1016/j.copbio.2014.11.012; Dai ZW, 2020, NAT REV GENET, V21, P737, DOI 10.1038/s41576-020-0270-8; Dai ZW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04426-y; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Demetriadou C, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00352-w; Demetriadou C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1487-3; Deng Y, 2021, NOVEL BISUBSTRATE IN, DOI 10.1101/2021.01.24.427995; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farria A, 2015, ONCOGENE, V34, P4901, DOI 10.1038/onc.2014.453; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Ju JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00988-5; Karoutas A, 2021, NAT CELL BIOL, V23, P116, DOI 10.1038/s41556-020-00630-5; Kinnaird A, 2016, NAT REV CANCER, V16, P694, DOI 10.1038/nrc.2016.82; Koufaris C, 2020, CANCERS, V12, DOI 10.3390/cancers12092631; Lee S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1936-4; Liu Z, 2009, INT J BIOCHEM CELL B, V41, P2528, DOI 10.1016/j.biocel.2009.08.009; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lund E, 2013, GENOME RES, V23, P1580, DOI 10.1101/gr.159400.113; Magin RS, 2015, STRUCTURE, V23, P332, DOI 10.1016/j.str.2014.10.025; Marine JC, 2020, NAT REV CANCER, V20, P743, DOI 10.1038/s41568-020-00302-4; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Nacev BA, 2019, NATURE, V567, P473, DOI 10.1038/s41586-019-1038-1; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roy DG, 2020, CELL METAB, V31, P250, DOI 10.1016/j.cmet.2020.01.006; Salvarani N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09929-w; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Serefidou M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00764; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Shuvalov O, 2017, ONCOTARGET, V8, P23955, DOI 10.18632/oncotarget.15053; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Varghese V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38017-0; Wakasa K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123076; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Ye CQ, 2018, TRENDS ENDOCRIN MET, V29, P626, DOI 10.1016/j.tem.2018.06.002; Ye CQ, 2017, MOL CELL, V66, P180, DOI 10.1016/j.molcel.2017.02.026; Zhang Y, 2004, J BIOL CHEM, V279, P21866, DOI 10.1074/jbc.M400099200	48	1	1	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					571	585		10.1038/s41388-021-02113-9	http://dx.doi.org/10.1038/s41388-021-02113-9		NOV 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785778	hybrid, Green Published			2022-12-26	WOS:000719277200004
J	Kerimov, D; Tamminen, P; Viskari, H; Lehtimaki, L; Aittoniemi, J				Kerimov, Dominik; Tamminen, Pekka; Viskari, Hanna; Lehtimaki, Lauri; Aittoniemi, Janne			Sampling site for SARS-CoV-2 RT-PCR-An intrapatient four-site comparison from Tampere, Finland	PLOS ONE			English	Article								Background SARS-CoV-2 diagnosis relies on the performance of nasopharyngeal swabs. Alternative sample sites have been assessed but the heterogeneity of the studies have made comparing different sites difficult. Objectives Our aim was to compare the performance of four different sampling sites for SARS-CoV-2 samples with nasopharynx being the benchmark. Study design COVID-19 positive patients were recruited prospectively, and samples were collected and analysed for SARS-CoV-2 with RT-PCR from all four anatomical sites in 43 patients, who provided written informed consent. Results All anterior nasal and saliva samples were positive, while two oropharyngeal samples were negative. There was no significant difference in the cycle threshold values of nasopharyngeal and anterior nasal samples while saliva and oropharynx had higher cycle threshold values. Conclusions Anterior nasal swab performs as good as nasopharynx swab with saliva also finding all the positives but with higher cycle threshold values. Thus, we can conclude that anterior nasal swabs can be used for SARS-CoV-2 detection instead of nasopharyngeal swabs if the situation would require so.	[Kerimov, Dominik; Aittoniemi, Janne] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Tamminen, Pekka; Viskari, Hanna] Tampere Univ Hosp, Dept Internal Med, Tampere, Finland; [Tamminen, Pekka] Tampere Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tampere, Finland; [Viskari, Hanna; Lehtimaki, Lauri] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Lehtimaki, Lauri] Tampere Univ Hosp, Allergy Ctr, Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital	Kerimov, D (corresponding author), Fimlab Labs, Dept Clin Microbiol, Tampere, Finland.	dominik.kerimov@fimlab.fi		Lehtimaki, Lauri/0000-0003-1586-4998; Tamminen, Pekka/0000-0003-2139-6457	Tampere Tuberculosis Foundation; Research Foundation of the Pulmonary Diseases; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Tampere University Hospital Support Foundation	Tampere Tuberculosis Foundation; Research Foundation of the Pulmonary Diseases; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Tampere University Hospital Support Foundation	This work was supported by funding from Tampere Tuberculosis Foundation; Research Foundation of the Pulmonary Diseases; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Tampere University Hospital Support Foundation. Funders did not have any role in any part of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Hanson KE, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01824-20; Koskinen A, 2021, JAMA OTOLARYNGOL, V147, P671, DOI 10.1001/jamaoto.2021.0715; Lee RA, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02881-20; Moreira VM, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11020363; Nasiri K, 2021, J DENT SCI, V16, P799, DOI 10.1016/j.jds.2021.01.010; Rubin R, 2020, JAMA-J AM MED ASSOC, V324, P2015, DOI 10.1001/jama.2020.22003; Tsang NNY, 2021, LANCET INFECT DIS, V21, P1233, DOI 10.1016/S1473-3099(21)00146-8; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	12	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260184	10.1371/journal.pone.0260184	http://dx.doi.org/10.1371/journal.pone.0260184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784386	Green Published, gold			2022-12-26	WOS:000755277300047
J	Haruyama, N; Yamaza, T; Suzuki, S; Hall, B; Cho, A; Gibson, CW; Kulkarni, AB				Haruyama, Naoto; Yamaza, Takayoshi; Suzuki, Shigeki; Hall, Bradford; Cho, Andrew; Gibson, Carolyn W.; Kulkarni, Ashok B.			Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice	PLOS ONE			English	Article							ENAMEL MATRIX PROTEINS; GENE SPLICE PRODUCTS; MOUSE AMELOGENIN; RECEPTOR ACTIVATOR; REPORTER GENES; NITRIC-OXIDE; B LIGAND; EXPRESSION; CELLS; CD63	Amelogenins, major extra cellular matrix proteins of developing tooth enamel, are predominantly expressed by ameloblasts and play significant roles in the formation of enamel. Recently, amelogenin has been detected in various epithelial and mesenchymal tissues, implicating that it might have distinct functions in various tissues. We have previously reported that leucine rich amelogenin peptide (LRAP), one of the alternate splice forms of amelogenin, regulates receptor activator of NF-kappa B ligand (RANKL) expression in cementoblast/periodontal ligament cells, suggesting that the amelogenins, especially LRAP, might function as a signaling molecule in bone metabolism. The objective of this study was to identify and define LRAP functions in bone turnover. We engineered transgenic (TgLRAP) mice using a murine 2.3kb alpha 1(I)-collagen promoter to drive expression of a transgene consisting of LRAP, an internal ribosome entry site (IRES) and enhanced green fluorescent protein (EGFP) to study functions of LRAP in bone formation and resorption. Calvarial cell cultures from the TgLRAP mice showed increased alkaline phosphatase (ALP) activity and increased formation of mineralized nodules compared to the cells derived from wild-type (WT) mice. The TgLRAP calvarial cells also showed an inhibitory effect on osteoclastogenesis in vitro. Gene expression comparison by quantitative polymerase chain reaction (Q-PCR) in calvarial cells indicated that bone formation makers such as Runx2, Alp, and osteocalcin were increased in TgLRAP compared to the WT cells. Meanwhile, Rankl expression was decreased in the TgLRAP cells in vitro. The ovariectomized (OVX) TgLRAP mice resisted bone loss induced by ovariectomy resulting in higher bone mineral density in comparison to OVX WT mice. The quantitative analysis of calcein intakes indicated that the ovariectomy resulted in increased bone formation in both WT and TgLRAP mice; OVX TgLRAP appeared to show the most remarkably increased bone formation. The parameters for bone resorption in tissue sections showed increased number of osteoclasts in OVX WT, but not in OVX TgLRAP over that of sham operated WT or TgLRAP mice, supporting the observed bone phenotypes in OVX mice. This is the first report identifying that LRAP, one of the amelogenin splice variants, affects bone turnover in vivo.	[Haruyama, Naoto; Suzuki, Shigeki; Hall, Bradford; Cho, Andrew; Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Haruyama, Naoto] Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Fukuoka, Fukuoka, Japan; [Yamaza, Takayoshi] Kyushu Univ, Fac Dent Sci, Sect Mol Cell Biol & Oral Anat, Fukuoka, Fukuoka, Japan; [Suzuki, Shigeki] Tohoku Univ, Dept Periodontol & Endodontol, Grad Sch Dent, Sendai, Miyagi, Japan; [Gibson, Carolyn W.] Univ Penn, Dept Basic & Translat Sci, Sch Dent Med, Philadelphia, PA 19104 USA; [Haruyama, Naoto] Kyushu Univ, Grad Sch Dent, Fukuoka, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; Kyushu University; Tohoku University; University of Pennsylvania; Kyushu University	Haruyama, N; Kulkarni, AB (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.; Haruyama, N (corresponding author), Kyushu Univ, Fac Dent Sci, Sect Orthodont & Dentofacial Orthoped, Fukuoka, Fukuoka, Japan.; Haruyama, N (corresponding author), Kyushu Univ, Grad Sch Dent, Fukuoka, Japan.	haruyama@dent.kyushu-u.ac.jp; Ashok.Kulkarni@nih.gov	Haruyama, Naoto/D-1993-2011	Haruyama, Naoto/0000-0001-6225-5816; Yamaza, Takayoshi/0000-0001-7055-3370; Kulkarni, Ashok/0000-0001-9849-3250	Divison of Intramural Research of the NIDCR, NIH	Divison of Intramural Research of the NIDCR, NIH	This research was supported by the Divison of Intramural Research of the NIDCR, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Bartlett JD, 2006, J DENT RES, V85, P894, DOI 10.1177/154405910608501004; Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; BouGharios G, 1996, J CELL BIOL, V134, P1333, DOI 10.1083/jcb.134.5.1333; Campbell Graeme M, 2014, Bonekey Rep, V3, P564, DOI 10.1038/bonekey.2014.59; Cardaropoli G, 2002, J PERIODONTOL, V73, P501, DOI 10.1902/jop.2002.73.5.501; Cho Andrew, 2009, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1911s42; Collier PM, 1997, ARCH ORAL BIOL, V42, P235, DOI 10.1016/S0003-9969(96)00099-4; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; Eapen A, 2012, J BIOL CHEM, V287, P5211, DOI 10.1074/jbc.M111.290080; Fan X, 2004, ENDOCRINOLOGY, V145, P751, DOI 10.1210/en.2003-0726; Gestrelius S, 1997, J CLIN PERIODONTOL, V24, P685, DOI 10.1111/j.1600-051X.1997.tb00250.x; Gibson CW, 2007, J DENT RES, V86, P331, DOI 10.1177/154405910708600406; Gibson CW, 2005, GENE, V350, P15, DOI 10.1016/j.gene.2004.12.045; Gibson CW, 1995, CONNECT TISSUE RES, V32, P109, DOI 10.3109/03008209509013711; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x; Haruyama N, 2011, J ORAL BIOSCI, V53, P257, DOI 10.2330/joralbiosci.53.257; Hatakeyama J, 2006, J DENT RES, V85, P144, DOI 10.1177/154405910608500206; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Hu CC, 1997, J DENT RES, V76, P641, DOI 10.1177/00220345970760020401; Iacob S, 2008, BONE, V42, P1072, DOI 10.1016/j.bone.2008.01.023; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Li Y, 2008, J BIOL CHEM, V283, P15056, DOI 10.1074/jbc.M707992200; Li Y, 2006, EUR J ORAL SCI, V114, P190, DOI 10.1111/j.1600-0722.2006.00286.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Pacifici R, 1996, J BONE MINER RES, V11, P1043; Papagerakis P, 2005, J DENT RES, V84, P613, DOI 10.1177/154405910508400706; RAISZ LG, 1995, J NUTR, V125, pS2024, DOI 10.1093/jn/125.suppl_7.2024S; Ravindranath HH, 2004, BIOCHEM BIOPH RES CO, V323, P1075, DOI 10.1016/j.bbrc.2004.08.207; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Tompkins K, 2006, BONE, V38, P172, DOI 10.1016/j.bone.2005.08.013; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Velasquez-Plata D, 2002, J PERIODONTOL, V73, P433, DOI 10.1902/jop.2002.73.4.433; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Warotayanont R, 2008, BIOCHEM BIOPH RES CO, V367, P1, DOI 10.1016/j.bbrc.2007.12.048; Warotayanont R, 2009, BIOCHEM BIOPH RES CO, V387, P558, DOI 10.1016/j.bbrc.2009.07.058; WRIGHT JT, 1989, J DENT RES, V68, P1328, DOI 10.1177/00220345890680090801; Wright JT, 1997, ARCH ORAL BIOL, V42, P149, DOI 10.1016/S0003-9969(96)00096-9; Xiang A, 2007, BONE, V40, P1231, DOI 10.1016/j.bone.2007.01.010; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	59	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259966	10.1371/journal.pone.0259966	http://dx.doi.org/10.1371/journal.pone.0259966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780561	Green Published, gold			2022-12-26	WOS:000755305800074
J	Hu, JF; Wu, J; Zhao, C; Wang, P				Hu, Junfeng; Wu, Jiang; Zhao, Chuan; Wang, Peng			Challenges for China to achieve carbon neutrality and carbon peak goals: Beijing case study	PLOS ONE			English	Article							ENERGY-CONSUMPTION; ALTERNATIVES; FLOW	China has set a goal to achieve peak CO2 emissions before 2030 and carbon neutrality by 2060. To achieve the goals of carbon peak and carbon neutrality, China needs to address the challenge of the large and still growing CO2 emission base. This paper investigated the energy consumption and CO2 emission in Beijing from 2020-2035 based on the energy elasticity coefficient and contribution value of the sub-energy increment (CVSI) method. Beijing is one of the first cities in China to propose the "carbon peak" target as of 2020. From 2020 Beijing will strive to achieve the goal of carbon neutrality. The results show that in 2035 the CO2 emission in Beijing may drop to 50% of 2020. This decline would be affected by economic growth, energy efficiency and the proportion of renewable energy use. Beijing's energy supply mainly comes from outside the region. Therefore, for Beijing, in addition to increasing the proportion of renewable energy sources outside the region, its own energy acceptance also needs to be strengthened, including strengthening energy storage construction, actively researching and promoting carbon capture and utilization of gas-fired units, which are effective ways to achieve carbon neutrality target.	[Hu, Junfeng; Wu, Jiang] North China Elect Power Univ, Econ & Management Sch, Beijing Key Lab New Energy & Low Carbon Dev, Beijing, Peoples R China; [Zhao, Chuan; Wang, Peng] North China Elect Power Univ, Elect & Elect Engn Sch, Beijing, Peoples R China	North China Electric Power University; North China Electric Power University	Wang, P (corresponding author), North China Elect Power Univ, Elect & Elect Engn Sch, Beijing, Peoples R China.	wangpeng@ncepu.edu.cn	WANG, Peng/GSN-5263-2022					Abdelalim A, 2017, AUTOMAT CONSTR, V84, P258, DOI 10.1016/j.autcon.2017.09.012; Beijing Municipal Administration of Market Supervision:2021, 2021, REQ CARB DIOX EM ACC; bp, STAT REV WORLD EN 20, V69th; Donglin D, 2020, COAL EC RES, V40, P31; Ediger VolkanS, 2006, ENERG POLICY, V35; Feng YY, 2012, PROCEDIA ENVIRON SCI, V13, P632, DOI 10.1016/j.proenv.2012.01.055; Geem ZW, 2009, ENERG POLICY, V37, P4049, DOI 10.1016/j.enpol.2009.04.049; Khan H, 2020, ENERGY REP, V6, P859, DOI 10.1016/j.egyr.2020.04.002; Li H, 2020, ENV PROTECTION, V48, P24; Liu X, RES HIGH QUALITY DEV, DOI [10.15918/j.jbitss1009-3370.2021.7522, DOI 10.15918/J.JBITSS1009-3370.2021.7522]; Liu X, 2019, ENERGIES, V12, DOI 10.3390/en12132581; Liu XZ, 2016, APPL ENERG, V167, P336, DOI 10.1016/j.apenergy.2015.08.089; Magazzino C, 2021, ENERGY REP, V7, P1520, DOI 10.1016/j.egyr.2021.03.005; McPherson M, 2014, ENERG POLICY, V68, P146, DOI 10.1016/j.enpol.2014.01.028; Nawaz M.A., 2021, ENVIRON SCI POLLUT R, V28, P16014, DOI [10.1007/s11356-020-11823-8, DOI 10.1007/s11356-020-11823-8]; Nguyen C.P, ENERGY, V2021, P225; Perez-Lombard L, 2011, APPL ENERG, V88, P5020, DOI 10.1016/j.apenergy.2011.07.003; Perwez U, 2015, ENERGY, V93, P2423, DOI 10.1016/j.energy.2015.10.103; Soundararajan K, 2014, APPL ENERG, V136, P1035, DOI 10.1016/j.apenergy.2014.08.070; The State Council Information Office of the People's Republic of China, EN CHIN NEW ER EB OL; Wang FY, 2017, ENERGY ECOL ENVIRON, V2, P317, DOI 10.1007/s40974-017-0070-y; [谢和平 Xie Heping], 2019, [煤炭学报, Journal of China Coal Society], V44, P1949; Xinhuanet, 11 JINP SPEECH CLIM; Xinhuanet, 11 JINP SPEECH GEN D; Yang HH, 2020, ENERGIES, V13, DOI 10.3390/en13082076; Yi J, 2010, CHINA FOREIGN ENERGY, V15, P95; Zhang Y, 2018, BEIJING U TECHNOLOGY	27	6	6	32	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0258691	10.1371/journal.pone.0258691	http://dx.doi.org/10.1371/journal.pone.0258691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780491	gold, Green Published			2022-12-26	WOS:000755305800016
J	Kaneko, E; Sato, H; Fukamachi, S				Kaneko, Ena; Sato, Hinako; Fukamachi, Shoji			Validation of the three-chamber strategy for studying mate choice in medaka	PLOS ONE			English	Article							PREFERENCES; FISH; SIZE; COMPETITION; BEHAVIOR; FEMALES; COMPLEX; MALES; BIAS	The three-chamber experiment, in which one test animal can choose between two animals placed in physically inaccessible compartments, is a widely adopted strategy for studying sexual preference in animals. Medaka, a small freshwater teleost, is an emerging model for dissecting the neurological/physiological mechanisms underlying mate choice for which intriguing findings have been accumulating. The three-chamber strategy has rarely been adopted in this species; therefore, here we investigated its validity using medaka colour variants that mate assortatively. First, a total of 551 movies, in which a test male and two choice females interacted for 30 min under a free-swimming condition, were manually analysed. The sexual preference of the males, calculated as a courtship ratio, was highly consistent between human observers (r > 0.96), supporting the objectivity of this manual-counting strategy. Second, we tested two types of three-chamber apparatuses, in which choice fish were presented in either a face-to-face or side-by-side location. Test fish (regardless of sex) spent most of the time associating with choice fish in the compartments. However, their sexual preference, calculated as an association ratio, was poorly reproduced when the locations of the choice fish were swapped. Third, the sexual preferences of males quantified using the manual-counting and either of the three-chamber strategies did not correlate (r = 0.147 or 0.297). Hence, we concluded that, even for individuals of a species like medaka, which spawn every day, sexual preference could not be reliably evaluated using the three-chamber strategy. Optimization of the protocol may solve this problem; however, the explanation for the observation that animals that are ready for spawning persist with never-accessible mating partners must be reconsidered.	[Kaneko, Ena; Sato, Hinako; Fukamachi, Shoji] Japan Womens Univ, Dept Chem & Biol Sci, Lab Evolutionary Genet, Bunkyo Ku, Tokyo, Japan	Japan Womens University	Fukamachi, S (corresponding author), Japan Womens Univ, Dept Chem & Biol Sci, Lab Evolutionary Genet, Bunkyo Ku, Tokyo, Japan.	fukamachi@fc.jwu.ac.jp		Fukamachi, Shoji/0000-0001-7967-1883	Japan Society for the Promotion of Science (JSPS) [17K07506]; National Institutes of Natural Sciences (NINS) [01111904]; JWU	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Natural Sciences (NINS); JWU	This study was supported by a Grant-inAid for Scientific Research (C) (#17K07506) from the Japan Society for the Promotion of Science (JSPS), a grant for Joint Research (#01111904) by the National Institutes of Natural Sciences (NINS), and research funds from JWU to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida T, 1921, GENETICS, V6, P554; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Arriaga LR., 2013, PEERJ, V2013, P1; Baldauf SA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-301; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Espinedo CM, 2010, EVOL ECOL, V24, P865, DOI 10.1007/s10682-009-9343-z; Fujimoto S, 2014, ZOOL SCI, V31, P703, DOI 10.2108/zs140102; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Fukamachi S, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-64; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Gould JL, 1999, CURR BIOL, V9, P497, DOI 10.1016/S0960-9822(99)80217-6; GRANT JWA, 1995, ANIM BEHAV, V50, P1425, DOI 10.1016/0003-3472(95)80058-1; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Howard RD, 1998, ANIM BEHAV, V55, P1151, DOI 10.1006/anbe.1997.0682; Ikawa M, 2017, BIOL OPEN, V6, P244, DOI 10.1242/bio.022285; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Kamijo M, 2018, BEHAV PROCESS, V150, P25, DOI 10.1016/j.beproc.2018.02.006; Kanazawa N, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00801; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kraak SBM, 1998, ANIM BEHAV, V56, P859, DOI 10.1006/anbe.1998.0822; Matsunaga W, 2012, SCI REP-UK, V2, DOI 10.1038/srep00219; Nakao R, 2015, J EXP ZOOL PART A, V323, P349, DOI 10.1002/jez.1916; Nakayasu T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175059; Nakayasu T, 2014, ANIM COGN, V17, P559, DOI 10.1007/s10071-013-0687-y; Nishiike Y., 2021, CURR BIOL, P1; Ogden HJP, 2020, BEHAV ECOL, V31, P63, DOI 10.1093/beheco/arz156; Ogi A, 2021, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.590057; Okuyama T, 2017, DEV GROWTH DIFFER, V59, P211, DOI 10.1111/dgd.12359; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; Passos C, 2019, J ETHOL, V37, P301, DOI 10.1007/s10164-019-00601-w; Rosenthal GG, 1998, P NATL ACAD SCI USA, V95, P4431, DOI 10.1073/pnas.95.8.4431; Schlupp I, 2018, CURR ZOOL, V64, P393, DOI 10.1093/cz/zoy028; Schlupp I, 2018, CURR ZOOL, V64, P321, DOI 10.1093/cz/zoy037; Schupp I, 2005, BIOL LETT-UK, V1, P169, DOI 10.1098/rsbl.2005.0306; Turnell ER, 2003, BIOL BULL-US, V205, P225, DOI 10.2307/1543265; Utagawa U, 2016, HORM BEHAV, V84, P9, DOI 10.1016/j.yhbeh.2016.05.022; Wang MY, 2017, ELIFE, V6, DOI 10.7554/eLife.24728; Weir LK, 2010, BIOL LETTERS, V6, P727, DOI 10.1098/rsbl.2010.0139; Wong BBM, 2003, P ROY SOC B-BIOL SCI, V270, pS36, DOI 10.1098/rsbl.2003.0003; Yamanaka O, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.182469; Yokoi S, 2020, P NATL ACAD SCI USA, V117, P4802, DOI 10.1073/pnas.1921446117; Yokoi S, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0152-2; Yokoi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005009	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259741	10.1371/journal.pone.0259741	http://dx.doi.org/10.1371/journal.pone.0259741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780539	gold, Green Published			2022-12-26	WOS:000755305800044
J	Tian, L; Chavez, M; Chang, GS; Helton, NM; Katerndahl, CDS; Miller, CA; Wartman, LD				Tian, Ling; Chavez, Monique; Chang, Gue Su; Helton, Nichole M.; Katerndahl, Casey D. S.; Miller, Christopher A.; Wartman, Lukas D.			Kdm6a deficiency restricted to mouse hematopoietic cells causes an age- and sex-dependent myelodysplastic syndrome-like phenotype	PLOS ONE			English	Article							HISTONE DEMETHYLASE UTX; TRANSGENIC MICE; MUTATIONS; DIFFERENTIATION; CLASSIFICATION; LANDSCAPES; SUPPRESSOR; EXPRESSION; ENHANCERS	Kdm6a/Utx, a gene on the X chromosome, encodes a histone H3K27me3 demethylase that has an orthologue on the Y chromosome (Uty) (Zheng et al. 2018). We previously identified inactivating mutations of Kdm6a in approximately 50% of mouse acute promyelocytic leukemia samples; however, somatic mutations of KDM6A are more rare in human AML samples, ranging in frequency from 2-15% in different series of patients, where their role in pathogenesis is not yet clear. In this study, we show that female Kdm6a(flox/flox) mice (with allele inactivation initiated by Vav1-Cre in hematopoietic stem and progenitor cells (HSPCs) have a sex-specific phenotype that emerges with aging, with features resembling a myelodysplastic syndrome (MDS). Female Kdm6a-knockout (KO) mice have an age-dependent expansion of their HSPCs with aberrant self-renewal, but they did not differentiate normally into downstream progeny. These mice became mildly anemic and thrombocytopenic, but did not develop overt leukemia, or die from these cytopenias. ChIP-seq and ATAC-seq studies showed only minor changes in H3K27me3, H3K27ac, H3K4me, H3K4me3 and chromatin accessibility between Kdm6a-WT and Kdm6a-KO mice. Utilizing scRNA-seq, Kdm6a loss was linked to the transcriptional repression of genes that mediate hematopoietic cell fate determination. These data demonstrate that Kdm6a plays an important role in normal hematopoiesis, and that its inactivation may contribute to AML pathogenesis.	[Tian, Ling; Chavez, Monique; Helton, Nichole M.; Katerndahl, Casey D. S.; Miller, Christopher A.; Wartman, Lukas D.] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Chang, Gue Su; Miller, Christopher A.] Washington Univ, Sch Med, McDonnell Genome Inst, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Wartman, LD (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA.	lwartman@wustl.edu		Chavez, Monique/0000-0002-5317-3867	Division of Oncology; Barnes Jewish Hospital Foundation; McDonnell Genome Institute; National Institutes of Health [K08 CA166229, P01 CA101937, R50 CA211782]; National Institutes of Health, National Cancer Institute Cancer Center support grant [P30 CA91842]	Division of Oncology; Barnes Jewish Hospital Foundation; McDonnell Genome Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute Cancer Center support grant	This work was supported by institutional funds from the Division of Oncology, the Barnes Jewish Hospital Foundation, and the McDonnell Genome Institute. It was also supported by the following National Institutes of Health grants: K08 CA166229 (L.D.W.), P01 CA101937 (T.J. Ley, PI, C.A.M, Core C leader), and R50 CA211782 (C.A. M.). Flow cytometry was performed in the Siteman Cancer Center Flow Cytometry Core, which is supported in part by National Institutes of Health, National Cancer Institute Cancer Center support grant P30 CA91842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cole CB, 2016, J CLIN INVEST, V126, P85, DOI 10.1172/JCI82897; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; De Graaf CA, 2016, STEM CELL REP, V7, P571, DOI 10.1016/j.stemcr.2016.07.007; Duployez N, 2016, BLOOD, V127, P2451, DOI 10.1182/blood-2015-12-688705; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Glass JL, 2017, CANCER DISCOV, V7, P868, DOI 10.1158/2159-8290.CD-16-1032; Gozdecka M, 2018, NAT GENET, V50, P883, DOI 10.1038/s41588-018-0114-z; Herz HM, 2010, MOL CELL BIOL, V30, P2485, DOI 10.1128/MCB.01633-09; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Huppertz S, 2021, EXP HEMATOL, V99, P32, DOI 10.1016/j.exphem.2021.06.001; Jacquart A, 2017, CHEM-BIOL INTERACT, V267, P2, DOI 10.1016/j.cbi.2016.09.002; Jiang W, 2013, CELL RES, V23, P122, DOI 10.1038/cr.2012.119; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Petti AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11591-1; Ribera J, 2017, GENE CHROMOSOME CANC, V56, P810, DOI 10.1002/gcc.22486; Roy DM, 2014, PROTEIN CELL, V5, P265, DOI 10.1007/s13238-014-0031-6; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Sera Y, 2021, BLOOD, V137, P908, DOI 10.1182/blood.2019001044; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Spinella JF, 2016, ONCOTARGET, V7, P65485, DOI 10.18632/oncotarget.11796; Terashima M, 2010, BIOCHEM BIOPH RES CO, V399, P238, DOI 10.1016/j.bbrc.2010.07.061; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tsai MC, 2010, CELL CYCLE, V9, P2043, DOI 10.4161/cc.9.11.11845; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Wartman LD, 2011, J CLIN INVEST, V121, P1445, DOI 10.1172/JCI45284; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Wolff L, 2003, J VIROL, V77, P4965, DOI 10.1128/JVI.77.8.4965-4971.2003; Zheng LT, 2018, LEUKEMIA, V32, P1458, DOI 10.1038/s41375-018-0011-6	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0255706	10.1371/journal.pone.0255706	http://dx.doi.org/10.1371/journal.pone.0255706			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780480	gold, Green Submitted, Green Published			2022-12-26	WOS:000755305800004
J	Hao, XH; Bu, WQ; Lv, GS; Xu, LM; Hou, D; Wang, J; Liu, XJ; Yang, TT; Zhang, XY; Liu, Q; Gong, YQ; Shao, CS				Hao, Xiaohe; Bu, Wenqing; Lv, Guosheng; Xu, Limei; Hou, Dong; Wang, Jing; Liu, Xiaojie; Yang, Tingting; Zhang, Xiyu; Liu, Qiao; Gong, Yaoqin; Shao, Changshun			Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress	ONCOGENE			English	Article							CHECKPOINT KINASE 1; DNA-DAMAGE; CELL-CYCLE; CANCER-CELLS; CHK1; RESPIRATION; BIOGENESIS; METABOLISM; RESISTANCE; INHIBITION	Reactive oxygen species (ROS) serve as critical signals in various cellular processes. Excessive ROS cause cell death or senescence and mediates the therapeutic effect of many cancer drugs. Recent studies showed that ROS increasingly accumulate during G2/M arrest, the underlying mechanism, however, has not been fully elucidated. Here, we show that in cancer cells treated with anticancer agent TH287 or paclitaxel that causes M arrest, mitochondria accumulate robustly and produce excessive mitochondrial superoxide, which causes oxidative DNA damage and undermines cell survival and proliferation. While mitochondrial mass is greatly increased in cells arrested at M phase, the mitochondrial function is compromised, as reflected by reduced mitochondrial membrane potential, increased SUMOylation and acetylation of mitochondrial proteins, as well as an increased metabolic reliance on glycolysis. CHK1 functional disruption decelerates cell cycle, spares the M arrest and attenuates mitochondrial oxidative stress. Induction of mitophagy and blockade of mitochondrial biogenesis, measures that reduce mitochondrial accumulation, also decelerate cell cycle and abrogate M arrest-coupled mitochondrial oxidative stress. These results suggest that cell cycle progression and mitochondrial homeostasis are interdependent and coordinated, and that impairment of mitochondrial homeostasis and the associated redox signaling may mediate the antineoplastic effect of the M arrest-inducing chemotherapeutics. Our findings provide insights into the fate of cells arrested at M phase and have implications in cancer therapy.	[Hao, Xiaohe; Lv, Guosheng; Xu, Limei; Hou, Dong; Wang, Jing; Zhang, Xiyu; Liu, Qiao; Gong, Yaoqin; Shao, Changshun] Shandong Univ, Sch Basic Med Sci, Dept Genet, MOE Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Bu, Wenqing; Liu, Xiaojie; Yang, Tingting; Shao, Changshun] Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Suzhou 215123, Jiangsu, Peoples R China	Shandong University; Soochow University - China	Shao, CS (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Genet, MOE Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China.; Shao, CS (corresponding author), Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Suzhou 215123, Jiangsu, Peoples R China.	shaoc@suda.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Natural Science Foundation of China [31771260, 81572785, 81372241]; State Key Laboratory of Radiation Medicine and Protection, Soochow University [GZN1201804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Radiation Medicine and Protection, Soochow University	We thank Dr. Weihang Chai for critically reading and commenting on the manuscript. This study was supported by National Natural Science Foundation of China (31771260, 81572785 and 81372241), and the State Key Laboratory of Radiation Medicine and Protection, Soochow University (GZN1201804).	Busby EC, 2000, CANCER RES, V60, P2108; Carrassa L, 2009, J CELL MOL MED, V13, P1565, DOI [10.1111/j.1582-4934.2008.00362.x, 10.1111/j.1582-4934.2009.00362.x]; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Daud AI, 2015, J CLIN ONCOL, V33, P1060, DOI 10.1200/JCO.2014.57.5027; Dhimolea E, 2021, CANCER CELL, V39, P240, DOI 10.1016/j.ccell.2020.12.002; Fishler T, 2010, ONCOGENE, V29, P4007, DOI 10.1038/onc.2010.163; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Funakoshi T, 2019, NEUROTOXICOLOGY, V75, P70, DOI 10.1016/j.neuro.2019.09.001; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Glasauer A, 2014, BIOCHEM PHARMACOL, V92, P90, DOI 10.1016/j.bcp.2014.07.017; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Gul N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51205-w; Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Hou D, 2018, REDOX BIOL, V17, P99, DOI 10.1016/j.redox.2018.03.016; Kawamura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep26521; Leach JK, 2001, CANCER RES, V61, P3894; Liu EY, 2015, P NATL ACAD SCI USA, V112, P773, DOI 10.1073/pnas.1409563112; Liu QH, 2000, GENE DEV, V14, P1448; Ma CX, 2012, J CLIN INVEST, V122, P1541, DOI 10.1172/JCI58765; Macip S, 2006, ONCOGENE, V25, P6037, DOI 10.1038/sj.onc.1209629; Manic G, 2018, GUT, V67, P903, DOI 10.1136/gutjnl-2016-312623; Marcar L, 2019, CELL REP, V27, P3422, DOI 10.1016/j.celrep.2019.05.058; Matassa DS, 2016, CELL DEATH DIFFER, V23, P1542, DOI 10.1038/cdd.2016.39; Myers K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000324; Parmar K, 2019, CLIN CANCER RES, V25, P6127, DOI 10.1158/1078-0432.CCR-19-0448; Patterson JC, 2019, CELL SYST, V9, P74, DOI 10.1016/j.cels.2019.05.009; Patterson JC, 2019, CELL SYST, V8, P163, DOI 10.1016/j.cels.2019.01.005; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Qian X, 2019, MOL CELL, V76, P885, DOI 10.1016/j.molcel.2019.09.019; Rehman SK, 2021, CELL, V184, P226, DOI 10.1016/j.cell.2020.11.018; Rudd SG, 2020, CANCER RES, V80, P3530, DOI 10.1158/0008-5472.CAN-19-0883; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Summer R, 2019, AM J PHYSIOL-LUNG C, V316, pL1049, DOI 10.1152/ajplung.00244.2018; Takai H, 2000, GENE DEV, V14, P1439; Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang TS, 2019, MOL CELL, V75, P823, DOI 10.1016/j.molcel.2019.06.008; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Willis J, 2013, P NATL ACAD SCI USA, V110, P10592, DOI 10.1073/pnas.1301445110; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu B, 2014, MUTAT RES-FUND MOL M, V770, P1, DOI 10.1016/j.mrfmmm.2014.08.004; Xu LM, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101604; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yu D, 2020, P NATL ACAD SCI USA, V117, P9964, DOI 10.1073/pnas.1913633117; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zasadil LM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007965; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	63	4	4	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					427	443		10.1038/s41388-021-02105-9	http://dx.doi.org/10.1038/s41388-021-02105-9		NOV 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34773075	hybrid, Green Published			2022-12-26	WOS:000717915200002
J	Leiser, D; Samanta, S; Eley, J; Strauss, J; Creed, M; Kingsbury, T; Staats, PN; Bhandary, B; Chen, MJ; Dukic, T; Roy, S; Mahmood, J; Vujaskovic, Z; Shukla, HD				Leiser, Dominic; Samanta, Santanu; Eley, John; Strauss, Josh; Creed, Michael; Kingsbury, Tami; Staats, Paul N.; Bhandary, Binny; Chen, Minjie; Dukic, Tijana; Roy, Sanjit; Mahmood, Javed; Vujaskovic, Zeljko; Shukla, Hem D.			Role of caveolin-1 as a biomarker for radiation resistance and tumor aggression in lung cancer	PLOS ONE			English	Article							STEM-CELLS; RADIORESISTANCE; MECHANISMS; EXPRESSION; PATTERNS	Radiation therapy plays a major role in the treatment of lung cancer patients. However, cancer cells develop resistance to radiation. Tumor radioresistance is a complex multifactorial mechanism which may be dependent on DNA damage and repair, hypoxic conditions inside tumor microenvironment, and the clonal selection of radioresistant cells from the heterogeneous tumor site, and it is a major cause of treatment failure in non-small cell lung cancer (NSCLC). In the present investigation caveolin-1 (CAV-1) has been observed to be highly expressed in radiation resistant A549 lung cancer cells. CRISPR-Cas9 knockout of CAV-1 reverted the cells to a radio sensitive phenotype. In addition, CAV-1 overexpression in parental A549 cells, led to radiation resistance. Further, gene expression analysis of A549 parental, radiation resistant, and caveolin-1 overexpressed cells, exhibited overexpression of DNA repair genes RAD51B, RAD18, SOX2 cancer stem cell marker, MMPs, mucins and cytoskeleton proteins in resistant and caveolin-1 over expressed A549 cells, as compared to parental A549 cells. Bioinformatic analysis shows upregulation of BRCA1, Nuclear Excision DNA repair, TGFB and JAK/STAT signaling pathways in radioresistant and caveolin-1 overexpressed cells, which may functionally mediate radiation resistance. Immunohistochemistry data demonstrated heterogeneous expression of CAV-1 gene in human lung cancer tissues, which was analogous to its enhanced expression in human lung cancer cell line model and mouse orthotopic xenograft lung cancer model. Also, TCGA PanCancer clinical studies have demonstrated amplification, deletions and missense mutation in CAV-1 gene in lung cancer patients, and that CAV-1 alteration has been linked to poor prognosis, and poor survival in lung cancer patients. Interestingly, we have also optimized ELISA assay to measure caveolin-1 protein in the blood of A549 radiation resistant human xenograft preclinical mouse model and discovered higher level of caveolin-1 (950 pg/ml) in tumor bearing animals treated with radiation, as compared to xenograft with radiosensitive lung cancer cells (450 pg/ml). Thus, we conclude that caveolin-1 is involved in radio-resistance and contributes to tumor aggression, and it has potential to be used as prognostic biomarker for radiation treatment response, and tumor progression for precision medicine in lung cancer patients.	[Leiser, Dominic; Samanta, Santanu; Bhandary, Binny; Chen, Minjie; Dukic, Tijana; Roy, Sanjit; Mahmood, Javed; Vujaskovic, Zeljko; Shukla, Hem D.] Univ Maryland, Sch Med, Dept Radiat Oncol, Div Translat Radiat Sci DTRS, Baltimore, MD 21201 USA; [Eley, John; Strauss, Josh] Vanderbilt Univ, Sch Med, Dept Radiat Oncol, Nashville, TN 37212 USA; [Creed, Michael; Kingsbury, Tami] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Staats, Paul N.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Leiser, Dominic] Paul Scherrer Inst, WPTA 136, Villigen, Switzerland	University System of Maryland; University of Maryland Baltimore; Vanderbilt University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Shukla, HD (corresponding author), Univ Maryland, Sch Med, Dept Radiat Oncol, Div Translat Radiat Sci DTRS, Baltimore, MD 21201 USA.	hdshukla@som.umaryland.edu			American Cancer Society	American Cancer Society(American Cancer Society)	This study was funded by American Cancer Society to Dr. Hem D Shukla.	Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Bauer AK, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120941; Bazzani Lorenzo, 2018, Oncotarget, V9, P14939, DOI 10.18632/oncotarget.24499; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chatterjee M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10867; Choi JY, 2015, ONCOTARGET, V6, P22575, DOI 10.18632/oncotarget.4610; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Diaz-Valdivia N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1477-5; Do JH, 2008, MOL CELLS, V25, P279; Duregon E, 2015, ONCOTARGET, V6, P29626, DOI 10.18632/oncotarget.4988; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hehlgans S, 2011, AM J CANCER RES, V1, P521; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ketteler J, 2018, INT J CANCER, V143, P2092, DOI 10.1002/ijc.31369; Kim BM, 2015, INT J MOL SCI, V16, P26880, DOI 10.3390/ijms161125991; Kim M, 2015, BRIT J HAEMATOL, V168, P583, DOI 10.1111/bjh.13164; Klein D, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.9; Lakshmanan I, 2016, ONCOGENE, V35, P4112, DOI 10.1038/onc.2015.478; Liang H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01566-5; Lin CJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2066-3; Lu T, 2019, CANCER MANAG RES, V11, P943, DOI 10.2147/CMAR.S187317; Mahmood J, 2016, INT J RADIAT BIOL, V92, P747, DOI 10.1080/09553002.2016.1222096; Martinez-Outschoorn UE, 2015, NAT REV CANCER, V15, P225, DOI 10.1038/nrc3915; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Nwosu ZC, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0558-7; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peitzsch C, 2013, RADIOTHER ONCOL, V108, P378, DOI 10.1016/j.radonc.2013.06.003; Postel-Vinay S, 2012, NAT REV CLIN ONCOL, V9, P144, DOI 10.1038/nrclinonc.2012.3; Prager BC, 2019, CELL STEM CELL, V24, P41, DOI 10.1016/j.stem.2018.12.009; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sastry NG, 2020, NEURO-ONCOLOGY, V22, P1315, DOI 10.1093/neuonc/noaa032; Senetta R, 2013, J CELL MOL MED, V17, P325, DOI 10.1111/jcmm.12030; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Stewart CA, 2020, NAT CANCER, V1, P423, DOI 10.1038/s43018-019-0020-z; Tan XM, 2015, MOL CELL BIOCHEM, V408, P205, DOI 10.1007/s11010-015-2496-x; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Trakul N, 2012, J THORAC ONCOL, V7, P1462, DOI 10.1097/JTO.0b013e31825f22ce; Vyfhuis MAL, 2017, ADV RADIAT ONCOL, V2, P259, DOI 10.1016/j.adro.2017.07.009; Wang M, 2017, CANCER RES, V77, P2018, DOI 10.1158/0008-5472.CAN-16-0808; Wang ZY, 2015, ONCOTARGET, V6, P37135, DOI 10.18632/oncotarget.5789; Willers H, 2013, CANCER J, V19, P200, DOI 10.1097/PPO.0b013e318292e4e3; Zhu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012055; Zou W, 2015, ONCOL REP, V34, P3256, DOI 10.3892/or.2015.4320	47	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0258951	10.1371/journal.pone.0258951	http://dx.doi.org/10.1371/journal.pone.0258951			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762666	gold, Green Published			2022-12-26	WOS:000755316600009
J	Yin, FT; Zhang, FH; Wang, HR				Yin, Fating; Zhang, Fenghua; Wang, Haoran			Rhizosphere bacteria community and functions under typical natural halophyte communities in North China salinized areas	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; ORGANIC-CARBON; SALICORNIA-EUROPAEA; WATER-CONTENT; DIVERSITY; PLANTS; MICROORGANISMS; RECLAMATION; FARMLAND; ROOTS	Soil salinity is a serious environmental issue in arid China. Halophytes show extreme salt tolerance and are grow in saline-alkaline environments. There rhizosphere have complex bacterial communities, which mediate a variety of interactions between plants and soil. Highthroughput sequencing was used to investigated rhizosphere bacterial community changes under the typical halophyte species in arid China. Three typical halophytes were Leymus chinensis (LC), Puccinellia tenuiflora (PT), Suaeda glauca (SG). The dominant phyla were Proteobacteria, Actinobacteria, Chloroflexi, Gemmatimonadetes, Acidobacteria and Bacteroidetes, Suaeda glauca rhizosphere has stronger enrichment of Nitrospirae and Cyanobacteria. The Ace, Chao and Shannon indices were significantly higher in soils under LC and SG (P<0.05). Functional predictions, based on 16S rRNA gene by PICRUSt, indicated that Energy metabolism, Amino acid metabolism, Carbohydrate metabolism and Fatty acid metabolism are dominant bacterial functions in three halophytes rhizosphere soil. Carbon metabolism, Oxidative phosphorylation, Methane metabolism, Sulfur metabolism and Nitrogen metabolism in SG were significantly higher than that in LC and PT. Regression analysis revealed that rhizosphere soil bacterial community structure is influenced by soil organic matter (SOM) and soil water content (SWC), while soil bacterial community diversity is affected by soil pH. This study contributes to our understanding of the distribution characteristics and metabolic functions under different halophyte rhizosphere bacterial communities, and will provide references for the use of rhizosphere bacteria to regulate the growth of halophytes and ecological restoration of saline soil.	[Yin, Fating; Zhang, Fenghua; Wang, Haoran] Shihezi Univ, Agr Coll, Shihezi City, Peoples R China; [Yin, Fating; Zhang, Fenghua] Shihezi Univ, Key Lab Oasis Ecoagr, Xinjiang Prod & Construct Corps, Shihezi, Xinjiang, Peoples R China	Shihezi University; Shihezi University	Zhang, FH (corresponding author), Shihezi Univ, Agr Coll, Shihezi City, Peoples R China.; Zhang, FH (corresponding author), Shihezi Univ, Key Lab Oasis Ecoagr, Xinjiang Prod & Construct Corps, Shihezi, Xinjiang, Peoples R China.	zhangfenghua6088@126.com		Zhang, Fenghua/0000-0002-1666-9548	National Natural Science Foundation of China [31860360]; Major Program of Xinjiang Province [2018AA005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Xinjiang Province	This research was financially supported by the National Natural Science Foundation of China (31860360) and the Major Program of Xinjiang Province (2018AA005). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caravaca F, 2005, GEODERMA, V124, P375, DOI 10.1016/j.geoderma.2004.05.010; Chamizo S, 2018, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00049; Chaudhary DR, 2018, MICROB ECOL, V75, P729, DOI 10.1007/s00248-017-1083-y; Chaudhary DR, 2015, APPL SOIL ECOL, V91, P16, DOI 10.1016/j.apsoil.2015.02.003; Chen JH, 2019, GEODERMA, V354, DOI 10.1016/j.geoderma.2019.113894; Chen SF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067974, 10.1371/journal.pone.0054659]; Chen Y, 2020, ARCH MICROBIOL, V202, P1157, DOI 10.1007/s00203-020-01830-1; Cheng ZB, 2019, SOIL TILL RES, V187, P204, DOI 10.1016/j.still.2018.12.015; Cheng ZB, 2018, SCI TOTAL ENVIRON, V630, P799, DOI 10.1016/j.scitotenv.2018.02.259; Diaz-Zorita M, 1999, COMMUN SOIL SCI PLAN, V30, P739, DOI 10.1080/00103629909370242; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Etesami H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00148; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fischer H, 2007, SOIL BIOL BIOCHEM, V39, P2926, DOI 10.1016/j.soilbio.2007.06.014; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gomoryova E, 2013, EUR J SOIL BIOL, V55, P71, DOI 10.1016/j.ejsobi.2012.12.001; Govind Gupta, 2015, Journal of Microbial and Biochemical Technology, V7, P96; Guo HH, 2017, ECOTOX ENVIRON SAFE, V144, P300, DOI 10.1016/j.ecoenv.2017.06.048; Hasanuzzaman M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/589341; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Houfani AA, 2019, MICROB ECOL, V77, P713, DOI 10.1007/s00248-018-1251-8; Jacoby R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01617; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kearl J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01849; Khalmuratova I, 2015, MYCOBIOLOGY, V43, P373, DOI 10.5941/MYCO.2015.43.4.373; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li MY, 2021, CURR MICROBIOL, V78, P2720, DOI 10.1007/s00284-021-02536-3; Li N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28054-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma B, 2017, J SOIL SEDIMENT, V17, P2516, DOI 10.1007/s11368-017-1696-2; Marasco R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01286; Mendes LW, 2018, ISME J, V12, P212, DOI 10.1038/ismej.2017.158; Mukhtar S, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2509-5; Mukhtar S, 2017, POL J MICROBIOL, V66, P353, DOI 10.5604/01.3001.0010.4866; Neupane S, 2019, GEODERMA, V335, P112, DOI 10.1016/j.geoderma.2018.08.016; Niemhom N, 2013, INT J SYST EVOL MICR, V63, P66, DOI 10.1099/ijs.0.038851-0; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Pii Y, 2016, PLANT PHYSIOL BIOCH, V99, P39, DOI 10.1016/j.plaphy.2015.12.002; Qin Y, 2016, BIOTECHNOL ADV, V34, P1245, DOI 10.1016/j.biotechadv.2016.08.005; Rath KM, 2019, ISME J, V13, P836, DOI 10.1038/s41396-018-0313-8; Ravindran KC, 2007, SOIL BIOL BIOCHEM, V39, P2661, DOI 10.1016/j.soilbio.2007.02.005; RCore Team, 2020, R LANG ENV STAT COMP; Rukhovich DI, 2017, EURASIAN SOIL SCI+, V50, P276, DOI 10.1134/S1064229317010136; Sadeghi A, 2012, WORLD J MICROB BIOT, V28, P1503, DOI 10.1007/s11274-011-0952-7; Samaddar S, 2019, J MICROBIOL BIOTECHN, V29, P292, DOI 10.4014/jmb.1811.11018; Sanchez-Canizares C, 2017, CURR OPIN MICROBIOL, V38, P188, DOI 10.1016/j.mib.2017.07.001; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; SCHNURER J, 1986, MICROBIAL ECOL, V12, P217, DOI 10.1007/BF02011206; Sh YW, 2015, J MICROBIOL, V53, P678, DOI 10.1007/s12275-015-5080-x; Shi W, 2012, WORLD J MICROB BIOT, V28, P2147, DOI 10.1007/s11274-012-1020-7; Szymanska S, 2016, MICROBIOL RES, V192, P37, DOI 10.1016/j.micres.2016.05.012; Szymanska S, 2016, MICROBIOL RES, V182, P68, DOI 10.1016/j.micres.2015.09.007; Turner TR, 2013, ISME J, V7, P2248, DOI 10.1038/ismej.2013.119; Van Oosten MJ, 2015, ENVIRON EXP BOT, V111, P135, DOI 10.1016/j.envexpbot.2014.11.010; Wang M, 2007, PEDOSPHERE, V17, P545, DOI 10.1016/S1002-0160(07)60065-4; Yamamoto K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02878; Yang L, 2018, CAN J MICROBIOL, V64, P167, DOI 10.1139/cjm-2017-0443; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yin ZP, 2019, PLANT SOIL, V437, P137, DOI 10.1007/s11104-019-03955-9; Yuanchengpeng, 2019, IOP Conference Series: Earth and Environmental Science, V310, DOI 10.1088/1755-1315/310/4/042046; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22788-7	69	1	1	13	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259515	10.1371/journal.pone.0259515	http://dx.doi.org/10.1371/journal.pone.0259515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762689	Green Published			2022-12-26	WOS:000755316600024
J	Jiang, J; Liu, H; Wang, ZD; Tian, HL; Wang, S; Yang, JY; Ren, JY				Jiang, Jing; Liu, Hao; Wang, Zidong; Tian, Huiling; Wang, Shun; Yang, Jiayi; Ren, Jingyu			Electroacupuncture could balance the gut microbiota and improve the learning and memory abilities of Alzheimer's disease animal model	PLOS ONE			English	Article							CEREBROVASCULAR-DISEASE; MOUSE MODEL; PATHOGENESIS; ROLES; MICE	Alzheimer's disease (AD), as one of most common dementia, mainly affects older people from the worldwide. In this study, we intended to explore the possible mechanism of improving cognitive function and protecting the neuron effect by electroacupuncture. Method: We applied senescence-accelerated mouse prone 8 (SAMP8) mice as AD animal model, used Morris water maze, HE staining, 16S rDNA amplicon sequencing of gut microbiota and ELISA to demonstrate our hypothesis. Results: electroacupuncture improved the learning and memory abilities in SAMP8 mice (P<0.05) and could protect the frontal lobe cortex and hippocampus of SAMP8 mice; electroacupuncture significantly decreased the expression of IL-1 beta (P<0.01), IL-6 (P<0.01) and TNF-alpha (P<0.01 in hippocampus, P<0.05 in serum) in serum and hippocampus; electroacupuncture balanced the quantity and composition of gut microbiome, especially of the relative abundance in Delta-proteobacteria (P<0.05) and Epsilon-proteobacteria (P<0.05). Conclusion: electroacupuncture treatment could inhibit the peripheral and central nerve system inflammatory response by balancing the gut microbiota.	[Jiang, Jing; Liu, Hao; Wang, Zidong; Tian, Huiling; Wang, Shun; Yang, Jiayi; Ren, Jingyu] Beijing Univ Chinese Med, Beijing, Peoples R China	Beijing University of Chinese Medicine	Jiang, J (corresponding author), Beijing Univ Chinese Med, Beijing, Peoples R China.	yingxi7847@126.com	Wang, Zhiquan/HHS-6768-2022	Jiang, Jing/0000-0003-2731-4766	National Natural Science Foundation of China Youth Fund Project [818041787]	National Natural Science Foundation of China Youth Fund Project	This study was supported by the National Natural Science Foundation of China Youth Fund Project (Grant No. 818041787).	Aguilera M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158336; Askarova S, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00104; Astudillo AA, 2021, CUREUS, V13, DOI 10.7759/cureus.14519; Bachiller S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00488; Bauerl C, 2018, LETT APPL MICROBIOL, V66, P464, DOI 10.1111/lam.12882; Barage SH, 2015, NEUROPEPTIDES, V52, P1, DOI 10.1016/j.npep.2015.06.008; Bonfili L, 2021, FEBS J, V288, P2836, DOI 10.1111/febs.15571; Bostanciklioglu M, 2019, J APPL MICROBIOL, V127, P954, DOI 10.1111/jam.14264; Brandscheid C, 2017, J ALZHEIMERS DIS, V56, P775, DOI 10.3233/JAD-160926; Browning KN, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00413; Castillo-Alvarez F, 2022, NEUROLOGIA, V37, P492, DOI 10.1016/j.nrl.2019.03.017; Chen C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba0466; Chen JY, 2020, AGING-US, V12, P8434, DOI 10.18632/aging.103150; Chen YJ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/8456596; Chew H, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00598; Coman V, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111095; Cui B, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1223-4; Ding N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00037; Ding N, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/3435891; Dodiya HB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64797-5; Domingues C, 2017, CURR ALZHEIMER RES, V14, P870, DOI 10.2174/1567205014666170317113606; Goyal D, 2021, PROG NEURO-PSYCHOPH, V106, DOI 10.1016/j.pnpbp.2020.110112; Guest FL, 2020, ADV EXP MED BIOL, V1260, P175, DOI 10.1007/978-3-030-42667-5_8; Guo MY, 2021, J ALZHEIMERS DIS, V80, P299, DOI 10.3233/JAD-201040; He C, 2021, IRAN J BASIC MED SCI, V24, P341, DOI 10.22038/ijbms.2021.49147.11256; Iadecola C, 2018, CIRC RES, V123, P406, DOI 10.1161/CIRCRESAHA.118.313400; International Asd, 2020, WORLD ALZHEIMER REPO; Jia YJ, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2064-x; Jiang J, 2019, ACUPUNCT MED, V37, P64, DOI 10.1136/acupmed-2016-011310; Jiang J, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8296824; Jiang J, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3131586; Jiang J, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/142129; Jin GH, 2020, MOL THER-NUCL ACIDS, V20, P13, DOI 10.1016/j.omtn.2020.01.037; Kao YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041505; Khan MS, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040853; Koh A, 2020, MOL CELL, V78, P584, DOI 10.1016/j.molcel.2020.03.005; Kuang H, 2020, CNS NEUROSCI THER, V26, P155, DOI 10.1111/cns.13216; Leblhuber F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020361; Li Z, 2020, J NEUROCHEM, V155, P448, DOI 10.1111/jnc.15031; Lin CX, 2019, COMPUT STRUCT BIOTEC, V17, P1309, DOI 10.1016/j.csbj.2019.09.008; Lin DC, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1842992; Liu MH, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116459; Liu S, 2020, MOL NEUROBIOL, V57, P5026, DOI 10.1007/s12035-020-02073-3; Louca P, 2020, AM J HYPERTENS, V33, P473, DOI 10.1093/ajh/hpaa022; Love S, 2016, ACTA NEUROPATHOL, V131, P645, DOI 10.1007/s00401-015-1522-0; Lu J, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/8302950; Luca M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4730539; Maccioni RB, 2020, J ALZHEIMERS DIS, V76, P1199, DOI 10.3233/JAD-191014; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Mishra R, 2020, AGING DIS, V11, P1567, DOI 10.14336/AD.2020.0312; Mondragon-Rodriguez S, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/2960343; Muralidar S, 2020, INT J BIOL MACROMOL, V163, P1599, DOI 10.1016/j.ijbiomac.2020.07.327; Ng A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30487-6; Panza F, 2019, BRAIN, V142, P2905, DOI 10.1093/brain/awz244; Peirce JM, 2019, J NEUROSCI RES, V97, P1223, DOI 10.1002/jnr.24476; Peng WJ, 2018, AGING-US, V10, P4054, DOI 10.18632/aging.101693; Revi M, 2020, ADV EXP MED BIOL, V1195, P105, DOI 10.1007/978-3-030-32633-3_15; Ricciarelli R, 2017, CURR NEUROPHARMACOL, V15, P926, DOI 10.2174/1570159X15666170116143743; Saito S, 2016, CURR OPIN PSYCHIATR, V29, P168, DOI 10.1097/YCO.0000000000000239; Saji N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55851-y; Saksida T, 2018, J ALZHEIMERS DIS, V61, P619, DOI 10.3233/JAD-170538; Salazar N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081765; Sanchez JMS, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01959-2; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; Sheehan PW, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00703; Shen L, 2019, APPL MICROBIOL BIOT, V103, P7141, DOI 10.1007/s00253-019-09950-5; Shen L, 2017, J ALZHEIMERS DIS, V56, P385, DOI 10.3233/JAD-160884; Shinohara M, 2019, ADV EXP MED BIOL, V1128, P85, DOI 10.1007/978-981-13-3540-2_5; Shiro Y, 2021, PAIN MED, V22, P1522, DOI 10.1093/pm/pnaa401; Shukla PK, 2022, NUTR NEUROSCI, V25, P871, DOI 10.1080/1028415X.2020.1819105; Song YF, 2020, AM J CHINESE MED, V48, P77, DOI 10.1142/S0192415X20500044; Stoye NM, 2020, FASEB J, V34, P11883, DOI 10.1096/fj.201903128RR; Sun J, 2020, MOL NUTR FOOD RES, V64, DOI 10.1002/mnfr.201900636; Sun ZZ, 2020, APPL MICROBIOL BIOT, V104, P3507, DOI 10.1007/s00253-020-10461-x; Sureda A, 2020, PHARMACOL RES, V151, DOI 10.1016/j.phrs.2019.104582; Tian HL, 2019, JOVE-J VIS EXP, DOI 10.3791/60055; Tu CH, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00014; van Thiel IAM, 2020, AM J PHYSIOL-GASTR L, V318, pG1034, DOI 10.1152/ajpgi.00196.2019; Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143; Wang HY, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/4958294; Wang QJ, 2020, AGING-US, V12, P628, DOI 10.18632/aging.102645; Wang T, 2015, BENEF MICROBES, V6, P707, DOI 10.3920/BM2014.0177; Wang XH, 2021, J CLIN ENDOCR METAB, V106, pE4641, DOI 10.1210/clinem/dgab454; Wang XR, 2021, EUR J NUTR, V60, P3473, DOI 10.1007/s00394-021-02528-w; Wang XR, 2020, J AFFECT DISORDERS, V275, P290, DOI 10.1016/j.jad.2020.06.043; Wang Y, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01873-7; Webers A, 2020, IMMUNOL CELL BIOL, V98, P28, DOI 10.1111/imcb.12301; Wu YL, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00924-0; Yan XT, 2018, PROG NEURO-PSYCHOPH, V83, P64, DOI 10.1016/j.pnpbp.2017.12.016; Yang XQ, 2020, ACTA PHARM SIN B, V10, P475, DOI 10.1016/j.apsb.2019.07.001; Yu CC, 2019, CHIN J INTEGR MED, V25, P631, DOI 10.1007/s11655-018-2993-3; Zhan GF, 2018, AGING-US, V10, P1257, DOI 10.18632/aging.101464; Zhang FQ, 2021, HUM GENET, V140, P1267, DOI 10.1007/s00439-021-02288-x; Zhang FQ, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI145942; Zhang LL, 2020, MED RES REV, V40, P431, DOI 10.1002/med.21624; Zhang LY, 2021, DIABET METAB SYND OB, V14, P2595, DOI 10.2147/DMSO.S306861; Zhao Y, 2020, AGING DIS, V11, P1594, DOI 10.14336/AD.2020.0205; Zheng SY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02415; Zheng WM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196933; Zhu SB, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1705-z	100	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259530	10.1371/journal.pone.0259530	http://dx.doi.org/10.1371/journal.pone.0259530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748592	Green Published, gold			2022-12-26	WOS:000755468000034
J	Morsin, M; Nafisah, S; Sanudin, R; Razali, NL; Mahmud, F; Soon, CF				Morsin, Marlia; Nafisah, Suratun; Sanudin, Rahmat; Razali, Nur Liyana; Mahmud, Farhanahani; Soon, Chin Fhong			The role of positively charge poly-L-lysine in the formation of high yield gold nanoplates on the surface for plasmonic sensing application	PLOS ONE			English	Article							SEED-MEDIATED GROWTH; METAL NANOPARTICLES; BORIC-ACID; PERFORMANCE; RESONANCE; NANORODS; DESIGN	An anisotropic structure, gold (Au) nanoplates was synthesized using a two-step wet chemical seed mediated growth method (SMGM) directly on the substrate surface. Prior to the synthesis process, poly-l-lysine (PLL) as a cation polymer was used to enhance the yield of grown Au nanoplates. The electrostatic interaction of positive charged by PLL with negative charges from citrate-capped gold nanoseeds contributes to the yield increment. The percentage of PLL was varied from 0% to 10% to study the morphology of Au nanoplates in term of shape, size and surface density. 5% PLL with single layer treatment produce a variety of plate shapes such as hexagonal, flat rod and triangular obtained over the whole substrate surface with the estimated maximum yield up to ca. 48%. The high yield of Au nanoplates exhibit dual plasmonic peaks response that are associated with transverse and longitudinal localized surface plasmon resonance (TSPR and LSPR). Then, the PLL treatment process was repeated twice resulting the increment of Au nanoplates products to ca. 60%. The thin film Au nanoplates was further used as sensing materials in plasmonic sensor for detection of boric acid. The anisotropic Au nanoplates have four sensing parameters being monitored when the medium changes, which are peak position (wavelength shift), intensity of TSPR and LSPR, and the changes on sensing responses. The sensor responses are based on the interaction of light with dielectric properties from surrounding medium. The resonance effect produces by a collection of electron vibration on the Au nanoparticles surface after hit by light are captured as the responses. As a conclusion, it was found that the PLL treatment is capable to promote high yield of Au nanoplates. Moreover, the high yield of the Au nanoplates is an indication as excellent candidate for sensing material in plasmonic sensor.	[Morsin, Marlia; Sanudin, Rahmat; Razali, Nur Liyana; Mahmud, Farhanahani; Soon, Chin Fhong] Univ Tun Hussein Onn Malaysia, Microelect & Nanotechnol Shamsuddin Res Ctr MiNT, Inst Integrated Engn IIE, Pant Raja, Batu Pahat Joho, Malaysia; [Morsin, Marlia; Sanudin, Rahmat; Razali, Nur Liyana; Mahmud, Farhanahani; Soon, Chin Fhong] Univ Tun Hussein Onn Malaysia, Fac Elect & Elect Engn FKEE, Parit Raja, Batu Pahat Joho, Malaysia; [Nafisah, Suratun] Inst Teknol Sumatera ITERA, Dept Elect Engn, Lampung Selatan, Indonesia	University of Tun Hussein Onn Malaysia	Morsin, M (corresponding author), Univ Tun Hussein Onn Malaysia, Microelect & Nanotechnol Shamsuddin Res Ctr MiNT, Inst Integrated Engn IIE, Pant Raja, Batu Pahat Joho, Malaysia.; Morsin, M (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Elect & Elect Engn FKEE, Parit Raja, Batu Pahat Joho, Malaysia.	marlia@uthm.edu.my	Nafisah, Suratun/AAC-4140-2021	Nafisah, Suratun/0000-0002-0774-3304; Morsin, Marlia/0000-0002-5351-7826	Ministry of Higher Education (MOHE) Malaysia through Fundamental Research Grant Scheme [FRGS/1/2019/STG07/UTHM/02/1]; Hibah Penelitian GBU45 from Institut Teknologi Sumatera [B/515/IT9. C/PT.01.03/2021]; Universiti Tun Hussein Onn Malaysia	Ministry of Higher Education (MOHE) Malaysia through Fundamental Research Grant Scheme; Hibah Penelitian GBU45 from Institut Teknologi Sumatera; Universiti Tun Hussein Onn Malaysia	The research is supported by Ministry of Higher Education (MOHE) Malaysia through Fundamental Research Grant Scheme (FRGS/1/2019/STG07/UTHM/02/1) (MM, FM) (https://mygrants.gov.my) and Hibah Penelitian GBU45 (No. B/515/IT9. C/PT.01.03/2021) (SN) from Institut Teknologi Sumatera. The authors would also like to thank Universiti Tun Hussein Onn Malaysia for partially sponsored this work. The funders had a role in decision to publish the manuscript.	Ali NM., 2017, J TELECOMMUN ELECT C, V9, P67; Ang Swi See, 2010, American Journal of Applied Sciences, V7, P620, DOI 10.3844/ajassp.2010.620.627; AnNisa N. Z., 2019, ASM SCI J, V12, P139; Burrows ND, 2017, LANGMUIR, V33, P1891, DOI 10.1021/acs.langmuir.6b03606; Chau YFC, 2020, RESULTS PHYS, V17, DOI 10.1016/j.rinp.2020.103168; Chau YFC, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9121691; Chau YFC, 2019, RESULTS PHYS, V13, DOI 10.1016/j.rinp.2019.102290; Chau YFC, 2016, J APPL PHYS, V120, DOI 10.1063/1.4962175; Commission JFCA, 1989, JOINT FAO WHO FOOD S; Cox C., 2004, Journal of Pesticide Reform, V24, P10; De DS, 2020, PHYS CHEM CHEM PHYS, V22, P25366, DOI 10.1039/d0cp01300e; Hall DG, 2005, BORONIC ACIDS: PREPARATION AND APPLICATIONS IN ORGANIC SYNTHESIS AND MEDICINE, P1, DOI 10.1002/3527606548.ch1; Holzinger M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17051010; Hossain MF, 2019, SENSOR ACTUAT B-CHEM, V282, P780, DOI 10.1016/j.snb.2018.10.152; Huang ZD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14110; Kreibig U., 2013, SPRINGER SCI BUSINES, V25; Li M, 2015, ANALYST, V140, P386, DOI 10.1039/c4an01079e; LITOVITZ TL, 1988, AM J EMERG MED, V6, P209, DOI 10.1016/0735-6757(88)90001-0; Liu JS, 2019, ANAL BIOANAL CHEM, V411, P877, DOI 10.1007/s00216-018-1505-9; Lu LF, 2018, ACS CATAL, V8, P8484, DOI 10.1021/acscatal.8b01627; Marques-Hueso J, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/aae795; Shah NZAM, 2020, PLASMONICS, V15, P923, DOI 10.1007/s11468-019-01098-2; Morsin M, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17050947; Morsin M, 2017, INT J INTEGR ENG, V9, P27; Morsin M, 2017, PROCEDIA ENGINEER, V184, P637, DOI 10.1016/j.proeng.2017.04.130; Morsin M, 2014, KEY ENG MATER, V605, P356, DOI 10.4028/www.scientific.net/KEM.605.356; Nafisah S, 2020, INT J NANOELECTRON M, V13, P615; Nafisah S, 2021, J PHYS CHEM SOLIDS, V148, DOI 10.1016/j.jpcs.2020.109764; Nafisah S, 2020, IEEE SENS J, V20, P2378, DOI 10.1109/JSEN.2019.2953928; Nafisah S, 2018, METHODSX, V5, P1618, DOI 10.1016/j.mex.2018.12.002; Nafisah S, 2017, INT J INTEGR ENG, V9, P124; Nengsih S, 2011, SAINS MALAYS, V40, P231; OSHIMA M, 1990, ANAL SCI, V6, P627, DOI 10.2116/analsci.6.627; Pattadar DK, 2019, LANGMUIR, V35, P16416, DOI 10.1021/acs.langmuir.9b02421; Pattanayak S, 2018, INORG NANO-MET CHEM, V48, P535, DOI 10.1080/24701556.2019.1567543; Razali, 2017, JTEC, V9, P123; Razali NL, 2020, NANOMATER NANOTECHNO, V10, DOI 10.1177/1847980420965388; Razali NL, 2018, INT J INTEGR ENG, V10, P60; Shah S, 2017, OPT MATER EXPRESS, V7, P2069, DOI 10.1364/OME.7.002069; Shaik F, 2017, J PHYS CHEM C, V121, P9572, DOI 10.1021/acs.jpcc.7b01365; Sharifi M, 2020, TALANTA, V212, DOI 10.1016/j.talanta.2020.120782; Stobiecka M, 2011, BIOMATERIALS, V32, P3312, DOI 10.1016/j.biomaterials.2010.12.064; Wang Y, 2018, ANAL CHIM ACTA, V1002, P97, DOI 10.1016/j.aca.2017.11.067; Wankhede DS, 2012, ACTA CHIM SLOV, V59, P258; Weng GJ, 2018, SOLID STATE COMMUN, V272, P67, DOI 10.1016/j.ssc.2018.01.014; Yao K, 2019, ACS NANO, V13, P5397, DOI 10.1021/acsnano.9b00135; Yao QF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00970-1; Yaraki MT, 2020, PART PART SYST CHAR, V37, DOI 10.1002/ppsc.202000027; Zeng LM, 2010, J AM SOC MASS SPECTR, V21, P482, DOI 10.1016/j.jasms.2009.12.003; Zhang ZY, 2018, BIOSENS BIOELECTRON, V114, P52, DOI 10.1016/j.bios.2018.05.015; Zhao CH, 2020, J MATER SCI, V55, P3495, DOI 10.1007/s10853-019-04200-5; Zukovskaja O, 2019, TALANTA, V202, P171, DOI 10.1016/j.talanta.2019.04.047	52	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259730	10.1371/journal.pone.0259730	http://dx.doi.org/10.1371/journal.pone.0259730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748606	Green Published, gold			2022-12-26	WOS:000755468000050
J	Nakata, H; Takezawa, M; Kamijo, K; Shibasaki, M				Nakata, Hiroki; Takezawa, Miho; Kamijo, Keita; Shibasaki, Manabu			Modality differences in ERP components between somatosensory and auditory Go/No-go paradigms in prepubescent children	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; RESPONSE-INHIBITION; TEMPORAL DYNAMICS; P3 LATENCY; N1 WAVE; TASK; CONFLICT; EXECUTION; TIME; DISCRIMINATION	We investigated modality differences in the N2 and P3 components of event-related potentials (ERPs) between somatosensory and auditory Go/No-go paradigms in eighteen healthy prepubescent children (mean age: 125.9 +/- 4.2 months). We also evaluated the relationship between behavioral responses (reaction time, reaction time variability, and omission and commission error rates) and amplitudes and latencies of N2 and P3 during somatosensory and auditory Go/No-go paradigms. The peak latency of No-go-N2 was significantly shorter than that of Go-N2 during somatosensory paradigms, but not during auditory paradigms. The peak amplitude of P3 was significantly larger during somatosensory than auditory paradigms, and the peak latency of P3 was significantly shorter during somatosensory than auditory paradigms. Correlations between behavioral responses and the P3 component were not found during somatosensory paradigms. On the other hand, in auditory paradigms, correlations were detected between the reaction time and peak amplitude of No-go-P3, and between the reaction time variability and peak latency of No-go-P3. A correlation was noted between commission error and the peak latency of No-go-N2 during somatosensory paradigms. Compared with previous adult studies using both somatosensory and auditory Go/No-go paradigms, the relationships between behavioral responses and ERP components would be weak in prepubescent children. Our data provide findings to advance understanding of the neural development of motor execution and inhibition processing, that is dependent on or independent of the stimulus modality.	[Nakata, Hiroki; Shibasaki, Manabu] Nara Womens Univ, Fac Human Life & Environm, Dept Hlth Sci, Nara, Japan; [Takezawa, Miho] Nara Womens Univ, Elementary Sch, Nara, Japan; [Kamijo, Keita] Chukyo Univ, Fac Liberal Arts & Sci, Nagoya, Aichi, Japan	Nara Womens University; Nara Womens University; Chukyo University	Nakata, H (corresponding author), Nara Womens Univ, Fac Human Life & Environm, Dept Hlth Sci, Nara, Japan.	hiroki-nakata@cc.nara-wu.ac.jp			Japan Society for the Promotion of Science KAKENHI [19K11576]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Japan Society for the Promotion of Science KAKENHI Grant-in-Aid for Scientific Research C (19K11576) (to H. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2008, CEREB CORTEX, V18, P1350, DOI 10.1093/cercor/bhm166; Anderer P, 1998, EVOKED POTENTIAL, V108, P160, DOI 10.1016/S0168-5597(97)00080-4; Band GPH, 2003, PSYCHOL RES-PSYCH FO, V67, P266, DOI 10.1007/s00426-002-0127-0; Barry RJ, 2007, CLIN NEUROPHYSIOL, V118, P2692, DOI 10.1016/j.clinph.2007.08.023; Barry RJ, 2018, INT J PSYCHOPHYSIOL, V123, P74, DOI 10.1016/j.ijpsycho.2017.10.014; Barry RJ, 2015, PSYCHOPHYSIOLOGY, V52, P1228, DOI 10.1111/psyp.12447; Barry RJ, 2014, CLIN NEUROPHYSIOL, V125, P1995, DOI 10.1016/j.clinph.2014.02.018; Barry RJ, 2012, INT J PSYCHOPHYSIOL, V86, P251, DOI 10.1016/j.ijpsycho.2012.10.001; Bianco V, 2017, NEUROSCIENCE, V343, P260, DOI 10.1016/j.neuroscience.2016.12.006; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Ciesielski KT, 2004, PSYCHOPHYSIOLOGY, V41, P882, DOI 10.1111/j.1469-8986.2004.00250.x; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; FALKENSTEIN M, 1995, EVOKED POTENTIAL, V96, P36, DOI 10.1016/0013-4694(94)00182-K; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; GEMBA H, 1990, BRAIN RES, V537, P340, DOI 10.1016/0006-8993(90)90382-L; GIARD MH, 1994, ELECTROEN CLIN NEURO, V92, P238, DOI 10.1016/0168-5597(94)90067-1; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Imanaka M, 2017, NEUROREPORT, V28, P822, DOI 10.1097/WNR.0000000000000833; Inui K, 2003, NEUROSCIENCE, V120, P235, DOI 10.1016/S0306-4522(03)00261-6; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; Jonkman LM, 2003, PSYCHOPHYSIOLOGY, V40, P752, DOI 10.1111/1469-8986.00075; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kida T, 2006, NEUROIMAGE, V32, P1355, DOI 10.1016/j.neuroimage.2006.05.015; Kiefer M, 1998, NEUROREPORT, V9, P765, DOI 10.1097/00001756-199803090-00037; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Mizukami H, 2019, EXP BRAIN RES, V237, P521, DOI 10.1007/s00221-018-5443-8; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakata H, 2006, NEUROSCI LETT, V397, P318, DOI 10.1016/j.neulet.2005.12.041; Nakata H, 2005, EUR J NEUROSCI, V22, P1784, DOI 10.1111/j.1460-9568.2005.04368.x; Nakata H, 2008, NEUROIMAGE, V39, P1858, DOI 10.1016/j.neuroimage.2007.10.041; Nakata H, 2017, J APPL PHYSIOL, V123, P1246, DOI 10.1152/japplphysiol.00348.2017; Nakata H, 2016, J PSYCHOPHYSIOL, V30, P131, DOI 10.1027/0269-8803/a000163; Nakata H, 2015, EUR J NEUROSCI, V41, P1448, DOI 10.1111/ejn.12889; Nakata H, 2012, EUR J APPL PHYSIOL, V112, P207, DOI 10.1007/s00421-011-1973-5; Nakata H, 2010, NEUROSCI LETT, V478, P124, DOI 10.1016/j.neulet.2010.05.002; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; PFEFFERBAUM A, 1983, ELECTROEN CLIN NEURO, V55, P188, DOI 10.1016/0013-4694(83)90187-6; ROTH WT, 1978, PSYCHOPHYSIOLOGY, V15, P17, DOI 10.1111/j.1469-8986.1978.tb01328.x; Schmidt RA., 2001, HUMAN KINETICS, P55; Shibasaki M, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14003; Shibasaki M, 2017, SCI REP-UK, V7, DOI 10.1038/srep43528; Smith JL, 2006, INT J PSYCHOPHYSIOL, V61, P121, DOI 10.1016/j.ijpsycho.2005.07.013; Takezawa M, 2019, NEUROREPORT, V30, P1284, DOI 10.1097/WNR.0000000000001355; Yamashiro K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81852-x; Yamashiro K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142581; Yechiam E, 2006, PSYCHOL ASSESSMENT, V18, P239, DOI 10.1037/1040-3590.18.3.239; Zanini S, 2016, DEV MED CHILD NEUROL, V58, P855, DOI 10.1111/dmcn.13072	54	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259653	10.1371/journal.pone.0259653	http://dx.doi.org/10.1371/journal.pone.0259653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ4ST	34748591	Green Published, gold			2022-12-26	WOS:000755468000045
J	Hajek, A; De Bock, F; Sprengholz, P; Kretzler, B; Konig, HH				Hajek, Andre; De Bock, Freia; Sprengholz, Philipp; Kretzler, Benedikt; Koenig, Hans-Helmut			Attitudes towards the economic costs associated with measures against the spread of COVID-19: Population perceptions from repeated cross-sectional data of the nationally representative COVID-19 Snapshot Monitoring in Germany (COSMO)	PLOS ONE			English	Article								Introduction Our aim was to examine attitudes of the general population towards reasonableness of these costs, as well as the degree to which these costs are shared across society (solidarity financing) and to determine the factors associated with them. Method Repeated cross-sectional data from a nationally representative online-survey. More precisely, data from wave 8 (21-22 April 2020) and wave 16 (7-8 July 2020) were used (in wave 8: analytical sample with n = 976, average age was 47.0 years (SD: 15.3 years), ranging from 18 to 74 years, 51.8% female; in wave 16: analytical sample with n = 978, average age was 46.1 years (SD: 15.9 years), ranging from 18 to 74 years, 50.9% female). After a short introduction emphasizing considerable economic costs associated with the measures against the spread of the coronavirus, individuals were asked to rate the following statements (outcome measures), in each case from 1 = strongly disagree to 7 = strongly agree: "These economic costs are currently reasonable in relation to the objective pursued" (reasonableness of costs), "These economic costs should be borne jointly by all citizens and depending on income" (solidarity financing). Results In wave 8 (wave 16 in parentheses), the average rating for the attitude towards reasonableness of costs was 4.3, SD: 1.8 (wave 16, average: 4.2, SD: 1.8) and the average rating for the attitude towards solidarity financing was 3.7, SD: 1.9 (wave 16, average: 3.3, SD: 2.0). In wave 8, more positive attitudes towards the reasonableness of costs and solidarity financing were associated with being male, higher education, not being in a partnership/being unmarried, higher affect regarding COVID-19 and higher presumed severity with respect to COVID-19. Furthermore, more positive attitudes towards the reasonableness of costs were associated with having a migration background. More positive attitudes towards solidarity financing was associated with higher age groups. Mainly similar findings were observed in wave 16. Discussion Agreement with reasonableness of costs of preventative measures as well as solidarity financing was moderately high. Knowledge of these attitudes is important to ensure social cohesion during the fight against COVID-19.	[Hajek, Andre; Kretzler, Benedikt; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [De Bock, Freia] Fed Ctr Hlth Educ, Cologne, Germany; [Sprengholz, Philipp] Univ Erfurt, Dept Hlth Commun, Erfurt, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Erfurt	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Hlth Econ, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de		Hajek, Andre/0000-0002-6886-2745				Betsch C, 2020, LANCET, V395, P1255, DOI 10.1016/S0140-6736(20)30729-7; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Fineberg HV, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMe2007263; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; ifo Institute, 2021, IF I EC CONTR 66 PER; McKee M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1556; Munnich R, 2012, STICHPROBENOPTIMIERU; Reed S, 2020, VALUE HEALTH, V23, P1438, DOI 10.1016/j.jval.2020.07.003; Silverman M, 2020, CAN J PUBLIC HEALTH, V111, P462, DOI 10.17269/s41997-020-00396-1; Tepe M., 2020, PANDEMIC BALANCING A	10	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259451	10.1371/journal.pone.0259451	http://dx.doi.org/10.1371/journal.pone.0259451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739515	gold, Green Published			2022-12-26	WOS:000755000800034
J	Foliaki, ST; Race, B; Williams, K; Baune, C; Groveman, BR; Haigh, CL				Foliaki, Simote T.; Race, Brent; Williams, Katie; Baune, Chase; Groveman, Bradley R.; Haigh, Cathryn L.			Reduced SOD2 expression does not influence prion disease course or pathology in mice	PLOS ONE			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; CELL-DEATH; PROTEIN; SOD2(+/-); NEURONS; COPPER; MODEL; PROPAGATION; DEFICIENCY; APOPTOSIS	Prion diseases are progressive, neurodegenerative diseases affecting humans and animals. Also known as the transmissible spongiform encephalopathies, for the hallmark spongiform change seen in the brain, these diseases manifest increased oxidative damage early in disease and changes in antioxidant enzymes in terminal brain tissue. Superoxide dismutase 2 (SOD2) is an antioxidant enzyme that is critical for life. SOD2 knock-out mice can only be kept alive for several weeks post-birth and only with antioxidant therapy. However, this results in the development of a spongiform encephalopathy. Consequently, we hypothesized that reduced levels of SOD2 may accelerate prion disease progression and play a critical role in the formation of spongiform change. Using SOD2 heterozygous knock-out and litter mate wild-type controls, we examined neuronal long-term potentiation, disease duration, pathology, and degree of spongiform change in mice infected with three strains of mouse adapted scrapie. No influence of the reduced SOD2 expression was observed in any parameter measured for any strain. We conclude that changes relating to SOD2 during prion disease are most likely secondary to the disease processes causing toxicity and do not influence the development of spongiform pathology.	[Foliaki, Simote T.; Williams, Katie; Groveman, Bradley R.; Haigh, Cathryn L.] NIAID, Rocky Mt Labs, Prion Cell Biol Unit, Lab Persistent Viral Dis,NIH, Hamilton, MT 59840 USA; [Race, Brent; Baune, Chase] NIAID, Rocky Mt Labs, Vet Biol Unit, Lab Persistent Viral Dis,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Haigh, CL (corresponding author), NIAID, Rocky Mt Labs, Prion Cell Biol Unit, Lab Persistent Viral Dis,NIH, Hamilton, MT 59840 USA.	cathryn.haigh@nih.gov		Haigh, Cathryn/0000-0001-7591-1149; Baune, Chase/0000-0002-0157-7528				Akhtar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054454; Almomani R, 2020, J MED GENET, V57, P23, DOI 10.1136/jmedgenet-2019-106330; Andersen PM, 2019, NEW ENGL J MED, V381, P486, DOI 10.1056/NEJMc1905039; Andreassen OA, 2001, EXP NEUROL, V167, P189, DOI 10.1006/exnr.2000.7525; Asimakis GK, 2002, CIRCULATION, V105, P981, DOI 10.1161/hc0802.104502; Baur A, 2011, FREE RADICAL RES, V45, P550, DOI 10.3109/10715762.2011.555483; Boelsterli UA, 2008, DRUG DISCOV TODAY, V13, P982, DOI 10.1016/j.drudis.2008.08.002; Bourgognon JM, 2018, CELL DEATH DIFFER, V25, P1408, DOI 10.1038/s41418-018-0148-x; Brazier MW, 2008, FREE RADICAL BIO MED, V45, P184, DOI 10.1016/j.freeradbiomed.2008.04.006; Brazier MW, 2006, BRAIN RES BULL, V68, P346, DOI 10.1016/j.brainresbull.2005.09.010; Brown DR, 2001, J NEUROCHEM, V76, P69, DOI 10.1046/j.1471-4159.2001.00009.x; Carroll JA, 2018, J VIROL, V92, DOI 10.1128/JVI.00549-18; Carroll JA, 2017, J GEN VIROL, V98, P2190, DOI 10.1099/jgv.0.000876; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Choi SI, 1998, ACTA NEUROPATHOL, V96, P279, DOI 10.1007/s004010050895; Collins SJ, 2018, CELL MOL LIFE SCI, V75, P3231, DOI 10.1007/s00018-018-2790-3; Davies MJ, 2015, NEUROSCI LETT, V589, P138, DOI 10.1016/j.neulet.2015.01.053; Drew SC, 2011, J NEUROPATH EXP NEUR, V70, P143, DOI 10.1097/NEN.0b013e3182084a8c; Foliaki ST, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007712; Foliaki ST, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007214; Frau-Mendez MA, 2017, BRAIN PATHOL, V27, P95, DOI 10.1111/bpa.12408; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Frid K, 2020, NEUROBIOL AGING, V95, P231, DOI 10.1016/j.neurobiolaging.2020.07.030; Gasperini L, 2015, ANTIOXID REDOX SIGN, V22, P772, DOI 10.1089/ars.2014.6032; Guachalla LM, 2009, AGING-US, V1, P303, DOI 10.18632/aging.100030; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Haigh CL, 2015, CELL MOL LIFE SCI, V72, P1613, DOI 10.1007/s00018-014-1777-y; Haigh CL, 2011, FREE RADICAL BIO MED, V51, P594, DOI 10.1016/j.freeradbiomed.2011.03.035; Haigh CL, 2009, J CELL SCI, V122, P1518, DOI 10.1242/jcs.043604; Hinerfeld D, 2004, J NEUROCHEM, V88, P657, DOI 10.1046/j.1471-4159.2003.02195.x; Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lawson VA, 2010, ACS CHEM NEUROSCI, V1, P720, DOI 10.1021/cn100068x; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Pardo M, 2006, FREE RADICAL BIO MED, V41, P1795, DOI 10.1016/j.freeradbiomed.2006.08.027; Park FH, 2019, BRAIN, V142, P2230, DOI 10.1093/brain/awz182; Park JH, 2011, HIPPOCAMPUS, V21, P319, DOI 10.1002/hipo.20753; Race B, 2020, NEUROBIOL DIS, V144, DOI 10.1016/j.nbd.2020.105057; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Scheurmann J, 2014, ARCH DERMATOL RES, V306, P143, DOI 10.1007/s00403-013-1389-7; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Sinclair L, 2013, DIS MODEL MECH, V6, P952, DOI 10.1242/dmm.010678; Sorce S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004531; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Watt NT, 2007, FREE RADICAL BIO MED, V43, P959, DOI 10.1016/j.freeradbiomed.2007.06.004; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259597	10.1371/journal.pone.0259597	http://dx.doi.org/10.1371/journal.pone.0259597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735539	Green Published, gold			2022-12-26	WOS:000755077100098
J	Alvarez, AF; Rodriguez, C; Gonzalez-Chavez, R; Georgellis, D				Alvarez, Adrian F.; Rodriguez, Claudia; Gonzalez-Chavez, Ricardo; Georgellis, Dimitris			The Escherichia coli two-component signal sensor BarA binds protonated acetate via a conserved hydrophobic-binding pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL REGULATOR CSRA; HISTIDINE KINASE; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; RNA RECOGNITION; I-TASSER; DOMAIN; IDENTIFICATION; SYSTEM; FAMILY	The BarA/UvrY two-component signal transduction system is widely conserved in gamma-proteobacteria and provides a link between the metabolic state of the cells and the Csr post-transcriptional regulatory system. In Escherichia coli, the BarA/UvrY system responds to the presence of acetate and other short-chain carboxylic acids by activating transcription of the noncoding RNAs, CsrB and CsrC, which sequester the RNA-binding protein CsrA, a global regulator of gene expression. However, the state of the carboxyl group in the acetate molecule, which serves as the BarA stimulus, and the signal reception site of BarA remain unknown. In this study, we show that the deletion or replacement of the periplasmic domain of BarA and also the substitution of certain hydroxylated and hydrophobic amino acid residues in this region, result in a sensor kinase that remains unresponsive to its physiological stimulus, demonstrating that the periplasmic region of BarA constitutes a functional detector domain. Moreover, we provide evidence that the protonated state of acetate or formate serves as the physiological stimulus of BarA. In addition, modeling of the BarA sensor domain and prediction of the signal-binding site, by blind molecular docking, revealed a calcium channels and chemotaxis receptors domain with a conserved binding pocket, which comprised uncharged polar and hydrophobic amino acid residues. Based on the comparative sequence and phylogenetic analyses, we propose that, at least, two types of BarA orthologues diverged and evolved separately to acquire distinct signal-binding properties, illustrating the wide adaptability of the bacterial sensor kinase proteins.	[Alvarez, Adrian F.; Rodriguez, Claudia; Gonzalez-Chavez, Ricardo; Georgellis, Dimitris] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Georgellis, D (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City, DF, Mexico.	dimitris@ifc.unam.mx	Alvarez, Adrian F./L-4656-2019	Alvarez, Adrian F./0000-0003-4381-5691; Gonzalez-Chavez, Ricardo/0000-0002-2660-7244	Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM) [IN208721, IN207921]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [140614, 514856]	Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants IN208721 (A. F. A.) and IN207921 (D. G.) from the Direccion General de Asuntos del Personal Academico (DGAPA), Universidad Nacional Autonoma de Mexico (UNAM), and 140614 (A. F. A.) and 514856 (D. G.) from the Consejo Nacional de Ciencia y Tecnologia (CONACyT). The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	Ali-Ahmad A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11361-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ancona V, 2016, SCI REP-UK, V6, DOI 10.1038/srep37195; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Butz HA, 2021, MBIO, V12, DOI 10.1128/mBio.03380-20; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Figueroa-Bossi N, 2014, GENE DEV, V28, P1239, DOI 10.1101/gad.240192.114; Gerharz T, 2003, BIOCHEMISTRY-US, V42, P5917, DOI 10.1021/bi0340595; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Heroven AK, 2012, RNA BIOL, V9, P379, DOI 10.4161/rna.19333; Huertas-Rosales O, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.624061; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; Kinoshita-Kikuta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148294; Kneuper H, 2005, J BIOL CHEM, V280, P20596, DOI 10.1074/jbc.M502015200; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kwon O, 2000, J BACTERIOL, V182, P2960, DOI 10.1128/JB.182.10.2960-2966.2000; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Liu J, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.637595; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Liu Y, 2020, ACTA PHARMACOL SIN, V41, P138, DOI 10.1038/s41401-019-0228-6; Miller JH., 1972, EXPT MOL GENETICS; Mondragon V, 2006, J BACTERIOL, V188, P8303, DOI 10.1128/JB.01052-06; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Pokkuluri PR, 2013, MICROBIOLOGYOPEN, V2, P766, DOI 10.1002/mbo3.112; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Pourciau C, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.601352; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; Sobrero PM, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00127; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Upadhyay AA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004862; Vazquez-Ciros OJ, 2020, P NATL ACAD SCI USA, V117, P33530, DOI 10.1073/pnas.2006209117; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zere TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145035; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	66	3	3	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101383	10.1016/j.jbc.2021.101383	http://dx.doi.org/10.1016/j.jbc.2021.101383			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34743001	Green Published, gold			2022-12-26	WOS:000748084900012
J	Chavali, SS; Mali, SM; Bonn, R; Anitha, AS; Bennett, RP; Smith, HC; Fasan, R; Wedekind, JE				Chavali, Sai Shashank; Mali, Sachitanand M.; Bonn, Rachel; Anitha, Abhijith Saseendran; Bennett, Ryan P.; Smith, Harold C.; Fasan, Rudi; Wedekind, Joseph E.			Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; POLYMERASE-II TRANSCRIPTION; CARBOXYL-TERMINAL DOMAIN; TAR RNA; INTRACELLULAR DELIVERY; ELONGATION-FACTOR; FUSION INHIBITOR; GROWTH-HORMONE; BINDING; DISCOVERY	RNA represents a potential target for new antiviral therapies, which are urgently needed to address public health threats such as the human immunodeficiency virus (HIV). We showed previously that the interaction between the viral Tat protein and the HIV-1 trans-activation response (TAR) RNA was blocked by TB-CP-6.9a. This cyclic peptide was derived from a TAR-binding loop that emerged during lab evolution of a TAR-binding protein (TBP) family. Here we synthesized and characterized a next-generation, cyclic-peptide library based on the TBP scaffold. We sought to identify conserved RNA-binding interactions and the influence of cyclization linkers on RNA binding and antiviral activity. A diverse group of cyclization linkers, encompassing disulfide bonds to bicyclic aromatic staples, was used to restrain the cyclic peptide geometry. Thermodynamic profiling revealed specific arginine-rich sequences with low to submicromolar affinity driven by enthalpic and entropic contributions. The best compounds exhibited no appreciable off-target binding to related molecules, such as BIV TAR and human 7SK RNAs. A specific arginine-to-lysine change in the highest affinity cyclic peptide reduced TAR binding by tenfold, suggesting that TBP-derived cyclic peptides use an arginine-fork motif to recognize the TAR major groove while differentiating the mode of binding from other TAR-targeting molecules. Finally, we showed that HIV infectivity in cell culture was reduced in the presence of cyclic peptides constrained by methylene or naphthalene-based linkers. Our findings provide insight into the molecular determinants required for HIV-1 TAR recognition and antiviral activity. These findings are broadly relevant to the development of antivirals that target RNA molecules.	[Chavali, Sai Shashank; Bonn, Rachel; Smith, Harold C.; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Chavali, Sai Shashank; Bonn, Rachel; Smith, Harold C.; Wedekind, Joseph E.] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA; [Mali, Sachitanand M.; Anitha, Abhijith Saseendran; Fasan, Rudi] Univ Rochester, Dept Chem, Rochester, NY 14642 USA; [Bennett, Ryan P.; Smith, Harold C.] OyaGen Inc, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester	Wedekind, JE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.; Wedekind, JE (corresponding author), Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA.; Fasan, R (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14642 USA.	rudi.fasan@rochester.edu; joseph.wedekind@rochester.edu		Wedekind, Joseph/0000-0002-4269-4229; Chavali, Sai Shashank/0000-0002-3467-2257	National Institutes of Health [T32 GM135134, R01 AI150463, R01 GM134076]; Elon Huntington Hooker graduate fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elon Huntington Hooker graduate fellowship	This work was supported in part by National Institutes of Health grant R01 AI150463 (J. E. W.) and grant R01 GM134076 (R. F.). R. B. was supported in part from National Institutes of Health training grant T32 GM135134 and an Elon Huntington Hooker graduate fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anokhina VS, 2019, BIOORGAN MED CHEM, V27, P2972, DOI 10.1016/j.bmc.2019.05.009; Assem N, 2015, ANGEW CHEM INT EDIT, V54, P8665, DOI 10.1002/anie.201502607; Bannwarth S, 2005, CURR HIV RES, V3, P61, DOI 10.2174/1570162052772924; Belashov IA, 2018, NUCLEIC ACIDS RES, V46, P6401, DOI 10.1093/nar/gky529; Blose JM, 2009, J AM CHEM SOC, V131, P8474, DOI 10.1021/ja900065e; Blount KF, 2015, ANTIMICROB AGENTS CH, V59, P5736, DOI 10.1128/AAC.01282-15; Bock JE, 2013, ACS CHEM BIOL, V8, P488, DOI 10.1021/cb300515u; Bradrick TD, 2004, RNA, V10, P1459, DOI 10.1261/rna.7620304; Brodsky AS, 1997, J MOL BIOL, V267, P624, DOI 10.1006/jmbi.1996.0879; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Buckton LK, 2021, CHEM-EUR J, V27, P1487, DOI 10.1002/chem.201905385; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Campagne S, 2019, NAT CHEM BIOL, V15, P1191, DOI 10.1038/s41589-019-0384-5; Chavali SS, 2020, J BIOL CHEM, V295, P16470, DOI 10.1074/jbc.RA120.015444; Chavali SS, 2020, J AM CHEM SOC, V142, P19835, DOI 10.1021/jacs.0c09689; Chavali SS, 2019, J BIOL CHEM, V294, P9326, DOI 10.1074/jbc.REV119.006860; Choi JS, 2020, BIOMOL THER, V28, P18, DOI 10.4062/biomolther.2019.082; Christie M, 2014, J PHARM SCI-US, V103, P128, DOI 10.1002/jps.23794; Connelly CM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09493-3; Crawford DW, 2016, ACS CHEM BIOL, V11, P2206, DOI 10.1021/acschembio.6b00145; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; Davidson A, 2009, P NATL ACAD SCI USA, V106, P11931, DOI 10.1073/pnas.0900629106; Davila-Calderon J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18594-3; Davis HE, 2002, BIOPHYS CHEM, V97, P159, DOI 10.1016/S0301-4622(02)00057-1; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; DINGWALL C, 1989, P NATL ACAD SCI USA, V86, P6925, DOI 10.1073/pnas.86.18.6925; DINGWALL C, 1990, EMBO J, V9, P4145, DOI 10.1002/j.1460-2075.1990.tb07637.x; Dougherty PG, 2019, CHEM REV, V119, P10241, DOI 10.1021/acs.chemrev.9b00008; Foley B. T., 2018, HIV SEQUENCE COMPEND, DOI 10.2172/1458915; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Fradkin AH, 2009, J PHARM SCI-US, V98, P3247, DOI 10.1002/jps.21834; Freire E, 2009, CHEM BIOL DRUG DES, V74, P468, DOI 10.1111/j.1747-0285.2009.00880.x; Gang D, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110557; Ganser LR, 2018, NAT STRUCT MOL BIOL, V25, P425, DOI 10.1038/s41594-018-0062-4; Germain-Desprez D, 2001, GENE, V279, P109, DOI 10.1016/S0378-1119(01)00758-2; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hamy F, 1997, P NATL ACAD SCI USA, V94, P3548, DOI 10.1073/pnas.94.8.3548; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Hilimire TA, 2017, ACS CHEM BIOL, V12, P1674, DOI 10.1021/acschembio.7b00052; Hill TA, 2014, ANGEW CHEM INT EDIT, V53, P13020, DOI 10.1002/anie.201401058; Howe JA, 2016, RNA BIOL, V13, P946, DOI 10.1080/15476286.2016.1216304; Huthoff H, 2001, NUCLEIC ACIDS RES, V29, P2594, DOI 10.1093/nar/29.12.2594; Iannuzzelli JA, 2020, CHEM SCI, V11, P6202, DOI 10.1039/d0sc01699c; Isel C, 1999, J MOL BIOL, V290, P929, DOI 10.1006/jmbi.1999.2933; Jamjian MC, 2004, AM J HEALTH-SYST PH, V61, P1242, DOI 10.1093/ajhp/61.12.1242; Jiang BS, 2015, J MED CHEM, V58, P6306, DOI 10.1021/acs.jmedchem.5b00411; Kalafatovic D, 2017, MOLECULES, V22, DOI 10.3390/molecules22111929; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Kim YK, 2002, MOL CELL BIOL, V22, P4622, DOI 10.1128/MCB.22.13.4622-4637.2002; Kourra CMBK, 2016, CHEM SCI, V7, P7007, DOI 10.1039/c6sc02285e; Kubi GA, 2018, ANGEW CHEM INT EDIT, V57, P17183, DOI 10.1002/anie.201811940; Lalonde MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002038; Lee ER, 2009, RNA BIOL, V6, P187, DOI 10.4161/rna.6.2.7727; Lian WL, 2014, J AM CHEM SOC, V136, P9830, DOI 10.1021/ja503710n; Lippa Geoffrey M, 2012, Methods Mol Biol, V848, P159, DOI 10.1007/978-1-61779-545-9_11; Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v; Lonn Peter, 2014, J Control Release, V190, P56; Marcheschi RJ, 2011, ACS CHEM BIOL, V6, P857, DOI 10.1021/cb200082d; Martinez-Zapien D, 2017, NUCLEIC ACIDS RES, V45, P3568, DOI 10.1093/nar/gkw1351; Missra A, 2010, P NATL ACAD SCI USA, V107, P11301, DOI 10.1073/pnas.1000681107; Mousa R, 2018, CHEM SCI, V9, P4814, DOI 10.1039/c8sc01110a; Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Orlovsky NI, 2020, J AM CHEM SOC, V142, P907, DOI 10.1021/jacs.9b10535; Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217; Patel IH, 2005, CLIN PHARMACOKINET, V44, P175, DOI 10.2165/00003088-200544020-00003; Patwardhan NN, 2017, MEDCHEMCOMM, V8, P1022, DOI [10.1039/C6MD00729E, 10.1039/c6md00729e]; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pham VV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06591-6; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PUGLISI JD, 1995, SCIENCE, V270, P1200, DOI 10.1126/science.270.5239.1200; Qian ZQ, 2016, BIOCHEMISTRY-US, V55, P2601, DOI 10.1021/acs.biochem.6b00226; Qian ZQ, 2015, ANGEW CHEM INT EDIT, V54, P5874, DOI 10.1002/anie.201411594; Qian ZQ, 2014, BIOCHEMISTRY-US, V53, P4034, DOI 10.1021/bi5004102; Qian ZQ, 2013, ACS CHEM BIOL, V8, P423, DOI 10.1021/cb3005275; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; ROY S, 1990, GENE DEV, V4, P1365, DOI 10.1101/gad.4.8.1365; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Schulze-Gahmen U, 2018, P NATL ACAD SCI USA, V115, P12973, DOI 10.1073/pnas.1806438115; Sengupta S, 2018, IMMUNITY, V48, P872, DOI 10.1016/j.immuni.2018.04.030; Sheridan C, 2021, NAT BIOTECHNOL, V39, P6, DOI 10.1038/s41587-020-00788-1; Shortridge MD, 2019, NUCLEIC ACIDS RES, V47, P1523, DOI 10.1093/nar/gky1197; Srivastava Y, 2021, CRYSTALS, V11, DOI 10.3390/cryst11030273; Stanzl EG, 2013, ACCOUNTS CHEM RES, V46, P2944, DOI 10.1021/ar4000554; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Sukosd Z, 2015, NUCLEIC ACIDS RES, V43, P10168, DOI 10.1093/nar/gkv1039; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Tran B, 2020, CELL CHEM BIOL, V27, P1241, DOI 10.1016/j.chembiol.2020.07.021; Trinh TB, 2016, ACS COMB SCI, V18, P75, DOI 10.1021/acscombsci.5b00164; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Turpin JA, 1998, ANTIMICROB AGENTS CH, V42, P487, DOI 10.1128/AAC.42.3.487; Umuhire AC, 2021, SOL PHYS, V296, DOI 10.1007/s11207-020-01743-8; Usach I, 2019, ADV THER, V36, P2986, DOI 10.1007/s12325-019-01101-6; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Wright LR, 2003, CURR PROTEIN PEPT SC, V4, P105, DOI 10.2174/1389203033487252; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Ye XM, 1995, CHEM BIOL, V2, P827, DOI 10.1016/1074-5521(95)90089-6; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou Y, 2008, BLOOD, V112, P2474, DOI 10.1182/blood-2007-12-130211	107	2	2	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101390	10.1016/j.jbc.2021.101390	http://dx.doi.org/10.1016/j.jbc.2021.101390			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34767799	Green Published, gold			2022-12-26	WOS:000748084900010
J	Gerassimovich, YA; Miladinovski-Bangall, SJ; Bridges, KM; Boateng, L; Ball, LE; Valafar, H; Nag, A				Gerassimovich, Yevgeniy A.; Miladinovski-Bangall, Samantha J.; Bridges, Kaitlin M.; Boateng, Linkel; Ball, Lauren E.; Valafar, Homayoun; Nag, Anita			Proximity-dependent biotinylation detects associations between SARS coronavirus nonstructural protein 1 and stress granule-associated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOST GENE-EXPRESSION; BIOTIN LIGASE; NSP1; TRANSLATION; INSIGHTS; IDENTIFICATION; INHIBITION; PROTEOME	The nonstructural protein 1 (nsp1) of severe acute respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus 2 is a critical viral protein that suppresses host gene expression by blocking the assembly of the ribosome on host mRNAs. To understand the mechanism of inhibition of host gene expression, we sought to identify cellular proteins that interact with nsp1. Using proximity-dependent biotinylation followed by proteomic analyses of biotinylated proteins, here we captured multiple dynamic interactions of nsp1 with host cell proteins. In addition to ribosomal proteins, we identified several pre-mRNA processing proteins that interact with nsp1, including splicing factors and transcription termination proteins, as well as exosome, and stress granule (SG)-associated proteins. We found that the interactions with transcription termination factors are primarily governed by the C-terminal region of nsp1 and are disrupted by the mutation of amino acids K164 and H165 that are essential for its host shutoff function. We further show that nsp1 interacts with Ras GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) and colocalizes with G3BP1 in SGs under sodium arsenite-induced stress. Finally, we observe that the presence of nsp1 disrupts the maturation of SGs over a long period. Isolation of SG core at different times shows a gradual loss of G3BP1 in the presence of nsp1.	[Gerassimovich, Yevgeniy A.; Miladinovski-Bangall, Samantha J.; Bridges, Kaitlin M.; Nag, Anita] Univ South Carolina Upstate, Nat Sci & Engn, Spartanburg, SC 29303 USA; [Boateng, Linkel; Valafar, Homayoun] Univ South Carolina, Dept Comp Sci & Engn, Columbia, SC USA; [Ball, Lauren E.] Med Univ South Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Nag, A (corresponding author), Univ South Carolina Upstate, Nat Sci & Engn, Spartanburg, SC 29303 USA.	anitan@uscupstate.edu	Gerassimovich, Yevgeniy/AHA-5849-2022	Nag, Anita/0000-0003-0622-8535; Miladinovski, Samantha/0000-0002-1144-709X; Ball, Lauren/0000-0001-6780-1679	Student Assistantship program (the University of South Carolina Upstate); Magellan Award (the University of South Carolina); RISE award; UofSC VPR COVID-19 Initiative award; National Institutes of Health [S10OD025126, P20GM103542]; National Institute of General Medical Sciences of the National Institute of Health [P20GM103499]	Student Assistantship program (the University of South Carolina Upstate); Magellan Award (the University of South Carolina); RISE award; UofSC VPR COVID-19 Initiative award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding and additional information-Y. A. G. and S. J. M.-B. were supported by the Student Assistantship program (the University of South Carolina Upstate) ; Y. A. G. was also supported by the Magellan Award (the University of South Carolina) ; A. N. was supported by the RISE award; A. N. and H. V. were supported by the UofSC VPR COVID-19 Initiative award. The Mass Spectrometry Facility was supported by the National Institutes of Health: S10OD025126 (Orbitrap Fusion Lumos ETD MS) and P20GM103542. The research reported in this publication was partially supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number P20GM103499. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almeida MS, 2006, J BIOMOL NMR, V36, P46, DOI 10.1007/s10858-006-9018-9; Almeida MS, 2007, J VIROL, V81, P3151, DOI 10.1128/JVI.01939-06; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Clark LK, 2021, J VIROL, V95, DOI 10.1128/JVI.02019-20; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Gao B, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008690; Gaucherand L, 2019, CELL REP, V27, P776, DOI 10.1016/j.celrep.2019.03.063; Gomez GN, 2019, BIOCHEM CELL BIOL, V97, P758, DOI 10.1139/bcb-2018-0394; Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Gupta R, 2020, J BIOL CHEM, V295, P11742, DOI 10.1074/jbc.RA120.014873; Hartenian E, 2020, J BIOL CHEM, V295, P12910, DOI 10.1074/jbc.REV120.013930; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hockney R. W., 1988, COMPUTER SIMULATION, P564; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Jauregui AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062416; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Khong A, 2018, METHODS, V137, P49, DOI 10.1016/j.ymeth.2017.11.012; Khong A, 2017, MOL CELL, V68, P808, DOI 10.1016/j.molcel.2017.10.015; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Kim DI, 2016, METHODS MOL BIOL, V1411, P133, DOI 10.1007/978-1-4939-3530-7_8; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; May DG, 2019, METHODS MOL BIOL, V2008, P83, DOI 10.1007/978-1-4939-9537-0_7; McCormick C, 2017, NAT REV IMMUNOL, V17, P647, DOI 10.1038/nri.2017.63; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; McInerney GM, 2015, DNA CELL BIOL, V34, P557, DOI 10.1089/dna.2015.2957; Mehus AA, 2016, METHOD ENZYMOL, V569, P3, DOI 10.1016/bs.mie.2015.08.008; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Nag A, 2007, NAT STRUCT MOL BIOL, V14, P662, DOI 10.1038/nsmb1253; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Panas MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004659; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Poblete-Duran N, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8070180; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Sevajol M, 2014, VIRUS RES, V194, P90, DOI 10.1016/j.virusres.2014.10.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; So BR, 2019, MOL CELL, V76, P590, DOI 10.1016/j.molcel.2019.08.007; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Tsai WC, 2014, ANNU REV VIROL, V1, P147, DOI 10.1146/annurev-virology-031413-085505; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; V'kovski P, 2020, METHODS MOL BIOL, V2203, P187, DOI 10.1007/978-1-0716-0900-2_14; V'kovski P, 2019, ELIFE, V8, DOI 10.7554/eLife.42037; von Brunn A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000459; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; White JP, 2011, J VIROL, V85, P12442, DOI 10.1128/JVI.05888-11; Yang XD, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-018-0068-4; Zhang K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7386; Zhang L, 2010, J VIROL, V84, P6050, DOI 10.1128/JVI.00213-10; Zheng Zhou-Qin, 2021, Cell Discov, V7, P38, DOI 10.1038/s41421-021-00275-0	67	4	4	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101399	10.1016/j.jbc.2021.101399	http://dx.doi.org/10.1016/j.jbc.2021.101399			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774526	gold, Green Published			2022-12-26	WOS:000748397200011
J	Maitz, A; Haussner, F; Braumuller, S; Hoffmann, A; Lupu, L; Wachter, U; Radermacher, P; Braun, CK; Wilke, HJ; Vogt, M; Ignatius, A; Halbgebauer, R; Bettac, L; Barth, TFE; Huber-Lang, M; Palmer, A				Maitz, Alexander; Haussner, Felix; Braumueller, Sonja; Hoffmann, Andrea; Lupu, Ludmila; Wachter, Ulrich; Radermacher, Peter; Braun, Christian K.; Wilke, Hans-Joachim; Vogt, Morten; Ignatius, Anita; Halbgebauer, Rebecca; Bettac, Lucas; Barth, Thomas F. E.; Huber-Lang, Markus; Palmer, Annette			Temporal-spatial organ response after blast-induced experimental blunt abdominal trauma	FASEB JOURNAL			English	Article						abdominal trauma; damage; organs	SERUM AMYLASE; INJURY; MANAGEMENT; DIAGNOSIS; GENDER	Abdominal trauma (AT) is of major global importance, particularly with the increased potential for civil, terroristic, and military trauma. The injury pattern and systemic consequences of blunt abdominal injuries are highly variable and frequently underestimated or even missed, and the pathomechanisms remain still poorly understood. Therefore, we investigated the temporal-spatial organ and immune response after a standardized blast-induced blunt AT. Anesthetized mice were exposed to a single blast wave centered on the epigastrium. At 2, 6, or 24 h after trauma, abdominal organ damage was assessed macroscopically, microscopically, and biochemically. A higher degree of trauma severity, determined by a reduction of the distance between the epigastrium and blast inductor, was reflected by a reduced survival rate. The hemodynamic monitoring during the first 120 min after AT revealed a decline in the mean arterial pressure within the first 80 min, whereas the heart rate remained quite stable. AT induced a systemic damage and inflammatory response, evidenced by elevated HMGB-1 and IL-6 plasma levels. The macroscopic injury pattern of the abdominal organs (while complex) was consistent, with the following frequency: liver > pancreas > spleen > left kidney > intestine > right kidney > others > lungs and was reflected by microscopic liver and pancreas damages. Plasma levels of organ dysfunction markers increased during the first 6 h after AT and subsequently declined, indicating an early, temporal impairment of the function on a multi-organ level. The established highly reproducible murine blunt AT, with time- and trauma-severity-dependent organ injury patterns, systemic inflammatory response, and impairment of various organ functions, reflects characteristics of human AT. In the future, this model may help to study the complex immuno-pathophysiological consequences and innovative therapeutic approaches after blunt AT.	[Maitz, Alexander; Haussner, Felix; Braumueller, Sonja; Lupu, Ludmila; Halbgebauer, Rebecca; Huber-Lang, Markus; Palmer, Annette] Ulm Univ Med Ctr, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany; [Hoffmann, Andrea; Wachter, Ulrich; Radermacher, Peter] Ulm Univ Med Ctr, Inst Anesthesiol Pathophysiol & Proc Engn, Ulm, Germany; [Braun, Christian K.] Ulm Univ Med Ctr, Dept Pediat & Adolescent Med, Ulm, Germany; [Wilke, Hans-Joachim; Vogt, Morten; Ignatius, Anita] Ulm Univ Med Ctr, Inst Orthoped Res & Biomech, Ulm, Germany; [Bettac, Lucas] Ulm Univ Med Ctr, Dept Internal Med, Ulm, Germany; [Barth, Thomas F. E.] Ulm Univ Med Ctr, Inst Pathol, Ulm, Germany	Ulm University; Ulm University; Ulm University; Ulm University; Ulm University; Ulm University	Palmer, A (corresponding author), Ulm Univ Med Ctr, Inst Clin & Expt Trauma Immunol, Helmholtzstr 8-1, D-89081 Ulm, Germany.	annette.palmer@uniklinik-ulm.de	Braun, Christian K/I-5132-2018; Wilke, Hans-Joachim/M-6440-2014; Ignatius, Anita/M-6012-2013	Braun, Christian K/0000-0002-9854-3251; Wilke, Hans-Joachim/0000-0001-6007-8844; Ignatius, Anita/0000-0002-4782-1979; Lupu, Ludmila/0000-0002-0153-9345	German Research Foundation (DFG) [CRC1149, INST 40/479-2, INST 40/498-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	German Research Foundation (DFG; CRC1149) INST 40/479-2 and INST 40/498-2	Bala M, 2008, ANN SURG, V248, P303, DOI 10.1097/SLA.0b013e318180a3f7; Barkai O, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4353-6; Beltzer C, 2020, CHIRURG, V91, P567, DOI 10.1007/s00104-020-01158-y; Bouzat P, 2020, ANAESTH CRIT CARE PA, V39, P269, DOI 10.1016/j.accpm.2019.12.001; Brenner M, 2018, EMERG MED CLIN N AM, V36, P149, DOI 10.1016/j.emc.2017.08.012; BUECHTER KJ, 1990, AM SURGEON, V56, P204; Callahan Katherine, 2018, Acad Forensic Pathol, V8, P219, DOI 10.1177/1925362118782047; Cirocchi R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007438.pub3; Cortellini S, 2018, VET REC, V182, P228, DOI 10.1136/vr.k866; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Ferrah N, 2019, WORLD J SURG, V43, P1216, DOI 10.1007/s00268-018-04899-4; Gable A, 2019, RADIOLOGE, V59, P139, DOI 10.1007/s00117-018-0485-2; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Harmston C, 2018, EUR J TRAUMA EMERG S, V44, P369, DOI 10.1007/s00068-018-0902-2; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Jurkovich GJ, 2020, J TRAUMA ACUTE CARE, V88, P19, DOI 10.1097/TA.0000000000002546; Kamo N, 2013, HEPATOLOGY, V58, P351, DOI 10.1002/hep.26320; Karamercan MA, 2011, J TRAUMA, V71, P687, DOI 10.1097/TA.0b013e31820932bf; Kuza CM, 2020, SCAND J SURG, V109, P193, DOI 10.1177/1457496919851608; Mors K, 2016, IMMUNOBIOLOGY, V221, P904, DOI 10.1016/j.imbio.2016.03.005; Odedra D, 2020, CAN ASSOC RADIOL J, V71, P344, DOI 10.1177/0846537119888383; Osaka T, 2017, CAN J PHYSIOL PHARM, V95, P652, DOI 10.1139/cjpp-2016-0195; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Prachalias AA, 2014, CURR OPIN CRIT CARE, V20, P218, DOI 10.1097/MCC.0000000000000074; Qin H, 2020, MIL MED, V185, pE742, DOI 10.1093/milmed/usz372; Sambasivan CN, 2010, J TRAUMA, V69, pS168, DOI 10.1097/TA.0b013e3181e45cef; SIEKMANN L, 1985, J CLIN CHEM CLIN BIO, V23, P137; Singh RP., 2016, J CLIN DIAGN RES, V10, pC20; Smith IM, 2015, ANN SURG, V262, P389, DOI 10.1097/SLA.0000000000001002; Smith-Palmer T, 2002, J CHROMATOGR B, V781, P93, DOI 10.1016/S1570-0232(02)00617-7; Sun KX, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e729; Takishima T, 1997, ANN SURG, V226, P70, DOI 10.1097/00000658-199707000-00010; Tornqvist E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101638; VONGIERKE HE, 1968, ANN NY ACAD SCI, V152, P172; Voth M, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0267-9; Yagi M, 2020, SURGERY, V167, P638, DOI 10.1016/j.surg.2019.09.024; Yu YYR, 2018, J PEDIATR SURG, V53, P1028, DOI 10.1016/j.jpedsurg.2018.02.043; Zhao C, 2014, J TRAUMA ACUTE CARE, V76, P1222, DOI 10.1097/TA.0000000000000220; Zimmermann P, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023057	40	3	3	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22038	10.1096/fj.202100995R	http://dx.doi.org/10.1096/fj.202100995R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748229				2022-12-26	WOS:000722321300002
J	Ninkina, N; Millership, SJ; Peters, OM; Connor-Robson, N; Chaprov, K; Kopylov, AT; Montoya, A; Kramer, H; Withers, DJ; Buchman, VL				Ninkina, Natalia; Millership, Steven J.; Peters, Owen M.; Connor-Robson, Natalie; Chaprov, Kirill; Kopylov, Arthur T.; Montoya, Alex; Kramer, Holger; Withers, Dominic J.; Buchman, Vladimir L.			beta-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACKING ALPHA-SYNUCLEIN; MICE LACKING; GAMMA-SYNUCLEIN; MONOAMINE TRANSPORTER; NIGROSTRIATAL SYSTEM; NEUROTOXICITY; INACTIVATION; RESISTANCE; BEHAVIOR; REVEALS	Synucleins, a family of three proteins highly expressed in neurons, are predominantly known for the direct involvement of alpha-synuclein in the etiology and pathogenesis of Parkinson's and certain other neurodegenerative diseases, but their precise physiological functions are still not fully understood. Previous studies have demonstrated the importance of alpha-synuclein as a modulator of various mechanisms implicated in chemical neurotransmission, but information concerning the involvement of other synuclein family members, beta-synuclein and gamma-synuclein, in molecular processes within presynaptic terminals is limited. Here, we demonstrated that the vesicular monoamine transporter 2-dependent dopamine uptake by synaptic vesicles isolated from the striatum of mice lacking beta-synuclein is significantly reduced. Reciprocally, reintroduction, either in vivo or in vitro, of beta-synuclein but not alpha-synuclein or gamma-synuclein improves uptake by triple alpha/beta/gamma-synuclein-deficient striatal vesicles. We also showed that the resistance of dopaminergic neurons of the substantia nigra pars compacta to subchronic administration of the Parkinson's disease-inducing prodrug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine depends on the presence of beta-synuclein but only when one or both other synucleins are absent. Furthermore, proteomic analysis of synuclein-deficient synaptic vesicles versus those containing only beta-synuclein revealed differences in their protein compositions. We suggest that the observed potentiation of dopamine uptake by beta-synuclein might be caused by different protein architecture of the synaptic vesicles. It is also feasible that such structural changes improve synaptic vesicle sequestration of 1-methyl-4-phenylpyridinium, a toxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which would explain why dopaminergic neurons expressing beta-synuclein and lacking alpha-synuclein and/or gamma-synuclein are resistant to this neurotoxin.	[Ninkina, Natalia; Millership, Steven J.; Peters, Owen M.; Connor-Robson, Natalie; Chaprov, Kirill; Buchman, Vladimir L.] Cardiff Univ, Sch Biosci, Cardiff, Wales; [Ninkina, Natalia; Chaprov, Kirill; Buchman, Vladimir L.] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia; [Millership, Steven J.; Montoya, Alex; Kramer, Holger; Withers, Dominic J.] MRC London Inst Med Sci, Metab Signalling, London, England; [Millership, Steven J.; Withers, Dominic J.] Imperial Coll London, Fac Med, Inst Clin Sci, London, England; [Kopylov, Arthur T.] Inst Biomed Chem, Dept Prote Res & Mass Spectrometry, Moscow, Russia; [Millership, Steven J.] Imperial Coll London, Dept Metab Digest & Reprod, Du Cane Rd, London W12 0NN, England	Cardiff University; Russian Academy of Sciences; Institute of Physiologically Active Compounds of the Russian Academy of Sciences; Imperial College London; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Imperial College London	Buchman, VL (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, Wales.; Buchman, VL (corresponding author), Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka, Russia.	buchmanvl@cf.ac.uk	Chaprov, Kirill/P-9892-2017; Kopylov, Arthur/E-3288-2012; Buchman, Vladimir L/A-4814-2010	Chaprov, Kirill/0000-0002-0258-1879; Kopylov, Arthur/0000-0002-7199-372X; Buchman, Vladimir L/0000-0002-7631-8352	Russian Science Foundation [19-14-00064]; Wellcome Trust [075615/Z/04/z]; Medical Research Council [MC-A654-5QB40]; Imperial College/Wellcome Trust ISSF Springboard Fellowship [PS3619_WREC]; Society for Endocrinology Early Career Grant [WREC_P93206]; Russian Federation Fundamental Research Program	Russian Science Foundation(Russian Science Foundation (RSF)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Imperial College/Wellcome Trust ISSF Springboard Fellowship; Society for Endocrinology Early Career Grant; Russian Federation Fundamental Research Program	Studies of dopamine uptake were supported by the Russian Science Foundation (grant: 19-14-00064) to V. L. B. This work was also supported in part by The Wellcome Trust (program grant: 075615/Z/04/z) to V. L. B. and Russian Federation Fundamental Research Program for 2021 to 2030 to A. T. K. Funding from the Medical Research Council (MC-A654-5QB40) was received by D. J. W. S. J. M. was supported by an Imperial College/Wellcome Trust ISSF Springboard Fellowship (PS3619_WREC) and a Society for Endocrinology Early Career Grant (WREC_P93206).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Al-Wandi A, 2010, NEUROBIOL AGING, V31, P796, DOI 10.1016/j.neurobiolaging.2008.11.001; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Bachurin SO, 1996, NEUROTOXICOLOGY, V17, P897; Bras IC, 2020, J NEUROCHEM, V153, P433, DOI 10.1111/jnc.14965; Bras J, 2021, ACTA NEUROPATHOL, V141, P471, DOI 10.1007/s00401-020-02202-1; Burre J, 2007, J NEUROCHEM, V101, P1448, DOI 10.1111/j.1471-4159.2007.04453.x; Burre J, 2006, PROTEOMICS, V6, P6250, DOI 10.1002/pmic.200600357; Burre J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024091; Carnazza K.E., 2020, BETA GAMMA SYNUCLEIN, DOI [10.1101/2020.11.19.390419, DOI 10.1101/2020.11.19.390419]; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Connor-Robson N, 2016, NEUROBIOL AGING, V46, P107, DOI 10.1016/j.neurobiolaging.2016.06.020; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Holtje M, 2000, J NEUROSCI, V20, P2131; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Kopylov AT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76689-9; Kopylov AT, 2020, MOLECULES, V25, DOI 10.3390/molecules25030619; Krantz DE, 1997, J BIOL CHEM, V272, P6752, DOI 10.1074/jbc.272.10.6752; Li JY, 2002, NEUROSCIENCE, V113, P463, DOI 10.1016/S0306-4522(02)00143-4; Malatynska E, 2006, J MOL NEUROSCI, V29, P269, DOI 10.1385/JMN:29:3:269; Masato A, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0332-6; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Miller GW, 1999, TRENDS PHARMACOL SCI, V20, P424, DOI 10.1016/S0165-6147(99)01379-6; Millership SJ, 2018, J CLIN INVEST, V128, P3369, DOI 10.1172/JCI120115; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Mutch SA, 2011, J NEUROSCI, V31, P1461, DOI 10.1523/JNEUROSCI.3805-10.2011; NAKAJO S, 1994, MOL BRAIN RES, V27, P81, DOI 10.1016/0169-328X(94)90187-2; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Ninkina N, 2020, NEUROBIOL AGING, V91, P76, DOI 10.1016/j.neurobiolaging.2020.02.026; Ninkina N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16615; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sulzer D, 2019, J NEUROCHEM, V150, P475, DOI 10.1111/jnc.14810; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thomas B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016706; Tsudzuki T, 2004, J BIOCHEM, V136, P239, DOI 10.1093/jb/mvh113; Vargas KJ, 2017, CELL REP, V18, P161, DOI 10.1016/j.celrep.2016.12.023; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Windisch M, 2002, J MOL NEUROSCI, V19, P63, DOI 10.1007/s12031-002-0012-8	59	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101375	10.1016/j.jbc.2021.101375	http://dx.doi.org/10.1016/j.jbc.2021.101375			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34736896	Green Accepted, gold, Green Published			2022-12-26	WOS:000748084900009
J	Zegallai, HM; Abu-El-Rub, E; Cole, LK; Field, J; Mejia, EM; Gordon, JW; Marshall, AJ; Hatch, GM				Zegallai, Hana M.; Abu-El-Rub, Ejlal; Cole, Laura K.; Field, Jared; Mejia, Edgard M.; Gordon, Joseph W.; Marshall, Aaron J.; Hatch, Grant M.			Tafazzin deficiency impairs mitochondrial metabolism and function of lipopolysaccharide activated B lymphocytes in mice	FASEB JOURNAL			English	Article						B lymphocyte activation; cardiolipin; cell proliferation and survival; cytokines; immunoglobulin synthesis and secretion; immunoproteasome; lipopolysaccharide; mitochondria; proteasome; tafazzin	CELL ACTIVATION; LYMPHOBLAST MITOCHONDRIA; MEMBRANE-PROTEIN; PROTEASOME; CARDIOLIPIN; INHIBITION; COMPLEX; 26S; DYSFUNCTION; EXPRESSION	B lymphocytes are responsible for humoral immunity and play a key role in the immune response. Optimal mitochondrial function is required to support B cell activity during activation. We examined how deficiency of tafazzin, a cardiolipin remodeling enzyme required for mitochondrial function, alters the metabolic activity of B cells and their response to activation by lipopolysaccharide in mice. B cells were isolated from 3-month-old wild type or tafazzin knockdown mice and incubated for up to 72 h with lipopolysaccharide and cell proliferation, expression of cell surface markers, secretion of antibodies and chemokines, proteasome and immunoproteasome activities, and metabolic function determined. In addition, proteomic analysis was performed to identify altered levels of proteins involved in survival, immunogenic, proteasomal and mitochondrial processes. Compared to wild type lipopolysaccharide activated B cells, lipopolysaccharide activated tafazzin knockdown B cells exhibited significantly reduced proliferation, lowered expression of cluster of differentiation 86 and cluster of differentiation 69 surface markers, reduced secretion of immunoglobulin M antibody, reduced secretion of keratinocytes-derived chemokine and macrophage-inflammatory protein-2, reduced proteasome and immunoproteasome activities, and reduced mitochondrial respiration and glycolysis. Proteomic analysis revealed significant alterations in key protein targets that regulate cell survival, immunogenicity, proteasomal processing and mitochondrial function consistent with the findings of the above functional studies. The results indicate that the cardiolipin transacylase enzyme tafazzin plays a key role in regulating mouse B cell function and metabolic activity during activation through modulation of mitochondrial function.	[Zegallai, Hana M.; Cole, Laura K.; Field, Jared; Gordon, Joseph W.; Hatch, Grant M.] Childrens Hosp Res Inst Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB, Canada; [Zegallai, Hana M.; Cole, Laura K.; Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal] Yarmouk Univ, Dept Physiol & Pathophysiol, Irbid, Jordan; [Abu-El-Rub, Ejlal] Yarmouk Univ, Dept Basic Med Sci, Fac Med, Irbid, Jordan; [Abu-El-Rub, Ejlal] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Abu-El-Rub, Ejlal] Univ Manitoba, Rady Fac Hlth Sci, Dept Regenerat Med, Winnipeg, MB, Canada; [Field, Jared; Gordon, Joseph W.] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Mejia, Edgard M.; Marshall, Aaron J.] Univ Manitoba, Rady Fac Hlth Sci, Dept Immunol, Winnipeg, MB, Canada; [Gordon, Joseph W.] Univ Manitoba, Coll Nursing, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Yarmouk University; Yarmouk University; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Hatch, GM (corresponding author), Rady Fac Hlth Sci, Dept Pharmacol & Therapeut, 501C JBRC,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	ghatch@chrim.ca			Heart and Stroke Foundation of Canada (HSF); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Heart and Stroke Foundation of Canada (HSF)(Heart & Stroke Foundation of Canada); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Heart and Stroke Foundation of Canada (HSF); Gouvernement du Canada, Natural Sciences and Engineering Research Council of Canada (NSERC); Children's Hospital Foundation of Manitoba, Children's Hospital Research Institute of Manitoba (CHRIM)	Abu-El-Rub E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2634-6; Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Axelrad MD, 2013, JOVE-J VIS EXP, DOI 10.3791/50246; Azzam KM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91914; Barth Syndrome Foundation, 2018, MED US BARTH SYNDR; Berges C, 2008, IMMUNOLOGY, V124, P234, DOI 10.1111/j.1365-2567.2007.02761.x; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Chen TT, 2016, J EXP MED, V213, P3025, DOI 10.1084/jem.20151620; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Eissmann M, 2013, ONCOGENE, V32, P2586, DOI 10.1038/onc.2012.263; Elssner A, 2004, J IMMUNOL, V172, P7721, DOI 10.4049/jimmunol.172.12.7721; Finsterer J, 2013, CURR OPIN HEMATOL, V20, P36, DOI 10.1097/MOH.0b013e32835a01d9; Ghanem A, 2019, MOL BIOL REP, V46, P1369, DOI 10.1007/s11033-019-04587-z; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hoffman W, 2016, CLIN J AM SOC NEPHRO, V11, P137, DOI 10.2215/CJN.09430915; Hu Lina, 2004, BMC Immunology, V5; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128561; Ibanez-Vega J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00225; Ikon N, 2017, LIPIDS, V52, P99, DOI 10.1007/s11745-016-4229-7; Iosefson O, 2007, PROTEIN SCI, V16, P316, DOI 10.1110/ps.062459607; Jongstra-Bilen J, 2006, IMMUNOL RES, V35, P65, DOI 10.1385/IR:35:1:65; Krystof V, 2012, CURR PHARM DESIGN, V18, P2883, DOI 10.2174/138161212800672750; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Limon JJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00228; Liu WG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082894; Lu MF, 2016, INNATE IMMUN-LONDON, V22, P307, DOI 10.1177/1753425916644675; Ma HZ, 2019, EBIOMEDICINE, V39, P182, DOI 10.1016/j.ebiom.2018.12.022; Marshall-Clarke S, 2003, IMMUNOLOGY, V109, P102, DOI 10.1046/j.1365-2567.2003.01638.x; Martinez-Fonts K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13906-8; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mejia EM, 2018, J BIOL CHEM, V293, P7564, DOI 10.1074/jbc.RA117.001024; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Ning ZC, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.654960; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pacheu-Grau D, 2020, J MOL BIOL, V432, P2067, DOI 10.1016/j.jmb.2020.01.036; Peng B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0152-y; Rathmell JC, 2012, IMMUNOL REV, V249, P5, DOI 10.1111/j.1600-065X.2012.01158.x; Ren MD, 2019, AM J PHYSIOL-HEART C, V317, pH1183, DOI 10.1152/ajpheart.00504.2019; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rouette A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34019; Schmidt C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02386; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sokol AM, 2014, FEBS LETT, V588, P2484, DOI 10.1016/j.febslet.2014.05.028; Steward CG, 2019, CURR OPIN HEMATOL, V26, P6, DOI 10.1097/MOH.0000000000000472; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tar K, 2014, J BIOL CHEM, V289, P12145, DOI 10.1074/jbc.M114.554105; Tedder TF, 2005, ADV IMMUNOL, V88, P1, DOI 10.1016/S0065-2776(05)88001-0; Urbanczyk S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082192; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Weiss RS, 2003, MOL CELL BIOL, V23, P791, DOI 10.1128/MCB.23.3.791-803.2003; Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Zegallai HM, 2021, MOL CELL BIOCHEM, V476, P1605, DOI 10.1007/s11010-020-04021-0	66	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22023	10.1096/fj.202100811RR	http://dx.doi.org/10.1096/fj.202100811RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34767647				2022-12-26	WOS:000722321300020
J	Zuromski, KL; Kim, S; Sauer, RT; Baker, TA				Zuromski, Kristin L.; Kim, Sora; Sauer, Robert T.; Baker, Tania A.			Division of labor between the pore-1 loops of the D1 and D2 AAA+ rings coordinates substrate selectivity of the ClpAP protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RIBOSOME-RESCUE; TERMINAL DOMAIN; DEGRADATION; CHAPERONE; ADAPTER; RECOGNITION	ClpAP, an ATP-dependent protease consisting of ClpA, a double-ring hexameric unfoldase of the ATPases associated with diverse cellular activities superfamily, and the ClpP peptidase, degrades damaged and unneeded proteins to support cellular proteostasis. ClpA recognizes many protein substrates directly, but it can also be regulated by an adapter, ClpS, that modifies ClpA's substrate profile toward N-degron substrates. Conserved tyrosines in the 12 pore-1 loops lining the central channel of the stacked D1 and D2 rings of ClpA are critical for degradation, but the roles of these residues in individual steps during direct or adapter-mediated degradation are poorly understood. Using engineered ClpA hexamers with zero, three, or six pore-1 loop mutations in each ATPases associated with diverse cellular activities superfamily ring, we found that active D1 pore loops initiate productive engagement of substrates, whereas active D2 pore loops are most important for mediating the robust unfolding of stable native substrates. In complex with ClpS, active D1 pore loops are required to form a high affinity ClpA.ClpS.substrate complex, but D2 pore loops are needed to "tug on" and remodel ClpS to transfer the N-degron substrate to ClpA. Overall, we find that the pore-1 loop tyrosines in D1 are critical for direct substrate engagement, whereas ClpS-mediated substrate delivery requires unique contributions from both the D1 and D2 pore loops. In conclusion, our study illustrates how pore loop engagement, substrate capture, and powering of the unfolding/translocation steps are distributed between the two rings of ClpA, illuminating new mechanistic features that may be common to double-ring protein unfolding machines.	[Zuromski, Kristin L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Kim, Sora; Sauer, Robert T.; Baker, Tania A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Baker, TA (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	tabaker@mit.edu	; Kim, Sora/D-7707-2015	Zuromski, Kristin/0000-0003-0960-5009; Sauer, Robert/0000-0002-1719-5399; Baker, Tania/0000-0002-0737-3411; Kim, Sora/0000-0002-9856-9574	NIH [AI-016892]; Howard Hughes Medical Institute; National Science Foundation Graduate Research Fellowships [1745302]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF))	This work was supported by NIH grant AI-016892 (R. T. S. and T. A. B.), the Howard Hughes Medical Institute (T. A. B.), and the National Science Foundation Graduate Research Fellowships under Grant no. 1745302 (to K. L. Z. and S. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bell TA, 2019, ELIFE, V8, DOI 10.7554/eLife.46808; Bodnar Nicholas, 2017, F1000Res, V6, P1318, DOI 10.12688/f1000research.11683.1; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Doyle SM, 2012, J BIOL CHEM, V287, P28470, DOI 10.1074/jbc.M112.383091; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Erbse AH, 2008, FEBS J, V275, P1400, DOI 10.1111/j.1742-4658.2008.06304.x; Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; Iosefson O, 2015, NAT CHEM BIOL, V11, P201, DOI 10.1038/nchembio.1732; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Kotamarthi HC, 2020, CELL REP, V30, P2644, DOI 10.1016/j.celrep.2020.01.110; Kress W, 2009, J BIOL CHEM, V284, P31441, DOI 10.1074/jbc.M109.022319; Liu J, 2013, J BIOL CHEM, V288, P17597, DOI 10.1074/jbc.M113.458752; Lopez KE, 2020, NAT STRUCT MOL BIOL, V27, P406, DOI 10.1038/s41594-020-0409-5; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Maglica Z, 2008, J MOL BIOL, V384, P503, DOI 10.1016/j.jmb.2008.09.046; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Miller J, 2016, ARCHAEA, V2016, DOI 10.1155/2016/9294307; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Neuwald AF, 1999, GENOME RES, V9, P27; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Olivares AO, 2014, NAT STRUCT MOL BIOL, V21, P871, DOI 10.1038/nsmb.2885; Rivera-Rivera I., 2015, THESIS MIT; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Roman-Hernandez G, 2011, MOL CELL, V43, P217, DOI 10.1016/j.molcel.2011.06.009; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Saunders RA, 2020, P NATL ACAD SCI USA, V117, P28005, DOI 10.1073/pnas.2010804117; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; SEOL JH, 1994, J BIOL CHEM, V269, P29468; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Torres-Delgado A, 2020, J MOL BIOL, V432, P4908, DOI 10.1016/j.jmb.2020.07.007; Wang F, 2011, NATURE, V471, P331, DOI 10.1038/nature09780; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869; Zuromski KL, 2020, P NATL ACAD SCI USA, V117, P25455, DOI 10.1073/pnas.2014407117	57	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101407	10.1016/j.jbc.2021.101407	http://dx.doi.org/10.1016/j.jbc.2021.101407			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP0HN	34780718	Green Published, gold			2022-12-26	WOS:000748311800011
J	Palm, R; Fahsold, A; Roes, M; Holle, B				Palm, Rebecca; Fahsold, Anne; Roes, Martina; Holle, Bernhard			Context, mechanisms and outcomes of dementia special care units: An initial programme theory based on realist methodology	PLOS ONE			English	Article							HOME-LIKE FACILITIES; QUALITY-OF-LIFE; NURSING-HOME; SMALL-SCALE; PATIENT PARTICIPATION; FAMILY CAREGIVERS; OLDER-ADULTS; RESIDENTS; PREVALENCE; BEHAVIOR	Background Dementia special care units represent a widely implemented care model in nursing homes. Their benefits must be thoroughly evaluated given the risk of exclusion and stigma. The aim of this study is to present an initial programme theory that follows the principles of realist methodology. The theory development was guided by the question of the mechanisms at play in the context of dementia special care units to produce or influence outcomes of interest in people with dementia. Methods The initial programme theory is based on qualitative interviews with dementia special care stakeholders in Germany and a realist review of complex interventions in dementia special care units. The interviews were analysed using content analysis techniques. For the realist review, a systematic literature search was conducted in four scientific databases; studies were appraised for quality and relevance. All data were analysed independently by two researchers. A realist informed logic model was developed, and context-mechanism-outcome (CMO) configurations were described. Results We reviewed 16 empirical studies and interviewed 16 stakeholders. In the interviews, contextual factors at the system, organisation and individual levels that influence the provision of care in dementia special care units were discussed. The interviewees described the following four interventions typical of dementia special care units: adaptation to the environment, family and public involvement, provision of activities and behaviour management. With exception of family and public involvement, these interventions were the focus of the reviewed studies. The outcomes of interest of stakeholders include responsive behaviour and quality of life, which were also investigated in the empirical studies. By combining data from interviews and a realist review, we framed three CMO configurations relevant to environment, activity, and behaviour management. Discussion As important contextual factors of dementia special care units, we discuss the transparency of policies to regulate dementia care, segregation and admission policies, purposeful recruitment and education of staff and a good fit between residents and their environment.	[Palm, Rebecca; Fahsold, Anne; Roes, Martina; Holle, Bernhard] Witten Herdecke Univ, Fac Hlth, Sch Nursing Sci, Witten, Germany; [Fahsold, Anne; Roes, Martina; Holle, Bernhard] German Ctr Neurodegenerat Dis, Witten, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Palm, R (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Nursing Sci, Witten, Germany.	Rebecca.palm@uni-wh.de	Fahsold, Anne/ABC-8019-2021	Fahsold, Anne/0000-0002-7977-8805; Palm, Rebecca/0000-0002-4910-8413	German Center for Neurodegenerative Diseases	German Center for Neurodegenerative Diseases	The study received funding from our organization, the German Center for Neurodegenerative Diseases and did not received external funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Abbott KM, 2017, DEMENTIA-LONDON, V16, P1004, DOI 10.1177/1471301216630907; Abbott KM, 2017, DEMENTIA-LONDON, V16, P388, DOI 10.1177/1471301215594950; Altintas E, 2017, ARCH GERONTOL GERIAT, V70, P8, DOI 10.1016/j.archger.2016.12.004; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Appelhof B, 2019, AGING MENT HEALTH, V23, P581, DOI 10.1080/13607863.2018.1428935; Appelhof B, 2018, J AM MED DIR ASSOC, V19, P663, DOI 10.1016/j.jamda.2018.02.013; Astbury B, 2010, AM J EVAL, V31, P363, DOI 10.1177/1098214010371972; Cadigan RO, 2012, MED CARE, V50, P856, DOI 10.1097/MLR.0b013e31825dd713; Carder PC, 2017, GERONTOLOGIST, V57, P776, DOI 10.1093/geront/gnw197; Clark AM, 2013, SOC SCI MED, V93, P185, DOI 10.1016/j.socscimed.2012.03.035; Consult VS, 1989, SOFTWARE QUALITATIVE; Dalkin SM, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0237-x; de Boer B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0550-0; de Boer B, 2017, J AM MED DIR ASSOC, V18, P40, DOI 10.1016/j.jamda.2016.10.013; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gruneir A, 2008, J AGING HEALTH, V20, P837, DOI 10.1177/0898264308324632; Helgesen AK, 2014, NURS ETHICS, V21, P108, DOI 10.1177/0969733013486796; Helgesen AK, 2010, INT J OLDER PEOPLE N, V5, P169, DOI 10.1111/j.1748-3743.2010.00223.x; Hoffmann F, 2014, AGING CLIN EXP RES, V26, P555, DOI 10.1007/s40520-014-0210-6; Joyce NR, 2018, HEALTH SERV RES, V53, P3657, DOI 10.1111/1475-6773.12867; Kaskie B, 2001, J Aging Soc Policy, V12, P27, DOI 10.1300/J031v12n04_02; Kok JS, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0853-7; Kok JS, 2013, DEMENT GER COGN D EX, V3, P360, DOI 10.1159/000353441; Lai CKY, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006470.pub2; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; Marchal B, 2012, EVALUATION-US, V18, P192, DOI 10.1177/1356389012442444; Mayring P., 2010, QUALITATIVE INHALTSA, V2nd Aufl, DOI [10.1007/978-3-531-92052-8_42, DOI 10.1007/978-3-531-92052-8_42]; Morgan D G, 2005, J Psychiatr Ment Health Nurs, V12, P347, DOI 10.1111/j.1365-2850.2005.00846.x; Mukamel DB, 2012, HEALTH SERV RES, V47, P1791, DOI 10.1111/j.1475-6773.2012.01459.x; Palm R., 2018, OXFORD TXB GERIATRIC, V3rd ed, P281; Palm R, 2020, INT J NURS STUD, V109, DOI 10.1016/j.ijnurstu.2020.103601; Palm R, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.08.018; Palm R, 2014, INT J MENT HEALTH SY, V8, DOI 10.1186/1752-4458-8-39; Paterson C, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-18; Pawson R, 1997, REALISTIC EVALUATION; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Rohwer A, 2017, J CLIN EPIDEMIOL, V83, P37, DOI 10.1016/j.jclinepi.2016.06.012; Rolfe S, 2019, EVALUATION-US, V25, P294, DOI 10.1177/1356389019835229; Schaufele M, 2008, AKTUELLE INANSPRUCHN; Seitz D, 2010, INT PSYCHOGERIATR, V22, P1025, DOI 10.1017/S1041610210000608; Shearn K, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917741796; SLOANE PD, 1995, GERONTOLOGIST, V35, P103, DOI 10.1093/geront/35.1.103; Sloane PD, 2018, J AM MED DIR ASSOC, V19, P557, DOI 10.1016/j.jamda.2018.05.026; Smit D, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0564-7; Smit D, 2012, INT PSYCHOGERIATR, V24, P722, DOI 10.1017/S1041610211002377; Smith M, 2004, J AM GERIATR SOC, V52, P1755, DOI 10.1111/j.1532-5415.2004.52473.x; The RAMESES project II, 2020, WHAT REALISTS MEAN C; Verbeek H, 2014, INT PSYCHOGERIATR, V26, P657, DOI 10.1017/S1041610213002512; Verbeek H, 2012, INT J NURS STUD, V49, P21, DOI 10.1016/j.ijnurstu.2011.07.008; Verbeek H, 2010, J AM MED DIR ASSOC, V11, P662, DOI 10.1016/j.jamda.2010.08.001; Wong G, 2014, HEALTH SERV DELIVERY, V2014; Zimmerman S, 2013, J AM GERIATR SOC, V61, P1399, DOI 10.1111/jgs.12372; Zwijsen SA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-302; Zwijsen SA, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.04.007	54	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259496	10.1371/journal.pone.0259496	http://dx.doi.org/10.1371/journal.pone.0259496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784375	Green Published, gold			2022-12-26	WOS:000755277300012
J	Rad, AB; Galloway, C; Treiman, D; Xue, J; Li, Q; Sameni, R; Albert, D; Clifford, GD				Rad, Ali Bahrami; Galloway, Conner; Treiman, Daniel; Xue, Joel; Li, Qiao; Sameni, Reza; Albert, Dave; Clifford, Gari D.			Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach	PLOS ONE			English	Article							EPIDEMIOLOGY	Background Atrial fibrillation (AFib) is the most common cardiac arrhythmia associated with stroke, blood clots, heart failure, coronary artery disease, and/or death. Multiple methods have been proposed for AFib detection, with varying performances, but no single approach appears to be optimal. We hypothesized that each state-of-the-art algorithm is appropriate for different subsets of patients and provides some independent information. Therefore, a set of suitably chosen algorithms, combined in a weighted voting framework, will provide a superior performance to any single algorithm. Methods We investigate and modify 38 state-of-the-art AFib classification algorithms for a single-lead ambulatory electrocardiogram (ECG) monitoring device. All algorithms are ranked using a random forest classifier and an expert-labeled training dataset of 2,532 recordings. The seven top-ranked algorithms are combined by using an optimized weighting approach. Results The proposed fusion algorithm, when validated on a separate test dataset consisting of 4,644 recordings, resulted in an area under the receiver operating characteristic (ROC) curve of 0.99. The sensitivity, specificity, positive-predictive-value (PPV), negative-predictive-value (NPV), and F1-score of the proposed algorithm were 0.93, 0.97, 0.87, 0.99, and 0.90, respectively, which were all superior to any single algorithm or any previously published. Conclusion This study demonstrates how a set of well-chosen independent algorithms and a voting mechanism to fuse the outputs of the algorithms, outperforms any single state-of-the-art algorithm for AFib detection. The proposed framework is a case study for the general notion of crowdsourcing between open-source algorithms in healthcare applications. The extension of this framework to similar applications may significantly save time, effort, and resources, by combining readily existing algorithms. It is also a step toward the democratization of artificial intelligence and its application in healthcare.	[Rad, Ali Bahrami; Li, Qiao; Sameni, Reza; Clifford, Gari D.] Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA; [Galloway, Conner; Treiman, Daniel; Xue, Joel; Albert, Dave] AliveCor Inc, Mountain View, CA USA; [Clifford, Gari D.] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	Emory University; University System of Georgia; Georgia Institute of Technology	Rad, AB (corresponding author), Emory Univ, Dept Biomed Informat, Atlanta, GA 30322 USA.	ali.bahrami.rad@dbmi.emory.edu	Clifford, Gari/GRJ-0376-2022	Clifford, Gari/0000-0002-5709-201X	AliveCor; National Institute of Biomedical Imaging and Bioengineering (NIBIB) under NIH [R01EB030362]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR002378]	AliveCor; National Institute of Biomedical Imaging and Bioengineering (NIBIB) under NIH; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by AliveCor through an unrestricted donation. It was also partially supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under NIH grant number R01EB030362. G.C. and Q.L. are also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript with the exception of AliveCor, which provided access to the Kardia algorithm outputs and labeled data used in this study. AliveCor also contributed to review the manuscript to provide clarifications on data and provide feedback on any statements that were unclear, but did not alter the content of the manuscript.	Bonizzi P, 2017, 2017 COMPUTING CARDI; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 2001, MACH LEARN, V45, P5; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chandra BS, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.163-226; Christov I, 2017, 2017 COMPUTING CARDI; Christov I, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad9f0; Clifford GD, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.065-469; Clifford GD, 2020, ABS200710502 CORR; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Da Silva-Filarder M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.346-357; Datta S, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.173-154; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Ghiasi S, 2017, 2017 COMPUTING CARDI; Gliner Vadim, 2018, Physiol Meas, V39, P094007, DOI 10.1088/1361-6579/aadf49; Gliner V, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.170-101; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hasna OL, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.164-301; Isasi I, 2019, IEEE ACCESS, V7, P115147, DOI 10.1109/ACCESS.2019.2935096; Jekova II, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.345-029; Jimenez-Serrano S, 2017, 2017 COMPUTING CARDI; Kropf M, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aae13e; Kropf M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.168-168; Krstajic D, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-10; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li Q., 2016, MACH LEARNING HEAL T; Lippi G, 2021, INT J STROKE, V16, P217, DOI 10.1177/1747493019897870; Liu N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aac7aa; Liu Y, 2017, 2017 COMPUTING CARDI; Mahajan R, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.179-403; Moody G. B., 1983, Computers in Cardiology 10th Annual Meeting (IEEE Cat. No. 83CH1927-3), P227; Mukherjee A, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aaff04; Padanilam BJ, 2008, CONTEMP CARDIOL, P3, DOI 10.1007/978-1-59745-163-5_1; Patidar S, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.349-105; Plesinger F, 2017, 2017 COMPUTING CARDI; Plesinger F, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aad9ee; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Rogers J, 2006, LECT NOTES COMPUT SC, V3940, P173; Sadr N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aac76c; Schwartzman D., 2005, INNOVATIVE MANAGEMEN; Seiffert C, 2008, INT C PATT RECOG, P3650; Solinski M, 2017, 2017 COMPUTING CARDI; Sopic D, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.343-119; Stepien K, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.356-350; Turakhia MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195088; Warmuth MK, 2006, P 23 INT C MACHINE L, P1001, DOI DOI 10.1145/1143844.1143970; Yazdani S, 2017, 2017 COMPUTING CARDI; Zabihi M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.069-336; Zhu T., 2016, MACH LEARNING HEAL T; Zhu TT, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aac856; Zhu TT, 2015, ANN BIOMED ENG, V43, P2892, DOI 10.1007/s10439-015-1344-1; Zhu TT, 2013, COMPUT CARDIOL CONF, V40, P659; Zhu TT, 2014, ANN BIOMED ENG, V42, P871, DOI 10.1007/s10439-013-0964-6; Zoni-Berisso M, 2014, CLIN EPIDEMIOL, V6, P213, DOI 10.2147/CLEP.S47385	54	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259916	10.1371/journal.pone.0259916	http://dx.doi.org/10.1371/journal.pone.0259916			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784378	gold, Green Published			2022-12-26	WOS:000755277300029
J	Seo, SU; Woo, SM; Kim, S; Park, JW; Lee, HS; Bae, YS; Kim, SH; Im, SS; Seo, JH; Min, KJ; Kwon, TK				Seo, Seung Un; Woo, Seon Min; Kim, Shin; Park, Jong-Wook; Lee, Hyun-Shik; Bae, Young-Seuk; Kim, Sang Hyun; Im, Seung-Soon; Seo, Ji Hae; Min, Kyoung-Jin; Kwon, Taeg Kyu			Inhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo	ONCOGENE			English	Article							TUMOR-SUPPRESSOR P53; MEMBRANE PERMEABILIZATION; EXPRESSION; BCL-2	Cathepsin K is highly expressed in various types of cancers. However, the effect of cathepsin K inhibition in cancer cells is not well characterized. Here, cathepsin K inhibitor (odanacatib; ODN) and knockdown of cathepsin K (siRNA) enhanced oxaliplatin-induced apoptosis in multiple cancer cells through Bax upregulation. Bax knockdown significantly inhibited the combined ODN and oxaliplatin treatment-induced apoptotic cell death. Stabilization of p53 by ODN played a critical role in upregulating Bax expression at the transcriptional level. Casein kinase 2 (CK2)-dependent phosphorylation of OTUB1 at Ser16 played a critical role in ODN- and cathepsin K siRNA-mediated p53 stabilization. Interestingly, ODN-induced p53 and Bax upregulation were modulated by the production of mitochondrial reactive oxygen species (ROS). Mitochondrial ROS scavengers prevented OTUB1-mediated p53 stabilization and Bax upregulation by ODN. These in vitro results were confirmed by in mouse xenograft model, combined treatment with ODN and oxaliplatin significantly reduced tumor size and induced Bax upregulation. Furthermore, human renal clear carcinoma (RCC) tissues revealed a strong correlation between phosphorylation of OTUB1(Ser16) and p53/Bax expression. Our results demonstrate that cathepsin K inhibition enhances oxaliplatin-induced apoptosis by increasing OTUB1 phosphorylation via CK2 activation, thereby promoting p53 stabilization, and hence upregulating Bax.	[Seo, Seung Un; Woo, Seon Min; Kim, Shin; Park, Jong-Wook; Kwon, Taeg Kyu] Keimyung Univ, Sch Med, Dept Immunol, Daegu 42601, South Korea; [Lee, Hyun-Shik; Bae, Young-Seuk] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, BK21 Plus KNU Creat BioRes Grp, Daegu 41566, South Korea; [Kim, Sang Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Daegu 41944, South Korea; [Im, Seung-Soon] Keimyung Univ, Sch Med, Dept Physiol, Daegu 42601, South Korea; [Seo, Ji Hae] Keimyung Univ, Sch Med, Dept Biochem, Daegu 42601, South Korea; [Min, Kyoung-Jin] Daegu Gyeongbuk Med Innovat Fdn DGMIF, New Drug Dev Ctr, Daegu 41061, South Korea; [Kwon, Taeg Kyu] Keimyung Univ, Ctr Forens Pharmaceut Sci, Daegu 42601, South Korea	Keimyung University; Kyungpook National University; Kyungpook National University; Keimyung University; Keimyung University; Keimyung University	Kwon, TK (corresponding author), Keimyung Univ, Sch Med, Dept Immunol, Daegu 42601, South Korea.; Kwon, TK (corresponding author), Keimyung Univ, Ctr Forens Pharmaceut Sci, Daegu 42601, South Korea.	kwontk@dsmc.or.kr						Ashton TM, 2018, CLIN CANCER RES, V24, P2482, DOI 10.1158/1078-0432.CCR-17-3070; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Brooks CL, 2004, CELL CYCLE, V3, P895; Dai R, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00433; Grabowska UB, 2005, CURR OPIN DRUG DISC, V8, P619; Gu XY, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.05.011; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Hock AK, 2014, BBA-MOL CELL RES, V1843, P137, DOI 10.1016/j.bbamcr.2013.05.022; Kim S, 2019, CANCERS, V11, DOI 10.3390/cancers11030344; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Leusink FK, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4315-8; Liang WP, 2019, J CANCER RES CLIN, V145, P1999, DOI 10.1007/s00432-019-02950-y; Mauri G, 2020, CANCER TREAT REV, V91, DOI 10.1016/j.ctrv.2020.102112; Min KJ, 2020, TOXICOL RES-GER, V36, P167, DOI 10.1007/s43188-019-00025-1; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Petermann I, 2006, FASEB J, V20, P1266, DOI 10.1096/fj.05-5517fje; Saldana M, 2019, ENDOCR-RELAT CANCER, V26, pR1, DOI 10.1530/ERC-18-0264; Seo BR, 2017, ANTIOXID REDOX SIGN, V27, P215, DOI 10.1089/ars.2016.6749; Seo J, 2018, ONCOGENE, V37, P4994, DOI 10.1038/s41388-018-0323-z; Seo SU, 2020, REDOX BIOL, V30, DOI 10.1016/j.redox.2019.101422; Seo SU, 2018, ONCOGENE, V37, P5205, DOI 10.1038/s41388-018-0345-6; Simpson D, 2003, DRUGS, V63, P2127, DOI 10.2165/00003495-200363190-00013; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Tsukuba T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082415; Verbovsek U, 2015, SEMIN CANCER BIOL, V35, P71, DOI 10.1016/j.semcancer.2015.08.010; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Yang H, 2020, MOLECULES, V25, DOI 10.3390/molecules25184136; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; ZHAN QM, 1994, ONCOGENE, V9, P3743	32	2	2	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2022	41	4					550	559		10.1038/s41388-021-02088-7	http://dx.doi.org/10.1038/s41388-021-02088-7		NOV 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YK9PJ	34785775	Green Published, hybrid			2022-12-26	WOS:000719277200002
J	Shi, Y; Li, XN				Shi, Yin; Li, Xiaoni			Determinants of financial distress in the European air transport industry: The moderating effect of being a flag-carrier	PLOS ONE			English	Article							CAPITAL STRUCTURE; MARKET POWER; COST; AIRLINE; RISK; PREDICTION; RATIOS; BANKS	Due to the COVID-induced global collapse in demand for air travel, the year 2020 was a catastrophic one for the aviation industry. A dramatic drop in operating revenues along with continuing fixed expenses drained the cash reserves of airlines, with consequent risks of financial distress and, potentially, even of bankruptcy. Flag-carriers are a special group in the airline business-they are considered to have privileges in terms of the support given by governments while, on the other hand, are often viewed as having low efficiency and performance. This study aims to estimate for European airlines the interaction effect of being a flag-carrier (flagship) with the relationship between leverage, liquidity, profitability, and the degree of financial distress. Findings obtained from analysing 99 European airlines over a period of ten years, indicate that the negative influence of leverage on financial stability is higher in the case of flag carriers (flagship). The impact of liquidity and profitability on financial health is more positive for flagship than for non-flagship carriers. These findings are not limited to contributing to the existing literature, but also have significant practical implications for executives, managers, and policy makers in the European air transport sector.	[Shi, Yin; Li, Xiaoni] Univ Rovira & Virgili, Fac Econ & Management, Reus, Spain	Universitat Rovira i Virgili	Shi, Y (corresponding author), Univ Rovira & Virgili, Fac Econ & Management, Reus, Spain.	yin.shi@estudiants.urv.cat		Shi, Yin/0000-0001-6354-5399; LI, XIAONI/0000-0002-4047-4046				Abate M, 2020, J AIR TRANSP MANAG, V89, DOI 10.1016/j.jairtraman.2020.101931; Abigail N, 2020, CNBC; Agrawal A, 2021, J REVENUE PRICING MA, V20, P457, DOI 10.1057/s41272-020-00257-z; Akbar A., 2011, PAKISTAN J SOCIAL SC, V31, P145; Altman E.I., 1983, CORPORATE FINANCIAL; Altman EI, 2017, J INT FIN MANAG ACC, V28, P131, DOI 10.1111/jifm.12053; ALTMAN EI, 1968, J FINANC, V23, P589, DOI 10.2307/2978933; [Anonymous], 2015, J CONT ACCOUNTING EC; Balasubramanian S G.S.R., 2019, INT J LAW MANAG, V61, P457; Balcaen S., 2006, BRIT ACCOUNT REV, V38, P63, DOI DOI 10.1016/J.BAR.2005.09.001; Barrett SD, 2006, J AIR TRANSP MANAG, V12, P159, DOI 10.1016/j.jairtraman.2005.11.001; Barros CP, 2009, INT J PROD ECON, V122, P525, DOI 10.1016/j.ijpe.2009.04.016; BEAVER W, 1970, ACCOUNT REV, V45, P654; BEAVER WH, 1966, J ACCOUNTING RES, V4, P71, DOI 10.2307/2490171; Bellovary J.L., 2007, J FINANCIAL ED, V33, P1; BENZION U, 1975, J FINANC, V30, P1015; Beria P, 2011, J AIR TRANSP MANAG, V17, P215, DOI 10.1016/j.jairtraman.2011.02.007; Bezerra ES, 2019, CONTAB GEST GOV, V22, P405, DOI 10.21714/1984-3925_2019v22n3a6; Capobianco HMP, 2004, TRANSPORT RES A-POL, V38, P421, DOI 10.1016/j.tra.2004.03.002; Carreras-Maide J, 2020, J AIR TRANSP MANAG, V88, DOI 10.1016/j.jairtraman.2020.101887; Chow G., 1991, J TRANSPORTATION RES, V31, P371; Christopoulos AG, 2019, J OPER RES SOC, V70, P1817, DOI 10.1080/01605682.2018.1460017; Chung C., 2012, J APPL BUSINESS RES, V12, P133; Cui Q, 2017, TRANSPORT RES A-POL, V100, P121, DOI 10.1016/j.tra.2017.04.013; Davalos S., 1999, J AIR TRANSP MANAG, V5, P81; EHRLICH I, 1994, J POLIT ECON, V102, P1006, DOI 10.1086/261962; Garrow L, 2021, J REVENUE PRICING MA, V20, P3, DOI 10.1057/s41272-020-00271-1; Golaszewski R., 1992, J TRANSPORTATION RES, V32, P313; Goodfriend J., 2005, CREDIT FINANCIAL MAN, V10; Gritta R., 2006, CREDIT FINANCIAL MAN, V7, P11; Gritta R., 1982, J AIR LAW COMMERCE, V48, P89; Gritta R., 2011, J TRANSPORTATION RES, V47; Gritta R., 2010, J TRANSPORTATION RES; Halpern P, 2009, Q REV ECON FINANC, V49, P772, DOI 10.1016/j.qref.2008.09.002; Halteh K, 2018, MANAG FINANC, V44, P759, DOI 10.1108/MF-12-2016-0372; HARRIS M, 1991, J FINANC, V46, P297, DOI 10.1111/j.1540-6261.1991.tb03753.x; IATA, 2020, EC PERF AIRL IND; Kim SY, 2018, SERV BUS, V12, P483, DOI 10.1007/s11628-018-0365-x; Kiraci K, 2019, SCI ANN ECON BUS, V66, P335, DOI 10.2478/saeb-2019-0025; Kiraci K, 2018, SCI ANN ECON BUS, V65, P227, DOI 10.2478/saeb-2018-0018; Kolte A, 2018, INT J MANAG FINANC A, V10, P391, DOI 10.1504/IJMFA.2018.095976; Kristanti FT, 2016, PROCD SOC BEHV, V219, P440, DOI 10.1016/j.sbspro.2016.05.018; Kroeze C, 2004, DIGITAL SCHOLARSHIP, DOI [10.25669/wzdf-dyf8, DOI 10.25669/WZDF-DYF8]; Kumar B., 2019, INT J BUSINESS APPL, V8, P30; Kumar PR, 2007, EUR J OPER RES, V180, P1, DOI 10.1016/j.ejor.2006.08.043; Lange Robert., 2020, AGIFORS 60 ANN S OCT; Lee CH, 2012, J AIR TRANSP MANAG, V24, P31, DOI 10.1016/j.jairtraman.2012.06.003; Lee JS, 2007, TOURISM MANAGE, V28, P434, DOI 10.1016/j.tourman.2006.03.012; Lee S, 2011, INT J HOSP MANAG, V30, P429, DOI 10.1016/j.ijhm.2010.11.002; Liang L., 2008, SOCIOECON PLANN SCI, V42, P206; Logue DennisE., 1972, FINANC MANAGE, V1, P37, DOI 10.2307/3665142; Pham MH, 2020, J ASIAN FINANC ECON, V7, P47, DOI 10.13106/jafeb.2020.vol7.no6.047; MODIGLIANI F, 1958, AM ECON REV, V48, P261; Moon J, 2015, J AIR TRANSP MANAG, V42, P282, DOI 10.1016/j.jairtraman.2014.11.009; MOYER RC, 1983, J ECON BUS, V35, P123, DOI 10.1016/0148-6195(83)90035-8; MYERS SC, 1984, J FINANC, V39, P575, DOI 10.2307/2327916; Nguyen TD, 2020, J ASIAN FINANC ECON, V7, P877, DOI 10.13106/jafeb.2020.vol7.no11.877; O'Leary M, 2020, FINANC TIMES; Oliveira M, 2017, J CORP FINANC, V42, P131, DOI 10.1016/j.jcorpfin.2016.11.009; Orazalin N, 2019, ENVIRON SCI POLLUT R, V26, P8157, DOI 10.1007/s11356-019-04325-9; Pilarski A., 1999, HDB AIRLINE FINANCE, P329; Pindado J, 2005, FINANC MARK PORTFOLI, V19, P343; Pongpirul K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237299; Rababah A, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2440; Ramamurti R., 1997, INT TRADE J, V11, P389; Scaggs M.B., 1986, REV REGIONAL EC BUSI, V11, P11; Scarpa C., 2007, 2 PAESE; SHLEIFER A, 1992, J FINANC, V47, P1343, DOI 10.2307/2328943; Springate G., 1978, THESIS SIMON FRASER; STAPLETON RC, 1981, J FINANC, V36, P982, DOI 10.2307/2327568; Stepanyan A., 2014, INT J ADV MANAGEMENT, V3, P16; Stupp D., 2015, PREVISAO INSOLVENCIA; SULLIVAN TG, 1978, REV ECON STAT, V60, P209, DOI 10.2307/1924974; Turaboglu T., 2017, BUS ECON RES J, V8, P247; Venkadasalam S, 2020, INT J EMERG MARK, V15, P875, DOI 10.1108/IJOEM-07-2019-0493; Winarna Jaka, 2017, Global Business and Finance Review, V22, P34; WINDLE RJ, 1991, J TRANSP ECON POLICY, V25, P31; Yang AS, 2017, FINANC RES LETT, V23, P291, DOI 10.1016/j.frl.2017.05.005; Zhang X, 2020, ECON MODEL, V92, P87, DOI 10.1016/j.econmod.2020.07.005; ZMIJEWSKI ME, 1984, J ACCOUNTING RES, V22, P59, DOI 10.2307/2490859	80	0	0	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259149	10.1371/journal.pone.0259149	http://dx.doi.org/10.1371/journal.pone.0259149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780487	gold, Green Published			2022-12-26	WOS:000755305800021
J	Chen, LG; Wu, PA; Tu, HY; Sheu, MH; Huang, LC				Chen, Li-Guo; Wu, Ping-An; Tu, Hsing-Yang; Sheu, Ming-Huei; Huang, Li-Chuan			Variation in tube voltage for pediatric neck 64VCT: Effect on radiation dose and image quality	PLOS ONE			English	Article							CT; PHANTOM; RECONSTRUCTION; REDUCTION; EXPOSURE	Exposure to ionizing radiation can cause cancer, especially in children. In computed tomography (CT), a trade-off exists between the radiation dose and image quality. Few studies have investigated the effect of dose reduction on image quality in pediatric neck CT. We aimed to assess the effect of peak kilovoltage on the radiation dose and image quality in pediatric neck multidetector-row CT. Measurements were made using three phantoms representative of children aged 1, 5, and 10 years, with tube voltages of 80, 100, and 120 kilovoltage peak (kVp); tube current of 10, 40, 80, 120, 150, 200, and 250 mA; and exposure time = 0.5 s (pitch, 0.984:1). Radiation dose estimates were derived from the dose-length product with a 64-multidetector-row CT scanner. Images obtained from the control protocol (120 kVp) were compared with the 80- and 100-kVp protocols. The effective dose (ED) was determined for each protocol and compared with the 120-kVp protocol. Quantitative analysis entailed noise measurements by recording the standard deviation of attenuation for a circular 1-cm(2) region of interest placed on homogeneous soft tissue structures in the phantom. The mean noise of the various kVp protocols was compared using the unpaired Student t-test. Reduction of ED was 37.58% and 68.58% for neck CT with 100 kVp and 80 kVp, respectively. The image noise level increased with the decrease in peak kilovoltage. Noise values were higher at 80 kVp at all neck levels, but did not increase at 100 kVp, compared to 120 kVp in the three phantoms. The measured noise difference was the greatest at 80 kVp (absolute increases<2.5 HU). The subjective image quality did not differ among the protocols. Thus, reducing voltage from 120 to 80 kVp for neck CT may achieve ED reduction of 68.58%, without compromising image quality.	[Chen, Li-Guo; Wu, Ping-An; Tu, Hsing-Yang; Sheu, Ming-Huei; Huang, Li-Chuan] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Imaging, Hualien, Taiwan; [Huang, Li-Chuan] Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University of Science & Technology	Huang, LC (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Imaging, Hualien, Taiwan.; Huang, LC (corresponding author), Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan.	hcl301@gmail.com	huang, lily/GLR-3494-2022					[Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Beir V, 2005, HLTH RISKS EXPOSURE; D'Angelo T, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180546; Estay C, 2015, J DIGEST DIS, V16, P83, DOI 10.1111/1751-2980.12213; Gunn ML, 2009, J COMPUT ASSIST TOMO, V33, P987, DOI 10.1097/RCT.0b013e3181a776ff; Higaki T, 2020, ACAD RADIOL, V27, P82, DOI 10.1016/j.acra.2019.09.008; Hoang JK, 2012, AM J ROENTGENOL, V198, P621, DOI 10.2214/AJR.11.6831; Inkoom S, 2017, RADIAT PROT DOSIM, V173, P361, DOI 10.1093/rpd/ncw007; Kadowaki Y, 2021, INT J CANCER, V148, P2429, DOI 10.1002/ijc.33436; Karmazyn B, 2013, AM J ROENTGENOL, V200, P1001, DOI 10.2214/AJR.12.9828; Lee E, 2015, PEDIATR RADIOL, V45, P1282, DOI 10.1007/s00247-015-3331-y; Masuda T, 2018, CAN ASSOC RADIOL J, V69, P390, DOI 10.1016/j.carj.2018.05.004; Meulepas JM, 2019, JNCI-J NATL CANCER I, V111, P256, DOI 10.1093/jnci/djy104; Nelson TR, 2014, J AM COLL RADIOL, V11, P292, DOI 10.1016/j.jacr.2013.10.011; NRC, 2006, HLTH RISKS EXP LOW L, V7; Papadakis AE, 2013, INVEST RADIOL, V48, P192, DOI 10.1097/RLI.0b013e31827efc17; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rehani MM, 2020, EUR RADIOL, V30, P1828, DOI 10.1007/s00330-019-06523-y; Reid J, 2010, AM J ROENTGENOL, V195, P1015, DOI 10.2214/AJR.09.3862; Siegel MJ, 2004, RADIOLOGY, V233, P515, DOI 10.1148/radiol.2332032107; Smith-Bindman R, 2019, JAMA-J AM MED ASSOC, V322, P843, DOI 10.1001/jama.2019.11456; Tipnis SV, 2019, AM J NEURORADIOL, V40, P1067, DOI 10.3174/ajnr.A6073; Vachha B, 2013, EUR J RADIOL, V82, P2222, DOI 10.1016/j.ejrad.2013.08.014; Yang P, 2020, CLIN ORAL INVEST, V24, P4617, DOI 10.1007/s00784-020-03331-3; Yu LF, 2011, RADIOGRAPHICS, V31, P835, DOI 10.1148/rg.313105079	25	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259772	10.1371/journal.pone.0259772	http://dx.doi.org/10.1371/journal.pone.0259772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767600	gold, Green Published			2022-12-26	WOS:000755249300044
J	Ahmadkhosravi, N; Khosravi, AD; Dezfuli, AAZ; Hashemzadeh, M; Saki, M; Mehr, FJ; Izadpour, F				Ahmadkhosravi, Nazanin; Khosravi, Azar Dokht; Dezfuli, Aram Asareh Zadegan; Hashemzadeh, Mohammad; Saki, Morteza; Mehr, Fatemeh Jahangiri; Izadpour, Farokh			Study of aerobic and anaerobic bacterial profile of nosocomial infections and their antibiotic resistance in a referral center, Southwest Iran: A three year cross-sectional study	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANT; PATTERNS; ADULTS	Background The drug resistance is expected to be the most important challenge in infection control in Iran, where there is no local report or standard drug resistance monitoring system. Therefore, this study aimed to investigate the aerobic and anaerobic bacterial profile of nosocomial infections and their antibiotic resistance in Ahvaz, southwest Iran. Methodology The gram-positive and gram-negative bacteria were identified on the basis of conventional culture and biochemical tests. The antibiotic resistance of the bacterial isolates against antibiotics was determined by the disk diffusion method. Results Among total 1156 collected positive samples, E. coli and coagulase-negative staphylococci (CoNS) were the most frequent pathogenic gram negative bacteria (GNB) and gram positive bacteria (GPB) respectively. Drug susceptibility testing revealed that among GNB, P. aeruginosa was 100% resistant to amikacin, cefepime, ciprofloxacin and tetracycline. In the case of E. coli, the resistance rate was (98%) for trimethoprim sulfamethoxazole and cefepime. For GPB, S. aureus showed the highest resistance rates to amikacin (100%) and clindamycin (100%). In addition, CoNS strains showed a high level of resistance to doxycycline (100%), erythromycin (100%) and cefoxitin (97%). In Bacteroeides fragilis isolates, the highest resistance rate belonged to clindamycin (72%), and Clostridium perfringens strains showed high level of resistance to penicillin (46%). Conclusion The results highlighted that there are distinct factors leading to antimicrobial resistance in Ahvaz, southwest Iran. The primary contributors to the resistance development, include poor surveillance of drug-resistant infections, poor quality of available antibiotics, clinical misuse, and the ease of access to antibiotics. Moreover, similar factors such as self-medication and the lack of regulation on medication imports play a role in antibiotic resistance in the region.	[Ahmadkhosravi, Nazanin; Dezfuli, Aram Asareh Zadegan] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran; [Ahmadkhosravi, Nazanin; Khosravi, Azar Dokht; Dezfuli, Aram Asareh Zadegan; Hashemzadeh, Mohammad; Saki, Morteza] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahvaz, Iran; [Khosravi, Azar Dokht; Dezfuli, Aram Asareh Zadegan; Hashemzadeh, Mohammad; Saki, Morteza] Ahvaz Jundishapur Univ Med Sci, Dept Microbiol, Fac Med, Ahvaz, Iran; [Khosravi, Azar Dokht] Iranian Study Grp Microbial Drug Resistance, Ahvaz, Iran; [Mehr, Fatemeh Jahangiri] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Pain Res Ctr, Ahvaz, Iran; [Izadpour, Farokh] Ahvaz Jundishapur Univ Med Sci, Emam Khomeini Teaching Hosp, Microbiol Sect Med Lab, Ahvaz, Iran	Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS); Ahvaz Jundishapur University of Medical Sciences (AJUMS)	Dezfuli, AAZ (corresponding author), Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran.; Dezfuli, AAZ (corresponding author), Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahvaz, Iran.; Dezfuli, AAZ (corresponding author), Ahvaz Jundishapur Univ Med Sci, Dept Microbiol, Fac Med, Ahvaz, Iran.	aramasareh836@yahoo.com	Saki, Morteza/R-8319-2017; Dezfuli, Aram Asarehzadegan/AAX-1264-2020	Saki, Morteza/0000-0001-7419-0116; Dezfuli, Aram Asarehzadegan/0000-0003-3947-146X	Students Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran [99S40]	Students Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran	The authors received a limited funding for this work from Students Research Committee (Code: 99S40), Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. The funder is Dr. Nazanin Ahmadkhosravi listed as first author.	Abayneh M, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/4846159; Akhi MT, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.20309v2; Alemayehu T, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4210-1; [Anonymous], 2020, PERFORMANCE STANDARD, V30th; [Anonymous], 2019, PERFORMANCE STANDARD, V29; Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12; Askari E, 2012, IRAN J BASIC MED SCI, V15, P1010; Azimi T, 2019, INFECT DRUG RESIST, V12, P2089, DOI 10.2147/IDR.S215329; Dadgostar P, 2019, INFECT DRUG RESIST, V12, P3903, DOI 10.2147/IDR.S234610; Hemmati H, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05223-x; Hosseini-Divkolaye NS, 2009, FORCED MIGR REV, P66; Kashefieh M, 2021, IRAN J TROP MED, V14, P2021, DOI [10.1155/2021/9195184, DOI 10.1155/2021/9195184]; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mahmoudi H, 2016, IRAN J MED MICROBIOL, V10, P69; Mahmoudi S, 2017, J GLOB ANTIMICROB RE, V11, P17, DOI 10.1016/j.jgar.2017.04.013; Matsumoto T, 2004, INT J ANTIMICROB AG, V24, pS35, DOI 10.1016/j.ijantimicag.2004.03.001; Mave V, 2017, J INFECT DIS, V215, P1312, DOI 10.1093/infdis/jix114; Mihankhah A, 2017, J RES MED SCI, V22, DOI 10.4103/jrms.JRMS_889_16; Montazeri EA, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200847; Moosavian M, 2020, INFECT DRUG RESIST, V13, P1033, DOI 10.2147/IDR.S244896; Mori T, 2007, TUBERCULOSIS, V87, pS5, DOI 10.1016/j.tube.2007.05.007; Nurain Aymen Mudawe, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P1055, DOI 10.1016/j.apjtb.2015.09.015; Onanuga A, 2011, J HEALTH POPUL NUTR, V29, P446; Rajivgandhi G., 2018, FRONT LAB MED, V2, P5, DOI [DOI 10.1016/J.FLM.2018.01.001, 10.1016/j.flm.2018.01.001]; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Razavi S, 2018, ARCH CLIN INFECT DIS, V13, DOI 10.5812/archcid.58410; Saeed NK, 2010, SAUDI MED J, V31, P1341; Salih M. K., 2016, OJMM, V6, P59; Savas L, 2005, EUR J GEN MED, V2, P20, DOI 10.29333/ejgm/82261; Sheikh AF, 2019, INFECT DRUG RESIST, V12, P1771, DOI 10.2147/IDR.S204432; Snydman DR, 2002, CLIN INFECT DIS, V35, pS126, DOI 10.1086/341934; Sorsa A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0486-6; Stromberg ZR, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.035063; Tille P., 2017, BAILEY SCOTTS DIAGNO; World Health Organization, 2015, WORLDW COUNTR SIT AN	36	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259512	10.1371/journal.pone.0259512	http://dx.doi.org/10.1371/journal.pone.0259512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752474	Green Published, gold			2022-12-26	WOS:000754499700017
J	Peng, SH; Wang, AQ; Lian, YY; Zhang, X; Zeng, B; Chen, QL; Yang, HM; Li, JL; Li, LM; Dan, JG; Liao, JJ; Zhou, SH				Peng, Sihua; Wang, Aqiang; Lian, Yuyang; Zhang, Xi; Zeng, Bei; Chen, Qiulin; Yang, Heming; Li, Jinlei; Li, Limin; Dan, Jianguo; Liao, Jianjun; Zhou, Shihao			Smartphone-based molecularly imprinted sensors for rapid detection of thiamethoxam residues and applications	PLOS ONE			English	Article							CARBON; IMMUNOSENSORS; PESTICIDES; VEGETABLES; PLATFORM	In order to achieve rapid detection of thiamethoxam residues in mango, cowpea and water, this study modified the screen printed carbon electrode (SPCE) to make a specific molecular imprinting sensor (Thiamethoxam-MIP/Au/rGO/SPCE) for thiamethoxam. An integrated smartphone platform was also built for thiamethoxam residue analysis. The performance of the complete system was analyzed by cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The system was then applied for the rapid determination of thiamethoxam residues in water, mango and cowpea samples. The results showed that the molecular sensor showed good linearity in the range 0.5-3.0 mu mol/L of thiamethoxam. The detection limit of thiamethoxam was 0.5 mu mol/L. Moreover, the sensor had good reproducibility and anti-interference performance. The average recovery rates of the pesticide residues in water, mango and cowpea samples were in the range of 90-110% with relative standard deviations < 5%. The rapid detection system for thiamethoxam residue constructed in this study was simple, reliable, reproducible and had strong anti-interference. It has broad application prospects in the field detection of thiamethoxam residue, and serves as a valuable reference for the further development of rapid detection technology of pesticide residues in the field of environment and food safety.	[Peng, Sihua; Wang, Aqiang; Lian, Yuyang; Zhang, Xi; Chen, Qiulin; Yang, Heming; Li, Jinlei; Li, Limin; Zhou, Shihao] Hainan Univ, Sanya Nanfan Res Inst, Haikou, Hainan, Peoples R China; [Peng, Sihua; Zeng, Bei; Dan, Jianguo] Hainan Univ, Coll Plant Protect, Haikou, Hainan, Peoples R China; [Liao, Jianjun] Hainan Univ, Coll Ecol & Environm, Haikou, Hainan, Peoples R China; [Zhou, Shihao] Hainan Univ, Coll Forestry, Key Lab Germplasm Resources Biol Trop Special Orn, Haikou, Hainan, Peoples R China	Hainan University; Hainan University; Hainan University; Hainan University	Zhou, SH (corresponding author), Hainan Univ, Sanya Nanfan Res Inst, Haikou, Hainan, Peoples R China.; Dan, JG (corresponding author), Hainan Univ, Coll Plant Protect, Haikou, Hainan, Peoples R China.; Liao, JJ (corresponding author), Hainan Univ, Coll Ecol & Environm, Haikou, Hainan, Peoples R China.; Zhou, SH (corresponding author), Hainan Univ, Coll Forestry, Key Lab Germplasm Resources Biol Trop Special Orn, Haikou, Hainan, Peoples R China.	jianguodan@gmail.com; liaojianjun008@63.com; zsh88200939@126.com			Natural Science Foundation of China [21866012, 22166016, 31760518]; High-level Talent Project of Hainan Natural Science Foundation [320RC499]; Key RAMP;D Projects of Hainan Province [ZDYF2019096]; Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program DProjectDProject [QCXM201908]; Open Project of Key Laboratory of Tropical Fruit Tree Biology of Hainan Province [KFZX2020001]; College Students' innovation and Entrepreneurship Project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-level Talent Project of Hainan Natural Science Foundation; Key RAMP;D Projects of Hainan Province; Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program DProjectDProject; Open Project of Key Laboratory of Tropical Fruit Tree Biology of Hainan Province; College Students' innovation and Entrepreneurship Project	This study was funded in the form of grants by Natural Science Foundation of China (Grant No. 21866012; 22166016; 31760518), High-level Talent Project of Hainan Natural Science Foundation (Grant No. 320RC499), Key R&D Projects of Hainan Province (Grant No. ZDYF2019096), Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program DProject (Grant No. QCXM201908), The Open Project of Key Laboratory of Tropical Fruit Tree Biology of Hainan Province (Grant No. KFZX2020001), and College Students' innovation and Entrepreneurship Project.	Amatatongchai M, 2019, ANAL CHIM ACTA, V1077, P255, DOI 10.1016/j.aca.2019.05.047; Cao J, 2020, J AGR FOOD CHEM, V68, P7298, DOI 10.1021/acs.jafc.0c01962; Della Pelle F, 2018, TALANTA, V186, P389, DOI 10.1016/j.talanta.2018.04.082; Dong T, 2017, BIOSENS BIOELECTRON, V94, P321, DOI 10.1016/j.bios.2017.03.005; Fan XQ, 2019, REGUL TOXICOL PHARM, V101, P135, DOI 10.1016/j.yrtph.2018.11.003; Fang Y, 2016, BIOSENS BIOELECTRON, V85, P603, DOI 10.1016/j.bios.2016.05.060; [郭明 Guo Ming], 2014, [农药学学报, Chinese Journal of Pesticide Science], V16, P559; Hu HY, 2020, J ENVIRON SCI HEAL B, V56, P168, DOI 10.1080/03601234.2020.1853460; Huang XW, 2018, ANALYST, V143, P5339, DOI 10.1039/c8an01269e; Ibanez-Redin G, 2019, MAT SCI ENG C-MATER, V99, P1502, DOI 10.1016/j.msec.2019.02.065; Jamaluddin RZAR, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051343; Jewell E, 2016, BIOSENSORS-BASEL, V6, DOI 10.3390/bios6030030; Ji DZ, 2019, BIOSENS BIOELECTRON, V129, P216, DOI 10.1016/j.bios.2018.09.082; Jiang JG, 2018, CHEMOSPHERE, V201, P159, DOI 10.1016/j.chemosphere.2018.02.168; Jiang XS, 2008, BIOSENS BIOELECTRON, V23, P1577, DOI 10.1016/j.bios.2008.01.035; Kayis T, 2019, ENVIRON SCI POLLUT R, V26, P36623, DOI 10.1007/s11356-019-06810-7; Khairy M, 2018, FOOD CHEM, V255, P104, DOI 10.1016/j.foodchem.2018.02.004; Liang B, 2013, BIOSENS BIOELECTRON, V43, P131, DOI 10.1016/j.bios.2012.11.040; Liang WQ, 2017, J CHROMATOGR A, V1491, P9, DOI 10.1016/j.chroma.2017.02.034; Lu CS, 2018, ENVIRON SCI TECHNOL, V52, P3175, DOI 10.1021/acs.est.7b05596; Maienfisch P, 2001, PEST MANAG SCI, V57, P906, DOI 10.1002/ps.365; Meng BH, 2018, BIOMED CHROMATOGR, V32, DOI 10.1002/bmc.4225; Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67; Namwongsa S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203394; Nie ZW, 2019, CELL SIGNAL, V53, P294, DOI 10.1016/j.cellsig.2018.08.014; Gonzalez GP, 2009, ANAL BIOANAL CHEM, V394, P963, DOI 10.1007/s00216-008-2584-9; Periasamy AP, 2009, SENSORS-BASEL, V9, P4034, DOI 10.3390/s90604034; Qin DQ, 2020, ECOTOX ENVIRON SAFE, V194, DOI 10.1016/j.ecoenv.2020.110391; Saraiva AS, 2017, ECOTOX ENVIRON SAFE, V137, P240, DOI 10.1016/j.ecoenv.2016.12.009; Sjerps RMA, 2019, CHEMOSPHERE, V235, P510, DOI 10.1016/j.chemosphere.2019.06.207; Tang J, 2018, MICROCHIM ACTA, V185, DOI 10.1007/s00604-018-3089-7; Wang Y, 2021, ANALYST, V146, P2886, DOI 10.1039/d1an00029b; Wu CC, 2020, PEST MANAG SCI, V76, P2190, DOI 10.1002/ps.5756; Wu M, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11111770; Xia YQ, 2019, ACS SENSORS, V4, P3298, DOI 10.1021/acssensors.9b01927; Xu YL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18124281; Yan S, 2021, PEST MANAG SCI, V77, P1954, DOI 10.1002/ps.6223; Yang DQ, 2021, CHEMOSPHERE, V273, DOI 10.1016/j.chemosphere.2021.129727; Zhang C, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105719; Zhao WS, 2020, J MOL MODEL, V26, DOI 10.1007/s00894-020-04362-z; Zhao YT, 2018, ANAL CHEM, V90, P7391, DOI 10.1021/acs.analchem.8b00837; Zhou Y, 2021, SCI TOTAL ENVIRON, V782, DOI 10.1016/j.scitotenv.2021.146803	42	3	3	7	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258508	10.1371/journal.pone.0258508	http://dx.doi.org/10.1371/journal.pone.0258508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748559	Green Published, gold			2022-12-26	WOS:000755468000009
J	Sheppard, WEA; Dickerson, P; Baraas, RC; Mon-Williams, M; Barrett, BT; Wilkie, RM; Coats, RO				Sheppard, William E. A.; Dickerson, Polly; Baraas, Rigmor C.; Mon-Williams, Mark; Barrett, Brendan T.; Wilkie, Richard M.; Coats, Rachel O.			Exploring the effects of degraded vision on sensorimotor performance	PLOS ONE			English	Article							BINOCULAR VISION; VISUAL IMPAIRMENT; OLDER-ADULTS; CATARACT-SURGERY; ONLINE CONTROL; STEREO VISION; AMBLYOPIA; IMPACT; REHABILITATION; COORDINATION	Purpose Many people experience unilateral degraded vision, usually owing to a developmental or age-related disorder. There are unresolved questions regarding the extent to which such unilateral visual deficits impact on sensorimotor performance; an important issue as sensorimotor limitations can constrain quality of life by restricting 'activities of daily living'. Examination of the relationship between visual deficit and sensorimotor performance is essential for determining the functional implications of ophthalmic conditions. This study attempts to explore the effect of unilaterally degraded vision on sensorimotor performance. Methods In Experiment 1 we simulated visual deficits in 30 participants using unilateral and bilateral Bangerter filters to explore whether motor performance was affected in water pouring, peg placing, and aiming tasks. Experiment 2 (n = 74) tested the hypothesis that kinematic measures are associated with visuomotor deficits by measuring the impact of small visual sensitivity decrements created by monocular viewing on sensorimotor interactions with targets presented on a planar surface in aiming, tracking and steering tasks. Results In Experiment 1, the filters caused decreased task performance-confirming that unilateral (and bilateral) visual loss has functional implications. In Experiment 2, kinematic measures were affected by monocular viewing in two of three tasks requiring rapid online visual feedback (aiming and steering). Conclusions Unilateral visual loss has a measurable impact on sensorimotor performance. The benefits of binocular vision may be particularly important for some groups (e.g. older adults) where an inability to complete sensorimotor tasks may necessitate assisted living. There is an urgent need to develop rigorous kinematic approaches to the quantification of the functional impact of unilaterally degraded vision and of the benefits associated with treatments for unilateral ophthalmic conditions to enable informed decisions around treatment.	[Sheppard, William E. A.; Mon-Williams, Mark; Wilkie, Richard M.; Coats, Rachel O.] Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England; [Dickerson, Polly] York Teaching Hosp NHS Fdn Trust, Dept Ophthalmol, York, N Yorkshire, England; [Baraas, Rigmor C.; Mon-Williams, Mark] Univ South Eastern Norway, Natl Ctr Opt Vis & Eye Care, Dept Optometry Radiog & Lighting Design, Kongsberg, Norway; [Mon-Williams, Mark] Bradford Teaching Hosp NHS Fdn Trust, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Barrett, Brendan T.] Univ Bradford, Fac Life Sci, Sch Optometry & Vis Sci, Bradford, W Yorkshire, England	University of Leeds; University College of Southeast Norway; University of Bradford	Sheppard, WEA (corresponding author), Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England.	w.e.sheppard@leeds.ac.uk	Sheppard, William/GWC-4902-2022; Baraas, Rigmor/H-9137-2016	Mon-Williams, Mark/0000-0001-7595-8545; Coats, Rachel/0000-0003-4415-408X; Baraas, Rigmor/0000-0003-3259-7617; Sheppard, William/0000-0002-2691-6469	Medical Research Council [MR/S037527/1]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council's ActEarly program through a grant awarded to MM (MR/S037527/1).	ADAMS GL, 1965, RES QUART, V36, P3, DOI 10.1080/10671188.1965.10614650; Adrian J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226308; Alramis F, 2016, HUM MOVEMENT SCI, V46, P52, DOI 10.1016/j.humov.2015.12.006; [Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18680; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Baker DH, 2018, PSYCHOL BULL, V144, P1186, DOI 10.1037/bul0000163; Banks MS, 2001, J VISION, V1, P55, DOI 10.1167/1.2.1; Bauer A, 2001, GRAEF ARCH CLIN EXP, V239, P400, DOI 10.1007/s004170100273; Bilen NB, 2016, INT J OPHTHALMOL-CHI, V9, P1127, DOI 10.18240/ijo.2016.08.07; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coull J, 2000, J MOTOR BEHAV, V32, P347, DOI 10.1080/00222890009601385; Culmer PC., 2016, EUR J DENT EDUC, V11, P1, DOI [10.1111/eje.1221427324833, DOI 10.1111/EJE.1221427324833]; Culmer PR, 2009, J NEUROSCI METH, V184, P184, DOI 10.1016/j.jneumeth.2009.07.025; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Dev MK, 2014, CURR EYE RES, V39, P232, DOI 10.3109/02713683.2013.838973; Domkin Dmitry, 2016, J Optom, V9, P93, DOI 10.1016/j.optom.2015.03.003; Dougherty K, 2019, CURR BIOL, V29, P381, DOI 10.1016/j.cub.2018.12.004; DVLA, 2018, DRIV EYES RUL; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Fricke T. R., 1997, CLIN EXPT OPTOMETRY, V80, P165, DOI [DOI 10.1111/J.1444-0938.1997.TB04876.X, DOI 10.1111/J.1444-0938.1997]; Gopinath B, 2014, MATURITAS, V77, P263, DOI 10.1016/j.maturitas.2013.12.001; Grant S, 2019, EXP BRAIN RES, V237, P1239, DOI 10.1007/s00221-019-05503-4; Grant S, 2015, EXP BRAIN RES, V233, P3489, DOI 10.1007/s00221-015-4421-7; Grant S, 2011, STRABISMUS, V19, P119, DOI 10.3109/09273972.2011.600423; Hill LJ., 2021, WELLCOME OPEN RES, V6, P53; Jackson SR, 1997, VIS COGN, V4, P113, DOI 10.1080/713756755; JASP Team, 2018, JASP VERS 092 COMP S; Johnson RL, 2010, EXP BRAIN RES, V207, P291, DOI 10.1007/s00221-010-2438-5; JONES RK, 1981, J EXP PSYCHOL HUMAN, V7, P30, DOI 10.1037/0096-1523.7.1.30; Kallie CS., 2010, J VIS 0901, V10, P1, DOI [10.1167/10.11.1, DOI 10.1167/10.11.1]; Kempen GIJM, 2012, QUAL LIFE RES, V21, P1405, DOI 10.1007/s11136-011-0061-y; To KG, 2014, CLIN INTERV AGING, V9, P743, DOI 10.2147/CIA.S61224; Lappin JS., 2014, FRONTIERS PSYCHOL; Maiello G, 2018, EXP BRAIN RES, V236, P691, DOI 10.1007/s00221-017-5160-8; MAROTTA JJ, 1995, EXP BRAIN RES, V104, P107; Mazyn LIN, 2007, EXP BRAIN RES, V179, P723, DOI 10.1007/s00221-007-0957-5; Mazyn LIN, 2004, EXP BRAIN RES, V157, P383, DOI 10.1007/s00221-004-1926-x; MCKNIGHT AJ, 1991, ACCIDENT ANAL PREV, V23, P225, DOI 10.1016/0001-4575(91)90002-M; Meuleners LB, 2012, OPHTHAL EPIDEMIOL, V19, P23, DOI 10.3109/09286586.2011.628776; Mon-Williams M, 1999, EXP BRAIN RES, V128, P578, DOI 10.1007/s002210050885; O'Connor AR, 2010, INVEST OPHTH VIS SCI, V51, P2019, DOI 10.1167/iovs.09-4434; Olivier I, 1998, J MOTOR BEHAV, V30, P343, DOI 10.1080/00222899809601348; Orban GA, 2006, TRENDS NEUROSCI, V29, P466, DOI 10.1016/j.tins.2006.06.012; Ozek D, 2018, ARQ BRAS OFTALMOL, V81, P475, DOI 10.5935/0004-2749.20180089; Perez GM, 2010, INVEST OPHTH VIS SCI, V51, P609, DOI 10.1167/iovs.09-3726; Piano MEF, 2013, INVEST OPHTH VIS SCI, V54, P8204, DOI 10.1167/iovs.12-10934; Preston N, 2016, DISABIL REHABIL-ASSI, V11, P281, DOI 10.3109/17483107.2014.932020; Raw RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211706; Raw RK, 2012, EXP BRAIN RES, V217, P35, DOI 10.1007/s00221-011-2971-x; Read JCA, 2013, I-PERCEPTION, V4, P101, DOI 10.1068/i0565; Reed-Jones RJ, 2013, MATURITAS, V75, P22, DOI 10.1016/j.maturitas.2013.01.019; RNIB, 2017, SURG DEF SIGHT DEN V; ROGERS B, 1989, NATURE, V339, P135, DOI 10.1038/339135a0; ROGERS BJ, 1993, NATURE, V361, P253, DOI 10.1038/361253a0; Rosenthal R, 1991, METAANALYTIC PROCEDU; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rstudio T, 2020, RSTUDIO INT DEV R; SERVOS P, 1994, EXP BRAIN RES, V98, P119; SERVOS P, 1992, VISION RES, V32, P1513, DOI 10.1016/0042-6989(92)90207-Y; Shire K., 2020, WELLCOME OPEN RES, V5, P47, DOI [10.12688/wellcomeopenres.15610.1, DOI 10.12688/WELLCOMEOPENRES.15610.1]; Siderov J, 1999, ACTA OPHTHALMOL SCAN, V77, P673, DOI 10.1034/j.1600-0420.1999.770613.x; Simpson WA, 2009, ACTA PSYCHOL, V131, P93, DOI 10.1016/j.actpsy.2009.03.006; Stewart HJ, 2013, AUTISM RES, V6, P522, DOI 10.1002/aur.1312; Tabrett DR, 2011, INVEST OPHTH VIS SCI, V52, P5293, DOI 10.1167/iovs.10-7055; Tiffin J, 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tresilian JR, 1999, P ROY SOC B-BIOL SCI, V266, P39, DOI 10.1098/rspb.1999.0601; Vera J, 2020, EUR J SPORT SCI, V20, P157, DOI 10.1080/17461391.2019.1617354; Webber AL, 2008, INVEST OPHTH VIS SCI, V49, P594, DOI 10.1167/iovs.07-0869; White AD, 2014, SURG ENDOSC, V28, P1188, DOI 10.1007/s00464-013-3307-7; WOOD JM, 1994, HUM FACTORS, V36, P476, DOI 10.1177/001872089403600305; Wood J, 2011, OPHTHAL PHYSL OPT, V31, P201, DOI 10.1111/j.1475-1313.2011.00842.x; Wood J, 2009, VISION RES, V49, P2225, DOI 10.1016/j.visres.2009.06.017; Wood JM, 2014, INVEST OPHTH VIS SCI, V55, P2284, DOI 10.1167/iovs.13-13369	78	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258678	10.1371/journal.pone.0258678	http://dx.doi.org/10.1371/journal.pone.0258678			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ4ST	34748569	Green Published, gold			2022-12-26	WOS:000755468000012
J	Zumbro, E; Alexander-Katz, A				Zumbro, Emiko; Alexander-Katz, Alfredo			Multivalent polymers can control phase boundary, dynamics, and organization of liquid-liquid phase separation	PLOS ONE			English	Article							RNA-BINDING DOMAINS; DISORDERED PROTEINS; BIOLOGICAL-SYSTEMS; TRANSITIONS; BEHAVIOR; DENSITY	Multivalent polymers are a key structural component of many biocondensates. When interacting with their cognate binding proteins, multivalent polymers such as RNA and modular proteins have been shown to influence the liquid-liquid phase separation (LLPS) boundary to both control condensate formation and to influence condensate dynamics after phase separation. Much is still unknown about the function and formation of these condensed droplets, but changes in their dynamics or phase separation are associated with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer's Disease. Therefore, investigation into how the structure of multivalent polymers relates to changes in biocondensate formation and maturation is essential to understanding and treating these diseases. Here, we use a coarse-grain, Brownian Dynamics simulation with reactive binding that mimics specific interactions in order to investigate the difference between non-specific and specific multivalent binding polymers. We show that non-specific binding interactions can lead to much larger changes in droplet formation at lower protein-polymer interaction energies than their specific, valence-limited counterparts. We also demonstrate the effects of solvent conditions and polymer length on phase separation, and we present how modulating binding energy to the polymer can change the organization of a droplet in a three component system of polymer, binding protein, and solvent. Finally, we compare the effects of surface tension and polymer binding on the condensed phase dynamics, and show that both lower protein solubilities and higher attraction/affinity of the protein to the polymer result in slower droplet dynamics. This research will help to better understand experimental systems and provides additional insight into how multivalent polymers can control LLPS.	[Zumbro, Emiko; Alexander-Katz, Alfredo] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Alexander-Katz, A (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	aalexand@mit.edu			Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program; Ida M. Green Fellowship through the Massachusetts Institute of Technology Office of Graduate Education; Collamore-Rogers Fellowship through the Massachusetts Institute of Technology Office of Graduate Education	Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program(United States Department of Defense); Ida M. Green Fellowship through the Massachusetts Institute of Technology Office of Graduate Education; Collamore-Rogers Fellowship through the Massachusetts Institute of Technology Office of Graduate Education	E. Z. was supported by the Department of Defense (DoD) through the National Defense Science and Engineering Graduate (NDSEG) Fellowship Program. (https://ndseg.sysplus.com) E. Z. was also supported by the Ida M. Green Fellowship and the Collamore-Rogers Fellowship through the Massachusetts Institute of Technology Office of Graduate Education. (https://oge.mit.edu/finances/fellowships/odgefellowships) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Alexander-Katz A, 2008, MACROMOLECULES, V41, P3363, DOI 10.1021/ma702331d; Alexander-Katz A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.028102; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banani SF, 2016, CELL, V166, P651, DOI 10.1016/j.cell.2016.06.010; Bates FS, 1999, PHYS TODAY, V52, P32, DOI 10.1063/1.882522; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Brackley CA, 2013, P NATL ACAD SCI USA, V110, pE3605, DOI 10.1073/pnas.1302950110; Choi JM, 2020, ANNU REV BIOPHYS, V49, P107, DOI 10.1146/annurev-biophys-121219-081629; Choi JM, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007028; Deviri D, 2020, SOFT MATTER, V16, P5458, DOI 10.1039/c9sm02408e; Ditlev JA, 2018, J MOL BIOL, V430, P4666, DOI 10.1016/j.jmb.2018.08.003; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Espinosa JR, 2020, P NATL ACAD SCI USA, V117, P13238, DOI 10.1073/pnas.1917569117; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Flory P., 1989, STAT MECH CHAIN MOL; Gomes E, 2019, J BIOL CHEM, V294, P7115, DOI 10.1074/jbc.TM118.001192; Harmon TS, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aab8d9; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Jacobs WM, 2017, BIOPHYS J, V112, P683, DOI 10.1016/j.bpj.2016.10.043; Jacobs WM, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4878836; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jawerth L, 2020, SCIENCE, V370, P1317, DOI 10.1126/science.aaw4951; Jawerth LM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.258101; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King MR, 2001, P NATL ACAD SCI USA, V98, P14919, DOI 10.1073/pnas.261272498; Kolmakov GV, 2009, ACS NANO, V3, P885, DOI 10.1021/nn900052h; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lodge T. P., 2007, POLYM CHEM-UK; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Mao S, 2019, SOFT MATTER, V15, P1297, DOI 10.1039/c8sm02045k; Martin EW, 2020, SCIENCE, V367, P694, DOI 10.1126/science.aaw8653; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nandi SK, 2019, INTERACTING MULTIVAL; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Onuchic PL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48457-x; Osmanovic D, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4952981; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Ranganathan S, 2020, ELIFE, V9, DOI 10.7554/eLife.56159; Riback JA, 2020, NATURE, V581, P209, DOI 10.1038/s41586-020-2256-2; Sanders DW, 2020, CELL, V181, P306, DOI 10.1016/j.cell.2020.03.050; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; SHAMOO Y, 1994, BIOCHEMISTRY-US, V33, P8272, DOI 10.1021/bi00193a014; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Sing CE, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.198302; Sing CE, 2011, MACROMOLECULES, V44, P6962, DOI 10.1021/ma200830t; Singh K, 2020, MACROMOLECULES, V53, P3883, DOI 10.1021/acs.macromol.0c00258; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Tuu-Szabo B, 2019, BBA-PROTEINS PROTEOM, V1867, P988, DOI 10.1016/j.bbapap.2019.04.005; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; Zumbro E, 2020, BIOPHYS J, V119, P1849, DOI 10.1016/j.bpj.2020.09.035; Zumbro E, 2020, ACS OMEGA, V5, P10774, DOI 10.1021/acsomega.0c00334; Zumbro E, 2019, BIOPHYS J, V117, P892, DOI 10.1016/j.bpj.2019.07.026	61	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0245405	10.1371/journal.pone.0245405	http://dx.doi.org/10.1371/journal.pone.0245405			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748548	Green Published, gold, Green Submitted			2022-12-26	WOS:000755468000001
J	Leverkus, AB; Levy, L; Andivia, E; Annighofer, P; De Cuyper, B; Ivetic, V; Lazdina, D; Lof, M; Villar-Salvador, P				Leverkus, Alexandro B.; Levy, Laura; Andivia, Enrique; Annighoefer, Peter; De Cuyper, Bart; Ivetic, Vladan; Lazdina, Dagnija; Loef, Magnus; Villar-Salvador, Pedro			Restoring oak forests through direct seeding or planting: Protocol for a continental-scale experiment	PLOS ONE			English	Article							RESTORATION; GROWTH	The choice of revegetating via direct seeding or planting nursery-grown seedlings influences the potential stresses suffered by seedlings such as herbivory and drought. The outcome of the balance between both revegetation methods may ultimately depend on how species identity and traits such as seed and seedling size interact with environmental conditions. To test this, we will conduct a continental-scale experiment consisting of one mini-experiment replicated by multiple participants across Europe. Each participant will establish a site with seeded and planted individuals of one or more native, locally growing oak (Quercus) species; the selection of this genus aims to favour continental-scale participation and to allow testing the response of a widely distributed genus of broad ecological and economic relevance. At each site, participants will follow the present protocol for seed collection, seeding in the field, nursery cultivation, outplanting, protection against herbivores, site maintenance, and measurement of seedling performance and environmental variables. Each measurement on each species at each site will produce one effect size; the data will be analysed through mixed-effects meta-analysis. With this approach we will assess the main effect of revegetation method, species, plant functional traits, and the potential effect of site-specific effect moderators. Overall, we will provide a continental-scale estimate on the seeding vs. planting dilemma and analyse to what extent the differences in environmental conditions across sites, seed size, functional traits, and the phylogenetic relatedness of species can account for the differences in the effect of revegetation method on seedling performance across study sites and species.	[Leverkus, Alexandro B.; Levy, Laura] Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain; [Leverkus, Alexandro B.] Univ Granada, Inst Interuniv Invest Sistema Tierra Andalucia II, Lab Ecol, Granada, Spain; [Andivia, Enrique] Univ Complutense Madrid, Dept Biodiversidad Ecol & Evoluc, Madrid, Spain; [Annighoefer, Peter] Tech Univ Munich, Professorship Forest & Agroforest Syst, Freising Weihenstephan, Germany; [De Cuyper, Bart] Res Inst Nat & Forest, Brussels, Belgium; [Ivetic, Vladan] Univ Belgrade, Fac Forestry, Belgrade, Serbia; [Lazdina, Dagnija] Latvian State Forest Res Inst Silava, Salaspils, Latvia; [Loef, Magnus] Swedish Univ Agr Sci, Southern Swedish Forest Res Ctr, Lomma, Sweden; [Villar-Salvador, Pedro] Univ Alcala, Dept Ciencias Vida, Grp Ecol & Restauracio Forestal FORECO, Madrid, Spain	University of Granada; Universidad de Cordoba; Universidad de Jaen; University of Granada; Instituto Interuniversitario de Investigacion del Sistema Tierra en Andalucia; Complutense University of Madrid; Technical University of Munich; Research Institute for Nature & Forest; University of Belgrade; Latvian State Forest Research Institute "Silava"; Swedish University of Agricultural Sciences; Universidad de Alcala	Leverkus, AB (corresponding author), Univ Granada, Fac Ciencias, Dept Ecol, Granada, Spain.; Leverkus, AB (corresponding author), Univ Granada, Inst Interuniv Invest Sistema Tierra Andalucia II, Lab Ecol, Granada, Spain.	leverkus@ugr.es	Villar-Salvador, Pedro/L-1380-2014; Ivetić, Vladan/U-1544-2019; Andivia, Enrique/B-3088-2017	Villar-Salvador, Pedro/0000-0001-9338-4530; Ivetić, Vladan/0000-0003-0587-1422; Leverkus, Alexandro B./0000-0001-5452-3614; De Cuyper, Bart/0000-0002-4553-0182; Andivia, Enrique/0000-0002-9096-3294				Bonfil C, 1998, AM J BOT, V85, P79, DOI 10.2307/2446557; Borenstein M, 2009, INTRO META ANAL; Castro J, 2015, NEW FOREST, V46, P919, DOI 10.1007/s11056-015-9478-4; Cernansky R, 2018, NATURE, V560, P542, DOI 10.1038/d41586-018-06031-x; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Palma AC, 2015, APPL VEG SCI, V18, P561, DOI 10.1111/avsc.12173; Gurevich J, 2013, HDB METAANALYSIS ECO, P313; Hartig GL., 1819, ANWEISUNG TAXATION B, V4th; Jin Y, 2019, ECOGRAPHY, V42, P1353, DOI 10.1111/ecog.04434; Jones HP, 2021, RESTOR ECOL, V29, DOI 10.1111/rec.13343; Koricheva J., 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.23943/PRINCETON/9780691137285.001.0001; Leverkus AB, 2021, RESTOR ECOL, V29, DOI 10.1111/rec.13372; Leverkus AB, 2021, J ECOL, V109, P3224, DOI 10.1111/1365-2745.13581; Leverkus AB, 2015, ECOL ENG, V83, P276, DOI 10.1016/j.ecoleng.2015.06.033; Lof M, 2019, FOREST ECOL MANAG, V448, P474, DOI 10.1016/j.foreco.2019.06.032; Nave LE, 2018, P NATL ACAD SCI USA, V115, P2776, DOI 10.1073/pnas.1719685115; Tsakaldimi M, 2009, PLANT SOIL, V324, P103, DOI 10.1007/s11104-009-9974-4; Zadworny M, 2014, FOREST ECOL MANAG, V318, P133, DOI 10.1016/j.foreco.2014.01.017	18	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259552	10.1371/journal.pone.0259552	http://dx.doi.org/10.1371/journal.pone.0259552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735541	Green Published, Green Accepted, gold			2022-12-26	WOS:000755077100091
J	Pajarillo, E; Digman, A; Nyarko-Danquah, I; Son, DS; Soliman, KFA; Aschner, M; Lee, E				Pajarillo, Edward; Digman, Alexis; Nyarko-Danquah, Ivan; Son, Deok-Soo; Soliman, Karam F. A.; Aschner, Michael; Lee, Eunsook			Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTIVE SILENCER ELEMENT; EXCITATORY AMINO-ACIDS; YIN YANG 1; GENE-EXPRESSION; HUNTINGTONS-DISEASE; FACTOR REST/NRSF; BRAIN-LESIONS; RAT STRIATUM; KAPPA-B; REPRESSOR	Chronic exposure to high levels of manganese (Mn) leads to manganism, a neurological disorder with similar symptoms to those inherent to Parkinson's disease. However, the underlying mechanisms of this pathological condition have yet to be established. Since the human excitatory amino acid transporter 2 (EAAT2) (glutamate transporter 1 in rodents) is predominantly expressed in astrocytes and its dysregulation is involved in Mn-induced excitotoxic neuronal injury, characterization of the mechanisms that mediate the Mn-induced impairment in EAAT2 function is crucial for the development of novel therapeutics against Mn neurotoxicity. Repressor element 1-silencing transcription factor (REST) exerts protective effects in many neurodegenerative diseases. But the effects of REST on EAAT2 expression and ensuing neuroprotection are unknown. Given that the EAAT2 promoter contains REST binding sites, the present study investigated the role of REST in EAAT2 expression at the transcriptional level in astrocytes and Mn-induced neurotoxicity in an astrocyte-neuron coculture system. The results reveal that astrocytic REST positively regulates EAAT2 expression with the recruitment of an epigenetic modifier, cAMP response element-binding protein-binding protein/p300, to its consensus binding sites in the EAAT2 promoter. Moreover, astrocytic overexpression of REST attenuates Mn-induced reduction in EAAT2 expression, leading to attenuation of glutamate-induced neurotoxicity in the astrocyte-neuron coculture system. Our findings demonstrate that astrocytic REST plays a critical role in protection against Mn-induced neurotoxicity by attenuating Mn-induced EAAT2 repression and the ensuing excitotoxic dopaminergic neuronal injury. This indicates that astrocytic REST could be a potential molecular target for the treatment of Mn toxicity and other neurological disorders associated with EAAT2 dysregulation.	[Pajarillo, Edward; Digman, Alexis; Nyarko-Danquah, Ivan; Soliman, Karam F. A.; Lee, Eunsook] Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA; [Son, Deok-Soo] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Aschner, Michael] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Aschner, Michael] Sechenov First Moscow State Med Univ, Inst Personalized Med, Lab Mol Nutr, Moscow, Russia	State University System of Florida; Florida A&M University; Meharry Medical College; Yeshiva University; Albert Einstein College of Medicine; Sechenov First Moscow State Medical University	Lee, E (corresponding author), Florida A&M Univ, Dept Pharmaceut Sci, Tallahassee, FL 32307 USA.	eunsook.lee@famu.edu		Pajarillo, Edward Alain/0000-0002-5044-7607; Nyarko-Danquah, Ivan/0000-0003-2481-0721	National Institute of Environmental Health Sciences, National Institutes of Health [R01 ES024756, R01 ES031282, R01 ES07331, R01 ES020852]; National Institute on Minority Health and Health Disparities, National Institutes of Health [U54 MD007582]; National Cancer Institute, National Institutes of Health [SC1 CA200519]	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities, National Institutes of Health; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Environmental Health Sciences, National Institutes of Health grants R01 ES024756 (to E. L.), R01 ES031282 (to E. L.), R01 ES07331 (to M. A.), R01 ES020852 (to M. A.), National Institute on Minority Health and Health Disparities, National Institutes of Health grant U54 MD007582 (to K. F. A. S.), and National Cancer Institute, National Institutes of Health grant SC1 CA200519 (to D.-S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Abramovitz L, 2008, J BIOL CHEM, V283, P110, DOI 10.1074/jbc.M707366200; Bai G, 2003, J NEUROCHEM, V86, P992, DOI 10.1046/j.1471-4159.2003.01922.x; Bergsland M, 2014, STEM CELLS, V32, P2539, DOI 10.1002/stem.1749; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; Betarbet R, 1999, EXP NEUROL, V159, P401, DOI 10.1006/exnr.1999.7154; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BUTCHER SP, 1987, J NEUROCHEM, V48, P713, DOI 10.1111/j.1471-4159.1987.tb05575.x; BUTCHER SP, 1987, J NEUROCHEM, V49, P1355, DOI 10.1111/j.1471-4159.1987.tb00999.x; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Chotibut T, 2017, MOVEMENT DISORD, V32, P1547, DOI 10.1002/mds.27077; Chung EKY, 2008, J COMP NEUROL, V511, P421, DOI 10.1002/cne.21852; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DONALDSON J, 1982, CAN J PHYSIOL PHARM, V60, P1398, DOI 10.1139/y82-208; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Ekici M, 2012, J CELL BIOCHEM, V113, P528, DOI 10.1002/jcb.23376; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Garcia-Manteiga JM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00438; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Groger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084081; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Hohl M, 2005, EUR J NEUROSCI, V22, P2216, DOI 10.1111/j.1460-9568.2005.04404.x; Holmer HK, 2005, NEUROSCIENCE, V136, P333, DOI 10.1016/j.neuroscience.2005.08.003; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Jiang LC, 2008, J NEUROSCI RES, V86, P1209, DOI 10.1002/jnr.21595; Johnson J, 2018, NEUROTOXICOLOGY, V67, P112, DOI 10.1016/j.neuro.2018.05.001; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Karki P, 2015, J BIOL CHEM, V290, P23725, DOI 10.1074/jbc.M115.649327; Karki P, 2014, MOL CELL BIOL, V34, P1280, DOI 10.1128/MCB.01176-13; Karki P, 2013, J BIOL CHEM, V288, P28975, DOI 10.1074/jbc.M113.483826; Kawamura M, 2019, NEUROSCI LETT, V699, P59, DOI 10.1016/j.neulet.2019.01.042; Kornbuber J, 1998, J NEURAL TRANSM-SUPP, P277; Kreisler A, 2010, ONCOGENE, V29, P5828, DOI 10.1038/onc.2010.321; Lee ESY, 2009, J NEUROCHEM, V110, P530, DOI 10.1111/j.1471-4159.2009.06105.x; Li H, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165590; Li ZC, 2020, BIOL TRACE ELEM RES, V197, P544, DOI 10.1007/s12011-019-02001-0; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Luo P, 2020, BRAIN RES BULL, V156, P50, DOI 10.1016/j.brainresbull.2020.01.001; MAREYSEMPER I, 1995, J NEUROSCI, V15, P5912; Masserdotti G, 2015, CELL STEM CELL, V17, P74, DOI 10.1016/j.stem.2015.05.014; Mergler D, 1997, ENVIRON RES, V73, P92, DOI 10.1006/enrs.1997.3710; Moreno-Gonzalez G, 2008, BIOSCIENCE REP, V28, P177, DOI 10.1042/BSR20080058; Navarrete-Modesto V, 2019, EPILEPSY BEHAV, V94, P118, DOI 10.1016/j.yebeh.2019.02.012; NEFF NH, 1969, EXPERIENTIA, V25, P1140, DOI 10.1007/BF01900234; OLNEY JW, 1969, SCIENCE, V166, P386, DOI 10.1126/science.166.3903.386; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pajarillo Edward, 2021, Adv Neurotoxicol, V5, P215, DOI 10.1016/bs.ant.2020.11.003; Pajarillo E, 2020, J BIOL CHEM, V295, P15662, DOI 10.1074/jbc.RA120.015552; Pajarillo E, 2020, J BIOL CHEM, V295, P3040, DOI 10.1074/jbc.RA119.011446; Pajarillo E, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.03.002; Pajarillo E, 2018, NEUROTOXICOLOGY, V65, P280, DOI 10.1016/j.neuro.2017.11.008; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Ponzoni S, 2002, NEUROSCI LETT, V328, P170, DOI 10.1016/S0304-3940(02)00464-0; Prabhakaran K, 2008, BRAIN RES BULL, V76, P361, DOI 10.1016/j.brainresbull.2008.03.004; Prada I, 2011, J CELL BIOL, V193, P537, DOI 10.1083/jcb.201010126; Rigamonti D, 2009, CURR PHARM DESIGN, V15, P3958, DOI 10.2174/138161209789649303; ROTHSTEIN JD, 1991, ANN NEUROL, V30, P224, DOI 10.1002/ana.410300223; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Ryan BJ, 2021, J NEUROSCI, V41, P3731, DOI 10.1523/JNEUROSCI.1478-20.2021; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Seth KA, 2001, J BIOL CHEM, V276, P13917, DOI 10.1074/jbc.M007745200; Shimojo M, 2004, LIFE SCI, V74, P2213, DOI 10.1016/j.lfs.2003.08.045; Shimojo M, 1999, MOL CELL BIOL, V19, P6788; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; STOREY E, 1992, ANN NEUROL, V32, P526, DOI 10.1002/ana.410320408; Wisman LAB, 2003, NEUROREPORT, V14, P1967, DOI 10.1097/00001756-200310270-00017; Xu B, 2010, EXP TOXICOL PATHOL, V62, P381, DOI 10.1016/j.etp.2009.05.007; Yu M, 2013, NEUROBIOL AGING, V34, P916, DOI 10.1016/j.neurobiolaging.2012.06.002; Zullo JM, 2019, NATURE, V574, P359, DOI 10.1038/s41586-019-1647-8	78	3	3	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101372	10.1016/j.jbc.2021.101372	http://dx.doi.org/10.1016/j.jbc.2021.101372			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34756885	Green Published, gold			2022-12-26	WOS:000748084900005
J	Yang, CY; Chang, PY; Wu, BS; Tarng, DC; Lee, OKS				Yang, Chih-Yu; Chang, Pu-Yuan; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng			Mechanical and chemical cues synergistically promote human venous smooth muscle cell osteogenesis through integrin beta 1-ERK1/2 signaling: A cell model of hemodialysis fistula calcification	FASEB JOURNAL			English	Article						arteriovenous fistula; hyperphosphatemia; osteogenesis; shear stress; venous smooth muscle cell	WALL SHEAR-STRESS; VASCULAR ACCESS CALCIFICATION; OSTEOBLASTIC DIFFERENTIATION; ARTERIAL ENLARGEMENT; DOWN-REGULATION; PROLIFERATION; EXPRESSION; ACTIVATION; SCLEROSTIN; INHIBITOR	Arteriovenous fistula (AVF) is the vascular access of choice for renal replacement therapy. However, AVF is susceptible to calcification with a high prevalence of 40%-65% in chronic hemodialysis patients. Repeated needle puncture for hemodialysis cannulation results in intimal denudation of AVF. We hypothesized that exposure to blood shear stress in the medial layer promotes venous smooth muscle cell (SMC) osteogenesis. While previous studies of shear stress focused on arterial-type SMCs, SMCs isolated from the vein had not been investigated. This study established a venous cell model of AVF using the fluid shear device, combined with a high phosphate medium to mimic the uremic milieu. Osteogenic gene expression of venous SMCs upon mechanical and chemical cues was analyzed in addition to the activated cell signaling pathways. Our findings indicated that upon shear stress and high phosphate environment, mechanical stimulation (shear stress) had an additive effect in up-regulation of an early osteogenic marker, Runx2. We further identified that the integrin beta 1-ERK1/2 signaling pathway was responsible for the molecular basis of venous SMC osteogenesis upon shear stress exposure. Mitochondrial biogenesis also took part in the early stage of this venopathy pathogenesis, evident by the up-regulated mitochondrial transcription factor A and mitochondrial DNA polymerase gamma in venous SMCs. In conclusion, synergistic effects of fluid shear stress and high phosphate induce venous SMC osteogenesis via the ERK1/2 pathway through activating the mechanosensing integrin beta 1 signaling. The present study identified a promising druggable target for reducing AVF calcification, which deserves further in vivo investigations.	[Yang, Chih-Yu; Chang, Pu-Yuan; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, 2F,Shou Ren Bldg 155,Sec 2,Li Nong St, Taipei 11221, Taiwan; [Yang, Chih-Yu; Wu, Bo-Sheng; Tarng, Der-Cherng; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Sch Med, Fac Med, Taipei, Taiwan; [Yang, Chih-Yu; Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Yang, Chih-Yu; Tarng, Der-Cherng] Ctr Intelligent Drug Syst & Smart Bio Devices IDS, Minist Educ, Taipei, Taiwan; [Yang, Chih-Yu; Lee, Oscar Kuang-Sheng] Natl Yang Ming Chiao Tung Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Lee, Oscar Kuang-Sheng] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Yang, CY (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, 2F,Shou Ren Bldg 155,Sec 2,Li Nong St, Taipei 11221, Taiwan.; Yang, CY (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan.	cyyang3@vghtpe.gov.tw		Yang, Chih-Yu/0000-0001-9899-3159	School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan [107F-M01-0504, 107F-M01-0510]; Ministry of Science and Technology, Taiwan [MOST 105-2628-B-075-008-MY3, MOST 108-2923-B-010-002-MY3, MOST 108-2813-C-010-034-B, MOST 109-2314-B-010-053-MY3, MOST 109-2926-I-010-502, MOST 109-2823-8-010-003-CV, MOST 109-2811-B]	School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors acknowledge the financial support for research purposes by the "Yin Yen--Liang Foundation Development and Construction Plan" of the School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan (107F-M01-0504 and 107F-M01-0510), the Ministry of Science and Technology, Taiwan (MOST 105-2628-B-075-008-MY3, MOST 108-2923-B-010-002-MY3, MOST 108-2813-C-010-034-B, MOST 109-2314-B-010-053-MY3, MOST 109-2926-I-010-502, MOST 109-2823-8-010-003-CV, MOST 109-2811-B-	Adragao T, 2008, KIDNEY INT, V74, P1505, DOI 10.1038/ki.2008.503; Alesutan I, 2020, J MOL MED, V98, P985, DOI 10.1007/s00109-020-01925-8; Asada H, 2005, J VASC SURG, V42, P772, DOI 10.1016/j.jvs.2005.05.046; Balci M, 2015, HERZ, V40, P289, DOI 10.1007/s00059-013-3992-y; Becker A, 2004, J INORG BIOCHEM, V98, P2032, DOI 10.1016/j.jinorgbio.2004.09.006; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen NX, 2018, KIDNEY INT, V93, P343, DOI 10.1016/j.kint.2017.07.019; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Feng H, 2019, ANTIOXID REDOX SIGN, V31, P75, DOI 10.1089/ars.2018.7620; Fitzgerald TN, 2008, J CELL PHYSIOL, V216, P389, DOI 10.1002/jcp.21404; Garanich JS, 2005, AM J PHYSIOL-HEART C, V288, pH2244, DOI 10.1152/ajpheart.00428.2003; Goldsmith D, 2004, KIDNEY INT, V66, P1315, DOI 10.1111/j.1523-1755.2004.00895.x; Guzman RJ, 1997, SURGERY, V122, P273, DOI 10.1016/S0039-6060(97)90018-0; Guzman RJ, 2002, J SURG RES, V108, P112, DOI 10.1006/jsre.2002.6530; Haga M, 2003, J VASC SURG, V37, P1277, DOI 10.1016/S0741-5214(03)00329-X; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; Huang J, 2013, INT J MOL MED, V32, P423, DOI 10.3892/ijmm.2013.1398; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jankovic A, 2017, INT UROL NEPHROL, V49, P881, DOI 10.1007/s11255-017-1515-0; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kang HY, 2017, SCI REP-UK, V7, DOI 10.1038/srep42092; Kang HY, 2011, AM J PHYSIOL-HEART C, V300, pH76, DOI 10.1152/ajpheart.00905.2010; Kim SM, 2019, ANN VASC SURG, V58, P331, DOI 10.1016/j.avsg.2018.10.057; Kim SA, 2017, BIOCHEM BIOPH RES CO, V490, P1369, DOI 10.1016/j.bbrc.2017.07.033; Kirkpantur A, 2016, NEFROLOGIA, V36, P24, DOI 10.1016/j.nefro.2015.07.006; Koga N, 1989, ASAIO Trans, V35, P193, DOI 10.1097/00002480-198907000-00005; Kreke MR, 2008, TISSUE ENG PT A, V14, P529, DOI 10.1089/tea.2007.0068; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Krishnamoorthy MK, 2008, KIDNEY INT, V74, P1410, DOI 10.1038/ki.2008.379; Lam CF, 2006, AM J PHYSIOL-HEART C, V290, pH786, DOI 10.1152/ajpheart.00759.2005; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee AR, 2019, ARCH PHARM RES, V42, P1052, DOI 10.1007/s12272-019-01198-x; Liang QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033126; Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8; Lin MC, 2009, KIDNEY INT, V75, P1117, DOI 10.1038/ki.2009.34; Lu X, 2001, AM J PHYSIOL-HEART C, V280, pH1547, DOI 10.1152/ajpheart.2001.280.4.H1547; Lu ZF, 2008, BIOCHEM BIOPH RES CO, V372, P547, DOI 10.1016/j.bbrc.2008.05.063; Ma WQ, 2019, MOL CELL ENDOCRINOL, V479, P39, DOI 10.1016/j.mce.2018.08.012; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Moon DK, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01684-9; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; Nanjo H, 2006, EXP MOL PATHOL, V80, P38, DOI 10.1016/j.yexmp.2005.04.005; Olsson LF, 2001, AM J KIDNEY DIS, V38, P377, DOI 10.1053/ajkd.2001.26104; Palumbo R, 2000, CIRCULATION, V102, P225, DOI 10.1161/01.CIR.102.2.225; Papadaki M, 1996, BIOTECHNOL BIOENG, V50, P555, DOI 10.1002/(SICI)1097-0290(19960605)50:5<555::AID-BIT10>3.0.CO;2-I; Qiu JH, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0852; Rajabi-Jagahrgh E, 2013, SEMIN DIALYSIS, V26, P511, DOI 10.1111/sdi.12045; REIDY MA, 1985, AM J PATHOL, V118, P173; Roca-Tey R, 2009, NEFROLOGIA, V29, P214, DOI 10.3265/Nefrologia.2009.29.3.5103.en.full; Schlieper G, 2008, KIDNEY INT, V74, P1582, DOI 10.1038/ki.2008.458; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Sho E, 2004, J VASC SURG, V39, P601, DOI 10.1016/j.jvs.2003.10.058; Sho M, 2002, EXP MOL PATHOL, V72, P150, DOI 10.1006/exmp.2002.2426; Singh TM, 1998, J SURG RES, V77, P165, DOI 10.1006/jsre.1998.5376; Sugiyama T, 1997, ARTERIOSCL THROM VAS, V17, P3083, DOI 10.1161/01.ATV.17.11.3083; Sullivan RJ, 2018, CANCER DISCOV, V8, P184, DOI 10.1158/2159-8290.CD-17-1119; Toth A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100963; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Ueba H, 1997, ARTERIOSCL THROM VAS, V17, P1512, DOI 10.1161/01.ATV.17.8.1512; Wang HQ, 2007, EUR J CELL BIOL, V86, P51, DOI 10.1016/j.ejcb.2006.09.001; Wu W, 2011, CIRCULATION, V124, P633, DOI 10.1161/CIRCULATIONAHA.110.005108; Zhang LL, 2016, EUR J PHARMACOL, V792, P15, DOI 10.1016/j.ejphar.2016.10.023; Zhang ZQ, 2016, CELL PHYSIOL BIOCHEM, V39, P423, DOI 10.1159/000445636; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595; Zhu Y, 2019, CELL SIGNAL, V58, P53, DOI 10.1016/j.cellsig.2019.03.006; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	69	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22042	10.1096/fj.202101064RR	http://dx.doi.org/10.1096/fj.202101064RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34758125				2022-12-26	WOS:000722321300050
J	DiNardo, J; Stierhoff, KL; Semmens, BX				DiNardo, Jordan; Stierhoff, Kevin L.; Semmens, Brice X.			Modeling the past, present, and future distributions of endangered white abalone (Haliotis sorenseni) to inform recovery efforts in California	PLOS ONE			English	Article								White abalone (Haliotis sorenseni) was once commonly found in coastal waters of the Southern California Bight (SCB) and south to Punta Abreojos, Baja California, Mexico. During the 1970s, white abalone supported a commercial fishery, which reduced the population and resulted in the closure of the fishery in 1996. When population levels continued to decline, National Marine Fisheries Service (NMFS) listed the species as endangered under the Endangered Species Act. The California Department of Fish and Wildlife and NMFS began surveying the wild populations, propagating specimens in captivity, and protecting its seabed habitat. We modeled coarse-scale (17 x 17 km) historical (using fishery-dependent data [1955-1996]) and contemporary (using fishery-independent data [1996-2017]) distributions of white abalone throughout its historical domain using random forests and maximum entropy (MaxEnt), respectively, and its fine-scale (10 x 10 m) contemporary distribution (fishery-independent data) using MaxEnt. We also investigated potential outplanting habitat farther north under two scenarios of future climate conditions. The coarse-scale models identified potential regions to focus outplanting efforts within SCB while fine-scale models can inform population monitoring and outplanting activities in these particular areas. These models predict that areas north of Point Conception may become candidate outplant sites as seawater temperatures continue to rise in the future due to climate change. Collectively, these results provide guidance on the design and potential locations for experimental outplanting at such locations to ultimately improve methods and success of recovery efforts.	[DiNardo, Jordan; Semmens, Brice X.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Stierhoff, Kevin L.] Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, La Jolla, CA 92038 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Oceanic Atmospheric Admin (NOAA) - USA	DiNardo, J (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jdinardo@ucsd.edu			Cooperative Institute for Marine Ecosystems	Cooperative Institute for Marine Ecosystems	This work was funded supported by the Cooperative Institute for Marine Ecosystems, https://scripps.ucsd.edu/cimec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Assis J, 2018, GLOBAL ECOL BIOGEOGR, V27, P277, DOI 10.1111/geb.12693; Behrens MD, 2005, P 6 CAL ISL S 2003 I; Bell T, **DATA OBJECT**, DOI 10.6073/pasta/5d3fb6fd293bd403a0714d870a4dd7d8; Bogosian V., 2010, THESIS SO ILLINOIS U; Breiman L., 2001, MACH LEARN, V45, P5; Brooker RW, 2018, J APPL ECOL, V55, P621, DOI 10.1111/1365-2664.13008; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Butler J, 2006, FISH B-NOAA, V104, P521; California Department of Fish and Game (CDFG) Marine Region, 2005, AB REC MAN PLAN; COX KEITH W., 1962, CALIF DEPT FISH AND GAME FISH BULL, V118, P3; CSUMB SFML, 2008, SFML DAT; Davis GE, 1998, J SHELLFISH RES, V17, P871; Davis GE, 1996, T AM FISH SOC, V125, P42, DOI 10.1577/1548-8659(1996)125<0042:SATOWA>2.3.CO;2; Di Lorenzo E, 2005, J PHYS OCEANOGR, V35, P336, DOI 10.1175/JPO-2690.1; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hobday A.J., 2000, NOAA TECHNICAL MEMOR; Hofmeister JKK, 2018, HYDROBIOLOGIA, V813, P123, DOI 10.1007/s10750-018-3514-2; LEIGHTON DL, 1972, FISH BULL NATL OC AT, V70, P373; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Moore JD, 2000, J AQUAT ANIM HEALTH, V12, P26, DOI [10.1577/1548-8667(2000)012<0026:WSIFRA>2.0.CO;2, 10.1577/1548-8667(2000)012&lt;0026:WSIFRA&gt;2.0.CO;2]; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; National Marine Fisheries Service, 2008, WHIT AB REC PLAN HAL; NOAA, 2018, WHAT IS BIGHT; NOAA SWFSC, 2017, CALCOFI NOAAHYDROS; R Core Team, 2021, R LANGUAGE ENV STAT; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; REEF, 2007, REEF ENV ED FDN VOL; Rogers-Bennett L, 2002, CONSERV BIOL, V16, P1308, DOI 10.1046/j.1523-1739.2002.01002.x; Rogers-Bennett L, 2010, J SHELLFISH RES, V29, P599, DOI 10.2983/035.029.0308; Santa Barbara Coastal LTER, 2006, KELP FOR; Shuman C., 2009, MARINE REGION GIS DO; Stierhoff KL, 2012, BIOL CONSERV, V152, P46, DOI 10.1016/j.biocon.2012.03.013; Tegner MJ, 1996, CAL COOP OCEAN FISH, V37, P111; Tutschulte TC, 1976, THESIS U CALIFORNIA; Tyberghein L, 2012, GLOBAL ECOL BIOGEOGR, V21, P272, DOI 10.1111/j.1466-8238.2011.00656.x; van Toor ML, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160164; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	39	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259716	10.1371/journal.pone.0259716	http://dx.doi.org/10.1371/journal.pone.0259716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788315	gold, Green Published			2022-12-26	WOS:000735920500036
J	Hanley, S; Moodley, D; Naidoo, M				Hanley, Sherika; Moodley, Dhayendre; Naidoo, Mergan			Obesity in young South African women living with HIV: A cross-sectional analysis of risk factors for cardiovascular disease	PLOS ONE			English	Article							EFAVIRENZ; ATHEROSCLEROSIS; COUNTRIES	Background Young South African women are faced with a dual epidemic of HIV and obesity, placing them at a high risk of developing atherosclerotic cardiovascular disease (CVD). We sought to determine the prevalence of CVD risk factors in a cohort of reproductive-aged South African women living with HIV (WLHIV). Methods While the main purpose of an ongoing intervention study is the reduction of cardiovascular disease through the integration of CVD screening and prevention in the HIV management plan for women of reproductive age (ISCHeMiA trial), we present the prevalence of risk factors for CVD in this cohort of young women at baseline. Sociodemographic, conventional CVD risk factors, HIV-related factors and self body image perception were assessed through study questionnaires and standardized clinical and laboratory procedures. Results Of the 372 WLHIV enrolled from November 2018 to May 2019, 97% had received efavirenz-based antiretroviral treatment (ART) for at least 1 year and 67.5% (248/367) of women were overweight or obese at the time of enrolment. The prevalence of metabolic syndrome was 17.6% (95%CI 11.6-22.8) at a median age of 35 years (IQR 30.5-40.5). A significant proportion of women had abnormally low levels of high-density lipoprotein (43.2%, 80/185) and elevated levels of high sensitivity C-reactive protein (59.5%, 110/185). Seventy five percent of overweight women with an increased waist circumference reported to be satisfied with their body image. Conclusions The high prevalence of metabolic syndrome, obesity and elevated markers of inflammation in young South African WLHIV, underscores the need for a proactive integrated management approach to prevent atherosclerotic cardiovascular disease in low and middle income settings.	[Hanley, Sherika] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Umlazi Clin Res Unit, Durban, South Africa; [Moodley, Dhayendre] Univ KwaZulu Natal, Dept Obstet & Gynaecol, Durban, South Africa; [Naidoo, Mergan] Univ KwaZulu Natal, Dept Family Med, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Hanley, S (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Umlazi Clin Res Unit, Durban, South Africa.	hanley@ukzn.ac.za	Hanley, Sherika/AHA-7014-2022	Hanley, Sherika/0000-0002-4343-7646; Naidoo, Mergan/0000-0002-4287-1168	National Research Foundation of South Africa [117730]; Fogarty International Center (FIC); NIH Common Fund, Office of Strategic Coordination, Office of the Director (OD/OSC/CF/NIH); Office of AIDS Research, Office of the Director (OAR/NIH); National Institute of Mental Health (NIMH/NIH) of the National Institutes of Health [D43TW010131]; President's Emergency Plan for AIDS Relief (PEPFAR) through DAIDS/NIAID/NIH [5UM1AI069469]	National Research Foundation of South Africa(National Research Foundation - South Africa); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Common Fund, Office of Strategic Coordination, Office of the Director (OD/OSC/CF/NIH); Office of AIDS Research, Office of the Director (OAR/NIH); National Institute of Mental Health (NIMH/NIH) of the National Institutes of Health; President's Emergency Plan for AIDS Relief (PEPFAR) through DAIDS/NIAID/NIH	This work is based on the research supported in part by the National Research Foundation of South Africa (Grant Number: 117730) awarded to SH. https://www.nrf.ac.za/Research reported in this publication is also supported by the Fogarty International Center (FIC), NIH Common Fund, Office of Strategic Coordination, Office of the Director (OD/OSC/CF/NIH), Office of AIDS Research, Office of the Director (OAR/NIH), National Institute of Mental Health (NIMH/NIH) of the National Institutes of Health under Award Number D43TW010131. SH is a sub awardee. https://www.fic.nih.gov/Funding/Pages/Fogarty-Funding-Opps.aspx The PROMOTE study is funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through DAIDS/NIAID/NIH grants to CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment, grant #5UM1AI069469. SH is a site investigator in the PROMOTE study. https://www.hiv.gov/federalresponse/pepfar-global-aids/pepfar The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Research Foundation of South Africa and National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; [Anonymous], 2019, END AIDS PROGR 90 90; [Anonymous], 2020, UNAIDS DAT 2020; Blaha MJ, 2011, ARTERIOSCL THROM VAS, V31, P1430, DOI 10.1161/ATVBAHA.111.223768; Calmy A, 2015, CURR VASC PHARMACOL, V13, P167, DOI 10.2174/1570161111999131203092322; Croffut SE, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12446; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Faltz M, 2017, CARDIOVASC TOXICOL, V17, P393, DOI 10.1007/s12012-016-9397-4; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gilotra Tarvinder S, 2017, J Clin Med Res, V9, P891, DOI 10.14740/jocmr3154w; Gleason RL, 2016, J BIOMECH, V49, P2584, DOI 10.1016/j.jbiomech.2016.05.018; Gupta SK, 2015, J ANTIMICROB CHEMOTH, V70, P2889, DOI 10.1093/jac/dkv195; Hsu DC, 2016, AIDS, V30, P2065, DOI 10.1097/QAD.0000000000001149; Hyle EP, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4940-1; Kabudula CW, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4312-x; Klug E. Q., 2018, SAMJ - South African Medical Journal, V108, P973; Lake JE, 2013, LANCET INFECT DIS, V13, P964, DOI 10.1016/S1473-3099(13)70271-8; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Naidu S, 2017, AIDS PATIENT CARE ST, V31, P1, DOI 10.1089/apc.2016.0140; Oni T, 2015, INT HEALTH, V7, P390, DOI 10.1093/inthealth/ihv040; Patel P, 2018, AIDS, V32, pS5, DOI 10.1097/QAD.0000000000001888; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Shikuma CM, 2011, AIDS RES HUM RETROV, V27, P461, DOI 10.1089/aid.2010.0154; Siegel MO, 2015, ATHEROSCLEROSIS, V243, P19, DOI 10.1016/j.atherosclerosis.2015.08.036; Statistics South Africa, 2019, MORT CAUS DEATH S AF; Stone L, 2017, CURR OPIN HIV AIDS, V12, P585, DOI 10.1097/COH.0000000000000413; Vachiat A, 2017, J AM COLL CARDIOL, V69, P73, DOI 10.1016/j.jacc.2016.09.979; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; World Health Organization, WHO STEPWISE APPR NO; World Health Organization, 2010, PACK ESS NONC PEN DI; World Health Organization, 2007, PREV CARD DIS POCK G	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0255652	10.1371/journal.pone.0255652	http://dx.doi.org/10.1371/journal.pone.0255652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780476	gold, Green Published			2022-12-26	WOS:000755305800003
J	Grimes, T; Datta, S				Grimes, Tyler; Datta, Somnath			A novel probabilistic generator for large-scale gene association networks	PLOS ONE			English	Article							INVERSE COVARIANCE ESTIMATION; INFERENCE; DATABASE; CONSTRUCTION; DISEASE; SERVER; MODEL; V3; V2	Motivation Gene expression data provide an opportunity for reverse-engineering gene-gene associations using network inference methods. However, it is difficult to assess the performance of these methods because the true underlying network is unknown in real data. Current benchmarks address this problem by subsampling a known regulatory network to conduct simulations. But the topology of regulatory networks can vary greatly across organisms or tissues, and reference-based generators-such as GeneNetWeaver-are not designed to capture this heterogeneity. This means, for example, benchmark results from the E. coli regulatory network will not carry over to other organisms or tissues. In contrast, probabilistic generators do not require a reference network, and they have the potential to capture a rich distribution of topologies. This makes probabilistic generators an ideal approach for obtaining a robust benchmarking of network inference methods. Results We propose a novel probabilistic network generator that (1) provides an alternative to address the inherent limitation of reference-based generators and (2) is able to create realistic gene association networks, and (3) captures the heterogeneity found across gold-standard networks better than existing generators used in practice. Eight organism-specific and 12 human tissue-specific gold-standard association networks are considered. Several measures of global topology are used to determine the similarity of generated networks to the gold-standards. Along with demonstrating the variability of network structure across organisms and tissues, we show that the commonly used "scale-free" model is insufficient for replicating these structures. Availability This generator is implemented in the R package "SeqNet" and is available on CRAN (https:// cran.r-project.org/web/packages/SeqNet/index.html).	[Grimes, Tyler; Datta, Somnath] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Datta, S (corresponding author), Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.	somnath.datta@ufl.edu		Grimes, Tyler/0000-0002-5653-3418; Datta, Somnath/0000-0003-4381-1842	National Institutes of Health, USA [5R03DE025625-02]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant 5R03DE025625-02 from the National Institutes of Health, USA.	Allen GI, 2013, IEEE T NANOBIOSCI, V12, P189, DOI 10.1109/TNB.2013.2263838; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Casella G., 2002, STAT INFERENCE, V2nd; Cho A, 2014, NUCLEIC ACIDS RES, V42, pW76, DOI 10.1093/nar/gku367; Choi H, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0561-z; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danaher P, 2014, J R STAT SOC B, V76, P373, DOI 10.1111/rssb.12033; Deng WP, 2018, BIOINFORMATICS, V34, P3470, DOI 10.1093/bioinformatics/bty354; Emmert-Streib F, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00038; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Grimes T, 2021, J STAT SOFTW, V98, P1, DOI 10.18637/jss.v098.i12; Grimes T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41918-3; Ha MJ, 2015, BIOINFORMATICS, V31, P3413, DOI 10.1093/bioinformatics/btv406; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HO THD, 1993, J PLANT GROWTH REGUL, V12, P197; Ji JD, 2017, BIOINFORMATICS, V33, P3080, DOI 10.1093/bioinformatics/btx360; Kim E, 2016, NUCLEIC ACIDS RES, V44, pD848, DOI 10.1093/nar/gkv1155; Kim H, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav001; Kim H, 2014, NUCLEIC ACIDS RES, V42, pD731, DOI 10.1093/nar/gkt981; Kim JH, 2021, STAT ANAL DATA MIN, V14, P18, DOI 10.1002/sam.11483; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; KOLLER D., 2009, PROBABILISTIC GRAPHI; Le OY, 2019, IEEE T CYBERNETICS, V49, P3494, DOI 10.1109/TCYB.2018.2845838; Lee T, 2019, PLANT J, V99, P571, DOI 10.1111/tpj.14341; Lee T, 2015, NUCLEIC ACIDS RES, V43, pD996, DOI 10.1093/nar/gku1053; Liu XR, 2019, INVERSE PROBL, V35, DOI 10.1088/1361-6420/ab1af3; Liu ZQ, 2016, J COMPUT BIOL, V23, P192, DOI 10.1089/cmb.2015.0102; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Maetschke SR, 2014, BRIEF BIOINFORM, V15, P195, DOI 10.1093/bib/bbt034; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Neuberg LG, 2003, ECONOMET THEOR, V19, P675, DOI 10.1017/S026646603004109; Omony J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214868; Parsana P, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1700-9; Petereit J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0298-8; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Shim H, 2016, NUCLEIC ACIDS RES, V44, P9611, DOI 10.1093/nar/gkw897; Shin J, 2015, NUCLEIC ACIDS RES, V43, pW91, DOI 10.1093/nar/gkv453; Shojaie A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082393; SPEED TP, 1986, ANN STAT, V14, P138, DOI 10.1214/aos/1176349846; Sulaimanov N, 2019, BIOINFORMATICS, V35, P987, DOI 10.1093/bioinformatics/bty716; Tu JJ, 2020, BIOINFORMATICS, V36, P2755, DOI 10.1093/bioinformatics/btaa014; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; van der Knaap JA, 2016, GENE DEV, V30, P2345, DOI 10.1101/gad.289140.116; Wang ZM, 2017, BIOINFORMATICS, V33, P2173, DOI 10.1093/bioinformatics/btx131; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Wu NS, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00623; Xu T, 2018, IEEE ACM T COMPUT BI, V15, P2079, DOI 10.1109/TCBB.2018.2809603; Yang GX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02762-5; Zhang XF, 2017, BIOINFORMATICS, V33, P2436, DOI 10.1093/bioinformatics/btx208; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753; Zitnik M, 2015, BIOINFORMATICS, V31, P230, DOI 10.1093/bioinformatics/btv258	60	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259193	10.1371/journal.pone.0259193	http://dx.doi.org/10.1371/journal.pone.0259193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767561	Green Published, gold			2022-12-26	WOS:000755249300022
J	Heiser, D; Rubert, J; Unterreiner, A; Maurer, C; Kamke, M; Bodendorf, U; Farady, CJ; Roediger, B; Bornancin, F				Heiser, Diane; Rubert, Joelle; Unterreiner, Adeline; Maurer, Claudine; Kamke, Marion; Bodendorf, Ursula; Farady, Christopher J.; Roediger, Ben; Bornancin, Frederic			Evaluation of protein kinase D auto-phosphorylation as biomarker for NLRP3 inflammasome activation	PLOS ONE			English	Article							PHOSPHORYLATION; RECRUITMENT; INHIBITION; SENSOR	Background The NLRP3 inflammasome is a critical component of sterile inflammation, which is involved in many diseases. However, there is currently no known proximal biomarker for measuring NLRP3 activation in pathological conditions. Protein kinase D (PKD) has emerged as an important NLRP3 kinase that catalyzes the release of a phosphorylated NLRP3 species that is competent for inflammasome complex assembly. Methods To explore the potential for PKD activation to serve as a selective biomarker of the NLRP3 pathway, we tested various stimulatory conditions in THP-1 and U937 cell lines, probing the inflammasome space beyond NLRP3. We analyzed the correlation between PKD activation (monitored by its auto-phosphorylation) and functional inflammasome readouts. Results PKD activation/auto-phosphorylation always preceded cleavage of caspase-1 and gasdermin D, and treatment with the PKD inhibitor CRT0066101 could block NLRP3 inflammasome assembly and interleukin-1 beta production. Conversely, blocking NLRP3 either genetically or using the MCC950 inhibitor prevented PKD auto-phosphorylation, indicating a bidirectional functional crosstalk between NLRP3 and PKD. Further assessments of the pyrin and NLRC4 pathways, however, revealed that PKD auto-phosphorylation can be triggered by a broad range of stimuli unrelated to NLRP3 inflammasome assembly. Conclusion Although PKD and NLRP3 become functionally interconnected during NLRP3 activation, the promiscuous reactivity of PKD challenges its potential use for tracing the NLRP3 inflammasome pathway.	[Heiser, Diane; Rubert, Joelle; Unterreiner, Adeline; Maurer, Claudine; Kamke, Marion; Bodendorf, Ursula; Farady, Christopher J.; Roediger, Ben; Bornancin, Frederic] Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland	Novartis	Bornancin, F (corresponding author), Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland.	frederic.bornancin@novartis.com		Bornancin, Frederic/0000-0002-0152-6720; Roediger, Ben/0000-0002-4593-091X				Alimov I, 2019, J BIOL CHEM, V294, P3359, DOI 10.1074/jbc.RA118.005103; Baker PJ, 2017, PHYSIOL REV, V97, P1165, DOI 10.1152/physrev.00026.2016; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Coll RC, 2019, NAT CHEM BIOL, V15, P556, DOI 10.1038/s41589-019-0277-7; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Guo CS, 2016, IMMUNITY, V45, P802, DOI 10.1016/j.immuni.2016.09.008; Harikumar KB, 2010, MOL CANCER THER, V9, P1136, DOI 10.1158/1535-7163.MCT-09-1145; He YF, 2019, MATH PROBL ENG, V2019, DOI [10.1155/2019/4203821, 10.1155/2019/8193134]; Jing WD, 2021, CELL MICROBIOL, V23, DOI 10.1111/cmi.13309; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Magupalli VG, 2020, SCIENCE, V369, P1448, DOI 10.1126/science.aas8995; Malla N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020616; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mortimer L, 2016, NAT IMMUNOL, V17, P1176, DOI 10.1038/ni.3538; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Pelegrin P, 2021, BIOCHEM PHARMACOL, V187, DOI 10.1016/j.bcp.2020.114385; Reinhardt R, 2020, BIOESSAYS, V42, DOI 10.1002/bies.201900222; Sandall CF, 2019, ARCH BIOCHEM BIOPHYS, V670, P43, DOI 10.1016/j.abb.2019.02.020; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Shim DW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01054; Song N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02305; Song N, 2017, MOL CELL, V68, P185, DOI 10.1016/j.molcel.2017.08.017; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stutz A, 2017, J EXP MED, V214, P1725, DOI 10.1084/jem.20160933; Tapia-Abelian A, 2019, NAT CHEM BIOL, V15, P560, DOI 10.1038/s41589-019-0278-6; Unterreiner A, 2021, BIOCHEM BIOPH RES CO, V545, P177, DOI 10.1016/j.bbrc.2021.01.051; Tran UT, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0244-y; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Zhang Z, 2017, J EXP MED, V214	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0248668	10.1371/journal.pone.0248668	http://dx.doi.org/10.1371/journal.pone.0248668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767572	Green Published, gold, Green Submitted			2022-12-26	WOS:000755249300001
J	Alkema, W; Boekhorst, J; Eijlander, RT; Schnittger, S; De Gruyter, F; Lukovac, S; Schilling, K; Kortman, GAM				Alkema, Wynand; Boekhorst, Jos; Eijlander, Robyn T.; Schnittger, Steve; De Gruyter, Fini; Lukovac, Sabina; Schilling, Kurt; Kortman, Guus A. M.			Charting host-microbe co-metabolism in skin aging and application to metagenomics data	PLOS ONE			English	Article							COMMUNITIES	During aging of human skin, a number of intrinsic and extrinsic factors cause the alteration of the skin's structure, function and cutaneous physiology. Many studies have investigated the influence of the skin microbiome on these alterations, but the molecular mechanisms that dictate the interplay between these factors and the skin microbiome are still not fully understood. To obtain more insight into the connection between the skin microbiome and the human physiological processes involved in skin aging, we performed a systematic study on interconnected pathways of human and bacterial metabolic processes that are known to play a role in skin aging. The bacterial genes in these pathways were subsequently used to create Hidden Markov Models (HMMs), which were applied to screen for presence of defined functionalities in both genomic and metagenomic datasets of skin-associated bacteria. These models were further applied on 16S rRNA gene sequencing data from skin microbiota samples derived from female volunteers of two different age groups (25-28 years ('young') and 59-68 years ('old')). The results show that the main bacterial pathways associated with aging skin are those involved in the production of pigmentation intermediates, fatty acids and ceramides. This study furthermore provides evidence for a relation between skin aging and bacterial enzymes involved in protein glycation. Taken together, the results and insights described in this paper provide new leads for intervening with bacterial processes that are associated with aging of human skin.	[Alkema, Wynand; Boekhorst, Jos; Eijlander, Robyn T.; De Gruyter, Fini; Lukovac, Sabina; Kortman, Guus A. M.] NIZO Food Res BV, Ede, Netherlands; [Schnittger, Steve; Schilling, Kurt] Estee Lauder Co, Melville, NY USA; [Alkema, Wynand] TenWise BV, Oss, Netherlands; [Boekhorst, Jos] Wageningen Univ & Res, Dept Anim Sci, Host Microbe Interact Grp, Wageningen, Netherlands; [De Gruyter, Fini] Univ Med Ctr Utrecht, Dept Genet, Sect Genome Diagnost, Utrecht, Netherlands; [Lukovac, Sabina] Hub Organoid Technol HUB, Utrecht, Netherlands	NIZO Food Research; Estee Lauder Companies; Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Kortman, GAM (corresponding author), NIZO Food Res BV, Ede, Netherlands.	Guus.Kortman@nizo.com		Boekhorst, Jos/0000-0002-4807-7838				Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaudhari NM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02322; Chng KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.106, 10.1038/nmicrobiol.2016.106]; Dimitriu PA, 2019, MBIO, V10, DOI 10.1128/mBio.00839-19; Ebrahimpoor M., 2019, BRIEF BIOINFORM; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekseth OK, 2014, BIOINFORMATICS, V30, P734, DOI 10.1093/bioinformatics/btt582; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Huang S., 2020, MSYSTEMS, P5; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Juge R, 2018, J APPL MICROBIOL, V125, P907, DOI 10.1111/jam.13929; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim HJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53266-3; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kuehne A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3547-3; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Mallick H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1359-z; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Prestat E, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku702; Price MN, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00039-17; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Sankaranarayanan K, 2015, CURR BIOL, V25, P3161, DOI 10.1016/j.cub.2015.10.060; Shibagaki N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10834-9; Somboonna N, 2017, ARCH MICROBIOL, V199, P1035, DOI 10.1007/s00203-017-1375-0; Sun LX, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/1824624; Szalkai B, 2019, GENOMICS, V111, P883, DOI 10.1016/j.ygeno.2018.05.016; Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x; Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.88, 10.1038/NMICROBIOL.2016.88]; Vukmanovic-Stejic M, 2011, CURR OPIN IMMUNOL, V23, P525, DOI 10.1016/j.coi.2011.05.008; Wilantho A, 2017, PEERJ, V5, DOI 10.7717/peerj.4084; Wu L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00558-19; Yao JW, 2017, BIOCHIMIE, V141, P30, DOI 10.1016/j.biochi.2017.06.015; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zhai WF, 2018, J DERMATOL, V45, P1289, DOI 10.1111/1346-8138.14594	34	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258960	10.1371/journal.pone.0258960	http://dx.doi.org/10.1371/journal.pone.0258960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758050	Green Published, gold			2022-12-26	WOS:000755112500014
J	Bawore, SG; Adissu, W; Niguse, B; Larebo, YM; Ermolo, NA; Gedefaw, L				Bawore, Solomon Gebre; Adissu, Wondimagegn; Niguse, Berhanu; Larebo, Yilma Markos; Ermolo, Nigussie Abebe; Gedefaw, Lealem			A pattern of platelet indices as a potential marker for prediction of pre-eclampsia among pregnant women attending a Tertiary Hospital, Ethiopia: A case-control study	PLOS ONE			English	Article							HYPERTENSIVE DISORDERS; COUNT; MANAGEMENT; CLASSIFICATION; GUIDELINES; DEATH; RISK	Introduction Preeclampsia is the most serious health risk during pregnancy for both the mother and the fetus. Even though platelet parameters are among the proposed biomarkers for the prediction of preeclampsia, the use of its indices in the diagnosis of preeclampsia is not increasing in Ethiopia. There is little information on platelet patterns in preeclampsia and normal pregnancy. The purpose of this study was to determine the pattern of platelet indices in women with preeclampsia in our study setting. Methods A case-control study was conducted among 180 pregnant women who attended anti-natal follow-ups from January 1 to April 3, 2019. An Ethylene Diamine Tetra Acetic Acid anti-coagulated venous blood was collected and analyzed using a hematology analyzer (MINDRAY (R)-BC-300Plus, Shenzhen China). The SPSS software version 26 was used to run the Mann Whitney U test, Kruskal-Wallis H test, and Kolmogorov-Smirnov normality test, Post-hock test augmented with Benforeni, receiver operating characteristics curve, and Spear Man rank-order correlation. A P-value of <0.05 was considered statistically significant. Results A total of 180 pregnant women were included in the study. Platelet count and platelet crit levels tend to decrease as pre-eclampsia becomes more severe. In contrast, the mean platelet volume and platelet distribution widths were significantly increased with the severity of pre-eclampsia (P<0.001). Platelet distribution width (rho = 0.731, p<0.001) and mean platelet volume (rho = 0.674, p<0.001) had statistically significant positive relationships with mean arterial pressure. The best metric for predicting preeclampsia was platelet distribution width (AUC = 0.986; 95%CI; 0.970, 1). Conclusions Platelet indices, including platelet count, mean platelet volume, platelet distribution width, and Platelet crit, have been identified as promising candidate markers for predicting pre-eclampsia in pregnant women. In the future, a serial examination of these indicators during several trimesters of pregnancy should be conducted.	[Bawore, Solomon Gebre] Wachemo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hosaena, Ethiopia; [Adissu, Wondimagegn; Gedefaw, Lealem] Jimma Univ, Inst Hlth, Sch Med Lab Sci, Jimma, Ethiopia; [Niguse, Berhanu] Wachemo Univ, Nigist Eleni Mohammed Mem Comprehens & Specialize, Southern Nation Nationality People Reg, Hosaena, Ethiopia; [Larebo, Yilma Markos] Wachemo Univ, Dept Epidemiol, Coll Med & Hlth Sci, Hosaena, Ethiopia; [Ermolo, Nigussie Abebe] Wachemo Univ, Dept Hlth Serv Management, Coll Med & Hlth Sci, Hosaena, Ethiopia	Jimma University	Bawore, SG (corresponding author), Wachemo Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hosaena, Ethiopia.	solomongebre16@gmail.com	Adissu, Wondimagegn/AAY-2236-2021	Adissu, Wondimagegn/0000-0003-1624-3114	Jimma University (JU)	Jimma University (JU)	This study was sponsored by the Jimma University (JU), as one of the 1st generations higher Institution University in Jimma, Oromia, Ethiopia financed this study as part of a community research project for research and community service. The funder had no role in the design of the study, data collection, and analysis, interpretation of the data, and preparation of the manuscript.	Abass A-E., 2016, IOSR J DENT MED SCI, V1, P5; Ahmad AS, 2012, BJOG-INT J OBSTET GY, V119, P1521, DOI 10.1111/j.1471-0528.2012.03460.x; Alkholy Ea-M., 2013, AAMJ, V11; AlSheeha MA, 2016, VASC HEALTH RISK MAN, V12, P477, DOI 10.2147/VHRM.S120944; Amita K., 2015, INDIAN J PATHOL ONCO, V2, P57; Annam V, 2011, INT J BIOL MED RES, V2, P425; [Anonymous], 2018, ZONAL HOSP HLTH INFO; Bhavana T., 2016, J CONT MED DENT, V4, P20; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Birhaneselassie Misganaw, 2013, BMC Hematol, V13, P11, DOI 10.1186/2052-1839-13-11; Briggs C, 2007, INT J LAB HEMATOL, V29, P77, DOI 10.1111/j.1751-553X.2007.00909.x; Can MM., 2016, J CLIN GYNECOL OBSTE, V5, P27; Ceyhan T, 2006, ANN HEMATOL, V85, P320, DOI 10.1007/s00277-006-0091-7; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Dadhich S, 2012, J SAFOG, V4, P17; Dhakre R., 2018, INT J REPROD CONTRAC, V7, P1417; Dogan K, 2015, HYPERTENS PREGNANCY, V34, P434, DOI 10.3109/10641955.2015.1060244; Donimath KV, 2016, INT J REPROD CONTRAC, V5, P808; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Freitas LG, 2013, HEMATOLOGY, V18, P359, DOI 10.1179/1607845413Y.0000000098; Gameti DPV, 2018, J MED SCI CLIN RES, V6; Gongora MC, 2015, INT J MOL SCI, V16, P23905, DOI 10.3390/ijms161023905; Gupta A, 2018, INT J RES MED SCI, V6, P671; Han L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114488; Jena M, 2016, INT J PHARM RES ALLI, V5, P326; Karolina Pogorzelska Anna., 2020, CHARACTERISTICS PLAT; Kundu R, 2017, CARDIOLOGY ANGIOLOGY, V6, P1, DOI DOI 10.9734/CA/2017; Kurtoglu E, 2016, J EXP CLIN MED, V33, P57; Leveno K., 2014, MED; Lowe SA, 2015, AUST NZ J OBSTET GYN, V55, pe1, DOI 10.1111/ajo.12399; Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004; Mathur A, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4183; Meads CA, 2008, HEALTH TECHNOL ASSES, V12, P1; Mirkovic L, 2018, VOJNOSANIT PREGL, V75, P83, DOI 10.2298/VSP1604212301M; MOHR R, 1986, CIRCULATION, V74, P153; Nooh AM AH, 2015, OPEN J OBSTET GYNECO, V5, P703; ONISAI M., 2007, MEDICA J CLIN MED, V2, P214; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Revs IJMR., 2014, INT J MODN RES REVS, V2, P447; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sameer M., 2014, IOSR J DENT MED SCI, V13, P39; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sitotaw C, 2018, PREGNANCY HYPERTENS, V13, P242, DOI 10.1016/j.preghy.2018.06.006; Townsend R, 2016, INTEGR BLOOD PRESS C, V9, P79, DOI 10.2147/IBPC.S77344; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Wagnew M, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.supp.2016.25.2.9716; World Health Organization, 2011, WHO REC PREV TREATM; Xu RL, 2013, EXP THER MED, V5, P209, DOI 10.3892/etm.2012.799; Yang S., 2017, SW RESPIR CRIT CARE, V5, P34, DOI [10.12746/swrccc.v5i19.391, DOI 10.12746/SWRCCC.V5I19.391]; Yang SW, 2014, EUR J OBSTET GYN R B, V175, P107, DOI 10.1016/j.ejogrb.2013.12.036	50	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259543	10.1371/journal.pone.0259543	http://dx.doi.org/10.1371/journal.pone.0259543			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752500	Green Published, gold			2022-12-26	WOS:000754499700019
J	Deng, HF; Du, J; Gao, JX; Wang, Q				Deng, Hengfang; Du, Jing; Gao, Jianxi; Wang, Qi			Network percolation reveals adaptive bridges of the mobility network response to COVID-19	PLOS ONE			English	Article							EPIDEMIC; SPREAD; OUTBREAKS; PATTERNS; MODEL	Human mobility is crucial to understand the transmission pattern of COVID-19 on spatially embedded geographic networks. This pattern seems unpredictable, and the propagation appears unstoppable, resulting in over 350,000 death tolls in the U.S. by the end of 2020. Here, we create the spatiotemporal inter-county mobility network using 10 TB (Terabytes) trajectory data of 30 million smart devices in the U.S. in the first six months of 2020. We investigate the bond percolation process by removing the weakly connected edges. As we increase the threshold, the mobility network nodes become less interconnected and thus experience surprisingly abrupt phase transitions. Despite the complex behaviors of the mobility network, we devised a novel approach to identify a small, manageable set of recurrent critical bridges, connecting the giant component and the second-largest component. These adaptive links, located across the United States, played a key role as valves connecting components in divisions and regions during the pandemic. Beyond, our numerical results unveil that network characteristics determine the critical thresholds and the bridge locations. The findings provide new insights into managing and controlling the connectivity of mobility networks during unprecedented disruptions. The work can also potentially offer practical future infectious diseases both globally and locally.	[Deng, Hengfang; Wang, Qi] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Du, Jing] Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL USA; [Gao, Jianxi] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; [Gao, Jianxi] Rensselaer Polytech Inst, Ctr Network Sci & Technol, Troy, NY 12180 USA	Northeastern University; State University System of Florida; University of Florida; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Wang, Q (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.; Gao, JX (corresponding author), Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA.; Gao, JX (corresponding author), Rensselaer Polytech Inst, Ctr Network Sci & Technol, Troy, NY 12180 USA.	gaoj8@rpi.edu; q.wang@northeastern.edu	Gao, Jianxi/I-1300-2013; Deng, Hengfang/HHS-7369-2022	Gao, Jianxi/0000-0002-3952-208X; Deng, Hengfang/0000-0001-8083-8441; Wang, Qi/0000-0001-6804-1173	National Science Foundation [2027744, 2027708]	National Science Foundation(National Science Foundation (NSF))	Q.W. acknowledges the support from National Science Foundation (No. 2027744). https://www.nsf.gov/awardsearch/showAward? AWD_ID=2027744&HistoricalAwards=false. J.D. acknowledges the support from National Science Foundation (No. 2027708). https://www.nsf.gov/ awardsearch/showAward?AWD_ID= 2027708&HistoricalAwards=false. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandretti L, 2020, NATURE, V587, P402, DOI 10.1038/s41586-020-2909-1; Aleta A, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110068; Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Barabasi A.-L., 2016, NETWORK SCI; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cohen R, 2000, PHYS REV LETT, V85, P4626, DOI 10.1103/PhysRevLett.85.4626; Cohen R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036113; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Findlater A, 2018, TRENDS PARASITOL, V34, P772, DOI 10.1016/j.pt.2018.07.004; Galeazzi A., 2020, ARXIV PREPRINT ARXIV; Gao J., 2020, QUANTIFYING POLICY R; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gao JX, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.195701; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gleeson JP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056103; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gross B, 2020, EPL-EUROPHYS LETT, V131, DOI 10.1209/0295-5075/131/58003; Hadjidemetriou Georgios M, 2020, Transp Res Interdiscip Perspect, V6, P100167, DOI 10.1016/j.trip.2020.100167; Huang R, 2020, J INFECT DEV COUNTR, V14, P246, DOI 10.3855/jidc.12585; Jia JSS, 2020, NATURE, V582, P389, DOI [10.1038/s41586-020-2284-y, 10.1109/LGRS.2020.3028443]; Klein B. T., 2020, RESHAPING NATION MOB; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kreiner CT, 2018, P NATL ACAD SCI USA, V115, P11754, DOI 10.1073/pnas.1811455115; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Li M, 2021, PHYS REP, V907, P1, DOI 10.1016/j.physrep.2020.12.003; Litman T, 2003, ITE J, V73, P28; Luo FX, 2016, APPL GEOGR, V70, P11, DOI 10.1016/j.apgeog.2016.03.001; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Pappalardo L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9166; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Pepe E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00575-2; Phillips NE, 2021, SOCIOL METHOD RES, V50, P1110, DOI 10.1177/0049124119852386; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sirkeci I, 2020, MIGR LETT, V17, P379, DOI 10.33182/ml.v17i2.935; Wang D., 2011, P 17 ACM SIGKDD INT, P1100, DOI DOI 10.1145/2020408.2020581; Wang Q, 2018, P NATL ACAD SCI USA, V115, P7735, DOI 10.1073/pnas.1802537115; Wang W, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa5398; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wei H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1388; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Zeng GW, 2020, P NATL ACAD SCI USA, V117, P17528, DOI 10.1073/pnas.1907493117; Zeng GW, 2019, P NATL ACAD SCI USA, V116, P23, DOI 10.1073/pnas.1801545116; Zhong L., 2020, COUNTRY DISTANCING R; Zhou X, 2013, IEEE COMMUN LETT, V17, P1877, DOI 10.1109/LCOMM.2013.090213.130924	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0258868	10.1371/journal.pone.0258868	http://dx.doi.org/10.1371/journal.pone.0258868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY0QZ	34752462	Green Published, Green Submitted, gold			2022-12-26	WOS:000754499700006
J	Aatresh, AV; Cummings, K; Gerstein, H; Knight, CS; Limberopolous, A; Stasi, MA; Bedugnis, A; Somberg, KA; Franca, CT; Mina, MJ				Aatresh, Aishani V.; Cummings, Kate; Gerstein, Hilary; Knight, Christopher S.; Limberopolous, Andreas; Stasi, Megan A.; Bedugnis, Alice; Somberg, Kenneth A.; Franca, Camila T.; Mina, Michael J.			Development of at-home sample collection logistics for large-scale seroprevalence studies	PLOS ONE			English	Article							ANTIBODIES	Background Serological studies rely on the recruitment of representative cohorts; however, such efforts are specially complicated by the conditions surrounding the COVID19 pandemic. Methods We aimed to design and implement a fully remote methodology for conducting safe serological surveys that also allow for the engagement of representative study populations. Results This design was well-received and effective. 2,066 participants >= 18 years old were enrolled, reflecting the ethnic and racial composition of Massachusetts. >70% of them reported being satisfied/extremely satisfied with the online enrollment and at-home self-collection of blood samples. While 18.6% reported some discomfort experienced with the collection process, 72.2% stated that they would be willing to test weekly if enrolled in a long-term study. Conclusions High engagement and positive feedback from participants, as well as the quality of self-collected specimens, point to the usefulness of this fully remote, self-collection-based study design for future safer and efficient population-level serological surveys.	[Aatresh, Aishani V.; Bedugnis, Alice; Franca, Camila T.; Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Aatresh, Aishani V.] Harvard Univ, Cambridge, MA USA; [Cummings, Kate; Gerstein, Hilary; Knight, Christopher S.; Limberopolous, Andreas; Stasi, Megan A.; Somberg, Kenneth A.] TrialSpark Inc, New York, NY USA; [Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mina, Michael J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Mina, Michael J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Franca, CT; Mina, MJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA.; Mina, MJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Mina, MJ (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Mina, MJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	cfranca@hsph.harvard.edu; mmina@hsph.harvard.edu		Aatresh, Aishani/0000-0002-9774-2435				Bajema KL, 2021, JAMA INTERN MED, V181, P450, DOI 10.1001/jamainternmed.2020.7976; Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2021, ARCH PATHOL LAB MED, V145, P415, DOI 10.5858/arpa.2020-0713-SA; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Kalish H, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abh3826; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; McDade TW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237833; Mina MJ, 2020, ELIFE, V9, DOI 10.7554/eLife.58989; Morley GL, 2020, EMERG INFECT DIS, V26, P2970, DOI 10.3201/eid2612.203309; Nash D., 2021, RECENT SARS COV 2 SE, P1, DOI 10.1101/2021.02.12.21251659; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258516	10.1371/journal.pone.0258516	http://dx.doi.org/10.1371/journal.pone.0258516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735477	Green Published, gold			2022-12-26	WOS:000755077100026
J	Abro, Z; Kimathi, E; De Groote, H; Tefera, T; Sevgan, S; Niassy, S; Kassie, M				Abro, Zewdu; Kimathi, Emily; De Groote, Hugo; Tefera, Tadele; Sevgan, Subramanian; Niassy, Saliou; Kassie, Menale			Socioeconomic and health impacts of fall armyworm in Ethiopia	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; JE SMITH; PUSH-PULL; FARMERS; MAIZE; PESTICIDES; DETERMINANTS; RESISTANCE; BENEFIT; STRIGA	Since 2016, fall armyworm (FAW) has threatened sub-Saharan 'Africa's fragile food systems and economic performance. Yet, there is limited evidence on this transboundary pest's economic and food security impacts in the region. Additionally, the health and environmental consequences of the insecticides being used to control FAW have not been studied. This paper presents evidence on the impacts of FAW on maize production, food security, and human and environmental health. We use a combination of an agroecology-based community survey and nationally representative data from an agricultural household survey to achieve our objectives. The results indicate that the pest causes an average annual loss of 36% in maize production, reducing 0.67 million tonnes of maize (0.225 million tonnes per year) between 2017 and 2019. The total economic loss is US$ 200 million, or 0.08% of the gross domestic product. The lost production could have met the per capita maize consumption of 4 million people. We also find that insecticides to control FAW have more significant toxic effects on the environment than on humans. This paper highlights governments and development partners need to invest in sustainable FAW control strategies to reduce maize production loss, improve food security, and protect human and environmental health.	[Abro, Zewdu; Tefera, Tadele] Int Ctr Insect Physiol & Ecol Icipe, Addis Ababa, Ethiopia; [Kimathi, Emily; Sevgan, Subramanian; Niassy, Saliou; Kassie, Menale] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [De Groote, Hugo] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya	International Centre of Insect Physiology & Ecology (ICIPE); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Kassie, M (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	mkassie@icipe.org	Kassie, Menale/ADT-2906-2022; Abro, Zewdu/AFL-0442-2022	Abro, Zewdu/0000-0002-4116-7945; , Menale Kassie/0000-0002-6754-2432				Abay KA, 2019, J DEV ECON, V139, P171, DOI 10.1016/j.jdeveco.2019.03.008; Abedullah, 2015, J AGR ECON, V66, P66, DOI 10.1111/1477-9552.12072; Akutse KS, 2019, J APPL ENTOMOL, V143, P626, DOI 10.1111/jen.12634; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Athukorala W, 2012, J AGR ECON, V63, P158, DOI 10.1111/j.1477-9552.2011.00326.x; Badu-Apraku B, 2007, EXP AGR, V43, P183, DOI 10.1017/S0014479706004601; Baltzer JL, 2012, ECOL EVOL, V2, P2682, DOI 10.1002/ece3.383; Baudron F, 2019, CROP PROT, V120, P141, DOI 10.1016/j.cropro.2019.01.028; Bellon MR, 2005, FOOD POLICY, V30, P476, DOI 10.1016/j.foodpol.2005.09.003; Chapman D, 2017, GLOBAL ECOL BIOGEOGR, V26, P907, DOI 10.1111/geb.12599; CSA, 2019, STAT B, V589; Day R., 2017, Outlooks on Pest Management, V28, P196, DOI 10.1564/v28_oct_02; De Groote Hugo, 2002, Insect Science and its Application, V22, P89; De Groote H, 2020, AGR ECOSYST ENVIRON, V292, DOI 10.1016/j.agee.2019.106804; Deshmukh S, 2020, FLA ENTOMOL, V103, P221, DOI 10.1653/024.103.0211; Dorosh P., 2020, ETHIOPIAS AGRIFOOD S; Early R, 2018, NEOBIOTA, P25, DOI 10.3897/neobiota.40.28165; FAO, 2019, FAOSTAT DAT COLL; Gautam S, 2017, CROP PROT, V102, P161, DOI 10.1016/j.cropro.2017.08.022; Ghimire N, 2013, ECOL ECON, V89, P73, DOI 10.1016/j.ecolecon.2013.02.003; Grant J., 2020, CALCULATOR FIELD USE; Gutierrez-Moreno R, 2019, J ECON ENTOMOL, V112, P792, DOI 10.1093/jee/toy372; Hailu G, 2021, INT J TROP INSECT SC, V41, P1753, DOI 10.1007/s42690-020-00381-8; Hailu G, 2018, AGRON J, V110, P2513, DOI 10.2134/agronj2018.02.0110; Harrison RD, 2019, J ENVIRON MANAGE, V243, P318, DOI 10.1016/j.jenvman.2019.05.011; Hruska A. J., 2019, CAB Reviews, V14, P1, DOI 10.1079/PAVSNNR201914043; IPC, 2020, ETH BELG PAST AGR PR; Jaleta M, 2018, FOOD SECUR, V10, P81, DOI 10.1007/s12571-017-0759-y; Jeger M, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4927; Kansiime MK, 2019, PEST MANAG SCI, V75, P2840, DOI 10.1002/ps.5504; Kasoma C, 2021, J CROP IMPROV, V35, P111, DOI 10.1080/15427528.2020.1802800; Kassie M, 2020, EUR REV AGRIC ECON, V47, P1473, DOI 10.1093/erae/jbz048; Kniss AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131200; Koffi D, 2020, J INTEGR PEST MANAG, V11, DOI 10.1093/jipm/pmaa015; Kosmowski F, 2021, FOOD POLICY, V102, DOI 10.1016/j.foodpol.2021.102122; Kovach J., 1992, NEW YORKS FOOD LIFE, V139; Kumela T, 2019, INT J PEST MANAGE, V65, P1, DOI 10.1080/09670874.2017.1423129; Lai WY, 2017, J ENVIRON ECON MANAG, V86, P93, DOI 10.1016/j.jeem.2017.05.006; Laminou SA, 2020, INSECTS, V11, DOI 10.3390/insects11070430; Leach AW, 2008, ENVIRON POLLUT, V151, P139, DOI 10.1016/j.envpol.2007.02.019; Legesse T., 2017, FALL ARMYWORM CONTIN; Liu H., 1995, J HYG RES, V24, P356; Matova PM, 2020, CROP SCI, V60, P2951, DOI 10.1002/csc2.20317; Midega CAO, 2018, CROP PROT, V105, P10, DOI 10.1016/j.cropro.2017.11.003; Midingoyi SKG, 2019, J AGR ECON, V70, P452, DOI 10.1111/1477-9552.12306; MoA, 2020, **NON-TRADITIONAL**; Mullen J. D., 1997, Journal of Agricultural and Applied Economics, V29, P243; Muricho G, 2014, CROSS COUNTRY REPORT; Njuguna E., 2021, J INTEGR PEST MANAG, V12, P1; Otim MH., 2021, MANAGING TRANSBOUNDA, DOI [10.5772/intechopen.96637, DOI 10.5772/INTECHOPEN.96637]; Overton K, 2021, CROP PROT, V145, DOI 10.1016/j.cropro.2021.105641; Ozkara A., 2016, ENV HLTH RISK HAZARD, DOI DOI 10.5772/63094; Pingali PL, 2001, ENVIRON DEV ECON, V6, P483, DOI 10.1017/S1355770X01000274; Prasanna B.M., 2018, FALL ARMYWORM AFRICA; Ramirez-Cabral NYZ, 2017, J AGR SCI-CAMBRIDGE, V155, P1219, DOI 10.1017/S0021859617000314; Rwomushana I., 2018, KNOWLEDGE LIFE; Salato Z., 2017, FALL ARMYWORM MAIZE; Sharma R, 2016, CROP PROT, V84, P105, DOI 10.1016/j.cropro.2016.02.014; Sisay B, 2019, INSECTS, V10, DOI 10.3390/insects10070195; Sisay B, 2019, INSECTS, V10, DOI 10.3390/insects10020045; Sisay B, 2018, J APPL ENTOMOL, V142, P800, DOI 10.1111/jen.12534; Skevas T, 2013, J AGR ECON, V64, P624, DOI 10.1111/1477-9552.12007; Sonder K, 2016, GLOBAL MAP MAIZE MEG, VV4; Tambo JA, 2020, INT J PEST MANAGE, V66, P298, DOI 10.1080/09670874.2019.1646942; Veettil PC, 2017, AUST J AGR RESOUR EC, V61, P115, DOI 10.1111/1467-8489.12171; WHO, 2009, WHO REC CLASS PEST H; World Bank, 2021, WORLD DEV IND 2021; Wyckhuys KAG, 2007, AGR HUM VALUES, V24, P307, DOI 10.1007/s10460-007-9068-y; Yang XM, 2021, J ENVIRON MANAGE, V282, DOI 10.1016/j.jenvman.2021.111949; YU SJ, 1991, PESTIC BIOCHEM PHYS, V39, P84, DOI 10.1016/0048-3575(91)90216-9	70	5	5	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0257736	10.1371/journal.pone.0257736	http://dx.doi.org/10.1371/journal.pone.0257736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735485	Green Published, gold			2022-12-26	WOS:000755077100017
J	Adeleye, BN; Osabohien, R; Lawal, AI; De Alwis, T				Adeleye, Bosede Ngozi; Osabohien, Romanus; Lawal, Adedoyin Isola; De Alwis, Tyrone			Energy use and the role of per capita income on carbon emissions in African countries	PLOS ONE			English	Article							CO2 EMISSIONS; DIOXIDE EMISSIONS; ECONOMIC-GROWTH; FINANCIAL DEVELOPMENT; RENEWABLE ENERGY; DRIVING FORCES; KUZNETS CURVE; PANEL-DATA; CONSUMPTION; URBANIZATION	This study contributes towards the realization of Sustainable Development Goal (SDG) 13 which aims "take urgent action to combat climate change and its impacts" by investigating the role of per capita income in moderating the impact of energy use on carbon emissions. Using data from 28 selected African countries covering 1990 to 2019 and deploying the FGLS, PCSE, and MM-QR techniques, findings reveal, among others, that: at the 1% significance level, a percentage change in energy use leads to between 0.60% and 0.70% increase in carbon emissions, on average, ceteris paribus. Correspondingly, income shows to be a positive driver of emissions contributing between 0.87% and 0.84% percentage increase, on average, ceteris paribus. Also, per capita income attenuates the impact of energy use on emissions by between -0.27% and -0.23%, on average, ceteris paribus. However, significant heterogeneities occur across the sub-regions. Specifically, Southern Africa shows the largest energy contributor to emissions 1.65% while Central Africa contributes the most to aggravating emissions by 1.87% through increase in per capita income. West Africa shows the largest moderation effect at -0.56%. Across the quartiles, the effects of energy use and per capita are positive. Given these, we submit that the strong correlation between energy usage and per capita income (i.e. economic growth) poses a dilemma for African economies in their drive for growth. Leaving room for trade-offs. Perhaps, the lesson is that as African countries seek for more development without contributing to carbon emissions, governments should invest more in renewable energy.	[Adeleye, Bosede Ngozi; Osabohien, Romanus] Covenant Univ, Dept Econ & Dev Studies, Ota, Nigeria; [Adeleye, Bosede Ngozi] Covenant Univ, Reg Ctr Expertise RCE Ogun, Ota, Nigeria; [Adeleye, Bosede Ngozi; Osabohien, Romanus] Covenant Univ, Ctr Econ Policy & Dev Res CEPDeR, Ota, Nigeria; [Lawal, Adedoyin Isola] Landmark Univ, Dept Accounting & Finance, Omu Aran, Nigeria; [De Alwis, Tyrone] Univ Colombo, Dept Econ, Colombo, Sri Lanka	Covenant University; Covenant University; Covenant University; Landmark University; University of Colombo	Osabohien, R (corresponding author), Covenant Univ, Dept Econ & Dev Studies, Ota, Nigeria.; Osabohien, R (corresponding author), Covenant Univ, Ctr Econ Policy & Dev Res CEPDeR, Ota, Nigeria.	romanus.osabohien@covenantuniversity.edu.ng	Osabohien, Romanus/R-2284-2019; ADELEYE, Bosede Ngozi/Q-9703-2019	Osabohien, Romanus/0000-0003-4359-1368; ADELEYE, Bosede Ngozi/0000-0002-1274-714X; Osabohien, Romanus/0000-0002-9483-1395				Adams S, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.07.094; Adeel-Farooq RM, 2021, MANAG ENVIRON QUAL, V32, P277, DOI 10.1108/MEQ-07-2020-0149; Adeleye BN, 2021, ESTUD ECON APL, V39, P1; Adu DT., 2018, KASETSART J SOCIAL S; Al-Mulali U, 2012, ENERGY, V39, P180, DOI 10.1016/j.energy.2012.01.032; ALDY JE, 2005, J ENVIRON DEV, V14, P48, DOI DOI 10.1177/1070496504273514; Ali G, 2019, SUSTAIN CITIES SOC, V51, DOI 10.1016/j.scs.2019.101763; Anser MK, 2022, CURR ISSUES TOUR, V25, P2388, DOI 10.1080/13683500.2021.1965554; Asumadu-Sarkodie S, 2017, ENVIRON ENG RES, V22, P116, DOI 10.4491/eer.2016.097; Aye GC, 2017, COGENT ECON FINANC, V5, DOI 10.1080/23322039.2017.1379239; Azizalrahman H, 2019, SUSTAIN CITIES SOC, V44, P46, DOI 10.1016/j.scs.2018.09.035; Bai CQ, 2020, J ENVIRON MANAGE, V264, DOI 10.1016/j.jenvman.2020.110482; Balezentis T, 2020, J ENVIRON MANAGE, V267, DOI 10.1016/j.jenvman.2020.110635; Cameron A., 2005, MICROECONOMETRICS; Chandran VGR, 2013, RENEW SUST ENERG REV, V24, P445, DOI 10.1016/j.rser.2013.03.054; Chang CP, 2019, ECON MODEL, V77, P70, DOI 10.1016/j.econmod.2019.01.021; Ditzen J., 2016, XTDCCE2 ESTIMATING D, P1; Ditzen J, 2018, STATA J, V18, P585, DOI 10.1177/1536867X1801800306; Dogan E, 2017, RENEW SUST ENERG REV, V77, P239, DOI 10.1016/j.rser.2017.03.111; Grunewald N, 2017, ECOL ECON, V142, P249, DOI 10.1016/j.ecolecon.2017.06.034; Han XY, 2019, J CLEAN PROD, V238, DOI 10.1016/j.jclepro.2019.117958; Hoechle D, 2007, STATA J, V7, P281, DOI 10.1177/1536867X0700700301; Huo TF, 2020, SUSTAIN CITIES SOC, V56, DOI 10.1016/j.scs.2020.102068; IEA, 2019, GLOB EN TRANS; IEA, 2019, SE AS EN OUTL 2019; Ike GN, 2020, SCI TOTAL ENVIRON, V711, DOI 10.1016/j.scitotenv.2019.135208; International Energy Agency (IEA), 2019, ROL GAS TOD EN TRANS; Ivanovski K, 2020, ECON PAP, V39, P167, DOI 10.1111/1759-3441.12277; Jin T, 2018, RENEW SUST ENERG REV, V91, P464, DOI 10.1016/j.rser.2018.04.022; Kao C, 1999, J ECONOMETRICS, V90, P1, DOI 10.1016/S0304-4076(98)00023-2; Khan H, 2020, ENERGY REP, V6, P859, DOI 10.1016/j.egyr.2020.04.002; Khan Z, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138945; Kohler M, 2013, ENERG POLICY, V63, P1042, DOI 10.1016/j.enpol.2013.09.022; Levin A, 2002, J ECONOMETRICS, V108, P1, DOI 10.1016/S0304-4076(01)00098-7; Li SJ, 2019, SCI TOTAL ENVIRON, V663, P426, DOI 10.1016/j.scitotenv.2019.01.373; Lin SF, 2017, J CLEAN PROD, V166, P952, DOI 10.1016/j.jclepro.2017.08.107; Liu CJ, 2019, J CLEAN PROD, V217, P380, DOI 10.1016/j.jclepro.2019.01.242; Liu FY, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118226; Ma XJ, 2019, SCI TOTAL ENVIRON, V648, P1411, DOI 10.1016/j.scitotenv.2018.08.183; Machado JAF, 2019, J ECONOMETRICS, V213, P145, DOI 10.1016/j.jeconom.2019.04.009; Mahmood H, 2020, ENERGY REP, V6, P1553, DOI 10.1016/j.egyr.2020.06.004; Mardani A, 2019, SCI TOTAL ENVIRON, V649, P31, DOI 10.1016/j.scitotenv.2018.08.229; Murshed M, 2020, ENERGIES, V13, DOI 10.3390/en13246565; Murshed M, 2022, GEOJOURNAL, V87, P535, DOI 10.1007/s10708-020-10270-9; Nathaniel S, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2141; Nathaniel S, 2019, ENVIRON SCI POLLUT R, V26, P27168, DOI 10.1007/s11356-019-05924-2; Nathaniel SP, J CLEAN PROD, V2021, P1; Okafor V, 2021, INT J ENERGY EC POLI, V11, P112; Okoro EE, 2021, ENERG POLICY, V153, DOI 10.1016/j.enpol.2021.112260; Okoye LU, 2021, INT J ENERGY EC POLI, V11, P378, DOI [10.32479/ijeep.10768, DOI 10.32479/IJEEP.10768]; Osabuohien E, 2015, MANAG ENVIRON QUAL, V26, P118, DOI 10.1108/MEQ-04-2014-0058; Osabuohien ES, 2014, J ENVIRON POL PLAN, V16, P517, DOI 10.1080/1523908X.2013.867802; Pesaran MH, 2007, J APPL ECONOMET, V22, P265, DOI 10.1002/jae.951; Pesaran MH, 2021, EMPIR ECON, V60, P13, DOI 10.1007/s00181-020-01875-7; Ridzuan NHAM, 2020, RESOUR CONSERV RECY, V160, DOI 10.1016/j.resconrec.2020.104879; Rojas-Vallejos J, 2020, ENERG POLICY, V139, DOI 10.1016/j.enpol.2020.111302; Sarkodie SA, 2018, ENVIRON SCI POLLUT R, V25, P21993, DOI 10.1007/s11356-018-2347-x; Shahbaz M, 2019, J CLEAN PROD, V217, P603, DOI 10.1016/j.jclepro.2019.01.282; Shahbaz M, 2019, J ECON STUD, V46, P106, DOI 10.1108/JES-09-2017-0249; Shahbaz M, 2015, ECOL INDIC, V50, P215, DOI 10.1016/j.ecolind.2014.11.007; Sharif A, 2019, RENEW ENERG, V133, P685, DOI 10.1016/j.renene.2018.10.052; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Sweidan OD, 2016, RENEW SUST ENERG REV, V55, P1363, DOI 10.1016/j.rser.2015.06.001; U. S. E. I. Administration, 2019, INT ENERGY OUTLOOK 2, DOI [10.5860/choice.44-3624, DOI 10.5860/CHOICE.44-3624]; UNDP, 2018, TRANSF LIV REN EN AC; United Nations Environment Programme, 2017, ATL AFR EN RES; Urhie E, 2020, COGENT SOC SCI, V6, DOI 10.1080/23311886.2020.1719570; Wang Q, 2019, SUSTAIN CITIES SOC, V51, DOI 10.1016/j.scs.2019.101758; Wang SJ, 2019, J CLEAN PROD, V216, P217, DOI 10.1016/j.jclepro.2019.01.143; Westerlund J, 2007, OXFORD B ECON STAT, V69, P709, DOI 10.1111/j.1468-0084.2007.00477.x; Yang N, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072569; Yao XL, 2018, ENVIRON IMPACT ASSES, V71, P70, DOI 10.1016/j.eiar.2018.04.005; Yazdi SK, 2019, ECON RES-EKON ISTRAZ, V32, P510, DOI 10.1080/1331677X.2018.1556107; Zhou CS, 2019, SCI TOTAL ENVIRON, V675, P472, DOI 10.1016/j.scitotenv.2019.04.269	74	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259488	10.1371/journal.pone.0259488	http://dx.doi.org/10.1371/journal.pone.0259488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735547	gold, Green Published			2022-12-26	WOS:000755077100080
J	Barros, IMM; Barros, MVL; Martins, LNA; Ribeiro, ALP; de Camargo, RSS; Oliveira, CDL; Ferreira, AM; de Oliveira, LC; Bierrenbach, AL; Haikal, DS; Sabino, EC; Cardoso, CS; Nunes, MCP				Martins Barros, Isabella Morais; Barros, Marcio Vinicius L.; Almeida Martins, Larissa Natany; Ribeiro, Antonio Luiz P.; de Camargo, Raul Silva Simoes; Oliveira, Claudia Di Lorenzo; Ferreira, Ariela Mota; de Oliveira, Lea Campos; Bierrenbach, Ana Luiza; Haikal, Desiree Sant'Ana; Sabino, Ester Cerdeira; Cardoso, Clareci S.; Pereira Nunes, Maria Carmo			Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study	PLOS ONE			English	Article							AMERICAN SOCIETY; EUROPEAN ASSOCIATION; VENTRICULAR FUNCTION; CARDIAC ULTRASOUND; SYSTOLIC FUNCTION; RISK SCORE; RECOMMENDATIONS; CARDIOMYOPATHY; MORTALITY; DEATH	Background Chagas disease remains a major cause of cardiovascular death in endemic areas. Focused echocardiography (FoCUS) is a point-of-care means of assessing cardiac function which can be useful for the diagnosis of cardiac involvement. Objective This study aims evaluating the characteristics of validity and reliability of FoCUS applied on Chagas disease patients. Methods Patients with Chagas disease coming from an endemic area were selected from a large cohort (SaMi-Trop). A simplified echocardiogram with only three images was extracted from the conventional echocardiogram performed in this cohort. The images were evaluated by an observer who was blinded to the clinical and echocardiographic data, to determine the accuracy and reliability of FoCUS for cardiac assessment. The analysis constituted of 5 prespecified variables, dichotomized in absence or presence: left ventricular (LV) size and systolic function, right ventricular (RV) size and systolic function, and LV aneurysm. Results We included 725 patients with a mean age of 63.4 +/- 12.3 years, 483 (67%) female. Abnormal electrocardiogram was observed in 81.5% of the patients. Left and right ventricular dysfunctions were found in 103 (14%) and 49 (7%) of the patients, respectively. Sensitivity, specificity, positive predictive value and negative predictive value were 84%, 94%, 70% and 97% for LV enlargement and 81%, 93%, 68% and 97% for LV systolic dysfunction, respectively, and 46%, 99%, 60% and 98% for RV dilatation, and 37%, 100%, 100% and 96% for RV dysfunction, respectively. Inter and intraobserver agreement were 61% and 87% for LV enlargement and 63% and 92% for LV dysfunction, respectively, and 50% and 49% for RV size and 46% and 79% for RV dysfunction, respectively. LV apical aneurysm was found in 45 patients (6.2%) with the lowest sensitivity of FoCUS study (11%; 95% CI 2-28%). Conclusions FoCUS showed satisfactory values of validity and reliability for assessment of cardiac chambers in patients with Chagas disease, except for apical aneurysm. This tool can identify heart disease with potential impact on patient management in the limited-resource setting.	[Martins Barros, Isabella Morais; Barros, Marcio Vinicius L.; Ribeiro, Antonio Luiz P.; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil; [Almeida Martins, Larissa Natany] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Stat, Belo Horizonte, MG, Brazil; [Ribeiro, Antonio Luiz P.; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil; [Ferreira, Ariela Mota; Pereira Nunes, Maria Carmo] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil; [Oliveira, Claudia Di Lorenzo; Cardoso, Clareci S.] Univ Fed Sao Joao del Rei, Divinopolis, Brazil; [Ferreira, Ariela Mota; Haikal, Desiree Sant'Ana] Univ Estadual Montes Claros, Hlth Sci Program, Montes Claros, MG, Brazil; [de Oliveira, Lea Campos] Univ Sao Paulo, Hosp Clin, Fac Med, Lab Invest Med LIM03, Sao Paulo, Brazil; [Bierrenbach, Ana Luiza] Hosp Sirio Libanes, Res & Educ Inst, Sao Paulo, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Fac Med, Inst Med Trop, Sao Paulo, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei; Universidade Estadual de Montes Claros; Universidade de Sao Paulo; Hospital Sirio Libanes; Universidade de Sao Paulo; Universidade de Sao Paulo	Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Sch Med, Postgrad Course Infect Dis & Trop Med, Belo Horizonte, MG, Brazil.; Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil.; Nunes, MCP (corresponding author), Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.	mcarmo@waymail.com.br	Sabino, Ester C/F-7750-2010; Barros, Marcio/GXF-3499-2022; Cardoso, Clareci S/E-8549-2015; Haikal, Desirée/AIC-0869-2022	Sabino, Ester C/0000-0003-2623-5126; Cardoso, Clareci S/0000-0003-0689-1644; Haikal, Desirée/0000-0002-0331-0747				Acquatella H, 2007, CIRCULATION, V115, P1124, DOI 10.1161/CIRCULATIONAHA.106.627323; Acquatella H, 2018, J AM SOC ECHOCARDIOG, V31, P3, DOI 10.1016/j.echo.2017.10.019; dos Santos JPA, 2017, ARQ BRAS CARDIOL, V108, P370, DOI 10.5935/abc.20170047; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Bellsham-Revell HR, 2013, J AM SOC ECHOCARDIOG, V26, P52, DOI 10.1016/j.echo.2012.09.020; Benassi MD., 2020, REV ARGENT CARDIOL, V88, P1; Benchimol-Barbosa PR, 2013, BRAZ J MED BIOL RES, V46, P974, DOI 10.1590/1414-431X20133141; Bestetti RB, 2011, INT J CARDIOL, V151, P205, DOI 10.1016/j.ijcard.2010.05.033; Cardoso CS, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011181; Chagas Carlos, 1909, Bulletin de la Societe de Pathologie Exotique Paris, V2; Chamsi-Pasha MA, 2017, CIRCULATION, V136, P2178, DOI 10.1161/CIRCULATIONAHA.117.026622; de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002; Galderisi M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-51; Issa VS, 2010, CIRC-HEART FAIL, V3, P82, DOI 10.1161/CIRCHEARTFAILURE.109.882035; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Liebo MJ, 2011, ANN INTERN MED, V155, P33, DOI 10.7326/0003-4819-155-1-201107050-00005; Ling LF, 2012, J AM SOC ECHOCARDIOG, V25, P709, DOI 10.1016/j.echo.2012.03.018; Magunia H, 2017, J CARDIOTHOR VASC AN, V31, P595, DOI 10.1053/j.jvca.2016.11.020; Marbach JA, 2019, ANN INTERN MED, V171, P264, DOI 10.7326/M19-1337; Melamed R, 2009, CHEST, V135, P1416, DOI 10.1378/chest.08-2440; Nascimento BR, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008039; Neskovic AN, 2014, EUR HEART J-CARD IMG, V15, P956, DOI 10.1093/ehjci/jeu081; Nunes MCP, 2018, EUR HEART J-CARD IMG, V19, P459, DOI 10.1093/ehjci/jex154; Nunes MCP, 2018, CIRCULATION, V138, pE169, DOI 10.1161/CIR.0000000000000599; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Razi R, 2011, J AM SOC ECHOCARDIOG, V24, P1319, DOI 10.1016/j.echo.2011.07.013; Ribeiro ALP, 2008, J CARDIOVASC ELECTR, V19, P502, DOI 10.1111/j.1540-8167.2007.01088.x; Romano MMD, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3820191; Schneider M, 2019, INT J CARDIOVAS IMAG, V35, P2001, DOI 10.1007/s10554-019-01653-2; Spencer KT, 2013, J AM SOC ECHOCARDIOG, V26, P567, DOI 10.1016/j.echo.2013.04.001; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Xavier SS., 2005, SOCERJ, V18, P351; Xie TR, 2004, CLIN CARDIOL, V27, P241, DOI 10.1002/clc.4960270414	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258767	10.1371/journal.pone.0258767	http://dx.doi.org/10.1371/journal.pone.0258767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735475	Green Published, gold			2022-12-26	WOS:000755077100033
J	Veliz, D; Rojas-Hernandez, N; Fibla, P; Dewitte, B; Cornejo-Guzman, S; Parada, C				Veliz, David; Rojas-Hernandez, Noemi; Fibla, Pablo; Dewitte, Boris; Cornejo-Guzman, Sebastian; Parada, Carolina			High levels of connectivity over large distances in the diadematid sea urchin Centrostephanus sylviae	PLOS ONE			English	Article							POPULATION-STRUCTURE; VERTICAL MIGRATION; LARVAL DEVELOPMENT; GENETIC DIVERSITY; JASUS-FRONTALIS; ROCK LOBSTER; EDIBLE CRAB; R PACKAGE; DISPERSAL; RETENTION	Most benthic marine invertebrates with sedentary benthic adult phases have planktonic larvae that permit connectivity between geographically isolated populations. Planktonic larval duration and oceanographic processes are vital to connecting populations of species inhabiting remote and distant islands. In the present study, we analyzed the population genetic structure of the sea urchin Centrostephanus sylviae, which inhabits only the Juan Fernandez Archipelago and the Desventuradas islands, separated by more than 800 km. For 92 individuals collected from Robinson Crusoe and Selkirk Islands (Juan Fernandez Archipelago) and San Ambrosio Island (Desventuradas Islands), 7,067 single nucleotide polymorphisms (SNPs) were obtained. The results did not show a spatial genetic structure for C. sylviae; relative high migration rates were revealed between the islands. An analysis of the water circulation pattern in the area described a predominant northward water flow with periods of inverted flow, suggesting that larvae could move in both directions. Overall, this evidence suggests that C. sylviae comprises a single large population composed of individuals separated by more than 800 km.	[Veliz, David; Rojas-Hernandez, Noemi; Fibla, Pablo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Veliz, David; Dewitte, Boris; Cornejo-Guzman, Sebastian; Parada, Carolina] Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Coquimbo, Chile; [Veliz, David] Inst Ecol & Biodiversidad IEB, Santiago, Chile; [Dewitte, Boris] Ctr Estudios Avanzados Zonas Aridas CEAZA, Coquimbo, Chile; [Dewitte, Boris] Univ Toulouse, CNRS, CERFACS, Toulouse, France; [Cornejo-Guzman, Sebastian; Parada, Carolina] Univ Concepcion, Dept Geofis, Concepcion, Chile	Universidad de Chile; Centre National de la Recherche Scientifique (CNRS); CERFACS; Universite de Toulouse; Universidad de Concepcion	Veliz, D (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.; Veliz, D (corresponding author), Nucleo Milenio Ecol & Manejo Sustentable ESMOI, Coquimbo, Chile.; Veliz, D (corresponding author), Inst Ecol & Biodiversidad IEB, Santiago, Chile.	dveliz@uchile.cl	Veliz, David/J-4205-2013	Veliz, David/0000-0002-5768-9887				Addison JA, 2004, MAR BIOL, V144, P243, DOI 10.1007/s00227-003-1193-6; Arana E. P., 1987, ISLAS OCEANICAS CHIL, P319; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Becker RA, **DATA OBJECT**; Becker RA, **DATA OBJECT**; BELKHIR K, 1996, GENETIX 4 05 WINDOWS; Bell JJ, 2008, BIOL CONSERV, V141, P2807, DOI 10.1016/j.biocon.2008.08.017; Benham CE, 2012, J EXP MAR BIOL ECOL, V432, P47, DOI 10.1016/j.jembe.2012.07.011; Casilagan ILN, 2013, J EXP MAR BIOL ECOL, V449, P284, DOI 10.1016/j.jembe.2013.09.012; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dewitte B, 2021, AQUAT CONSERV, V31, P232, DOI 10.1002/aqc.3506; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Duran S, 2004, MOL ECOL, V13, P3317, DOI 10.1111/j.1365-294X.2004.02338.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; FELL FJ, 1975, J ROY SOC NEW ZEAL, V5, P179, DOI 10.1080/03036758.1975.10419371; Fernandez E, 2018, 001030 CMEMSGLOPUM; Flanagan SP, 2017, J HERED, V108, P561, DOI 10.1093/jhered/esx048; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Friedlander AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145059; Gruber B, 2018, MOL ECOL RESOUR, V18, P691, DOI 10.1111/1755-0998.12745; Gurvan M, 2019, ZENODO, DOI [10.5281/zenodo.3878122, DOI 10.5281/ZENODO.3878122]; Hellberg ME, 1996, EVOLUTION, V50, P1167, DOI 10.1111/j.1558-5646.1996.tb02357.x; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Huggett MJ, 2005, INVERTEBR REPROD DEV, V47, P197, DOI 10.1080/07924259.2005.9652160; Jenkins SR, 2003, HYDROBIOLOGIA, V503, P143, DOI 10.1023/B:HYDR.0000008496.68710.22; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Luu K, 2017, MOL ECOL RESOUR, V17, P67, DOI 10.1111/1755-0998.12592; Marta-Almeida M, 2006, MAR ECOL PROG SER, V307, P1, DOI 10.3354/meps307001; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Meerhoff E, 2018, B MAR SCI, V94, P753, DOI 10.5343/bms.2017.1114; PENNINGTON JT, 1986, J EXP MAR BIOL ECOL, V104, P69, DOI 10.1016/0022-0981(86)90098-5; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Porobic J., 2012, LAT AM J AQUAT RES, V40, P613; Porobic J, 2013, J HERED, V104, P223, DOI 10.1093/jhered/ess141; Pritchard J.K., 2010, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Quintana R., 1983, REP USA MAR BIOL I K, V5, P1; R Core Team, 2016, R FDN STAT COMP; Riginos C, 2019, DIVERS DISTRIB, V25, P1684, DOI 10.1111/ddi.12969; Rojas-Hernandez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166029; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Ungfors A, 2009, ICES J MAR SCI, V66, P462, DOI 10.1093/icesjms/fsn223; von Schuckmann K, 2016, NAT CLIM CHANGE, V6, P138, DOI 10.1038/NCLIMATE2876; Weiss M, 2009, J MAR BIOL ASSOC UK, V89, P753, DOI 10.1017/S0025315409003269; White TD, 2020, CONSERV BIOL, V34, P1571, DOI 10.1111/cobi.13584; Xuereb A, 2018, MOL ECOL, V27, P2347, DOI 10.1111/mec.14589	51	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259595	10.1371/journal.pone.0259595	http://dx.doi.org/10.1371/journal.pone.0259595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735545	gold, Green Published			2022-12-26	WOS:000755077100097
J	Gavgani, HN; Fawaz, R; Ehyaei, N; Walls, D; Pawlowski, K; Fulgos, R; Park, S; Assar, Z; Ghanbarpour, A; Geiger, JH				Gavgani, Hadi Nayebi; Fawaz, Remie; Ehyaei, Nona; Walls, David; Pawlowski, Kathryn; Fulgos, Raoul; Park, Sunghoon; Assar, Zahra; Ghanbarpour, Alireza; Geiger, James H.			A structural explanation for the mechanism and specificity of plant branching enzymes I and IIb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STARCH GRANULES; FINE-STRUCTURE; SUBSTRATE; ISOFORMS; AMYLOSE; COMPLEX; BEI; OLIGOSACCHARIDES; AMYLOPECTIN	Branching enzymes (BEs) are essential in the biosynthesis of starch and glycogen and play critical roles in determining the fine structure of these polymers. The substrates of these BEs are long carbohydrate chains that interact with these enzymes via multiple binding sites on the enzyme's surface. By controlling the branched-chain length distribution, BEs can mediate the physiological properties of starch and glycogen moieties; however, the mechanism and structural determinants of this specificity remain mysterious. In this study, we identify a large dodecaose binding surface on rice BE I (BEI) that reaches from the outside of the active site to the active site of the enzyme. Mutagenesis activity assays confirm the importance of this binding site in enzyme catalysis, from which we conclude that it is likely the acceptor chain binding site. Comparison of the structures of BE from Cyanothece and BE1 from rice allowed us to model the location of the donor-binding site. We also identified two loops that likely interact with the donor chain and whose sequences diverge between plant BE1, which tends to transfer longer chains, and BEIIb, which transfers exclusively much shorter chains. When the sequences of these loops were swapped with the BEIIb sequence, rice BE1 also became a short-chain transferring enzyme, demonstrating the key role these loops play in specificity. Taken together, these results provide a more complete picture of the structure, selectivity, and activity of BEs.	[Gavgani, Hadi Nayebi; Fawaz, Remie; Ehyaei, Nona; Walls, David; Pawlowski, Kathryn; Fulgos, Raoul; Assar, Zahra; Ghanbarpour, Alireza; Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Park, Sunghoon] Sangmyung Univ, Coll Nat Sci, Dept Foodserv Management & Nutr, Seoul, South Korea; [Park, Sunghoon] Gangneung Wonju Natl Univ, Dept Food & Nutr, Kangnung 25457, South Korea; [Assar, Zahra] Cayman Chem, 1180 E Ellsworth Rd, Ann Arbor, MI 48108 USA; [Ghanbarpour, Alireza] Yale Sch Med, 333 Cedar St, New Haven, CT 06520 USA	Michigan State University; Sang Myung University; Kangnung Wonju National University; Yale University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geigerj@msu.edu		Ghanbarpour, Alireza/0000-0002-7485-029X; Fawaz, Remie/0000-0001-7458-0122; Nayebi, Hadi/0000-0002-3172-6627; park, sunghoon/0000-0002-3032-5901	NIH [R01GM101353]; DOE [DE-FG02-06ER15822]; US DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; MSU office of the Vice President for Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); US DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; MSU office of the Vice President for Research	Generous support was provided by the NIH (R01GM101353) and DOE (DE-FG02-06ER15822). All crystallo-graphic data were collected at the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, supported by the US DOE under contract no. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation, the Michigan Technology Tri-Corridor (grant 085P1000817), and the MSU office of the Vice President for Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abad MC, 2002, J BIOL CHEM, V277, P42164, DOI 10.1074/jbc.M205746200; Akasaka T, 2009, BIOSCI BIOTECH BIOCH, V73, P2516, DOI 10.1271/bbb.90352; Blennow A, 2010, TRENDS PLANT SCI, V15, P236, DOI 10.1016/j.tplants.2010.01.009; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Chaen K, 2012, BIOCHEM BIOPH RES CO, V424, P508, DOI 10.1016/j.bbrc.2012.06.145; CURA JA, 1995, STARCH-STARKE, V47, P207, DOI 10.1002/star.19950470602; DENYER K, 1993, PLANT J, V4, P191, DOI 10.1046/j.1365-313X.1993.04010191.x; Feng L, 2016, ACTA CRYSTALLOGR D, V72, P641, DOI 10.1107/S2059798316003272; Feng L, 2015, BIOCHEMISTRY-US, V54, P6207, DOI 10.1021/acs.biochem.5b00228; Froese DS, 2015, HUM MOL GENET, V24, P5667, DOI 10.1093/hmg/ddv280; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Hamada S, 2002, J BIOL CHEM, V277, P16538, DOI 10.1074/jbc.M110497200; Hayashi M, 2017, J BIOL CHEM, V292, P5465, DOI 10.1074/jbc.M116.755629; Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999; Li C, 2016, PLANTA, V243, P13, DOI 10.1007/s00425-015-2421-2; Lu B, 2008, SCI CHINA SER C, V51, P863, DOI 10.1007/s11427-008-0120-y; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Mizuno K, 2001, PLANT CELL PHYSIOL, V42, P349, DOI 10.1093/pcp/pce042; Nakamura Y, 2015, BIOCHEM STRUCTURAL P; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Popov D, 2009, MACROMOLECULES, V42, P1167, DOI 10.1021/ma801789j; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Sawada T, 2014, ARCH BIOCHEM BIOPHYS, V562, P9, DOI 10.1016/j.abb.2014.07.032; Sun CX, 1998, PLANT PHYSIOL, V118, P37, DOI 10.1104/pp.118.1.37; Suzuki E, 2016, CELL MOL LIFE SCI, V73, P2643, DOI 10.1007/s00018-016-2243-9; Tetlow IJ, 2014, IUBMB LIFE, V66, P546, DOI 10.1002/iub.1297; Vismeh R, 2013, CARBOHYD POLYM, V94, P791, DOI 10.1016/j.carbpol.2013.02.005; Wang Z, 2019, PROTEIN EXPRES PURIF, V164, DOI 10.1016/j.pep.2019.105478; Wu AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065768	34	0	0	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN	2022	298	1							101395	10.1016/j.jbc.2021.101395	http://dx.doi.org/10.1016/j.jbc.2021.101395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1JM	34762912	Green Published, gold			2022-12-26	WOS:000748384500005
J	Beak, JY; Kang, HS; Huang, W; Deshmukh, R; Hong, SJ; Kadakia, N; Aghajanian, A; Gerrish, K; Jetten, A; Jensen, B				Beak, Ju Youn; Kang, Hong Soon; Huang, Wei; Deshmukh, Rishi; Hong, Seok Jae; Kadakia, Nishi; Aghajanian, Amir; Gerrish, Kevin; Jetten, Anton; Jensen, Brian			The nuclear receptor ROR alpha preserves cardiomyocyte mitochondrial function by regulating caveolin-3-mediated mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; EXPRESSION; HYPOXIA; HEART; HYPERTROPHY; AUTOPHAGY; METABOLISM; PROTECTION; CAVEOLIN; MOUSE	Preserving optimal mitochondrial function is critical in the heart, which is the most ATP-avid organ in the body. Recently, we showed that global deficiency of the nuclear receptor ROR alpha in the "staggerer" mouse exacerbates angiotensin II- induced cardiac hypertrophy and compromises cardiomyocyte mitochondrial function. However, the mechanisms underlying these observations have not been defined previously. Here, we used pharmacological and genetic gain and loss-of-function tools to demonstrate that ROR alpha regulates cardiomyocyte mitophagy to preserve mitochondrial abundance and function. We found that cardiomyocyte mitochondria in staggerer mice with lack of functional ROR alpha were less numerous and exhibited fewer mitophagy events than those in WT controls. The hearts of our novel cardiomyocytespecific ROR alpha KO mouse line demonstrated impaired contractile function, enhanced oxidative stress, increased apoptosis, and reduced autophagic flux relative to Cre(-) littermates. We found that cardiomyocyte mitochondria in "staggerer" mice with lack of functional ROR alpha were upregulated by hypoxia, a classical inducer of mitophagy. The loss of ROR alpha blunted mitophagy and broadly compromised mitochondrial function in normoxic and hypoxic conditions in vivo and in vitro. We also show that ROR alpha is a direct transcriptional regulator of the mitophagy mediator caveolin3 in cardiomyocytes and that enhanced expression of ROR alpha increases caveolin-3 abundance and enhances mitophagy. Finally, knockdown of ROR alpha impairs cardiomyocyte mitophagy, compromises mitochondrial function, and induces apoptosis, but these defects could be rescued by caveolin-3 overexpression. Collectively, these findings reveal a novel role for ROR alpha in regulating mitophagy through caveolin-3 and expand our currently limited understanding of the mechanisms underlying ROR alpha-mediated cardioprotection.	[Beak, Ju Youn; Huang, Wei; Deshmukh, Rishi; Hong, Seok Jae; Aghajanian, Amir; Jensen, Brian] Univ N Carolina, Sch Med, McAllister Heart Inst, Chapel Hill, NC 27515 USA; [Kang, Hong Soon; Jetten, Anton] NIEHS, Immun Inflammat & Dis Lab, NIH, Durham, NC USA; [Kadakia, Nishi] Campbell Univ, Sch Osteopath Med, Lillington, NC USA; [Aghajanian, Amir] Univ N Carolina, Dept Cell Biol & Physiol, Sch Med, Chapel Hill, NC 27515 USA; [Gerrish, Kevin] NIEHS, Mol Genom Core Lab, Durham, NC USA; [Jensen, Brian] Univ N Carolina, Div Cardiol, Sch Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Campbell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Jensen, B (corresponding author), Univ N Carolina, Sch Med, McAllister Heart Inst, Chapel Hill, NC 27515 USA.; Jensen, B (corresponding author), Univ N Carolina, Div Cardiol, Sch Med, Chapel Hill, NC 27515 USA.	bcjensen@med.unc.edu	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445; Kadakia, Nishi/0000-0002-4013-0710	Hugh A. McAllister Research Foundation; Intramural Research Program of the National Institute of Environmental Health Sciences; National Institutes of Health [Z01-ES101586, R01HL140067]	Hugh A. McAllister Research Foundation; Intramural Research Program of the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B. J. receives funding support from NIH (R01HL140067) and Hugh A. McAllister Research Foundation. A. J. receives funding support from Intramural Research Program of the National Institute of Environmental Health Sciences and the National Institutes of Health [Z01-ES101586]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beak JY, 2019, AM J PHYSIOL-HEART C, V316, pH186, DOI 10.1152/ajpheart.00531.2018; Besnard S, 2002, FEBS LETT, V511, P36, DOI 10.1016/S0014-5793(01)03275-6; Besnard S, 2002, CIRC RES, V90, P820, DOI 10.1161/01.RES.0000014489.24705.71; Byun JK, 2015, HEPATOLOGY, V61, P953, DOI 10.1002/hep.27577; Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256; Chauvet C, 2004, BIOCHEM J, V384, P79, DOI 10.1042/BJ20040709; Cook Donald N, 2015, Nucl Receptor Res, V2; Fridolfsson HN, 2012, FASEB J, V26, P4637, DOI 10.1096/fj.12-215798; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Horikawa YT, 2008, J MOL CELL CARDIOL, V44, P123, DOI 10.1016/j.yjmcc.2007.10.003; Horikawa YT, 2011, J AM COLL CARDIOL, V57, P2273, DOI 10.1016/j.jacc.2010.12.032; Jeon K, 2019, STEM CELLS, V37, P202, DOI 10.1002/stem.2941; Kassan A, 2016, AM J PHYSIOL-CELL PH, V311, pC854, DOI 10.1152/ajpcell.00147.2016; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim EJ, 2008, ARTERIOSCL THROM VAS, V28, P1796, DOI 10.1161/ATVBAHA.108.171546; Kim HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16077-y; Kim K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00215-1; Kong CHT, 2019, EXP PHYSIOL, V104, P654, DOI 10.1113/EP087304; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Mauvezin C, 2015, AUTOPHAGY, V11, P1437, DOI 10.1080/15548627.2015.1066957; Moyzis AG, 2015, AM J PHYSIOL-HEART C, V308, pH183, DOI 10.1152/ajpheart.00708.2014; Nah J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.71; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; Ratajczak P, 2003, CARDIOVASC RES, V57, P358, DOI 10.1016/S0008-6363(02)00660-0; Sharifi MN, 2015, METHODS MOL BIOL, V1292, P129, DOI 10.1007/978-1-4939-2522-3_10; Shirakabe A, 2016, J MOL CELL CARDIOL, V92, P134, DOI 10.1016/j.yjmcc.2016.02.007; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Tuong ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147179; Vega RB, 2017, J CLIN INVEST, V127, P1155, DOI 10.1172/JCI88888; Wahyuni T, 2021, AM J PHYSIOL-CELL PH, V321, pC82, DOI 10.1152/ajpcell.00568.2020; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Wang Y, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7954657; Wang YJ, 2016, ACS CHEM NEUROSCI, V7, P143, DOI 10.1021/acschemneuro.5b00159; Zhang H, 2020, J CEREBR BLOOD F MET, V40, P1806, DOI 10.1177/0271678X20924107; Zhao YC, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12378; Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849; Zhou QQ, 2018, J MOL CELL CARDIOL, V116, P115, DOI 10.1016/j.yjmcc.2018.02.008	44	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101358	10.1016/j.jbc.2021.101358	http://dx.doi.org/10.1016/j.jbc.2021.101358			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756888	gold, Green Published			2022-12-26	WOS:000765319800003
J	Gouda, H; Mascarenhas, R; Pillay, S; Ruetz, M; Koutmos, M; Banerjee, R				Gouda, Harsha; Mascarenhas, Romila; Pillay, Shubhadra; Ruetz, Markus; Koutmos, Markos; Banerjee, Ruma			Patient mutations in human ATP:cob(I)alamin adenosyltransferase differentially affect its catalytic versus chaperone functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLMALONYL-COA MUTASE; COENZYME B-12; ATP-COB(I)ALAMIN ADENOSYLTRANSFERASE; COMPLEMENTATION GROUP; HUMAN ATP; IDENTIFICATION; ENZYME; VITAMIN-B-12; DISORDERS; MECHANISM	Human ATP:cob(I)alamin adenosyltransferase (ATR) is a mitochondrial enzyme that catalyzes an adenosyl transfer to cob(I)alamin, synthesizing 5'-deoxyadenosylcobalamin (AdoCbl) or coenzyme B-12. ATR is also a chaperone that escorts AdoCbl, transferring it to methylmalonyl-CoA mutase, which is important in propionate metabolism. Mutations in ATR lead to methylmalonic aciduria type B, an inborn error of B-12 metabolism. Our previous studies have furnished insights into how ATR protein dynamics influence redox-linked cobalt coordination chemistry, controlling its catalytic versus chaperone functions. In this study, we have characterized three patient mutations at two conserved active site residues in human ATR, R190C/H, and E193K and obtained crystal structures of R190C and E193K variants, which display only subtle structural changes. All three mutations were found to weaken affinities for the cob(II)alamin substrate and the AdoCbl product and increase K-M(ATP). P-31 NMR studies show that binding of the triphosphate product, formed during the adenosylation reaction, is also weakened. However, although the k(cat) of this reaction is significantly diminished for the R190C/H mutants, it is comparable with the WT enzyme for the E193K variant, revealing the catalytic importance of Arg-190. Furthermore, although the E193K mutation selectively impairs the chaperone function by promoting product release into solution, its catalytic function might be unaffected at physiological ATP concentrations. In contrast, the R190C/H mutations affect both the catalytic and chaperoning activities of ATR. Because the E193K mutation spares the catalytic activity of ATR, our data suggest that the patients carrying this mutation are more likely to be responsive to cobalamin therapy.	[Gouda, Harsha; Mascarenhas, Romila; Pillay, Shubhadra; Ruetz, Markus; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Koutmos, Markos] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Koutmos, Markos] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Koutmos, Markos/0000-0003-0933-6312; Pillay, Shubhadra/0000-0001-6442-9453; Gouda, Harsha/0000-0003-4511-5875	National Institutes of Health [DK45776]; American Heart Association [19POST34370113]; National Science Foundation [NSF-CHE 1945174]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by grants from the National Institutes of Health (DK45776 to R. B.), the American Heart Association (19POST34370113 to R. M.), and the National Science Foundation (NSF-CHE 1945174 to M. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2021, ACCOUNTS CHEM RES, V54, P2003, DOI 10.1021/acs.accounts.1c00083; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Beilsten-Edmands J, 2020, ACTA CRYSTALLOGR D, V76, P385, DOI 10.1107/S2059798320003198; Brasil S, 2018, BBA-MOL BASIS DIS, V1864, P640, DOI 10.1016/j.bbadis.2017.11.024; CALAFAT AM, 1993, J AM CHEM SOC, V115, P9182, DOI 10.1021/ja00073a037; Campanello GC, 2018, J AM CHEM SOC, V140, P13205, DOI 10.1021/jacs.8b08659; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039; Jorge-Finnigan A, 2013, HUM MOL GENET, V22, P3680, DOI 10.1093/hmg/ddt217; Jorge-Finnigan A, 2010, HUM MUTAT, V31, P1033, DOI 10.1002/humu.21307; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Leal NA, 2004, J BIOL CHEM, V279, P47536, DOI 10.1074/jbc.M405449200; Leal NA, 2003, J BIOL CHEM, V278, P9227, DOI 10.1074/jbc.M212739200; Lerner-Ellis JP, 2006, MOL GENET METAB, V87, P219, DOI 10.1016/j.ymgme.2005.11.011; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mascarenhas R, 2020, P NATL ACAD SCI USA, V117, P30412, DOI 10.1073/pnas.2007332117; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Padovani D, 2008, NAT CHEM BIOL, V4, P194, DOI 10.1038/nchembio.67; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Padovani D, 2009, P NATL ACAD SCI USA, V106, P21567, DOI 10.1073/pnas.0908106106; Padovani D, 2009, BIOCHEMISTRY-US, V48, P5350, DOI 10.1021/bi900454s; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruetz M, 2019, SCIENCE, V366, P589, DOI 10.1126/science.aay0934; Ruetz M, 2019, CELL CHEM BIOL, V26, P960, DOI 10.1016/j.chembiol.2019.03.014; Schubert HL, 2006, BIOCHEMISTRY-US, V45, P15188, DOI 10.1021/bi061396f; Stich TA, 2005, J AM CHEM SOC, V127, P7660, DOI 10.1021/ja050546r; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Vitvitsky V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100736; Watkins D, 2011, AM J MED GENET C, V157C, P33, DOI 10.1002/ajmg.c.30288; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamanishi M, 2005, J AM CHEM SOC, V127, P526, DOI 10.1021/ja044365l; Yamanishi M, 2005, TRENDS BIOCHEM SCI, V30, P304, DOI 10.1016/j.tibs.2005.04.008; Zhang J, 2006, MOL GENET METAB, V87, P315, DOI 10.1016/j.ymgme.2005.12.003; Zhang J, 2009, MOL GENET METAB, V98, P278, DOI 10.1016/j.ymgme.2009.06.014	45	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101373	10.1016/j.jbc.2021.101373	http://dx.doi.org/10.1016/j.jbc.2021.101373			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34757128	Green Submitted, gold, Green Published			2022-12-26	WOS:000748084900011
J	Dongol, S; Kayastha, G; Maharjan, N; Pyatha, S; Rajkumar, KC; Thwaites, L; Basnyat, B; Baker, S; Karkey, A				Dongol, Sabina; Kayastha, Gyan; Maharjan, Nhukesh; Pyatha, Sarita; Rajkumar, K. C.; Thwaites, Louise; Basnyat, Buddha; Baker, Stephen; Karkey, Abhilasha			Epidemiology, etiology, and diagnosis of health care acquired pneumonia including ventilator-associated pneumonia in Nepal	PLOS ONE			English	Article							NOSOCOMIAL INFECTION-CONTROL; RESISTANT; OUTCOMES; IMPACT; ADULTS; UNITS	Epidemiologic data regarding health care acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) from Nepal are negligible. We conducted a prospective observational cohort study in the intensive care unit (ICU) of a major tertiary hospital in Nepal between April 2016 and March 2018, to calculate the incidence of VAP, and to describe clinical variables, microbiological etiology, and outcomes. Four hundred and thirty-eight patients were enrolled in the study. Demographic data, medical history, antimicrobial administration record, chest X-ray, biochemical, microbiological and haematological results, acute physiology and chronic health evaluation II score and the sequential organ failure assessment scores were recorded. Categorical variables were expressed as count and percentage and analyzed using the Fisher's exact test. Continuous variables were expressed as median and interquartile range and analyzed using Kruskal-Wallis rank sum test and the pairwise Wilcoxon rank-sum test. 46.8% (205/438) of the patients required intubation. Pneumonia was common in both intubated (94.14%; 193/205) and non-intubated (52.36%; 122/233) patients. Pneumonia developed among intubated patients in the ICU had longer days of stay in the ICU (median of 10, IQR 5-15, P<0.001) when compared to non-intubated patients with pneumonia (median of 4, IQR 3-6, P<0.001). The incidence rate of VAP was 20% (41/205) and incidence density was 16.45 cases per 1,000 ventilator days. Mortality was significantly higher in patients with pneumonia requiring intubation (44.6%, 86/193) than patients with pneumonia not requiring intubation (10.7%, 13/122, p<0.001, Fisher's exact test). Gram negative bacteria such as Klebsiella and Acinetobacter species were the dominant organisms from both VAP and non-VAP categories. Multi-drug resistance was highly prevalent in bacterial isolates associated with VAP (90%; 99/110) and non-VAP categories (81.5%; 106/130). HAP including VAP remains to be the most prevalent hospital-acquired infections (HAIs) at Patan hospital. A local study of etiological agents and outcomes of HAP and VAP are required for setting more appropriate guidelines for management of such diseases.	[Dongol, Sabina; Maharjan, Nhukesh; Pyatha, Sarita; Rajkumar, K. C.; Basnyat, Buddha; Karkey, Abhilasha] Univ Oxford, Patan Hosp, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal; [Kayastha, Gyan] Patan Hosp, Patan Acad Hlth Sci, Kathmandu, Nepal; [Thwaites, Louise] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Baker, Stephen] Univ Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis CIT, Dept Med, Cambridge, England	University of Oxford; University of Oxford; University of Cambridge	Karkey, A (corresponding author), Univ Oxford, Patan Hosp, Patan Acad Hlth Sci, Clin Res Unit, Kathmandu, Nepal.	akarkey@oucru.org			Oak Foundation [OCAY-15-547]	Oak Foundation	This project and AK was funded as a leadership fellow through the Oak Foundation (OCAY-15-547). URL:https://oakfnd.org/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bonell A, 2019, CLIN INFECT DIS, V68, P511, DOI 10.1093/cid/ciy543; Centers for Disease Control and Prevention, 2015, CTR DIS CONTROL PREV, V2015, P1; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chawla R, 2008, AM J INFECT CONTROL, V36, pS93, DOI 10.1016/j.ajic.2007.05.011; Ewig S, 2002, THORAX, V57, P366, DOI 10.1136/thorax.57.4.366; Feng DY, 2019, INFECT DRUG RESIST, V12, P993, DOI 10.2147/IDR.S204671; Frota OP, 2014, REV ESC ENFERM USP, V48, P618, DOI 10.1590/S0080-623420140000400007; Giuliano KK, 2018, AM J INFECT CONTROL, V46, P322, DOI 10.1016/j.ajic.2017.09.005; Inchai J, 2015, JPN J INFECT DIS, V68, P181, DOI 10.7883/yoken.JJID.2014.282; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; Joshi SG, ACINETOBACTER BAUMAN, DOI [10.5495/wjcid.v3.i3.25, DOI 10.5495/WJCID.V3.I3.25]; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Klompas M, 2012, CLIN INFECT DIS, V54, P370, DOI 10.1093/cid/cir832; Leblebicioglu H, 2007, J HOSP INFECT, V65, P251, DOI 10.1016/j.jhin.2006.10.012; Leone M, 2018, ANAESTH CRIT CARE PA, V37, P83, DOI 10.1016/j.accpm.2017.11.006; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mathai AS, 2016, LUNG INDIA, V33, P512, DOI 10.4103/0970-2113.188971; Melsen WG, 2013, LANCET INFECT DIS, V13, P665, DOI 10.1016/S1473-3099(13)70081-1; Ohara Hiroshi, 2013, Trop Med Health, V41, P113, DOI 10.2149/tmh.2013-03; Papazian L, 2020, INTENS CARE MED, V46, P888, DOI 10.1007/s00134-020-05980-0; Patil Harsha V, 2017, J Nat Sci Biol Med, V8, P46, DOI 10.4103/0976-9668.198360; Pontikis K, 2014, INT J ANTIMICROB AG, V43, P52, DOI 10.1016/j.ijantimicag.2013.09.010; Ranjit S, 2011, Kathmandu Univ Med J (KUMJ), V9, P28; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Rosenthal VD, 2012, INFECT CONT HOSP EP, V33, P704, DOI 10.1086/666342; Timsit Jean-Francois, 2017, F1000Res, V6, P2061, DOI 10.12688/f1000research.12222.1; Torres A, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00028-2018; Torres A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00582-2017; Le Minh V, 2015, J MED MICROBIOL, V64, P1162, DOI 10.1099/jmm.0.000137; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Phu VD, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0266-4; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Werarak P., J MED ASSOC THAILAND, P93; Xu Y, 2019, CLIN INTERV AGING, V14, P1027, DOI 10.2147/CIA.S197146	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259634	10.1371/journal.pone.0259634	http://dx.doi.org/10.1371/journal.pone.0259634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788314	gold, Green Published			2022-12-26	WOS:000735920500032
J	Han, Y				Han, Ye			Effects of cigarette smoking on the growth of Streptococcus mutans biofilms: An in vitro study	PLOS ONE			English	Article							DENTAL-CARIES; TOBACCO-SMOKE; GLUCOSYLTRANSFERASES; DISEASES; IGA	The increased incidence of dental caries by cigarette smoking (CS) has been widely reported in epidemiological studies, but the relationship between CS and cariogenic biofilm growth has been rarely studied. This study aims to investigate the effects of CS exposure on the growth and virulence of Streptococcus mutans biofilms (S. mutans). Briefly, S. mutans biofilms were formed on saliva-coated hydroxyapatite disks, which were exposed to CS 1, 3, and 6 times per day, respectively. In addition, S. mutans biofilms without CS exposure were considered as the control group. Acidogenicity, dry weight, colony-forming units (CFUs), water-soluble/insoluble extracellular polysaccharides (EPSs), and intracellular polysaccharides (IPSs) were analyzed and confocal laser scanning microscopy (CLSM) images of 74-h-old S. mutans biofilms were obtained. The lowest accumulation of biofilms and EPSs were detected in the 6 times/day CS exposure group compared with those of the control group and other CS exposure groups in 74-h-old S. mutans biofilms. CLSM also revealed the lowest bacterial count (live and dead cells) and EPSs biovolume in the six times/day CS exposure group in 74-h-old S. mutans biofilms. CS exposure inhibited the growth of S. mutans biofilm in vitro study, the anti-cariogenic biofilm formation was enhanced with a dose (frequency)-dependent at which frequency has more influence in the present findings.	[Han, Ye] Jeonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Dept Prevent Dent, Jeonju, South Korea; [Han, Ye] Jeonbuk Natl Univ, BK Plus Program 21, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University	Han, Y (corresponding author), Jeonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Dept Prevent Dent, Jeonju, South Korea.; Han, Y (corresponding author), Jeonbuk Natl Univ, BK Plus Program 21, Jeonju, South Korea.	hanye1747@gmail.com			National Research Foundation of Korean grant (NRF) - Korean government (MSIT) [2019R1H1A2080006]	National Research Foundation of Korean grant (NRF) - Korean government (MSIT)	This work supported by the National Research Foundation of Korean grant (NRF) funded by the Korean government (MSIT) (No.2019R1H1A2080006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Zinser V, 2008, CARIES RES, V42, P255, DOI 10.1159/000135670; Benderli Y, 2000, ORAL SURG ORAL MED O, V89, P588, DOI 10.1067/moe.2000.105144; Bernabe E, 2017, J DENT RES, V96, P171, DOI 10.1177/0022034516678181; Bernabe E, 2014, COMMUNITY DENT ORAL, V42, P428, DOI 10.1111/cdoe.12101; Borgerding M, 2005, EXP TOXICOL PATHOL, V57, P43, DOI 10.1016/j.etp.2005.05.010; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Campus G, 2011, CARIES RES, V45, P40, DOI 10.1159/000322852; Cogulu D, 2006, ARCH ORAL BIOL, V51, P23, DOI 10.1016/j.archoralbio.2005.06.001; Cuadra GA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16101669; Fujinami Y, 2011, CARIES RES, V45, P561, DOI 10.1159/000331926; Gregoire S, 2007, J APPL MICROBIOL, V103, P1960, DOI 10.1111/j.1365-2672.2007.03441.x; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Hwang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32841; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Koo H, 2009, Adv Dent Res, V21, P63, DOI 10.1177/0895937409335629; Kwon YR, 2010, ORAL DIS, V16, P204, DOI 10.1111/j.1601-0825.2009.01636.x; Lemos JA, 2013, MICROBIOL-SGM, V159, P436, DOI 10.1099/mic.0.066134-0; Lemos JA, 2010, METHODS MOL BIOL, V666, P87, DOI 10.1007/978-1-60761-820-1_7; Marsh PD, 2010, J DENT, V38, pS11, DOI 10.1016/S0300-5712(10)70005-1; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Dang MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24626-2; Nobre MD, 2017, J DENT, V67, P36, DOI 10.1016/j.jdent.2017.07.013; Pandit S, 2015, J APPL MICROBIOL, V119, P571, DOI 10.1111/jam.12851; Pandit S, 2011, ARCH ORAL BIOL, V56, P643, DOI 10.1016/j.archoralbio.2010.12.012; Reibel J, 2003, MED PRIN PRACT, V12, P22, DOI 10.1159/000069845; Shenkin JD, 2004, J PUBLIC HEALTH DENT, V64, P184, DOI 10.1111/j.1752-7325.2004.tb02750.x; Takahashi N, 2008, CARIES RES, V42, P409, DOI 10.1159/000159604; Talhout R, 2011, INT J ENV RES PUB HE, V8, P613, DOI 10.3390/ijerph8020613; Thielen A, 2008, EXP TOXICOL PATHOL, V60, P141, DOI 10.1016/j.etp.2008.01.014; Zappacosta B, 2002, HUM EXP TOXICOL, V21, P7, DOI 10.1191/0960327102ht202oa; Zhang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166997; Zhou L, 2013, ORAL DIS, V19, P494, DOI 10.1111/odi.12031	34	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259895	10.1371/journal.pone.0259895	http://dx.doi.org/10.1371/journal.pone.0259895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780570	Green Submitted, gold, Green Published			2022-12-26	WOS:000755305800065
J	Gandhi, S; Maharatha, TM; Dash, U; Babu, MS				Gandhi, Sumirtha; Maharatha, Tulasi Malini; Dash, Umakant; Babu, Suresh M.			Level of inequality and the role of governance indicators in the coverage of reproductive maternal and child healthcare services: Findings from India	PLOS ONE			English	Article							COUNTDOWN; NEWBORN; EQUITY; INTERVENTIONS	Background Diligent monitoring of inequalities in the coverage of essential reproductive, maternal, new-born and child health related (RMNCH) services becomes imperative to smoothen the journey towards Sustainable Development Goals (SDGs). In this study, we aim to measure the magnitude of inequalities in the coverage of RMNCH services. We also made an attempt to divulge the relationship between the various themes of governance and RMNCH indices. Methods We used National Family Health Survey dataset (2015-16) and Public Affairs Index (PAI), 2016 for the analysis. Two summative indices, namely Composite Coverage Index (CCI) and Co-Coverage (Co-Cov) indicator were constructed to measure the RMNCH coverage. Slope Index of Inequality (SII) and Relative Index of Inequality (RII) were employed to measure inequality in the distribution of coverage of RMNCH. In addition, we have used Spearman's rank correlation matrix to glean the association between governance indicator and coverage indices. Results & conclusions Our study indicates an erratic distribution in the coverage of CCI and Co-Cov across wealth quintiles and state groups. We found that the distribution of RII values for Punjab, Tamil Nadu, and West Bengal hovered around 1. Whereas, RII values for Haryana was 2.01 indicating maximum inequality across wealth quintiles. Furthermore, the essential interventions like adequate antenatal care services (ANC4) and skilled birth attendants (SBA) were the most inequitable interventions, while tetanus toxoid and Bacilli Calmette-Guerin (BCG) were least inequitable. The Spearman's rank correlation matrix demonstrated a strong and positive correlation between governance indicators and coverage indices.	[Gandhi, Sumirtha] Bengaluru Dr BR Ambedkar Sch Econ, Bengaluru, Karnataka, India; [Maharatha, Tulasi Malini; Dash, Umakant; Babu, Suresh M.] Indian Inst Technol, Dept Humanities & Social Sci, Chennai, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gandhi, S (corresponding author), Bengaluru Dr BR Ambedkar Sch Econ, Bengaluru, Karnataka, India.	sumirtha@gmail.com						Akseer N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1608; Akseer N, 2016, LANCET GLOB HEALTH, V4, pE395, DOI 10.1016/S2214-109X(16)30002-X; [Anonymous], 2018, WORLD HLTH STAT 2018; [Anonymous], 2010, J FAM WELFARE, DOI [10.1016/j.apmr.2015.12.003, DOI 10.1016/J.APMR.2015.12.003]; Bala T, 2016, IRA INT J MANAGEMENT, V3, P439; Barros AJD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001390; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Barros FC, 2010, AM J PUBLIC HEALTH, V100, P1877, DOI 10.2105/AJPH.2010.196816; De PK, 2020, HEALTH ECON, V29, P1202, DOI 10.1002/hec.4129; Division for Sustainable Development Goals, TRANSF OUR WORLD 203; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Himanshu M, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0573-3; Keats EC, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5152; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Kumalija CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142066; Kumar V, 2017, CLIN EPIDEMIOL GLOB, V5, P1, DOI 10.1016/j.cegh.2016.08.001; Laxminarayan R, 2011, HEALTH AFFAIR, V30, P1096, DOI 10.1377/hlthaff.2011.0405; National Health Profile, 2017, CENTR BUR HLTH INT; Navaneetham K, 2002, SOC SCI MED, V55, P1849, DOI 10.1016/S0277-9536(01)00313-6; Olafsdottir AE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-237; PMNCH, 2011, GLOB REV KEY INT REL, P12, DOI [10.1063/1.3481923, DOI 10.1063/1.3481923]; Prinja S, 2019, MATERN CHILD HLTH J, V23, P1025, DOI 10.1007/s10995-019-02733-4; Prinja S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160986; Sample Registration System, 2020, SPEC B MAT MORT IND; Sample Registration System, 2011, MAT CHILD MORT TOT F; Sample Registration System, 2020, SRS STAT REP 2018; Sen S, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100619; Singh PK, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22217; Smith SL, 2014, SOC SCI MED, V100, P46, DOI 10.1016/j.socscimed.2013.10.029; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; United Nations Inter-Agency Group for Child Mortality Estimation (UNIGME), 2020, LEVELS TRENDS CHILD; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Wadhwa M., 2019, ICT INTERVENTIONS IM; Wehrmeister FC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000437; Wehrmeister FC, 2016, B WORLD HEALTH ORGAN, V94, P903, DOI 10.2471/BLT.16.173138	38	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258244	10.1371/journal.pone.0258244	http://dx.doi.org/10.1371/journal.pone.0258244			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767556	Green Published, gold			2022-12-26	WOS:000755249300005
J	Ong, JX; Zandi, R; Fawzi, AA				Ong, Janice X.; Zandi, Roya; Fawzi, Amani A.			Early-stage macular telangiectasia type 2 vascular abnormalities are associated with interdigitation zone disruption	PLOS ONE			English	Article							VISUAL-ACUITY; OUTER RETINA; PHOTORECEPTORS; PROGRESSION; IMAGES; BANDS; LINE	Purpose To investigate the relationship between disruption in different photoreceptor layers and deep capillary plexus (DCP) telangiectasias in eyes with macular telangiectasia type 2 (MacTel). Methods 35 eyes (21 patients) with MacTel imaged with optical coherence tomography angiography (OCTA) were included. Circumscribed areas of DCP telangiectasia were traced from OCTA slabs and the corresponding spectral-domain OCT (SD-OCT) slabs were used to visualize the photoreceptor layer interdigitation zone (IZ) and ellipsoid zone (EZ). IZ attenuation, IZ loss, and EZ loss were graded by reviewing en face SD-OCT slabs for hypo-reflective areas and confirming their status on cross-sectional views. Total area of photoreceptor disruption and overlap with DCP telangiectasia were evaluated with respect to OCT-based MacTel stage. Longitudinal changes were evaluated in a subset of patients with follow-up imaging. Results Overlap of DCP telangiectasia with IZ attenuation significantly decreased with MacTel severity, while overlap with IZ and EZ loss significantly increased. Overlap with IZ loss peaked in moderate MacTel (Stages 3-5). Longitudinal imaging showed that new EZ loss at 6 months was largely predicted by baseline IZ loss. Conclusions Worsening MacTel severity is characterized by greater overlap between DCP telangiectasia and zones of increasing severity of photoreceptor disruption, with EZ loss enlarging over time within areas of preexisting IZ disruption. We suggest that IZ disruption may indicate early photoreceptor dysfunction that eventually progresses to EZ loss, with IZ loss being a more reliable metric than IZ attenuation. Additional studies will be necessary to further explore long-term photoreceptor changes and evaluate their relationship with visual function in MacTel.	[Ong, Janice X.; Zandi, Roya; Fawzi, Amani A.] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	afawzimd@gmail.com		fawzi, amani/0000-0002-9568-3558	NIH [R01 EY031815-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01 EY031815-01 received by author A.A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optovue Inc. provided research instrument and technical support with no involvement in research funding, design, recruitment, or manuscript production.	ANDERSON DH, 1983, INVEST OPHTH VIS SCI, V24, P906; Bottoni F, 2011, INVEST OPHTH VIS SCI, V52, P4439, DOI 10.1167/iovs.10-6732; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Clemons TE, 2013, OPHTHAL EPIDEMIOL, V20, P109, DOI 10.3109/09286586.2013.766757; Fisher S.K., 1995, WEBVISION ORG RETINA; Gaudric A, 2015, RETINA-J RET VIT DIS, V35, P2300, DOI 10.1097/IAE.0000000000000799; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Gu RP, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0862-7; Hagiwara A, 2013, BRIT J OPHTHALMOL, V97, P237, DOI 10.1136/bjophthalmol-2012-302510; Heeren TFC, 2018, RETINA-J RET VIT DIS, V38, pS20, DOI 10.1097/IAE.0000000000001715; Heeren TFC, 2015, INVEST OPHTH VIS SCI, V56, P3905, DOI 10.1167/iovs.15-16915; Helb HM, 2008, RETINA-J RET VIT DIS, V28, P808, DOI 10.1097/IAE.0b013e31816d81aa; Hirota K, 2015, RETINA-J RET VIT DIS, V35, P908, DOI 10.1097/IAE.0000000000000414; Hwang JC, 2006, INVEST OPHTH VIS SCI, V47, P2655, DOI 10.1167/iovs.05-1027; Issa PC, 2013, PROG RETIN EYE RES, V34, P49, DOI 10.1016/j.preteyeres.2012.11.002; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Jacob J, 2015, AM J OPHTHALMOL, V159, P118, DOI 10.1016/j.ajo.2014.09.043; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Jonnal RS, 2014, INVEST OPHTH VIS SCI, V55, P7904, DOI 10.1167/iovs.14-14907; Jonnal RS, 2010, OPT EXPRESS, V18, P5257, DOI 10.1364/OE.18.005257; Kraker JA, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.11.7; Krivosic V., 2020, OPHTHALMOL RETINA; Litts KM, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.4.27; Luo L, 2013, ELIFE, V2, DOI 10.7554/eLife.00324; Micevych PS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224393; Molday RS, 2015, J CELL SCI, V128, P4039, DOI 10.1242/jcs.175687; Park DW, 2017, OPHTHALMOL RETINA, V1, P394, DOI 10.1016/j.oret.2017.05.005; Pauleikhoff D, 2019, GRAEF ARCH CLIN EXP, V257, P1381, DOI 10.1007/s00417-019-04323-0; Peto T, 2018, RETINA-J RET VIT DIS, V38, pS8, DOI 10.1097/IAE.0000000000001697; Powner MB, 2013, OPHTHALMOLOGY, V120, P2344, DOI 10.1016/j.ophtha.2013.04.013; Powner MB, 2010, OPHTHALMOLOGY, V117, P2407, DOI 10.1016/j.ophtha.2010.04.001; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P7889, DOI 10.1167/iovs.12-10765; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P6145, DOI 10.1167/iovs.12-10580; Scarinci F, 2017, RETINA-J RET VIT DIS, V37, P851, DOI 10.1097/IAE.0000000000001245; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scoles D, 2016, RETINA-J RET VIT DIS, V36, P91, DOI 10.1097/IAE.0000000000000618; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Sorzano COS, 2005, IEEE T BIO-MED ENG, V52, P652, DOI 10.1109/TBME.2005.844030; Spaide RF, 2015, JAMA OPHTHALMOL, V133, P66, DOI 10.1001/jamaophthalmol.2014.3950; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Yannuzzi LA, 2006, ARCH OPHTHALMOL-CHIC, V124, P450, DOI 10.1001/archopht.124.4.450; Zandi R, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103149	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259811	10.1371/journal.pone.0259811	http://dx.doi.org/10.1371/journal.pone.0259811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767582	gold, Green Published			2022-12-26	WOS:000755249300048
J	Fowler-Davis, S; Platts, K; Thelwell, M; Woodward, A; Harrop, D				Fowler-Davis, Sally; Platts, Katharine; Thelwell, Michael; Woodward, Amie; Harrop, Deborah			A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Covid?	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; HEART-RATE-VARIABILITY; GRADED-EXERCISE; FOLLOW-UP; DOXYCYCLINE TREATMENT; CONTROLLED-TRIAL; EFFICACY; MANAGEMENT; FIBROMYALGIA; REHABILITATION	Objectives Fatigue syndromes have been widely observed following post-viral infection and are being recognised because of Covid19. Interventions used to treat and manage fatigue have been widely researched and this study aims to synthesise the literature associated with fatigue interventions to investigate the outcomes that may be applicable to 'long Covid'. Method The study was registered with PROSPERO (CRD42020214209) in October 2020 and five electronic databases were searched. Papers were screened, critically appraised and data extracted from studies that reported outcomes of fatigue interventions for post-viral syndromes. The narrative synthesis includes statistical analysis associated with effectiveness and then identifies the characteristics of the interventions, including identification of transferable learning for the treatment of fatigue in long Covid. An expert panel supported critical appraisal and data synthesis. Results Over 7,000 research papers revealed a diverse range of interventions and fatigue outcome measures. Forty papers were selected for data extraction after final screening. The effectiveness of all interventions was assessed according to mean differences (MD) in measured fatigue severity between each experimental group and a control following the intervention, as well as standardised mean differences as an overall measure of effect size. Analyses identified a range of effects-from most effective MD -39.0 [95% CI -51.8 to -26.2] to least effective MD 42.28 [95% CI 33.23 to 51.34]-across a range of interventions implemented with people suffering varying levels of fatigue severity. Interventions were multimodal with a range of supportive therapeutic methods and varied in intensity and requirements of the participants. Those in western medical systems tended to be based on self- management and education principles (i.e., group cognitive behavioural therapy (CBT). Conclusion Findings suggest that the research is highly focussed on a narrow participant demographic and relatively few methods are effective in managing fatigue symptoms. Selected literature reported complex interventions using self-rating fatigue scales that report effect. Synthesis suggests that long Covid fatigue management may be beneficial when a) physical and psychological support, is delivered in groups where people can plan their functional response to fatigue; and b) where strengthening rather than endurance is used to prevent deconditioning; and c) where fatigue is regarded in the context of an individual's lifestyle and home-based activities are used.	[Fowler-Davis, Sally; Platts, Katharine; Thelwell, Michael; Harrop, Deborah] Sheffield Hallam Univ, Hlth Res Inst, Adv Wellbeing Res Ctr, Sheffield, S Yorkshire, England; [Woodward, Amie] Univ York, Dept Hlth Sci, York, N Yorkshire, England	Sheffield Hallam University; University of York - UK	Fowler-Davis, S (corresponding author), Sheffield Hallam Univ, Hlth Res Inst, Adv Wellbeing Res Ctr, Sheffield, S Yorkshire, England.	s.fowler-davis@shu.ac.uk		Fowler Davis, Sally/0000-0002-3870-9272; Thelwell, Michael/0000-0003-0145-0452; Woodward, Amie/0000-0002-9579-4012; Platts, Katharine/0000-0001-7284-9183	Westfield Health	Westfield Health	SFD received part funding from Westfield Health https://www.westfieldhealth.com/mywestfield/overview for the purpose of a research assistant (namely AW and MT) only, all other contributions were undertaken under the auspices of the employment contract of the University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Shaheed CA, 2020, EUR J PAIN, V24, P518, DOI 10.1002/ejp.1505; Alwan N.A., 2020, WELLCOME OPEN RES, V39, P73, DOI [10.12688/wellcomeopenres.16307.1, DOI 10.12688/WELLCOMEOPENRES.16307.1]; [Anonymous], 2020, COVID 19 GUIDELINE S; [Anonymous], 2021, MYALGIC ENCEPHALOMYE; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Bongi SM, 2016, COMPLEMENT THER CLIN, V24, P109, DOI 10.1016/j.ctcp.2016.05.010; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Christodoulou C, 2005, ISS CLIN COGN NEUROP, P19; Clark LV, 2017, LANCET, V390, P363, DOI 10.1016/S0140-6736(16)32589-2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramp F, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub3; Cramp F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008322.pub2; Dailey DL, 2013, PAIN, V154, P2554, DOI 10.1016/j.pain.2013.07.043; Decary S, 2021, J ORTHOP SPORT PHYS, V51, P197, DOI 10.2519/jospt.2021.0106; Demirbag BC, 2012, IRAN J PUBLIC HEALTH, V41, P44; El-Mokadem J., 2020, SPIRITUAL CLIN PRACT; Elbers RG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010925.pub2; Ericsson A, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1073-3; Faghy MA, 2021, PROG CARDIOVASC DIS, V67, P2, DOI 10.1016/j.pcad.2021.01.004; Fernie BA, 2016, BEHAV COGN PSYCHOTH, V44, P397, DOI 10.1017/S135246581500017X; Fitzgibbon BM, 2018, EUR J PAIN, V22, P1255, DOI 10.1002/ejp.1213; Friedberg F, 2016, FATIGUE, V4, P158, DOI 10.1080/21641846.2016.1205876; Garrigues E, 2020, J INFECTION, V81, pE4, DOI 10.1016/j.jinf.2020.08.029; Gemelli Against Covid 19 Post, 2020, AGING CLIN EXP RES, V32, P1613, DOI 10.1007/s40520-020-01616-x; Goertz Y., 2020, ELSEVIER PUBLIC HLTH, V7; Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026; Hansen AL, 2013, J PSYCHOPHYSIOL, V27, P67, DOI 10.1027/0269-8803/a000088; Heald A, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016720; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Islam MS, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18041453; Islam MF, 2020, FATIGUE, V8, P61, DOI 10.1080/21641846.2020.1778227; Jason LA., 2008, FATIGUE SCI HUMAN HL, P1, DOI [10.1007/978-4-431-73464-2_1, DOI 10.1007/978-4-431-73464-2_1]; Jason LA, 2010, PM&R, V2, P327, DOI 10.1016/j.pmrj.2010.03.028; Jason LA, 2010, J CLIN PSYCHOL, V66, P249, DOI 10.1002/jclp.20648; Keijmel SP, 2017, CLIN INFECT DIS, V64, P998, DOI 10.1093/cid/cix013; Kim G, 2020, J AM GERIATR SOC, V68, P1155, DOI 10.1111/jgs.16513; Kim HG, 2013, J ALTERN COMPLEM MED, V19, P134, DOI 10.1089/acm.2011.0503; Kim JE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0857-0; Kos D, 2007, MULT SCLER J, V13, P996, DOI 10.1177/1352458507078392; Larun L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub8; Lee JH, 2015, J ALTERN COMPLEM MED, V21, P422, DOI 10.1089/acm.2014.0271; Machado GC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1225; Marques M, 2015, INT J BEHAV MED, V22, P187, DOI 10.1007/s12529-014-9432-4; Marques MM, 2017, J PSYCHOSOM RES, V94, P24, DOI 10.1016/j.jpsychores.2016.12.012; Marques MM, 2015, CLIN PSYCHOL REV, V40, P123, DOI 10.1016/j.cpr.2015.05.009; Mist SD, 2018, PAIN MED, V19, P1862, DOI 10.1093/pm/pnx322; Mock V, 2001, CANCER-AM CANCER SOC, V92, P1699, DOI 10.1002/1097-0142(20010915)92:6+<1699::AID-CNCR1500>3.0.CO;2-9; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Mucke M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006788.pub3; Murad MH, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4817; National Institute for Health and Care Excellence, 2007, CHRONIC FATIGUE SYND; NHS, 2020, NHS LAUNCH 40 LONG C; NHS, 2020, CAR NEEDS INP REC CO; Nurek M., 2021, LANCET; O'Cathain A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4587; O'Dowd H, 2006, HEALTH TECHNOL ASSES, V10, P1; Oka T, 2014, BIOPSYCHOSOC MED, V8, DOI 10.1186/s13030-014-0027-8; Parkin A, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/21501327211010994; Perrin R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110055; Perrin RN, 2011, INT J OSTEOPATH MED, V14, P96, DOI 10.1016/j.ijosm.2010.12.002; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; Popay J, 2006, PRODUCT ESRC METHODS, pb92, DOI DOI 10.13140/2.1.1018.4643; Powell P, 2004, BRIT J PSYCHIAT, V184, P142, DOI 10.1192/bjp.184.2.142; Racine M, 2019, J PAIN, V20, P420, DOI 10.1016/j.jpain.2018.09.013; Raijmakers RPH, 2019, J PSYCHOSOM RES, V116, P62, DOI 10.1016/j.jpsychores.2018.11.007; Ridsdale L, 2012, PSYCHOL MED, V42, P2217, DOI 10.1017/S0033291712000256; Sadeghniiat-Haghighi Khosro, 2015, Ind Psychiatry J, V24, P12, DOI 10.4103/0972-6748.160915; Savitz DA, 2019, AM J EPIDEMIOL, V188, P1581, DOI 10.1093/aje/kwz131; Sharpe M, 2015, LANCET PSYCHIAT, V2, P1067, DOI 10.1016/S2215-0366(15)00317-X; Shu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep37846; Ng SM, 2013, ALTERN THER HEALTH M, V19, P21; Stubhaug B, 2008, BRIT J PSYCHIAT, V192, P217, DOI 10.1192/bjp.bp.106.031815; SURAWY C, 1995, BEHAV RES THER, V33, P535, DOI 10.1016/0005-7967(94)00077-W; Tummers M, 2010, J CONSULT CLIN PSYCH, V78, P724, DOI 10.1037/a0020052; Turner-Stokes L, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4774; Ugurlu FG, 2017, ACTA REUMATOL PORT, V42, P32; Van Hoof E., 2003, J CHRONIC FATIGUE SY, V11, P37; Vos-Vromans DCWM, 2016, J INTERN MED, V279, P268, DOI 10.1111/joim.12402; Wearden AJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1777; Weatherley-Jones E, 2004, J PSYCHOSOM RES, V56, P189, DOI 10.1016/S0022-3999(03)00377-5; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Wiborg JF, 2015, PSYCHOTHER PSYCHOSOM, V84, P368, DOI 10.1159/000438867; Windthorst P, 2017, J PSYCHOSOM RES, V93, P6, DOI 10.1016/j.jpsychores.2016.11.014; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n405; Woodyard Catherine, 2011, Int J Yoga, V4, P49, DOI 10.4103/0973-6131.85485; Wu S, 2020, J ACUPUNCT TUINA SCI, V18, P53, DOI 10.1007/s11726-020-1157-0	86	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259533	10.1371/journal.pone.0259533	http://dx.doi.org/10.1371/journal.pone.0259533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY0QZ	34752489	Green Accepted, Green Published, gold			2022-12-26	WOS:000754499700018
J	Li, Y; Liu, HT; Chen, X; Wang, YW; Tian, YR; Ma, RR; Song, L; Zou, YX; Gao, P				Li, Yan; Liu, Hai-Ting; Chen, Xu; Wang, Ya-Wen; Tian, Ya-Ru; Ma, Ran-ran; Song, Lin; Zou, Yong-Xin; Gao, Peng			Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer	ONCOGENE			English	Article							REPULSIVE GUIDANCE MOLECULE; DNA METHYLATION; APOPTOSIS; SURVIVAL; PROLIFERATION; INACTIVATION; RECEPTORS; ADHESION; GROWTH; CELLS	Breast cancer (BC) is the most common cancer in women worldwide, and the exploration of aberrantly expressed genes might clarify tumorigenesis and help uncover new therapeutic strategies for BC. Although RGMA was recently recognized as a tumor suppressor gene, its detailed biological function and regulation in BC remain unclear. Herein, we found that RGMA was downregulated in BC tissues compared with non-tumorous breast tissues, particularly in metastatic BC samples, and that patients with low RGMA expression manifested a poorer prognosis. Furthermore, DNMT1 and DNMT3A were found to be recruited to the RGMA promoter and induced aberrant hypermethylation, resulting in downregulation of RGMA expression in BC. In contrast, RGMA overexpression suppressed BC cell proliferation and colony-formation capabilities and increased BC cell apoptosis. Furthermore, RGMA knockdown accelerated BC cell proliferation and suppressed cellular apoptosis in vitro and in vivo. Reversal of RGMA promoter methylation with 5-Aza-CdR restored RGMA expression and blocked tumor growth. Overall, DNMT1- and DNMT3A-mediated RGMA promoter hypermethylation led to downregulation of RGMA expression, and low RGMA expression contributed to BC growth via activation of the FAK/Src/PI3K/AKT-signaling pathway. Our data thus suggested that RGMA might be a promising therapeutic target in BC.	[Li, Yan; Liu, Hai-Ting; Chen, Xu; Wang, Ya-Wen; Tian, Ya-Ru; Ma, Ran-ran; Song, Lin; Gao, Peng] Shandong Univ, Dept Pathol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Li, Yan; Liu, Hai-Ting; Chen, Xu; Wang, Ya-Wen; Tian, Ya-Ru; Ma, Ran-ran; Song, Lin; Zou, Yong-Xin; Gao, Peng] Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ,Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Li, Yan] Shandong Univ, Qilu Hosp Qingdao, Dept Gastroenterol, Qingdao 266035, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Gao, P (corresponding author), Shandong Univ, Dept Pathol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China.; Zou, YX; Gao, P (corresponding author), Shandong Univ, Cheeloo Coll Med, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ,Dept Pathol, Jinan 250012, Shandong, Peoples R China.	zouyongxin@sdu.edu.cn; gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81872362, 82072665]; Taishan Scholars Program of Shandong Province [ts201511096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholars Program of Shandong Province	We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this paper. This study was supported by the National Natural Science Foundation of China (Grant No. 81872362 and 82072665) and the Taishan Scholars Program of Shandong Province (Grant No. ts201511096).	Abdel-Hafiz HA, 2015, EPIGENOMICS-UK, V7, P847, DOI 10.2217/epi.15.10; Bao RK, 2017, ENVIRON SCI POLLUT R, V24, P20342, DOI 10.1007/s11356-017-9422-6; Borges S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3460; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Feng FB, 2018, BIOMED PHARMACOTHER, V102, P1209, DOI 10.1016/j.biopha.2018.03.142; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Jia XQ, 2019, J BUON, V24, P1985; Klutstein M, 2016, CANCER RES, V76, P3446, DOI 10.1158/0008-5472.CAN-15-3278; Korecka JA, 2017, J NEUROSCI, V37, P9361, DOI 10.1523/JNEUROSCI.0084-17.2017; Ku JL, 2011, METHODS MOL BIOL, V791, P23, DOI 10.1007/978-1-61779-316-5_3; Li J, 2012, INT J ONCOL, V40, P544, DOI 10.3892/ijo.2011.1251; Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005; Li Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.559486; Li Y, 2020, CLIN BREAST CANCER, V20, pE113, DOI 10.1016/j.clbc.2019.08.010; Liu H, 2020, CELL DEATH DIFFER, V27, P966, DOI 10.1038/s41418-019-0389-3; Lu YJ, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108608; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Mirza S, 2010, MOL CELL BIOCHEM, V342, P101, DOI 10.1007/s11010-010-0473-y; Niit Maximilian, 2015, BioMolecular Concepts, V6, P383, DOI 10.1515/bmc-2015-0022; O'Leary C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081711; Pathania R, 2016, CANCER RES, V76, P3224, DOI 10.1158/0008-5472.CAN-15-2249; Pathania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7910; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schoeps A, 2014, GENET EPIDEMIOL, V38, P84, DOI 10.1002/gepi.21771; Siebold C, 2017, TRENDS CELL BIOL, V27, P365, DOI 10.1016/j.tcb.2016.11.009; Specht E, 2015, HISTOPATHOLOGY, V67, P368, DOI 10.1111/his.12662; Subramaniam D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00080; Xiao B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4314-9; Zhang G, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00504; Zhang Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00138; Zhao ZW, 2012, ONCOL REP, V27, P1653, DOI 10.3892/or.2012.1693	33	5	5	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					361	371		10.1038/s41388-021-02083-y	http://dx.doi.org/10.1038/s41388-021-02083-y		NOV 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34754080				2022-12-26	WOS:000716255200001
J	Friedrich, I; Bodenberger, B; Neubauer, H; Hertel, R; Daniel, R				Friedrich, Ines; Bodenberger, Bernhard; Neubauer, Hannes; Hertel, Robert; Daniel, Rolf			Down in the pond: Isolation and characterization of a new Serratia marcescens strain (LVF3) from the surface water near frog's lettuce (Groenlandia densa)	PLOS ONE			English	Article							SP NOV.; GENOME; BACTERIOPHAGES; BIOSYNTHESIS; PRODIGIOSIN; INFECTION; TAXONOMY; IDENTIFICATION; ANNOTATION; PHYLOGENY	Serratia marcescens is a species that belongs to the family of Yersiniaceae. This family comprises taxa representing opportunistic human- and phytopathogens but also plant growth-promoting rhizobacteria (PGPR). This study describes a novel Gram-negative strain (LVF3(R)) of the species Serratia marcescens. The strain was characterized genomically, morphologically, and physiologically. In addition, the potential of the isolate to act as a host strain to assess the diversity of Serratia associated phages in environmental samples was explored. Average nucleotide identity analysis revealed that LVF3(R) belongs to the species Serratia marcescens. In silico analysis and ProphageSeq data resulted in the identification of one prophage, which is capable of viral particle formation. Electron microscopy showed cells of a rod-shaped, flagellated morphotype. The cells revealed a length and width of 1-1.6 mu m and 0.8 mu m, respectively. LVF3(R) showed optimal growth at 30 C and in the presence of up to 2% (w/v) NaCl. It exhibited resistances to ampicillin, erythromycin, oxacillin, oxytetracycline, rifampicin, tetracycline, and vancomycin. Genome data indicate that strain S. marcescens LVF3(R) is a potential PGPR strain. It harbors genes coding for indole acetic acid (IAA) biosynthesis, siderophore production, plant polymer degradation enzymes, acetoin synthesis, flagellar proteins, type IV secretion system, chemotaxis, phosphorous solubilization, and biofilm formation.	[Friedrich, Ines; Bodenberger, Bernhard; Neubauer, Hannes; Hertel, Robert; Daniel, Rolf] Georg August Univ Gottingen, Inst Microbiol & Genet, Genom & Appl Microbiol, Gottingen, Germany; [Friedrich, Ines; Bodenberger, Bernhard; Neubauer, Hannes; Hertel, Robert; Daniel, Rolf] Georg August Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany; [Hertel, Robert] BTU Cottbus Senftenberg, Inst Biotechnol, FG Synthet Microbiol, Senftenberg, Germany	University of Gottingen; University of Gottingen; Brandenburg University of Technology Cottbus	Daniel, R (corresponding author), Georg August Univ Gottingen, Inst Microbiol & Genet, Genom & Appl Microbiol, Gottingen, Germany.; Daniel, R (corresponding author), Georg August Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany.	rdaniel@gwdg.de		Friedrich, Ines/0000-0002-7328-0432; Daniel, Rolf/0000-0002-8646-7925	Open Access Publication Funds of the University of Gottingen	Open Access Publication Funds of the University of Gottingen	We thank Dr. Anja Poehlein for sequencing, Sarah-Theresa Schussler and Mechthild Bomeke for technical assistance, Dr. Dominik Schneider for his help with bioinformatics and Dr. Michael Hoppert for support with TEM-imaging. We thank Avril von Hoyningen-Huene for her diligent proofreading of this paper. We also acknowledge support by the Open Access Publication Funds of the University of Gottingen.	Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Abreo E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37118-0; Adeolu M, 2016, INT J SYST EVOL MICR, V66, P5575, DOI 10.1099/ijsem.0.001485; Ajithkumar B, 2003, INT J SYST EVOL MICR, V53, P253, DOI 10.1099/ijs.0.02158-0; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bennett JW, 2000, ADV APPL MICROBIOL, V47, P1, DOI 10.1016/s0065-2164(00)47000-0; Bhadra B, 2005, INT J SYST EVOL MICR, V55, P2155, DOI 10.1099/ijs.0.63674-0; Bhetwal A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3723254; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Bogomol'naya LM, 2010, APPL BIOCHEM MICRO+, V46, P390, DOI 10.1134/S0003683810040046; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Bruder S, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0526-3; Carter M.E., 1990, DIAGNOSTIC PROCEDURE, V5th ed., P107, DOI [10.1016/B978-0-12-161775-2.50014-1, DOI 10.1016/B978-0-12-161775-2.50014-1]; Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848; Chun J, 2018, INT J SYST EVOL MICR, V68, P461, DOI [10.1099/ijsem.0.002532, 10.1099/ijsem.0.002516]; CLARKE PH, 1952, J GEN MICROBIOL, V6, P187, DOI 10.1099/00221287-6-1-2-187; CLAUS D, 1992, WORLD J MICROB BIOT, V8, P451, DOI 10.1007/BF01198764; Dekkers LC, 1998, MOL PLANT MICROBE IN, V11, P763, DOI 10.1094/MPMI.1998.11.8.763; Devi K. A., 2016, Hayati Journal of Biosciences, V23, P173, DOI 10.1016/j.hjb.2016.12.006; Evans TJ, 2010, MICROBIOL-SGM, V156, P240, DOI 10.1099/mic.0.032797-0; FREDERICK GL, 1995, WATER SCI TECHNOL, V31, P291, DOI 10.1016/0273-1223(95)00517-Q; Friedrich I., 2021, APPL MICROBIOL, V1, P38, DOI [10.3390/applmicrobiol1010005, DOI 10.3390/APPLMICROBIOL1010005]; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Gillis A, 2014, EUR J PLANT PATHOL, V138, P1, DOI 10.1007/s10658-013-0300-x; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haddix PL, 2018, ARCH MICROBIOL, V200, P989, DOI 10.1007/s00203-018-1508-0; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hertel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120759; Hong B, 2014, CANCER RES, V74, P1153, DOI 10.1158/0008-5472.CAN-13-0955; Ibrahim D., 2014, J APPL PHARM SCI, V4, P1, DOI [10.7324/JAPS.2014.401001, DOI 10.7324/JAPS.2014.401001]; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Khan AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171534; Khanna A, 2013, J CLIN DIAGN RES, V7, P243, DOI 10.7860/JCDR/2013/5010.2737; Kohm K, 2021, ARCH VIROL, V166, P2119, DOI 10.1007/s00705-021-05116-9; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; MAKI DG, 1973, J INFECT DIS, V128, P579, DOI 10.1093/infdis/128.5.579; Manfredi R, 2000, EUR J CLIN MICROBIOL, V19, P248, DOI 10.1007/s100960050471; Matilla MA, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01752-16, 10.1128/genomea.01752-16]; Matilla MA, 2016, ENVIRON MICROBIOL, V18, P3635, DOI 10.1111/1462-2920.13241; Matsushita K, 2009, FEMS MICROBIOL LETT, V291, P201, DOI 10.1111/j.1574-6968.2008.01455.x; Matteoli FP, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5130-y; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Meier-Kolthoff JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10210-3; Luduena LM, 2018, APPL SOIL ECOL, V126, P107, DOI 10.1016/j.apsoil.2017.12.024; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Parmar KM, 2018, ARCH MICROBIOL, V200, P611, DOI 10.1007/s00203-017-1471-1; Parte AC, 2020, INT J SYST EVOL MICR, V70, P5607, DOI 10.1099/ijsem.0.004332; Parte AC, 2018, INT J SYST EVOL MICR, V68, P1825, DOI 10.1099/ijsem.0.002786; PRINSLOO HE, 1966, J GEN MICROBIOL, V45, P205, DOI 10.1099/00221287-45-2-205; PRINSLOO HE, 1964, NATURE, V203, P211, DOI 10.1038/202211b0; Pritchard L, 2016, ANAL METHODS-UK, V8, P12, DOI [10.1039/c5ay02550h, 10.1039/C5AY02550H]; R Core Team, 2020, R LANG ENV STAT COMP; Rascoe J, 2003, PHYTOPATHOLOGY, V93, P1233, DOI 10.1094/PHYTO.2003.93.10.1233; Ray U., 2015, JMM CASE REP, V2, P1; Reimer LC, 2019, NUCLEIC ACIDS RES, V47, pD631, DOI 10.1093/nar/gky879; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Roy P, 2014, J CLIN DIAGN RES, V8, pDD5, DOI 10.7860/JCDR/2014/8629.4513; Ruiu L, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10060861; Sikora EJ, 2012, PLANT DIS, V96, P761, DOI 10.1094/PDIS-09-11-0739-PDN; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Wickham H., 2016, J STAT SOFTW, DOI DOI 10.18637/JSS.V077.B02; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WIJEWANTA EA, 1970, VET REC, V87, P282, DOI 10.1136/vr.87.10.282; Willms IM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060146; Willms IM, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw208; Zhang CX, 2009, INT J SYST EVOL MICR, V59, P1603, DOI 10.1099/ijs.0.65718-0	69	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259673	10.1371/journal.pone.0259673	http://dx.doi.org/10.1371/journal.pone.0259673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748577	Green Published, gold			2022-12-26	WOS:000755468000047
J	Adarmanabadi, SR; Jafari, M; Farrash, SMH; Heidari, M				Adarmanabadi, Sedigheh Ranjkesh; Jafari, Mohammad; Farrash, Seyyed Mahdi Hosseini; Heidari, Mehdi			Effect of nano clay, nano-graphene oxide and carbon nanotubes on the mechanical and tribological properties of crosslinked epoxy nanocomposite	PLOS ONE			English	Article							HYBRID NANOCOMPOSITES; MATRIX COMPOSITES; CERAMIC MATERIALS; WEAR-RESISTANCE; ABRASIVE WEAR; PERFORMANCE; DISPERSION; BEHAVIOR; ENHANCEMENT; IMPROVE	The objective of this study is to investigate the effects of different nanoparticles as reinforcement in a polymeric matrix on the mechanical and tribological properties of the composite. The different particles including nanoclay (NC), nano-graphene oxide (NGO), and carbon nanotubes (CNT) with various weight percentages were incorporated into the epoxy matrix. Young's modulus, ultimate tensile strength, strain at the fracture point, and the fracture toughness of nanocomposite samples were investigated. Besides, the tribological performance of these fabricated nanocomposites was evaluated and discussed. The results show that a significant change in the mechanical properties of the nanocomposites compared to the epoxy matrix. Also, the results reveal that the combination of NC with NGO improves the mechanical properties of graphene nanocomposites. It is found that adding NC to the NG/epoxy composite, may increase the fracture toughness up to 2 times as well as improve the ultimate tensile strength and strain at the fracture point. However, there was no significant change in Young's modulus.	[Adarmanabadi, Sedigheh Ranjkesh; Jafari, Mohammad; Farrash, Seyyed Mahdi Hosseini; Heidari, Mehdi] Shahrood Univ Technol, Fac Mech & Mechatron Engn, Shahrood, Iran	Shahrood University of Technology	Jafari, M (corresponding author), Shahrood Univ Technol, Fac Mech & Mechatron Engn, Shahrood, Iran.	m_jafari821@shahroodut.ac.ir	Heidari, Mehdi/P-2683-2017	Heidari, Mehdi/0000-0001-9703-2495; Jafari, Mohammad/0000-0002-4199-0368				Abdolmaleki M, 2019, COMPOS SCI TECHNOL, V184, DOI 10.1016/j.compscitech.2019.107879; Avila AF, 2011, INT J IMPACT ENG, V38, P669, DOI 10.1016/j.ijimpeng.2011.03.002; Banisaeid M, 2020, FULLER NANOTUB CAR N, V28, P582, DOI 10.1080/1536383X.2020.1724966; Cai DY, 2012, COMPOS SCI TECHNOL, V72, P702, DOI 10.1016/j.compscitech.2012.01.020; Chan ML, 2011, COMPOS PART B-ENG, V42, P1708, DOI 10.1016/j.compositesb.2011.03.011; Chen BB, 2018, COMPOS PART A-APPL S, V115, P157, DOI 10.1016/j.compositesa.2018.09.021; Chen HY, 2007, POLYM TEST, V26, P351, DOI 10.1016/j.polymertesting.2006.11.004; Cicero Gonzalez S., 2020, GRAPHENE OXIDE DOES; Cicero S, 2020, PROCEDIA STRUCT INTE, V28, P67, DOI 10.1016/j.prostr.2020.10.009; Compbell FC., 2010, STRUCTURAL COMPOSITE, V1; Cui LJ, 2013, CARBON, V54, P277, DOI 10.1016/j.carbon.2012.11.039; Dasari A, 2009, MAT SCI ENG R, V63, P31, DOI 10.1016/j.mser.2008.10.001; Gandhi RA, 2013, MATER DESIGN, V48, P52, DOI 10.1016/j.matdes.2012.08.081; Ha SR, 2010, COMPOS PART B-ENG, V41, P602, DOI 10.1016/j.compositesb.2010.09.015; Jagtap SB, 2013, EXPRESS POLYM LETT, V7, P329, DOI 10.3144/expresspolymlett.2013.30; Jen YM, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12091895; Jin FL, 2015, J IND ENG CHEM, V29, P1, DOI 10.1016/j.jiec.2015.03.026; Jojibabu P, 2020, INT J ADHES ADHES, V98, DOI 10.1016/j.ijadhadh.2019.102521; Khan A, 2020, CARBOHYD POLYM, V239, DOI 10.1016/j.carbpol.2020.116248; Kim DH, 2013, COMPOS PART B-ENG, V55, P86, DOI 10.1016/j.compositesb.2013.05.041; Kostagiannakopoulou C, 2012, PROC SPIE, V8409, DOI 10.1117/12.923336; Le MT, 2015, MATERIALS, V8, P5526, DOI 10.3390/ma8085262; Lim KH, 2017, J PHYS CONF SER, V908, DOI 10.1088/1742-6596/908/1/012010; Lin YT, 2019, SURF COAT TECH, V374, P1128, DOI 10.1016/j.surfcoat.2018.01.050; Manral ARS, 2020, MATER TODAY-PROC, V26, P2805, DOI 10.1016/j.matpr.2020.02.582; Mishra BP., 2020, MATER TODAY-PROC; Mohan VB, 2018, COMPOS PART B-ENG, V142, P200, DOI 10.1016/j.compositesb.2018.01.013; Olowojoba GB, 2016, APPL NANOSCI, V6, P1015, DOI 10.1007/s13204-016-0518-y; Papageorgiou DG, 2019, COMPOS SCI TECHNOL, V175, P60, DOI 10.1016/j.compscitech.2019.03.006; Rafiee R, 2018, COMPOS PART B-ENG, V152, P31, DOI 10.1016/j.compositesb.2018.06.033; Rahman AS, 2018, COMPOS STRUCT, V187, P481, DOI 10.1016/j.compstruct.2017.12.054; Rahsepar M, 2018, TRIBOL INT, V118, P148, DOI 10.1016/j.triboint.2017.09.023; Rajaei M, 2019, COMPOS PART B-ENG, V165, P65, DOI 10.1016/j.compositesb.2018.11.089; Ruiz-Hitzky E, 2016, ADV FUNCT MATER, V26, P7394, DOI 10.1002/adfm.201603103; Sakka MM, 2017, FRICTION, V5, P171, DOI 10.1007/s40544-017-0144-z; Sari MG, 2020, CORROS SCI, V173, DOI 10.1016/j.corsci.2020.108799; Shubham SK., 2020, MATER TODAY-PROC, V26, P3024, DOI [DOI 10.1016/j.matpr.2020.02.629, 10.1016/j.matpr.2020.02.629]; Singh J, 2016, CERAM INT, V42, P56, DOI 10.1016/j.ceramint.2015.08.150; Subhani T, 2015, MATER DESIGN, V87, P436, DOI 10.1016/j.matdes.2015.08.059; Trezona RI, 1999, WEAR, V225, P205, DOI 10.1016/S0043-1648(98)00358-5; Tuzemen MC, 2017, COMPOS PART B-ENG, V128, P146, DOI 10.1016/j.compositesb.2017.07.001; Vite-Torres M, 2011, WEAR, V271, P1231, DOI 10.1016/j.wear.2010.12.021; Wang JW, 2007, MATER LETT, V61, P4222, DOI 10.1016/j.matlet.2007.01.058; Wirojanupatump S, 1999, WEAR, V233, P655, DOI 10.1016/S0043-1648(99)00208-2; Xiao YL, 2020, COMPOS PART B-ENG, V182, DOI 10.1016/j.compositesb.2019.107616; Zabihi O, 2018, COMPOS PART B-ENG, V135, P1, DOI 10.1016/j.compositesb.2017.09.066; Zhao XR, 2019, COMPOS SCI TECHNOL, V171, P180, DOI 10.1016/j.compscitech.2018.12.023	47	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259401	10.1371/journal.pone.0259401	http://dx.doi.org/10.1371/journal.pone.0259401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739499	gold, Green Published			2022-12-26	WOS:000755000800031
J	Hu, BH; Dong, YQ; Zhou, WJ; Ma, YC; Li, LY; Fu, XH; Zhang, WX; Luo, YY; Pu, JY; Deng, X; Zhang, R; Liu, SQ				Hu, Binhong; Dong, Yuqing; Zhou, Wenjing; Ma, Yichuan; Li, Luyao; Fu, Xianhua; Zhang, Wenxuan; Luo, Yuanyue; Pu, Jingyu; Deng, Xin; Zhang, Rong; Liu, Songqing			Effect of Inonotus obliquus polysaccharide on composition of the intestinal flora in mice with acute endometritis	PLOS ONE			English	Article							GUT MICROBIOTA; HEALTH	Inonotus obliquus Polysaccharide (IOP) is a large molecule extracted from Inonotus obliqus, a medicinal fungus, which has a wide range of biological activities and has been shown to be associated with inflammation. The purpose of this study is to investigate whether IOP can help to reduce acute endometritis by regulating intestinal flora. We observed pathological changes in mice with endometritis following treatment with IOP and evaluated changes in the levels of interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF-alpha), and further studied the effects of IOP on the intestinal flora of endometritis mice using 16S rRNA high-throughput sequencing. The results showed that IOP improved the condition of uterine tissues and reduced the release of pro-inflammatory cytokines. Meanwhile, the 16S rRNA sequencing results showed that IOP could regulate the changes in intestinal microflora at the level of genera, possibly by changing the relative abundance of some genera.	[Hu, Binhong; Dong, Yuqing; Zhou, Wenjing; Ma, Yichuan; Fu, Xianhua; Zhang, Wenxuan; Luo, Yuanyue; Pu, Jingyu; Deng, Xin; Liu, Songqing] Chengdu Normal Univ, Coll Chem & Life Sci, Chengdu, Peoples R China; [Hu, Binhong; Liu, Songqing] Chengdu Normal Univ, Sichuan Prov Key Lab Dev & Utilizat Characterist, Chengdu, Peoples R China; [Dong, Yuqing] Sichuan Agr Univ, Coll Forestry, Chengdu, Peoples R China; [Li, Luyao; Zhang, Rong] Shanghai Tech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China	Chengdu Normal University; Chengdu Normal University; Sichuan Agricultural University; ShanghaiTech University	Liu, SQ (corresponding author), Chengdu Normal Univ, Coll Chem & Life Sci, Chengdu, Peoples R China.; Liu, SQ (corresponding author), Chengdu Normal Univ, Sichuan Prov Key Lab Dev & Utilizat Characterist, Chengdu, Peoples R China.; Zhang, R (corresponding author), Shanghai Tech Univ, Sch Phys Sci & Technol, Shanghai, Peoples R China.	z_rong@yeah.net; songqingliu@cdnu.edu.cn		Dong, Yuqing/0000-0002-6793-1104				Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P1611, DOI 10.1016/j.ajog.2006.04.010; Blasco-Baque V, 2017, DIABETOLOGIA, V60, P690, DOI 10.1007/s00125-017-4209-3; Boer CG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12873-4; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borella F, 2021, ACS INFECT DIS, V7, P987, DOI 10.1021/acsinfecdis.0c00839; Brodzki P, 2014, ANIM REPROD SCI, V148, P109, DOI 10.1016/j.anireprosci.2014.06.021; Cameron EA, 2015, CELL HOST MICROBE, V18, P275, DOI 10.1016/j.chom.2015.08.007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen YF, 2019, ARTIF CELL NANOMED B, V47, P757, DOI 10.1080/21691401.2019.1577877; Choi DH, 2020, EXP MOL MED, V52, P1564, DOI 10.1038/s12276-020-00487-6; Choi SY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943516; CZERNOBILSKY B, 1978, FERTIL STERIL, V30, P119; Fang RL, 2016, AM J TRANSL RES, V8, P1581; Han YQ, 2019, INT J BIOL MACROMOL, V131, P769, DOI 10.1016/j.ijbiomac.2019.03.033; Hu Y, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0341-1; Ju MJ, 2018, CELL CYCLE, V17, P2001, DOI 10.1080/15384101.2018.1509635; Ju TT, 2019, ISME J, V13, P1520, DOI 10.1038/s41396-019-0364-5; Kalkanbaeva Ch. K., 2017, Kazanskii Meditsinskii Zhurnal, V98, P913, DOI 10.17750/KMJ2017-913; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Kitaya K, 2018, FERTIL STERIL, V110, P344, DOI 10.1016/j.fertnstert.2018.04.012; Liu GM, 2018, INT J BIOL MACROMOL, V115, P711, DOI 10.1016/j.ijbiomac.2018.04.127; Liu LQ, 2019, INT J BIOL MACROMOL, V121, P743, DOI 10.1016/j.ijbiomac.2018.10.083; Liu RP, 2020, HEPATOLOGY, V71, P611, DOI 10.1002/hep.30827; Lu XM, 2010, J SCI FOOD AGR, V90, P276, DOI 10.1002/jsfa.3809; Ma LS, 2013, FOOD CHEM, V139, P503, DOI 10.1016/j.foodchem.2013.01.030; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martin AM, 2019, P NATL ACAD SCI USA, V116, P19802, DOI 10.1073/pnas.1909311116; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sarichai P, 2020, MICROBIOL IMMUNOL, V64, P679, DOI 10.1111/1348-0421.12837; Shanmuganandam S, 2020, PEERJ, V8, DOI 10.7717/peerj.9564; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Sommer F, 2017, NAT REV MICROBIOL, V15, P630, DOI 10.1038/nrmicro.2017.58; Sommer Felix., 2017, MICROBIOMARKERS INFL, V7, DOI [10.1136/gutjnl-2016-313678, DOI 10.1136/GUTJNL-2016-313678]; Tang YJ, 2019, PEERJ, V7, DOI 10.7717/peerj.7149; Tian J, 2017, INT J BIOL MACROMOL, V95, P160, DOI 10.1016/j.ijbiomac.2016.11.054; Ursell LK, 2014, GASTROENTEROLOGY, V146, P1470, DOI 10.1053/j.gastro.2014.03.001; Valdes AM, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2179; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waters JL, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0699-4; Wei YR, 2020, GUT, V69, P569, DOI 10.1136/gutjnl-2018-317836; Wu HC, 2018, INT IMMUNOPHARMACOL, V61, P156, DOI 10.1016/j.intimp.2018.06.002; Wu HC, 2016, J AGR FOOD CHEM, V64, P6171, DOI 10.1021/acs.jafc.6b02304; Wu J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212063; Zhang XY, 2018, J PHARMACEUT BIOMED, V156, P221, DOI 10.1016/j.jpba.2018.04.048; Zhang XY, 2018, J PHARMACOL SCI, V137, P324, DOI 10.1016/j.jphs.2018.03.006; Zhao G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01916; Zhao H, 2019, BIOCHEM BIOPH RES CO, V518, P632, DOI 10.1016/j.bbrc.2019.08.109; Zhou M, 2019, INFLAMMATION, V42, P81, DOI 10.1007/s10753-018-0874-8	53	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259570	10.1371/journal.pone.0259570	http://dx.doi.org/10.1371/journal.pone.0259570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739514	Green Published, gold			2022-12-26	WOS:000755000800039
J	Noguchi-Shinohara, M; Koike, M; Morise, H; Kudo, K; Tsuchimine, S; Komatsu, J; Abe, C; Kitagawa, S; Ikeda, Y; Yamada, M				Noguchi-Shinohara, Moeko; Koike, Masato; Morise, Hirofumi; Kudo, Kiwamu; Tsuchimine, Shoko; Komatsu, Junji; Abe, Chiemi; Kitagawa, Sachiko; Ikeda, Yoshihisa; Yamada, Masahito			MEG activity of the dorsolateral prefrontal cortex during optic flow stimulations detects mild cognitive impairment due to Alzheimer's disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; PERCEPTUAL DECISION; NATIONAL INSTITUTE; GETTING LOST; MEMORY; RECOMMENDATIONS; MOVEMENT; DEMENTIA; LESIONS	Dorsal stream, which has a neuronal connection with dorsolateral prefrontal cortex (DLPFC), is known to be responsible for detection of motion including optic flow perception. Using magnetoencephalography (MEG), this study aimed to examine neural responses to optic flow stimuli with looming motion in the DLPFC in patients with mild cognitive impairment due to Alzheimer's disease (AD-MCI) compared with cognitively unimpaired participants (CU). We analyzed the neural responses by evaluating maximum source-localized power for the AD-MCI group (n = 11) and CU (n = 20), focusing on six regions of interest (ROIs) that form the DLPFC: right and left dorsal Brodmann area 9/46 (A9/46d), Brodmann area 46 (A46) and ventral Brodmann area 9/46 (A9/46v). We found significant differences in the maximum power between the groups in the left A46 and A9/46v. Moreover, in the left A9/46v, the maximum power significantly correlated with the Wechsler Memory Scale-Revised general memory score and delayed recall score. The maximum power in the left A9/46v also revealed high performance in AD-MCI versus CU classification with the area under the ROC curve of 0.90. This study demonstrated that MEG during the optic flow task can be useful in discriminating AD-MCI from CU.	[Noguchi-Shinohara, Moeko; Koike, Masato; Komatsu, Junji; Abe, Chiemi; Kitagawa, Sachiko; Ikeda, Yoshihisa; Yamada, Masahito] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan; [Noguchi-Shinohara, Moeko; Komatsu, Junji; Abe, Chiemi] Kanazawa Univ, Grad Sch Med Sci, Dept Preempt Med Dementia, Kanazawa, Ishikawa, Japan; [Koike, Masato; Morise, Hirofumi; Kudo, Kiwamu; Tsuchimine, Shoko] Ricoh Co Ltd, Med Imaging Business Ctr, Tokyo, Japan; [Yamada, Masahito] Kudanzaka Hosp, Tokyo, Japan	Kanazawa University; Kanazawa University; Ricoh Company, Ltd.	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan.; Yamada, M (corresponding author), Kudanzaka Hosp, Tokyo, Japan.	m-yamada@med.kanazawa-u.ac.jp						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Botly LCP, 2012, CEREB CORTEX, V22, P2441, DOI 10.1093/cercor/bhr331; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Clery JC, 2020, NEUROIMAGE, V215, DOI 10.1016/j.neuroimage.2020.116815; Dhanjal NS, 2014, ANN NEUROL, V76, P241, DOI 10.1002/ana.24199; Diekmann V, 2009, EXP BRAIN RES, V195, P101, DOI 10.1007/s00221-009-1753-1; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Hinderaker M, 2020, J MOTOR BEHAV, V52, P466, DOI 10.1080/00222895.2019.1645639; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Johnson DK, 2009, ARCH NEUROL-CHICAGO, V66, P1254, DOI 10.1001/archneurol.2009.158; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kovacs G, 2010, NEUROIMAGE, V51, P329, DOI 10.1016/j.neuroimage.2010.02.011; Kremlacek J, 2007, DOC OPHTHALMOL, V115, P95, DOI 10.1007/s10633-007-9063-z; Kumihashi I, 2010, IEEE T BIO-MED ENG, V57, P1358, DOI 10.1109/TBME.2010.2040735; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Mapstone M, 2003, NEUROLOGY, V60, P802, DOI 10.1212/01.WNL.0000049471.76799.DE; Matsuda H, 2012, NEUROIMAG CLIN N AM, V22, P57, DOI 10.1016/j.nic.2011.11.005; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morinaga A, 2010, DEMENT GERIATR COGN, V30, P285, DOI 10.1159/000320265; Noguchi-Shinohara M, 2013, J ALZHEIMERS DIS, V37, P691, DOI 10.3233/JAD-130398; O'Brien HL, 2001, CEREB CORTEX, V11, P1083, DOI 10.1093/cercor/11.11.1083; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Richter N, 2017, NEUROBIOL AGING, V53, P27, DOI 10.1016/j.neurobiolaging.2017.01.012; Rizzo M, 1998, BRAIN, V121, P2259, DOI 10.1093/brain/121.12.2259; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Talamonti D, 2020, NEUROIMAGE, V222, DOI 10.1016/j.neuroimage.2020.117223; Tetewsky SJ, 1999, NEUROLOGY, V52, P958, DOI 10.1212/WNL.52.5.958; Tobimatsu S, 2006, CLIN NEUROPHYSIOL, V117, P1414, DOI 10.1016/j.clinph.2006.01.004; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yeterian EH, 2012, CORTEX, V48, P58, DOI 10.1016/j.cortex.2011.03.004	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259677	10.1371/journal.pone.0259677	http://dx.doi.org/10.1371/journal.pone.0259677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739526	gold, Green Published			2022-12-26	WOS:000755000800049
J	Ortlieb, N; Klenk, E; Kulik, A; Niedermeyer, THJ				Ortlieb, Nico; Klenk, Elke; Kulik, Andreas; Niedermeyer, Timo Horst Johannes			Development of an agar-plug cultivation system for bioactivity assays of actinomycete strain collections	PLOS ONE			English	Article							NATURAL-PRODUCTS; BACTERIAL STRAINS; DISCOVERY; METABOLITES; GROWTH; OXAZOLOMYCIN; TAXONOMY; STORAGE	Natural products are an important source of lead compounds for the development of drug substances. Actinomycetes have been valuable especially for the discovery of antibiotics. Increasing occurrence of antibiotic resistance among bacterial pathogens has revived the interest in actinomycete natural product research. Actinobacteria produce a different set of natural products when cultivated on solid growth media compared with submersed culture. Bioactivity assays involving solid media (e.g. agar-plug assays) require manual manipulation of the strains and agar plugs. This is less convenient for the screening of larger strain collections of several hundred or thousand strains. Thus, the aim of this study was to develop a 96-well microplate-based system suitable for the screening of actinomycete strain collections in agar-plug assays. We developed a medium-throughput cultivation and agar-plug assay workflow that allows the convenient inoculation of solid agar plugs with actinomycete spore suspensions from a strain collection, and the transfer of the agar plugs to petri dishes to conduct agar-plug bioactivity assays. The development steps as well as the challenges that were overcome during the development (e.g. system sterility, handling of the agar plugs) are described. We present the results from one exemplary screening campaign targeted to identify compounds inhibiting Agr-based quorum sensing where the workflow was used successfully. We present a novel and convenient workflow to combine agar diffusion assays with microtiter-plate-based cultivation systems in which strains can grow on a solid surface. This workflow facilitates and speeds up the initial medium throughput screening of natural product-producing actinomycete strain collections against monitor strains in agar-plug assays.	[Ortlieb, Nico; Klenk, Elke; Kulik, Andreas; Niedermeyer, Timo Horst Johannes] Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Dept Microbiol Biotechnol, Tubingen, Germany; [Ortlieb, Nico; Niedermeyer, Timo Horst Johannes] German Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany; [Ortlieb, Nico; Niedermeyer, Timo Horst Johannes] Martin Luther Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Biol Pharmacognosy, Halle, Germany; [Kulik, Andreas] Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Dept Microbial Bioact Cpds, Tubingen, Germany; [Ortlieb, Nico] Bayer AG, Prod Supply Pharmaceut, Pharmaceut Affairs, Berlin, Germany; [Klenk, Elke] Eberhard Karls Univ Tubingen, Dept Microbial Interact, IMIT ZMBP, Tubingen, Germany	Eberhard Karls University of Tubingen; German Center for Infection Research; Martin Luther University Halle Wittenberg; Eberhard Karls University of Tubingen; Bayer AG; Eberhard Karls University of Tubingen	Niedermeyer, THJ (corresponding author), Eberhard Karls Univ Tubingen, Interfac Inst Microbiol & Infect Med, Dept Microbiol Biotechnol, Tubingen, Germany.; Niedermeyer, THJ (corresponding author), German Ctr Infect Res DZIF, Partner Site Tubingen, Tubingen, Germany.; Niedermeyer, THJ (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Biol Pharmacognosy, Halle, Germany.	timo.niedermeyer@pharmazie.uni-halle.de		Kulik, Andreas/0000-0002-6914-7313; Niedermeyer, Timo/0000-0003-1779-7899				Abdelmohsen UR, 2015, BIOTECHNOL ADV, V33, P798, DOI 10.1016/j.biotechadv.2015.06.003; Alanjary M, 2019, NUCLEIC ACIDS RES, V47, pW276, DOI 10.1093/nar/gkz282; [Anonymous], 2017, WHO MODEL LIST ESSEN; Baltz RH, 2010, ASM MANUAL IND MICRO; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; BAYER E, 1972, HELV CHIM ACTA, V55, P224, DOI 10.1002/hlca.19720550126; Betts JI, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-21; BICKEL H, 1960, HELV CHIM ACTA, V43, P2118, DOI 10.1002/hlca.19600430731; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Crusemann M, 2017, J NAT PROD, V80, P588, DOI [10.1021/acsjnatprod.6b00722, 10.1021/acs.jnatprod.6b00722]; Demain AL, 2014, J IND MICROBIOL BIOT, V41, P185, DOI 10.1007/s10295-013-1325-z; Donadio S, 2002, J BIOTECHNOL, V99, P187, DOI 10.1016/S0168-1656(02)00209-2; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Duetz WA, 2007, TRENDS MICROBIOL, V15, P469, DOI 10.1016/j.tim.2007.09.004; Fiedler H-P, 1989, SECONDARY METABOLITE; Floss HG, 2009, J ANTIBIOT, V62, P405, DOI 10.1038/ja.2009.58; Genilloud O, 2017, NAT PROD REP, V34, P1203, DOI 10.1039/c7np00026j; Genilloud O, 2011, J IND MICROBIOL BIOT, V38, P375, DOI 10.1007/s10295-010-0882-7; GRIGORJEV PA, 1992, PHARMAZIE, V47, P707; Grkovic T, 2020, ACS CHEM BIOL, V15, P1104, DOI 10.1021/acschembio.0c00139; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hentzer M, 2003, J CLIN INVEST, V112, P1300, DOI [10.1172/JCI20074, 10.1172/JCI200320074]; Herrmann J, 2017, NAT PROD REP, V34, P135, DOI 10.1039/c6np00106h; Hug JJ, 2018, ANTIBIOTICS-BASEL, V7, DOI 10.3390/antibiotics7020044; Katz L, 2016, J IND MICROBIOL BIOT, V43, P155, DOI 10.1007/s10295-015-1723-5; Kaufmann GF, 2008, EXPERT OPIN BIOL TH, V8, P719, DOI 10.1517/14712598.8.6.719 ; KAWAI S, 1989, AGR BIOL CHEM TOKYO, V53, P1127, DOI 10.1080/00021369.1989.10869398; Kiran MD, 2008, MOL PHARMACOL, V73, P1578, DOI 10.1124/mol.107.044164; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Le KY, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01174; MAZZA G, 1983, APPL ENVIRON MICROB, V45, P1949, DOI 10.1128/AEM.45.6.1949-1952.1983; Micheletti M, 2006, CURR OPIN BIOTECH, V17, P611, DOI 10.1016/j.copbio.2006.10.006; Minas W, 2000, ANTON LEEUW INT J G, V78, P297, DOI 10.1023/A:1010254013352; Moloney Mark G, 2004, Curr Drug Discov Technol, V1, P181, DOI 10.2174/1570163043334974; MORI T, 1985, TETRAHEDRON LETT, V26, P1073, DOI 10.1016/S0040-4039(00)98515-0; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; Niedermeyer T, 2012, MICROALGAL BIOTECHNOLOGY: INTEGRATION AND ECONOMY, P169; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; Powers JH, 2004, CLIN MICROBIOL INFEC, V10, P23, DOI 10.1111/j.1465-0691.2004.1007.x; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rossolini GM, 2014, CURR OPIN PHARMACOL, V18, P56, DOI 10.1016/j.coph.2014.09.006; Rutala W.A., 2008, CTR DIS CONTROL PREV; Salvador-Reyes LA, 2015, NAT PROD REP, V32, P478, DOI 10.1039/c4np00104d; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Siebenberg S, 2010, J BIOSCI BIOENG, V109, P230, DOI 10.1016/j.jbiosc.2009.08.479; Sohoni SV, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-9; Steele AD, 2019, J BIOL CHEM, V294, P16567, DOI 10.1074/jbc.REV119.006514; Wagenaar MM, 2008, MOLECULES, V13, P1406, DOI 10.3390/molecules13061406; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wex KW, 2021, CELL CHEM BIOL, V28, P1242, DOI 10.1016/j.chembiol.2021.02.022; Wink J, 2011, MICROBIOL AUST, V32, P81; Wright GD, 2015, ACS INFECT DIS, V1, P80, DOI 10.1021/id500052s	54	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0258934	10.1371/journal.pone.0258934	http://dx.doi.org/10.1371/journal.pone.0258934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739482	Green Published, gold			2022-12-26	WOS:000755000800011
J	Jonathan, O; Mnisi, CM; Kumanda, C; Mlambo, V				Jonathan, Ontiretse; Mnisi, Caven Mguvane; Kumanda, Cebisa; Mlambo, Victor			Effect of dietary red grape pomace on growth performance, hematology, serum biochemistry, and meat quality parameters in Hy-line Silver Brown cockerels	PLOS ONE			English	Article							VITAMIN-E; CHEMICAL-COMPOSITION; ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION; GENETIC DIVERSITY; DIGESTIBILITY; CHICKEN; SEED; SUPPLEMENTATION; CONCENTRATE	Red grape (Vitis vinifera L.) pomace's (RGP) beneficial bioactive compounds could improve growth and meat quality traits in chickens and thus valorize RGP waste that is usually disposed in landfills to the detriment of the environment. This study investigated the effect of RGP inclusion in diets of Hy-line Silver Brown cockerels on physiological and meat quality responses. Five isonitrogenous and isocaloric diets were formulated by mixing a standard grower diet with RGP at 0 (G0), 15 (G15), 30 (G30), 45 (G45) and 60 g/kg (G60). A total of 250, 5-week-old cockerels (304.6 +/- 6.57 g live-weight) were evenly allocated to 25 pens replicated 5 times per experimental diet. No linear and quadratic trends (P > 0.05) were observed for overall feed intake, body weight gain, feed conversion ratio, and meat quality traits as dietary RGP levels increased. Erythrocytes linearly decreased (P < 0.05), whereas mean corpuscular hemoglobin and urea linearly increased (P < 0.05) with RGP levels. There were significant quadratic effects for glucose, phosphorus, total protein, albumin, globulin, and cholesterol, from which a maximum RGP inclusion level was calculated to be 43 g/kg. In conclusion, dietary red grape pomace had no adverse effect on physiological parameters and meat quality traits of Hy-line Silver Brown cockerels. However, including red grape pomace beyond 43 g/kg could compromise serum biochemical parameters of the birds.	[Jonathan, Ontiretse; Mnisi, Caven Mguvane] North West Univ, Dept Anim Sci, Fac Nat & Agr Sci, Mafikeng, South Africa; [Mnisi, Caven Mguvane] North West Univ, Food Secur & Safety Niche Area, Fac Nat & Agr Sci, Mafikeng, South Africa; [Kumanda, Cebisa] Univ Pretoria, Dept Anim Sci, Pretoria, South Africa; [Mlambo, Victor] Univ Mpumalanga, Sch Agr Sci, Fac Agr & Nat Sci, Nelspruit, South Africa	North West University - South Africa; North West University - South Africa; University of Pretoria	Mnisi, CM (corresponding author), North West Univ, Dept Anim Sci, Fac Nat & Agr Sci, Mafikeng, South Africa.; Mnisi, CM (corresponding author), North West Univ, Food Secur & Safety Niche Area, Fac Nat & Agr Sci, Mafikeng, South Africa.	mnisiecm@gmail.com	Mnisi, Caven Mguvane/L-7199-2019	Mnisi, Caven Mguvane/0000-0003-1385-1093				Aditya S, 2018, ANIM NUTR, V4, P210, DOI 10.1016/j.aninu.2018.01.004; [Anonymous], 1976, CIE PUBLICATION, V15 (E-1. 3. 1); Atela JA, 2019, ANIM NUTR, V5, P179, DOI 10.1016/j.aninu.2018.08.002; Brenes A, 2008, POULTRY SCI, V87, P307, DOI 10.3382/ps.2007-00297; Chamorro S, 2015, FOOD RES INT, V73, P197, DOI 10.1016/j.foodres.2014.11.054; Ebrahimzadeh SK, 2018, S AFR J ANIM SCI, V48, P324, DOI 10.4314/sajas.v48i2.13; El-Dein A. K. A., 2017, Egyptian Poultry Science Journal, V37, P855; EVANS RJ, 1992, NATURE, V357, P503, DOI 10.1038/357503a0; Francesch A, 2015, BRIT POULTRY SCI, V56, P477, DOI 10.1080/00071668.2015.1062842; Grau R., 1957, Z FUR LEBENSM UND FO, V105, P446, DOI [DOI 10.1007/BF01126901, 10.1007/BF01126901]; Hoffmann I, 2005, WORLD POULTRY SCI J, V61, P57, DOI 10.1079/WPS200449; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; Iqbal Z, 2014, J ANIM PLANT SCI, V24, P1579; Kaluza J, 2012, STROKE, V43, P2556, DOI 10.1161/STROKEAHA.112.663286; Kara K., 2012, Erciyes Universitesi Veteriner Fakultesi Dergisi, V9, P183; Kara K, 2016, J APPL ANIM RES, V44, P303, DOI 10.1080/09712119.2015.1031785; Khodayari F., 2014, Advances in Bio Research, V5, P82; Kumanda C, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11071931; Landy N, 2011, LIVEST SCI, V142, P305, DOI 10.1016/j.livsci.2011.08.017; Larbi A., 2013, AGING HLTH, V9, P35, DOI [10.2217/ahe.12.78, DOI 10.2217/AHE.12.78]; Lichovnikova M, 2015, TURK J VET ANIM SCI, V39, P406, DOI 10.3906/vet-1403-64; Mtileni BJ, 2011, J ANIM BREED GENET, V128, P209, DOI 10.1111/j.1439-0388.2010.00891.x; Nicodemus N, 2007, J ANIM SCI, V85, P181, DOI 10.2527/jas.2005-365; Priolo A, 2002, MEAT SCI, V62, P179, DOI 10.1016/S0309-1740(01)00244-3; Reece OW., 2009, FUNCTIONAL ANATOMY P, V4th ed., P49; SAS, 2010, US GUID STAT VER 9 4; Sayago-Ayerdi SG, 2009, LWT-FOOD SCI TECHNOL, V42, P971, DOI 10.1016/j.lwt.2008.12.006; Shanmuganayagam D, 2007, ATHEROSCLEROSIS, V190, P135, DOI 10.1016/j.atherosclerosis.2006.03.017; Spradling VB., 2008, PHENOLICS RED WINE P; Tavarez MA, 2011, POULTRY SCI, V90, P922, DOI 10.3382/ps.2010-01180; Toghyani M, 2010, LIVEST SCI, V129, P173, DOI 10.1016/j.livsci.2010.01.021; van Marle-Koster E, 2008, S AFR J ANIM SCI, V38, P271; Van Niekerk RF, 2020, BRIT POULTRY SCI, V61, P566, DOI 10.1080/00071668.2020.1755014; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Zalikarenab L, 2007, J ANIM VET ADV, V6, P1107	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259630	10.1371/journal.pone.0259630	http://dx.doi.org/10.1371/journal.pone.0259630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735548	Green Published, gold			2022-12-26	WOS:000755077100100
J	Munetsuna, E; Yamada, H; Yamazaki, M; Ando, Y; Mizuno, G; Hattori, Y; Kageyama, I; Teshigawara, A; Nouchi, Y; Ishikawa, H; Fujii, R; Ohta, Y; Suzuki, K; Shimono, Y; Ohashi, K; Hashimoto, S				Munetsuna, Eiji; Yamada, Hiroya; Yamazaki, Mirai; Ando, Yoshitaka; Mizuno, Genki; Hattori, Yuji; Kageyama, Itsuki; Teshigawara, Atsushi; Nouchi, Yuki; Ishikawa, Hiroaki; Fujii, Ryosuke; Ohta, Yoshiji; Suzuki, Koji; Shimono, Yohei; Ohashi, Koji; Hashimoto, Shuji			Maternal fructose intake predisposes rat offspring to metabolic disorders via abnormal hepatic programming	FASEB JOURNAL			English	Article						DOHaD; hepatic microRNA expression; insulin-like growth factor-1; maternal nutrition; offspring	HIGH-FAT-DIET; INSULIN-RESISTANCE; DNA METHYLATION; LIVER-DISEASE; IGF-I; EXPRESSION; CONSUMPTION; HEALTH; RISK; EPIGENETICS	Given that fructose consumption has increased by more than 10-fold in recent decades, it is possible that excess maternal fructose consumption causes harmful effects in the next generation. This study attempted to elucidate the mechanism of the harmful effects of excessive maternal fructose intake from the perspective of offspring liver function. Female rats during gestation and lactation were fed water containing fructose, and their offspring were fed normal water. We attempted to elucidate the mechanism of fructose-induced transgenerational toxicity by conducting a longitudinal study focusing on hepatic programming prior to disease onset. Impaired Insulin resistance and decreased high-density lipoprotein-cholesterol levels were observed at 160 days of age. However, metabolic disorders were not observed in 60-day-old offspring. Microarray analysis of 60-day-old offspring livers showed the reduction of hepatic insulin-like growth factor-1 (Igf1) mRNA expression. This reduction continued until the rats were aged 160 days and attenuated Igf1 signaling. Hepatic microRNA-29 (miR-29a) and miR-130a, which target Igf1 mRNA, were also found to be upregulated. Interestingly, these miRNAs were upregulated in the absence of metabolic disorder. In this study, we found that maternal fructose intake resulted in dysregulated expression of Igf1 and its target miRNAs in the offspring liver, and that these offspring were more likely to develop metabolic disorders. Abnormal hepatic programming induced by an imbalanced maternal nutritional environment is maintained throughout life, implying that it may contribute to metabolic disorders.	[Munetsuna, Eiji; Shimono, Yohei] Fujita Hlth Univ, Dept Biochem, Sch Med, Toyoake, Aichi, Japan; [Yamada, Hiroya; Hashimoto, Shuji] Fujita Hlth Univ, Dept Hyg, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan; [Yamazaki, Mirai] Kagawa Prefectural Univ Hlth Sci, Dept Med Technol, Takamatsu, Kagawa, Japan; [Ando, Yoshitaka; Kageyama, Itsuki; Teshigawara, Atsushi; Nouchi, Yuki; Ishikawa, Hiroaki; Ohashi, Koji] Fujita Hlth Univ, Dept Clin Biochem, Sch Med Sci, Toyoake, Aichi, Japan; [Mizuno, Genki; Teshigawara, Atsushi] Fujita Hlth Univ Hosp, Deparment Joint Res Lab Clin Med, Toyoake, Aichi, Japan; [Mizuno, Genki; Hattori, Yuji; Fujii, Ryosuke; Suzuki, Koji] Fujita Hlth Univ, Dept Prevent Med Sci, Sch Med Sci, Toyoake, Aichi, Japan; [Ohta, Yoshiji] Fujita Hlth Univ, Dept Chem, Sch Med, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University; Fujita Health University	Yamada, H (corresponding author), Fujita Hlth Univ, Dept Hyg, Sch Med, 1-98 Dengakugakubo, Toyoake, Aichi 4701192, Japan.	hyamada@fujita-hu.ac.jp		Mizuno, Genki/0000-0001-8052-5146	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20H04134, 17K07805, 18K05493]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant/Award Number: 20H04134, 17K07805 and 18K05493	Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Chao YM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00660-z; Clayton ZE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141962; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Fu Q, 2015, FASEB J, V29, P1176, DOI 10.1096/fj.14-258442; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Fukunaga K, 2018, AM J PHYSIOL-ENDOC M, V315, pE1232, DOI 10.1152/ajpendo.00134.2018; Gillman MW, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0031; Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062; Hiratsuka I, 2015, ENDOCR J, V62, P1059, DOI 10.1507/endocrj.EJ15-0448; Hong H, 2017, NUTR DIABETES, V7, DOI 10.1038/s41387-017-0002-0; Hsu CN, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900073; Hsu CN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091229; Hung YH, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01367; Keleher MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192606; Koo S, 2021, NUTR RES PRACT, V15, P160, DOI 10.4162/nrp.2021.15.2.160; Lara-Diaz VJ, 2017, J PHYSIOL BIOCHEM, V73, P245, DOI 10.1007/s13105-016-0545-x; Liang S, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0275-7; Lu L, 2015, BIOCHEM BIOPH RES CO, V465, P387, DOI 10.1016/j.bbrc.2015.08.012; Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032; Mizuno G, 2021, NUTR RES, V92, P40, DOI 10.1016/j.nutres.2021.06.002; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; Mouralidarane A, 2015, INT J OBESITY, V39, P1339, DOI 10.1038/ijo.2015.85; Munetsuna E, 2019, J NUTR BIOCHEM, V67, P44, DOI 10.1016/j.jnutbio.2019.01.016; Munetsuna E, 2018, LIFE SCI, V202, P117, DOI 10.1016/j.lfs.2018.04.006; Ogden C. L., 2011, NCHS Data Briefs; Ohashi K, 2015, BIOCHEM BIOPH RES CO, V468, P185, DOI 10.1016/j.bbrc.2015.10.134; Ohashi K, 2015, NUTR RES, V35, P259, DOI 10.1016/j.nutres.2014.11.001; Ouni M, 2016, PHARMACOGENOMICS J, V16, P102, DOI 10.1038/tpj.2015.26; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Saad AF, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.038; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Siddeek B, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0153-y; Sohi G, 2015, ENDOCRINOLOGY, V156, P3069, DOI [10.1210/en.2015-1058, 10.1210/EN.2015-1058]; Stanhope KL, 2013, CURR OPIN LIPIDOL, V24, P198, DOI 10.1097/MOL.0b013e3283613bca; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yamada H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84707-7; Yamada H, 2019, FASEB J, V33, P11431, DOI 10.1096/fj.201901072R; Yamazaki M, 2020, J NUTR BIOCHEM, V82, DOI 10.1016/j.jnutbio.2020.108386; Yamazaki M, 2018, FASEB J, V32, P2549, DOI 10.1096/fj.201700783RR; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang Q, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00871; Zheng J, 2016, ENDOCRINE, V54, P70, DOI 10.1007/s12020-016-0959-9	49	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22030	10.1096/fj.202101276R	http://dx.doi.org/10.1096/fj.202101276R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34748238				2022-12-26	WOS:000722321300008
J	Fanaeian, MM; Alibeik, N; Ganji, A; Fakheri, H; Ekhlasi, G; Shahbazkhani, B				Fanaeian, Mohammad M.; Alibeik, Nazanin; Ganji, Azita; Fakheri, Hafez; Ekhlasi, Golnaz; Shahbazkhani, Bijan			Prevalence of migraine in adults with celiac disease: A case control cross-sectional study	PLOS ONE			English	Article							PSYCHIATRIC MANIFESTATIONS; DIABETES-MELLITUS; GLUTEN; SYMPTOMS; DISORDERS; DIAGNOSIS	Aim Celiac disease (CD) is an immune-mediated disorder with various manifestations. The aim of this study was to evaluate the prevalence of gastrointestinal (GI) and extra-intestinal symptoms of celiac patients, especially migraine, and compare it with healthy individuals. Methods We compared 1000 celiac subjects (CS) registered at our celiac center with the control group for headache-based on International Classification of Headache Disorders, third edition criteria and their GI symptoms. Besides, CS with migraine and non-migrainous headache were compared in terms of GI symptoms and accompanied conditions. Results Headache was more common in CS than controls (34% vs 27% respectively, P value<0.001) and more prevalent in females (71.9% in females vs 28% in males, P value = 0.004). Moreover, the prevalence of migraine in CS was higher than controls (20.7 vs 11.9% respectively, P value<0.001). Furthermore, migraine was more prevalent in females with CD (80% in females vs 19% in males, P value = 0.033), and often without aura (76%). Abdominal pain (76.9%, P value = 0.025), diarrhea (54.9%, P value = 0.002), and constipation (42.9%, P value = 0.011) were the most common GI symptoms in CS with headache and more prevalent in CS with migraine. Conversely, type 1 diabetes mellitus was less common in CS with migraine than in CS with non-migrainous headache. (P value = 0.001). On multivariate logistic regression analysis, female sex (OR 1.50, 95%CI 1.22-1.83, P value < 0.001), and CD (OR 1.36, 95%CI 1.12-1.65, P value = 0.002) were independent predictors of headache, whereas age more than 60 years (OR 0.70, 95%CI 0.50-0.97, P value = 0.032) had a protective effect. Conclusion Headache especially migraine is more prevalent in CS than healthy controls. In addition, abdominal pain, diarrhea, and constipation are more common in CS with migraine than in CS with non-migrainous headaches. Therefore, evaluation of CD in patients with migraine and these simultaneous GI symptoms seems reasonable.	[Fanaeian, Mohammad M.] Univ Tehran Med Sci, Imam Khomeini Hosp Complex, Div Gastroenterol & Liver Dis, Tehran, Iran; [Alibeik, Nazanin] Iran Univ Med Sci, Firoozgar Hosp, Clin Res Dev Ctr, Tehran, Iran; [Ganji, Azita] Mashhad Univ Med Sci, Dept Gastroenterol & Hepatol, Mashahd, Iran; [Fakheri, Hafez] Mazandaran Univ Med Sci, Noncommunicable Dis Inst, Gut & Liver Res Ctr, Sari, Iran; [Ekhlasi, Golnaz] Univ Tehran Med Sci, Golnaz Ekhlasi Digest Dis Res Inst, Shariati Hosp, Tehran, Iran; [Shahbazkhani, Bijan] Univ Tehran Med Sci, Dept Gastroenterol & Liver Dis, Tehran, Iran	Tehran University of Medical Sciences; Iran University of Medical Sciences; Mashhad University Medical Science; Mazandaran University Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Alibeik, N (corresponding author), Iran Univ Med Sci, Firoozgar Hosp, Clin Res Dev Ctr, Tehran, Iran.	Alibeik.n@iums.ac.ir	Ganji, Azita/AAW-7769-2020; Fakheri, Hafez Tirgar/G-7638-2017; Fanaeian, Mohammad Mahdi/CAH-4355-2022; Fanaeian, Mohammad Mahdi/CAE-9082-2022	Ganji, Azita/0000-0002-8161-6629; Fakheri, Hafez Tirgar/0000-0002-0579-6111; Fanaeian, Mohammad Mahdi/0000-0002-4867-8334; Fanaeian, Mohammad Mahdi/0000-0002-4867-8334; Alibeik, Nazanin/0000-0001-8780-2249				Aamodt AH, 2007, EUR J NEUROL, V14, P738, DOI 10.1111/j.1468-1331.2007.01765.x; Alehan F, 2008, CEPHALALGIA, V28, P945, DOI 10.1111/j.1468-2982.2008.01630.x; Ameghino L, 2019, J ORAL FACIAL PAIN H, V33, P294, DOI 10.11607/ofph.2079; Aurora SK, 2021, HEADACHE, V61, P576, DOI 10.1111/head.14099; Briani C, 2008, J NEUROIMMUNOL, V195, P171, DOI 10.1016/j.jneuroim.2008.01.008; Burk K, 2009, MOVEMENT DISORD, V24, P2358, DOI 10.1002/mds.22821; Camara-Lemarroy CR, 2016, WORLD J GASTROENTERO, V22, P8149, DOI 10.3748/wjg.v22.i36.8149; Charles A, 2013, HEADACHE, V53, P413, DOI 10.1111/head.12026; Cicarelli G, 2003, NEUROL SCI, V24, P311, DOI 10.1007/s10072-003-0181-4; Croall ID, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238283; Dimitrova AK, 2013, HEADACHE, V53, P344, DOI 10.1111/j.1526-4610.2012.02260.x; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Finkel AG, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0373-4; Gabrielli M, 2003, AM J GASTROENTEROL, V98, P625, DOI [10.1111/j.1572-0241.2003.07300.x, 10.1016/S0002-9270(02)06022-7]; Gerth WC, 2001, PHARMACOECONOMICS, V19, P197, DOI 10.2165/00019053-200119020-00006; Griauzdaite K, 2020, MED HYPOTHESES, V142, DOI 10.1016/j.mehy.2020.109738; Hadjivassiliou M, 1998, LANCET, V352, P1582, DOI 10.1016/S0140-6736(98)05342-2; Hagen K, 2018, CEPHALALGIA, V38, P417, DOI 10.1177/0333102417690488; Holtmeier W, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-3; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Kelly CP, 2015, GASTROENTEROLOGY, V148, P1175, DOI 10.1053/j.gastro.2015.01.044; Kelman L, 2006, CEPHALALGIA, V26, P548, DOI 10.1111/j.1468-2982.2006.01075.x; Kemper RHA, 2001, CEPHALALGIA, V21, P549, DOI 10.1046/j.1468-2982.2001.00196.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Oxentenko AS, 2019, MAYO CLIN PROC, V94, P2556, DOI 10.1016/j.mayocp.2019.02.019; PRADILLA G, 1995, NEUROLOGY, V45, P1030; Ruggieri M, 2008, J PEDIATR, V152, P244, DOI 10.1016/j.jpeds.2007.06.042; Samsam M., 2012, ANTIINFLAMM ANTIALLE, V9, P170; Shahbazkhani B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59532-z; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SILBERSTEIN SD, 1995, HEADACHE, V35, P387, DOI 10.1111/j.1526-4610.1995.hed3507387.x; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Tantucci C, 2001, J APPL PHYSIOL, V90, P889, DOI 10.1152/jappl.2001.90.3.889; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Wang YF, 2012, CEPHALALGIA, V32, P1180, DOI 10.1177/0333102412461401; White NH, 2015, PEDIATR CLIN N AM, V62, P889, DOI 10.1016/j.pcl.2015.04.004; Zelnik N, 2004, PEDIATRICS, V113, P1672, DOI 10.1542/peds.113.6.1672	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259502	10.1371/journal.pone.0259502	http://dx.doi.org/10.1371/journal.pone.0259502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788304	gold, Green Published			2022-12-26	WOS:000735920500029
J	Gerretsen, P; Kim, J; Caravaggio, F; Quilty, L; Sanches, M; Wells, S; Brown, EE; Agic, B; Pollock, BG; Graff-Guerrero, A				Gerretsen, Philip; Kim, Julia; Caravaggio, Fernando; Quilty, Lena; Sanches, Marcos; Wells, Samantha; Brown, Eric E.; Agic, Branka; Pollock, Bruce G.; Graff-Guerrero, Ariel			Individual determinants of COVID-19 vaccine hesitancy	PLOS ONE			English	Article							ATTITUDES; VALIDITY	Background Novel coronavirus disease 2019 (COVID-19) vaccine hesitancy is a barrier to achieving herd immunity, and thus, a prominent public health concern. This study aimed to identify the determinants of COVID-19 vaccine hesitancy based on the World Health Organization's '3Cs' model (i.e., confidence, complacency, and convenience) in the United States (U.S.) and Canada. Methods Data from 7678 adults ages 18 or older were collected from the four most populous U.S. States, specifically New York, California, Florida, and Texas, and from English-speaking Canada at three timepoints, in May and July 2020, and March 2021 using a web-based survey (www.covid19-database.com). Sociodemographic information was collected, and comprehensive psychological assessments were administered. Univariate analyses were performed to identify the individual determinants of vaccine hesitancy, which were categorized as: 1) vaccine confidence, 2) vaccine complacency, 3) sociodemographic, and 4) other psychological factors. A series of models were computed using these categorizations. Results Mistrust of vaccine benefit (beta(SE) = 0.67(0.01), p<0.001, partial eta(2) = 0.26) and lower perceived seriousness of COVID-19 (beta(SE) = 0.68(0.02), p<0.001, partial eta(2) = 0.12) were the principal determinants of vaccine hesitancy. Right-wing political affiliation (beta(SE) = 0.32(0.02), p<0.001, partial eta(2) = 0.03), higher risk propensity (beta(SE) = 0.24(0.02), p<0.001, partial eta(2) = 0.03), and less negative mental health effects of the COVID-19 pandemic (beta(SE) = 0.20(0.01), p<0.001, partial eta(2) = 0.03) were the main sociodemographic and psychological determinants. Other sociodemographic determinants included younger age, women, race, and employment status. Lack of vaccine confidence and complacency explained 38% and 21% of the variance in vaccine hesitancy, respectively; whereas, sociodemographic and psychological determinants explained 13% and 11% of the variance in vaccine hesitancy, respectively. Discussion Targeted and tailored public health interventions that enhance the public's confidence in vaccines and emphasize the risk and seriousness of COVID-19 may address COVID-19 vaccine hesitancy. Efforts directed toward specific marginalized and underserved groups may be required to promote vaccine confidence.	[Gerretsen, Philip; Caravaggio, Fernando; Quilty, Lena; Brown, Eric E.; Pollock, Bruce G.; Graff-Guerrero, Ariel] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gerretsen, Philip; Brown, Eric E.; Pollock, Bruce G.; Graff-Guerrero, Ariel] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Gerretsen, Philip; Kim, Julia; Pollock, Bruce G.; Graff-Guerrero, Ariel] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Sanches, Marcos] Krembil Ctr Neuroinformat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Wells, Samantha] Inst Mental Hlth Policy Res, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Agic, Branka] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Agic, Branka] Prov Syst Support Program PSSP, Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Gerretsen, P (corresponding author), Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada.; Gerretsen, P (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; Gerretsen, P (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	philgerretsen@yahoo.com		POLLOCK, BRUCE/0000-0003-0802-3998	Centre for Addiction and Mental Health Foundation; Department of Psychiatry, University of Toronto; Canadian Institute of Health Research (CIHR) [PJT159807]	Centre for Addiction and Mental Health Foundation; Department of Psychiatry, University of Toronto; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Centre for Addiction and Mental Health Foundation (PG), an Academic Scholars Award from the Department of Psychiatry, University of Toronto (PG), and the Canadian Institute of Health Research (CIHR) (PJT159807 to PG).	[Anonymous], 2020, EKOS POL; Brennan K.AC.C.L., 1998, ATTACHMENT THEORY CL, P46, DOI DOI 10.1037/T03763-000; Burki T, 2019, LANCET DIGIT HEALTH, V1, pE258, DOI 10.1016/S2589-7500(19)30136-0; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornwall, 2020, SCIENCE, DOI [DOI 10.1126/SCIENCE.ABB9969, 10.1126/science.abb9969, 10.1126/science.abd6018]; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Duncan LA, 2009, PERS INDIV DIFFER, V47, P541, DOI 10.1016/j.paid.2009.05.001; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Grimmelikhuijsen S, 2017, INT REV ADM SCI, V83, P583, DOI 10.1177/0020852315585950; Hamel L, 2020, KFF COVID 19 VACCINE; Hyland ME, 2003, COMPLEMENT THER MED, V11, P33, DOI 10.1016/S0965-2299(02)00113-9; Kotov R. I., 2004, MULTIDIMENSIONAL IOW; Krause P, 2020, LANCET, V396, P741, DOI 10.1016/S0140-6736(20)31821-3; Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Lonnqvist JE, 2007, EUR J PERSONALITY, V21, P1017, DOI 10.1002/per.655; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Martin LR, 2017, ANN BEHAV MED, V51, P652, DOI 10.1007/s12160-017-9888-y; Meertens RM, 2008, J APPL SOC PSYCHOL, V38, P1506, DOI 10.1111/j.1559-1816.2008.00357.x; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; RIGBY K, 1987, J PERS ASSESS, V51, P615, DOI 10.1207/s15327752jpa5104_14; Risko EF, 2006, J PERS ASSESS, V87, P269, DOI 10.1207/s15327752jpa8703_08; SAPP SG, 1993, PSYCHOL REP, V72, P539, DOI 10.2466/pr0.1993.72.2.539; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397	28	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0258462	10.1371/journal.pone.0258462	http://dx.doi.org/10.1371/journal.pone.0258462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	34788308	Green Published, gold			2022-12-26	WOS:000735920500005
J	Xu, YF; Xu, XH; Bhandari, K; Gin, A; Rao, CV; Morris, KT; Hannafon, BN; Ding, WQ				Xu, Yi-Fan; Xu, Xiaohui; Bhandari, Kritisha; Gin, Amy; Rao, Chinthalapally, V; Morris, Katherine T.; Hannafon, Bethany N.; Ding, Wei-Qun			Isolation of extra-cellular vesicles in the context of pancreatic adenocarcinomas: Addition of one stringent filtration step improves recovery of specific microRNAs	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CIRCULATING EXOSOMES; MUTANT KRAS; BIOMARKERS; PLASMA; BIOGENESIS; EXPRESSION; DIAGNOSIS; SECRETION; MIRNA	microRNAs (miRNA) in extracellular vesicles (EVs) have been investigated as potential biomarkers for pancreatic ductal adenocarcinoma (PDAC). However, a mixed population of EVs is often obtained using conventional exosome isolation methods for biomarker development. EVs are derived from different cellular processes and present in various sizes, therefore miRNA expression among them is undoubtedly different. We developed a simple protocol utilizing sequential filtration and ultracentrifugation to separate PDAC EVs into three groups, one with an average diameter of more than 220 nm, named operational 3 (OP3); one with average diameters between 100-220 nm, named operational 2 (OP2); and another with average diameters around 100 nm, named operational 1 (OP1)). EVs were isolated from conditioned cell culture media and plasma of human PDAC xenograft mice and early stage PDAC patients, and verified by nanoparticle tracking, western blot, and electronic microscopy. We demonstrate that exosome specific markers are only enriched in the OP1 group. qRT-PCR analysis of miRNA expression in EVs from PDAC cells revealed that expression of miR-196a and miR-1246, two previously identified miRNAs highly enriched in PDAC cell-derived exosomes, is significantly elevated in the OP1 group relative to the other EV groups. This was confirmed using plasma EVs from PDAC xenograft mice and patients with localized PDAC. Our results indicate that OP1 can be utilized for the identification of circulating EV miRNA signatures as potential biomarkers for PDAC.	[Xu, Yi-Fan; Xu, Xiaohui; Bhandari, Kritisha; Gin, Amy; Ding, Wei-Qun] Univ Oklahoma, Coll Med, Stephenson Canc Ctr, Dept Pathol,Hlth Sci Ctr, Oklahoma City, OK 73117 USA; [Xu, Xiaohui] Soochow Univ, Peoples Hosp Taicang City 1, Dept Gen Surg, Taicang Affiliated Hosp, Suzhou, Peoples R China; [Rao, Chinthalapally, V] Univ Oklahoma, Coll Med, Stephenson Canc Ctr, Dept Med,Hematol Oncol Sect,Hlth Sci Ctr, Oklahoma City, OK 73190 USA; [Morris, Katherine T.] Univ Oklahoma, Coll Med, Stephenson Canc Ctr, Dept Surg,Hlth Sci Ctr, Oklahoma City, OK 73190 USA; [Hannafon, Bethany N.] Univ Oklahoma, Coll Med, Stephenson Canc Ctr, Dept Obstet & Gynecol,Hlth Sci Ctr, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Soochow University - China; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ding, WQ (corresponding author), Univ Oklahoma, Coll Med, Stephenson Canc Ctr, Dept Pathol,Hlth Sci Ctr, Oklahoma City, OK 73117 USA.	weiqun-ding@ouhsc.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640]; National Cancer Institute [CA235208-01]; Oklahoma Center for the Advancement of Science and Technology [HR14-147]; Presbyterian Health Foundation; Peggy and Charles Stephenson Cancer Center	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Oklahoma Center for the Advancement of Science and Technology; Presbyterian Health Foundation; Peggy and Charles Stephenson Cancer Center	WQD received funding from the National Institute of General Medical Sciences of the National Institutes of Health (P20GM103640), the National Cancer Institute (CA235208-01), the Oklahoma Center for the Advancement of Science and Technology (HR14-147), the Presbyterian Health Foundation, and the Peggy and Charles Stephenson Cancer Center.	Allenson K, 2017, ANN ONCOL, V28, P741, DOI 10.1093/annonc/mdx004; Bobrie A, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18397; Castillo J, 2018, ANN ONCOL, V29, P223, DOI 10.1093/annonc/mdx542; Chen CY, 2013, METHOD ENZYMOL, V524, P225, DOI 10.1016/B978-0-12-397945-2.00013-5; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; Cote GA, 2014, AM J GASTROENTEROL, V109, P1942, DOI 10.1038/ajg.2014.331; Couto N, 2018, BIOCHIMIE, V155, P2, DOI 10.1016/j.biochi.2018.03.006; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Falasca M, 2016, BBA-REV CANCER, V1865, P123, DOI 10.1016/j.bbcan.2016.01.001; Frampton AE, 2015, EUR J CANCER, V51, P1389, DOI 10.1016/j.ejca.2015.04.006; Hannafon BN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0753-x; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Hernandez YG, 2016, WORLD J GASTRO ONCOL, V8, P18, DOI 10.4251/wjgo.v8.i1.18; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kim KM, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1413; Kosaka N, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020022; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lai XY, 2017, CANCER LETT, V393, P86, DOI 10.1016/j.canlet.2017.02.019; Le Large TYS, 2015, EXPERT REV MOL DIAGN, V15, P1525, DOI 10.1586/14737159.2015.1112273; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Manri C, 2017, APPL BIOCHEM BIOTECH, V182, P609, DOI 10.1007/s12010-016-2348-5; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Permuth-Wey J, 2015, CANCER PREV RES, V8, P826, DOI 10.1158/1940-6207.CAPR-15-0094; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Shao HL, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150180; Tucher C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00534; Xu YF, 2017, ONCOTARGET, V8, P77028, DOI 10.18632/oncotarget.20332; Yang SJ, 2017, CANCER BIOL THER, V18, P158, DOI 10.1080/15384047.2017.1281499	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0259563	10.1371/journal.pone.0259563	http://dx.doi.org/10.1371/journal.pone.0259563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784377	gold, Green Published			2022-12-26	WOS:000755277300013
J	Darga, EP; Dolce, EM; Fang, F; Kidwell, KM; Gersch, CL; Kregel, S; Thomas, DG; Gill, A; Brown, ME; Gross, S; Connelly, M; Holinstat, M; Cobain, EF; Rae, JM; Hayes, DF; Paoletti, C				Darga, Elizabeth P.; Dolce, Emily M.; Fang, Fang; Kidwell, Kelley M.; Gersch, Christina L.; Kregel, Steven; Thomas, Dafydd G.; Gill, Anoop; Brown, Martha E.; Gross, Steven; Connelly, Mark; Holinstat, Michael; Cobain, Erin F.; Rae, James M.; Hayes, Daniel F.; Paoletti, Costanza			PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer	PLOS ONE			English	Article							BIOMARKER; SURVIVAL; PROGRESSION; CHALLENGES	Background Immune checkpoint inhibition is effective in several cancers. Expression of programmed death-ligand 1 (PD-L1) on circulating tumor or immune effector cells could provide insights into selection of patients for immune checkpoint inhibition. Methods Whole blood was collected at serial timepoints from metastatic breast cancer patients and healthy donors for circulating tumor cell (CTC) and platelet PD-L1 analysis with a phycoerythrin-labeled anti-human PD-L1 monoclonal antibody (Biolegend clone 29E.2A3) using the CellSearch (R) assay. CTC PD-L1 was considered positive if detected on at least 1% of the cells; platelet PD-L1 was considered positive if >= 100 platelets per CellSearch frame expressed PD-L1. Results A total of 207 specimens from 124 metastatic breast cancer patients were collected. 52/124 (42%) samples at timepoint-1 (at or close to time of progressive disease) had >= 5 CTC/7.5ml whole blood. Of those, 21 (40%) had positive CTC PD-L1. In addition, platelet PD-L1 expression was observed in 35/124 (28%) at timepoint-1. Platelet PD-L1 was not detected in more than 70 specimens from 12 healthy donors. Platelet PD-L1 was associated with >= 5 CTC/7.5ml whole blood (p = 0.0002), less likely in patients with higher red blood cell counts (OR = 0.72, p<0.001) and a history of smoking tobacco (OR = 0.76, p<0.001). Platelet PD-L1 staining was not associated with tumor marker status, recent procedures or treatments, platelet-affecting drugs, or CTC PD-L1 expression. Conclusion PD-L1 expression was found in metastatic breast cancer patients on both CTC and platelets in an independent fashion. Inter-patient platelet PD-L1 expression was highly heterogeneous suggesting that it is a biological event associated with cancer in some but not all patients. Taken together, our data suggest that CTC and platelet PD-L1 expression could play a role in predicting which patients should receive immune checkpoint inhibition and as a pharmacodynamics biomarker during treatment.	[Darga, Elizabeth P.; Dolce, Emily M.; Gersch, Christina L.; Gill, Anoop; Brown, Martha E.; Cobain, Erin F.; Rae, James M.; Hayes, Daniel F.; Paoletti, Costanza] Univ Michigan, Sch Med, Dept Internal Med, Breast Oncol Program, Ann Arbor, MI 48109 USA; [Darga, Elizabeth P.; Dolce, Emily M.; Kidwell, Kelley M.; Gersch, Christina L.; Kregel, Steven; Thomas, Dafydd G.; Gill, Anoop; Brown, Martha E.; Cobain, Erin F.; Rae, James M.; Hayes, Daniel F.; Paoletti, Costanza] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [Fang, Fang; Kidwell, Kelley M.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Kregel, Steven] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Gross, Steven; Connelly, Mark] Menarini Silicon Biosyst, Huntingdon Valley, PA USA; [Holinstat, Michael; Rae, James M.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Paoletti, Costanza] EISAI Inc, Woodcliff Lake, NJ USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Eisai Co Ltd	Hayes, DF (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Breast Oncol Program, Ann Arbor, MI 48109 USA.; Hayes, DF (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	hayessdf@umich.edu		Kidwell, Kelley M/0000-0002-1717-4483; Dolce, Emily/0000-0001-7212-8116	Menarini Silicon Biosystems; Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale T; National Cancer Institute Cancer Center Support Grant [P30CA046592]	Menarini Silicon Biosystems(Menarini Group); Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale T; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Menarini Silicon Biosystems, the Fashion Footwear Charitable Foundation of New York/QVC Presents Shoes on Sale T (D.F.H.), and the National Cancer Institute Cancer Center Support Grant (P30CA046592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, JAMA ONCOL, V5, P1205, DOI 10.1001/jamaoncol.2018.7147; Anantharaman A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2758-3; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Boffa DJ, 2017, CANCER EPIDEM BIOMAR, V26, P1139, DOI 10.1158/1055-9965.EPI-17-0120; Carretero R, 2008, IMMUNOGENETICS, V60, P439, DOI 10.1007/s00251-008-0303-5; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Constantinidou A, 2019, PHARMACOL THERAPEUT, V194, P84, DOI 10.1016/j.pharmthera.2018.09.008; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Davis AA, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0768-9; Doroshow DB, 2019, CLIN CANCER RES, V25, P4592, DOI 10.1158/1078-0432.CCR-18-1538; Emens LA, 2017, EUR J CANCER, V81, P116, DOI 10.1016/j.ejca.2017.01.035; Gonzalez TL, 2020, BREAST CANCER RES TR, V180, P611, DOI 10.1007/s10549-020-05564-y; Haemmerle M, 2018, CANCER CELL, V33, P965, DOI 10.1016/j.ccell.2018.03.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jacot W, 2020, CLIN CHEM, V66, P1093, DOI 10.1093/clinchem/hvaa121; Janning M, 2019, CANCERS, V11, DOI 10.3390/cancers11060835; Jenne CN, 2014, BLOOD, V124, P671, DOI 10.1182/blood-2014-05-572875; Khattak MA, 2020, ONCOLOGIST, V25, pE520, DOI 10.1634/theoncologist.2019-0557; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Mittendorf EA, 2014, CANCER IMMUNOL RES, V2, P361, DOI 10.1158/2326-6066.CIR-13-0127; Nabet BY, 2020, CELL, V183, P363, DOI 10.1016/j.cell.2020.09.001; Nami N, 2016, PLATELETS, V27, P143, DOI 10.3109/09537104.2015.1048216; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Paoletti C, 2018, CLIN CANCER RES, V24, P5860, DOI 10.1158/1078-0432.CCR-18-1569; Paoletti C, 2018, CANCER RES, V78, P1110, DOI 10.1158/0008-5472.CAN-17-2686; Paoletti C, 2016, MOL ONCOL, V10, P1078, DOI 10.1016/j.molonc.2016.04.006; Paoletti C, 2015, CLIN CANCER RES, V21, P2771, DOI 10.1158/1078-0432.CCR-14-2781; Paoletti C, 2015, CLIN CANCER RES, V21, P2487, DOI 10.1158/1078-0432.CCR-14-1913; Prestipino A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7729; Rolfes Verena, 2018, Oncotarget, V9, P27460, DOI 10.18632/oncotarget.25446; Scher HI, 2015, J CLIN ONCOL, V33, P1348, DOI 10.1200/JCO.2014.55.3487; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Schott DS, 2017, ONCOTARGET, V8, P72755, DOI 10.18632/oncotarget.20346; Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561; Szczerba BM, 2019, NATURE, V566, P553, DOI 10.1038/s41586-019-0915-y; Tamminga M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0649-2; Wang Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36096-7; Wei XL, 2018, J CANCER, V9, P4325, DOI 10.7150/jca.27735; Zaslavsky AB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76351-4; Zhang JF, 2018, NATURE, V553, P91, DOI 10.1038/nature25015	42	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260124	10.1371/journal.pone.0260124	http://dx.doi.org/10.1371/journal.pone.0260124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780566	Green Submitted, gold, Green Published			2022-12-26	WOS:000755305800094
J	Fauk, NK; Ward, PR; Hawke, K; Mwanri, L				Fauk, Nelsensius Klau; Ward, Paul Russell; Hawke, Karen; Mwanri, Lillian			Cultural and religious determinants of HIV transmission: A qualitative study with people living with HIV in Belu and Yogyakarta, Indonesia	PLOS ONE			English	Article							FEMALE SEX WORKERS; CONDOM USE; CLIENTS; WOMEN; RISK; PREVALENCE; HIV/AIDS; VIOLENCE; IMPACT; AIDS	As a part of a larger qualitative study to understand HIV-risk factors and impacts on people living with HIV (PLHIV) (52 women and 40 men) in Belu and Yogyakarta, Indonesia, this paper reports the influences of cultural practices and religious beliefs on sexual relationships and behaviours of participants as contributors for HIV transmission. This study was conducted from June to December 2020. Data collection was conducted using one-one-one in-depth interviews. Participants were recruited using the snowball sampling technique. Data analysis was guided by a qualitative data analysis framework. The findings showed that cultural practices in Belu related to the use of bride wealth, managing spousal disputes, marriage, and condom use, influenced spousal relationships and sexual behaviours or practices which contributed to HIV transmission. Javanese cultural practices and expectation of an 'ideal wife', Islamic religious beliefs about expected husband-wife relationships, forbidden premarital sex, and the participants' individual interpretation of their religious beliefs about condom use spousal sexual relations, also influenced spousal sexual relations and behaviours, which supported HIV transmission among the participants. The findings indicate the need for HIV education programs that address cultural practices and religious beliefs for community members and population groups to enhance their understanding about HIV, condom use, and how cultural practices and religious beliefs play a role in HIV transmission. The findings also indicate the need for involvement of religious leaders in HIV education programs to bring insights to people and help them interpret their religious beliefs in health promoting ways. Future studies that explore different aspects of culture and religion which may contribute to HIV transmission are recommended.	[Fauk, Nelsensius Klau; Ward, Paul Russell; Mwanri, Lillian] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Fauk, Nelsensius Klau] Inst Resource Governance & Social Change, Kupang, Nusa Tenggara T, Indonesia; [Hawke, Karen] South Australian Hlth & Med Res Inst, Infect Dis Aboriginal Hlth, Adelaide, SA, Australia	Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Fauk, NK (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia.; Fauk, NK (corresponding author), Inst Resource Governance & Social Change, Kupang, Nusa Tenggara T, Indonesia.	nelsen_klau@yahoo.com	Fauk, Nelsensius/L-8024-2015; Mwanri, Lillian/AGG-3711-2022	Fauk, Nelsensius/0000-0002-1325-2640; Mwanri, Lillian/0000-0002-5792-7785; Ward, Paul/0000-0002-5559-9714				Ajzen I., 1988, ATTITUDES PERSONALIT; Allsop J., 2013, RES HLTH QUALITATIVE; Bartholomew LK, 2011, PLANNING HLTH PROMOT; Belu Dinkes., 2020, LAPORAN PERKEMBANGAN; Bingenheimer JB, 2015, STUD FAMILY PLANN, V46, P1, DOI 10.1111/j.1728-4465.2015.00012.x; BPS (Indonesia Statistic Government Office), 2021, BANGK REG FIG 2021; BPS Kota Yogyakarta, 2015, SOS DAN KEP; BPS Propinsi DIY, 2020, SOC KEP; Chen QS, 2019, ECLINICALMEDICINE, V16, P121, DOI 10.1016/j.eclinm.2019.10.003; Couture MC, 2008, SEX TRANSM DIS, V35, P849, DOI 10.1097/OLQ.0b013e318177ec5c; Dambach P, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08838-8; Dinkes Propinsi D.I., 2020, DATA KASUS HIV AIDS; Dinkes Propinsi DIY, 2018, LAPORAN TAHUNAN DINA; Efendi F, 2020, AFR HEALTH SCI, V20, P83, DOI 10.4314/ahs.v20i1.13; Emusu D, 2009, AIDS CARE, V21, P1363, DOI 10.1080/09540120902883077; Fauk NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207647; Fauk NK, 2018, AM J MENS HEALTH, V12, P1175, DOI 10.1177/1557988318779737; Fauk NK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178736; Fauk NK, 2015, INT J HUM RIGHTS HEA, V8, P144, DOI 10.1108/IJHRH-10-2014-0028; Fauk NK., 2017, GLOBAL J HLTH SCI, V9, P47; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gilbert SS, 2008, AIDS EDUC PREV, V20, P399, DOI 10.1521/aeap.2008.20.5.399; Halimang St., 2017, J PEMIKIRAN ISLAM, V3, P130; Hassan R, 1995, Plan Parent Chall, P5; Hinanti RE., 2020, E J FATWA HUKUM, V3, P1; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Indonesia BPS., 2021, PEND MEN WIL DAN AG; Isiugo-Abanihe U C, 1994, Health Transit Rev, V4, P111; Januraga PP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-832; Kementerian Kesehatan RI., LAPORAN SITUASI PERK; Kementerian Pendidikan dan Kebudayaan RI, 2019, BAH DAN PET BAH; Koffi AK, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-408; Koniak-Griffin D, 2003, RES NURS HEALTH, V26, P4, DOI 10.1002/nur.10062; MacLachlan E, 2009, AIDS CARE, V21, P355, DOI 10.1080/09540120802184121; Manopaiboon C, 1998, J ACQ IMMUN DEF SYND, V18, P54, DOI 10.1097/00042560-199805010-00009; MCGRATH JW, 1993, AIDS CARE, V5, P55, DOI 10.1080/09540129308258584; McVey R.T., 1963, INDONESIAN CULTURES, P78; Mugweni E, 2012, CULT HEALTH SEX, V14, P577, DOI 10.1080/13691058.2012.671962; Munir Lily Zakiyah, 2002, SOJOURN, V17, P191; Mwanri L, 2018, SEX HEALTH, V15, P246, DOI [10.1071/SH17137, 10.1071/sh17137]; Nguyen NT, 2009, AIDS BEHAV, V13, P881, DOI 10.1007/s10461-008-9463-4; Patel SN, 2014, AIDS BEHAV, V18, P1970, DOI 10.1007/s10461-014-0792-1; Rahmalia Annisa, 2015, BMC Res Notes, V8, P757, DOI 10.1186/s13104-015-1748-x; Regmi K, 2010, INT J QUAL METH, V9, P16, DOI 10.1177/160940691000900103; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Saffier IP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2795-9; Semerdjian E., 2009, OXFORD ENCY ISLAMIC; Sexuality DialmyA., 2010, REPROD HEALTH, V15, P160; Shaw SY, 2013, SEX TRANSM DIS, V40, P482, DOI 10.1097/OLQ.0b013e3182904a9a; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Ssewanyana D, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7375831; Suryawanshi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073470; Thanh DC, 2009, AIDS BEHAV, V13, P1151, DOI 10.1007/s10461-008-9451-8; Thapa S, 2016, WOMEN HEALTH, V56, P745, DOI 10.1080/03630242.2015.1118726; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2020, UNAIDS DAT; UNAIDS, 2019, UNAIDS DAT 2019; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; Van der Kroef JM, 1953, SOC RES, V20, P193; Vatican The., 2012, CATECHISM CATHOLIC C; Volkmann T, 2014, ARCH SEX BEHAV, V43, P719, DOI 10.1007/s10508-013-0149-2; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yang X., 2020, AIDS ED PREVENTION, V22, P69; Yang YR, 2016, J NURS SCHOLARSHIP, V48, P154, DOI 10.1111/jnu.12193	64	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0257906	10.1371/journal.pone.0257906	http://dx.doi.org/10.1371/journal.pone.0257906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780506	gold, Green Published			2022-12-26	WOS:000755305800012
J	Sotiros, A; Thornhill, D; Post, MD; Winn, VD; Armstrong, J				Sotiros, Alexandra; Thornhill, Dianne; Post, Miriam D.; Winn, Virginia D.; Armstrong, Jennifer			Inflammatory cytokines, placental pathology, and neurological outcomes in infants born to preterm preeclamptic mothers	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; FETAL SEX; PREGNANCY; BIRTH; GESTATION; LESIONS; IMPACT	Preeclampsia is both a vascular and inflammatory disorder. Since the placenta is a conduit for fetal development, preeclampsia should be a presumed cause of adverse infant outcomes. Yet, the relationship of placental pathology, inflammation and neurological outcomes after preeclampsia are understudied. We prospectively examined a cohort of maternal-infant dyads with preeclampsia for maternal inflammatory cytokines at time of preeclampsia diagnosis and delivery, and fetal cord blood cytokines (IL-1 beta, IL-6, IL-8, and TNF-alpha). Placentas were analyzed for inflammatory and vascular pathologies. Neurodevelopmental assessment of infants utilizing the Pediatric Stroke Outcome Measure (PSOM) was conducted at 6-month corrected gestational age. Eighty-one maternal-newborn dyads were examined. Worse neurological outcomes were not associated with elevated maternal / fetal cytokines. Early preterm birth (gestational age <= 32 weeks) was associated with worse neurological outcomes at 6-months regardless of maternal/ fetal cytokine levels, placental pathology, or cranial ultrasound findings (OR 1.70, [1.16-2.48], p = 0.006). When correcting for gestational age, elevated IL-6 approached significance as a predictor for worse developmental outcome (OR 1.025 [0.985-1.066], p = 0.221). Pathological evidence of maternal malperfusion and worse outcomes were noted in early preterm, although our sample size was small. Our study did not demonstrate an obvious association of inflammation and placental pathology in preeclampsia and adverse neurodevelopmental outcome at 6-month corrected age but does suggest maternal malperfusion at earlier gestational age may be a risk factor for worse outcome.	[Sotiros, Alexandra] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Thornhill, Dianne; Armstrong, Jennifer] Univ Colorado, Hemophilia & Thrombosis Ctr, Anschutz Med Campus, Boulder, CO 80309 USA; [Post, Miriam D.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO USA; [Winn, Virginia D.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Armstrong, Jennifer] Univ Colorado, Dept Pediat, Sect Neurol, Anschutz Med Campus, Aurora, CO 80309 USA; [Armstrong, Jennifer] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO 80309 USA; [Armstrong, Jennifer] Univ Colorado, Dept Obstet & Gynecol, Div Basic Reprod Sci, Anschutz Med Campus, Aurora, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Armstrong, J (corresponding author), Univ Colorado, Hemophilia & Thrombosis Ctr, Anschutz Med Campus, Boulder, CO 80309 USA.; Armstrong, J (corresponding author), Univ Colorado, Dept Pediat, Sect Neurol, Anschutz Med Campus, Aurora, CO 80309 USA.; Armstrong, J (corresponding author), Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO 80309 USA.; Armstrong, J (corresponding author), Univ Colorado, Dept Obstet & Gynecol, Div Basic Reprod Sci, Anschutz Med Campus, Aurora, CO 80309 USA.	jennifer.armstrong@cuanschutz.edu		Armstrong, Jennifer/0000-0003-3797-3562; Winn, Virginia/0000-0003-1136-2907	NIH BIRCWH [K12 KD HDO57022]; AHA SouthWest Affiliates Clinical Research Grant [10CRP3670014]; Maternal and Child Bureau 340B program [H30MC24049]	NIH BIRCWH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA SouthWest Affiliates Clinical Research Grant; Maternal and Child Bureau 340B program	NIH BIRCWH K12 KD HDO57022 (JA), AHA SouthWest Affiliates Clinical Research Grant 10CRP3670014 (JA), and Maternal and Child Bureau 340B program H30MC24049 (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alijotas-Reig J, 2017, CLIN REV ALLERG IMMU, V53, P40, DOI 10.1007/s12016-016-8596-x; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; Armstrong-Wells J, 2013, J DEV ORIG HLTH DIS, V4, P249, DOI 10.1017/S2040174413000056; Armstrong-Wells J, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.09.016; Backes CH, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/214365; Bekedam DJ, 2002, AM J OBSTET GYNECOL, V187, P1605, DOI 10.1067/mob.2002.127379; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chen JJ, 2017, PROG MOL BIOL TRANSL, V148, P87, DOI 10.1016/bs.pmbts.2017.04.001; Cheng SW, 2004, EARLY HUM DEV, V76, P39, DOI 10.1016/j.earlhumdev.2003.10.004; Cubro H, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0833-7; de Vries LS, 2013, NEURORADIOLOGY, V55, P13, DOI 10.1007/s00234-013-1233-y; Engle WA, 2006, SEMIN PERINATOL, V30, P2, DOI 10.1053/j.semperi.2006.01.007; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Filiano AJ, 2015, BRAIN RES, V1617, P18, DOI 10.1016/j.brainres.2014.07.050; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gumusoglu SB, 2020, TRENDS NEUROSCI, V43, P253, DOI 10.1016/j.tins.2020.02.003; Guney G, 2020, EUR CYTOKINE NETW, V31, P18, DOI 10.1684/ecn.2020.0443; Harmon AC, 2016, CLIN SCI, V130, P409, DOI 10.1042/CS20150702; Ibrahim J, 2018, PEDIATR RES, V84, P799, DOI 10.1038/s41390-018-0194-6; Johnston MV, 2007, DEV MED CHILD NEUROL, V49, P74, DOI 10.1017/S0012162207000199; Jonakait GM, 2007, INT J DEV NEUROSCI, V25, P415, DOI 10.1016/j.ijdevneu.2007.08.017; Jonsson Y, 2006, J REPROD IMMUNOL, V70, P83, DOI 10.1016/j.jri.2005.10.007; Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC; Kitchen L, 2012, STROKE, V43, P1602, DOI 10.1161/STROKEAHA.111.639583; Krasnyi AM, 2018, B EXP BIOL MED+, V164, P721, DOI 10.1007/s10517-018-4066-1; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Maher GM, 2019, INT J DEV NEUROSCI, V77, P69, DOI 10.1016/j.ijdevneu.2018.10.004; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; O'Shea TM, 2013, BRAIN BEHAV IMMUN, V29, P104, DOI 10.1016/j.bbi.2012.12.012; ORVIETO R, 1994, MED HYPOTHESES, V43, P315, DOI 10.1016/0306-9877(94)90109-0; Paulson L TD., 2021, J CHILDHOOD DEV DISO, V7; Pierrat V, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3448; Prins JR, 2018, J REPROD IMMUNOL, V126, P18, DOI 10.1016/j.jri.2018.01.004; Purisch SE, 2017, SEMIN PERINATOL, V41, P387, DOI 10.1053/j.semperi.2017.07.009; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reid SM, 2016, DEV MED CHILD NEUROL, V58, P43, DOI 10.1111/dmcn.13021; Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Schepanski S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02186; Schlapbach LJ, 2010, ACTA PAEDIATR, V99, P1504, DOI 10.1111/j.1651-2227.2010.01861.x; Setanen S, 2016, DEV MED CHILD NEUROL, V58, P721, DOI 10.1111/dmcn.13030; Stevens DU, 2013, PLACENTA, V34, P805, DOI 10.1016/j.placenta.2013.05.008; Sun BZ, 2020, JAMA PSYCHIAT, V77, P823, DOI 10.1001/jamapsychiatry.2020.0306; Taylor BD, 2018, PREGNANCY HYPERTENS, V12, P53, DOI 10.1016/j.preghy.2018.02.009; Than NG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01661; Vinnars MT, 2014, HYPERTENS PREGNANCY, V33, P145, DOI 10.3109/10641955.2013.842584; Weiner E, 2018, PREGNANCY HYPERTENS, V12, P6, DOI 10.1016/j.preghy.2018.02.001; Zeitlin J, 2004, AM J OBSTET GYNECOL, V190, P1322, DOI 10.1016/j.ajog.2003.10.703	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260094	10.1371/journal.pone.0260094	http://dx.doi.org/10.1371/journal.pone.0260094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780565	gold, Green Published			2022-12-26	WOS:000755305800093
J	Davanzo, EFA; Dos Santos, RL; Castro, VHD; Palma, JM; Pribul, BR; Dallago, BSL; Fuga, B; Medeiros, M; De Almeida, SST; Da Costa, HMB; Rodrigues, DD; Lincopan, N; Perecmanis, S; Santana, AP				Agostinho Davanzo, Emilia Fernanda; dos Santos, Rebecca Lavarini; de Lemos Castro, Virgilio Hipolito; Palma, Joana Marchesini; Pribul, Bruno Rocha; Lima Dallago, Bruno Stefano; Fuga, Bruna; Medeiros, Margareti; Titze de Almeida, Simoneide Souza; Boaventura da Costa, Hayanna Maria; Rodrigues, Dalia Dos Prazeres; Lincopan, Nilton; Perecmanis, Simone; Santana, Angela Patricia			Molecular characterization of Salmonella spp. and Listeria monocytogenes strains from biofilms in cattle and poultry slaughterhouses located in the federal District and State of Goias, Brazil	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; PREMATURE STOP CODONS; FOOD-CONTACT SURFACES; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; TRUNCATED INTERNALIN; STAINLESS-STEEL; BEEF; GENES; INLA	Listeria monocytogenes and Salmonella spp. are considered important foodborne pathogens that are commonly associated with foods of animal origin. The aim of this study was to perform molecular characterization of L. monocytogenes and Salmonella spp. isolated from biofilms of cattle and poultry slaughterhouses located in the Federal District and State of Goias, Brazil. Fourteen L. monocytogenes isolates and one Salmonella sp. were detected in poultry slaughterhouses. No isolates were detected in cattle slaughterhouses. All L. monocytogenes isolates belonged to lineage II, and 11 different pulsotypes were detected. Pulsed-field gel electrophoresis analysis revealed the dissemination of two strains within one plant, in addition to the regional dissemination of one of them. The Salmonella isolate was identified via whole genome sequencing as Salmonella enterica serovar Minnesota ST548. In the sequence analysis, no premature stop codons were detected in the inlA gene of Listeria. All isolates demonstrated the ability to adhere to Caco-2 cells, while 50% were capable of invading them. Antimicrobial resistance was detected in 57.1% of the L. monocytogenes isolates, and resistance to sulfonamide was the most common feature. The tetC, ermB, and tetM genes were detected, and four isolates were classified as multidrug-resistant. Salmonella sp. was resistant to nine antimicrobials and was classified as multidrug-resistant. Resistance genes qnrB19, bla(CMY-2), aac(6')-Iaa, sul2, and tetA, and a mutation in the parC gene were detected. The majority (78.5%) of the L. monocytogenes isolates were capable of forming biofilms after incubation at 37 degrees C for 24 h, and 64.3% were capable of forming biofilms after incubation at 12 degrees C for 168 h. There was no statistical difference in the biofilm-forming capacity under the different evaluated conditions. Salmonella sp. was capable of forming biofilms at both tested temperatures. Biofilm characterization was confirmed by collecting the samples consistently, at the same sampling points, and by assessing biofilm formation in vitro. These results highlight the potential risk of cross-contamination in poultry slaughterhouses and the importance of surveillance and pathogen control maintenance programs within the meat production industry.	[Agostinho Davanzo, Emilia Fernanda; dos Santos, Rebecca Lavarini; de Lemos Castro, Virgilio Hipolito; Palma, Joana Marchesini; Lima Dallago, Bruno Stefano; Medeiros, Margareti; Titze de Almeida, Simoneide Souza; Boaventura da Costa, Hayanna Maria; Perecmanis, Simone; Santana, Angela Patricia] Univ Brasilia UnB, Fac Agron & Vet Med, Brasilia, DF, Brazil; [Pribul, Bruno Rocha; Rodrigues, Dalia Dos Prazeres] Oswaldo Cruz Inst, Natl Reference Lab Bacterial Enter Infect, Rio De Janeiro, RJ, Brazil; [Fuga, Bruna; Lincopan, Nilton] Univ Sao Paulo, Biomed Sci Inst, Lab Bacterial Resistance & Therapeut Alternat, Sao Paulo, SP, Brazil	Universidade de Brasilia; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Davanzo, EFA (corresponding author), Univ Brasilia UnB, Fac Agron & Vet Med, Brasilia, DF, Brazil.	emiliadavanzo@unb.br	marchesini palma, joana/AAE-6282-2022; Lincopan, Nilton/C-3818-2012	marchesini palma, joana/0000-0003-4958-2569; Lincopan, Nilton/0000-0003-0161-5800; Lavarini dos Santos, Rebecca/0000-0001-8051-501X; Agostinho Davanzo, Emilia Fernanda/0000-0003-4406-026X; Dallago, Bruno/0000-0003-4883-1076	FAPDF [3/2016]; CAPES, via PROAP; DPG of University of Brasilia	FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CAPES, via PROAP(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); DPG of University of Brasilia	APS was supported by FAPDF (spontaneous demand n.3/2016).EFAD was funded as well by CAPES, via PROAP and DPG of University of Brasilia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2000, VET MICROBIOL, V74, P353, DOI 10.1016/S0378-1135(00)00197-8; Agencia Nacional de Vigilancia Sanitaria, 2004, PROGR NAC MON PREV R; Alvarez J, 2004, J CLIN MICROBIOL, V42, P1734, DOI 10.1128/JCM.42.4.1734-1738.2004; [Anonymous], 2002, 65792002 ISO, P27; AO of the UN WHO WHO FAO F, 2007, FAO AGR CONSUM PROT, V63, P68; Barros MAF, 2007, MEAT SCI, V76, P591, DOI 10.1016/j.meatsci.2007.01.016; Berrang ME, 2010, J FOOD PROTECT, V73, P286, DOI 10.4315/0362-028X-73.2.286; Berrang ME, 2005, J FOOD PROTECT, V68, P980, DOI 10.4315/0362-028X-68.5.980; Berrang ME, 2002, J FOOD PROTECT, V65, P1574, DOI 10.4315/0362-028X-65.10.1574; Bertrand S, 2005, J MED MICROBIOL, V54, P1151, DOI 10.1099/jmm.0.46142-0; Borges KA, 2018, PESQUI VET BRASIL, V38, P71, DOI 10.1590/1678-5150-pvb-4928; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Camargo AC, 2019, ENVIRON MICROBIOL, V21, P4478, DOI 10.1111/1462-2920.14726; Camargo AC, 2015, MICROB DRUG RESIST, V21, P458, DOI 10.1089/mdr.2014.0270; Camargo AC, 2015, FOODBORNE PATHOG DIS, V12, P323, DOI 10.1089/fpd.2014.1875; Moraes Dunya Mara Cardoso, 2014, Arq. Inst. Biol., V81, P195, DOI 10.1590/1808-1657001092012; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Carrascosa C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18042014; CDC (Centers for Disease Control and Prevention), 2017, PNL06; Charpentier E, 1999, ANTIMICROB AGENTS CH, V43, P2103, DOI 10.1128/AAC.43.9.2103; Chen BY, 2010, LETT APPL MICROBIOL, V50, P626, DOI 10.1111/j.1472-765X.2010.02843.x; Chiarini E, 2009, POULTRY SCI, V88, P791, DOI 10.3382/ps.2008-00396; Clinical and Laboratory Standards Institute,, 2020, PERFORMANCE STANDARD; Craig AM, 2019, OBSTET GYNECOL SURV, V74, P362, DOI 10.1097/OGX.0000000000000683; D'Agostino M, 2004, J FOOD PROTECT, V67, P1646, DOI 10.4315/0362-028X-67.8.1646; da Cunha-Neto A, 2018, POULTRY SCI, V97, P1373, DOI 10.3382/ps/pex406; da Silva MF, 2017, FOOD MICROBIOL, V63, P6, DOI 10.1016/j.fm.2016.10.033; Dantas STA, 2020, FOOD RES INT, V129, DOI 10.1016/j.foodres.2019.108835; Datta AR, 2018, FOOD MICROBIOL, V75, P18, DOI 10.1016/j.fm.2017.06.013; Davis MA, 2011, APPL ENVIRON MICROB, V77, P3293, DOI 10.1128/AEM.02588-10; de Freitas CG, 2010, INT J FOOD MICROBIOL, V139, P15, DOI 10.1016/j.ijfoodmicro.2010.02.007; Di Bonaventura G, 2008, J APPL MICROBIOL, V104, P1552, DOI 10.1111/j.1365-2672.2007.03688.x; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Escolar C, 2017, FOODBORNE PATHOG DIS, V14, P357, DOI 10.1089/fpd.2016.2248; EUCAST,, 2019, BREAKPOINT TABLES IN; European Food Safety Author, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3196; Ferrari RG, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00591-19; Ferreira V, 2014, J FOOD PROTECT, V77, P150, DOI 10.4315/0362-028X.JFP-13-150; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Harvey J, 2007, FOOD MICROBIOL, V24, P380, DOI 10.1016/j.fm.2006.06.006; Haubert L, 2016, LETT APPL MICROBIOL, V62, P23, DOI 10.1111/lam.12516; Vitas AI, 2007, J FOOD PROTECT, V70, P2402, DOI 10.4315/0362-028X-70.10.2402; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jeon HY, 2019, POULTRY SCI, V98, P1766, DOI 10.3382/ps/pey514; Joseph B, 2001, INT J FOOD MICROBIOL, V64, P367, DOI 10.1016/S0168-1605(00)00466-9; Kasnowski MC., 2010, REV CIENTIFICA ELETR, VVIII; Kerouanton A, 2010, J MICROBIOL METH, V80, P134, DOI 10.1016/j.mimet.2009.11.008; Larsen MH, 2014, FOOD CONTROL, V44, P92, DOI 10.1016/j.foodcont.2014.03.039; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Loura CAC, 2005, J FOOD SAFETY, V25, P19, DOI 10.1111/j.0149-6085.2005.25551.x; Lunden JM, 2000, J FOOD PROTECT, V63, P1204, DOI 10.4315/0362-028X-63.9.1204; Luque-Sastre L, 2018, ANTIMICROBIAL RESISTANCE IN BACTERIA FROM LIVESTOCK AND COMPANION ANIMALS, P237, DOI 10.1128/9781555819804.ch11; Ma YB, 2018, INT J FOOD MICROBIOL, V286, P190, DOI 10.1016/j.ijfoodmicro.2018.09.022; Magalhaes R, 2017, ACTA ALIMENT HUNG, V46, P43, DOI 10.1556/066.2017.46.1.6; Magalhaes Vanda D., 2005, Revista do Instituto Adolfo Lutz, V64, P155; Manuel CS, 2015, APPL ENVIRON MICROB, V81, P8339, DOI 10.1128/AEM.02752-15; Maung AT, 2019, INT J FOOD MICROBIOL, V304, P49, DOI 10.1016/j.ijfoodmicro.2019.05.016; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; McEwen SA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0009-2017; Medeiros M, 2021, FOODBORNE PATHOG DIS, V18, P243, DOI 10.1089/fpd.2020.2855; Ministerio da Agricultura Pecuaria e Abastecimento, 2003, INSTR NORM 13; Ministerio da Agricultura Pecuaria e Abastecimento Secretaria de Defesa Agropecuaria, 2016, INSTR NORM 13; Monte DF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45838-0; Moreira G do N., 2008, REV INST ADOLFO LUTZ, P126; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Moretro T, 2017, COMPR REV FOOD SCI F, V16, P1022, DOI 10.1111/1541-4337.12283; Moroni O, 2006, APPL ENVIRON MICROB, V72, P6894, DOI 10.1128/AEM.00928-06; Morvan A, 2010, ANTIMICROB AGENTS CH, V54, P2728, DOI 10.1128/AAC.01557-09; Nicolau AI, 2014, METHODS MOL BIOL, V1157, P3, DOI 10.1007/978-1-4939-0703-8_1; Nightingale KK, 2008, APPL ENVIRON MICROB, V74, P6570, DOI 10.1128/AEM.00997-08; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Olier M, 2005, INFECT IMMUN, V73, P644, DOI 10.1128/IAI.73.1.644-648.2005; Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Palma JM, 2016, PESQUI VET BRASIL, V36, P957, DOI 10.1590/s0100-736x2016001000007; PAMvet-PR, 2005, LEV US COM MED VET F; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Phelps CC, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00555-18; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Poyart C, 1996, MICROBIOL-SGM, V142, P173, DOI 10.1099/13500872-142-1-173; Quereda JJ, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.08.022; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodrigues Cesar Alessandra Paro, 2011, Ciencia Animal Brasileira, V12, P339, DOI 10.5216/cab.v12i2.7452; Rodrigues LB, 2010, BRAZ J MICROBIOL, V41, P1082, DOI 10.1590/S1517-838220100004000029.; Ryser ET., 2015, COMPENDIUM METHODS M, V5th; Schafer DF, 2017, LWT-FOOD SCI TECHNOL, V86, P393, DOI 10.1016/j.lwt.2017.08.024; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; Sereno MJ, 2019, FOOD MICROBIOL, V84, DOI 10.1016/j.fm.2019.05.018; Sinde E, 2000, FOOD MICROBIOL, V17, P439, DOI 10.1006/fmic.2000.0339; Srinivasan V, 2005, FOODBORNE PATHOG DIS, V2, P201, DOI 10.1089/fpd.2005.2.201; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P2562, DOI 10.1128/AAC.40.11.2562; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Teixeira LAC, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010018; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; Vestby LK, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-20; Vilela FP, 2019, MICROB DRUG RESIST, V25, P143, DOI 10.1089/mdr.2017.0329; Vinueza-Burgos C, 2019, INT J FOOD MICROBIOL, V299, P1, DOI 10.1016/j.ijfoodmicro.2019.03.014; Voss-Rech D, 2017, FOODBORNE PATHOG DIS, V14, P116, DOI 10.1089/fpd.2016.2228; Wang YG, 2019, FOODBORNE PATHOG DIS, V16, P604, DOI 10.1089/fpd.2018.2611; Ward TJ, 2010, J FOOD PROTECT, V73, P861, DOI 10.4315/0362-028X-73.5.861; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; WHO OIE FAO, 2017, EARLY IMPLEMENTATION; Wick RR, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005595; Wiedmann M, 2002, J AOAC INT, V85, P524; World Health Organization, 2019, MODEL LIST ESSENTIAL; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Yamatogi RS, 2015, J INFECT DEV COUNTR, V9, P1161, DOI 10.3855/jidc.5634; Yin BR, 2018, FOODBORNE PATHOG DIS, V15, P660, DOI 10.1089/fpd.2018.2466; Zhang SK, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01746-19; Zhang YF, 2007, INT J FOOD MICROBIOL, V113, P47, DOI 10.1016/j.ijfoodmicro.2006.07.010; Zhu YT, 2017, INT J FOOD MICROBIOL, V259, P43, DOI 10.1016/j.ijfoodmicro.2017.07.023	119	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259687	10.1371/journal.pone.0259687	http://dx.doi.org/10.1371/journal.pone.0259687			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767604	Green Published, gold			2022-12-26	WOS:000755249300040
J	Cao, D; Zhang, XL; Liu, MJ; Yang, QG; Gu, SH; Gao, TJ; Cong, L; Ma, DH; Lin, HJ; Chen, ST				Cao, Di; Zhang, Xiaolin; Liu, Mingjun; Yang, Qiguang; Gu, Shuhong; Gao, Tianjiao; Cong, Lin; Ma, Dehui; Lin, Hongju; Chen, Shaotao			Efficacy and safety of manual acupuncture for the treatment of upper limb motor dysfunction after stroke: Protocol for a systematic review and meta-analysis	PLOS ONE			English	Review							INTERRATER RELIABILITY; THERAPY; RECOVERY	Introduction The incidence of stroke sequelae among patients is as high as 70%-80%. Flexor spasm is the most common stroke sequela, presenting a heavy burden to the patients and their families. This study will evaluate the results of randomized controlled trials to determine the efficacy and safety of hand manipulation acupuncture for the treatment of upper limb motor dysfunction after stroke. Methods Eight databases, including China National Knowledge Infrastructure, Chinese Scientific Journal Database, Cochrane Central Register of Controlled Trials, Embase, MEDLINE, PubMed, Wanfang Database, and Web of Science, will be searched using English and Chinese search strategies. In addition, manual retrieval of research papers, conference papers, ongoing experiments, and internal reports, among others, will supplement electronic retrieval. All eligible studies published on or before January 15, 2021 will be selected. To enhance the effectiveness of the study, only clinical randomized controlled trials related to the use of manual acupuncture for the treatment of upper limb motor dysfunction after stroke will be included. Analysis The Fugl-Meyer upper extremity assessment will be the primary outcome measure, whereas the Wolf Motor Function Test, Modified Ashworth Scale, arm movement survey test table, and upper extremity freehand muscle strength assessment scores will be the secondary outcomes. Side effects and adverse events will be included as safety evaluations. To ensure the quality of the systematic evaluation, study selection, data extraction, and quality assessment will be independently performed by two authors, and a third author will resolve any disagreement. Ethics and dissemination This systematic review will evaluate the efficacy and safety of manual acupuncture for the treatment of upper limb motor dysfunction after stroke. Since all included data will be obtained from published articles, it does not require ethical approval and will be published in a peer-reviewed journal.	[Cao, Di; Yang, Qiguang; Gu, Shuhong; Lin, Hongju] Changchun Univ Chinese Med, Affiliated Hosp 2, Changchun Hosp Chinese Med, Dept Rehabil, Changchun, Peoples R China; [Zhang, Xiaolin; Liu, Mingjun; Gao, Tianjiao; Cong, Lin; Ma, Dehui; Chen, Shaotao] Changchun Univ Chinese Med, Changchun, Peoples R China; [Liu, Mingjun; Chen, Shaotao] Changchun Univ Chinese Med, Affiliated Hosp 3, Acupuncture & Massage Ctr, Changchun, Peoples R China	Changchun University of Chinese Medicine; Changchun University of Chinese Medicine; Changchun University of Chinese Medicine	Chen, ST (corresponding author), Changchun Univ Chinese Med, Changchun, Peoples R China.; Chen, ST (corresponding author), Changchun Univ Chinese Med, Affiliated Hosp 3, Acupuncture & Massage Ctr, Changchun, Peoples R China.	Shaochen3600@163.com			School construction project of National Administration of traditional Chinese medicine [LPGZS22014-11]; Jilin Local Standard Construction Project [DBXM097-2020]; State Administration of Traditional Chinese Medicine of Jilin Province [zybz-zc2020-004]	School construction project of National Administration of traditional Chinese medicine; Jilin Local Standard Construction Project; State Administration of Traditional Chinese Medicine of Jilin Province	This work was supported by the School construction project of National Administration of traditional Chinese medicine (Grant Number LPGZS22014-11, http://www.satcm.gov.cn/renjiaosi/zhengcewenjian/2018-03-24/1840.html), The Jilin Local Standard Construction Project (Grant Number: DBXM097-2020, http://scjg.jl.gov.cn/zw/gsgg/202105/t20210526_8082979.html) and the State Administration of Traditional Chinese Medicine of Jilin Province(Grant Number: zybz-zc2020-004, http://jltcm.jl.gov.cn/tzgg/xgdt/202107/t20210706_8130847.html).	Bleyenheuft Y, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00459; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bovolenta F, 2009, J REHABIL MED, V41, P971, DOI 10.2340/16501977-0402; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Cerebrovascular Disease Group Neurology Branch Chinese Medical Association, 2018, CHINESE J NEUROLOGY, V51, P666; Chavez LM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112270; Dawson J, 2020, NEUROREHAB NEURAL RE, V34, P609, DOI 10.1177/1545968320924361; Desheng Han, 2020, J CLIN ACUPUNCTURE, V36, P25; Evans J, 2019, EYE, V33, P882, DOI 10.1038/s41433-019-0357-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hua Zhang, 2001, CHINA REHABILITATION, V16, P171; Huang CY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004508; Invernizzi M, 2013, EUR J PHYS REHAB MED, V49, P311; Jia J., 2015, GERIATRICS HLTH CARE, V21, P129; Jiang T, 2015, J CHANGCHUN U CHINES; Langer G, 2013, Z EVIDENZ FORTBILD Q, V107, P646, DOI 10.1016/j.zefq.2013.10.034; Lim SM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/7324857; Marigold DS, 2005, J AM GERIATR SOC, V53, P416, DOI 10.1111/j.1532-5415.2005.53158.x; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Monge-Pereira E, 2017, PM&R, V9, P918, DOI 10.1016/j.pmrj.2017.04.016; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nordin A, 2014, J REHABIL MED, V46, P738, DOI 10.2340/16501977-1831; Page SJ, 2012, ARCH PHYS MED REHAB, V93, P2373, DOI 10.1016/j.apmr.2012.06.017; Raghavan P, 2015, PHYS MED REH CLIN N, V26, P599, DOI 10.1016/j.pmr.2015.06.008; Sabini RC, 2013, J HAND THER, V26, P124, DOI 10.1016/j.jht.2012.08.002; Sale P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-104; Schaechter JD, 2007, J ALTERN COMPLEM MED, V13, P527, DOI 10.1089/acm.2007.6316; Sheng Bi, 2006, CHINESE J REHABILITA, V21, P1084; Singer Barbara, 2017, J Physiother, V63, P53, DOI 10.1016/j.jphys.2016.08.010; Su Zheng, 2018, J ACUPUNCTURE MOXIBU, V34, P24; Sullivan KJ, 2011, STROKE, V42, P427, DOI 10.1161/STROKEAHA.110.592766; Veerbeek JM, 2017, NEUROREHAB NEURAL RE, V31, P107, DOI 10.1177/1545968316666957; Wu HM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004131.pub2; Xiaofen Li, 2017, SHANXI MED J, V46, P2740; Xiaowei Sun, 2019, J CLIN ACUPUNCTURE, V35, P58; Xu Y, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2585-8; Xueping Yu, 2019, J CLIN ACUPUNCTURE, V35, P61; Zheng MX, 2018, NEW ENGL J MED, V378, P22, DOI 10.1056/NEJMoa1615208	38	1	1	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258921	10.1371/journal.pone.0258921	http://dx.doi.org/10.1371/journal.pone.0258921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767554	gold, Green Published			2022-12-26	WOS:000755249300016
J	Sugihara, J; Shibata, S; Doi, M; Shimmura, T; Inoue, S; Matsumoto, O; Suzuki, H; Makino, A; Miyazaki, Y				Sugihara, Jun; Shibata, Sho; Doi, Masafumi; Shimmura, Takuya; Inoue, Shinichiro; Matsumoto, Osamu; Suzuki, Hiroyuki; Makino, Ayaka; Miyazaki, Yasunari			Atypical lymphocytes in the peripheral blood of COVID-19 patients: A prognostic factor for the clinical course of COVID-19	PLOS ONE			English	Article							DIAGNOSIS	Background Clinical observations have shown that there is a relationship between coronavirus disease 2019 (COVID-19) and atypical lymphocytes in the peripheral blood; however, knowledge about the time course of the changes in atypical lymphocytes and the association with the clinical course of COVID-19 is limited. Objective Our purposes were to investigate the dynamics of atypical lymphocytes in COVID-19 patients and to estimate their clinical significance for diagnosis and monitoring disease course. Materials and methods We retrospectively identified 98 inpatients in a general ward at Kashiwa Municipal Hospital from May 1st, 2020, to October 31st, 2020. We extracted data on patient demographics, symptoms, comorbidities, blood test results, radiographic findings, treatment after admission and clinical course. We compared clinical findings between patients with and without atypical lymphocytes, investigated the behavior of atypical lymphocytes throughout the clinical course of COVID-19, and determined the relationships among the development of pneumonia, the use of supplemental oxygen and the presence of atypical lymphocytes. Results Patients with atypical lymphocytes had a significantly higher prevalence of pneumonia (80.4% vs. 42.6%, p < 0.0001) and the use of supplemental oxygen (25.5% vs. 4.3%, p = 0.0042). The median time to the appearance of atypical lymphocytes after disease onset was eight days, and atypical lymphocytes were observed in 16/98 (16.3%) patients at the first visit. Atypical lymphocytes appeared after the confirmation of lung infiltrates in 31/41 (75.6%) patients. Of the 13 oxygen-treated patients with atypical lymphocytes, approximately two-thirds had a stable or improved clinical course after the appearance of atypical lymphocytes. Conclusion Atypical lymphocytes frequently appeared in the peripheral blood of COVID-19 patients one week after disease onset. Patients with atypical lymphocytes were more likely to have pneumonia and to need supplemental oxygen; however, two-thirds of them showed clinical improvement after the appearance of atypical lymphocytes.	[Sugihara, Jun; Shibata, Sho; Doi, Masafumi; Shimmura, Takuya; Inoue, Shinichiro] Kashiwa Municipal Hosp, Dept Resp Med, Kashiwa, Chiba, Japan; [Sugihara, Jun; Shibata, Sho; Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Matsumoto, Osamu; Suzuki, Hiroyuki; Makino, Ayaka] Kashiwa Municipal Hosp, Clin Lab, Kashiwa, Chiba, Japan	Tokyo Medical & Dental University (TMDU)	Sugihara, J (corresponding author), Kashiwa Municipal Hosp, Dept Resp Med, Kashiwa, Chiba, Japan.; Sugihara, J (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	sugihara.pulm@tmd.ac.jp		Sugihara, Jun/0000-0002-9372-9671				Chng J, 2005, CLIN LAB HAEMATOL, V27, P15, DOI 10.1111/j.1365-2257.2004.00652.x; Chong VCL, 2020, BRIT J HAEMATOL, V189, P844, DOI 10.1111/bjh.16690; Cunha BA, 2016, EUR J CLIN MICROBIOL, V35, P1399, DOI 10.1007/s10096-016-2675-z; Dong Jinhui, 2021, NAT MICROBIOL, V6, P1233, DOI [10.1038/s41564-021-00972-2, DOI 10.1038/S41564-021-00972-2, DOI 10.1038/S41564-021-00961-5]; El Jamal SM, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153063; Fauci AS., 2008, HARRISONS PRINCIPLES, V17th; Gelarden I, 2021, HUM PATHOL, V113, P92, DOI 10.1016/j.humpath.2021.04.010; He RY, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104361; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Merino A, 2022, J CLIN PATHOL, V75, P104, DOI 10.1136/jclinpath-2020-207087; Nakanishi H, 2020, TOHOKU J EXP MED, V252, P109, DOI 10.1620/tjem.252.109; Pozdnyakova O, 2021, AM J CLIN PATHOL, V155, P364, DOI [10.1093/ajcp/aqaa231, 10.1093/AJCP/AQAA231]; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Weinberg SE, 2020, BRIT J HAEMATOL, V190, P36, DOI 10.1111/bjh.16848	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259910	10.1371/journal.pone.0259910	http://dx.doi.org/10.1371/journal.pone.0259910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767614	Green Published, gold			2022-12-26	WOS:000755249300055
J	Sulman, S; Shahid, S; Khaliq, A; Ambreen, A; Khan, IH; Cooper, AM; Akhtar, MW				Sulman, Sadaf; Shahid, Saher; Khaliq, Aasia; Ambreen, Atiqa; Khan, Imran H.; Cooper, Andrea M.; Akhtar, Muhammad Waheed			Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis	PLOS ONE			English	Article							ANTIGENS; IMMUNOGENICITY; REGIONS; IMMUNE	Serodiagnosis of tuberculosis (TB) can be rapid, reliable and cost-effective if the issue of variable antibody responses of TB patients against different Mycobacterium tuberculosis (Mtb) antigens can be overcome by developing fusion proteins containing epitopes from multiple antigens of Mtb. In this study, Mtb antigens Rv1793, Rv2628, Rv2608 and a truncated variant produced by removing non-epitopic region from N-terminal of Rv2608 (tnRv2608), and the fusion protein Rv1793-Rv2628-tnRv2608 (TriFu64), were expressed in E. coli and purified. Plasma samples from TB patients characterized by sex, age and sputum/culture positivity, were used to compare the sensitivity of the single antigens with the fusion protein. Sensitivity of Rv1793, Rv2628 and Rv2608, was 27.8%, 39% and 36.3%, respectively. Truncation of Rv2608 increased sensitivity by approximately 35% in confirmed TB cases. Sensitivity of the fusion construct, TriFu64 increased to 66% with a specificity of 100%. Importantly, tnRv2608 was better able to detect sputum and culture negative patients, and this carried through to the fusion protein. We demonstrate that fusion of Mtb proteins ensures broad sensitivity across disease types, sex and age groups in a Pakistani population.	[Sulman, Sadaf; Shahid, Saher; Akhtar, Muhammad Waheed] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Khaliq, Aasia] Armed Forces Inst Pathol, Rawalpindi, Pakistan; [Ambreen, Atiqa] Gulab Devi Hosp, Dept Microbiol, Lahore, Pakistan; [Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Cooper, Andrea M.] Univ Leicester, Dept Resp Sci, Leicester, Leics, England	University of Punjab; University of California System; University of California Davis; University of Leicester	Akhtar, MW (corresponding author), Univ Punjab, Sch Biol Sci, Lahore, Pakistan.	mwa.sbs@pu.edu.pk	Khan, imran/GQQ-2176-2022; Khan, Imran Ali/GVT-0232-2022; Nadeem, Muhammad Shahid/H-2372-2017	Khan, Imran Ali/0000-0002-8774-2896; Nadeem, Muhammad Shahid/0000-0003-4112-0925; Khaliq, Aasia/0000-0003-1833-0940	Pakistan Academy of Sciences [59/PAS/1269]; Medical Research Council [MR/PO11136/1]; Common Wealth Commission Split-site Scholarship [PKCN-2017-158]	Pakistan Academy of Sciences; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Common Wealth Commission Split-site Scholarship	1) MWA Grant No. 59/PAS/1269 Pakistan Academy of Sciences No role 2)AMC MR/PO11136/1 Medical Research Council No role 3)SS PKCN-2017-158 Common Wealth Commission Split-site Scholarship No role.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Afzal M, 2015, J MICROBIOL METH, V115, P104, DOI 10.1016/j.mimet.2015.06.003; Akhter M, 2020, TUBERCULOSIS, V124, DOI 10.1016/j.tube.2020.101981; Alderson MR, 2000, J EXP MED, V191, P551, DOI 10.1084/jem.191.3.551; Arif S, 2021, TUBERCULOSIS, V127, DOI 10.1016/j.tube.2021.102053; Bai XJ, 2016, COMP IMMUNOL MICROB, V44, P8, DOI 10.1016/j.cimid.2015.11.002; Chakhaiyar P, 2004, J INFECT DIS, V190, P1237, DOI 10.1086/423938; Chavez K, 2016, TUBERCULOSIS, V99, P17, DOI 10.1016/j.tube.2016.03.009; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Goletti D, 2010, EUR RESPIR J, V36, P135, DOI 10.1183/09031936.00140009; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Jaganath D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234130; Janson G, 2017, BIOINFORMATICS, V33, P444, DOI 10.1093/bioinformatics/btw638; Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Khalid R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163349; Khaliq A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173359; Khurshid S, 2013, TUBERCULOSIS, V93, P654, DOI 10.1016/j.tube.2013.07.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu Y, 2012, SCAND J IMMUNOL, V76, P271, DOI 10.1111/j.1365-3083.2012.02726.x; MacLean E, 2019, NAT MICROBIOL, V4, P748, DOI 10.1038/s41564-019-0380-2; Peng C, 2012, HUM VACC IMMUNOTHER, V8, P435, DOI 10.4161/hv.18861; Penn-Nicholson A, 2018, LANCET RESP MED, V6, P287, DOI [10.1016/S2213-2600(18)30077-8, 10.1016/s2213-2600(18)30077-8]; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; ROELSGAARD E, 1957, Bull World Health Organ, V17, P187; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Vipond J, 2006, VACCINE, V24, P6340, DOI 10.1016/j.vaccine.2006.05.025; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; WHO, HIGH PRIOR TARG PROC; WHO, 2020, GLOB TB REP; Yan ZH, 2018, INT J TUBERC LUNG D, V22, P959, DOI 10.5588/ijtld.18.0060; Yoshiyama T, 2010, INT J TUBERC LUNG D, V14, P819; Zhang SL, 2009, TUBERCULOSIS, V89, P278, DOI 10.1016/j.tube.2009.05.005	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258389	10.1371/journal.pone.0258389	http://dx.doi.org/10.1371/journal.pone.0258389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767571	gold, Green Published			2022-12-26	WOS:000755249300008
J	Negishi, K; Ayaki, M				Negishi, Kazuno; Ayaki, Masahiko			Presbyopia developed earlier during the COVID-19 pandemic	PLOS ONE			English	Article							UNITED-STATES; EYE; MANIFESTATIONS	Purpose The aim of this cohort study was to evaluate the development and progression of presbyopia and the status of dry eye-related symptoms from 2017 to 2020, to assess the impact of the COVID-19 pandemic. Methods Near add power at 30 cm was measured in 339 participants aged between 40 and 55 from 2017 to 2021 at Japanese eye clinics. Regression analysis of near add power and age was analyzed to compare 2017 with later years up to the pandemic. The prevalence of dry eye-related signs and six common symptoms were compared. Results The number and mean age (y) of participants were 183 (48.6 +/- 4.1) in 2017, 46 (51.3 +/- 7.5) in 2019, and 110 (49.2 +/- 3.7) in 2020-21, respectively. The mean progression rate of near add power (D/y) was 0.13 for 2017, 0.09 for 2019 (P = 0.028, vs 2017), and 0.08 for 2020-21 (P<0.001, vs 2017). The slope (rate of presbyopia progression) became flatter from 2017 to 2021 and the estimated near add power at the age of 40 increased from 2017 to 2020-2021, implicating presbyopia developed earlier and worsened during the study period. The 2017 values were comparable with previous studies described in 1922 and 2019. The standardized correlation coefficient between age and near add power was 0.816 for 2017, 0.671 for 2019 (P = 0.084, vs 2017), and 0.572 for 2020-21 (P<0.001, vs 2017). Multiple regression analysis revealed age and COVID-19 pandemic were significantly correlated with near add power. The prevalence of dryness irritation, and pain was greater in 2020-21 than in 2017 with no difference in the prevalence of eye fatigue, blurring, and photophobia. There was no difference in the prevalence of short tear break-up time and positive corneal staining among 2017, 2019 and 2020-21. Conclusion Estimated presbyopia developed earlier and progressed slower from 2017 to 2021, the COVID-19 pandemic. Stress and rapid digitalization related to strict infection control and quarantine might be contributing factors.	[Negishi, Kazuno; Ayaki, Masahiko] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Ayaki, Masahiko] Otake Clin Moon View Eye Ctr, Yamato, Kanagawa, Japan	Keio University	Negishi, K; Ayaki, M (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.; Ayaki, M (corresponding author), Otake Clin Moon View Eye Ctr, Yamato, Kanagawa, Japan.	kazunonegishi@keio.jp; mayaki@olive.ocn.ne.jp						Ahuja S., 2020, WORLD SOC PSYCHIAT, V2, P171, DOI [DOI 10.4103/WSP.WSP_21_20, 10.4103/WSP.WSP_21_20]; Alabdulkader B, 2021, CLIN EXP OPTOM, V104, P698, DOI 10.1080/08164622.2021.1878843; Applegate RA, 2007, J OPT SOC AM A, V24, P578, DOI 10.1364/JOSAA.24.000578; Ayaki M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211631; Bahkir FA, 2020, INDIAN J OPHTHALMOL, V68, P2378, DOI 10.4103/ijo.IJO_2306_20; Boccardo L, 2022, CONTACT LENS ANTERIO, V45, DOI 10.1016/j.clae.2021.01.003; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; Feng YL, 2021, CLIN OPHTHALMOL, V15, P1551, DOI 10.2147/OPTH.S301040; Fukuyama M, 1999, OPHTHALMOLOGY, V106, P1178, DOI 10.1016/S0161-6420(99)90259-2; Galor A, 2012, AM J OPHTHALMOL, V154, P340, DOI 10.1016/j.ajo.2012.02.009; Gammoh Y, 2021, CUREUS, V13, DOI 10.7759/cureus.13575; Ganne P, 2021, OPHTHAL EPIDEMIOL, V28, P285, DOI 10.1080/09286586.2020.1862243; Grueschow M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22509-1; Hanyuda A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8040077; Hanyuda A, 2020, OCUL SURF, V18, P56, DOI 10.1016/j.jtos.2019.09.007; Hickenbotham A, 2012, INVEST OPHTH VIS SCI, V53, P3215, DOI 10.1167/iovs.12-9791; Krystal JH, 2020, NAT MED, V26, P639, DOI 10.1038/s41591-020-0878-4; Kubota M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082678; Liang CY, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01395-z; Lida Y, 2008, J REFRACT SURG, V24, P696, DOI 10.3928/1081597X-20080901-09; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P2555, DOI 10.1001/jama.2020.21231; Mohan A, 2021, INDIAN J OPHTHALMOL, V69, P140, DOI 10.4103/ijo.IJO_2535_20; Negishi K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250087; Nirmalan PK, 2006, INVEST OPHTH VIS SCI, V47, P2324, DOI 10.1167/iovs.05-1192; Rabbetts RB., 1998, ACCOMMODATION NEAR V, P114; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Sheppard AL, 2018, BMJ OPEN OPHTHALMOL, V3, DOI 10.1136/bmjophth-2018-000146; Tawonkasiwattanakun P, 2021, PUBLIC HEALTH, V197, pE26, DOI 10.1016/j.puhe.2021.02.028; Tisdale AK, 2020, CURR OPIN OPHTHALMOL, V31, P489, DOI 10.1097/ICU.0000000000000707; Tsuneyoshi Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07208-6; Tutar NK, 2021, INDIAN J OPHTHALMOL, V69, P773, DOI 10.4103/ijo.IJO_3589_20; Wang JX, 2021, JAMA OPHTHALMOL, V139, P293, DOI 10.1001/jamaophthalmol.2020.6239; Weale RA, 2003, SURV OPHTHALMOL, V48, P515, DOI 10.1016/S0039-6257(03)00086-9; Wu P, 2020, JAMA OPHTHALMOL, V138, P575, DOI 10.1001/jamaophthalmol.2020.1291; Yokoi N, 2017, AM J OPHTHALMOL, V180, P72, DOI 10.1016/j.ajo.2017.05.022; Zhong B, 2020, J MED INTERNET RES, V22, DOI 10.2196/23696	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259142	10.1371/journal.pone.0259142	http://dx.doi.org/10.1371/journal.pone.0259142			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762654	gold, Green Published			2022-12-26	WOS:000755316600014
J	Pawlow, X; Ott, R; Winkler, C; Ziegler, AG; Hummel, S				Pawlow, Xenia; Ott, Raffael; Winkler, Christiane; Ziegler, Anette-G; Hummel, Sandra			A new mathematical approach to improve the original dietary inflammatory index (DII) calculation	PLOS ONE			English	Article							FATTY-ACIDS; RISK; MORTALITY; CHILDREN	Accumulating evidence links dietary intake to inflammatory processes involved in non-communicable disease (NCD) development. The dietary inflammatory index (DII) designed by Shivappa et al. has been shown to capture the inflammatory potential of dietary behavior in a large number of epidemiological studies. Thus, the DII may serve as future tool to assess someone's nutritional inflammatory capacities and hence, the individual risks for NCD development later in life. The calculation method of the DII, however, can benefit from alternative mathematical steps, particularly regarding the transformation from standardized daily food consumption to percentile scores. Here, we provide novel approaches, the scaling-formula (SF) and scaling-formula with outlier detection (SFOD) methods, with the aim to optimize the DII calculation method proposed by Shivappa and colleagues. We illustrate on simulated data specific limitations of the original DII calculation and show the benefits of the SF/SFOD by using simulated data and data from the prospective TEENDIAB study cohort, which supports the application of SF/SFOD in future epidemiological and clinical studies.	[Pawlow, Xenia; Ott, Raffael; Winkler, Christiane; Ziegler, Anette-G; Hummel, Sandra] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Diabet Res, Neuherberg, Germany; [Pawlow, Xenia; Ott, Raffael; Winkler, Christiane; Ziegler, Anette-G; Hummel, Sandra] Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Neuherberg, Germany; [Pawlow, Xenia; Ott, Raffael; Winkler, Christiane; Ziegler, Anette-G; Hummel, Sandra] Forschergrp Diabet eV, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Ott, R (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Diabet Res, Neuherberg, Germany.; Ott, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Forschergrp Diabet, Neuherberg, Germany.; Ott, R (corresponding author), Forschergrp Diabet eV, Neuherberg, Germany.	raffael.ott@helmholtz-muenchen.de		Ott, Raffael/0000-0002-5178-1033	H2020 Joint Programming Initiative a Healthy Diet for a Healthy Life (JPI HDHL) [655]; Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research [FKZ 01GI0805]; Diabetes Hilfs-und Forschungsfond Deutschland (DHFD)	H2020 Joint Programming Initiative a Healthy Diet for a Healthy Life (JPI HDHL); Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) - Federal Ministry of Education and Research; Diabetes Hilfs-und Forschungsfond Deutschland (DHFD)	XP, RO and SH were supported by the H2020 Joint Programming Initiative a Healthy Diet for a Healthy Life (JPI HDHL) under proposal number 655 (PREcisE Project). https://www.healthydietforhealthylife.eu/The TEENDIAB study was supported by Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI0805), and by the `Diabetes Hilfs-und Forschungsfond Deutschland (DHFD)'. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman Ahmed Abdulahi, 2020, Human Antibodies, V28, P1, DOI 10.3233/HAB-190387; Almeida-de-Souza J, 2018, EUR J CLIN NUTR, V72, P710, DOI 10.1038/s41430-017-0013-x; Asadi Z, 2020, IUBMB LIFE, V72, P706, DOI 10.1002/iub.2172; Aslani Z, 2019, BRIT J NUTR, V121, P340, DOI 10.1017/S0007114518003240; Barragan-Vazquez S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123658; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Coheley LM, 2019, OSTEOPOROSIS INT, V30, P1645, DOI 10.1007/s00198-019-04946-3; Corley J, 2019, J NUTR HEALTH AGING, V23, P628, DOI 10.1007/s12603-019-1221-y; da Silva A, 2021, PUBLIC HEALTH NUTR, V24, P3331, DOI 10.1017/S136898002000378X; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ezzati M, 2018, NATURE, V559, P507, DOI 10.1038/s41586-018-0306-9; Galbete C, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1082-y; Ghazizadeh H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02663-4; Jiang Q, 2014, FREE RADICAL BIO MED, V72, P76, DOI 10.1016/j.freeradbiomed.2014.03.035; Khan S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080993; Kopp W, 2019, DIABET METAB SYND OB, V12, P2221, DOI 10.2147/DMSO.S216791; Kotemori A, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.604296; Kotemori A, 2020, NUTRITION, V69, DOI 10.1016/j.nut.2019.110569; Matsumoto Y, 2021, ARTHRITIS RES THER, V23, DOI 10.1186/s13075-021-02478-y; Mayr HL, 2018, NUTR RES, V55, P94, DOI 10.1016/j.nutres.2018.04.006; Namazi N, 2018, HORM METAB RES, V50, P345, DOI 10.1055/a-0596-8204; Paquet M, 2020, AM J EPIDEMIOL, V189, P95, DOI 10.1093/aje/kwz192; Peres LC, 2017, INT J CANCER, V140, P535, DOI 10.1002/ijc.30467; Phillips CM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081873; Rahbarinejad P, 2019, ANN NUTR METAB, V75, P179, DOI 10.1159/000502330; Ramallal R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135221; Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Ryu I, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112560; Saghafi-Asl M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86993-7; Schotthoefer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179655; Schwingshackl L, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101063; Shivappa N, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600707; Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stoeckli R, 2004, PHYSIOL BEHAV, V83, P611, DOI 10.1016/j.physbeh.2004.07.030; Tabung FK, 2017, AM J EPIDEMIOL, V186, P514, DOI 10.1093/aje/kwx115; Tsigalou C, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8070201; Ungethum K, 2019, DIABETIC MED, V36, P366, DOI 10.1111/dme.13819; Vahid Farhad, 2018, Asian Pac J Cancer Prev, V19, P1471, DOI 10.22034/APJCP.2018.19.6.1471; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Weber KS, 2015, PUBLIC HEALTH NUTR, V18, P50, DOI 10.1017/S1368980013003406; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wirth MD, 2017, J NUTR HEALTH AGING, V21, P487, DOI 10.1007/s12603-016-0775-1; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0; Ziegler AG, 2012, PEDIATR DIABETES, V13, P438, DOI 10.1111/j.1399-5448.2011.00763.x	49	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259629	10.1371/journal.pone.0259629	http://dx.doi.org/10.1371/journal.pone.0259629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748580	Green Published, gold			2022-12-26	WOS:000755468000042
J	Cheng, JX; Cui, JB; Yu, WW; Kang, H; Tian, YM; Jiang, XL				Cheng, Jingxia; Cui, Jinbo; Yu, Wenwen; Kang, Hua; Tian, Yongming; Jiang, Xiaolian			Factors influencing nurses' behavioral intention toward caring for COVID-19 patients on mechanical ventilation: A cross-sectional study	PLOS ONE			English	Article							NEW-YORK-CITY; COMPASSION FATIGUE; CARE; WILLINGNESS; PERCEPTIONS; EXPERIENCE; OUTBREAK; OUTCOMES; STRESS; WORK	Objectives To investigate nurses' behavioral intention toward caring for COVID-19 patients on mechanical ventilation, as well as the factors affecting their intention. Background COVID-19 patients undergoing mechanical ventilation have many care needs and pose more challenges for nurses, which might adversely affect nurses' intention toward caring behavior. Methods A cross-sectional study was conducted by using simple random sampling to recruit 598 nurses from five tertiary hospitals in Sichuan Province, China. The participants responded to an online questionnaire that included questions on demographic characteristics; the Attitude, Subjective Norms, and Behavioral Intention of Nurses toward Mechanically Ventilated Patients (ASIMP) questionnaire; the Nursing Professional Identity Scale (NPIS); and the Compassion Fatigue-Short Scale (CF-Short Scale). ANOVA, Spearman correlation analysis, and multiple linear regression were performed to analyze the data. Results The mean total behavioral intention score was 179.46 ( 14.83) out of a total score of 189.00, which represented a high level of intention toward caring for patients on mechanical ventilation. Multiple linear regression revealed that subjective norms (beta = 0.390, P<0.001), perceived behavioral control (beta = 0.149, P<0.001), professional identity (beta = 0.101, P = 0.009), and compassion fatigue (beta = 0.088 P = 0.024) were significant predictors of nurses' behavioral intention. Conclusions Most nurses have a positive behavioral intention to care for COVID-19 patients undergoing mechanical ventilation. The findings in this study provide some insight for developing effective and tailored strategies to promote nurses' behavioral intention toward caring for ventilated patients under the pandemic situation.	[Cheng, Jingxia; Cui, Jinbo; Yu, Wenwen; Jiang, Xiaolian] Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu, Sichuan, Peoples R China; [Kang, Hua] Chengdu Univ Tradit Chinese Med, Coll Nursing, Chengdu, Sichuan, Peoples R China; [Tian, Yongming] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Chengdu University of Traditional Chinese Medicine; Sichuan University	Jiang, XL (corresponding author), Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu, Sichuan, Peoples R China.	jiangxiaolianhl@163.com						Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x; Ajzen I., 2006, CONSTRUCTING THEORY; Anderson H, 2020, J CLIN NURS, V29, P1195, DOI 10.1111/jocn.15155; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Bai XL, 2019, J CLIN NURS, V28, P2101, DOI 10.1111/jocn.14791; Cao XY, 2016, J NURS MANAGE, V24, pE77, DOI 10.1111/jonm.12292; Chow M., 2005, IDENTIFICATION FACTO; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Damery S, 2010, J MED ETHICS, V36, P12, DOI 10.1136/jme.2009.032821; Dosil M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.606121; Drury V, 2014, J NURS MANAGE, V22, P519, DOI 10.1111/jonm.12168; Ferencz-Kaddari M, 2016, PSYCHOL REP, V118, P691, DOI 10.1177/0033294116647691; Fernandez-Castillo RJ, 2021, NURS CRIT CARE, V26, P397, DOI 10.1111/nicc.12589; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hu Y., 2017, NURS RES, V5; Inocian EP, 2021, J CLIN NURS, DOI 10.1111/jocn.15937; Joanne Elliot Zoe, 2018, Nurs Stand, V32, P41, DOI 10.7748/ns.2018.e10710; Kang H., 2006, STUDY BEHAV INTENTIO; Keim-Malpass Jessica, 2021, Int J Nurs Stud Adv, V3, P100019, DOI 10.1016/j.ijnsa.2021.100019; Kim Cho-Ja, 2006, Taehan Kanho Hakhoe Chi, V36, P596; Kim JS, 2016, NURS HEALTH SCI, V18, P299, DOI 10.1111/nhs.12269; Kinnear B, 2021, J HOSP MED, V16, P44, DOI [10.12788/jhm.3540|10.12788/jhm.3540, 10.12788/jhm.3540]; Lang KLR, 2021, AM J BIOETHICS, V21, P84, DOI 10.1080/15265161.2020.1850914; Langendyk V, 2015, ACAD MED, V90, P732, DOI 10.1097/ACM.0000000000000714; Lee JY, 2020, NURS HEALTH SCI, V22, P82, DOI 10.1111/nhs.12652; Li ZY, 2021, NURS OUTLOOK, V69, P389, DOI 10.1016/j.outlook.2020.09.006; Lou B., 2012, STRUCTURE MACH COMP; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1201; Oh N, 2017, ASIAN NURS RES, V11, P230, DOI 10.1016/j.anr.2017.08.005; Orru G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010337; Pesiridis T, 2021, AIMS PUBLIC HEALTH, V8, P456, DOI 10.3934/publichealth.2021035; Raso R, 2021, J NURS ADMIN, V51, P257, DOI 10.1097/NNA.0000000000001010; Rezaee N, 2020, J MED ETHICS HIST ME, V13; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Schunemann HJ, 2020, ANN INTERN MED, V173, P204, DOI 10.7326/M20-2306; Serin EK, 2021, PERSPECT PSYCHIATR C, V57, P371, DOI 10.1111/ppc.12607; Nia HS, 2021, J CLIN NURS, V30, P1684, DOI 10.1111/jocn.15723; Sheeran P., 2002, EUR REV SOC PSYCHOL, V12, P1, DOI [DOI 10.1080/14792772143000003, 10.1080/14792772143000003]; Sheng QQ, 2020, J NURS MANAGE, V28, P1662, DOI 10.1111/jonm.13122; Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018; Via-Clavero G, 2019, J ADV NURS, V75, P2036, DOI 10.1111/jan.14046; World Health Organization, 2021, WHO COR DIS COVID 19; World Health Organization, 2020, DIR GEN OP REM MED B; Wu CC, 2012, INT J HUM RESOUR MAN, V23, P2698, DOI 10.1080/09585192.2011.637056; Xie WQ, 2021, J CLIN NURS, V30, P615, DOI 10.1111/jocn.15565; Zakeri MA, 2021, NURS OPEN, V8, P354, DOI 10.1002/nop2.636; Zhao H., 2010, CHIN NURS MANAG, V10, P49	48	5	5	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259658	10.1371/journal.pone.0259658	http://dx.doi.org/10.1371/journal.pone.0259658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739532	gold, Green Published			2022-12-26	WOS:000755000800047
J	Elbez, R; Folz, J; McLean, A; Roca, H; Labuz, JM; Pienta, KJ; Takayama, S; Kopelman, R				Elbez, Remy; Folz, Jeff; McLean, Alan; Roca, Hernan; Labuz, Joseph M.; Pienta, Kenneth J.; Takayama, Shuichi; Kopelman, Raoul			Cell-morphodynamic phenotype classification with application to cancer metastasis using cell magnetorotation and machine-learning	PLOS ONE			English	Article							DYNAMICS; SHAPE; HETEROGENEITY; RELIABILITY; CULTURE	We define cell morphodynamics as the cell's time dependent morphology. It could be called the cell's shape shifting ability. To measure it we use a biomarker free, dynamic histology method, which is based on multiplexed Cell Magneto-Rotation and Machine Learning. We note that standard studies looking at cells immobilized on microscope slides cannot reveal their shape shifting, no more than pinned butterfly collections can reveal their flight patterns. Using cell magnetorotation, with the aid of cell embedded magnetic nanoparticles, our method allows each cell to move freely in 3 dimensions, with a rapid following of cell deformations in all 3-dimensions, so as to identify and classify a cell by its dynamic morphology. Using object recognition and machine learning algorithms, we continuously measure the real-time shape dynamics of each cell, where from we successfully resolve the inherent broad heterogeneity of the morphological phenotypes found in a given cancer cell population. In three illustrative experiments we have achieved clustering, differentiation, and identification of cells from (A) two distinct cell lines, (B) cells having gone through the epithelial-to-mesenchymal transition, and (C) cells differing only by their motility. This microfluidic method may enable a fast screening and identification of invasive cells, e.g., metastatic cancer cells, even in the absence of biomarkers, thus providing a rapid diagnostics and assessment protocol for effective personalized cancer therapy.	[Elbez, Remy; Kopelman, Raoul] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; [Folz, Jeff; Kopelman, Raoul] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [McLean, Alan; Kopelman, Raoul] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Roca, Hernan] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Labuz, Joseph M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Johns Hopkins Univ Hosp, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA; [Takayama, Shuichi] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; University System of Georgia; Georgia Institute of Technology	Kopelman, R (corresponding author), Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA.; Kopelman, R (corresponding author), Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA.; Kopelman, R (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	kopelman@umich.edu		McLean, Alan/0000-0002-7226-7076	National Institute of Health/National Cancer Institute IMAT program through an NIH-NCI [R21 CA160157]; National Institute of Health/National Cancer Institute IMAT program through NIH [CA136829, R01CA186769, 1R01CA250499]; University of Michigan Tissue Engineering and Regenerative Medicine Training Program [NIH T32-DE007057]; US Department of Education GAANN fellowship; University of Michigan Microfluidics in Biomedical Sciences Training Program [NIH T32 EB005582-05]	National Institute of Health/National Cancer Institute IMAT program through an NIH-NCI; National Institute of Health/National Cancer Institute IMAT program through NIH; University of Michigan Tissue Engineering and Regenerative Medicine Training Program; US Department of Education GAANN fellowship(US Department of Education); University of Michigan Microfluidics in Biomedical Sciences Training Program(University of Michigan System)	The authors wish to thank the National Institute of Health/National Cancer Institute IMAT program for financial support through an NIH-NCI (IMAT) grant R21 CA160157 (RK), as well as NIH grants CA136829 (ST), R01CA186769 (RK) and 1R01CA250499 (RK). JML gratefully acknowledges support from the University of Michigan Tissue Engineering and Regenerative Medicine Training Program (NIH T32-DE007057), a US Department of Education GAANN fellowship, and the University of Michigan Microfluidics in Biomedical Sciences Training Program (NIH T32 EB005582-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abdullah CS, 2020, MOL PHARMACEUT, V17, P4676, DOI 10.1021/acs.molpharmaceut.0c00963; Alizadeh E, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104044; Alizadeh E, 2016, INTEGR BIOL-UK, V8, P1183, DOI 10.1039/c6ib00100a; Andree KC, 2016, MOL ONCOL, V10, P395, DOI 10.1016/j.molonc.2015.12.002; Asai Ayumu, 2021, Oncotarget, V12, P1687, DOI 10.18632/oncotarget.28035; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen Hong-Chen, 2004, V294, P15; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Das A., 2012, PHARMACOL RES PERSPE, V9, pe00753; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Eefting D, 2009, AM J SURG PATHOL, V33, P50, DOI 10.1097/PAS.0b013e31817eec2b; Elbez R., 2015, THESIS U MICHIGAN; Elbez R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028475; Engers R, 2007, WORLD J UROL, V25, P595, DOI 10.1007/s00345-007-0209-0; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Folz J., 2020, THESIS U MICHIGAN; Freund Y., 1999, Journal of Japanese Society for Artificial Intelligence, V14, P771; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Giri A, 2013, FASEB J, V27, P4089, DOI 10.1096/fj.12-224352; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Guttilla IK, 2012, BREAST CANCER RES TR, V132, P75, DOI 10.1007/s10549-011-1534-y; Hasan MR, 2018, COMPUT METH PROG BIO, V156, P105, DOI 10.1016/j.cmpb.2017.12.003; Institute for Health Metrics and Evaluation (IHME), 2018, FIND GLOB BURD DIS S; Joshi K, 2020, ADV BIOSYST, V4, DOI 10.1002/adbi.202000160; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kosla J, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-51; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lyons SM, 2016, BIOL OPEN, V5, P289, DOI 10.1242/bio.013409; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mitchell MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00044; Oliver CR, 2019, LAB CHIP, V19, P1162, DOI 10.1039/c8lc01387j; Park JY, 2010, MICROFLUID NANOFLUID, V8, P263, DOI 10.1007/s10404-009-0503-9; Park MH, 2017, J AM CHEM SOC, V139, P2741, DOI 10.1021/jacs.6b12236; Pasqualato A, 2012, EXP CELL RES, V318, P835, DOI 10.1016/j.yexcr.2012.01.022; Pasqualato A, 2013, CELL ADHES MIGR, V7, P450, DOI 10.4161/cam.26765; Ren ZX, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150070; Roca H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076773; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Steinley D, 2006, BRIT J MATH STAT PSY, V59, P1, DOI 10.1348/000711005X48266; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tremblay PL, 2008, CANCER RES, V68, P5167, DOI 10.1158/0008-5472.CAN-08-1229; TURITTO VT, 1982, PROG HEMOST THROMB, V6, P139; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu PH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw6938; Wu PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18437; Zhou ZP, 2019, P NATL ACAD SCI USA, V116, P24408, DOI 10.1073/pnas.1909630116	51	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259462	10.1371/journal.pone.0259462	http://dx.doi.org/10.1371/journal.pone.0259462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788313	gold, Green Published			2022-12-26	WOS:000735920500028
J	Rwibasira, GN; Malamba, SS; Musengimana, G; Nkunda, RCM; Omolo, J; Remera, E; Masengesho, V; Mbonitegeka, V; Dzinamarira, T; Kayirangwa, E; Mugwaneza, P				Rwibasira, Gallican N.; Malamba, Samuel S.; Musengimana, Gentille; Nkunda, Richard C. M.; Omolo, Jared; Remera, Eric; Masengesho, Vedaste; Mbonitegeka, Valens; Dzinamarira, Tafadzwa; Kayirangwa, Eugenie; Mugwaneza, Placidie			Recent infections among individuals with a new HIV diagnosis in Rwanda, 2018-2020	PLOS ONE			English	Article								Background Despite Rwanda's progress toward HIV epidemic control, 16.2% of HIV-positive individuals are unaware of their HIV positive status. Tailoring the public health strategy could help reach these individuals with new HIV infection and achieve epidemic control. Recency testing is primarily for surveillance, monitoring, and evaluation but it's not for diagnostic purposes. However, it's important to know what proportion of the newly diagnosed are recent infections so that HIV prevention can be tailored to the profile of people who are recently infected. We therefore used available national data to characterize individuals with recent HIV infection in Rwanda to inform the epidemic response. Methods We included all national-level data for recency testing reported from October 2018 to June 2020. Eligible participants were adults (aged >= 15 years) who had a new HIV diagnosis, who self-reported being antiretroviral therapy (ART) naive, and who had consented to recency testing. Numbers and proportions of recent HIV infections were estimated, and precision around these estimates was calculated with 95% confidence intervals (CI). Logistic regression was used to assess factors associated with being recently (within 12 months) infected with HIV. Results Of 7,785 eligible individuals with a new HIV-positive diagnosis, 475 (6.1%) met the criteria for RITA recent infection. The proportion of RITA recent infections among individuals with newly identified HIV was high among those aged 15-24 years (9.6%) and in men aged >= 65 years (10.3%) compared to other age groups; and were higher among women (6.7%) than men (5.1%). Of all recent cases, 68.8% were women, and 72.2% were aged 15-34 years. The Northern province had the fewest individuals with newly diagnosed HIV but had the highest proportion of recent infections (10.0%) compared to other provinces. Recent infections decreased by 19.6% per unit change in time (measured in months). Patients aged >= 25 years were less likely to have recent infection than those aged 15-24 years with those aged 35-49 years being the least likely to have recent infection compared to those aged 15-24 years (adjusted odds ratio [aOR], 0.415 [95% CI: 0.316-0.544]). Conclusion Public health surveillance targeting the areas and the identified groups with high risk of recent infection could help improve outcomes.	[Rwibasira, Gallican N.; Masengesho, Vedaste; Dzinamarira, Tafadzwa] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Program ICAP, Kigali, Rwanda; [Malamba, Samuel S.; Nkunda, Richard C. M.; Omolo, Jared; Kayirangwa, Eugenie] US Centers Dis Control & Prevent, Ctrs Global Hlth, Div Global HIV AIDS & TB, Kigali, Rwanda; [Musengimana, Gentille; Remera, Eric; Mbonitegeka, Valens; Mugwaneza, Placidie] Rwanda Biomed Ctr RBC, Minist Hlth, Viral Hepatitis & Other Viral Dis Control, Dept HIV AIDS Dis Prevent & Control,Div HIV,STI, Kigali, Rwanda		Musengimana, G (corresponding author), Rwanda Biomed Ctr RBC, Minist Hlth, Viral Hepatitis & Other Viral Dis Control, Dept HIV AIDS Dis Prevent & Control,Div HIV,STI, Kigali, Rwanda.	qvx2@cdc.gov	Dzinamarira, Tafadzwa/AAK-5667-2020	Dzinamarira, Tafadzwa/0000-0002-9929-5739; Musengimana, Gentille/0000-0002-9552-3298	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC) [GH001612]	President's Emergency Plan for AIDS Relief (PEPFAR) through Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was implemented under Active HIV Case Based Surveillance for HIV and has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of CoAg #GH001612. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.2.20673; AIDS TEGP Foundation Keneya Project, HIV STAT DISCL TEST; Asante HIV-1 T Recency R Assay., 2019, RAPID IN VITRO IMMUN; Binagwaho Agnes CJ., 2009, ELISABETTA EXPLORING; Dalal S, 2017, AIDS, V31, P1867, DOI 10.1097/QAD.0000000000001555; Duong YT, 2019, AIDS RES HUM RETROV, V35, P896, DOI [10.1089/aid.2018.0284, 10.1089/AID.2018.0284]; Galiwango RM, 2021, AIDS RES HUM RETROV, V37, P893, DOI [10.1089/aid.2020.0279, 10.1089/AID.2020.0279]; Hoang H., USE ASANTETM RAPID R; Hofmann A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2585-4; Ingabire R, 2019, INT J STD AIDS, V30, P557, DOI 10.1177/0956462418817050; Mutagoma M, 2015, INT J STD AIDS, V26, P810, DOI 10.1177/0956462414555931; Nash D, 2018, J VIRUS ERAD, V4, P1; Nsanzimana S, 2017, LANCET HIV, V4, pE457, DOI 10.1016/S2352-3018(17)30124-8; Penda CI, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1235-3; Romero A, 2012, EUR J PUBLIC HEALTH, V22, P802, DOI 10.1093/eurpub/ckr179; Ross J, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25279; Rwanda Ministry of Health, 2020, RWAND POP BAS HIV IM; Rwanda Ministry of Health, 2018, NATIONAL HIV AIDS TA; UNAIDS), 2018, UNAIDS DAT 2019; UNAIDS, 2019, UNAIDS DAT 2018; Welty S, 2020, JAIDS-J ACQ IMM DEF, V84, P5, DOI 10.1097/QAI.0000000000002317	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259708	10.1371/journal.pone.0259708	http://dx.doi.org/10.1371/journal.pone.0259708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XW9HJ	34788323	Green Published, gold			2022-12-26	WOS:000735920500035
J	Lagarrigue, Y; Cappe, C; Tallet, J				Lagarrigue, Yannick; Cappe, Celine; Tallet, Jessica			Regular rhythmic and audio-visual stimulations enhance procedural learning of a perceptual-motor sequence in healthy adults: A pilot study	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SENSORIMOTOR SYNCHRONIZATION; AUDITORY DISTRACTION; STIMULUS INTERVAL; SPATIAL-ATTENTION; SERIAL; IMPLICIT; MEMORY; BRAIN; SKILL	Procedural learning is essential for the effortless execution of many everyday life activities. However, little is known about the conditions influencing the acquisition of procedural skills. The literature suggests that sensory environment may influence the acquisition of perceptual-motor sequences, as tested by a Serial Reaction Time Task. In the current study, we investigated the effects of auditory stimulations on procedural learning of a visuo-motor sequence. Given that the literature shows that regular rhythmic auditory rhythm and multisensory stimulations improve motor speed, we expected to improve procedural learning (reaction times and errors) with repeated practice with auditory stimulations presented either simultaneously with visual stimulations or with a regular tempo, compared to control conditions (e.g., with irregular tempo). Our results suggest that both congruent audio-visual stimulations and regular rhythmic auditory stimulations promote procedural perceptual-motor learning. On the contrary, auditory stimulations with irregular or very quick tempo alter learning. We discuss how regular rhythmic multisensory stimulations may improve procedural learning with respect of a multisensory rhythmic integration process.	[Lagarrigue, Yannick; Tallet, Jessica] Univ Toulouse, Toulouse NeuroImaging Ctr, UPS, INSERM,ToNIC, Toulouse, France; [Cappe, Celine] Univ Toulouse, Ctr Rech Cerveau & Cognit, CNRS, Cerco,UMR 5549, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lagarrigue, Y (corresponding author), Univ Toulouse, Toulouse NeuroImaging Ctr, UPS, INSERM,ToNIC, Toulouse, France.	yannicklagarrigue@outlook.fr		Lagarrigue, Yannick/0000-0003-2905-7759; TALLET, Jessica/0000-0002-2832-6112				Abrahamse EL, 2008, PSYCHOL RES-PSYCH FO, V72, P397, DOI 10.1007/s00426-007-0123-5; Abrahamse EL, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00082; Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Aizenstein HJ, 2004, CEREB CORTEX, V14, P199, DOI 10.1093/cercor/bhg119; Barakat B, 2015, CURR BIOL, V25, pR60, DOI 10.1016/j.cub.2014.12.011; Bardy BG, 2015, ANN NY ACAD SCI, V1337, P94, DOI 10.1111/nyas.12650; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Bigliassi M, 2018, INT J PSYCHOPHYSIOL, V133, P131, DOI 10.1016/j.ijpsycho.2018.07.475; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Bridges D, 2020, PEERJ, V8, DOI 10.7717/peerj.9414; Censor N, 2013, NEUROSCIENCE, V250, P201, DOI 10.1016/j.neuroscience.2013.06.062; Censor N, 2012, NAT REV NEUROSCI, V13, P658, DOI 10.1038/nrn3315; Chan RW, 2020, BEHAV BRAIN RES, V384, DOI 10.1016/j.bbr.2020.112536; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Clegg BA, 2005, Q J EXP PSYCHOL-A, V58, P1087, DOI 10.1080/02724980443000485; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Coomans D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00465; DeCoster J, 2011, J MOTOR BEHAV, V43, P263, DOI 10.1080/00222895.2011.574171; Deroost N, 2006, Q J EXP PSYCHOL, V59, P449, DOI 10.1080/17470210500462684; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dominey PF, 1998, COGNITIVE BRAIN RES, V6, P163, DOI 10.1016/S0926-6410(97)00029-3; FELDMAN J, 1995, INTELLIGENCE, V20, P87, DOI 10.1016/0160-2896(95)90007-1; Fraisse P, 1946, ANN PSYCHOL, V47-48, P11; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Gobel EW, 2011, J EXP PSYCHOL LEARN, V37, P994, DOI 10.1037/a0022959; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Hecht D, 2008, EXP BRAIN RES, V189, P133, DOI 10.1007/s00221-008-1410-0; Helmuth LL, 2000, NEUROPSYCHOLOGIA, V38, P1443, DOI 10.1016/S0028-3932(00)00059-2; Hoch L, 2013, PSYCHON B REV, V20, P142, DOI 10.3758/s13423-012-0309-8; Hoffmann J, 2001, J EXP PSYCHOL LEARN, V27, P470, DOI 10.1037//0278-7393.27.2.470; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kim D, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00130; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Kudo K, 2006, J EXP PSYCHOL HUMAN, V32, P599, DOI 10.1037/0096-1523.32.3.599; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lopresti-Goodman SM, 2008, J MOTOR BEHAV, V40, P3, DOI 10.3200/JMBR.40.1.3-10; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Maslovat D, 2006, J MOTOR BEHAV, V38, P101, DOI 10.3200/JMBR.38.2.101-117; Mayr U, 1996, J EXP PSYCHOL LEARN, V22, P350, DOI 10.1037/0278-7393.22.2.350; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Michaelis K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00252; Mitchel AD, 2011, J EXP PSYCHOL LEARN, V37, P1081, DOI 10.1037/a0023700; Miyawaki K, 2006, PSYCHOL RES-PSYCH FO, V70, P262, DOI 10.1007/s00426-005-0216-y; Molinari M, 2007, CEREBELLUM, V6, P18, DOI 10.1080/14734220601142886; Nicolson RI, 2010, DYSLEXIA, V16, P194, DOI 10.1002/dys.408; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; O'Reilly JX, 2008, J NEUROPHYSIOL, V99, P2731, DOI 10.1152/jn.01141.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Piitulainen H, 2015, HUM BRAIN MAPP, V36, P5168, DOI 10.1002/hbm.23001; Plancher G, 2018, J EXP PSYCHOL LEARN, V44, P812, DOI 10.1037/xlm0000481; Reber AS, IMPLICIT EXPLICIT LE, P9; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Robertson EM, 2001, EXP BRAIN RES, V137, P336, DOI 10.1007/s002210000673; Roer JP, 2018, J EXP CHILD PSYCHOL, V172, P41, DOI 10.1016/j.jecp.2018.02.005; Roerdink M, 2013, ANN BIOMED ENG, V41, P1726, DOI 10.1007/s10439-012-0680-7; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Runger D, 2008, J EXP PSYCHOL LEARN, V34, P1011, DOI 10.1037/a0012942; Runger D, 2012, PSYCHOL RES-PSYCH FO, V76, P579, DOI 10.1007/s00426-011-0367-y; Russeler J, 2000, ACTA PSYCHOL, V104, P45, DOI 10.1016/S0001-6918(99)00053-0; Saywell Nicola, 2008, Physiotherapy Theory and Practice, V24, P321, DOI 10.1080/09593980701884832; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schwarb H, 2012, ADV COGN PSYCHOL, V8, P165, DOI [10.5709/acp-0113-1, 10.2478/v10053-008-0113-1]; Seitz AR, 2007, PERCEPTION, V36, P1445, DOI 10.1068/p5843; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Selchenkova T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112233; Selchenkova T, 2014, Q J EXP PSYCHOL, V67, P2360, DOI 10.1080/17470218.2014.929155; Serrien DJ, 2010, NEUROSCI LETT, V486, P215, DOI 10.1016/j.neulet.2010.09.056; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Shanks DR, 2010, ANNU REV PSYCHOL, V61, P273, DOI 10.1146/annurev.psych.093008.100519; Shin JC, 2002, J EXP PSYCHOL LEARN, V28, P445, DOI 10.1037//0278-7393.28.3.445; Smucny J, 2013, BRAIN COGNITION, V81, P263, DOI 10.1016/j.bandc.2012.11.008; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 2014, NAT REV NEUROSCI, V15, P520, DOI 10.1038/nrn3742; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; THAUT M, 1991, J MUSIC THER, V28, P64, DOI 10.1093/jmt/28.2.64; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; Thaut MH, 2015, PROG BRAIN RES, V217, P253, DOI 10.1016/bs.pbr.2014.11.030; Thaut MH, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01185; Tubau E, 2007, J EXP PSYCHOL GEN, V136, P43, DOI 10.1037/0096-3445.136.1.43; Varlet M, 2020, PSYCHOL RES-PSYCH FO, V84, P568, DOI 10.1007/s00426-018-1074-8; Vekony T., CEREBRAL CORTEX COMM, V1, DOI [10.1093/texcom/tgaa041, DOI 10.1093/TEXCOM/TGAA041]; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; Willingham DB, 1997, MEM COGNITION, V25, P534, DOI 10.3758/BF03201128; Yoles-Frenkel M, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00001	101	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259081	10.1371/journal.pone.0259081	http://dx.doi.org/10.1371/journal.pone.0259081			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780497	Green Published, gold			2022-12-26	WOS:000755305800019
J	Himbert, S; Qadri, SM; Sheffield, WP; Schubert, P; D'Alessandro, A; Rheinstadter, MC				Himbert, Sebastian; Qadri, Syed M.; Sheffield, William P.; Schubert, Peter; D'Alessandro, Angelo; Rheinstadter, Maikel C.			Blood bank storage of red blood cells increases RBC cytoplasmic membrane order and bending rigidity	PLOS ONE			English	Article							OLDER STORED-BLOOD; DI(2-ETHYLHEXYL) PHTHALATE; OXYGEN PERMEABILITY; IN-VIVO; TRANSFUSION; CHOLESTEROL; EXPOSURE; IDENTIFICATION; DEFORMABILITY; CLEARANCE	Blood banks around the world store blood components for several weeks ensuring its availability for transfusion medicine. Red blood cells (RBCs) are known to undergo compositional changes during storage, which may impact the cells' function and eventually the recipients' health. We extracted the RBC's cytoplasmic membrane (RBCcm) to study the effect of storage on the membranes' molecular structure and bending rigidity by a combination of X-ray diffraction (XRD), X-ray diffuse scattering (XDS) and coarse grained Molecular Dynamics (MD) simulations. Blood was stored in commercial blood bags for 2 and 5 weeks, respectively and compared to freshly drawn blood. Using mass spectrometry, we measured an increase of fatty acids together with a slight shift towards shorter tail lengths. We observe an increased fraction (6%) of liquid ordered (l(o)) domains in the RBC(cm)s with storage time, and an increased lipid packing in these domains, leading to an increased membrane thickness and membrane order. The size of both, l(o) and liquid disordered (l(d)) lipid domains was found to decrease with increased storage time by up to 25%. XDS experiments reveal a storage dependent increase in the RBCcm's bending modulus kappa by a factor of 2.8, from 1.9 k(B)T to 5.3 k(B)T. MD simulations were conducted in the absence of proteins. The results show that the membrane composition has a small contribution to the increased bending rigidity and suggests additional protein-driven mechanisms.	[Himbert, Sebastian; Rheinstadter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada; [Himbert, Sebastian; Rheinstadter, Maikel C.] McMaster Univ, Origins Inst, Hamilton, ON, Canada; [Qadri, Syed M.] Ontario Tech Univ, Fac Hlth Sci, Oshawa, ON, Canada; [Sheffield, William P.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Sheffield, William P.] Canadian Blood Serv, Ctr Innovat, Hamilton, ON, Canada; [Schubert, Peter] Canadian Blood Serv, Ctr Innovat, Vancouver, BC, Canada; [Schubert, Peter] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [D'Alessandro, Angelo] Univ Colorado Denver, Anschutz Med Campus, Aurora, CO USA	McMaster University; McMaster University; McMaster University; Canadian Blood Services; Canadian Blood Services; University of British Columbia; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Himbert, S; Rheinstadter, MC (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON, Canada.; Himbert, S; Rheinstadter, MC (corresponding author), McMaster Univ, Origins Inst, Hamilton, ON, Canada.	himberts@mcmaster.ca; rheinstadter@mcmaster.ca	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Rheinstadter, Maikel/0000-0002-0558-7475	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; National Institute of General and Medical Sciences [RM1GM131968]; National Heart, Lung, and Blood Institute [R01HL146442, R01HL149714, R01HL148151, R21HL150032]; Province of Ontario	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; National Institute of General and Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Province of Ontario	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. This research was also supported by funds RM1GM131968 (ADA) from the National Institute of General and Medical Sciences, and R01HL146442 (ADA), R01HL149714 (ADA), R01HL148151 (ADA), R21HL150032 (ADA), from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. John F. Nagle from Carnegie Mellon University for helpful discussion and advice for the analysis of the X-ray diffraction experiments. M.C.R. is the recipient of an Early Researcher Award of the Province of Ontario and a University Scholar of McMaster University.	Aimon S, 2014, DEV CELL, V28, P212, DOI 10.1016/j.devcel.2013.12.012; Alessandro AD, 2021, HAEMATOLOGICA, V106, P1290, DOI 10.3324/haematol.2020.246603; Almizraq R, 2013, TRANSFUSION, V53, P2258, DOI 10.1111/trf.12080; Armstrong CL, 2014, SOFT MATTER, V10, P2600, DOI 10.1039/c3sm51757h; Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162; Auth T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051910; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bider RC, 2020, LANGMUIR, V36, P11899, DOI 10.1021/acs.langmuir.0c01964; Bosman GJCGM, 2008, TRANSFUSION MED, V18, P335, DOI 10.1111/j.1365-3148.2008.00892.x; Bosman GJCGM, 2008, TRANSFUSION, V48, P827, DOI 10.1111/j.1537-2995.2007.01630.x; Brown FLH, 2008, ANNU REV PHYS CHEM, V59, P685, DOI 10.1146/annurev.physchem.59.032607.093550; CAILLE A, 1972, CR ACAD SCI B PHYS, V274, P891; Carmen Raleigh, 1993, Transfusion Medicine Reviews, V7, P1, DOI 10.1016/S0887-7963(93)70027-9; Chaudhary R, 2012, BLOOD TRANSFUS-ITALY, V10, P59, DOI 10.2450/2011.0107-10; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Cluitmans JCA, 2012, BLOOD TRANSFUS-ITALY, V10, pS12, DOI 10.2450/2012.004S; D'Alessandro A, 2021, BLOOD, V137, P2275, DOI 10.1182/blood.2021010946; D'Alessandro A, 2016, BLOOD TRANSFUS-ITALY, V14, P140, DOI 10.2450/2015.0210-15; D'Alessandro A, 2012, HAEMATOL-HEMATOL J, V97, P107, DOI 10.3324/haematol.2011.051789; Dinkla S, 2014, BLOOD TRANSFUS-ITALY, V12, P204, DOI 10.2450/2013.0106-13; Dotson RJ, 2017, BIOPHYS J, V112, P2336, DOI 10.1016/j.bpj.2017.04.046; Fowler PW, 2016, SOFT MATTER, V12, P7792, DOI 10.1039/c6sm01186a; Gerber DR, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.05.007; Ghysels A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13432-7; Grimshaw K, 2011, TRANSFUSION, V51, P874, DOI 10.1111/j.1537-2995.2011.03095.x; Himbert S., 2022, PLOS ONE, V17, DOI [10.1371/journal.pone.0269619, DOI 10.1371/JOURNAL.PONE.0269619]; Himbert S, 2020, ADV BIOSYST, V4, DOI 10.1002/adbi.201900185; Himbert S, 2017, SCI REP-UK, V7, DOI 10.1038/srep39661; HOROWITZ B, 1985, VOX SANG, V48, P150, DOI 10.1111/j.1423-0410.1985.tb00162.x; Hossein A, 2020, BIOPHYS J, V118, P624, DOI 10.1016/j.bpj.2019.11.3398; Huruta RR, 1998, BLOOD, V92, P2975, DOI 10.1182/blood.V92.8.2975.splL4_2975_2977; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kanias T, 2010, FEBS J, V277, P343, DOI 10.1111/j.1742-4658.2009.07472.x; Kozlova E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08255-9; Kriebardis AG, 2007, TRANSFUSION, V47, P1212, DOI 10.1111/j.1537-2995.2007.01254.x; LACELLE PL, 1969, TRANSFUSION, V9, P238; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; Liu YF, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.040901; Lyatskaya Y, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.011907; Melzak KA, 2020, VOX SANG, V115, P655, DOI 10.1111/vox.12924; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; NAGLE JF, 1989, BIOPHYS J, V55, P309, DOI 10.1016/S0006-3495(89)82806-1; NETZ RR, 1995, PHYS REV E, V52, P4114, DOI 10.1103/PhysRevE.52.4114; Nickels JD, 2019, J PHYS CHEM B, V123, P2050, DOI 10.1021/acs.jpcb.8b12126; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rael LT, 2009, OXID MED CELL LONGEV, V2, P166, DOI 10.4161/oxim.2.3.8608; Rangamani P, 2014, BIOPHYS J, V107, P751, DOI 10.1016/j.bpj.2014.06.010; Reisz JA, 2019, METHODS MOL BIOL, V1978, P121, DOI 10.1007/978-1-4939-9236-2_8; Rheinstadter MC, 2013, CURR OPIN COLLOID IN, V18, P440, DOI 10.1016/j.cocis.2013.07.001; ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198; Roussel C, 2021, BLOOD, V137, P2285, DOI 10.1182/blood.2020008563; Silliman CC, 2011, TRANSFUSION, V51, P2549, DOI 10.1111/j.1537-2995.2011.03186.x; Solomon SB, 2013, BLOOD, V121, P1663, DOI 10.1182/blood-2012-10-462945; Spinella PC, 2009, CRIT CARE, V13, DOI 10.1186/cc8050; Stefanoni D, 2020, HAEMATOLOGICA, V105, P2174, DOI 10.3324/haematol.2019.229930; SUBCZYNSKI WK, 1989, P NATL ACAD SCI USA, V86, P4474, DOI 10.1073/pnas.86.12.4474; Thomas T, 2021, TRANSFUSION, V61, P1867, DOI 10.1111/trf.16402; Thomas T, 2020, J PROTEOME RES, V19, P4455, DOI 10.1021/acs.jproteome.0c00606; Toppozini L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.228101; Tristram-Nagle S, 2007, BIOPHYS J, V93, P2048, DOI 10.1529/biophysj.107.109181; von Laue M., 1914, JB RADIOAKTIVITAT EL, V11, P308; Wang D, 2012, TRANSFUSION, V52, P1184, DOI 10.1111/j.1537-2995.2011.03466.x; Xu Z., 2018, MICROSYSTEMS NANOENG, V4, P1; Yoshida T, 2019, BLOOD TRANSFUS-ITALY, V17, P27, DOI 10.2450/2019.0217-18; Zolla L, 2013, J INTEGRATED OMICS, V3, P11	70	6	6	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259267	10.1371/journal.pone.0259267	http://dx.doi.org/10.1371/journal.pone.0259267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767588	Green Published, gold			2022-12-26	WOS:000755249300027
J	Derndorfer, J; Disslbacher, F; Lechinger, V; Mader, K; Six, E				Derndorfer, Judith; Disslbacher, Franziska; Lechinger, Vanessa; Mader, Katharina; Six, Eva			Home, sweet home? The impact of working from home on the division of unpaid work during the COVID-19 lockdown	PLOS ONE			English	Article							HOUSEHOLD DECISION-MAKING; GENDER DIVISION; OF-LABOR; MARRIAGE; SPECIALIZATION; HOUSEWORK; CRISIS; HEALTH; FAMILY; TIME	A lockdown implies a shift from the public to the private sphere, and from market to non-market production, thereby increasing the volume of unpaid work. Already before the pandemic, unpaid work was disproportionately borne by women. This paper studies the effect of working from home for pay (WFH), due to a lockdown, on the change in the division of housework and childcare within couple households. While previous studies on the effect of WFH on the reconciliation of work and family life and the division of labour within the household suffered from selection bias, we are able to identify this effect by drawing upon the shock of the first COVID-19 lockdown in Austria. The corresponding legal measures left little choice over WFH. In any case, WFH is exogenous, conditional on a small set of individual and household characteristics we control for. We employ data from a survey on the gendered aspects of the lockdown. The dataset includes detailed information on time use during the lockdown and on the quality and experience of WFH. Uniquely, this survey data also includes information on the division, and not only magnitude, of unpaid work within households. Austria is an interesting case in this respect as it is characterized by very conservative gender norms. The results reveal that the probability of men taking on a larger share of housework increases if men are WFH alone or together with their female partner. By contrast, the involvement of men in childcare increased only in the event that the female partner was not able to WFH. Overall, the burden of childcare, and particularly homeschooling, was disproportionately borne by women.	[Derndorfer, Judith; Disslbacher, Franziska; Lechinger, Vanessa; Six, Eva] WU Vienna Univ Econ & Business, Res Inst Econ Inequal, Vienna, Austria; [Disslbacher, Franziska; Mader, Katharina] Chamber Labor, Dept Econ & Stat, Vienna, Austria; [Disslbacher, Franziska] WU Vienna Univ Econ & Business, Inst Econ Geog & GISci, Vienna, Austria; [Mader, Katharina] WU Vienna Univ Econ & Business, Dept Econ, Vienna, Austria	Vienna University of Economics & Business; Vienna University of Economics & Business; Vienna University of Economics & Business	Disslbacher, F; Lechinger, V (corresponding author), WU Vienna Univ Econ & Business, Res Inst Econ Inequal, Vienna, Austria.; Disslbacher, F (corresponding author), Chamber Labor, Dept Econ & Stat, Vienna, Austria.; Disslbacher, F (corresponding author), WU Vienna Univ Econ & Business, Inst Econ Geog & GISci, Vienna, Austria.	franziska.disslbacher@wu.ac.at; vanessa.lechinger@wu.ac.at	Derndorfer, Judith/HHS-5310-2022	Lechinger, Vanessa/0000-0002-7930-4968; Six, Eva/0000-0002-6858-9232; Disslbacher, Franziska/0000-0003-0191-0404	Vienna Science and Technology Fund (WWTF) [COV20-040]; Vienna Chamber of Labour under the grant "Multiple Burdens of COVID-19"	Vienna Science and Technology Fund (WWTF); Vienna Chamber of Labour under the grant "Multiple Burdens of COVID-19"	KM received funding from the Vienna Science and Technology Fund (WWTF), grant number COV20-040 (URL of the funder: https://www.wwtf.at).KM received funding from the Vienna Chamber of Labour under the grant "Multiple Burdens of COVID-19" (URL of the funder: https://wien.arbeiterkammer.at/index.html) VL, JD and ES were funded by these grants. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BP, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.241102; Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; Agarwal B., 1997, BARGAINING GENDER RE; Alon Titan, 2020, 15149 CEPR, DOI DOI 10.3386/W27660; Anderson CL, 2017, WORLD DEV, V90, P169, DOI 10.1016/j.worlddev.2016.09.005; Annan J, 2011, J CONFLICT RESOLUT, V55, P877, DOI 10.1177/0022002711408013; Baker MJ, 2007, J LABOR ECON, V25, P763, DOI 10.1086/522907; Bianchi SM, 2000, SOC FORCES, V79, P191, DOI 10.2307/2675569; Biroli P., 2020, FAMILY LIFE LOCKDOWN; Bittman M, 2003, AM J SOCIOL, V109, P186, DOI 10.1086/378341; Bock-Schappelwein J, 2020, WIFO RES BRIEFS; Bonke J, 2008, SOC SCI QUART, V89, P1023, DOI 10.1111/j.1540-6237.2008.00597.x; BRINES J, 1994, AM J SOCIOL, V100, P652, DOI 10.1086/230577; Buschner A, 2018, Z FAMILIENFORSCH, V30, P96, DOI 10.3224/zff.v30i1.06; Charmes J., 2019, UNPAID CARE WORK LAB; Chawla AJ, 1993, THESIS U MICHIGAN; Chen ZQ, 2001, ECON J, V111, P722, DOI 10.1111/1468-0297.00657; Collins AB, 2019, INT J DRUG POLICY, V69, P43, DOI 10.1016/j.drugpo.2019.05.002; Collins C, 2021, GENDER WORK ORGAN, V28, P101, DOI 10.1111/gwao.12506; Davis SN, 2009, ANNU REV SOCIOL, V35, P87, DOI 10.1146/annurev-soc-070308-115920; Dema-Moreno S, 2009, FEM ECON, V15, P27, DOI 10.1080/13545700802620575; Denton F., 2002, Gender and Development, V10, P10, DOI 10.1080/13552070215903; Dito BB, 2015, FEM ECON, V21, P168, DOI 10.1080/13545701.2015.1007073; Doss C, 2013, WORLD BANK RES OBSER, V28, P52, DOI 10.1093/wbro/lkt001; European Commission B, 2017, SPECIAL EUROBAROMETE; Eurostat, 2019, AGR FOR FISH STAT; Farre L., 2020, COVID 19 LOCKDOWN AF, P1; Fodor E, 2021, EUR SOC, V23, pS95, DOI 10.1080/14616696.2020.1817522; Greenstein TN, 2000, J MARRIAGE FAM, V62, P322, DOI 10.1111/j.1741-3737.2000.00322.x; Hanzl L, 2021, IFSO WORKING PAPER S, P12; Hupkau C, 2020, FISC STUD, V41, P623, DOI 10.1111/1475-5890.12245; Jenkins F, 2021, ECON LABOUR RELAT RE, V32, P22, DOI 10.1177/1035304620983608; KANBUR R, 1994, OXFORD ECON PAP, V46, P445, DOI 10.1093/oxfordjournals.oep.a042140; Karamessini M., 2014, WOMEN AUSTERITY EC C; Kohlrausch B., 2020, CORONA KRISE TRIFFT; Laura A, 2018, CARE WORK CARE JOBS; Lott Y., 2020, WORK LIFE BALANCE HO; Lott Y, 2020, SOC INDIC RES, V151, P471, DOI 10.1007/s11205-018-2031-z; LUNDBERG S, 1993, J POLIT ECON, V101, P988, DOI 10.1086/261912; Lyngstad TH, 2011, EUR SOCIOL REV, V27, P624, DOI 10.1093/esr/jcq028; Mader K., 2012, STATISTIK AUSTRIA, V12, P983; MANSER M, 1980, INT ECON REV, V21, P31, DOI 10.2307/2526238; MCELROY MB, 1981, INT ECON REV, V22, P333, DOI 10.2307/2526280; McKay A, 2013, FEM ECON, V19, P108, DOI 10.1080/13545701.2013.808762; Nelson V., 2002, Gender and Development, V10, P51, DOI 10.1080/13552070215911; Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x; Piwoz E. G., 1985, Food and Nutrition Bulletin, V7, P1; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Richardson DM, 2020, INVAD NAT SPRING SER, V14, P67, DOI 10.1007/978-3-030-32394-3_3; Schmieder J, 2020, GLEICHSTELLUNGSPOLIT; Sevilla A, 2020, OXFORD REV ECON POL, V36, pS169, DOI 10.1093/oxrep/graa027; Sikorski U, 2012, STAT BUNDESAMT WIRTS, P492; Siminski P, 2020, IZA DISCUSSION PAPER; Statistics Austria, 2020, TOD; Statistics Austria, 2016, GEB WOHN; Walker E.A., 2007, WOMEN MANAG REV, V22, P122, DOI [10.1108/09649420710732088, DOI 10.1108/09649420710732088]; Wellington AJ, 2006, LABOUR ECON, V13, P357, DOI 10.1016/j.labeco.2004.10.005; Wheatley D, 2012, NEW TECH WORK EMPLOY, V27, P224, DOI 10.1111/j.1468-005X.2012.00289.x; Xue BW, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247959; Yerkes MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242249	60	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259580	10.1371/journal.pone.0259580	http://dx.doi.org/10.1371/journal.pone.0259580			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ4ST	34748585	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000755468000036
J	Flanagan, S; Rowe, A; Duggan, V; Markle, E; O'Brien, M; Barry, G				Flanagan, Sharon; Rowe, Aine; Duggan, Vivienne; Markle, Erin; O'Brien, Maureen; Barry, Gerald			Development of a real-time PCR assay to detect the single nucleotide polymorphism causing Warmblood Fragile Foal Syndrome	PLOS ONE			English	Article								Warmblood Fragile Foal syndrome (WFFS) is an autosomal recessive condition that affects the maturation of collagen in affected foals. Foals affected with the disease typically die or are euthanised shortly after birth. WFFS is caused by a single nucleotide change at position 2032 of the equine PLOD1 gene, causing an impairment of the wild-type enzyme. A commercial test for the causative genetic mutation is currently available from companies operating under licence from Cornell University but it has limitations. This test requires amplification of a region of the PLOD1 gene encompassing the site of interest, followed by Sanger sequencing of that region and computational analysis. We describe here the development of an alternative, real-time PCR based assay that rapidly and reliably differentiates between the wild-type and WFFS associated nucleotides without the need for sequencing, thus increasing the potential for high throughput analysis of large numbers of samples in a cost-effective manner.	[Flanagan, Sharon; Rowe, Aine; Duggan, Vivienne; Markle, Erin; O'Brien, Maureen; Barry, Gerald] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland	University College Dublin	Barry, G (corresponding author), Univ Coll Dublin, Sch Vet Med, Dublin, Ireland.	gerald.barry@ucd.ie	; Duggan, Vivienne/P-2733-2015	Barry, Gerald/0000-0002-6262-3380; Duggan, Vivienne/0000-0003-2012-066X	Zoetis Inc.; University College Dublin; Irish Department of Agriculture, Food and The Marine	Zoetis Inc.; University College Dublin; Irish Department of Agriculture, Food and The Marine	GB, AR, VD, MO'B - Direct funding from University College Dublin EM -Industrial funding from Zoetis Inc. http://www.zoetis.com/SF - Direct funding from University College Dublin and The Irish Department of Agriculture, Food and The Marine. https://www.gov.ie/en/organisation/department-of-agriculture-food-and-the-marine/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich C, 2019, ANIM REPROD SCI, V211, DOI 10.1016/j.anireprosci.2019.106202; Bellone RR, 2020, EQUINE VET J, V52, P411, DOI 10.1111/evj.13182; Dias NM, 2019, VET J, V248, P101, DOI 10.1016/j.tvjl.2019.05.002; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Martin K, 2021, ANIM GENET, V52, P137, DOI 10.1111/age.13020; MCCORMICK RJ, 1994, MEAT SCI, V36, P79, DOI 10.1016/0309-1740(94)90035-3; Metzger J, 2021, EQUINE VET J, V53, P51, DOI 10.1111/evj.13271; Monthoux C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0318-8; Reiter S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121518; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Winand Nena J., 2012, IDENTIFICATION CAUSA	11	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259316	10.1371/journal.pone.0259316	http://dx.doi.org/10.1371/journal.pone.0259316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748589	Green Published, gold			2022-12-26	WOS:000755468000024
J	Powers, MJ; Martz, LD; Burton, RS; Hill, GE; Weaver, RJ				Powers, Matthew J.; Martz, Lucas D.; Burton, Ronald S.; Hill, Geoffrey E.; Weaver, Ryan J.			Evidence for hybrid breakdown in production of red carotenoids in the marine invertebrate Tigriopus californicus	PLOS ONE			English	Article							MITOCHONDRIAL ELECTRON-TRANSPORT; COPEPOD TIGRIOPUS; INTERPOPULATION HYBRIDS; HARPACTICOID COPEPOD; DIETARY CAROTENOIDS; DEPENDENT SIGNALS; OXIDATIVE STRESS; SEXUAL SELECTION; SKELETAL-MUSCLE; TRADE-OFFS	The marine copepod, Tigriopus californicus, produces the red carotenoid pigment astaxanthin from yellow dietary precursors. This 'bioconversion' of yellow carotenoids to red is hypothesized to be linked to individual condition, possibly through shared metabolic pathways with mitochondrial oxidative phosphorylation. Experimental inter-population crosses of lab-reared T. californicus typically produces low-fitness hybrids is due in large part to the disruption of coadapted sets nuclear and mitochondrial genes within the parental populations. These hybrid incompatibilities can increase variability in life history traits and energy production among hybrid lines. Here, we tested if production of astaxanthin was compromised in hybrid copepods and if it was linked to mitochondrial metabolism and offspring development. We observed no clear mitonuclear dysfunction in hybrids fed a limited, carotenoid-deficient diet of nutritional yeast. However, when yellow carotenoids were restored to their diet, hybrid lines produced less astaxanthin than parental lines. We observed that lines fed a yeast diet produced less ATP and had slower offspring development compared to lines fed a more complete diet of algae, suggesting the yeast-only diet may have obscured effects of mitonuclear dysfunction. Astaxanthin production was not significantly associated with development among lines fed a yeast diet but was negatively related to development in early generation hybrids fed an algal diet. In lines fed yeast, astaxanthin was negatively related to ATP synthesis, but in lines fed algae, the relationship was reversed. Although the effects of the yeast diet may have obscured evidence of hybrid dysfunction, these results suggest that astaxanthin bioconversion may still be related to mitochondrial performance and reproductive success.	[Powers, Matthew J.; Hill, Geoffrey E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Martz, Lucas D.; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Weaver, Ryan J.] Iowa State Univ, Ecol Evolut & Organismal Biol Dept, Ames, IA USA	Auburn University System; Auburn University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Iowa State University	Powers, MJ (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.; Martz, LD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mjp0044@auburn.edu; ldmartz97@gmail.com	Burton, R/F-7694-2010	Burton, R/0000-0002-6995-5329; Martz, Lucas/0000-0002-9464-5015; Powers, Matthew/0000-0003-3499-0877; Weaver, Ryan/0000-0002-6160-4735	National Science Foundation, Division of Integrative Organismal Systems, NSF-IOS [1701827]	National Science Foundation, Division of Integrative Organismal Systems, NSF-IOS(National Science Foundation (NSF))	Funding for this project received by GEH and RSB. Grant/Award from National Science Foundation, Division of Integrative Organismal Systems, NSF-IOS 1701827. https://www.nsf.gov/div/index.jsp?div=IOS.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2014, FOOD CHEM, V165, P300, DOI 10.1016/j.foodchem.2014.05.107; Akinola FF, 2010, SCI RES ESSAYS, V5, P1145; Alonso-Alvarez C, 2008, J EVOLUTION BIOL, V21, P1789, DOI 10.1111/j.1420-9101.2008.01591.x; Anderson AJ, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190126; Baldwin J, 2012, J EXP BIOL, V215, P1184, DOI 10.1242/jeb.067512; Baldwin J, 2009, J EXP BIOL, V212, P3762, DOI 10.1242/jeb.028027; Barreto FS, 2018, NAT ECOL EVOL, V2, P1250, DOI 10.1038/s41559-018-0588-1; Barreto FS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1521; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; BROWN AF, 1991, BIOL BULL, V181, P123, DOI 10.2307/1542494; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2013, ANNU REV ECOL EVOL S, V44, P281, DOI 10.1146/annurev-ecolsys-110512-135758; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; BURTON RS, 1990, EVOLUTION, V44, P1814, DOI 10.1111/j.1558-5646.1990.tb05252.x; Cantarero A, 2020, EVOLUTION, V74, P2348, DOI 10.1111/evo.14073; Cantarero A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221436; Cantarero A, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0455; Caramujo MJ, 2012, MAR DRUGS, V10, P998, DOI 10.3390/md10050998; Celotto AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025823; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Csernetics A, 2015, WORLD J MICROB BIOT, V31, P321, DOI 10.1007/s11274-014-1784-z; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; Davenport J, 2004, MAR ECOL PROG SER, V276, P299, DOI 10.3354/meps276299; del Val E, 2009, NATURWISSENSCHAFTEN, V96, P989, DOI 10.1007/s00114-009-0554-5; del Val E, 2009, NATURWISSENSCHAFTEN, V96, P797, DOI 10.1007/s00114-009-0534-9; Ellison CK, 2010, J EVOLUTION BIOL, V23, P528, DOI 10.1111/j.1420-9101.2009.01917.x; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Ellison CK, 2006, EVOLUTION, V60, P1382, DOI 10.1111/j.0014-3820.2006.tb01217.x; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Feoli AM, 2006, NUTRITION, V22, P160, DOI 10.1016/j.nut.2005.06.007; Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004; Foley HB, 2019, EXP GERONTOL, V119, P146, DOI 10.1016/j.exger.2019.02.006; Ge ZY, 2015, PHYSIOL BIOCHEM ZOOL, V88, P444, DOI 10.1086/681992; GREEN J, 1965, BIOL REV, V40, P580, DOI 10.1111/j.1469-185X.1965.tb00817.x; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; HAIRSTON NG, 1976, P NATL ACAD SCI USA, V73, P971, DOI 10.1073/pnas.73.3.971; Harada AE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00213; Harrison JS, 2006, MOL BIOL EVOL, V23, P559, DOI 10.1093/molbev/msj058; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Healy TM, 2020, P NATL ACAD SCI USA, V117, P6616, DOI 10.1073/pnas.1910141117; Healy TM, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.213405; Heine KB, 2021, MITOCHONDRION, V56, P82, DOI 10.1016/j.mito.2020.11.001; Heine KB, 2020, BIOL REV, V95, P730, DOI 10.1111/brv.12584; Hill GE, 2019, OX ECOL EV, P1, DOI 10.1093/oso/9780198818250.001.0001; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; HILL GE, 1990, ANIM BEHAV, V40, P563, DOI 10.1016/S0003-3472(05)80537-8; Hill GE, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1354; Hill GE, 2014, INTEGR COMP BIOL, V54, P645, DOI 10.1093/icb/icu029; Hill GE, 2012, AM NAT, V180, pE127, DOI 10.1086/667861; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Hill Geoffrey E., 2007, P41; Johnson JD, 2013, BIOCHIMIE, V95, P436, DOI 10.1016/j.biochi.2012.10.021; Koch RE, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.188102; Koch RE, 2018, FUNCT ECOL, V32, P1908, DOI 10.1111/1365-2435.13122; Koch RE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02974-x; Koch RE, 2017, BIOL REV, V92, P1459, DOI 10.1111/brv.12291; Koch RE, 2016, PHYSIOL BIOCHEM ZOOL, V89, P61, DOI 10.1086/684485; KODRICBROWN A, 1985, BEHAV ECOL SOCIOBIOL, V17, P199, DOI 10.1007/BF00300137; Koutsos EA, 2003, J NUTR, V133, P1132, DOI 10.1093/jn/133.4.1132; LaFountain AM, 2015, ARCH BIOCHEM BIOPHYS, V572, P201, DOI 10.1016/j.abb.2015.01.016; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Li N, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07179-5; Lima TG, 2019, EVOLUTION, V73, P609, DOI 10.1111/evo.13690; Lopes RJ, 2016, CURR BIOL, V26, P1427, DOI 10.1016/j.cub.2016.03.076; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Maoka T, 2011, MAR DRUGS, V9, P278, DOI 10.3390/md9020278; McGraw KJ, 2004, J AVIAN BIOL, V35, P471, DOI 10.1111/j.0908-8857.2004.03405.x; Mojib N, 2014, MOL ECOL, V23, P2740, DOI 10.1111/mec.12781; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Mundy NI, 2016, CURR BIOL, V26, P1435, DOI 10.1016/j.cub.2016.04.047; Nguyen NH, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0132-5; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Parry HA, 2020, INT J SPORTS MED, V41, P349, DOI 10.1055/a-1121-7851; Peneaux C, 2021, IBIS, V163, P20, DOI 10.1111/ibi.12866; Pereira RJ, 2016, MOL ECOL, V25, P1478, DOI 10.1111/mec.13579; Pereira RJ., 2020, MOL ECOL; Picard M, 2021, NEUROSCI BIOBEHAV R, V120, P595, DOI 10.1016/j.neubiorev.2020.04.017; Powers MJ, 2021, INTEGR COMP BIOL, V61, P1811, DOI 10.1093/icb/icab056; Powers MJ, 2020, MAR BIOL, V167, DOI 10.1007/s00227-020-03765-z; Powers MJ, 2020, ETHOLOGY, V126, P344, DOI 10.1111/eth.12976; Powlik JJ, 1997, CRUSTACEANA, V70, P324, DOI 10.1163/156854097X00609; Prado-Cabrero A, 2020, MAR DRUGS, V18, DOI 10.3390/md18100506; Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005; Salin K, 2015, P ROY SOC B-BIOL SCI, V282, P14, DOI 10.1098/rspb.2015.1028; Schneider T, 2016, LIMNOL OCEANOGR, V61, P1201, DOI 10.1002/lno.10283; Simons MJP, 2014, AM NAT, V184, P741, DOI 10.1086/678402; Simons MJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043088; Sommaruga R, 2010, HYDROBIOLOGIA, V648, P143, DOI 10.1007/s10750-010-0141-y; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Srejber M, 2018, J INORG BIOCHEM, V183, P117, DOI 10.1016/j.jinorgbio.2018.03.002; Stephensen C. B., 2013, CAROTENOIDS HUMAN HL, P261, DOI [10.1007/978-1-62703-203-2, DOI 10.1007/978-1-62703-203-2]; Svensson PA, 2011, BEHAVIOUR, V148, P131, DOI 10.1163/000579510X548673; Torrissen OJ, 1995, J APPL ICHTHYOL, V11, P225, DOI 10.1111/j.1439-0426.1995.tb00022.x; Tward CE, 2019, COMP BIOCHEM PHYS B, V228, P41, DOI 10.1016/j.cbpb.2018.11.003; Twomey E, 2020, MOL ECOL, V29, P2004, DOI 10.1111/mec.15466; Twyman H, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1136-y; Verhulst S, 1999, P NATL ACAD SCI USA, V96, P4478, DOI 10.1073/pnas.96.8.4478; Vittor BA, 1971, THESIS DEP BIOL OREG; von Lintig J, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158580; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; Weaver RJ, 2020, BIOL BULL-US, V238, P119, DOI 10.1086/708625; Weaver RJ, 2019, INTEGR COMP BIOL, V59, P994, DOI 10.1093/icb/icz015; Weaver RJ, 2018, J PLANKTON RES, V40, P142, DOI 10.1093/plankt/fbx072; Weaver RJ, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0343; Weaver RJ, 2016, ECOL INDIC, V70, P393, DOI 10.1016/j.ecolind.2016.06.040; Willett Christopher S., 2018, Bulletin Southern California Academy of Sciences, V117, P150, DOI 10.3160/3712.1; Willett CS, 2010, EVOLUTION, V64, P2521, DOI 10.1111/j.1558-5646.2010.01008.x; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183; Wybouw N, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1039	115	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259371	10.1371/journal.pone.0259371	http://dx.doi.org/10.1371/journal.pone.0259371			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748608	gold, Green Published			2022-12-26	WOS:000755468000026
J	Ul Alam, MN; Jewel, GMNA; Azim, T; Seraj, ZI				Ul Alam, Md Nafis; Jewel, G. M. Nurnabi Azad; Azim, Tomalika; Seraj, Zeba, I			Novel QTLs for salinity tolerance revealed by genome-wide association studies of biomass, chlorophyll and tissue ion content in 176 rice landraces from Bangladesh	PLOS ONE			English	Article							STRESS; TRAITS	Farmland is on the decline and worldwide food security is at risk. Rice is the staple of choice for over half the Earth's people. To sustain current demands and ascertain a food secure future, substandard farmland affected by abiotic stresses must be utilized. For rapid crop improvement, a broader understanding of polygenic traits like stress tolerance and crop yield is indispensable. To this end, the hidden diversity of resilient and neglected wild varieties must be traced back to their genetic roots. In this study, we separately assayed 11 phenotypes in a panel of 176 diverse accessions predominantly comprised of local landraces from Bangladesh. We compiled high resolution sequence data for these accessions. We collectively studied the ties between the observed phenotypic differences and the examined additive genetic effects underlying these variations. We applied a fixed effect model to associate phenotypes with genotypes on a genomic scale. Discovered QTLs were mapped to known genes. Our explorations yielded 13 QTLs related to various traits in multiple trait classes. 10 identified QTLs were equivalent to findings from previous studies. Integrative analysis assumes potential novel functionality for a number of candidate genes. These findings will usher novel avenues for the bioengineering of high yielding crops of the future fortified with genetic defenses against abiotic stressors.	[Ul Alam, Md Nafis; Jewel, G. M. Nurnabi Azad; Azim, Tomalika; Seraj, Zeba, I] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Jewel, G. M. Nurnabi Azad] Shahjalal Univ Sci & Technol, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh	University of Dhaka; Shahjalal University of Science & Technology (SUST)	Seraj, ZI (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	zebai@du.ac.bd	seraj, zeba/H-2111-2017	seraj, zeba/0000-0002-1702-8574; Alam, Md Nafis Ul/0000-0003-3088-5279				Amin M, 2012, MOL BREEDING, V30, P345, DOI 10.1007/s11032-011-9625-3; annieart0, FREE BANGL MAP ILL; Bhowmik Salil Kumar, 2007, Pak J Biol Sci, V10, P4449, DOI 10.3923/pjbs.2007.4449.4454; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cui YR, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01464; De Leon TB, 2016, RICE, V9, DOI 10.1186/s12284-016-0125-2; Delorean E.E., 2016, DETECTING DURABLE RE; Dingkuhn M, 2017, J EXP BOT, V68, P4389, DOI 10.1093/jxb/erx250; Diop B, 2020, J EXP BOT, V71, P4188, DOI 10.1093/jxb/eraa182; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Eynard A, 2005, J SUSTAIN AGR, V27, P5, DOI 10.1300/J064v27n01_03; Formentin E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00204; Frouin J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190964; Fusi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5890; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; German Environment Agency F.M.f.E.C.a.D.., 2015, 10 MILL HECT AR WORL; Golldack D, 2003, PLANT MOL BIOL, V51, P71, DOI 10.1023/A:1020763218045; Gregorio G., 1997, THESIS U PHILIPPINES; Gupta G.S.J.R.E.S., 2019, LAND DEGRADATION CHA, V11, P63; Hosseinalipour S, 2021, IEEE T CLOUD COMPUT, V9, P881, DOI [10.1109/TCC.2019.2901785, 10.1002/er.4930]; Huang M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy154; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; To HTM, 2019, RICE, V12, DOI 10.1186/s12284-019-0327-5; IRRI I.J.I.R.R.I., 2002, STAND EV SYST RIC, P1; Jeong J, 2013, MOL CELLS, V35, P371, DOI 10.1007/s10059-013-0135-5; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kromdijk J, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2578; Krusell L, 2002, NATURE, V420, P422, DOI 10.1038/nature01207; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Mai N.T.P.., 2020, DISCOVERY NEW GENETI; Mansueto L, 2017, NUCLEIC ACIDS RES, V45, pD1075, DOI 10.1093/nar/gkw1135; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Misra G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12778-6; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Pires IS, 2015, PHYSIOL PLANTARUM, V155, P43, DOI 10.1111/ppl.12356; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Schlappi MR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00957; Solis CA, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00323; Tang Y, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0120; Tao YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198589; Tsioumani E., 2019, Environmental Policy and Law, V49, P110; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu J, 2017, MOL GENET GENOMICS, V292, P1391, DOI 10.1007/s00438-017-1354-9; Zhang J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4221-5; Zhang Y, 2020, PLANT GROWTH REGUL, V92, P365, DOI 10.1007/s10725-020-00644-x; Zhao Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39280-5	53	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259456	10.1371/journal.pone.0259456	http://dx.doi.org/10.1371/journal.pone.0259456			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739483	Green Published, gold			2022-12-26	WOS:000755000800035
J	Chatterjee, E; Sennott, C				Chatterjee, Esha; Sennott, Christie			Fertility intentions and child health in India: Women's use of health services, breastfeeding, and official birth documentation following an unwanted birth	PLOS ONE			English	Article							UNINTENDED PREGNANCY; PROPENSITY SCORE; MATERNAL BEHAVIORS; MATCHING METHODS; LESS LIKELIHOOD; INFANT; CHILDBEARING; RISK; CARE; CONSEQUENCES	This study examines the relationship between women's prospective fertility intentions and child health, measured via access to healthcare facilities for children and postpartum maternal behaviors that are indicative of future child health. We analyze two waves of nationally representative data (2005 and 2012) from the India Human Development Survey (IHDS). The analytic sample includes 3,442 non-pregnant, currently married women aged 18-40 in 2005 who participated in both rounds of the IHDS, and had at least one birth between 2005 and 2012. We investigate the influence of women's prospective fertility intentions on access to benefits from the Integrated Child Development Services (ICDS), indicators of breastfeeding as recommended by the World Health Organization, and official documentation of births via birth certificates or registration. We find that 58 percent of births among women in the sample were labeled as unwanted. We use an adaptation of propensity score matching-the inverse-probability-weighted regression adjustment (IPWRA) estimator-and show that, after accounting for maternal and household characteristics that are known to be associated with maternal and child health, children who resulted from unwanted births were less likely to obtain any benefits or immunizations from the ICDS, to be breastfed within one hour of birth, and to have an official birth certificate. Results from this study have direct policy significance given the evidence that women's fertility intentions can have negative implications for child health and wellbeing in the short and longer term.	[Chatterjee, Esha] Indian Inst Technol Kanpur, Dept Humanities & Social Sci, Kanpur, Uttar Pradesh, India; [Sennott, Christie] Purdue Univ, Dept Sociol, W Lafayette, IN 47907 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sennott, C (corresponding author), Purdue Univ, Dept Sociol, W Lafayette, IN 47907 USA.	csennott@purdue.edu	Chatterjee, Esha/ACD-3352-2022	Sennott, Christie/0000-0002-3760-6271; Chatterjee, Esha/0000-0002-6855-2966				Awofeso N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-358; Barber JS, 2009, CHILD DEV, V80, P921, DOI 10.1111/j.1467-8624.2009.01306.x; Berra S, 2001, ACTA PAEDIATR, V90, P544, DOI 10.1080/080352501750197692; Bhatia A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001926; Bhatia A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0635-6; Binns C., 2019, OXFORD RES ENCY GLOB; Binns C, 2016, ASIA-PAC J PUBLIC HE, V28, P7, DOI 10.1177/1010539515624964; Brolan CE, 2017, LANCET, V389, P1084, DOI 10.1016/S0140-6736(17)30753-5; Brown SS., 1995, BEST INTENTIONS UNIN, P338; Cattaneo MD, 2010, J ECONOMETRICS, V155, P138, DOI 10.1016/j.jeconom.2009.09.023; Chalasani S., ANN M POP ASS AM NEW, P29; Chatterjee E, 2020, POP STUD-J DEMOG, V74, P55, DOI 10.1080/00324728.2019.1672881; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Chinebuah B, 2001, J NUTR, V131, P1247, DOI 10.1093/jn/131.4.1247; Chowdhury P., 2021, BMJ OPEN, V11; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Desai S., 2010, HUMAN DEV INDIA CHAL; Desai S, 2010, MARGIN, V4, P293, DOI 10.1177/097380101000400303; DRAKE C, 1993, BIOMETRICS, V49, P1231, DOI 10.2307/2532266; Eggleston E, 2001, AM J PUBLIC HEALTH, V91, P808, DOI 10.2105/AJPH.91.5.808; Fanzo J., 2019, GLOBAL NUTR REPORT; FRENZEN PD, 1982, DEMOGRAPHY, V19, P391, DOI 10.2307/2060978; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Greiner T., 2000, WORLD BANK UNICEF JO; Guzzo KB, 2012, SOC SCI RES, V41, P1138, DOI 10.1016/j.ssresearch.2012.03.002; Horta BL, 2019, BREASTFEED MED, V14, pS11, DOI 10.1089/bfm.2019.0032; Hromi-Fiedler AJ, 2006, PUBLIC HEALTH NUTR, V9, P306, DOI 10.1079/PHN2006856; Imbens GW, 2015, J HUM RESOUR, V50, P373, DOI 10.3368/jhr.50.2.373; India G of. Child Development, 2000, MINISTRY HUMAN RESOU; International Institute for Population Sciences,, 2017, NATL FAMILY HLTH SUR; International Institute for Population Sciences, 2007, NATL FAMILY HLTH SUR; Jain AK, 2017, STUD FAMILY PLANN, V48, P269, DOI 10.1111/sifp.12023; Jensen ER, 2002, B INDONES ECON STUD, V38, P43, DOI 10.1080/000749102753620275; Jensen ER., 1999, MULTICOUNTRY ANAL IM; Joyce T, 2000, Matern Child Health J, V4, P171, DOI 10.1023/A:1009571313297; Kandpal E, 2011, WORLD DEV, V39, P1410, DOI 10.1016/j.worlddev.2010.12.013; Kebebe E, 2017, FOREST POLICY ECON, V75, P67, DOI 10.1016/j.forpol.2016.12.001; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Korenman S, 2002, PERSPECT SEX REPRO H, V34, P198, DOI 10.2307/3097730; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Kost K, 2015, DEMOGRAPHY, V52, P83, DOI 10.1007/s13524-014-0359-9; Lawrence RA, 2000, CURR OPIN OBSTET GYN, V12, P519, DOI 10.1097/00001703-200012000-00011; Leon-Cava N., 2002, QUANTIFYING BENEFITS, P3; Lindberg L, 2015, MATERN CHILD HLTH J, V19, P1087, DOI 10.1007/s10995-014-1609-6; Lokshin M, 2005, DEV CHANGE, V36, P613, DOI 10.1111/j.0012-155X.2005.00427.x; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Manikam L, 2018, PUBLIC HEALTH NUTR, V21, P637, DOI [10.1017/S136898001700297X, 10.1017/s136898001700297x]; MARSIGLIO W, 1988, J MARRIAGE FAM, V50, P1023, DOI 10.2307/352112; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Messer LC, 2010, AM J EPIDEMIOL, V171, P664, DOI 10.1093/aje/kwp435; Miller WB, 2017, POP STUD-J DEMOG, V71, P101, DOI 10.1080/00324728.2016.1253858; Miller WB, 2013, POP STUD-J DEMOG, V67, P25, DOI 10.1080/00324728.2012.738823; Mishra US., 1998, J FAM WELFARE, V44, P1; Montgomery MR., 1997, CONSEQUENCES IMPERFE; Parliament of India Rajya Sabha (Upper House), 2003, DEP REL PARL STAND C; Perez-Escamilla R, 1999, PUBLIC HEALTH NUTR, V2, P461, DOI 10.1017/S1368980099000646; Ramani KV., 2010, VIKALPA, V35, P9; Rammohan A, 2015, SOC SCI MED, V145, P163, DOI 10.1016/j.socscimed.2015.05.004; Roy TK, 2003, INT FAM PLAN PERSPEC, V29, P25, DOI 10.2307/3180998; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Sennott C, 2018, J MARRIAGE FAM, V80, P888, DOI 10.1111/jomf.12489; Shapiro-Mendoza C, 2005, INT J EPIDEMIOL, V34, P387, DOI 10.1093/ije/dyh354; Singh A, 2017, STUD FAMILY PLANN, V48, P55, DOI 10.1111/sifp.12017; Singh A, 2013, MATERN CHILD HLTH J, V17, P493, DOI 10.1007/s10995-012-1023-x; Singh A, 2012, POP STUD-J DEMOG, V66, P223, DOI 10.1080/00324728.2012.697568; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Smith-Greenaway E, 2016, DEMOGRAPHY, V53, P805, DOI 10.1007/s13524-016-0475-9; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Taylor JS, 2002, J FAM PRACTICE, V51, P431; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; UNICEF, 2019, STATE WORLDS CHILDRE; Upadhyay AK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0909-9; Victora CG, 2015, LANCET GLOB HEALTH, V3, pE199, DOI 10.1016/S2214-109X(15)70002-1; World Health Organization, 2013, LONG TERM EFFECTS BR; Yeatman S, 2015, MATERN CHILD HLTH J, V19, P1593, DOI 10.1007/s10995-015-1669-2	80	1	1	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259311	10.1371/journal.pone.0259311	http://dx.doi.org/10.1371/journal.pone.0259311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735493	Green Published, gold			2022-12-26	WOS:000755077100063
J	Naruke, A; Nakano, R; Nunomura, J; Suwabe, Y; Nakano, M; Namba, S; Kitanaka, T; Kitanaka, N; Sugiya, H; Nakayama, T				Naruke, Atsuto; Nakano, Rei; Nunomura, Junichi; Suwabe, Yoko; Nakano, Masumi; Namba, Shinichi; Kitanaka, Taku; Kitanaka, Nanako; Sugiya, Hiroshi; Nakayama, Tomohiro			Tpl2 contributes to IL-1 beta-induced IL-8 expression via ERK1/2 activation in canine dermal fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; NEUTROPHIL CHEMOTACTIC FACTOR; GENE-EXPRESSION; INFLAMMATORY RESPONSES; SYNOVIAL FIBROBLASTS; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; WOUND REPAIR; INTERLEUKIN-8; CELLS	In autoimmune diseases, fibroblasts produce and secrete various cytokines and act as sentinel immune cells during inflammatory states. However, the contribution of sentinel immune cells (i.e. dermal fibroblasts) in autoimmune diseases of the skin, such as atopic dermatitis, has been obscure. The pro-inflammatory cytokine interleukin 1 beta (IL-1 beta) induces the expression of chemokines, such as interleukin 8 (IL-8), in autoimmune diseases of the skin. IL-8 induces the activation and recruitment of innate immune cells such as neutrophils to the site of inflammation. IL-1 beta-mediated induction of IL-8 expression is important for the pathogenesis of autoimmune diseases; however, the intracellular singling remains to be understood. To elucidate the mechanism of the onset of autoimmune diseases, we established a model for IL-1 beta-induced dermatitis and investigated MAPK signaling pathways in IL-1 beta-induced IL-8 expression. We also identified that a MAP3K Tpl2 acts as an upstream modulator of IL-1 beta-induced ERK1/2 activation in dermal fibroblasts. We observed an increase in the expression of IL-8 mRNA and protein in cells treated with IL-1 beta. ERK1/2 inhibitors significantly reduced IL-1 beta-induced IL-8 expression, whereas the inhibitor for p38 MAPK or JNK had no effect. IL-1 beta induced ERK1/2 phosphorylation, which was attenuated in the presence of an ERK1/2 inhibitor. IL-1 beta failed to induce IL-8 expression in cells transfected with siRNA for ERK1, or ERK2. Notably, a Tpl2 inhibitor reduced IL-1 beta-induced IL-8 expression and ERK1/2 phosphorylation. We confirmed that the silencing of Tpl2 in siRNA-transfected fibroblasts prevented both in IL-1 beta-induced IL-8 expression and ERK1/2 phosphorylation. Taken together, our data indicate the importance of Tpl2 in the modulation of ERK1/2 signaling involved in the IL-1 beta-induced development of autoimmune diseases affecting the dermal tissue, such as atopic dermatitis.	[Naruke, Atsuto; Nakano, Rei; Nunomura, Junichi; Suwabe, Yoko; Nakano, Masumi; Namba, Shinichi; Kitanaka, Taku; Kitanaka, Nanako; Sugiya, Hiroshi; Nakayama, Tomohiro] Nihon Univ, Labs Vet Radiotherapy, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN Ctr Integrat Med Sci, Lab Cellular Funct Convers Technol, Suehiro Cho, Yokohama, Kanagawa, Japan	Nihon University; RIKEN	Nakano, R (corresponding author), Nihon Univ, Labs Vet Radiotherapy, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan.; Nakano, R (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Cellular Funct Convers Technol, Suehiro Cho, Yokohama, Kanagawa, Japan.	rei.nakano@riken.jp	Nakayama, Tomohiro/GYU-0303-2022					ABRUZZO LV, 1992, AM J PATHOL, V140, P365; Acuff NV, 2017, COMPARATIVE MED, V67, P344; Avazi DO, 2019, CYTOKINE, V113, P128, DOI 10.1016/j.cyto.2018.06.024; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Benakanakere MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep31180; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bratka-Robia CB, 2002, VET DERMATOL, V13, P1, DOI 10.1046/j.0959-4493.2001.00276.x; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Carroll TP, 2005, J IMMUNOL, V175, P7594, DOI 10.4049/jimmunol.175.11.7594; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; El-Hadi M, 2012, CAN J VET RES, V76, P8; Ellis S, 2018, CURR DERMATOL REP, V7, P350, DOI 10.1007/s13671-018-0234-9; Floras ANK, 2014, J VET INTERN MED, V28, P1447, DOI 10.1111/jvim.12409; Gantke T, 2012, IMMUNOL REV, V246, P168, DOI 10.1111/j.1600-065X.2012.01104.x; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gelaleti GB, 2012, VET IMMUNOL IMMUNOP, V146, P106, DOI 10.1016/j.vetimm.2012.02.005; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haas M, 2016, J VET MED SCI, V78, P375, DOI 10.1292/jvms.15-0415; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kanwal S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90992-z; Kany S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236008; Karlsson I, 2012, REPROD DOMEST ANIM, V47, P337, DOI 10.1111/rda.12034; Karlsson I, 2015, THERIOGENOLOGY, V84, P34, DOI 10.1016/j.theriogenology.2015.02.008; Kitanaka N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222869; Kitanaka N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220262; Kitanaka N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208955; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Konno T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166707; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LARSEN CG, 1989, IMMUNOLOGY, V68, P31; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199; Liu XF, 2014, INFLAMMATION, V37, P1486, DOI 10.1007/s10753-014-9874-5; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Martin P, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.652846; Mavropoulou A, 2016, VET J, V211, P45, DOI 10.1016/j.tvjl.2016.03.002; Mei B, 2018, J THORAC CARDIOV SUR, V156, P696, DOI 10.1016/j.jtcvs.2018.03.151; Nakano R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.579266; Nakano R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229892; Nakano R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26473-7; Nakano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141581; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Olivry T, 2016, J INVEST DERMATOL, V136, P1961, DOI 10.1016/j.jid.2016.05.117; Ou HL, 2016, INNATE IMMUN-LONDON, V22, P452, DOI 10.1177/1753425916654011; PEVERI P, 1988, J EXP MED, V167, P1547, DOI 10.1084/jem.167.5.1547; Rasmussen MK, 2008, INFLAMM RES, V57, P329, DOI 10.1007/s00011-007-7220-1; RATHANASWAMI P, 1993, ARTHRITIS RHEUM, V36, P1295, DOI 10.1002/art.1780360914; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; Senger K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4273; Smith RS, 1997, AM J PATHOL, V151, P317; Sodin-Semrl S, 2000, J IMMUNOL, V164, P2660, DOI 10.4049/jimmunol.164.5.2660; Sooranna SR, 2005, J CLIN ENDOCR METAB, V90, P3517, DOI 10.1210/jc.2004-1390; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; Suwabe Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243859; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Varin EM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.399; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; WALZ A, 1987, BIOCHEM BIOPH RES CO, V149, P755, DOI 10.1016/0006-291X(87)90432-3; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xu DQ, 2018, PHARMACOL RES, V129, P188, DOI 10.1016/j.phrs.2017.11.031; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Yoshitake R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64832-5; Zarrin AA, 2021, NAT REV DRUG DISCOV, V20, P39, DOI 10.1038/s41573-020-0082-8	75	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259489	10.1371/journal.pone.0259489	http://dx.doi.org/10.1371/journal.pone.0259489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735542	Green Published, gold			2022-12-26	WOS:000755077100081
J	Tekalegn, Y; Engida, ZT; Sahiledengle, B; Rogers, HL; Seyoum, K; Woldeyohannes, D; Legese, B; Ayele, TA				Tekalegn, Yohannes; Engida, Zinash Teferu; Sahiledengle, Biniyam; Rogers, Heather L.; Seyoum, Kenbon; Woldeyohannes, Demelash; Legese, Birhan; Ayele, Tadesse Awoke			Individual and community-level determinants of overweight and obesity among urban men: Further analysis of the Ethiopian demographic and health survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PHYSICAL-ACTIVITY; FATNESS; EPIDEMIOLOGY; UNDERWEIGHT; TELEVISION; PREVALENCE; COUNTRIES; DISEASE; BURDEN	Background Overweight and obesity have become a serious public health problem in both developed and developing countries, particularly in urban areas. However, there are limited studies conducted to identify the risk factors of overweight and obesity in Ethiopia, especially among men. Therefore, this study aimed to assess individual and community level determinants of overweight and obesity among urban men in Ethiopia. Methods This study used the 2016 Ethiopian Demographic and Health Survey (EDHS) data. A weighted sample of 2259 urban men aged 15-59 years were included in this analysis. A multilevel logistic regression model was used to assess the determinants of overweight and obesity among the study participants. Results Men aged 30-44 years old (AOR = 3.1, 95% CI: 2.3-4.11), 45-59 years old (AOR = 4.8, 95% CI: 3.4-6.9), married (AOR = 1.7, 95% CI: 1.3-2.2), with secondary education (AOR = 2.7, 95% CI: 1.6-4.7), with higher education (AOR = 3.6, 95% CI: 2.1-6.2), watching television at least once a week (AOR = 1.7, 95% CI: 1.1-2.7), being from high rich communities (AOR = 2.4, 95% CI: 1.5-3.7), and living in three metropolises (Addis Ababa, Harari, Diredawa) were more likely to be overweight or obese (AOR = 1.8, 95% CI: 1.1-2.9). However, currently unemployed men were less likely to be overweight or obese (AOR = 0.5, 95% CI: 0.3-0.7). Conclusion Being older age, being married, having higher educational status, having higher frequency of watching television, being residents of three metropolises (Addis Ababa, Harari, and Diredawa), and being from high rich communities were found to be predictors of overweight and obesity in Ethiopian men. Therefore, it is essential to design strategies and programs to reduce or prevent overweight and obesity with special focus on the identified risk factors.	[Tekalegn, Yohannes; Engida, Zinash Teferu; Sahiledengle, Biniyam] Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Publ Hlth, Goba, Ethiopia; [Rogers, Heather L.] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain; [Rogers, Heather L.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Seyoum, Kenbon] Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Midwifery, Goba, Ethiopia; [Woldeyohannes, Demelash] Wachemo Univ, Sch Med & Hlth Sci, Dept Publ Hlth, Hosana, Ethiopia; [Legese, Birhan] Ambo Univ, Sch Med & Hlth Sci, Dept Publ Hlth, Ambo, Ethiopia; [Ayele, Tadesse Awoke] Univ Gondar, Dept Epidemiol & Biostat, Gondar, Ethiopia	Basque Foundation for Science; Ambo University; University of Gondar	Tekalegn, Y (corresponding author), Madda Walabu Univ, Goba Referral Hosp, Sch Hlth Sci, Dept Publ Hlth, Goba, Ethiopia.	yohannesefa@gmail.com	Rogers, Heather L./AAB-8486-2022; Sahiledengle, Biniyam/AAG-9457-2020	Rogers, Heather L./0000-0002-7562-4542; Sahiledengle, Biniyam/0000-0002-1114-4849; Tekalegn, Yohannes/0000-0001-6628-8180				Abrha S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3315-3; Addo J, 2009, PUBLIC HEALTH, V123, P365, DOI 10.1016/j.puhe.2009.02.003; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Agency CS, 2017, DHS PROGRAM ICF, V363, P364; Amin Faridah, 2015, BMC Obes, V2, P16, DOI 10.1186/s40608-015-0044-6; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Bollyky TJ, 2017, HEALTH AFFAIR, V36, P1866, DOI 10.1377/hlthaff.2017.0708; Boutayeb A., 2010, HDB DIS BURDENS QUAL, V531; Burke V, 2006, INT J PEDIATR OBES, V1, P248, DOI 10.1080/17477160600984975; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen CY, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015600480; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Croft TN, 2018, GUIDE DHS STAT; Dagne S, 2019, DIABETES METAB SYNDR, V12, P391, DOI 10.2147/DMSO.S179699; Darebo Teshale, 2019, BMC Obes, V6, P8, DOI 10.1186/s40608-019-0227-7; Das Gupta R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024680; Delbiso TD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30204; Demographic E, 2012, HLTH SURVEY 2011 CEN; Doku DT, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2033-6; Ghavamzadeh S, 2013, J HEALTH POPUL NUTR, V31, P334; Ghose B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014399; Gouda J, 2014, J HEALTH POPUL NUTR, V32, P79; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; ICF C. Central Statistical Agency [Ethiopia] and ICF International, 2011, ETH DEM HLTH SURV; Janghorbani M, 2007, OBESITY, V15, P2797, DOI 10.1038/oby.2007.332; Kamadjeu RM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-228; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kassie AM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039200; Kassie AM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08941-w; Kragelund C, 2005, LANCET, V366, P1589, DOI 10.1016/S0140-6736(05)67642-8; Lipowicz A, 2002, AM J HUM BIOL, V14, P468, DOI 10.1002/ajhb.10062; Little Matthew, 2016, BMC Obes, V3, P12, DOI 10.1186/s40608-016-0091-7; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mekonnen T, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0262-8; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Olsen NJ, 2009, OBES REV, V10, P68, DOI 10.1111/j.1467-789X.2008.00523.x; Olufemi A. J., 2013, International Journal of Humanities and Social Science, V3, P234; Organization WH, 2012, OB OV FACT SHEET 311; Piryani S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010335; Sen J, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8741; Shayo GA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-365; Shinde PP, 2013, J EVOL MED DENT SCI-, V2, P364; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; Sowers JR, 2003, AM J MED, V115, P37, DOI 10.1016/j.amjmed.2003.08.012; Tabrizi JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165264; Tanwi TS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7221-3; Tebekaw Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1126; Tekalegn Y, 2021, J OBES, V2021, DOI 10.1155/2021/6627328; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wagner DR, 1999, RES Q EXERCISE SPORT, V70, P135, DOI 10.1080/02701367.1999.10608031; Wang XH, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00127; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, OB OV FACTSH; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280; Yeshaw Y, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034963; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P590, DOI 10.5604/12321966.1120608	58	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259412	10.1371/journal.pone.0259412	http://dx.doi.org/10.1371/journal.pone.0259412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735510	Green Submitted, Green Published, gold			2022-12-26	WOS:000755077100072
J	Defnet, AE; Shah, SD; Huang, WL; Shapiro, P; Deshpande, DA; Kane, MA				Defnet, Amy E.; Shah, Sushrut D.; Huang, Weiliang; Shapiro, Paul; Deshpande, Deepak A.; Kane, Maureen A.			Dysregulated retinoic acid signaling in airway smooth muscle cells in asthma	FASEB JOURNAL			English	Article						airway inflammation; airway smooth muscle; asthma; retinoic acid; retinoids; vitamin A	VITAMIN-A; BODY IRRADIATION; GENE; QUANTIFICATION; AP-1; PROLIFERATION; MODEL; TRANSACTIVATION; IDENTIFICATION; MECHANISMS	Vitamin A deficiency has been shown to exacerbate allergic asthma. Previous studies have postulated that retinoic acid (RA), an active metabolite of vitamin A and high-affinity ligand for RA receptor (RAR), is reduced in airway inflammatory condition and contributes to multiple features of asthma including airway hyperresponsiveness and excessive accumulation of airway smooth muscle (ASM) cells. In this study, we directly quantified RA and examined the molecular basis for reduced RA levels and RA-mediated signaling in lungs and ASM cells obtained from asthmatic donors and in lungs from allergen-challenged mice. Levels of RA and retinol were significantly lower in lung tissues from asthmatic donors and house dust mite (HDM)-challenged mice compared to non-asthmatic human lungs and PBS-challenged mice, respectively. Quantification of mRNA and protein expression revealed dysregulation in the first step of RA biosynthesis consistent with reduced RA including decreased protein expression of retinol dehydrogenase (RDH)-10 and increased protein expression of RDH11 and dehydrogenase/reductase (DHRS)-4 in asthmatic lung. Proteomic profiling of non-asthmatic and asthmatic lungs also showed significant changes in the protein expression of AP-1 targets consistent with increased AP-1 activity. Further, basal RA levels and RA biosynthetic capabilities were decreased in asthmatic human ASM cells. Treatment of human ASM cells with all-trans RA (ATRA) or the RAR gamma-specific agonist (CD1530) resulted in the inhibition of mitogen-induced cell proliferation and AP-1-dependent transcription. These data suggest that RA metabolism is decreased in asthmatic lung and that enhancing RAR signaling using ATRA or RAR gamma agonists may mitigate airway remodeling associated with asthma.	[Defnet, Amy E.; Huang, Weiliang; Shapiro, Paul; Kane, Maureen A.] Univ Maryland, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA; [Shah, Sushrut D.; Deshpande, Deepak A.] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA	University System of Maryland; University of Maryland Baltimore; Jefferson University	Kane, MA (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 20 N Pine St,Rm N731, Baltimore, MD 21201 USA.; Deshpande, DA (corresponding author), Thomas Jefferson Univ, Dept Med, Ctr Translat Med, 1020 Locust St,Rm 543B, Philadelphia, PA 19107 USA.	deepak.deshpande@jefferson.edu; mkane@rx.umaryland.edu		Deshpande, Deepak/0000-0002-6187-5332; Shah, Sushrut/0000-0002-4201-6532	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI26492]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [T32 GM066706]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI26492; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: T32 GM066706	Agache I, 2021, ALLERGY, V76, P14, DOI 10.1111/all.14425; Amrani Y, 2003, INT J BIOCHEM CELL B, V35, P272, DOI 10.1016/S1357-2725(02)00259-5; Arora P, 2002, PEDIATR ALLERGY IMMU, V13, P223, DOI 10.1034/j.1399-3038.2002.00010.x; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Biesalski HK, 1999, AM J CLIN NUTR, V69, P931; Black JL, 2001, AM J RESP CRIT CARE, V164, pS63, DOI 10.1164/ajrccm.164.supplement_2.2106059; Bourke JE, 2011, EUR RESPIR J, V37, P173, DOI 10.1183/09031936.00008109; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911; Chen F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120398; Chen F, 2014, J CLIN INVEST, V124, P801, DOI 10.1172/JCI70291; CHEN JY, 1995, EMBO J, V14, P1187, DOI 10.1002/j.1460-2075.1995.tb07102.x; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Cunningham TJ, 2015, NAT REV MOL CELL BIO, V16, P110, DOI 10.1038/nrm3932; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Defnet AE, 2019, FASEB J, V33, P10833, DOI 10.1096/fj.201900680R; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Dutta A, 2010, CELL ADHES MIGR, V4, P409, DOI 10.4161/cam.4.3.11682; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Ghyselinck NB, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.167502; Huang WL, 2020, HEALTH PHYS, V119, P604, DOI 10.1097/HP.0000000000001351; Huang WL, 2019, HEALTH PHYS, V116, P503, DOI 10.1097/HP.0000000000000956; Huang WL, 2019, HEALTH PHYS, V116, P516, DOI 10.1097/HP.0000000000000951; Hufnagl K, 2018, ALLERGO J, V27, P21, DOI 10.1007/s40629-018-0054-2; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Jones JW, 2015, HEALTH PHYS, V109, P452, DOI 10.1097/HP.0000000000000346; Jones JW, 2015, ANAL CHEM, V87, P3222, DOI 10.1021/ac504597q; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Marquez Hector A, 2016, Mol Cell Pediatr, V3, P28, DOI 10.1186/s40348-016-0054-6; McGowan SE, 2002, AM J PHYSIOL-LUNG C, V282, pL1031, DOI 10.1152/ajplung.00319.2001; McKeever TM, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-67; MORABIA A, 1989, AM REV RESPIR DIS, V140, P1312, DOI 10.1164/ajrccm/140.5.1312; Napoli JL, 2020, METHOD ENZYMOL, V637, P27, DOI 10.1016/bs.mie.2020.02.003; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri Reynold A. Jr., 2002, Journal of Allergy and Clinical Immunology, V110, pS269, DOI 10.1067/mai.2002.129429; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Shannon SR, 2020, METHOD ENZYMOL, V637, P367, DOI 10.1016/bs.mie.2020.03.011; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Smolinska MJ, 2011, J IMMUNOL, V187, P6043, DOI 10.4049/jimmunol.1100967; Tang XH, 2014, P NATL ACAD SCI USA, V111, P8907, DOI 10.1073/pnas.1404828111; Thatcher JE, 2011, MOL PHARMACOL, V80, P228, DOI 10.1124/mol.111.072413; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tian X, 2018, EXP LUNG RES, V44, P217, DOI 10.1080/01902148.2018.1493551; Tong L, 2004, CELL SIGNAL, V16, P1123, DOI 10.1016/j.cellsig.2004.03.003; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; Wang S, 2020, PHARMACOL THERAPEUT, V205, DOI 10.1016/j.pharmthera.2019.107415; Zhou XF, 1999, MOL ENDOCRINOL, V13, P276, DOI 10.1210/me.13.2.276; Zou DD, 2012, LEUKEMIA RES, V36, P219, DOI 10.1016/j.leukres.2011.09.012	62	2	2	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2021	35	12							e22016	10.1096/fj.202100835R	http://dx.doi.org/10.1096/fj.202100835R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	XC9HG	34784434	Green Accepted			2022-12-26	WOS:000722321300027
J	Sargeant, J; Seiler, DK; Costain, T; Madreiter-Sokolowski, CT; Gordon, DE; Peden, AA; Malli, R; Graier, WF; Hay, JC				Sargeant, John; Seiler, Danette Kowal; Costain, Tucker; Madreiter-Sokolowski, Corina T.; Gordon, David E.; Peden, Andrew A.; Malli, Roland; Graier, Wolfgang F.; Hay, Jesse C.			ALG-2 and peflin regulate COPII targeting and secretion in response to calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM EXIT SITES; PROTEIN SECRETION; SEC31A; LOCALIZATION; ORGANIZATION; EXPRESSION; PATHWAY	ER-to-Golgi transport is the first step in the constitutive secretory pathway, which, unlike regulated secretion, is believed to proceed nonstop independent of Ca2+ flux. However, here we demonstrate that penta-EF hand (PEF) proteins ALG-2 and peflin constitute a hetero-bifunctional COPII regulator that responds to Ca2+ signaling by adopting one of several distinct activity states. Functionally, these states can adjust the rate of ER export of COPII-sorted cargos up or down by similar to 50%. We found that at steady-state Ca2+, ALG-2/peflin hetero-complexes bind to ER exit sites (ERES) through the ALG-2 subunit to confer a low, buffered secretion rate, while peflin-lacking ALG-2 complexes markedly stimulate secretion. Upon Ca2+ signaling, ALG-2 complexes lacking peflin can either increase or decrease the secretion rate depending on signaling intensity and duration- phenomena that could contribute to cellular growth and intercellular communication following secretory increases or protection from excitotoxicity and infection following decreases. In epithelial normal rat kidney (NRK) cells, the Ca2+-mobilizing agonist ATP causes ALG-2 to depress ER export, while in neuroendocrine PC12 cells, Ca2++ mobilization by ATP results in ALG-2-dependent enhancement of secretion. Furthermore, distinct Ca2+ signaling patterns in NRK cells produce opposing ALG-2-dependent effects on secretion. Mechanistically, ALG-2-dependent depression of secretion involves decreased levels of the COPII outer shell and increased peflin targeting to ERES, while ALG-2-dependent enhancement of secretion involves increased COPII outer shell and decreased peflin at ERES. These data provide insights into how PEF protein dynamics affect secretion of important physiological cargoes such as collagen I and significantly impact ER stress.	[Sargeant, John; Seiler, Danette Kowal; Costain, Tucker; Hay, Jesse C.] Univ Montana, Div Biol Sci, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA; [Madreiter-Sokolowski, Corina T.; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Graz, Austria; [Gordon, David E.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Peden, Andrew A.] Univ Sheffield, Ctr Membrane Interact & Dynam, Sheffield, S Yorkshire, England	University of Montana System; University of Montana; Medical University of Graz; University of California System; University of California San Francisco; University of Sheffield; University of Sheffield	Hay, JC (corresponding author), Univ Montana, Div Biol Sci, Ctr Struct & Funct Neurosci, Missoula, MT 59812 USA.	jesse.hay@umontana.edu	Graier, Wolfgang F./B-7052-2008	Graier, Wolfgang F./0000-0003-1871-3298; Madreiter-Sokolowski, Corina T./0000-0002-8631-9949; Hay, Jesse/0000-0002-9831-9583; Peden, Andrew/0000-0003-0144-7712; Malli, Roland/0000-0001-6327-8729	NIH [1R15GM106323-02]; University of Montana Center for Biomolecular Structure and Dynamics NIH [P20GM103546]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Montana Center for Biomolecular Structure and Dynamics NIH	Funding and additional information-This work was supported by NIH grant 1R15GM106323-02 to J. C. H., and the University of Montana Center for Biomolecular Structure and Dynamics NIH grant P20GM103546. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Cho HJ, 2020, BIOL CELL, V112, P439, DOI 10.1111/boc.201900062; Cho HJ, 2018, FASEB J, V32, P4641, DOI 10.1096/fj.201701523R; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hu H, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03083; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Ireland S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100952; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kitaura Y, 2002, ARCH BIOCHEM BIOPHYS, V399, P12, DOI 10.1006/abbi.2001.2736; Kitaura Y, 2001, J BIOL CHEM, V276, P14053, DOI 10.1074/jbc.M008649200; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; la Cour JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075309; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Ma W, 2017, ELIFE, V6, DOI 10.7554/eLife.26624; Madreiter-Sokolowski CT, 2019, REDOX BIOL, V20, P458, DOI 10.1016/j.redox.2018.11.003; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Maki M., 2007, CALCIUM BIND PROTEIN, V2, P4; McCaughey J, 2016, CELL REP, V15, P1648, DOI 10.1016/j.celrep.2016.04.062; McGourty CA, 2016, CELL, V167, P525, DOI 10.1016/j.cell.2016.09.026; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; Omari S, 2018, P NATL ACAD SCI USA, V115, pE10099, DOI 10.1073/pnas.1814552115; Raote I, 2018, ELIFE, V7, DOI 10.7554/eLife.32723; Rauter T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102311; Rayl M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157227; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sasaki-Osugi K, 2013, J BIOL CHEM, V288, P33361, DOI 10.1074/jbc.M113.497479; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Shibata H, 2010, BIOSCI BIOTECH BIOCH, V74, P1819, DOI 10.1271/bbb.100215; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Tabata KV, 2009, EMBO J, V28, P3279, DOI 10.1038/emboj.2009.269; Takahara T, 2017, J BIOL CHEM, V292, P17057, DOI 10.1074/jbc.M117.800201; Takahashi T, 2015, INT J MOL SCI, V16, P3677, DOI 10.3390/ijms16023677; Veglia E, 2015, INFLAMM RES, V64, P261, DOI 10.1007/s00011-015-0807-z; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yoshibori M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040765	43	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101393	10.1016/j.jbc.2021.101393	http://dx.doi.org/10.1016/j.jbc.2021.101393			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34762908	Green Accepted, gold, Green Published			2022-12-26	WOS:000748397200007
J	Xu, CH; Tang, JL; Yang, Q; Zhao, H; Liu, YL; Cao, J; Zhou, Y; Chen, XW; Chen, JZ				Xu, Chonghui; Tang, Jielin; Yang, Qi; Zhao, He; Liu, Yaling; Cao, Juan; Zhou, Yuan; Chen, Xinwen; Chen, Jizheng			Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-kappa B signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION; SUBUNIT; IKK	Histone deacetylase 5 (HDAC5) has been reported to have a strong regulatory function in the proinflammatory response, but the mechanism is still unknown. Here, we identified HDAC5 as a positive regulator of NF-kappa B signaling in vivo. HDAC5-deficient mice exhibited enhanced survival in response to LPS challenge. Using LPS, TNFa, different kinds of viruses, hydrogen peroxide, or ultraviolet stimulation, we demonstrate that HDAC5-mediated regulation of NF-kappa B occurs in manners both dependent on and independent of IKK, an upstream kinase in the NF-kappa B signaling pathway. Deficiency in HDAC5 impaired the phosphorylation of IKK beta, subsequent phosphorylation of the NF-kappa B inhibitor protein I kappa B alpha and NF-kappa B subunit p65. We also show that the phosphatase PP2A repressed transcriptional activation of NF-kappa B by decreasing phosphorylation of IKK beta, p65, and I kappa B alpha. In vitro deacetylation experiments and site-directed mutagenesis experiments indicated that HDAC5 directly deacetylated PP2Ac at Lys136, which resulted in the deactivation of PP2A. Our data add mechanistic insight into the cross talk between epigenetic and post-translational modifications regulating NF-kappa B signaling and protein phosphatase activation that mediate survival in response to inflammatory challenges.	[Xu, Chonghui; Tang, Jielin; Yang, Qi; Zhao, He; Liu, Yaling; Cao, Juan; Zhou, Yuan; Chen, Xinwen; Chen, Jizheng] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Xu, Chonghui; Liu, Yaling; Cao, Juan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Jielin; Chen, Xinwen; Chen, Jizheng] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Peoples R China; [Yang, Qi] Guangzhou Women & Childrens Med Ctr, Dept Gastroenterol, Guangzhou, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Chen, XW; Chen, JZ (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.; Chen, XW; Chen, JZ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Peoples R China.	chenxw@wh.iov.cn; chenjz@wh.iov.cn			National Key Research and Development Program of China; Program for Youth Innovation Promotion Association in Chinese Academy	National Key Research and Development Program of China; Program for Youth Innovation Promotion Association in Chinese Academy	This study was supported by the National Key Research and Development Program of China (2018YFA0507201to X. C. and 2018YFA0507202to Y. Z.), the Program for Youth Innovation Promotion Association in Chinese Academy to J. C.	Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Brechmann M, 2012, IMMUNITY, V37, P697, DOI 10.1016/j.immuni.2012.07.014; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Eichhorn PJA, 2007, PLOS GENET, V3, P2381, DOI 10.1371/journal.pgen.0030218; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Heyninck Karen, 2001, Molecular Cell Biology Research Communications, V4, P259, DOI 10.1006/mcbr.2001.0295; Hsieh CY, 2011, J BIOL CHEM, V286, P5942, DOI 10.1074/jbc.M110.123968; Hu TJ, 2019, J BIOL CHEM, V294, P8640, DOI 10.1074/jbc.RA118.007006; Kondylis V, 2017, IMMUNOL REV, V277, P113, DOI 10.1111/imr.12550; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Poralla L, 2015, J CELL MOL MED, V19, P2162, DOI 10.1111/jcmm.12595; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Tang JL, 2021, PROTEIN CELL, V12, P261, DOI 10.1007/s13238-020-00751-5; THEVENIN C, 1990, New Biologist, V2, P793; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048; Yang JM, 2001, J BIOL CHEM, V276, P47828, DOI 10.1074/jbc.M106103200; Yang Q, 2020, J MOL CELL BIOL, V12, P933, DOI 10.1093/jmcb/mjaa043; Yang Q, 2019, J MOL CELL BIOL, V11, P158, DOI 10.1093/jmcb/mjy035; Zhang GL, 2001, J CLIN INVEST, V107, P13, DOI 10.1172/JCI11837; Zhao YH, 2019, LIFE SCI, V221, P13, DOI 10.1016/j.lfs.2019.02.004	28	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101380	10.1016/j.jbc.2021.101380	http://dx.doi.org/10.1016/j.jbc.2021.101380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YO6YS	34740611	Green Published, gold			2022-12-26	WOS:000748084900007
J	Ghada, W; Estrella, N; Ankerst, DP; Menzel, A				Ghada, Wael; Estrella, Nicole; Ankerst, Donna P.; Menzel, Annette			Universal thermal climate index associations with mortality, hospital admissions, and road accidents in Bavaria	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; AIR-TEMPERATURE; CARDIOVASCULAR MORTALITY; TIME-SERIES; WEATHER; RISK; STRESS; URBAN; UTCI; VEGETATION	When meteorological conditions deviate from the optimal range for human well-being, the risks of illness, injury, and death increase, and such impacts are feared in particular with more frequent and intense extreme weather conditions resulting from climate change. Thermal indices, such as the universal thermal climate index (UTCI), can better assess human weather-related stresses by integrating multiple weather components. This paper quantifies and compares the seasonal and spatial association of UTCI with mortality, morbidity, and road accidents in the federal state of Bavaria, Germany. Linear regression was applied to seasonally associate daily 56 million hospital admissions and 2.5 million death counts (1995-2015) as well as approximately 930,000 road accidents and 1.7 million people injured (2002-2015) with spatially interpolated same day- and lagged- (up to 14 days) average UTCI values. Additional linear regressions were performed stratifying by age, gender, region, and district. UTCI effects were clear in all three health outcomes studied: Increased UTCI resulted in immediate (1-2 days) rises in morbidity and even more strongly in mortality in summer, and lagged (up to 14 days) decreases in fall, winter, and spring. The strongest UTCI effects were found for road accidents where increasing UTCI led to immediate decreases in daily road accidents in winter but pronounced increases in all other seasons. Differences in UTCI effects were observed e.g. between in warmer north-western regions (Franconia, more districts with heat stress-related mortality, but hospital admissions for lung, heart and external reasons decreasing with summer heat stress), the touristic alpine regions in the south (immediate effect of increasing UTCI on road accidents in summer), and the colder south-eastern regions (increasing hospital admissions for lung, heart and external reasons in winter with UTCI). Districts with high percentages of elderly suffered from higher morbidity and mortality, particularly in winter. The influences of UTCI as well as the spatial and temporal patterns of this influence call for improved infrastructure planning and resource allocation in the health sector.	[Ghada, Wael; Estrella, Nicole; Ankerst, Donna P.; Menzel, Annette] Tech Univ Munich, Dept Life Sci Syst, Freising Weihenstephan, Germany; [Ankerst, Donna P.] Tech Univ Munich, Dept Math, Garching, Germany; [Menzel, Annette] Tech Univ Munich, Inst Adv Study, Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Ghada, W (corresponding author), Tech Univ Munich, Dept Life Sci Syst, Freising Weihenstephan, Germany.	ghada@wzw.tum.de	Menzel, Annette/B-1105-2013	Menzel, Annette/0000-0002-7175-2512; Ghada, Wael/0000-0003-3184-9683; Estrella, Nicole/0000-0002-1028-0048	Bavarian State Ministry of the Environment and Consumer Protection; Bavarian State Ministry of Health and Care [K3-8503-PN 18-18D14187/2018]	Bavarian State Ministry of the Environment and Consumer Protection; Bavarian State Ministry of Health and Care	This study was conducted in the WIKLIGE network as part of the joint project "Climate Change and Health", funded by the Bavarian State Ministry of the Environment and Consumer Protection as well as the Bavarian State Ministry of Health and Care (K3-8503-PN 18-18D14187/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadalipour A, 2018, ENVIRON INT, V117, P215, DOI 10.1016/j.envint.2018.05.014; Ali AM, 2015, INJURY, V46, P945, DOI 10.1016/j.injury.2015.03.016; Becker N, 2020, NAT HAZARD EARTH SYS, V20, P2857, DOI 10.5194/nhess-20-2857-2020; Bergel-Hayat R, 2013, ACCIDENT ANAL PREV, V60, P456, DOI 10.1016/j.aap.2013.03.006; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Blazejczyk K, 2013, GEOGR POL, V86, P5, DOI 10.7163/GPol.2013.1; Blazejczyk K, 2012, INT J BIOMETEOROL, V56, P515, DOI 10.1007/s00484-011-0453-2; Bobb JF, 2017, AM J EPIDEMIOL, V185, P283, DOI 10.1093/aje/kww219; Breitner S, 2014, HEART, V100, P1272, DOI 10.1136/heartjnl-2014-305578; Breitner S, 2014, SCI TOTAL ENVIRON, V485, P49, DOI 10.1016/j.scitotenv.2014.03.048; Brode P, 2012, INT J BIOMETEOROL, V56, P481, DOI 10.1007/s00484-011-0454-1; Bundi M, 2018, UNFALLCHIRURG, V121, P10, DOI 10.1007/s00113-016-0267-0; Burkart K, 2016, ENVIRON HEALTH PERSP, V124, P927, DOI 10.1289/ehp.1409529; Burkart K, 2014, INT J BIOMETEOROL, V58, P227, DOI 10.1007/s00484-013-0668-5; Calleja-Agius J, 2021, EARLY HUM DEV, V155, DOI 10.1016/j.earlhumdev.2020.105222; Chen JJ, 2019, ENVIRON INT, V128, P271, DOI 10.1016/j.envint.2019.04.049; Deutscher Wetterdienst, HOURL CLIM OBS; Di Napoli C, 2019, J APPL METEOROL CLIM, V58, P1177, DOI 10.1175/JAMC-D-18-0246.1; Di Napoli C, 2018, INT J BIOMETEOROL, V62, P1155, DOI 10.1007/s00484-018-1518-2; Drosu A, 2020, INT J AUTO TECH-KOR, V21, P309, DOI 10.1007/s12239-020-0029-4; European Commission, 2011, COM2011144 EUR COMM; Federal Statistical Office Germany, BEV GEM GESCHL QUART; Federal Statistical Office Germany, KRANK KREIS KRANK BE; Federal Statistical Office Germany, POP ADM DISTR REF DA; Gao JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37300; Ghada W, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.143772; Gifford RM, 2019, ENVIRON RES, V171, P24, DOI 10.1016/j.envres.2018.10.020; Greve F, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03572-z; Guo YM, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1026; Hind J, 2020, INJURY, V51, P2209, DOI 10.1016/j.injury.2020.07.014; Hopp S, 2018, PREV MED, V110, P81, DOI 10.1016/j.ypmed.2018.02.001; Ilango SD, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2020.105541; Iniguez C, 2021, ENVIRON RES, V192, DOI 10.1016/j.envres.2020.110191; Islam MM, 2019, CLIMATE, V7, DOI 10.3390/cli7090103; Jendritzky G, 2012, INT J BIOMETEOROL, V56, P421, DOI 10.1007/s00484-011-0513-7; Kampe EOI, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010399; Kuchcik M, 2021, INT J BIOMETEOROL, V65, P1529, DOI 10.1007/s00484-020-01995-w; Lane K, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/913064; Lee H, 2020, SCI TOTAL ENVIRON, V746, DOI 10.1016/j.scitotenv.2020.141261; Lee WK, 2014, ENVIRON RES, V132, P290, DOI 10.1016/j.envres.2014.04.019; Liu A, 2017, SCI TOTAL ENVIRON, V580, P550, DOI 10.1016/j.scitotenv.2016.11.211; Liu C, 2019, NEW ENGL J MED, V381, P705, DOI 10.1056/NEJMoa1817364; Merrill RM, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/6942787; Nassiri P, 2017, IND HEALTH, V55, P437, DOI 10.2486/indhealth.2017-0018; Nastos PT, 2012, THEOR APPL CLIMATOL, V108, P591, DOI 10.1007/s00704-011-0555-0; Pan RB, 2019, SCI TOTAL ENVIRON, V691, P296, DOI 10.1016/j.scitotenv.2019.07.026; Pascal M, 2018, ENVIRON INT, V121, P189, DOI 10.1016/j.envint.2018.08.049; Pauls LA, 2017, J HOSP MED, V12, P760, DOI 10.12788/jhm.2815; Pena-Angulo D, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2020JD032798; Rail M, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab5ca6; Research Data Center of the Federal Statistical Office and the Statistical Offices of the federal states (RDC), 1995, TOD; Research Data Center of the Federal Statistical Office and the Statistical Offices of the federal states (RDC), 2002, STAT STRASS 46241; Research Data Center of the Federal Statistical Office and the Statistical Offices of the federal states (RDC), 1995, KRANK 2; RKI, 2017, TIM TRENDS INC MORT; Sato T, 2020, SOLA, V16, P104, DOI 10.2151/sola.2020-018; Scheiner J, 2011, ACCIDENT ANAL PREV, V43, P307, DOI 10.1016/j.aap.2010.08.029; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Son JY, 2016, ENVIRON RES, V151, P728, DOI 10.1016/j.envres.2016.09.001; Sorensen CJ, 2020, ANN EMERG MED, V76, P168, DOI 10.1016/j.annemergmed.2020.03.010; Su XM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010184; Theofilatos A, 2014, ACCIDENT ANAL PREV, V72, P244, DOI 10.1016/j.aap.2014.06.017; Tieges Z, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124577; Tomczyk AM, 2020, THEOR APPL CLIMATOL, V139, P893, DOI 10.1007/s00704-019-02998-3; TraumaRegister DGU, 2014, INJURY, V45, pS14, DOI 10.1016/j.injury.2014.08.012; Urban A, 2019, INT J BIOMETEOROL, V63, P535, DOI 10.1007/s00484-019-01684-3; Urban A, 2014, INT J ENV RES PUB HE, V11, P952, DOI 10.3390/ijerph110100952; van Steen Y, 2019, INT ARCH OCC ENV HEA, V92, P37, DOI 10.1007/s00420-018-1360-1; Vinogradova V, 2021, INT J BIOMETEOROL, V65, P1473, DOI 10.1007/s00484-020-01901-4; Wang ZH, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01517-7; Watson KE, 2020, J PUBLIC HEALTH-UK, V42, P333, DOI 10.1093/pubmed/fdz033; Williams S, 2012, ENVIRON INT, V40, P33, DOI 10.1016/j.envint.2011.11.011; Wilson JM, 2018, ADV ORTHOP, V2018, DOI 10.1155/2018/6057357; Winquist A, 2016, ENVIRON RES, V147, P314, DOI 10.1016/j.envres.2016.02.022; Wu CYH, 2018, ACCIDENT ANAL PREV, V119, P195, DOI 10.1016/j.aap.2018.07.025; Wu FF, 2019, SCI TOTAL ENVIRON, V665, P1003, DOI 10.1016/j.scitotenv.2019.02.190; Zhan ZY, 2020, SCI TOTAL ENVIRON, V720, DOI 10.1016/j.scitotenv.2020.137482	76	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2021	16	11							e0259086	10.1371/journal.pone.0259086	http://dx.doi.org/10.1371/journal.pone.0259086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XW9HJ	34788302	gold, Green Published			2022-12-26	WOS:000735920500013
J	Keramat, SA; Alam, K; Rana, RH; Chowdhury, R; Farjana, F; Hashmi, R; Gow, J; Biddle, SJH				Keramat, Syed Afroz; Alam, Khorshed; Rana, Rezwanul Hasan; Chowdhury, Rupok; Farjana, Fariha; Hashmi, Rubayyat; Gow, Jeff; Biddle, Stuart J. H.			Obesity and the risk of developing chronic diseases in middle-aged and older adults: Findings from an Australian longitudinal population survey, 2009-2017	PLOS ONE			English	Article							QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; OVERWEIGHT; CANCER; ASSOCIATION; DEPRESSION; MECHANISMS; WEIGHT; TRENDS	Background Overweight and obesity impose a significant health burden in Australia, predominantly the middle-aged and older adults. Studies of the association between obesity and chronic diseases are primarily based on cross-sectional data, which is insufficient to deduce a temporal relationship. Using nationally representative panel data, this study aims to investigate whether obesity is a significant risk factor for type 2 diabetes, heart diseases, asthma, arthritis, and depression in Australian middle-aged and older adults. Methods Longitudinal data comprising three waves (waves 9, 13 and 17) of the Household, Income and Labour Dynamics in Australia (HILDA) survey were used in this study. This study fitted longitudinal random-effect logistic regression models to estimate the between-person differences in the association between obesity and chronic diseases. Results The findings indicated that obesity was associated with a higher prevalence of chronic diseases among Australian middle-aged and older adults. Obese adults (Body Mass Index [BMI] >= 30) were at 12.76, 2.05, 1.97, 2.25, and 1.96, times of higher risks of having type 2 diabetes (OR: 12.76, CI 95%: 8.88-18.36), heart disease (OR: 2.05, CI 95%: 1.54-2.74), asthma (OR: 1.97, CI 95%: 1.49-2.62), arthritis (OR: 2.25, 95% CI: 1.90-2.68) and depression (OR: 1.96, CI 95%: 1.56-2.48), respectively, compared with healthy weight counterparts. However, the study did not find any evidence of a statistically significant association between obesity and cancer. Besides, gender stratified regression results showed that obesity is associated with a higher likelihood of asthma (OR: 2.64, 95% CI: 1.84-3.80) among female adults, but not in the case of male adults. Conclusion Excessive weight is strongly associated with a higher incidence of chronic disease in Australian middle-aged and older adults. This finding has clear public health implications. Health promotion programs and strategies would be helpful to meet the challenge of excessive weight gain and thus contribute to the prevention of chronic diseases.	[Keramat, Syed Afroz; Chowdhury, Rupok; Farjana, Fariha] Khulna Univ, Social Sci Sch, Econ Discipline, Khulna, Bangladesh; [Keramat, Syed Afroz; Alam, Khorshed; Rana, Rezwanul Hasan; Hashmi, Rubayyat; Gow, Jeff] Univ Southern Queensland, Sch Business, Toowoomba, Qld, Australia; [Keramat, Syed Afroz; Alam, Khorshed; Hashmi, Rubayyat; Biddle, Stuart J. H.] Univ Southern Queensland, Ctr Hlth Res, Toowoomba, Qld, Australia; [Rana, Rezwanul Hasan] Macquarie Univ, Ctr Hlth Econ, Sydney, NSW, Australia; [Gow, Jeff] Univ KwaZulu Natal, Sch Accounting Econ & Finance, Durban, South Africa	Khulna University; University of Southern Queensland; University of Southern Queensland; Macquarie University; University of Kwazulu Natal	Keramat, SA (corresponding author), Khulna Univ, Social Sci Sch, Econ Discipline, Khulna, Bangladesh.; Keramat, SA (corresponding author), Univ Southern Queensland, Sch Business, Toowoomba, Qld, Australia.; Keramat, SA (corresponding author), Univ Southern Queensland, Ctr Hlth Res, Toowoomba, Qld, Australia.	syed.afroz@econ.ku.ac.bd	Hashmi, Rubayyat/P-3211-2018; Keramat, Syed Afroz/AAN-2755-2020	Hashmi, Rubayyat/0000-0002-5953-0650; Keramat, Syed Afroz/0000-0001-8747-9891; Rana, Rezwanul/0000-0002-3347-3205; Chowdhury, Rupok/0000-0002-7801-4600				Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Akil L, 2011, J HEALTH CARE POOR U, V22, P61, DOI 10.1353/hpu.2011.0166; [Anonymous], 2017, AUSTR BURDEN DIS STU; Atlantis E, 2009, OBES REV, V10, P543, DOI 10.1111/j.1467-789X.2009.00590.x; Australian Institute of Health and Welfare, 2019, AUSTR BURD DIS STUD, V19; Biring MS, 1999, AM J MED SCI, V318, P293, DOI 10.1097/00000441-199911000-00002; Bjerregaard LG, 2020, TRENDS CARDIOVAS MED, V30, P39, DOI 10.1016/j.tcm.2019.01.011; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005; Drew JE, 2012, P NUTR SOC, V71, P175, DOI 10.1017/S0029665111003259; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Grantham NM, 2013, PUBLIC HEALTH NUTR, V16, P339, DOI 10.1017/S1368980012001310; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hardy LL, 2017, INT J OBESITY, V41, P76, DOI 10.1038/ijo.2016.204; Jia HM, 2005, J PUBLIC HEALTH-UK, V27, P156, DOI 10.1093/pubmed/fdi025; Kearns K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-143; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Keramat SA, 2021, SSM-POPUL HLTH, V16, DOI 10.1016/j.ssmph.2021.100923; Keramat SA, 2021, CLINICOECONOMIC OUTC, V13, P777, DOI 10.2147/CEOR.S318094; Keramat SA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90750-1; Keramat SA, 2021, SSM-POPUL HLTH, V14, DOI 10.1016/j.ssmph.2021.100765; Keramat SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238260; Keramat SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233512; Keramat SA, 2020, J COMMUN HEALTH, V45, P288, DOI 10.1007/s10900-019-00735-5; King LK, 2013, INDIAN J MED RES, V138, P185; Koliaki C, 2019, METABOLISM, V92, P98, DOI 10.1016/j.metabol.2018.10.011; Lemay V, 2019, J PEDIAT HEMATOL ONC, V41, pE450, DOI 10.1097/MPH.0000000000001426; Lementowski Peter W, 2008, Am J Orthop (Belle Mead NJ), V37, P148; Lemstra ME, 2016, J MULTIDISCIP HEALTH, V9, P103, DOI 10.2147/JMDH.S100693; March LM., 2004, MED J AUSTRALIA, V180, DOI [10.5694/j.1326-5377.2004.tb06230.x, DOI 10.5694/J.1326-5377.2004.TB06230.X]; Markowitz S, 2008, CLIN PSYCHOL-SCI PR, V15, P1, DOI 10.1111/j.1468-2850.2008.00106.x; McKercher C, 2013, PSYCHOSOM MED, V75, P366, DOI 10.1097/PSY.0b013e31828c4d53; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Preiss K, 2013, OBES REV, V14, P906, DOI 10.1111/obr.12052; Rebar AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1088; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Tyrrell J, 2019, INT J EPIDEMIOL, V48, P834, DOI 10.1093/ije/dyy223; WOODEN M, 2002, AUSTR EC REV, V0035; World Health Organization, 2021, OB OV FACT SHEETS; ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0260158	10.1371/journal.pone.0260158	http://dx.doi.org/10.1371/journal.pone.0260158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1XV	34784404	Green Published, Green Accepted, gold			2022-12-26	WOS:000755277300045
J	Tong, XQ; Wu, JY; Mei, L; Wang, YJ				Tong, Xiaoqing; Wu, Jiayi; Mei, Li; Wang, Yongjun			Detecting Phytophthora cinnamomi associated with dieback disease on Carya cathayensis using loop-mediated isothermal amplification	PLOS ONE			English	Article							LAMP; SPP.; PCR	Chinese hickory (Carya cathayensis Sarg.) is an economically and ecologically important nut plant in China. Dieback and basal stem necrosis have been observed in the plants since 2016, and its recent spread has significantly affected plant growth and nut production. Therefore, a survey was conducted to evaluate the disease incidence at five sites in Linan County, China. The highest incidence was recorded at the Tuankou site at up to 11.39% in 2019. The oomycete, Phytophthora cinnamomi, was isolated from symptomatic plant tissue and plantation soil using baiting and selective media-based detection methods and identified. Artificial infection with the representative P. cinnamomi ST402 isolate produced vertically elongated discolorations in the outer xylem and necrotic symptoms in C. cathayensis seedlings in a greenhouse trial. Molecular detections based on loop-mediated isothermal amplification (LAMP) specific to P. cinnamomi ST402 were conducted. Result indicated that LAMP detection showed a high coherence level with the baiting assays for P. cinnamomi detection in the field. This study provides the evidence of existence of high-pathogenic P. cinnamomi in the C. cathayensis plantation soil in China and the insights into a convenient tool developed for conducting field monitoring of this aggressive pathogen.	[Tong, Xiaoqing; Wu, Jiayi; Wang, Yongjun] Zhejiang A&F Univ, Coll Forestry & Biotechnol, Dept Forest Protect, Hangzhou, Zhejiang, Peoples R China; [Mei, Li] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University	Wang, YJ (corresponding author), Zhejiang A&F Univ, Coll Forestry & Biotechnol, Dept Forest Protect, Hangzhou, Zhejiang, Peoples R China.	wangyj@zafu.edu.cn	吴, 家怡/GSI-7419-2022	Wang, Yongjun/0000-0002-8488-3423	Zhejiang Key Research and Development Program of China [2019C0203002]	Zhejiang Key Research and Development Program of China	Financial support for this work was provided by grants from Zhejiang Key Research and Development Program of China (2019C0203002) awarded by Wang Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukawa Y, 2016, LETT APPL MICROBIOL, V63, P202, DOI 10.1111/lam.12597; Bienapfl JC, 2014, PLANT DIS, V98, P134, DOI 10.1094/PDIS-06-13-0662-RE; Bose T, 2021, MICROB ECOL, V81, P122, DOI 10.1007/s00248-020-01563-0; Brazee NJ, 2017, PLANT PATHOL, V66, P805, DOI 10.1111/ppa.12617; Brazee NJ, 2016, MYCOLOGIA, V108, P6, DOI 10.3852/15-038; Burgess TI, 2021, PLANT PATHOL, V70, P604, DOI 10.1111/ppa.13312; Burgess TI, 2017, GLOBAL CHANGE BIOL, V23, P1661, DOI 10.1111/gcb.13492; CAHILL DM, 1994, PHYTOPATHOLOGY, V84, P193, DOI 10.1094/Phyto-84-193; Dai TT, 2019, PLANT DIS, V103, P3101, DOI 10.1094/PDIS-04-19-0781-RE; Davison EM, 2005, AUSTRALAS PLANT PATH, V34, P293, DOI 10.1071/AP05060; Ferguson AJ, 1999, PLANT DIS, V83, P1129, DOI 10.1094/PDIS.1999.83.12.1129; Fukuta S, 2013, EUR J PLANT PATHOL, V136, P689, DOI 10.1007/s10658-013-0198-3; Ghimire SR, 2009, PLANT PATHOL, V58, P577, DOI 10.1111/j.1365-3059.2008.02016.x; Gonzalez M, 2019, PLANT PATHOL, V68, P901, DOI 10.1111/ppa.13024; Gonzalez M, 2017, PLANT PATHOL, V66, P941, DOI 10.1111/ppa.12649; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Ramirez-Gil JG, 2020, CROP PROT, V137, DOI 10.1016/j.cropro.2020.105271; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Hardham AR, 2018, MOL PLANT PATHOL, V19, P260, DOI 10.1111/mpp.12568; Jeff-Ego OS, 2020, PLANT PATHOL, V69, P1270, DOI 10.1111/ppa.13208; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kunadiya MB, 2019, PLANT DIS, V103, P2443, DOI 10.1094/PDIS-09-18-1641-RE; Langrell SRH, 2011, FUNGAL BIOL-UK, V115, P672, DOI 10.1016/j.funbio.2011.04.009; Le Fevre R, 2016, MOL PLANT MICROBE IN, V29, P385, DOI 10.1094/MPMI-12-15-0276-R; Martin FN, 2012, PLANT DIS, V96, P1080, DOI 10.1094/PDIS-12-11-1036-FE; Moradi A, 2012, EUR J PLANT PATHOL, V133, P609, DOI 10.1007/s10658-012-9939-y; Morales-Rodriguez C, 2021, Fungal Syst Evol, V7, P99, DOI 10.3114/fuse.2021.07.05; Niu JH, 2012, PLANT PATHOL, V61, P809, DOI 10.1111/j.1365-3059.2011.02562.x; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Osswald W, 2014, FOREST PATHOL, V44, P169, DOI 10.1111/efp.12096; Robideau GP, 2011, MOL ECOL RESOUR, V11, P1002, DOI 10.1111/j.1755-0998.2011.03041.x; Schwingle BW, 2008, PLANT DIS, V92, P642, DOI 10.1094/PDIS-92-4-0642; Sena K, 2018, PLANT HLTH PROG, V19, P193, DOI 10.1094/PHP-01-18-0004-RS; Vettraino AM, 2003, PLANT PATHOL, V52, P491, DOI 10.1046/j.1365-3059.2003.00864.x; Vitale S, 2019, FOREST PATHOL, V49, DOI 10.1111/efp.12477; Wong YP, 2018, J APPL MICROBIOL, V124, P626, DOI 10.1111/jam.13647; Xu SE, 2018, FOREST PATHOL, V48, DOI 10.1111/efp.12464; Yao JL, 2019, SCI HORTIC-AMSTERDAM, V248, P184, DOI 10.1016/j.scienta.2019.01.014	40	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2021	16	11							e0257785	10.1371/journal.pone.0257785	http://dx.doi.org/10.1371/journal.pone.0257785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1XV	34784360	Green Submitted, gold, Green Published			2022-12-26	WOS:000755277300001
J	Kawahito, Y; Takakubo, Y; Morinobu, A; Matsubara, N; Nagy, O; Sugiyama, E				Kawahito, Yutaka; Takakubo, Yuya; Morinobu, Akio; Matsubara, Naoko; Nagy, Orsolya; Sugiyama, Eiji			Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE)	PLOS ONE			English	Article							WORK DISABILITY; THERAPY; RECOMMENDATIONS; CLASSIFICATION; ADHERENCE; ATTITUDES; AMERICAN	Objective To evaluate treatment satisfaction, disease outcomes, and perspectives of patients with poorly controlled rheumatoid arthritis (RA) treated with conventional synthetic, targeted synthetic, or biologic disease-modifying antirheumatic drugs (DMARDs), we conducted a subgroup (post hoc) analysis of Japanese patients participating in the SENSE study. Methods Data for Japanese patients (n/N = 118/1629) from the global, multicenter, cross-sectional, observational SENSE study were analyzed. The primary endpoint was the global satisfaction subscore assessed using the Treatment Satisfaction Questionnaire for Medication (TSQM) version 1.4. Other patient-reported outcomes included self-reported RA medication adherence and Work Productivity and Activity Impairment-RA. Patient perspectives included patients' expectations and preference of pharmacologic treatment. Results Median (range) age and RA disease duration were 67.0 (18.0-87.0) years and 8 (0.0-54) years, respectively; 81.4% of patients were female. Mean (SD) TSQM global satisfaction subscore was 56.8 (17.5), and only 5.9% of patients reported good satisfaction with treatment (TSQM global >= 80). Mean (SD) self-reported treatment adherence using VAS was high (93.5% [13.8%]). Mean (SD) total work productivity impairment was 45.6% (32.0%); presenteeism contributed toward more total work productivity impairment (43.9% [30.4%]) than absenteeism (8.3% [24.4%]). Patients expected improvement in all parameters from their treatment, especially improvement in joint symptoms. Most patients (80.7%) preferred oral medication and 18.7% preferred monotherapy. Patient acceptability of potentially manageable side effects was high (7.5%-34.0%). Although most patients (81.3%) found combination therapy acceptable, 43.2% were receiving DMARD monotherapy. Conclusion Although most Japanese patients with RA with moderate-to-high disease activity were dissatisfied with their current DMARD treatment, high treatment adherence, high acceptability of combination therapy, high acceptability of manageable potential side effects, and preference for oral medication were reported. Data support the development of a more individualized and patient-centric approach for RA treatment.	[Kawahito, Yutaka] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kyoto, Japan; [Takakubo, Yuya] Yamagata Univ, Fac Med, Dept Orthopaed Surg, Yamagata, Japan; [Morinobu, Akio] Kobe Univ, Grad Sch Med, Rheumatol & Clin Immunol, Kobe, Hyogo, Japan; [Matsubara, Naoko] AbbVie GK, Evidence Solut Grp Med, Study Design & Data Sci Team, Tokyo, Japan; [Nagy, Orsolya] AbbVie, Global Med Affairs, Chicago, IL USA; [Sugiyama, Eiji] Hiroshima Univ Hosp, Dept Clin Immunol & Rheumatol, Hiroshima, Japan; [Morinobu, Akio] Kyoto Univ, Grad Sch Med, Rheumatol & Clin Immunol, Kyoto, Japan; [Morinobu, Akio] Kyoto Univ, Fac Med, Kyoto, Japan	Kyoto Prefectural University of Medicine; Yamagata University; Kobe University; AbbVie; AbbVie; Hiroshima University; Kyoto University; Kyoto University	Kawahito, Y (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Inflammat & Immunol, Kyoto, Japan.	kawahity@koto.kpu-m.ac.jp			Abbvie	Abbvie(AbbVie)	The design, study conduct, and financial support for the study were provided by Abbvie. Abbvie participated in the interpretation of data, review, medical writing, and approval of the publication. No honoraria or payments were made for authorship.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Atkinson Mark J, 2004, Health Qual Life Outcomes, V2, P12, DOI 10.1186/1477-7525-2-12; Barbosa CD, 2012, PATIENT PREFER ADHER, V6, P39, DOI 10.2147/PPA.S24752; BRODY DS, 1989, J GEN INTERN MED, V4, P506, DOI 10.1007/BF02599549; Cella D, 2005, J RHEUMATOL, V32, P811; Druce KL, 2016, RHEUMATOLOGY, V55, P1786, DOI 10.1093/rheumatology/kew241; Funahashi K, 2012, CLIN RHEUMATOL, V31, P1559, DOI 10.1007/s10067-012-2048-7; Higashi T, 2012, J EVAL CLIN PRACT, V18, P290, DOI 10.1111/j.1365-2753.2010.01575.x; Jacobs JWG, 2012, RHEUMATOLOGY, V51, piv3, DOI 10.1093/rheumatology/kes083; Karve S, 2009, CURR MED RES OPIN, V25, P2303, DOI 10.1185/03007990903126833; Kato E, 2017, INT J RHEUM DIS, V20, P839, DOI 10.1111/1756-185X.12998; Kay J, 2012, RHEUMATOLOGY, V51, P5, DOI 10.1093/rheumatology/kes279; Khan NA, 2009, J RHEUMATOL, V36, P2435, DOI 10.3899/jrheum.081175; Kim H, 2017, PATIENT EDUC COUNS, V100, P1073, DOI 10.1016/j.pec.2017.01.015; Koike T., 2015, INT J CLIN RHEUMATOL, V10, P235; Kojima M, 2009, J PSYCHOSOM RES, V67, P425, DOI 10.1016/j.jpsychores.2009.01.001; Laucis NC, 2015, J BONE JOINT SURG AM, V97A, P1628, DOI 10.2106/JBJS.O.00030; Norman CD, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e27; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Pincus T, 2013, BULL HOSP JT DIS, V71, pS33; Radawski C, 2019, RHEUMATOL THER, V6, P461, DOI 10.1007/s40744-019-00168-5; Richtering Sarah S, 2017, JMIR Hum Factors, V4, pe4, DOI 10.2196/humanfactors.6217; Safiri S, 2019, ANN RHEUM DIS, V78, P1463, DOI 10.1136/annrheumdis-2019-215920; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Sruamsiri R, 2018, MOD RHEUMATOL, V28, P482, DOI 10.1080/14397595.2017.1361893; Takahashi N, 2012, MOD RHEUMATOL, V22, P376, DOI 10.1007/s10165-011-0531-7; Taylor PC, 2021, ANN RHEUM DIS, V80, P489, DOI 10.1136/annrheumdis-2021-eular.842; Taylor PC., 2020, EULAR 2020 VIRT M AN; Taylor PC, 2021, PATIENT PREFER ADHER, V15, P359, DOI 10.2147/PPA.S289692; Tennant B, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3992; ter Wee MM, 2012, ANN RHEUM DIS, V71, P161, DOI 10.1136/ard.2011.154583; van Tuyl LHD, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-28; Wen HY, 2012, INT J RHEUM DIS, V15, P380, DOI 10.1111/j.1756-185X.2012.01752.x; Wolfe F, 1998, J RHEUMATOL, V25, P2108; Xavier RM, 2019, ADV RHEUMATOL, V59, DOI 10.1186/s42358-019-0090-8; Yamamoto K, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1542-y; Yamanaka H, 2014, MOD RHEUMATOL, V24, P33, DOI 10.3109/14397595.2013.854059	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259389	10.1371/journal.pone.0259389	http://dx.doi.org/10.1371/journal.pone.0259389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780502	Green Published, gold			2022-12-26	WOS:000755305800027
J	Kenmotsu, H; Takabayashi, E; Takase, A; Hirose, Y; Eki, T				Kenmotsu, Harutaro; Takabayashi, Emi; Takase, Akinori; Hirose, Yuu; Eki, Toshihiko			Use of universal primers for the 18S ribosomal RNA gene and whole soil DNAs to reveal the taxonomic structures of soil nematodes by high-throughput amplicon sequencing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; THELASTOMATIDAE; DIVERSITY; OXYURIDA; PARASITE; TRAVASSOSINEMATIDAE; GRYLLOTALPIDAE; ORTHOPTERA; FERTILIZER; RESPONSES	Nematodes are abundant metazoans that play crucial roles in nutrient recycle in the pedosphere. Although high-throughput amplicon sequencing is a powerful tool for the taxonomic profiling of soil nematodes, polymerase chain reaction (PCR) primers for amplification of the 18S ribosomal RNA (SSU) gene and preparation of template DNAs have not been sufficiently evaluated. We investigated nematode community structure in copse soil using four nematode-specific (regions 1-4) and two universal (regions U1 and U2) primer sets for the SSU gene regions with two DNAs prepared from copse-derived mixed nematodes and whole soil. The major nematode-derived sequence variants (SVs) identified in each region was detected in both template DNAs. Order level taxonomy and feeding type of identified nematode-derived SVs were distantly related between the two DNA preparations, and the region U2 was closely related to region 4 in the non-metric multidimensional scaling (NMDS) based on Bray-Curtis dissimilarity. Thus, the universal primers for region U2 could be used to analyze soil nematode communities. We further applied this method to analyze the nematodes living in two sampling sites of a sweet potato-cultivated field, where the plants were differently growing. The structure of nematode-derived SVs from the two sites was distantly related in the principal coordinate analysis (PCoA) with weighted unifrac distances, suggesting their distinct soil environments. The resultant ecophysiological status of the nematode communities in the copse and field on the basis of feeding behavior and maturity indices was fairly consistent with those of the copse- and the cultivated house garden-derived nematodes in prior studies. These findings will be useful for the DNA metabarcoding of soil eukaryotes, including nematodes, using soil DNAs.	[Kenmotsu, Harutaro; Takabayashi, Emi; Takase, Akinori; Hirose, Yuu; Eki, Toshihiko] Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Mol Genet Lab, Toyohashi, Aichi, Japan; [Hirose, Yuu; Eki, Toshihiko] Toyohashi Univ Technol, Res Ctr Agrotechnol & Biotechnol, Toyohashi, Aichi, Japan	Toyohashi University of Technology; Toyohashi University of Technology	Eki, T (corresponding author), Toyohashi Univ Technol, Dept Appl Chem & Life Sci, Mol Genet Lab, Toyohashi, Aichi, Japan.; Eki, T (corresponding author), Toyohashi Univ Technol, Res Ctr Agrotechnol & Biotechnol, Toyohashi, Aichi, Japan.	eki@chem.tut.ac.jp		Eki, Toshihiko/0000-0003-1553-8279	Toyohashi University of Technology; Takahashi Industrial and Economic Research Foundation	Toyohashi University of Technology; Takahashi Industrial and Economic Research Foundation	This work was supported by grants for scientific research and education by Toyohashi University of Technology and Takahashi Industrial and Economic Research Foundation (http://takahashi-f.or.jp) to T.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Babalola OO, 2021, CURR MICROBIOL, V78, P1069, DOI 10.1007/s00284-021-02375-2; Baermann G., 1917, Geneeskundig Tijdschrift voor Nederlandsch-Indie Batavia, V57; Bastida F, 2020, MOL ECOL, V29, P752, DOI 10.1111/mec.15299; Bongers T, 1999, TRENDS ECOL EVOL, V14, P224, DOI 10.1016/S0169-5347(98)01583-3; Bongers T, 1998, APPL SOIL ECOL, V10, P239, DOI 10.1016/S0929-1393(98)00123-1; BONGERS T, 1990, OECOLOGIA, V83, P14, DOI 10.1007/BF00324627; Bongiorno G, 2019, MOL ECOL, V28, P4987, DOI 10.1111/mec.15270; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Camino NB, 2000, MEM I OSWALDO CRUZ, V95, P49, DOI 10.1590/S0074-02762000000100007; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen XY, 2010, EUR J SOIL BIOL, V46, P319, DOI 10.1016/j.ejsobi.2010.05.002; COOMANS AV, 1988, J NEMATOL, V20, P288; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Crowther TW, 2019, SCIENCE, V365, P772, DOI 10.1126/science.aav0550; Dong K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03655-3; Du XF, 2020, APPL SOIL ECOL, V152, DOI 10.1016/j.apsoil.2020.103562; Ferris H., NEMATODE ECOPHYSIOLO; Geisen S, 2018, METHODS ECOL EVOL, V9, P1366, DOI 10.1111/2041-210X.12999; Gutierrez C, 2016, ENVIRON POLLUT, V213, P184, DOI 10.1016/j.envpol.2016.02.012; Guzeeva E. A., 2009, Parazitologiya (St. Petersburg), V43, P299; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Herren GL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230153; Hodda M, 2009, NEMATODES AS ENVIRONMENTAL INDICATORS, P45, DOI 10.1079/9781845933852.0045; Hugerth LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095567; Hunt DJ, 1996, FUND APPL NEMATOL, V19, P7; Ito T, 2015, APPL SOIL ECOL, V89, P50, DOI 10.1016/j.apsoil.2014.12.010; Kenmotsu H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249571; Kenmotsu H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240336; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang WJ, 2005, J NEMATOL, V37, P254; Liu T, 2016, AGR ECOSYST ENVIRON, V232, P199, DOI 10.1016/j.agee.2016.07.015; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matus-Acuna V, 2021, FEMS MICROBIOL ECOL, V97, DOI 10.1093/femsec/fiab066; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; MORAVEC F, 1994, PARASITOL RES, V80, P29, DOI 10.1007/BF00932620; Morise H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051785; Muller CA, 2019, FOREST ECOL MANAG, V453, DOI 10.1016/j.foreco.2019.117591; Mulder C, 2005, ECOTOX ENVIRON SAFE, V62, P278, DOI 10.1016/j.ecoenv.2005.03.028; Neher DA, 2005, APPL SOIL ECOL, V30, P47, DOI 10.1016/j.apsoil.2005.01.002; Neher DA, 1999, J NEMATOL, V31, P142; Nielsen UN, 2014, GLOBAL ECOL BIOGEOGR, V23, P968, DOI 10.1111/geb.12177; Okada H, 2007, APPL SOIL ECOL, V35, P582, DOI 10.1016/j.apsoil.2006.09.008; Ozawa S, 2016, ACTA PARASITOL, V61, P241, DOI 10.1515/ap-2016-0034; Pan FJ, 2010, EUR J SOIL BIOL, V46, P105, DOI 10.1016/j.ejsobi.2010.01.004; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pothula SK, 2019, J NEMATOL, V51, DOI 10.21307/jofnem-2019-011; PROCTER DLC, 1990, J NEMATOL, V22, P1; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; Ritz K, 1999, PLANT SOIL, V212, P1, DOI 10.1023/A:1004673027625; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sapkota R, 2015, BMC ECOL, V15, DOI 10.1186/s12898-014-0034-4; Seesao Y, 2017, J MICROBIOL METH, V138, P37, DOI 10.1016/j.mimet.2016.05.030; Sikder MM, 2021, J EXP BOT, V72, P3835, DOI 10.1093/jxb/erab104; Singh N, 2015, BIOINFORMATION, V11, P343, DOI 10.6026/97320630011343; Song DG, 2017, APPL SOIL ECOL, V114, P161, DOI [10.1016/j.apsoil.2017.02.013, 10.10]; Starke R, 2016, SOIL BIOL BIOCHEM, V96, P30, DOI 10.1016/j.soilbio.2016.01.009; Treonis AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20366-5; van den Hoogen J, 2019, NATURE, V572, P194, DOI 10.1038/s41586-019-1418-6; Verschoor BC, 2002, J ECOL, V90, P753, DOI 10.1046/j.1365-2745.2002.00710.x; Wilschut RA, 2019, GLOBAL CHANGE BIOL, V25, P2714, DOI 10.1111/gcb.14657; YEATES GW, 1993, J NEMATOL, V25, P315; Yeates GW, 1999, AGR ECOSYST ENVIRON, V74, P113, DOI 10.1016/S0167-8809(99)00033-X; Zhang RF, 2017, CURR OPIN MICROBIOL, V37, P8, DOI 10.1016/j.mib.2017.03.008; Zhao J, 2013, APPL SOIL ECOL, V64, P135, DOI 10.1016/j.apsoil.2012.11.008	67	0	0	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259842	10.1371/journal.pone.0259842	http://dx.doi.org/10.1371/journal.pone.0259842			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780544	Green Published, gold			2022-12-26	WOS:000755305800057
J	Liu, Y; Liu, SL; Jiang, GT; Dai, QZ				Liu, Yang; Liu, Shengli; Jiang, Guitao; Dai, Qiuzhong			Optimization of exogenous carbohydrases supplemented in broiler diets using in vitro simulated gastrointestinal digestion and response surface methodology	PLOS ONE			English	Article							ALPHA-AMYLASE SUPPLEMENTATION; GROWTH-PERFORMANCE; NUTRITIONAL-VALUE; ENZYME-ACTIVITIES; STARCH DIGESTION; GUT HEALTH; DIGESTIBILITY; ENERGY; WHEAT; CHICKENS	The present study aimed to explore the optimal zymogram of combination of 6 carbohydrases (glucoamylase, pullulanase, maltase, thermostable alpha-amylase, medium temperature alpha-amylase, and cold-active alpha-amylase) supplemented in corn-soybean based diet of broilers aged 1 to 3 wk for the maximum starch digestibility, by using in vitro simulated gastrointestinal digestion and response surface method. The third generation of simulated monogastric animal digestion system was used for in vitro digestion experiment. By using single factor completely random design, the optimal supplement levels of single carbohydras were determined by the reducing sugar release amount and improved dry matter digestibility, which were the parameters representing the starch digestibility of the diet. Additionally, Box-Behnken response surface method was used to predict the optimal combination of 6 carbohydrases. The results showed that the optimistic zymogram of 6 carbohydrases in corn-soybean based diet for broilers aged 1 to 3 wk were 297.39 U/g glucoamylase, 549.72 U/g pullulanase, 3.01 U/g maltase, 1,455.73 U/g thermostable alpha-amylase, 278.64 U/g medium temperature alpha-amylase, and 1,985.97 U/g cold-active alpha-amylase, and the associated reduced sugar release amount and improved dry matter digestibility were 215.98 mg/g, and 6.23%, respectively. Furthermore, we conducted in vitro digestion experiments with diets supplemented with the predicted optimistic zymogram and found that the experimental reduced sugar release amount and improved dry matter digestibility were 219.26 mg/g and 6.31% respectively, whose errors to the predicted optimistic reducing sugar release amount and the improved dry matter digestibility were 1.05% and 1.02%. To sum up, the predicted optimal zymogram of 6 carbohydrases in the present study were capable to improve the starch digestibility in diet for broilers aged 1 to 3 wk, which were represented by increased reduced sugar release amount and improved dry matter digestibility.	[Liu, Yang; Jiang, Guitao; Dai, Qiuzhong] Hunan Inst Anim Husb & Vet Med, Changsha, Peoples R China; [Liu, Yang] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Peoples R China; [Liu, Shengli] Shandong Lonct Enzymes Co Ltd, Linyi, Shandong, Peoples R China	Hunan Agricultural University	Dai, QZ (corresponding author), Hunan Inst Anim Husb & Vet Med, Changsha, Peoples R China.	daiqiuzhong@163.com		Liu, Yang/0000-0002-6579-3633	Shandong Lonct Enzymes Co., Ltd.; China Agriculture Research System of MOF and MARA	Shandong Lonct Enzymes Co., Ltd.; China Agriculture Research System of MOF and MARA(Ministry of Oceans & Fisheries (MOF), Republic of Korea)	We declare that Shandong Lonct Enzymes Co., Ltd. provided support in the form of salaries for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. This study was supported by China Agriculture Research System of MOF and MARA.	Aderibigbe A, 2020, POULTRY SCI, V99, P6867, DOI 10.1016/j.psj.2020.09.007; Aderibigbe A, 2020, POULTRY SCI, V99, P5907, DOI 10.1016/j.psj.2020.08.036; Bi JH, 2020, APPL MICROBIOL BIOT, V104, P7551, DOI 10.1007/s00253-020-10764-z; Bozic N, 2017, AMYLASE, V1, P12, DOI DOI 10.1515/AMYLASE-2017-0002; Cramer KR, 2003, J APPL POULTRY RES, V12, P404, DOI 10.1093/japr/12.4.404; Gracia MI, 2003, POULTRY SCI, V82, P436, DOI 10.1093/ps/82.3.436; Jiang ZY, 2008, ASIAN AUSTRAL J ANIM, V21, P97, DOI 10.5713/ajas.2008.70110; Lei Z, 2016, J AGR FOOD CHEM, V64, P4932, DOI 10.1021/acs.jafc.6b01272; MAHAGNA M, 1995, REPROD NUTR DEV, V35, P201, DOI 10.1051/rnd:19950208; Malathi V, 2001, POULTRY SCI, V80, P302, DOI 10.1093/ps/80.3.302; Marin-Navarro J, 2011, APPL MICROBIOL BIOT, V89, P1267, DOI 10.1007/s00253-010-3034-0; Mehta D, 2014, APPL MICROBIOL BIOT, V98, P4503, DOI 10.1007/s00253-013-5459-8; Mineo H., 2008, Journal of Applied Glycoscience, V55, P203; MORAN ET, 1982, POULTRY SCI, V61, P1257, DOI 10.3382/ps.0611257; Narasimha J, 2013, VET WORLD, V6, P525, DOI [10.5455/vetworld.2013.525-529, 10.14202/vetworld.2013.754-760]; Ravindran V, 2013, J APPL POULTRY RES, V22, P628, DOI 10.3382/japr.2013-00739; RITZ CW, 1995, POULTRY SCI, V74, P1329, DOI 10.3382/ps.0741329; Romero LF, 2014, POULTRY SCI, V93, P2501, DOI 10.3382/ps.2013-03789; Serrano MP, 2012, POULTRY SCI, V91, P2838, DOI 10.3382/ps.2012-02371; Singh J, 2010, TRENDS FOOD SCI TECH, V21, P168, DOI 10.1016/j.tifs.2009.12.001; Svihus B, 2014, POULTRY SCI, V93, P2394, DOI 10.3382/ps.2014-03905; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vieira SL, 2015, BRAZ J POULTRY SCI, V17, P227, DOI 10.1590/1516-635x1702227-236; Waterschoot J, 2015, STARCH-STARKE, V67, P14, DOI 10.1002/star.201300238; You YX, 2020, INT J BIOL MACROMOL, V159, P823, DOI 10.1016/j.ijbiomac.2020.05.156; Zhang GY, 2006, BIOMACROMOLECULES, V7, P3252, DOI 10.1021/bm060342i; Zhang L, 2019, POULTRY SCI, V98, P1280, DOI 10.3382/ps/pey450; Zhao F, 2014, POULTRY SCI, V93, P1410, DOI 10.3382/ps.2013-03532; Zimonja O, 2007, CAN J ANIM SCI, V87, P553, DOI 10.4141/CJAS07044; Zimonja O, 2009, ANIM FEED SCI TECH, V149, P287, DOI 10.1016/j.anifeedsci.2008.06.010	30	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259865	10.1371/journal.pone.0259865	http://dx.doi.org/10.1371/journal.pone.0259865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780535	gold, Green Published			2022-12-26	WOS:000755305800061
J	Athanasiou, A; Tennstedt, P; Wittig, A; Huber, R; Straub, O; Schiess, R; Steuber, T				Athanasiou, Alcibiade; Tennstedt, Pierre; Wittig, Anja; Huber, Ramy; Straub, Oliver; Schiess, Ralph; Steuber, Thomas			A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; MANAGEMENT; SCORE	The objective was to determine the prognostic utility of a new biomarker combination in prostate cancer (PCa) patients undergoing Radical Prostatectomy (RP). Serum samples and clinical data of 557 men who underwent RP for PCa with pathological stage (pT) <3 at Martini Clinic (Hamburg, Germany) were used for analysis. Clinical Grade Group and clinical stage was determined using biopsy samples while tumor marker concentrations were measured in serum using immunoassays. The prognostic utility of the proposed marker combination was assessed using Cox proportional hazard regression and Kaplan-Meier analysis. The performance was compared to the Cancer of the Prostate Risk Assessment (CAPRA) score in the overall cohort and in a low-risk patient subset. A multivariable model comprising fibronectin 1, galectin-3-binding protein, lumican, matrix metalloprotease 9, thrombospondin-1 and PSA together with clinical Grade Group (GG) and clinical stage (cT) was created. The proposed model was a significant predictor of biochemical recurrence (BCR) (HR 1.29 per 5 units score, 95%CI 1.20-1.38, p<0.001). The Kaplan-Meier analysis showed that the proposed model had a better prediction for low-risk disease after RP compared to CAPRA (respectively 5.0% vs. 9.1% chance of BCR). In a pre-defined low risk population subset, the risk of BCR using the proposed model was below 5.2% and thus lower when compared to CAPRA = 0-2 (9%), GG<2 (7%) and NCCN = low-risk (6%) subsets. Additionally, the proposed model could significantly (p<0.001) discriminate patients with adverse pathology (AP) events at RP from those without. In conclusion, the proposed model is superior to CAPRA for the prediction of BCR after RP in the overall cohort as well as a in a pre-defined low risk patient population subset. It is also significantly associated with AP at RP.	[Athanasiou, Alcibiade; Wittig, Anja; Huber, Ramy; Straub, Oliver; Schiess, Ralph] Proteomedix AG, Zurich, Switzerland; [Tennstedt, Pierre; Steuber, Thomas] Univ Hosp Hamburg Eppendorf, Martini Klin, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schiess, R (corresponding author), Proteomedix AG, Zurich, Switzerland.	schiess@proteomedix.com		Huber, Ramy/0000-0001-5018-8513				Artibani W, 2018, UROL INT, V100, P251, DOI 10.1159/000481438; Bair EL, 2006, PROSTATE, V66, P283, DOI 10.1002/pros.20343; Blute ML, 2001, J UROLOGY, V165, P119, DOI 10.1097/00005392-200101000-00030; Bolton DM, 2014, WORLD J UROL, V32, P431, DOI 10.1007/s00345-013-1125-0; Cima I, 2011, P NATL ACAD SCI USA, V108, P3342, DOI 10.1073/pnas.1013699108; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Coulson-Thomas VJ, 2013, EXP CELL RES, V319, P967, DOI 10.1016/j.yexcr.2013.01.023; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Das DK., 2017, RNA DIS, P4; Endt K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181557; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Kornberg Z, 2019, J UROLOGY, V202, P702, DOI 10.1097/JU.0000000000000290; Kozminski MA, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.03.019; Macagno A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233442; Morgia G, 2005, UROL RES, V33, P44, DOI 10.1007/s00240-004-0440-8; Network NCC, 2021, NCCN CLIN PRACTICE G, VV2; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Therneau T, 2017, SURVIVAL VIGNETTES	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259093	10.1371/journal.pone.0259093	http://dx.doi.org/10.1371/journal.pone.0259093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767586	Green Published, gold			2022-12-26	WOS:000755249300021
J	McCann, JJ; Vasilevskaya, IA; McNair, C; Gallagher, P; Neupane, NP; de Leeuw, R; Shafi, AA; Dylgjeri, E; Mandigo, AC; Schiewer, MJ; Knudsen, KE				McCann, Jennifer J.; Vasilevskaya, Irina A.; McNair, Christopher; Gallagher, Peter; Neupane, Neermala Poudel; de Leeuw, Renee; Shafi, Ayesha A.; Dylgjeri, Emanuela; Mandigo, Amy C.; Schiewer, Matthew J.; Knudsen, Karen E.			Mutant p53 elicits context-dependent pro-tumorigenic phenotypes	ONCOGENE			English	Article							GAIN-OF-FUNCTION; MUTATIONAL LANDSCAPE; DRIVE CANCER; DNA-BINDING; COMBINATIONS; ANTAGONISTS; CHROMATIN; EVOLUTION; PATHWAYS; GENOMICS	The tumor suppressor gene TP53 is the most frequently mutated gene in numerous cancer types, including prostate cancer (PCa). Specifically, missense mutations in TP53 are selectively enriched in PCa, and cluster to particular "hot spots" in the p53 DNA binding domain with mutation at the R273 residue occurring most frequently. While this residue is similarly mutated to R273C-p53 or R273H-p53 in all cancer types examined, in PCa selective enrichment of R273C-p53 is observed. Importantly, examination of clinical datasets indicated that TP53 heterozygosity can either be maintained or loss of heterozygosity (LOH) occurs. Thus, to mimic tumor-associated mutant p53, R273C-p53 and R273H-p53 isogenic PCa models were developed in the presence or absence of wild-type p53. In the absence of wild-type p53, both R273C-p53 and R273H-p53 exhibited similar loss of DNA binding, transcriptional profiles, and loss of canonical tumor suppressor functions associated with wild-type p53. In the presence of wild-type p53 expression, both R273C-p53 and R273H-p53 supported canonical p53 target gene expression yet elicited distinct cistromic and transcriptional profiles when compared to each other. Moreover, heterozygous modeling of R273C-p53 or R273H-p53 expression resulted in distinct phenotypic outcomes in vitro and in vivo. Thus, mutant p53 acts in a context-dependent manner to elicit pro-tumorigenic transcriptional profiles, providing critical insight into mutant p53-mediated prostate cancer progression.	[McCann, Jennifer J.; Vasilevskaya, Irina A.; McNair, Christopher; Gallagher, Peter; Neupane, Neermala Poudel; de Leeuw, Renee; Shafi, Ayesha A.; Dylgjeri, Emanuela; Mandigo, Amy C.; Schiewer, Matthew J.; Knudsen, Karen E.] Sidney Kimmel Med Coll, Dept Canc Biol, Philadelphia, PA 19107 USA	Jefferson University	Knudsen, KE (corresponding author), Sidney Kimmel Med Coll, Dept Canc Biol, Philadelphia, PA 19107 USA.	karen.knudsen@jefferson.edu		Shafi, Ayesha/0000-0003-0335-638X; Dylgjeri, Emanuela/0000-0002-1784-634X	National Cancer Institute [F99CA212225, 5R01CA17640105, 5R01CA18256905, 5R01CA21732903]; Sidney Kimmel Cancer Center [5P30CA056036-17]; Laboratory Animals, MetaOmics, Translational Pathology shared resources; Prostate Cancer Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sidney Kimmel Cancer Center; Laboratory Animals, MetaOmics, Translational Pathology shared resources; Prostate Cancer Foundation	We gratefully thank all members of the Knudsen laboratory for their invaluable input and support. We also thank the institutions that supported this work: The National Cancer Institute (F99CA212225 JJM, 5R01CA17640105 KEK, 5R01CA18256905 KEK, 5R01CA21732903 KEK), the Sidney Kimmel Cancer Center (Support Grant 5P30CA056036-17), the Laboratory Animals, MetaOmics, Translational Pathology shared resources, as well as awards from the Prostate Cancer Foundation.	Abida W, 2019, P NATL ACAD SCI USA, V116, P11428, DOI 10.1073/pnas.1902651116; Abida W, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00029; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Boettcher S, 2019, SCIENCE, V365, P599, DOI 10.1126/science.aax3649; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chicas A, 2000, BIOCHEM BIOPH RES CO, V279, P383, DOI 10.1006/bbrc.2000.3965; Comel A, 2014, FEBS LETT, V588, P2600, DOI 10.1016/j.febslet.2014.04.015; De Laere B, 2019, CLIN CANCER RES, V25, P1766, DOI 10.1158/1078-0432.CCR-18-1943; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hainaut P, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026179; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henrich IC, 2021, CANCER RES, V81, P2171, DOI 10.1158/0008-5472.CAN-20-1458; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Joerger AC, 2016, ANNU REV BIOCHEM, V85, P375, DOI 10.1146/annurev-biochem-060815-014710; Junk DJ, 2008, NEOPLASIA, V10, P450, DOI 10.1593/neo.08120; Kim MP, 2018, CELL DEATH DIFFER, V25, P161, DOI 10.1038/cdd.2017.185; Knudsen KE, 2010, TRENDS ENDOCRIN MET, V21, P315, DOI 10.1016/j.tem.2010.01.002; Kregel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053701; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehen'kyi V, 2007, ONCOGENE, V26, P7380, DOI 10.1038/sj.onc.1210545; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu Y, 2016, NATURE, V531, P471, DOI 10.1038/nature17157; Mantovani F, 2019, CELL DEATH DIFFER, V26, P199, DOI 10.1038/s41418-018-0246-9; McCann JJ, 2020, CANCER RES, V80, P430, DOI 10.1158/0008-5472.CAN-19-1033; McNair C, 2017, ONCOGENE, V36, P1655, DOI 10.1038/onc.2016.334; McNair C, 2018, J CLIN INVEST, V128, P341, DOI 10.1172/JCI93566; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mirosevich J, 2006, PROSTATE, V66, P1013, DOI 10.1002/pros.20299; Morselli E, 2008, CELL CYCLE, V7, P3056, DOI 10.4161/cc.7.19.6751; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NGUYEN B, 2020, EUR UROL; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Polotskaia A, 2015, P NATL ACAD SCI USA, V112, pE1220, DOI 10.1073/pnas.1416318112; Powell E, 2014, CANCER DISCOV, V4, P405, DOI 10.1158/2159-8290.CD-13-0136; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159; Ren SC, 2018, EUR UROL, V73, P322, DOI 10.1016/j.eururo.2017.08.027; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sandy Z, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111557; Schrecengost RS, 2014, CANCER RES, V74, P272, DOI 10.1158/0008-5472.CAN-13-1954; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shiota M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060602; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stopsack KH, 2020, CLIN CANCER RES, V26, P3230, DOI 10.1158/1078-0432.CCR-20-0168; Tang QS, 2020, TRENDS CANCER, V6, P62, DOI 10.1016/j.trecan.2019.11.004; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yamamoto S, 2019, CANCERS, V11, DOI 10.3390/cancers11010004; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	75	5	5	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					444	458		10.1038/s41388-021-01903-5	http://dx.doi.org/10.1038/s41388-021-01903-5		NOV 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34773073	Green Published, hybrid			2022-12-26	WOS:000717915200004
J	Weigand, R; Moosmayer, A; Jacobsen, T				Weigand, Rosalie; Moosmayer, Annika; Jacobsen, Thomas			Does self-reported chronic pain influence savoring of aesthetic experiences?	PLOS ONE			English	Article							MASLOWS HIERARCHY; MINDFULNESS; PERSONALITY; COMPONENTS; JUDGMENTS; CONTEXT; IMPACT; REWARD; STATES; DRIVE	Background Aesthetic experiences elicit a wide range of positive emotions and have a positive impact on various health outcomes. In this context, savoring refers to a cognitive form of emotion regulation used to maintain and extend positive emotional experiences and is considered to contribute to health and well-being. Chronic pain has been linked to reduced reward-seeking behavior. This is the first study to investigate the relationship between self-reported chronic pain and savoring. Methods We conducted an anonymous cross-sectional survey in a large non-clinical sample (opera, theater, and cabaret visitors; n = 322). The variables were assessed with a two-item-questionnaire. Results Self-reported chronic pain was significantly negatively correlated with savoring (r = -.547) Conclusion Altogether, this result helps to develop a better understanding of the effects of chronic pain in humans and to shed light on state-dependent differences in aesthetic experiences.	[Weigand, Rosalie; Moosmayer, Annika; Jacobsen, Thomas] Helmut Schmidt Univ, Expt Psychol Unit, Humanities & Social Sci, Univ Fed Armed Forces Hamburg, Hamburg, Germany	Helmut Schmidt University	Weigand, R (corresponding author), Helmut Schmidt Univ, Expt Psychol Unit, Humanities & Social Sci, Univ Fed Armed Forces Hamburg, Hamburg, Germany.	weigandr@hsu-hh.de	Jacobsen, Thomas/B-5796-2011	Jacobsen, Thomas/0000-0002-1523-3996; Weigand, Rosalie/0000-0001-6996-6055				[Anonymous], 2007, PSYCHOL SCI; Becker S, 2012, NEUROSCI LETT, V520, P182, DOI 10.1016/j.neulet.2012.03.013; Benson Suzanne G, 2003, J Nurs Manag, V11, P315, DOI 10.1046/j.1365-2834.2003.00409.x; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Brielmann Aenne A, 2019, Front Psychol, V10, P2420, DOI 10.3389/fpsyg.2019.02420; Brown K, 2006, MENT HEALTH RELIG CU, V9, P99, DOI 10.1080/13694670500071695; Bryant F.B., 2003, J MENTAL HLTH, V12, P175, DOI [10.1080/0963823031000103489, DOI 10.1080/0963823031000103489]; BRYANT FB, 1989, J PERS, V57, P773, DOI 10.1111/j.1467-6494.1989.tb00494.x; Carpinelli L, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13531; Chamorro-Premuzic T, 2009, BRIT J PSYCHOL, V100, P501, DOI 10.1348/000712608X366867; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; Dansie EJ, 2013, BRIT J ANAESTH, V111, P19, DOI 10.1093/bja/aet124; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Dixon D, 2007, PAIN, V130, P249, DOI 10.1016/j.pain.2006.12.004; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Fechner G.T., 1876, VORSCHULE AESTHETIK; Fredrickson BL, 2013, ADV EXP SOC PSYCHOL, V47, P1, DOI 10.1016/B978-0-12-407236-7.00001-2; Furnham A, 2001, EUR J PERSONALITY, V15, P57, DOI 10.1002/per.340; Gandhi W, 2013, EUR J PAIN, V17, P1093, DOI 10.1002/j.1532-2149.2012.00281.x; Garland EL, 2020, PSYCHOL MED, V50, P1977, DOI 10.1017/S0033291719002010; Garland EL, 2019, CURR OPIN PSYCHOL, V28, P184, DOI 10.1016/j.copsyc.2019.01.004; Geiger PJ, 2017, PERS INDIV DIFFER, V105, P164, DOI 10.1016/j.paid.2016.09.049; Gerger G, 2014, ACTA PSYCHOL, V151, P174, DOI 10.1016/j.actpsy.2014.06.008; Gorsuch R., 1983, FACTOR ANAL; Gruner S, 2019, EMPIR STUD ARTS, V37, P138, DOI 10.1177/0276237418822896; Hauser W, 2013, SCHMERZ, V27, P46, DOI 10.1007/s00482-012-1280-z; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hevner K, 1937, PSYCHOL REV, V44, P245, DOI 10.1037/h0053980; Hurley DB, 2012, J HAPPINESS STUD, V13, P579, DOI 10.1007/s10902-011-9280-8; IASP, 1986, PAIN S, V3, pS1; Ishizu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021852; Jackson W, 2019, J PAIN RES, V12, P179, DOI 10.2147/JPR.S172733; Jacobsen T, 2002, PERCEPT MOTOR SKILL, V95, P755, DOI 10.2466/PMS.95.7.755-766; Jacobsen T, 2010, ADV CONSC RES, V78, P245; Jacobsen T, 2010, J ANAT, V216, P184, DOI 10.1111/j.1469-7580.2009.01164.x; Jose PE, 2012, J POSIT PSYCHOL, V7, P176, DOI 10.1080/17439760.2012.671345; Karnatovskaia LV, 2015, J CRIT CARE, V30, P210, DOI 10.1016/j.jcrc.2014.09.003; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Liu XH, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/6760121; Mallik A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41952; Manraj K, 2013, J PHYSIOTHER, V59, P60, DOI 10.1016/S1836-9553(13)70153-X; Marchand WR, 2012, J PSYCHIATR PRACT, V18, P233, DOI 10.1097/01.pra.0000416014.53215.86; Markovic S, 2012, I-PERCEPTION, V3, P1, DOI 10.1068/i0450aap; Maslow AH., 1972, PEOPLE BUILDINGS, P212; Maslow AH., 1987, MOTIVATION PERSONALI, P59; Menninghaus W, 2019, PSYCHOL REV, V126, P171, DOI 10.1037/rev0000135; Mogg K, 1998, BEHAV RES THER, V36, P227, DOI 10.1016/S0005-7967(97)00062-4; Mullennix JW, 2018, PSYCHOL AESTHET CREA, V12, P166, DOI 10.1037/aca0000128; Rawlings D, 2003, PERS INDIV DIFFER, V34, P395, DOI 10.1016/S0191-8869(02)00062-4; Reuband K., 2013, JB KULTURMANAGEMANAG, VIV, P229, DOI [10.1055/s-0033-1334953, DOI 10.1055/S-0033-1334953]; Saeednia Y., 2009, US CHINA ED REV, V6, P52; Schall M, 2017, MOTIV EMOTION, V41, P38, DOI 10.1007/s11031-016-9591-5; Schell E, 2011, WORK, V39, P203, DOI 10.3233/WOR-2011-1182; Silvia PJ, 2009, PSYCHOL AESTHET CREA, V3, P48, DOI 10.1037/a0014632; Smith BH, 1997, PAIN, V71, P141, DOI 10.1016/S0304-3959(97)03347-2; Sundararajan L, 2010, REV GEN PSYCHOL, V14, P22, DOI 10.1037/a0018122; VONKORFF M, 1990, PAIN, V40, P279, DOI 10.1016/0304-3959(90)91125-3; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Weigand R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248529; Weytens F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095677; Wilhelm O, 2010, J INDIVID DIF, V31, P1, DOI 10.1027/1614-0001/a000001; Zalenski RJ, 2006, J PALLIAT MED, V9, P1120, DOI 10.1089/jpm.2006.9.1120; Zautra AJ, 2005, J CONSULT CLIN PSYCH, V73, P212, DOI 10.1037/0022-006X.73.2.212	64	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259198	10.1371/journal.pone.0259198	http://dx.doi.org/10.1371/journal.pone.0259198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767583	Green Published, gold			2022-12-26	WOS:000755249300023
J	Lim, YJ; Kong, M				Lim, Yu Jin; Kong, Moonkyoo			Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma	PLOS ONE			English	Article							RATE INTERSTITIAL BRACHYTHERAPY; DEFINITIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; FRACTIONS; CAVITY; RISK; CARE	Purpose Although recent clinical guidelines do allow primary radiotherapy for selected patients with early-stage oral tongue cancer, there has been little knowledge on the treatment outcomes of non-operative radiotherapy using modern treatment techniques. This study evaluated recent prognostic differences between primary radiotherapy and surgical resection in T1-2N0 oral tongue squamous cell carcinoma. Methods Patients diagnosed with T1-2N0 oral tongue squamous cell carcinoma were identified from the Surveillance, Epidemiology, and End Results database. After propensity score matching, the disease-specific survival of primary radiotherapy and surgery was compared. Results From a total of 8,458 patients initially identified, we defined matched cohorts: cohort A, comparing surgery alone vs. primary radiotherapy (n = 230 vs. 230), and cohort B, comparing surgery plus adjuvant radiotherapy vs. primary radiotherapy (n = 230 vs. 230). The 7-year disease-specific survival rates were 77% vs. 35% (cohort A) and 65% vs. 35% (cohort B) (P < 0.001 for all comparisons). Primary radiotherapy was independently associated with worse disease-specific survival in both cohorts A (hazard ratio 4.06; 95% confidence interval 2.53-6.52) and B (hazard ratio 2.81; 95% confidence interval 1.96-4.04). Time-course hazard rate function plots showed a distinct short-term risk increment in disease-specific mortality in the primary radiotherapy group. Conclusion In the contemporary treatment era, the use of radiotherapy as a definitive treatment resulted in an inferior prognosis in patients with T1-2N0 oral tongue squamous cell carcinoma. The present population-based data suggest that primary radiotherapy cannot be used as an alternative to surgical management and it needs to be avoided as much as possible in early-stage tumors.	[Lim, Yu Jin; Kong, Moonkyoo] Kyung Hee Univ, Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Kyung Hee University	Lim, YJ (corresponding author), Kyung Hee Univ, Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	yujindw@gmail.com			National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, Information and Communications Technology & Future Planning) [2021R1C1C1005297]	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, Information and Communications Technology & Future Planning)(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science, Information and Communications Technology & Future Planning) (2021R1C1C1005297).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2012, J RADIAT RES, V53, P722, DOI 10.1093/jrr/rrs027; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bansal A, 2016, J CONTEMP BRACHYTHER, V8, P56, DOI 10.5114/jcb.2016.58082; Cabrera-Rodriguez JJ., 2016, PLASTAESTHET RES, V3, P158, DOI 10.20517/2347-9264.2016.13; Ellis MA, 2018, OTOLARYNG HEAD NECK, V158, P649, DOI 10.1177/0194599817746909; Fujita M, 1999, INT J RADIAT ONCOL, V44, P767, DOI 10.1016/S0360-3016(99)00068-1; Ganly I, 2013, CANCER-AM CANCER SOC, V119, P1168, DOI 10.1002/cncr.27872; Gayen S, 2020, RADIAT ONCOL J, V38, P138, DOI 10.3857/roj.2020.00143; Han K, 2013, INT J RADIAT ONCOL, V87, P111, DOI 10.1016/j.ijrobp.2013.05.033; Hosni A, 2021, RADIOTHER ONCOL, V154, P70, DOI 10.1016/j.radonc.2020.08.013; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Huang YM, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051688; Kovacs G, 2017, RADIOTHER ONCOL, V122, P248, DOI 10.1016/j.radonc.2016.10.008; Lau HY, 1996, RADIOTHER ONCOL, V39, P15, DOI 10.1016/0167-8140(95)01686-4; LEUNG TW, 1993, ACTA ONCOL, V32, P559, DOI 10.3109/02841869309096118; Liu WC, 2021, HEAD NECK-J SCI SPEC, V43, P1142, DOI 10.1002/hed.26575; Liu WC, 2020, RADIOTHER ONCOL, V151, P214, DOI 10.1016/j.radonc.2020.08.016; Guinot JL, 2010, BRACHYTHERAPY, V9, P227, DOI 10.1016/j.brachy.2009.10.003; Matsumoto K, 2013, JPN J CLIN ONCOL, V43, P1012, DOI 10.1093/jjco/hyt108; Maxwell JH, 2015, JAMA OTOLARYNGOL, V141, P1104, DOI 10.1001/jamaoto.2015.1351; National Cancer Institute, 2021, SAMPL SEER RES DAT U; National Cancer Institute, 2021, OV SEER PROGR; National Cancer Institute, 2021, SEER STAT SOFTW; National Cancer Institute, 2021, REG GROUP SEER DAT S; National Cancer Institute, 2021, DOC SEER DAT; National Comprehensive Cancer Network`, 2021, NCCN CLIN PRACTICE G, DOI 10.6004/jnccn.2009.0057; Oota S, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-21; Orton A, 2016, BRACHYTHERAPY, V15, P851, DOI 10.1016/j.brachy.2016.05.007; Pernot M, 1996, OTOLARYNG HEAD NECK, V115, P519, DOI 10.1016/S0194-5998(96)70006-2; Petereit DG, 2015, J CLIN ONCOL, V33, P980, DOI 10.1200/JCO.2014.59.8128; Rusthoven K, 2008, CANCER-AM CANCER SOC, V112, P345, DOI 10.1002/cncr.23183; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sinha N, 2018, MODERN PATHOL, V31, P772, DOI 10.1038/modpathol.2017.183; Thorwarth D, 2019, PHYS IMAG RADIAT ONC, V12, P63, DOI 10.1016/j.phro.2019.11.008; Yamazaki H, 2007, ANTICANCER RES, V27, P491	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259384	10.1371/journal.pone.0259384	http://dx.doi.org/10.1371/journal.pone.0259384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762670	gold, Green Published			2022-12-26	WOS:000755316600022
J	Fuller, SS; Clarke, E; Harding-Esch, EM				Fuller, Sebastian S.; Clarke, Eleanor; Harding-Esch, Emma M.			Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development	PLOS ONE			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; NEISSERIA-GONORRHOEAE; TRACHOMATIS; WOMEN; DIAGNOSTICS; MEDICINE; IMPACT; SERVICES; BENEFITS; CT/NG	Background Sexually Transmitted Infections, including Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), continue to be a global health problem. Increased access to point-of-caretests (POCTs) could help detect infection and lead to appropriate management of cases and contacts, reducing transmission and development of reproductive health sequelae. Yet diagnostics with good clinical effectiveness evidence can fail to be implemented into routine care. Here we assess values beyond clinical effectiveness for molecular CT/NG POCTs implemented across diverse routine practice settings. Methods We conducted a systematic review of peer-reviewed primary research and conference abstract publications in Medline and Embase reporting on molecular CT/NG POCT implementation in routine clinical practice until 16th February 2021. Results were extracted into EndNote software and initially screened by title and abstract by one author according to the inclusion and exclusion criteria. Articles that met the criteria, or were unclear, were included for full-text assessment by all authors. Results were synthesised to assess the tests against guidance criteria and develop a CT/NG POCT value proposition for multiple stakeholders and settings. Findings The systematic review search returned 440 articles; 28 were included overall. The Cepheid CT/NG GeneXpert was the only molecular CT/NG POCT implemented and evaluated in routine practice. It did not fulfil all test guidance criteria, however, studies of test implementation showed multiple values for test use across various healthcare settings and locations. Our value proposition highlights that the majority of values are setting-specific. Sexual health services and outreach services have the least overlap, with General Practice and other non-sexual health specialist services serving as a "bridge" between the two. Conclusions Those wishing to improve CT/NG diagnosis should be supported to identify the values most relevant to their settings and context, and prioritise implementation of tests that are most closely aligned with those values.	[Fuller, Sebastian S.; Harding-Esch, Emma M.] St Georges Univ London, Appl Diagnost Res & Evaluat Unit, Inst Infect & Immun, London, England; [Fuller, Sebastian S.] Univ Oxford, Nuffield Dept Med, Hlth Syst Collaborat, Oxford, England; [Clarke, Eleanor; Harding-Esch, Emma M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England	St Georges University London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Fuller, SS (corresponding author), St Georges Univ London, Appl Diagnost Res & Evaluat Unit, Inst Infect & Immun, London, England.; Fuller, SS (corresponding author), Univ Oxford, Nuffield Dept Med, Hlth Syst Collaborat, Oxford, England.	sebastian.fuller@ndm.ox.ac.uk		Fuller, Sebastian/0000-0002-9284-6630; Harding-Esch, Emma/0000-0002-1432-8109				Adams EJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005322; Badman SG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1573-4; Barnett J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-342; Barrow RY, 2020, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6805a1; Bell SFE, 2020, SEX HEALTH, V17, P359, DOI 10.1071/SH19233; Bourgeois-Nicolaos N, 2015, SEX TRANSM DIS, V42, P652, DOI 10.1097/OLQ.0000000000000351; Bristow CC, 2019, SEX HEALTH, V16, P314, DOI 10.1071/SH18079; Bristow CC, 2017, INT J STD AIDS, V28, P1130, DOI 10.1177/0956462416689755; Center for Evidence-Based Management, CRIT APPR QUEST SURV; Cohen S, 2019, SEX TRANSM INFECT, V95, pA71, DOI 10.1136/sextrans-2019-sti.185; Cristillo AD, 2017, SEX TRANSM DIS, V44, P211, DOI 10.1097/OLQ.0000000000000572; Deloitte Development LLC, 2017, FRAM COMPR ASS VAL D; Fifer H, 2020, INT J STD AIDS, V31, P4, DOI 10.1177/0956462419886775; Fitzpatrick C, 2020, INT J STD AIDS, V31, P702, DOI 10.1177/0956462420901989; Fraser A, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0207-7; Fuller SS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215380; Garcia PJ, 2015, LANCET GLOB HEALTH, V3, pE257, DOI 10.1016/S2214-109X(15)70089-6; Garrett NJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196209; Gaydos CA, 2019, ANN EMERG MED, V74, P36, DOI 10.1016/j.annemergmed.2018.09.012; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Gettinger J, 2020, SEX TRANSM DIS, V47, P67, DOI 10.1097/OLQ.0000000000001083; Gift TL, 1999, SEX TRANSM DIS, V26, P232, DOI 10.1097/00007435-199904000-00010; Goldenberg MJ, 2006, SOC SCI MED, V62, P2621, DOI 10.1016/j.socscimed.2005.11.031; Greenhalgh T, 2018, IMPLEMENT EVIDENCE B, DOI [10.1097/XEB.0000000000000147, DOI 10.1097/XEB.0000000000000147]; Guy RJ, 2018, LANCET INFECT DIS, V18, P1117, DOI 10.1016/S1473-3099(18)30429-8; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; Harding-Esch EM, 2017, SEX TRANSM INFECT, V93, P424, DOI 10.1136/sextrans-2016-052988; Herbst De Cortina S., 2016, INFECT DIS OBSTET GY, V2016; Hesse EA, 2015, SEX HEALTH, V12, P71, DOI 10.1071/SH14132; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Huang W, 2013, SEX TRANSM INFECT, V89, P108, DOI 10.1136/sextrans-2011-050355; Jacobsson S, 2018, APMIS, V126, P907, DOI 10.1111/apm.12902; JBI, CRIT APPR TOOLS; Keizur EM, 2020, SEX TRANSM DIS, V47, P19, DOI 10.1097/OLQ.0000000000001088; Kelly H, 2017, SEX TRANSM INFECT, V93, pS22, DOI 10.1136/sextrans-2016-053067; Kerry-Barnard S, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-5062-5; Kettler H, 2003, MAPPING LANDSCAPE DI; Lambert H, 2006, SOC SCI MED, V62, P2633, DOI 10.1016/j.socscimed.2005.11.023; Land KJ, 2019, NAT MICROBIOL, V4, P46, DOI 10.1038/s41564-018-0295-3; Lowndes CM, 2014, LANCET, V384, P47; Ma LL, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00238-8; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Mandlik E., 2017, SEX TRANSM INFECT S1, V93; Martin Kevin, 2021, Lancet Child Adolesc Health, V5, P122, DOI 10.1016/S2352-4642(20)30335-7; May L, 2016, SEX TRANSM DIS, V43, P290, DOI 10.1097/OLQ.0000000000000438; Murtagh M., 2019, WHO POINT OF CAR DIA; Mvumbi G., 2017, TROP MED INT HEAL; National Heart Lung and Blood Institute; U.S. Department of Health and Human Services, STUD QUAL ASS TOOLS; National Institute for Clinical Excelllence (NICE), APPR CHECKL EV TABL; Natoli L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006922; Natoli L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145993; Natoli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100518; Nicholls JE, 2018, SEX TRANSM INFECT, V94, P93, DOI 10.1136/sextrans-2016-052942; Nwokolo NC, 2015, UK NATL GUIDELINE MA; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Neill J., 2016, Tackling drug-resistant infections globally: final report and recommendations; Pacho A, 2019, SEX TRANSM INFECT, V95, pA97, DOI 10.1136/sextrans-2019-sti.247; Page MJ, 2021, INT J SURG, V88, DOI 10.1016/j.ijsu.2021.105906; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Pittman E, TESTING CHLAMYDIA MO; Price CP, 2016, CLIN CHIM ACTA, V462, P183, DOI 10.1016/j.cca.2016.09.006; Price CP, 2014, CLIN CHIM ACTA, V436, P104, DOI 10.1016/j.cca.2014.05.017; Price CP, 2014, CLIN CHIM ACTA, V427, P71, DOI 10.1016/j.cca.2013.09.043; Public Health England, 2014, MAK IT WORK GUID WHO; Rivard KR, 2017, DIAGN MICR INFEC DIS, V87, P175, DOI 10.1016/j.diagmicrobio.2016.10.019; Rowley J, 2019, B WORLD HEALTH ORGAN, V97, P548, DOI 10.2471/BLT.18.228486; Skaletz-Rorowski A, 2021, J EUR ACAD DERMATOL, V35, P241, DOI 10.1111/jdv.16913; St John A, 2018, CLIN CHIM ACTA, V477, P154, DOI 10.1016/j.cca.2017.12.007; Toskin I., 2017, SEX TRANSM INFECT, V93; Toskin I, 2017, SEX TRANSM INFECT, V93, pS69, DOI 10.1136/sextrans-2016-053071; Tuite AR, 2017, J INFECT DIS, V216, P1141, DOI [10.1093/inFdis/jix450, 10.1093/infdis/jix450]; Turner KME, 2014, SEX TRANSM INFECT, V90, P104, DOI 10.1136/sextrans-2013-051147; Unemo M, 2020, INT J STD AIDS, DOI 10.1177/0956462420949126; Unemo M., 2013, LAB DIAGNOSIS SEXUAL; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Walter FM., 2019, BMC CANCER, V19, P1, DOI [10.1186/s12885-018-5219-3, DOI 10.1186/S12885-018-5219-3]; Whitlock G., 2015, INT J STD AIDS, V26, P88; Whitlock GG, 2018, INT J STD AIDS, V29, P474, DOI 10.1177/0956462417736431; Wi TEC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25343; Widdice LE, 2018, SEX TRANSM DIS, V45, P723, DOI 10.1097/OLQ.0000000000000865; Wingrove I, 2014, SEX TRANSM INFECT, V90, P474, DOI 10.1136/sextrans-2014-051580; World Health Organization, 2018, REP GLOB SEX TRANSM; World Health Organization Priority Medical Devices Project., 2010, BARRIERS INNOVATION; Wynn A., 2019, BMJ; Wynn A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1251238	87	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259593	10.1371/journal.pone.0259593	http://dx.doi.org/10.1371/journal.pone.0259593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748579	Green Accepted, Green Published, gold			2022-12-26	WOS:000755468000039
J	Jeewandara, C; Guruge, D; Jayathilaka, D; Madhusanka, PAD; Pushpakumara, PD; Ramu, ST; Aberathna, IS; Danasekara, DRSR; Pathmanathan, T; Gunatilaka, B; Malavige, S; Dias, Y; Wijayamuni, R; Ogg, GS; Malavige, GN				Jeewandara, Chandima; Guruge, Dinuka; Jayathilaka, Deshni; Madhusanka, Panambara Arachchige Deshan; Pushpakumara, Pradeep Darshana; Ramu, Shyrar Tanussiya; Aberathna, Inoka Sepali; Danasekara, Danasekara Rallage Saubhagya Rasikangani; Pathmanathan, Thilagaraj; Gunatilaka, Buddhini; Malavige, Sauni; Dias, Yowan; Wijayamuni, Ruwan; Ogg, Graham S.; Malavige, Gathsaurie Neelika			Transmission dynamics, clinical characteristics and sero-surveillance in the COVID-19 outbreak in a population dense area of Colombo, Sri Lanka April- May 2020	PLOS ONE			English	Article								Background The transmission dynamics of SARS-CoV-2 varies depending on social distancing measures, circulating SARS-CoV-2 variants, host factors and other environmental factors. We sought to investigate the clinical and epidemiological characteristics of a SARS-CoV-2 outbreak that occurred in a highly dense population area in Colombo, Sri Lanka from April to May 2020. Methodology/principal findings We carried out RT-qPCR for SARS-CoV2, assessed the SARS-CoV-2 specific total and neutralizing antibodies (Nabs) in a densely packed, underserved settlement (n = 2722) after identification of the index case on 15th April 2020. 89/2722 individuals were detected as infected by RT-qPCR with a secondary attack rate among close contacts being 0.077 (95% CI 0.063-0.095). Another 30 asymptomatic individuals were found to have had COVID-19 based on the presence of SARS-CoV-2 specific antibodies. However, only 61.5% of those who were initially seropositive for SARS-CoV-2 had detectable total antibodies at 120 to 160 days, while only 40.6% had detectable Nabs. 74/89 (83.1%) of RT-qPCR positive individuals were completely asymptomatic and all 15 (16.9%) who experienced symptoms were classified as having a mild illness. 18 (20.2%) were between the ages of 61 to 80. 11/89 (12.4%) had diabetes, 8/89 (9%) had cardiovascular disease and 4 (4.5%) had asthma. Of the two viruses that were sequenced and were of the B.1 and B.4 lineages with one carrying the D614G mutation. Discussion/conclusion Almost all infected individuals developed mild or asymptomatic illness despite the presence of comorbid illnesses. Since the majority of those who were in this underserved settlement were not infected despite circulation of the D614G variant, it would be important to further study environmental and host factors that lead to disease severity and transmission.	[Jeewandara, Chandima; Jayathilaka, Deshni; Madhusanka, Panambara Arachchige Deshan; Pushpakumara, Pradeep Darshana; Ramu, Shyrar Tanussiya; Aberathna, Inoka Sepali; Danasekara, Danasekara Rallage Saubhagya Rasikangani; Pathmanathan, Thilagaraj; Gunatilaka, Buddhini; Malavige, Sauni; Dias, Yowan; Malavige, Gathsaurie Neelika] Univ Sri Jayewardenepura, Dept Immunol & Mol Med, Allergy Immunol & Cell Biol Unit, Nugegoda, Sri Lanka; [Guruge, Dinuka; Wijayamuni, Ruwan] Colombo Municipal Council, Colombo, Sri Lanka; [Ogg, Graham S.; Malavige, Gathsaurie Neelika] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England	University Sri Jayewardenepura; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayewardenepura, Dept Immunol & Mol Med, Allergy Immunol & Cell Biol Unit, Nugegoda, Sri Lanka.; Malavige, GN (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	gathsaurie.malavige@ndm.ox.ac.uk	SAMINENI, RAMU/AAS-5148-2020	SAMINENI, RAMU/0000-0002-8652-2883	Centre for Dengue Research, Allergy Immunology and Cell Biology Unit UK Medical Research Council; World Health Organization; WHO Unity Studies, a global sero-epidemiological standardization initiative; COVID-19 Solidarity Response Fund; German Federal Ministry of Health (BMG) COVID-19 Research and development Fund	Centre for Dengue Research, Allergy Immunology and Cell Biology Unit UK Medical Research Council; World Health Organization(World Health Organization); WHO Unity Studies, a global sero-epidemiological standardization initiative; COVID-19 Solidarity Response Fund; German Federal Ministry of Health (BMG) COVID-19 Research and development Fund	Funding was provided by the Centre for Dengue Research, Allergy Immunology and Cell Biology Unit UK Medical Research Council and World Health Organization. This study has been supported by WHO Unity Studies, a global sero-epidemiological standardization initiative, with funding to WHO by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development Fund.	Albitar O, 2020, DIABETES RES CLIN PR, V166, DOI 10.1016/j.diabres.2020.108293; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, PHYLOGENETIC ASSIGNM; Centre CR, 2020, MORT AN JOHN HOPK U; Chandima Jeewandara DJ, 2020, RES SQUARE; Control ECfDPa, 2020, RISK REL SPREAD NEW; Epidemiology unit MoH Sri Lanka, 2020, COR DIS 2019 COVID 1; Epidemiology unit MoH Sri Lanka, COVID 19 NAT EP REP; Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750; Golechha M, 2020, J URBAN HEALTH, V97, P796, DOI 10.1007/s11524-020-00474-2; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lee K, 2009, GLOB INST, P1; Newcombe RG., 2013, CONFIDENCE INTERVALS, VFirst, P470; Organization WH., 2021, COVID 19 VIRT PRESS; Organization WH, 2020, COR DIS COVID 19 TEC; Pangolin, 2020, SARS COV2 LIN 2020 L; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; SARS-CoV-2 Variants, 2020, SARS COV 2 VAR; Singer J., 2020, COV GLUE WEB APPL TR, DOI [10.20944/preprints202006.0225.v1, DOI 10.20944/PREPRINTS202006.0225.V1]; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Tian WJ, 2020, J MED VIROL, V92, P1875, DOI 10.1002/jmv.26050; Wang Guyi, 2020, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V45, P542, DOI 10.11817/j.issn.1672-7347.2020.200292; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Young BE, 2020, LANCET, V396, P603, DOI 10.1016/S0140-6736(20)31757-8	25	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0257548	10.1371/journal.pone.0257548	http://dx.doi.org/10.1371/journal.pone.0257548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748557	Green Published, gold			2022-12-26	WOS:000755468000004
J	Mummadi, MK; Pandurangi, R; Geddam, JJB; Sinha, SN; Rajendran, A; Sivaperumal, P; Ramachandrappa, NK; Ramakrishna, KS; Sreenu, P				Mummadi, Mahesh Kumar; Pandurangi, Raghavendra; Geddam, J. J. Babu; Sinha, Sukesh Narayan; Rajendran, Ananthan; Sivaperumal, P.; Ramachandrappa, Naveen K.; Ramakrishna, Sree K.; Sreenu, Pagidoju			Investigation of an acute neurological outbreak in Eluru, India, 2020	PLOS ONE			English	Article								On 4th December 2020, a sudden outbreak, with neurological symptoms like seizures, loss of consciousness etc., was reported in a town from south India. By 3(rd) day about 400 people were involved. A multi disciplinary team from our institute visited the site to investigate the outbreak. Based on the case history and clinical examination of the patients, the team suspected a probable diagnosis of an acute pesticide, heavy metal and/or mycotoxin exposure for which, biological samples (blood, urine) were collected from those who reported the symptoms as well as from a few who did not report symptoms (controls). To identify the source, water and food samples were collected. The samples were subjected to ICP-MS for heavy metal analysis, LC-MS/MS for pesticide analysis, microbiological analysis and ELISA-Kit method for aflatoxins if any. Clinical and dietary details were collected from a total of 112 participants, of which, 103 cases (77 active cases at Hospital and 26 recovered cases from community) and 9 were controls. A total of 109 biological samples, 36 water samples and food samples were collected. The mean age of the study participants was 29.2 years. Among cases, Seizures were seen in 84%, loss of consciousness in 66%, mental confusion in 35%, pinpoint pupil in 11%. Triazophos (organophosphate) pesticide was present in 74% of Blood samples and its metabolites were present in 98% of the urine samples collected from the cases. All the ten heavy metals investigated including lead, mercury and nickel were found to be within permissible limits except for a few samples. No presence of mycotoxins was observed in Food samples. Water samples which included Head pump and reservoir were free from pesticides; however, all water samples from households of cases had triazophos pesticide with a mean concentration of 1.00 ug/L. Thus, it was concluded that, the probable cause of outbreak was Triazophos (Organophosphate) pesticide contamination in water at the Household level. Regular surveillance for the presence of residual pesticides in soil, water and food with heightened vigour is recommended to prevent future outbreaks.	[Mummadi, Mahesh Kumar; Pandurangi, Raghavendra; Geddam, J. J. Babu; Sinha, Sukesh Narayan; Rajendran, Ananthan; Ramachandrappa, Naveen K.; Ramakrishna, Sree K.; Sreenu, Pagidoju] Indian Council Med Res, Natl Inst Nutr ICMR NIN, Hyderabad, India; [Sivaperumal, P.] Indian Council Med Res, Natl Inst Occupat Hlth ICMR NIOH, Ahmadabad, Gujarat, India	Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR)	Sinha, SN (corresponding author), Indian Council Med Res, Natl Inst Nutr ICMR NIN, Hyderabad, India.	sukeshnr_sinha@yahoo.com	R, Dr Naveen kumar/AFU-5785-2022	R, Dr Naveen kumar/0000-0002-8984-5741; Pandurangi, Raghavendra/0000-0002-2262-0759; narayan, sukesh/0000-0001-8180-5115; Mummadi, Mahesh Kumar/0000-0002-0412-425X	ICMR-NIN	ICMR-NIN	Indian Council of Medical Research is the premier agency to conduct medical research in the country, of which National Institute of Nutrition is a subsidiary. The institute was requested to conduct the epidemiological investigation by the government of Andhra Pradesh. Study is funded from internal funds of ICMR-NIN. Funding department of NIN has not involved in data collection and analysing and report preparation.	[Anonymous], 2005, WHO RECOMMENDED CLAS; [Anonymous], 2020, SCROLLIN 1206; [Anonymous], 2020, BBC NEWS 1208; [Anonymous], 2020, FIRSTPOST 1207; Board TE, 2020, LOS ANGELES TIMES; Bureau of Indian Standards, 2012, IS105002012; FERRER A, 1989, FOOD ADDIT CONTAM, V6, pS95, DOI 10.1080/02652038909373763; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139; Julshamn K, 2013, J AOAC INT, V96, P1101, DOI 10.5740/jaoacint.13-143; Jyothi M, 2018, INT J COMPUTER SCI E, V6; Larramendy M.L., 2019, PESTICIDES USE MISUS; Levy-Khademi F, 2007, PEDIATR EMERG CARE, V23, P716, DOI 10.1097/PEC.0b013e318155ae0e; Medithi S, 2017, INDAN J COMMUNITY HE, V29, P410; Nicolopoulou-Stamati P, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00148; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; Panda M, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/692496; Rather IA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00830; Shrivastava A, 2017, LANCET GLOB HEALTH, V5, pE458, DOI [10.1016/S2214-109X(17)30035-9, 10.1016/s2214-109x(17)30035-9]; Sinha SN, 2021, CHEMOSPHERE, V268, DOI 10.1016/j.chemosphere.2020.129488; Sinha SN, 2014, ANAL METHODS-UK, V6, P1825, DOI 10.1039/c3ay41958d; Sinha SN, 2012, FOOD CHEM, V132, P1574, DOI 10.1016/j.foodchem.2011.11.102; Sinha SN, 2011, INT J MASS SPECTROM, V300, P12, DOI 10.1016/j.ijms.2010.11.006; Sreenivas R. A.P, 2020, HINDU	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259192	10.1371/journal.pone.0259192	http://dx.doi.org/10.1371/journal.pone.0259192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748567	Green Published, gold			2022-12-26	WOS:000755468000020
J	Teng, GW; Xiong, DQ; Ma, R; An, P				Teng, Guowei; Xiong, Danqi; Ma, Ran; An, Ping			Decision tree accelerated CTU partition algorithm for intra prediction in versatile video coding	PLOS ONE			English	Article							CU SIZE DECISION; MODE DECISION; HEVC; OPTIMIZATION	Versatile video coding (VVC) achieves enormous improvement over the advanced high efficiency video coding (HEVC) standard due to the adoption of the quadtree with nested multi-type tree (QTMT) partition structure and other coding tools. However, the computational complexity increases dramatically as well. To tackle this problem, we propose a decision tree accelerated coding tree units (CTU) partition algorithm for intra prediction in VVC. Firstly, specially designated image features are extracted to characterize the coding unit (CU) complexity. Then, the trained decision tree is employed to predict the partition results. Finally, based on our newly designed intra prediction framework, the partition process is early terminated or redundant partition modes are screened out. The experimental results show that the proposed algorithm could achieve around 52% encoding time reduction for various test video sequences on average with only 1.75% Bjontegaard delta bit rate increase compared with the reference test model VTM9.0 of VVC.	[Teng, Guowei; Xiong, Danqi; Ma, Ran; An, Ping] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China	Shanghai University	Teng, GW (corresponding author), Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China.	tenggw@shu.edu.cn		Xiong, Danqi/0000-0002-1245-2747	National Natural Science Foundation of China [62020106011]; Chen Guang Project - Shanghai Municipal Education Commission [17CG41]; Shanghai Education Development Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chen Guang Project - Shanghai Municipal Education Commission; Shanghai Education Development Foundation	This research is funded by the National Natural Science Foundation of China Project (grant number 62020106011) and is a part of Chen Guang Project (grant number 17CG41) supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, PICT COD SYMP, P113, DOI 10.1109/PCS.2013.6737696; An J., 2016, JVETB0023; Baroncini V., 2018, JVETK0004; Bjontegard G., 2001, ITUTVCEGM33; Bross B., 2018, P 10 JVET M SAN DIEG; Correa G., 2014, 2014 22 EUR SIGN PRO; Correa G, 2015, IEEE T CIRC SYST VID, V25, P660, DOI 10.1109/TCSVT.2014.2363753; Correa G, 2013, IEEE DATA COMPR CONF, P43, DOI 10.1109/DCC.2013.12; De-Luxan-Hernandez S., 2019, JVETM0102V5; Duanmu F, 2015, IEEE IMAGE PROC, P4972, DOI 10.1109/ICIP.2015.7351753; Grellert M, 2019, IEEE T CIRC SYST VID, V29, P1741, DOI 10.1109/TCSVT.2018.2849941; Gweon RH, 2012, IEICE T FUND ELECTR, VE95A, P1215, DOI 10.1587/transfun.E95.A.1215; Kim HS, 2016, IEEE T CIRC SYST VID, V26, P130, DOI 10.1109/TCSVT.2015.2444672; Li J., 2017, 2017 DAT COMPR C DCC; Liu XG, 2019, IEEE T CIRC SYST VID, V29, P144, DOI 10.1109/TCSVT.2017.2777903; Liu Y-C., 2015, 2015 DAT COMPR C; Liu ZY, 2016, IEEE T IMAGE PROCESS, V25, P5088, DOI 10.1109/TIP.2016.2601264; Liu ZY, 2016, IEEE INT SYMP CIRC S, P2270, DOI 10.1109/ISCAS.2016.7539036; Luo F., 2017, 2017 IEEE INT S CIRC; Ma S., 2013, 2013 DAT COMPR C; Min B, 2015, IEEE T CIRC SYST VID, V25, P892, DOI 10.1109/TCSVT.2014.2363739; Sahring K., 2020, JVETK0003; Segall A., 2017, JVETH1002; Shen LQ, 2014, IEEE T CIRC SYST VID, V24, P1709, DOI 10.1109/TCSVT.2014.2313892; Shen LQ, 2014, IEEE T IMAGE PROCESS, V23, P4232, DOI 10.1109/TIP.2014.2341927; Shen LQ, 2013, IEEE T CONSUM ELECTR, V59, P207, DOI 10.1109/TCE.2013.6490261; Shen LQ, 2013, IEEE T MULTIMEDIA, V15, P465, DOI 10.1109/TMM.2012.2231060; Shen XL, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-4; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Tian GF, 2012, 2012 PICTURE CODING SYMPOSIUM (PCS), P405, DOI 10.1109/PCS.2012.6213317; Wang SS, 2016, J VIS COMMUN IMAGE R, V35, P120, DOI 10.1016/j.jvcir.2015.12.005; Wang Z, 2017, IEEE DATA COMPR CONF, P23, DOI 10.1109/DCC.2017.70; Xiong J, 2014, IEEE T MULTIMEDIA, V16, P2141, DOI 10.1109/TMM.2014.2356795; Xu M, 2018, IEEE T IMAGE PROCESS, V27, P5044, DOI 10.1109/TIP.2018.2847035; Yang H, 2020, IEEE T CIRC SYST VID, V30, P1668, DOI 10.1109/TCSVT.2019.2904198; Zhang MM, 2012, IEEE IMAGE PROC, P221, DOI 10.1109/ICIP.2012.6466835; Zhang Y, 2018, IEEE T CIRC SYST VID, V28, P3208, DOI 10.1109/TCSVT.2017.2747659; Zhang Y, 2015, IEEE T IMAGE PROCESS, V24, P2225, DOI 10.1109/TIP.2015.2417498; Zhu LW, 2018, IEEE T BROADCAST, V64, P681, DOI 10.1109/TBC.2017.2762470; Zhu LW, 2017, IEEE T BROADCAST, V63, P547, DOI 10.1109/TBC.2017.2711142	40	1	1	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0258890	10.1371/journal.pone.0258890	http://dx.doi.org/10.1371/journal.pone.0258890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748550	Green Published, gold			2022-12-26	WOS:000755468000015
J	Amboko, B; Stepniewska, K; Malla, L; Machini, B; Bejon, P; Snow, RW; Zurovac, D				Amboko, Beatrice; Stepniewska, Kasia; Malla, Lucas; Machini, Beatrice; Bejon, Philip; Snow, Robert W.; Zurovac, Dejan			Determinants of improvement trends in health workers' compliance with outpatient malaria case-management guidelines at health facilities with available "test and treat" commodities in Kenya	PLOS ONE			English	Article							QUALITY-OF-CARE; INTEGRATED MANAGEMENT; COST-EFFECTIVENESS; CHILDHOOD ILLNESS; SUPERVISION; PERFORMANCE; AFRICA; GAP; ERA	Background Health workers' compliance with outpatient malaria case-management guidelines has been improving in Africa. This study examined the factors associated with the improvements. Methods Data from 11 national, cross-sectional health facility surveys undertaken from 2010-2016 were analysed. Association between 31 determinants and improvement trends in five outpatient compliance outcomes were examined using interactions between each determinant and time in multilevel logistic regression models and reported as an adjusted odds ratio of annual trends (T-aOR). Results Among 9,173 febrile patients seen at 1,208 health facilities and by 1,538 health workers, a higher annual improvement trend in composite "test and treat" performance was associated with malaria endemicity-lake endemic (T-aOR = 1.67 annually; p<0.001) and highland epidemic (T-aOR = 1.35; p<0.001) zones compared to low-risk zone; with facilities stocking rapid diagnostic tests only (T-aOR = 1.49; p<0.001) compared to microscopy only services; with faith-based/non-governmental facilities compared to government-owned (T-aOR = 1.15; p = 0.036); with a daily caseload of >25 febrile patients (T-aOR = 1.46; p = 0.003); and with under-five children compared to older patients (T-aOR = 1.07; p = 0.013). Other factors associated with the improvement trends in the "test and treat" policy components and artemether-lumefantrine administration at the facility included the absence of previous RDT stock-outs, community health workers dispensing drugs, access to malaria case-management and Integrated Management of Childhood Illness (IMCI) guidelines, health workers' gender, correct health workers' knowledge about the targeted malaria treatment policy, and patients' main complaint of fever. The odds of compliance at the baseline were variable for some of the factors. Conclusions Targeting of low malaria risk areas, low caseload facilities, male and government health workers, continuous availability of RDTs, improving health workers' knowledge about the policy considering age and fever, and dissemination of guidelines might improve compliance with malaria guidelines. For prompt treatment and administration of the first artemether-lumefantrine dose at the facility, task-shifting duties to community health workers can be considered.	[Amboko, Beatrice; Malla, Lucas; Bejon, Philip; Snow, Robert W.; Zurovac, Dejan] KEMRI Wellcome Trust Res Programme, Nairobi, Kenya; [Stepniewska, Kasia] WorldWide Antimalarial Resistance Network, Oxford, England; [Stepniewska, Kasia; Bejon, Philip; Snow, Robert W.; Zurovac, Dejan] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Machini, Beatrice] Minist Hlth, Div Natl Malaria Programme, Nairobi, Kenya	Worldwide Antimalarial Resistance Network (WWARN); University of Oxford	Amboko, B (corresponding author), KEMRI Wellcome Trust Res Programme, Nairobi, Kenya.	indimulib06@gmail.com	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Amboko, Beatrice/0000-0002-5754-3853				Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; Amboko B, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03479-z; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; Ayieko P, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0868-4; Barbour V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000188; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Bawate C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1153-5; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Bosch-Capblanch X, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006413.pub2; Boyce MR, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4398-1; Bruxvoort KJ, 2017, AM J TROP MED HYG, V97, P1170, DOI 10.4269/ajtmh.16-0955; Burchett HED, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012973; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Candrinho B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2796-9; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chandler CIR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170998; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dieleman M, 2006, IMPROVING HLTH WORKE, P5; Epstein A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4205-z; Faust C, 2015, AM J TROP MED HYG, V93, P159, DOI 10.4269/ajtmh.14-0595; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Gage AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208898; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Guilbert JJ, 2006, EDUC HEALTH, V19, P385, DOI 10.1080/13576280600937911; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; Ikeda DJ, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1176; Institute Of Medicine (IOM), 2015, MYALGIC ENCEPHALOMYE; Jesus TS, 2020, PHYSIOTHER CAN, V72, P122, DOI 10.3138/ptc-2018-0065; Kabaghe AN, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1218-5; Kaula H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2577-x; Klootwijk L, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4544-9; Leonard KL, 2007, HEALTH AFFAIR, V26, pW380, DOI 10.1377/hlthaff.26.3.w380; Leslie HH, 2016, HEALTH AFFAIR, V35, P1716, DOI 10.1377/hlthaff.2016.0261; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lourenco C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-508; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; MalariaCare, 2016, UN DIAGN TREATM IMPR; MalariaCare, 2017, UN DIAGN TREATM IMPR; MalariaCare, 2015, UN DIAGN TREATM IMPR; Mangham-Jefferies L, 2015, HEALTH POLICY PLANN, V30, P1129, DOI 10.1093/heapol/czu118; Masanja IM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-221; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; Ministry of Health, KEN HLTH MAST FAC LI, DOI [10.1080/16549716.2017.1413266, DOI 10.1080/16549716.2017.1413266]; Ministry of Health, 2009, HLTH FIN POL REV; Ministry of Health, 2006, HLTH STATUS PALESTIN; Ministry of Public Health Sanitation/Ministry of Medical Services, 2010, NAT ROADM ACC ATT MD; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Namuyinga RJ, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1693-3; National Malaria Control Programme, 2016, MON OUTP MAL CAS MAN; Nguyen DTK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066030; Nursing and Midwifery Board of Australia, 2019, NURS MIDW BOARD AUST; Nyandigisi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024781; O'Boyle S, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1483-6; Odhiambo F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2018-2; Plucinski MM, 2018, AM J TROP MED HYG, V99, P670, DOI 10.4269/ajtmh.18-0312; Plucinski MM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1843-7; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK., 2017, 66 ANN M AM SOC TROP; Rowe AK, 2018, LANCET GLOB HEALTH, V6, pE1163, DOI 10.1016/S2214-109X(18)30398-X; Rowe AK, 2012, TROP MED INT HEALTH, V17, P438, DOI 10.1111/j.1365-3156.2012.02976.x; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Russell D, 2018, AM J INFECT CONTROL, V46, P1211, DOI 10.1016/j.ajic.2018.05.005; Selemani M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-334; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Steinhardt LC, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0910-4; Steinhardt LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089050; Steinhardt LC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-64; Tulloch J., 1999, Lancet (British edition), V354, P16, DOI 10.1016/S0140-6736(99)90252-0; Visser T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173093; Wanja E, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1856-2; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2010, PROGR SAN DRINK WAT, P6; Zurovac D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092782; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	83	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0259020	10.1371/journal.pone.0259020	http://dx.doi.org/10.1371/journal.pone.0259020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY7XS	34739519	Green Published, gold			2022-12-26	WOS:000755000800015
J	Amoo, OS; Adewara, F; Tijani, B; Onuigbo, TI; Ikemefuna, AS; Oraegbu, JI; Rizvi, T; Okwuraiwe, A; Onwuamah, C; Shaibu, J; James, A; Ohihoin, G; Ige, F; Kareithi, D; David, A; Karera, S; Agboola, H; Adeniyi, A; Obi, J; Achanya, D; Odewale, E; Oforomeh, O; Liboro, G; Nwogbe, O; Ezechi, O; Adegbola, R; Audu, R; Salako, B				Amoo, Olufemi Samuel; Adewara, Funmi; Tijani, Bosun; Onuigbo, Tochukwu Ifeanyi; Ikemefuna, Amaka Stephanie; Oraegbu, Joy Isioma; Rizvi, Tazeen; Okwuraiwe, Azuka; Onwuamah, Chika; Shaibu, Joseph; James, Ayorinde; Ohihoin, Greg; Ige, Fehintola; Kareithi, Dorcas; David, Agatha; Karera, Steven; Agboola, Hammed; Adeniyi, Anthony; Obi, Josephine; Achanya, Dominic; Odewale, Ebenezer; Oforomeh, Osaga; Liboro, Gideon; Nwogbe, Olayemi; Ezechi, Oliver; Adegbola, Richard; Audu, Rosemary; Salako, Babatunde			The use of DIY (Do it yourself) sampling and telemonitoring model for COVID-19 qPCR testing scale up	PLOS ONE			English	Article								The first case of COVID-19 in Nigeria was recorded on February 27, 2020, being an imported case by an Italian expatriate, to the country. Since then, there has been steady increase in the number of cases. However, the number of cases in Nigeria is low in comparison to cases reported by other countries with similar large populations, despite the poor health system prevailing in the country. This has been mainly attributed to the low testing capacity in Nigeria among other factors. Therefore, there is a need for innovative ways to increase the number of persons testing for COVID-19. The aim of the study was to pilot a nasopharyngeal swab self-sample collection model that would help increase COVID-19 testing while ensuring minimal person-to-person contact being experienced at the testing center. 216 participants took part in this study which was carried out at the Nigerian Institute of Medical Research between June and July 2020. Amongst the 216 participants, 174 tested negatives for both self-collected samples and samples collected by Professionals, 30 tested positive for both arms, with discrepancies occurring in 6 samples where the self-collected samples were positive while the ones collected by the professionals were negative. The same occurred in another set of 6 samples with the self-collected samples being negative and the professional-collected sample coming out positive, with a sensitivity of 83.3% and a specificity of 96.7%. The results of the interrater analysis are Kappa = 0.800 (95% CI, 0.690 to 0.910) which implies an outstanding agreement between the two COVID-19 sampling methods. Furthermore, since p< 0.001 Kappa (k) coefficient is statistically different from zero, our findings have shown that self-collected samples can be reliable in the diagnosis of COVID-19.	[Amoo, Olufemi Samuel; Onuigbo, Tochukwu Ifeanyi; Ikemefuna, Amaka Stephanie; Oraegbu, Joy Isioma; Okwuraiwe, Azuka; Onwuamah, Chika; Shaibu, Joseph; Ige, Fehintola; Agboola, Hammed; Adeniyi, Anthony; Obi, Josephine; Achanya, Dominic; Odewale, Ebenezer; Oforomeh, Osaga; Liboro, Gideon; Audu, Rosemary; Salako, Babatunde] Nigerian Inst Med Res, Dept Microbiol, Lagos, Nigeria; [Adewara, Funmi; Rizvi, Tazeen] Mobihealth Int Ltd, Abuja, Nigeria; [Tijani, Bosun; Kareithi, Dorcas; Karera, Steven] Cocreat Hub, Lagos, Nigeria; [James, Ayorinde; Adegbola, Richard] Nigerian Inst Med Res, Dept Biochem, Lagos, Nigeria; [Ohihoin, Greg; David, Agatha; Ezechi, Oliver] Nigerian Inst Med Res, Clin Sci Dept, Lagos, Nigeria; [Nwogbe, Olayemi] Nigerian Inst Med Res, Dept Lib & Informat Technol, Lagos, Nigeria		Onuigbo, TI (corresponding author), Nigerian Inst Med Res, Dept Microbiol, Lagos, Nigeria.	Onuigbotochukwuifeanyi@gmail.com	Amoo, Olufemi/GVR-9974-2022; David, Agatha/HHM-3295-2022; Onwuamah, Chika Kingsley/ABB-9926-2020	Amoo, Olufemi/0000-0003-1076-7910; Onwuamah, Chika Kingsley/0000-0002-5111-1822; Karera, Steven/0000-0003-4045-1060; Kareithi, Dorcas/0000-0002-2161-8542; Onuigbo, Tochukwu/0000-0001-7719-5158				Abdollahi Alireza, 2020, Iran J Pathol, V15, P313, DOI 10.30699/ijp.2020.127312.2387; [Anonymous], 2020, NIGERIAN CTR DIS CON; [Anonymous], 2020, WORLD DATA ATLAS; Bozorgmehr K, 2020, LANCET PUBLIC HEALTH, V5, pE247, DOI 10.1016/S2468-2667(20)30078-5; Bwire George M, 2020, SN Compr Clin Med, V2, P874, DOI 10.1007/s42399-020-00341-w; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Cui YQ, 2018, J INT MED RES, V46, P5257, DOI 10.1177/0300060518807292; de la Vega R, 2020, GLOB PUBLIC HEALTH, V15, P1278, DOI 10.1080/17441692.2020.1791212; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Global Health 5050, COVID 19 SEX DIS DAT; Goudouris ES, 2021, J PEDIAT-BRAZIL, V97, P7, DOI 10.1016/j.jped.2020.08.001; Groneberg DA, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-8; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; McCulloch DJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16382; Nundy S., 2020, JAMA HLTH FORUM PUBL, P16; Prajapat M, 2020, INDIAN J PHARMACOL, V52, P56, DOI 10.4103/ijp.IJP_115_20; Ribeiro ALR, 2020, SCI TOTAL ENVIRON, V737, DOI 10.1016/j.scitotenv.2020.140211; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Seaman CP, 2019, J CLIN VIROL, V118, P28, DOI 10.1016/j.jcv.2019.07.010; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WHO, 2021, SIT REP; Wilson RF, 2020, MMWR-MORBID MORTAL W, V69, P1497, DOI 10.15585/mmwr.mm6941e2; World Health Organization, COR DIS 2019 COVID 1; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259398	10.1371/journal.pone.0259398	http://dx.doi.org/10.1371/journal.pone.0259398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735503	gold, Green Published			2022-12-26	WOS:000755077100071
J	Szulawski, M; Baka, L; Prusik, M; Olafsen, AH				Szulawski, Michal; Baka, Lukasz; Prusik, Monika; Olafsen, Anja H.			The basic psychological needs satisfaction and frustration scale at work: A validation in the Polish language	PLOS ONE			English	Article							OF-FIT INDEXES; SELF-DETERMINATION; MEASUREMENT INVARIANCE; MOTIVATION; VERSION; PERSPECTIVE; PERFORMANCE; CONVERGENT; DIRECTIONS; BEHAVIORS	The aim of this research project was to validate the work-related version of the Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS) into the Polish language and culture. Although studies have demonstrated the benefits associated with basic psychological need satisfaction and the costs associated with need frustration at work, the concept of needs has been neglected both in Polish scientific research and in practical organizational studies. The adaptation of the BPNSFS-Work Domain may change this situation and stimulate research in the Polish community. The scale has been validated in a sample consisting of three occupational groups: healthcare workers, education staff and customer service workers (N = 1315, M-age = 43.8). The findings suggest that the Polish scale has robust psychometric features. The CFA analysis proves that the scale has a six-dimensional structure similar to the original scale. These dimensions show satisfactory to high Cronbach's alpha and McDonalds omega reliability, and high criterion validity is shown by association of the six need dimensions with correlates of both positive (i.e., engagement, job crafting and self-efficacy) and negative aspects of work (i.e., burnout and stress). The structure of the scale is the same in all three occupational groups, although the regression weights and covariances are only partially invariant. The validated version of the BPNSFS-Work Domain can be used in future basic and applied studies in the paradigm of self-determination theory.	[Szulawski, Michal; Baka, Lukasz] Maria Grzegorzewska Univ, Warsaw, Poland; [Prusik, Monika] Univ Warsaw, Warsaw, Poland; [Olafsen, Anja H.] Univ South Eastern Norway, Honefoss, Norway	The Maria Grzegorzewska University; University of Warsaw; University College of Southeast Norway	Szulawski, M (corresponding author), Maria Grzegorzewska Univ, Warsaw, Poland.	mszulawski@aps.edu.pl	Prusik, Monika/AAT-8031-2021	Prusik, Monika/0000-0001-8552-9920				Baard PP, 2004, J APPL SOC PSYCHOL, V34, P2045, DOI 10.1111/j.1559-1816.2004.tb02690.x; Baka L., 2019, COPENHAGEN PSYCHOSOC; Baka L, 2016, MED PR, V67, P29, DOI 10.13075/mp.5893.00353; Bakker AB, 2017, J OCCUP HEALTH PSYCH, V22, P273, DOI 10.1037/ocp0000056; Bartholomew K., 2011, SPORT EXERCISE PSYCH, V7, P23; Behling O., 2000, TRANSLATING QUESTION, V133; Benita M, 2020, MOTIV EMOTION, V44, P67, DOI 10.1007/s11031-019-09781-x; Breaugh J, 2018, PUBLIC MANAG REV, V20, P1423, DOI 10.1080/14719037.2017.1400580; Bruning PF, 2019, BUS HORIZONS, V62, P625, DOI 10.1016/j.bushor.2019.05.003; Brunner B, 2019, EUR J HEALTH ECON, V20, P1165, DOI 10.1007/s10198-019-01084-9; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Campbell R, 2018, MOTIV EMOTION, V42, P671, DOI 10.1007/s11031-018-9699-x; Cerasoli CP, 2014, PSYCHOL BULL, V140, P980, DOI 10.1037/a0035661; Chen BW, 2015, MOTIV EMOTION, V39, P216, DOI 10.1007/s11031-014-9450-1; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Costa L.C.A.D., 2017, J PHYS ED, V28; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deci EL, 2001, PERS SOC PSYCHOL B, V27, P930, DOI 10.1177/0146167201278002; Decuypere A, 2020, GER J HUM RESOUR MAN, V34, P69, DOI 10.1177/2397002219892197; Demerouti E, 2003, EUR J PSYCHOL ASSESS, V19, P12, DOI 10.1027//1015-5759.19.1.12; Foss NJ, 2009, HUM RESOUR MANAGE-US, V48, P871, DOI 10.1002/hrm.20320; Grala K., 2021, INT J OCCUP SAF ERGO; Graves LM, 2013, MOTIV EMOTION, V37, P518, DOI 10.1007/s11031-012-9336-z; Greguras GJ, 2010, PERS PSYCHOL, V63, P539, DOI 10.1111/j.1744-6570.2010.01180.x; Guntert ST, 2015, MOTIV EMOTION, V39, P74, DOI 10.1007/s11031-014-9412-7; Hetzel-Riggin MD, 2020, PSYCHOL REP, V123, P1835, DOI 10.1177/0033294119876076; Jang H, 2016, LEARN INSTR, V43, P27, DOI 10.1016/j.learninstruc.2016.01.002; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kuzma B, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.03034; Leiter MP, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P164; Little TD, 2013, CHILD DEV PERSPECT, V7, P199, DOI 10.1111/cdep.12043; Milfont TL, 2010, INT J PSYCHOL RES, V3, P111; Nishimura T, 2016, JPN PSYCHOL RES, V58, P320, DOI 10.1111/jpr.12131; Olafsen AH, 2018, MOTIV EMOTION, V42, P178, DOI 10.1007/s11031-017-9646-2; Olafsen AH, 2017, EUR J WORK ORGAN PSY, V26, P275, DOI 10.1080/1359432X.2016.1257611; Olafsen AH, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.697306; Ozyilmaz A, 2018, J OCCUP ORGAN PSYCH, V91, P181, DOI 10.1111/joop.12189; Pejtersen JH, 2010, SCAND J PUBLIC HEALT, V38, P8, DOI 10.1177/1403494809349858; Prusik M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01290; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Rigby CS, 2018, ADV DEV HUM RESOUR, V20, P133, DOI 10.1177/1523422318756954; Rigotti T, 2008, J CAREER ASSESSMENT, V16, P238, DOI 10.1177/1069072707305763; Rogala A, 2019, MED PR, V70, P445, DOI 10.13075/mp.5893.00822; Ryan RM, 2017, SELF-DETERMINATION THEORY: BASIC PSYCHOLOGICAL NEEDS IN MOTIVATION, DEVELOPMENT, AND WELLNESS, P1, DOI 10.1521/978.14625/28806; Schaufeli W.B., 2002, J HAPPINESS STUD, V3, P72, DOI [10.1023/A:1015630930326, DOI 10.1023/A:1015630930326]; Schultz PP, 2015, MINDFULNESS, V6, P971, DOI 10.1007/s12671-014-0338-7; Stebbings J, 2012, J SPORT EXERCISE PSY, V34, P481, DOI 10.1123/jsep.34.4.481; Steenkamp JBEM, 1998, J CONSUM RES, V25, P78, DOI 10.1086/209528; Szabowska-Walaszczyk A, 2011, PSYCHOL JAKOSCI ZYCI, V10, P57; Tanaka JS., 1993, TESTING STRUCTURAL E, P10; Taylor BM, 2015, PERFORM IMPROV, V54, P28, DOI 10.1002/pfi.21481; Tims M, 2012, J VOCAT BEHAV, V80, P173, DOI 10.1016/j.jvb.2011.05.009; Van Wingerden J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197599; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vansteenkiste M, 2020, MOTIV EMOTION, V44, P1, DOI 10.1007/s11031-019-09818-1; Vansteenkiste M, 2013, J PSYCHOTHER INTEGR, V23, P263, DOI 10.1037/a0032359; Vansteenkiste M, 2009, J EDUC PSYCHOL, V101, P671, DOI 10.1037/a0015083; West S. G., 1995, STRUCTURAL EQUATION, P56; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Zayed KN, 2021, BMC PSYCHOL, V9, DOI 10.1186/s40359-020-00506-1	61	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0258948	10.1371/journal.pone.0258948	http://dx.doi.org/10.1371/journal.pone.0258948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9AG	34735468	Green Published, gold			2022-12-26	WOS:000755077100041
J	Chiang, YP; Li, ZQ; Chen, Y; Cao, Y; Jiang, XC				Chiang, Yeun-po; Li, Zhiqiang; Chen, Yang; Cao, Yu; Jiang, Xian-Cheng			Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CERAMIDE; IDENTIFICATION; DIACYLGLYCEROL; EXPRESSION; APOPTOSIS; MECHANISM; FAMILY; D609; ROS	Many studies have confirmed the enzymatic activity of a mammalian phosphatidylcholine (PC) phospholipase C (PLC) (PC-PLC), which produces diacylglycerol (DAG) and phosphocholine through the hydrolysis of PC in the absence of ceramide. However, the protein(s) responsible for this activity have never yet been identified. Based on the fact that tricyclodecan-9-yl-potassium xanthate can inhibit both PC-PLC and sphingomyelin synthase (SMS) activities, and SMS1 and SMS2 have a conserved catalytic domain that could mediate a nucleophilic attack on the phosphodiester bond of PC, we hypothesized that both SMS1 and SMS2 might have PC-PLC activity. In the present study, we found that purified recombinant SMS1 and SMS2 but not SMS-related protein have PC-PLC activity. Moreover, we prepared liver-specific Sms1/global Sms2 double-KO mice. We found that liver PC-PLC activity was significantly reduced and steady-state levels of PC and DAG in the liver were regulated by the deficiency, in comparison with control mice. Using adenovirus, we expressed Sms1 and Sms2 genes in the liver of the double-KO mice, respectively, and found that expressed SMS1 and SMS2 can hydrolyze PC to produce DAG and phosphocholine. Thus, SMS1 and SMS2 exhibit PC-PLC activity in vitro and in vivo.	[Chiang, Yeun-po; Li, Zhiqiang; Jiang, Xian-Cheng] SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Brooklyn, NY 11203 USA; [Li, Zhiqiang; Jiang, Xian-Cheng] VA New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA; [Chen, Yang; Cao, Yu] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Inst Precis Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Jiang, XC (corresponding author), SUNY Downstate Hlth Sci Univ, Dept Cell Biol, Brooklyn, NY 11203 USA.; Jiang, XC (corresponding author), VA New York Harbor Healthcare Syst, Mol & Cellular Cardiol Program, Brooklyn, NY 11209 USA.; Cao, Y (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Inst Precis Med, Shanghai, Peoples R China.	yu.cao@shsmu.edu.cn; XJiang@downstate.edu	Cao, Yu/GNP-6653-2022; Chiang, Yeun-po/ABD-2961-2021	Cao, Yu/0000-0003-1409-2068; Chiang, Yeun-po/0000-0003-0054-596X	Veterans Affairs Merit award [I01BX000900]; National Institutes of Health [HL139582, HL149730]	Veterans Affairs Merit award(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by a Veterans Affairs Merit award I01BX000900 and National Institutes of Health (HL139582 and HL149730).	Adibhatla RM, 2012, NEUROCHEM RES, V37, P671, DOI 10.1007/s11064-011-0659-z; Amtmann E, 1996, DRUG EXP CLIN RES, V22, P287; Cheng ML, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00266; Cheng YZ, 2006, FEBS LETT, V580, P4911, DOI 10.1016/j.febslet.2006.08.008; Chiang Y. P., 1866, BBA-MOL CELL BIOL L; Ding TB, 2015, J LIPID RES, V56, P537, DOI 10.1194/jlr.M054627; Flickinger BD, 2003, LIPIDS, V38, P129, DOI 10.1007/s11745-003-1042-8; HUANG KP, 1989, TRENDS NEUROSCI, V12, P425, DOI 10.1016/0166-2236(89)90091-X; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Li Z., 1866, BBA-MOL CELL BIOL L; Lou B, 2018, J BIOL CHEM, V293, P18328, DOI 10.1074/jbc.RA118.005904; Luberto C, 1998, J BIOL CHEM, V273, P14550, DOI 10.1074/jbc.273.23.14550; Miao JY, 1997, ENDOTHELIUM-NEW YORK, V5, P231, DOI 10.3109/10623329709052588; Murakami C, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100454; Pettitt TR, 1997, J BIOL CHEM, V272, P17354, DOI 10.1074/jbc.272.28.17354; Pilkington LI, 2020, EUR J MED CHEM, V191, DOI 10.1016/j.ejmech.2020.112162; SHEIKHNEJAD RG, 1986, J BIOL CHEM, V261, P7544; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Spadaro F, 2008, CANCER RES, V68, P6541, DOI 10.1158/0008-5472.CAN-07-6763; Spadaro F, 2006, EUR J IMMUNOL, V36, P3277, DOI 10.1002/eji.200635927; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; WOLF RA, 1985, J BIOL CHEM, V260, P7295; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yeang C, 2008, BBA-MOL CELL BIOL L, V1781, P610, DOI 10.1016/j.bbalip.2008.07.002; Zhao J, 2007, J CELL BIOCHEM, V102, P421, DOI 10.1002/jcb.21301	28	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101398	10.1016/j.jbc.2021.101398	http://dx.doi.org/10.1016/j.jbc.2021.101398			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774525	Green Published, gold			2022-12-26	WOS:000748397200005
J	Romanelli, SM; Lewis, KT; Nishii, A; Rupp, AC; Li, ZR; Mori, H; Schill, RL; Learman, BS; Rhodes, CJ; MacDougald, OA				Romanelli, Steven M.; Lewis, Kenneth T.; Nishii, Akira; Rupp, Alan C.; Li, Ziru; Mori, Hiroyuki; Schill, Rebecca L.; Learman, Brian S.; Rhodes, Christopher J.; MacDougald, Ormond A.			BAd-CRISPR: Inducible gene knockout in interscapular brown adipose tissue of adult mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; LIPID-METABOLISM; WILD-TYPE; LIPOLYSIS; MOUSE; FAT; THERMOGENESIS; ADIPOCYTES; DYNAMICS; DELIVERY	CRISPR/Cas9 has enabled inducible gene knockout in numerous tissues; however, its use has not been reported in brown adipose tissue (BAT). Here, we developed the brown adipocyte CRISPR (BAd-CRISPR) methodology to rapidly interrogate the function of one or multiple genes. With BAd-CRISPR, an adeno-associated virus (AAV8) expressing a single guide RNA (sgRNA) is administered directly to BAT of mice expressing Cas9 in brown adipocytes. We show that the local administration of AAV8-sgRNA to interscapular BAT of adult mice robustly transduced brown adipocytes and ablated expression of adiponectin, adipose triglyceride lipase, fatty acid synthase, perilipin 1, or stearoyl-CoA desaturase 1 by >90%. Administration of multiple AAV8 sgRNAs led to simultaneous knockout of up to three genes. BAd-CRISPR induced frame-shift mutations and suppressed target gene mRNA expression but did not lead to substantial accumulation of off-target mutations in BAT. We used BAd-CRISPR to create an inducible uncoupling protein 1 (ucp1) knockout mouse to assess the effects of UCP1 loss on adaptive thermogenesis in adult mice. Inducible ucp1 knockout did not alter core body temperature; however, BAd-CRISPR ucp1 mice had elevated circulating concentrations of fibroblast growth factor 21 and changes in BAT gene expression consistent with heat production through increased peroxisomal lipid oxidation. Other molecular adaptations predict additional cellular inefficiencies with an increase in both protein synthesis and turnover, and mitochondria with reduced reliance on mitochondrial-encoded gene expression and increased expression of nuclear-encoded mitochondrial genes. These data suggest that BAd-CRISPR is an efficient tool to speed discoveries in adipose tissue biology.	[Romanelli, Steven M.; Lewis, Kenneth T.; Nishii, Akira; Li, Ziru; Mori, Hiroyuki; Schill, Rebecca L.; Learman, Brian S.; MacDougald, Ormond A.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Rupp, Alan C.; MacDougald, Ormond A.] Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI 48109 USA; [Rhodes, Christopher J.] AstraZeneca, Res & Early Dev Cardiovasc Renal & Metab CVRM, BioPharmaceut R&D, Gaithersburg, MD USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; AstraZeneca	MacDougald, OA (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; MacDougald, OA (corresponding author), Univ Michigan, Med Sch, Dept Internal Med, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	; Lewis, Kenneth/E-6593-2019	Rhodes, Christopher/0000-0002-7450-1110; Lewis, Kenneth/0000-0002-0936-6434; MacDougald, Ormond/0000-0001-6907-7960; Schill, Rebecca/0000-0001-7123-0418	NIH [R01 DK121759, R01 DK125513, T32 GM835326, F31 DK122723, T32 DK071212, F32 DK122654, T32 DK101357, F32 DK123887]; American Diabetes Association [1-18-PDF-087]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association)	Funding and additional information-This work was supported by grants from the NIH to O. A. M. (R01 DK121759 and R01 DK125513) , S. M. R. (T32 GM835326 and F31 DK122723) , K. T. L. (T32 DK071212 and F32 DK122654) , R. L. S. (T32 DK101357 and F32 DK123887) , and the American Diabetes Association to Z. L. (1-18-PDF-087) . The content is solely the responsibility of the au-thors and does not necessarily represent the official views of the National Institutes of Health.	Alexander CM, 2015, J LIPID RES, V56, P2061, DOI 10.1194/jlr.R062893; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Bagchi DP, 2020, MOL METAB, V42, DOI 10.1016/j.molmet.2020.101078; Bagchi DP, 2019, JOVE-J VIS EXP, DOI 10.3791/59499; Bagchi DP, 2018, CELL METAB, V27, P264, DOI 10.1016/j.cmet.2017.11.012; Balkow Aileen, 2016, J Biol Methods, V3, pe48, DOI 10.14440/jbm.2016.123; Bartelt A, 2018, NAT MED, V24, P292, DOI 10.1038/nm.4481; Bates R, 2020, MOL THER-METH CLIN D, V19, P236, DOI 10.1016/j.omtm.2020.09.009; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Bozec A, 2013, J CELL SCI, V126, P5432, DOI 10.1242/jcs.134510; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Corsa CAS, 2021, DIABETES, V70, P1970, DOI 10.2337/db20-1001; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dow LE, 2015, TRENDS MOL MED, V21, P609, DOI 10.1016/j.molmed.2015.07.006; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Edraki A, 2019, MOL CELL, V73, P714, DOI 10.1016/j.molcel.2018.12.003; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gomez-Banoy N, 2017, METHODS MOL BIOL, V1566, P108, DOI 10.1007/978-1-4939-6820-6_11; Grimpo K, 2014, J LIPID RES, V55, P398, DOI 10.1194/jlr.M042895; Guilherme A, 2017, MOL METAB, V6, P781, DOI 10.1016/j.molmet.2017.05.012; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huang W, 2019, METHODS MOL BIOL, V1950, P389, DOI 10.1007/978-1-4939-9139-6_23; Huang W, 2017, MOL THER-METH CLIN D, V6, P68, DOI 10.1016/j.omtm.2017.06.002; Huang W, 2016, MOL THER, V24, P1062, DOI 10.1038/mt.2016.34; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jimenez V, 2013, DIABETES, V62, P4012, DOI 10.2337/db13-0311; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kamble PG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67293-y; Kazak L, 2017, P NATL ACAD SCI USA, V114, P7981, DOI 10.1073/pnas.1705406114; Keipert S, 2017, CELL METAB, V26, P437, DOI 10.1016/j.cmet.2017.07.016; Keipert S, 2015, MOL METAB, V4, P537, DOI 10.1016/j.molmet.2015.04.006; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li ZR, 2021, BEST PRACT RES CL EN, V35, DOI 10.1016/j.beem.2021.101547; Liu XL, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2013.8; Livneh I, 2016, CELL RES, V26, P869, DOI 10.1038/cr.2016.86; Lodhi IJ, 2014, CELL METAB, V19, P380, DOI 10.1016/j.cmet.2014.01.002; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; Maurer SF, 2020, AM J PHYSIOL-ENDOC M, V318, pE198, DOI 10.1152/ajpendo.00121.2019; Meyer CW, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00520; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P515, DOI 10.1139/Y02-067; Mori H, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3000988; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; O'Neill SM, 2014, GENE THER, V21, P653, DOI 10.1038/gt.2014.38; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Pollo-Oliveira L, 2019, BIOCHEMISTRY-US, V58, P355, DOI 10.1021/acs.biochem.8b01035; Romanelli SM, 2020, DIABETES, V69, P2581, DOI 10.2337/dbi20-0036; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sakaguchi M, 2017, CELL METAB, V25, P448, DOI 10.1016/j.cmet.2016.12.008; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schreiber R, 2017, CELL METAB, V26, P753, DOI 10.1016/j.cmet.2017.09.004; Seeley RJ, 2021, NAT METAB, V3, P443, DOI 10.1038/s42255-021-00372-0; Sentmanat MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19441-8; Shapiro J, 2020, MOL THER-METH CLIN D, V17, P1097, DOI 10.1016/j.omtm.2020.04.027; Shen YF, 2018, J BIOL CHEM, V293, P17291, DOI 10.1074/jbc.RA118.004554; Souza SC, 2007, J LIPID RES, V48, P1273, DOI 10.1194/jlr.M700047-JLR200; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Torrent M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6409; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Wang QA, 2014, ADIPOCYTE, V3, P146, DOI 10.4161/adip.27656; Wold WSM, 2013, CURR GENE THER, V13, P421; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yan S, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI144888; Ye RS, 2015, MOL METAB, V4, P771, DOI 10.1016/j.molmet.2015.08.004; Zafra MP, 2016, TRENDS MOL MED, V22, P831, DOI 10.1016/j.molmed.2016.08.004; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	86	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101402	10.1016/j.jbc.2021.101402	http://dx.doi.org/10.1016/j.jbc.2021.101402			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YP1OJ	34774798	Green Published, gold			2022-12-26	WOS:000748397200008
J	Espinosa, MJC; Schmidgall, T; Wagner, G; Kappelmeyer, U; Schreiber, S; Heipieper, HJ; Eberlein, C				Espinosa, Maria Jose Cardenas; Schmidgall, Tabea; Wagner, Georg; Kappelmeyer, Uwe; Schreiber, Stephan; Heipieper, Hermann J.; Eberlein, Christian			An optimized method for RNA extraction from the polyurethane oligomer degrading strain Pseudomonas capeferrum TDA1 growing on aromatic substrates such as phenol and 2,4-diaminotoluene	PLOS ONE			English	Article							QUALITY TOTAL RNA; MICROBIAL-DEGRADATION; BIODEGRADATION; TISSUES; SAMPLES; SEEDS; GENE	Bacterial degradation of xenobiotic compounds is an intense field of research already for decades. Lately, this research is complemented by downstream applications including Next Generation Sequencing (NGS), RT-PCR, qPCR, and RNA-seq. For most of these molecular applications, high-quality RNA is a fundamental necessity. However, during the degradation of aromatic substrates, phenolic or polyphenolic compounds such as polycatechols are formed and interact irreversibly with nucleic acids, making RNA extraction from these sources a major challenge. Therefore, we established a method for total RNA extraction from the aromatic degrading Pseudomonas capeferrum TDA1 based on RNAzol (R) RT, glycogen and a final cleaning step. It yields a high-quality RNA from cells grown on TDA1 and on phenol compared to standard assays conducted in the study. To our knowledge, this is the first report tackling the problem of polyphenolic compound interference with total RNA isolation in bacteria. It might be considered as a guideline to improve total RNA extraction from other bacterial species.	[Espinosa, Maria Jose Cardenas; Schmidgall, Tabea; Wagner, Georg; Kappelmeyer, Uwe; Heipieper, Hermann J.; Eberlein, Christian] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Schreiber, Stephan] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Eberlein, C (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany.	christian.eberlein@ufz.de	Heipieper, Hermann/D-1864-2010; Kappelmeyer, Uwe/H-4026-2015	Heipieper, Hermann/0000-0002-3723-9600; Eberlein, Christian/0000-0003-4521-8145; Kappelmeyer, Uwe/0000-0001-7029-6407; Schreiber, Stephan/0000-0001-5219-7974	European Union's Horizon 2020 Research and Innovation Program [633962]; German Federal Ministry of Education and Research via the project NO STRESS [031B085C]	European Union's Horizon 2020 Research and Innovation Program; German Federal Ministry of Education and Research via the project NO STRESS	The Financial support by the European Union's Horizon 2020 Research and Innovation Program under grant agreement no. 633962 for the project P4SB is greatly appreciated. Additionally, this work was supported by the German Federal Ministry of Education and Research via the project NO STRESS under grant number 031B085C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Maspons A, 2019, BIOTECHNIQUES, V66, P96, DOI 10.2144/btn-2018-0129; [Anonymous], 2012, IJESAT; Arias Duverney Gaviria, 2012, Braz. J. Plant Physiol., V24, P261, DOI 10.1590/S1677-04202012000400005; Assefa AT, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6721-y; Atashgahi S, 2018, SCIENCE, V360, P743, DOI 10.1126/science.aar3778; Badejo AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058066; Bhardwaj P, 2015, BIOCHEM ENG J, V102, P125, DOI 10.1016/j.bej.2015.02.029; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Breitler J-C., 2016, SCI REP-UK, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Cao B, 2009, APPL MICROBIOL BIOT, V85, P207, DOI 10.1007/s00253-009-2192-4; Carpinetti PD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0255245; Carvalhais V, 2013, J MICROBIOL METH, V95, P195, DOI 10.1016/j.mimet.2013.08.010; Chomczynski P., 2010, NAT METHODS, V7, P4, DOI [10.1038/nmeth.f.315, DOI 10.1038/NMETH.F.315]; Choudhary SB, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0415-9; Cinar O, 2004, BIOPROC BIOSYST ENG, V26, P341, DOI 10.1007/s00449-004-0364-2; Dash PK, 2013, 3 BIOTECH, V3, P109, DOI 10.1007/s13205-012-0075-3; Desjardins Philippe, 2010, J Vis Exp, DOI 10.3791/2565; Diaz E, 2000, CURR OPIN BIOTECH, V11, P467, DOI 10.1016/S0958-1669(00)00126-9; Die JV, 2012, J EXP BOT, V63, P6069, DOI 10.1093/jxb/ers276; Duy J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1299-5; El-Najjar N, 2011, PHYTOCHEM REV, V10, P353, DOI 10.1007/s11101-011-9209-1; Espinosa MJC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00404; Footitt S, 2018, SEED SCI RES, V28, P360, DOI 10.1017/S0960258518000296; Fromm Bastian, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-217; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Gautam A, 2016, MOL BIOL REP, V43, P1165, DOI 10.1007/s11033-016-4043-6; George KW, 2011, ADV APPL MICROBIOL, V74, P1, DOI 10.1016/B978-0-12-387022-3.00005-7; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Goh YJ, 2021, MBIO, V12, DOI 10.1128/mBio.03399-20; Gu QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02162; Guray M. Z, 2009, PARTIAL PURIFICATION; Haussmann U, 2009, PROTEOMICS, V9, P3635, DOI 10.1002/pmic.200900025; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Japelaghi RH, 2011, MOL BIOTECHNOL, V49, P129, DOI 10.1007/s12033-011-9384-8; Kalinowska E, 2012, ACTA BIOCHIM POL, V59, P391; Kanani P, 2019, J KING SAUD UNIV SCI, V31, P1202, DOI 10.1016/j.jksus.2018.12.008; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Koetsier G., 2019, PRACTICAL GUIDE ANAL; Kraushar ML, 2021, MOL CELL, V81, P304, DOI 10.1016/j.molcel.2020.11.037; Lan TY, 2013, ANAL BIOCHEM, V438, P11, DOI 10.1016/j.ab.2013.03.012; Liao X., 2020, SIMPLE RAPID METHOD, DOI [10.1101/2020.07.06.189506, DOI 10.1101/2020.07.06.189506]; Liu LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196592; Loomis W D, 1974, Methods Enzymol, V31, P528; Ma ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130234; Mandic M, 2019, CATALYSTS, V9, DOI 10.3390/catal9070629; Manfredonia I, 2020, NUCLEIC ACIDS RES, V48, P12436, DOI 10.1093/nar/gkaa1053; Mornkham Tanupat, 2013, Plants-Basel, V2, P302, DOI 10.3390/plants2020302; Perez-Pantoja D., 2016, HDB HYDROCARBON LIPI, DOI [10.1007/978-3-319-39782-5_10-1, DOI 10.1007/978-3-319-39782-5_10-1]; Pimviriyakul P, 2020, MICROB BIOTECHNOL, V13, P67, DOI 10.1111/1751-7915.13488; Ramadoss N, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2925; Riesgo A, 2012, MOL ECOL RESOUR, V12, P312, DOI 10.1111/j.1755-0998.2011.03097.x; RNAzol RT (R4533), TECHN B SIGM ALDR; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Ruocco N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172171; Sah S. K., 2014, American Journal of Plant Sciences, V5, P3129, DOI 10.4236/ajps.2014.521329; Sanchez C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2906-x; Sangha Jatinder Singh, 2010, BMC Res Notes, V3, P126, DOI 10.1186/1756-0500-3-126; Semple KT, 1999, FEMS MICROBIOL LETT, V170, P291, DOI 10.1111/j.1574-6968.1999.tb13386.x; Shrivastava R., 2012, MICROORGANISMS ENV M, P451, DOI [10.1007/978-94-007-2229-3_21, DOI 10.1007/978-94-007-2229-3_21]; Shu CW, 2014, ELECTRON J BIOTECHN, V17, DOI 10.1016/j.ejbt.2013.12.009; Sigurgeirsson B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091851; Singh P, 2019, J POLYM ENVIRON, V27, P901, DOI 10.1007/s10924-019-01416-z; Technologies N, 2007, ND 1000 SPECTR V3 5; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Toivonen PMA, 2008, POSTHARVEST BIOL TEC, V48, P1, DOI 10.1016/j.postharvbio.2007.09.004; Toni LS, 2018, METHODSX, V5, P599, DOI 10.1016/j.mex.2018.05.011; Utomo RNC, 2020, ACS SUSTAIN CHEM ENG, V8, P17466, DOI 10.1021/acssuschemeng.0c06019; Wan L, 2012, BIOSTATISTICS, V13, P734, DOI 10.1093/biostatistics/kxs001; Wang LM, 2010, BIOMATERIALS, V31, P1612, DOI 10.1016/j.biomaterials.2009.11.024; Xiao HG, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0376-3; Yang G, 2008, PREP BIOCHEM BIOTECH, V38, P257, DOI 10.1080/10826060802164991	71	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260002	10.1371/journal.pone.0260002	http://dx.doi.org/10.1371/journal.pone.0260002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780548	Green Published, gold			2022-12-26	WOS:000755305800081
J	Rachamin, Y; Ackermann, CJ; Senn, O; Grischott, T				Rachamin, Yael; Ackermann, Christoph Jakob; Senn, Oliver; Grischott, Thomas			Price trends of reimbursed oncological drugs in Switzerland in 2005-2019: A descriptive analysis	PLOS ONE			English	Article							ANTICANCER DRUGS; CANCER DRUGS; COUNTRIES; BENEFIT; LAUNCH; MARKET; COSTS	Increasing oncological treatment costs are a major global concern with the risk of entailing two-tiered health care. Among cost determining factors is the price of individual drugs. In recognition of the central role of this factor, we present a comprehensive overview of the development of monthly prices of oncological drugs introduced over the last 15 years in Switzerland. We identified all oncological drugs newly reimbursed by mandatory health insurance in 2005-2019, and searched public repositories for their package prices, indications with approval dates, and treatment regimens for the calculation of (indication-specific) monthly prices. We found 81 products covering 77 different substances (39.5% protein kinase inhibitors, 21.0% monoclonal antibodies). Most indications related to the topography "blood", followed by "lung and thorax" and "digestive tract". From 2005-2009 to 2015-2019, the median monthly product price over all distinct indications of all products decreased by 7.56% (CHF 5,699 [interquartile range 4,483-7,321] to CHF 5,268 [4,19-6,967]), whereas it increased by 73.7% for monoclonal antibodies. In December 2019, six products had monthly prices over CHF 10,000, all approved for hematological or dermatological cancers. Our analysis suggests that individual price developments of oncological drugs are presently not the major driver of rising cancer treatment costs. However, rising launch prices of some new, mostly hematological drugs are of concern and require continued monitoring.	[Rachamin, Yael; Senn, Oliver; Grischott, Thomas] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Rachamin, Yael; Senn, Oliver; Grischott, Thomas] Univ Hosp Zurich, Zurich, Switzerland; [Ackermann, Christoph Jakob] Spital STS AG, Dept Med Oncol, Thun, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Grischott, T (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.; Grischott, T (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	thomas.grischott@usz.ch	; Grischott, Thomas/AAB-2260-2020	Senn, Oliver/0000-0003-4422-7250; Grischott, Thomas/0000-0002-1564-5296; Rachamin, Yael/0000-0002-1484-6934				[Anonymous], 2020, EXZESSIV UBERHOHTE P, P63; Belloni A., 2016, OECD HLTH WORKING PA; Bennette CS, 2016, HEALTH AFFAIR, V35, P805, DOI 10.1377/hlthaff.2015.1145; Bhoo-Pathy N, 2017, EUR J CANCER, V74, P26, DOI 10.1016/j.ejca.2016.12.014; Dusetzina SB, 2016, JAMA ONCOL, V2, P960, DOI 10.1001/jamaoncol.2016.0648; Dvortsin E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146551; Executive B, 2018, MED VACC HLTH PROD C; Feldges D, 2019, NEUE ZURCHER ZEITUNG; Gordon N, 2018, J CLIN ONCOL, V36, P319, DOI 10.1200/JCO.2016.72.2124; HCI Solutions AG, SWISS DRUG COMP; Howard DH, 2015, J ECON PERSPECT, V29, P139, DOI 10.1257/jep.29.1.139; Karikios DJ, 2014, INTERN MED J, V44, P458, DOI 10.1111/imj.12399; Lin LF, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0783-9; Manganelli A, 2017, VALUE HEALTH, V20, pA467, DOI 10.1016/j.jval.2017.08.391; Melaku YA, 2018, CANCER EPIDEMIOL, V52, P43, DOI 10.1016/j.canep.2017.11.007; R Core Team, 2020, R LANG ENV STAT COMP; Ripley BD., LOESS LOCAL POLYNOMI; Rodwin MA, 2021, EUR J CANCER, V145, P11, DOI 10.1016/j.ejca.2020.11.031; Saluja R, 2018, J ONCOL PRACT, V14, P316, DOI 10.1200/JOP.17.00058; Savage P, 2015, BRIT J CANCER, V112, P1037, DOI 10.1038/bjc.2015.56; Savage P, 2017, J ONCOL PRACT, V13, P384, DOI 10.1200/JOP.2016.014431; Schneider R., 2019, HELSANA MED REPORT S; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Swiss Agency for Therapeutic Products, 2020, SWISSM J SWISS AG TH; Swiss Federal Office of Public Health, SPEZ SL SWISS FED I; Swiss Federal Office of Public Health, IND THER REG SWISS F; Swiss Federal Office of Public Health, TRIENN REV DRUGS FED; Swiss Federal Statistical Office, CONS PRIC IND; Swiss National Bank (SNB), INT RAT YIELDS FOR E; Turck R, 2017, ANN ONCOL, V28, P427, DOI 10.1093/annonc/mdw548; Vokinger KN, 2021, JAMA ONCOL, V7, DOI 10.1001/jamaoncol.2021.2026; Vokinger KN, 2020, LANCET ONCOL, V21, P664, DOI 10.1016/S1470-2045(20)30139-X; Vokinger KN, 2020, HEALTH POLICY, V124, P261, DOI 10.1016/j.healthpol.2019.12.006; WHO Collaborating Centre for Drug Statistics Methodology, AN THER CHEM CLASS A; Wieser S., 2014, KOSTEN NICHTUBERTRAG; World Health A, 2017, CANC PREV CONTR CONT; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn	37	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259936	10.1371/journal.pone.0259936	http://dx.doi.org/10.1371/journal.pone.0259936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780556	Green Published, gold			2022-12-26	WOS:000755305800069
J	Cui, YY; Li, JZ; Deng, D; Lu, HJ; Tian, ZM; Liu, ZC; Ma, XY				Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong			Solid-state fermentation by Aspergillus niger and Trichoderma koningii improves the quality of tea dregs for use as feed additives	PLOS ONE			English	Article							GROWTH-PERFORMANCE; ANTIOXIDANT ACTIVITY; AMINO-ACIDS; WASTE; SUPPLEMENTATION; METABOLITES; PRODUCTS; POWDER; LEAVES	This study evaluated the ability of Aspergillus niger and Trichoderma koningii to improve the quality of tea dregs (TDs) through solid-state fermentation as well as the value of the fermented tea dregs (FTDs) produced for use as bio-feed additives. After fermentation, FTDs differed in color and structure. Fermentation with A. niger and T. koningii increased the contents of crude protein, crude fiber, neutral detergent fiber, and acid detergent fiber of TDs. Compared to the unfermented group, the contents of reducing sugar, total flavonoids, total polyphenols, and theasaponins were increased in A. niger FTDs, while in T. koningii FTDs caffeine was completely degraded, the theasaponins were lower, and the contents of reducing sugar and caffeine higher. Regarding free amino acids, A. niger FTDs had the highest content of total amino acids, total essential amino acids, total non-essential amino acids, total aromatic amino acids, total branched-chain amino acids, and total non-protein amino acids, and all types of essential amino acids, followed by T. koningii FTDs and the control TDs. Fungal fermentation had similar effects on the content of various hydrolytic amino acids as those on above free amino acids, and increased the content of bitter and umami components. The composition of essential amino acids of TDs or FTDs was similar to that of the standard model, except for sulfur-containing amino acids and isoleucine. Solid-state fermentation with A. niger and T. koningii effectively improved the nutritional value of TDs, increased the contents of functional substances, and improved the flavor of TDs. This study demonstrated a feasible approach to utilize TDs that not only increases animal feed resources, but also reduces the production of resource waste and pollution.	[Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Peoples R China; [Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong] State Key Lab Livestock & Poultry Breeding, Guangzhou, Peoples R China; [Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong] Minist Agr, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Peoples R China; [Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong] Guangdong Prov Key Lab Anim Breeding & Nutr, Guangzhou, Peoples R China; [Cui, Yiyan; Li, Jiazhou; Deng, Dun; Lu, Huijie; Tian, Zhimei; Liu, Zhichang; Ma, Xianyong] Guangdong Engn Technol Res Ctr Anim Meat Qual & S, Guangzhou, Peoples R China; [Ma, Xianyong] Guangdong Lab Lingnan Modern Agr, Maoming Branch, Maoming, Peoples R China	Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Ma, XY (corresponding author), Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou, Peoples R China.; Ma, XY (corresponding author), State Key Lab Livestock & Poultry Breeding, Guangzhou, Peoples R China.; Ma, XY (corresponding author), Minist Agr, Key Lab Anim Nutr & Feed Sci South China, Guangzhou, Peoples R China.; Ma, XY (corresponding author), Guangdong Prov Key Lab Anim Breeding & Nutr, Guangzhou, Peoples R China.; Ma, XY (corresponding author), Guangdong Engn Technol Res Ctr Anim Meat Qual & S, Guangzhou, Peoples R China.; Ma, XY (corresponding author), Guangdong Lab Lingnan Modern Agr, Maoming Branch, Maoming, Peoples R China.	maxianyong@gdaas.cn		ma, xianyong/0000-0002-5712-2573	Provincial Agricultural Science and Technology Innovation Promotion and Agricultural Resources and Ecological Environmental Protection Construction Project [2021KJ266]; Agricultural competitive industry discipline team building project of Guangdong Academy of Agricultural Sciences [202118TD]; Guangzhou Rural Science and Technology Commissioner Project [20212100077]; Guangdong Modern Agroindustry Technology Research System [2021KJ115]; Talent Project of the Guangdong Academy of Agricultural Sciences [R2017PYJG001]; Special Fund for Scientific Innovation Strategy-Construction of High Level Academy of Agriculture Science-Distinguished Scholar [R2020PY-JC001, R2020YJ-YB2002]; Shaoguan Science and Technology Project [200731114530834]	Provincial Agricultural Science and Technology Innovation Promotion and Agricultural Resources and Ecological Environmental Protection Construction Project; Agricultural competitive industry discipline team building project of Guangdong Academy of Agricultural Sciences; Guangzhou Rural Science and Technology Commissioner Project; Guangdong Modern Agroindustry Technology Research System; Talent Project of the Guangdong Academy of Agricultural Sciences; Special Fund for Scientific Innovation Strategy-Construction of High Level Academy of Agriculture Science-Distinguished Scholar; Shaoguan Science and Technology Project	This research was supported by the Provincial Agricultural Science and Technology Innovation Promotion and Agricultural Resources and Ecological Environmental Protection Construction Project (2021KJ266), Agricultural competitive industry discipline team building project of Guangdong Academy of Agricultural Sciences (202118TD), Guangzhou Rural Science and Technology Commissioner Project (20212100077), Guangdong Modern Agroindustry Technology Research System (2021KJ115), Talent Project of the Guangdong Academy of Agricultural Sciences (R2017PYJG001), Special Fund for Scientific Innovation Strategy-Construction of High Level Academy of Agriculture Science-Distinguished Scholar (R2020PY-JC001, R2020YJ-YB2002), Shaoguan Science and Technology Project (200731114530834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Hack ME, 2018, ENVIRON SCI POLLUT R, V25, P14397, DOI 10.1007/s11356-018-2052-9; Adi AJ, 2009, BIORESOURCE TECHNOL, V100, P1027, DOI 10.1016/j.biortech.2008.07.024; Ahmed ST, 2015, J ANIM PHYSIOL AN N, V99, P1127, DOI 10.1111/jpn.12279; [Anonymous], 1973, WHO CHRON, V27, P481; [Anonymous], 2006, USER MANUAL L 8900 H, V4th; Bai WF, 2013, INDIAN J MICROBIOL, V53, P70, DOI 10.1007/s12088-012-0345-0; Baskan KS, 2016, TALANTA, V147, P162, DOI 10.1016/j.talanta.2015.09.049; Bi W, 2016, ACTA PHARM SIN B, V6, P170, DOI 10.1016/j.apsb.2015.11.003; Camps C, 2019, MOLECULES, V24, DOI 10.3390/molecules24050967; Chedea VS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050588; Chen XY, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030370; Chen YY, 2020, FOODS, V9, DOI 10.3390/foods9010066; Chi X, 2017, POULTRY SCI, V96, P3058, DOI 10.3382/ps/pex127; Ding XQ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10020185; Dulf FV, 2017, CHEM CENT J, V11, DOI 10.1186/s13065-017-0323-z; Feng L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60265-2; Food and Agriculture Organization of the United Nations Statistics Division, WORLD TEA PRODUCTION; Food China., 2016, GB50092682016; Hu JH, 2012, LWT-FOOD SCI TECHNOL, V45, P8, DOI 10.1016/j.lwt.2011.08.002; Huang YY, 2019, J CLEAN PROD, V210, P231, DOI 10.1016/j.jclepro.2018.10.304; Jiao J, 2018, IND CROP PROD, V112, P252, DOI 10.1016/j.indcrop.2017.12.017; Kim WJ, 2019, MOL REPROD DEV, V86, P32, DOI 10.1002/mrd.23079; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kondo M, 2018, ANIM SCI J, V89, P1656, DOI 10.1111/asj.13106; Lakshmi V, 2013, J ENVIRON BIOL, V34, P701; Li HC, 2016, THESIS S CHINA AGR U; Li H, 2017, PEERJ, V5, DOI 10.7717/peerj.3264; Li X., 2019, CHIN AGR SCI B, V35, P126; Liu LN, 2019, THESIS GUANGDONG OCE; Liu WY, 2018, ENVIRON SCI POLLUT R, V25, P375, DOI 10.1007/s11356-017-0442-z; Mao XB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215249; Nasehi M, 2018, SMALL RUMINANT RES, V168, P52, DOI 10.1016/j.smallrumres.2018.09.006; Nguyen KA, 2019, BIOL OPEN, V8, DOI 10.1242/bio.047183; Nykiel-Szymanska J, 2018, ECOTOX ENVIRON SAFE, V162, P1, DOI 10.1016/j.ecoenv.2018.06.060; Oyerinde A., 2009, INT J BIOL CHEM SCI, V3, P681, DOI [10.4314/ijbcs.v3i4.47177, DOI 10.4314/IJBCS.V3I4.47177]; Postio LOCY, 2021, FOOD BIOSCI, V41, DOI 10.1016/j.fbio.2021.100926; [任泽文 Ren Zewen], 2019, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V34, P99; Ricci A, 2019, J SCI FOOD AGR, V99, P6761, DOI 10.1002/jsfa.9958; Shah AM, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090590; Shi CY, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0015-2; Shibuya E, 2014, CELL BIOCHEM FUNCT, V32, P236, DOI 10.1002/cbf.3006; Starzynska-Janiszewska A, 2017, CEREAL CHEM, V94, P619, DOI 10.1094/CCHEM-10-16-0264-R; Sui WJ, 2019, J FOOD ENG, V261, P51, DOI 10.1016/j.jfoodeng.2019.03.015; Sun LP, 2017, MOLECULES, V22, DOI 10.3390/molecules22030350; Takagi H, 2019, BIOSCI BIOTECH BIOCH, V83, P1449, DOI 10.1080/09168451.2019.1576500; Tang GY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246196; Troesch B, 2013, FOOD NUTR BULL, V34, pS90, DOI 10.1177/15648265130342S111; Tseng YH, 2005, FOOD CHEM, V90, P409, DOI 10.1016/j.foodchem.2004.03.054; Uzun S, 2020, AN ACAD BRAS CIENC, V92, DOI 10.1590/0001-3765202020190030; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Velazquez JE, 2021, J APPL MICROBIOL, V130, P76, DOI 10.1111/jam.14777; Wang JH, 2018, INT J BIOL SCI, V14, P736, DOI 10.7150/ijbs.24523; [熊乙 Xiong Yi], 2018, [草地学报, Acta Agrestia Sinica], V26, P1262; Xu MX., 2017, VEGETABLES, V2, P26, DOI [10.3969/j.issn.1001-8336.2017.02.008, DOI 10.3969/J.ISSN.1001-8336.2017.02.008]; Yan YH, 2019, BIORESOURCE TECHNOL, V279, P166, DOI 10.1016/j.biortech.2019.01.107; Yang DD, 2016, J SCI FOOD AGR, V96, P680, DOI 10.1002/jsfa.7140; Yue L., 2019, FEED IND, V40, P34, DOI [10.13302/j.cnki.fi.2019.05.006, DOI 10.13302/J.CNKI.FI.2019.05.006]; Zhang HY, 2017, THESIS SW U; Zhao B, 2020, INT J BIOL MACROMOL, V150, P737, DOI 10.1016/j.ijbiomac.2020.02.016; Zheng QM, 2017, FISH PHYSIOL BIOCHEM, V43, P361, DOI 10.1007/s10695-016-0292-5; Zheng XL, 2019, CHEMOSPHERE, V233, P110, DOI 10.1016/j.chemosphere.2019.05.205; Zhou BX, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1640-2; Zhou BX, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1194-8; Zhu Fei, 2018, Chinese Journal of Animal Nutrition, V30, P4269; Zhu YC, 2016, FOOD CHEM, V194, P643, DOI 10.1016/j.foodchem.2015.08.054	65	1	1	11	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0260045	10.1371/journal.pone.0260045	http://dx.doi.org/10.1371/journal.pone.0260045			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767609	Green Published, gold			2022-12-26	WOS:000755249300060
J	Camicia, F; Vaca, HR; Park, SK; Bivona, AE; Naidich, A; Preza, M; Koziol, U; Celentano, AM; Marchant, JS; Rosenzvit, MC				Camicia, Federico; Vaca, Hugo R.; Park, Sang-Kyu; Bivona, Augusto E.; Naidich, Ariel; Preza, Matias; Koziol, Uriel; Celentano, Ana M.; Marchant, Jonathan S.; Rosenzvit, Mara C.			Characterization of a new type of neuronal 5-HT G-protein coupled receptor in the cestode nervous system	PLOS ONE			English	Article							ECHINOCOCCUS-GRANULOSUS CESTODA; IN-VITRO; SEROTONIN; LOCALIZATION; MODULATION; PREDICTION	Cestodes are platyhelminth parasites with a wide range of hosts that cause neglected diseases. Neurotransmitter signaling is of critical importance for these parasites which lack circulatory, respiratory and digestive systems. For example, serotonin (5-HT) and serotonergic G-protein coupled receptors (5-HT GPCRs) play major roles in cestode motility, development and reproduction. In previous work, we deorphanized a group of 5-HT7 type GPCRs from cestodes. However, little is known about another type of 5-HT GPCR, the 5-HT1 Glade, which has been studied in several invertebrate phyla but not in platyhel-minthes. Three putative 5 HT GPCRs from Echinococcus canadensis, Mesocestoides vogae (syn. M. cotti) and Hymenolepis microstoma were cloned, sequenced and bioinformatically analyzed. Evidence grouped these new sequences within the 5-HT1 clade of GPCRs but differences in highly conserved GPCR motifs were observed. Transcriptomic analysis, heterologous expression and immunolocalization studies were performed to characterize the E. canadensis receptor, called Eca-5-HT1a . Functional heterologous expression studies showed that Eca-5-HT1a is highly specific for serotonin. 5-Methoxytryptamine and amethylserotonin, both known 5-HT GPCR agonists, give stimulatory responses whereas methysergide, a known 5-HT GPCR ligand, give an antagonist response in Eca-5-HT1a. Mutants obtained by the substitution of key predicted residues resulted in severe impairment of receptor activity, confirming that indeed, these residues have important roles in receptor function. Immunolocalization studies on the protoscolex stage from E. canadensis, showed that Eca-5-HT1a is localized in branched fibers which correspond to the nervous system of the parasite. The patterns of immunoreactive fibers for Eca-5-HT1a and for serotonin were intimately intertwined but not identical, suggesting that they are two separate groups of fibers. These data provide the first functional, pharmacological and localization report of a serotonergic receptor that putatively belongs to the 5-HT1 type of GPCRs in cestodes. The serotonergic GPCR characterized here may represent a new target for antiparasitic intervention.	[Camicia, Federico] Univ Buenos Aires UBA, Fac Med, Ctr Patol Expt & Aplicada, Lab Toxinopatol, Buenos Aires, DF, Argentina; [Vaca, Hugo R.; Bivona, Augusto E.; Celentano, Ana M.; Rosenzvit, Mara C.] Univ Buenos Aires UBA, Fac Med FMed, Inst Invest Microbiol & Parasitol Med IMPaM, IMPaM,UBA CONICET,Consejo Nacl Invest Cient & Tec, Buenos Aires, DF, Argentina; [Vaca, Hugo R.; Bivona, Augusto E.; Celentano, Ana M.; Rosenzvit, Mara C.] Univ Buenos Aires UBA, Fac Med, Dept Microbiologra Parasitol & Inmunol, Buenos Aires, DF, Argentina; [Park, Sang-Kyu; Marchant, Jonathan S.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Naidich, Ariel] INEI ANLIS Dr Carlos G Malbran, Dept Parasitol, Buenos Aires, DF, Argentina; [Preza, Matias; Koziol, Uriel] Univ La Republ, Fac Ciencias, Secc Biol Celular, Montevideo, Uruguay	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Medical College of Wisconsin; Universidad de la Republica, Uruguay	Rosenzvit, MC (corresponding author), Univ Buenos Aires UBA, Fac Med FMed, Inst Invest Microbiol & Parasitol Med IMPaM, IMPaM,UBA CONICET,Consejo Nacl Invest Cient & Tec, Buenos Aires, DF, Argentina.; Rosenzvit, MC (corresponding author), Univ Buenos Aires UBA, Fac Med, Dept Microbiologra Parasitol & Inmunol, Buenos Aires, DF, Argentina.; Marchant, JS (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	jmarchant@mcw.edu; mrosenzvit@fmed.uba.ar	Preza, Matías/AAW-4208-2021; Marchant, Jonathan/Q-5484-2019	Preza, Matías/0000-0002-4725-541X; Marchant, Jonathan/0000-0001-6592-0877; Bivona, Augusto/0000-0002-0520-0226; ROSENZVIT, MARA CECILIA/0000-0002-5271-6321; Vaca, Hugo Rolando/0000-0002-5395-8402; Naidich, Ariel/0000-0003-0977-9666	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Secretaria de Ciencia y Tecnica (UBACyT), Universidad de Buenos Aires, Facultad de Medicina, Argentina; Project Programacion Cientifica 2016 [20020150100160BA]; CONICET postdoctoral fellowship; NIH [R01 AI145871]; PICT 2017 [2966]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica (UBACyT), Universidad de Buenos Aires, Facultad de Medicina, Argentina; Project Programacion Cientifica 2016; CONICET postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PICT 2017	This work was supported by Consejo Nacional de Investigaciones Cienti ' ficas y Te ' cnicas (CONICET), Argentina and by Secretaria de Ciencia y Te ' cnica (UBACyT), Universidad de Buenos Aires, Facultad de Medicina, Argentina. Project Programacio ' n Cienti ' fica 2016, code 20020150100160BA, PICT 2017 N degrees 2966. HRV is a recipient of a CONICET postdoctoral fellowship. JSM and SKP were supported by the NIH (R01 AI145871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAZ A, 1995, IMMUNOLOGY, V84, P350; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BROWNLEE DJA, 1994, PARASITOLOGY, V109, P233, DOI 10.1017/S0031182000076356; Bunin MA, 1998, J NEUROSCI, V18, P4854; Camicia F, 2013, INT J PARASITOL, V43, P647, DOI 10.1016/j.ijpara.2013.03.006; Camicia F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006267; Chan JD, 2018, ELIFE, V7, DOI [10.7554/eLife.35755, 10.7554/elife.35755]; Chan JD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02084-0; Chan JD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005651; Chan JD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004063; Coghlan A, 2019, NAT GENET, V51, P163, DOI 10.1038/s41588-018-0262-1; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; CONN DB, 1990, J PARASITOL, V76, P453, DOI 10.2307/3282690; Cucher M, 2011, INT J PARASITOL, V41, P439, DOI 10.1016/j.ijpara.2010.11.010; Cunningham LJ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-123; FAIRWEATHER I, 1994, PARASITOL RES, V80, P649, DOI 10.1007/BF00932948; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; Gurel G, 2012, GENETICS, V192, P1359, DOI 10.1534/genetics.112.142125; Hemphill A, 2010, PARASITOLOGY, V137, P329, DOI 10.1017/S0031182010000132; Herz M, 2021, PARASITE VECTOR, V14, DOI 10.1186/s13071-020-04533-0; Hobson RJ, 2003, J NEUROCHEM, V87, P22, DOI 10.1046/j.1471-4159.2003.01967.x; HOYER D, 1994, PHARMACOL REV, V46, P157; Hrckova G, 2002, PARASITOLOGY, V124, P409, DOI 10.1017/S0031182001001329; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kia HK, 1996, J NEUROSCI RES, V46, P697; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; Koziol U, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-24; Koziol U, 2011, MOL BIOCHEM PARASIT, V175, P181, DOI 10.1016/j.molbiopara.2010.11.009; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Law WJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004794; Li L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006309; Lindquist HDA., 2017, INFECT DIS-NOR, VFourth Edition, P1763, DOI 10.1016/B978-0-7020-6285-8.00195-7; Maldonado LL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3574-0; Markoski MM, 2003, J PARASITOL, V89, P27, DOI 10.1645/0022-3395(2003)089[0027:IVSIOM]2.0.CO;2; McCorvy JD, 2015, PHARMACOL THERAPEUT, V150, P129, DOI 10.1016/j.pharmthera.2015.01.009; McVeigh P., 2019, OXFORD HDB INVERTEBR, P40, DOI [10.1093/oxfordhb/9780190456757.013.8, DOI 10.1093/OXFORDHB/9780190456757.013.8]; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Patocka N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003878; Pilnick AR, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-90564-1, 10.1155/2014/139030, 10.18280/isi.270101]; Rambaut A, 2010, FIGTREE V131; Ribeiro P, 2015, TRENDS PARASITOL, V31, P404, DOI 10.1016/j.pt.2015.07.003; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Sgourakis NG, 2005, BIOINFORMATICS, V21, P4101, DOI 10.1093/bioinformatics/bti679; Tierney AJ, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.184838; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Vleugels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065052; Vuitton DA, 2020, PARASITE, V27, DOI 10.1051/parasite/2020024; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; White WH, 2007, VET PARASITOL, V146, P58, DOI 10.1016/j.vetpar.2007.02.014; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng HJ, 2013, NAT GENET, V45, P1168, DOI 10.1038/ng.2757	59	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259104	10.1371/journal.pone.0259104	http://dx.doi.org/10.1371/journal.pone.0259104			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762657	Green Published, gold			2022-12-26	WOS:000755316600012
J	Huang, CH; He, JY; Austin, E; Seto, E; Novosselov, I				Huang, Ching-Hsuan; He, Jiayang; Austin, Elena; Seto, Edmund; Novosselov, Igor			Assessing the value of complex refractive index and particle density for calibration of low-cost particle matter sensor for size-resolved particle count and PM2.5 measurements	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; LABORATORY EVALUATION; TEMPORAL VARIATIONS; MASS CONCENTRATION; FIELD-EVALUATION; FINE PARTICLES; PERFORMANCE; MORTALITY; QUALITY; HEALTH	Low-cost optical scattering particulate matter (PM) sensors report total or size-specific particle counts and mass concentrations. The PM concentration and size are estimated by the original equipment manufacturer (OEM) proprietary algorithms, which have inherent limitations since particle scattering depends on particles' properties such as size, shape, and complex index of refraction (CRI) as well as environmental parameters such as temperature and relative humidity (RH). As low-cost PM sensors are not able to resolve individual particles, there is a need to characterize and calibrate sensors' performance under a controlled environment. Here, we present improved calibration algorithms for Plantower PMS A003 sensor for mass indices and size-resolved number concentration. An aerosol chamber experimental protocol was used to evaluate sensor-to-sensor data reproducibility. The calibration was performed using four polydisperse test aerosols. The particle size distribution OEM calibration for PMS A003 sensor did not agree with the reference single particle sizer measurements. For the number concentration calibration, the linear model without adjusting for the aerosol properties and environmental conditions yields an absolute error (NMAE) of similar to 4.0% compared to the reference instrument. The calibration models adjusted for particle CRI and density account for non-linearity in the OEM's mass concentrations estimates with NMAE within 5.0%. The calibration algorithms developed in this study can be used in indoor air quality monitoring, occupational/industrial exposure assessments, or near-source monitoring scenarios where field calibration might be challenging.	[Huang, Ching-Hsuan; Austin, Elena; Seto, Edmund] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [He, Jiayang; Novosselov, Igor] Univ Washington, Dept Mech Engn, Coll Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Novosselov, I (corresponding author), Univ Washington, Dept Mech Engn, Coll Engn, Seattle, WA 98195 USA.	ivn@uw.edu	Huang, Ching-Hsuan/AAD-5297-2022	Huang, Ching-Hsuan/0000-0002-7283-7032; He, Jiayang/0000-0002-9740-791X	National Institute of Environmental Health Sciences [1R21ES024715, 1R33ES024715]; National Institute of Biomedical Imaging and Bioengineering [U01 EB021923]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by the National Institute of Environmental Health Sciences [grant numbers 1R21ES024715 and 1R33ES024715]; and the National Institute of Biomedical Imaging and Bioengineering [grant number U01 EB021923].	Afshar-Mohajer N, 2015, BUILD ENVIRON, V93, P293, DOI 10.1016/j.buildenv.2015.07.013; Austin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137789; Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Brown JS, 2002, AM J RESP CRIT CARE, V166, P1240, DOI 10.1164/rccm.200205-399OC; Chakrabarti B, 2004, ATMOS ENVIRON, V38, P3329, DOI 10.1016/j.atmosenv.2004.03.007; Chen JM, 2017, SCI TOTAL ENVIRON, V579, P1000, DOI 10.1016/j.scitotenv.2016.11.025; Duncan GE, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/12023; Elbayoumi M, 2015, BUILD ENVIRON, V90, P157, DOI 10.1016/j.buildenv.2015.03.036; Feenstra B, 2019, ATMOS ENVIRON, V216, DOI 10.1016/j.atmosenv.2019.116946; Gall ET, 2013, AM J PUBLIC HEALTH, V103, pE67, DOI 10.2105/AJPH.2012.300955; He JY, 2017, AEROSOL SCI TECH, V51, P1016, DOI 10.1080/02786826.2017.1329515; Hegde S, 2020, AEROSOL AIR QUAL RES, V20, P381, DOI 10.4209/aaqr.2019.01.0046; Jayaratne R, 2018, ATMOS MEAS TECH, V11, P4883, DOI 10.5194/amt-11-4883-2018; Jiao W, 2016, ATMOS MEAS TECH, V9, P5281, DOI 10.5194/amt-9-5281-2016; Kelly KE, 2017, ENVIRON POLLUT, V221, P491, DOI 10.1016/j.envpol.2016.12.039; Kinney PL, 2011, ENVIRON SCI POLICY, V14, P369, DOI 10.1016/j.envsci.2011.02.005; Krewski D, 2003, J TOXICOL ENV HEAL A, V66, P1507, DOI 10.1080/15287390306424; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Krzyzanowski M., 2004, COMP QUANTIFICATION, P1353; Kuhn T, 2021, J AEROSOL SCI, V152, DOI 10.1016/j.jaerosci.2020.105707; Li JY, 2018, BUILD ENVIRON, V127, P138, DOI 10.1016/j.buildenv.2017.11.001; Liu HY, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10020041; Liu XT, 2020, ENVIRON RES, V185, DOI 10.1016/j.envres.2020.109438; Makhsous S, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21113928; Malm WC, 2000, J AIR WASTE MANAGE, V50, P686, DOI 10.1080/10473289.2000.10464117; Manikonda A, 2016, J AEROSOL SCI, V102, P29, DOI [10.1016/j.jaerosci.2016.08.010, 10.1016/j.jaerosci.2016.11.010]; Cordero JM, 2018, SENSOR ACTUAT B-CHEM, V267, P245, DOI 10.1016/j.snb.2018.04.021; Molenar J. V., THEORETICAL ANAL PM; Nagy A, 2007, J AEROSOL SCI, V38, P467, DOI 10.1016/j.jaerosci.2007.02.005; Njalsson T, 2018, J AEROSOL SCI, V119, P1, DOI 10.1016/j.jaerosci.2018.01.003; Patel MM, 2009, ATMOS ENVIRON, V43, P4975, DOI 10.1016/j.atmosenv.2009.07.004; Phuleria HC, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004626; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Renard JB, 2016, ATMOS MEAS TECH, V9, P1721, DOI 10.5194/amt-9-1721-2016; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Sayahi T, 2019, ENVIRON POLLUT, V245, P932, DOI 10.1016/j.envpol.2018.11.065; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Seto E., 2014, USE LOW COST PARTICL; Shefelbine T., 2015, 3MTM CERAMIC MICROSP; Sioutas C, 2000, ATMOS ENVIRON, V34, P4829, DOI 10.1016/S1352-2310(00)00244-2; Sousan S, 2016, AEROSOL SCI TECH, V50, P462, DOI 10.1080/02786826.2016.1162901; Tryner J, 2020, ATMOS ENVIRON, V220, DOI 10.1016/j.atmosenv.2019.117067; Vaddi RS, 2020, J AEROSOL SCI, V148, DOI 10.1016/j.jaerosci.2020.105587; Vaddi RS., 2019, ARXIV190202986; Wallace LA, 2004, ENVIRON SCI TECHNOL, V38, P2304, DOI 10.1021/es0306260; Wang Y, 2015, AEROSOL SCI TECH, V49, P1063, DOI 10.1080/02786826.2015.1100710; Wang ZQ, 2020, BUILD ENVIRON, V171, DOI 10.1016/j.buildenv.2020.106654; Xiang JB, 2020, ENVIRON SCI TECHNOL, V54, P4286, DOI 10.1021/acs.est.0c00612; Zusman M, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105329	51	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0259745	10.1371/journal.pone.0259745	http://dx.doi.org/10.1371/journal.pone.0259745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762676	Green Published, Green Submitted, gold			2022-12-26	WOS:000755316600035
J	Qu, JW; Hou, YF; Chen, QX; Chen, J; Li, Y; Zhang, EF; Gu, HY; Xu, RY; Liu, Y; Cao, W; Zhang, JN; Cao, LQ; He, JS; Cai, Z				Qu, Jianwei; Hou, Yifan; Chen, Qingxiao; Chen, Jing; Li, Yi; Zhang, Enfan; Gu, Huiyao; Xu, Ruyi; Liu, Yang; Cao, Wen; Zhang, Jinna; Cao, Liqin; He, Jingsong; Cai, Zhen			RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-kappa B and MAPK signaling pathways	ONCOGENE			English	Article							LARGE-CELL LYMPHOMA; GENE-EXPRESSION; MOLECULAR CLASSIFICATION; NUCLEAR-RNA; STEM-CELLS; LEUKEMIA; N6-METHYLADENOSINE; HYPERDIPLOIDY; METHYLATION; PROGRESSION	N-6-methyladenosine (m(6)A), an internal modification in mRNA, plays a critical role in regulating gene expression. Dysregulation of m(6)A modifiers promotes oncogenesis through enzymatic functions that disrupt the balance between the deposition and removal of m(6)A modification on critical transcripts. However, the roles of mRNA m(6)A in multiple myeloma (MM) are poorly understood. The present study showed that RNA demethylase ALKBH5 was overexpressed in MM and associated with a poor prognosis in MM patients. Knocking down ALKBH5 induced apoptosis and inhibited the growth of MM cells in vitro. Xenograft models and gene set enrichment analysis with patient transcriptome datasets also supported the oncogenic role of ALKBH5 in MM. Mechanistic studies showed that ALKBH5 exerted tumorigenic effects in myeloma in an m(6)A-dependent manner, and TNF receptor-associated factor 1 (TRAF1) was a critical target of ALKBH5. Specifically, ALKBH5 regulated TRAF1 expression via decreasing m(6)A abundance in the 3'-untranslated region (3'-UTR) of TRAF1 transcripts and enhancing TRAF1 mRNA stability. As a result, ALKBH5 promoted MM cell growth and survival through TRAF1-mediated activation of NF-kappa B and MAPK signaling pathways. Collectively, our data demonstrated that ALKBH5 played a critical role in MM tumorigenesis and suggested that ALKBH5 could be a novel therapeutic target in MM.	[Qu, Jianwei; Hou, Yifan; Chen, Qingxiao; Chen, Jing; Li, Yi; Zhang, Enfan; Gu, Huiyao; Xu, Ruyi; Liu, Yang; Cao, Wen; Zhang, Jinna; Cao, Liqin; He, Jingsong; Cai, Zhen] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China; [Cai, Zhen] Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, Z (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China.; Cai, Z (corresponding author), Zhejiang Univ, Inst Hematol, Hangzhou, Zhejiang, Peoples R China.	caiz@zju.edu.cn			National Natural Science Foundation of China [81800201, 81800202, 81872322]; Zhejiang Key Research and Development Project [2020C03014]; National Major Scientific and Technological Special Project for Significant New Drug Development [2018ZX09733-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Research and Development Project; National Major Scientific and Technological Special Project for Significant New Drug Development	We thank the members of our laboratory for helpful discussions and assistance. This study was supported by grants from the National Natural Science Foundation of China (81800201, 81800202, and 81872322), the Zhejiang Key Research and Development Project (2020C03014), and the National Major Scientific and Technological Special Project for Significant New Drug Development (2018ZX09733-003).	Abate F, 2015, LEUKEMIA, V29, P1390, DOI 10.1038/leu.2014.347; Aik W, 2014, NUCLEIC ACIDS RES, V42, P4741, DOI 10.1093/nar/gku085; Alzrigat M, 2018, SEMIN CANCER BIOL, V51, P101, DOI 10.1016/j.semcancer.2017.09.007; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen Y, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01207-4; Chng W, 2006, LEUKEMIA, V20, P807, DOI 10.1038/sj.leu.2404172; Chretien ML, 2015, BLOOD, V126, P2713, DOI 10.1182/blood-2015-06-650242; Dixit D, 2021, CANCER DISCOV, V11, P480, DOI 10.1158/2159-8290.CD-20-0331; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Durkop H, 2003, J PATHOL, V200, P229, DOI 10.1002/path.1351; Edilova MI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02969; Feldman AL, 2013, GENE CHROMOSOME CANC, V52, P1097, DOI 10.1002/gcc.22104; Hao LL, 2021, AGING-US, V13, P4045, DOI 10.18632/aging.202371; Heuck CJ, 2014, LEUKEMIA, V28, P2410, DOI 10.1038/leu.2014.232; Hideshima T, 2021, CANCERS, V13, DOI 10.3390/cancers13020216; Huang HL, 2020, CANCER CELL, V37, P270, DOI 10.1016/j.ccell.2020.02.004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jiang FJ, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01066-6; Kumar SK, 2018, NAT REV CLIN ONCOL, V15, P409, DOI 10.1038/s41571-018-0018-y; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Li J, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01259-6; Li Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03763-z; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Mao SW, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04192-8; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mitchell JS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12050; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Munzert G, 2002, BLOOD, V100, P3749, DOI 10.1182/blood.V100.10.3749; Pan YT, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0590-8; Paris J, 2019, CELL STEM CELL, V25, P137, DOI 10.1016/j.stem.2019.03.021; Pawlyn C, 2015, BLOOD, V125, P831, DOI 10.1182/blood-2014-07-584268; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Pinto V, 2020, CANCERS, V12, DOI 10.3390/cancers12020407; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Ren ZH, 2019, BLOOD, V134, P1176, DOI 10.1182/blood.2019000578; Shen C, 2020, CELL STEM CELL, V27, P64, DOI 10.1016/j.stem.2020.04.009; Shen XD, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.592042; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; Todoerti K, 2013, CLIN CANCER RES, V19, P3247, DOI 10.1158/1078-0432.CCR-12-3461; van de Donk NWCJ, 2021, LANCET, V397, P410, DOI 10.1016/S0140-6736(21)00135-5; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang JZ, 2020, CELL STEM CELL, V27, P81, DOI 10.1016/j.stem.2020.04.001; Wang JY, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01807-0; Wang QS, 2018, CANCER RES, V78, P3982, DOI 10.1158/0008-5472.CAN-18-0429; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Weinhold N, 2016, BLOOD, V128, P1735, DOI 10.1182/blood-2016-06-723007; Wen XX, 2018, CLIN RESPIR J, V12, P2197, DOI 10.1111/crj.12789; Wu TF, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695930; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yang Y, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00980-5; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zapata JM, 2000, J IMMUNOL, V165, P5084, DOI 10.4049/jimmunol.165.9.5084; Zapata Juan M, 2002, Sci STKE, V2002, ppe27; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhong L, 2019, CANCER LETT, V442, P252, DOI 10.1016/j.canlet.2018.11.006; Zhu SN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02111	68	6	6	3	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2022	41	3					400	413		10.1038/s41388-021-02095-8	http://dx.doi.org/10.1038/s41388-021-02095-8		NOV 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YF8LK	34759347	Green Published, hybrid			2022-12-26	WOS:000716867900004
J	Takagi, S; Chijiiwa, H; Arahori, M; Saito, A; Fujita, K; Kuroshima, H				Takagi, Saho; Chijiiwa, Hitomi; Arahori, Minori; Saito, Atsuko; Fujita, Kazuo; Kuroshima, Hika			Socio-spatial cognition in cats: Mentally mapping owner's location from voice	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; ORANGUTANS PONGO-PYGMAEUS; OBJECT PERMANENCE; VOCAL RECOGNITION; GORILLA-GORILLA; DISPLACEMENT; TESTS; TASKS	Many animals probably hold mental representations about the whereabouts of others; this is a form of socio-spatial cognition. We tested whether cats mentally map the spatial position of their owner or a familiar cat to the source of the owner's or familiar cat's vocalization. In Experiment 1, we placed one speaker outside a familiar room (speaker 1) and another (speaker 2) inside the room, as far as possible from speaker 1, then we left the subject alone in the room. In the habituation phase, the cat heard its owner's voice calling its name five times from speaker 1. In the test phase, shortly after the 5(th) habituation phase vocalization, one of the two speakers played either the owner's voice or a stranger's voice calling the cat's name once. There were four test combinations of speaker location and sound: Same(sound)Same(location), Same(sound)Diff(location), Diff(sound)Same(location), Diff(sound)Diff(location). In line with our prediction, cats showed most surprise in the Same(sound)Diff(location) condition, where the owner suddenly seemed to be in a new place. This reaction disappeared when we used cat vocalizations (Experiment 2) or non-vocal sounds (Experiment 3) as the auditory stimuli. Our results suggest that cats have mental representations about their out-of-sight owner linked to hearing the owner's voice, indicating a previously unidentified socio-spatial cognitive ability.	[Takagi, Saho; Chijiiwa, Hitomi; Fujita, Kazuo; Kuroshima, Hika] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto, Japan; [Takagi, Saho] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Arahori, Minori] Anicom Special Med Inst Inc, Res & Dev Sect, Yokohama, Kanagawaken, Japan; [Arahori, Minori] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan; [Saito, Atsuko] Sophia Univ, Fac Human Sci, Dept Psychol, Chiyoda Ku, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University; Sophia University	Takagi, S (corresponding author), Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Kyoto, Japan.; Takagi, S (corresponding author), Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan.	sa-takagi@azabu-u.ac.jp		Takagi, Saho/0000-0002-3303-9521				Audacity team. Audacity&REG; software is copyright &COPY; 1999-2021 Audacity Team, 2019, NAME AUDACITY IS REG; BAILLARGEON R, 1987, DEV PSYCHOL, V23, P655, DOI 10.1037/0012-1649.23.5.655; Barth J, 2006, J EXP PSYCHOL ANIM B, V32, P239, DOI 10.1037/0097-7403.32.3.239; Bates D, 2012, PACKAGELME4; Beran MJ., 2000, INT J COMP PSYCHOL, V13; Bradshaw J., 2000, DOMESTIC CAT BIOL IT, P67; Brown SL., 1993, THESIS U SOUTHAMPTON; Call J, 2003, PRIMATES, V44, P347, DOI 10.1007/s10329-003-0048-6; Call J, 2001, J COMP PSYCHOL, V115, P159, DOI 10.1037//0735-7036.115.2.159; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; Collier-Baker E, 2006, J COMP PSYCHOL, V120, P89, DOI 10.1037/0735-7036.120.2.89; DORE FY, 1986, J COMP PSYCHOL, V100, P340, DOI 10.1037/0735-7036.100.4.340; Dore FY, 1996, ANIM LEARN BEHAV, V24, P142, DOI 10.3758/BF03198962; Edwards C, 2007, J VET BEHAV, V2, P119, DOI 10.1016/j.jveb.2007.06.004; Fox J, 2013, R J, V5, P39; Hartmann D, 2017, J COMP PSYCHOL, V131, P290, DOI 10.1037/com0000077; HASKINS R, 1979, ANIM BEHAV, V27, P726, DOI 10.1016/0003-3472(79)90008-3; Heffner HE, 2007, J AM ASSOC LAB ANIM, V46, P20; HEFFNER RS, 1985, HEARING RES, V19, P85, DOI 10.1016/0378-5955(85)90100-5; Jaakkola K, 2014, J COMP PSYCHOL, V128, P225, DOI 10.1037/a0035675; Jaakkola K, 2010, ANIM COGN, V13, P103, DOI 10.1007/s10071-009-0250-z; Kubinyi E., 2007, COMP COG BEHAV REV, V2; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; NATALE F, 1986, J COMP PSYCHOL, V100, P335, DOI 10.1037/0735-7036.100.4.335; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Noe R, 2014, ANIM COGN, V17, P597, DOI 10.1007/s10071-013-0690-3; Piaget J., 1954, DEV OBJECT CONCEPT; Quaranta A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10071107; R Core Team, 2020, R LANG ENV STAT COMP; Radford AN, 2005, ANIM BEHAV, V70, P1227, DOI 10.1016/j.anbehav.2005.04.002; Root-Gutteridge H, 2021, ANIM COGN, V24, P947, DOI 10.1007/s10071-021-01490-8; Saito A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40616-4; Saito A, 2013, ANIM COGN, V16, P685, DOI 10.1007/s10071-013-0620-4; Tabor RK, 1983, WILD LIFE DOMESTIC C; Takagi S, 2019, ANIM COGN, V22, P901, DOI 10.1007/s10071-019-01265-2; Takagi S, 2016, ANIM COGN, V19, P1043, DOI 10.1007/s10071-016-1001-6; Tami G, 2009, APPL ANIM BEHAV SCI, V120, P159, DOI 10.1016/j.applanim.2009.06.009; Townsend SW, 2012, BIOL LETTERS, V8, P179, DOI 10.1098/rsbl.2011.0844; Townsend SW, 2011, BEHAV ECOL SOCIOBIOL, V65, P1927, DOI 10.1007/s00265-011-1202-6; Turner D.C., 2000, DOMESTIC CAT BIOL IT; Zentall TR, 2016, CURR DIR PSYCHOL SCI, V25, P357, DOI 10.1177/0963721416664861; Zucca P, 2007, ANIM COGN, V10, P243, DOI 10.1007/s10071-006-0063-2	43	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0257611	10.1371/journal.pone.0257611	http://dx.doi.org/10.1371/journal.pone.0257611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY9NU	34758043	Green Published, gold			2022-12-26	WOS:000755112500002
J	Tuholske, C; Halpern, BS; Blasco, G; Villasenor, JC; Frazier, M; Caylor, K				Tuholske, Cascade; Halpern, Benjamin S.; Blasco, Gordon; Villasenor, Juan Carlos; Frazier, Melanie; Caylor, Kelly			Mapping global inputs and impacts from of human sewage in coastal ecosystems	PLOS ONE			English	Article							WASTE-WATER TREATMENT; CLIMATE-CHANGE; CRYPTOSPORIDIUM EMISSIONS; DEAD ZONES; NITROGEN; POLLUTION; PHOSPHORUS; INDICATOR; FOOD; POPULATION	Coastal marine ecosystems face a host of pressures from both offshore and land-based human activity. Research on terrestrial threats to coastal ecosystems has primarily focused on agricultural runoff, specifically showcasing how fertilizers and livestock waste create coastal eutrophication, harmful algae blooms, or hypoxic or anoxic zones. These impacts not only harm coastal species and ecosystems but also impact human health and economic activities. Few studies have assessed impacts of human wastewater on coastal ecosystems and community health. As such, we lack a comprehensive, fine-resolution, global assessment of human sewage inputs that captures both pathogens and nutrient flows to coastal waters and the potential impacts on coastal ecosystems. To address this gap, we use a new high-resolution geospatial model to measure and map nitrogen (N) and pathogen-fecal indicator organisms (FIO)-inputs from human sewage for similar to 135,000 watersheds globally. Because solutions depend on the source, we separate nitrogen and pathogen inputs from sewer, septic, and direct inputs. Our model indicates that wastewater adds 6.2Tg nitrogen into coastal waters, which is approximately 40% of total nitrogen from agriculture. Of total wastewater N, 63% (3.9Tg N) comes from sewered systems, 5% (0.3Tg N) from septic, and 32% (2.0Tg N) from direct input. We find that just 25 watersheds contribute nearly half of all wastewater N, but wastewater impacts most coastlines globally, with sewered, septic, and untreated wastewater inputs varying greatly across watersheds and by country. Importantly, model results find that 58% of coral and 88% of seagrass beds are exposed to wastewater N input. Across watersheds, N and FIO inputs are generally correlated. However, our model identifies important fine-grained spatial heterogeneity that highlight potential tradeoffs and synergies essential for management actions. Reducing impacts of nitrogen and pathogens on coastal ecosystems requires a greater focus on where wastewater inputs vary across the planet. Researchers and practitioners can also overlay these global, high resolution, wastewater input maps with maps describing the distribution of habitats and species, including humans, to determine the where the impacts of wastewater pressures are highest. This will help prioritize conservation efforts.Without such information, coastal ecosystems and the human communities that depend on them will remain imperiled.	[Tuholske, Cascade; Caylor, Kelly] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Tuholske, Cascade; Halpern, Benjamin S.; Blasco, Gordon; Frazier, Melanie] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Tuholske, Cascade] Columbia Univ, Ctr Int Int Earth Sci Informat Network, Columbia Climate Sch, Palisades, NY 10964 USA; [Tuholske, Cascade] Columbia Univ, Its Earth Inst, Palisades, NY 10964 USA; [Halpern, Benjamin S.; Villasenor, Juan Carlos; Caylor, Kelly] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Columbia University; Columbia University; University of California System; University of California Santa Barbara	Tuholske, C (corresponding author), Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA.; Tuholske, C (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.; Tuholske, C (corresponding author), Columbia Univ, Ctr Int Int Earth Sci Informat Network, Columbia Climate Sch, Palisades, NY 10964 USA.; Tuholske, C (corresponding author), Columbia Univ, Its Earth Inst, Palisades, NY 10964 USA.	cascade@ucsb.edu	Villaseñor-Derbez, Juan Carlos/HGB-9506-2022; Caylor, Kelly/B-7734-2008	Villaseñor-Derbez, Juan Carlos/0000-0003-1245-589X; Caylor, Kelly/0000-0002-6466-6448; Tuholske, Cascade/0000-0002-4806-0462				Altieri AH, 2017, P NATL ACAD SCI USA, V114, P3660, DOI 10.1073/pnas.1621517114; Beal CD, 2005, AUST J SOIL RES, V43, P781, DOI 10.1071/SR05018; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Beusen AHW., 2015, COUPLING GLOBAL MODE; Beusen AHW, 2016, BIOGEOSCIENCES, V13, P2441, DOI 10.5194/bg-13-2441-2016; Bouwman AF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002314; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dillon KS, 2008, ESTUAR COAST, V31, P360, DOI 10.1007/s12237-007-9028-1; Farr T.G., 2000, EOS T AM GEOPHYS UN, V81, P583, DOI [DOI 10.1029/EO081I048P00583, 10.1029/EO081i048p00583]; Fertig B, 2014, J COASTAL RES, V30, P881, DOI 10.2112/JCOASTRES-D-11-00231.1; Florczyk A, 2019, DESCRIPTION GHS URBA, DOI DOI 10.2760/037310; Food and Agriculture Organization of the United Nations Rome, 2017, PROTEIN SUPPLY QUANT; GERRITSE RG, 1995, WATER RES, V29, P2055, DOI 10.1016/0043-1354(95)00023-E; Grant SB, 2012, SCIENCE, V337, P681, DOI 10.1126/science.1216852; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; He Q, 2019, CURR BIOL, V29, pR1021, DOI 10.1016/j.cub.2019.08.042; Hofstra N, 2013, SCI TOTAL ENVIRON, V442, P10, DOI 10.1016/j.scitotenv.2012.10.013; Hofstra N, 2016, INT J HYG ENVIR HEAL, V219, P599, DOI 10.1016/j.ijheh.2016.06.005; Howarth RW, 2008, HARMFUL ALGAE, V8, P14, DOI 10.1016/j.hal.2008.08.015; Islam MMM, 2018, J HYDROL, V563, P1000, DOI 10.1016/j.jhydrol.2018.06.077; Islam MMM, 2018, INT J HYG ENVIR HEAL, V221, P283, DOI 10.1016/j.ijheh.2017.11.006; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Kay D, 2008, WATER RES, V42, P442, DOI 10.1016/j.watres.2007.07.036; Kiulia NM, 2015, PATHOGENS, V4, P229, DOI 10.3390/pathogens4020229; Kroeze C, 2016, CURR OPIN ENV SUST, V23, P35, DOI 10.1016/j.cosust.2016.11.014; Lamb JB, 2017, SCIENCE, V355, P731, DOI 10.1126/science.aal1956; Lassaletta L, 2014, BIOGEOCHEMISTRY, V118, P225, DOI 10.1007/s10533-013-9923-4; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Leyk S, 2019, EARTH SYST SCI DATA, V11, P1385, DOI 10.5194/essd-11-1385-2019; Lovelock CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005600; Malik OA, 2015, ENVIRON SCI POLICY, V48, P172, DOI 10.1016/j.envsci.2015.01.005; Malone TC, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00670; Mara DD, 2003, PUBLIC HEALTH, V117, P452, DOI 10.1016/S0033-3506(03)00143-4; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; Mekonnen MM, 2015, ENVIRON SCI TECHNOL, V49, P12860, DOI 10.1021/acs.est.5b03191; Moree AL, 2013, GLOBAL BIOGEOCHEM CY, V27, P836, DOI 10.1002/gbc.20072; Morrissey CA, 2013, HYDROBIOLOGIA, V700, P231, DOI 10.1007/s10750-012-1233-7; Organization WH., 2019, PROGR HOUSEHOLD DRIN; Pagilla KR, 2008, WATER SCI TECHNOL, V57, P1511, DOI 10.2166/wst.2008.213; Pehlivanoglu-Mantas E, 2008, WATER RES, V42, P3890, DOI 10.1016/j.watres.2008.05.017; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Reder K, 2017, ECOL MODEL, V351, P129, DOI 10.1016/j.ecolmodel.2017.02.008; Sans P, 2015, MEAT SCI, V109, P106, DOI 10.1016/j.meatsci.2015.05.012; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Seitzinger SP., 2010, GLOBAL BIOGEOCHEM CY, P24; Smil V, 2002, AMBIO, V31, P126, DOI 10.1639/0044-7447(2002)031[0126:NAFPPF]2.0.CO;2; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tuholske C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13137329; UNEP-WCMC Centre W WRI TNC, 2018, GLOB DISTR WARM WAT; Unep-Wcmc SFT, 2018, GLOBAL DISTRIBUTION, DOI DOI 10.34892/X6R3-D211; United Nations Statistics division, 2013, STAND COUNTR AR COD; United States Geologic Survey (USGS), 2020, WIKIPEDIA; Van Drecht G, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002060; Van Drecht G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003458; van Puijenbroek PJTM, 2019, J ENVIRON MANAGE, V231, P446, DOI 10.1016/j.jenvman.2018.10.048; Vermeulen LC, 2019, WATER RES, V149, P202, DOI 10.1016/j.watres.2018.10.069; Vilmin L, 2018, GLOBAL PLANET CHANGE, V163, P67, DOI 10.1016/j.gloplacha.2018.02.007; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wang X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10445-0; Wear SL, 2021, BIOL CONSERV, V255, DOI 10.1016/j.biocon.2021.109010; Wear SL, 2019, BIOSCIENCE, V69, P360, DOI 10.1093/biosci/biz025; Wear SL, 2015, ANN NY ACAD SCI, V1355, P15, DOI 10.1111/nyas.12785; WHO/UNICEF, 2017, 2017 WHO UNICEF JOIN	69	7	7	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258898	10.1371/journal.pone.0258898	http://dx.doi.org/10.1371/journal.pone.0258898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758036	gold, Green Published			2022-12-26	WOS:000755112500013
J	Chevalere, J; Cazenave, L; Berthon, M; Martinez, R; Mazenod, V; Borion, MC; Pailler, D; Rocher, N; Cadet, R; Lenne, C; Maionchi-Pino, N; Huguet, P				Chevalere, Johann; Cazenave, Lorelei; Berthon, Mickael; Martinez, Ruben; Mazenod, Vincent; Borion, Marie-Claude; Pailler, Delphine; Rocher, Nicolas; Cadet, Remi; Lenne, Catherine; Maionchi-Pino, Norbert; Huguet, Pascal			Computer-assisted instruction versus inquiry-based learning: The importance of working memory capacity	PLOS ONE			English	Article							INTELLIGENT TUTORING SYSTEMS; ACADEMIC SELF-CONCEPT; COGNITIVE LOAD; PERFORMANCE; PERSPECTIVE; DISCOVERY; ATTENTION; MARSH	The Covid-19 pandemic has led millions of students worldwide to intensify their use of digital education. This massive change is not reflected by the scant scientific research on the effectiveness of methods relying on digital learning compared to other innovative and more popular methods involving face-to-face interactions. Here, we tested the effectiveness of computer-assisted instruction (CAI) in Science and Technology compared to inquiry-based learning (IBL), another modern method which, however, requires students to interact with each other in the classroom. Our research also considered socio-cognitive factors-working memory (WM), socioeconomic status (SES), and academic self-concept (ASC)-known to predict academic performance but usually ignored in research on IBL and CAI. Five hundred and nine middle-school students, a fairly high sample size compared with relevant studies, received either IBL or CAI for a period varying from four to ten weeks prior to the Covid-19 events. After controlling for students' prior knowledge and socio-cognitive factors, multilevel modelling showed that CAI was more effective than IBL. Although CAI-related benefits were stable across students' SES and ASC, they were particularly pronounced for those with higher WM capacity. While indicating the need to adapt CAI for students with poorer WM, these findings further justify the use of CAI both in normal times (without excluding other methods) and during pandemic episodes.	[Chevalere, Johann; Cazenave, Lorelei; Berthon, Mickael; Borion, Marie-Claude; Maionchi-Pino, Norbert; Huguet, Pascal] Univ Clermont Auvergne, Lab Psychol Sociale & Cognit LAPSCO, Clermont Ferrand, France; [Chevalere, Johann; Cazenave, Lorelei; Berthon, Mickael; Martinez, Ruben; Mazenod, Vincent; Borion, Marie-Claude; Maionchi-Pino, Norbert; Huguet, Pascal] CNRS, Clermont Ferrand, France; [Martinez, Ruben; Mazenod, Vincent] Univ Clermont Auvergne, Lab Informat Modelisat & Optimisat Systemes LIMOS, Clermont Ferrand, France; [Borion, Marie-Claude; Pailler, Delphine; Rocher, Nicolas] Rectorat Clermont Ferrand, Clermont Ferrand, France; [Cadet, Remi] Univ Clermont Auvergne, Lab Act Connaissance Tranmiss Educ ACTe, Clermont Ferrand, France; [Cadet, Remi; Lenne, Catherine] Univ Clermont Auvergne, Maison Pour Sci Auvergne MPSA, Clermont Ferrand, France; [Lenne, Catherine] Univ Clermont Auvergne, Lab Phys & Physiol Integrat Arbre Environm Fluctu, Clermont Ferrand, France; [Lenne, Catherine] INRAe, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA); INRAE	Chevalere, J (corresponding author), Univ Clermont Auvergne, Lab Psychol Sociale & Cognit LAPSCO, Clermont Ferrand, France.; Chevalere, J (corresponding author), CNRS, Clermont Ferrand, France.	chevalere@uni-potsdam.de; pascal.huguet@uca.fr		Chevalere, Johann/0000-0002-6380-3615; Pailler, Delphine/0000-0003-0019-9040	Ministere de l'Education et de la Jeunesse/Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation/Mission Monteil pour le numerique educatif/Programme d'investissements d'avenir, action EFRAN; National EFRAN research program on digital education	Ministere de l'Education et de la Jeunesse/Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation/Mission Monteil pour le numerique educatif/Programme d'investissements d'avenir, action EFRAN(French National Research Agency (ANR)); National EFRAN research program on digital education	Financial support was provided to P. Huguet by the "Ministere de l'Education et de la Jeunesse/Ministere de l'Enseignement Superieur, de la Recherche et de l'Innovation/Mission Monteil pour le numerique educatif/Programme d'investissements d'avenir, action EFRAN" for a project titled "e.P3C: digital technologies at the service of the Plurality of Contexts, Skills and Behaviors". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.r We thank all study site lead investigators (Yannick Morice, Delphine Pailler, Florence Prost, Annabelle Restoy) and the numerous teachers who participated in this research. Financial support was provided to P. Huguet by the National EFRAN research program on digital education for a project titled "e.P3C: digital technologies at the service of the Plurality of Contexts, Skills and Behaviours". The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Special thanks to Marie-Danielle Campion (Rector) and her successors (Benoit Delaunay and Karim Benmiloud) who strongly supported this project.	Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; [Anonymous], 2017, ANN PSYCHOL; [Anonymous], 2020, EUR J PSYCHOL EDUC; [Anonymous], 2006, COMMUN EDUC; Baker RS, 2016, INT J ARTIF INTELL E, V26, P600, DOI 10.1007/s40593-016-0105-0; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1995, SELF EFFICACY CHANGI, Vxv; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell T, 2010, INT J SCI EDUC, V32, P349, DOI 10.1080/09500690802582241; Bembenutty H, 2009, J ADV ACAD, V20, P740, DOI 10.1177/1932202X0902000407; Bittinger ML., 1968, MATH TEACH, V61, P140; Blake J, 1999, ABNF J, V10, P43; Blom H, 2018, J COMPUT ASSIST LEAR, V34, P306, DOI 10.1111/jcal.12243; Botsas G., 2017, EUROPEAN J SPECIAL E, V2; Bourdieu P., 1990, REPROD ED SOC CULTUR, Vxxvi, P254; Bray J.W., 2008, ANAL DATA NONRANDOMI, P0008, DOI [10.3768/rtipress.2008.mr.0008.0811, DOI 10.3768/RTIPRESS.2008.MR.0008.0811]; Camos V., 2018, WORKING MEMORY DEV; CAMPBELL DL, 1987, ECTJ-EDUC COMMUN TEC, V35, P95; CARBONEL.JR, 1970, IEEE T MAN MACHINE, VMM11, P190, DOI 10.1109/TMMS.1970.299942; Castro-Schilo L, 2018, J SOC PERS RELAT, V35, P32, DOI 10.1177/0265407517718387; Cevik V, 2016, J COMPUT ASSIST LEAR, V32, P594, DOI 10.1111/jcal.12156; Chang YJ, 2018, CBE-LIFE SCI EDUC, V17, DOI 10.1187/cbe.17-09-0199; Conto MCA., 2020, UNICEF IRC INNOCENTI; Cooper H, 1996, REV EDUC RES, V66, P227, DOI 10.2307/1170523; Cotton, 2008, ENCY SPECIAL ED, P514, DOI [10.1002/9780470373699.speced0481, DOI 10.1002/9780470373699.SPECED0481]; CROY MJ, 1988, COMPUT HUMANITIES, V22, P277, DOI 10.1007/BF00118603; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; David Y, 2020, COVID 19 SIMILAR FUT; de Jong T, 2010, INSTR SCI, V38, P105, DOI 10.1007/s11251-009-9110-0; Dobber M, 2017, EDUC RES REV-NETH, V22, P194, DOI 10.1016/j.edurev.2017.09.002; Dreesen T., 2020, 202010 UNICEFIRC; Engle RW, 2018, PERSPECT PSYCHOL SCI, V13, P190, DOI 10.1177/1745691617720478; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Epstein Daniel, 2013, 2013 IEEE Frontiers in Education Conference (FIE), P1072, DOI 10.1109/FIE.2013.6684991; FINNEGAN R, 1991, J READING, V35, P108; Font JTP, 2019, GAMILEARN, V2427; Fox J., 2019, R COMPANION APPL REG, V.; Frey N, 2017, J ADOLESC ADULT LIT, V60, P567, DOI 10.1002/jaal.576; Godwin KE., 2016, COG SCI; Graesser A, 2010, EDUC PSYCHOL-US, V45, P234, DOI 10.1080/00461520.2010.515933; Gray SA, 2012, J CHILD PSYCHOL PSYC, V53, P1277, DOI 10.1111/j.1469-7610.2012.02592.x; HERMANN G, 1969, J EXP EDUC, V38, P58, DOI 10.1080/00220973.1969.11011167; Hollingshead AB., 2012, THEORIES TEAM COGNIT, P421; Hovardas T, 2014, COMPUT EDUC, V71, P133, DOI 10.1016/j.compedu.2013.09.019; Huguet P, 2009, J PERS SOC PSYCHOL, V97, P156, DOI 10.1037/a0015558; Institut national de la statistique et des etudes economiques, 2018, NOM PROF CAT SOC EMP; Jansen B.A., 2011, LIB MEDIA CONNECTION, V29, P10; Jerrim J, 2019, LEARN INSTR, V61, P35, DOI [10.1016/j.learninstruc.2018.12.004, 10.1016/j.learninstruc.2020.101310]; Kaiser I, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02440; Killen R., 2007, TEACHING STRATEGIES; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; KLAHR D, 1988, COGNITIVE SCI, V12, P1, DOI 10.1207/s15516709cog1201_1; Kuech R., 2004, J CLASSROOM INTERACT, V39, P30; KULIK CLC, 1991, COMPUT HUM BEHAV, V7, P75, DOI 10.1016/0747-5632(91)90030-5; Kulik J., 2003, EFFECTS USING INSTRU; Kulik JA, 2016, REV EDUC RES, V86, P42, DOI 10.3102/0034654315581420; Lazonder AW, 2016, REV EDUC RES, V86, P681, DOI 10.3102/0034654315627366; Lewis K, 2011, ORGAN SCI, V22, P1254, DOI 10.1287/orsc.1110.0647; Lipsky M, 2010, STREET-LEVEL BUREAUCRACY: DILEMMAS OF THE INDIVIDUAL IN PUBLIC SERVICES, 30TH EDITION, P1; Ma WT, 2014, J EDUC PSYCHOL, V106, P901, DOI 10.1037/a0037123; Madan CR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00507; Maltese AV, 2011, SCI EDUC, V95, P877, DOI 10.1002/sce.20441; Maor D., 1994, AUST SCI TEACH J, V40, P65; Marsh HW, 2006, PERSPECT PSYCHOL SCI, V1, P133, DOI 10.1111/j.1745-6916.2006.00010.x; MARSH HW, 1990, J EDUC PSYCHOL, V82, P623, DOI 10.1037/0022-0663.82.4.623; Mingo I, 2018, SOC INDIC RES, V135, P629, DOI 10.1007/s11205-016-1511-2; Ministeres de l'Education Nationale de l'Enseignement Superieur de la Recherche et de l'Innovation, 2018, DIR EV PROSP PERF RE; Monteil JM., 1999, SOCIAL CONTEXT COGNI; Moran J, 2008, J LIT RES, V40, P6, DOI 10.1080/10862960802070483; Moreno R, 1999, J EDUC PSYCHOL, V91, P358, DOI 10.1037/0022-0663.91.2.358; O'Neil HF., 1991, INTELLIGENT TUTORING, P69; OECD, 2016, LOW PERF STUD WHY TH; OECD (Organisation for Economic Co-operation and Development), 1997, 471 OECD, DOI [10.1787/9789264071247-en, DOI 10.1787/9789264071247-EN]; Osman G, 2011, ASIA PAC EDUC REV, V12, P547, DOI 10.1007/s12564-011-9156-y; Oswald FL, 2015, BEHAV RES METHODS, V47, P1343, DOI 10.3758/s13428-014-0543-2; PAAS FGWC, 1994, PERCEPT MOTOR SKILL, V79, P419, DOI 10.2466/pms.1994.79.1.419; Paas F, 2020, CURR DIR PSYCHOL SCI, V29, P394, DOI 10.1177/0963721420922183; Pedaste M, 2015, EDUC RES REV-NETH, V14, P47, DOI 10.1016/j.edurev.2015.02.003; Perin D, 2011, COMMUNITY COLL REV, V39, P268, DOI 10.1177/0091552111416227; R Core Team, 2020, R LANG ENV STAT COMP; Rodrigues C., 2017, DIGITAL TECHNOLOGIES; Rulke DL, 2000, GROUP ORGAN MANAGE, V25, P373, DOI 10.1177/1059601100254004; Scharinger C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130608; Sosa GW, 2011, REV EDUC RES, V81, P97, DOI 10.3102/0034654310378174; Steenbergen-Hu S, 2014, J EDUC PSYCHOL, V106, P331, DOI 10.1037/a0034752; Steffens MC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01907; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Sweller J, 1998, EDUC PSYCHOL REV, V10, P251, DOI 10.1023/A:1022193728205; Tanchuk N, 2020, J PHILOS EDUC, V54, P1167, DOI 10.1111/1467-9752.12435; TROLLIP S, 1977, INSTR SCI, V6, P135, DOI 10.1007/BF00121083; UNESCO, 2021, UNESCO SCI REPORT RA; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; Van der Kleij FM, 2015, REV EDUC RES, V85, P475, DOI 10.3102/0034654314564881; Ventures, 2020, EUR EDTECH FUND REP; Vista A., 2018, USE DATA 21 ST CENTU; Wang PH, 2015, PROCD SOC BEHV, V174, P1292, DOI 10.1016/j.sbspro.2015.01.750; Watts G, 2020, LANCET DIGIT HEALTH, V2, pE395, DOI 10.1016/S2589-7500(20)30169-2; Wegner D.M., 1987, THEORIES GROUP BEHAV, P185, DOI DOI 10.1007/978-1-4612-4634-3_9; Xiao ZM, 2019, J EXP EDUC, V87, P17, DOI 10.1080/00220973.2017.1380591; Zhan ZH, 2013, COMPUT EDUC, V69, P131, DOI 10.1016/j.compedu.2013.07.002	101	1	1	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2021	16	11							e0259664	10.1371/journal.pone.0259664	http://dx.doi.org/10.1371/journal.pone.0259664			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YY0QZ	34752504	gold, Green Published			2022-12-26	WOS:000754499700023
J	Sanchez-Taltavull, D; Castelo-Szekely, V; Murugan, S; Hamley, JID; Rollenske, T; Ganal-Vonarburg, SC; Buchi, I; Keogh, A; Li, H; Salm, L; Spari, D; Yilmaz, B; Zimmermann, J; Gerfin, M; Roldan, E; Beldi, G				Sanchez-Taltavull, Daniel; Castelo-Szekely, Violeta; Murugan, Shaira; Hamley, Jonathan I. D.; Rollenske, Tim; Ganal-Vonarburg, Stephanie C.; Buechi, Isabel; Keogh, Adrian; Li, Hai; Salm, Lilian; Spari, Daniel; Yilmaz, Bahtiyar; Zimmermann, Jakob; Gerfin, Michael; Roldan, Edgar; Beldi, Guido		UVCM-COVID Researchers	Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures	PLOS ONE			English	Article								Protecting healthcare professionals is crucial in maintaining a functioning healthcare system. The risk of infection and optimal preventive strategies for healthcare workers during the COVID-19 pandemic remain poorly understood. Here we report the results of a cohort study that included pre- and asymptomatic healthcare workers. A weekly testing regime has been performed in this cohort since the beginning of the COVID-19 pandemic to identify infected healthcare workers. Based on these observations we have developed a mathematical model of SARS-CoV-2 transmission that integrates the sources of infection from inside and outside the hospital. The data were used to study how regular testing and a desynchronisation protocol are effective in preventing transmission of COVID-19 infection at work, and compared both strategies in terms of workforce availability and cost-effectiveness. We showed that case incidence among healthcare workers is higher than would be explained solely by community infection. Furthermore, while testing and desynchronisation protocols are both effective in preventing nosocomial transmission, regular testing maintains work productivity with implementation costs.	[Sanchez-Taltavull, Daniel; Castelo-Szekely, Violeta; Murugan, Shaira; Hamley, Jonathan I. D.; Rollenske, Tim; Ganal-Vonarburg, Stephanie C.; Buechi, Isabel; Keogh, Adrian; Li, Hai; Salm, Lilian; Spari, Daniel; Yilmaz, Bahtiyar; Zimmermann, Jakob; Beldi, Guido] Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Bern, Switzerland; [Sanchez-Taltavull, Daniel; Castelo-Szekely, Violeta; Murugan, Shaira; Hamley, Jonathan I. D.; Rollenske, Tim; Ganal-Vonarburg, Stephanie C.; Buechi, Isabel; Keogh, Adrian; Li, Hai; Salm, Lilian; Spari, Daniel; Yilmaz, Bahtiyar; Zimmermann, Jakob; Beldi, Guido] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Sanchez-Taltavull, Daniel; Castelo-Szekely, Violeta; Murugan, Shaira; Hamley, Jonathan I. D.; Buechi, Isabel; Keogh, Adrian; Salm, Lilian; Spari, Daniel; Beldi, Guido] Bern Ctr Precis Med, Bern, Switzerland; [Gerfin, Michael] Univ Bern, Dept Econ, Bern, Switzerland; [Roldan, Edgar] Abdus Salaam Int Ctr Theoret Phys, Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	University of Bern; University Hospital of Bern; University of Bern; University of Bern; Abdus Salam International Centre for Theoretical Physics (ICTP)	Sanchez-Taltavull, D; Beldi, G (corresponding author), Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Bern, Switzerland.; Sanchez-Taltavull, D; Beldi, G (corresponding author), Univ Bern, Dept Biomed Res, Bern, Switzerland.; Sanchez-Taltavull, D; Beldi, G (corresponding author), Bern Ctr Precis Med, Bern, Switzerland.	daniel.sanchez@dbmr.unibe.ch; guido.beldi@insel.ch	Zimmermann, Jakob/U-4766-2017; Ganal-Vonarburg, Stephanie C./AAE-5705-2019	Zimmermann, Jakob/0000-0002-6302-6844; Ganal-Vonarburg, Stephanie C./0000-0002-2548-7754; Buchi, Isabel/0000-0002-6266-0042; Salm, Lilian/0000-0002-6812-3678; Yilmaz, Bahtiyar/0000-0003-1888-9226; Roldan, Edgar/0000-0001-7196-8404; Sanchez-Taltavull, Daniel/0000-0002-4944-0360; Beldi, Guido/0000-0002-9914-3807; Young, Ian/0000-0001-6250-9820				Adams-Prassl Abi., 2020, WORK CAN BE DONE HOM, P62; Althaus ChristianL., 2020, MEDRXIV 202007212015; [Anonymous], 2021, STAT WAGES; [Anonymous], 2020, DAENUPROBST COVID19; Bi Q., 2021, HOUSEHOLD TRANSMISSI; Birrell P, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0279; Boonyasiri A., 2020, 8 IMP COLL LOND; Folgueira MariaDolores., 2020, MEDRXIV 202004072005; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Gardiner C, 2009, STOCHASTIC METHODS, V4; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gomez-Ochoa SA, 2021, AM J EPIDEMIOL, V190, P161, DOI 10.1093/aje/kwaa191; Hanrath AT, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.636160; Karin Omer, 2020, MEDRXIV, DOI [10.1101/2020.04.04.20053579, DOI 10.1101/2020.04.04.20053579]; Lemaitre Joseph C, 2020, Swiss Med Wkly, V150, pw20295, DOI 10.4414/smw.2020.20295; Lim CY, 2020, CLIN BIOCHEM, V86, P15, DOI 10.1016/j.clinbiochem.2020.09.003; McEllistrem MC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248347; Nopsopon T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0238088; Sanchez-Taltavull Daniel., 2020, MODELLING STRATEGIES; Schwartz KevinL., 2020, MEDRXIV2020061220129; Zheng Charlotte., 2020, CHARACTERISTICS TRAN	21	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0258700	10.1371/journal.pone.0258700	http://dx.doi.org/10.1371/journal.pone.0258700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739484	Green Published, Green Submitted, gold			2022-12-26	WOS:000755000800008
J	Wang, CC; Huang, CY; Lee, MC; Tsai, DJ; Wu, CC; Su, SL				Wang, Chih-Chien; Huang, Chih-Yun; Lee, Meng-Chang; Tsai, Dung-Jang; Wu, Chia-Chun; Su, Sui-Lung			Genetic association between TNF-alpha G-308A and osteoarthritis in Asians: A case-control study and meta-analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KNEE OSTEOARTHRITIS; POLYMORPHISMS; RISK; COLLAGENASE; INTERLEUKIN-1-BETA; SCHIZOPHRENIA; INHIBITION; EXPRESSION; ARTHRITIS	Background Osteoarthritis (OA) is an important health issue in elderly people. Many studies have suggested that genetic factors are important risk factors for OA, of which tumor necrosis factor-alpha (TNF-alpha) is one of the most examined genes. Moreover, several studies have investigated the relationship between TNF-alpha G-308A polymorphisms and OA risk, but consistent results have not been obtained. Objective This study examines the association between TNF-alpha G-308A polymorphisms and knee OA. Moreover, meta-analysis and trial sequential analysis (TSA) was used to determine whether this is a susceptibility gene for knee OA. Methods Between 2015 and 2019, 591 knee OA cases and 536 healthy controls were recruited. The Kellgren-Lawrence grading system was used to identify the knee OA cases. A meta-analysis was conducted including related studies published until 2020 from PubMed, Embase, and previous meta-analysis to improve the evidence level of the current study. The results were expressed as odds ratios (ORs) with corresponding 95% confidence intervals (CI) to evaluate the effect of this polymorphism on knee OA risk. The TSA was used to estimate the sample sizes required in this issue. Results A nonsignificant association was found between the AA genotype and knee OA [adjusted OR, 0.84; 95% CI, 0.62-1.15) in the recessive model] in the present case-control study, and analysis of other genetic models showed a similar trend. After adding the critical case-control samples for Asians, the TNF-alpha G-308A, AA genotype exhibited 2.57 times more risk of developing arthritis when compared with the GG + GA genotype (95% CI, 1.56-4.23), and the cumulative samples for TSA (n = 2182) were sufficient to obtain a definite conclusion. Conclusions The results of this meta-analysis revealed that the TNF-alpha G-308A, AA genotype is a susceptible genotype for OA in the Asian population. This study integrated all current evidence to arrive at this conclusion, suggesting that future studies on Asians are not required.	[Wang, Chih-Chien; Wu, Chia-Chun] Triserv Gen Hosp, Dept Orthoped, Taipei, Taiwan; [Wang, Chih-Chien; Wu, Chia-Chun] Natl Def Med Ctr, Taipei, Taiwan; [Huang, Chih-Yun; Lee, Meng-Chang; Tsai, Dung-Jang; Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Tsai, Dung-Jang] Triserv Gen Hosp, Artificial Intelligence Things Ctr, Natl Def Med Ctr, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Su, SL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	a131419@gmail.com		Lee, Meng Chang/0000-0003-0165-9459				Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen C, 2015, ACTA BIOCH BIOPH SIN, V47, P121, DOI 10.1093/abbs/gmu116; Chen JY, 2020, AGING-US, V12, P8434, DOI 10.18632/aging.103150; Chen J, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187311, 10.1590/1414-431x20187311]; Cohen OS, 2016, MOL PSYCHIATR, V21, P975, DOI 10.1038/mp.2015.137; Dai DJ, 2014, BIOMED REP, V2, P886, DOI 10.3892/br.2014.324; Damen J, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-018-1785-7; Englaro W, 1999, ONCOGENE, V18, P1553, DOI 10.1038/sj.onc.1202446; FIRESTEIN GS, 1991, ARTHRITIS RHEUM, V34, P1094, DOI 10.1002/art.1780340905; Munoz-Valle JF, 2014, CLIN EXP MED, V14, P61, DOI 10.1007/s10238-012-0216-3; Galil SMA, 2017, CLIN RHEUMATOL, V36, P2525, DOI 10.1007/s10067-017-3727-1; Han L, 2012, KOREAN J PATHOL, V46, P30, DOI 10.4132/KoreanJPathol.2012.46.1.30; Hou L, 2020, MOL MED, V26, DOI 10.1186/s10020-019-0133-y; Ji B, 2013, INT ORTHOP, V37, P2061, DOI 10.1007/s00264-013-1931-4; Ji HH, 2015, EXP THER MED, V9, P1831, DOI 10.3892/etm.2015.2327; Jiang L, 2019, J CLIN ENDOCR METAB, V104, P4539, DOI 10.1210/jc.2019-00495; Jin GH, 2020, MOL THER-NUCL ACIDS, V20, P13, DOI 10.1016/j.omtn.2020.01.037; Kan MY, 2015, EXP BIOL MED, V240, P230, DOI 10.1177/1535370214553770; Kan MY, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-73; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kou ST, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-373; Li HM, 2019, AGING-US, V11, P7620, DOI 10.18632/aging.102275; Liu MH, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116459; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Moos V, 2000, ARTHRITIS RHEUM, V43, P2417, DOI 10.1002/1529-0131(200011)43:11<2417::AID-ANR7>3.0.CO;2-R; OMALLEY WE, 1963, CANCER RES, V23, P890; Fernandes MTP, 2019, ADV RHEUMATOL, V59, DOI 10.1186/s42358-019-0068-6; Pooja S, 2011, BREAST CANCER RES TR, V126, P739, DOI 10.1007/s10549-010-1175-6; Raafat N, 2020, GENE REP, V21; Reginato AM, 2002, ARTHRITIS RES, V4, P337, DOI 10.1186/ar595; Rogoveanu OC, 2018, EXP THER MED, V16, P2659, DOI 10.3892/etm.2018.6477; Schwarzer G, 2012, META META ANAL R; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sezgin M, 2008, CLIN EXP RHEUMATOL, V26, P763; Shlopov BV, 2000, ARTHRITIS RHEUM-US, V43, P195, DOI 10.1002/1529-0131(200001)43:1<195::AID-ANR24>3.0.CO;2-G; Sobhan MR, 2018, J ORTHOP, V15, P747, DOI 10.1016/j.jor.2018.05.047; Spector TD, 1996, BRIT MED J, V312, P940; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Thorlund K., 2011, USER MANUAL TRIAL SE; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Vnukov V V, 2016, Adv Gerontol, V29, P52; Wang XH, 2021, J CLIN ENDOCR METAB, V106, pE4641, DOI 10.1210/clinem/dgab454; Wang XR, 2021, EUR J NUTR, V60, P3473, DOI 10.1007/s00394-021-02528-w; WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557; Wu YL, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00902-6; Xiang YQ, 2014, MOL HUM REPROD, V20, P875, DOI 10.1093/molehr/gau048; Xu MQ, 2007, CIRCULATION, V116, P1356, DOI 10.1161/CIRCULATIONAHA.107.728857; Xu MQ, 2007, SCHIZOPHR RES, V91, P6, DOI 10.1016/j.schres.2006.12.008; Xu MQ, 2011, PROG NEURO-PSYCHOPH, V35, P1255, DOI 10.1016/j.pnpbp.2010.11.001; Xu MQ, 2010, ATHEROSCLEROSIS, V213, P191, DOI 10.1016/j.atherosclerosis.2010.07.046; Yan XT, 2018, PROG NEURO-PSYCHOPH, V83, P64, DOI 10.1016/j.pnpbp.2017.12.016; Yu H, 2020, EXP MOL PATHOL, V116, DOI 10.1016/j.yexmp.2020.104493; Zhang Fuquan, 2022, Eur Respir J, V60, DOI 10.1183/13993003.01273-2021; Zhang FQ, 2021, HUM GENET, V140, P1267, DOI 10.1007/s00439-021-02288-x; Zhang FQ, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI145942; Zheng SY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02415; Zhou XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19910	61	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259561	10.1371/journal.pone.0259561	http://dx.doi.org/10.1371/journal.pone.0259561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735544	Green Published, gold			2022-12-26	WOS:000755077100093
J	Chen, XL; Liu, HJ; Li, A; Ji, SS; Fei, H				Chen, Xiaolong; Liu, Hanjie; Li, Ang; Ji, Shuangshuang; Fei, Hao			Hydrophobicity-tuned anion responsiveness underlies endosomolytic cargo delivery mediated by amphipathic vehicle peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PENETRATING PEPTIDES; CATIONIC ANTIMICROBIAL PEPTIDES; METABOLIC-INHIBITORS; PROTEIN DELIVERY; MEMBRANE; MECHANISMS; ACID; DRUG; DESTABILIZATION; RESISTANCE	Peptide conformation can change subject to environment cues. This concept also applies to many cationic amphipathic peptides (CAPs) known to have cell membrane lytic or penetrative activities. Well-conditioned CAPs can match the properties of the target membrane to support their intended biological functions, e.g., intracellular cargo delivery; however, the intricacy in such conditioning surpasses our current un-derstanding. Here we focused on hydrophobicity, a key bio-physical property that dictates the membrane activity of CAPs, and applied a structure-function strategy to evolve a template peptide for endosomolytic cargo delivery. The template was subjected to iterative adjustment to balance hydrophobicity between its N-terminal linear and C-terminal helical domains. We demonstrate that the obtained peptide, LP6, could dramatically promote cargo cell entry and facilitate cytosolic delivery of biomacromolecules such as FITC-dextran, saporin, and human IgG. Among the evolved peptide series, LP6 has low cytotoxicity and moderate hydrophobicity, exhibits maximum change in helical conformation in response to negatively charged phospholipids, and also shows an apparent aggregational behavior in response to sialic acid enrichment. These attributes of LP6 collectively indicate that its anion-responsive conformational change is a critical underlining of its endosomolytic cargo delivery capability. Our results also suggest that modulation of hydrophobicity serves as a key to the precise tuning of CAP's membrane activity for future biomedical applications.	[Chen, Xiaolong; Liu, Hanjie; Li, Ang; Ji, Shuangshuang; Fei, Hao] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, CAS Key Lab Nanobio Interface, Suzhou, Peoples R China; [Chen, Xiaolong; Liu, Hanjie; Li, Ang; Ji, Shuangshuang; Fei, Hao] Univ Sci & Technol China, Sch Nanotech & Nanobion, Hefei, Peoples R China	Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Fei, H (corresponding author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, CAS Key Lab Nanobio Interface, Suzhou, Peoples R China.; Fei, H (corresponding author), Univ Sci & Technol China, Sch Nanotech & Nanobion, Hefei, Peoples R China.	hfei2008@sinano.ac.cn		Fei, Hao/0000-0002-9506-3420	National Natural Science Foundation of China [32071393, 81573339, 31170777]; Ministry of Science and Technology of China [2017YFA0205504]; Ministry of Science and Technology of Jiangsu Province [BE2021666]; Bureau of International Cooperation Chinese Academy of Sciences [GJHZ2021136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology of Jiangsu Province; Bureau of International Cooperation Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (32071393, 81573339, 31170777), the Ministry of Science and Technology of China (2017YFA0205504), the Ministry of Science and Technology of Jiangsu Province (BE2021666), the Bureau of International Cooperation Chinese Academy of Sciences (GJHZ2021136). We are thankful to the Core Facilities of SINANO Nano-Bio-Chem and Biomedicine Division for technical assistances.	Ageitos JM, 2017, BIOCHEM PHARMACOL, V133, P117, DOI 10.1016/j.bcp.2016.09.018; Akasaki K, 1996, J BIOCHEM-TOKYO, V120, P1088; Akishiba M, 2017, NAT CHEM, V9, P751, DOI [10.1038/NCHEM.2779, 10.1038/nchem.2779]; Allolio C, 2018, P NATL ACAD SCI USA, V115, P11923, DOI 10.1073/pnas.1811520115; Arafiles JVV, 2020, BIOCONJUGATE CHEM, V31, P547, DOI 10.1021/acs.bioconjchem.0c00064; Azuma Y, 2018, ANGEW CHEM INT EDIT, V57, P12771, DOI 10.1002/anie.201807534; Baxter AA, 2017, CELL MOL LIFE SCI, V74, P3809, DOI 10.1007/s00018-017-2604-z; Bolognesi A, 1996, INT J CANCER, V68, P349, DOI 10.1002/(SICI)1097-0215(19961104)68:3<349::AID-IJC13>3.0.CO;2-3; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Castelletto V, 2018, BIOMACROMOLECULES, V19, P2782, DOI 10.1021/acs.biomac.8b00391; Chang KH, 2006, CHEM COMMUN, P629, DOI 10.1039/b514915k; Chen CX, 2020, LANGMUIR, V36, P9800, DOI 10.1021/acs.langmuir.0c01311; Chen XL, 2020, J MED CHEM, V63, P1132, DOI 10.1021/acs.jmedchem.9b01458; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Dixon JE, 2016, P NATL ACAD SCI USA, V113, pE291, DOI 10.1073/pnas.1518634113; Epand RM, 2011, J PEPT SCI, V17, P298, DOI 10.1002/psc.1319; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Futaki S, 2017, ACCOUNTS CHEM RES, V50, P2449, DOI 10.1021/acs.accounts.7b00221; Guha S, 2019, CHEM REV, V119, P6040, DOI 10.1021/acs.chemrev.8b00520; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951; Han YY, 2013, BIOCHEM PHARMACOL, V86, P1254, DOI 10.1016/j.bcp.2013.08.008; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Hovakeemian SG, 2015, SOFT MATTER, V11, P6840, DOI 10.1039/c5sm01521a; Hyun S, 2014, BIOMACROMOLECULES, V15, P3746, DOI 10.1021/bm501026e; Ishikawa K, 2017, CELL CHEM BIOL, V24, P149, DOI 10.1016/j.chembiol.2016.12.009; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Ji SS, 2020, CHEM SCI, V11, P9126, DOI 10.1039/d0sc03975f; Khan MM, 2021, J CONTROL RELEASE, V330, P1220, DOI 10.1016/j.jconrel.2020.11.028; Khara JS, 2017, ACTA BIOMATER, V57, P103, DOI 10.1016/j.actbio.2017.04.032; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Komin A, 2017, ADV DRUG DELIVER REV, V110, P52, DOI 10.1016/j.addr.2016.06.002; Liu XL, 2016, J MED CHEM, V59, P5238, DOI 10.1021/acs.jmedchem.5b02016; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Midoux P, 1998, BIOCONJUGATE CHEM, V9, P260, DOI 10.1021/bc9701611; Mookherjee N, 2020, NAT REV DRUG DISCOV, V19, P311, DOI 10.1038/s41573-019-0058-8; Moon SC, 2016, BIOCHEM BIOPH RES CO, V476, P159, DOI 10.1016/j.bbrc.2016.05.020; Najjar K, 2017, BIOCONJUGATE CHEM, V28, P2932, DOI 10.1021/acs.bioconjchem.7b00560; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nielsen SL, 2007, PROTEIN SCI, V16, P1969, DOI 10.1110/ps.072966007; Nomura Y, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127362; Qiu YS, 2017, MOL PHARMACEUT, V14, P4606, DOI 10.1021/acs.molpharmaceut.7b00725; Ramsey JD, 2015, PHARMACOL THERAPEUT, V154, P78, DOI 10.1016/j.pharmthera.2015.07.003; Rillahan CD, 2012, NAT CHEM BIOL, V8, P661, DOI [10.1038/NCHEMBIO.999, 10.1038/nchembio.999]; Sanchez-Navarro M, 2021, ADV DRUG DELIVER REV, V171, P187, DOI 10.1016/j.addr.2021.02.003; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Sinthuvanich C, 2012, J AM CHEM SOC, V134, P6210, DOI 10.1021/ja210569f; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; SUBBARAO NK, 1987, BIOCHEMISTRY-US, V26, P2964, DOI 10.1021/bi00385a002; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang J, 2016, CHEM SOC REV, V45, P5589, DOI 10.1039/c6cs00176a; Wang LB, 2016, BBA-PROTEINS PROTEOM, V1864, P143, DOI 10.1016/j.bbapap.2015.07.007; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Wolf J, 2017, BIOPHYS J, V113, P1290, DOI 10.1016/j.bpj.2017.06.053; Wreden CC, 2005, J BIOL CHEM, V280, P1408, DOI 10.1074/jbc.M411295200; Yans LZ, 1998, J BIOL CHEM, V273, P2059, DOI 10.1074/jbc.273.4.2059; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	1	1	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101364	10.1016/j.jbc.2021.101364	http://dx.doi.org/10.1016/j.jbc.2021.101364			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34736897	gold, Green Published			2022-12-26	WOS:000765319800001
J	Moss, DL; Rappaport, J				Moss, Daniel L.; Rappaport, Jay			SARS-CoV-2 beta variant substitutions alter spike glycoprotein receptor binding domain structure and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMICS; EVASION	The emergence of severe acute respiratory syndrome-related pandemic have visited a terrible cost on the world in the forms of disease, death, and economic turmoil. The rapid development and deployment of extremely effective vaccines against SARS-CoV-2 have seemingly brought within reach the end of the pandemic. However, the virus has acquired mutations. and emerging variants of concern are more infectious and reduce the efficacy of existing vaccines. Although promising efforts to combat these variants are underway, the evolutionary pressures leading to these variants are poorly understood. To that end, here we have studied the effects on the structure and function of the SARS-CoV-2 spike glycoprotein receptor-binding domain of three amino-acid substitutions found in several variants of concern, including alpha (B.1.1.7), beta (B.1.351), and gamma (P.1). We found that these substitutions alter the receptor-binding domain structure, stability, and ability to bind to angiotensin converting enzyme 2, in such a way as to possibly have opposing and compensatory effects. These findings provide new insights into how these variants of concern may have been selected for infectivity while maintaining the structure and stability of the receptor binding domain.	[Moss, Daniel L.; Rappaport, Jay] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA; [Rappaport, Jay] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Moss, DL (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.	dmoss2@tulane.edu		Moss, Daniel/0000-0001-7639-7276; Rappaport, Jay/0000-0001-7916-3571				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahmed W., 2021, STABLE INTERACTION U, DOI [10.1101/2021.01.07.425307, DOI 10.1101/2021.01.07.425307]; Ali Fedaa, 2021, Med Drug Discov, V10, P100086, DOI 10.1016/j.medidd.2021.100086; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Feehana J, 2021, MATURITAS, V149, P56, DOI 10.1016/j.maturitas.2021.02.001; Frampton D, 2021, LANCET INFECT DIS, V21, P1246, DOI 10.1016/S1473-3099(21)00170-5; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamenik AS, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0022135; Khan A, 2021, J CELL PHYSIOL, V236, P7045, DOI 10.1002/jcp.30367; Laffeber C, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167058; Letko M., 2020, NAT MICROBIOL, V5, P562, DOI [DOI 10.1038/s41564-020-0688-y, 10.1038/s41564-020-0688-y]; Lindahl, 2021, Zenodo, DOI 10.5281/ZENODO.4420785; Luan BQ, 2022, J MED CHEM, V65, P2820, DOI 10.1021/acs.jmedchem.1c00311; Luan BQ, 2021, FEBS LETT, V595, P1454, DOI 10.1002/1873-3468.14076; Machado Y, 2016, J ALLERGY CLIN IMMUN, V137, P1525, DOI 10.1016/j.jaci.2015.09.026; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; Moss DL, 2021, BIOCHEMISTRY-US, V60, P1578, DOI 10.1021/acs.biochem.1c00095; Moss DL, 2019, J BIOL CHEM, V294, P4667, DOI 10.1074/jbc.RA118.006704; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nelson G., 2021, BIORXIV, DOI [10.1101/2021.01.13.426558, 10.1101/2021.01.13.426558v1]; Rezaei S, 2022, J BIOMOL STRUCT DYN, V40, P4662, DOI 10.1080/07391102.2020.1860829; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Tian F., 2021, MUTATION N501Y RBD S, DOI [10.1101/2021.02.14.431117, DOI 10.1101/2021.02.14.431117]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang W. B., 2021, J MOL GRAPH MODEL, DOI [10.1101/2021.02.17.431566, DOI 10.1016/J.JMGM.2021.108035]; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; West Anthony P Jr, 2021, bioRxiv, DOI [10.1038/s41467-021-25168-4, 10.1101/2021.02.14.431043]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Yang ZY, 2005, P NATL ACAD SCI USA, V102, P797, DOI 10.1073/pnas.0409065102; Yesudhas D, 2021, PROTEINS, V89, P1158, DOI 10.1002/prot.26088; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037	39	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2021	297	6							101371	10.1016/j.jbc.2021.101371	http://dx.doi.org/10.1016/j.jbc.2021.101371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ZN8ZV	34756892	Green Published, gold			2022-12-26	WOS:000765319800012
J	Al-Amer, OM; Oyouni, AAA; Alshehri, MA; Alasmari, A; Alzahrani, OR; Aljohani, SAS; Alasmael, N; Theyab, A; Algahtani, M; Al Sadoun, H; Alsharif, KF; Hamad, A; Abdali, WA; Hawasawi, YM				Al-Amer, Osama M.; Oyouni, Atif Abdulwahab A.; Alshehri, Mohammed Ali; Alasmari, Abdulrahman; Alzahrani, Othman R.; Aljohani, Saad Ali S.; Alasmael, Noura; Theyab, Abdulrahman; Algahtani, Mohammad; Al Sadoun, Hadeel; Alsharif, Khalaf F.; Hamad, Abdullah; Abdali, Wed A.; Hawasawi, Yousef MohammedRabaa			Association of SNPs within TMPRSS6 and BMP2 genes with iron deficiency status in Saudi Arabia	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; BONE MORPHOGENETIC PROTEIN; ANEMIA; PREVALENCE; HEPCIDIN; MUTATIONS; SUSCEPTIBILITY; VARIANTS; INCOME	Background Globally, iron-deficiency anemia (IDA) remains a major health obstacle. This health condition has been identified in 47% of pre-school students (aged 0 to 5 years), 42% of pregnant females, and 30% of non-pregnant females (aged 15 to 50 years) worldwide according to the WHO. Environmental and genetic factors play a crucial role in the development of IDA; genetic testing has revealed the association of a number of polymorphisms with iron status and serum ferritin. Aim The current study aims to reveal the association of TMPRSS6 rs141312 and BMP2 rs235756 with the iron status of females in Saudi Arabia. Methods A cohort of 108 female university students aged 18-25 years was randomly selected to participate: 50 healthy and 58 classified as iron deficient. A 3-5 mL sample of blood was collected from each one and analyzed based on hematological and biochemical iron status followed by genotyping by PCR. Results The genotype distribution of TMPRSS6 rs141312 was 8% (TT), 88% (TC) and 4% (CC) in the healthy group compared with 3.45% (TT), 89.66% (TC) and 6.89% (CC) in the iron-deficient group (P = 0.492), an insignificant difference in the allelic distribution. The genotype distribution of BMP2 rs235756 was 8% (TT), 90% (TC) and 2% (CC) in the healthy group compared with 3.45% (TT), 82.76% (TC) and 13.79% (CC) in iron-deficient group (P = 0.050) and was significantly associated with decreased ferritin status (P = 0.050). In addition, TMPRSS6 rs141312 is significantly (P<0.001) associated with dominant genotypes (TC+CC) and increased risk of IDA while BMP2 rs235756 is significantly (P<0.026) associated with recessive homozygote CC genotypes and increased risk of IDA. Conclusion Our finding potentially helps in the early prediction of iron deficiency in females through the genetic testing.	[Al-Amer, Osama M.; Hamad, Abdullah] Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk, Saudi Arabia; [Al-Amer, Osama M.; Oyouni, Atif Abdulwahab A.; Alshehri, Mohammed Ali; Alasmari, Abdulrahman; Alzahrani, Othman R.] Univ Tabuk, Fac Sci, Genome & Biotechnol Unit, Tabuk, Saudi Arabia; [Oyouni, Atif Abdulwahab A.; Alshehri, Mohammed Ali; Alasmari, Abdulrahman; Alzahrani, Othman R.] Univ Tabuk, Fac Sci, Dept Biol, Tabuk, Saudi Arabia; [Aljohani, Saad Ali S.] Alrayan Coll, Fac Med, Dept Basic Med Sci, Al Munawarrah, Saudi Arabia; [Alasmael, Noura] King Abdullah Univ Sci & Technol, Thuwal, Saudi Arabia; [Theyab, Abdulrahman; Algahtani, Mohammad] Secur Forces Hosp, Dept Lab Med, Mecca, Saudi Arabia; [Al Sadoun, Hadeel] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Technol, Jeddah, Saudi Arabia; [Alsharif, Khalaf F.] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, At Taif, Saudi Arabia; [Abdali, Wed A.; Hawasawi, Yousef MohammedRabaa] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Jeddah, Saudi Arabia; [Hawasawi, Yousef MohammedRabaa] Al Faisal Univ, Coll Med, Riyadh, Saudi Arabia	University of Tabuk; University of Tabuk; University of Tabuk; King Abdullah University of Science & Technology; Security Forces Hospital - Saudi Arabia; King Abdulaziz University; Taif University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Al-Amer, OM (corresponding author), Univ Tabuk, Fac Appl Med Sci, Dept Med Lab Technol, Tabuk, Saudi Arabia.; Al-Amer, OM (corresponding author), Univ Tabuk, Fac Sci, Genome & Biotechnol Unit, Tabuk, Saudi Arabia.; Hawasawi, YM (corresponding author), King Faisal Specialist Hosp & Res Ctr, Res Ctr, Jeddah, Saudi Arabia.; Hawasawi, YM (corresponding author), Al Faisal Univ, Coll Med, Riyadh, Saudi Arabia.	oalamer@ut.edu.sa; hyousef@kfshrc.edu.sa	Alshehri, Mohammed/GQH-3567-2022; Oyouni, Atif Abdulwahab A./GSE-1275-2022; Alsadoun, Hadeel/GQI-4184-2022; Theyab, Abdulrahman/CAH-4618-2022; Alshehri, Mohammed/AGO-9872-2022; Theyab, Abdulrahman/GRR-7809-2022; Hawsawi, Yousef/K-8070-2019; Al-Amer, Osama M./ABB-5368-2020	Oyouni, Atif Abdulwahab A./0000-0001-8762-4999; Theyab, Abdulrahman/0000-0002-6152-7709; Hawsawi, Yousef/0000-0003-1901-697X; Alshehri, Mohammed Ali/0000-0002-0188-1634	University of Tabuk, Tabuk [S-1441-0080]; Taif University, Saudi Arabia [TURSP-2020/153]	University of Tabuk, Tabuk; Taif University, Saudi Arabia	This project was supported by the Deanship of Scientific Research (DSR), University of Tabuk, Tabuk, under grant No. (S-1441-0080). This work was also supported by Taif University Researchers Supporting Program (project number: TURSP-2020/153), Taif University, Saudi Arabia.	Al Hassan Nora Nasir, 2015, J Microsc Ultrastruct, V3, P25, DOI 10.1016/j.jmau.2014.11.003; Al Hawsawi ZM, 2015, SAUDI MED J, V36, P1067, DOI 10.15537/smj.2015.9.11844; Al Sulayyim HJ, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1704-3; Al-Amer O, 2020, GENE, V751, DOI 10.1016/j.gene.2020.144767; Alquaiz AM, 2015, PUBLIC HEALTH NUTR, V18, P3192, DOI 10.1017/S1368980015001214; AlSheikh MH, 2018, PREVALENCE, V7, P148; Alsohime F, 2021, J CLIN IMMUNOL, V41, P217, DOI 10.1007/s10875-020-00870-y; Alzaheb RA, 2017, CLIN MED INSIGHTS-WO, V10, DOI 10.1177/1179562X17745088; Alzahrani FA, 2021, MOL GENET GENOM MED, V9, DOI 10.1002/mgg3.1707; Alzahrani FA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69033-8; An P, 2012, HUM MOL GENET, V21, P2124, DOI 10.1093/hmg/dds028; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Cau M, 2010, EXPERT REV HEMATOL, V3, P205, DOI 10.1586/EHM.10.2; El Fakih R, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7010004; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2009, SEMIN HEMATOL, V46, P378, DOI 10.1053/j.seminhematol.2009.06.006; Gichohi-Wainaina W.N., 2015, GENES NUTR, V10; Gupta AK, 2004, J CUTAN MED SURG, V8, P338, DOI 10.1007/s10227-005-0023-5; Hawsawi Y, 2016, ONCOTARGET, V7, P32129, DOI 10.18632/oncotarget.8534; Hawsawi Y, 2013, BBA-REV CANCER, V1836, P345, DOI 10.1016/j.bbcan.2013.10.005; Hawsawi YM, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.879; Hawsawi YM, 2020, J BIOL RES-THESSALON, V27, DOI 10.1186/s40709-020-00128-z; Jordan VC, 2016, DISCOV MED, V21, P411; Kotb A, 2018, EXP HEMATOL, V67, P1, DOI 10.1016/j.exphem.2018.07.007; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Maximov PY, 2020, MOL PHARMACOL, V98, P24, DOI 10.1124/mol.120.119776; McLaren CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038339; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milet J, 2007, AM J HUM GENET, V81, P799, DOI 10.1086/520001; Milet J, 2010, BLOOD CELL MOL DIS, V44, P34, DOI 10.1016/j.bcmd.2009.10.001; Moyo VM, 1998, BLOOD, V91, P1076; Musaiger Abdulrahman O., 2002, Nutrition and Health (Bicester), V16, P161; Pasricha SR, 2013, BLOOD, V121, P2607, DOI 10.1182/blood-2012-09-453522; Pei SN, 2014, INT J MED SCI, V11, P614, DOI 10.7150/ijms.8582; Semlali A, 2018, ONCOTARGETS THER, V11, P8127, DOI 10.2147/OTT.S168478; Semlali A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203376; Shill KB, 2014, J HEALTH POPUL NUTR, V32, P103; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Simetic L, 2016, BIOCHEM MEDICA, V26, P34, DOI 10.11613/BM.2016.003; TABAS JA, 1991, GENOMICS, V9, P283, DOI 10.1016/0888-7543(91)90254-C; Timmer T, 2019, MUTAT RES-REV MUTAT, V779, P58, DOI 10.1016/j.mrrev.2019.01.002; Wang CY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00114; World Health Organisation, 2001, GUIDE PROGRAMME MANA; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012	45	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0257895	10.1371/journal.pone.0257895	http://dx.doi.org/10.1371/journal.pone.0257895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780475	Green Published, gold			2022-12-26	WOS:000755305800011
J	El-Zamkan, MA; Mohamed, HMA				El-Zamkan, Mona A.; Mohamed, Hams M. A.			Antimicrobial resistance, virulence genes and biofilm formation in Enterococcus species isolated from milk of sheep and goat with subclinical mastitis	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SURFACE PROTEIN; STAPHYLOCOCCUS-AUREUS; FERMENTED MEAT; FAECALIS; ESP; SAMPLES; SPP.; RAW; DAIRY	This study is designed to discuss the antimicrobial resistance, virulence determinants and biofilm formation capacity of Enterococcus spp. isolated from milk of sheep and goat with subclinical mastitis in Qena, Egypt. The obtained isolates were identified by the VITEK2 system and 16S rDNA sequencing as E. faecalis, E. faecium, E. casseliflavus and E. hirae. Overall, E. faecalis and E. faecium were the dominant species recovered from mastitic milk samples. The antimicrobial susceptibility test evidenced multidrug resistance of the isolates against the following antimicrobials: oxacillin (89.2.%), followed by vancomycin (75.7%) and linezolid (70.3%). Also, most of these isolates (73%) could form biofilms. For example, 18.9% of Enterococcus strains formed strong biofilm, whereas 32.4% of isolates formed moderate biofilm and 21.6% of isolates formed weak biofilm. The most prevalent resistance genes found in our isolates were blaZ (54%), vanA (40%), ermB (51.4%), tetM (13.5%) and optrA (10.8%). Moreover, asa1 (37.8%), cylA (42.3%), gelE (78.4%), esp (32.4%), EF3314 (48.6%) and ace (75.5%) were the most common virulence genes. A significant correlation was found between biofilm formation, multidrug resistance and virulence genes of the isolates. This study highlights several aspects of virulence and harmfulness of Enterococcus strains isolated from subclinical mastitic milk, which necessitates continuous inspection and monitoring of dairy animals.	[El-Zamkan, Mona A.] South Valley Univ, Fac Vet Med, Dept Food Hyg & Control, Qena, Egypt; [Mohamed, Hams M. A.] South Valley Univ, Fac Vet Med, Dept Microbiol, Qena, Egypt	Egyptian Knowledge Bank (EKB); South Valley University Egypt; Egyptian Knowledge Bank (EKB); South Valley University Egypt	El-Zamkan, MA (corresponding author), South Valley Univ, Fac Vet Med, Dept Food Hyg & Control, Qena, Egypt.	m_zam@vet.svu.edu.eg	Mohamed, Hams M.A./AAC-6104-2022; El-Zamkan, Mona Ahmed/AAA-5698-2022	El-Zamkan, Mona Ahmed/0000-0002-7155-3732; Mohamed Ahmed Mohamed Elhsany, Hams/0000-0002-0650-204X				Abdeltawab AA., 2019, NATURE SCI, V17; Abed AH, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9061175; Ahmed W, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10020097; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atulya M, 2014, RES VET SCI, V96, P25, DOI 10.1016/j.rvsc.2013.12.001; Berg C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3933; Bialvaei AZ, 2017, J ANTIMICROB CHEMOTH, V72, P354, DOI 10.1093/jac/dkw450; Bosshard PP, 2006, J CLIN MICROBIOL, V44, P1359, DOI 10.1128/JCM.44.4.1359-1366.2006; Bourabah A., 2013, Global Veterinaria, V11, P604; Cameron M, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00079; Cariolato D, 2008, FOOD CONTROL, V19, P886, DOI 10.1016/j.foodcont.2007.08.019; CDC, 2019, ANT RES THREAT US CD, P2019, DOI DOI 10.15620/CDC:82532; Ch'ng JH, 2019, NAT REV MICROBIOL, V17, P82, DOI 10.1038/s41579-018-0107-z; Cha E, 2014, J DAIRY SCI, V97, P2101, DOI 10.3168/jds.2013-7067; Chajecka-Wierzchowska W., 2017, FOODBORNE PATHOG DIS, P349, DOI [10.1002/9781119139188.ch15, DOI 10.1002/9781119139188.CH15]; Citak S, 2006, MILCHWISSENSCHAFT, V61, P150; Clinical and Laboratory Standards Institute (CLSI), 2022, PERFORMANCE STANDARD, V32nd; Cobirka M, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10122212; Cortes C, 2006, INT J FOOD MICROBIOL, V110, P100, DOI 10.1016/j.ijfoodmicro.2006.01.033; Creti R, 2004, J MED MICROBIOL, V53, P13, DOI 10.1099/jmm.0.05353-0; Creti R, 2009, INT J ARTIF ORGANS, V32, P611, DOI 10.1177/039139880903200910; Cui PF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01250; Dale JL, 2015, ANTIMICROB AGENTS CH, V59, P4094, DOI 10.1128/AAC.00344-15; Di Rosa R, 2006, FEMS MICROBIOL LETT, V256, P145, DOI 10.1111/j.1574-6968.2006.00112.x; Domig KJ, 2003, INT J FOOD MICROBIOL, V88, P147, DOI 10.1016/S0168-1605(03)00177-6; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duez C, 2004, J BACTERIOL, V186, P4412, DOI 10.1128/JB.186.13.4412-4416.2004; Elhadidy M, 2014, LETT APPL MICROBIOL, V58, P248, DOI 10.1111/lam.12184; Elhadidy M, 2013, J MICROBIOL IMMUNOL, V46, P80, DOI 10.1016/j.jmii.2012.02.002; Elsayed MSA, 2019, MOL BIOL REP, V46, P6533, DOI 10.1007/s11033-019-05099-6; Erbas G, 2016, ACTA VET-BEOGRAD, V66, P336, DOI 10.1515/acve-2016-0029; Ezzat Alnakip Mohamed, 2014, J Vet Med, V2014, P659801, DOI 10.1155/2014/659801; Fernandes MD, 2017, INT DAIRY J, V72, P23, DOI 10.1016/j.idairyj.2017.03.016; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Foka FET, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5921840; Francesca N, 2013, ANN MICROBIOL, V63, P53, DOI 10.1007/s13213-012-0444-5; Franz CMAP, 1999, INT J FOOD MICROBIOL, V47, P1, DOI 10.1016/S0168-1605(99)00007-0; Franz CMAP, 2001, APPL ENVIRON MICROB, V67, P4385, DOI 10.1128/AEM.67.9.4385-4389.2001; Gaglio R, 2016, INT J FOOD MICROBIOL, V236, P107, DOI 10.1016/j.ijfoodmicro.2016.07.020; Gao X, 2019, MICROB PATHOGENESIS, V129, P82, DOI 10.1016/j.micpath.2019.01.031; Gawryszewska I, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx021; Golob M, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2815279; Hamed SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30756-4; Hammad AM, 2015, FOOD CONTROL, V50, P815, DOI 10.1016/j.foodcont.2014.10.020; Hamzah AM., 2018, J ENTOMOL ZOOL STUD, V6, P218; Hancock LE, 2004, J BACTERIOL, V186, P5629, DOI 10.1128/JB.186.17.5629-5639.2004; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; Igbinosa EO, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00728; Ikiz S, 2013, TURK J VET ANIM SCI, V37, P569, DOI 10.3906/vet-1302-63; Ispirli H, 2017, LWT-FOOD SCI TECHNOL, V75, P358, DOI 10.1016/j.lwt.2016.09.010; Jahan M, 2014, INT J FOOD MICROBIOL, V170, P65, DOI 10.1016/j.ijfoodmicro.2013.11.002; Jamet E, 2012, FOOD MICROBIOL, V31, P191, DOI 10.1016/j.fm.2012.03.009; Jimenez E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-288; Kateete DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063413; Kim J, 2012, J MICROBIOL, V50, P540, DOI 10.1007/s12275-012-1579-6; Komiyama EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163001; Kristich CJ, 2004, J BACTERIOL, V186, P154, DOI 10.1128/JB.186.1.154-163.2004; Krocko M, 2011, CZECH J FOOD SCI, V29, P654, DOI 10.17221/246/2010-CJFS; Macun HC., 2011, J FAC VET MED U ERCI, V8, P83; Medeiros AW, 2014, BRAZ J MICROBIOL, V45, P327, DOI 10.1590/S1517-83822014005000031; Moemen D, 2015, BRAZ J MICROBIOL, V46, P777, DOI 10.1590/S1517-838246320140403; Mohamed JA, 2005, J CLIN MICROBIOL, V43, P5405, DOI 10.1128/JCM.43.10.5405-5407.2005; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mohamed JA, 2006, J MED MICROBIOL, V55, P1747, DOI 10.1099/jmm.0.46729-0; Murray BE, 1998, EMERG INFECT DIS, V4, P37, DOI 10.3201/eid0401.980106; Nam HM, 2010, ZOONOSES PUBLIC HLTH, V57, pE59, DOI 10.1111/j.1863-2378.2009.01307.x; Necidova L, 2009, CZECH J FOOD SCI, V27, pS354, DOI 10.17221/1087-CJFS; Piggot AM, 2012, APPL ENVIRON MICROB, V78, P5973, DOI 10.1128/AEM.00603-12; Preethirani PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142717; Ribeiro T, 2011, J FOOD PROTECT, V74, P465, DOI 10.4315/0362-028X.JFP-10-309; Rozanska H, 2019, J VET RES, V63, P93, DOI 10.2478/jvetres-2019-0014; Valenzuela AS, 2009, FOOD CONTROL, V20, P381, DOI 10.1016/j.foodcont.2008.06.004; Sanciu G, 2013, EPIDEMIOL INFECT, V141, P582, DOI 10.1017/S0950268812000647; Sandoe JAT, 2003, J MED MICROBIOL, V52, P547, DOI 10.1099/jmm.0.05201-0; Sarathy MV., 2020, MODEL ORGANISMS MICR, P131, DOI [10.1007/978-981-15-1695-5_9, DOI 10.1007/978-981-15-1695-5_9]; Simner PJ, 2015, ANTIMICROB AGENTS CH, V59, P4315, DOI 10.1128/AAC.00384-15; Soares RO, 2014, VIRULENCE, V5, P634, DOI 10.4161/viru.28998; St Rose SG, 2003, J DAIRY RES, V70, P387, DOI 10.1017/S0022029903006460; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tendolkar PM, 2004, INFECT IMMUN, V72, P6032, DOI 10.1128/IAI.72.10.6032-6039.2004; Tenke P, 2006, WORLD J UROL, V24, P13, DOI 10.1007/s00345-005-0050-2; Teuber M, 1999, ANTON LEEUW INT J G, V76, P115, DOI 10.1023/A:1002035622988; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001; Trivedi K, 2011, VET MED-CZECH, V56, P352, DOI 10.17221/1584-VETMED; Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7; Weber M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222238; Werner G, 2011, J ANTIMICROB CHEMOTH, V66, P273, DOI 10.1093/jac/dkq455; WHO, 2017, WORLD HLTH ORG, P7, DOI DOI 10.1016/S1473-3099(09)70222-1; Wozniak-Biel A, 2019, MICROB DRUG RESIST, V25, P277, DOI 10.1089/mdr.2018.0221; Yang F, 2016, J DAIRY SCI, V99, P4300, DOI 10.3168/jds.2015-10756; Yesilmen S., 2012, DICLE U VET FAK DERG, V1, P24; Yoon S, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11030661	95	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259584	10.1371/journal.pone.0259584	http://dx.doi.org/10.1371/journal.pone.0259584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780540	gold, Green Published			2022-12-26	WOS:000755305800033
J	Gong, RG; Ye, XY; Wang, SH; Ren, ZJ				Gong, Ruiguang; Ye, Xiangyang; Wang, Shuhui; Ren, Zhanjun			Isolation, identification, and biological characteristics of Clostridium sartagoforme from rabbit	PLOS ONE			English	Article							BACTERIA; DEGRADATION; COMBINATION; ACIDITY; STRAIN	In order to develop microbial additives for rabbit feed, a spore-forming bacteria was isolated from the feces of Hyla rabbit using reinforced clostridium medium (RCM). The 16S rDNA sequence of the bacterium was subjected to pairwise sequence alignment using BLAST; the colony morphology, and physiological, biochemical, and stress resistance were studied. The results showed that the bacterium was Clostridium sartagoforme, a gram positive anaerobe, which can produce spores. The colony diameter was 0.5 mm-2.5 mm, the diameter of the bacteria was 0.5 mu m-1.0 mu m x 2.0 mu m-6.3 mu m, and the spore diameter was 1 mu m-1.2 mu m x 1 mu m-1.2 mu m. C. sartagoforme can utilize various sugars and alcohols such as fructose, galactose, sorbitol, and inositol. It secreted cellulase into the extracellular environment to form a transparent hydrolysis circle in Congo red medium, it could not liquify gelatin, and the lysine decarboxylase reaction was positive. In liquid medium it entered the stable growth period after 9 h of inoculation. Additionally, it had good stress resistance with a survival rate that exceeded 53% after gastric juice (pH 2.5) treatment for 3 h, it grew in a medium with a bile salt concentration of 0.3%, and the survival rate exceeded 85% after 10 minutes at 80 degrees C. Moreover, animal testing indicated that this strain has no adverse effects on the morbidity and mortality of rabbits. In summary, C. sartagoforme XN-T4 was isolated from rabbit feces. This bacterium has good resistance to stress, can decompose a variety of monosaccharides and polysaccharides including cellulose, which is relatively harmless for animal health.	[Gong, Ruiguang; Wang, Shuhui; Ren, Zhanjun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Ye, Xiangyang] Guangdong Acad Agr Sci, State Key Lab Livestock & Poultry Breeding, Inst Anim Sci,Key Lab Anim Nutr & Feed Sci South, Minist Agr & Rural Affairs,Guangdong Key Lab Anim, Guanghzou, Peoples R China	Northwest A&F University - China; Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Ren, ZJ (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	renzhanjun@nwafu.edu.cn			Shaanxi Province Science and Technology Project [K3310216062]; Shaanxi Province Agricultural Science and Technology Innovation and Research Project [16NY-108]; Shaanxi Province Agricultural Science and Technology Innovation Transformation Project [NYKJ-2020-YL-16]; Yangling Demonstration Zone Industry-UniversityResearch Collaborative Innovation Major Project [1017cxy-15]; Key R&D project of Shaanxi Province [2018ZDXM-NY-041]	Shaanxi Province Science and Technology Project; Shaanxi Province Agricultural Science and Technology Innovation and Research Project; Shaanxi Province Agricultural Science and Technology Innovation Transformation Project; Yangling Demonstration Zone Industry-UniversityResearch Collaborative Innovation Major Project; Key R&D project of Shaanxi Province	This study received funding from the following sources, all awarded to RZ: Shaanxi Province Science and Technology Project (K3310216062); Shaanxi Province Agricultural Science and Technology Innovation and Research Project (16NY-108); Shaanxi Province Agricultural Science and Technology Innovation Transformation Project (NYKJ-2020-YL-16); Yangling Demonstration Zone Industry-UniversityResearch Collaborative Innovation Major Project (1017cxy-15); Key R&D project of Shaanxi Province (2018ZDXM-NY-041)].	BEAUVILLE M, 1963, J PHYSIOL-PARIS, V55, P625; Bogatyrev SR, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-0785-4; Buchanan RE., 1991, BERGEYS MANUAL SYSTE, V9th; Chen JD., 2017, ANIMAL HUSBANDRY MIC, V6th; Dabrowski S, 2012, ACTA BIOCHIM POL, V59, P353; DAPAAH SY, 1992, BIOTECHNOL BIOENG, V40, P1353, DOI 10.1002/bit.260401109; Ding XS., 2012, ISOLATION IDENTIFICA; Dinsmore JE, 1997, J PEDIATR SURG, V32, P1014, DOI 10.1016/S0022-3468(97)90389-4; Gerbino A, 2004, GASTROENTEROLOGY, V126, P182, DOI 10.1053/j.gastro.2003.10.068; Ihara Y, 2013, ANIM SCI J, V84, P434, DOI 10.1111/asj.12020; Kim M, 2018, FOOD SCI NUTR, V6, P1904, DOI 10.1002/fsn3.762; King T, 2003, INT J FOOD MICROBIOL, V84, P133, DOI 10.1016/S0168-1605(02)00404-X; Larsen N, 2014, APPL MICROBIOL BIOT, V98, P1105, DOI 10.1007/s00253-013-5343-6; Liao XD., 2015, THESIS CHINA AGR U; MARTY J, 1984, BRIT J NUTR, V51, P265, DOI 10.1079/BJN19840031; Nathani NM, 2016, J APPL ANIM RES, V44, P498, DOI 10.1080/09712119.2015.1091346; Nizzy AM, 2020, CURR MICROBIOL, V77, P2544, DOI 10.1007/s00284-020-02092-2; Shcherbakova VA, 2015, APPL BIOCHEM MICRO+, V51, P209, DOI 10.1134/S0003683815020179; Shen P., 2016, MICROBIOLOGY; Simonova MP, 2020, PROBIOTICS ANTIMICRO, V12, P732, DOI 10.1007/s12602-019-09584-z; Simunek J, 2001, FOLIA MICROBIOL, V46, P76, DOI 10.1007/BF02825892; SOAVE O, 1991, CORNELL VET, V81, P357; Song AX, 2019, INT J BIOL MACROMOL, V133, P957, DOI [10.1016/j.ijbiomac.2019.04.108, 10.1016/j.ijbiomac.2019.]; Sun X., 2019, THESIS JILIN U; Wang TH, 2015, THESIS ZHEJIANG U; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Zeng C., 2016, STUDY CHARACTERISTIC; Zeng Y, 2019, ANAL BIOANAL CHEM, V411, P2161, DOI 10.1007/s00216-019-01651-2; Zhang DD, 2016, BIORESOURCE TECHNOL, V221, P686, DOI 10.1016/j.biortech.2016.09.087; Zhang JN, 2015, BIORESOURCE TECHNOL, V192, P60, DOI 10.1016/j.biortech.2015.05.034	30	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259715	10.1371/journal.pone.0259715	http://dx.doi.org/10.1371/journal.pone.0259715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780527	gold, Green Published			2022-12-26	WOS:000755305800042
J	Lindberg, M; Ranner, M; Mansson-Lexell, E; Jacobsson, L; Larsson-Lund, M				Lindberg, Monika; Ranner, Maria; Mansson-Lexell, Eva; Jacobsson, Lars; Larsson-Lund, Maria			Work and everyday life in a digitalized time: Experiences of people with subjective cognitive difficulties related to neurological disorders	PLOS ONE			English	Article							PARKINSONS-DISEASE; OBSERVED ABILITY; TECHNOLOGY; RETURN; ASSOCIATION; EMPLOYMENT; WORKPLACE; STROKE; IMPACT	Introduction Digitalization has changed working life and increased cognitive demands on employees in general. Nevertheless, the consequences for employees with cognitive impairments and subjective cognitive difficulties are to a large extent unexplored. The aim of this study was to explore and describe how employees with subjective cognitive difficulties who are performing digital work tasks experience their vocational situation and how this situation influences their everyday life. Methods A qualitative, descriptive, multiple-case study was designed. Self-reports, assessments and qualitative interviews were used to collect data from the seven participants with neurological disorders. The data were analysed using pattern matching. Findings The analysed data formed four categories conceptualized as "Working to my full potential", "Working, but it is largely up to me", "Working at the expense of everyday life" and "Working without known difficulties", and these categories included one to four subcategories. Conclusion Managing subjective cognitive difficulties in vocational situations and everyday life was challenging in a digitalized working life for participants with neurological disorders. To provide equal access to preventive measures and rehabilitation and a sustainable working life, it is important to investigate the influence of subjective cognitive difficulties systematically on work, everyday life and management strategies in people with neurological disorders in digitalized work.	[Lindberg, Monika; Ranner, Maria; Jacobsson, Lars; Larsson-Lund, Maria] Lulea Univ Technol, Dept Hlth Educ & Technol, Div Hlth Med & Rehabil, Lulea, Sweden; [Mansson-Lexell, Eva] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Mansson-Lexell, Eva] Skane Univ Hosp, Dept Neurol & Rehabil Med, Lund, Sweden	Lulea University of Technology; Lund University; Lund University; Skane University Hospital	Lindberg, M (corresponding author), Lulea Univ Technol, Dept Hlth Educ & Technol, Div Hlth Med & Rehabil, Lulea, Sweden.	monika.lindberg@ltu.se		Larsson-Lund, Maria/0000-0002-0341-6197	Neurofonden Sweden	Neurofonden Sweden	The research was founded by Neurofonden Sweden (https://neuro.se/vaartarbete/forskning/) by a grant to MLL (no grant number assigned). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson G, 2018, GRANSLOST ARBETE FOR, V2018, P1; Asaba E, 2022, SCAND J OCCUP THER, V29, P116, DOI 10.1080/11038128.2020.1829036; Ashley KD, 2019, WORKPLACE HEALTH SAF, V67, P87, DOI 10.1177/2165079918812483; Balasooriya-Smeekens C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009974; Boaz A, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0337-6; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Campbell J, 2017, POSTGRAD MED J, V93, P143, DOI 10.1136/postgradmedj-2016-134071; Colbert A, 2016, ACAD MANAGE J, V59, P731, DOI 10.5465/amj.2016.4003; Coyne Karin S, 2015, Int J MS Care, V17, P245, DOI 10.7224/1537-2073.2014-051; Edwards JD, 2018, INT J STROKE, V13, P243, DOI 10.1177/1747493017743059; Ekbladh E., 2012, INSTRUMENT WORKER RO, DOI [10.1371/journal.pone.0038021, DOI 10.1371/JOURNAL.PONE.0038021]; Ekbladh E., 2010, WEIS S VERSION 3; Ekbladh E, 2014, WORK, V47, P213, DOI 10.3233/WOR-121574; Erlandsson L-K., 2020, VALMO MODELLEN ARBET; Forsyth Kirsty, 2006, Work, V27, P313; Franssila H, 2016, ERGONOMICS, V59, P435, DOI 10.1080/00140139.2015.1073795; Gillberg N, 2018, NYA SATT ATT ORGANIS, V2018, P2; Gulliksen J., 2015, DIGITAL ARBETSMILJO, V17, DOI [10.1080/10640266.2014.981429, DOI 10.1080/10640266.2014.981429]; Guzik A, 2020, WORK, V65, P447, DOI 10.3233/WOR-203097; Hellmann-Regen J, 2013, EUR ARCH PSY CLIN N, V263, pS123, DOI 10.1007/s00406-013-0448-6; Hertel PT, 2000, PSYCHOL LEARN MOTIV, V39, P47, DOI 10.1016/S0079-7421(00)80030-4; Holloway I., 2017, QUALITATIVE RES NURS, V4th; Ilmarinen J, 2009, SCAND J WORK ENV HEA, V35, P1; Jahkola, 1998, WORK ABILITY INDEX; Johansson L., 2013, INT J PHYS MED REHAB, V2; Karlsson T., 2014, HJARNVANLIGA ARBETSP, V2; Kielhofner G., 2007, MODEL HUMAN OCCUPATI, V4th; Kjeldsen PL, 2019, ACTA NEUROL SCAND, V140, P375, DOI 10.1111/ane.13158; Koerts J, 2016, PARKINSONISM RELAT D, V27, P9, DOI 10.1016/j.parkreldis.2016.03.017; Kvale S., 2014, KVALITATIVA FORSKNIN; Larsson-Lund M, 2017, SCAND J OCCUP THER, V24, P281, DOI 10.1080/11038128.2016.1194466; Lederer V, 2014, J OCCUP REHABIL, V24, P242, DOI 10.1007/s10926-013-9459-4; Lindgren I, 2022, DISABIL REHABIL, V44, P2500, DOI 10.1080/09638288.2020.1836522; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lund ML, 2012, SCAND J OCCUP THER, V19, P164, DOI 10.3109/11038128.2011.582651; Malinowsky C, 2014, SCAND J OCCUP THER, V21, P465, DOI 10.3109/11038128.2014.919020; Meyer S., 2018, INT J ENV RES PUB HE, V15; Mullin RL, 2018, DISABIL REHABIL, V40, P2032, DOI 10.1080/09638288.2017.1323237; Murphy R, 2013, IRISH J MED SCI, V182, P415, DOI 10.1007/s11845-013-0902-5; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nybergh L, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10045-4; Nygard L, 2022, SCAND J OCCUP THER, V29, P139, DOI 10.1080/11038128.2021.1925740; Palstam A, 2019, ACTA NEUROL SCAND, V139, P382, DOI 10.1111/ane.13067; Raggi A, 2016, DISABIL REHABIL, V38, P936, DOI 10.3109/09638288.2015.1070295; Sandblad B., 2018, DIGITALISERINGEN ARB, V1st ed; Sellberg C, 2014, COGN TECHNOL WORK, V16, P187, DOI 10.1007/s10111-013-0256-9; Stadin M, 2021, COMPUT HUM BEHAV, V114, DOI 10.1016/j.chb.2020.106486; Swedish government, 2021, GOD ARBETSMILJO FRAM; Tarafdar M., 2005, EXPLORING IMPACT TEC; Tengland PA, 2011, J OCCUP REHABIL, V21, P275, DOI 10.1007/s10926-010-9269-x; van der Kemp J, 2019, NEUROPSYCHOL REHABIL, V29, P638, DOI 10.1080/09602011.2017.1313746; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Wagman P, 2014, SCAND J OCCUP THER, V21, P227, DOI 10.3109/11038128.2014.900571; Wickstrom A, 2017, MULT SCLER J, V23, P1137, DOI 10.1177/1352458516671818; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed	55	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0260013	10.1371/journal.pone.0260013	http://dx.doi.org/10.1371/journal.pone.0260013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780560	Green Published, gold			2022-12-26	WOS:000755305800084
J	Sinclair, DR; Maharani, A; Stow, D; Welsh, CE; Matthews, FE				Sinclair, David R.; Maharani, Asri; Stow, Daniel; Welsh, Claire E.; Matthews, Fiona E.			Can vaccination roll-out be more equitable if population risk is taken into account?	PLOS ONE			English	Article							OLDER-ADULTS; FRAILTY; COVID-19; MULTICENTER; ASSOCIATION; MORTALITY	Background COVID-19 vaccination in many countries, including England, has been prioritised primarily by age. However, people of the same age can have very different health statuses. Frailty is a commonly used metric of health and has been found to be more strongly associated with mortality than age among COVID-19 inpatients. Methods We compared the number of first vaccine doses administered across the 135 NHS Clinical Commissioning Groups (CCGs) of England to both the over 50 population and the estimated frail population in each area. Area-based frailty estimates were generated using the English Longitudinal Survey of Ageing (ELSA), a national survey of older people. We also compared the number of doses to the number of people with other risk factors associated with COVID-19: atrial fibrillation, chronic kidney disease, diabetes, learning disabilities, obesity and smoking status. Results We estimate that after 79 days of the vaccine program, across all Clinical Commissioning Group areas, the number of people who received a first vaccine per frail person ranged from 4.4 (95% CI 4.0-4.8) and 20.1 (95% CI 18.3-21.9). The prevalences of other risk factors were also poorly associated with the prevalence of vaccination across England. Conclusions Vaccination with age-based priority created area-based inequities in the number of doses administered relative to the number of people who are frail or have other risk factors associated with COVID-19. As frailty has previously been found to be more strongly associated with mortality than age for COVID-19 inpatients, an age-based priority system may increase the risk of mortality in some areas during the vaccine roll-out period. Authorities planning COVID-19 vaccination programmes should consider the disadvantages of an age-based priority system.	[Sinclair, David R.; Stow, Daniel; Welsh, Claire E.; Matthews, Fiona E.] Newcastle Univ, Populat Hlth Sci Inst, Biomed Res Bldg,Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Maharani, Asri] Univ Manchester, Div Nursing Midwifery & Social Work, Manchester, Lancs, England	Newcastle University - UK; University of Manchester	Sinclair, DR (corresponding author), Newcastle Univ, Populat Hlth Sci Inst, Biomed Res Bldg,Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.	David.R.Sinclair@newcastle.ac.uk	Welsh, Claire E/AAB-3743-2019; Maharani, Asri/U-7663-2017	Welsh, Claire E/0000-0001-9477-0775; Maharani, Asri/0000-0002-5931-8692; Sinclair, David/0000-0002-3468-7475; Stow, Daniel/0000-0002-9534-4521	National Institute for Health Research Policy Research Unit in Older People and Frailty [PRPRU-1217-21502]; Integrated Covid Hub North East; NIHR School for Primary Care Research [SPCR-PDF-2020-161]	National Institute for Health Research Policy Research Unit in Older People and Frailty; Integrated Covid Hub North East; NIHR School for Primary Care Research	DSi, AM CW and FM are funded by the National Institute for Health Research Policy Research Unit in Older People and Frailty (PRPRU-1217-21502). DSi, CW and FM are also funded by the Integrated Covid Hub North East. DSt is funded by NIHR School for Primary Care Research (SPCR-PDF-2020-161). The views expressed are those of the author(s) and not necessarily those of of the NIHR, the Department of Health and Social Care, or the Integrated Covid Hub North East.	Abell J., 2018, DYNAMICS AGEING EVID; Ainslie D, 2021, CORONAVIRUS VACCINE; Alsahab M, 2021, AGE AGEING, V50, P617, DOI 10.1093/ageing/afab026; Andrew MK, 2017, J INFECT DIS, V216, P405, DOI 10.1093/infdis/jix282; [Anonymous], 2020, HOSP START BIGGEST E; Aw D, 2020, AGE AGEING, V49, P915, DOI 10.1093/ageing/afaa184; Bandeen-Roche K, 2015, J GERONTOL A-BIOL, V70, P1427, DOI 10.1093/gerona/glv133; Brunner EJ, 2018, LANCET PUBLIC HEALTH, V3, pE313, DOI 10.1016/S2468-2667(18)30079-3; Cabinet Office, COVID 19 RESP SPRING; Centers for Disease Control and Prevention, CDCS COVID 19 VACC R; Chinnadurai R, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01803-5; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Curran D, 2021, J AM GERIATR SOC, V69, P744, DOI 10.1111/jgs.16917; European Centre for Disease Prevention and Control, OV IMPL COVID 19 VAC; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hancock M, STAT VACC PROGR NEW; Hewitt J, 2020, LANCET PUBLIC HEALTH, V5, pE444, DOI 10.1016/S2468-2667(20)30146-8; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; McLennan D., 2019, ENGLISH INDICES DEPR; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski A, 2017, J GERONTOL A-BIOL, V72, P877, DOI 10.1093/gerona/glw089; NHS England, NHS ENGL INV EV AG 5; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Petermann-Rocha F, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01822-4; Ramsay M, 2021, IMMUNISATION INFECT, P12; Ramsay M, IMMUNISATION INFECT; Ridda I, 2009, VACCINE, V27, P1628, DOI 10.1016/j.vaccine.2008.11.098; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sablerolles RSG, 2021, LANCET HEALTH LONGEV, V2, pE163, DOI 10.1016/S2666-7568(21)00006-4; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Taylor D, 2019, EXP GERONTOL, V123, P57, DOI 10.1016/j.exger.2019.05.010; Wade KF, 2017, J GERONTOL A-BIOL, V72, P403, DOI 10.1093/gerona/glw226; West D., 2021, HEALTH SERV J; Wu CK, 2018, J GERONTOL A-BIOL, V73, P102, DOI 10.1093/gerona/glx098; Zhang Yanjie, 2021, Glob Health J, V5, P51, DOI 10.1016/j.glohj.2021.02.005	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259990	10.1371/journal.pone.0259990	http://dx.doi.org/10.1371/journal.pone.0259990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ2IU	34780553	gold, Green Published			2022-12-26	WOS:000755305800080
J	Yang, HS; Choi, YJ; Han, HY; Kim, HS; Park, SH; Lee, KS; Lim, SH; Heo, DJ; Choi, S				Yang, Hyun Seung; Choi, Young Je; Han, Hee Yong; Kim, Hak Su; Park, So Hyun; Lee, Kyung Sub; Lim, Sang Hwa; Heo, Doo Jin; Choi, Sangkyung			Serum and aqueous humor adiponectin levels correlate with diabetic retinopathy development and progression	PLOS ONE			English	Article							OBESITY; MELLITUS; RATIO	Purpose To compare adiponectin (APN) levels in the serum and aqueous humor (AH) and evaluate their association with the development/progression of diabetic retinopathy (DR). Methods Diabetic patients with (group 3; n = 59) and without (group 2; n = 39) DR and age- and sexmatched normal subjects (group 1; n = 35) were compared. Duration of diabetes, body mass index, serum HbA1c, vascular endothelial growth factor (VEGF), APN, pentraxin 3 (PTX3), platelet derived growth factor (PDGF), intercellular adhesion molecule-1 (ICAM-1), and APN were measured and analyzed. Results One hundred and thirty-three participants were included. Compared to patients without diabetes, diabetic patients with DR had significantly elevated average serum APN levels (5.99 +/- 3.89 mu g/ ml versus 3.51 +/- 1.44 mu g/ ml, P = 0.002) and average AH APN levels (10.94 +/- 11.74 ng/ml versus 3.65 +/- 3.33 ng/ml, P< 0.001). Serum APN was significantly correlated with AH APN (R = 0.512, P< 0.001) and AH VEGF (R = 0.202, P = 0.020). The log serum APN was significantly correlated with intraocular cytokines, including log APN, log VEGF, log ICAM, log leptin, log PTX3, log PDGF, angiopoietin, C-reactive protein, and interleukins (IL)-5 and IL-10 (P< 0.001, P = 0.020, P< 0.001, P< 0.001, P = 0.001, P< 0.001, P = 0.008, P = 0.009, P< 0.001, and P = 0.046, respectively). Log serum VEGF showed a significant correlation only with log AH VEGF (P = 0.001). Multivariate logistic analysis was performed to evaluate the association of DR progression and cytokine concentrations; log Serum APN and log AH APN showed good correlation with the DR progression in each model. Conclusions AH APN levels correlated well with DR development and progression. Serum APN could be a better marker for estimating intraocular cytokines, including both intraocular APN and VEGF concentrations in clinical field, than serum VEGF in DR patients.	[Yang, Hyun Seung] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Yang, Hyun Seung; Lee, Kyung Sub; Lim, Sang Hwa; Heo, Doo Jin] Seoul Shinsegae Eye Ctr, Dept Ophthalmol, Eui Jung Bu, Gyeonggi Do, South Korea; [Choi, Young Je; Han, Hee Yong; Choi, Sangkyung] Vet Hlth Serv Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Kim, Hak Su] Vet Hlth Serv Med Ctr, Vet Med Res Inst, Seoul, South Korea; [Park, So Hyun] Seoul Chuk Hosp, Dept Endocrinol, Eui Jung Bu, Gyeonggi Do, South Korea	Seoul National University (SNU); Veterans Health Service Medical Center; Veterans Health Service Medical Center	Choi, S (corresponding author), Vet Hlth Serv Med Ctr, Dept Ophthalmol, Seoul, South Korea.	pfskchoi@gmail.com	Yang, Hyun Seung/GRS-1440-2022; Yang, Hyun Seung/AAC-4319-2020	Yang, Hyun Seung/0000-0002-0470-676X	Veterans Health Service Medical Center Research Grant, Republic of Korea [VHSMC20029]	Veterans Health Service Medical Center Research Grant, Republic of Korea	This study was supported by a Veterans Health Service Medical Center Research Grant, Republic of Korea (grant VHSMC20029). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Behre CJ, 2007, SCAND J CLIN LAB INV, V67, P449, DOI 10.1080/00365510601158717; Bondor CI, 2015, INT UROL NEPHROL, V47, P1173, DOI 10.1007/s11255-015-1004-2; Bresnick G H, 1988, J Diabet Complications, V2, P105, DOI 10.1016/S0891-6632(88)80017-5; Chakraborti CK, 2015, WORLD J DIABETES, V6, P1296, DOI 10.4239/wjd.v6.i15.1296; Davis SK, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0005-5; Ebrahimi-Mamaeghani M, 2015, VASC HEALTH RISK MAN, V11, P55, DOI 10.2147/VHRM.S48753; Engin A, 2017, ADV EXP MED BIOL, V960, P415, DOI 10.1007/978-3-319-48382-5_18; Fang H, 2018, COMPR PHYSIOL, V8, P1031, DOI 10.1002/cphy.c170046; Fu ZF, 2016, BBA-MOL BASIS DIS, V1862, P1392, DOI 10.1016/j.bbadis.2016.05.002; Hadjadj S, 2005, DIABETOLOGIA, V48, P1088, DOI 10.1007/s00125-005-1747-x; Huang YC, 2021, GENES-BASEL, V12, DOI 10.3390/genes12010017; Jung CH, 2014, J DIABETES INVEST, V5, P333, DOI 10.1111/jdi.12144; Kadowaki T, 2014, LANCET DIABETES ENDO, V2, P8, DOI 10.1016/S2213-8587(13)70120-7; Kato K, 2008, CLIN ENDOCRINOL, V68, P442, DOI 10.1111/j.1365-2265.2007.03063.x; Khalfaoui T, 2009, PATHOL BIOL, V57, P513, DOI 10.1016/j.patbio.2008.07.021; Kuo JZ, 2015, J CLIN ENDOCR METAB, V100, P3348, DOI 10.1210/jc.2015-1221; Liao HC, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-120; Liao WL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014878; Majumdar I, 2012, ENDOCRINE, V41, P442, DOI 10.1007/s12020-011-9589-4; Mao DN, 2012, CURR EYE RES, V37, P803, DOI 10.3109/02713683.2012.676700; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsuzawa Yuji, 2005, Semin Vasc Med, V5, P34, DOI 10.1055/s-2005-871744; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Omae T, 2015, INVEST OPHTH VIS SCI, V56, P4143, DOI 10.1167/iovs.15-16447; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Recasens M, 2004, Rev Med Univ Navarra, V48, P49; Shimada K, 2004, CLIN CHIM ACTA, V344, P1, DOI 10.1016/j.cccn.2004.02.020; Ucgun NI, 2020, MOL VIS, V26, P718; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Yang HS, 2014, INVEST OPHTH VIS SCI, V55, P5989, DOI 10.1167/iovs.14-14864; Yilmaz MI, 2004, EUR J ENDOCRINOL, V151, P135, DOI 10.1530/eje.0.1510135; Zaletel J, 2010, J ENDOCRINOL INVEST, V33, P514, DOI [10.1007/BF03346639, 10.3275/6811]; Zietz B, 2008, EXP CLIN ENDOCR DIAB, V116, P532, DOI 10.1055/s-2008-1058086	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2021	16	11							e0259683	10.1371/journal.pone.0259683	http://dx.doi.org/10.1371/journal.pone.0259683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2IU	34780524	Green Published, gold			2022-12-26	WOS:000755305800040
J	Akram, W; Ejaz, MB; Mallhi, TH; Sulaiman, SAB; Khan, AH				Akram, Waqas; Ejaz, Muhammad Bilal; Mallhi, Tauqeer Hussain; Sulaiman, Syed Azhar bin Syed; Khan, Amer Hayat			Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan	PLOS ONE			English	Article							FUNGAL-INFECTIONS; DIABETES-MELLITUS; GLOBAL BURDEN; TUBERCULOSIS; MANAGEMENT; DIAGNOSIS; SPECTRUM; GALACTOMANNAN; DISEASE	Background Chronic pulmonary aspergillosis (CPA) has a wide spectrum of illnesses depending on the progression of the disease and comorbid conditions. However, there is an inadequacy of investigations regarding clinical, laboratory, risk factor and prognostic data on CPA. The current study is aimed to consider the clinical manifestations, risk factors and outcomes of CPA. Methodology Retrospective records of all patients with a confirmed diagnosis of CPA who sought treatment at Gulab Devi Chest Hospital Lahore, Pakistan from January 2017 to December 2019 were evaluated. Data regarding demographics, clinical manifestations, comorbidities, radiographic and microbiological findings, length of hospital stay (LOS) and intensive care unit (ICU) admission was collected and analyzed to identify the factors associated with mortality. The independent factors associated with mortality were also identified by appropriate analyses. Results A total of 218 CPA patients were included in this study. The mean age was 45.75 6.26 years. Of these, 160 (73.4%) were male, and 65 (29.8%) had diabetes. The mean LOS was 18.5 +/- 10.9 days. The most common type of CPA was simple aspergilloma (56%) followed by chronic cavitary pulmonary aspergillosis (CCPA) (31.2%). About one half of the patients had a history of pulmonary tuberculosis (TB) and treatment response rates were low in patients with active TB. The overall mortality rate was 27.1%. ICU admission was required for 78 (35.8%) patients. Diabetes mellitus (DM), hematological malignancies and chronic kidney disease (CKD) were the common underlying conditions predicting a poor outcome. Mean LOS, hematological malignancies, consolidation and ICU admission were identified as the independent factors leading to mortality. Conclusions CPA had a significant association with TB in the majority of cases. Treatment response rates in cases with active TB were comparatively low. Cases with high mean LOS, hematological malignancies, consolidation, ICU admission, CKD and DM experienced poor outcomes. High mean LOS, hematological malignancies, consolidation and ICU stay were identified as independent risk factors for mortality. Future large prospective studies, involving aspergillus specific immunoglobulin G (IgG) antibody testing, are required for a better understanding of CPA in Pakistan.	[Akram, Waqas; Sulaiman, Syed Azhar bin Syed; Khan, Amer Hayat] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Akram, Waqas; Ejaz, Muhammad Bilal] Univ Cent Punjab, Fac Pharm, Lahore, Punjab, Pakistan; [Ejaz, Muhammad Bilal] Gulab Devi Teaching Hosp, Lahore, Pakistan; [Mallhi, Tauqeer Hussain] Jouf Univ, Coll Pharm, Dept Clin Pharm, Al Jouf, Saudi Arabia	Universiti Sains Malaysia; University of Central Punjab; Al Jouf University	Akram, W; Khan, AH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.; Akram, W (corresponding author), Univ Cent Punjab, Fac Pharm, Lahore, Punjab, Pakistan.	waqas.akram@student.usm.my; dramer@usm.my	Mallhi, Tauqeer Hussain/W-5155-2017; Khan, Amer Hayat/O-5310-2018; Khan, Yusra Habib/AFK-9024-2022	Mallhi, Tauqeer Hussain/0000-0001-9957-5362; Khan, Amer Hayat/0000-0003-4802-6181; Khan, Yusra Habib/0000-0002-9479-6147				Ader F, 2005, CLIN MICROBIOL INFEC, V11, P427, DOI 10.1111/j.1469-0691.2005.01143.x; ADEYEMO AO, 1984, THORAX, V39, P862, DOI 10.1136/thx.39.11.862; Bakula Z, 2019, INFECT GENET EVOL, V72, P16, DOI 10.1016/j.meegid.2019.02.029; BODEY G, 1992, EUR J CLIN MICROBIOL, V11, P99, DOI 10.1007/BF01967060; Bongomin F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193732; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Campbell CK, 2013, IDENTIFICATION PATHO; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; Dani A, 2014, CENT EUR J UROL, V67, P86, DOI 10.5173/ceju.2014.01.art19; Dar W, 2015, J GEN PRACTICE, V3, P2; Denning DW, 2018, EMERG INFECT DIS, V24, pE1, DOI 10.3201/eid2408.171312; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2013, EUR RESPIR J, V41, P621, DOI 10.1183/09031936.00226911; Denning DW, 2011, B WORLD HEALTH ORGAN, V89, P864, DOI 10.2471/BLT.11.089441; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; GRAHAMECLARKE CNE, 1994, RESP MED, V88, P465, DOI 10.1016/S0954-6111(05)80051-4; Iqbal N, 2020, J FUNGI, V6, DOI 10.3390/jof6020041; Iqbal N, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000155; Jabeen K, 2017, EUR J CLIN MICROBIOL, V36, P949, DOI 10.1007/s10096-017-2919-6; Jain Lakshmi R, 2006, J Infect, V52, pe133, DOI 10.1016/j.jinf.2005.08.022; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Kurosaki F, 2014, INTERNAL MED, V53, P1299, DOI 10.2169/internalmedicine.53.1578; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Lin Y, 2019, INT J TUBERC LUNG D, V23, P771, DOI 10.5588/ijtld.19.0119; Longe J.L., 2015, GALE ENCY MED; Maghrabi F, 2017, CURR FUNGAL INFECT R, V11, P242, DOI 10.1007/s12281-017-0304-7; Muldoon EG, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0276-3; Munteanu O, 2018, EUR RESP SOC; Nomellini V., 2012, J SURG RES, V173, P45; Nucci M, 2013, NEOPLASTIC DIS BLOOD, P1149; O'Malley KJ, 2005, HEALTH SERV RES, V40, P1620, DOI 10.1111/j.1475-6773.2005.00444.x; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Oladele RO, 2017, INT J TUBERC LUNG D, V21, P1056, DOI 10.5588/ijtld.17.0060; Page ID, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01184-2018; Patterson TF, 2000, MEDICINE, V79, P250, DOI 10.1097/00005792-200007000-00006; Prattes J., 2019, DIAGNOSTIC APPROACHE; Salzer HJF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02223; Sepehri Z., 2010, IS PULMONARY ASPERGI; Sherif R, 2010, CURR OPIN PULM MED, V16, P242, DOI 10.1097/MCP.0b013e328337d6de; Shin B, 2014, J INFECTION, V68, P494, DOI 10.1016/j.jinf.2014.01.005; Singh Urvinder Pal, 2013, Indian J Tuberc, V60, P55; Smith NL, 2011, EUR RESPIR J, V37, P865, DOI 10.1183/09031936.00054810; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Takazono T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01810; Thompson GR., 2008, SEMIN RESP CRIT CARE; Urabe N, 2017, J CLIN MICROBIOL, V55, P1738, DOI 10.1128/JCM.02497-16; Uzunhan Y, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02396-2016; Ved P, 2014, INT J MED RES HEALTH, V3, P92, DOI 10.5958/j.2319-5886.3.1.019	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259766	10.1371/journal.pone.0259766	http://dx.doi.org/10.1371/journal.pone.0259766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767589	Green Published, gold			2022-12-26	WOS:000755249300042
J	Arora, C; Kaur, D; Naorem, LD; Raghava, GPS				Arora, Chakit; Kaur, Dilraj; Naorem, Leimarembi Devi; Raghava, Gajendra P. S.			Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway	PLOS ONE			English	Article							HUMAN PROTEIN ATLAS; BRAF MUTATIONS; CANCER; METASTASIS	Aberrant expressions of apoptotic genes have been associated with papillary thyroid carcinoma (PTC) in the past, however, their prognostic role and utility as biomarkers remains poorly understood. In this study, we analysed 505 PTC patients by employing Cox-PH regression techniques, prognostic index models and machine learning methods to elucidate the relationship between overall survival (OS) of PTC patients and 165 apoptosis related genes. It was observed that nine genes (ANXA1, TGFBR3, CLU, PSEN1, TNFRSF12A, GPX4, TIMP3, LEF1, BNIP3L) showed significant association with OS of PTC patients. Five out of nine genes were found to be positively correlated with OS of the patients, while the remaining four genes were negatively correlated. These genes were used for developing risk prediction models, which can be utilized to classify patients with a higher risk of death from the patients which have a good prognosis. Our voting-based model achieved highest performance (HR = 41.59, p = 3.36x10(-4), C = 0.84, logrank-p = 3.8x10(-8)). The performance of voting-based model improved significantly when we used the age of patients with prognostic biomarker genes and achieved HR = 57.04 with p = 10(-4) (C = 0.88, logrank-p = 1.44x10(-9)). We also developed classification models that can classify high risk patients (survival <= 6 years) and low risk patients (survival > 6 years). Our best model achieved AUROC of 0.92. Further, the expression pattern of the prognostic genes was verified at mRNA level, which showed their differential expression between normal and PTC samples. Also, the immunostaining results from HPA validated these findings. Since these genes can also be used as potential therapeutic targets in PTC, we also identified potential drug molecules which could modulate their expression profile. The study briefly revealed the key prognostic biomarker genes in the apoptotic pathway whose altered expression is associated with PTC progression and aggressiveness. In addition to this, risk assessment models proposed here can help in efficient management of PTC patients.	[Arora, Chakit; Kaur, Dilraj; Naorem, Leimarembi Devi; Raghava, Gajendra P. S.] Indraprastha Inst Informat Technol Delhi, Dept Computat Biol, New Delhi, India	Indraprastha Institute of Information Technology Delhi	Raghava, GPS (corresponding author), Indraprastha Inst Informat Technol Delhi, Dept Computat Biol, New Delhi, India.	raghava@iiitd.ac.in	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022	Raghava, Gajendra P.S./0000-0002-8902-2876; Arora, Chakit/0000-0001-8613-0647				Abbott KL, 2015, NUCLEIC ACIDS RES, V43, pD844, DOI 10.1093/nar/gku770; Are C, 2006, ANN SURG ONCOL, V13, P453, DOI 10.1245/ASO.2006.05.042; Arora C, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04811; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bajbouj K, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818764470; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bhalla S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231629; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Carrillo JF, 2000, OTOLARYNG HEAD NECK, V122, P917, DOI 10.1016/S0194-5998(00)70025-8; Chang YS, 2018, ENDOCR PATHOL, V29, P324, DOI 10.1007/s12022-018-9543-6; Charles EM, 2014, MOL CELL ONCOL, V1, DOI 10.4161/23723548.2014.964037; Chaudharyl K, 2018, CLIN CANCER RES, V24, P1248, DOI 10.1158/1078-0432.CCR-17-0853; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Dhall A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00221; Ding LX, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01199-7; Ding Z, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.03.010; Dong TY, 2017, ONCOL REP, V38, P1287, DOI 10.3892/or.2017.5777; Dyrskjot L, 2017, EUR UROL, V72, P461, DOI 10.1016/j.eururo.2017.05.040; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; Fuzio P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1348-0; Gu Y, 2019, BIOFACTORS, V45, P902, DOI 10.1002/biof.1561; Gugnoni M, 2017, ONCOGENE, V36, P667, DOI 10.1038/onc.2016.237; Kauffmann RM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4181-4; Kaur D, 2021, MOL DIAGN THER, V25, P629, DOI 10.1007/s40291-021-00539-1; Kaur D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00071; Kazaure HS, 2018, CURR OPIN ENDOCRINOL, V25, P330, DOI 10.1097/MED.0000000000000430; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lathwal A, 2020, J CANCER RES CLIN, V146, P2743, DOI 10.1007/s00432-020-03318-3; Lathwal A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217527; Li P, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011839; Li XY, 2019, INT J GENOMICS, V2019, DOI 10.1155/2019/5894926; Lian M, 2020, ONCOL LETT, V19, P3634, DOI 10.3892/ol.2020.11530; Liu YQ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01433; LiVolsi VA, 2011, MODERN PATHOL, V24, pS1, DOI 10.1038/modpathol.2010.129; Luo J, 2019, FUTURE ONCOL, V15, P1303, DOI 10.2217/fon-2018-0885; Ma LF, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.04.004; Mao YS, 2016, ENDOCR-RELAT CANCER, V23, P313, DOI 10.1530/ERC-15-0445; Marques O, 2014, CANCER LETT, V347, P1, DOI 10.1016/j.canlet.2014.01.029; McCann JC, 2011, FASEB J, V25, P1793, DOI 10.1096/fj.11-180885; Musa A, 2018, BRIEF BIOINFORM, V19, P506, DOI 10.1093/bib/bbw112; Nagpal G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42851; Nakano T, 2020, ANTICANCER RES, V40, P1007, DOI 10.21873/anticanres.14035; Pandya V, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2654-2; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Pomaznoy M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2533-3; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Qiu J, 2018, BIOL RES, V51, DOI 10.1186/s40659-018-0188-1; Reyes I, 2019, CANCER BIOMARK, V24, P71, DOI 10.3233/CBM-181758; Rinner B, 2004, ANTICANCER RES, V24, P495; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shen YJ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9710421; Shinwari Z, 2008, J NEURO-ONCOL, V87, P123, DOI 10.1007/s11060-007-9502-4; Singh H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2082-y; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Soares P, 2014, VIRCHOWS ARCH, V464, P333, DOI 10.1007/s00428-013-1521-2; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Todorovic L, 2018, MED ONCOL, V35, DOI 10.1007/s12032-017-1066-3; Tuttle RM, 2017, THYROID, V27, P751, DOI 10.1089/thy.2017.0102; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; van der Net JB, 2009, AM J CARDIOL, V103, P375, DOI 10.1016/j.amjcard.2008.09.093; Wang SH, 2001, THYROID, V11, P725, DOI 10.1089/10507250152484556; Wang SH., 2006, COMPREHENSIVE GUIDE, VSecond, P55, DOI [10.1007/978-1-59259-995-0_6, DOI 10.1007/978-1-59259-995-0_6]; Wang YZ, 2018, CANCER MED-US, V7, P5632, DOI 10.1002/cam4.1806; Wei L, 2018, BIOINFORMATICS, V34, P1615, DOI 10.1093/bioinformatics/btx812; Wu MW, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00790; Yang HL, 2003, J CLIN ENDOCR METAB, V88, P763, DOI 10.1210/jc.2002-020992; Yang YJ, 2018, MED SCI MONITOR, V24, P6735, DOI 10.12659/MSM.910325; Zarkesh M, 2018, INT J ENDOCRINOL MET, V16, DOI 10.5812/ijem.56120; Zeestraten Eliane C M, 2013, Biomark Cancer, V5, P13, DOI 10.4137/BIC.S11475; Zeng SX, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5814-y; Zhao N, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00268	77	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0259534	10.1371/journal.pone.0259534	http://dx.doi.org/10.1371/journal.pone.0259534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ1NM	34767591	Green Submitted, Green Published, gold			2022-12-26	WOS:000755249300034
J	Kleinerman, A; Rosenfeld, A; Benrimoh, D; Fratila, R; Armstrong, C; Mehltretter, J; Shneider, E; Yaniv-Rosenfeld, A; Karp, J; Reynolds, CF; Turecki, G; Kapelner, A				Kleinerman, Akiva; Rosenfeld, Ariel; Benrimoh, David; Fratila, Robert; Armstrong, Caitrin; Mehltretter, Joseph; Shneider, Eliyahu; Yaniv-Rosenfeld, Amit; Karp, Jordan; Reynolds, Charles F.; Turecki, Gustavo; Kapelner, Adam			Treatment selection using prototyping in latent-space with application to depression treatment	PLOS ONE			English	Article							ANTIDEPRESSANT RESPONSE; MEDICATION ADHERENCE; PRECISION MEDICINE; TERM OUTCOMES; RATIONALE; SUBGROUPS; DISORDER; ADULTS; BLIND	Machine-assisted treatment selection commonly follows one of two paradigms: a fully personalized paradigm which ignores any possible clustering of patients; or a sub-grouping paradigm which ignores personal differences within the identified groups. While both paradigms have shown promising results, each of them suffers from important limitations. In this article, we propose a novel deep learning-based treatment selection approach that is shown to strike a balance between the two paradigms using latent-space prototyping. Our approach is specifically tailored for domains in which effective prototypes and sub-groups of patients are assumed to exist, but groupings relevant to the training objective are not observable in the non-latent space. In an extensive evaluation, using both synthetic and Major Depressive Disorder (MDD) real-world clinical data describing 4754 MDD patients from clinical trials for depression treatment, we show that our approach favorably compares with state-of-the-art approaches. Specifically, the model produced an 8% absolute and 23% relative improvement over random treatment allocation. This is potentially clinically significant, given the large number of patients with MDD. Therefore, the model can bring about a much desired leap forward in the way depression is treated today.	[Kleinerman, Akiva; Rosenfeld, Ariel; Shneider, Eliyahu] Bar Ilan Univ, Ramat Gan, Israel; [Benrimoh, David] McGill Univ, Montreal, PQ, Canada; [Benrimoh, David; Fratila, Robert; Armstrong, Caitrin; Mehltretter, Joseph; Turecki, Gustavo] Aifred Hlth, Montreal, PQ, Canada; [Yaniv-Rosenfeld, Amit] Shalvata Mental Hlth Ctr, Hod Hasharon, Israel; [Yaniv-Rosenfeld, Amit] Tel Aviv Univ, Tel Aviv, Israel; [Karp, Jordan] Univ Arizona, Tucson, AZ USA; [Reynolds, Charles F.] Univ Pittsburgh, Pittsburgh, PA USA; [Kapelner, Adam] Queens Coll, New York, NY USA	Bar Ilan University; McGill University; Tel Aviv University; Tel Aviv University; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; Queens College NY (CUNY)	Kleinerman, A (corresponding author), Bar Ilan Univ, Ramat Gan, Israel.	akiva.kleinerman@biu.ac.il		Fratila, Robert/0000-0002-3292-6233	Chief Scientist Office, Israeli Ministry of Health (CSOMOH, IL) within Era-PerMed [3000015730]; Canadian arm (ERA-Permed Vision 2020 supporting IMADAPT)	Chief Scientist Office, Israeli Ministry of Health (CSOMOH, IL) within Era-PerMed; Canadian arm (ERA-Permed Vision 2020 supporting IMADAPT)	AK and AR were supported by the Chief Scientist Office, Israeli Ministry of Health (CSOMOH, IL url: https://www.health.gov.il/English/Pages/HomePage.aspx) as part of grant #3000015730 within Era-PerMed. DB, CA, JM, RF and GT were also funded by the Canadian arm of this grant (ERA-Permed Vision 2020 supporting IMADAPT), with DB, CA, JM, RF funded via their involvement in Aifred Health, which was subcontracted to complete work as part of this grant. This was the grant which served as the primary funder of this work. The funders (the granting agencies) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arnow BA, 2015, AM J PSYCHIAT, V172, P743, DOI 10.1176/appi.ajp.2015.14020181; Beijers L, 2019, MOL PSYCHIATR, V24, P888, DOI 10.1038/s41380-019-0385-5; Benrimoh D, 2020, USING SIMULATION CTR; Benrimoh D, 2018, NIPS 17 COMPETITION; Bica I, 2021, CLIN PHARMACOL THER, V109, P87, DOI 10.1002/cpt.1907; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P91; Bridge D, 2005, KNOWL ENG REV, V20, P315, DOI 10.1017/S0269888906000567; Chen CF, 2019, ADV NEUR IN, V32; Das KK, 2008, INDIAN J MED RES, V128, P412; de la Fuente-Tomas L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210314; Demsar J, 2006, J MACH LEARN RES, V7, P1; Rodriguez JD, 2010, IEEE T PATTERN ANAL, V32, P569, DOI 10.1109/TPAMI.2009.187; Doraiswamy PM, 2020, ARTIF INTELL MED, V102, DOI 10.1016/j.artmed.2019.101753; Feczko E, 2019, TRENDS COGN SCI, V23, P584, DOI 10.1016/j.tics.2019.03.009; Freudenreich O, 2009, HARVARD REV PSYCHIAT, V17, P35, DOI 10.1080/10673220902724565; Ginsburg GS, 2018, HEALTH AFFAIR, V37, P694, DOI 10.1377/hlthaff.2017.1624; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hockenberry JM, 2019, JAMA PSYCHIAT, V76, P810, DOI 10.1001/jamapsychiatry.2019.0633; Homicsko K, 2020, CURR OPIN BIOTECH, V65, P242, DOI 10.1016/j.copbio.2020.05.002; Jaeger S, 2012, PSYCHIAT RES, V200, P83, DOI 10.1016/j.psychres.2012.03.033; Jha MK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010233; Kennedy SH, 2016, CAN J PSYCHIAT, V61, P540, DOI 10.1177/0706743716659417; Khoury MJ, 2016, JAMA-J AM MED ASSOC, V316, P1357, DOI 10.1001/jama.2016.12260; Kraus S, 2018, HAI'18: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON HUMAN-AGENT INTERACTION, P1, DOI 10.1145/3284432.3287194; Kunzel SR, 2019, P NATL ACAD SCI USA, V116, P4156, DOI 10.1073/pnas.1804597116; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lenze EJ, 2015, LANCET, V386, P2404, DOI 10.1016/S0140-6736(15)00308-6; Leuchter Andrew F, 2009, Dialogues Clin Neurosci, V11, P435; Li O, 2018, AAAI CONF ARTIF INTE, P3530; Lim T, 2013, INT J ADV COMPUTER S, V4; Marquand Andre F, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P433; McFee B., 2010, P 27 INT C MACHINE L, P775; Mehltretter J, 2018, DIFFERENTIAL TREATME; Metz C, 2020, SHOWS PROMISE ASSIST; Miller T, 2019, ARTIF INTELL, V267, P1, DOI 10.1016/j.artint.2018.07.007; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; MONTGOMERY SA, 1992, INT CLIN PSYCHOPHARM, V6, P91, DOI 10.1097/00004850-199206004-00015; Napierala Matthew A, 2012, AAOS NOW, V2012, P40, DOI [10.1002/pra2.29, DOI 10.1002/PRA2.29]; O'Donnell MR, 2017, J NATL COMPR CANC NE, V15, P926, DOI 10.6004/jnccn.2017.0116; Oberski D, 2016, HUM-COMPUT INT-SPRIN, P275, DOI 10.1007/978-3-319-26633-6_12; Papadakis GZ, 2019, BIOMED REP, V10, P215, DOI 10.3892/br.2019.1199; Pereira DG, 2015, COMMUN STAT-SIMUL C, V44, P2636, DOI 10.1080/03610918.2014.931971; Price RB, 2017, NEUROPSYCHOPHARMACOL, V42, P2623, DOI 10.1038/npp.2017.97; Quitkin FM, 2005, J CLIN PSYCHIAT, V66, P670, DOI 10.4088/JCP.v66n0601; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Rosenfeld A., 2021, APPL BIG DATA HEALTH, V23, P137, DOI [10.1016/B978-0-12-820203-6.00001-1, DOI 10.1016/B978-0-12-820203-6.00001-1]; Ross MK, 2018, ANN AM THORAC SOC, V15, P49, DOI 10.1513/AnnalsATS.201702-101OC; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2011, AM J PSYCHIAT, V168, P689, DOI 10.1176/appi.ajp.2011.10111645; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Saunders R, 2020, BEHAV RES THER, V124, DOI 10.1016/j.brat.2019.103505; Saunders R, 2016, J AFFECT DISORDERS, V197, P107, DOI 10.1016/j.jad.2016.03.011; Shalit U, 2017, PR MACH LEARN RES, V70; Shi C, 2019, ADV NEUR IN, V32; Shi Yue, 2012, P 6 ACM C REC SYST, P139, DOI DOI 10.1145/2365952.2365981; Stahl SM, 2013, STAHLS ESSENTIAL PSY; Taheri SM, 2013, STAT PAP, V54, P457, DOI 10.1007/s00362-012-0443-4; Tomlinson A, 2020, EVID-BASED MENT HEAL, V23, P52, DOI 10.1136/ebmental-2019-300118; Torrent-Fontbona F, 2019, EXPERT SYST APPL, V121, P338, DOI 10.1016/j.eswa.2018.12.036; Trivedi MH, 2016, J PSYCHIATR RES, V78, P11, DOI 10.1016/j.jpsychires.2016.03.001; Trivedi MH, 2008, PSYCHOPHARMACOL BULL, V41, P5; Webb CA, 2019, PSYCHOL MED, V49, P1118, DOI 10.1017/S0033291718001708; Winerman L, 2017, NUMBERS ANTIDEPRESSA; World Health Organization, 2020, DEPRESSION; Yao L, REPRESENTATION LEARN	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2021	16	11							e0258400	10.1371/journal.pone.0258400	http://dx.doi.org/10.1371/journal.pone.0258400			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YZ1NM	34767577	Green Published, gold			2022-12-26	WOS:000755249300009
J	Abidin, SAIZ; Paterson, IC; Hunt, S; Lambert, DW; Higginbotham, S; Pink, RC				Abidin, Siti Amalina Inche Zainal; Paterson, Ian Charles; Hunt, Stuart; Lambert, Daniel W.; Higginbotham, Samuel; Pink, Ryan Charles			Myofibroblast transdifferentiation is associated with changes in cellular and extracellular vesicle miRNA abundance	PLOS ONE			English	Article							FIBROBLASTS; CARCINOMA; MICRORNAS; FIBROSIS	Transforming growth factor-beta 1 (TGF-beta 1), a pro-fibrotic tumour-derived factor promotes fibroblast differentiation in the tumour microenvironment and is thought to contribute to the development of pro-tumourigenic cancer-associated fibroblasts (CAFs) by promoting myofibroblast differentiation. miRNA dysregulation has been demonstrated in myofibroblast transdifferentiation and CAF activation, however, their expression varies among cell types and with the method of fibroblast induction. Here, the expression profile of miRNA in human primary oral fibroblasts treated with TGF-beta 1, to derive a myofibroblastic, CAF-like phenotype, was determined compared to untreated fibroblasts. Myofibroblast transdifferentiation was determined by the expression of alpha-smooth muscle actin (alpha-SMA) and fibronectin-1 extra domain A (FN-EDA1) using quantitative real-time PCR (qRT-PCR) and western blot. The formation of stress fibres was assessed by fluorescence microscopy, and associated changes in contractility were assessed using collagen contraction assays. Extracellular vesicles (EVs) were purified by using size exclusion chromatography and ultracentrifugation and their size and concentration were determined by nanoparticle tracking analysis. miRNA expression profiling in oral fibroblasts treated with TGF-beta 1 and their extracellular vesicles was carried out using tiling low-density array cards. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) was used to perform functional and pathway enrichment analysis of target genes. In this study, TGF-beta 1 induced a myofibroblastic phenotype in normal oral fibroblasts as assessed by expression of molecular markers, the formation of stress fibres and increased contractility. TaqMan Low-Density Array (TLDA) analysis demonstrated that miR-503 and miR-708 were significantly upregulated, while miR-1276 was significantly downregulated in TGF-beta 1-treated oral fibroblasts (henceforth termed experimentally-derived CAF, eCAF). The gene functional enrichment analysis showed that the candidate miRNAs have the potential to modulate various pathways; including the Ras associated protein 1 (Rapt ), PI3K-Akt, and tumour necrosis factor (TNF) signalling pathways. In addition, altered levels of several miRNAs were detected in eCAF EV, including miR-142 and miR-222. No differences in size or abundance of EV were detected between eCAF and normal oral fibroblast (NOF). Little overlap was observed between changes in cellular and EV miRNA profiles, suggesting the possibility of selective loading of EV miRNA. The study reveals miRNA expression signature could be involved in myofibroblast transdifferentiation and the miRNA cargo of their EV, providing novel insight into the involvement of miRNA in CAF development and function.	[Abidin, Siti Amalina Inche Zainal; Paterson, Ian Charles] Univ Malaya, Fac Dent, Dept Oral & Craniofacial Sci, Kuala Lumpur, Malaysia; [Abidin, Siti Amalina Inche Zainal; Paterson, Ian Charles] Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia; [Abidin, Siti Amalina Inche Zainal; Hunt, Stuart; Lambert, Daniel W.; Higginbotham, Samuel] Univ Sheffield, Sch Clin Dent, Integrated Biosci, Sheffield, S Yorkshire, England; [Higginbotham, Samuel] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England; [Pink, Ryan Charles] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford, England	Universiti Malaya; Universiti Malaya; University of Sheffield; University of Sheffield; Oxford Brookes University	Abidin, SAIZ (corresponding author), Univ Malaya, Fac Dent, Dept Oral & Craniofacial Sci, Kuala Lumpur, Malaysia.; Abidin, SAIZ (corresponding author), Univ Malaya, Fac Dent, Oral Canc Res & Coordinating Ctr, Kuala Lumpur, Malaysia.; Abidin, SAIZ (corresponding author), Univ Sheffield, Sch Clin Dent, Integrated Biosci, Sheffield, S Yorkshire, England.	sitiamalina@um.edu.my	ABIDIN, SITI AMALINA ZAINAL/N-1496-2018; Paterson, Ian/G-8688-2011	Paterson, Ian/0000-0001-9156-401X; Pink, Ryan Charles/0000-0001-7501-558X	University of Malaya (UM), Malaysia; Ministry of Higher Education (MoHE), Malaysia; University Malaya Research Fund Assistance (BKP) [BK026-2018]	University of Malaya (UM), Malaysia(Universiti Malaya); Ministry of Higher Education (MoHE), Malaysia; University Malaya Research Fund Assistance (BKP)	SAIZA was funded by the University of Malaya (UM), Malaysia and the Ministry of Higher Education (MoHE), Malaysia. This work is part of research funded by The University Malaya Research Fund Assistance (BKP) [Grant number: BK026-2018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Caja L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051294; Chatterjee A, 2019, BRIT J CANCER, V121, P679, DOI 10.1038/s41416-019-0566-7; Dally J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091843; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Gebert LFR, 2019, NAT REV MOL CELL BIO, V20, P21, DOI 10.1038/s41580-018-0045-7; Gupta K, 2015, J CANCER RES THER, V11, P893, DOI 10.4103/0973-1482.147700; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Holdbrooks AT, 2018, J BIOL CHEM, V293, P1610, DOI 10.1074/jbc.M117.801480; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YP, 2020, BIOCHEM PHARMACOL, V180, DOI 10.1016/j.bcp.2020.114172; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kis K, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001967; Li ZH, 2018, CELL PHYSIOL BIOCHEM, V51, P610, DOI 10.1159/000495281; Liang YK, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0073-7; Luo K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022137; Mansoori B, 2019, J CELL PHYSIOL, V234, P9816, DOI 10.1002/jcp.27670; Melling GE, 2018, CARCINOGENESIS, V39, P798, DOI 10.1093/carcin/bgy032; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Nithiananthan S, 2017, J CELL BIOCHEM, V118, P878, DOI 10.1002/jcb.25767; Peacock B, 2018, J ORAL PATHOL MED, V47, P954, DOI 10.1111/jop.12781; Piersma B, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13324; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Prasad B Vikas, 2016, J Contemp Dent Pract, V17, P857; Ragni E, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12040347; Ribatti D, 2019, INFLAMM RES, V68, P241, DOI 10.1007/s00011-018-01211-x; Rodriguez P, 2019, EUR HEART J, V40, P967, DOI 10.1093/eurheartj/ehy188; Saadat S, 2021, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.588347; Shelton M, 2021, BBA-REV CANCER, V1875, DOI 10.1016/j.bbcan.2020.188456; Shen ZZ, 2017, ONCOTARGET, V8, P1290, DOI 10.18632/oncotarget.13609; Suzuki HI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071901; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Weber CE, 2015, ONCOGENE, V34, P4821, DOI 10.1038/onc.2014.410; Wei P, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1873-x; Wei YB, 2020, J CANCER, V11, P4453, DOI 10.7150/jca.44441; Wu QY, 2020, J CELL MOL MED, V24, P14339, DOI 10.1111/jcmm.16051; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xu T, 2020, J CELL MOL MED, V24, P7127, DOI 10.1111/jcmm.15119; Yang B, 2020, ONCOGENE, V39, P6529, DOI 10.1038/s41388-020-01450-5; Zhang YE, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022129; Zhou YH, 2016, J CELL MOL MED, V20, P495, DOI 10.1111/jcmm.12754	43	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2021	16	11							e0256812	10.1371/journal.pone.0256812	http://dx.doi.org/10.1371/journal.pone.0256812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ2MY	34762649	Green Published, Green Accepted			2022-12-26	WOS:000755316600003
J	Grant, BD; Anderson, CE; Alonzo, LF; Garing, SH; Williford, JR; Baughman, TA; Rivera, R; Glukhova, VA; Boyle, DS; Dewan, PK; Weigl, BH; Nichols, KP				Grant, Benjamin D.; Anderson, Caitlin E.; Alonzo, Luis F.; Garing, Spencer H.; Williford, John R.; Baughman, Ted A.; Rivera, Rafael; Glukhova, Veronika A.; Boyle, David S.; Dewan, Puneet K.; Weigl, Bernhard H.; Nichols, Kevin P.			A SARS-CoV-2 coronavirus nucleocapsid protein antigen-detecting lateral flow assay	PLOS ONE			English	Article							COVID-19	Inexpensive, simple, rapid diagnostics are necessary for efficient detection, treatment, and mitigation of COVID-19. Assays for SARS-CoV2 using reverse transcription polymerase chain reaction (RT-PCR) offer good sensitivity and excellent specificity, but are expensive, slowed by transport to centralized testing laboratories, and often unavailable. Antigen-based assays are inexpensive and can be rapidly mass-produced and deployed at point-of-care, with lateral flow assays (LFAs) being the most common format. While various manufacturers have produced commercially available SARS-Cov2 antigen LFAs, access to validated tests remains difficult or cost prohibitive in low-and middle-income countries. Herein, we present a visually read open-access LFA (OA-LFA) using commercially-available antibodies and materials for the detection of SARS-CoV-2. The LFA yielded a Limit of Detection (LOD) of 4 TCID50/swab of gamma irradiated SARS-CoV-2 virus, meeting the acceptable analytical sensitivity outlined by in World Health Organization target product profile. The open-source architecture presented in this manuscript provides a template for manufacturers around the globe to rapidly design a SARS-CoV2 antigen test.	[Grant, Benjamin D.; Anderson, Caitlin E.; Alonzo, Luis F.; Garing, Spencer H.; Baughman, Ted A.; Rivera, Rafael; Glukhova, Veronika A.; Dewan, Puneet K.; Weigl, Bernhard H.; Nichols, Kevin P.] Global Hlth Labs, Bellevue, WA 98007 USA; [Williford, John R.] Intellectual Ventures Lab, Bellevue, WA USA; [Boyle, David S.] PATH, Seattle, WA USA; [Williford, John R.] Nortis Inc, Woodinville, WA, Australia; [Nichols, Kevin P.] Amazon Dx, Seattle, WA USA	Intellectual Ventures	Grant, BD (corresponding author), Global Hlth Labs, Bellevue, WA 98007 USA.	ben.grant@ghlabs.org		Grant, Benjamin/0000-0001-7168-6474; Anderson, Caitlin/0000-0002-5324-2340				[Anonymous], 2020, SARS COV 2 ANTIGEN D; [Anonymous], 2021, VERITORTM SYSTEM RAP, P15; [Anonymous], 2020, ANTIGEN DETECTION DI; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bachman CM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256352; Bose ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166800; Cate D., 2020, ANTIBODY SCREENING R; FIND, 2021, SARS COV 2 TEST TRAC; Grant BD, 2020, ANAL CHEM, V92, P11305, DOI 10.1021/acs.analchem.0c01975; Kuppalli K, 2021, LANCET, V397, P2132, DOI 10.1016/S0140-6736(21)01121-1; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Rahimi F, 2020, ARCH MED RES, V51, P453, DOI 10.1016/j.arcmed.2020.04.008; Thornton J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2659; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	16	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0258819	10.1371/journal.pone.0258819	http://dx.doi.org/10.1371/journal.pone.0258819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758052	Green Published, gold			2022-12-26	WOS:000755112500010
J	Walczak, BE; Miller, K; Behun, MA; Sienkiewicz, L; Stokes, HH; McCabe, R; Baer, GS				Walczak, Brian E.; Miller, Kyle; Behun, Michael A.; Sienkiewicz, Lisa; Stokes, Heather Hartwig; McCabe, Ron; Baer, Geoffrey S.			Quantifying the differential functional behavior between the medial and lateral meniscus after posterior meniscus root tears	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; REPAIR; FIXATION; OUTCOMES	Meniscus tears of the knee are among the most common orthopedic knee injury. Specifically, tears of the posterior root can result in abnormal meniscal extrusion leading to decreased function and progressive osteoarthritis. Despite contemporary surgical treatments of posterior meniscus root tears, there is a low rate of healing and an incidence of residual meniscus extrusion approaching 30%, illustrating an inability to recapitulate native meniscus function. Here, we characterized the differential functional behavior of the medial and lateral meniscus during axial compression load and dynamic knee motion using a cadaveric model. We hypothesized essential differences in extrusion between the medial and lateral meniscus in response to axial compression and knee range of motion. We found no differences in the amount of meniscus extrusion between the medial and lateral meniscus with a competent posterior root (0.338mm vs. 0.235mm; p-value = 0.181). However, posterior root detachment resulted in a consistently increased meniscus extrusion for the medial meniscus compared to the lateral meniscus (2.233mm vs. 0.4705mm; p-value < 0.0001). Moreover, detachment of the posterior root of the medial meniscus resulted in an increase in extrusion at all angles of knee flexion and was most pronounced (4.00mm +/- 1.26mm) at 30-degrees of knee flexion. In contrast, the maximum mean extrusion of the lateral meniscus was 1.65mm +/- 0.97mm, occurring in full extension. Furthermore, only the medial meniscus extruded during dynamic knee flexion after posterior root detachment. Given the differential functional behaviors between the medial and lateral meniscus, these findings suggest that posterior root repair requires reducing overall meniscus extrusion and recapitulating the native functional responses specific to each meniscus.	[Walczak, Brian E.; Miller, Kyle; Behun, Michael A.; Sienkiewicz, Lisa; Stokes, Heather Hartwig; McCabe, Ron; Baer, Geoffrey S.] Univ Wisconsin, Wisconsin Inst Med Res WIMR, Adv Translat Orthoped & Med Sci ATOMS Lab, Dept Orthoped & Rehabil, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Walczak, BE (corresponding author), Univ Wisconsin, Wisconsin Inst Med Res WIMR, Adv Translat Orthoped & Med Sci ATOMS Lab, Dept Orthoped & Rehabil, Madison, WI 53715 USA.	walczak@ortho.wisc.edu		Walczak, Brian/0000-0003-2452-4215				Allaire R, 2008, J BONE JOINT SURG AM, V90A, P1922, DOI 10.2106/JBJS.G.00748; BAKER BE, 1985, AM J SPORT MED, V13, P1, DOI 10.1177/036354658501300101; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1398, DOI 10.2106/JBJS.I.00539; Berthiaume MJ, 2005, ANN RHEUM DIS, V64, P556, DOI 10.1136/ard.2004.023796; Camarda L, 2017, ARCH ORTHOP TRAUM SU, V137, P1301, DOI 10.1007/s00402-017-2739-2; Chahla J, 2019, ARTHROSCOPY, V35, P1304, DOI 10.1016/j.arthro.2019.02.010; Chernchujit Bancha, 2018, Eur J Orthop Surg Traumatol, V28, P727, DOI 10.1007/s00590-018-2138-6; Chung KS, 2018, ARTHROSCOPY, V34, P530, DOI [10.1016/j.arthro.2017.08.266, 10.1016/j.arthro.2017.09.041]; Chung KS, 2016, KNEE SURG SPORT TR A, V24, P1455, DOI 10.1007/s00167-015-3832-0; Chung KS, 2015, ARTHROSCOPY, V31, P1941, DOI 10.1016/j.arthro.2015.03.035; Daney BT, 2019, AM J SPORT MED, V47, P1591, DOI 10.1177/0363546519844250; Driban JB, 2019, ARTHRITIS RHEUMATOL, V71, P1089, DOI 10.1002/art.40826; Feucht MJ, 2015, KNEE SURG SPORT TR A, V23, P119, DOI 10.1007/s00167-014-2904-x; Forkel P, 2017, KNEE SURG SPORT TR A, V25, P403, DOI 10.1007/s00167-016-4237-4; Furumatsu T, 2019, ORTHOP TRAUMATOL-SUR, V105, P107, DOI 10.1016/j.otsr.2018.10.001; Furumatsu Takayuki, 2017, Knee Surg Relat Res, V29, P295, DOI 10.5792/ksrr.17.027; Kamatsuki Y, 2018, J ORTHOP RES, V36, P1894, DOI 10.1002/jor.23861; Kaplan DJ, 2018, KNEE SURG SPORT TR A, V26, P2826, DOI 10.1007/s00167-017-4755-8; Kim Young-Mo, 2016, Knee Surg Relat Res, V28, P147, DOI 10.5792/ksrr.2016.28.2.147; Koo JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141021; Krych AJ, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120961368; Krych AJ, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118765722; LaPrade CM, 2015, AM J SPORT MED, V43, P363, DOI 10.1177/0363546514559684; Lee DW, 2018, ORTHOP TRAUMATOL-SUR, V104, P1009, DOI 10.1016/j.otsr.2018.07.010; Mochizuki Y, 2021, EUR J ORTHOP SURG TR, V31, P1235, DOI 10.1007/s00590-021-02874-9; Okazaki Yoshiki, 2019, Knee Surg Relat Res, V31, P120, DOI 10.5792/ksrr.18.059; Pache S, 2018, ARCH BONE JT SURG-AB, V6, P250; Robinson JR, 2018, AM J SPORT MED, V46, P924, DOI 10.1177/0363546517749807; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; Steineman BD, 2019, ARTHROSCOPY, V35, P1232, DOI 10.1016/j.arthro.2018.11.041; Vrancken ACT, 2014, KNEE, V21, P1033, DOI 10.1016/j.knee.2014.08.006; Walczak BE., 2021, Dryad, DOI 10.5061/dryad.1ns1rn8v9; Wang JY, 2021, J ORTHOP SURG RES, V16, DOI 10.1186/s13018-021-02435-0; Zheng T, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/2325967121989678; Zhuo HW, 2021, AM J SPORT MED, V49, P450, DOI 10.1177/0363546520976635	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2021	16	11							e0259678	10.1371/journal.pone.0259678	http://dx.doi.org/10.1371/journal.pone.0259678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9NU	34758053	Green Published, gold			2022-12-26	WOS:000755112500024
J	Bombi, P; Salvi, D; Shuuya, T; Vignoli, L; Wassenaar, T				Bombi, Pierluigi; Salvi, Daniele; Shuuya, Titus; Vignoli, Leonardo; Wassenaar, Theo			Climate change effects on desert ecosystems: A case study on the keystone species of the Namib Desert Welwitschia mirabilis	PLOS ONE			English	Article							POTENTIAL IMPACTS; RANGE; PLANT; BIODIVERSITY; PHOTOSYNTHESIS; RESPONSES; STRESS; MODELS; FUTURE; SHIFTS	Deserts have been predicted to be one of the most responsive ecosystems to global climate change. In this study, we examine the spatial and demographic response of a keystone endemic plant of the Namib Desert (Welwitschia mirabilis), for which displacement and reduction of suitable climate has been foreseen under future conditions. The main aim is to assess the association between ongoing climate change and geographical patterns of welwitschia health, reproductive status, and size. We collected data on welwitschia distribution, health condition, reproductive status, and plant size in northern Namibia. We used ecological niche models to predict the expected geographic shift of suitability under climate change scenarios. For each variable, we compared our field measurements with the expected ongoing change in climate suitability. Finally, we tested the presence of simple geographical gradients in the observed patterns. The historically realized thermal niche of welwitschia will be almost completely unavailable in the next 30 years in northern Namibia. Expected reductions of climatic suitability in our study sites were strongly associated with indicators of negative population conditions, namely lower plant health, reduced recruitment and increased adult mortality. Population condition does not follow simple latitudinal or altitudinal gradients. The observed pattern of population traits is consistent with climate change trends and projections. This makes welwitschia a suitable bioindicator (i.e. a 'sentinel') for climate change effect in the Namib Desert ecosystems. Our spatially explicit approach, combining suitability modeling with geographic combinations of population conditions measured in the field, could be extensively adopted to identify sentinel species, and detect population responses to climate change in other regions and ecosystems.	[Bombi, Pierluigi; Vignoli, Leonardo] CNR, Inst Res Terr Ecosyst, Rome, Italy; [Salvi, Daniele] Univ Aquila, Dept Hlth Life & Environm Sci, Laquila, Italy; [Shuuya, Titus] Gobabeb Namib Res Inst, Walvis Bay, Namibia; [Vignoli, Leonardo] Univ Roma Tre, Dept Sci, Rome, Italy; [Wassenaar, Theo] Namibia Univ Sci & Technol, Dept Agr & Nat Resources Sci, Windhoek, Namibia	Consiglio Nazionale delle Ricerche (CNR); University of L'Aquila; Italfarmaco; Roma Tre University; Namibia University of Science & Technology	Bombi, P (corresponding author), CNR, Inst Res Terr Ecosyst, Rome, Italy.	pierluigi.bombi@cnr.it	Vignoli, Leonardo/F-2663-2011; Salvi, Daniele/I-6360-2013	Vignoli, Leonardo/0000-0002-1599-092X; Salvi, Daniele/0000-0002-3804-2690; Bombi, Pierluigi/0000-0002-7322-5724	Mohamed bin Zayed Species Conservation Fund [182519816]	Mohamed bin Zayed Species Conservation Fund	This study was supported by the Mohamed bin Zayed Species Conservation Fund (www.speciesconservation.org) to PB (Project N 182519816).; We wish to thank our Himba guides and friends Riatunga Koruhama and Mavekaumba Tjiposa; Karen Nott of IRDNC, who facilitated access to the area; Vera De Cauwer of the SCIONA project (EuropeAid/156423/DD/ACT/Multi), for the constructive collaboration. We are also grateful to the Okondjombo Communal Conservancy.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Bachelet D, 2016, J ARID ENVIRON, V127, P17, DOI 10.1016/j.jaridenv.2015.10.003; Belsley D. A., 1991, Computer Science in Economics and Management, V4, P33; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Blach-Overgaard A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12611; Bombi P, 2018, J ARID LAND, V10, P663, DOI 10.1007/s40333-018-0067-1; Bombi P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189468; BORNMAN CH, 1972, ENDEAVOUR, V31, P95; Breiman L., 2001, MACH LEARN, V45, P5; Bubenzer O., 2004, DIGITAL ATLAS NAMIBI; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Cristofari R, 2018, NAT CLIM CHANGE, V8, P245, DOI 10.1038/s41558-018-0084-2; Diaz FP, 2019, GLOBAL CHANGE BIOL, V25, P1733, DOI 10.1111/gcb.14583; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fei SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603055; Foden W, 2007, DIVERS DISTRIB, V13, P645, DOI 10.1111/j.1472-4642.2007.00391.x; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Ge XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141111; Getis A., 2010, HDB APPL SPATIAL ANA, P255, DOI [10.1007/978-3-642-03647-7_14, DOI 10.1007/978-3-642-03647-7_14, 10.1007/978-3-642-03647-7]; Giess W., 1969, FIL DINTERIA, P1; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 1996, NULL MODELS ECOLOGY; HARVEY PH, 1983, ANNU REV ECOL SYST, V14, P189, DOI 10.1146/annurev.es.14.110183.001201; Hastie T., 1986, STAT SCI, V1, P297; Henschel JR, 2000, PLANT ECOL, V150, P7, DOI 10.1023/A:1026512608982; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Huntley B, 2012, DIVERS DISTRIB, V18, P769, DOI 10.1111/j.1472-4642.2012.00890.x; IDSO SB, 1982, AGR METEOROL, V27, P27, DOI 10.1016/0002-1571(82)90016-4; Iknayan KJ, 2018, P NATL ACAD SCI USA, V115, P8597, DOI 10.1073/pnas.1805123115; Jacobson KM, 2003, J HERED, V94, P212, DOI 10.1093/jhered/esg051; KERS LARS E., 1967, SVENSK BOT TIDSKR, V61, P97; KHOSHOO TN, 1963, CHROMOSOMA, V14, P522, DOI 10.1007/BF00321471; Kirchhof S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2033; Larcher W., 1995, PHYSL PLANT ECOLOGY; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; McCullagh P, 1989, GEN LINEAR MODELS; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Menzies IJ, 2016, J ECOL, V104, P104, DOI 10.1111/1365-2745.12494; Midgley GF, 2007, J ARID ENVIRON, V70, P615, DOI 10.1016/j.jaridenv.2006.11.020; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Midgley GF, 2015, NAT CLIM CHANGE, V5, P823, DOI [10.1038/NCLIMATE2753, 10.1038/nclimate2753]; Midgley GF, 2011, REG ENVIRON CHANGE, V11, pS127, DOI 10.1007/s10113-010-0191-8; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearman PB, 2010, ECOGRAPHY, V33, P990, DOI 10.1111/j.1600-0587.2010.06443.x; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; R Core Team, 2020, R LANG ENV STAT COMP; Revermann R., 2018, BIODIVERS ECOL; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ripley B. D., 1996, PATTERN RECOGNITION; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Roskov Y, 2019, ANN CHECKLIST; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salguero-Gomez R, 2012, PHILOS T R SOC B, V367, P3100, DOI 10.1098/rstb.2012.0074; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Schoeneweiss D. F., 1978, Water Deficits and Plant Growth. Volume V. Water and Plant Disease, P61; Shuuya T., 2016, INVESTIGATING ENV AN; Smith SD, 2000, NATURE, V408, P79, DOI 10.1038/35040544; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thuiller W., 2014, PACKAGE BIOMOD2 ENSE; Tielborger K, 2014, PROG BOT, V75, P377, DOI 10.1007/978-3-642-38797-5_12; Vale CG, 2015, GLOB ECOL CONSERV, V4, P369, DOI 10.1016/j.gecco.2015.07.012; VanDerWal J, 2013, NAT CLIM CHANGE, V3, P239, DOI [10.1038/nclimate1688, 10.1038/NCLIMATE1688]; von Willert DJ, 2005, FUNCT PLANT BIOL, V32, P389, DOI 10.1071/FP01241; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WorldClim global climate data, 2016, DATA FUT COND	78	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259767	10.1371/journal.pone.0259767	http://dx.doi.org/10.1371/journal.pone.0259767			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748593	gold, Green Published			2022-12-26	WOS:000755468000054
J	Bulut, G; Oytun, MG; Almuradova, E; Harman, M; Uslu, R; Karabulut, B				Bulut, Gulcan; Oytun, Merve Guner; Almuradova, Elvina; Harman, Mustafa; Uslu, Ruchan; Karabulut, Bulent			Contribution of "complete response to treatment" to survival in patients with unresectable metastatic colorectal cancer: A retrospective analysis	PLOS ONE			English	Article							BONE-MARROW METASTASIS; CHEMOTHERAPY; RESECTION; PLUS; TRIAL; KRAS	Background The aim of the study is to reveal the contribution of complete response (CR) to treatment to overall survival (OS) in patients with unresectable metastatic colorectal cancer. In addition, to evaluate progression-free survival (PFS) in patients who attained CR to treatment and to examine the clinicopathologic features of the patient group with CR. Methods This article is a retrospective chart review. Patients diagnosed with metastatic colorectal cancer were divided into two groups. The systemic treatment was compared with the patients who received a full response according to the Response Evaluation Criteria in Solid Tumors (RECIST1.1) and those who did not attain CR (progression partial response and stable response) in terms of both PFS and OS data, and the effect of attaining CR to treatment on prognosis was evaluated. Results A total of 222 patients were included in the study. 202 of 222 patients could be evaluated in terms of complete response. All data from their files were tabulated and analyzed retrospectively. The mean age of diagnosis of the study group was 60.13 12.52 years. The total number of patients who attained CR to treatment was 31 (15.3%); 171 (84.6%) patients did not attain CR. Patients who had a CR had longer median PFS times than patients who did not have a CR (15.2 vs. 7.4 months, P<0.001). Patients who had CR had longer median survival times than patients who did not have a CR (39.2 vs. 16.9 months, P<0.001). In subgroup patients who underwent primary surgery, the number of patients who attained CR was statistically higher compared with the number of patients who did not attain CR (p<0.001). Complete response was less common in the presence of liver metastasis and bone metastasis (p = 0.041 and p = 0.046, respectively), had a negative prognostic effect. In other words, 89.1% of patients with liver metastasis, 100.0% of patients with bone metastasis, and 88.7% of those who died did not have a CR to the treatment. According to multivariate analysis, CR to treatment, primary surgery, first-line chemotherapy (combination compared with fluoropyrimidine), and no bone metastasis were found to be predictors for OS. Conclusion Providing CR with systemic treatment in patients with unresectable metastatic colorectal cancer (mCRC) contributes to prognosis. The primary resection in our secondary acquisitions from the study, the number of metastatic regions and the combination therapy regimens also contributed to the prognosis.	[Bulut, Gulcan] Defne Hosp, Div Med Oncol, Antakya, Hatay, Turkey; [Oytun, Merve Guner] Hacettepe Univ, Dept Internal Med, Div Geriatr Med, Med Sch, Ankara, Turkey; [Almuradova, Elvina; Karabulut, Bulent] Ege Univ, Dept Internal Med, Div Med Oncol, Med Sch, Izmir, Turkey; [Harman, Mustafa] Ege Univ, Dept Radiol, Med Sch, Izmir, Turkey; [Uslu, Ruchan] Celal Bayar Univ, Dept Internal Med, Div Med Oncol, Med Sch, Manisa, Turkey	Defne Hospital; Hacettepe University; Ege University; Ege University; Celal Bayar University	Bulut, G (corresponding author), Defne Hosp, Div Med Oncol, Antakya, Hatay, Turkey.	gulcanbulut07@gmail.com	; Uslu, Ruchan/C-6855-2008	Guner, Merve/0000-0002-7417-5415; Uslu, Ruchan/0000-0002-9584-6134; Bulut, Gulcan/0000-0001-7382-0972				Arslan C, 2015, EXPERT REV GASTROENT, V9, P727, DOI 10.1586/17474124.2015.1025053; Cashin PH, 2012, EJSO-EUR J SURG ONC, V38, P509, DOI 10.1016/j.ejso.2012.03.001; D'Angelica MI, 2015, ANN SURG, V261, P353, DOI 10.1097/SLA.0000000000000614; DAngelica M, 1997, J AM COLL SURGEONS, V185, P554; Davis LE, 2018, AM J MANAG CARE, V24, pS107; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Hamers PAH, 2021, INT J CANCER, V148, P296, DOI 10.1002/ijc.33200; Kim TW, 2016, BRIT J CANCER, V115, P1206, DOI 10.1038/bjc.2016.309; Lieu CH, 2014, J CLIN ONCOL, V32, P2975, DOI 10.1200/JCO.2013.54.9329; Mocellin S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006875.pub3; Modest DP, 2018, EUR J CANCER, V88, P77, DOI 10.1016/j.ejca.2017.10.028; Nakamura S, 2017, ONCOTARGETS THER, V10, P1143, DOI 10.2147/OTT.S129275; Network NCC, 2019, COL CANC VERS 1 2019; Price TJ, 2014, LANCET ONCOL, V15, pE582, DOI 10.1016/S1470-2045(14)70401-2; Rogers JE, 2019, EXPERT OPIN PHARMACO, V20, P2139, DOI 10.1080/14656566.2019.1657826; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; 't Lam-Boer J, 2016, INT J CANCER, V139, P2082, DOI 10.1002/ijc.30240; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Vogel A, 2018, INNOV SURG SCI, V3, P127, DOI 10.1515/iss-2018-0012	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2021	16	11							e0259622	10.1371/journal.pone.0259622	http://dx.doi.org/10.1371/journal.pone.0259622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YZ4ST	34748587	Green Published, gold			2022-12-26	WOS:000755468000041
J	Balicki, I; Goleman, M; Balicka, A				Balicki, Ireneusz; Goleman, Malgorzata; Balicka, Agnieszka			Ocular abnormalities in Polish Hunting Dogs	PLOS ONE			English	Article							RETINAL DEGENERATION SYNDROME	This study aimed to describe and determine the prevalence of ocular abnormalities in Polish Hunting Dogs. The study was conducted with 193 Polish Hunting Dogs: 101 female and 92 male animals, aged between 3 months and 12 years. Ophthalmic examinations were performed using slit lamp biomicroscopy, ophthalmoscopy, and tonometry based on the ophthalmological protocol for the examination of hereditary eye diseases. Spectral-domain optical coherence tomography (SD-OCT) was performed for dogs with sudden acquired retinal degeneration syndrome (SARDS) and progressive retinal atrophy (PRA), while electroretinography was also performed in dogs with SARDS. Five dogs (2.6%) were diagnosed with cataract, iris coloboma in 3 dogs (1.6%), ocular dermoid in 1 dog (0.5%), and retinal dysplasia, distichiasis and entropion in 1 dog (1%). Three dogs (1.6%) were diagnosed with PRA and SARDS occurred in 1 dog. Retinal lesions was observed in 16 dogs (8.3%). The clinical signs of retinopathy observed in Polish Hunting Dogs included discoloration of the tapetal fundus, patchy increased reflectivity in the region of discoloration, focus of hyperpigmentation and an area of tapetal hyper-reflectivity with a pigmented center. SD-OCT performed in the 3 dogs with PRA revealed alteration in the retinal layers, which was most advanced in the non-tapetal fundus. Although SD-OCT revealed retinal layers with normal architecture only in some parts of the dorsal, nasal and temporal regions in dogs with SARDS, areas of disorganized external limiting membrane, myeloid zone, ellipsoid zone, outer photoreceptor segment and interdigitation zone were also observed. Polish Hunting Dogs should undergo periodic ophthalmological examination for the evaluation of other hereditary eye diseases. The prevalence of retinal lesions in Polish Hunting Dogs requires further research.	[Balicki, Ireneusz] Univ Life Sci Lublin, Fac Vet Med, Dept & Clin Anim Surg, Lublin, Poland; [Goleman, Malgorzata] Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Dept Anim Ethol & Wildlife Management, Lublin, Poland; [Balicka, Agnieszka] Univ Vet Med & Pharm Kosice, Small Anim Clin, Kosice, Slovakia	University of Life Sciences in Lublin; University of Life Sciences in Lublin; University of Veterinary Medicine Kosice	Goleman, M (corresponding author), Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Dept Anim Ethol & Wildlife Management, Lublin, Poland.	malgorzata.goleman@up.lublin.pl						Acland GM., 1984, T AM COLL VET OPHTHA, V15, P86; Acland GM., 1986, T AM COLL VET OPHTHA, V17, P58; Balicki I., PENDING PUBLICATION; Balicki I, 2013, VET OPHTHALMOL, V16, P397, DOI 10.1111/vop.12007; Bedford P., 2006, 2006 World Congress Proceedings. 31st World Small Animal Association Congress, 12th European Congress FECAVA, & 14th Czech Small Animal Veterinary Association Congress, Prague, Czech Republic, 11-14 October, 2006, P609; Brabletz A, 2006, GONCZY POLSKI PIES D, P61; Genetics Committee of the American College of Veterinary Ophthalmologists, 2019, OCULAR DISORDERS PRE; Goleman M, 2019, LIVEST SCI, V229, P114, DOI 10.1016/j.livsci.2019.09.017; Grahn BH., 2007, VET OPHTHALMOL, V4th, P435; Kamierski A, 2014, ZKWP OPOLE, P20149; Kelawala DN, 2017, IRAN J VET RES, V18, P119; McLellan G. J., 2014, BSAVA manual of canine and feline ophthalmology, P322; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Narfstrom K., 2008, SLATTERS FUNDAMENTAL, V4th, P989; Narfstrom K., 2007, VET OPHTHALMOL, V4th ed, P989; Ofri R., 2008, SLATTERS FUNDAMENTAL, V4th, P347; Oh A, 2019, VET OPHTHALMOL, V22, P842, DOI 10.1111/vop.12661; Osinchuk SC, 2019, VET OPHTHALMOL, V22, P398, DOI 10.1111/vop.12602; OTOOLE D, 1992, VET REC, V130, P157, DOI 10.1136/vr.130.8.157; Sargolzaei M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P27; Stades FC., 2007, OPHTHALMOLOGY VET PR, V2nd ed; Stuckey JA, 2013, JAVMA-J AM VET MED A, V243, P1426, DOI 10.2460/javma.243.10.1426; Van der Woerdt A., 1991, PROG VET COMP OPHTHA, V1, P11	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0258636	10.1371/journal.pone.0258636	http://dx.doi.org/10.1371/journal.pone.0258636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739488	Green Published, gold			2022-12-26	WOS:000755000800007
J	Rahman, N; Xu, K; Omer, M; Budde, MD; Brown, A; Baron, CA				Rahman, Naila; Xu, Kathy; Omer, Mohammad; Budde, Matthew D.; Brown, Arthur; Baron, Corey A.			Test-retest reproducibility of in vivo oscillating gradient and microscopic anisotropy diffusion MRI in mice at 9.4 Tesla	PLOS ONE			English	Article							WATER DIFFUSION; TENSOR; BRAIN; NMR; QUANTIFICATION; ECCENTRICITY; OGSE	Background and purpose Microstructure imaging with advanced diffusion MRI (dMRI) techniques have shown increased sensitivity and specificity to microstructural changes in various disease and injury models. Oscillating gradient spin echo (OGSE) dMRI, implemented by varying the oscillating gradient frequency, and microscopic anisotropy (mu A) dMRI, implemented via tensor valued diffusion encoding, may provide additional insight by increasing sensitivity to smaller spatial scales and disentangling fiber orientation dispersion from true microstructural changes, respectively. The aims of this study were to characterize the test-retest reproducibility of in vivo OGSE and mu A dMRI metrics in the mouse brain at 9.4 Tesla and provide estimates of required sample sizes for future investigations. Methods Twelve adult C57Bl/6 mice were scanned twice (5 days apart). Each imaging session consisted of multifrequency OGSE and mu A dMRI protocols. Metrics investigated included mu A, linear diffusion kurtosis, isotropic diffusion kurtosis, and the diffusion dispersion rate (Lambda), which explores the power-law frequency dependence of mean diffusivity. The dMRI metric maps were analyzed with mean region-of-interest (ROI) and whole brain voxel-wise analysis. Bland-Altman plots and coefficients of variation (CV) were used to assess the reproducibility of OGSE and mu A metrics. Furthermore, we estimated sample sizes required to detect a variety of effect sizes. Results Bland-Altman plots showed negligible biases between test and retest sessions. ROI-based CVs revealed high reproducibility for most metrics (CVs < 15%). Voxel-wise CV maps revealed high reproducibility for <mu>A (CVs ~ 10%), but low reproducibility for OGSE metrics (CVs ~ 50%). Conclusion Most of the mu A dMRI metrics are reproducible in both ROI-based and voxel-wise analysis, while the OGSE dMRI metrics are only reproducible in ROI-based analysis. Given feasible sample sizes (10-15), mu A metrics and OGSE metrics may provide sensitivity to subtle microstructural changes (4-8%) and moderate changes (> 6%), respectively.	[Rahman, Naila; Omer, Mohammad; Baron, Corey A.] Univ Western Ontario, Ctr Funct & Metab Mapping CFMM, Robarts Res Inst, London, ON, Canada; [Rahman, Naila; Omer, Mohammad; Baron, Corey A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada; [Xu, Kathy; Brown, Arthur] Univ Western Ontario, Schulich Sch Med & Dent, Robarts Res Inst, Translat Neurosci Grp, London, ON, Canada; [Budde, Matthew D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Brown, Arthur] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Medical College of Wisconsin; Western University (University of Western Ontario)	Rahman, N (corresponding author), Univ Western Ontario, Ctr Funct & Metab Mapping CFMM, Robarts Res Inst, London, ON, Canada.; Rahman, N (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada.	nrahma25@uwo.ca		Rahman, Naila/0000-0003-1296-5240				Aggarwal M, 2020, MAGN RESON MED, V84, P1564, DOI 10.1002/mrm.28189; Aggarwal M, 2012, MAGN RESON MED, V67, P98, DOI 10.1002/mrm.22981; Albi A, 2017, HUM BRAIN MAPP, V38, P12, DOI 10.1002/hbm.23350; Alexander DC, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3841; Andersen KW, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa077; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Arbabi A, 2020, MAGN RESON MED, V83, P2197, DOI 10.1002/mrm.28083; Arezza NJJ, 2021, MAGN RESON IMAGING, V80, P132, DOI 10.1016/j.mri.2021.04.015; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Baron C, 2021, BARON LAB PULSE SEQU; Baron CA, TEST RETEST OSCILLAT; Baron CA, 2014, MAGN RESON MED, V72, P726, DOI 10.1002/mrm.24987; Baron CA, 2015, STROKE, V46, P2136, DOI 10.1161/STROKEAHA.115.008815; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 1996, MAGNET RESON MED, V36, P39, DOI 10.1002/mrm.1910360108; Bongers A, 2018, INT J RADIAT ONCOL, V102, P1014, DOI 10.1016/j.ijrobp.2017.12.280; Borsos KB, 2021, FREQUENCY TUNED BIPO; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Burcaw LM, 2015, NEUROIMAGE, V114, P18, DOI 10.1016/j.neuroimage.2015.03.061; Cheng Y, 1999, J AM CHEM SOC, V121, P7935, DOI 10.1021/ja9843324; Chuang N, 2011, NEUROIMAGE, V54, P80, DOI 10.1016/j.neuroimage.2010.07.043; Does MD, 2003, MAGN RESON MED, V49, P206, DOI 10.1002/mrm.10385; Drobnjak I, 2016, MAGN RESON MED, V75, P688, DOI 10.1002/mrm.25631; Ero C, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00084; Gao FS, 2021, J CEREBR BLOOD F MET, V41, P1240, DOI 10.1177/0271678X20944353; Gazdzinski LM, 2020, J NEUROTRAUM, V37, P1818, DOI 10.1089/neu.2020.6992; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; Harkins KD, 2021, NEUROIMAGE, V227, DOI 10.1016/j.neuroimage.2020.117619; He Y, 2021, NEUROIMAGE-CLIN, V30, DOI 10.1016/j.nicl.2021.102675; Henriques RN, 2019, MAGN RESON MED, V81, P3245, DOI 10.1002/mrm.27606; Henriques RN, 2021, EVIDENCE MICROSCOPIC, P1; Ianus A, 2018, NEUROIMAGE, V183, P934, DOI 10.1016/j.neuroimage.2018.08.034; Ianus A, 2016, NMR BIOMED, V29, P672, DOI 10.1002/nbm.3496; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jespersen SN, 2019, J MAGN RESON, V300, P84, DOI 10.1016/j.jmr.2019.01.007; Jespersen SN, 2013, NMR BIOMED, V26, P1647, DOI 10.1002/nbm.2999; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kakkar LS, 2018, NEUROIMAGE, V182, P314, DOI 10.1016/j.neuroimage.2017.07.060; Kasa LW, 2021, J MAGN RESON IMAGING, V53, P1175, DOI 10.1002/jmri.27408; Kohn MA., 2021, UCSF CTSI; Lasic S, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00011; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maekawa T, 2020, MAGN RESON IMAGING, V72, P34, DOI 10.1016/j.mri.2020.06.018; Mazzoli V, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.608549; McCunn P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215974; MITRA PP, 1995, PHYS REV B, V51, P15074, DOI 10.1103/PhysRevB.51.15074; Nilsson M, 2020, MAGN RESON MED, V83, P608, DOI 10.1002/mrm.27959; Nilsson M, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3711; Novikov DS, 2021, J NEUROSCI METH, V351, DOI 10.1016/j.jneumeth.2020.108947; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Ozarslan E, 2009, J MAGN RESON, V199, P56, DOI 10.1016/j.jmr.2009.04.002; Schachter M, 2000, J MAGN RESON, V147, P232, DOI 10.1006/jmre.2000.2203; Shahim P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11747-3; Shattuck DW, 2000, LECT NOTES COMPUT SC, V1935, P50; Shemesh N, 2016, MAGN RESON MED, V75, P82, DOI 10.1002/mrm.25901; Shemesh N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5958; Shemesh N, 2012, MAGN RESON MED, V68, P794, DOI 10.1002/mrm.23300; Shemesh N, 2011, MAGN RESON MED, V65, P1216, DOI 10.1002/mrm.22738; Siow B., 2013, DIFFUS FUNDAM, V18, P1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tetreault P, 2020, NEUROIMAGE, V210, DOI 10.1016/j.neuroimage.2020.116533; Tournier JD, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116137; van Belle G., 2018, STAT RULES THUMB, P27; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2011, MAGN RESON MED, V66, P678, DOI 10.1002/mrm.22835; Vos SB, 2017, MAGN RESON MED, V77, P285, DOI 10.1002/mrm.26124; Westin CF, 2016, NEUROIMAGE, V135, P345, DOI 10.1016/j.neuroimage.2016.02.039; Wright D.K., 2019, SCI REP, V9, P1; Wu D, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3917; Wu D, 2014, MAGN RESON MED, V72, P1366, DOI 10.1002/mrm.25441; Xu JZ, 2021, J NEUROSCI METH, V349, DOI 10.1016/j.jneumeth.2020.109024; Xu JZ, 2021, MAGN RESON MED, V85, P748, DOI 10.1002/mrm.28454; Xu JZ, 2011, MAGN RESON IMAGING, V29, P380, DOI 10.1016/j.mri.2010.10.002; Xu XY, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01161-2; Yang G, 2018, MAGN RESON MED, V80, P507, DOI 10.1002/mrm.27043	79	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2021	16	11							e0255711	10.1371/journal.pone.0255711	http://dx.doi.org/10.1371/journal.pone.0255711			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY7XS	34739479	Green Submitted, gold, Green Published			2022-12-26	WOS:000755000800004
J	Khuntayaporn, P; Thirapanmethee, K; Kanathum, P; Chitsombat, K; Chomnawang, MT				Khuntayaporn, Piyatip; Thirapanmethee, Krit; Kanathum, Pohnvipa; Chitsombat, Kanokwan; Chomnawang, Mullika Traidej			Comparative study of phenotypic-based detection assays for carbapenemase-producing Acinetobacter baumannii with a proposed algorithm in resource-limited settings	PLOS ONE			English	Article							MODIFIED HODGE TEST; INACTIVATION METHOD; RAPID DETECTION; NP TEST; RESISTANCE	The increasing incidence of carbapenem resistance in Acinetobacter baumannii is a critical concern worldwide owing to the limitations of therapeutic alternatives. The most important carbapenem resistance mechanism for A. baumannii is the enzymatic hydrolysis mediated by carbapenemases, mostly OXA-type carbapenemases (class D) and, to a lesser extent, metallo-beta-lactamases (class B). Therefore, early and accurate detection of carbapenemase-producing A. baumannii is required to achieve the therapeutic efficacy of such infections. Many methods for carbapenemase detection have been proposed as effective tests for A. baumannii; however, none of them are officially recommended. In this study, three carbapenemase detection methods, namely, CarbaAcineto NP test, modified carbapenem inactivation method (mCIM), and simplified carbapenem inactivation method (sCIM) were evaluated for phenotypic detection of clinically isolated A. baumannii. The MICs of imipenem, meropenem, and doripenem were determined for 123 clinically isolated A. baumannii strains before performing three phenotypic detections. The overall sensitivity and specificity values were 89.09%/100% for the carbAcineto NP test, 71.82%/100% for sCIM, and 32.73%/33.13% for mCIM. CarbAcineto NP test and sCIM performed excellently (100% sensitivity) when both Class B and Class D carbapenemases were present in the same isolate. Based on the results, the combined detection method of sCIM and CarbAcineto NP test was proposed to detect carbapenemase-producing A. baumannii rather than a single assay, significantly increasing the sensitivity of detection to 98.18%. The proposed algorithm was more reliable and cost-effective than the CarbAcineto NP test alone. It can be easily applied in routine microbiology laboratories for developing countries with limited resources.	[Khuntayaporn, Piyatip; Thirapanmethee, Krit; Kanathum, Pohnvipa; Chomnawang, Mullika Traidej] Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok, Thailand; [Khuntayaporn, Piyatip; Thirapanmethee, Krit; Chomnawang, Mullika Traidej] Mahidol Univ, Fac Pharm, Antimicrobial Resistance Interdisciplinary Grp Am, Bangkok, Thailand; [Chitsombat, Kanokwan] Mahidol Univ, Biopharmaceut Sci Program, Fac Pharm, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Chomnawang, MT (corresponding author), Mahidol Univ, Fac Pharm, Dept Microbiol, Bangkok, Thailand.; Chomnawang, MT (corresponding author), Mahidol Univ, Fac Pharm, Antimicrobial Resistance Interdisciplinary Grp Am, Bangkok, Thailand.	mullika.tra@mahidol.ac.th	Khuntayaporn, Piyatip/AAC-3191-2022	Khuntayaporn, Piyatip/0000-0003-3236-8240; Chomnawang, Mullika/0000-0002-3200-9259; Kanathum, Pohnvipa/0000-0002-6861-4282				[Anonymous], 2015, M100S25 CLSI; Brown S, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2004.01016.x; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Center for Disease Control and Prevention U.S. Department of Health & Human Services, 2021, 2019 AR THREATS REP; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V28th, DOI DOI 10.1108/08876049410065598; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, VEleventh; Djuikoue IC, 2016, J INFECT DEV COUNTR, V10, P1135, DOI 10.3855/jidc.7616; Dortet L, 2014, J CLIN MICROBIOL, V52, P2359, DOI 10.1128/JCM.00594-14; European Society of Clinical Microbiology and Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing, 2017, EUCAST GUIDELINES DE; Fan SJ, 2020, INFECT DRUG RESIST, V13, P4283, DOI 10.2147/IDR.S281049; Jing XP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02391; Khuntayaporn P, 2021, ANN CLIN MICROB ANTI, V20, DOI 10.1186/s12941-021-00424-z; Literacka E, 2017, EUR J CLIN MICROBIOL, V36, P2281, DOI 10.1007/s10096-017-3062-0; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Moubareck CA, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9030119; Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852; National Antimicrobial Resistance Surveillance Thailand, 2020, ANTIMICROBIAL RESIST; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Oviano M, 2016, INT J ANTIMICROB AG, V48, P655, DOI 10.1016/j.ijantimicag.2016.08.024; Pierce VM, 2017, J CLIN MICROBIOL, V55, P2321, DOI 10.1128/JCM.00193-17; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Ramirez MS, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050720; Simner PJ, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01369-17; Vu TN, 2020, ANN LAB MED, V40, P21, DOI 10.3343/alm.2020.40.1.21; Thirapanmethee K, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9120864; Torol S, 2013, J ENZYM INHIB MED CH, V28, P836, DOI 10.3109/14756366.2012.689296; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Vazquez-Lopez R, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9040205; Wan DP, 2020, J INFECT CHEMOTHER, V26, P636, DOI 10.1016/j.jiac.2020.02.012; WATANABE M, 1991, ANTIMICROB AGENTS CH, V35, P147, DOI 10.1128/AAC.35.1.147; WHO, 2017, WHO PUBLISHES LIST B; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259686	10.1371/journal.pone.0259686	http://dx.doi.org/10.1371/journal.pone.0259686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735533	Green Published, gold			2022-12-26	WOS:000755077100103
J	Uchiyama, Y; Sakai, H; Ando, T; Tachibana, A; Sadato, N				Uchiyama, Yuji; Sakai, Hiroyuki; Ando, Takafumi; Tachibana, Atsumichi; Sadato, Norihiro			BOLD signal response in primary visual cortex to flickering checkerboard increases with stimulus temporal frequency in older adults	PLOS ONE			English	Article							FUNCTIONAL MRI RESPONSE; CEREBRAL-BLOOD-FLOW; FIELD-OF-VIEW; LUMINANCE CONTRAST; NEGATIVE BOLD; STRIATE; OXYGEN; BRAIN; FMRI; DEGRADATION	Many older adults have difficulty seeing brief visual stimuli which younger adults can easily recognize. The primary visual cortex (V1) may induce this difficulty. However, in neuroimaging studies, the V1 response change to the increase of temporal frequency of visual stimulus in older adults was unclear. Here we investigated the association between the temporal frequency of flickering stimuli and the BOLD activity within V1 in older adults, using surface-based fMRI analysis. The fMRI data from 29 healthy older participants stimulated by contrast-reversing checkerboard at temporal flicker frequencies of 2, 4, and 8 Hz were obtained. The participants also performed a useful field of view (UFOV) test. The slope coefficient of BOLD activity regarding the temporal frequency of the visual stimulus averaged within V1 regions of interest was positive and significantly different from zero. Group analysis in the V1 showed significant clusters with positive slope and no significant clusters with a negative slope. The correlation coefficient between the slope coefficient and UFOV performance was not significant. The results indicated that V1 BOLD response to a flickering visual stimulus increases as the stimulus temporal frequency increases from 2 to 8 Hz in older adults.	[Uchiyama, Yuji; Sakai, Hiroyuki; Ando, Takafumi; Tachibana, Atsumichi] Toyota Cent Res & Dev Labs Inc, Strateg Res Div, Human Sci Res Domain, Nagakute, Aichi, Japan; [Sadato, Norihiro] Natl Inst Physiol Sci, Dept Syst Neurosci, Div Cerebral Integrat, Okazaki, Aichi, Japan; [Ando, Takafumi] Natl Inst Adv Ind Sci & Technol, Human Ctr Mobil Res Ctr, Tsukuba, Japan; [Tachibana, Atsumichi] Dokkyo Med Univ, Dept Histol & Neurobiol, Mibu, Tochigi, Japan	Toyota Central R&D Labs Inc; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institute of Advanced Industrial Science & Technology (AIST); Dokkyo Medical University	Uchiyama, Y (corresponding author), Toyota Cent Res & Dev Labs Inc, Strateg Res Div, Human Sci Res Domain, Nagakute, Aichi, Japan.	uchiyama@mosk.tytlabs.co.jp	Uchiyama, Yuji/GVS-0186-2022; Ando, Takafumi J/AAQ-8302-2020	Uchiyama, Yuji/0000-0003-1581-8668; Ando, Takafumi J/0000-0003-0357-2939				Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Ando T, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0484-6; ARTAL P, 1993, J OPT SOC AM A, V10, P1656, DOI 10.1364/JOSAA.10.001656; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bellot E, 2016, NEUROIMAGE, V139, P415, DOI 10.1016/j.neuroimage.2016.06.051; Bressler D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000410; Brodoehl S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62832-z; Buckner RL, 2000, J COGNITIVE NEUROSCI, V12, P24, DOI 10.1162/089892900564046; Chai YH, 2019, NEUROIMAGE, V197, P13, DOI 10.1016/j.neuroimage.2019.04.048; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Cliff M, 2013, CORTEX, V49, P1304, DOI 10.1016/j.cortex.2012.04.003; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Goodyear BG, 1998, J NEUROPHYSIOL, V79, P2204, DOI 10.1152/jn.1998.79.4.2204; HEMENGER RP, 1984, APPL OPTICS, V23, P1972, DOI 10.1364/AO.23.001972; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Huisingh C, 2014, J AM GERIATR SOC, V62, P123, DOI 10.1111/jgs.12594; Hutchison JL, 2014, J NEUROSCI METH, V226, P57, DOI 10.1016/j.jneumeth.2014.01.012; Iseki R., 2020, ANOVAKUN, V4.8.5; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Lindquist MA, 2009, NEUROIMAGE, V45, pS187, DOI 10.1016/j.neuroimage.2008.10.065; Mentis MJ, 1997, NEUROIMAGE, V5, P116, DOI 10.1006/nimg.1997.0256; Okada T, 2005, ACAD RADIOL, V12, P142, DOI 10.1016/j.acra.2004.11.012; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Owsley C, 2013, VISION RES, V90, P52, DOI 10.1016/j.visres.2012.11.014; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; Rosenke M, 2018, NEUROIMAGE, V170, P257, DOI 10.1016/j.neuroimage.2017.02.040; Ross MH, 1997, NEUROLOGY, V48, P173, DOI 10.1212/WNL.48.1.173; Sakai H, 2015, GERIATR GERONTOL INT, V15, P659, DOI 10.1111/ggi.12328; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; SEKULER R, 1986, J OPT SOC AM A, V3, P864, DOI 10.1364/JOSAA.3.000864; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; Vafaee MS, 1999, J CEREBR BLOOD F MET, V19, P272, DOI 10.1097/00004647-199903000-00005; Wang YC, 2005, CEREB CORTEX, V15, P403, DOI 10.1093/cercor/bhh143; West KL, 2019, NEUROIMAGE, V188, P198, DOI 10.1016/j.neuroimage.2018.12.012; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zhang J, 2008, EUR J NEUROSCI, V28, P201, DOI 10.1111/j.1460-9568.2008.06300.x	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2021	16	11							e0259243	10.1371/journal.pone.0259243	http://dx.doi.org/10.1371/journal.pone.0259243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YY9AG	34735509	gold, Green Published			2022-12-26	WOS:000755077100057
